PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kearns, JD; Hoffmann, A				Kearns, Jeffrey D.; Hoffmann, Alexander			Integrating Computational and Biochemical Studies to Explore Mechanisms in NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MATHEMATICAL-MODELS; TEMPORAL CONTROL; GENE-EXPRESSION; OSCILLATIONS; DYNAMICS; PROTEIN		[Kearns, Jeffrey D.; Hoffmann, Alexander] Univ Calif San Diego, Signaling Syst Lab, Dept Chem & Biochem, San Diego, CA 92093 USA	University of California System; University of California San Diego	Hoffmann, A (corresponding author), Univ Calif San Diego, Signaling Syst Lab, Dept Chem & Biochem, San Diego, CA 92093 USA.	ahoffmann@ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM069013, R21GM069013, R01GM072024, R01GM071573] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM71573, GM69013, R01 GM72024] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon U, 2007, INTRO SYSTEMS BIOL D; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barken D, 2005, SCIENCE, V308, DOI 10.1126/science.1107904; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Eungdamrong NJ, 2004, TRENDS CELL BIOL, V14, P661, DOI 10.1016/j.tcb.2004.10.007; Fuss H, 2005, BRIEF BIOINFORM, V6, P163, DOI 10.1093/bib/6.2.163; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ingolia NT, 2004, PLOS BIOL, V2, P805, DOI 10.1371/journal.pbio.0020123; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Laberge MA, 2005, ANN MED, V37, P130, DOI 10.1080/07853890510007304; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ng A, 2006, BRIEF BIOINFORM, V7, P318, DOI 10.1093/bib/bbl036; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Robertson SH, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-46; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319	39	25	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5439	5443		10.1074/jbc.R800008200	http://dx.doi.org/10.1074/jbc.R800008200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	18940809	hybrid, Green Published			2022-12-27	WOS:000263560600004
J	Carman, GM; Han, GS				Carman, George M.; Han, Gil-Soo			Phosphatidic Acid Phosphatase, a Key Enzyme in the Regulation of Lipid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							YEAST SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID BIOSYNTHESIS; SUBCELLULAR-LOCALIZATION; GENE-EXPRESSION; PHOSPHORYLATION; PROTEIN; TISSUE; ROLES; LIVER; GLUCOCORTICOIDS		[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health [GM-28140, GM-50679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140, R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-28140 and GM-50679 from the United States Public Health Service. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	BOU KM, 2008, J LIPID RES IN PRESS; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gowri PM, 2007, ENDOCRINOLOGY, V148, P3685, DOI 10.1210/en.2006-1728; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nanjundan M, 2003, AM J PHYSIOL-LUNG C, V284, pL1, DOI 10.1152/ajplung.00029.2002; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SMITH SW, 1957, J BIOL CHEM, V228, P915; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; VANCE DE, 1996, BIOCH LIPIDS LIPOPRO, P153; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Yao-Borengasser A, 2006, DIABETES, V55, P2811, DOI 10.2337/db05-1688; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	54	141	149	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2593	2597		10.1074/jbc.R800059200	http://dx.doi.org/10.1074/jbc.R800059200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	18812320	Green Published, hybrid			2022-12-27	WOS:000262700900001
J	Starostina, E; Xu, AG; Lin, HP; Pikielny, CW				Starostina, Elena; Xu, Aiguo; Lin, Heping; Pikielny, Claudio W.			A Drosophila Protein Family Implicated in Pheromone Perception Is Related to Tay-Sachs GM2-Activator Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ODORANT-BINDING PROTEINS; MALE COURTSHIP BEHAVIOR; MITE ALLERGEN DER-F-2; CRYSTAL-STRUCTURE; TASTE RECEPTORS; SENSITIVE NEURONS; OLFACTORY NEURONS; PSI-BLAST; MELANOGASTER; EXPRESSION	Low volatility, lipid-like cuticular hydrocarbon pheromones produced by Drosophila melanogaster females play an essential role in triggering and modulating mating behavior, but the chemosensory mechanisms involved remain poorly understood. Recently, we showed that the CheB42a protein, which is expressed in only 10 pheromone-sensing taste hairs on the front legs of males, modulates progression to late stages of male courtship behavior in response to female-specific cuticular hydrocarbons. Here we report that expression of all 12 genes in the CheB gene family is predominantly or exclusively gustatory-specific, and occurs in many different, often non-overlapping patterns. Only the Gr family of gustatory receptor genes displays a comparable variety of gustatory-specific expression patterns. Unlike Grs, however, expression of all but one CheB gene is sexually dimorphic. Like CheB42a, other CheBs may therefore function specifically in gustatory perception of pheromones. We also show that CheBs belong to the ML superfamily of lipid-binding proteins, and are most similar to human GM2-activator protein (GM2-AP). In particular, GM2-AP residues involved in ligand binding are conserved in CheBs but not in other ML proteins. Finally, CheB42a is specifically secreted into the inner lumen of pheromone-sensing taste hairs, where pheromones interact with membrane-bound receptors. We propose that CheB proteins interact directly with lipid-like Drosophila pheromones and modulate their detection by the gustatory signal transduction machinery. Furthermore, as loss of GM2-AP in Tay-Sachs disease prevents degradation of GM2 gangliosides and results in neurodegeneration, the function of CheBs in pheromone response may involve biochemical mechanisms critical for lipid metabolism in human neurons.	[Starostina, Elena; Xu, Aiguo; Lin, Heping; Pikielny, Claudio W.] Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; [Starostina, Elena; Xu, Aiguo; Lin, Heping; Pikielny, Claudio W.] Dartmouth Med Sch, Ctr Neurosci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Pikielny, CW (corresponding author), Dartmouth Med Sch, Dept Genet, Vail 604, Hanover, NH 03755 USA.	CWP@Dartmouth.edu			National Institutes of Health NIDCD [RO1DC04284, R01DC007911]; Howard Hughes Medical Institute to Dartmouth Medical School [76200-560801]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007911, R01DC004284] Funding Source: NIH RePORTER	National Institutes of Health NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute to Dartmouth Medical School(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health NIDCD Grants RO1DC04284 and R01DC007911 ( to C. W. P.). This work was also supported by Award 76200-560801 from the Biomedical Research Support Program for Medical Schools from the Howard Hughes Medical Institute to Dartmouth Medical School. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, PHEROMONES ANIMAL BE; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Berger AC, 2005, EUKARYOT CELL, V4, P1851, DOI 10.1128/EC.4.11.1851-1862.2005; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; BRAND AH, 1993, DEVELOPMENT, V118, P401; de Bruyne M, 2006, BIOESSAYS, V28, P23, DOI 10.1002/bies.20338; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; DIVIACCO S, 1992, GENE, V122, P313, DOI 10.1016/0378-1119(92)90220-J; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Huang X, 2007, DEVELOPMENT, V134, P3733, DOI 10.1242/dev.004572; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Johannessen BR, 2005, FEBS LETT, V579, P1208, DOI 10.1016/j.febslet.2004.11.115; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Mahuran DJ, 1998, BBA-LIPID LIPID MET, V1393, P1, DOI 10.1016/S0005-2760(98)00057-5; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Marcillac F, 2004, J EXP BIOL, V207, P3927, DOI 10.1242/jeb.01236; Meunier N, 2003, CHEM SENSES, V28, P671, DOI 10.1093/chemse/bjg059; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Park SK, 2000, CELL TISSUE RES, V300, P181, DOI 10.1007/s004410050059; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Pophof B, 2002, NATURWISSENSCHAFTEN, V89, P515, DOI 10.1007/s00114-002-0364-5; POSSIDENTE DR, 1989, DEV BIOL, V132, P448, DOI 10.1016/0012-1606(89)90241-8; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suzuki M, 2006, BIOCHEM BIOPH RES CO, V339, P679, DOI 10.1016/j.bbrc.2005.11.065; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; VENARD R, 1989, NEUROBIOLOGY OF SENSORY SYSTEMS, P377; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; Vosshall LB, 2008, NEURON, V59, P685, DOI 10.1016/j.neuron.2008.08.014; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wicker-Thomas C, 2007, J INSECT PHYSIOL, V53, P1089, DOI 10.1016/j.jinsphys.2007.07.003; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; Wright CS, 2004, J MOL BIOL, V342, P585, DOI 10.1016/j.jmb.2004.07.063; Wright CS, 2000, J MOL BIOL, V304, P411, DOI 10.1006/jmbi.2000.4225; Wright CS, 2005, BIOCHEMISTRY-US, V44, P13510, DOI 10.1021/bi050668w; Xu A, 2002, CELL TISSUE RES, V307, P381, DOI 10.1007/s00441-002-0524-0; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zufall F, 2007, CURR OPIN NEUROBIOL, V17, P483, DOI 10.1016/j.conb.2007.07.012	67	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					585	594		10.1074/jbc.M806474200	http://dx.doi.org/10.1074/jbc.M806474200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952610	Green Published, hybrid			2022-12-27	WOS:000261974800064
J	Downie, BR; Sanchez, A; Knotgen, H; Contreras-Jurado, C; Gymnopoulos, M; Weber, C; Stuhmer, W; Pardo, LA				Downie, Bryan R.; Sanchez, Araceli; Knoetgen, Hendrik; Contreras-Jurado, Constanza; Gymnopoulos, Marco; Weber, Claudia; Stuehmer, Walter; Pardo, Luis A.			Eag1 Expression Interferes with Hypoxia Homeostasis and Induces Angiogenesis in Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-GO-GO; GATED POTASSIUM CHANNELS; HIF-ALPHA; ETHER; CANCER; PROLIFERATION; CELLS	Ether-a-go-go-1 (Eag1) is a CNS-localized voltage-gated potassium channel that is found ectopically expressed in a majority of extracranial solid tumors. While circumstantial evidence linking Eag1 to tumor biology has been well established, the mechanisms by which the channel contributes to tumor progression remain elusive. In this study, we have used in vivo and in vitro techniques to identify a candidate mechanism. A mutation that eliminates ion permeation fails to completely abolish xenograft tumor formation by transfected cells, indicating that Eag1 contributes to tumor progression independently of its primary function as an ion channel. Our data suggest that Eag1 interferes with the cellular mechanism for maintaining oxygen homeostasis, increasing HIF-1 activity, and thereby VEGF secretion and tumor vascularization.	[Downie, Bryan R.; Sanchez, Araceli; Contreras-Jurado, Constanza; Weber, Claudia; Stuehmer, Walter; Pardo, Luis A.] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Knoetgen, Hendrik; Gymnopoulos, Marco; Pardo, Luis A.] IOnGen AG, D-37077 Gottingen, Germany	Max Planck Society	Pardo, LA (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.		Stuehmer, Walter/A-2176-2009; Pardo, Luis/C-5066-2013; Contreras-Jurado, Constanza/K-9028-2014	Stuehmer, Walter/0000-0002-0642-7764; Pardo, Luis/0000-0003-1375-4349; Contreras-Jurado, Constanza/0000-0002-4578-801X; Downie, Bryan/0000-0001-8278-722X				Arcangeli A, 2005, NOVART FDN SYMP, V266, P232, DOI [10.100210470021r12X.ch 17, DOI 10.1002/0470021R12X.CH]; Arcangeli Annarosa, 2005, V266, P225; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Conti DJ, 2004, AM J TRANSPLANT, V4, P166; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; Dubois JM, 2004, EUR BIOPHYS J BIOPHY, V33, P227, DOI 10.1007/s00249-003-0364-1; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hegle AP, 2006, P NATL ACAD SCI USA, V103, P2886, DOI 10.1073/pnas.0505909103; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Masi A, 2005, BRIT J CANCER, V93, P781, DOI 10.1038/sj.bjc.6602775; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Meyer R, 1999, J MEMBRANE BIOL, V171, P107, DOI 10.1007/s002329900563; Meyer R, 1998, J PHYSIOL-LONDON, V508, P49, DOI 10.1111/j.1469-7793.1998.049br.x; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Murata H, 2002, CANCER RES, V62, P7004; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2005, J MEMBRANE BIOL, V205, P115, DOI 10.1007/s00232-005-0776-1; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; ROUZAIREDUBOIS B, 2002, ION CHANNELS PHYSIOP, P187; Schafer WF, 2006, ANNU REV GENET, V40, P487, DOI 10.1146/annurev.genet.40.110405.090527; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; Stuhmer W, 2006, FEBS LETT, V580, P2850, DOI 10.1016/j.febslet.2006.03.062; Tomlinson VAL, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-113; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135	40	123	125	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36234	36240		10.1074/jbc.M801830200	http://dx.doi.org/10.1074/jbc.M801830200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18927085	hybrid, Green Published			2022-12-27	WOS:000261840500018
J	Clausen, JD; McIntosh, DB; Woolley, DG; Andersen, JP				Clausen, Johannes D.; McIntosh, David B.; Woolley, David G.; Andersen, Jens Peter			Critical Interaction of Actuator Domain Residues Arginine 174, Isoleucine 188, and Lysine 205 with Modulatory Nucleotide in Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED PHOSPHORYLATION LOOP; CA2+-DEPENDENT ATP HYDROLYSIS; ALKALI-METAL SALTS; CALCIUM-PUMP; FUNCTIONAL CONSEQUENCES; REACTION-MECHANISM; CRYSTAL-STRUCTURE; CATALYTIC SITE; PHOSPHOENZYME INTERMEDIATE; ADENOSINE-TRIPHOSPHATASE	ATP plays dual roles in the reaction cycle of the sarcoplasmic reticulum Ca2+-ATPase by acting as the phosphorylating substrate as well as in nonphosphorylating (modulatory) modes accelerating conformational transitions of the enzyme cycle. Here we have examined the involvement of actuator domain residues Arg(174), Ile(188), Lys(204), and Lys(205) by mutagenesis. Alanine mutations to these residues had little effect on the interaction of the Ca(2)E1 state with nucleotide or on the H(n)E2 to Ca(2)E1 transition of the dephosphoenzyme. The phosphoenzyme processing steps, Ca(2)E1P to E2P and E2P dephosphorylation, and their stimulation by MgATP/ATP were markedly affected by mutations to Arg(174), Ile(188), and Lys(205). Replacement of Ile(188) with alanine abolished nucleotide modulation of dephosphorylation but not the modulation of the Ca(2)E1P to E2P transition. Mutation to Arg(174) interfered with nucleotide modulation of either of the phosphoenzyme processing steps, indicating a significant overlap between the modulatory nucleotide-binding sites involved. Mutation to Lys(205) enhanced the rates of the phosphoenzyme processing steps in the absence of nucleotide and disrupted the nucleotide modulation of the Ca(2)E1P to E2P transition. Remarkably, the mutants with alterations to Lys(205) showed an anomalous inhibition by ATP of the dephosphorylation, and in the alanine mutant the affinity for the inhibition by ATP was indistinguishable from that for stimulation by ATP of the wild type. Hence, the actuator domain is an important player in the function of ATP as modulator of phosphoenzyme processing, with Arg(174), Ile(188), and Lys(205) all being critically involved, although in different ways. The data support a variable site model for the modulatory effects with the nucleotide binding somewhat differently in each of the conformational states occurring during the transport cycle.	[Clausen, Johannes D.; Andersen, Jens Peter] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [McIntosh, David B.; Woolley, David G.] Univ Cape Town, Fac Hlth Sci, Div Chem Pathol, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	Aarhus University; University of Cape Town	Andersen, JP (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ole Worms Alle 1185, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council; Danish National Research Foundation (PUMPKIN Centre); Novo Nordisk Foundation, Denmark; Lundbeck Foundation, Denmark; Research Foundation of Aarhus University; National Research Foundation of South Africa	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Research Foundation (PUMPKIN Centre)(Danmarks Grundforskningsfond); Novo Nordisk Foundation, Denmark(Novo Nordisk Foundation); Lundbeck Foundation, Denmark(Lundbeckfonden); Research Foundation of Aarhus University; National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported in part by grants from the Danish Medical Research Council, the Danish National Research Foundation (PUMPKIN Centre), the Novo Nordisk Foundation, Denmark, the Lundbeck Foundation, Denmark, the Research Foundation of Aarhus University (to J.P.A.), and the National Research Foundation of South Africa (to D.B.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; ARAV R, 1983, J BIOL CHEM, V258, P433; ARIKI M, 1980, BIOCHEMISTRY-US, V19, P2001, DOI 10.1021/bi00550a042; ASKARI A, 1982, BIOCHEM BIOPH RES CO, V104, P1447, DOI 10.1016/0006-291X(82)91412-7; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BISHOP JE, 1987, J BIOL CHEM, V262, P4658; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; CABLE MB, 1985, BIOCHEMISTRY-US, V24, P5612, DOI 10.1021/bi00341a049; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; Clarke RJ, 2007, BIOCHEMISTRY-US, V46, P7034, DOI 10.1021/bi700619s; Clausen JD, 2006, J BIOL CHEM, V281, P9471, DOI 10.1074/jbc.M512371200; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Clausen JD, 2001, J BIOL CHEM, V276, P35741, DOI 10.1074/jbc.M105434200; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; COLL RJ, 1991, BIOCHEMISTRY-US, V30, P1456, DOI 10.1021/bi00220a002; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DUPONT Y, 1977, EUR J BIOCHEM, V72, P185, DOI 10.1111/j.1432-1033.1977.tb11238.x; FORGE V, 1993, J BIOL CHEM, V268, P10961; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LACAPERE JJ, 1990, J BIOL CHEM, V265, P348; LACAPERE JJ, 1993, EUR J BIOCHEM, V211, P117, DOI 10.1111/j.1432-1033.1993.tb19877.x; Mahmmoud YA, 2008, P NATL ACAD SCI USA, V105, P1757, DOI 10.1073/pnas.0711838105; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh DB, 2008, BIOCHEMISTRY-US, V47, P6386, DOI 10.1021/bi800290q; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McIntosh DB, 2004, J BIOL CHEM, V279, P32515, DOI 10.1074/jbc.M403242200; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P5553, DOI 10.1021/bi00415a025; PICK U, 1982, J BIOL CHEM, V257, P6111; Reenstra WW, 2007, BIOCHEMISTRY-US, V46, P10145, DOI 10.1021/bi700991n; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1458; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; SUZUKI H, 1990, BIOCHEMISTRY-US, V29, P7040, DOI 10.1021/bi00482a013; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P7309, DOI 10.1021/bi00483a022; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762	62	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35703	35714		10.1074/jbc.M806795200	http://dx.doi.org/10.1074/jbc.M806795200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18930923	hybrid, Green Published			2022-12-27	WOS:000261687900044
J	Vacaresse, N; Moller, B; Danielsen, EM; Okada, M; Sap, J				Vacaresse, Nathalie; Moller, Bente; Danielsen, E. Michael; Okada, Masato; Sap, Jan			Activation of c-Src and Fyn Kinases by Protein-tyrosine Phosphatase RPTP alpha Is Substrate-specific and Compatible with Lipid Raft Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY KINASES; PTP-ALPHA; DOWN-REGULATION; RECEPTOR; ADHESION; PHOSPHORYLATION; CD45; MEMBRANE; PAXILLIN; CELLS	Src family tyrosine kinases (SFKs) function in multiple signaling pathways, raising the question of how appropriate regulation and substrate choice are achieved. SFK activity is modulated by several protein-tyrosine phosphatases, among which RPTP alpha and SHP2 are the best established. We studied how RPTP alpha affects substrate specificity and regulation of c-Src and Fyn in response to epidermal growth factor and platelet-derived growth factor. We find that RPTP alpha, in a growth factor-specific manner, directs the specificity of these kinases toward a specific subset of SFK substrates, particularly the focal adhesion protein Paxillin and the lipid raft scaffolding protein Cbp/PAG. A significant fraction of RPTP alpha is present in lipid rafts, where its targets Fyn and Cbp/PAG reside, and growth factor-mediated SFK activation within this compartment is strictly dependent on RPTP alpha. Forced concentration of RPTP alpha into lipid rafts is compatible with activation of Fyn. Finally, RPTP alpha-induced phosphorylation of Paxillin and Cbp/PAG induces recruitment of the SFK inhibitory kinase Csk, indicative of negative feedback loops limiting SFK activation by RPTP alpha . Our findings indicate that individual SFK-controlling PTPs play important and specific roles in dictating SFK substrate specificity and regulatory mechanism.	[Vacaresse, Nathalie; Moller, Bente; Sap, Jan] Copenhagen Bioctr, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Vacaresse, Nathalie; Moller, Bente; Sap, Jan] Univ Copenhagen, Inst Biomed Sci, DK-2200 Copenhagen N, Denmark; [Danielsen, E. Michael] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Vacaresse, Nathalie; Sap, Jan] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Osaka 5650871, Japan	University of Copenhagen; University of Copenhagen; New York University; Osaka University	Sap, J (corresponding author), Univ Paris 07, UFR Sci Vivant, UMR Epigenet & Destin Cellulaire, Batiment Lamarck,Case 7042, F-75014 Paris, France.	jan.sap@univ-paris-diderot.fr			National Cancer Institute [R01 CA87005]; Danish Cancer Society; NATIONAL CANCER INSTITUTE [R01CA087005] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danish Cancer Society(Danish Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA87005 from the National Cancer Institute. This work was also supported by funds from the Danish Cancer Society (to J.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abreu MTH, 2008, AM J PHYSIOL-CELL PH, V294, pC931, DOI 10.1152/ajpcell.00359.2007; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Brandt DT, 2003, J BIOL CHEM, V278, P34073, DOI 10.1074/jbc.M211650200; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chen X, 2001, J BIOL CHEM, V276, P34617, DOI 10.1074/jbc.M103995200; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Dalgarno D, 2006, CHEM BIOL DRUG DES, V67, P46, DOI 10.1111/j.1747-0285.2005.00316.x; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; He X, 2002, EUR J IMMUNOL, V32, P2578, DOI 10.1002/1521-4141(200209)32:9<2578::AID-IMMU2578>3.0.CO;2-3; Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.011; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Le HT, 2006, J NEUROCHEM, V98, P1798, DOI 10.1111/j.1471-4159.2006.04075.x; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Lennmyr F, 2004, ACTA NEUROL SCAND, V110, P175, DOI 10.1111/j.1600-0404.2004.00306.x; Maksumova L, 2005, J IMMUNOL, V175, P7947, DOI 10.4049/jimmunol.175.12.7947; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; TRACY S, 1995, J BIOL CHEM, V270, P10587, DOI 10.1074/jbc.270.18.10587; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Yang T, 2006, J NEUROBIOL, V66, P1420, DOI 10.1002/neu.20291; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	45	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35815	35824		10.1074/jbc.M807964200	http://dx.doi.org/10.1074/jbc.M807964200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948260	Green Published, hybrid			2022-12-27	WOS:000261687900056
J	Ishima, Y; Akaike, T; Kragh-Hansen, U; Hiroyama, S; Sawa, T; Suenaga, A; Maruyama, T; Kai, T; Otagiri, M				Ishima, Yu; Akaike, Takaaki; Kragh-Hansen, Ulrich; Hiroyama, Shuichi; Sawa, Tomohiro; Suenaga, Ayaka; Maruyama, Toru; Kai, Toshiya; Otagiri, Masaki			S-Nitrosylated Human Serum Albumin-mediated Cytoprotective Activity Is Enhanced by Fatty Acid Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; PHARMACOKINETIC ANALYSIS; LIGAND-BINDING; ISCHEMIA; PROTEINS; INJURY; NITROSOTHIOLS; REPERFUSION; CYSTEINE-34; PLASMA	Binding of oleate to S-nitrosylated human serum albumin (SNO-HSA) enhances its cytoprotective effect on liver cells in a rat ischemia/reperfusion model. It enhances the antiapoptotic effect of SNO-HSA on HepG2 cells exposed to anti-Fas antibody. To identify some of the reasons for the increased cytoprotective effects, additional experiments were performed with glutathione and HepG2 cells. As indicated by 5,5'-dithiobis-2-nitrobenzoic acid binding, the addition of oleate increased the accessibility of the single thiol group of albumin. Binding of increasing amounts of oleate resulted in increasing and more rapid S-transnitrosation of glutathione. Likewise, binding of oleate, or of a mixture of endogenous fatty acids, improved S-denitrosation of SNO-HSA by HepG2 cells. Oleate also enhanced S-transnitrosation by HepG2 cells, as detected by intracellular fluorescence of diaminofluorescein-FM. All of the S-transnitrosation caused by oleate binding was blocked by filipin III. Oleate also increased, in a dose-dependent manner, the binding of SNO-HSA labeled with fluorescein isothiocyanate to the surface of the hepatocytes. A model in two parts was worked out for S-transnitrosation, which does not involve low molecular weight thiols. Fatty acid binding facilitates S-denitrosation of SNO-HSA, increases its binding to HepG2 cells and greatly increases S-transnitrosation by hepatocytes in a way that is sensitive to filipin III. A small nitric oxide transfer takes place in a slow system, which is unaffected by fatty acid binding to SNO-HSA and not influenced by filipin III. Thus, fatty acids could be a novel type of mediator for S-transnitrosation.	[Ishima, Yu; Hiroyama, Shuichi; Suenaga, Ayaka; Maruyama, Toru; Kai, Toshiya; Otagiri, Masaki] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan; [Akaike, Takaaki; Sawa, Tomohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Kragh-Hansen, Ulrich] Univ Aarhus, Dept Med Biochem, DK-8000 Aarhus C, Denmark; [Kai, Toshiya] Nipro Corp, Pharmaceut Res Ctr, Shiga, Japan	Kumamoto University; Kumamoto University; Aarhus University; Nipro Corporation	Otagiri, M (corresponding author), 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	otagirim@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology, Japan [18390051]; Fonden af 1870	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fonden af 1870	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (JSPS), a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology (18390051), Japan, and by Fonden af 1870. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akaike T, 1997, J BIOCHEM-TOKYO, V122, P459; CHEN RF, 1967, J BIOL CHEM, V242, P173; Crane MS, 2002, J BIOL CHEM, V277, P46858, DOI 10.1074/jbc.M208608200; DASGUPTA A, 1990, CLIN PHYSIOL BIOCH, V8, P238; Dworschak M, 2004, PHARMACOLOGY, V72, P106, DOI 10.1159/000079139; Gryzunov YA, 2003, ARCH BIOCHEM BIOPHYS, V413, P53, DOI 10.1016/S0003-9861(03)00091-2; Hallstrom S, 2008, CARDIOVASC RES, V77, P506, DOI 10.1093/cvr/cvm052; Hallstrom S, 2002, CIRCULATION, V105, P3032, DOI 10.1161/01.CIR.0000018745.11739.9B; HNATOWICH DJ, 1982, INT J APPL RADIAT IS, V33, P327, DOI 10.1016/0020-708X(82)90144-2; Ikebe N, 2000, J PHARMACOL EXP THER, V295, P904; Ishima Y, 2007, BIOCHEM BIOPH RES CO, V364, P790, DOI 10.1016/j.bbrc.2007.10.094; Ishima Y, 2007, J PHARMACOL EXP THER, V320, P969, DOI 10.1124/jpet.106.114959; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; MAEDA H, 1969, J BIOCHEM-TOKYO, V65, P777, DOI 10.1093/oxfordjournals.jbchem.a129077; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Narazaki R, 1997, BBA-PROTEIN STRUCT M, V1338, P275, DOI 10.1016/S0167-4838(96)00221-X; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Pohl J, 2002, J LIPID RES, V43, P1390, DOI 10.1194/jlr.M100404-JLR200; Pohl R, 2004, P NUTR SOC, V63, P259, DOI 10.1079/PNS2004341; Ristic V, 2006, RENAL FAILURE, V28, P211, DOI 10.1080/08860220600574897; Shah CM, 2007, NITRIC OXIDE-BIOL CH, V16, P135, DOI 10.1016/j.niox.2006.08.001; SIMON DI, 1993, ARTERIOSCLER THROMB, V13, P791, DOI 10.1161/01.ATV.13.6.791; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stremmel W, 2001, LIPIDS, V36, P981, DOI 10.1007/s11745-001-0809-2; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Watanabe H, 2001, PHARMACEUT RES, V18, P1775, DOI 10.1023/A:1013391001141; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Yamasaki Y, 2002, J PHARMACOL EXP THER, V301, P467, DOI 10.1124/jpet.301.2.467	30	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34966	34975		10.1074/jbc.M807009200	http://dx.doi.org/10.1074/jbc.M807009200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940810	Green Published, hybrid			2022-12-27	WOS:000261469100053
J	Mahul-Mellier, AL; Strappazzon, F; Petiot, A; Chatellard-Causse, C; Torch, S; Blot, B; Freeman, K; Kuhn, L; Garin, J; Verna, JM; Fraboulet, S; Sadoul, R				Mahul-Mellier, Anne-Laure; Strappazzon, Flavie; Petiot, Anne; Chatellard-Causse, Christine; Torch, Sakina; Blot, Beatrice; Freeman, Kimberley; Kuhn, Loriane; Garin, Jerome; Verna, Jean-Marc; Fraboulet, Sandrine; Sadoul, Remy			Alix and ALG-2 Are Involved in Tumor Necrosis Factor Receptor 1-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA; CALCIUM CONCENTRATIONS; ENDOPLASMIC-RETICULUM; PROTEIN ALG-2; APOPTOSIS; TNF-RECEPTOR-1; INTRANUCLEAR; TRAFFICKING; ACTIVATION; AIP1/ALIX	Alix/AIP1 regulates cell death in a way involving interactions with the calcium-binding protein ALG-2 and with proteins of ESCRT((e) under bar ndosomal (s) under bar orting (c) under bar omplex (r) under bar equired for (t) under bar ransport). Using mass spectrometry we identified caspase-8 among proteins co-immunoprecipitating with Alix in dying neurons. We next demonstrated that Alix and ALG-2 interact with pro-caspase-8 and that Alix forms a complex with the TNF alpha receptor-1 (TNF-R1), depending on its capacity to bind ESCRT proteins. Thus, Alix and ALG-2 may allow the recruitment of pro-caspase-8 onto endosomes containing TNF-R1, a step thought to be necessary for activation of the apical caspase. In line with this, expression of Alix deleted of its ALG-2-binding site (Alix Delta ALG-2) significantly reduced TNF-R1-induced cell death, without affecting endocytosis of the receptor. In a more physiological setting, we found that programmed cell death of motoneurons, which can be inhibited by Alix Delta ALG-2, is regulated by TNF-R1. Taken together, these results highlight Alix and ALG-2 as new actors of the TNF-R1 pathway.	[Mahul-Mellier, Anne-Laure; Strappazzon, Flavie; Petiot, Anne; Chatellard-Causse, Christine; Torch, Sakina; Blot, Beatrice; Freeman, Kimberley; Verna, Jean-Marc; Fraboulet, Sandrine; Sadoul, Remy] INSERM, U836, Equipe 2, F-38042 Grenoble, France; [Kuhn, Loriane; Garin, Jerome] Commissariat Energie Atom, Dept Sci Vivant Lab Etud Dynam Proteomes, F-38054 Grenoble, France; [Kuhn, Loriane; Garin, Jerome] INSERM, U880, F-38054 Grenoble, France; [Mahul-Mellier, Anne-Laure; Strappazzon, Flavie; Petiot, Anne; Chatellard-Causse, Christine; Torch, Sakina; Blot, Beatrice; Freeman, Kimberley; Kuhn, Loriane; Verna, Jean-Marc; Fraboulet, Sandrine; Sadoul, Remy] Univ Grenoble 1, Grenoble Inst Neurosci, F-38042 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fraboulet, S (corresponding author), Univ Oxford, MRC Funct Genet Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England.	sandrine.fraboulet@dpag.ox.ac.uk; remy.sadoul@ujf-grenoble.fr	TORCH, sakina/N-7717-2013; FRABOULET, Sandrine/D-5046-2019; Strappazzon, Flavie/ABB-6775-2020; TORCH, SAKINA/AAC-2994-2019; Strappazzon, Flavie/K-6035-2016; FRABOULET, sandrine/H-5677-2012	FRABOULET, Sandrine/0000-0002-2651-9084; Strappazzon, Flavie/0000-0003-0285-7449; TORCH, Sakina/0000-0003-3691-4376; SADOUL, Remy/0000-0002-4763-0320; Kuhn, Lauriane/0000-0002-2637-1024; PETIOT, Anne/0000-0001-8038-470X	INSERM; University Joseph Fourier; Association Francaise contre les Myopathies; Association pour la Recherche sur la Sclerose Laterale Amyotrophique; Association pour la Recherche contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Joseph Fourier; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur la Sclerose Laterale Amyotrophique; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by INSERM, the University Joseph Fourier, and grants from the Association Francaise contre les Myopathies, the Association pour la Recherche sur la Sclerose Laterale Amyotrophique, and the Association pour la Recherche contre le Cancer. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a fellowship from the Association Francaise contre les Myopathies. Present address: Imperial College London, Experimental Medicine&Toxicology, London W120NN, UK.	Barker PA, 2002, TRENDS NEUROSCI, V25, P379, DOI 10.1016/S0166-2236(02)02199-9; BELLOMO G, 1992, CANCER RES, V52, P1342; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Draper DW, 2004, J IMMUNOL, V172, P2416, DOI 10.4049/jimmunol.172.4.2416; Ferro M, 2000, ELECTROPHORESIS, V21, P3517; Fraboulet S, 2003, GENE EXPR PATTERNS, V3, P139, DOI 10.1016/S1567-133X(03)00025-5; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; HASEGAWA Y, 1989, J IMMUNOL, V142, P2670; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kong SK, 1997, ONCOLOGY-BASEL, V54, P55; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McFarlane SM, 2000, MOL CELL BIOCHEM, V211, P19, DOI 10.1023/A:1007189911897; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; MORITA E, 2007, EMBO J, V13, P13; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Narita T, 2005, EXP CELL RES, V304, P256, DOI 10.1016/j.yexcr.2004.11.005; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Raoul C, 2000, CURR OPIN NEUROBIOL, V10, P111, DOI 10.1016/S0959-4388(99)00055-0; Sadoul R, 2006, BIOL CELL, V98, P69, DOI 10.1042/BC20050007; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sedel F, 2004, J NEUROSCI, V24, P2236, DOI 10.1523/JNEUROSCI.4464-03.2004; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Todd I, 2004, IMMUNOLOGY, V113, P65, DOI 10.1111/j.1365-2567.2004.01942.x; Trioulier Y, 2004, J BIOL CHEM, V279, P2046, DOI 10.1074/jbc.M309243200; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035	42	53	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34954	34965		10.1074/jbc.M803140200	http://dx.doi.org/10.1074/jbc.M803140200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936101	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000261469100052
J	Lin, ZH; Gao, C; Ning, YH; He, X; Wu, W; Chen, YG				Lin, Zhenghong; Gao, Chan; Ning, Yuanheng; He, Xi; Wu, Wei; Chen, Ye-Guang			The Pseudoreceptor BMP and Activin Membrane-bound Inhibitor Positively Modulates Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; BETA-CATENIN; TGF-BETA; TRANSCRIPTIONAL REGULATION; NEGATIVE REGULATOR; COLORECTAL-CANCER; CYCLIN D1; AXIN; BAMBI; EXPRESSION	The canonical Wnt/beta-catenin pathway plays a pivotal role in regulating embryogenesis and tumorigenesis by promoting cell proliferation. BAMBI (BMP and activin membrane-bound inhibitor) has previously been shown to negatively regulate the signaling activity of transforming growth factor-beta, activin, and BMP and was identified as a target of beta-catenin in colorectal and hepatocellular tumor cells. In this study, we provide evidence that BAMBI can promote the transcriptional activity of Wnt/beta-catenin signaling. Overexpression of BAMBI enhances the expression of Wnt-responsive reporters, whereas knockdown of endogenous BAMBI attenuates them. Accordingly, BAMBI also promotes the nuclear translocation of beta-catenin. BAMBI interacts with Wnt receptor Frizzled5, coreceptor LRP6, and Dishevelled2 and increases the interaction between Frizzled5 and Dishevelled2. Finally we show that BAMBI promotes the expression of c-myc and cyclin D1 and increases Wnt-promoted cell cycle progression. Altogether, our data indicate that BAMBI can function as a positive regulator of the Wnt/beta-catenin pathway to promote cell proliferation.	[Lin, Zhenghong; Gao, Chan; Ning, Yuanheng; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Lin, Zhenghong; Gao, Chan; Ning, Yuanheng; Wu, Wei; Chen, Ye-Guang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [He, Xi] Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA	Tsinghua University; Tsinghua University; Harvard University; Boston Children's Hospital; Harvard Medical School	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Gao, Chan/D-7964-2013; Chen, Ye-Guang/L-6998-2019	Lin, Zhenghong/0000-0002-6354-0042	National Natural Science Foundation of China [30430360, 30671033, 90713045]; 973 Program [2004CB720002, 2006CB943401, 2006CB910102]; 863 Program [2006AA02Z172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (Grants 30430360, 30671033, and 90713045), the 973 Program (Grants 2004CB720002, 2006CB943401, and 2006CB910102), and the 863 Program (Grant 2006AA02Z172). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Degen WGJ, 1996, INT J CANCER, V65, P460, DOI 10.1002/(SICI)1097-0215(19960208)65:4<460::AID-IJC12>3.3.CO;2-B; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Higashihori N, 2008, DEV DYNAM, V237, P1500, DOI 10.1002/dvdy.21529; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loveland KL, 2003, ENDOCRINOLOGY, V144, P4180, DOI 10.1210/en.2002-0124; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sasaki T, 2004, ONCOL REP, V11, P1219; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tsang M, 2000, GENESIS, V28, P47, DOI 10.1002/1526-968X(200010)28:2<47::AID-GENE20>3.0.CO;2-S; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603	40	46	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33053	33058		10.1074/jbc.M804039200	http://dx.doi.org/10.1074/jbc.M804039200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838381	Green Published, hybrid			2022-12-27	WOS:000261183700005
J	Saini, Y; Harkema, JR; Lapres, JJ				Saini, Yogesh; Harkema, Jack R.; Lapres, John J.			HIF1 alpha Is Essential for Normal Intrauterine Differentiation of Alveolar Epithelium and Surfactant Production in the Newborn Lung of Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; FACTOR 1-ALPHA; C/EBP-ALPHA; CELL-DEATH; MATURATION; GENE; MORPHOGENESIS; HIF-1-ALPHA; VASCULARIZATION; DEFICIENCY	Neonatal respiratory distress syndrome (RDS) is mainly the result of perturbation in surfactant production and is a common complication seen in premature infants. Normal fetal lung development and alveolar cell differentiation is regulated by a network of transcription factors. Functional loss of any of these factors will alter the developmental program and impact surfactant production and normal gas exchange. During development, the fetus is exposed to varying oxygen concentrations and must be able to quickly adapt to these changes in order to survive. Hypoxia-inducible factor 1 alpha(HIF1 alpha) is the primary transcription factor that is responsible for regulating the cellular response to changes in oxygen tension and is essential for normal development. Its role in lung maturation is not well defined and to address this knowledge gap, a lung-specific HIF1 alpha knock-out model has been developed. Loss of HIF1 alpha early in lung development leads to pups that die within hours of parturition, exhibiting symptoms similar to RDS. Lungs from these pups display impaired alveolar epithelial differentiation and an almost complete loss of surfactant protein expression. Ultrastructural analysis of lungs from HIF1 alpha deletion pups had high levels of glycogen, aberrant septal development, and decreased expression of several factors necessary for proper lung development, including HIF2 alpha, beta-catenin, and vascular endothelial growth factor. These results suggest that HIF1 alpha is essential for proper lung maturation and alteration in its normal signaling during premature delivery might explain the pathophysiology of neonatal RDS.	[Saini, Yogesh; Lapres, John J.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Saini, Yogesh; Lapres, John J.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Harkema, Jack R.] Michigan State Univ, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [Saini, Yogesh; Harkema, Jack R.; Lapres, John J.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA; [Lapres, John J.] Michigan State Univ, Natl Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University	Lapres, JJ (corresponding author), 224 Biochem Bldg, E Lansing, MI 48824 USA.	lapres@Msu.edu	Saini, Yogesh/AAM-5046-2020; saini, yogesh/D-1080-2010	saini, yogesh/0000-0002-8324-2122	National Institutes of Health [R01-ES12186, P42 ES04911-17]; Michigan Agriculture Experimental Station; Michigan State University Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004911, R01ES012186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Agriculture Experimental Station; Michigan State University Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-ES12186 and P42 ES04911-17. This work was also supported by the Michigan Agriculture Experimental Station and the Michigan State University Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asikainen TM, 2006, FASEB J, V20, P1698, DOI 10.1096/fj.06-5887fje; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cassel TN, 2000, ANN NY ACAD SCI, V923, P300; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Devriendt K, 1998, NEW ENGL J MED, V338, P1317, DOI 10.1056/NEJM199804303381817; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Groenman F, 2005, BIOL NEONATE, V87, P164, DOI 10.1159/000082595; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Liu C, 2002, AM J PHYSIOL-LUNG C, V283, pL468, DOI 10.1152/ajplung.00044.2002; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; METCALFE J, 1967, PHYSIOL REV, V47, P782, DOI 10.1152/physrev.1967.47.4.782; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Ryan HE, 2000, CANCER RES, V60, P4010; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza Gregg L, 2005, Proc Am Thorac Soc, V2, P68, DOI 10.1513/pats.200404-029MS; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL202, DOI 10.1152/ajplung.2001.281.1.L202; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Vengellur A, 2004, TOXICOL SCI, V82, P638, DOI 10.1093/toxsci/kfh278; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912	29	54	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33650	33657		10.1074/jbc.M805927200	http://dx.doi.org/10.1074/jbc.M805927200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18801745	Green Published, hybrid			2022-12-27	WOS:000261183700071
J	Karradt, A; Sobanski, J; Mattow, J; Lockau, W; Baier, K				Karradt, Anne; Sobanski, Johanna; Mattow, Jens; Lockau, Wolfgang; Baier, Kerstin			NblA, a Key Protein of Phycobilisome Degradation, Interacts with ClpC, a HSP100 Chaperone Partner of a Cyanobacterial Clp Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-7120; ADAPTER PROTEIN; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; RESPONSE REGULATOR; NITROGEN; COMPETENCE; EXPRESSION; STRESS; GENE	When cyanobacteria are starved for nitrogen, expression of the NblA protein increases and thereby induces proteolytic degradation of phycobilisomes, light-harvesting complexes of pigmented proteins. Phycobilisome degradation leads to a color change of the cells from blue-green to yellow-green, referred to as bleaching or chlorosis. As reported previously, NblA binds via a conserved region at its C terminus to the alpha-subunits of phycobiliproteins, the main components of phycobilisomes. We demonstrate here that a highly conserved stretch of amino acids in the N-terminal helix of NblA is essential for protein function in vivo. Affinity purification of glutathione S-transferase-tagged NblA, expressed in a Nostoc sp. PCC7120 mutant lacking wildtype NblA, resulted in co-precipitation of ClpC, encoded by open reading frame alr2999 of the Nostoc chromosome. ClpC is a HSP100 chaperone partner of the Clp protease. ATP-dependent binding of NblA to ClpC was corroborated by in vitro pull-down assays. Introducing amino acid exchanges, we verified that the conserved N-terminal motif of NblA mediates the interaction with ClpC. Further results indicate that NblA binds phycobiliprotein subunits and ClpC simultaneously, thus bringing the proteins into close proximity. Altogether these results suggest that NblA may act as an adaptor protein that guides a ClpC.ClpP complex to the phycobiliprotein disks in the rods of phycobilisomes, thereby initiating the degradation process.	[Karradt, Anne; Sobanski, Johanna; Lockau, Wolfgang; Baier, Kerstin] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Mattow, Jens] Max Planck Inst Infekt Biol, Immunol Abt, D-10117 Berlin, Germany	Humboldt University of Berlin; Max Planck Society	Lockau, W (corresponding author), Humboldt Univ, Inst Biol, Chausseestr 117, D-10115 Berlin, Germany.				Deutsche Forschungsgemeinschaft [LO 286/8-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Grant LO 286/8-2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; ALLEN MM, 1969, ARCH MIKROBIOL, V69, P114, DOI 10.1007/BF00409755; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; Baier K, 2001, FEMS MICROBIOL LETT, V195, P35, DOI 10.1111/j.1574-6968.2001.tb10494.x; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; BLACK TA, 1994, J BACTERIOL, V176, P2282, DOI 10.1128/JB.176.8.2282-2292.1994; BOGORAD L, 1975, ANNU REV PLANT PHYS, V26, P369, DOI 10.1146/annurev.pp.26.060175.002101; Boresch K., 1910, LOTOS, V58, P344; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Clarke AK, 1996, PLANT MOL BIOL, V31, P721, DOI 10.1007/BF00019460; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Dines M, 2008, J BIOL CHEM, V283, P30330, DOI 10.1074/jbc.M804241200; Dines M, 2007, J STRUCT BIOL, V158, P116, DOI 10.1016/j.jsb.2006.10.021; Doherty NS, 1998, ELECTROPHORESIS, V19, P355, DOI 10.1002/elps.1150190234; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; GLAZER AN, 1982, ANNU REV MICROBIOL, V36, P173, DOI 10.1146/annurev.mi.36.100182.001133; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Horwich AL, 1999, P NATL ACAD SCI USA, V96, P11033, DOI 10.1073/pnas.96.20.11033; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU RH, 1977, J BACTERIOL, V132, P771, DOI 10.1128/JB.132.3.771-778.1977; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Li H, 2002, ARCH MICROBIOL, V178, P256, DOI 10.1007/s00203-002-0446-y; Luque I, 2003, MOL MICROBIOL, V50, P1043, DOI 10.1046/j.1365-2958.2003.03768.x; Luque I, 2001, MOL MICROBIOL, V41, P937, DOI 10.1046/j.1365-2958.2001.02566.x; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MARSH JL, 1984, GENE, V32, P481, DOI 10.1016/0378-1119(84)90022-2; Mattow J, 2007, PROTEOMICS, V7, P1687, DOI 10.1002/pmic.200600928; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Persuh M, 2002, J BACTERIOL, V184, P2310, DOI 10.1128/JB.184.8.2310-2313.2002; Richaud C, 2001, J BACTERIOL, V183, P2989, DOI 10.1128/JB.183.10.2989-2994.2001; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Schwarz R, 1998, P NATL ACAD SCI USA, V95, P11008, DOI 10.1073/pnas.95.18.11008; Sendersky E, 2005, MOL MICROBIOL, V58, P659, DOI 10.1111/j.1365-2958.2005.04844.x; SHANKLIN J, 1995, PLANT CELL, V7, P1713, DOI 10.1105/tpc.7.10.1713; Shin DH, 1996, J MOL BIOL, V262, P71, DOI 10.1006/jmbi.1996.0499; SINGH SK, 1994, J BIOL CHEM, V269, P29537; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; TANDAEU DMN, 1988, METHOD ENZYMOL, V167, P318; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 2001, MOL MICROBIOL, V42, P717, DOI 10.1046/j.1365-2958.2001.02623.x; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; van Waasbergen LG, 2002, J BACTERIOL, V184, P2481, DOI 10.1128/JB.184.9.2481-2490.2002; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; WOLK CP, 1973, BACTERIOL REV, V37, P32, DOI 10.1128/MMBR.37.1.32-101.1973; YAMANAKA G, 1980, ARCH MICROBIOL, V124, P39, DOI 10.1007/BF00407026; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	74	60	61	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32394	32403		10.1074/jbc.M805823200	http://dx.doi.org/10.1074/jbc.M805823200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818204	hybrid			2022-12-27	WOS:000260893700027
J	Pata, M; Heraud, C; Vacher, J				Pata, Monica; Heraud, Celine; Vacher, Jean			OSTM1 Bone Defect Reveals an Intercellular Hematopoietic Crosstalk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; OSTEOCLAST DEVELOPMENT; A3 SUBUNIT; T-CELLS; MOUSE; GENE; MUTATIONS; MARROW; PU.1; MICE	The most severe form of bone autosomal recessive osteopetrosis both in humans and in the gray-lethal (gl/gl) mouse is caused by mutations in the Ostm1 gene. Although osteopetrosis is usually associated with a defect in the hematopoietic-derived osteoclast cells, this study determined that Ostm1 is expressed in many hematopoietic cells of the myeloid and lymphoid B- and T-lineages. Hematopoiesis in gl/gl mice is characterized by a marked expansion of the osteoclast lineage but also by deregulation of the lymphoid lineages with a decrease in B- lymphoid cell populations and altered distribution in T-lymphoid double and single CD4 CD8-positive cells. In committed gl/gl osteoclasts, specific Ostm1 transgene targeting showed a requirement of additional factors and/or cells for normal osteoclast function, and importantly, defined the gl osteopetrotic defect as non-cell autonomous. By contrast, gl/gl osteoclast, B- and T-lymphoid lineage phenotypes were rescued when Ostm1 is expressed under PU.1 regulation from a bacterial artificial chromosome transgene, which established an essential role for Ostm1 in hematopoietic cells in addition to osteoclasts. Together these experiments are the first to demonstrate the existence of hematopoietic crosstalk for the production of functional and active osteoclasts.	[Pata, Monica; Heraud, Celine; Vacher, Jean] Univ Montreal, Fac Med, Inst Rech Clin Montreal, Dept Cellular Interact & Dev, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Vacher, J (corresponding author), Univ Montreal, Fac Med, Inst Rech Clin Montreal, Dept Cellular Interact & Dev, 110 Ave Pins W, Montreal, PQ H2W 1R7, Canada.	vacherj@ircm.qc.ca		Heraud, Celine/0000-0002-9208-2335	Canadian Institutes of Health Research; National Sciences and Engineering Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research and National Sciences and Engineering Council of Canada grants (to J. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Balemans W, 2005, CALCIFIED TISSUE INT, V77, P263, DOI 10.1007/s00223-005-0027-6; Blin-Wakkach C, 2004, LEUKEMIA, V18, P1505, DOI 10.1038/sj.leu.2403449; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cao MY, 1999, J EXP MED, V190, P1527, DOI 10.1084/jem.190.10.1527; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Eapen M, 1998, BONE MARROW TRANSPL, V22, P941, DOI 10.1038/sj.bmt.1701474; Ferron M, 2005, GENESIS, V41, P138, DOI 10.1002/gene.20108; GERRITSEN EJA, 1994, J PEDIATR-US, V125, P896, DOI 10.1016/S0022-3476(05)82004-9; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Hayase Y, 1997, EXP HEMATOL, V25, P19; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; ISCOVE NN, 1974, J CELL PHYSIOL, V83, P309, DOI 10.1002/jcp.1040830218; Janssens K, 2002, HUM MOL GENET, V11, P2385, DOI 10.1093/hmg/11.20.2385; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lazner F, 1999, HUM MOL GENET, V8, P1839, DOI 10.1093/hmg/8.10.1839; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Lorenzo J, 2000, J CLIN INVEST, V106, P749, DOI 10.1172/JCI11089; Maranda B, 2008, J BONE MINER RES, V23, P296, DOI 10.1359/JBMR.071015; Menaa C, 2000, BIOCHEM BIOPH RES CO, V267, P943, DOI 10.1006/bbrc.1999.2042; Michigami T, 2002, BONE, V30, P436, DOI 10.1016/S8756-3282(01)00684-6; NILSSON SK, 1994, DEV BIOL, V164, P456, DOI 10.1006/dbio.1994.1215; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Quarello P, 2004, J BONE MINER RES, V19, P1194, DOI 10.1359/JBMR.040407; Rajapurohitam V, 2001, BONE, V28, P513, DOI 10.1016/S8756-3282(01)00416-1; REDDY SV, 1993, J BONE MINER RES, V8, P1263; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Scimeca JC, 2003, HUM MUTAT, V21, P151, DOI 10.1002/humu.10165; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; Tagaya H, 2000, BLOOD, V95, P3363, DOI 10.1182/blood.V95.11.3363.011k29_3363_3370; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; WALKER DG, 1975, SCIENCE, V190, P784, DOI 10.1126/science.1105786; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Wilson CJ, 2000, ARCH DIS CHILD, V83, P449, DOI 10.1136/adc.83.5.449; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	46	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30522	30530		10.1074/jbc.M805242200	http://dx.doi.org/10.1074/jbc.M805242200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18790735	Green Published, hybrid			2022-12-27	WOS:000260544800010
J	Bateman, RL; Rauh, D; Tavshanjian, B; Shokat, KM				Bateman, Raynard L.; Rauh, Daniel; Tavshanjian, Brandon; Shokat, Kevan M.			Human Carbonyl Reductase 1 Is an S-Nitrosoglutathione Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE-ADENINE DINUCLEOTIDE; FORMYLGLUTATHIONE HYDROLASE; REDOX STATE; RAT LIVER; DEHYDROGENASE; NITROSOTHIOLS; GLUTATHIONE; CRYSTALLOGRAPHY; DECOMPOSITION; FORMALDEHYDE	Human carbonyl reductase 1 (hCBR1) is an NADPH-dependent short chain dehydrogenase/reductase with broad substrate specificity and is thought to be responsible for the in vivo reduction of quinones, prostaglandins, and other carbonyl-containing compounds including xenobiotics. In addition, hCBR1 possesses a glutathione binding site that allows for increased affinity toward GSH-conjugated molecules. It has been suggested that the GSH-binding site is near the active site; however, no structures with GSH or GSH conjugates have been reported. We have solved the x-ray crystal structures of hCBR1 and a substrate mimic in complex with GSH and the catalytically inert GSH conjugate hydroxymethylglutathione (HMGSH). The structures reveal the GSH-binding site and provide insight into the affinity determinants for GSH-conjugated substrates. We further demonstrate that the structural isostere of HMGSH, S-nitrosoglutathione, is an ideal hCBR1 substrate (K-m = 30 mu M, k(cat) = 450 min(-1)) with kinetic constants comparable with the best known hCBR1 substrates. Furthermore, we demonstrate that hCBR1 dependent GSNO reduction occurs in A549 lung adenocarcinoma cell lysates and suggest that hCBR1 may be involved in regulation of tissue levels of GSNO.	[Bateman, Raynard L.; Rauh, Daniel; Tavshanjian, Brandon; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Bateman, Raynard L.; Tavshanjian, Brandon] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94143 USA.	shokat@cmp.ucsf.edu	Rauh, Daniel/G-1595-2013	Rauh, Daniel/0000-0002-1970-7642	National Institutes of Health [RO1 AI44009]; Sandler Program for Asthma Research; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program for Asthma Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI44009 (to K.M.S.). This work was also supported by an award from the Sandler Program for Asthma Research (to K.M.S.) and by funds from the Deutsche Forschungsgemeinschaft (to D.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Bateman R, 2007, ORG BIOMOL CHEM, V5, P3363, DOI 10.1039/b707602a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Doorn JA, 2004, BIOCHEMISTRY-US, V43, P13106, DOI 10.1021/bi049136q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang KH, 2000, AM J PHYSIOL-LUNG C, V279, pL716, DOI 10.1152/ajplung.2000.279.4.L716; Forrest GL, 2000, CHEM-BIOL INTERACT, V129, P21, DOI 10.1016/S0009-2797(00)00196-4; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hedberg JJ, 2003, EUR J BIOCHEM, V270, P1249, DOI 10.1046/j.1432-1033.2003.03486.x; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; Hou YC, 1996, BIOCHEM BIOPH RES CO, V228, P88, DOI 10.1006/bbrc.1996.1620; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; KOIVUSALO M, 1995, ADV EXP MED BIOL, V372, P427; LASKOWSKI ER, 1993, MAYO CLIN PROC, V68, P1029, DOI 10.1016/S0025-6196(12)62282-4; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; REISS PD, 1984, ANAL BIOCHEM, V140, P162, DOI 10.1016/0003-2697(84)90148-9; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Tinguely JN, 1999, EUR J BIOCHEM, V260, P9, DOI 10.1046/j.1432-1327.1999.00089.x; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Uotila L, 1997, ADV EXP MED BIOL, V414, P365; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	31	106	110	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35756	35762		10.1074/jbc.M807125200	http://dx.doi.org/10.1074/jbc.M807125200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18826943	hybrid, Green Published			2022-12-27	WOS:000261687900049
J	Elias, EV; Quiroga, R; Gottig, N; Nakanishi, H; Nash, TE; Neiman, A; Lujan, HD				Elias, Eliana V.; Quiroga, Rodrigo; Gottig, Natalia; Nakanishi, Hideki; Nash, Theodore E.; Neiman, Aaron; Lujan, Hugo D.			Characterization of SNAREs Determines the Absence of a Typical Golgi Apparatus in the Ancient Eukaryote Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYST WALL; PRIMITIVE EUKARYOTE; ENDOPLASMIC-RETICULUM; PERIPHERAL VACUOLES; SECRETORY PATHWAY; PROTEIN-STRUCTURE; SURFACE-PROTEINS; SYNTAXIN GENES; BREFELDIN-A; IDENTIFICATION	Giardia is a eukaryotic protozoal parasite with unusual characteristics, such as the absence of a morphologically evident Golgi apparatus. Although both constitutive and regulated pathways for protein secretion are evident in Giardia, little is known about the mechanisms involved in vesicular docking and fusion. In higher eukaryotes, soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) of the vesicle-associated membrane protein and syntaxin families play essential roles in these processes. In this work we identified and characterized genes for 17 SNAREs in Giardia to define the minimal set of subcellular organelles present during growth and encystation, in particular the presence or not of a Golgi apparatus. Expression and localization of all Giardia SNAREs demonstrate their presence in distinct subcellular compartments, which may represent the extent of the endomembrane system in eukaryotes. Remarkably, Giardia SNAREs, homologous to Golgi SNAREs from other organisms, do not allow the detection of a typical Golgi apparatus in either proliferating or differentiating trophozoites. However, some features of the Golgi, such as the packaging and sorting function, seem to be performed by the endoplasmic reticulum and/or the nuclear envelope. Moreover, depletion of individual genes demonstrated that several SNAREs are essential for viability, whereas others are dispensable. Thus, Giardia requires a smaller number of SNAREs compared with other eukaryotes to accomplish all of the vesicle trafficking events that are critical for the growth and differentiation of this important human pathogen.	[Elias, Eliana V.; Quiroga, Rodrigo; Gottig, Natalia; Lujan, Hugo D.] Catholic Univ Cordoba, Sch Med, Natl Council Sci & Technol, Biochem & Mol Biol Lab, Cordoba, Argentina; [Nakanishi, Hideki; Neiman, Aaron] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Nash, Theodore E.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Catholic University of Cordoba; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lujan, HD (corresponding author), Univ Catolica Cordoba, Fac Med, Lab Bioquim & Biol Mol, Jacinto Rios 571,CP X5004ASK, Cordoba, Argentina.	hlujan@ucc.edu.ar	Quiroga, Rodrigo/GLT-7145-2022; Elias, Eliana Vanina/AAF-1997-2021	Quiroga, Rodrigo/0000-0001-5015-0531; Neiman, Aaron/0000-0002-6600-6996	National Institutes of Health NIAID Intramural Research Program; Agencia Nacional para la Promocion de la Ciencia y la Tecnologia (FONCYT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Howard Hughes Medical Institute (HHMI); Universidad Catolica de Cordoba; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000161, ZIAAI000161] Funding Source: NIH RePORTER	National Institutes of Health NIAID Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agencia Nacional para la Promocion de la Ciencia y la Tecnologia (FONCYT)(FONCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Universidad Catolica de Cordoba; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health NIAID Intramural Research Program. This work was also supported by the Agencia Nacional para la Promocion de la Ciencia y la Tecnologia (FONCYT), the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Howard Hughes Medical Institute (HHMI), and the Universidad Catolica de Cordoba. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Ayong L, 2007, MOL BIOCHEM PARASIT, V152, P113, DOI 10.1016/j.molbiopara.2006.12.007; Besteiro S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-250; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BOUCHER SEM, 1990, INFECT IMMUN, V58, P3516, DOI 10.1128/IAI.58.11.3516-3522.1990; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Chaturvedi S, 1999, J BIOL CHEM, V274, P2424, DOI 10.1074/jbc.274.4.2424; Cole L, 2000, FUNGAL GENET BIOL, V29, P95, DOI 10.1006/fgbi.2000.1190; Dacks JB, 2004, MOL BIOCHEM PARASIT, V136, P123, DOI 10.1016/j.molbiopara.2004.02.014; Dacks JB, 2002, J CELL SCI, V115, P1635; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; Gottig N, 2006, J BIOL CHEM, V281, P18156, DOI 10.1074/jbc.M602081200; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hay JC, 1996, J BIOL CHEM, V271, P5671, DOI 10.1074/jbc.271.10.5671; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jarroll EL, 2001, J EUKARYOT MICROBIOL, V48, P22, DOI 10.1111/j.1550-7408.2001.tb00412.x; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Karr CD, 2004, MICROBIOL-SGM, V150, P1237, DOI 10.1099/mic.0.26922-0; Kissmehl R, 2007, TRAFFIC, V8, P523, DOI 10.1111/j.1600-0854.2007.00544.x; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Knodler LA, 1999, J BIOL CHEM, V274, P29805, DOI 10.1074/jbc.274.42.29805; Kubista H, 2004, J CELL SCI, V117, P955, DOI 10.1242/jcs.00941; Kuratsu M, 2007, FUNGAL GENET BIOL, V44, P1310, DOI 10.1016/j.fgb.2007.04.012; Lanfredi-Rangel A, 1998, J STRUCT BIOL, V123, P225, DOI 10.1006/jsbi.1998.4035; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Lujan HD, 1996, BIOL CELL, V86, P11, DOI 10.1016/0248-4900(96)89519-0; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; Lujan HD, 1998, PARASITOL TODAY, V14, P446, DOI 10.1016/S0169-4758(98)01333-7; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Marti M, 2003, J BIOL CHEM, V278, P24837, DOI 10.1074/jbc.M302082200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; MOWATT MR, 1994, INFECT IMMUN, V62, P1213, DOI 10.1128/IAI.62.4.1213-1218.1994; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; NASH TE, 1993, P NATL ACAD SCI USA, V90, P5489, DOI 10.1073/pnas.90.12.5489; NASH TE, 1988, J IMMUNOL, V141, P636; Regoes A, 2005, BIOTECHNIQUES, V39, P809, DOI 10.2144/000112054; REINER DS, 1990, EUR J CELL BIOL, V53, P142; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tamaki H, 2002, J HISTOCHEM CYTOCHEM, V50, P1611, DOI 10.1177/002215540205001205; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teng FYH, 2001, GENOME BIOL, V2; Touz MC, 2004, MOL BIOL CELL, V15, P3053, DOI 10.1091/mbc.E03-10-0744; Touz MC, 2003, J BIOL CHEM, V278, P6420, DOI 10.1074/jbc.M208354200; Touz MC, 2002, J BIOL CHEM, V277, P50557, DOI 10.1074/jbc.M202558200; Touz MC, 2002, J BIOL CHEM, V277, P8474, DOI 10.1074/jbc.M110250200; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Weiland MEL, 2003, INT J PARASITOL, V33, P1341, DOI 10.1016/S0020-7519(03)00201-7; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; YEE J, 1995, P NATL ACAD SCI USA, V92, P5615, DOI 10.1073/pnas.92.12.5615; YEE J, 1992, J BIOL CHEM, V267, P7539; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	76	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35996	36010		10.1074/jbc.M806545200	http://dx.doi.org/10.1074/jbc.M806545200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18930915	Green Published, hybrid			2022-12-27	WOS:000261687900074
J	Navadgi-Patil, VM; Burgers, PM				Navadgi-Patil, Vasundhara M.; Burgers, Peter M.			Yeast DNA Replication Protein Dpb11 Activates the Mec1/ATR Checkpoint Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; POLYMERASE-EPSILON; DAMAGE; PHOSPHORYLATION; CLAMP; ATR; TOPBP1; ALPHA; RAD9	The Saccharomyces cerevisiae Mec1-Ddc2 protein kinase (human ATR-ATRIP) initiates a signal transduction pathway in response to DNA damage and replication stress to mediate cell cycle arrest. The yeast DNA damage checkpoint clamp Ddc1-Mec3- Rad17 (human Rad9-Hus1-Rad1:9-1-1) is loaded around effector DNA and thereby activates Mec1 kinase. Dpb11 (Schizosaccharomyces pombe Cut5/Rad4 or human TopBP1) is an essential protein required for the initiation of DNA replication and has a role in checkpoint activation. In this study, we demonstrate that Dpb11 directly activates the Mec1 kinase in phosphorylating the downstream effector kinase Rad53 (human Chk1/2) and DNA bound RPA. However, DNA was not required for Dpb11 to function as an activator. Dpb11 and yeast 9-1-1 independently activate Mec1, but substantial synergism in activation was observed when both activators were present. Our studies suggest that Dpb11 and 9-1-1 may partially compensate for each other during yeast checkpoint function.	[Navadgi-Patil, Vasundhara M.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM32431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431, R01GM083970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32431. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartrand AJ, 2004, J BIOL CHEM, V279, P26762, DOI 10.1074/jbc.M312353200; Brush GS, 2000, NUCLEIC ACIDS RES, V28, P3725, DOI 10.1093/nar/28.19.3725; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; DUrso G, 1997, P NATL ACAD SCI USA, V94, P12491, DOI 10.1073/pnas.94.23.12491; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Frei C, 2000, GENE DEV, V14, P81; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim HS, 2003, DNA REPAIR, V2, P1321, DOI 10.1016/j.dnarep.2003.07.004; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lawrence JC, 2003, CURR TOP MICROBIOL, V279, P199; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Longhese MP, 2003, MUTAT RES-FUND MOL M, V532, P41, DOI 10.1016/j.mrfmmm.2003.08.009; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Majka J, 2007, CELL CYCLE, V6, P1157, DOI 10.4161/cc.6.10.4221; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Parrilla-Castellar E, 2003, J BIOL CHEM, V278, P45507, DOI 10.1074/jbc.C300418200; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Puddu F, 2008, MOL CELL BIOL, V28, P4782, DOI 10.1128/MCB.00330-08; Rouse J, 2002, MOL CELL, V9, P857, DOI 10.1016/S1097-2765(02)00507-5; SAKA Y, 1994, EMBO J, V13, P5319, DOI 10.1002/j.1460-2075.1994.tb06866.x; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Wang H, 2002, GENETICS, V160, P1295; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	46	93	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35853	35859		10.1074/jbc.M807435200	http://dx.doi.org/10.1074/jbc.M807435200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18922789	Green Published, hybrid			2022-12-27	WOS:000261687900060
J	Takasawa, A; Kato, I; Takasawa, K; Ishii, Y; Yoshida, T; Shehata, MH; Kawaguchi, H; Mohafez, OMM; Sasahara, M; Hiraga, K				Takasawa, Akira; Kato, Ichiro; Takasawa, Kumi; Ishii, Yoko; Yoshida, Toshiko; Shehata, Mohammad H.; Kawaguchi, Hiroshi; Mohafez, Omar M. M.; Sasahara, Masakiyo; Hiraga, Koichi			Mutation-, Aging-, and Gene Dosage-dependent Accumulation of Neuroserpin (G392E) in Endoplasmic Reticula and Lysosomes of Neurons in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; SERINE-PROTEASE INHIBITOR; INCLUSION-BODIES; FAMILIAL ENCEPHALOPATHY; FORMS POLYMERS; INTRACELLULAR ACCUMULATION; ANTITHROMBIN DEFICIENCY; PROTEINASE-INHIBITOR; DEMENTIA FENIB; EXPRESSION	Mutations in human neuroserpin gene cause an autosomal dementia, familial encephalopathy with neuroserpin inclusion bodies (FENIB). We generated and analyzed transgenic mice expressing high levels of either FENIB-type (G392E) or wildtype human neuroserpin in neurons of the central nervous system. G392E neuroserpin accumulated age-dependently in neurons of the neocortex, thalamus, amygdala, pons, and spinal cord of homozygous transgenic mice. Such accumulations were not observed in hemizygous transgenic mice nor in transgenic mice for wild-type neuroserpin. In differential centrifugation of brain homogenates, G392E neuroserpin recovered in the nucleus-rich fraction dramatically increased along with aging, suggesting that the aggregations gradually increase their densities presumably by their conversion into heavier and more compact configurations. In immunoelectron microscopical analyses, immunopositivities for G392E neuroserpin were found not only in endoplasmic reticulum but also in lysosomes. G392E neuroserpin transgenic mice were much more susceptible to seizures induced by kainate administration than nontransgenic mice. Overall, G392E neuroserpin accumulated in the central nervous system neurons of transgenic mice in mutation-, aging-, and gene dosage- dependent manners. The established transgenic mice will be valuable to elucidate not only mechanisms for the formation of G392E neuroserpin aggregations but also pathways for the degradation and/or clearance of the already formed aggregations in neurons.	[Takasawa, Akira; Kato, Ichiro; Takasawa, Kumi; Shehata, Mohammad H.; Kawaguchi, Hiroshi; Mohafez, Omar M. M.; Hiraga, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, Toyama 9300194, Japan; [Ishii, Yoko; Sasahara, Masakiyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pathol, Toyama 9300194, Japan; [Yoshida, Toshiko] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 9300194, Japan; [Takasawa, Akira] Hokkaido Univ, Grad Sch Med, Dept Surg Pathol, Kita Ku, Sapporo, Hokkaido 0608648, Japan	University of Toyama; University of Toyama; University of Toyama; Hokkaido University	Kato, I (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, 2630 Sugitani, Toyama 9300194, Japan.	ichikato@med.u-toyama.ac.jp	Mohafez, Omar/AAA-4883-2022	Mohafez, Omar/0000-0001-5352-8210	Ministry of Education, Culture, Sports, Science and Technology of Japan [18590285]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research 18590285 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Belorgey D, 2004, EUR J BIOCHEM, V271, P3360, DOI 10.1111/j.1432-1033.2004.04270.x; Belorgey D, 2002, J BIOL CHEM, V277, P17367, DOI 10.1074/jbc.M200680200; Briand C, 2001, FEBS LETT, V505, P18, DOI 10.1016/S0014-5793(01)02764-8; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Cuadrado A, 2002, NUCLEIC ACIDS RES, V30, P2202, DOI 10.1093/nar/30.10.2202; Davis RL, 1999, AM J PATHOL, V155, P1901, DOI 10.1016/S0002-9440(10)65510-1; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; Galliciotti G, 2007, AM J PATHOL, V170, P1305, DOI 10.2353/ajpath.2007.060910; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hansen TWR, 2001, PEDIATR RES, V49, P203, DOI 10.1203/00006450-200102000-00012; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Hasumi H, 2005, INT J CANCER, V115, P911, DOI 10.1002/ijc.20967; JOCHMANS K, 1994, BLOOD, V83, P146; KATO I, 1995, J BIOL CHEM, V270, P30045, DOI 10.1074/jbc.270.50.30045; KELLEY KA, 1994, MOL BRAIN RES, V24, P261, DOI 10.1016/0169-328X(94)90139-2; Krueger SR, 1997, J NEUROSCI, V17, P8984; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Madani R, 2003, MOL CELL NEUROSCI, V23, P473, DOI 10.1016/S1044-7431(03)00077-0; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Onda M, 2005, J BIOL CHEM, V280, P13735, DOI 10.1074/jbc.M413282200; Osterwalder T, 1998, J BIOL CHEM, V273, P2312, DOI 10.1074/jbc.273.4.2312; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Parmar PK, 2002, J NEUROCHEM, V82, P1406, DOI 10.1046/j.1471-4159.2002.01100.x; Schauwecker PE, 2004, J COMP NEUROL, V477, P96, DOI 10.1002/cne.20245; SEYAMA K, 1991, J BIOL CHEM, V266, P12627; STEINBERGER D, 1995, HUM GENET, V96, P113, DOI 10.1007/BF00214198; Takao M, 2000, J NEUROPATH EXP NEUR, V59, P1070, DOI 10.1093/jnen/59.12.1070; Tanaka Y, 2002, J BIOL CHEM, V277, P51058, DOI 10.1074/jbc.M210231200; Umemura K, 2007, STROKE, V38, P1063, DOI 10.1161/01.STR.0000257981.09329.d2; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Yepes M, 2000, BLOOD, V96, P569	35	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35606	35613		10.1074/jbc.M804125200	http://dx.doi.org/10.1074/jbc.M804125200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18940798	hybrid			2022-12-27	WOS:000261687900033
J	Liu, LN; Aartsma, TJ; Thomas, JC; Lamers, GEM; Zhou, BC; Zhang, YZ				Liu, Lu-Ning; Aartsma, Thijs J.; Thomas, Jean-Claude; Lamers, Gerda E. M.; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Watching the Native Supramolecular Architecture of Photosynthetic Membrane in Red Algae TOPOGRAPHY OF PHYCOBILISOMES AND THEIR CROWDING, DIVERSE DISTRIBUTION PATTERNS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II; PORPHYRIDIUM-CRUENTUM; THYLAKOID MEMBRANES; CRYSTAL-STRUCTURE; SYNECHOCOCCUS-ELONGATUS; 3-DIMENSIONAL STRUCTURE; EXCITATION-ENERGY; CORE COMPLEX; ATOMIC-FORCE; ORGANIZATION	The architecture of the entire photosynthetic membrane network determines, at the supramolecular level, the physiological roles of the photosynthetic protein complexes involved. So far, a precise picture of the native configuration of red algal thylakoids is still lacking. In this work, we investigated the supramolecular architectures of phycobilisomes (PBsomes) and native thylakoid membranes from the unicellular red alga Porphyridium cruentum using atomic force microscopy (AFM) and transmission electron microscopy. The topography of single PBsomes was characterized by AFM imaging on both isolated and membrane-combined PBsomes complexes. The native organization of thylakoid membranes presented variable arrangements of PBsomes on the membrane surface. It indicates that different light illuminations during growth allow diverse distribution of PBsomes upon the isolated photosynthetic membranes from P. cruentum, random arrangement or rather ordered arrays, to be observed. Furthermore, the distributions of PBsomes on the membrane surfaces are mostly crowded. This is the first investigation using AFM to visualize the native architecture of PBsomes and their crowding distribution on the thylakoid membrane from P. cruentum. Various distribution patterns of PBsomes under different light conditions indicate the photoadaptation of thylakoid membranes, probably promoting the energy-harvesting efficiency. These results provide important clues on the supramolecular architecture of red algal PBsomes and the diverse organizations of thylakoid membranes in vivo.	[Liu, Lu-Ning; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Liu, Lu-Ning; Aartsma, Thijs J.] Leiden Univ, Dept Biophys, Huygens Lab, NL-2300 RA Leiden, Netherlands; [Thomas, Jean-Claude] CNRS, UMR 8186, F-75230 Paris, France; [Thomas, Jean-Claude] Ecole Normale Super, F-75230 Paris, France; [Lamers, Gerda E. M.] Leiden Univ, Inst Biol, NL-2333 AL Leiden, Netherlands	Shandong University; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Leiden University; Leiden University - Excl LUMC	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Liu, Lu-Ning/B-1460-2009	Liu, Lu-Ning/0000-0002-8884-4819	National Natural Science Foundation of China [40676078]; Hi-Tech Research and Development program of China [2008AA09Z404]; Key International S&T Cooperation Project of China [2008DFA30440]; Netherlands Organization for Scientific Research and the Foundation for Earth and Life Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); Key International S&T Cooperation Project of China; Netherlands Organization for Scientific Research and the Foundation for Earth and Life Sciences	The work was supported by the National Natural Science Foundation of China (Grant 40676078), by the Hi-Tech Research and Development program of China (Grant 2008AA09Z404), and by the Key International S&T Cooperation Project of China (Grant 2008DFA30440). This project is part of the research programme "From Molecule to Cell" funded by the Netherlands Organization for Scientific Research and the Foundation for Earth and Life Sciences. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Arteni AA, 2008, PHOTOSYNTH RES, V95, P169, DOI 10.1007/s11120-007-9264-z; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; Bald D, 1996, PHOTOSYNTH RES, V49, P103, DOI 10.1007/BF00117661; Barber J, 2003, PHOTOCH PHOTOBIO SCI, V2, P536, DOI 10.1039/b300063j; Betz M, 1997, BIOL CHEM, V378, P167; BRIMBLE S, 1989, BIOCHIM BIOPHYS ACTA, V973, P315, DOI 10.1016/S0005-2728(89)80438-4; Bumba L, 2004, EUR J BIOCHEM, V271, P2967, DOI 10.1111/j.1432-1033.2004.04226.x; CUNNINGHAM FX, 1990, PLANT PHYSIOL, V93, P888, DOI 10.1104/pp.93.3.888; DILWORTH MF, 1981, PLANT PHYSIOL, V67, P608, DOI 10.1104/pp.67.4.608; Ducret A, 1998, J MOL BIOL, V278, P369, DOI 10.1006/jmbi.1998.1678; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; Frese RN, 2008, BIOPHYS J, V94, P640, DOI 10.1529/biophysj.107.116913; GANTT E, 1966, J CELL BIOL, V29, P423, DOI 10.1083/jcb.29.3.423; GANTT E, 1976, BIOCHIM BIOPHYS ACTA, V430, P375, DOI 10.1016/0005-2728(76)90093-1; Gantt E., 1994, MOL BIOL CYANOBACTER, P119; GANTT E, 1986, PHOTOSYNTHESIS, V3, P260; Gantt E., 1980, INT REV CYTOL, V66, P45, DOI 10.1016/S0074-7696(08)61971-3; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; Gardian Z, 2007, BBA-BIOENERGETICS, V1767, P725, DOI 10.1016/j.bbabio.2007.01.021; GIDDINGS TH, 1983, PLANT PHYSIOL, V71, P409, DOI 10.1104/pp.71.2.409; GINDT YM, 1994, BBA-BIOENERGETICS, V1186, P153, DOI 10.1016/0005-2728(94)90174-0; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; GLAZER AN, 1985, SCIENCE, V230, P1051, DOI 10.1126/science.230.4729.1051; Goncalves RP, 2005, J STRUCT BIOL, V152, P221, DOI 10.1016/j.jsb.2005.10.002; Gradinaru CC, 2004, ULTRAMICROSCOPY, V99, P235, DOI 10.1016/j.ultramic.2003.12.009; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; HOUMARD J, 1990, P NATL ACAD SCI USA, V87, P2152, DOI 10.1073/pnas.87.6.2152; JONES RF, 1963, PHYSIOL PLANTARUM, V16, P636, DOI 10.1111/j.1399-3054.1963.tb08342.x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Joshua S, 2005, PLANT PHYSIOL, V138, P1577, DOI 10.1104/pp.105.061168; Joshua S, 2004, PLANT PHYSIOL, V135, P2112, DOI 10.1104/pp.104.046110; Kaftan D, 2002, EMBO J, V21, P6146, DOI 10.1093/emboj/cdf624; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; LEFORTTRAN M, 1973, J ULTRA MOL STRUCT R, V44, P199, DOI 10.1016/S0022-5320(73)80056-5; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Liu LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003134; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; McConnell MD, 2002, PLANT PHYSIOL, V130, P1201, DOI 10.1104/pp.009845; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Mullineaux CW, 1997, NATURE, V390, P421, DOI 10.1038/37157; Mullineaux CW, 1999, AUST J PLANT PHYSIOL, V26, P671, DOI 10.1071/PP99027; MULLINEAUX CW, 2008, PHOTOCHEM P IN PRESS; MUSTARDY L, 1992, P NATL ACAD SCI USA, V89, P10021, DOI 10.1073/pnas.89.21.10021; Nevo R, 2007, EMBO J, V26, P1467, DOI 10.1038/sj.emboj.7601594; Nield J, 2000, J BIOL CHEM, V275, P27940; OHKI K, 1985, PLANT PHYSIOL, V79, P943, DOI 10.1104/pp.79.4.943; REDECKER D, 1993, EUR J CELL BIOL, V62, P442; REDLINGER T, 1981, PLANT PHYSIOL, V68, P1375, DOI 10.1104/pp.68.6.1375; REDLINGER T, 1982, P NATL ACAD SCI-BIOL, V79, P5542, DOI 10.1073/pnas.79.18.5542; Ritz M, 1998, J PHYCOL, V34, P835, DOI 10.1046/j.1529-8817.1998.340835.x; Sarcina M, 2001, J BIOL CHEM, V276, P46830, DOI 10.1074/jbc.M107111200; Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085; Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879; Scheuring S, 2004, P NATL ACAD SCI USA, V101, P11293, DOI 10.1073/pnas.0404350101; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Shimoni E, 2005, PLANT CELL, V17, P2580, DOI 10.1105/tpc.105.035030; Sidler W.A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Tsekos I, 2004, PHYCOLOGIA, V43, P543, DOI 10.2216/i0031-8884-43-5-543.1; Tsekos I, 1996, NEW PHYTOL, V133, P543, DOI 10.1111/j.1469-8137.1996.tb01923.x; WANNER G, 1980, PROTOPLASMA, V102, P97, DOI 10.1007/BF01276950; Yi ZW, 2005, FEBS LETT, V579, P3569, DOI 10.1016/j.febslet.2005.05.033; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	65	31	33	2	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34946	34953		10.1074/jbc.M805114200	http://dx.doi.org/10.1074/jbc.M805114200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930925	Green Published, hybrid			2022-12-27	WOS:000261469100051
J	Atsawasuwan, P; Mochida, Y; Katafuchi, M; Kaku, M; Fong, KSK; Csiszar, K; Yamauchi, M				Atsawasuwan, Phimon; Mochida, Yoshiyuki; Katafuchi, Michitsuna; Kaku, Masaru; Fong, Keith S. K.; Csiszar, Katalin; Yamauchi, Mitsuo			Lysyl Oxidase Binds Transforming Growth Factor-beta and Regulates Its Signaling via Amine Oxidase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; TGF-BETA; EXTRACELLULAR-MATRIX; OSTEOBLAST DIFFERENTIATION; COLLAGEN FIBRILLOGENESIS; SMALL PROTEOGLYCANS; DECORIN EXPRESSION; DEMINERALIZED BONE; ENZYME-ACTIVITY; UP-REGULATION	Lysyl oxidase (LOX), an amine oxidase critical for the initiation of collagen and elastin cross-linking, has recently been shown to regulate cellular activities possibly by modulating the functions of growth factors. In this study, we investigated the interaction between LOX and transforming growth factor-beta 1 (TGF-beta 1), a potent growth factor abundant in bone, the effect of LOX on TGF-beta 1 signaling, and its potential mechanism. The specific binding between mature LOX and mature TGF-beta 1 was demonstrated by immunoprecipitation and glutathione S-transferase pulldown assay in vitro. Both proteins were colocalized in the extracellular matrix in an osteoblastic cell culture system, and the binding complex was identified in the mineral-associated fraction of bone matrix. Furthermore, LOX suppressed TGF-beta 1-induced Smad3 phosphorylation likely through its amine oxidase activity. The data indicate that LOX binds to mature TGF-beta 1 and enzymatically regulates its signaling in bone and thus may play an important role in bone maintenance and remodeling.	[Atsawasuwan, Phimon; Mochida, Yoshiyuki; Katafuchi, Michitsuna; Kaku, Masaru; Yamauchi, Mitsuo] Univ N Carolina, Dent Res Ctr, Chapel Hill, NC 27599 USA; [Fong, Keith S. K.; Csiszar, Katalin] Univ Hawaii, John A Burns Sch Med, Cardiovasc Res Ctr, Honolulu, HI 96822 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Hawaii System	Yamauchi, M (corresponding author), Univ N Carolina, Dent Res Ctr, CB 7455, Chapel Hill, NC 27599 USA.	Mitsuo_Yamauchi@dentistry.unc.edu	Kaku, Masaru/K-5041-2019; Ariel, Pablo/AGJ-4118-2022; Kaku, Masaru/S-7309-2017	Kaku, Masaru/0000-0002-7988-6435; Kaku, Masaru/0000-0002-7988-6435; Atsawasuwan, Phimon/0000-0002-2576-060X; Fong, Keith/0000-0001-6845-1754; Mochida, Yoshiyuki/0000-0002-2115-4303	National Institutes of Health [R01 DE10489, R21 AR052824]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR052824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DE10489 (to M. Y.) and R21 AR052824 (to M. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Beekman B, 1997, EXP CELL RES, V237, P135, DOI 10.1006/excr.1997.3771; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; BOAK AM, 1994, AM J RESP CELL MOL, V11, P751, DOI 10.1165/ajrcmb.11.6.7946403; BONAR LC, 1970, J ULTRA MOL STRUCT R, V32, P545, DOI 10.1016/S0022-5320(70)80027-2; Bonewald L. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P239; Bonewald L.F., 2002, PRINCIPLES BONE BIOL, Vsecond, P903; Bose KK, 2000, J OCCUP ENVIRON MED, V42, P582, DOI 10.1097/00043764-200006000-00005; BREUER B, 1990, BIOCHEM J, V269, P551, DOI 10.1042/bj2690551; Cheng H, 1999, CONNECT TISSUE RES, V40, P37, DOI 10.3109/03008209909005276; CRONLUND AL, 1985, CONNECT TISSUE RES, V14, P109, DOI 10.3109/03008208509015017; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; Domenicucci C, 1997, CONNECT TISSUE RES, V36, P151, DOI 10.3109/03008209709160217; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Ekholm EC, 2000, BONE, V27, P551, DOI 10.1016/S8756-3282(00)00359-8; Feres EJ, 1995, J BIOL CHEM, V270, P30797, DOI 10.1074/jbc.270.51.30797; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Fox SW, 2005, MOL CELL ENDOCRINOL, V243, P19, DOI 10.1016/j.mce.2005.09.008; Fromigue O, 2004, CURR PHARM DESIGN, V10, P2593, DOI 10.2174/1381612043383773; Gacheru SN, 1997, J CELL BIOCHEM, V65, P395, DOI 10.1002/(SICI)1097-4644(19970601)65:3<395::AID-JCB9>3.0.CO;2-N; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Giampuzzi M, 2003, BBA-PROTEINS PROTEOM, V1647, P245, DOI 10.1016/S1570-9639(03)00059-1; Goto Y, 2005, VIRCHOWS ARCH, V447, P859, DOI 10.1007/s00428-005-0001-8; HAUSSER H, 1994, FEBS LETT, V353, P243, DOI 10.1016/0014-5793(94)01044-7; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Hong HH, 1999, LAB INVEST, V79, P1655; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; KAGAN HM, 1995, METHOD ENZYMOL, V258, P122; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; KAGAN HM, 1983, BIOCHEM BIOPH RES CO, V115, P186, DOI 10.1016/0006-291X(83)90987-7; Kahai S, 2004, MATRIX BIOL, V23, P445, DOI 10.1016/j.matbio.2004.09.004; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; LEVENE CI, 1959, J EXP MED, V110, P771, DOI 10.1084/jem.110.5.771; Li PA, 2004, MOL BRAIN RES, V120, P115, DOI 10.1016/j.molbrainres.2003.10.013; Li WD, 2003, J CELL BIOCHEM, V88, P152, DOI 10.1002/jcb.10304; LINDE A, 1980, J BIOL CHEM, V255, P5931; Luppen CA, 2003, J BIOL CHEM, V278, P44995, DOI 10.1074/jbc.M306730200; MACHWATE M, 1995, MOL ENDOCRINOL, V9, P187, DOI 10.1210/me.9.2.187; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Markmann A, 2000, MATRIX BIOL, V19, P631, DOI 10.1016/S0945-053X(00)00097-4; Mochida Y, 2006, ADV EXP MED BIOL, V585, P101; Mochida Y, 2006, J BIOL CHEM, V281, P36044, DOI 10.1074/jbc.M604787200; MURPHYULLRICH JE, 1992, MOL BIOL CELL, V3, P181, DOI 10.1091/mbc.3.2.181; Oleggini R, 2007, MATRIX BIOL, V26, P494, DOI 10.1016/j.matbio.2007.02.003; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; PFEILSCHIFTER J, 1990, BIOCHEM J, V270, P269, DOI 10.1042/bj2700269; PIRCHER R, 1986, BIOCHEM BIOPH RES CO, V136, P30, DOI 10.1016/0006-291X(86)90872-7; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Riquelme C, 2001, J BIOL CHEM, V276, P3589, DOI 10.1074/jbc.M004602200; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 1998, KIDNEY INT, V54, P1529, DOI 10.1046/j.1523-1755.1998.00149.x; Schaefer L, 2001, FASEB J, V15, P559; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; Shanley CJ, 1997, J VASC SURG, V25, P446, DOI 10.1016/S0741-5214(97)70254-4; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X; TERMINE JD, 1981, J BIOL CHEM, V256, P403; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Wong M, 2002, TISSUE ENG, V8, P979, DOI 10.1089/107632702320934074; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Yamane K, 2005, J CELL PHYSIOL, V202, P822, DOI 10.1002/jcp.20205; Yamauchi M, 1988, COLLAGEN, P157; YEAGER V L, 1985, Journal of Experimental Pathology (New York), V2, P1; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	75	90	96	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34229	34240		10.1074/jbc.M803142200	http://dx.doi.org/10.1074/jbc.M803142200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835815	Green Published, hybrid			2022-12-27	WOS:000261277700051
J	Antenos, M; Zhu, J; Jetly, NM; Woodruff, TK				Antenos, Monica; Zhu, Jie; Jetly, Niti M.; Woodruff, Teresa K.			An Activin/Furin Regulatory Loop Modulates the Processing and Secretion of Inhibin alpha- and beta(B)-Subunit Dimers in Pituitary Gonadotrope Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE FOLLICULAR-FLUID; PROPROTEIN CONVERTASES; GENE-EXPRESSION; FURIN; RAT; HORMONE; PROLIFERATION; EMBRYOGENESIS; ENDOPROTEASE; SUPPRESSION	Of all ligands of the transforming growth factor beta superfamily, inhibins and activins are a physiologically relevant pair that are functional antagonists of each other. Activin stimulates whereas inhibin blocks follicle-stimulating hormone biosynthesis and secretion from pituitary gonadotrope cells, and together, inhibin and activin control the pituitary gonadal axis essential for normal reproductive function. Sharing a similar beta-subunit, the secretion of inhibin heterodimers (alpha/beta) or activin homodimers (beta/beta) as mature bioactive ligands depends, in part, on the proteolytic processing of precursor proteins. A short loop regulatory pathway controlling precursor processing and dimer secretion was discovered. Activin stimulates endogenous inhibin alpha- and beta(B)-subunit mRNA, protein, and proteolytic processing. Simultaneously, activin stimulated the proconvertase furin through a Smad2/3-dependent process. The data provide a mechanism where the regulation of furin and inhibin subunits cooperates in an important positive short feedback loop. This regulatory loop augments the secretion of bioactive mature activin B, as well as inhibin B dimers, necessary for local follicle-stimulating hormone beta regulation.	[Antenos, Monica; Zhu, Jie; Woodruff, Teresa K.] Northwestern Univ, Feinburg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Antenos, Monica; Zhu, Jie; Jetly, Niti M.; Woodruff, Teresa K.] Northwestern Univ, Ctr Reprod Sci, Evanston, IL 60208 USA; [Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Woodruff, TK (corresponding author), Northwestern Univ, Feinburg Sch Med, Dept Obstet & Gynecol, Lurie 10-250,303 E Super St, Chicago, IL 60611 USA.	tkw@northwestern.edu	Antenos, Monica/J-8985-2017	Antenos, Monica/0000-0001-6350-2911; Woodruff, Teresa/0000-0002-1197-3399	National Institutes of Health [R01 HD37096]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD37096. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Blanchette F, 1997, J CLIN INVEST, V99, P1974, DOI 10.1172/JCI119365; Blanchette F, 2001, J CELL PHYSIOL, V188, P264, DOI 10.1002/jcp.1116; Constam DB, 2000, DEVELOPMENT, V127, P245; Constam DB, 2000, GENE DEV, V14, P1146; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; DEKRETSER DM, 1989, BIOL REPROD, V40, P33, DOI 10.1095/biolreprod40.1.33; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; LING N, 1985, P NATL ACAD SCI USA, V82, P7217, DOI 10.1073/pnas.82.21.7217; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZEN JR, 1981, AM J PHYSIOL, V240, pE209, DOI 10.1152/ajpendo.1981.240.2.E209; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; MATHER JP, 1990, ENDOCRINOLOGY, V127, P3206, DOI 10.1210/endo-127-6-3206; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Nachtigal MW, 1996, P NATL ACAD SCI USA, V93, P7711, DOI 10.1073/pnas.93.15.7711; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nicol L, 2008, J ENDOCRINOL, V196, P497, DOI 10.1677/jOE-07-0542; Pangas SA, 2002, J ENDOCRINOL, V172, P199, DOI 10.1677/joe.0.1720199; Rivier C, 1990, Recent Prog Horm Res, V46, P231; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SCHWARTZ NB, 1977, P NATL ACAD SCI USA, V74, P5721, DOI 10.1073/pnas.74.12.5721; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Suszko MI, 2006, J MOL ENDOCRINOL, V36, P591, DOI 10.1677/jme.1.01936; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; WOODRUFF TK, 1990, ENDOCRINOLOGY, V127, P3196, DOI 10.1210/endo-127-6-3196; Zhang H, 2006, MOL ENDOCRINOL, V20, P2909, DOI 10.1210/me.2006-0109	32	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33059	33068		10.1074/jbc.M804190200	http://dx.doi.org/10.1074/jbc.M804190200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826955	Green Published, hybrid			2022-12-27	WOS:000261183700006
J	Davies, KD; Goebel-Goody, SM; Coultrap, SJ; Browning, MD				Davies, Kurtis D.; Goebel-Goody, Susan M.; Coultrap, Steven J.; Browning, Michael D.			Long Term Synaptic Depression That Is Associated with GluR1 Dephosphorylation but Not alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; D-ASPARTATE RECEPTOR; GLUTAMATE RECEPTORS; SURFACE EXPRESSION; REGULATORY PHOSPHORYLATION; MEDIATED ENDOCYTOSIS; RAPID REDISTRIBUTION; RAT HIPPOCAMPUS; CA1 REGION; AREA CA1	Long lasting changes in the strength of synaptic transmission in the hippocampus are thought to underlie certain forms of learning and memory. Accordingly, the molecular mechanisms that account for these changes are heavily studied. Postsynaptically, changes in synaptic strength can occur by altering the amount of neurotransmitter receptors at the synapse or by altering the functional properties of synaptic receptors. In this study, we examined the biochemical changes produced following chemically induced long term depression in acute hippocampal CA1 minislices. Using three independent methods, we found that this treatment did not lead to an internalization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid ( AMPA) receptors. Furthermore, when the plasma membrane was separated into synaptic membrane-enriched and extrasynaptic membrane-enriched fractions, we actually observed a significant increase in the concentration of AMPA receptors at the synapse. However, phosphorylation of Ser-845 on the AMPA receptor subunit GluR1 was significantly decreased throughout the neuron, including in the synaptic membrane-enriched fraction. In addition, phosphorylation of Ser-831 on GluR1 was decreased specifically in the synaptic membrane-enriched fraction. Phosphorylation of these residues has been demonstrated to control AMPA receptor function. From these data, we conclude that the decrease in synaptic strength is likely the result of a change in the functional properties of AMPA receptors at the synapse and not a decrease in the amount of synaptic receptors.	[Davies, Kurtis D.; Coultrap, Steven J.; Browning, Michael D.] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA; [Goebel-Goody, Susan M.; Browning, Michael D.] Univ Colorado, Hlth Sci Ctr, Program Neurosci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Browning, MD (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Mail Stop 8303,POB 6511, Aurora, CO 80045 USA.	michael.browning@uchsc.edu			National Institutes of Health Research [AA014691, AA09675]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014691, R01AA009675] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Research Grants AA014691 and AA09675. M. D. B. has a financial interest in PhosphoSolutions, a company that provided several of the antibodies used in this study. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COTMAN CW, 1972, J CELL BIOL, V55, P696, DOI 10.1083/jcb.55.3.696; CRAIN B, 1973, BRAIN RES, V63, P195, DOI 10.1016/0006-8993(73)90088-7; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Davies KD, 2007, BRAIN RES, V1158, P39, DOI 10.1016/j.brainres.2007.05.008; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Goebel SM, 2005, MOL BRAIN RES, V142, P65, DOI 10.1016/j.molbrainres.2005.09.012; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Hall RA, 1997, NEUROSCIENCE, V78, P361, DOI 10.1016/S0306-4522(96)00525-8; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Holman D, 2007, NEUROPHARMACOLOGY, V52, P92, DOI 10.1016/j.neuropharm.2006.05.022; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Huang CC, 2004, J NEUROCHEM, V89, P217, DOI 10.1111/j.1471-4159.2003.02307.x; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; MATUS AI, 1978, PROC R SOC SER B-BIO, V203, P135, DOI 10.1098/rspb.1978.0097; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4	52	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33138	33146		10.1074/jbc.M803431200	http://dx.doi.org/10.1074/jbc.M803431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18819923	Green Published, hybrid			2022-12-27	WOS:000261183700015
J	Sweet, L; Zhang, WH; Torres-Fewell, H; Serianni, A; Boggess, W; Schorey, J				Sweet, Lindsay; Zhang, Wenhui; Torres-Fewell, Heidi; Serianni, Anthony; Boggess, William; Schorey, Jeffrey			Mycobacterium avium Glycopeptidolipids Require Specific Acetylation and Methylation Patterns for Signaling through Toll-like Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROVAR-SPECIFIC GLYCOPEPTIDOLIPIDS; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; IMMUNE-RESPONSES; NONTUBERCULOUS MYCOBACTERIA; MICROBIAL LIPOPROTEINS; PSEUDOMONAS-AERUGINOSA; CUTTING EDGE; SMEGMATIS; MACROPHAGES; MICE	Toll-like receptors (TLRs) recognize pathogen- associated molecules and play a vital role in promoting an immune response against invading microbes. TLR2, one of the key members of the TLR family, recognizes a wide variety of microbial products, including lipoproteins and lipopeptides, from a number of pathogens. Recent studies from our laboratory indicate that glycopeptidolipids (GPLs), a major surface component of Mycobacterium avium and other non-tuberculosis mycobacteria, are ligands for TLR2. However, the molecular requirements necessary for the GPL-TLR2 interaction were not defined in this report. In the present study we isolated different GPL species from M. avium, and using mass spectrometry and NMR analyses, characterized the molecular requirements of the GPL-TLR2 interaction. Interestingly, the extent of the respective acetylation and methylation of the 6-deoxytalose and rhamnose contained within the core GPL structure dictated whether the GPL signaled through TLR2. These experiments illustrate how subtle changes in a complex TLR2 ligand can alter its affinity for this important receptor, and suggest that M. avium could potentially modify its GPL structure to limit its interaction with TLR2.	[Schorey, Jeffrey] Univ Notre Dame, Dept Biol Sci, Eck Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA; [Zhang, Wenhui; Serianni, Anthony; Boggess, William] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Schorey, J (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Ctr Global Hlth & Infect Dis, 130 Galvin Life Sci Ctr, Notre Dame, IN 46556 USA.	schorey.1@nd.edu	Zhang, Wenhui/B-1695-2013		National Institutes of Health; NIAID [AI056979, AI052439]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052439, R01AI056979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI056979 and AI052439 from NIAID. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or NIH. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bernardo J, 1998, INFECT IMMUN, V66, P28, DOI 10.1128/IAI.66.1.28-35.1998; BRENNAN PJ, 1982, J CLIN MICROBIOL, V15, P447, DOI 10.1128/JCM.15.3.447-455.1982; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Eckstein TM, 2003, MICROBIOL-SGM, V149, P2797, DOI 10.1099/mic.0.26528-0; Ernst RK, 1999, J INFECT DIS, V179, pS326, DOI 10.1086/513850; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gomes MS, 2004, IMMUNOLOGY, V111, P179, DOI 10.1111/j.0019-2805.2003.01807.x; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hilborn ED, 2006, APPL ENVIRON MICROB, V72, P5864, DOI 10.1128/AEM.00759-06; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Horgen L, 2000, MICROB PATHOGENESIS, V29, P9, DOI 10.1006/mpat.2000.0358; HORSBURGH CR, 1991, AM REV RESPIR DIS, V144, P557, DOI 10.1164/ajrccm/144.3_Pt_1.557; HORSBURGH CR, 1986, ANTIMICROB AGENTS CH, V30, P955, DOI 10.1128/AAC.30.6.955; Horsburgh CR, 1999, J INFECT DIS, V179, pS461; Kang BK, 1998, INFECT IMMUN, V66, P2769, DOI 10.1128/IAI.66.6.2769-2777.1998; Kano H, 2005, BIOL PHARM BULL, V28, P335, DOI 10.1248/bpb.28.335; Krzywinska E, 2005, MOL MICROBIOL, V56, P1262, DOI 10.1111/j.1365-2958.2005.04608.x; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Means TK, 1999, J IMMUNOL, V163, P3920; Mukherjee R, 2005, MICROBIOL-SGM, V151, P2385, DOI 10.1099/mic.0.27908-0; Ojha AK, 2002, MICROBIOL-SGM, V148, P3039, DOI 10.1099/00221287-148-10-3039; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Sweet L, 2006, J LEUKOCYTE BIOL, V80, P415, DOI 10.1189/jlb.1205702; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Villeneuve C, 2003, J BIOL CHEM, V278, P51291, DOI 10.1074/jbc.M306554200; Wieland CW, 2004, AM J RESP CRIT CARE, V170, P1367, DOI 10.1164/rccm.200404-525OC; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; YAKRUS MA, 1990, J CLIN MICROBIOL, V28, P926, DOI 10.1128/JCM.28.5.926-929.1990; Yamazaki Y, 2006, CELL MICROBIOL, V8, P806, DOI 10.1111/j.1462-5822.2005.00667.x	49	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33221	33231		10.1074/jbc.M805539200	http://dx.doi.org/10.1074/jbc.M805539200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824550	hybrid, Green Published			2022-12-27	WOS:000261183700025
J	Duriez, M; Rossignol, JM; Sitterlin, D				Duriez, Marion; Rossignol, Jean-Michel; Sitterlin, Delphine			The Hepatitis B Virus Precore Protein Is Retrotransported from Endoplasmic Reticulum (ER) to Cytosol through the ER-associated Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE ENVELOPE PROTEIN; E-ANTIGEN; MISFOLDED PROTEINS; IN-VITRO; VERTICAL TRANSMISSION; MOLECULAR CHAPERONES; VIRAL REPLICATION; MESSENGER-RNA; CHOLERA-TOXIN; CELL-DEATH	The hepatitis B virus precore protein is closely related to the nucleocapsid core protein but is processed distinctly in the cell and plays a different role in the viral cycle. Precore is addressed to the endoplasmic reticulum (ER) through a signal peptide, and the form present in the ER is the P22 protein. P22 is then cleaved in its C-terminal part to be secreted as HBe antigen. In addition, a cytosolic form of 22 kDa less characterized has been observed. Precore gene was shown to be implicated in viral persistence, but until now, the actual protein species involved has not been determined. Our work focuses on the cytosolic form of precore. Using human cells expressing precore and a convenient fractionation assay, we demonstrated that the cytosolic form is identical to the ER form and retrotransported in the cytoplasm through the ER-associated degradation pathway. This cellular machinery translocates misfolded proteins to the cytoplasm, where they are ubiquitinated on lysine residues and degraded by proteasome. We showed that precore escapes proteasome due to its low lysine content and accumulates in the cytosol. The role of this retrotransport was investigated. In the presence of precore, we found a specific redistribution of the Grp78/BiP chaperone protein to cytosol and demonstrated a specific interaction between precore and Grp78/BiP. Altogether, these data support the idea that the hepatitis B virus develops a strategy to take advantage of the ER-associated degradation pathway, allowing distinct subcellular localization and probably distinct roles for the viral precore protein.			Sitterlin, D (corresponding author), Univ Versailles St Quentin, CNRS, Lab Genet & Biol Cellulaire, Ecole Prat Hautes Etud,UMR 8159, 45 Ave Etats Unis, F-7803 Versailles, France.	delphine.sitterlin@uvsq.fr			Agence Nationale de Recherches sur le SIDA et les Hepatites virales [07309]; Association pour la Recherche sur le Cancer [3404]	Agence Nationale de Recherches sur le SIDA et les Hepatites virales(ANRSFrench National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by Agence Nationale de Recherches sur le SIDA et les Hepatites virales, Grant 07309 and Association pour la Recherche sur le Cancer, Grant 3404. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Awe K, 2008, FEBS LETT, V582, P3179, DOI 10.1016/j.febslet.2008.07.062; BEASLEY RP, 1977, AM J EPIDEMIOL, V105, P94, DOI 10.1093/oxfordjournals.aje.a112370; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHANG C, 1987, J VIROL, V61, P3322, DOI 10.1128/JVI.61.10.3322-3325.1987; CHEN HS, 1992, J VIROL, V66, P5682, DOI 10.1128/JVI.66.9.5682-5684.1992; Chen YY, 2006, CELL MOL IMMUNOL, V3, P373; Cho DY, 2003, J VIROL, V77, P2784, DOI 10.1128/JVI.77.4.2784-2788.2003; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Friedt M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-11; Guidotti LG, 1996, J VIROL, V70, P7056, DOI 10.1128/JVI.70.10.7056-7061.1996; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Huang ZM, 2005, MOL CELL BIOL, V25, P7522, DOI 10.1128/MCB.25.17.7522-7533.2005; Kimura T, 2005, J BIOL CHEM, V280, P21713, DOI 10.1074/jbc.M501564200; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Laine S, 2003, J VIROL, V77, P12875, DOI 10.1128/JVI.77.23.12875-12880.2003; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; LAMBERTS C, 1993, J VIROL, V67, P3756, DOI 10.1128/JVI.67.7.3756-3762.1993; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu H, 1998, J BIOL CHEM, V273, P12858, DOI 10.1074/jbc.273.21.12858; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Messageot F, 2003, J BIOL CHEM, V278, P891, DOI 10.1074/jbc.M207634200; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Milich DR, 1998, J IMMUNOL, V160, P2013; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; OU JH, 1986, P NATL ACAD SCI USA, V83, P1578, DOI 10.1073/pnas.83.6.1578; OU JH, 1989, J VIROL, V63, P5238, DOI 10.1128/JVI.63.12.5238-5243.1989; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; Scaglioni PP, 1997, VIROLOGY, V233, P374, DOI 10.1006/viro.1997.8594; SCHLICHT HJ, 1987, J VIROL, V61, P3701, DOI 10.1128/JVI.61.12.3701-3709.1987; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; STEVENS CE, 1979, J MED VIROL, V3, P237, DOI 10.1002/jmv.1890030310; Uetrecht C, 2008, P NATL ACAD SCI USA, V105, P9216, DOI 10.1073/pnas.0800406105; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Wang XL, 2006, J BIOL CHEM, V281, P8636, DOI 10.1074/jbc.M513920200; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yu ZF, 1999, EXP NEUROL, V155, P302, DOI 10.1006/exnr.1998.7002	51	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32352	32360		10.1074/jbc.M807178200	http://dx.doi.org/10.1074/jbc.M807178200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805786	hybrid			2022-12-27	WOS:000260893700022
J	Li, GD; Zhang, X; Li, R; Wang, YD; Wang, YL; Han, KJ; Qian, XP; Yang, CG; Liu, P; Wei, Q; Chen, WF; Zhang, J; Zhang, Y				Li, Guo-Dong; Zhang, Xi; Li, Rong; Wang, Yue-Dan; Wang, Yan-Li; Han, Ke-Jun; Qian, Xiao-Ping; Yang, Cheng-Gang; Liu, Ping; Wei, Qun; Chen, Wei-Feng; Zhang, Jun; Zhang, Yu			CHP2 Activates the Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway and Enhances the Oncogenic Potential of HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER; PHOSPHATASE-ACTIVITY; TRANSCRIPTION FACTOR; HOMOLOGOUS PROTEIN; B-SUBUNIT; NFAT; EXPRESSION; OVEREXPRESSION; CALMODULIN; INHIBITOR	CHP2 (calcineurin B homologous protein 2) was initially identified as a tumor-associated antigen highly expressed in hepatocellular carcinoma. Its biological function remains largely unknown except for a potential role in transmembrane Na+/H+ exchange. In the present study, we observed that ectopic expression of CHP2 promoted the proliferation of HEK293 cells, whereas knockdown of endogenous CHP2 expression in HepG2 inhibited cell proliferation. When inoculated into nude mice, CHP2 transfected HEK293 cells displayed markedly increased oncogenic potential. In analysis of the underlying molecular mechanisms, we found that like calcineurin B, CHP2 was able to bind to and stimulate the phosphatase activity of calcineurin A. In accord with this, CHP2-transfected cells showed increased nuclear presence of NFATc3 (nuclear factor of activated T cells) and enhanced NFAT activity. Finally, both accelerated cell proliferation and NFAT activation following CHP2 transfection could be suppressed by the calcineurin inhibitor cyclosporine A, suggesting an intrinsic connection between these events. Taken together, our results highlighted a potential role of CHP2 in tumorigenesis and revealed a novel function of CHP2 as an activator of the calcineurin/NFAT signaling pathway.	[Li, Guo-Dong; Zhang, Xi; Li, Rong; Wang, Yue-Dan; Han, Ke-Jun; Qian, Xiao-Ping; Chen, Wei-Feng; Zhang, Jun; Zhang, Yu] Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100191, Peoples R China; [Wang, Yan-Li; Yang, Cheng-Gang; Liu, Ping; Wei, Qun] Beijing Normal Univ, Dept Biochem & Mol Biol, Sch Life Sci, Beijing 100875, Peoples R China	Peking University; Beijing Normal University	Zhang, J (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	junzhang@bjmu.edu.cn; zhangyu007@hsc.pku.edu.cn	Chen, Wei/GZK-7348-2022		National Basic Research Program of China [2006CB504307, 2006CB910101]; Ludwig Institute for Cancer Research [KSP 003]; National Natural Science Foundation of China [30300309, 30525044]; Beijing Natural Science Foundation [7061003]	National Basic Research Program of China(National Basic Research Program of China); Ludwig Institute for Cancer Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Basic Research Program of China Grants 2006CB504307 and 2006CB910101, James R. Kerr Program, Ludwig Institute for Cancer Research Grant KSP 003, National Natural Science Foundation of China Grants 30300309 and 30525044, and Beijing Natural Science Foundation Grant 7061003.	Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Glud SZ, 2005, BLOOD, V106, P3546, DOI 10.1182/blood-2005-02-0493; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jin Q, 2007, IN VIVO, V21, P593; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kashishian A, 1998, J BIOL CHEM, V273, P27412, DOI 10.1074/jbc.273.42.27412; KINCAID RL, 1986, P NATL ACAD SCI USA, V83, P1193, DOI 10.1073/pnas.83.5.1193; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Kuwahara H, 2003, J BIOCHEM, V134, P245, DOI 10.1093/jb/mvg137; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Lakshmikuttyamma A, 2005, J CELL BIOCHEM, V95, P731, DOI 10.1002/jcb.20437; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Liu P, 2005, BIOCHIMIE, V87, P215, DOI 10.1016/j.biochi.2004.10.009; Lu HT, 2007, CURR CANCER DRUG TAR, V7, P343, DOI 10.2174/156800907780809750; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marafiot T, 2005, BRIT J HAEMATOL, V128, P333, DOI 10.1111/j.1365-2141.2004.05313.x; Matsumoto M, 2001, J BIOCHEM, V130, P217, DOI 10.1093/oxfordjournals.jbchem.a002975; Medyouf H, 2008, CELL CYCLE, V7, P297, DOI 10.4161/cc.7.3.5357; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; Qin YL, 2005, BBA-PROTEINS PROTEOM, V1747, P171, DOI 10.1016/j.bbapap.2004.11.002; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; RYOEM S, 2008, CANCER CELL, V13, P420; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Wang YL, 2008, CANCER SCI, V99, P1100, DOI 10.1111/j.1349-7006.2008.00799.x; Wei Q, 1997, BIOCHEM MOL BIOL INT, V41, P169; Zaun HC, 2008, J BIOL CHEM, V283, P12456, DOI 10.1074/jbc.M800267200; 韩克军, 2003, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V19, P31	40	17	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32660	32668		10.1074/jbc.M806684200	http://dx.doi.org/10.1074/jbc.M806684200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815128	hybrid			2022-12-27	WOS:000260893700056
J	Garcia-Elias, A; Lorenzo, IM; Vicente, R; Valverde, MA				Garcia-Elias, Anna; Lorenzo, Ivan M.; Vicente, Ruben; Valverde, Miguel A.			IP3 Receptor Binds to and Sensitizes TRPV4 Channel to Osmotic Stimuli via a Calmodulin-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; CATION CHANNEL; ION-CHANNEL; HYPERALGESIA; MODULATION; EXPRESSION; DOMAINS; COMPLEX; ENTRY	Activation of the non-selective cation channel TRPV4 by mechanical and osmotic stimuli requires the involvement of phospholipase A(2) and the subsequent production of the arachidonic acid metabolites, epoxieicosatrienoic acids (EET). Previous studies have shown that inositol trisphosphate (IP3) sensitizes TRPV4 to mechanical, osmotic, and direct EET stimulation. We now search for the IP3 receptor-binding site on TRPV4 and its relevance to IP3-mediated sensitization. Three putative sites involved in protein-protein interactions were evaluated: a proline-rich domain (PRD), a calmodulin (CaM)-binding site, and the last four amino acids (DAPL) that show a PDZ-binding motif-like. TRPV4-Delta CaM-(Delta 812-831) channels preserved activation by hypotonicity, 4 alpha-phorbol 12,13-didecanoate, and EET but lost their physical interaction with IP3 receptor 3 and IP3-mediated sensitization. Deletion of a PDZ-binding motif-like (TRPV4-Delta DAPL) did not affect channel activity or IP3-mediated sensitization, whereas TRPV4-Delta PRD-(Delta 132-144) resulted in loss of channel function despite correct trafficking. We conclude that IP3-mediated sensitization requires IP3 receptor binding to a TRPV4 C-terminal domain that overlaps with a previously described calmodulin-binding site.	[Garcia-Elias, Anna; Lorenzo, Ivan M.; Vicente, Ruben; Valverde, Miguel A.] Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Barcelona 08003, Spain	Pompeu Fabra University	Valverde, MA (corresponding author), Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Parc Recerca Biomed Barcelona,C Dr Aiguader 88, Barcelona 08003, Spain.	miguel.valverde@upf.edu	Garcia-Elias Heras, Anna/K-4367-2014; García, Rubén Vicente/L-1097-2014	Garcia-Elias Heras, Anna/0000-0002-6609-6119; García, Rubén Vicente/0000-0003-0401-4808; Valverde, Miguel A./0000-0002-6961-3361	Spanish Ministries of Education and Science [SAF2006-04973, SAF2006-13893-C02-02]; Spanish Ministries of Health; Generalitat de Catalunya [SGR05-266]; Fundacio la Marato de TV3 [061331]	Spanish Ministries of Education and Science(Spanish Government); Spanish Ministries of Health(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio la Marato de TV3	This work was supported by grants from the Spanish Ministries of Education and Science (Grant SAF2006-04973 and SAF2006-13893-C02-02), Spanish Ministries of Health (Fondo de Investigacion Sanitaria, Red HERACLES RD06/0009), Generalitat de Catalunya (SGR05-266), and Fundacio la Marato de TV3 (061331). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Cohen DM, 2007, CURR OPIN NEPHROL HY, V16, P451, DOI 10.1097/MNH.0b013e32821f6060; Cohen DM, 2005, PFLUG ARCH EUR J PHY, V451, P168, DOI 10.1007/s00424-005-1456-9; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3; Fu Y, 2006, AM J PHYSIOL-RENAL, V290, pF1305, DOI 10.1152/ajprenal.00391.2005; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Guler AD, 2002, J NEUROSCI, V22, P6408; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Plant T. D., 2007, V179, P189; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	35	61	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31284	31288		10.1074/jbc.C800184200	http://dx.doi.org/10.1074/jbc.C800184200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18826956	hybrid			2022-12-27	WOS:000260760800004
J	Ishikawa, Y; Vranka, J; Wirz, J; Nagata, K; Bachinger, HP				Ishikawa, Yoshihiro; Vranka, Janice; Wirz, Jackie; Nagata, Kazuhiro; Baechinger, Hans Peter			The Rough Endoplasmic Reticulum-resident FK506-binding Protein FKBP65 Is a Molecular Chaperone That Interacts with Collagens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; OSTEOGENESIS IMPERFECTA; TRIPLE-HELIX; IN-VITRO; DISULFIDE-ISOMERASE; THERMAL-STABILITY; NEUROSPORA-CRASSA; BINDING-PROTEIN; MUTATIONS; HSP47	The rough endoplasmic reticulum-resident FK-506-binding protein FKBP65 can be isolated from chick embryos on a gelatin-Sepharose column, indicating some involvement in the biosynthesis of procollagens. The peptidylprolyl cis-trans-isomerase activity of FKBP65 was previously shown to have only marginal effects on the rate of triple helix formation (Zeng, B., MacDonald, J. R., Bann, J. G., Beck, K., Gambee, J. E., Boswell, B. A., and Bachinger, H. P. (1998) Biochem. J. 330, 109 - 114). Here we show that FKBP65 is a monomer in solution and acts as a chaperone molecule when tested with two classic chaperone assays: FKBP65 inhibits the thermal aggregation of citrate synthase and is active in the denatured rhodanese refolding and aggregation assay. The chaperone activity is comparable to that of protein-disulfide isomerase, a well characterized chaperone. FKBP65 delays the in vitro fibril formation of type I collagen, indicating that FKBP65 is also able to interact with triple helical collagen, and acts as a collagen chaperone.	[Ishikawa, Yoshihiro; Vranka, Janice; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Wirz, Jackie; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan	Oregon Health & Science University; Kyoto University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Ishikawa, Yoshihiro/0000-0003-2013-0518; Wirz, Jacqueline/0000-0003-2046-610X	Shriners Hospitals for Children	Shriners Hospitals for Children	This work was supported by a grant from the Shriners Hospitals for Children (to H. P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; BUSH KT, 1994, BIOCHEM J, V303, P705, DOI 10.1042/bj3030705; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; COSS MC, 1995, J BIOL CHEM, V270, P29336, DOI 10.1074/jbc.270.49.29336; Coss MC, 1998, CELL GROWTH DIFFER, V9, P41; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; Main ERG, 1999, J MOL BIOL, V291, P429, DOI 10.1006/jmbi.1999.2941; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; PARTALEDIS JA, 1993, P NATL ACAD SCI USA, V90, P5450, DOI 10.1073/pnas.90.12.5450; Patterson CE, 2000, MOL BIOL CELL, V11, P3925, DOI 10.1091/mbc.11.11.3925; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; Tremmel D, 2007, J MOL BIOL, V369, P55, DOI 10.1016/j.jmb.2007.01.092; Tremmel D, 2007, FEBS LETT, V581, P2036, DOI 10.1016/j.febslet.2007.04.042; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	34	91	95	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31584	31590		10.1074/jbc.M802535200	http://dx.doi.org/10.1074/jbc.M802535200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786928	hybrid			2022-12-27	WOS:000260760800038
J	Ng, SW; Di Capite, J; Singaravelu, K; Parekh, AB				Ng, Siaw Wei; Di Capite, Joseph; Singaravelu, Karthika; Parekh, Anant B.			Sustained Activation of the Tyrosine Kinase Syk by Antigen in Mast Cells Requires Local Ca2+ Influx through Ca2+ Release-activated Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; BASOPHILIC LEUKEMIA-CELLS; LEUKOTRIENE C-4 SECRETION; CRAC CHANNEL; CALCIUM-CHANNELS; PORE SUBUNIT; PHOSPHORYLATION; MICRODOMAINS; DOMAINS	Mast cell activation involves cross-linking of IgE receptors followed by phosphorylation of the non-receptor tyrosine kinase Syk. This results in activation of the plasma membrane-bound enzyme phospholipase C gamma 1, which hydrolyzes the minor membrane phospholipid phosphatidylinositol 4,5-bisphosphate to generate diacylglycerol and inositol trisphosphate. Inositol trisphosphate raises cytoplasmic Ca2+ concentration by releasing Ca2+ from intracellular stores. This Ca2+ release phase is accompanied by sustained Ca2+ influx through store-operated Ca2+ release-activated Ca2+ (CRAC) channels. Here, we find that engagement of IgE receptors activates Syk, and this leads to Ca2+ release from stores followed by Ca2+ influx. The Ca2+ influx phase then sustains Syk activity. The Ca2+ influx pathway activated by these receptors was identified as the CRAC channel, because pharmacological block of the channels with either a low concentration of Gd3+ or exposure to the novel CRAC channel blocker 3-fluoropyridine-4-carboxylic acid (2', 5'-dimethoxybiphenyl-4-yl) amide or RNA interference knockdown of Orai1, which encodes the CRAC channel pore, all prevented the increase in Syk activity triggered by Ca2+ entry. CRAC channels and Syk are spatially close together, because increasing cytoplasmic Ca2+ buffering with the fast Ca2+ chelator 1,2-bis(2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid tetrakis failed to prevent activation of Syk by Ca2+ entry. Our results reveal a positive feedback step in mast cell activation where receptor-triggered Syk activation and subsequent Ca2+ release opens CRAC channels, and the ensuing local Ca2+ entry then maintains Syk activity. Ca2+ entry through CRAC channels therefore provides a means whereby the Ca2+ and tyrosine kinase signaling pathways can interact with one another.	[Ng, Siaw Wei; Di Capite, Joseph; Singaravelu, Karthika; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council; MRC [G0601485] Funding Source: UKRI; Medical Research Council [G0601485] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Medical Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Dauvillier S, 2002, J IMMUNOL, V169, P2274, DOI 10.4049/jimmunol.169.5.2274; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fierro L, 1999, J PHYSIOL-LONDON, V520, P407, DOI 10.1111/j.1469-7793.1999.00407.x; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kuehn HS, 2007, IMMUNOL LETT, V113, P59, DOI 10.1016/j.imlet.2007.08.007; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; MINOGUCHI K, 1994, J BIOL CHEM, V269, P16902; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; PAREKH AB, 1995, P NATL ACAD SCI USA, V92, P7907, DOI 10.1073/pnas.92.17.7907; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 1997, CELL, V89, P973, DOI 10.1016/S0092-8674(00)80282-2; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney J W Jr, 2001, Mol Interv, V1, P84; Rezaul K, 1997, BIOCHEM BIOPH RES CO, V239, P23, DOI 10.1006/bbrc.1997.7419; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SEGAL DM, 1977, P NATL ACAD SCI USA, V74, P2993, DOI 10.1073/pnas.74.7.2993; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Stenton GR, 2002, J IMMUNOL, V169, P1028, DOI 10.4049/jimmunol.169.2.1028; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; Xu DZ, 2006, MOL CELL BIOL, V26, P5043, DOI 10.1128/MCB.02387-05; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoon E, 2004, BIOCHEM BIOPH RES CO, V325, P117, DOI 10.1016/j.bbrc.2004.09.216; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	48	96	97	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31348	31355		10.1074/jbc.M804942200	http://dx.doi.org/10.1074/jbc.M804942200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18806259	hybrid			2022-12-27	WOS:000260760800012
J	Prabhakar, V; Capila, I; Soundararajan, V; Raman, R; Sasisekharan, R				Prabhakar, Vikas; Capila, Ishan; Soundararajan, Venkataramanan; Raman, Rahul; Sasisekharan, Ram			Recombinant Expression, Purification, and Biochemical Characterization of Chondroitinase ABC II from Proteus vulgaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; AC LYASE; FLAVOBACTERIUM-HEPARINUM; ESCHERICHIA-COLI; CLONING; COMPLEX	Chondroitin lyases (or chondroitinases) are a family of enzymes that depolymerize chondroitin sulfate (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology. Two distinct chondroitinase ABC enzymes, cABCI and cABCII, were identified in Proteus vulgaris. Recently, cABCI was cloned, recombinantly expressed, and extensively characterized structurally and biochemically. This study focuses on recombinant expression, purification, biochemical characterization, and understanding the structure-function relationship of cABCII. The biochemical parameters for optimal activity and kinetic parameters associated with processing of various CS and DS substrates were determined. The profile of products formed by action of cABCII on different substrates was compared with product profile of cABCI. A homology-based structural model of cABCII and its complexes with CS oligosaccharides was constructed. This structural model provided molecular insights into the experimentally observed differences in the product profile of cABCII as compared with that of cABCI. The critical active site residues involved in the catalytic activity of cABCII identified based on the structural model were validated using site-directed mutagenesis and kinetic characterization of the mutants. The development of such a contaminant-free cABCII enzyme provides additional tools to decode the biologically important structure-function relationship of CS and DS galactosaminoglycans and offers novel therapeutic strategies for recovery after central nervous system injury.	[Sasisekharan, Ram] Harvard Univ, MIT, Div Hlth Sci & Technol, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), 77 Massachusetts Ave,Rm 16-561, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [GM57073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008334, R01GM057073, R37GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57073. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Guda C, 2001, Pac Symp Biocomput, P275; Hamai A, 1997, J BIOL CHEM, V272, P9123; Hartmann U, 2001, MATRIX BIOL, V20, P23, DOI 10.1016/S0945-053X(00)00137-2; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; HUIGE CJM, 1995, J COMPUT CHEM, V16, P56, DOI 10.1002/jcc.540160106; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; Pojasek K, 2002, J BIOL CHEM, V277, P31179, DOI 10.1074/jbc.M201552200; Pojasek K, 2001, BIOCHEM BIOPH RES CO, V286, P343, DOI 10.1006/bbrc.2001.5380; Prabhakar V, 2005, BIOCHEM J, V390, P395, DOI 10.1042/BJ20050532; Prabhakar V, 2005, BIOCHEM J, V386, P103, DOI 10.1042/BJ20041222; Prabhakar V, 2006, BIOCHEMISTRY-US, V45, P11130, DOI 10.1021/bi0605484; RYAN MJ, 1994, Patent No. 9425567; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; SATO N, 1994, APPL MICROBIOL BIOT, V41, P39, DOI 10.1007/s002530050104; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523	24	36	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					974	982		10.1074/jbc.M806630200	http://dx.doi.org/10.1074/jbc.M806630200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18849565	Green Published, hybrid			2022-12-27	WOS:000262122900033
J	Fogarty, S; Hardie, DG				Fogarty, Sarah; Hardie, D. Grahame			C-terminal Phosphorylation of LKB1 Is Not Required for Regulation of AMP-activated Protein Kinase, BRSK1, BRSK2, or Cell Cycle Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; SKELETAL-MUSCLE; UPSTREAM KINASE; SUBSTRATE; ENERGY; IDENTIFICATION; POLARIZATION; CONTRACTION; DEFICIENCY; LKB1/STK11	The tumor suppressor protein kinase LKB1 exerts its effects by phosphorylating and activating AMP-activated protein kinase (AMPK) and members of the AMPK-related kinase family, such as the brain-specific kinases BRSK1/BRSK2 (SAD-B/SAD-A). LKB1 contains a conserved serine residue near the C terminus (Ser-431 in mouse LKB1) that is phosphorylated by cyclic AMP-dependent protein kinase and p90-RSK. Although some studies suggest that LKB1 is constitutively active and is not rate-limiting for activation of AMPK, others have suggested that phosphorylation of Ser-431 is necessary to allow LKB1 to phosphorylate and activate AMPK and other downstream kinases. Prompted by our discovery of an LKB1 splice variant (LKB1(S)) that lacks Ser-431, we have reinvestigated this question. In HeLa cells (which lack endogenous LKB1), co-expression with STRAD alpha and MO25 alpha of wild type LKB1, the S431A or S431E mutants of LKB1, or LKB1S gave equal levels of activation of endogenous AMPK. Similarly, recombinant STRAD alpha center dot MO25 alpha complexes containing these LKB1 variants were equally effective at phosphorylating and activating AMPK, BRSK1, and BRSK2 in cell-free assays. Finally, all four LKB1 variants and a truncated LKB1 lacking the C-terminal region altogether were equally effective at causing cell cycle arrest when co-expressed with STRAD alpha and MO25 alpha in the G361 melanoma cell line. Our results do not support the idea that phosphorylation of Ser-431 increases the ability of LKB1 to phosphorylate downstream targets.	[Fogarty, Sarah; Hardie, D. Grahame] Univ Dundee, Div Mol Physiol, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Hardie, DG (corresponding author), Univ Dundee, Div Mol Physiol, Coll Life Sci, Dow St, Dundee DD1 5EH, Scotland.	d.g.hardie@dundee.ac.uk	Hardie, David/Z-1979-2019	Hardie, Grahame/0000-0002-8373-7379	Wellcome Trus; European Commission [LSHM-CT-2004-005272]; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck Co. Inc; Merck KgaA; Pfizer	Wellcome Trus(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck Co. Inc(Merck & Company); Merck KgaA; Pfizer(Pfizer)	This work was also supported by a Wellcome Trust Programme Grant, by EXGENESIS Integrated Project Grant LSHM-CT-2004-005272 of the European Commission, and by the pharmaceutical companies supporting the Division of Signal Transduction Therapy at Dundee (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck & Co. Inc, Merck KgaA and Pfizer). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2000, METH MOL B, V99, P63; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2002, BIOCHEM J, V368, P507, DOI 10.1042/BJ20021284; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490	36	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					77	84		10.1074/jbc.M806152200	http://dx.doi.org/10.1074/jbc.M806152200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18854318	Green Published, hybrid			2022-12-27	WOS:000261974800009
J	Sawano, Y; Hatano, K; Miyakawa, T; Tanokura, M				Sawano, Yoriko; Hatano, Ken-ichi; Miyakawa, Takuya; Tanokura, Masaru			Absolute Side-chain Structure at Position 13 Is Required for the Inhibitory Activity of Bromein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-PROTEINASE-INHIBITOR; BOWMAN-BIRK INHIBITOR; AMINO-ACID-SEQUENCES; BROMELAIN-INHIBITOR; PINEAPPLE STEM; PROTEASE INHIBITORS; SECONDARY STRUCTURE; VI; TRYPSIN; PAPAIN	Bromelain isoinhibitor (bromein), a cysteine proteinase inhibitor from pineapple stem, has a unique double-chain structure. The bromein precursor protein includes three homologous inhibitor domains, each containing an interchain peptide between the light and heavy chains. The interchain peptide in the single-chain precursor is immediately processed by bromelain, a target proteinase. In the present study, to clarify the essential inhibitory site of bromein, we constructed 44 kinds of site-directed and deletion mutants and investigated the inhibitory activity of each toward bromelain. As a result, the complete chemical structure of Leu(13) in the light chain was revealed to be essential for inhibition. Pro(12) prior to the leucine residue was also involved in the inhibitory activity and would control the location of the leucine side chain by the fixed phi dihedral angle of proline. Furthermore, the five-residue length of the interchain peptide was strictly required for the inhibitory activity. On the other hand, no inhibitory activity against bromelain was observed by the substitution of proline for the N terminus residue Thr(15) of the interchain peptide. In summary, these mutational analyses of bromein demonstrated that the appropriate position and conformation of Leu(13) are absolutely crucial for bromelain inhibition.	[Sawano, Yoriko; Miyakawa, Takuya; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Hatano, Ken-ichi] Gunma Univ, Fac Engn, Dept Chem & Chem Biol, Gunma 3768515, Japan	University of Tokyo; Gunma University	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp		Tanokura, Masaru/0000-0001-5072-2480	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research and by the 21st Century Center of Excellence Program from the Ministry of Education, Science, Sports, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARRETT AJ, 1986, BIOCHEM J, V236, P312, DOI 10.1042/bj2360312; Brauer ABE, 2002, BIOCHEMISTRY-US, V41, P10608, DOI 10.1021/bi026050t; Brzin J, 2000, J BIOL CHEM, V275, P20104, DOI 10.1074/jbc.M001392200; HARRY JB, 1970, EUR J BIOCHEM, V16, P174, DOI 10.1111/j.1432-1033.1970.tb01069.x; Hatano K, 2003, BIOL CHEM, V384, P93, DOI 10.1515/BC.2003.010; HATANO K, 1995, EUR J BIOCHEM, V232, P335, DOI 10.1111/j.1432-1033.1995.335zz.x; Hatano K, 1998, J BIOCHEM-TOKYO, V124, P457, DOI 10.1093/oxfordjournals.jbchem.a022135; Hatano K, 1996, P JPN ACAD B-PHYS, V72, P104, DOI 10.2183/pjab.72.104; Hatano K, 1996, BIOCHEMISTRY-US, V35, P5379, DOI 10.1021/bi952754+; Hatano KI, 2006, BIOPOLYMERS, V81, P309, DOI 10.1002/bip.20419; Hatano KI, 2002, BIOL CHEM, V383, P1151, DOI 10.1515/BC.2002.126; Heinrikson R L, 1976, Methods Enzymol, V45, P740; KRIZAJ I, 1993, FEBS LETT, V333, P15, DOI 10.1016/0014-5793(93)80366-3; Lenarcic B, 1998, BIOL CHEM, V379, P105; MITCHEL REJ, 1970, J BIOL CHEM, V245, P3485; Murachi T., 1970, METHOD ENZYMOL, V19, P273, DOI [10.1016/0076-6879(70)19021-5, DOI 10.1016/0076-6879(70)19021-5]; PERLSTEIN S H, 1973, Journal of Supramolecular Structure, V1, P249, DOI 10.1002/jss.400010309; Prakash B, 1996, J MOL EVOL, V42, P560, DOI 10.1007/BF02352286; Qi RF, 2005, ACTA BIOCH BIOPH SIN, V37, P283, DOI 10.1111/j.1745-7270.2005.00048.x; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; REDDY MN, 1975, J BIOL CHEM, V250, P1741; RITONJA A, 1989, FEBS LETT, V247, P419, DOI 10.1016/0014-5793(89)81383-3; Sawano Y, 2005, BIOL CHEM, V386, P491, DOI 10.1515/BC.2005.058; Sawano Y, 2002, J BIOL CHEM, V277, P28222, DOI 10.1074/jbc.M202600200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHRODER E, 1993, FEBS LETT, V315, P38, DOI 10.1016/0014-5793(93)81128-M; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Umezawa H, 1976, Methods Enzymol, V45, P678; WERNER MH, 1991, BIOCHEMISTRY-US, V30, P3356, DOI 10.1021/bi00228a002; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Yamamoto Y, 1999, FEBS LETT, V448, P257, DOI 10.1016/S0014-5793(99)00382-8	32	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36338	36343		10.1074/jbc.M806748200	http://dx.doi.org/10.1074/jbc.M806748200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18948264	Green Published, hybrid			2022-12-27	WOS:000261840500030
J	Liu, XB; Yamada, N; Maruyama, W; Osawa, T				Liu, Xuebo; Yamada, Naruomi; Maruyama, Wakako; Osawa, Toshihiko			Formation of Dopamine Adducts Derived from Brain Polyunsaturated Fatty Acids MECHANISM FOR PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; DOCOSAHEXAENOIC ACID; LIPID HYDROPEROXIDE; INDUCED NEUROTOXICITY; SUBSTANTIA-NIGRA; PROTEIN ADDUCTS; NEURONAL DEATH; LYSINE ADDUCT; IN-VIVO; MITOCHONDRIA	Oxidative stress appears to be directly involved in the pathogenesis of the neurodegeneration of dopaminergic systems in Parkinson disease. In this study, we formed four dopamine modification adducts derived from docosahexaenoic acid (C22:6/omega-3) and arachidonic acid (C18:4/omega-6), which are known as the major polyunsaturated fatty acids in the brain. Upon incubation of dopamine with fatty acid hydroperoxides and an in vivo experiment using rat brain tissue, all four dopamine adducts were detected. Furthermore, hexanoyl dopamine (HED), an arachidonic acid-derived adduct, caused severe cytotoxicity in human dopaminergic neuroblastoma SH-SY5Y cells, whereas the other adducts were only slightly affected. The HED-induced cell death was found to include apoptosis, which also seems to be mediated by reactive oxygen species generation and mitochondrial abnormality. Additionally, the experiments using monoamine transporter inhibitor and mouse embryonic fibroblast NIH-3T3 cells that lack the monoamine transporter indicate that the HED-induced cytotoxicity might specially occur in the neuronal cells. These data suggest that the formation of the docosahexaenoic acid- and arachidonic acid-derived dopamine adducts in vitro and in vivo, and HED, the arachidonic acid- derived dopamine modification adduct, which caused selective cytotoxicity of neuronal cells, may indicate a novel mechanism responsible for the pathogenesis in Parkinson disease.	[Liu, Xuebo; Yamada, Naruomi; Osawa, Toshihiko] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; [Maruyama, Wakako] Natl Inst Longev Sci, Dept Basic Gerontol, Obu 4748522, Japan	Nagoya University	Osawa, T (corresponding author), Furo Cho,Chikusa Ku, Nagoya, Aichi 4648601, Japan.	osawat@agr.nagoya-u.ac.jp						Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bazan NG, 2002, MOL NEUROBIOL, V26, P283, DOI 10.1385/MN:26:2-3:283; Beermann C, 2005, LIPIDS, V40, P211, DOI 10.1007/s11745-005-1377-1; Berman SB, 1999, J NEUROCHEM, V73, P1127, DOI 10.1046/j.1471-4159.1999.0731127.x; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; Buhmann C, 2004, NEUROBIOL DIS, V15, P160, DOI 10.1016/j.nbd.2003.10.003; Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; DIEZ E, 1994, BIOCHEM J, V301, P721, DOI 10.1042/bj3010721; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; Galvan A, 2008, CLIN NEUROPHYSIOL, V119, P1459, DOI 10.1016/j.clinph.2008.03.017; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Gorman AM, 2000, DEV NEUROSCI-BASEL, V22, P348, DOI 10.1159/000017460; GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8; Graumann R, 2002, POL J PHARMACOL, V54, P573; Hadders-Algra M, 2008, J PERINAT MED, V36, P101, DOI 10.1515/JPM.2008.029; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Izumi Y, 2005, J NEUROSCI RES, V79, P849, DOI 10.1002/jnr.20382; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jia ZQ, 2008, BRAIN RES, V1197, P159, DOI 10.1016/j.brainres.2007.12.044; Kato Y, 1999, J BIOL CHEM, V274, P20406, DOI 10.1074/jbc.274.29.20406; Kato Y, 1997, J LIPID RES, V38, P1334; Kato Y, 1998, ARCH BIOCHEM BIOPHYS, V351, P106, DOI 10.1006/abbi.1997.0519; Kawai Y, 2004, BIOCHEM BIOPH RES CO, V313, P271, DOI 10.1016/j.bbrc.2003.11.123; Kawai Y, 2003, J LIPID RES, V44, P1124, DOI 10.1194/jlr.M200442-JLR200; Kawai Y, 2006, J LIPID RES, V47, P1386, DOI 10.1194/jlr.M600091-JLR200; Kita T, 2003, J PHARMACOL SCI, V92, P178; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; LaVoie MJ, 1999, J NEUROCHEM, V73, P2546, DOI 10.1046/j.1471-4159.1999.0732546.x; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu Hai-Yan, 2008, Chinese Journal of Zoology, V43, P26; Long EK, 2008, J NEUROCHEM, V105, P714, DOI 10.1111/j.1471-4159.2007.05175.x; Ma QL, 2007, J NEUROSCI, V27, P14299, DOI 10.1523/JNEUROSCI.3593-07.2007; Maharaj H, 2005, BRAIN RES, V1063, P180, DOI 10.1016/j.brainres.2005.09.041; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Maruyama Wakako, 2002, Journal of Neurology, V249, P6; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Pezzella A, 1997, J MED CHEM, V40, P2211, DOI 10.1021/jm970099t; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Qu Y, 2003, BRAIN RES PROTOC, V12, P16, DOI 10.1016/S1385-299X(03)00057-6; Rapoport SI, 1999, NEUROCHEM RES, V24, P1403, DOI 10.1023/A:1022584707352; Rosenberger TA, 2004, J NEUROCHEM, V88, P1168, DOI 10.1046/j.1471-4159.2003.02246.x; SANER A, 1971, MOL PHARMACOL, V7, P147; Schapira AHV, 2001, ADV NEUROL, V86, P155; Shamoto-Nagai M, 2003, J NEUROSCI RES, V74, P589, DOI 10.1002/jnr.10777; Shibata T, 2006, J BIOL CHEM, V281, P1196, DOI 10.1074/jbc.M509065200; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Wakamatsu K, 2003, J NEUROCHEM, V86, P1015, DOI 10.1046/j.1471-4159.2003.01917.x; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	62	57	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34887	34895		10.1074/jbc.M805682200	http://dx.doi.org/10.1074/jbc.M805682200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922792	Green Published, hybrid			2022-12-27	WOS:000261469100045
J	Janumyan, Y; Cui, QH; Yan, L; Sansam, CG; Valentin, M; Yang, E				Janumyan, Yelena; Cui, Qinghua; Yan, Ling; Sansam, Courtney G.; Valentin, Mayda; Yang, Elizabeth			G(0) Function of BCL2 and BCL-x(L) Requires BAX, BAK, and p27 Phosphorylation by Mirk, Revealing a Novel Role of BAX and BAK in Quiescence Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ENTRY; TRANSGENIC MICE; DEPENDENT KINASE; UBIQUITIN LIGASE; INHIBITOR P27; B-CELLS; P27(KIP1); PROGRESSION; SURVIVAL; DEATH	BCL2 and BCL-x(L) facilitate G(0) quiescence by decreasing RNA content and cell size and up-regulating p27 protein, but the precise mechanism is not understood. We investigated the relationship between cell cycle regulation and the anti-apoptosis function of BCL2 and BCL-x(L). Neither caspase inhibition nor abrogation of mitochondria-dependent apoptosis by BAX and BAK deletion fully recapitulated the G(0) effects of BCL2 or BCL-x(L), suggesting that mechanisms in addition to anti-apoptosis are involved in the cell cycle arrest function of BCL2 or BCL-x(L). We found that BCL2 and BCL-x(L) expression in bax(-/-) bak(-/-) cells did not confer cell cycle effects, consistent with the G(0) function of BCL2 and BCL-x(L) being mediated through BAX or BAK. Stabilization of p27 in G(0) in BCL2 or BCL-x(L) cells was due to phosphorylation of p27 at Ser(10) by the kinase Mirk. In bax(-/-) bak(-/-) cells, total p27 and p27 phosphorylated at Ser(10) were elevated. Re-expression of BAX in bax(-/-) bak(-/-) cells and silencing of BAX and BAK in wild type cells confirmed that endogenous BAX and BAK modulated p27. These data revealed a novel role for BAX and BAK in the regulation of G(0) quiescence.	[Yang, Elizabeth] Vanderbilt Univ, Med Ctr, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Yang, E (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Dept Pediat, 397 PRB, Nashville, TN 37232 USA.	elizabeth.yang@vanderbilt.edu		Janumyan, Yelena/0000-0001-9860-6366; Sansam, Courtney/0000-0002-0253-8643	National Institutes of Health [RO1CA78443]; NATIONAL CANCER INSTITUTE [R01CA078443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA78443. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Bartek J, 2001, NAT CELL BIOL, V3, pE95, DOI 10.1038/35070160; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cepero E, 2005, ONCOGENE, V24, P6354, DOI 10.1038/sj.onc.1208793; Cheng NL, 2004, ONCOGENE, V23, P3770, DOI 10.1038/sj.onc.1207478; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P401; de la Coste A, 1999, CANCER RES, V59, P5017; Deng XB, 2004, J BIOL CHEM, V279, P22498, DOI 10.1074/jbc.M400479200; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Furth PA, 1999, ONCOGENE, V18, P6589, DOI 10.1038/sj.onc.1203073; Greider C, 2002, ONCOGENE, V21, P7765, DOI 10.1038/sj.onc.1205928; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Lim S, 2002, J BIOL CHEM, V277, P25040, DOI 10.1074/jbc.M203257200; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; LINETTE GP, 1995, BLOOD, V86, P1255, DOI 10.1182/blood.V86.4.1255.bloodjournal8641255; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; MARVEL J, 1994, ONCOGENE, V9, P1117; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Murphy KL, 1999, ONCOGENE, V18, P6597, DOI 10.1038/sj.onc.1203099; Olson NE, 2003, J IMMUNOL, V170, P6065, DOI 10.4049/jimmunol.170.12.6065; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pierce RH, 2002, AM J PATHOL, V160, P1555, DOI 10.1016/S0002-9440(10)61101-7; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Vail ME, 2001, CANCER RES, V61, P594; Vairo G, 2000, MOL CELL BIOL, V20, P4745, DOI 10.1128/MCB.20.13.4745-4753.2000; Vairo G, 1996, ONCOGENE, V13, P1511; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976	45	46	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34108	34120		10.1074/jbc.M806294200	http://dx.doi.org/10.1074/jbc.M806294200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818203	Green Published, hybrid			2022-12-27	WOS:000261277700039
J	Sharlow, ER; Giridhar, KV; Lavalle, CR; Chen, J; Leimgruber, S; Barrett, R; Bravo-Altamirano, K; Wipf, P; Lazo, JS; Wang, QJ				Sharlow, Elizabeth R.; Giridhar, Karthik V.; Lavalle, Courtney R.; Chen, Jun; Leimgruber, Stephanie; Barrett, Rebecca; Bravo-Altamirano, Karla; Wipf, Peter; Lazo, John S.; Wang, Q. Jane			Potent and Selective Disruption of Protein Kinase D Functionality by a Benzoxoloazepinolone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MU; D ACTIVATION; MOLECULAR-CLONING; PROSTATE-CANCER; DNA-SYNTHESIS; PKC-MU; PATHWAY; INHIBITORS; TRANSPORT; FAMILY	Protein kinase D (PKD) is a novel family of serine/threonine kinases targeted by the second messenger diacylglycerol. It has been implicated in many important cellular processes and pathological conditions. However, further analysis of PKD in these processes is severely hampered by the lack of a PKD-specific inhibitor that can be readily applied to cells and in animal models. We now report the discovery of the first potent and selective cell-active small molecule inhibitor for PKD, benzoxoloazepinolone (CID755673). This inhibitor was identified from the National Institutes of Health small molecule repository library of 196,173 compounds using a human PKD1 (PKC mu)-based fluorescence polarization high throughput screening assay. CID755673 suppressed half of the PKD1 enzyme activity at 182 nM and exhibited selective PKD1 inhibition when compared with AKT, polo-like kinase 1 (PLK1), CDK activating kinase (CAK), CAMKII alpha, and three different PKC isoforms. Moreover, it was not competitive with ATP for enzyme inhibition. In cell-based assays, CID755673 blocked phorbol ester-induced endogenous PKD1 activation in LNCaP cells in a concentration-dependent manner. Functionally, CID755673 inhibited the known biological actions of PKD1 including phorbol ester-induced class IIa histone deacetylase 5 nuclear exclusion, vesicular stomatitis virus glycoprotein transport from the Golgi to the plasma membrane, and the ilimaquinone-induced Golgi fragmentation. Moreover, CID755673 inhibited prostate cancer cell proliferation, cell migration, and invasion. In summary, our findings indicate that CID755673 is a potent and selective PKD1 inhibitor with valuable pharmacological and cell biological potential.	[Sharlow, Elizabeth R.; Giridhar, Karthik V.; Lavalle, Courtney R.; Chen, Jun; Lazo, John S.; Wang, Q. Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Sharlow, Elizabeth R.; Leimgruber, Stephanie; Barrett, Rebecca; Wipf, Peter; Lazo, John S.] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15261 USA; [Bravo-Altamirano, Karla; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, QJ (corresponding author), E1354 BST, Pittsburgh, PA 15261 USA.	qjw1@pitt.edu	Wang, Qiming Jane/B-6064-2012; Wipf, Peter/AAG-1771-2021	Wang, Qiming Jane/0000-0002-9502-4851; Wipf, Peter/0000-0001-7693-5863; Giridhar, Karthik/0000-0003-4640-9197	National Institutes of Health [R03 MH082038-01, R01 DK066168-01, 1U54MH074411, GM067082]; NATIONAL CANCER INSTITUTE [R01CA129127, R01CA142580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R03 MH082038-01, R01 DK066168-01, 1U54MH074411, and GM067082. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gschwendt M, 1997, J BIOL CHEM, V272, P20742, DOI 10.1074/jbc.272.33.20742; Guha S, 2002, CANCER RES, V62, P1632; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jaggi M, 2005, CANCER RES, V65, P483; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; JOHANNES FJ, 1995, EUR J BIOCHEM, V227, P303, DOI 10.1111/j.1432-1033.1995.tb20389.x; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lu GW, 2007, CELL SIGNAL, V19, P867, DOI 10.1016/j.cellsig.2006.10.012; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sharlow ER, 2008, NAT PROTOC, V3, P1350, DOI 10.1038/nprot.2008.111; Sharlow ER, 2007, ASSAY DRUG DEV TECHN, V5, P723, DOI 10.1089/adt.2007.102; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sonoda H, 2007, J BIOL CHEM, V282, P34085, DOI 10.1074/jbc.M705593200; Stewart JR, 2000, BIOCHEM PHARMACOL, V60, P1355, DOI 10.1016/S0006-2952(00)00450-0; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	37	105	108	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33516	33526		10.1074/jbc.M805358200	http://dx.doi.org/10.1074/jbc.M805358200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829454	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000261183700056
J	Shinomura, T; Nakamura, S; Ito, K; Shirasawa, S; Hook, M; Kimura, JH				Shinomura, Tamayuki; Nakamura, Sayaka; Ito, Kazuo; Shirasawa, Shin-ichi; Hook, Magnus; Kimura, James H.			Adsorption of Follicular Dendritic Cell-secreted Protein (FDC-SP) onto Mineral Deposits APPLICATION OF A NEW STABLE GENE EXPRESSION SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; SALIVARY STATHERIN; CHONDROGENESIS; HYDROXYAPATITE; LINE	Follicular dendritic cell-secreted protein (FDC-SP) is a small secretory protein having structural similarities to statherin, a protein in saliva thought to play a role in calcium retention in saliva. In contrast, FDC-SP is thought to play a role in the immune system associated with germinal centers. We report here the very specific expression of FDC-SP in junctional epithelium at the gingival crevice. This region is very important for the host defense against pathogens and for periodontal protection. To be able to better understand the function of FDC-SP, we developed a novel gene expression system that exploited gene trapping and site-specific gene integration to introduce the protein into a mammalian cell culture system. Using this system we were able to express FDC-SP as a fusion protein with green fluorescent protein in an osteogenic progenitor cell line with long term stability, which we then used to find that the fusion protein specifically adsorbs onto mineral deposits and the surface of hydroxyapatite particles exogenously added to the culture. This adsorption was highly dependent on the structural integrity of FDC-SP. These results suggest that FDC-SP may play an important role, adsorbing onto the surface of cementum and alveolar bone adjacent to periodontal ligament and onto tooth surface at the gingival crevice.	[Shinomura, Tamayuki; Nakamura, Sayaka; Shirasawa, Shin-ichi] Tokyo Med & Dent Univ, Dept Hard Tissue Engn, Tokyo 1138549, Japan; [Ito, Kazuo] Yamagata Univ, Sch Med, Dept Orthopaed Surg, Yamagata 9909585, Japan; [Hook, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Kimura, James H.] Univ Hawaii, John A Burns Sch Med, Dept Surg, Manoa, HI 96822 USA	Tokyo Medical & Dental University (TMDU); Yamagata University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Hawaii System; University of Hawaii Manoa	Shinomura, T (corresponding author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138549, Japan.	t.shinomura.trg@tmd.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [19659485]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 19659485 from the Ministry of Education, Science, Sports and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBank (TM)/EBI Data Bank with accession number( s) AB375112, AB375113, and AB375115.	Al-Alwan M, 2007, J IMMUNOL, V178, P7859, DOI 10.4049/jimmunol.178.12.7859; Amano A, 1996, INFECT IMMUN, V64, P4249, DOI 10.1128/IAI.64.10.4249-4254.1996; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009; Goobes G, 2006, P NATL ACAD SCI USA, V103, P16083, DOI 10.1073/pnas.0607193103; Isogai Z, 1996, CANCER RES, V56, P3902; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kawashima N, 2005, J BONE MINER METAB, V23, P123, DOI 10.1007/s00774-004-0550-y; King KB, 2003, J CELL BIOCHEM, V89, P992, DOI 10.1002/jcb.10571; Marshall AJ, 2002, J IMMUNOL, V169, P2381, DOI 10.4049/jimmunol.169.5.2381; Nakamura S, 2005, BIOCHEM BIOPH RES CO, V338, P1197, DOI 10.1016/j.bbrc.2005.10.076; Niemi LD, 2004, INFECT IMMUN, V72, P782, DOI 10.1128/IAI.72.2.782-787.2004; RAJ PA, 1992, J BIOL CHEM, V267, P5968; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Schroeder HE, 1997, PERIODONTOL 2000, V13, P91, DOI 10.1111/j.1600-0757.1997.tb00097.x; Shinomura T, 2006, BIOCHEM BIOPH RES CO, V341, P167, DOI 10.1016/j.bbrc.2005.12.169; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Shirasawa S, 2005, J BIOCHEM, V137, P79, DOI 10.1093/jb/mvi013; UMEZAWA A, 1992, J CELL PHYSIOL, V151, P197, DOI 10.1002/jcp.1041510125	20	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33658	33664		10.1074/jbc.M800719200	http://dx.doi.org/10.1074/jbc.M800719200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18806264	Green Published, hybrid			2022-12-27	WOS:000261183700072
J	Smith, AJ; Sanders, MA; Juhlmann, BE; Hertzel, AV; Bernlohr, DA				Smith, Anne J.; Sanders, Mark A.; Juhlmann, Brittany E.; Hertzel, Ann V.; Bernlohr, David A.			Mapping of the Hormone-sensitive Lipase Binding Site on the Adipocyte Fatty Acid-binding Protein (AFABP) IDENTIFICATION OF THE CHARGE QUARTET ON THE AFABP/aP2 HELIX-TURN-HELIX DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMAGEJ PLUG-IN; LIPID-BINDING; PERILIPIN; MICE; LIPOLYSIS; DROPLETS; PHOSPHORYLATION; MECHANISMS; FAMILY; ADRP	The hormone-sensitive lipase (HSL) and adipocyte fatty acid-binding protein (AFABP/aP2) form a physical complex that affects basal and hormone-stimulated adipocyte fatty acid efflux. Previous work has established that AFABP/aP2-HSL complex formation requires that HSL be in its activated, phosphorylated form and AFABP/aP2 have a bound fatty acid. To identify the HSL binding site of AFABP/aP2 a combination of alanine-scanning mutagenesis and fluorescence resonance energy transfer was used. Mutation of Asp(17), Asp(18), Lys(21), or Arg(30) (but not other amino acids in the helix-turn-helix region) to alanine inhibited interaction with HSL without affecting fatty acid binding. The cluster of residues on the helical domain of AFABP/aP2 form two ion pairs (Asp(17)-Arg(30) and Asp(18)-Lys(21)) and identifies the region we have termed the charge quartet as the HSL interaction site. To demonstrate direct association, the non-interacting AFABP/aP2-D18K mutant was rescued by complementary mutation of HSL(K196E). The charge quartet is conserved on other FABPs that interact with HSL such as the heart and epithelial FABPs but not on non-interacting proteins from the liver or intestine and may be a general protein interaction domain utilized by fatty acid-binding proteins in regulatory control of lipid metabolism.	[Smith, Anne J.; Juhlmann, Brittany E.; Hertzel, Ann V.; Bernlohr, David A.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sanders, Mark A.] Univ Minnesota Twin Cities, Imaging Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	Bernl001@umn.edu		Juhlmann, Brittany/0000-0002-9000-6179	National Institutes of Health [DK053189, P30 DK050456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK053189, R01DK053189, P30DK050456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK053189 (to D. A. B.) and P30 DK050456 (to the Minnesota Obesity Center). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baar RA, 2005, AM J PHYSIOL-ENDOC M, V288, pE187, DOI 10.1152/ajpendo.00256.2004; BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Helledie T, 2000, J LIPID RES, V41, P1740; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; LiCata VJ, 1998, PROTEINS, V33, P577, DOI 10.1002/(SICI)1097-0134(19981201)33:4<577::AID-PROT10>3.0.CO;2-2; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Shen WJ, 2001, J BIOL CHEM, V276, P49443, DOI 10.1074/jbc.M104095200; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; XU ZH, 1991, J BIOL CHEM, V266, P14367; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; YOUVAN DC, 1997, BIOTECHNOLOGY ALIA, V1, P1	28	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33536	33543		10.1074/jbc.M806732200	http://dx.doi.org/10.1074/jbc.M806732200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18820256	Green Published, hybrid			2022-12-27	WOS:000261183700058
J	Hoffmann, A; Funkner, A; Neumann, P; Juhnke, S; Walther, M; Schierhorn, A; Weininger, U; Balbach, J; Reuter, G; Stubbs, MT				Hoffmann, Anita; Funkner, Andreas; Neumann, Piotr; Juhnke, Susanne; Walther, Matthias; Schierhorn, Angelika; Weininger, Ulrich; Balbach, Jochen; Reuter, Gunter; Stubbs, Milton T.			Biophysical Characterization of Refolded Drosophila Spatzle, a Cystine Knot Protein, Reveals Distinct Properties of Three Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; TOLL RECEPTOR-LIGAND; PRO-PEPTIDE; DORSOVENTRAL AXIS; INNATE IMMUNITY; ACTIVATION; EMBRYO; COMPLEX; BINDING; NGF	The Drosophila Spatzle protein, involved in the embryonic development of the dorsal-ventral axis and in the adult immune response, is expressed as a proprotein and is activated by the serine proteinases Easter or Spatzle-processing enzyme. Proteolytic cleavage generates a 106-amino acid COOH-terminal fragment, C106, homologous to the mature form of nerve growth factor NGF, a cystine knot protein. Through alternative splicing, the Spatzle gene encodes for several isoforms that ( with one exception, the "propeptide isoform") share C106 but differ in the prosequence. Three isoforms have been expressed recombinantly in Escherichia coli strains. The propeptide isoform could be expressed in soluble form and is unstructured according to CD and NMR measurements. Dimeric full-length Spatzle isoforms have been refolded from insoluble inclusion bodies and are able to rescue Spatzle-deficient embryos. Although the two full-length isoforms exhibit similar far-UV CD spectra, large differences in tryptophan fluorescence quenching by the respective pro-parts are observed. Both full-length isoforms exhibited highly cooperative folding transitions. Proteolytic digestion using trypsin resulted in C106, whose unfolding exhibits lower thermodynamic stability and cooperativity compared with the full-length proteins. The structure of C106 reveals a T-shaped dimer with significant differences to NGF and a deep internal cavity. Substantial beta-sheet formation is observed between the two monomers, whereas a long loop containing the single tryptophan residue is disordered in the crystals. Our results suggest that the propeptides stabilize the tertiary structure of the "mature" Spatzle cystine knot.	[Hoffmann, Anita; Funkner, Andreas; Neumann, Piotr; Juhnke, Susanne; Stubbs, Milton T.] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Walther, Matthias; Reuter, Gunter] Univ Halle Wittenberg, Inst Genet, D-06120 Halle, Germany; [Weininger, Ulrich; Balbach, Jochen] Univ Halle Wittenberg, Inst Phys, D-06120 Halle, Germany; [Balbach, Jochen; Stubbs, Milton T.] Univ Halle Wittenberg, Mitteldeutsch Zentrum Struktur & Dynam Prot, D-06120 Halle, Germany; [Schierhorn, Angelika] Max Planck Forsch Sstelle Enzymol Prot Faltung, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Max Planck Society	Stubbs, MT (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	stubbs@biochemtech.uni-halle.de	Stubbs, Milton/ABC-7585-2020	Stubbs, Milton/0000-0003-1278-9013; Weininger, Ulrich/0000-0003-0841-8332	Deutsche Forschungsgemeinschaft [SFB610, GRK1026]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB610 "Protein-Zustande mit Zellbiologischer und Medizinischer Relevanz" and GRK1026 "Conformational Transitions in Macromolecular Interactions." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bax B, 1997, STRUCTURE, V5, P1275, DOI 10.1016/S0969-2126(97)00280-3; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W, 2002, PYMOL 0 99; DeLotto Y, 2001, MOL GEN GENET, V264, P643, DOI 10.1007/s004380000350; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Hillger F, 2005, J BIOL CHEM, V280, P14974, DOI 10.1074/jbc.M414413200; Hoffmann A, 2008, ACTA CRYSTALLOGR F, V64, P707, DOI 10.1107/S1744309108018812; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HOLLAND DR, 1994, J MOL BIOL, V239, P385, DOI 10.1006/jmbi.1994.1380; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kliemannel M, 2004, FEBS LETT, V566, P207, DOI 10.1016/j.febslet.2004.04.034; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; McMahon GA, 1996, BIOCHEM J, V313, P343, DOI 10.1042/bj3130343; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Muller YA, 2002, J BIOL CHEM, V277, P43410, DOI 10.1074/jbc.M206438200; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; Rehm T, 2002, STRUCTURE, V10, P1613, DOI 10.1016/S0969-2126(02)00894-8; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; STEIN D, 1991, CELL, V65, P725, DOI 10.1016/0092-8674(91)90381-8; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955	49	32	34	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32598	32609		10.1074/jbc.M801815200	http://dx.doi.org/10.1074/jbc.M801815200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790733	hybrid			2022-12-27	WOS:000260893700049
J	Ono, K; Condron, MM; Ho, L; Wang, J; Zhao, W; Pasinetti, GM; Teplow, DB				Ono, Kenjiro; Condron, Margaret M.; Ho, Lap; Wang, Jun; Zhao, Wei; Pasinetti, Giulio M.; Teplow, David B.			Effects of Grape Seed-derived Polyphenols on Amyloid beta-Protein Self-assembly and Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILS IN-VITRO; ALZHEIMERS-DISEASE; CROSS-LINKING; SYNAPTIC PLASTICITY; WINE CONSUMPTION; APOLIPOPROTEIN-E; TRANSGENIC MICE; ALPHA-SYNUCLEIN; FRENCH PARADOX; MOUSE MODEL	Epidemiological evidence suggests that moderate consumption of red wine reduces the incidence of Alzheimer disease (AD). To study the protective effects of red wine, experiments recently were executed in the Tg2576 mouse model of AD. These studies showed that a commercially available grape seed polyphenolic extract, MegaNatural-AZ (MN), significantly attenuated AD-type cognitive deterioration and reduced cerebral amyloid deposition (Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., Chen, L., Humala, N., Teplow, D. B., and Pasinetti, G. M. (2008) J. Neurosci. 28, 6388-6392). To elucidate the mechanistic bases for these observations, here we used CD spectroscopy, photo-induced cross-linking of unmodified proteins, thioflavin T fluorescence, size exclusion chromatography, and electron microscopy to examine the effects of MN on the assembly of the two predominant disease-related amyloid beta-protein alloforms, A beta 40 and A beta 42. We also examined the effects of MN on A beta-induced cytotoxicity by assaying 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide metabolism and lactate dehydrogenase activity in A beta-treated, differentiated pheochromocytoma (PC12) cells. Initial studies revealed that MN blocked A beta fibril formation. Subsequent evaluation of the assembly stage specificity of the effect showed thatMNwas able to inhibit protofibril formation, pre-protofibrillar oligomerization, and initial coil -> alpha-helix/beta-sheet secondary structure transitions. Importantly, MN had protective effects in assays of cytotoxicity in which MN was mixed with A beta prior to peptide assembly or following assembly and just prior to peptide addition to cells. These data suggest that MN is worthy of consideration as a therapeutic agent for AD.	[Ho, Lap; Wang, Jun; Zhao, Wei; Pasinetti, Giulio M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Ono, Kenjiro; Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Ono, Kenjiro] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol, Kanazawa, Ishikawa 9208640, Japan; [Ho, Lap; Wang, Jun; Zhao, Wei; Pasinetti, Giulio M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Ho, Lap; Pasinetti, Giulio M.] Bronx Vet Adm Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Kanazawa University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Dept Psychiat, 1468 Madison Ave,Rm 14-94C, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu; dteplow@ucla.edu		Zhao, Wei/0000-0002-3449-2395; Pasinetti, Giulio/0000-0002-1524-5196	National Institutes of Health [PO1 AT004511]; NCCAM; Department of Veterans Affairs Merit Review; James J. Peters Veterans Affairs Medical Center Geriatric Research Education Clinical Center Program, and Polyphenolics; Japan Human Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research; Alzheimer's Association; Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers at UCLA;  [AG027818]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); James J. Peters Veterans Affairs Medical Center Geriatric Research Education Clinical Center Program, and Polyphenolics; Japan Human Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research; Alzheimer's Association(Alzheimer's Association); Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers at UCLA; ; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AT004511 through the NCCAM (to L. H., G. M. P., and D. B. T.) and Grant AG027818(to (D. B. T.). This work also was supported by the Department of Veterans Affairs Merit Review grant and a grant from the James J. Peters Veterans Affairs Medical Center Geriatric Research Education Clinical Center Program, and Polyphenolics (to G. M. P.); grants from the Japan Human Science Foundation and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to K. O.); and grants from the Alzheimer's Association, and the Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers at UCLA (to D. B. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dorozynski A, 1997, BRIT MED J, V314, P997; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Ferrieres J, 2004, HEART, V90, P107, DOI 10.1136/heart.90.1.107; Flamini R, 2003, MASS SPECTROM REV, V22, P218, DOI 10.1002/mas.10052; Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hirohata M, 2007, BIOCHEMISTRY-US, V46, P1888, DOI 10.1021/bi061540x; HO L, 2008, J ALZHEIMER IN PRESS; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Le Bars PL, 2002, NEUROPSYCHOBIOLOGY, V45, P19, DOI 10.1159/000048668; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LETENNEUR L, 1993, ANN INTERN MED, V118, P317, DOI 10.7326/0003-4819-118-4-199302150-00028; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naiki H, 1996, LAB INVEST, V74, P374; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	53	153	173	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32176	32187		10.1074/jbc.M806154200	http://dx.doi.org/10.1074/jbc.M806154200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815129	Green Published, hybrid			2022-12-27	WOS:000260893700004
J	Wang, JZ; Sen, J; Rong, LJ; Caffrey, M				Wang, Jizhen; Sen, Jayita; Rong, Lijun; Caffrey, Michael			Role of the HIV gp120 Conserved Domain 1 in Processing and Viral Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; MUTATIONAL ANALYSIS; GP41; CLEAVAGE; ECTODOMAIN; FURIN; USAGE	The importance of the N-terminal region of HIV gp120 conserved domain 1 (gp120-C1) to envelope function has been examined by alanine-scanning mutagenesis and subsequent characterization of the mutagenic effects on viral entry; envelope expression, processing, and incorporation; and gp120 association with gp41. With respect to the wild-type gp120, mutational effects on viral entry fall into two classes: functional, as defined by > 20% entry with respect to wild type, and impaired, as defined by < 20% entry with respect to wild type. Based on Western blot analyses of cell lysates and virions, the entry impairment of W35A, V38A, Y39A, Y40A, G41A, V42A, and I52A is due primarily to disruption of envelope processing. The entry impairment of P43A and W45A is apparently due to a combination of effects on processing and incorporation into virions. In contrast, the entry impairment of V44A and F53A is primarily due to disruption of the gp120-gp41 interaction, which results in dissociation of gp120 from the virion. We present a model for gp120-C1 interactions with gp120-C5 and the gp41 disulfide loop in unprocessed gp160 and processed gp120/gp41.	[Wang, Jizhen; Sen, Jayita; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Rong, Lijun] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Caffrey, M (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	caffrey@uic.edu			National Institutes of Health [RO1 AI47674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI47674 ( to M. C.).	Bazan HA, 1998, J VIROL, V72, P4485, DOI 10.1128/JVI.72.5.4485-4491.1998; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BIRD C, 1990, J BIOL CHEM, V265, P19151; Bjorndal A, 1997, J VIROL, V71, P7478; BOSCH V, 1990, J VIROL, V64, P2337, DOI 10.1128/JVI.64.5.2337-2344.1990; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Douglas NW, 1997, J MOL BIOL, V273, P122, DOI 10.1006/jmbi.1997.1277; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FREED EO, 1989, J VIROL, V63, P4670, DOI 10.1128/JVI.63.11.4670-4675.1989; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Guilhaudis L, 2002, EUR J BIOCHEM, V269, P4860, DOI 10.1046/j.1432-1033.2002.03187.x; Hansen JE, 1996, PROTEINS, V25, P1, DOI 10.1002/(SICI)1097-0134(199605)25:1<1::AID-PROT1>3.0.CO;2-N; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; IVEYHOYLE M, 1991, J VIROL, V65, P2682, DOI 10.1128/JVI.65.5.2682-2685.1991; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Moulard M, 1999, VIRUS RES, V60, P55, DOI 10.1016/S0168-1702(99)00002-7; Otteken A, 1996, J VIROL, V70, P3407, DOI 10.1128/JVI.70.6.3407-3415.1996; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Sen J, 2008, BIOCHEMISTRY-US, V47, P7788, DOI 10.1021/bi800227z; Sen J, 2007, PROTEIN SCI, V16, P1236, DOI 10.1110/ps.072771407; Wyatt R, 1997, J VIROL, V71, P9722, DOI 10.1128/JVI.71.12.9722-9731.1997	31	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32644	32649		10.1074/jbc.M806099200	http://dx.doi.org/10.1074/jbc.M806099200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815131	Green Published, hybrid			2022-12-27	WOS:000260893700054
J	Zhang, Q; Hong, M; Duan, P; Pan, Z; Ma, JJ; You, GF				Zhang, Qiang; Hong, Mei; Duan, Peng; Pan, Zui; Ma, Jianjie; You, Guofeng			Organic Anion Transporter OAT1 Undergoes Constitutive and Protein Kinase C-regulated Trafficking through a Dynamin- and Clathrin-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; EXPRESSION CLONING; ENDOCYTOSIS; PHOSPHORYLATION; IDENTIFICATION; INHIBITION; MEMBRANE; INTERNALIZATION; GLYCOSYLATION	Organic anion transporter 1 (OAT1) mediates the body disposition of a diverse array of environmental toxins and clinically important drugs. Therefore, understanding the regulation of this transporter has profound clinical significance. We previously demonstrate that OAT1 activity was down-regulated by activation of protein kinase C (PKC), kinetically revealed as a decrease in the maximum transport velocity V-max without significant change in the substrate affinity K-m of the transporter. In the current study, we showed that OAT1 constitutively internalized from and recycled back to the plasma membrane, and PKC activation accelerated OAT1 internalization without affecting OAT1 recycling. We further showed that treatment of OAT1expressing cells with concanavalin A, depletion of K+ from the cells, or transfection of dominant negative mutants of dynamin-2 or Eps15 into the cells, all of which block the clathrin-dependent endocytotic pathway, significantly blocked constitutive and PKC-regulated OAT1 internalization. We finally showed that OAT1 colocalized with transferrin, a marker for clathrin-dependent endocytosis, at the cell surface and in the EEA1-positive early endosomes. Together, our findings demonstrated for the first time that (i) OAT1 constitutively traffics between plasma membrane and recycling endosomes, (ii) PKC activation down-regulates OAT1 activity by altering already existent OAT1 trafficking, and (iii) OAT1 internalization occurs partly through a dynamin- and clathrin-dependent pathway.	[Zhang, Qiang; Hong, Mei; Duan, Peng; You, Guofeng] Rutgers State Univ, Dept Pharmaceut, Piscataway, NJ 08854 USA; [You, Guofeng] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Pan, Zui; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	You, GF (corresponding author), Rutgers State Univ, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	gyou@rci.rutgers.edu		Pan, Zui/0000-0003-4105-901X	National Institutes of Health [R01-DK 60034, R01-GM 079123]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK 60034 and R01-GM 079123 ( to G.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benmerah A, 1999, J CELL SCI, V112, P1303; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Cihlar T, 1999, MOL PHARMACOL, V56, P570, DOI 10.1124/mol.56.3.570; Cobb BR, 2002, AM J PHYSIOL-LUNG C, V282, pL12, DOI 10.1152/ajplung.2002.282.1.L12; Ekaratanawong S, 2004, J PHARMACOL SCI, V94, P297, DOI 10.1254/jphs.94.297; Gekle M, 1999, AM J PHYSIOL-RENAL, V277, pF251, DOI 10.1152/ajprenal.1999.277.2.F251; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Halpin PA, 1996, AM J PHYSIOL-REG I, V271, pR1372, DOI 10.1152/ajpregu.1996.271.5.R1372; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hong M, 2005, J BIOL CHEM, V280, P32285, DOI 10.1074/jbc.M501447200; HORI R, 1993, AM J PHYSIOL, V264, pF975, DOI 10.1152/ajprenal.1993.264.6.F975; Idkowiak-Baldys J, 2006, J BIOL CHEM, V281, P22321, DOI 10.1074/jbc.M512540200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kazanietz MG, 2001, ARCH BIOCHEM BIOPHYS, V388, P74, DOI 10.1006/abbi.2000.2264; Klahr S, 1998, KIDNEY INT, V54, P286; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Klahr S, 2000, KIDNEY PHYSL PATHOPH, P2473; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675; Li DL, 1998, AM J PHYSIOL-RENAL, V275, pF863, DOI 10.1152/ajprenal.1998.275.6.F863; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lu R, 1999, AM J PHYSIOL-RENAL, V276, pF295, DOI 10.1152/ajprenal.1999.276.2.F295; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Miller DS, 1998, AM J PHYSIOL-RENAL, V274, pF156, DOI 10.1152/ajprenal.1998.274.1.F156; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nagai K, 2006, ARCH BIOCHEM BIOPHYS, V452, P29, DOI 10.1016/j.abb.2006.06.006; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Rangel LBA, 2002, BBA-BIOMEMBRANES, V1564, P310, DOI 10.1016/S0005-2736(02)00472-8; Sekine T, 1998, FEBS LETT, V429, P179, DOI 10.1016/S0014-5793(98)00585-7; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Shin HJ, 2007, HEPATOLOGY, V45, P1046, DOI 10.1002/hep.21596; Shuprisha A, 2000, AM J PHYSIOL-RENAL, V278, pF104, DOI 10.1152/ajprenal.2000.278.1.F104; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; Takano M, 1996, AM J PHYSIOL-RENAL, V271, pF469, DOI 10.1152/ajprenal.1996.271.2.F469; Tanaka K, 2004, J BIOL CHEM, V279, P14961, DOI 10.1074/jbc.M400197200; Teter K, 1998, J BIOL CHEM, V273, P19625, DOI 10.1074/jbc.273.31.19625; Tremblay F, 2003, FRONT BIOSCI-LANDMRK, V8, pD1072, DOI 10.2741/1137; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Villar SR, 2005, KIDNEY INT, V68, P2704, DOI 10.1111/j.1523-1755.2005.00741.x; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wolff NA, 2003, J AM SOC NEPHROL, V14, P1959, DOI 10.1097/01.ASN.0000079040.55124.25; Wolff NA, 1997, FEBS LETT, V417, P287, DOI 10.1016/S0014-5793(97)01304-5; You GF, 2004, MED RES REV, V24, P762, DOI 10.1002/med.20014; You GF, 2004, CURR DRUG METAB, V5, P55, DOI 10.2174/1389200043489207; You GF, 2000, J BIOL CHEM, V275, P10278, DOI 10.1074/jbc.275.14.10278; You GF, 2002, MED RES REV, V22, P602, DOI 10.1002/med.10019; Youngblood GL, 2004, AM J PHYSIOL-RENAL, V287, pF236, DOI 10.1152/ajprenal.00012.2004; Zhang XH, 2002, AM J PHYSIOL-RENAL, V283, pF124, DOI 10.1152/ajprenal.00367.2001; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200; Zhou FF, 2007, AM J PHYSIOL-ENDOC M, V293, pE57, DOI 10.1152/ajpendo.00696.2006; Zhou FF, 2006, EUR J PHARM SCI, V27, P518, DOI 10.1016/j.ejps.2005.09.008; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	59	78	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32570	32579		10.1074/jbc.M800298200	http://dx.doi.org/10.1074/jbc.M800298200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818201	hybrid, Green Published			2022-12-27	WOS:000260893700046
J	Leboeuf, AC; Levy, SF; Gaylord, M; Bhattacharya, A; Singh, AK; Jordan, MA; Wilson, L; Feinstein, SC				Leboeuf, Adria C.; Levy, Sasha F.; Gaylord, Michelle; Bhattacharya, Arnab; Singh, Ambuj K.; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.			FTDP-17 Mutations in Tau Alter the Regulation of Microtubule Dynamics AN "ALTERNATIVE CORE" MODEL FOR NORMAL AND PATHOLOGICAL TAU ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY-PROMOTING FACTORS; NEURITE OUTGROWTH; PROTEIN-TAU; NEURODEGENERATIVE DISORDERS; NEUROFIBRILLARY PATHOLOGY; INDIVIDUAL MICROTUBULES; KINETIC STABILIZATION; ALZHEIMERS-DISEASE; MISSENSE MUTATIONS; DEMENTIA FTDP-17	Mutations affecting either the structure or regulation of the microtubule-associated protein Tau cause neuronal cell death and dementia. However, the molecular mechanisms mediating these deleterious effects remain unclear. Among the most characterized activities of Tau is the ability to regulate microtubule dynamics, known to be essential for proper cell function and viability. Here we have tested the hypothesis that Tau mutations causing neurodegeneration also alter the ability of Tau to regulate the dynamic instability behaviors of microtubules. Using in vitro microtubule dynamics assays to assess average microtubule growth rates, microtubule growth rate distributions, and catastrophe frequencies, we found that all tested mutants possessing amino acid substitutions or deletions mapping to either the repeat or interrepeat regions of Tau do indeed compromise its ability to regulate microtubule dynamics. Further mutational analyses suggest a novel mechanism of Tau regulatory action based on an "alternative core" of microtubule binding and regulatory activities composed of two repeats and the interrepeat between them. In this model, the interrepeat serves as the primary regulator of microtubule dynamics, whereas the flanking repeats serve as tethers to properly position the interrepeat on the microtubule. Importantly, since there are multiple interrepeats on each Tau molecule, there are also multiple cores on each Tau molecule, each with distinct mechanistic capabilities, thereby providing significant regulatory potential. Taken together, the data are consistent with a microtubule misregulation mechanism for Tau-mediated neuronal cell death and provide a novel mechanistic model for normal and pathological Tau action.	[Leboeuf, Adria C.; Levy, Sasha F.; Gaylord, Michelle; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Leboeuf, Adria C.; Levy, Sasha F.; Gaylord, Michelle; Jordan, Mary Ann; Wilson, Leslie; Feinstein, Stuart C.] Univ Calif Santa Barbara, Dept Mol & Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Bhattacharya, Arnab; Singh, Ambuj K.] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Leboeuf, Adria C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Leboeuf, Adria C.] Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; [Levy, Sasha F.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Bhattacharya, Arnab] Indian Inst Technol, Dept Comp Sci & Engn, Kanpur 208016, Uttar Pradesh, India	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; New York University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Feinstein, SC (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Bldg 571,Rm 6129, Santa Barbara, CA 93106 USA.	feinstei@lifesci.ucsb.edu	LeBoeuf, Adria C/F-1837-2017	LeBoeuf, Adria C/0000-0002-2931-1510; Bhattacharya, Arnab/0000-0001-7331-0788; Levy, Sasha/0000-0002-0923-1636	National Institutes of Health [NS-35010, NS-13560, CA-57291]; National Science Foundation [ITR-0331697]; IIT Kanpur; NATIONAL CANCER INSTITUTE [R01CA057291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013560, R01NS035010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); IIT Kanpur; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-35010 (to S. C. F.), NS-13560 (to L. W.), and CA-57291 (to M. A. J.). This work was also supported by a National Science Foundation predoctoral fellowship (to S. F. L.), an initiation grant from IIT Kanpur (to A. B.), and National Science Foundation Grant ITR-0331697 (to A. K. S., S. C. F., and L. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Arrasate M, 1999, FEBS LETT, V446, P199, DOI 10.1016/S0014-5793(99)00210-0; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Bhattacharya A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-339; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Delobel P, 2002, J BIOL CHEM, V277, P9199, DOI 10.1074/jbc.M107716200; DeTure M, 2000, BRAIN RES, V853, P5, DOI 10.1016/S0006-8993(99)02124-1; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Duff K, 2005, NAT MED, V11, P826, DOI 10.1038/nm0805-826; ESMAELIAZAD B, 1994, J CELL SCI, V107, P869; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; FELLOUS A, 1977, EUR J BIOCHEM, V78, P167, DOI 10.1111/j.1432-1033.1977.tb11726.x; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P15009, DOI 10.1021/bi035722s; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan Mary Ann, 2008, P47, DOI 10.1007/978-1-59745-336-3_3; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; LEVY SF, 2005, J BIOL CHEM; Liu CWA, 1999, CELL MOTIL CYTOSKEL, V43, P232, DOI 10.1002/(SICI)1097-0169(1999)43:3<232::AID-CM6>3.0.CO;2-7; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Rizzini C, 2000, J NEUROPATH EXP NEUR, V59, P990, DOI 10.1093/jnen/59.11.990; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; TOSO RJ, 1993, BIOCHEMISTRY-US, V32, P1285, DOI 10.1021/bi00056a013; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WERMAN M, 1985, COMPUT VISION GRAPH, V32, P328, DOI 10.1016/0734-189X(85)90055-6; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yen SH, 1999, BRAIN PATHOL, V9, P695; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	65	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36406	36415		10.1074/jbc.M803519200	http://dx.doi.org/10.1074/jbc.M803519200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940799	Green Published, hybrid			2022-12-27	WOS:000261840500038
J	Sakr, SW; Potter-Perigo, S; Kinsella, MG; Johnson, PY; Braun, KR; Goueffic, Y; Rosenfeld, ME; Wight, TN				Sakr, Sana W.; Potter-Perigo, Susan; Kinsella, Michael G.; Johnson, Pamela Y.; Braun, Kathleen R.; Goueffic, Yann; Rosenfeld, Michael E.; Wight, Thomas N.			Hyaluronan Accumulation Is Elevated in Cultures of Low Density Lipoprotein Receptor-deficient Cells and Is Altered by Manipulation of Cell Cholesterol Content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELL; FAT-FED RABBITS; ENDOPLASMIC-RETICULUM STRESS; WHHL-RABBIT; FAMILIAL HYPERCHOLESTEROLEMIA; PLASMA-MEMBRANE; ANIMAL-MODEL; LDL RECEPTOR; GLYCOSAMINOGLYCAN SYNTHESIS; ATHEROSCLEROTIC LESIONS	The extracellular matrix molecule hyaluronan (HA) accumulates in human atherosclerotic lesions. Yet the reasons for this accumulation have not been adequately addressed. Because abnormalities in lipid metabolism promote atherosclerosis, we have asked whether disrupted cholesterol homeostasis alters HA accumulation in low density lipoprotein receptor-deficient cell cultures. Cultured aortic smooth muscle cells (ASMC) from Watanabe heritable hyperlipidemic (WHHL) rabbits and skin fibroblasts from homozygous patients with familial hypercholesterolemia accumulated 2-4-fold more HA than corresponding cells from age- and sex-matched normolipidemic rabbits and individuals. This occurred in both cell-associated and secreted HA fractions and was independent of cell density or medium serum concentration. WHHL ASMC cultures synthesized twice the proportion of high molecular mass HA(> 2 x 10(6) Da) as normal rabbit ASMC but showed a lower capacity to degrade exogenous [H-3] HA. Most importantly, cholesterol depletion or blocking cholesterol synthesis markedly reduced HA accumulation in WHHL ASMC cultures, whereas cholesterol replenishment or stimulation of cholesterol synthesis restored elevated HA levels. We conclude the following: 1) maintaining normal HA levels in cell cultures requires normal cell cholesterol homeostasis; 2) HA degradation may contribute to but is not the predominant mechanism to increase high molecular mass HA accumulation in low density lipoprotein receptor-deficient WHHL ASMC cultures; and 3) elevated accumulation of HA depends on cellular or membrane cholesterol content and, potentially, intact cholesterol-rich microdomains.	[Sakr, Sana W.; Potter-Perigo, Susan; Kinsella, Michael G.; Johnson, Pamela Y.; Braun, Kathleen R.; Goueffic, Yann; Wight, Thomas N.] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA; [Rosenfeld, Michael E.] Univ Washington, Dept Nutr, Seattle, WA 98195 USA; [Rosenfeld, Michael E.] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; [Rosenfeld, Michael E.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wight, TN (corresponding author), Benaroya Res Inst Virginia Mason, Hope Heart Program, 1201 9th Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org	Goueffic, Yann/L-7438-2015		National Institutes of Health [HL 18645, DK 02456]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 18645 and DK 02456. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGREN UM, 1994, ANAL BIOCHEM, V217, P311, DOI 10.1006/abio.1994.1124; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BJORKERUD S, 1995, BBA-MOL CELL RES, V1268, P237, DOI 10.1016/0167-4889(95)00065-Z; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chajara A, 2001, ATHEROSCLEROSIS, V157, P293, DOI 10.1016/S0021-9150(00)00727-9; Chajara A, 2000, ARTERIOSCL THROM VAS, V20, P1480, DOI 10.1161/01.ATV.20.6.1480; CHEN M, 1995, BBA-MOL BASIS DIS, V1272, P101, DOI 10.1016/0925-4439(95)00073-D; Christian AE, 1997, J LIPID RES, V38, P2264; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Dattilo JB, 1998, ANN VASC SURG, V12, P168, DOI 10.1007/s100169900136; ECSEDI GG, 1986, METHOD FIND EXP CLIN, V8, P535; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evanko SP, 1998, AM J PATHOL, V152, P533; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; FU ST, 1972, ARCH PATHOL, V94, P466; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; IKEDA U, 1994, ATHEROSCLEROSIS, V110, P87, DOI 10.1016/0021-9150(94)90071-X; Ilangumaran S, 1998, BLOOD, V91, P3901; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Kaneko E, 2000, CORONARY ARTERY DIS, V11, P599, DOI 10.1097/00019501-200012000-00005; KITA T, 1981, P NATL ACAD SCI-BIOL, V78, P2268, DOI 10.1073/pnas.78.4.2268; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEVESQUE H, 1994, ATHEROSCLEROSIS, V105, P51, DOI 10.1016/0021-9150(94)90007-8; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; MCGUIRE PG, 1987, J CELL PHYSIOL, V133, P267, DOI 10.1002/jcp.1041330210; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Papakonstantinou E, 1998, ATHEROSCLEROSIS, V138, P79, DOI 10.1016/S0021-9150(98)00006-9; PHILIPSON LH, 1984, J BIOL CHEM, V259, P5017; PREHM P, 1984, BIOCHEM J, V220, P597, DOI 10.1042/bj2200597; Pummill PE, 2003, J BIOL CHEM, V278, P19808, DOI 10.1074/jbc.M301097200; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P680, DOI 10.1161/01.ATV.10.5.680; ROSENFELD ME, 1987, ARTERIOSCLEROSIS, V7, P9, DOI 10.1161/01.ATV.7.1.9; ROSENFELD ME, 1987, ARTERIOSCLEROSIS, V7, P24, DOI 10.1161/01.ATV.7.1.24; ROSENFELD ME, 1988, ARTERIOSCLEROSIS, V8, P338, DOI 10.1161/01.ATV.8.4.338; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; SCOTT LJ, 1987, ATHEROSCLEROSIS, V63, P145, DOI 10.1016/0021-9150(87)90114-6; Seike M, 2006, J DERMATOL SCI, V41, P197, DOI 10.1016/j.jdermsci.2005.10.008; Sheehan KM, 2004, LIFE SCI, V75, P3087, DOI 10.1016/j.lfs.2004.02.038; SHIMADA Y, 1981, EUR J BIOCHEM, V118, P557, DOI 10.1111/j.1432-1033.1981.tb05555.x; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Soccio RE, 2005, J BIOL CHEM, V280, P19410, DOI 10.1074/jbc.M501778200; SRINIVASAN SR, 1980, ATHEROSCLEROSIS, V36, P25, DOI 10.1016/0021-9150(80)90195-1; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; TANZAWA K, 1980, FEBS LETT, V118, P81, DOI 10.1016/0014-5793(80)81223-3; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; UNDERHILL CB, 1979, J CELL BIOL, V82, P475, DOI 10.1083/jcb.82.2.475; WATANABE Y, 1980, ATHEROSCLEROSIS, V36, P261, DOI 10.1016/0021-9150(80)90234-8; Weigel PH, 2006, J BIOL CHEM, V281, P36542, DOI 10.1074/jbc.M606529200; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WIECZOREK AJ, 1985, ARTERIOSCLEROSIS, V5, P434, DOI 10.1161/01.ATV.5.5.434; WIGHT TN, 1999, GLYCOFORUM; Wilkinson TS, 2006, J CELL PHYSIOL, V206, P378, DOI 10.1002/jcp.20468; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; YAMAMOTO T, 1986, SCIENCE, V232, P1230, DOI 10.1126/science.3010466; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497	77	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36195	36204		10.1074/jbc.M807772200	http://dx.doi.org/10.1074/jbc.M807772200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18948257	hybrid, Green Published			2022-12-27	WOS:000261840500014
J	Shawgo, ME; Shelton, SN; Robertson, JD				Shawgo, Mary E.; Shelton, Shary N.; Robertson, John D.			Caspase-mediated Bak Activation and Cytochrome c Release during Intrinsic Apoptotic Cell Death in Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBERS; SERINE-PROTEASE; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL EVENTS; CLEAVAGE; PROTEINS; REQUIREMENT; XIAP; MECHANISMS; APOPTOSOME	Mitochondrial outer membrane permeabilization and the release of intermembrane space proteins, such as cytochrome c, are early events during intrinsic (mitochondria-mediated) apoptotic signaling. Although this process is generally accepted to require the activation of Bak or Bax, the underlying mechanism responsible for their activation during true intrinsic apoptosis is not well understood. In the current study, we investigated the molecular requirements necessary for Bak activation using distinct clones of Bax-deficient Jurkat T-lymphocytes in which the intrinsic pathway had been inhibited. Cells stably overexpressing Bcl-2/Bcl-xL or stably depleted of Apaf-1 were equally resistant to apoptosis induced by the DNA-damaging anticancer drug etoposide as determined by phosphatidylserine externalization and caspase activation. Strikingly, characterization of mitochondrial apoptotic events in all three drug-resistant cell lines revealed that, without exception, resistance to apoptosis was associated with an absence of Bak activation, cytochrome c release, and mitochondrial membrane depolarization. Furthermore, we found that etoposide-induced apoptosis and mitochondrial events were inhibited in cells stably overexpressing either full-length X-linked inhibitor of apoptosis protein (XIAP) or the BIR1/BIR2 domains of XIAP. Combined, our findings suggest that caspase-mediated positive amplification of initial mitochondrial changes can determine the threshold for irreversible activation of the intrinsic apoptotic pathway.	[Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Robertson, JD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jrobertson3@kumc.edu			National Institutes of Health [K22 ES011647]; IDeA Networks of Biomedical Research Excellence Program of the NCRR [P20 RR016475]; National Center for Research Resources [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDeA Networks of Biomedical Research Excellence Program of the NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 ES011647 ( to J. D. R.) and P20 RR016475 from the IDeA Networks of Biomedical Research Excellence Program of the NCRR. The Flow Cytometry Core is supported in part by National Institutes of Health Grant P20 RR016443 from the National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Berger AB, 2006, CELL RES, V16, P961, DOI 10.1038/sj.cr.7310112; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Petak I, 2000, CANCER RES, V60, P2643; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	49	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35532	35538		10.1074/jbc.M807656200	http://dx.doi.org/10.1074/jbc.M807656200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18927073	hybrid, Green Published			2022-12-27	WOS:000261687900025
J	Brandt, S; von Stetten, D; Gunther, M; Hildebrandt, P; Frankenberg-Dinkel, N				Brandt, Sonja; von Stetten, David; Guenther, Mina; Hildebrandt, Peter; Frankenberg-Dinkel, Nicole			The Fungal Phytochrome FphA from Aspergillus nidulans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGROBACTERIUM-TUMEFACIENS; HISTIDINE KINASES; LIGHT; CHROMOPHORE; BACTERIOPHYTOCHROMES; REVEALS; TRANSCRIPTION; NEUROSPORA; ATTACHMENT; SENSORS	The red light-sensing photoreceptor FphA from Aspergillus nidulans is involved in the regulation of developmental processes in response to light. Here we present extended biochemical and spectroscopic characterization of recombinant FphA using a synthetic gene with host-adapted codon usage. The recombinant photosensory domain FphAN753 was shown to display all features of a bona fide phytochrome. It covalently binds biliverdin as chromophore and undergoes red/far-red light-inducible photoconversion with both parent states being protonated. The large N-terminal variable extension of FphA exerts a stabilizing effect on the active Pfr state. Upon substitution of the highly conserved histidine 504, involved in the hydrogen-bonding network of the protein moiety and the chromophore, chromophore attachment and photoreversibility were completely impaired. FphA is a functional sensor histidine kinase with a strong red-light-dependent autophosphorylation activity. Furthermore, intermolecular trans-phosphorylation to the response regulator domain of a second monomer could be demonstrated. Interestingly, co-incubation of FphA and FphA variants led to enhanced autophosphorylation, including the "inactive" Pr form. The latter observed phenomenon might suggest that auto- and trans-phosphorylation activity is modulated by additional interaction partners leading to variable phosphorylation events that trigger a specific output response.	[Brandt, Sonja; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, D-44780 Bochum, Germany; [von Stetten, David; Guenther, Mina; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, Sekretariat PC14, D-10623 Berlin, Germany	Ruhr University Bochum; Technical University of Berlin	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44780 Bochum, Germany.	nicole.frankenberg@rub.de	Hildebrandt, Peter/J-5658-2014; Frankenberg-Dinkel, Nicole/C-1058-2011	Hildebrandt, Peter/0000-0003-1030-5900; Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; von Stetten, David/0000-0001-7906-9788	Volkswagen Foundation; Deutsche Forschungsgemeinschaft [SFB 498]	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Volkswagen Foundation (to N.F.D.) and funds from the Deutsche Forschungsgemeinschaft (Grant SFB 498 to P. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Azuma N, 2007, BIOSCI BIOTECH BIOCH, V71, P2493, DOI 10.1271/bbb.70292; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Bhoo SH, 1997, J AM CHEM SOC, V119, P11717, DOI 10.1021/ja972875s; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; CHERRY JR, 1992, P NATL ACAD SCI USA, V89, P5039, DOI 10.1073/pnas.89.11.5039; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Eichenberg K, 2000, FEBS LETT, V470, P107, DOI 10.1016/S0014-5793(00)01301-6; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Hubschmann T, 2001, EUR J BIOCHEM, V268, P2055, DOI 10.1046/j.1432-1327.2001.02083.x; Jorissen HJMM, 2002, EUR J BIOCHEM, V269, P2662, DOI 10.1046/j.1432-1033.2002.02928.x; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kim D, 2006, BIOCHEMISTRY-US, V45, P14772, DOI 10.1021/bi061429r; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; Lamparter T, 2005, BIOCHEMISTRY-US, V44, P8461, DOI 10.1021/bi047510g; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; LI LM, 1992, J BIOL CHEM, V267, P19204; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; MOONEY JL, 1990, GENE DEV, V4, P1473, DOI 10.1101/gad.4.9.1473; Pao GM, 1997, J MOL EVOL, V44, P605, DOI 10.1007/PL00006183; Pendrak ML, 2004, J BIOL CHEM, V279, P3426, DOI 10.1074/jbc.M311550200; PURSCHWITZ J, 2008, MOL GEN GEN IN PRESS; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Purschwitz J, 2006, CURR OPIN MICROBIOL, V9, P566, DOI 10.1016/j.mib.2006.10.011; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; VIERSTRA RD, 1982, P NATL ACAD SCI-BIOL, V79, P5272, DOI 10.1073/pnas.79.17.5272; Von Stetten D., 2008, THESIS TU BERLIN; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	42	63	66	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34605	34614		10.1074/jbc.M805506200	http://dx.doi.org/10.1074/jbc.M805506200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18931394	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000261469100015
J	Rickert, KW; Kelley, P; Byrne, NJ; Diehl, RE; Hall, DL; Montalvo, AM; Reid, JC; Shipman, JM; Thomas, BW; Munshi, SK; Darke, PL; Su, HP				Rickert, Keith W.; Kelley, Paul; Byrne, Noel J.; Diehl, Ronald E.; Hall, Dawn L.; Montalvo, Allison M.; Reid, John C.; Shipman, Jennifer M.; Thomas, Bradley W.; Munshi, Sanjeev K.; Darke, Paul L.; Su, Hua-Poo			Structure of Human Prostasin, a Target for the Regulation of Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNELS; CRYSTAL-STRUCTURE; NA+ CHANNELS; ACTIVATION; EXPRESSION; THROMBIN; PROTEIN; CRYSTALLIZATION; LOCALIZATION; SUBSTRATE	Prostasin (also called channel activating protease-1 (CAP1)) is an extracellular serine protease implicated in the modulation of fluid and electrolyte regulation via proteolysis of the epithelial sodium channel. Several disease states, particularly hypertension, can be affected by modulation of epithelial sodium channel activity. Thus, understanding the biochemical function of prostasin and developing specific agents to inhibit its activity could have a significant impact on a widespread disease. We report the expression of the prostasin proenzyme in Escherichia coli as insoluble inclusion bodies, refolding and activating via proteolytic removal of the N-terminal propeptide. The refolded and activated enzyme was shown to be pure and monomeric, with kinetic characteristics very similar to prostasin expressed from eukaryotic systems. Active prostasin was crystallized, and the structure was determined to 1.45 angstrom resolution. These apoprotein crystals were soaked with nafamostat, allowing the structure of the inhibited acyl-enzyme intermediate structure to be determined to 2.0 angstrom resolution. Comparison of the inhibited and apoprotein forms of prostasin suggest a mechanism of regulation through stabilization of a loop which interferes with substrate recognition.	[Rickert, Keith W.; Kelley, Paul; Byrne, Noel J.; Diehl, Ronald E.; Hall, Dawn L.; Montalvo, Allison M.; Reid, John C.; Shipman, Jennifer M.; Thomas, Bradley W.; Munshi, Sanjeev K.; Darke, Paul L.; Su, Hua-Poo] Merck Res Labs, Dept Global Struct Biol, West Point, PA 19486 USA	Merck & Company	Rickert, KW (corresponding author), WP26-354,POB 4, West Point, PA 19486 USA.	keith_rickert@merck.com; hua-poo_su@merck.com		Su, Hua-Poo/0000-0003-3808-7837				Abbenante Giovanni, 2005, Med Chem, V1, P71, DOI 10.2174/1573406053402569; Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; ALOBEIDI AM, 1988, J BIOL CHEM, V263, P8642; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7; CORRAN PH, 1989, HPLC MACROMOLECULES, P127; Czapinska H, 2004, J MOL BIOL, V344, P1005, DOI 10.1016/j.jmb.2004.09.088; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHLHAMMER H, 1975, J MOL BIOL, V98, P683, DOI 10.1016/S0022-2836(75)80004-0; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Greig ER, 2004, J PATHOL, V204, P84, DOI 10.1002/path.1613; HEARN MTW, 2002, HPLC BIOL MACROMOLEC, P99; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Hink-Schauer C, 2002, J BIOL CHEM, V277, P50923, DOI 10.1074/jbc.M207962200; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MEYER E, 1988, ACTA CRYSTALLOGR B, V44, P26, DOI 10.1107/S0108768187007559; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Ramjee MK, 2000, THROMB RES, V98, P559, DOI 10.1016/S0049-3848(00)00206-1; Rohr KB, 2006, J MOL BIOL, V357, P195, DOI 10.1016/j.jmb.2005.12.037; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Tong ZY, 2004, AM J PHYSIOL-LUNG C, V287, pL928, DOI 10.1152/ajplung.00160.2004; TSUKADA H, 1985, J MOL BIOL, V184, P703, DOI 10.1016/0022-2836(85)90314-6; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Williams SP, 2005, CURR OPIN CHEM BIOL, V9, P371, DOI 10.1016/j.cbpa.2005.06.007; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; YU JX, 1994, J BIOL CHEM, V269, P18843	47	26	26	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34864	34872		10.1074/jbc.M805262200	http://dx.doi.org/10.1074/jbc.M805262200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922802	Green Published, hybrid			2022-12-27	WOS:000261469100042
J	Lin, G; Tsu, C; Dick, L; Zhou, XK; Nathan, C				Lin, Gang; Tsu, Christopher; Dick, Lawrence; Zhou, Xi K.; Nathan, Carl			Distinct Specificities of Mycobacterium tuberculosis and Mammalian Proteasomes for N-Acetyl Tripeptide Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; MICROBIAL PERSISTENCE; TUBERCLE BACILLI; INHIBITORS; RESISTANCE; LIBRARIES; ACTIVATOR; POTENT; ACIDS; PA28	The proteasome of Mycobacterium tuberculosis (Mtb) is a validated and drug-treatable target for therapeutics. To lay groundwork for developing peptide-based inhibitors with a useful degree of selectivity for the Mtb proteasome over those of the host, we used a library of 5,920 N-acetyl tripeptide-aminomethylcoumarins to contrast the substrate preferences of the recombinant Mtb proteasome wild type and open gate mutant, the Rhodococcus erythropolis proteasome, and the bovine proteasome with activator PA28. The Mtb proteasome was distinctive in strictly preferring P1 = tryptophan, particularly in combination with P3 = glycine, proline, lysine or arginine. Screening results were validated with Michalis-Menten kinetic analyses of 21 oligopeptide aminomethyl-coumarin substrates. Bortezomib, a proteasome inhibitor in clinical use, and 17 analogs varying only at P1 were used to examine the differential impact of inhibitors on human and Mtb proteasomes. The results with the inhibitor panel confirmed those with the substrate panel in demonstrating differential preferences of Mtb and mammalian proteasomes at the P1 amino acid. Changing P1 in bortezomib from Leu to m-CF3-Phe led to a 220-fold increase in IC50 against the human proteasome, whereas changing a P1 Ala to m-FPhe decreased the IC50 400-fold against the Mtb proteasome. The change of a P1 Ala tom-Cl-Phe led to an 8000-fold shift in inhibitory potency in favor of the Mtb proteasome, resulting in 8-fold selectivity. Combinations of preferred amino acids at different sites may thus improve the species selectivity of peptide-based inhibitors that target the Mtb proteasome.	[Lin, Gang; Nathan, Carl] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Tsu, Christopher; Dick, Lawrence] Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; [Zhou, Xi K.] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10065 USA	Cornell University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Cornell University	Lin, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	gal2005@med.cornell.edu; cnathan@med.cornell.edu	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405	National Institutes of Health [PO1-AI06293]; Milstein Program in Chemical Biology of Infectious Diseases; National Institutes of Health Clinical and Translational Science Award [UL1-RR024996]; William Randolph Hearst Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milstein Program in Chemical Biology of Infectious Diseases; National Institutes of Health Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Randolph Hearst Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1-AI06293. This work was also supported by the Milstein Program in Chemical Biology of Infectious Diseases, in part by National Institutes of Health Clinical and Translational Science Award UL1-RR024996. The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Goldberg AL, 1995, COLD SPRING HARB SYM, V60, P479, DOI 10.1101/SQB.1995.060.01.052; Groll M, 2002, CHEM BIOL, V9, P655, DOI 10.1016/S1074-5521(02)00144-8; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Harris JL, 2001, CHEM BIOL, V8, P1131, DOI 10.1016/S1074-5521(01)00080-1; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Kropff M, 2007, BRIT J HAEMATOL, V138, P330, DOI 10.1111/j.1365-2141.2007.06656.x; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; McCUNE ROBERT M., 1966, J EXP MED, V123, P469, DOI 10.1084/jem.123.3.469; MCGUIRE MJ, 1989, BIOCHEM BIOPH RES CO, V160, P911, DOI 10.1016/0006-291X(89)92521-7; Nazif T, 2001, P NATL ACAD SCI USA, V98, P2967, DOI 10.1073/pnas.061028898; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Sheppeck JE, 2000, BIOORG MED CHEM LETT, V10, P2639, DOI 10.1016/S0960-894X(00)00545-X; Song XL, 1996, J BIOL CHEM, V271, P26410, DOI 10.1074/jbc.271.42.26410; Song XL, 1997, J BIOL CHEM, V272, P27994, DOI 10.1074/jbc.272.44.27994; Spigelman MK, 2007, J INFECT DIS, V196, pS28, DOI 10.1086/518663; Stein RL, 1996, BIOCHEMISTRY-US, V35, P3899, DOI 10.1021/bi952262x; Wang CC, 2003, J BIOL CHEM, V278, P15800, DOI 10.1074/jbc.M300195200; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05	31	41	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34423	34431		10.1074/jbc.M805324200	http://dx.doi.org/10.1074/jbc.M805324200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18829465	hybrid, Green Published			2022-12-27	WOS:000261277700070
J	Bennett, RP; Salter, JD; Liu, X; Wedekind, JE; Smith, HC				Bennett, Ryan P.; Salter, Jason D.; Liu, Xiang; Wedekind, Joseph E.; Smith, Harold C.			APOBEC3G Subunits Self-associate via the C-terminal Deaminase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 VIF; B MESSENGER-RNA; ACTIVATION-INDUCED DEAMINASE; RETRACTED ARTICLE. SEE; CYTIDINE DEAMINASE; CRYSTAL-STRUCTURE; HIV-1 INFECTION; VIRAL-RNA; IDENTIFICATION; MODEL	Human APOBEC3G (hA3G) is a cytidine deaminase active on HIV single-stranded DNA. Small angle x-ray scattering and molecular envelope restorations predicted a C-terminal dimeric model for RNA-depleted hA3G in solution. Each subunit was elongated, suggesting that individual domains of hA3G are solvent-exposed and therefore may interact with other macromolecules even as isolated substructures. In this study, co-immunoprecipitation and in-cell quenched fluorescence resonance energy transfer assays reveal that hA3G forms RNA-independent oligomers through interactions within its C terminus. Residues 209-336 were necessary and sufficient for homoligomerization. N-terminal domains of hA3G were unable to multimerize but remained functional for Gag and viral infectivity factor (Vif) interactions when expressed apart from the C terminus. These findings corroborate the small angle x-ray scattering structural model and are instructive for development of high throughput screens that target specific domains and their functions to identify HIV/AIDS therapeutics.	[Bennett, Ryan P.; Salter, Jason D.; Wedekind, Joseph E.; Smith, Harold C.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Liu, Xiang] Univ Rochester, Sch Med & Dent, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Wedekind, JE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	joseph.wedekind@rochester.edu; harold.smith@rochester.edu		Smith, Harold/0000-0001-6257-6791	National Institutes of Health [AI058789, AI076085, T32 AI49815]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076085, R33AI076085, T32AI049815, R21AI058789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health from the NIAID Grants AI058789 (to H. C. S.) and AI076085 (to J. E. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health HIV Training Grant T32 AI49815 to S. Dewhurst.; We thank Dr. Jay Reeder for use of a fluorescence microscope and for helpful discussions on quantification of data and software manipulations and Dr. Baek Kim for providing the HIV viral DNA constructs. The following reagents were obtained from the National Institutes of Health AIDS Research and Reference Reagent Program, Division of AIDS, NIAID: HIV-1 p24 monoclonal antibody (183-H12-5C) from Dr. B. Chesebro and K. Wehrly and HIV-1 Vif monoclonal antibody (antibody number 319) from Dr. M. H. Malim.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Brar SS, 2008, DNA REPAIR, V7, P77, DOI 10.1016/j.dnarep.2007.08.002; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kuratani M, 2005, J BIOL CHEM, V280, P16002, DOI 10.1074/jbc.M414541200; LAU PP, 1994, P NATL ACAD SCI USA, V91, P8522, DOI 10.1073/pnas.91.18.8522; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; MACELREVEY C, 2008, RNA DNA EDITING MOL, P369; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Oka K, 1997, J BIOL CHEM, V272, P1456, DOI 10.1074/jbc.272.39.24387; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith HC, 2007, METHOD ENZYMOL, V424, P389, DOI 10.1016/S0076-6879(07)24018-2; Smith HC, 1998, METHODS, V15, P27, DOI 10.1006/meth.1998.0603; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wang JS, 2006, J BIOL CHEM, V281, P19115, DOI 10.1074/jbc.M601645200; Wang XJ, 2007, J BIOL CHEM, V282, P1585, DOI 10.1074/jbc.M610150200; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378	65	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33329	33336		10.1074/jbc.M803726200	http://dx.doi.org/10.1074/jbc.M803726200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18842592	hybrid, Green Published			2022-12-27	WOS:000261183700037
J	McLean, KJ; Carroll, P; Lewis, DG; Dunford, AJ; Seward, HE; Neeli, R; Cheesman, MR; Marsollier, L; Douglas, P; Smith, WE; Rosenkrands, I; Cole, ST; Leys, D; Parish, T; Munro, AW				McLean, Kirsty J.; Carroll, Paul; Lewis, D. Geraint; Dunford, Adrian J.; Seward, Harriet E.; Neeli, Rajasekhar; Cheesman, Myles R.; Marsollier, Laurent; Douglas, Philip; Smith, W. Ewen; Rosenkrands, Ida; Cole, Stewart T.; Leys, David; Parish, Tanya; Munro, Andrew W.			Characterization of Active Site Structure in CYP121 A CYTOCHROME P450 ESSENTIAL FOR VIABILITY OF MYCOBACTERIUM TUBERCULOSIS H37Rv	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOPHYSICAL CHARACTERIZATION; CRYSTAL-STRUCTURE; AZOLE ANTIFUNGALS; ESSENTIAL GENES; HEME-PROTEINS; IN-VITRO; EXPRESSION; P450BM3; AGENTS; IDENTIFICATION	Mycobacterium tuberculosis (Mtb) cytochrome P450 gene CYP121 is shown to be essential for viability of the bacterium in vitro by gene knock-out with complementation. Production of CYP121 protein in Mtb cells is demonstrated. Minimum inhibitory concentration values for azole drugs against Mtb H37Rv were determined, the rank order of which correlated well with K-d values for their binding to CYP121. Solution-state spectroscopic, kinetic, and thermodynamic studies and crystal structure determination for a series of CYP121 active site mutants provide further insights into structure and biophysical features of the enzyme. Pro(346) was shown to control heme cofactor conformation, whereas Arg(386) is a critical determinant of heme potential, with an unprecedented 280-mV increase in heme iron redox potential in a R386L mutant. A homologous Mtb redox partner system was reconstituted and transported electrons faster to CYP121 R386L than to wild type CYP121. Hemepotential was not perturbed in a F338H mutant, suggesting that a proposed P450 superfamily-wide role for the phylogenetically conserved phenylalanine in heme thermodynamic regulation is unlikely. Collectively, data point to an important cellular role for CYP121 and highlight its potential as a novel Mtb drug target.	[McLean, Kirsty J.; Lewis, D. Geraint; Dunford, Adrian J.; Neeli, Rajasekhar; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Carroll, Paul; Parish, Tanya] Ctr Infect Dis, Inst Cell & Mol Sci, London E1 2AT, England; [Seward, Harriet E.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Cheesman, Myles R.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England; [Marsollier, Laurent] Inst Pasteur, Unite Genet Mol Bacterienne, Paris, France; [Douglas, Philip; Smith, W. Ewen] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland; [Rosenkrands, Ida] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark; [Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Stn 15, CH-1015 Lausanne, Switzerland	University of Manchester; University of London; Queen Mary University London; University of Leicester; University of East Anglia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Strathclyde; Statens Serum Institut; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	McLean, KJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	Kirsty.McLean@Manchester.ac.uk; Andrew.Munro@Manchester.ac.uk	Marsollier, Laurent/P-6178-2015; Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044; Laurent, Marsollier/0000-0001-5497-5995	United Kingdom Biotechnology and Biological Sciences Research Council [BBS/B/06288/2, C19757/2]; European Union [NM4TB]; Royal Society Leverhulme Trust Research Fellowship; Biotechnology and Biological Sciences Research Council [C19757/2, BBS/B/06288/2] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Royal Society Leverhulme Trust Research Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Grants BBS/B/06288/2 and C19757/2 and by European Union FP6 Project NM4TB. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a Royal Society Leverhulme Trust Research Fellowship. To whom correspondence may be addressed. Tel.: 44-161-3065151; Fax: 44-161-3068918; E-mail: Andrew. Munro@Manchester.ac.uk.	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Aoyama Y, 1998, J BIOCHEM-TOKYO, V124, P694; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Burguiere A, 2005, MICROBIOL-SGM, V151, P2087, DOI 10.1099/mic.0.27938-0; Byrne ST, 2007, J MED MICROBIOL, V56, P1047, DOI 10.1099/jmm.0.47058-0; Chen ZC, 2004, BIOCHEMISTRY-US, V43, P1798, DOI 10.1021/bi034920g; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Dunford AJ, 2007, J BIOL CHEM, V282, P24816, DOI 10.1074/jbc.M702958200; Dutton P L, 1978, Methods Enzymol, V54, P411; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer F, 2002, EUR J BIOCHEM, V269, P3005, DOI 10.1046/j.1432-1033.2002.02989.x; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gao Q, 2005, MICROBIOL-SGM, V151, P5, DOI 10.1099/mic.0.27539-0; Guardiola-Diaz HM, 2001, BIOCHEM PHARMACOL, V61, P1463, DOI 10.1016/S0006-2952(01)00571-8; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; HILDEBRANDT P, 1989, EUR J BIOCHEM, V186, P291, DOI 10.1111/j.1432-1033.1989.tb15208.x; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Jackson CJ, 2000, FEMS MICROBIOL LETT, V192, P159, DOI 10.1111/j.1574-6968.2000.tb09375.x; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Matsumoto M, 2007, CURR TOP MED CHEM, V7, P499, DOI 10.2174/156802607780059727; Matsuura K, 2005, J BIOL CHEM, V280, P9088, DOI 10.1074/jbc.M413042200; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2003, BIOCHEM J, V372, P317, DOI 10.1042/BJ20021692; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Parish T, 2000, J BACTERIOL, V182, P5715, DOI 10.1128/JB.182.20.5715-5720.2000; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Podust LM, 2004, STRUCTURE, V12, P1937, DOI 10.1016/j.str.2004.08.009; POULOS TL, 1987, BIOCHEMISTRY-US, V26, P8165, DOI 10.1021/bi00399a022; Rosenkrands I, 2008, TUBERCULOSIS, V88, P335, DOI 10.1016/j.tube.2007.12.001; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Smith SJ, 2003, BIOPOLYMERS, V70, P620, DOI 10.1002/bip.10502; Spigelman MK, 2007, J INFECT DIS, V196, pS28, DOI 10.1086/518663; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101	54	98	104	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33406	33416		10.1074/jbc.M802115200	http://dx.doi.org/10.1074/jbc.M802115200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18818197	hybrid, Green Published			2022-12-27	WOS:000261183700045
J	Basu, S; Pathak, SK; Chatterjee, G; Pathak, S; Basu, J; Kundu, M				Basu, Sanchita; Pathak, Sushil Kumar; Chatterjee, Gargi; Pathak, Shresh; Basu, Joyoti; Kundu, Manikuntala			Helicobacter pylori Protein HP0175 Transactivates Epidermal Growth Factor Receptor through TLR4 in Gastric Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; TYROSINE PHOSPHORYLATION; GASTROINTESTINAL-TRACT; SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; FACTOR EXPRESSION; CANCER-CELLS; LIPID RAFTS; PROLIFERATION; INFECTION	The pathophysiology of Helicobacter pylori-associated gastroduodenal diseases, ulcerogenesis, and carcinogenesis is intimately linked to activation of epidermal growth factor receptor (EGFR) and production of vascular endothelial growth factor (VEGF). Extracellular virulence factors, such as CagA and VacA, have been proposed to regulate EGFR activation and VEGF production in gastric epithelial cells. We demonstrate that the H. pylori secretory protein, HP0175, by virtue of its ability to bind TLR4, transactivates EGFR and stimulates EGFR-dependent VEGF production in the gastric cancer cell line AGS. Knock-out of the hp0175 gene attenuates the ability of the resultant H. pylori strain to activate EGFR or to induce VEGF production. HP0175-induced activation of EGFR is preceded by translocation of TLR4 into lipid rafts. In lipid rafts, the Src kinase family member Lyn interacts with TLR4, leading to tyrosine phosphorylation of TLR4. Knockdown of Lyn prevents HP0175-induced activation of EGFR and VEGF production. Tyrosine-phosphorylated TLR4 interacts with EGFR. This interaction is necessary for the activation of EGFR. Disruption of lipid rafts with methyl beta-cyclodextrin prevents HP0175-induced tyrosine phosphorylation of TLR4 and activation of EGFR. This mechanism of transactivation of EGFR is novel and distinct from that of metalloprotease-dependent shedding of EGF-like ligands, leading to autocrine activation of EGFR. It provides new insight into our understanding of the receptor cross-talk network.	[Basu, Sanchita; Pathak, Sushil Kumar; Chatterjee, Gargi; Pathak, Shresh; Basu, Joyoti; Kundu, Manikuntala] Bose Inst, Dept Chem, Kolkata 700009, W Bengal, India	Department of Science & Technology (India); Bose Institute	Kundu, M (corresponding author), Bose Inst, Dept Chem, 93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, W Bengal, India.	manikuntala@vsnl.net	PATHAK, SHRESH/I-6938-2012; Bhattacharyya, Asima/J-7423-2012	Bhattacharyya, Asima/0000-0001-7292-6644; PATHAK, SHRESH/0000-0001-5275-1816	Department of Atomic Energy, Government of India; Indian Council of Medical Research	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported in part by grants from the Department of Atomic Energy, Government of India, and the Indian Council of Medical Research (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Basak C, 2005, J IMMUNOL, V174, P5672, DOI 10.4049/jimmunol.174.9.5672; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Bhattacharyya A, 2002, BIOCHEM J, V368, P121, DOI 10.1042/BJ20020555; BLASER MJ, 1995, CANCER RES, V55, P2111; BROWN LF, 1993, CANCER RES, V53, P4727; Caputo R, 2003, CLIN CANCER RES, V9, P2015; Caruso R, 2006, AM J PATHOL, V169, P268, DOI 10.2353/ajpath.2006.050841; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; de Bono JS, 2002, TRENDS MOL MED, V8, pS19, DOI 10.1016/S1471-4914(02)02306-7; Eriksson U, 1999, CURR TOP MICROBIOL, V237, P41; Evdonin AL, 2006, FEBS LETT, V580, P6674, DOI 10.1016/j.febslet.2006.11.024; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; GOLDMAN CK, 1993, MOL BIOL CELL, V4, P121, DOI 10.1091/mbc.4.1.121; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Johns TG, 2003, P NATL ACAD SCI USA, V100, P15871, DOI 10.1073/pnas.2036503100; Keates S, 2001, J BIOL CHEM, V276, P48127, DOI 10.1074/jbc.M107630200; Keates S, 2007, J INFECT DIS, V196, P95, DOI 10.1086/518440; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Maity A, 2000, CANCER RES, V60, P5879; Mandal D, 2005, J BIOL CHEM, V280, P39460, DOI 10.1074/jbc.M506928200; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Romano M, 2006, NAT CLIN PRACT GASTR, V3, P622, DOI 10.1038/ncpgasthep0634; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slichenmyer WJ, 2001, SEMIN ONCOL, V28, P67, DOI 10.1053/sonc.2001.28557; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Strowski MZ, 2004, FASEB J, V18, P218, DOI 10.1096/fj.03-0055fje; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Yoshimura T, 2002, J INFECT DIS, V185, P332, DOI 10.1086/338191; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	45	42	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32369	32376		10.1074/jbc.M805053200	http://dx.doi.org/10.1074/jbc.M805053200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806258	hybrid			2022-12-27	WOS:000260893700024
J	Legan, SK; Rebrin, I; Mockett, RJ; Radyuk, SN; Klichko, VI; Sohal, RS; Orr, WC				Legan, Susan K.; Rebrin, Igor; Mockett, Robin J.; Radyuk, Svetlana N.; Klichko, Vladimir I.; Sohal, Rajindar S.; Orr, William C.			Overexpression of Glucose-6-phosphate Dehydrogenase Extends the Life Span of Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE REDOX STATE; SUPEROXIDE-DISMUTASE; TRANSGENIC DROSOPHILA; MECHANISMS; EXPRESSION; EXTENSION; REDUCTASE; CATALASE; OXIDANT; STRESS	The redox state of tissues tends to become progressively more prooxidizing during the aging process. The hypothesis tested in this study was that enhancement of reductive capacity by overexpression of glucose-6-phosphate dehydrogenase (G6PD), a key enzyme for NADPH biosynthesis, could protect against oxidative stress and extend the life span of transgenic Drosophila melanogaster. Overexpression of G6PD was achieved by combining a UAS-G6PD responder transgene at one of four independent loci with either a broad expression (armadillo-GAL4, Tubulin-GAL4, C23-GAL4, and da-GAL4) or a neuronal driver (D42-GAL4 and Appl-GAL4). The mean life spans of G6PD overexpressor flies were extended, in comparison with driver and responder controls, as follows: armadillo-GAL4 (up to 38%), Tubulin-GAL4 (up to 29%), C23-GAL4 (up to 27%), da-GAL4 (up to 24%), D42-GAL4 (up to 18%), and Appl-GAL4 (up to 16%). The G6PD enzymatic activity was increased, as were the levels of NADPH, NADH, and the GSH/GSSG ratio. Resistance to experimental oxidative stress was enhanced. Furthermore, metabolic rates and fertility were essentially the same in G6PD overexpressors and control flies. Collectively, the results demonstrate that enhancement of the NADPH biosynthetic capability can extend the life span of a relatively long-lived strain of flies, which supports the oxidative stress hypothesis of aging.	[Legan, Susan K.; Radyuk, Svetlana N.; Klichko, Vladimir I.; Orr, William C.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Rebrin, Igor; Mockett, Robin J.; Sohal, Rajindar S.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	Southern Methodist University; University of Southern California	Orr, WC (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	borr@smu.edu		Radyuk, Svetlana/0000-0002-3467-5255	National Institutes of Health, NIA [RO1 AG15122]; NATIONAL INSTITUTE ON AGING [R01AG015122] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grant RO1 AG15122. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bayne ACV, 2005, BIOCHEM J, V391, P277, DOI 10.1042/BJ20041872; Beutler E, 1971, RED CELL METABOLISM, P62; CLARK AG, 1988, GENETICS, V119, P565; Corcoran CM, 1996, GENE, V173, P241, DOI 10.1016/0378-1119(96)00094-7; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; LUZZATTO L, 1967, BIOCHIM BIOPHYS ACTA, V146, P18, DOI 10.1016/0005-2744(67)90069-1; Mockett RJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P260, DOI 10.1006/abbi.1999.1460; Mockett RJ, 2002, METHOD ENZYMOL, V349, P213, DOI 10.1016/S0076-6879(02)49336-6; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Rebrin I, 2004, BIOCHEM J, V382, P131, DOI 10.1042/BJ20040506; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STANTON RC, 1991, J BIOL CHEM, V266, P12442; Sun JT, 1999, MOL CELL BIOL, V19, P216; Tatar M, 1999, AM NAT, V154, pS67, DOI 10.1086/303284; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005	28	86	90	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32492	32499		10.1074/jbc.M805832200	http://dx.doi.org/10.1074/jbc.M805832200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809674	Green Published, hybrid			2022-12-27	WOS:000260893700037
J	Tsang, E; Giannetti, AM; Shaw, D; Dinh, M; Tse, JKY; Gandhi, S; Ho, HD; Wang, S; Papp, E; Bradshaw, JM				Tsang, Emily; Giannetti, Anthony M.; Shaw, David; Dinh, Marie; Tse, Joyce K. Y.; Gandhi, Shaan; Ho, Hoangdung; Wang, Sandra; Papp, Eva; Bradshaw, J. Michael			Molecular Mechanism of the Syk Activation Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; PROTEIN-TYROSINE KINASE; PHOSPHOTYROSINE-BINDING DOMAIN; PHOSPHORYLATED ITAM PEPTIDE; STEADY-STATE KINETICS; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; LOOP TYROSINES; ZAP-70; INHIBITION	Many immune signaling pathways require activation of the Syk tyrosine kinase to link ligation of surface receptors to changes in gene expression. Despite the central role of Syk in these pathways, the Syk activation process remains poorly understood. In this work we quantitatively characterized the molecular mechanism of Syk activation in vitro using a real time fluorescence kinase assay, mutagenesis, and other biochemical techniques. We found that dephosphorylated full-length Syk demonstrates a low initial rate of substrate phosphorylation that increases during the kinase reaction due to autophosphorylation. The initial rate of Syk activity was strongly increased by either pre-autophosphorylation or binding of phosphorylated immune tyrosine activation motif peptides, and each of these factors independently fully activated Syk. Deletion mutagenesis was used to identify regions of Syk important for regulation, and residues 340-356 of the SH2 kinase linker region were identified to be important for suppression of activity before activation. Comparison of the activation processes of Syk and Zap-70 revealed that Syk is more readily activated by autophosphorylation than Zap-70, although both kinases are rapidly activated by Src family kinases. We also studied Syk activity in B cell lysates and found endogenous Syk is also activated by phosphorylation and immune tyrosine activation motif binding. Together these experiments show that Syk functions as an "OR-gate" type of molecular switch. This mechanism of switch-like activation helps explain how Syk is both rapidly activated after receptor binding but also sustains activity over time to facilitate longer term changes in gene expression.	[Tsang, Emily; Dinh, Marie; Tse, Joyce K. Y.; Gandhi, Shaan; Papp, Eva; Bradshaw, J. Michael] Roche Palo Alto LLC, Dept Inflammat Discovery, Palo Alto, CA 94304 USA; [Giannetti, Anthony M.] Roche Palo Alto LLC, Dept Biophys & Crystallog, Palo Alto, CA 94304 USA; [Shaw, David; Ho, Hoangdung; Wang, Sandra] Roche Palo Alto LLC, Dept Mol & Prot Sci, Palo Alto, CA 94304 USA	Roche Holding; Roche Holding; Roche Holding	Bradshaw, JM (corresponding author), 3431 Hillview Ave,Mailstop R2-101, Palo Alto, CA 94304 USA.	Michael.bradshaw@roche.com		Gandhi, Shaan-Chirag/0000-0001-6272-5531				Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Arias-Palomo E, 2007, BBA-PROTEINS PROTEOM, V1774, P1493, DOI 10.1016/j.bbapap.2007.10.008; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Bajpai M, 2008, EXPERT OPIN INV DRUG, V17, P641, DOI [10.1517/13543784.17.5.641, 10.1517/13543784.17.5.641 ]; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dinh M, 2007, J BIOL CHEM, V282, P8768, DOI 10.1074/jbc.M609920200; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Flaswinkel H, 1995, Semin Immunol, V7, P21, DOI 10.1016/1044-5323(95)90004-7; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Grucza RA, 1999, BIOCHEMISTRY-US, V38, P5024, DOI 10.1021/bi9829938; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kappes DJ, 2007, IMMUNITY, V27, P691, DOI 10.1016/j.immuni.2007.11.002; Kimura T, 1996, MOL CELL BIOL, V16, P1471; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kumaran S, 2003, P NATL ACAD SCI USA, V100, P14828, DOI 10.1073/pnas.2432867100; LI M, 2008, ANAL BIOCH IN PRESS; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; MALMQVIST M, 1993, NATURE, V361, P186, DOI 10.1038/361186a0; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Oh H, 2007, J BIOL CHEM, V282, P33760, DOI 10.1074/jbc.M704846200; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; Prehoda KE, 2002, CURR OPIN CELL BIOL, V14, P149, DOI 10.1016/S0955-0674(02)00307-1; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Shults MD, 2005, NAT METHODS, V2, P277, DOI 10.1038/NMETH747; Shults MD, 2006, ANAL BIOCHEM, V352, P198, DOI 10.1016/j.ab.2006.03.003; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Ulanova M, 2005, EXPERT OPIN THER TAR, V9, P901, DOI 10.1517/14728222.9.5.901; Visco C, 2000, BIOCHEMISTRY-US, V39, P2784, DOI 10.1021/bi991840x; Wong BR, 2004, EXPERT OPIN INV DRUG, V13, P743, DOI 10.1517/13543784.13.7.743; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 1998, J IMMUNOL, V161, P4366	43	103	106	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32650	32659		10.1074/jbc.M806340200	http://dx.doi.org/10.1074/jbc.M806340200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818202	hybrid			2022-12-27	WOS:000260893700055
J	Cyr, JL; Heinen, CD				Cyr, Jennifer L.; Heinen, Christopher D.			Hereditary Cancer-associated Missense Mutations in hMSH6 Uncouple ATP Hydrolysis from DNA Mismatch Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MSH6 GERMLINE MUTATIONS; REPAIR GENES; RECOGNITION COMPLEX; FUNCTIONAL-ANALYSIS; MOLECULAR SWITCH; LYNCH-SYNDROME; HNPCC; MALIGNANCIES; INSTABILITY	Hereditary nonpolyposis colorectal cancer is caused by germline mutations in DNA mismatch repair genes. The majority of cases are associated with mutations in hMSH2 or hMLH1; however, about 12% of cases are associated with alterations in hMSH6. The hMSH6 protein forms a heterodimer with hMSH2 that is capable of recognizing a DNA mismatch. The heterodimer then utilizes its adenosine nucleotide processing ability in an, as of yet, unclear mechanism to facilitate communication between the mismatch and a distant strand discrimination site. The majority of reported mutations in hMSH6 are deletions or truncations that entirely eliminate the function of the protein; however, nearly a third of the reported variations are missense mutations whose functional significance is unclear. We analyzed seven cancer-associated single amino acid alterations in hMSH6 distributed throughout the functional domains of the protein to determine their effect on the biochemical activity of the hMSH2-hMSH6 heterodimer. Five alterations affect mismatch-stimulated ATP hydrolysis activity providing functional evidence that missense variants of hMSH6 can disrupt mismatch repair function and may contribute to disease. Of the five mutants that affect mismatch-stimulated ATP hydrolysis, only two (R976H and H1248D) affect mismatch recognition. Thus, three of the mutants (G566R, V878A, and D803G) appear to uncouple the mismatch binding and ATP-hydrolysis activities of the heterodimer. We also demonstrate that these three mutations alter ATP-dependent conformation changes of hMSH2-hMSH6, suggesting that cancer-associated mutations in hMSH6 can disrupt the intramolecular signaling that coordinates mismatch binding with adenosine nucleotide processing.	[Cyr, Jennifer L.; Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA	University of Connecticut	Heinen, CD (corresponding author), Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, 263 Farmington Ave,ML3101, Farmington, CT 06030 USA.	cheinen@uchc.edu			National Institutes of Health [CA115783]; Wendy Will Case Cancer Foundation; American Cancer Society [RSG-07-145-01-CCG]; NATIONAL CANCER INSTITUTE [R01CA115783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wendy Will Case Cancer Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115783 (NCI). This work was also supported by the Wendy Will Case Cancer Foundation, Grant RSG-07-145-01-CCG from the American Cancer Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Bandipalliam P, 2005, FAM CANCER, V4, P323, DOI 10.1007/s10689-005-8351-6; Berends MJW, 2002, AM J HUM GENET, V70, P26, DOI 10.1086/337944; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Drotschmann K, 1999, CURR BIOL, V9, P907, DOI 10.1016/S0960-9822(99)80396-0; Duval A, 2002, CANCER RES, V62, P2447; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Guerrette S, 1998, MOL CELL BIOL, V18, P6616, DOI 10.1128/MCB.18.11.6616; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Heinen CD, 2002, CANCER CELL, V1, P469, DOI 10.1016/S1535-6108(02)00073-9; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kariola R, 2002, HUM MOL GENET, V11, P1303, DOI 10.1093/hmg/11.11.1303; Kolodner RD, 1999, CANCER RES, V59, P5068; Laguri C, 2008, BIOCHEMISTRY-US, V47, P6199, DOI 10.1021/bi7024639; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lynch HT, 1997, CANCER GENET CYTOGEN, V93, P84, DOI 10.1016/S0165-4608(96)00290-7; Martik D, 2004, J BIOL CHEM, V279, P28402, DOI 10.1074/jbc.M312108200; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ou J, 2007, HUM MUTAT, V28, P1047, DOI 10.1002/humu.20580; Plaschke J, 2002, INT J CANCER, V97, P643, DOI 10.1002/ijc.10097; Poley JW, 2007, CANCER-AM CANCER SOC, V109, P2349, DOI 10.1002/cncr.22697; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Woods MO, 2007, HUM MUTAT, V28, P669, DOI 10.1002/humu.20502; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612	39	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31641	31648		10.1074/jbc.M806018200	http://dx.doi.org/10.1074/jbc.M806018200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18790734	hybrid, Green Published			2022-12-27	WOS:000260760800045
J	Hurtel-Lemaire, AS; Mentaverri, R; Caudrillier, A; Cournarie, F; Wattel, A; Kamel, S; Terwilliger, EF; Brown, EM; Brazier, M				Hurtel-Lemaire, Anne S.; Mentaverri, Romuald; Caudrillier, Axelle; Cournarie, Fabienne; Wattel, Alice; Kamel, Said; Terwilliger, Ernest F.; Brown, Edward M.; Brazier, Michel			The Calcium-sensing Receptor Is Involved in Strontium Ranelate-induced Osteoclast Apoptosis NEW INSIGHTS INTO THE ASSOCIATED SIGNALING PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAINTAINING BONE-FORMATION; RESORPTION IN-VITRO; EXTRACELLULAR CALCIUM; POSTMENOPAUSAL OSTEOPOROSIS; CA2+-SENSING RECEPTOR; VERTEBRAL FRACTURE; KAPPA-B; RATS; DIFFERENTIATION; WOMEN	Strontium ranelate exerts both an anti-catabolic and an anabolic effect on bone cells. To further investigate the molecular mechanism whereby strontium ranelate inhibits bone resorption, we focused our attention on the effects of strontium ranelate on osteoclast apoptosis and on the underlying mechanism(s). Using primary mature rabbit osteoclasts, we demonstrated that strontium (Sr-o(2+)) dose-dependently stimulates the apoptosis of mature osteoclasts. As shown previously for calcium (Ca-o(2+)), the Sr-o(2+)-induced effect on mature osteoclasts is mediated by the Ca-o(2+)-sensing receptor, CaR, which in turn stimulates a phospholipase C-dependent signaling pathway and nuclear translocation of NF-kappa B. Unlike Ca-o(2+), however, Sr-o(2+)-induced osteoclast apoptosis was shown to depend on PKC beta II activation and to be independent of inositol 1,4,5-trisphosphate action. As a consequence of these differences in their intracellular signaling pathways, Sr-o(2+) and Ca-o(2+) in combination were shown to exert a greater effect on mature osteoclast apoptosis than did either divalent cation by itself. Altogether, our results show that Sr-o(2+) acts through the CaR and induces osteoclast apoptosis through a signaling pathway similar to but different in certain respects from that of Ca-o(2+). This difference in the respective signaling cascades enables Sr-o(2+) to potentiate Ca-o(2)+ induced osteoclast apoptosis and vice versa. In this manner, it is conceivable that Sr-o(2+) and Ca-o(2+) act together to inhibit bone resorption in strontium ranelate-treated patients.	[Hurtel-Lemaire, Anne S.; Mentaverri, Romuald; Caudrillier, Axelle; Wattel, Alice; Kamel, Said; Brazier, Michel] Univ Picardie Jules Verne, INSERM, ERI 12, F-80037 Amiens, France; [Cournarie, Fabienne] Inst Rech Int Servier, F-92415 Courbevoie, France; [Terwilliger, Ernest F.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Mentaverri, Romuald; Brown, Edward M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Servier; Institut de Recherches Internationales Servier; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Brazier, M (corresponding author), Univ Picardie Jules Verne, INSERM, ERI 12, 1 Rue Louvels, F-80037 Amiens, France.	michel.brazier@sa.u-picardie.fr	Kamel, Said/HGA-7781-2022		Institut de Recherches Internationales Servier	Institut de Recherches Internationales Servier(Servier)	This work was supported by research grants from the Institut de Recherches Internationales Servier. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ammann P, 2004, J BONE MINER RES, V19, P2012, DOI 10.1359/JBMR.040906; AMMANN P, 2006, SUPPL NY S1, V38, pS15; Bai M, 1997, J CLIN INVEST, V99, P88, DOI 10.1172/JCI119137; Bai M, 2004, CELL CALCIUM, V35, P197, DOI 10.1016/j.ceca.2003.10.018; Baron R, 2002, EUR J PHARMACOL, V450, P11, DOI 10.1016/S0014-2999(02)02040-X; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Breitwieser GE, 2004, CELL CALCIUM, V35, P209, DOI 10.1016/j.ceca.2003.10.013; Brown EM, 2003, OSTEOPOROSIS INT, V14, pS25, DOI 10.1007/s00198-002-1343-6; Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7; Butters RR, 1997, J BONE MINER RES, V12, P568, DOI 10.1359/jbmr.1997.12.4.568; Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4; Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P65; Coulombe J, 2004, BIOCHEM BIOPH RES CO, V323, P1184, DOI 10.1016/j.bbrc.2004.08.209; Delannoy P, 2002, METABOLISM, V51, P906, DOI 10.1053/meta.2002.33360; Delmas PD, 2005, OSTEOPOROSIS INT, V16, P1, DOI 10.1007/s00198-004-1813-0; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Foged NT, 1996, J BONE MINER RES, V11, P226; Hott M, 2003, BONE, V33, P115, DOI 10.1016/S8756-3282(03)00115-7; Huang Y, 2007, J BIOL CHEM, V282, P19000, DOI 10.1074/jbc.M701096200; KAMEDA T, 1995, BIOCHEM BIOPH RES CO, V207, P753, DOI 10.1006/bbrc.1995.1251; Korcok J, 2004, J BONE MINER RES, V19, P642, DOI 10.1359/JBMR.040108; Lee SW, 2003, BONE, V32, P217, DOI 10.1016/S8756-3282(02)00976-6; Lorget F, 2000, BIOCHEM BIOPH RES CO, V268, P899, DOI 10.1006/bbrc.2000.2229; Marie PJ, 2006, CURR OPIN RHEUMATOL, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b; MARIE PJ, 1993, J BONE MINER RES, V8, P607; Marie PJ, 2003, OSTEOPOROSIS INT, V14, pS9, DOI 10.1007/s00198-002-1344-5; Marin Maria Susana, 2006, Revista de la Facultad de Ciencias Agrarias Universidad Nacional de Cuyo, V38, P1; Mentaverri R, 2006, FASEB J, V20, P2562, DOI 10.1096/fj.06-6304fje; Mentaverri R, 2003, J CELL BIOCHEM, V88, P1145, DOI 10.1002/jcb.10463; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Moonga BS, 1996, CALCIFIED TISSUE INT, V59, P105, DOI 10.1007/s002239900095; Reginster Jean-Yves, 2005, Curr Osteoporos Rep, V3, P30; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Rizzoli R, 2005, J Endocrinol Invest, V28, P50; Roux C, 2006, J BONE MINER RES, V21, P536, DOI 10.1359/JBMR.060101; Tai YH, 2008, NEUROSCIENCE, V153, P823, DOI 10.1016/j.neuroscience.2008.02.055; Takahashi N, 2003, J BONE MINER RES, V18, P1082, DOI 10.1359/jbmr.2003.18.6.1082; TETI A, 1995, J BONE NY, V17, P175; Tfelt-Hansen J, 2003, AM J PHYSIOL-ENDOC M, V285, pE329, DOI 10.1152/ajpendo.00489.2002; Vaananen K, 2005, ADV DRUG DELIVER REV, V57, P959, DOI 10.1016/j.addr.2004.12.018; Ward BK, 2004, J CLIN ENDOCR METAB, V89, P3721, DOI 10.1210/jc.2003-031653; Zhang ZX, 2001, J BIOL CHEM, V276, P5316, DOI 10.1074/jbc.M005958200	43	178	194	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					575	584		10.1074/jbc.M801668200	http://dx.doi.org/10.1074/jbc.M801668200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18927086	hybrid			2022-12-27	WOS:000261974800063
J	Miyoshi, T; Nomura, T; Uchiumi, T				Miyoshi, Tomohiro; Nomura, Takaomi; Uchiumi, Toshio			Engineering and Characterization of the Ribosomal L10.L12 Stalk Complex A STRUCTURAL ELEMENT RESPONSIBLE FOR HIGH TURNOVER OF THE ELONGATION FACTOR G-DEPENDENT GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; ESCHERICHIA-COLI RIBOSOMES; NUCLEAR-MAGNETIC-RESONANCE; PROTEIN L7/L12; EF-G; TRANSLATION ELONGATION; ANGSTROM RESOLUTION; FACTOR-BINDING; FACTORS TU; SUBUNIT	The ribosomal stalk protein L12 is essential for events dependent on the GTP-binding translation factors. It has been recently shown that ribosomes from Thermus thermophilus contain a heptameric complex L10.(L12)(2).(L12)(2).(L12)(2), rather than the conventional pentameric complex L10(L12)(2).( L12)(2). Here we describe the reconstitution of the heptameric complex from purified L10 and L12 and the characterization of its role in elongation factor G-dependent GTPase activity using a hybrid system with Escherichia coli ribosomes. The T. thermophilus heptameric complex resulted in a 2.5-fold higher activity than the E. coli pentameric complex. The structural element of the T. thermophilus complex responsible for the higher activity was investigated using a chimeric L10 protein ( Ec-Tt-L10), in which the C-terminal L12-binding site in E. coli L10 was replaced with the same region from T. thermophilus, and two chimeric L12 proteins: Ec-Tt-L12, in which the E. coli N-terminal domain was fused with the T. thermophilus C-terminal domain, and Tt.Ec-L12, in which the T. thermophilus N-terminal domain was fused with the E. coli C-terminal domain. High GTPase turnover was observed with the pentameric chimeric complex formed from E. coli L10 and Ec-Tt-L12 but not with the heptameric complex formed from Ec-Tt-L10 and Tt.c-L12. This suggested that the C-terminal region of T. thermophilus L12, rather than the heptameric nature of the complex, was responsible for the high GTPase turnover. Further analyses with other chimeric L12 proteins identified helix alpha 6 as the region most likely to contain the responsible element.	[Miyoshi, Tomohiro; Uchiumi, Toshio] Niigata Univ, Fac Sci, Dept Biol, Niigata 9502181, Japan; [Nomura, Takaomi] Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 3868567, Japan	Niigata University; Shinshu University	Uchiumi, T (corresponding author), Niigata Univ, Fac Sci, Dept Biol, Ikarashi 2-8050, Niigata 9502181, Japan.	uchiumi@bio.sc.niigata-u.ac.jp			Uchida Energy Science Promotion Foundation [14035222]; Naito Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Uchida Energy Science Promotion Foundation(Uchida Energy Science Promotion Foundation); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research 14035222 (to T. U.), grants from the Uchida Energy Science Promotion Foundation (to T. U.) and the Naito Foundation (to T. U.), and a Grant-in-Aid for Global COE Program (to T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARAI KI, 1972, J BIOL CHEM, V247, P7029; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bocharov EV, 1996, FEBS LETT, V379, P291, DOI 10.1016/0014-5793(95)01531-0; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; BUSHUEV VN, 1989, J BIOL CHEM, V264, P4498; Christodoulou J, 2004, P NATL ACAD SCI USA, V101, P10949, DOI 10.1073/pnas.0400928101; COWGILL CA, 1984, J BIOL CHEM, V259, P5257; DABBS ER, 1979, J BACTERIOL, V140, P734, DOI 10.1128/JB.140.2.734-737.1979; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Griaznova O, 2000, BIOCHEMISTRY-US, V39, P4075, DOI 10.1021/bi992621e; Gudkov AT, 1997, FEBS LETT, V407, P253, DOI 10.1016/S0014-5793(97)00361-X; GUDKOV AT, 1978, EUR J BIOCHEM, V90, P313, DOI 10.1111/j.1432-1033.1978.tb12606.x; GUDKOV AT, 1982, FEBS LETT, V138, P229, DOI 10.1016/0014-5793(82)80448-1; HAMEL E, 1972, J BIOL CHEM, V247, P805; Hamman BD, 1996, BIOCHEMISTRY-US, V35, P16680, DOI 10.1021/bi9624189; HARDY SJS, 1975, MOL GEN GENET, V140, P253, DOI 10.1007/BF00334270; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; KOTELIANSKY VE, 1977, FEBS LETT, V73, P6, DOI 10.1016/0014-5793(77)80003-3; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; LEIJONMARCK M, 1987, J MOL BIOL, V195, P555, DOI 10.1016/0022-2836(87)90183-5; LILJAS A, 1987, BIOCHIMIE, V69, P1043, DOI 10.1016/0300-9084(87)90004-6; MAKAROV EM, 1993, BIOCHIMIE, V75, P963, DOI 10.1016/0300-9084(93)90146-J; Maki Y, 2007, J BIOL CHEM, V282, P32827, DOI 10.1074/jbc.M705412200; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; Nomura T, 2003, BIOCHEMISTRY-US, V42, P4691, DOI 10.1021/bi027087g; Nomura T, 2008, J BIOCHEM, V144, P665, DOI 10.1093/jb/mvn113; Nomura T, 2006, BIOCHEM J, V396, P565, DOI 10.1042/BJ20060038; OLSON HM, 1986, J BIOL CHEM, V261, P6924; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANDER G, 1975, BIOCHEMISTRY-US, V14, P1805, DOI 10.1021/bi00680a001; SANDER G, 1972, BIOCHEM BIOPH RES CO, V47, P866, DOI 10.1016/0006-291X(72)90573-6; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shcherbakov D, 2006, NUCLEIC ACIDS RES, V34, P5800, DOI 10.1093/nar/gkl751; SUBRAMANIAN AR, 1975, J MOL BIOL, V95, P1, DOI 10.1016/0022-2836(75)90330-7; TOKIMATSU H, 1981, J MOL BIOL, V152, P397, DOI 10.1016/0022-2836(81)90250-3; Uchiumi T, 1999, J BIOL CHEM, V274, P27578, DOI 10.1074/jbc.274.39.27578; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174	47	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					85	92		10.1074/jbc.M806024200	http://dx.doi.org/10.1074/jbc.M806024200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18936095	hybrid			2022-12-27	WOS:000261974800010
J	Anastasia, L; Papini, N; Colazzo, F; Palazzolo, G; Tringali, C; Dileo, L; Piccoli, M; Conforti, E; Sitzia, C; Monti, E; Sampaolesi, M; Tettamanti, G; Venerando, B				Anastasia, Luigi; Papini, Nadia; Colazzo, Francesca; Palazzolo, Giacomo; Tringali, Cristina; Dileo, Loredana; Piccoli, Marco; Conforti, Erika; Sitzia, Clementina; Monti, Eugenio; Sampaolesi, Maurilio; Tettamanti, Guido; Venerando, Bruno			NEU3 Sialidase Strictly Modulates GM3 Levels in Skeletal Myoblasts C2C12 Thus Favoring Their Differentiation and Protecting Them from Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; GROWTH-FACTOR RECEPTOR; CELL-DIFFERENTIATION; ACTIVE CASPASE-3; TYROSINE KINASE; CRUCIAL ROLE; OVEREXPRESSION; ACTIVATION; GLYCOSYLATION; INVOLVEMENT	Membrane-bound sialidase NEU3, often referred to as the "ganglioside sialidase," has a critical regulatory function on the sialoglycosphingolipid pattern of the cell membrane, with an anti-apoptotic function, especially in cancer cells. Although other sialidases have been shown to be involved in skeletal muscle differentiation, the role of NEU3 had yet to be disclosed. Herein we report that NEU3 plays a key role in skeletal muscle differentiation by strictly modulating the ganglioside content of adjacent cells, with special regard to GM3. Induced down-regulation of NEU3 in murine C2C12 myoblasts, even when partial, totally inhibits their capability to differentiate by increasing the GM3 level above a critical point, which causes epidermal growth factor receptor inhibition (and ultimately its down-regulation) and an higher responsiveness of myoblasts to the apoptotic stimuli.	[Anastasia, Luigi; Papini, Nadia; Colazzo, Francesca; Palazzolo, Giacomo; Tringali, Cristina; Dileo, Loredana; Piccoli, Marco; Conforti, Erika; Sitzia, Clementina; Venerando, Bruno] Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20090 Milan, Italy; [Anastasia, Luigi; Papini, Nadia; Colazzo, Francesca; Palazzolo, Giacomo; Dileo, Loredana; Piccoli, Marco; Conforti, Erika; Sitzia, Clementina; Tettamanti, Guido; Venerando, Bruno] IRCCS, Policlin San Donato, Lab Stem Cells Tissue Engn, I-20097 San Donato Milanese, Italy; [Monti, Eugenio] Univ Brescia, Dept Biomed & Biotechnol Sci, I-25123 Brescia, Italy; [Sampaolesi, Maurilio] Univ Hosp Gasthuisberg, Stem Cell Res Inst, B-3000 Louvain, Belgium; [Sampaolesi, Maurilio] Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy	University of Milan; IRCCS Policlinico San Donato; University of Brescia; KU Leuven; University Hospital Leuven; University of Pavia	Anastasia, L (corresponding author), Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20090 Milan, Italy.	luigi.anastasia@unimi.it; bruno.venerando@unimi.it	Piccoli, Marco/S-3731-2019; papini, nadia/M-2425-2017; Anastasia, Luigi/AAN-1964-2020; sitzia, Clementina/L-2736-2019; Sampaolesi, Maurilio/H-6509-2013; Tringali, Cristina Alessandra/Q-7259-2017	Piccoli, Marco/0000-0002-9461-2715; papini, nadia/0000-0003-4066-4955; Anastasia, Luigi/0000-0002-0712-2161; Sampaolesi, Maurilio/0000-0002-2422-3757; Tringali, Cristina Alessandra/0000-0002-0632-6197; MONTI, Eugenio/0000-0002-4742-7445; COLAZZO, FRANCESCA/0000-0002-5782-1606; Sitzia, Clementina/0000-0001-5415-7597	Research Projects of National Interest; Italian Ministries of Health and Research; Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato	Research Projects of National Interest(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministries of Health and Research(Ministry of Education, Universities and Research (MIUR)); Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato	This work was supported by Research Projects of National Interest (to B. V., E. M., and G. T.), the Italian Ministries of Health and Research, and the Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Champigny MJ, 2005, EXP CELL RES, V311, P157, DOI 10.1016/j.yexcr.2005.08.023; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Fanzani A, 2003, FEBS LETT, V547, P183, DOI 10.1016/S0014-5793(03)00709-9; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Formigli L, 2007, EUR J HISTOCHEM, V51, P21; Haga Y, 2008, BBA-GEN SUBJECTS, V1780, P393, DOI 10.1016/j.bbagen.2007.10.018; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; LESKAWA KC, 1988, MOL CELL BIOCHEM, V83, P47; Liu YH, 2008, GLYCOBIOLOGY, V18, P593, DOI 10.1093/glycob/cwn039; MILJAN EA, 2002, SCI STKE, pRE15; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Rohn TT, 2004, EXP CELL RES, V295, P215, DOI 10.1016/j.yexcr.2003.12.029; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Sato K, 1996, BIOCHEM BIOPH RES CO, V221, P826, DOI 10.1006/bbrc.1996.0681; SMITH CK, 1994, J CELL PHYSIOL, V159, P379, DOI 10.1002/jcp.1041590222; Szymczyk KH, 2006, J CELL PHYSIOL, V209, P836, DOI 10.1002/jcp.20770; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; TRUDEL GC, 1992, BIOCHEM BIOPH RES CO, V184, P125, DOI 10.1016/0006-291X(92)91167-O; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Wang XQ, 2002, J BIOL CHEM, V277, P47028, DOI 10.1074/jbc.M208257200; Wang XQ, 2001, GLYCOBIOLOGY, V11, P515, DOI 10.1093/glycob/11.7.515; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503	42	43	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36265	36271		10.1074/jbc.M805755200	http://dx.doi.org/10.1074/jbc.M805755200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18945680	Green Published, hybrid			2022-12-27	WOS:000261840500022
J	Liu, JM; Gurpur, PB; Kaufman, SJ				Liu, Jianming; Gurpur, Praveen B.; Kaufman, Stephen J.			Genetically Determined Proteolytic Cleavage Modulates alpha 7 beta 1 Integrin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE REGENERATION; UROKINASE PLASMINOGEN-ACTIVATOR; ALPHA 7 INTEGRIN; IN-VIVO; MUSCULAR-DYSTROPHY; SATELLITE CELLS; DIFFERENTIAL EXPRESSION; EXTRACELLULAR SEGMENT; CYTOPLASMIC DOMAINS; TUMOR PROGRESSION	The dystrophin-glycoprotein complex and the alpha 7 beta 1 integrin are trans-sarcolemmal linkage systems that connect and transduce contractile forces between muscle fibers and the extracellular matrix. alpha 7 beta 1 is the major laminin binding integrin in skeletal muscle. Different functional variants of this integrin are generated by alternative splicing and post-translational modifications such as glycosylation and ADP-ribosylation. Here we report a species-specific difference in alpha 7 chains that results from an intra-peptide proteolytic cleavage, by a serine protease, at the (603)RRQ(605) site. Site-directed mutagenesis of RRQ to GRQ prevents this cleavage. This RRQ sequence in the alpha 7 integrin chain is highly conserved among vertebrates but it is absent in mice. Protein structure modeling indicates this cleavage site is located in an open region between the alpha-propeller and thigh domains of the alpha 7 chain. Compared with the non-cleavable alpha 7 chain, the cleaved form enhances cell adhesion and spreading on laminin. Cleavage of the alpha 7 chain is elevated upon myogenic differentiation, and this cleavage may be mediated by urokinase-type plasminogen activator. These results suggest proteolytic cleavage is a novel mechanism that regulates alpha 7 integrin functions in skeletal muscle, and that the generation of such cleavage sites is another evolutionary mechanism for expanding and modifying protein functions.	[Liu, Jianming; Gurpur, Praveen B.; Kaufman, Stephen J.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kaufman, SJ (corresponding author), B107 Chem & Life Sci Lab, 601 S Goodwin Ave, Urbana, IL 61801 USA.	stephenk@illinois.edu			National Institutes of Health [AG14632]; Muscular Dystrophy Association; NATIONAL INSTITUTE ON AGING [R01AG014632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health NIA Grant AG14632. This work was also supported by the Muscular Dystrophy Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Blanco-Bose WE, 2001, DEV BIOL, V233, P148, DOI 10.1006/dbio.2001.0177; Bonavaud S, 1997, J CELL SCI, V110, P1083; Boppart MD, 2006, AM J PHYSIOL-CELL PH, V290, pC1660, DOI 10.1152/ajpcell.00317.2005; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; BUCK CA, 1987, J CELL SCI, P231; Burkin DJ, 2005, AM J PATHOL, V166, P253, DOI 10.1016/S0002-9440(10)62249-3; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chernousov MA, 2007, GLIA, V55, P1134, DOI 10.1002/glia.20536; Choong PFM, 2003, CLIN ORTHOP RELAT R, pS46, DOI 10.1097/01.blo.0000093845.72468.bd; COLLO G, 1993, J BIOL CHEM, V268, P19019; Crawley S, 1997, EXP CELL RES, V235, P274, DOI 10.1006/excr.1997.3671; Davis TL, 2002, CELL GROWTH DIFFER, V13, P107; Davis TL, 2001, J BIOL CHEM, V276, P26099, DOI 10.1074/jbc.M102811200; Demetriou MC, 2004, EXP CELL RES, V294, P550, DOI 10.1016/j.yexcr.2003.11.023; Demetriou MC, 2004, J CELL BIOCHEM, V91, P26, DOI 10.1002/jcb.10675; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; FESTOFF BW, 1994, J CELL PHYSIOL, V159, P11, DOI 10.1002/jcp.1041590103; FESTOFF BW, 1990, J CELL PHYSIOL, V144, P262, DOI 10.1002/jcp.1041440212; Fibbi G, 2002, BIOL CHEM, V383, P127, DOI 10.1515/BC.2002.013; Fibbi G, 2001, LAB INVEST, V81, P27, DOI 10.1038/labinvest.3780209; FOSTER RF, 1987, DEV BIOL, V122, P11, DOI 10.1016/0012-1606(87)90327-7; Ge Y, 2004, ELECTROPHORESIS, V25, P2576, DOI 10.1002/elps.200406013; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Harbeck N, 2004, THROMB HAEMOSTASIS, V91, P450, DOI 10.1160/TH03-12-0798; HEMLER ME, 1990, IMMUNOL REV, V114, P45, DOI 10.1111/j.1600-065X.1990.tb00561.x; HEMLER ME, 1987, J BIOL CHEM, V262, P11478; Hodges BL, 1997, J CELL SCI, V110, P2873; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; HUMPHRIES MJ, 1990, J CELL SCI, V97, P585; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jethanandani P, 2005, J BIOL CHEM, V280, P36037, DOI 10.1074/jbc.M508698200; Kaariainen M, 2002, AM J PATHOL, V161, P1023, DOI 10.1016/S0002-9440(10)64263-0; KASSNER PD, 1992, ADV EXP MED BIOL, V323, P163; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Kugler MC, 2003, CURR PHARM DESIGN, V9, P1565, DOI 10.2174/1381612033454658; Laufs S, 2006, CELL CYCLE, V5, P1760; Le Moigne A, 1990, Int J Dev Biol, V34, P171; Lluis F, 2001, BLOOD, V97, P1703, DOI 10.1182/blood.V97.6.1703; Lopez-Alemany R, 2005, FRONT BIOSCI-LANDMRK, V10, P30, DOI 10.2741/1503; LOWREY AA, 1989, EXP CELL RES, V183, P1, DOI 10.1016/0014-4827(89)90414-X; Magdolen V, 2003, RECENT RESULTS CANC, V162, P43; Malik RK, 1997, J PEDIAT HEMATOL ONC, V19, P541, DOI 10.1097/00043426-199711000-00013; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; Miralles F, 1999, THROMB HAEMOSTASIS, V81, P767, DOI 10.1055/s-0037-1614569; Nozaki S, 2006, ANTI-CANCER DRUG, V17, P1109, DOI 10.1097/01.cad.0000231483.09439.3a; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; PARKER CM, 1993, J BIOL CHEM, V268, P7028; Pawar SC, 2007, EXP CELL RES, V313, P1080, DOI 10.1016/j.yexcr.2007.01.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pillay V, 2007, TRENDS BIOTECHNOL, V25, P33, DOI 10.1016/j.tibtech.2006.10.011; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; QUAX PHA, 1992, DEV BIOL, V151, P166, DOI 10.1016/0012-1606(92)90224-5; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Ren BG, 2007, J NATL CANCER I, V99, P868, DOI 10.1093/jnci/djk199; RONNE E, 1994, J IMMUNOL METHODS, V167, P91, DOI 10.1016/0022-1759(94)90078-7; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; SANADA Y, 1978, J BIOCHEM, V83, P27, DOI 10.1093/oxfordjournals.jbchem.a131901; SCHMALBRUCH H, 1986, BIBL ANAT, V29, P126; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Snider L, 2003, CELL, V113, P811, DOI 10.1016/S0092-8674(03)00474-4; SONG WK, 1993, J CELL SCI, V106, P1139; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; Suelves M, 2005, FRONT BIOSCI-LANDMRK, V10, P2978, DOI 10.2741/1754; Suelves M, 2002, BLOOD, V99, P2835, DOI 10.1182/blood.V99.8.2835; Suelves M, 2007, J CELL BIOL, V178, P1039, DOI 10.1083/jcb.200705127; Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200; TEIXIDO J, 1992, J BIOL CHEM, V267, P1786; Tomatis D, 1999, EXP CELL RES, V246, P421, DOI 10.1006/excr.1998.4315; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; Wells JM, 1997, J CELL PHYSIOL, V171, P217, DOI 10.1002/(SICI)1097-4652(199705)171:2<217::AID-JCP13>3.0.CO;2-A; Xiao JQ, 2003, J BIOL CHEM, V278, P49780, DOI 10.1074/jbc.M308542200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598; Yeh MG, 2003, MOL BIOL CELL, V14, P3507, DOI 10.1091/mbc.E02-12-0824; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200; Zhao ZF, 2005, BIOCHEM J, V385, P309, DOI 10.1042/BJ20040590; Ziober BL, 1997, MOL BIOL CELL, V8, P1723, DOI 10.1091/mbc.8.9.1723; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773; Zolkiewska A, 1997, ADV EXP MED BIOL, V419, P297	94	9	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35668	35678		10.1074/jbc.M804661200	http://dx.doi.org/10.1074/jbc.M804661200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18940796	Green Published, hybrid			2022-12-27	WOS:000261687900041
J	Margolin, Y; Shafirovich, V; Geacintov, NE; Demott, MS; Dedon, PC				Margolin, Yelena; Shafirovich, Vladimir; Geacintov, Nicholas E.; Demott, Michael S.; Dedon, Peter C.			DNA Sequence Context as a Determinant of the Quantity and Chemistry of Guanine Oxidation Produced by Hydroxyl Radicals and One-electron Oxidants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-IRRADIATED DNA; STRAND BREAKS; PARAMAGNETIC-RESONANCE; SELECTIVE OXIDATION; CHEMICAL-STABILITY; RADIATION-DAMAGE; EXONUCLEASE-III; GGG TRIPLETS; PLASMID DNA; DUPLEX DNA	DNA sequence context has emerged as a critical determinant of the location and quantity of nucleobase damage caused by many oxidizing agents. However, the complexity of nucleobase and 2-deoxyribose damage caused by strong oxidants such as ionizing radiation and the Fenton chemistry of Fe2+-EDTA/H2O2 poses a challenge to defining the location of nucleobase damage and the effects of sequence context on damage chemistry in DNA. To address this problem, we developed a gel-based method that allows quantification of nucleobase damage in oxidized DNA by exploiting Escherichia coli exonuclease III to remove fragments containing direct strand breaks and abasic sites. The rigor of the method was verified in studies of guanine oxidation by photooxidized riboflavin and nitrosoperoxycarbonate, for which different effects of sequence context have been demonstrated by other approaches (Margolin, Y., Cloutier, J. F., Shafirovich, V., Geacintov, N. E., and Dedon, P. C. (2006) Nat. Chem. Biol. 2, 365-366). Using duplex oligodeoxynucleotides containing all possible three-nucleotide sequence contexts for guanine, the method was used to assess the role of DNA sequence context in hydroxyl radical-induced guanine oxidation associated with gamma-radiation and Fe2+-EDTA/H2O2. The results revealed both differences and similarities for G oxidation by hydroxyl radicals and by one-electron oxidation by riboflavin-mediated photooxidation, which is consistent with the predominance of oxidation pathways for hydroxyl radicals other than one-electron oxidation to form guanine radical cations. Although the relative quantities of G oxidation produced by hydroxyl radicals were more weakly correlated with sequence-specific ionization potential than G oxidation produced by riboflavin, damage produced by both hydroxyl radical generators and riboflavin within two- and three-base runs of G showed biases in location that are consistent with a role for electron transfer in defining the location of the damage products. Furthermore, both gamma-radiation and Fe2+-EDTA/H2O2 showed relatively modest effects of sequence context on the proportions of different damage products sensitive to E. coli formamidopyrimidine DNA glycosylase and hot piperidine, although GT-containing sequence contexts displayed subtle biases in damage chemistry (formamidopyrimidine DNA glycosylase/piperidine ratio). Overall, the results are consistent with the known chemistry of guanine oxidation by hydroxyl radical and demonstrate that charge migration plays a relatively minor role in determining the location and chemistry of hydroxyl radical-mediated oxidative damage to guanine in DNA.	[Margolin, Yelena; Demott, Michael S.; Dedon, Peter C.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Margolin, Yelena; Demott, Michael S.; Dedon, Peter C.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; [Shafirovich, Vladimir; Geacintov, Nicholas E.] NYU, Dept Chem & Radiat, New York, NY 10003 USA; [Shafirovich, Vladimir; Geacintov, Nicholas E.] NYU, Solid State Lab, New York, NY 10003 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); New York University; New York University	Dedon, PC (corresponding author), MIT, Dept Biol Engn, NE47-277,77 Massachusetts Ave, Cambridge, MA 02139 USA.	pcdedon@mit.edu		Dedon, Peter/0000-0003-0011-3067	National Institutes of Health [CA110261 (NCI), ES002109]; NATIONAL CANCER INSTITUTE [R01CA110261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA110261 (NCI) and ES002109 (NIEHS Center grant). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; BECKER D, 1993, ADV RADIAT BIOL, V17, P121; BERNHARD WA, 1989, J PHYS CHEM-US, V93, P2187, DOI 10.1021/j100343a003; Box HC, 1999, RADIAT RES, V152, P575, DOI 10.2307/3580252; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Cadet J, 1999, MUTAT RES-FUND MOL M, V424, P9, DOI 10.1016/S0027-5107(99)00004-4; CADET J, 1994, J AM CHEM SOC, V116, P7403, DOI 10.1021/ja00095a052; CADET J, 1985, INT J RADIAT BIOL, V47, P127, DOI 10.1080/09553008514550201; Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e; Candeias LP, 2000, CHEM-EUR J, V6, P475, DOI 10.1002/(SICI)1521-3765(20000204)6:3<475::AID-CHEM475>3.0.CO;2-E; Crean C, 2008, CHEMBIOCHEM, V9, P1985, DOI 10.1002/cbic.200800105; CULLIS PM, 1992, J CHEM SOC PERK T 2, P1409, DOI 10.1039/p29920001409; Cullis PM, 1996, CHEM COMMUN, P985, DOI 10.1039/cc9960000985; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; DEDON PC, 1992, CHEM RES TOXICOL, V5, P311, DOI 10.1021/tx00027a001; Dedon PC, 2008, CHEM RES TOXICOL, V21, P206, DOI 10.1021/tx700283c; Delaney JC, 2008, CHEM RES TOXICOL, V21, P232, DOI 10.1021/tx700292a; Ding H, 2007, J AM CHEM SOC, V129, P772, DOI 10.1021/ja0678931; DIZDAROGLU M, 1986, FASEB J, V45, P1626; Doddridge ZA, 1998, J AM CHEM SOC, V120, P10998, DOI 10.1021/ja9816234; Douki T, 2002, CHEM RES TOXICOL, V15, P445, DOI 10.1021/tx0155909; Douki T, 1999, INT J RADIAT BIOL, V75, P571; Frelon S, 2002, J CHEM SOC PERK T 1, P2866, DOI 10.1039/b207532f; Gasparutto D, 1998, J AM CHEM SOC, V120, P10283, DOI 10.1021/ja980674y; Giese B, 2001, NATURE, V412, P318, DOI 10.1038/35085542; Greenberg MM, 2004, BIOCHEMISTRY-US, V43, P8178, DOI 10.1021/bi0496236; GREGOLI S, 1982, RADIAT RES, V89, P238, DOI 10.2307/3575770; Hall DB, 1996, NATURE, V382, P731, DOI 10.1038/382731a0; Haraguchi K, 2002, J AM CHEM SOC, V124, P3263, DOI 10.1021/ja012135q; Henderson PT, 1999, P NATL ACAD SCI USA, V96, P8353, DOI 10.1073/pnas.96.15.8353; Ito K, 1997, BIOCHEMISTRY-US, V36, P1774, DOI 10.1021/bi9620161; ITO T, 1993, INT J RADIAT BIOL, V63, P289, DOI 10.1080/09553009314550391; Joffe A, 2003, CHEM RES TOXICOL, V16, P1528, DOI 10.1021/tx034142t; JONES GDD, 1994, INT J RADIAT BIOL, V66, P441, DOI 10.1080/09553009414551431; Kino K, 2001, CHEM BIOL, V8, P369, DOI 10.1016/S1074-5521(01)00019-9; Kobayashi K, 2003, J AM CHEM SOC, V125, P10213, DOI 10.1021/ja036211w; KOPPENOL WH, 1984, J PHYS CHEM-US, V88, P99, DOI 10.1021/j150645a024; KOW YW, 1989, BIOCHEMISTRY-US, V28, P3280, DOI 10.1021/bi00434a024; Leipold MD, 2000, BIOCHEMISTRY-US, V39, P14984, DOI 10.1021/bi0017982; Luo GM, 2001, FEBS LETT, V492, P29, DOI 10.1016/S0014-5793(01)02226-8; Margolin Y, 2006, NAT CHEM BIOL, V2, P365, DOI 10.1038/nchembio796; Matter B, 2006, NUCLEIC ACIDS RES, V34, P5449, DOI 10.1093/nar/gkl596; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; MILLIGAN JR, 1993, RADIAT RES, V133, P151, DOI 10.2307/3578350; Misiaszek R, 2004, J BIOL CHEM, V279, P32106, DOI 10.1074/jbc.M313904200; MurataKamiya N, 1997, J RADIAT RES, V38, P121, DOI 10.1269/jrr.38.121; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Patrzyc HB, 2001, RADIAT RES, V155, P634, DOI 10.1667/0033-7587(2001)155[0634:DLAPID]2.0.CO;2; Paul T, 2000, BIOCHEMISTRY-US, V39, P4129, DOI 10.1021/bi991463o; Pouget JP, 2002, RADIAT RES, V157, P589, DOI 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2; PRICE MA, 1992, METHOD ENZYMOL, V212, P194; Purkayastha S, 2004, J PHYS CHEM B, V108, P18377, DOI 10.1021/jp048539x; Purkayastha S, 2007, RADIAT RES, V168, P357, DOI 10.1667/RR0964.1; PUTNEY SD, 1981, P NATL ACAD SCI-BIOL, V78, P7350, DOI 10.1073/pnas.78.12.7350; Qian SY, 1999, FREE RADICAL BIO MED, V26, P1447, DOI 10.1016/S0891-5849(99)00002-7; Ravanat JL, 2003, J AM CHEM SOC, V125, P2030, DOI 10.1021/ja028608q; REINKE LA, 1994, FREE RADICAL BIO MED, V16, P485, DOI 10.1016/0891-5849(94)90126-0; Rodriguez H, 1997, CANCER RES, V57, P2394; ROOTS R, 1975, RADIAT RES, V64, P306, DOI 10.2307/3574267; RUSH JD, 1986, J BIOL CHEM, V261, P6730; Saito I, 1998, J AM CHEM SOC, V120, P12686, DOI 10.1021/ja981888i; SAWYER DT, 1993, J AM CHEM SOC, V115, P5817, DOI 10.1021/ja00066a057; Senthilkumar K, 2003, J AM CHEM SOC, V125, P13658, DOI 10.1021/ja037027d; SEVILLA MD, 1991, J PHYS CHEM-US, V95, P3409, DOI 10.1021/j100161a080; Shafirovich V, 2004, TOP CURR CHEM, V237, P129, DOI 10.1007/b94475; Spassky A, 1997, BIOCHEMISTRY-US, V36, P6571, DOI 10.1021/bi962761d; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Steenken S, 2000, J AM CHEM SOC, V122, P2373, DOI 10.1021/ja993508e; Sugiyama H, 1996, J AM CHEM SOC, V118, P7063, DOI 10.1021/ja9609821; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; Tretyakova NY, 2000, CHEM RES TOXICOL, V13, P658, DOI 10.1021/tx000083x; Tretyakova NY, 2000, MUTAT RES-FUND MOL M, V447, P287, DOI 10.1016/S0027-5107(99)00221-3; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; von Sonntag C., 2006, FREE RADICAL INDUCED; Welch KD, 2002, ARCH BIOCHEM BIOPHYS, V397, P360, DOI 10.1006/abbi.2001.2694; WINK DA, 1994, P NATL ACAD SCI USA, V91, P6604, DOI 10.1073/pnas.91.14.6604; Yang X, 2004, P NATL ACAD SCI USA, V101, P17588, DOI 10.1073/pnas.0405157101; Yoshioka Y, 1999, J AM CHEM SOC, V121, P8712, DOI 10.1021/ja991032t	79	37	39	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35569	35578		10.1074/jbc.M806809200	http://dx.doi.org/10.1074/jbc.M806809200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948263	hybrid, Green Published			2022-12-27	WOS:000261687900029
J	Matsuura, A; Ito, M; Sakaidani, Y; Kondo, T; Murakami, K; Furukawa, K; Nadano, D; Matsuda, T; Okajima, T				Matsuura, Aiko; Ito, Makiko; Sakaidani, Yuta; Kondo, Tatsuhiko; Murakami, Kosuke; Furukawa, Koichi; Nadano, Daita; Matsuda, Tsukasa; Okajima, Tetsuya			O-Linked N-Acetylglucosamine Is Present on the Extracellular Domain of Notch Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-LIKE; LIGAND-BINDING; PROTEIN O-FUCOSYL-TRANSFERASE-1; CYTOPLASMIC PROTEINS; FUCOSYL-TRANSFERASE; DELTA INTERACTIONS; DROSOPHILA NOTCH; MODIFIES NOTCH; FRINGE; GLYCOSYLATION	Rare types of glycosylation often occur in a domain-specific manner and are involved in specific biological processes. In particular, O-fucose glycans are reported to regulate the functions of EGF domain-containing proteins such as Notch receptors. In the course of mass spectrometric analysis of O-glycans displayed on Drosophila Notch receptors expressed in S2 cells, we found an unusual O-linked N-acetylhexosamine (HexNAc) modification which occurs at a site distinct from those of O-fucose and O-glucose glycosylations. Modification site mapping by mass spectrometry and amino acid substitution studies revealed that O-HexNAc modification occurs on a serine or threonine located between the fifth and sixth cysteines within the EGF domain. This modification occurs simultaneously along with other closely positioned O-glycosylations. This modification was determined to be O-beta-GlcNAc by galactosyltransferase labeling and beta-N-acetyl-hexosaminidase digestion experiments and by immunoblotting with a specific antibody. O-GlcNAc modification occurs at multiple sites on Notch epidermal growth factor repeats. O-GlcNAc modification was also found on the extracellular domain of Delta, a ligand for Notch receptors. Although the O-GlcNAc modification is known to regulate a wide range of cellular processes, the list of known modified proteins has previously been limited to intracellular proteins in animals. Thus, the finding of O-GlcNAc modification in extracellular environments predicts a distinct glycosylation process that might be associated with a novel regulatory mechanism for Notch receptor activity.	[Matsuura, Aiko; Ito, Makiko; Sakaidani, Yuta; Kondo, Tatsuhiko; Murakami, Kosuke; Nadano, Daita; Matsuda, Tsukasa; Okajima, Tetsuya] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Furukawa, Koichi; Okajima, Tetsuya] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4660065, Japan	Nagoya University; Nagoya University	Okajima, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Dept Appl Mol Biosci, Furo Cho, Nagoya, Aichi 4648601, Japan.	tokajima@med.nagoya-u.ac.jp	Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X	Japanese Ministry of Education, Science, Sports, and Culture and the 21st Century Center of Excellence Program; Uehara Memorial Foundation, Takeda Science Foundation, and Human Frontier Science Program	Japanese Ministry of Education, Science, Sports, and Culture and the 21st Century Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation, Takeda Science Foundation, and Human Frontier Science Program(Takeda Science Foundation (TSF)Uehara Memorial Foundation)	This work was supported by grants from the Japanese Ministry of Education, Science, Sports, and Culture and the 21st Century Center of Excellence Program ( to T. O., D. N. and T. M.), the Uehara Memorial Foundation, Takeda Science Foundation, and Human Frontier Science Program ( to T. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABEIJON C, 1988, P NATL ACAD SCI USA, V85, P1010, DOI 10.1073/pnas.85.4.1010; Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BJOERN S, 1991, J BIOL CHEM, V266, P11051; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; JONES MD, 1994, ANAL BIOCHEM, V216, P135, DOI 10.1006/abio.1994.1017; KEARSE KP, 1991, ARCH BIOCHEM BIOPHYS, V290, P543, DOI 10.1016/0003-9861(91)90579-8; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2000, J BIOL CHEM, V275, P40498, DOI 10.1074/jbc.M006902200; Okajima T, 2008, J BIOCHEM, V144, P1, DOI 10.1093/jb/mvn016; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Previato JO, 1998, J BIOL CHEM, V273, P14982, DOI 10.1074/jbc.273.24.14982; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wang F, 2003, J BIOL CHEM, V278, P51395, DOI 10.1074/jbc.M308756200; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200	37	131	132	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35486	35495		10.1074/jbc.M806202200	http://dx.doi.org/10.1074/jbc.M806202200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948267	hybrid			2022-12-27	WOS:000261687900020
J	Zhang, J; Gao, ZG; Yin, J; Quon, MJ; Ye, JP				Zhang, Jin; Gao, Zhanguo; Yin, Jun; Quon, Michael J.; Ye, Jianping			S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-alpha Signaling through IKK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-1 TYROSINE PHOSPHORYLATION; NECROSIS-FACTOR INHIBITION; MULTIPLE SERINE KINASES; RECEPTOR SUBSTRATE-1; PROTEIN-KINASE; SKELETAL-MUSCLE; KAPPA-B; MAMMALIAN TARGET; 3T3-L1 ADIPOCYTES; FATTY-ACID	S6K1 (p70S6K) is a serine kinase downstream from Akt in the insulin signaling pathway that is involved in negative feedback regulation of insulin action. S6K1 is also activated by TNF-alpha, a pro- inflammatory cytokine. However, its role remains to be characterized. In the current study, we elucidated a mechanism for S6K1 to mediate TNF-alpha-induced insulin resistance in adipocytes and hepatocytes. S6K1 was phosphorylated at Thr-389 in response to TNF-alpha. This led to phosphorylation of IRS-1 by S6K1 at multiple serine residues including Ser-270, Ser-307, Ser-636, and Ser-1101 in human IRS-1 (Ser-265, Ser-302, Ser-632, and Ser- 1097, in rodent IRS-1). Direct phosphorylation of these sites by S6K1 was observed in an in vitro kinase assay using purified IRS-1 and S6K1. Phosphorylation of all these serines was increased in the adipose tissue of obese mice. RNAi knockdown demonstrated an important role for S6K1 in mediating TNF-alpha-induced IRS-1 inhibition that led to impaired insulin-stimulated glucose uptake in adipocytes. A point mutant of IRS-1 (S270A) impaired association of IRS-1 with S6K1 resulting in diminished phosphorylation of IRS-1 at three other S6K1 phosphorylation sites (Ser- 307, Ser- 636, and Ser- 1101). Expression of a dominant negative S6K1 mutant prevented TNF-induced Ser- 270 phosphorylation and IRS-1 protein degradation. Moreover, in IKK2 (but not IKK1)-null cells, TNF-alpha treatment did not result in Thr-389 phosphorylation of S6K1. We present a new mechanism for TNF-alpha to induce insulin resistance that involves activation of S6K by an IKK2-dependent pathway. S6K directly phosphorylates IRS-1 on multiple serine residues to inhibit insulin signaling.	[Zhang, Jin; Gao, Zhanguo; Yin, Jun; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Quon, Michael J.] Natl Ctr Complementary & Alternat Med, Diabet Unit, NIH, Bethesda, MD 20892 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	yej@pbrc.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X; Quon, Michael/0000-0002-9601-9915; QUON, MICHAEL/0000-0002-5289-3707	National Institutes of Health Intramural Research Program (NCCAM) [1P30 DK072476]; NIH Grant [DK68036]; ADA Research Award [7-07-RA-189]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [ZIAAT000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R56DK068036, R01DK068036] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA Research Award; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program (NCCAM) ( to M. J. Q.), NIDDK CNRU Grant 1P30 DK072476 ( Genomic Core), and the NIH Grant DK68036 and ADA Research Award 7-07-RA-189 ( to J. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; ARAKI E, 1993, DIABETES, V42, P1041, DOI 10.2337/diabetes.42.7.1041; Bourbon NA, 2002, J BIOL CHEM, V277, P3286, DOI 10.1074/jbc.M110541200; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Dey D, 2005, CELL PHYSIOL BIOCHEM, V16, P217, DOI 10.1159/000089847; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; Engelman JA, 2000, MOL ENDOCRINOL, V14, P1557, DOI 10.1210/me.14.10.1557; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; Ilouz R, 2006, J BIOL CHEM, V281, P30621, DOI 10.1074/jbc.M604633200; Jiang GQ, 2003, J BIOL CHEM, V278, P180, DOI 10.1074/jbc.M205565200; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim JA, 2005, J BIOL CHEM, V280, P23173, DOI 10.1074/jbc.M501439200; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Patti ME, 2004, NAT MED, V10, P1049, DOI 10.1038/nm1004-1049; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Peraldi P, 1998, MOL CELL BIOCHEM, V182, P169, DOI 10.1023/A:1006865715292; Peraldi P, 1997, J CLIN INVEST, V100, P1863, DOI 10.1172/JCI119715; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Xie P, 2000, J BIOL CHEM, V275, P24907, DOI 10.1074/jbc.M001051200; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	50	207	223	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35375	35382		10.1074/jbc.M806480200	http://dx.doi.org/10.1074/jbc.M806480200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952604	Green Published, hybrid			2022-12-27	WOS:000261687900008
J	Gundimeda, U; Schiffman, JE; Chhabra, D; Wong, J; Wu, A; Gopalakrishna, R				Gundimeda, Usha; Schiffman, Jason Eric; Chhabra, Divya; Wong, Jourdan; Wu, Adela; Gopalakrishna, Rayudu			Locally Generated Methylseleninic Acid Induces Specific Inactivation of Protein Kinase C Isoenzymes RELEVANCE TO SELENIUM-INDUCED APOPTOSIS IN PROSTATE CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN REDUCTASE; MALIGNANT MESOTHELIOMA CELLS; REGULATED GENE-EXPRESSION; PHORBOL ESTER BINDING; CHEMOPREVENTIVE AGENTS; SELENOCOMPOUNDS INDUCE; LIPID OXIDATION; DELTA-PKC; IN-VITRO; INHIBITION	In this study, we show that methylselenol, a selenometabolite implicated in cancer prevention, did not directly inactivate protein kinase C (PKC). Nonetheless, its oxidation product, methylseleninic acid (MSA), inactivated PKC at low micromolar concentrations through a redox modification of vicinal cysteine sulfhydryls in the catalytic domain of PKC. This modification of PKC that occurred in both isolated form and in intact cells was reversed by a reductase system involving thioredoxin reductase, a selenoprotein. PKC isoenzymes exhibited variable sensitivity to MSA with Ca2+-dependent PKC isoenzymes (alpha, beta, and gamma) being the most susceptible, followed by isoenzymes delta and epsilon. Other enzymes tested were inactivated only with severalfold higher concentrations of MSA than those required for PKC inactivation. This specificity for PKC was further enhanced when MSA was generated within close proximity to PKC through a reaction of methylselenol with PKC-bound lipid peroxides in the membrane. The MSA-methylselenol redox cycle resulted in the catalytic oxidation of sulfhydryls even with nanomolar concentrations of selenium. MSA inhibited cell growth and induced apoptosis in DU145 prostate cancer cells at a concentration that was higher than that needed to inhibit purified PKC alpha but in a range comparable with that required for the inhibition of PKC epsilon. This MSA-induced growth inhibition and apoptosis decreased with a conditional overexpression of PKC epsilon and increased with its knock-out by small interfering RNA. Conceivably, when MSA is generated within the vicinity of PKC, it specifically inactivates PKC isoenzymes, particularly the promitogenic and prosurvival epsilon isoenzyme, and this inactivation causes growth inhibition and apoptosis.	[Gundimeda, Usha; Schiffman, Jason Eric; Chhabra, Divya; Wong, Jourdan; Wu, Adela; Gopalakrishna, Rayudu] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA	University of Southern California	Gopalakrishna, R (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, BMT 403,1333 San Pablo St, Los Angeles, CA 90089 USA.	rgopalak@usc.edu		Wu, Adela/0000-0003-4543-9300				Bae KM, 2007, CANCER RES, V67, P6053, DOI 10.1158/0008-5472.CAN-06-4037; Berggren M, 1996, ANTICANCER RES, V16, P3459; Bjornstedt M, 1996, BIOCHEMISTRY-US, V35, P8511, DOI 10.1021/bi9528762; BLUMBERG PM, 1991, MOL CARCINOGEN, V4, P339, DOI 10.1002/mc.2940040502; BONI LT, 1985, J BIOL CHEM, V260, P819; BOREK C, 1986, P NATL ACAD SCI USA, V83, P1490, DOI 10.1073/pnas.83.5.1490; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; CACACE AM, 1993, ONCOGENE, V8, P2095; CHEN SJ, 1993, BIOCHEMISTRY-US, V32, P1032, DOI 10.1021/bi00055a006; Christensen MJ, 2007, NUTR CANCER, V58, P197, DOI 10.1080/01635580701328701; Chu F, 2004, CARCINOGENESIS, V25, P585, DOI 10.1093/carcin/bgh041; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; CLARK LC, 1985, FED PROC, V44, P2584; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; COTGREAVE IA, 1992, CHEM-BIOL INTERACT, V84, P69, DOI 10.1016/0009-2797(92)90121-Z; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Drake EN, 2006, MED HYPOTHESES, V67, P318, DOI 10.1016/j.mehy.2006.01.058; El-Bayoumy K, 2001, NUTR CANCER, V40, P18, DOI 10.1207/S15327914NC401_6; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fleshner N, 1999, J UROLOGY, V161, P1651, DOI 10.1016/S0022-5347(05)68998-7; FORMAN HJ, 1989, ARCH BIOCHEM BIOPHYS, V274, P443, DOI 10.1016/0003-9861(89)90457-8; FROSCIO M, 1989, BIOCHEM PHARMACOL, V38, P2087, DOI 10.1016/0006-2952(89)90061-0; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; Ghosh J, 2004, BIOCHEM BIOPH RES CO, V315, P624, DOI 10.1016/j.bbrc.2004.01.100; Ghosh J, 1997, BIOCHEM BIOPH RES CO, V235, P418, DOI 10.1006/bbrc.1997.6799; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; GOPALAKRISHNA R, 1993, ANAL BIOCHEM, V212, P296, DOI 10.1006/abio.1993.1331; Gopalakrishna R, 2002, J NUTR, V132, p3819S, DOI 10.1093/jn/132.12.3819S; Gopalakrishna R, 2001, NUTR CANCER, V40, P55, DOI 10.1207/S15327914NC401_11; Gopalakrishna R, 1997, ARCH BIOCHEM BIOPHYS, V348, P37, DOI 10.1006/abbi.1997.0335; Gopalakrishna R, 1997, ARCH BIOCHEM BIOPHYS, V348, P25, DOI 10.1006/abbi.1997.0334; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; GOPALAKRISHNA R, 1992, ANAL BIOCHEM, V206, P24, DOI 10.1016/S0003-2697(05)80006-5; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; GREEDER GA, 1980, SCIENCE, V209, P825, DOI 10.1126/science.7406957; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Gromer S, 2002, J BIOL CHEM, V277, P9701, DOI 10.1074/jbc.M109234200; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Holmgren A, 2006, FREE RADICAL BIO MED, V41, P862, DOI 10.1016/j.freeradbiomed.2006.05.024; IP C, 1990, CANCER RES, V50, P1206; Ip C, 2000, CANCER RES, V60, P2882; Jiang C, 2001, CANCER RES, V61, P3062; Kahlos K, 2003, MOL CELL BIOCHEM, V254, P47, DOI 10.1023/A:1027380828645; Karp JE, 1996, CANCER RES, V56, P5547; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; KILLILEA SD, 1979, ARCH BIOCHEM BIOPHYS, V193, P130, DOI 10.1016/0003-9861(79)90016-X; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; KOSAKA Y, 1988, BIOCHEM BIOPH RES CO, V151, P973, DOI 10.1016/S0006-291X(88)80461-3; Kumar S, 1999, CARCINOGENESIS, V20, P1761, DOI 10.1093/carcin/20.9.1761; Lamm MLG, 1997, ENDOCRINOLOGY, V138, P4657, DOI 10.1210/en.138.11.4657; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Moak MA, 2001, BIOL TRACE ELEM RES, V79, P257, DOI 10.1385/BTER:79:3:257; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murriel CL, 2003, ARCH BIOCHEM BIOPHYS, V420, P246, DOI 10.1016/j.abb.2003.08.038; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Nilsonne G, 2006, FREE RADICAL BIO MED, V41, P874, DOI 10.1016/j.freeradbiomed.2006.04.031; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OBRIAN CA, 1988, BIOCHEM BIOPH RES CO, V155, P1374, DOI 10.1016/S0006-291X(88)81293-2; OGITA K, 1992, P NATL ACAD SCI USA, V89, P1592, DOI 10.1073/pnas.89.5.1592; OLAH Z, 1994, ANAL BIOCHEM, V221, P94, DOI 10.1006/abio.1994.1384; Orlandi L, 2003, PROSTATE, V54, P133, DOI 10.1002/pros.10181; Park HS, 2000, J BIOL CHEM, V275, P2527, DOI 10.1074/jbc.275.4.2527; Parker TL, 2007, J NUTR BIOCHEM, V18, P746, DOI 10.1016/j.jnutbio.2006.12.013; SAIDO TC, 1992, BIOCHEMISTRY-US, V31, P482, DOI 10.1021/bi00117a026; SALGO MG, 1993, ARCH BIOCHEM BIOPHYS, V304, P123, DOI 10.1006/abbi.1993.1330; Seo YR, 2002, P NATL ACAD SCI USA, V99, P14548, DOI 10.1073/pnas.212319799; SHARMA S, 1994, CANCER RES, V54, P5848; Sies H, 1997, Adv Pharmacol, V38, P229; Sinha R, 2001, BIOCHEM PHARMACOL, V61, P311, DOI 10.1016/S0006-2952(00)00545-1; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; SPYROU G, 1995, FEBS LETT, V368, P59, DOI 10.1016/0014-5793(95)00599-5; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; SWEETMAN LL, 1995, ARCH BIOCHEM BIOPHYS, V323, P97, DOI 10.1006/abbi.1995.0014; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; THANNHAUSER TW, 1987, METHOD ENZYMOL, V143, P115; Thompson IM, 1997, PROSTATE, V33, P217, DOI 10.1002/(SICI)1097-0045(19971101)33:3<217::AID-PROS11>3.0.CO;2-N; Watson JA, 1999, BIOCHEM J, V343, P301, DOI 10.1042/0264-6021:3430301; WEBBER MM, 1985, BIOCHEM BIOPH RES CO, V130, P603, DOI 10.1016/0006-291X(85)90459-0; WENDEL A, 1984, BIOCHEM PHARMACOL, V33, P3241, DOI 10.1016/0006-2952(84)90084-4; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902; Wu DQ, 2002, CANCER RES, V62, P2423; Wycherly BJ, 2004, NUTR CANCER, V48, P78, DOI 10.1207/s15327914nc4801_11	88	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34519	34531		10.1074/jbc.M807007200	http://dx.doi.org/10.1074/jbc.M807007200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922790	hybrid, Green Published			2022-12-27	WOS:000261469100006
J	Marrichi, M; Camacho, L; Russell, DG; DeLisa, MP				Marrichi, Matthew; Camacho, Luis; Russell, David G.; DeLisa, Matthew P.			Genetic Toggling of Alkaline Phosphatase Folding Reveals Signal Peptides for All Major Modes of Transport across the Inner Membrane of Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE TRANSLOCATION PATHWAY; AERUGINOSA VIRULENCE FACTORS; MALTOSE-BINDING PROTEIN; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; RECOGNITION PARTICLE; EXPORTED PROTEINS; TOPOLOGY ANALYSIS; BETA-LACTAMASES; DISULFIDE BONDS	Prediction of export pathway specificity in prokaryotes is a challenging endeavor due to the similar overall architecture of N-terminal signal peptides for the Sec-, SRP- (signal recognition particle), and Tat (twin arginine translocation)-dependent pathways. Thus, we sought to create a facile experimental strategy for unbiased discovery of pathway specificity conferred by N-terminal signals. Using a limited collection of Escherichia coli strains that allow protein oxidation in the cytoplasm or, conversely, disable protein oxidation in the periplasm, we were able to discriminate the specific mode of export for PhoA (alkaline phosphatase) fusions to signal peptides for all of the major modes of transport across the inner membrane (Sec, SRP, or Tat). Based on these findings, we developed a mini-Tn5 phoA approach to isolate pathway-specific export signals from libraries of random fusions between exported proteins and the phoA gene. Interestingly, we observed that reduced PhoA was exported in a Tat-independent manner when targeted for Tat export in the absence of the essential translocon component TatC. This suggests that initial docking to TatC serves as a key specificity determinant for Tat-specific routing of PhoA, and in its absence, substrates can be rerouted to the Sec pathway, provided they remain compatible with the Sec export mechanism. Finally, the utility of our approach was demonstrated by experimental verification that four secreted proteins from Mycobacterium tuberculosis carrying putative Tat signals are bona fide Tat substrates and thus represent potential Tat-dependent virulence factors in this important human pathogen.	[Marrichi, Matthew; DeLisa, Matthew P.] Cornell Univ, Dept Microbiol & Immunol, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Camacho, Luis; Russell, David G.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	DeLisa, MP (corresponding author), 254 Olin Hall, Ithaca, NY 14853 USA.	md255@cornell.edu	Russell, David G/D-4533-2009; DeLisa, Matthew/AAE-7361-2019; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation Career Award [BES 0449080]; NYSTAR James D. Watson Award	National Science Foundation Career Award(National Science Foundation (NSF)); NYSTAR James D. Watson Award	This work was supported by National Science Foundation Career Award BES 0449080 and a NYSTAR James D. Watson Award (both to M. P. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; ALLARD JD, 1992, J BIOL CHEM, V267, P17809; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailey J, 2002, NAT BIOTECHNOL, V20, P839, DOI 10.1038/nbt715; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERG DE, 1983, GENETICS, V105, P813; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Braunstein M, 2000, J BACTERIOL, V182, P2732, DOI 10.1128/JB.182.10.2732-2740.2000; Bronstein P, 2004, RES MICROBIOL, V155, P803, DOI 10.1016/j.resmic.2004.06.013; Bronstein PA, 2005, J BACTERIOL, V187, P8450, DOI 10.1128/JB.187.24.8450-8461.2005; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chan CS, 2006, BIOCHEM BIOPH RES CO, V343, P244, DOI 10.1016/j.bbrc.2006.02.133; Chen G, 2001, NAT BIOTECHNOL, V19, P537, DOI 10.1038/89281; Cho DH, 2006, PROTEOMICS, V6, P5785, DOI 10.1002/pmic.200600207; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; DONNENBERG MS, 1990, INFECT IMMUN, V58, P1565, DOI 10.1128/IAI.58.6.1565-1571.1990; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FINLAY BB, 1988, MOL MICROBIOL, V2, P757, DOI 10.1111/j.1365-2958.1988.tb00087.x; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Froderberg L, 2003, MOL MICROBIOL, V47, P1015, DOI 10.1046/j.1365-2958.2003.03346.x; GILADI M, 1993, J BACTERIOL, V175, P4129, DOI 10.1128/JB.175.13.4129-4136.1993; GOTT P, 1988, MOL MICROBIOL, V2, P655, DOI 10.1111/j.1365-2958.1988.tb00074.x; GUTIERREZ C, 1987, J MOL BIOL, V195, P289, DOI 10.1016/0022-2836(87)90650-4; HERRERO M, 1988, J BACTERIOL, V170, P56, DOI 10.1128/jb.170.1.56-64.1988; HUANG HC, 1988, J BACTERIOL, V170, P4748, DOI 10.1128/jb.170.10.4748-4756.1988; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Kim J, 1998, J BACTERIOL, V180, P1396, DOI 10.1128/JB.180.6.1396-1401.1998; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; Kumar P, 2003, INFECT IMMUN, V71, P1929, DOI 10.1128/IAI.71.4.1929-1937.2003; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; LODGE JK, 1988, GENETICS, V120, P645; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; Lutz S, 2002, PROTEIN ENG, V15, P1025, DOI 10.1093/protein/15.12.1025; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Manoil C, 1997, J MOL BIOL, V267, P250, DOI 10.1006/jmbi.1996.0881; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Posey JE, 2006, J BACTERIOL, V188, P1332, DOI 10.1128/JB.188.4.1332-1340.2006; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; SARTHY A, 1981, J BACTERIOL, V145, P288, DOI 10.1128/JB.145.1.288-292.1981; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; WEBER RF, 1988, J MOL BIOL, V203, P467, DOI 10.1016/0022-2836(88)90013-7; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WEISS JB, 1988, P NATL ACAD SCI USA, V85, P8978, DOI 10.1073/pnas.85.23.8978	80	37	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35223	35235		10.1074/jbc.M802660200	http://dx.doi.org/10.1074/jbc.M802660200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18819916	Green Published, hybrid			2022-12-27	WOS:000261469100078
J	Mitsi, M; Forsten-Williams, K; Gopalakrishnan, M; Nugent, MA				Mitsi, Maria; Forsten-Williams, Kimberly; Gopalakrishnan, Manoj; Nugent, Matthew A.			A Catalytic Role of Heparin within the Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR BINDING; LIGAND DISSOCIATION KINETICS; MAST-CELLS; PLASMA FIBRONECTIN; GRANULE PROTEASES; IONIC-STRENGTH; BREAST-CANCER; MECHANISM; INTEGRIN; ANTITHROMBIN	We investigated the mechanism by which heparin enhances the binding of vascular endothelial growth factor ( VEGF) to the extracellular matrix protein fibronectin. In contrast to other systems, where heparin acts as a protein scaffold, we found that heparin functions catalytically to modulate VEGF binding site availability on fibronectin. By measuring the binding of VEGF and heparin to surface-immobilized fibronectin, we show that substoichiometric amounts of heparin exposed cryptic VEGF binding sites within fibronectin that remain available after heparin removal. Measurement of association and dissociation kinetics for heparin binding to fibronectin indicated that the interaction is rapid and transient. We localized the heparin-responsive element to the C-terminal 40-kDa Hep2 domain of fibronectin. A mathematical model of this catalytic process was constructed that supports a mechanism whereby the heparin-induced conformational change in fibronectin is accompanied by release of heparin. Experiments with endothelial extracellular matrix suggest that this process may also occur within biological matrices. These results indicate a novel mechanism whereby heparin catalyzes the conversion of fibronectin to an open conformation by transiently interacting with fibronectin and progressively hopping from molecule to molecule. Catalytic activation of the extracellular matrix might be an important mechanism for heparin to regulate function during normal and disease states.	[Mitsi, Maria; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Nugent, Matthew A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Nugent, Matthew A.] Boston Univ, Dept Biomed Engn, Boston, MA 02118 USA; [Forsten-Williams, Kimberly] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA; [Gopalakrishnan, Manoj] Harish Chandra Res Inst, Allahabad 211019, Uttar Pradesh, India	Boston University; Boston University; Boston University; Virginia Polytechnic Institute & State University; Harish Chandra Research Institute	Nugent, MA (corresponding author), Boston Univ, Sch Med, Dept Biochem, Rm K225,715 Albany St, Boston, MA 02118 USA.	mnugent@bu.edu	Gopalakrishnan, Manoj/D-3359-2014; Mitsi, Maria/S-2519-2017	Gopalakrishnan, Manoj/0000-0002-7931-5042; Mitsi, Maria/0000-0001-8983-1983; Nugent, Matthew/0000-0002-8630-4712	National Institutes of Health [HL56200, HL088572]; Massachusetts Lions Eye Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088572, R01HL056200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL56200 and HL088572. This work was also supported by a departmental grant from the Massachusetts Lions Eye Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AZIZKHAN RG, 1980, J EXP MED, V152, P931, DOI 10.1084/jem.152.4.931; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Borsig L, 2003, PATHOPHYSIOL HAEMO T, V33, P64, DOI 10.1159/000073298; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; CLARK RAF, 1982, J INVEST DERMATOL, V79, P269, DOI 10.1111/1523-1747.ep12500076; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Della Rovere F, 2007, ANTICANCER RES, V27, P2465; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; ERICKSON J, 1987, BIOPHYS J, V52, P657, DOI 10.1016/S0006-3495(87)83258-7; ERICKSON JW, 1991, BIOCHEMISTRY-US, V30, P2357, DOI 10.1021/bi00223a009; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; EVINGTON JRN, 1986, BIOCHIM BIOPHYS ACTA, V870, P92, DOI 10.1016/0167-4838(86)90012-9; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Goerges AL, 2004, J BIOL CHEM, V279, P2307, DOI 10.1074/jbc.M308482200; GOLDSTEIN B, 1989, BIOPHYS J, V56, P955, DOI 10.1016/S0006-3495(89)82741-9; Gopalakrishnan M, 2005, BIOPHYS J, V89, P3686, DOI 10.1529/biophysj.105.065300; Gopalakrishnan M, 2005, EUR BIOPHYS J BIOPHY, V34, P943, DOI 10.1007/s00249-005-0471-2; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Humphries DE, 1999, J HISTOCHEM CYTOCHEM, V47, P1645; INGHAM KC, 1993, BIOCHEMISTRY-US, V32, P12548, DOI 10.1021/bi00097a035; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Lagerholm BC, 1998, BIOPHYS J, V74, P1215, DOI 10.1016/S0006-3495(98)77836-1; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; MACHOVICH R, 1981, BIOCHEM J, V199, P521, DOI 10.1042/bj1990521; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miralem T, 2001, ONCOGENE, V20, P5511, DOI 10.1038/sj.onc.1204753; Mitsi M, 2006, BIOCHEMISTRY-US, V45, P10319, DOI 10.1021/bi060974p; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.3.CO;2-R; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Nader HB, 2004, CURR PHARM DESIGN, V10, P951, DOI 10.2174/1381612043452758; NESHEIM ME, 1983, J BIOL CHEM, V258, P4708; Nienartowicz A, 2006, MED SCI MONITOR, V12, pRA53; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; OSTERLUND E, 1985, BIOCHEMISTRY-US, V24, P2661, DOI 10.1021/bi00332a011; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; POMERANTZ MW, 1978, BIOCHIM BIOPHYS ACTA, V535, P66, DOI 10.1016/0005-2795(78)90033-8; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; RICHTER H, 1985, BIOL CHEM H-S, V366, P509, DOI 10.1515/bchm3.1985.366.1.509; ROCCO M, 1983, J BIOL CHEM, V258, P4545; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Samoszuk M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-121; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Stringer SE, 1997, INT J BIOCHEM CELL B, V29, P709, DOI 10.1016/S1357-2725(96)00170-7; Tsou R, 2001, MOL CELL BIOCHEM, V224, P81, DOI 10.1023/A:1011947301849; VUILLARD L, 1994, INT J BIOL MACROMOL, V16, P21, DOI 10.1016/0141-8130(94)90006-X; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973; Zacharski LR, 1998, THROMB HAEMOSTASIS, V80, P10; Zacharski LR, 2002, CANCER LETT, V186, P1, DOI 10.1016/S0304-3835(02)00258-6	62	59	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34796	34807		10.1074/jbc.M806692200	http://dx.doi.org/10.1074/jbc.M806692200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845539	Green Published, hybrid			2022-12-27	WOS:000261469100036
J	Chaineau, M; Danglot, L; Proux-Gillardeaux, V; Galli, T				Chaineau, Mathilde; Danglot, Lydia; Proux-Gillardeaux, Veronique; Galli, Thierry			Role of HRB in Clathrin-dependent Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; SYNAPTIC VESICLE; PLASMA-MEMBRANE; CELLULAR COFACTOR; SNARE COMPLEXES; COATED VESICLES; EH DOMAIN; TI-VAMP; IDENTIFICATION; EPS15	Human immunodeficiency virus Rev-binding protein (HRB), also called human Rev-interacting protein (hRIP) or Rev/Rex activation domain binding (RAB) is a partner of the tyrosine kinase substrate EPS15, and it has been recovered in the AP-2 interactome. EPS15 and AP-2 are involved in endocytosis, but the function of HRB in this process is still unknown. Here we identified HRB as a partner of the vesicular SNARE tetanus neurotoxin-insensitive vesicle-associated membrane protein (TI-VAMP, also called VAMP7) in yeast two-hybrid screens and using biochemical assays. In HeLa cells, HRB localized both in the nucleus and in the cytoplasm. In the cytoplasm, HRB colocalized with clathrin-, AP-2-, EPS15-, and transferrin receptor-containing vesicles. We did not see significant colocalization between HRB and TI-VAMP in HeLa cells, and we saw partial colocalization with green fluorescent protein-TI-VAMP in stably expressing Madin-Darby canine kidney cells. Nevertheless using a pHLuorin-tagged TI-VAMP construct, we found that HRB and TI-VAMP colocalize close to the plasma membrane after 5 min of anti-green fluorescent protein antibody uptake. These results suggest that TI-VAMP and HRB may interact only during the early stages of endocytosis. Furthermore uptake experiments followed by fluorescence-activated cell sorting showed that the endocytosis of fluorescent transferrin and pHLuorin-TI-VAMP is strongly reduced in HRB knockdown cells. Altogether these results suggest that HRB is involved in clathrin-dependent endocytosis and recruits TI-VAMP in this process.	Univ Paris 06, INSERM, Avenir Team, F-75005 Paris, France; Univ Paris 07, INSERM, Avenir Team, F-75005 Paris, France; Univ Paris 07, Inst Jacques Monod, CNRS, UMR7592, F-75005 Paris, France; Univ Paris 06, Inst Jacques Monod, CNRS, UMR7592, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Galli, T (corresponding author), Inst Jacques Monod, 2 Pl Jussieu, F-75251 Paris 05, France.	thierry@tgalli.net	DANGLOT, Lydia/G-5684-2013; Galli, Thierry/Q-2249-2019; Galli, Thierry/G-8842-2011	DANGLOT, Lydia/0000-0001-6190-6605; Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455	INSERM; European Commission [503229]; Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche ("PolarHiCell"); Mairie de Paris Medical Research and Health Program; Fondation pour la Recherche Medicale; Ministry of Research and la Ligue Contre le Cancer (Paris committee)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale pour la Recherche ("PolarHiCell")(French National Research Agency (ANR)); Mairie de Paris Medical Research and Health Program; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ministry of Research and la Ligue Contre le Cancer (Paris committee)	This work was supported in part by grants from INSERM (Avenir Program), the European Commission ("Signalling and Traffic" Specific Targeted Research Project Grant 503229), the Association pour la Recherche sur le Cancer, the Agence Nationale pour la Recherche ("PolarHiCell"), the Mairie de Paris Medical Research and Health Program, and the Fondation pour la Recherche Medicale (to T. G.). The CyAn ADP analyzer was bought with funds from the Ministry of Research and la Ligue Contre le Cancer (Paris committee). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alberts P, 2003, BIOL CELL, V95, P419, DOI 10.1016/S0248-4900(03)00074-1; Alberts P, 2003, MOL BIOL CELL, V14, P4207, DOI 10.1091/mbc.e03-03-0147; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; Doria M, 1999, J CELL BIOL, V147, P1379, DOI 10.1083/jcb.147.7.1379; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; GALLI T, 2004, SCI STKE, pRE19; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Juneja SC, 2005, HUM REPROD, V20, P881, DOI 10.1093/humrep/deh719; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; MIESENBOCK G, 2000, IMAGING NEURONS LAB; Mitsunari T, 2005, MOL CELL BIOL, V25, P9318, DOI 10.1128/MCB.25.21.9318-9323.2005; Morgan JR, 2003, J BIOL CHEM, V278, P33583, DOI 10.1074/jbc.M304346200; Morgan JR, 2002, NEUROMOL MED, V2, P101, DOI 10.1385/NMM:2:2:101; Muzerelle A, 2003, NEUROSCIENCE, V122, P59, DOI 10.1016/S0306-4522(03)00567-0; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; Proux-Gillardeaux V, 2007, BIOL CELL, V99, P261, DOI 10.1042/BC20060097; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rossi V, 2004, TRENDS BIOCHEM SCI, V29, P682, DOI 10.1016/j.tibs.2004.10.002; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sanchez-Velar N, 2004, GENE DEV, V18, P23, DOI 10.1101/gad.1149704; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STUTZ F, 1995, CELL, V82, P495, DOI 10.1016/0092-8674(95)90438-7; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Torrisi MR, 1999, MOL BIOL CELL, V10, P417, DOI 10.1091/mbc.10.2.417	45	48	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34365	34373		10.1074/jbc.M804587200	http://dx.doi.org/10.1074/jbc.M804587200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819912	Green Published, hybrid			2022-12-27	WOS:000261277700064
J	Lee, YM; Lee, JO; Jung, JH; Kim, JH; Park, SH; Park, JM; Kim, EK; Suh, PG; Kim, HS				Lee, Yun Mi; Lee, Jung Ok; Jung, Jin-Hee; Kim, Ji Hae; Park, Sun-Hwa; Park, Ji Man; Kim, Eung-Kyun; Suh, Pann-Ghill; Kim, Hyeon Soo			Retinoic Acid Leads to Cytoskeletal Rearrangement through AMPK-Rac1 and Stimulates Glucose Uptake through AMPK-p38 MAPK in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-INHIBITION; CANCER CELLS; FATTY-ACID; ACTIN; EXPRESSION; MOTILITY; DIFFERENTIATION; PATHWAY; CA2+	Retinoic acid (RA) is one of the major components of vitamin A. In the present study, we found that retinoic acid activated AMP-activated protein kinase (AMPK). RA induced Rac1-GTP formation and phosphorylation of its downstream target, p21-activated kinase (PAK), whereas the inhibition of AMPK blocked RA-induced Rac1 activation. Moreover, cofilin, an actin polymerization regulator, was activated when incubated with RA. We then showed that inhibition of AMPK by compound C, a selective inhibitor of AMPK, or small interfering RNA of AMPK alpha 1 blocked RA-induced cofilin phosphorylation. Additionally, we found that retinoic acid-stimulated glucose uptake in differentiated C2C12 myoblast cells and activated p38 mitogen-activated protein kinase (MAPK). Finally, the inhibition of AMPK and p38 MAPK blocked retinoic acid-induced glucose uptake. In summary, our results suggest that retinoic acid may have cytoskeletal roles in skeletal muscle cells via stimulation of the AMPK-Rac1-PAK-cofillin pathway and may also have beneficial roles in glucose metabolism via stimulation of the AMPK-p38 MAPK pathway.	[Lee, Yun Mi; Lee, Jung Ok; Jung, Jin-Hee; Kim, Ji Hae; Park, Sun-Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea; [Park, Ji Man; Kim, Eung-Kyun; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 770784, South Korea	Korea University; Korea University Medicine (KU Medicine); Pohang University of Science & Technology (POSTECH)	Kim, HS (corresponding author), 126-1,5 Ga Anam Dong, Seoul 136701, South Korea.	anatomykim@korea.ac.kr	Suh, Pann-Ghill/F-3610-2010		Korea University College of Medicine; Korea Science and Engineering Foundation [R01-2008-000-11180-0]	Korea University College of Medicine; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported Korea University College of Medicine and Korea Science and Engineering Foundation Grant KOSEF, R01-2008-000-11180-0. The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must therefore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1291, DOI 10.1152/ajpendo.00167.2001; Blutt SE, 1997, ENDOCRINOLOGY, V138, P1491, DOI 10.1210/en.138.4.1491; Carlier MF, 2003, BIOESSAYS, V25, P336, DOI 10.1002/bies.10257; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Fitzgerald P, 1997, CANCER RES, V57, P2642; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Hong SE, 2004, J MED FOOD, V7, P320, DOI 10.1089/1096620041938696; HONG WK, 1994, LEUKEMIA, V8, pS33; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Makinde AO, 1997, CIRC RES, V80, P482, DOI 10.1161/01.RES.80.4.482; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Montessuit C, 2008, ENDOCRINOLOGY, V149, P1064, DOI 10.1210/en.2007-0656; Nicholson-Dykstra S, 2005, CURR BIOL, V15, pR346, DOI 10.1016/j.cub.2005.04.029; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; ODWYER PJ, 1987, J SURG RES, V43, P550, DOI 10.1016/0022-4804(87)90130-2; OREFFO ROC, 1988, J BONE MINER RES, V3, P203; PANG J, 2005, J NEUOROCHEM, V93, P571; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; SHEIKH MS, 1994, J BIOL CHEM, V269, P21440; Shyu RY, 2003, J BIOMED SCI, V10, P313, DOI 10.1159/000070096; VARANI J, 1995, AM J PATHOL, V147, P718; Zhang WK, 2007, AM J PHYSIOL-RENAL, V292, pF1054, DOI 10.1152/ajprenal.00286.2006; Zitterbart K, 2001, NEOPLASMA, V48, P456; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	32	67	71	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33969	33974		10.1074/jbc.M804469200	http://dx.doi.org/10.1074/jbc.M804469200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18927084	Green Published, hybrid			2022-12-27	WOS:000261277700023
J	Wu, SF; Fadoju, D; Rezvani, G; De Luca, F				Wu, Shufang; Fadoju, Doris; Rezvani, Geoffrey; De Luca, Francesco			Stimulatory Effects of Insulin-like Growth Factor-I on Growth Plate Chondrogenesis Are Mediated by Nuclear Factor-kappa B p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGITUDINAL BONE-GROWTH; DISTINCT SIGNALING PATHWAYS; CELL-LINE; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIAPOPTOTIC ACTIONS; HUMAN CHONDROCYTES; GENE-EXPRESSION; IGF-I; ACTIVATION; KINASE	Insulin-like growth factor-I (IGF-I) is an important regulator of endochondral ossification. However, little is known about the signaling pathways activated by IGF-I in growth plate chondrocytes. We have previously shown that NF-kappa B-p65 facilitates growth plate chondrogenesis. In this study, we first cultured rat metatarsal bones with IGF-I and/or pyrrolidine dithiocarbamate (PDTC), a known NF-kappa B inhibitor. The IGF-I-mediated stimulation of metatarsal growth and growth plate chondrogenesis was neutralized by PDTC. In rat growth plate chondrocytes, IGF-I induced NF-kappa B-p65 nuclear translocation. The inhibition of NF-kappa B-p65 expression and activity (by p65 short interfering RNA and PDTC, respectively) in chondrocytes reversed the IGF-I-mediated induction of cell proliferation and differentiation and the IGF-I-mediated prevention of cell apoptosis. Moreover, the inhibition of the phosphatidylinositol 3-kinase and Akt abolished the effects of IGF-I on NF-kappa B activation. In conclusion, our findings indicate that IGF-I stimulates growth plate chondrogenesis by activating NF-kappa B-p65 in chondrocytes.	[Wu, Shufang; Fadoju, Doris; Rezvani, Geoffrey; De Luca, Francesco] Drexel Univ, St Christophers Hosp Children, Sect Endocrinol & Diabet, Dept Pediat,Coll Med, Philadelphia, PA 19134 USA	Drexel University	De Luca, F (corresponding author), Drexel Univ, St Christophers Hosp Children, Sect Endocrinol & Diabet, Dept Pediat,Coll Med, Erie Ave,Front St, Philadelphia, PA 19134 USA.	francesco.deluca@drexelmed.edu						Abbaspour A, 2008, BONE, V42, P98, DOI 10.1016/j.bone.2007.08.031; AHARINEJAD S, 1995, ANAT REC, V242, P111, DOI 10.1002/ar.1092420115; BAGI C, 1989, CALCIFIED TISSUE INT, V45, P342, DOI 10.1007/BF02556004; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baixeras E, 2001, ENDOCRINOLOGY, V142, P2968, DOI 10.1210/en.142.7.2968; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cherng YG, 2008, J ORTHOP RES, V26, P1018, DOI 10.1002/jor.20578; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; Ciarmatori S, 2007, J MOL ENDOCRINOL, V38, P493, DOI 10.1677/jme.1.02179; Cruickshank J, 2005, J ENDOCRINOL, V184, P543, DOI 10.1677/joe.1.05947; De Luca F, 2001, ENDOCRINOLOGY, V142, P430, DOI 10.1210/en.142.1.430; de Moissac D, 1999, J BIOL CHEM, V274, P29505, DOI 10.1074/jbc.274.41.29505; Del Rio MJ, 2006, GROWTH FACTORS, V24, P67, DOI 10.1080/08977190500361788; Eshet R, 2004, J ENDOCRINOL, V182, P165, DOI 10.1677/joe.0.1820165; FARNUM CE, 1987, MICROSCOP RES TECH, V28, P505; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Grey A, 2003, ENDOCRINOLOGY, V144, P4886, DOI 10.1210/en.2003-0350; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Heck S, 1999, J BIOL CHEM, V274, P9828, DOI 10.1074/jbc.274.14.9828; Hoshi K, 2004, J BONE MINER RES, V19, P214, DOI 10.1359/JBMR.0301221; HUNZIKER EB, 1994, J CLIN INVEST, V93, P1078, DOI 10.1172/JCI117058; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kiepe D, 2005, ENDOCRINOLOGY, V146, P3096, DOI 10.1210/en.2005-0324; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Liu WL, 2001, ENDOCRINOLOGY, V142, P1710, DOI 10.1210/en.142.5.1710; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mushtaq T, 2004, ENDOCRINOLOGY, V145, P2478, DOI 10.1210/en.2003-1435; Parrizas M, 1997, J BIOL CHEM, V272, P154; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Phornphutkul C, 2004, J ENDOCRINOL, V183, P477, DOI 10.1677/joe.1.05873; Pons S, 2000, J BIOL CHEM, V275, P38620, DOI 10.1074/jbc.M004531200; SCHEVEN BAA, 1991, ACTA ENDOCRINOL-COP, V124, P602, DOI 10.1530/acta.0.1240602; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Sugimori K, 2005, J BONE MINER METAB, V23, P411, DOI 10.1007/s00774-005-0622-7; Tsakiridis T, 2001, BIOCHEM BIOPH RES CO, V288, P205, DOI 10.1006/bbrc.2001.5762; Vallee S, 2003, BIOCHEM BIOPH RES CO, V305, P831, DOI 10.1016/S0006-291X(03)00866-0; Wang J, 2004, J ENDOCRINOL, V180, P247, DOI 10.1677/joe.0.1800247; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Wu GJ, 2007, J CELL BIOCHEM, V101, P1520, DOI 10.1002/jcb.21268; Wu SF, 2004, J BIOL CHEM, V279, P4642, DOI 10.1074/jbc.M305518200; Wu S, 2007, J BIOL CHEM, V282, P33698, DOI 10.1074/jbc.M702991200; Zhang LH, 2001, J BIOL CHEM, V276, P43534, DOI 10.1074/jbc.M104257200	45	36	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34037	34044		10.1074/jbc.M803754200	http://dx.doi.org/10.1074/jbc.M803754200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922796	Green Published, hybrid			2022-12-27	WOS:000261277700031
J	Tejero, JS; Biswas, A; Wang, ZQ; Page, RC; Haque, MM; Hemann, C; Zweier, JL; Misra, S; Stuehr, DJ				Tejero, Jesu S.; Biswas, Ashis; Wang, Zhi-Qiang; Page, Richard C.; Haque, Mohammad Mahfuzul; Hemann, Craig; Zweier, Jay L.; Misra, Saurav; Stuehr, Dennis J.			Stabilization and Characterization of a Heme-Oxy Reaction Intermediate in Inducible Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPOUND-I FORMATION; S HYDROGEN-BOND; ELECTRON-TRANSFER; OXYGENASE DOMAIN; L-ARGININE; CYTOCHROME P450CAM; SINGLE-TURNOVER; KINETIC CHARACTERIZATION; SUBUNIT DIMERIZATION; DIOXYGEN COMPLEX	Nitric-oxide synthases ( NOS) are heme-thiolate enzymes that N-hydroxylate L-arginine (L-Arg) to make NO. NOS contain a unique Trp residue whose side chain stacks with the heme and hydrogen bonds with the heme thiolate. To understand its importance we substituted His for Trp(188) in the inducible NOS oxygenase domain (iNOSoxy) and characterized enzyme spectral, thermodynamic, structural, kinetic, and catalytic properties. The W188H mutation had relatively small effects on L-Arg binding and on enzyme heme-CO and heme-NO absorbance spectra, but increased the heme midpoint potential by 88 mV relative to wildtype iNOSoxy, indicating it decreased heme-thiolate electronegativity. The protein crystal structure showed that the His(188) imidazole still stacked with the heme and was positioned to hydrogen bond with the heme thiolate. Analysis of a single turnover L-Arg hydroxylation reaction revealed that a new heme species formed during the reaction. Its build up coincided kinetically with the disappearance of the enzyme heme-dioxy species and with the formation of a tetrahydrobiopterin (H4B) radical in the enzyme, whereas its subsequent disappearance coincided with the rate of L-Arg hydroxylation and formation of ferric enzyme. We conclude: (i) W188H iNOSoxy stabilizes a heme-oxy species that forms upon reduction of the heme-dioxy species by H4B.(ii) The W188H mutation hinders either the processing or reactivity of the heme-oxy species and makes these steps become rate-limiting for L-Arg hydroxylation. Thus, the conserved Trp residue in NOS may facilitate formation and/or reactivity of the ultimate hydroxylating species by tuning heme-thiolate electronegativity.	[Tejero, Jesu S.; Biswas, Ashis; Wang, Zhi-Qiang; Haque, Mohammad Mahfuzul; Stuehr, Dennis J.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Page, Richard C.; Misra, Saurav] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Wang, Zhi-Qiang] Kent State Univ Tuscarawas, Dept Chem, New Philadelphia, OH 44663 USA; [Hemann, Craig; Zweier, Jay L.] Ohio State Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med,Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Tuscarawas; University System of Ohio; Ohio State University	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; HAQUE, MOHAMMAD/0000-0003-0852-6368; Misra, Saurav/0000-0002-1385-8554; Page, Richard/0000-0002-3006-3171; Hemann, Craig/0000-0002-7380-4072	National Institutes of Health [CA53914, GM51491, HL76491, GM080271, HL63744, HL65608, HL38324]; American Heart Association [0565297B]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL063744, R01HL038324, R29HL038324, P01HL065608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491, R01GM080271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53914, GM51491, HL76491 (to D. J. S.), GM080271 (to S. M.), HL63744, HL65608, and HL38324 (to J. L. Z.). This work was also supported by American Heart Association Beginning Grant-in-Aid 0565297B (to Z.-Q. W.). The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AbuSoud HM, 1997, J BIOL CHEM, V272, P17349, DOI 10.1074/jbc.272.28.17349; AbuSoud HM, 1997, BIOCHEMISTRY-US, V36, P10811, DOI 10.1021/bi971414g; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Barbato JE, 2004, J VASC SURG, V40, P187, DOI 10.1016/j.jvs.2004.03.043; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; Benson DE, 1997, BIOCHEMISTRY-US, V36, P5104, DOI 10.1021/bi963170q; Berka V, 2008, BIOCHEMISTRY-US, V47, P405, DOI 10.1021/bi701677r; Boggs S, 2000, BIOCHEMISTRY-US, V39, P2332, DOI 10.1021/bi9920228; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Cho KB, 2007, J AM CHEM SOC, V129, P3182, DOI 10.1021/ja066662r; Clark JP, 2006, J INORG BIOCHEM, V100, P1075, DOI 10.1016/j.jinorgbio.2005.11.020; Couture M, 2000, J BIOL CHEM, V275, P3201, DOI 10.1074/jbc.275.5.3201; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Davydov R, 2002, BIOCHEMISTRY-US, V41, P10375, DOI 10.1021/bi0260637; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; de Visser SP, 2008, J AM CHEM SOC, V130, P12961, DOI 10.1021/ja8010995; DeLano W.L, PYMOL MOL GRAPHICS S; Denisov IG, 2007, BIOCHEM BIOPH RES CO, V363, P954, DOI 10.1016/j.bbrc.2007.09.085; Efimov I, 2007, BIOCHEMISTRY-US, V46, P8017, DOI 10.1021/bi7006492; EGAWA T, 1994, BIOCHEM BIOPH RES CO, V201, P1464, DOI 10.1006/bbrc.1994.1868; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Glascock MC, 2005, J BIOL CHEM, V280, P42134, DOI 10.1074/jbc.M505426200; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Groves JT, 2000, CURR OPIN CHEM BIOL, V4, P687, DOI 10.1016/S1367-5931(00)00146-0; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Jung C, 2005, MAGN RESON CHEM, V43, pS84, DOI 10.1002/mrc.1694; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; Ledbetter AP, 1999, BIOCHEMISTRY-US, V38, P8014, DOI 10.1021/bi990619h; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Li HY, 2001, BIOCHEMISTRY-US, V40, P5399, DOI 10.1021/bi002658v; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Makris TM, 2006, J INORG BIOCHEM, V100, P507, DOI 10.1016/j.jinorgbio.2006.01.025; Mansuy Daniel, 1995, P537; Marchal S, 2004, J BIOL CHEM, V279, P19824, DOI 10.1074/jbc.M313587200; Matsumura H, 2008, BIOCHEMISTRY-US, V47, P4834, DOI 10.1021/bi800142v; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCMILLAN K, 1993, BIOCHEMISTRY-US, V32, P9875, DOI 10.1021/bi00089a001; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Ogliaro F, 2002, J INORG BIOCHEM, V91, P554, DOI 10.1016/S0162-0134(02)00437-3; Ogliaro F, 2000, J AM CHEM SOC, V122, P12892, DOI 10.1021/ja005619f; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; PAPALE D, 2007, J BIOL INORG CHEM, V12, pS199; Pfeiffer S, 1999, ANGEW CHEM INT EDIT, V38, P1715, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1714::AID-ANIE1714>3.0.CO;2-3; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Poulos TL, 2005, PHILOS T R SOC A, V363, P793, DOI 10.1098/rsta.2004.1537; Poulos TL, 1996, J BIOL INORG CHEM, V1, P356, DOI 10.1007/s007750050064; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Raner GM, 2006, J INORG BIOCHEM, V100, P2045, DOI 10.1016/j.jinorgbio.2006.09.025; Scheiner S, 2002, J AM CHEM SOC, V124, P13257, DOI 10.1021/ja027200q; Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; Shikama K, 2006, PROG BIOPHYS MOL BIO, V91, P83, DOI 10.1016/j.pbiomolbio.2005.04.001; Sligar SG, 2005, BIOCHEM BIOPH RES CO, V338, P346, DOI 10.1016/j.bbrc.2005.08.094; Song YF, 2006, BIOCHEMISTRY-US, V45, P7949, DOI 10.1021/bi052182l; SONO M, 1995, J BIOL CHEM, V270, P19943, DOI 10.1074/jbc.270.34.19943; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sorlie M, 2003, J BIOL CHEM, V278, P48602, DOI 10.1074/jbc.M305682200; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Suzuki N, 1999, J AM CHEM SOC, V121, P11571, DOI 10.1021/ja992511v; Ueyama N, 1996, INORG CHEM, V35, P6473, DOI 10.1021/ic9604324; Ueyama N, 1998, INORG CHEM, V37, P2415, DOI 10.1021/ic971140l; Voigt P, 2003, J BIOL CHEM, V278, P51993, DOI 10.1074/jbc.M307560200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang ZQ, 2002, J BIOL CHEM, V277, P12830, DOI 10.1074/jbc.M111967200; Wang ZQ, 2001, BIOCHEMISTRY-US, V40, P12819, DOI 10.1021/bi011182s; Wei CC, 2003, BIOCHEMISTRY-US, V42, P1969, DOI 10.1021/bi026898h; Wei CC, 2001, J BIOL CHEM, V276, P315, DOI 10.1074/jbc.M008441200; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; Whitwam RE, 1999, BIOCHEMISTRY-US, V38, P9608, DOI 10.1021/bi982568e; Wilson DJ, 2001, BIOCHEM BIOPH RES CO, V287, P126, DOI 10.1006/bbrc.2001.5559; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763; Yoshioka S, 2002, J AM CHEM SOC, V124, P14571, DOI 10.1021/ja0265409; Yoshioka S, 2000, J INORG BIOCHEM, V81, P141, DOI 10.1016/S0162-0134(00)00097-0; Yun HY, 1997, MOL PSYCHIATR, V2, P300, DOI 10.1038/sj.mp.4000272; Zhu YQ, 2008, BIOCHEMISTRY-US, V47, P2231, DOI 10.1021/bi7023817	96	45	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33498	33507		10.1074/jbc.M806122200	http://dx.doi.org/10.1074/jbc.M806122200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18815130	hybrid, Green Published			2022-12-27	WOS:000261183700054
J	Metzger, MB; Maurer, MJ; Dancy, BM; Michaelis, S				Metzger, Meredith Boyle; Maurer, Matthew J.; Dancy, Beverley M.; Michaelis, Susan			Degradation of a Cytosolic Protein Requires Endoplasmic Reticulum-associated Degradation Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER QUALITY-CONTROL; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN-PROTEASOME PATHWAY; HEAT-SHOCK PROTEINS; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; IN-VIVO; TRANSCRIPTIONAL REGULATOR; MAT-ALPHA-2 REPRESSOR; MISFOLDED PROTEINS	Protein misfolding is monitored by a variety of cellular "quality control" systems. Endoplasmic reticulum (ER) quality control handles misfolded secretory and membrane proteins and is well characterized. However, less is known about the quality control of misfolded cytosolic proteins (CytoQC). To study CytoQC, we have employed a genetic system in Saccharomyces cerevisiae using a transplantable degron, CL1 (1). Attachment of CL1 to the cytosolic protein Ura3p destabilizes Ura3p, targeting it for rapid proteasomal degradation. We have performed a comprehensive analysis of Ura3p-CL1 degradation requirements. As shown previously, we observe that the ER-localized ubiquitin E2 (Ubc6p, Ubc7p, and Cue1p) and E3 (Doa10p) machinery involved in ER-associated degradation (ERAD) are also responsible for the degradation of the cytosolic substrate Ura3p-CL1. Importantly, we find that the cytosol/ER membrane-localized chaperones Ydj1p and Ssa1p, known to be necessary for the ERAD of membrane proteins with misfolded cytosolic domains, are also required for the ubiquitination and degradation of Ura3p-CL1. In addition, we show a role for the Cdc48p-Npl4p-Ufd1p complex in the degradation of Ura3p-CL1. When ubiquitination is blocked, a portion of Ura3p-CL1 is ER membrane-localized. Furthermore, access to the cytosolic face of the ER is required for the degradation of CL1 degron-containing proteins. The ER is distributed throughout the cytosol, and our data, together with previous studies, suggest that the cytosolic face of the ER membrane serves as a "platform" for the degradation of Ura3p-CL1, which may also be the case for other CytoQC substrates.	[Metzger, Meredith Boyle; Maurer, Matthew J.; Dancy, Beverley M.; Michaelis, Susan] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Michaelis, S (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	michaelis@jhmi.edu	Rabbitts, Beverley M./W-1376-2019	Rabbitts, Beverley M./0000-0002-0896-6024; Maurer, Matthew/0000-0002-9150-0240; Metzger, Meredith/0000-0002-6248-0009	National Institutes of Health [GM51508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51508 (to S. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Bazirgan OA, 2008, J BIOL CHEM, V283, P12797, DOI 10.1074/jbc.M801122200; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1992, J BIOL CHEM, V267, P20927; den Boon JA, 2001, J VIROL, V75, P12370, DOI 10.1128/JVI.75.24.12370-12381.2001; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; GAIGG B, 1995, BBA-BIOMEMBRANES, V1234, P214, DOI 10.1016/0005-2736(94)00287-Y; Gandre S, 2002, BIOCHEM BIOPH RES CO, V293, P139, DOI 10.1016/S0006-291X(02)00194-8; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gilon T, 2000, MOL CELL BIOL, V20, P7214, DOI 10.1128/MCB.20.19.7214-7219.2000; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; HEINEMEYER W, 1991, BIOCHEM SOC T, V19, P724, DOI 10.1042/bst0190724; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JARIELENCONTRE I, 2008, BIOCH BIOPHYS ACTA; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Lenk U, 2000, J BIOL CHEM, V275, P39403, DOI 10.1074/jbc.M006949200; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; MICHAELIS S, 1988, MOL CELL BIOL, V8, P1309, DOI 10.1128/MCB.8.3.1309; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; SIKORSKI RS, 1989, GENETICS, V122, P19; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	77	103	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32302	32316		10.1074/jbc.M806424200	http://dx.doi.org/10.1074/jbc.M806424200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18812321	Green Published, hybrid			2022-12-27	WOS:000260893700017
J	Lu, LY; Wood, JL; Ye, L; Minter-Dykhouse, K; Saunders, TL; Yu, XC; Chen, JJ				Lu, Lin-Yu; Wood, Jamie L.; Ye, Lin; Minter-Dykhouse, Katherine; Saunders, Thomas L.; Yu, Xiaochun; Chen, Junjie			Aurora A Is Essential for Early Embryonic Development and Tumor Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; A KINASE; D-TACC; CHROMOSOMAL PASSENGERS; PROTEIN-KINASE; CANCER-THERAPY; ABL KINASE; PHOSPHORYLATION; CENTROSOME; TARGETS	Aurora A is a serine/threonine kinase that functions in various stages of mitosis. Accumulating evidence has demonstrated that gene amplification and overexpression of Aurora A are linked to tumorigenesis, suggesting that Aurora A is an oncogene. In addition, Aurora A overexpression has been used as a negative prognostic marker, because it is associated with resistance to anti-mitotic agents commonly used for cancer therapy. To understand the physiological functions of Aurora A, we generated Aurora A knock-out mice. Aurora A null mice die early during embryonic development before the 16-cell stage. These Aurora A null embryos have defects in mitosis, particularly in spindle assembly, supporting critical functions of Aurora A during mitotic transitions. Interestingly, Aurora A heterozygosity results in a significantly increased tumor incidence in mice, suggesting that Aurora A may also act as a haploinsufficient tumor suppressor. Consistently, Aurora A heterozygous mouse embryonic fibroblasts have higher rates of aneuploidy. We further discovered that VX-680, an Aurora kinase inhibitor currently in phase II clinical trials for cancer treatment, could induce aneuploidy in wild type mouse embryonic fibroblasts. We conclude that a balanced Aurora A level is critical for maintaining genomic stability and one needs to be fully aware of the potential side effects of anti-cancer therapy based on the use of Aurora A-specific inhibitors.	[Lu, Lin-Yu; Ye, Lin; Yu, Xiaochun] Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Sch Med, Transgen Anim Model Core, Ann Arbor, MI 48109 USA; [Wood, Jamie L.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Wood, Jamie L.; Minter-Dykhouse, Katherine] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Mayo Clinic	Yu, XC (corresponding author), Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, BSRB 1520, Ann Arbor, MI 48109 USA.	xiayu@umich.edu; junjie.chen@yale.edu	Minter Dykhouse, Katherine/L-4573-2013	Minter Dykhouse, Katherine/0000-0003-4363-5826; Saunders, Thom/0000-0003-2015-101X	National Institutes of Health [CA113381]; American Cancer Society [RSG-08-125-01-CCG]; NATIONAL CANCER INSTITUTE [R01CA113381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113381 ( to J. C.). This work was also supported American Cancer Society Grant RSG-08-125-01-CCG ( to X. Y.).	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Cazales M, 2005, CELL CYCLE, V4, P1233, DOI 10.4161/cc.4.9.1964; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheetham GMT, 2007, CANCER LETT, V251, P323, DOI 10.1016/j.canlet.2006.12.004; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Kimmins S, 2007, MOL ENDOCRINOL, V21, P726, DOI 10.1210/me.2006-0332; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sasai K, 2008, ONCOGENE, V27, P4122, DOI 10.1038/onc.2008.47; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	37	76	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31785	31790		10.1074/jbc.M805880200	http://dx.doi.org/10.1074/jbc.M805880200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801727	Green Published, hybrid			2022-12-27	WOS:000260760800061
J	Lukiw, WJ; Zhao, YH; Cui, JG				Lukiw, Walter J.; Zhao, Yuhai; Cui, Jian Guo			An NF-kappa B-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)	APR 30, 2008	Ft Lauderdale, FL	Assoc Res Vis & Ophthalmol (ARVO)			GENE-EXPRESSION; SMALL RNAS; MIRNAS; TRANSCRIPTION; INDUCTION; SURVIVAL; FETAL	Human brains retain discrete populations of micro RNA (miRNA) species that support homeostatic brain gene expression functions; however, specific miRNA abundance is significantly altered in neurological disorders such as Alzheimer disease (AD) when compared with age-matched controls. Here we provide evidence in AD brains of a specific up-regulation of an NF-kappa B-sensitive miRNA-146a highly complementary to the 3'-untranslated region of complement factor H (CFH), an important repressor of the inflammatory response of the brain. Up-regulation of miRNA-146a coupled to down-regulation of CFH was observed in AD brain and in interleukin-1 beta, A beta 42, and/or oxidatively stressed human neural (HN) cells in primary culture. Transfection of HN cells using an NF-kappa B-containing pre-miRNA-146a promoter-luciferase reporter construct in stressed HN cells showed significant up-regulation of luciferase activity that paralleled decreases in CFH gene expression. Treatment of stressed HN cells with the NF-kappa B inhibitor pyrollidine dithiocarbamate or the resveratrol analog CAY10512 abrogated this response. Incubation of an antisense oligonucleotide to miRNA-146a (anti-miRNA-146a; AM-146a) was found to restore CFH expression levels. These data indicate that NF-kappa B-sensitive miRNA-146a-mediated modulation of CFH gene expression may in part regulate an inflammatory response in AD brain and in stressed HN cell models of AD and illustrate the potential for anti-miRNAs as an effective therapeutic strategy against pathogenic inflammatory signaling.	Louisiana State Univ, Ctr Neurosci, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, 2020 Gravier St,Suite 8B8, New Orleans, LA 70112 USA.	wlukiw@lsuhsc.edu	ZHAO, YUHAI/A-1167-2010		NATIONAL INSTITUTE ON AGING [R01AG018031] Funding Source: NIH RePORTER; NIA NIH HHS [AG18031] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bazan NG, 2002, J BIOL CHEM, V277, P30359, DOI 10.1074/jbc.M203201200; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Cui JG, 2007, NEUROREPORT, V18, P115, DOI 10.1097/WNR.0b013e32801198bc; DeLegge MH, 2008, NUTR CLIN PRACT, V23, P35, DOI 10.1177/011542650802300135; Gustincich S, 2006, J PHYSIOL-LONDON, V575, P321, DOI 10.1113/jphysiol.2006.115568; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Ho Gilbert J., 2005, Current Drug Targets - Inflammation and Allergy, V4, P247, DOI 10.2174/1568010053586237; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hudder A, 2008, TOXICOL SCI, V103, P228, DOI 10.1093/toxsci/kfn033; Infante-Duarte C, 2008, J MOL MED, V86, P975, DOI 10.1007/s00109-007-0292-0; Jellinger KA, 2006, J ALZHEIMERS DIS, V9, P61; Kim VN, 2005, MOL CELLS, V19, P1; Letiembre M, 2007, NEUROSCIENCE, V146, P248, DOI 10.1016/j.neuroscience.2007.01.004; Lio D, 2006, AGING CLIN EXP RES, V18, P163, DOI 10.1007/BF03327434; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lukiw WJ, 2006, BIOCHEM SOC T, V34, P1277, DOI 10.1042/BST0341277; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw WJ, 2000, ALZHEIMERS REP, V3, P233; Lukiw WJ, 2004, NEUROCHEM RES, V29, P1287, DOI 10.1023/B:NERE.0000023615.89699.63; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Minghetti Luisa, 2007, Subcell Biochem, V42, P127; Mufson EJ, 2006, PROG BRAIN RES, V158, P197, DOI 10.1016/S0079-6123(06)58010-0; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; Niwa R, 2008, DEV BIOL, V315, P418, DOI 10.1016/j.ydbio.2007.12.044; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Rogaev EI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1404, DOI 10.1007/s10541-005-0276-z; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Singh SK, 2007, PHARMACOGENOMICS, V8, P971, DOI 10.2217/14622416.8.8.971; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Vasto S, 2007, PHARMACOGENOMICS, V8, P1735, DOI 10.2217/14622416.8.12.1735; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Zhao YH, 2006, MOL NEUROBIOL, V34, P181, DOI 10.1385/MN:34:3:181	38	351	375	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31315	31322		10.1074/jbc.M805371200	http://dx.doi.org/10.1074/jbc.M805371200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	370KJ	18801740	Green Published, hybrid			2022-12-27	WOS:000260760800008
J	Foucaud, M; Marco, E; Escrieut, C; Low, C; Kalindjian, B; Fourmy, D				Foucaud, Magali; Marco, Esther; Escrieut, Chantal; Low, Caroline; Kalindjian, Barret; Fourmy, Daniel			Linking Non-peptide Ligand Binding Mode to Activity at the Human Cholecystokinin-2 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CRYSTAL-STRUCTURE; GASTRIN RECEPTOR; ANTAGONISTS; ACTIVATION; RHODOPSIN; EXPRESSION; MECHANISM; AGONISTS; SITE	Given the importance of G-protein-coupled receptors as pharmacological targets in medicine, efforts directed at the understanding the molecular mechanism by which pharmacological compounds regulate their activity is of paramount importance. Here, we investigated at an atomic level the mechanism of inverse agonism and partial agonism of two high affinity, high selectivity very similar non-peptide ligands of the cholecystokinin-2 receptor (CCK2R) which differ by the absence or presence of a methyl group on their indole moiety. Using in silico, site-directed mutagenesis and pharmacological experiments, we demonstrated that these functionally different activities are due to differing anchoring modes of the two compounds to a residue of helix II (Thr-2.61) in the inactive state of the CCK2R. The binding mode of the inverse agonist allows the ligand to interact through its phenyl moiety with a key amino acid for CCK2R activation (Trp-6.48), preventing rotation of helix VI and, thus, CCK2R activation, whereas the partial agonist binds deeper into the binding pocket and closer to helix V, so that CCK2R activation is favored. This study on the molecular mechanism of ligand action opens the possibility of target-based optimization of G protein-coupled receptor non-peptide ligands.	[Fourmy, Daniel] INSERM, I2MR Equipe 13, U858, F-31432 Toulouse 4, France; [Foucaud, Magali; Marco, Esther; Escrieut, Chantal; Fourmy, Daniel] Univ Toulouse 3, F-31062 Toulouse, France; [Low, Caroline; Kalindjian, Barret] James Black Fdn, London SE24 9JE, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Fourmy, D (corresponding author), INSERM, I2MR Equipe 13, U858, 1 Ave Jean Poulhes,BP 84225, F-31432 Toulouse 4, France.	fourmyd@inserm.fr	Fourmy, Daniel/AAE-3703-2019	Fourmy, Daniel/0000-0001-9910-4827				Bayly CI, 1999, BIOORG MED CHEM LETT, V9, P307, DOI 10.1016/S0960-894X(98)00717-3; Becker OM, 2004, P NATL ACAD SCI USA, V101, P11304, DOI 10.1073/pnas.0401862101; Black JW, 2002, PHARMACOL TOXICOL, V91, P275, DOI 10.1034/j.1600-0773.2002.910602.x; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Foucaud M, 2006, MOL PHARMACOL, V69, P680, DOI 10.1124/mol.105.019992; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gales C, 2003, ONCOGENE, V22, P6081, DOI 10.1038/sj.onc.1206823; Gales C, 2003, MOL PHARMACOL, V63, P973, DOI 10.1124/mol.63.5.973; Herranz R, 2003, MED RES REV, V23, P559, DOI 10.1002/med.10042; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kalindjian SB, 1996, J MED CHEM, V39, P1806, DOI 10.1021/jm9508907; Kalindjian SB, 2001, J MED CHEM, V44, P1125, DOI 10.1021/jm0010668; KALINDJIAN SB, 1994, J MED CHEM, V37, P3671, DOI 10.1021/jm00048a001; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; Langer I, 2005, J BIOL CHEM, V280, P22198, DOI 10.1074/jbc.M501786200; Lu XP, 2004, MOL PHARMACOL, V66, P1192, DOI 10.1124/mol.104.000349; Marco E, 2007, J BIOL CHEM, V282, P28779, DOI 10.1074/jbc.M700349200; Noble F, 1999, PHARMACOL REV, V51, P745; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; POPLE JA, 2001, GAUSSIAN 98 REVISION; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; SADOWSKI J, 2008, CORINA 3 1; Silvente-Poirot S, 1999, J BIOL CHEM, V274, P23191, DOI 10.1074/jbc.274.33.23191; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	28	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35860	35868		10.1074/jbc.M805513200	http://dx.doi.org/10.1074/jbc.M805513200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18936102	hybrid			2022-12-27	WOS:000261687900061
J	Zhou, JL; Blue, EK; Hu, GQ; Herring, BP				Zhou, Jiliang; Blue, Emily K.; Hu, Guoqing; Herring, B. Paul			Thymine DNA Glycosylase Represses Myocardin-induced Smooth Muscle Cell Differentiation by Competing with Serum Response Factor for Myocardin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; EXCISION-REPAIR; TRANSCRIPTION; PROMOTER; ALPHA; ACTIVATION; PROGRAMS; FAMILY	Myocardin is a serum response factor (SRF) co-activator that regulates transcription of many smooth muscle-specific genes and is essential for development of vascular smooth muscle. We used a yeast two-hybrid screen, with myocardin as bait in a search for factors that regulate myocardin transcriptional activity. From this screen, thymine DNA glycosylase (TDG) was identified as a myocardin-associated protein. TDG was originally identified as an enzyme involved in base excision repair of T: G mismatches caused by spontaneous deamination of methylated cytosines. However, TDG has also been shown to act as a transcriptional co-activator or co-repressor. The interaction between TDG and myocardin was confirmed in vitro by glutathione S-transferase pull down and in vivo by co-immunoprecipitation assays. We found that TDG abrogates myocardin induced expression of smooth muscle-specific genes and represses the trans-activation of the promoters of myocardin of these genes. Overexpression of TDG in SMCs down-regulated smooth muscle marker expression. Conversely, depletion of endogenous TDG in SMCs increased smooth muscle-specific myosin heavy chain (SM MHC) and Telokin gene expression. Glutathione S-transferase pull-down assays demonstrated that TDG binds to a region of myocardin that includes the SRF binding domain. Furthermore, TDG was found to compete with SRF for binding to myocardin in vitro and in vivo, suggesting that TDG can inhibit expression of smooth muscle-specific genes, at least in part, through disrupting SRF/myocardin interactions. Finally, we demonstrated that the glycosylase activity of TDG is not required for its inhibitory effects on myocardin function. This study reveals a previously unsuspected role for the repair enzyme TDG as a repressor of smooth	[Zhou, Jiliang; Hu, Guoqing] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Blue, Emily K.; Herring, B. Paul] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Albany Medical College; Indiana University System; Indiana University-Purdue University Indianapolis	Zhou, JL (corresponding author), 47 New Scotland Ave, Albany, NY 12208 USA.	zhouj1@mail.amc.edu		Blue, Emily/0000-0001-8290-4473	National Institutes of Health [DK61130, DK65644]; American Heart Association postdoctoral fellowship and Scientist Development; Indiana University Diabetes and Obesity Training [DK064466]; American Heart Association predoctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064466, R01DK061130, R01DK065644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship and Scientist Development(American Heart Association); Indiana University Diabetes and Obesity Training; American Heart Association predoctoral fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61130 and DK65644 ( to B. P. H.). This work was also supported by an American Heart Association postdoctoral fellowship and Scientist Development grant ( to J. Z.), Indiana University Diabetes and Obesity Training Grant DK064466, and an American Heart Association predoctoral fellowship ( to E. K. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Herring BP, 1996, AM J PHYSIOL-CELL PH, V270, pC1656, DOI 10.1152/ajpcell.1996.270.6.C1656; Hoggatt AM, 2002, CIRC RES, V91, P1151, DOI 10.1161/01.RES.0000047508.30800.4F; JOST JP, 1993, P NATL ACAD SCI USA, V90, P4684, DOI 10.1073/pnas.90.10.4684; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lucey MJ, 2005, NUCLEIC ACIDS RES, V33, P6393, DOI 10.1093/nar/gki940; Mack CP, 1999, CIRC RES, V84, P852; Madsen CS, 1998, CIRC RES, V82, P908; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; Niederreither K, 1998, ONCOGENE, V17, P1577, DOI 10.1038/sj.onc.1202072; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Schmutte C, 1997, CANCER RES, V57, P3010; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	36	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35383	35392		10.1074/jbc.M805489200	http://dx.doi.org/10.1074/jbc.M805489200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945672	Green Published, hybrid			2022-12-27	WOS:000261687900009
J	Inaba, K; Suzuki, M; Maegawa, K; Akiyama, S; Ito, K; Akiyama, Y				Inaba, Kenji; Suzuki, Mamoru; Maegawa, Ken-ichi; Akiyama, Shuji; Ito, Koreaki; Akiyama, Yoshinori			A Pair of Circularly Permutated PDZ Domains Control RseP, the S2P Family Intramembrane Protease of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE-STRESS-RESPONSE; EXTRACYTOPLASMIC STRESS; REGULATED PROTEOLYSIS; SIGMA(E); YAEL; DEGS; RECOGNITION; BINDING; INHIBITION; CLEAVAGE	The sigma(E) pathway of extracytoplasmic stress responses in Escherichia coli is activated through sequential cleavages of the anti-sigma(E) protein, RseA, by membrane proteases DegS and RseP. Without the first cleavage by DegS, RseP is unable to cleave full-length RseA. We previously showed that a PDZ-like domain in the RseP periplasmic region is essential for this negative regulation of RseP. We now isolated additional deregulated RseP mutants. Many of the mutations affected a periplasmic region that is N-terminal to the previously defined PDZ domain. We expressed these regions and determined their crystal structures. Consistent with a recent prediction, our results indicate that RseP has tandem, circularly permutated PDZ domains (PDZ-N and PDZ-C). Strikingly, almost all the strong mutations have been mapped around the ligand binding cleft region in PDZ-N. These results together with those of an in vitro reaction reproducing the two-step RseA cleavage suggest that the proteolytic function of RseP is controlled by ligand binding to PDZ-N.	[Ito, Koreaki; Akiyama, Yoshinori] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Inaba, Kenji; Maegawa, Ken-ichi] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Suzuki, Mamoru] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Akiyama, Shuji] JST, PRESTO, Saitama 3320012, Japan; [Akiyama, Shuji] RIKEN Harima Inst, Hyogo 6795148, Japan	Kyoto University; Kyushu University; Osaka University; Japan Science & Technology Agency (JST); RIKEN	Akiyama, Y (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	yakiyama@virus.kyoto-u.ac.jp	Suzuki, Mamoru/G-6576-2016	Suzuki, Mamoru/0000-0001-7071-5093; AKIYAMA, Shuji/0000-0002-7184-189X; Inaba, Kenji/0000-0001-8229-0467	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Kyushu University Interdisciplinary Program in Education and Projects in Research Development; Grants-in-Aid for Scientific Research [20247020, 19GS0314] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyushu University Interdisciplinary Program in Education and Projects in Research Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Japan Society for the Promotion of Science (to Y.A.,K. Inaba, and K. Ito) and from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (to S.A. and Y.A.), by "Targeted Proteins Research Program from MEXT, Japan (to M.S.), and by Kyushu University Interdisciplinary Program in Education and Projects in Research Development (to K. Inaba). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bohn C, 2004, MOL MICROBIOL, V52, P427, DOI 10.1111/j.1365-2958.2004.03985.x; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; Harris BZ, 2001, J CELL SCI, V114, P3219; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito K, 2005, JPN J APPL PHYS 1, V44, P8684, DOI 10.1143/JJAP.44.8684; Iwanczyk J, 2007, J BACTERIOL, V189, P3176, DOI 10.1128/JB.01788-06; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Kanehara K, 2003, EMBO J, V22, P6389, DOI 10.1093/emboj/cdg602; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; Koide K, 2008, J BIOL CHEM, V283, P9562, DOI 10.1074/jbc.M709984200; Koide K, 2007, J BIOL CHEM, V282, P4553, DOI 10.1074/jbc.M607339200; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Rudolph MG, 2003, ACTA CRYSTALLOGR D, V59, P290, DOI 10.1107/S0907444902021704; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869	49	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35042	35052		10.1074/jbc.M806603200	http://dx.doi.org/10.1074/jbc.M806603200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945679	Green Published, hybrid			2022-12-27	WOS:000261469100061
J	Stevens, HC; Malone, L; Nichols, JW				Stevens, Haley C.; Malone, Lynn; Nichols, J. Wylie			The Putative Aminophospholipid Translocases, DNF1 and DNF2, Are Not Required for 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-phosphatidylserine Flip across the Plasma Membrane of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; FLUORESCENCE-LABELED PHOSPHOLIPIDS; ASYMMETRIC DISTRIBUTION; TRANSPORT PATHWAYS; YEAST; ENDOCYTOSIS; PROTEIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; DRS2P	The regulation of phosphatidylserine (PS) distribution across the plasma membrane of eukaryotic cells has been implicated in numerous cell functions (e.g. apoptosis and coagulation). In a recent study, fluorescent phospholipids labeled in the acyl chain with 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) were used to identify two members of the P4 subfamily of P-type ATPases, Dnf1p and Dnf2p, that are necessary for the inward-directed transport of phospholipids across the plasma membrane (flip) of yeast (Pomorski, T., Lombardi, R., Riezman, H., Devaux, P. F., Van Meer, G., and Holthuis, J.C. (2003) Mol. Biol. Cell 14, 1240 1254). Herein, we present evidence that the flip of NBD-labeled PS (NBD-PS) across the plasma membrane does not require the expression of Dnf1p or Dnf2p. In strains in which DNF1 and DNF2 are both deleted, the flip of NBD-PS is increased similar to 2-fold over that of the isogenic parent strain, whereas the flip of NBD-labeled phosphatidylcholine and NBD-labeled phosphatidylethanolamine are reduced to similar to 20 and similar to 50%, respectively. The mechanism responsible for NBD-PS flip is similar to that for NBD-labeled phosphatidylcholine and NBD-labeled phosphatidylethanolamine in its dependence on cellular ATP and the plasma membrane proton electrochemical gradient, as well as its regulation by the transcription factors Pdr1p and Pdr3p. Based on the observation that deletion or inactivation of all four members of the DRS2/DNF essential subfamily of P-type ATPases does not affect NBD-PS flip, we conclude that the activity reflected by NBD-PS internalization is not the essential function of the DRS2/DNF subfamily of P-type ATPases.	[Stevens, Haley C.; Malone, Lynn; Nichols, J. Wylie] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Nichols, JW (corresponding author), Emory Univ, Sch Med, Dept Physiol, 615 Michael St,605G Whitehead, Atlanta, GA 30322 USA.	wylie.nichols@emory.edu			Institute of General Medicine [GM64770]; University Research Committee of Emory University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064770] Funding Source: NIH RePORTER	Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Research Committee of Emory University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grant GM64770 from the Institute of General Medicine and by a grant from the University Research Committee of Emory University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Elvington SM, 2005, J BIOL CHEM, V280, P40957, DOI 10.1074/jbc.M507926200; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Grant AM, 2001, TRAFFIC, V2, P37, DOI 10.1034/j.1600-0854.2001.020106.x; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Hanson PK, 2001, J BIOL CHEM, V276, P9861, DOI 10.1074/jbc.M009065200; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Ikeda M, 2006, BIOL PHARM BULL, V29, P1542, DOI 10.1248/bpb.29.1542; Karpova TS, 2000, MOL BIOL CELL, V11, P1727, DOI 10.1091/mbc.11.5.1727; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; KEAN LS, 1993, J CELL BIOL, V123, P1403, DOI 10.1083/jcb.123.6.1403; Kean LS, 1997, J CELL BIOL, V138, P255, DOI 10.1083/jcb.138.2.255; Marx U, 1999, EUR J BIOCHEM, V263, P254, DOI 10.1046/j.1432-1327.1999.00497.x; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Nichols JW, 2002, SEMIN CELL DEV BIOL, V13, P179, DOI 10.1016/S1084-9521(02)00046-0; PAGANO RE, 1985, SCIENCE, V229, P1051, DOI 10.1126/science.4035344; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Prezant TR, 1996, MICROBIOL-SGM, V142, P3407, DOI 10.1099/13500872-142-12-3407; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; RIEZMAN H, 1986, TRENDS BIOCHEM SCI, V11, P325, DOI 10.1016/0968-0004(86)90290-2; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Sherman F., 1986, METHODS YEAST GENETI; Siegmund A, 1998, J BIOL CHEM, V273, P34399, DOI 10.1074/jbc.273.51.34399; Stevens HC, 2007, J BIOL CHEM, V282, P17563, DOI 10.1074/jbc.M700454200; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Yamaji-Hasegawa A, 2006, BIOL PHARM BULL, V29, P1547, DOI 10.1248/bpb.29.1547	40	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35060	35069		10.1074/jbc.M802379200	http://dx.doi.org/10.1074/jbc.M802379200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18931395	Green Published, hybrid			2022-12-27	WOS:000261469100063
J	Zhang, P; Samuel, CE				Zhang, Ping; Samuel, Charles E.			Induction of Protein Kinase PKR-dependent Activation of Interferon Regulatory Factor 3 by Vaccinia Virus Occurs through Adapter IPS-1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; ANTIVIRAL RESPONSE; I-INTERFERON; HUMAN-CELLS; TRANSCRIPTION FACTORS; ADENOSINE-DEAMINASE; IRF-3 ACTIVATION; INFECTED CELLS; PHOSPHORYLATION	Interferon regulatory factor 3 (IRF-3) undergoes phosphorylation-induced activation in virus-infected cells and plays an important role in the antiviral innate immune response. The E3L protein encoded by vaccinia virus is known to impair phosphorylation and activation of IRF-3. Kinases in addition to I kappa B kinase-related kinases are implicated in the IRF-3-dependent antiviral response. To test in human cells the role of the protein kinase regulated by RNA (PKR) in IRF-3 activation, HeLa cells made stably deficient in PKR using an RNA interference strategy were compared with PKR-sufficient cells. Rapid phosphorylation and nuclear accumulation of IRF-3 were detected in PKR-sufficient cells following infection with E3L deletion mutant (Delta E3L) virus. By contrast, the full IRF-3 activation response was largely abolished in PKR-deficient cells. The Delta E3L virus-induced IRF-3 activation seen in PKR-sufficient cells was diminished by treatment with cytosine beta-D-arabinofuranoside. Furthermore, the vaccinia mutant ts23, which displays increased viral double-stranded RNA production at 39 C, induced PKR-dependent IRF-3 phosphorylation at 39 C but not at 31 C. Both IRF-3 phosphorylation and cell apoptosis induced by infection with Delta E3L virus were dependent upon RIG-I-like receptor signal transduction components, including the adapter IPS-1. These data suggest that PKR facilitates the host innate immune response and apoptosis in virus-infected cells by mediating IRF-3 activation through the mitochondrial IPS-1 signal transduction pathway.	[Zhang, Ping; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			National Institutes of Health [AI-12520, AI-20611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020611, R01AI012520, R37AI012520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-12520 and AI-20611 (NIAID research grants from USPHS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Arsenio J, 2008, VIROLOGY, V377, P124, DOI 10.1016/j.virol.2008.04.014; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; BAYLISS CD, 1993, VIROLOGY, V194, P254, DOI 10.1006/viro.1993.1256; BEATTIE E, 1995, VIROLOGY, V210, P254, DOI 10.1006/viro.1995.1342; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bouxsein NF, 2007, BIOCHEMISTRY-US, V46, P4785, DOI 10.1021/bi062138l; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; COLBY C, 1971, J VIROL, V7, P71, DOI 10.1128/JVI.7.1.71-76.1971; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gil J, 2000, ONCOGENE, V19, P3665, DOI 10.1038/sj.onc.1203710; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Ho CK, 1996, J VIROL, V70, P2611, DOI 10.1128/JVI.70.4.2611-2614.1996; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Iordanov MS, 2005, APOPTOSIS, V10, P153, DOI 10.1007/s10495-005-6070-y; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson J, 2007, J BIOL CHEM, V282, P15022, DOI 10.1074/jbc.M700421200; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; Moss B, 2001, FIELDS VIROLOGY, P2849; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Onomoto K, 2007, CURR TOP MICROBIOL, V316, P193; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Uno T, 2005, MOL CANCER THER, V4, P799, DOI 10.1158/1535-7163.MCT-04-0317; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07	62	58	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34580	34587		10.1074/jbc.M807029200	http://dx.doi.org/10.1074/jbc.M807029200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18927075	Green Published, hybrid			2022-12-27	WOS:000261469100012
J	Ponticelli, S; Marasco, D; Tarallo, V; Albuquerque, RJC; Mitola, S; Takeda, A; Stassen, JM; Presta, M; Ambati, J; Ruvo, M; De Falco, S				Ponticelli, Salvatore; Marasco, Daniela; Tarallo, Valeria; Albuquerque, Romulo J. C.; Mitola, Stefania; Takeda, Atsunobu; Stassen, Jean-Marie; Presta, Marco; Ambati, Jayakrishna; Ruvo, Menotti; De Falco, Sandro			Modulation of Angiogenesis by a Tetrameric Tripeptide That Antagonizes Vascular Endothelial Growth Factor Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC PEPTIDE LIBRARY; CRYSTAL-STRUCTURE; TUMOR ANGIOGENESIS; VEGF RECEPTOR-1; FLT-1 RECEPTOR; AMINO-ACIDS; FACTOR-B; BINDING; ACTIVATION; CELLS	Vascular endothelial growth factor receptor-1 (VEGFR-1, also known as Flt-1) is involved in complex biological processes often associated to severe pathological conditions like cancer, inflammation, and metastasis formation. Consequently, the search for antagonists of Flt-1 has recently gained a growing interest. Here we report the identification of a tetrameric tripeptide from a combinatorial peptide library built using non-natural amino acids, which binds Flt-1 and inhibits in vitro its interaction with placental growth factor (PlGF) and vascular endothelial growth factor (VEGF) A and B (IC50 similar to 10 mu M). The peptide is stable in serum for 7 days and prevents both Flt-1 phosphorylation and the capillary-like tube formation of human primary endothelial cells stimulated by PlGF or VEGF-A. Conversely, the identified peptide does not interfere in VEGF-induced VEGFR-2 activation. In vivo, this peptide inhibits VEGF-A- and PlGF-induced neoangiogenesis in the chicken embryo chorioallantoic membrane assay. In contrast, in the cornea, where avascularity is maintained by high levels of expression of the soluble form of Flt-1 receptor (sFlt-1) that prevents the VEGF-A activity, the peptide is able to stimulate corneal mouse neovascularization in physiological condition, as reported previously for others neutralizing anti-Flt-1 molecules. This tetrameric tripeptide represents a new, promising compound for therapeutic approaches in pathologies where Flt-1 activation plays a crucial role.	[Ponticelli, Salvatore; Tarallo, Valeria; De Falco, Sandro] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Stem Cell Fate Lab, I-80131 Naples, Italy; [Ponticelli, Salvatore; Tarallo, Valeria; De Falco, Sandro] CNR, Angiogenesis Lab, I-80131 Naples, Italy; [Marasco, Daniela; Ruvo, Menotti] CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy; [Albuquerque, Romulo J. C.; Takeda, Atsunobu; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40536 USA; [Mitola, Stefania; Presta, Marco] Univ Brescia, Dept Biomed Sci & Biotechnol, Unit Gen Pathol & Immunol, I-25123 Brescia, Italy; [Stassen, Jean-Marie] Thrombogenics, B-3000 Louvain, Belgium	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Kentucky; University of Brescia	De Falco, S (corresponding author), CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Stem Cell Fate Lab, Via Pietro Castellino 111, I-80131 Naples, Italy.	defalco@igb.cnr.it	De Falco, Sandro/P-6724-2015; Presta, Marco/B-4345-2010; Marasco, Daniela/H-4848-2015	Marasco, Daniela/0000-0002-6618-2949; Tarallo, Valeria/0000-0002-6920-4402; PRESTA, Marco/0000-0002-4398-8376; De Falco, Sandro/0000-0002-6501-1697; MITOLA, Stefania/0000-0002-5557-738X	AIRC [4840]; Telethon-Italy [GGP08062]; FIRB [RBNE03PX83_005]; National Institutes of Health (NEI) [EY015422, EY018350, EY018836]; NATIONAL EYE INSTITUTE [R01EY018350, R01EY018836, R01EY015422] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); National Institutes of Health (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by AIRC (Associazione Italiana Ricerca sul Cancro, Grant 4840) and Telethon-Italy (Grant GGP08062) (to S. D. F.) and only in part by FIRB (Grant RBNE03PX83_005) (to M. R.) and National Institutes of Health (NEI) Grants EY015422, EY018350, and EY018836 (to J. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bae DG, 2005, CLIN CANCER RES, V11, P2651, DOI 10.1158/1078-0432.CCR-04-1564; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; CUNNINGHAM SA, 1995, J BIOL CHEM, V270, P20254, DOI 10.1074/jbc.270.35.20254; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; De Falco S, 2001, J BIOL CHEM, V276, P36613, DOI 10.1074/jbc.M102377200; El-Mousawi M, 2003, J BIOL CHEM, V278, P46681, DOI 10.1074/jbc.M308681200; Errico M, 2004, J BIOL CHEM, V279, P43929, DOI 10.1074/jbc.M401418200; FASSINA G, 1992, J CHROMATOGR, V591, P99, DOI 10.1016/0021-9673(92)80226-K; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; FURKA A, 1991, INT J PEPT PROT RES, V37, P487, DOI 10.1111/j.1399-3011.1991.tb00765.x; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Iyer S, 2001, J BIOL CHEM, V276, P12153, DOI 10.1074/jbc.M008055200; Iyer S, 2006, J MOL BIOL, V359, P76, DOI 10.1016/j.jmb.2006.03.002; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Luttun A, 2002, ANN NY ACAD SCI, V979, P80, DOI 10.1111/j.1749-6632.2002.tb04870.x; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Marino M, 2000, NAT BIOTECHNOL, V18, P735, DOI 10.1038/77296; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; Nishi JI, 2008, CIRC RES, V103, P261, DOI 10.1161/CIRCRESAHA.108.174128; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Taylor AP, 2007, MOL CANCER THER, V6, P524, DOI 10.1158/1535-7163.MCT-06-0461; Verdoliva A, 2005, CHEMBIOCHEM, V6, P1242, DOI 10.1002/cbic.200400368; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	48	35	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34250	34259		10.1074/jbc.M806607200	http://dx.doi.org/10.1074/jbc.M806607200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922791	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000261277700053
J	Chamberlain, KL; Marshall, RS; Jolliffe, NA; Frigerio, L; Ceriotti, A; Lord, JM; Roberts, LM				Chamberlain, Kerry L.; Marshall, Richard S.; Jolliffe, Nicholas A.; Frigerio, Lorenzo; Ceriotti, Aldo; Lord, J. Michael; Roberts, Lynne M.			Ricin B Chain Targeted to the Endoplasmic Reticulum of Tobacco Protoplasts Is Degraded by a CDC48-and Vacuole-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; PLANT-CELLS; A-CHAIN; ASIALOGLYCOPROTEIN RECEPTOR; PROTEASOMAL DEGRADATION; RETRO-TRANSLOCATION; MOVEMENT PROTEIN; MOSAIC-VIRUS; ER; TRANSPORT	The B chain of ricin was expressed and delivered to the endoplasmic reticulum of tobacco protoplasts where it disappeared with time in a manner consistent with degradation. This turnover did not occur in the vacuoles or upon secretion. Indeed, several lines of evidence indicate that, in contrast to the turnover of endoplasmic reticulum-targeted ricin A chain in the cytosol, the bulk of expressed ricin B chain was degraded in the secretory pathway.	[Chamberlain, Kerry L.; Marshall, Richard S.; Jolliffe, Nicholas A.; Frigerio, Lorenzo; Lord, J. Michael; Roberts, Lynne M.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Ceriotti, Aldo] CNR, Ist Biol & Biotecnol Agr, I-20133 Milan, Italy	University of Warwick; Consiglio Nazionale delle Ricerche (CNR)	Roberts, LM (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	lynne.roberts@warwick.ac.uk	Frigerio, Lorenzo/D-2685-2009; Frigerio, Lorenzo/M-6013-2019; Ceriotti, Aldo/A-1448-2016	Frigerio, Lorenzo/0000-0003-4100-6022; Frigerio, Lorenzo/0000-0003-4100-6022; Ceriotti, Aldo/0000-0002-8230-8863	Wellcome Trust [080566/Z/06/Z]; UK Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Wellcome Trust Programme Grant 080566/Z/06/Z (to L. M. R. and J. M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a Wellcome Trust Prize Studentship.; Supported by a studentship from the UK Biotechnology and Biological Sciences Research Council.	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; BARLOWE C, 1993, J BIOL CHEM, V268, P873; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; BENATTI L, 1989, EUR J BIOCHEM, V183, P465, DOI 10.1111/j.1432-1033.1989.tb14951.x; Blanchard N, 2008, CURR OPIN IMMUNOL, V20, P82, DOI 10.1016/j.coi.2007.12.004; Brandizzi F, 2003, PLANT J, V34, P269, DOI 10.1046/j.1365-313X.2003.01728.x; Brauer D, 1997, PLANT PHYSIOL, V113, P809, DOI 10.1104/pp.113.3.809; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; DENFERT C, 1991, MOL CELL BIOL, V11, P5727, DOI 10.1128/MCB.11.11.5727; DENFERT C, 1991, J CELL BIOL, V114, P663, DOI 10.1083/jcb.114.4.663; Di Cola A, 2005, PLANT PHYSIOL, V137, P287, DOI 10.1104/pp.104.055434; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; Donoso G, 2005, BIOCHEM J, V387, P897, DOI 10.1042/BJ20041312; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; ENDO Y, 1987, J BIOL CHEM, V262, P8128; FEILER HS, 1995, EMBO J, V14, P5626, DOI 10.1002/j.1460-2075.1995.tb00250.x; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FERRINI JB, 1995, EUR J BIOCHEM, V233, P772, DOI 10.1111/j.1432-1033.1995.772_3.x; Frigerio L, 1998, J BIOL CHEM, V273, P14194, DOI 10.1074/jbc.273.23.14194; Frigerio L, 2001, PLANT CELL, V13, P1109, DOI 10.1105/tpc.13.5.1109; Frigerio L, 1998, PLANT CELL, V10, P1031, DOI 10.1105/tpc.10.6.1031; Frigerio L, 2001, PLANT PHYSIOL, V126, P167, DOI 10.1104/pp.126.1.167; Frigerio L, 1998, J EXP BOT, V49, P1473, DOI 10.1093/jexbot/49.326.1473; Gillespie T, 2002, PLANT CELL, V14, P1207, DOI 10.1105/tpc.002303; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jolliffe NA, 2003, PLANT MOL BIOL, V51, P631, DOI 10.1023/A:1022553424859; Jolliffe NA, 2006, J BIOL CHEM, V281, P23377, DOI 10.1074/jbc.M602678200; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; LORD JM, 1985, EUR J BIOCHEM, V146, P411, DOI 10.1111/j.1432-1033.1985.tb08667.x; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; MA JKC, 1994, EUR J IMMUNOL, V24, P131, DOI 10.1002/eji.1830240120; MALIGA P, 1973, NATURE-NEW BIOL, V244, P29, DOI 10.1038/newbio244029a0; Marshall RS, 2008, J BIOL CHEM, V283, P15869, DOI 10.1074/jbc.M709316200; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Muller J, 2005, PLANT CELL, V17, P149, DOI 10.1105/tpc.104.026625; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nuttall J, 2003, PLANT MOL BIOL, V51, P885, DOI 10.1023/A:1023041901029; Nuttall J, 2002, EUR J BIOCHEM, V269, P6042, DOI 10.1046/j.1432-1033.2002.03302.x; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Pedrazzini E, 1997, PLANT CELL, V9, P1869, DOI 10.1105/tpc.9.10.1869; Phillipson BA, 2001, PLANT CELL, V13, P2005, DOI 10.1105/tpc.13.9.2005; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; Rancour DM, 2002, PLANT PHYSIOL, V130, P1241, DOI 10.1104/pp.011742; Reichel C, 2000, J VIROL, V74, P3330, DOI 10.1128/JVI.74.7.3330-3337.2000; Roberts LM, 2004, MINI-REV MED CHEM, V4, P505, DOI 10.2174/1389557043403846; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Saint-Jore-Dupas C, 2007, TRENDS BIOTECHNOL, V25, P317, DOI 10.1016/j.tibtech.2007.04.008; Schmitz A, 2004, EUR J CELL BIOL, V83, P501, DOI 10.1078/0171-9335-00412; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; Sheng XY, 2006, PLANT PHYSIOL, V141, P1578, DOI 10.1104/pp.106.081703; Smith DC, 2002, J IMMUNOL, V169, P99, DOI 10.4049/jimmunol.169.1.99; Speranza A, 2001, PLANT PHYSIOL, V126, P1150, DOI 10.1104/pp.126.3.1150; TABE LM, 1995, J ANIM SCI, V73, P2752; TAIZ L, 1992, J EXP BIOL, V172, P113; Tamura K, 2004, PLANT J, V39, P393, DOI 10.1111/j.1365-313X.2004.02141.x; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; Tormakangas K, 2001, PLANT CELL, V13, P2021, DOI 10.1105/tpc.13.9.2021; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; VITALE A, 1989, PLANT PHYSIOL, V89, P1079, DOI 10.1104/pp.89.4.1079; WALES R, 1991, J BIOL CHEM, V266, P19172; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; YUK MH, 1993, J CELL BIOL, V123, P1735, DOI 10.1083/jcb.123.6.1735	74	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33276	33286		10.1074/jbc.M805222200	http://dx.doi.org/10.1074/jbc.M805222200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832379	Green Published, hybrid			2022-12-27	WOS:000261183700031
J	Greeson, NT; Sengupta, R; Arida, AR; Jenuwein, T; Sanders, SL				Greeson, Nikole T.; Sengupta, Roopsha; Arida, Ahmad R.; Jenuwein, Thomas; Sanders, Steven L.			Di-methyl H4 Lysine 20 Targets the Checkpoint Protein Crb2 to Sites of DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; S-PHASE; HISTONE-H4 LYSINE-20; FISSION YEAST; TUDOR DOMAIN; METHYLATION; CHROMATIN; GENOME; REPAIR; 53BP1	Histone lysine methylation is an important chromatin modification that can be catalyzed to a mono-, di-, or tri-methyl state. An ongoing challenge is to decipher how these different methyllysine histone marks can mediate distinct aspects of chromatin function. The fission yeast checkpoint protein Crb2 is rapidly targeted to sites of DNA damage after genomic insult, and this recruitment requires methylation of histone H4 lysine 20 (H4K20). Here we show that the tandem tudor domains of Crb2 preferentially bind the di- methylated H4K20 residue. Loss of this interaction by disrupting either the tudor-binding motif or the H4K20 methylating enzyme Set9/Kmt5 ablates Crb2 localization to double-strand breaks and impairs checkpoint function. Further we show that dimethylation, but not tri-methylation, of H4K20 is required for Crb2 localization, checkpoint function, and cell survival after DNA damage. These results argue that the di- methyl H4K20 modification serves as a binding target that directs Crb2 to sites of genomic lesions and defines an important genome integrity pathway mediated by a specific methyl-lysine histone mark.	[Greeson, Nikole T.; Arida, Ahmad R.; Sanders, Steven L.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Greeson, Nikole T.; Arida, Ahmad R.; Sanders, Steven L.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Sengupta, Roopsha; Jenuwein, Thomas] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	Case Western Reserve University; Case Western Reserve University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Sanders, SL (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	steven.sanders@case.edu			International Human Frontier Science Program Organization [0017/2006-C]; Case Comprehensive Cancer Center and Radiation Resource Core Facility [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER	International Human Frontier Science Program Organization(Human Frontier Science Program); Case Comprehensive Cancer Center and Radiation Resource Core Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Career Development Award 0017/2006-C from the International Human Frontier Science Program Organization and Grant P30 CA43703 from the Case Comprehensive Cancer Center and Radiation Resource Core Facility. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Grenon M, 2007, YEAST, V24, P105, DOI 10.1002/yea.1441; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lancelot N, 2007, NUCLEIC ACIDS RES, V35, P5898, DOI 10.1093/nar/gkm607; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nakamura TM, 2005, MOL CELL BIOL, V25, P10721, DOI 10.1128/MCB.25.24.10721-10730.2005; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200	38	52	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33168	33174		10.1074/jbc.M806857200	http://dx.doi.org/10.1074/jbc.M806857200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826944	Green Published, hybrid			2022-12-27	WOS:000261183700019
J	Kariya, Y; Kato, R; Itoh, S; Fukuda, T; Shibukawa, Y; Sanzen, N; Sekiguchi, K; Wada, Y; Kawasaki, N; Gu, JG				Kariya, Yoshinobu; Kato, Rika; Itoh, Satsuki; Fukuda, Tomohiko; Shibukawa, Yukinao; Sanzen, Noriko; Sekiguchi, Kiyotoshi; Wada, Yoshinao; Kawasaki, Nana; Gu, Jianguo			N-Glycosylation of Laminin-332 Regulates Its Biological Functions A NOVEL FUNCTION OF THE BISECTING GlcNAc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; ACETYLGLUCOSAMINYLTRANSFERASE-V; CELL-MIGRATION; MATRIX METALLOPROTEASE-2; ALPHA-3-BETA-1 INTEGRIN; LIQUID-CHROMATOGRAPHY; PHASEOLUS-VULGARIS; MASS-SPECTROMETRY; TUMOR-GROWTH; HUMAN-BREAST	Laminin-332 (Lm332) is a large heterotrimeric glycoprotein that has been identified as a scattering factor, a regulator of cancer invasion as well as a prominent basement membrane component of the skin. Past studies have identified the functional domains of Lm332 and revealed the relationships between its activities and the processing of its subunits. However, there is little information available concerning the effects of N-glycosylation on Lm332 activities. In some cancer cells, an increase of beta 1,6-GlcNAc catalyzed by N-acetylglucosaminyltransferase V (GnT-V) is related to the promotion of cancer cell motility. By contrast, bisecting GlcNAc catalyzed by N-acetylglucosaminyltransferase III (GnT-III) suppresses the further processing with branching enzymes, such as GnT-V, and the elongation of N-glycans. To examine the effects of those N-glycosylations to Lm332 on its activities, we purified Lm332s from the conditioned media of GnT-III- and GnT-V-overexpressing MKN45 cells. Lectin blotting and mass spectrometry analyses revealed that N-glycans containing the bisecting GlcNAc and beta 1,6-GlcNAc structures were strongly expressed on Lm332 purified from GnT-III-overexpressing (GnT-III-Lm332) and GnT-V-overexpressing (GnT-V-Lm332) cells, respectively. Interestingly, the cell adhesion activity of GnT-III-Lm332 was apparently decreased compared with those of control Lm332 and GnT-V-Lm332. In addition, the introduction of bisecting GlcNAc to Lm332 resulted in a decrease in its cell scattering and migration activities. The weakened activities were most likely derived from the impaired alpha 3 beta 1 integrin clustering and resultant focal adhesion formation. Taken together, our results clearly demonstrate for the first time that N-glycosylation may regulate the biological function of Lm332. This finding could introduce a new therapeutic strategy for cancer.	[Kariya, Yoshinobu; Kato, Rika; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Itoh, Satsuki; Kawasaki, Nana] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Shibukawa, Yukinao; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Izumi Ku, Osaka 5941101, Japan; [Shibukawa, Yukinao; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka 5941101, Japan; [Sanzen, Noriko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Div Prot Chem, Suita, Osaka 5650871, Japan	Tohoku Medical & Pharmaceutical University; National Institute of Health Sciences - Japan; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Gu, Jianguo/ABC-9257-2020	Sanzen, Noriko/0000-0001-6518-403X	Core Research for Evolutional Science and Technology (CREST); apan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); apan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Core Research for Evolutional Science and Technology (CREST), the Japan Science and Technology Agency (JST), and the Academic Frontier Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; CARTER BZ, 1991, LAB INVEST, V65, P610; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DEAN JW, 1990, J BIOL CHEM, V265, P12553; DENNIS JW, 1989, CANCER RES, V49, P945; FERNANDES B, 1991, CANCER RES, V51, P718; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Granovsky M, 2000, NAT MED, V6, P306; GREEN TL, 1992, J BIOL CHEM, V267, P2014; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Handerson T, 2003, CANCER RES, V63, P5363; Hirosaki T, 2002, J BIOL CHEM, V277, P49287, DOI 10.1074/jbc.M111096200; HOWE CC, 1984, MOL CELL BIOL, V4, P1; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Itoh S, 2006, J CHROMATOGR A, V1103, P296, DOI 10.1016/j.chroma.2005.11.043; Kariya Y, 2003, J CELL BIOCHEM, V88, P506, DOI 10.1002/jcb.10350; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kunneken K, 2004, J BIOL CHEM, V279, P5184, DOI 10.1074/jbc.M310424200; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; MATSUI C, 1995, J BIOL CHEM, V270, P23496, DOI 10.1074/jbc.270.40.23496; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Murata K, 2000, CLIN CANCER RES, V6, P1772; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; Paret C, 2005, INT J CANCER, V115, P724, DOI 10.1002/ijc.20977; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; Ryan MC, 1996, MATRIX BIOL, V15, P369, DOI 10.1016/S0945-053X(96)90157-2; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; Tsubota Y, 2005, J BIOL CHEM, V280, P14370, DOI 10.1074/jbc.M413051200; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	44	36	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33036	33045		10.1074/jbc.M804526200	http://dx.doi.org/10.1074/jbc.M804526200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18812317	Green Published, hybrid			2022-12-27	WOS:000261183700003
J	Park, KM; Yule, DI; Bowers, WJ				Park, Keigan M.; Yule, David I.; Bowers, William J.			Tumor Necrosis Factor-alpha Potentiates Intraneuronal Ca2+ Signaling via Regulation of the Inositol 1,4,5-Trisphosphate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; N-TERMINAL KINASE; TRISPHOSPHATE RECEPTOR; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; GENE-EXPRESSION; CALCIUM-RELEASE; RAT; INHIBITION; MICROGLIA	Inflammatory events have long been implicated in initiating and/or propagating the pathophysiology associated with a number of neurological diseases. In addition, defects in Ca2+-handling processes, which shape membrane potential, influence gene transcription, and affect neuronal spiking patterns, have also been implicated in disease progression and cognitive decline. The mechanisms underlying the purported interplay that exists between neuroinflammation and Ca2+ homeostasis have yet to be defined. Herein, we describe a novel neuron-intrinsic pathway in which the expression of the type-1 inositol 1,4,5-trisphosphate receptor is regulated by the potent pro-inflammatory cytokine tumor necrosis factor-alpha. Exposure of primary murine neurons to tumor necrosis factor-alpha resulted in significant enhancement of Ca2+ signals downstream of muscarinic and purinergic stimulation. An increase in type-1 inositol 1,4,5-trisphosphate receptor mRNA and protein steady-state levels following cytokine exposure positively correlated with this alteration in Ca2+ homeostasis. Modulation of Ca2+ responses arising from this receptor subtype and its downstream effectors may exact significant consequences on neuronal function and could underlie the compromise in neuronal activity observed in the setting of chronic neuroinflammation, such as that associated with Parkinson disease and Alzheimer disease.	[Park, Keigan M.; Bowers, William J.] Univ Rochester, Med Ctr, Sch Med & Dent, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Yule, David I.; Bowers, William J.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Park, Keigan M.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Bowers, WJ (corresponding author), 601 Elmwood Ave,Box 645, Rochester, NY 14642 USA.	william_bowers@urmc.rochester.edu			National Institutes of Health [F31-NS056731]; Oral Biology Training [T32-DE07202]; NIH [R01-DK54588, R01-DE14756, R01-AG023593, R01AG026328]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK054588, R43DK054588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS056731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026328, R01AG023593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral Biology Training; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant F31-NS056731. This work was also supported by the Oral Biology Training Grant NIH T32-DE07202 (to K.M.P.), NIH Grants R01-DK54588 and R01-DE14756 (to D.I.Y.), and NIH Grants R01-AG023593 and NIH R01AG026328 (to W.J.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Bokkala S, 1999, ALCOHOL CLIN EXP RES, V23, P1875, DOI 10.1097/00000374-199912000-00004; Bruce JIE, 2004, J BIOL CHEM, V279, P12909, DOI 10.1074/jbc.M309070200; Camandola S, 2005, J BIOL CHEM, V280, P22287, DOI 10.1074/jbc.M410923200; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Deelman LE, 1998, GENE, V207, P219, DOI 10.1016/S0378-1119(97)00630-6; Detrait ER, 2002, MOL THER, V5, P723, DOI 10.1006/mthe.2002.0609; DieckmannSchuppert A, 1997, CELL TISSUE RES, V288, P119, DOI 10.1007/s004410050799; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; EDWARDS DR, 1985, EXP CELL RES, V157, P127, DOI 10.1016/0014-4827(85)90157-0; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GOEGER DE, 1988, BIOCHEM PHARMACOL, V37, P978, DOI 10.1016/0006-2952(88)90195-5; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Jara JH, 2007, J NEUROCHEM, V100, P1407, DOI 10.1111/j.1471-4159.2006.04330.x; JOSEPH SK, 1989, MOL PHARMACOL, V35, P355; JOSEPH SK, 1993, J BIOL CHEM, V268, P23059; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; LANSMAN JB, 1990, J GEN PHYSIOL, V95, P679, DOI 10.1085/jgp.95.4.679; LASTER SM, 1988, J IMMUNOL, V141, P2629; LU B, 1995, HUM GENE THER, V6, P419, DOI 10.1089/hum.1995.6.4-419; MATTSON MP, 1987, J NEUROSCI, V7, P4034; McGeer EG, 2005, NEUROBIOL AGING, V26, pS94, DOI 10.1016/j.neurobiolaging.2005.08.008; McGowan TA, 2000, KIDNEY INT, V58, pS99, DOI 10.1046/j.1523-1755.2000.07716.x; Muschol M, 1999, BIOPHYS J, V77, P577, DOI 10.1016/S0006-3495(99)76914-6; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; ORTALDO JR, 1986, NATURE, V321, P700, DOI 10.1038/321700a0; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; SICA A, 1990, J IMMUNOL, V144, P3034; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; TOKUYAMA Y, 1995, BIOCHEM BIOPH RES CO, V211, P211, DOI 10.1006/bbrc.1995.1798; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; WEISS GB, 1974, ANNU REV PHARMACOL, V14, P343, DOI 10.1146/annurev.pa.14.040174.002015; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	41	37	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33069	33079		10.1074/jbc.M802209200	http://dx.doi.org/10.1074/jbc.M802209200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838384	Green Published, hybrid			2022-12-27	WOS:000261183700007
J	Pioszak, AA; Parker, NR; Suino-Powell, K; Xu, HE				Pioszak, Augen A.; Parker, Naomi R.; Suino-Powell, Kelly; Xu, H. Eric			Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST EXTRACELLULAR DOMAIN; N-TERMINAL DOMAIN; COMPETITIVE ANTAGONISTS; LIGAND-BINDING; CRYSTAL-STRUCTURE; HIGH-AFFINITY; SOLUBLE FORM; PEPTIDE; UROCORTIN; IDENTIFICATION	The bimolecular interaction between corticotropin-releasing factor (CRF), a neuropeptide, and its type 1 receptor (CRFR1), a class B G-protein-coupled receptor (GPCR), is crucial for activation of the hypothalamic-pituitary-adrenal axis in response to stress, and has been a target of intense drug design for the treatment of anxiety, depression, and related disorders. As a class B GPCR, CRFR1 contains an N-terminal extracellular domain (ECD) that provides the primary ligand binding determinants. Here we present three crystal structures of the human CRFR1 ECD, one in a ligand-free form and two in distinct CRF-bound states. The CRFR1 ECD adopts the alpha-beta-beta alpha fold observed for other class B GPCR ECDs, but the N-terminal alpha-helix is significantly shorter and does not contact CRF. CRF adopts a continuous alpha-helix that docks in a hydrophobic surface of the ECD that is distinct from the peptide-binding site of other class B GPCRs, thereby providing a basis for the specificity of ligand recognition between CRFR1 and other class B GPCRs. The binding of CRF is accompanied by clamp-like conformational changes of two loops of the receptor that anchor the CRF C terminus, including the C-terminal amide group. These structural studies provide a molecular framework for understanding peptide binding and specificity by the CRF receptors as well as a template for designing potent and selective CRFR1 antagonists for therapeutic applications.	[Pioszak, Augen A.; Parker, Naomi R.; Suino-Powell, Kelly; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	Van Andel Institute	Pioszak, AA (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	augie.pioszak@vai.org; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301]; The Jay and Betty Van Andel Foundation; Michigan Economic Development Corporation [085P1000817]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Jay and Betty Van Andel Foundation; Michigan Economic Development Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662, DK066202, and HL089301. This work was also supported by The Jay and Betty Van Andel Foundation and Michigan Economic Development Corporation Grant 085P1000817. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Dautzenberg FM, 1998, P NATL ACAD SCI USA, V95, P4941, DOI 10.1073/pnas.95.9.4941; Dautzenberg FM, 1999, J NEUROCHEM, V73, P821, DOI 10.1046/j.1471-4159.1999.0730821.x; De Lano W.L., 2002, PY MOL MOL GRAPHICS; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; HERNANDEZ JF, 1993, J MED CHEM, V36, P2860, DOI 10.1021/jm00072a004; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; Klose J, 2005, BIOCHEMISTRY-US, V44, P1614, DOI 10.1021/bi049022e; KORNREICH WD, 1992, J MED CHEM, V35, P1870, DOI 10.1021/jm00088a024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; Liaw CW, 1997, MOL ENDOCRINOL, V11, P2048, DOI 10.1210/me.11.13.2048; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesleh MF, 2007, J BIOL CHEM, V282, P6338, DOI 10.1074/jbc.M609816200; MIRANDA A, 1994, J MED CHEM, V37, P1450, DOI 10.1021/jm00036a010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2007, J BIOL CHEM, V282, P37529, DOI 10.1074/jbc.M703748200; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rijkers DTS, 2004, CHEMBIOCHEM, V5, P340, DOI 10.1002/cbic.200300769; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; Ruhmann A, 1998, P NATL ACAD SCI USA, V95, P15264, DOI 10.1073/pnas.95.26.15264; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Wille S, 1999, J NEUROCHEM, V72, P388, DOI 10.1046/j.1471-4159.1999.0720388.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamada Y, 2004, J MED CHEM, V47, P1075, DOI 10.1021/jm034180+	52	132	139	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32900	32912		10.1074/jbc.M805749200	http://dx.doi.org/10.1074/jbc.M805749200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801728	hybrid, Green Published			2022-12-27	WOS:000260893700079
J	Ujvari, A; Hsieh, FK; Luse, SW; Studitsky, VM; Luse, DS				Ujvari, Andrea; Hsieh, Fu-Kai; Luse, Susan W.; Studitsky, Vasily M.; Luse, Donal S.			Histone N-terminal Tails Interfere with Nucleosome Traversal by RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE PARTICLES; RECOMBINANT HISTONES; CHIRAL TRANSITION; DNA INTERACTIONS; TRANSCRIPTION; CHROMATIN; ELONGATION; ACETYLATION; STABILITY; H2A/H2B	We determined the effect of the N-terminal histone tails on nucleosome traversal by yeast and human RNA polymerase II (pol II). Removal of H2A/H2B tails, H3/H4 tails, or all tails increased complete traversal of the nucleosome by human pol II, although the increase varied considerably depending on the template and on which tails were removed. Human pol II achieved >80% traversal of one nucleosomal template lacking the H2A/H2B tails, but even in those reactions, the transcript elongation rate was lower than the rate on pure DNA templates. For yeast pol II, transcription proceeded much farther into the nucleosome in the absence of tails, but complete read-through was not substantially increased by tail removal. Transcription factor IIS provided roughly the same level of read-through stimulation for transcript elongation in the presence or absence of tails. FACT also stimulated elongation on nucleosomal templates, and this effect was similar regardless of the presence of tails. For both polymerases, removal of the H2A/H2B tails reduced pausing throughout the nucleosome, suggesting that histone tails affect a common step at most points during nucleosome traversal. We conclude that histone tails provide a significant part of the nucleosomal barrier to pol II transcript elongation.	[Ujvari, Andrea; Luse, Susan W.; Luse, Donal S.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Hsieh, Fu-Kai; Studitsky, Vasily M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Cleveland Clinic Foundation; Rutgers State University New Brunswick; Rutgers State University Medical Center	Luse, DS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Genet, NE20,9500 Euclid Ave, Cleveland, OH 44195 USA.	lused@ccf.org	Studitsky, Vasily/A-9382-2014		National Institutes of Health [GM58650]; National Science Foundation [0646019, 0743298]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58650 (to V. M. S.). This work was also supported by National Science Foundation Grants 0646019 and 0743298 (to D. S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bertin A, 2007, EUR BIOPHYS J BIOPHY, V36, P1083, DOI 10.1007/s00249-007-0212-9; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Carruthers LM, 2000, J BIOL CHEM, V275, P37285, DOI 10.1074/jbc.M006801200; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FLETCHER TM, 1995, J BIOL CHEM, V270, P25359, DOI 10.1074/jbc.270.43.25359; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; HILL CS, 1990, EUR J BIOCHEM, V187, P145, DOI 10.1111/j.1432-1033.1990.tb15288.x; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KM, 1997, P NATL ACAD SCI USA, V94, P8959, DOI 10.1073/pnas.94.17.8959; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; MORSE RH, 1986, NUCLEIC ACIDS RES, V14, P3293, DOI 10.1093/nar/14.8.3293; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sivolob A, 2000, J MOL BIOL, V295, P55, DOI 10.1006/jmbi.1999.3302; Studitsky VM, 1999, METH MOL B, V119, P17; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Widlund HR, 2000, BIOCHEMISTRY-US, V39, P3835, DOI 10.1021/bi991957l; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200	37	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32236	32243		10.1074/jbc.M806636200	http://dx.doi.org/10.1074/jbc.M806636200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815126	Green Published, hybrid			2022-12-27	WOS:000260893700010
J	Anderka, O; Boyken, J; Aschenbach, U; Batzer, A; Boscheinen, O; Schmoll, D				Anderka, Oliver; Boyken, Janina; Aschenbach, Ursula; Batzer, Andreas; Boscheinen, Oliver; Schmoll, Dieter			Biophysical Characterization of the Interaction between Hepatic Glucokinase and Its Regulatory Protein IMPACT OF PHYSIOLOGICAL AND PHARMACOLOGICAL EFFECTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; LIVER GLUCOKINASE; LIGAND INTERACTIONS; GLUCOSE-METABOLISM; BINDING ENERGETICS; DIABETES THERAPY; HEAT-CAPACITY; THERMODYNAMICS; TRANSLOCATION; FRUCTOSE	Glucokinase (GK) is a key enzyme of glucose metabolism in liver and pancreatic beta-cells, and small molecule activators of GK (GKAs) are under evaluation for the treatment of type 2 diabetes. In liver, GK activity is controlled by the GK regulatory protein (GKRP), which forms an inhibitory complex with the enzyme. Here, we performed isothermal titration calorimetry and surface plasmon resonance experiments to characterize GK-GKRP binding and to study the influence that physiological and pharmacological effectors of GK have on the protein-protein interaction. In the presence of fructose-6-phosphate, GK-GKRP complex formation displayed a strong entropic driving force opposed by a large positive enthalpy; a negative change in heat capacity was observed (K-d = 45 nM, Delta H = 15.6 kcal/mol, T Delta S = 25.7 kcal/mol, Delta C-p = -354 cal mol(-1) K-1). With k(off) = 1.3 x 10(-2) s(-1), the complex dissociated quickly. The thermodynamic profile suggested a largely hydrophobic interaction. In addition, effects of pH and buffer demonstrated the coupled uptake of one proton and indicated an ionic contribution to binding. Glucose decreased the binding affinity between GK and GKRP. This decrease was potentiated by an ATP analogue. Prototypical GKAs of the amino-heteroaryl-amide type bound to GK in a glucose-dependent manner and impaired the association of GK with GKRP. This mechanism might contribute to the antidiabetic effects of GKAs.	[Anderka, Oliver; Boyken, Janina; Aschenbach, Ursula; Batzer, Andreas; Boscheinen, Oliver; Schmoll, Dieter] Sanofi Aventis Deutschland GmbH, Res & Dev, D-65926 Frankfurt, Germany; [Boyken, Janina] Ernst Moritz Arndt Univ Greifswald, Inst Med Biochem & Mol Biol, D-17487 Greifswald, Germany	Sanofi-Aventis; Ernst Moritz Arndt Universitat Greifswald	Anderka, O (corresponding author), Sanofi Aventis Deutschland GmbH, Res & Dev, D-65926 Frankfurt, Germany.	oliver.anderka@sanofi-aventis.com		Schmoll, Dieter/0000-0003-2578-3366				Agius L, 1998, ADV ENZYME REGUL, V38, P303, DOI 10.1016/S0065-2571(97)00001-0; Agius L, 1997, BIOCHEM SOC T, V25, P145, DOI 10.1042/bst0250145; AGIUS L, 1993, BIOCHEM J, V296, P785, DOI 10.1042/bj2960785; Anderka O, 2008, BIOCHEMISTRY-US, V47, P4683, DOI 10.1021/bi702397d; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Baltrusch S, 2006, DIABETES, V55, pS55, DOI 10.2337/db06-S008; Brocklehurst KJ, 2004, BIOCHEM J, V378, P693, DOI 10.1042/BJ20031414; Brocklehurst KJ, 2004, DIABETES, V53, P535, DOI 10.2337/diabetes.53.3.535; Chu CA, 2004, AM J PHYSIOL-GASTR L, V286, pG627, DOI 10.1152/ajpgi.00218.2003; DETHEUX M, 1991, EUR J BIOCHEM, V200, P553, DOI 10.1111/j.1432-1033.1991.tb16218.x; Doyle ML, 1995, METHOD ENZYMOL, V259, P183; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E; Futamura M, 2006, J BIOL CHEM, V281, P37668, DOI 10.1074/jbc.M605186200; Gakamsky DM, 2004, P NATL ACAD SCI USA, V101, P9063, DOI 10.1073/pnas.0402840101; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x; Holdgate GA, 2001, BIOTECHNIQUES, V31, P164; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kim YB, 2007, BIOCHEMISTRY-US, V46, P1423, DOI 10.1021/bi0617308; Ladbury JE, 2004, CURR OPIN STRUC BIOL, V14, P562, DOI 10.1016/j.sbi.2004.08.001; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; LUTHER MA, 1986, BIOCHEMISTRY-US, V25, P7931, DOI 10.1021/bi00372a022; Mackay JP, 2007, TRENDS BIOCHEM SCI, V32, P530, DOI 10.1016/j.tibs.2007.09.006; Matschinsky FM, 2006, DIABETES, V55, P1; Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470; Mookhtiar KA, 1996, DIABETES, V45, P1670, DOI 10.2337/diabetes.45.12.1670; Moukil MA, 2000, DIABETES, V49, P195, DOI 10.2337/diabetes.49.2.195; MURPHY KP, 1993, PROTEINS, V15, P113, DOI 10.1002/prot.340150203; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; O'Brien R, 2004, BIOCALORIMETRY, P1; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Ralph EC, 2008, BIOCHEMISTRY-US, V47, P5028, DOI 10.1021/bi702516y; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Shin JS, 2007, AM J PHYSIOL-REG I, V292, pR1381, DOI 10.1152/ajpregu.00260.2006; Shiota M, 1998, DIABETES, V47, P867, DOI 10.2337/diabetes.47.6.867; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Thomson J.A., 2004, BIOCALORIMETRY, P37; VANDERCAMMEN A, 1991, EUR J BIOCHEM, V200, P545, DOI 10.1111/j.1432-1033.1991.tb16217.x; VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; Veiga-da-Cunha M, 2003, DIABETOLOGIA, V46, P704, DOI 10.1007/s00125-003-1083-y; Veiga-da-Cunha M, 2002, J BIOL CHEM, V277, P8466, DOI 10.1074/jbc.M105984200; VeigadaCunha M, 1996, DIABETOLOGIA, V39, P1173, DOI 10.1007/BF02658503; VeigadaCunha M, 1996, J BIOL CHEM, V271, P6292, DOI 10.1074/jbc.271.11.6292; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; XIE D, 1994, PROTEINS, V19, P291, DOI 10.1002/prot.340190404; 1997, KINETIC AFFINITY ANA	53	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31333	31340		10.1074/jbc.M805434200	http://dx.doi.org/10.1074/jbc.M805434200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18809676	hybrid			2022-12-27	WOS:000260760800010
J	Gillette, TG; Kumar, B; Thompson, D; Slaughter, CA; DeMartino, GN				Gillette, Thomas G.; Kumar, Brajesh; Thompson, David; Slaughter, Clive A.; DeMartino, George N.			Differential Roles of the COOH Termini of AAA Subunits of PA700 (19 S Regulator) in Asymmetric Assembly and Activation of the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-MOLECULAR-WEIGHT; ATP-DEPENDENT ACTIVATOR; 20S PROTEASOME; MULTICATALYTIC PROTEINASE; CROSS-LINKING; PURIFICATION; PARTICLE; ATPASES; IDENTIFICATION; BINDING	The 26 S proteasome is an energy-dependent protease that degrades proteins modified with polyubiquitin chains. It is assembled from two multi-protein subcomplexes: a protease (20 S proteasome) and an ATPase regulatory complex (PA700 or 19 S regulatory particle) that contains six different AAA family subunits (Rpt1 to -6). Here we show that binding of PA700 to the 20 S proteasome is mediated by the COOH termini of two (Rpt2 and Rpt5) of the six Rpt subunits that constitute the interaction surface between the subcomplexes. COOH-terminal peptides of either Rpt2 or Rpt5 bind to the 20 S proteasome and activate hydrolysis of short peptide substrates. Simultaneous binding of both COOH-terminal peptides had additive effects on peptide substrate hydrolysis, suggesting that they bind to distinct sites on the proteasome. In contrast, only the Rpt5 peptide activated hydrolysis of protein substrates. Nevertheless, the COOH-terminal peptide of Rpt2 greatly enhanced this effect, suggesting that proteasome activation is a multistate process. Rpt2 and Rpt5 COOH-terminal peptides cross-linked to different but specific subunits of the 20 S proteasome. These results reveal critical roles of COOH termini of Rpt subunits of PA700 in the assembly and activation of eukaryotic 26 S proteasome. Moreover, they support a model in which Rpt subunits bind to dedicated sites on the proteasome and play specific, nonequivalent roles in the asymmetric assembly and activation of the 26 S proteasome.	[Gillette, Thomas G.; Kumar, Brajesh; Thompson, David; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Slaughter, Clive A.] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu			National Institutes of Health [R01 DK46181]; Welch Foundation [I-500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK46181. This work was also supported by Welch Foundation Grant I-500 (to G.N.D.).	Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beyer A, 1997, PROTEIN SCI, V6, P2043; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Burdine L, 2004, J AM CHEM SOC, V126, P11442, DOI 10.1021/ja045982c; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; GRAY CW, 1994, J MOL BIOL, V236, P7, DOI 10.1006/jmbi.1994.1113; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; MA CP, 1994, J BIOL CHEM, V269, P3539; MA CP, 1992, J BIOL CHEM, V267, P10515; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; MYKLES DL, 1991, ARCH BIOCHEM BIOPHYS, V288, P543, DOI 10.1016/0003-9861(91)90233-9; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Song XL, 1997, J BIOL CHEM, V272, P27994, DOI 10.1074/jbc.272.44.27994; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807	42	119	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31813	31822		10.1074/jbc.M805935200	http://dx.doi.org/10.1074/jbc.M805935200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18796432	Green Published, hybrid			2022-12-27	WOS:000260760800064
J	Wilson, BJ; Harada, R; Leduy, L; Hollenberg, MD; Nepveu, A				Wilson, Brian J.; Harada, Ryoko; LeDuy, Lam; Hollenberg, Morley D.; Nepveu, Alain			CUX1 Transcription Factor Is a Downstream Effector of the Proteinase- activated Receptor 2 (PAR(2))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT DISPLACEMENT PROTEIN; SMOOTH-MUSCLE-CELLS; CUT HOMEODOMAIN PROTEINS; DNA-BINDING; S-PHASE; THROMBIN RECEPTOR; CANCER-CELLS; CYCLOOXYGENASE-2 EXPRESSION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS	Proteinase-activated receptors (PARs) are G-protein-coupled receptors that have been linked to an array of cellular processes, including inflammation, migration, and proliferation. Although signal transduction downstream of PARs has been actively investigated, little is known about the mechanisms that lead to changes in transcriptional programs. Here we show that the CUX1 homeodomain protein is a downstream effector of PAR(2). Treatment of epithelial and fibroblastic cells with trypsin or the PAR(2)-activating peptide (PAR(2)-AP) caused a rapid increase in CUX1 DNA binding activity. The stimulation of CUX1 was specific to PAR(2) because no effect was observed with thrombin or the PAR(1)-AP. Using a panel of recombinant CUX1 proteins, the regulation was found to involve the cut repeat 3 (CR3) and the cut homeodomain, two DNA binding domains that are present in all CUX1 isoforms. Expression analysis in cux1(-/-) mouse embryo fibroblasts led to the identification of three genes that are regulated downstream of both PAR(2) and CUX1 as follows: interleukin-1 alpha, matrix metalloproteinase-10, and cyclo-oxygenase-2. p110CUX1 was able to activate each of these genes, both in reporter assays and following the infection of cells. Moreover, the treatment of Hs578T breast tumor cells with trypsin led to a rapid recruitment of p110 CUX1 to the promoter of these genes and to a concomitant increase in their mRNA steady-state levels. Altogether, these results suggest a model whereby activation of PAR(2) triggers a signaling cascade that culminates with the stimulation of p110 CUX1 DNA binding and the transcriptional activation of target genes.	[Wilson, Brian J.; Harada, Ryoko; LeDuy, Lam; Nepveu, Alain] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; [Nepveu, Alain] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada	McGill University; University of Calgary; McGill University; McGill University; McGill University	Nepveu, A (corresponding author), McGill Univ, Goodman Canc Ctr, 1160 Pine Ave W,Rm 410, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020; Hollenberg, Morley/AFV-6966-2022		Canadian Institute of Health Research of Canada [MOP-11590]; Canadian Institute of Health Research operating; Research Institute of the McGill University Health Centre	Canadian Institute of Health Research of Canada(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research operating(Canadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Centre	This work was supported in part by Canadian Institute of Health Research of Canada Grant MOP-11590 (toA.N.) and in part by Canadian Institute of Health Research operating grant (to M.D.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1; Supported by a fellowship from the Research Institute of the McGill University Health Centre.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; ANDRES V, 1992, DEVELOPMENT, V116, P321; Berger P, 2003, FASEB J, V17, P2139, DOI 10.1096/fj.03-0041fje; Berger P, 2001, J APPL PHYSIOL, V91, P1372, DOI 10.1152/jappl.2001.91.3.1372; Berger P, 2001, J APPL PHYSIOL, V91, P995, DOI 10.1152/jappl.2001.91.2.995; Bretschneider E, 1999, BRIT J PHARMACOL, V126, P1735, DOI 10.1038/sj.bjp.0702509; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chambers LS, 2003, AM J PHYSIOL-LUNG C, V285, pL619, DOI 10.1152/ajplung.00416.2002; Cheung WM, 1999, ARTERIOSCL THROM VAS, V19, P3014, DOI 10.1161/01.ATV.19.12.3014; Coqueret O, 1996, J BIOL CHEM, V271, P24862, DOI 10.1074/jbc.271.40.24862; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Dorn GW, 2000, MOL PHARMACOL, V57, P278; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; Goulet B, 2004, CELL CYCLE, V3, P986; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; Harada R, 2008, NUCLEIC ACIDS RES, V36, P189, DOI 10.1093/nar/gkm970; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Holzhausen M, 2005, J DENT RES, V84, P154, DOI 10.1177/154405910508400209; Houliston RA, 2002, THROMB HAEMOSTASIS, V88, P321; Huang YQ, 2000, J BIOL CHEM, V275, P6462, DOI 10.1074/jbc.275.9.6462; Huang YQ, 2001, THROMB HAEMOSTASIS, V86, P1094; Kamath L, 2001, CANCER RES, V61, P5933; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Kawagoe J, 2002, JPN J PHARMACOL, V88, P77, DOI 10.1254/jjp.88.77; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Li SD, 2000, P NATL ACAD SCI USA, V97, P7166, DOI 10.1073/pnas.130028697; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Major CD, 2003, ARTERIOSCL THROM VAS, V23, P931, DOI 10.1161/01.ATV.0000070100.47907.26; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Michl P, 2006, J BIOL CHEM, V281, P15138, DOI 10.1074/jbc.M600908200; Moffatt JD, 2002, AM J RESP CELL MOL, V26, P680, DOI 10.1165/ajrcmb.26.6.4693; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Okamoto T, 2001, J NEURAL TRANSM, V108, P125, DOI 10.1007/s007020170083; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; REUNING U, 1994, BLOOD, V84, P3700, DOI 10.1182/blood.V84.11.3700.bloodjournal84113700; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Santaguida M, 2001, J BIOL CHEM, V276, P45780, DOI 10.1074/jbc.M107978200; Seeliger S, 2003, FASEB J, V17, P1871, DOI 10.1096/fj.02-1112com; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Shi XL, 2004, MOL CANCER RES, V2, P395; Shpacovitch VM, 2002, J INVEST DERMATOL, V118, P380, DOI 10.1046/j.0022-202x.2001.01658.x; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Somasundaram P, 2005, J PATHOL, V205, P102, DOI 10.1002/path.1690; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Truscott M, 2004, J BIOL CHEM, V279, P49787, DOI 10.1074/jbc.M409484200; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Truscott M, 2007, J BIOL CHEM, V282, P30216, DOI 10.1074/jbc.M702328200; Tufarelli C, 1998, DEV BIOL, V200, P69, DOI 10.1006/dbio.1998.8950; Uehara A, 2003, J IMMUNOL, V170, P5690, DOI 10.4049/jimmunol.170.11.5690; VALARCHE I, 1993, DEVELOPMENT, V119, P881; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wilson SR, 2004, PROSTATE, V60, P168, DOI 10.1002/pros.20047; Yada K, 2005, J SURG ONCOL, V89, P79, DOI 10.1002/jso.20197; Yin YJ, 2003, FASEB J, V17, P163, DOI 10.1096/fj.02-0316com	71	12	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					36	45		10.1074/jbc.M803808200	http://dx.doi.org/10.1074/jbc.M803808200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952606	hybrid			2022-12-27	WOS:000261974800005
J	Saito, Y; Sano, Y; Vassar, R; Gandy, S; Nakaya, T; Yamamoto, T; Suzuki, T				Saito, Yuhki; Sano, Yoshitake; Vassar, Robert; Gandy, Sam; Nakaya, Tadashi; Yamamoto, Tohru; Suzuki, Toshiharu			X11 Proteins Regulate the Translocation of Amyloid beta-Protein Precursor (APP) into Detergent-resistant Membrane and Suppress the Amyloidogenic Cleavage of APP by beta-Site-cleaving Enzyme in Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE65-DEPENDENT GENE TRANSACTIVATION; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; LIPID RAFTS; TRANSGENIC MICE; MOUSE-BRAIN; KNOCKOUT MICE; RAT-BRAIN; METABOLISM; PHOSPHORYLATION	X11 and X11-like proteins (X11L) are neuronal adaptor proteins whose association to the cytoplasmic domain of amyloid beta-protein precursor (APP) suppresses the generation of amyloid beta-protein (A beta) implicated in Alzheimer disease pathogenesis. The amyloidogenic, but not amyloidolytic, metabolism of APP was selectively increased in the brain of mutant mice lacking X11L (Sano, Y., Syuzo-Takabatake, A., Nakaya, T., Saito, Y., Tomita, S., Itohara, S., and Suzuki, T. (2006) J. Biol. Chem. 281, 37853-37860). To reveal the actual role of X11 proteins (X11s) in suppressing amyloidogenic cleavage of APP in vivo, we generated X11 and X11L double knock-out mice and analyzed the metabolism of APP. The mutant mice showed enhanced beta-site cleavage of APP along with increased accumulation of A beta in brain and increased colocalization of APP with beta-site APP-cleaving enzyme (BACE). In the brains of mice deficient in both X11 and X11L, the apparent relative subcellular distributions of both mature APP and its beta-C-terminal fragment were shifted toward the detergent-resistant membrane (DRM) fraction, an organelle in which BACE is active and both X11s are not nearly found. These results indicate that X11s associate primarily with APP molecules that are outside of DRM, that the dissociation of APP-X11/X11L complexes leads to entry of APP into DRM, and that cleavage of uncomplexed APP by BACE within DRM is enhanced by X11s deficiency. Present results lead to an idea that the dysfunction of X11L in the interaction with APP may recruit more APP into DRM and increase the generation of A beta even if BACE activity did not increase in brain.	[Saito, Yuhki; Sano, Yoshitake; Nakaya, Tadashi; Yamamoto, Tohru; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Sano, Yoshitake] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3150198, Japan; [Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Gandy, Sam] Mt Sinai Sch Med, New York, NY 10029 USA	Hokkaido University; RIKEN; Northwestern University; Feinberg School of Medicine; Icahn School of Medicine at Mount Sinai	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Kita Ku, Kita12 Nishi6, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Yamamoto, Tohru/A-3801-2012; Suzuki, Toshiharu/B-5342-2013	Yamamoto, Tohru/0000-0002-1652-0233; Sano, Yoshitake/0000-0001-5188-3104	National Institutes of Health [P01 AG10491]; MEXT Japan [207900049, 20390018, 20023001]; NATIONAL INSTITUTE ON AGING [P01AG010491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AG10491 (to S.G.). This work was also supported by Grants-in-aid for Scientific Research 207900049 (to T.N.) and 20390018 (to T.S.) and 20023001 (to T.S.) from MEXT Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Mori A, 2002, NEUROSCI RES, V43, P251, DOI 10.1016/S0168-0102(02)00041-X; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; Nakaya T, 2006, GENES CELLS, V11, P633, DOI 10.1111/j.1365-2443.2006.00968.x; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; OUIMET CC, 1994, J COMP NEUROL, V348, P244, DOI 10.1002/cne.903480207; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Sawamura N, 2000, J BIOL CHEM, V275, P27901; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wolfe MS, 2008, CURR TOP MED CHEM, V8, P2, DOI 10.2174/156802608783334024; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	41	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35763	35771		10.1074/jbc.M801353200	http://dx.doi.org/10.1074/jbc.M801353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18845544	Green Published, hybrid			2022-12-27	WOS:000261687900050
J	Wang, SF; Shen, Y; Yuan, XH; Chen, K; Guo, XY; Chen, YC; Niu, YY; Li, J; Xu, RH; Yan, XY; Zhou, Q; Ji, WZ				Wang, Shufen; Shen, Yi; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang; Niu, Yuyu; Li, Jian; Xu, Ren-He; Yan, Xiyun; Zhou, Qi; Ji, Weizhi			Dissecting Signaling Pathways That Govern Self-renewal of Rabbit Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; MAINTAIN PLURIPOTENCY; FUNCTIONAL-ANALYSIS; FEEDER LAYERS; KINASE DOMAIN; DIFFERENTIATION; MAINTENANCE; ACTIVATION; RECEPTOR; LINES	The pluripotency and self-renewal of embryonic stem cells (ESC) are regulated by a variety of cytokines/growth factors with some species differences. We reported previously that rabbit ESC (rESC) are more similar to primate ESC than to mouse ESC. However, the signaling pathways that regulate rESC self-renewal had not been identified. Here we show that inhibition of the transforming growth factor beta(TGF beta), fibroblast growth factor (FGF), and canonical Wnt/beta-catenin (Wnt) pathways results in enhanced differentiation of rESC accompanied by down- regulation of Smad2/3 phosphorylation and beta-catenin expression and up-regulation of phosphorylation of Smad1 and beta-catenin. These results imply that the TGF beta, FGF, and Wnt pathways are required for rESC self-renewal. Inhibition of the MAPK/ERK and PI3K/AKT pathways, which lie downstream of the FGF pathway, led to differentiation of rESC accompanied by down-regulation of phosphorylation of ERK1/2 or AKT, respectively. Long-term self-renewal of rESC could be achieved by adding a mixture of TGF beta ligands (activin A, Nodal, or TGF beta 1) plus basic FGF( bFGF) and Noggin in the absence of serum and feeder cells. Our findings also suggest that there is a regulatory network consisting of the FGF, Wnt, and TGF beta pathways that controls rESC pluripotency and self-renewal. We conclude that bFGF controls the stem cell properties of rESC both directly and indirectly through TGF beta or other pathways, whereas the effect of Wnt on rESC might be mediated by the TGF beta pathway.	[Zhou, Qi] Chinese Acad Sci, Inst Zool, Beijing 100108, Peoples R China; [Wang, Shufen; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang; Niu, Yuyu; Li, Jian; Ji, Weizhi] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming 650223, Yunnan, Peoples R China; [Wang, Shufen; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang; Niu, Yuyu; Li, Jian; Ji, Weizhi] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Wang, Shufen; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang; Niu, Yuyu; Ji, Weizhi] Yunnan Key Lab Anim Reprod Biol, Kunming 650223, Yunnan, Peoples R China; [Shen, Yi; Yuan, Xiaohua; Chen, Kai; Guo, Xiangyu; Chen, Yongchang] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Shen, Yi; Yan, Xiyun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Xu, Ren-He] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Xu, Ren-He] Univ Connecticut, Hlth Ctr Regenerat Biol, Farmington, CT 06030 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Connecticut; University of Connecticut	Yan, XY (corresponding author), Chinese Acad Sci, Inst Zool, Beijing 100108, Peoples R China.	yanxy@sun5.ibp.ac.cn; qizhou@ioz.ac.cn; wji@mail.kiz.ac.cn	Xu, Ren-He/AAK-7392-2021; Xu, Ren-He/M-3125-2016	Ji, Weizhi/0000-0003-2550-4224	Chinese Major State Research Development Program [2005AA219010]; Chinese National Basic Research Program [2007CB947701, 2006CB701505]; Chinese Academy of Sciences [KSCX2-YWR-47]; Chinese National Science Foundation [30370166, 30700425]	Chinese Major State Research Development Program; Chinese National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the Chinese Major State Research Development Program (2005AA219010), the Chinese National Basic Research Program (2007CB947701 and 2006CB701505), The Chinese Academy of Sciences (KSCX2-YWR-47), and the Chinese National Science Foundation (30370166 and 30700425). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Hayes H, 2002, CYTOGENET GENOME RES, V98, P199, DOI 10.1159/000069807; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JAMES D, 2005, DEVELOPMENT, V132, P1273, DOI DOI 10.1242/DEV.01706; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nakayama K, 2003, J BONE MINER RES, V18, P827, DOI 10.1359/jbmr.2003.18.5.827; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Roman-Roman S, 2004, J BIOL CHEM, V279, P5725, DOI 10.1074/jbc.M309233200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sumi T, 2004, STEM CELLS, V22, P861, DOI 10.1634/stemcells.22-5-861; Thomson JA, 1996, BIOL REPROD, V55, P254, DOI 10.1095/biolreprod55.2.254; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang GW, 2005, BIOCHEM BIOPH RES CO, V330, P934, DOI 10.1016/j.bbrc.2005.03.058; Wang SF, 2007, STEM CELLS, V25, P481, DOI 10.1634/stemcells.2006-0226; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	53	42	49	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35929	35940		10.1074/jbc.M804091200	http://dx.doi.org/10.1074/jbc.M804091200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18940811	hybrid			2022-12-27	WOS:000261687900068
J	Chen, YY; Chu, HM; Pan, KT; Teng, CH; Wang, DL; Wang, AHJ; Khoo, KH; Meng, TC				Chen, Yi-Yun; Chu, Hsing-Mao; Pan, Kuan-Ting; Teng, Chun-Hung; Wang, Danny-Ling; Wang, Andrew H. -J.; Khoo, Kay-Hooi; Meng, Tzu-Ching			Cysteine S-Nitrosylation Protects Protein-tyrosine Phosphatase 1B against Oxidation-induced Permanent Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ACTIVE-SITE CYSTEINE; NF-KAPPA-B; REDOX REGULATION; IN-VIVO; REACTIVE OXYGEN; REVERSIBLE INACTIVATION; ISCHEMIA-REPERFUSION; SIGNAL-TRANSDUCTION; HUMAN ERYTHROCYTES	Protein S-nitrosylation mediated by cellular nitric oxide (NO) plays a primary role in executing biological functions in cGMP-independent NO signaling. Although S-nitrosylation appears similar to Cys oxidation induced by reactive oxygen species, the molecular mechanism and biological consequence remain unclear. We investigated the structural process of S-nitrosylation of protein-tyrosine phosphatase 1B (PTP1B). We treated PTP1B with various NO donors, including S-nitrosothiol reagents and compound-releasing NO radicals, to produce site-specific Cys S-nitrosylation identified using advanced mass spectrometry (MS) techniques. Quantitative MS showed that the active site Cys-215 was the primary residue susceptible to S-nitrosylation. The crystal structure of NO donor-reacted PTP1B at 2.6 angstrom resolution revealed that the S-NO state at Cys-215 had no discernible irreversibly oxidized forms, whereas other Cys residues remained in their free thiol states. We further demonstrated that S-nitrosylation of the Cys-215 residue protected PTP1B from subsequent H2O2-induced irreversible oxidation. Increasing the level of cellular NO by pretreating cells with an NO donor or by activating ectopically expressed NO synthase inhibited reactive oxygen species-induced irreversible oxidation of endogenous PTP1B. These findings suggest that S-nitrosylation might prevent PTPs from permanent inactivation caused by oxidative stress.	[Chen, Yi-Yun; Chu, Hsing-Mao; Teng, Chun-Hung; Wang, Andrew H. -J.; Khoo, Kay-Hooi; Meng, Tzu-Ching] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Chen, Yi-Yun; Pan, Kuan-Ting; Wang, Andrew H. -J.; Khoo, Kay-Hooi] Acad Sinica, Natl Core Facil Proteom Res, Taipei 11529, Taiwan; [Wang, Danny-Ling] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chen, Yi-Yun; Chu, Hsing-Mao; Wang, Andrew H. -J.; Khoo, Kay-Hooi; Meng, Tzu-Ching] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Khoo, KH (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	kkhoo@gate.sinica.edu.tw; tcmeng@gate.sinica.edu.tw	Meng, Tzu-Ching/G-5426-2019; Khoo, Kay-Hooi/E-1989-2019	Meng, Tzu-Ching/0000-0001-7693-2021; Khoo, Kay-Hooi/0000-0003-2906-406X; Pan, Kuan-Ting/0000-0001-6974-5324	Taiwan National Science Council [NSC95-3112-B-002-028, NSC-96-3112-B-002-018, NSC-94-3112-B009-Y, NSC-95-3112-B-001-014]; Academia Sinica	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Taiwan National Science Council Grants NSC95-3112-B-002-028, NSC-96-3112-B-002-018 ( to T. C.M.), NSC-94-3112-B009-Y, and NSC-95-3112-B-001-014 ( to the National Proteomic Core Facility). This work was also supported by Academia Sinica ( to T. C. M., K. H. K., D. L. W., and A. H. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barbul A, 1999, FEBS LETT, V455, P87, DOI 10.1016/S0014-5793(99)00822-4; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Bell RM, 2003, CARDIOVASC RES, V57, P405, DOI 10.1016/S0008-6363(02)00675-2; Chen YY, 2007, METHODS, V42, P243, DOI 10.1016/j.ymeth.2007.03.002; Ciana A, 2004, BIOELECTROCHEMISTRY, V62, P169, DOI 10.1016/j.bioelechem.2003.07.004; Cohen MV, 2006, CARDIOVASC RES, V70, P231, DOI 10.1016/j.cardiores.2005.10.021; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Datta B, 2004, CIRCULATION, V109, P1339, DOI 10.1161/01.CIR.0000124450.07016.1D; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones SP, 2006, J MOL CELL CARDIOL, V40, P16, DOI 10.1016/j.yjmcc.2005.09.011; Kaneko R, 2003, J MASS SPECTROM, V38, P526, DOI 10.1002/jms.466; Kanno S, 2000, CIRCULATION, V101, P2742, DOI 10.1161/01.CIR.101.23.2742; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kobayashi N, 2003, HYPERTENSION, V42, P1004, DOI 10.1161/01.HYP.0000097547.35570.70; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li S, 2005, J BIOL CHEM, V280, P20102, DOI 10.1074/jbc.M413164200; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; McCord J M, 1985, Adv Myocardiol, V5, P183; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Monteiro HP, 2000, FREE RADICAL BIO MED, V28, P174, DOI 10.1016/S0891-5849(99)00233-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Persson C, 2005, METHODS, V35, P37, DOI 10.1016/j.ymeth.2004.07.006; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wang QP, 2004, BIOCHEMISTRY-US, V43, P4294, DOI 10.1021/bi035986e; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Xu JW, 2004, HYPERTENSION, V44, P217, DOI 10.1161/01.HYP.0000135868.38343.c6; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504; Zhang YY, 1996, J BIOL CHEM, V271, P14271, DOI 10.1074/jbc.271.24.14271; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; Zipser Y, 2002, BIOCHEM J, V368, P137, DOI 10.1042/BJ20020359; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3	58	128	131	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35265	35272		10.1074/jbc.M805287200	http://dx.doi.org/10.1074/jbc.M805287200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18840608	Green Published, hybrid			2022-12-27	WOS:000261469100082
J	Nitta, RT; Chu, AH; Wong, AJ				Nitta, Ryan T.; Chu, Albert H.; Wong, Albert J.			Constitutive Activity of JNK2 alpha 2 Is Dependent on a Unique Mechanism of MAPK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; PROTEIN-KINASE; GLIOBLASTOMA CELLS; CRYSTAL-STRUCTURE; FACTOR-I; JNK2; AUTOPHOSPHORYLATION; APOPTOSIS; PATHWAYS; PROMOTES	c-Jun N-terminal kinases (JNKs) are part of the mitogen-activated protein kinase ( MAPK) family and are important regulators of cell growth, proliferation, and apoptosis. Typically, a sequential series of events are necessary for MAPK activation: phosphorylation, dimerization, and then subsequent translocation to the nucleus. Interestingly, a constitutively active JNK isoform, JNK2 alpha 2, possesses the ability to autophosphorylate and has been implicated in several human tumors, including glioblastoma multiforme. Because overexpression of JNK2 alpha 2 enhances several tumorigenic phenotypes, including cell growth and tumor formation in mice, we studied the mechanisms of JNK2 alpha 2 autophosphorylation and autoactivation. We find that JNK2 alpha 2 dimerization in vitro and in vivo occurs independently of its autophosphorylation but is dependent on nine amino acids, known as the alpha-region. Alanine scanning mutagenesis of the alpha-region reveals that five specific mutants (L218A, K220A, G221A, I224A, and F225A) prevent JNK2 alpha 2 dimerization rendering JNK2 alpha 2 inactive and incapable of stimulating tumor formation. Previous studies coupled with additional mutagenesis of neighboring isoleucines and leucines (I208A, I214A, I231A, and I238A) suggest that a leucine zipper may play an important role in JNK2 alpha 2 homodimerization. We also show that a kinase-inactive JNK2 alpha 2 mutant can interact with and inhibit wild type JNK2 alpha 2 autophosphorylation, suggesting that JNK2 alpha 2 undergoes trans-autophosphorylation. Together, our results demonstrate that JNK2 alpha 2 differs from other MAPK proteins in two major ways; its autoactivation/autophosphorylation is dependent on dimerization, and dimerization most likely precedes autophosphorylation. In addition, we show that dimerization is essential for JNK2 alpha 2 activity and that prevention of dimerization may decrease JNK2 alpha 2 induced tumorigenic phenotypes.	[Nitta, Ryan T.; Chu, Albert H.; Wong, Albert J.] Stanford Univ, Med Ctr, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Wong, Albert J.] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Wong, AJ (corresponding author), Stanford Univ, Med Ctr, Sch Med, Dept Neurosurg, 300 Pasteur Dr,Edwards Bldg 221, Stanford, CA 94305 USA.	ajwong@stanford.edu			National Institutes of Health [CA69495, CA124832]; National Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA069495, R01CA124832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA69495, CA96539 and CA124832 ( to A. J. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Mark Linder/American Brain Tumor Association fellowship.; Supported by a research grant from the National Brain Tumor Foundation.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Arbour N, 2002, J EXP MED, V195, P801, DOI 10.1084/jem.20011481; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Chen NY, 2001, CANCER RES, V61, P3908; Cheng HL, 1998, J BIOL CHEM, V273, P14560, DOI 10.1074/jbc.273.23.14560; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Ishii M, 2004, J IMMUNOL, V172, P2569, DOI 10.4049/jimmunol.172.4.2569; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kondoh K, 2005, CHROMOSOMA, V114, P86, DOI 10.1007/s00412-005-0341-9; Kyriakis John M, 2004, Methods Mol Biol, V250, P61; Lively TN, 2004, J BIOL CHEM, V279, P26257, DOI 10.1074/jbc.M400892200; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Nitta RT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000963; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Pimienta G, 2007, CELL CYCLE, V6, P1762, DOI 10.4161/cc.6.14.4434; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; ROBBINS DJ, 1993, J AM SOC NEPHROL, V4, P1104; Shaw D, 2008, J MOL BIOL, V383, P885, DOI 10.1016/j.jmb.2008.08.086; Tsuiki H, 2003, CANCER RES, V63, P250; Wilsbacher JL, 2006, BIOCHEMISTRY-US, V45, P13175, DOI 10.1021/bi061041w; Wilson DJ, 1996, EUR J IMMUNOL, V26, P989, DOI 10.1002/eji.1830260505; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2	30	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34935	34945		10.1074/jbc.M804970200	http://dx.doi.org/10.1074/jbc.M804970200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940813	Green Published, hybrid			2022-12-27	WOS:000261469100050
J	Monje, PV; Athauda, G; Wood, PM				Monje, Paula V.; Athauda, Gagani; Wood, Patrick M.			Protein Kinase A-mediated Gating of Neuregulin-dependent ErbB2-ErbB3 Activation Underlies the Synergistic Action of cAMP on Schwann Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CYCLIC-AMP; MAP KINASE; SIGNALING PATHWAYS; FACTOR RECEPTOR; HEREGULIN; AKT; EPAC; PHOSPHORYLATION; ERBB3	In Schwann cells (SCs), cyclic adenosine monophosphate (cAMP) enhances the action of neuregulin, the most potent known mitogen for SCs, by synergistically increasing the activation of two crucial signaling pathways: ERK and Akt. However, the underlying mechanism of cross-talk between neuregulin and cAMP signaling remains mostly undefined. Here, we report that the activation of protein kinase A (PKA), but not that of exchange protein activated by cAMP (EPAC), enhances S-phase entry of SCs by synergistically enhancing the ligand-dependent tyrosine phosphorylation/activation of the neuregulin co-receptor, ErbB2-ErbB3. The role of PKA in neuregulin-ErbB signaling was confirmed using PKA inhibitors, pathway-selective cAMP analogs, and natural ligands stimulating PKA activity in SCs, such as adenosine and epinephrine. Two basic observations defined the synergistic action of PKA as "gating" for neuregulin-ErbB signaling: 1) the activation of PKA was not sufficient to induce S-phase entry or the activation of either ErbB2 or ErbB3; and 2) the presence of neuregulin was strictly required to ignite ErbB activation and thereby ERK and Akt signaling. However, PKA directly phosphorylated ErbB2 on Thr-686, a highly conserved intracellular regulatory site that was required for the PKA-mediated synergistic enhancement of neuregulin-induced ErbB2-ErbB3 activation and proliferation in SCs. The gating action of PKA on neuregulin-induced ErbB2-ErbB3 activation has important biological significance, because it insures signal amplification into the ERK and Akt pathways without compromising either the neuregulin dependence or the high specificity of ErbB signaling pathways.	[Monje, Paula V.; Athauda, Gagani] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Wood, Patrick M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA	University of Miami; University of Miami	Monje, PV (corresponding author), 1095 NW 14th Terrace, Miami, FL 33136 USA.	MPaula@miamiproject.med.miami.edu	Monje, Paula/AAB-9099-2020		National Institutes of Grant [NS009923]; NINDS; The Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923] Funding Source: NIH RePORTER	National Institutes of Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); The Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Grant NS009923 from NINDS. This work was also supported by The Project to Cure Paralysis. The costs of publication of this article defrayed in part by the payment of page charges. This article must be hereby marked "advertisement" in accordance with 18 U. S. C. 1734 solely to indicate this fact.	ALIMANDI M, 1995, ONCOGENE, V10, P1813; Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; CARRAWAY KL, 1995, J BIOL CHEM, V270, P7111, DOI 10.1074/jbc.270.13.7111; CHENG L, 1995, J CELL BIOL, V129, P789, DOI 10.1083/jcb.129.3.789; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fink T, 1999, CAN J PHYSIOL PHARM, V77, P204, DOI 10.1139/cjpp-77-3-204; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Gulliford T, 1999, CELL SIGNAL, V11, P245, DOI 10.1016/S0898-6568(98)00058-8; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Kim HA, 1997, J NEUROSCI RES, V49, P236; Kim HA, 2001, J NEUROSCI, V21, P1110; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Piiper A, 2004, CURR PHARM DESIGN, V10, P3539, DOI 10.2174/1381612043382936; Piiper A, 2003, BIOCHEM BIOPH RES CO, V301, P848, DOI 10.1016/S0006-291X(03)00055-X; Piiper A, 2002, J BIOL CHEM, V277, P43623, DOI 10.1074/jbc.M203926200; RAFF MC, 1978, CELL, V15, P813, DOI 10.1016/0092-8674(78)90266-0; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; REHMANN H, 2005, EXPT PROCEDURES ENZY, V407, P159; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; Stevens B, 2004, NEURON GLIA BIOL, V1, P23, DOI 10.1017/s1740925x04000055; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; WOOD PM, 1975, NATURE, V256, P662, DOI 10.1038/256662a0; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366	47	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34087	34100		10.1074/jbc.M802318200	http://dx.doi.org/10.1074/jbc.M802318200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18799465	Green Published, hybrid			2022-12-27	WOS:000261277700037
J	Casagrande, F; Ratera, M; Schenk, AD; Chami, M; Valencia, E; Lopez, JM; Torrents, D; Engel, A; Palacin, M; Fotiadis, D				Casagrande, Fabio; Ratera, Merce; Schenk, Andreas D.; Chami, Mohamed; Valencia, Eva; Maria Lopez, Jesus; Torrents, David; Engel, Andreas; Palacin, Manuel; Fotiadis, Dimitrios			Projection Structure of a Member of the Amino Acid/Polyamine/Organocation Transporter Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINURIC PROTEIN INTOLERANCE; IMAGE-PROCESSING LIBRARY; EXTREME ACID RESISTANCE; ESCHERICHIA-COLI; PYROCOCCUS-HORIKOSHII; AGMATINE ANTIPORTER; MEMBRANE TOPOLOGY; APC SUPERFAMILY; ARGININE; PERMEASE	The L-arginine/agmatine antiporter AdiC is a key component of the arginine-dependent extreme acid resistance system of Escherichia coli. Phylogenetic analysis indicated that AdiC belongs to the amino acid/polyamine/organocation (APC) transporter superfamily having sequence identities of 15-17% to eukaryotic and human APC transporters. For functional and structural characterization, we cloned, overexpressed, and purified wild-type AdiC and the point mutant AdiC-W293L, which is unable to bind and consequently transport L-arginine. Purified detergent-solubilized AdiC particles were dimeric. Reconstitution experiments yielded two-dimensional crystals of AdiC-W293L diffracting beyond 6 angstrom resolution from which we determined the projection structure at 6.5 angstrom resolution. The projection map showed 10-12 density peaks per monomer and suggested mainly tilted helices with the exception of one distinct perpendicular membrane spanning alpha-helix. Comparison of AdiC-W293L with the projection map of the oxalate/formate antiporter from Oxalobacter formigenes, a member from the major facilitator superfamily, indicated different structures. Thus, two-dimensional crystals of AdiC-W293L yielded the first detailed view of a transport protein from the APC superfamily at sub-nanometer resolution.	[Casagrande, Fabio; Schenk, Andreas D.; Chami, Mohamed; Engel, Andreas; Fotiadis, Dimitrios] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; [Ratera, Merce; Valencia, Eva; Palacin, Manuel] Ctr Invest Biomed Red Enfermedades Raras, E-08028 Barcelona, Spain; [Maria Lopez, Jesus; Torrents, David] Barcelona Supercomp Ctr, Life Sci Program, E-08034 Barcelona, Spain; [Maria Lopez, Jesus] Natl Inst Bioinformat, E-08034 Barcelona, Spain; [Torrents, David] Inst Catalana Recerca & Estudis Avancats, E-08034 Barcelona, Spain; [Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Ratera, Merce; Valencia, Eva; Palacin, Manuel] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Inst Biomed Res, E-08028 Barcelona, Spain	University of Basel; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); ICREA; University of Bern; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Palacin, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Inst Biomed Res, Barcelona Sci Pk,Josep Samitier 1-5, E-08028 Barcelona, Spain.	manuel.palacin@irbbarcelona.org; dimitrios.fotiadis@mci.unibe.ch	Torrents, David/G-5785-2015	Torrents, David/0000-0002-6086-9037; Lopez Marti, Jesus Maria/0000-0002-3006-1360; Schenk, Andreas/0000-0001-9214-2505; Ratera, Merce/0000-0001-5224-9172; Palacin, Manuel/0000-0002-8670-293X	European Community Project [502802]; Berne University Research Foundation; Spanish Ministry of Science and Education [BFU2006-14600]; Swiss National Center of Competence in Research for Structural Biology; Maurice E. Muller Foundation of Switzerland; Fondo Social Europeo; ICREA Funding Source: Custom	European Community Project(European Commission); Berne University Research Foundation; Spanish Ministry of Science and Education(Spanish Government); Swiss National Center of Competence in Research for Structural Biology(Swiss National Science Foundation (SNSF)); Maurice E. Muller Foundation of Switzerland; Fondo Social Europeo(European Social Fund (ESF)European Commission); ICREA(ICREA)	This work was supported by the European Community Project Grant 502802 EUGINDAT (to D. F. and M. P.), by the Berne University Research Foundation (to D. F. and Matthias Hediger), by the Spanish Ministry of Science and Education Grant BFU2006-14600 (to M. P.), by the Swiss National Center of Competence in Research for Structural Biology (to A. E.), and by the Maurice E. Muller Foundation of Switzerland (to A. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a pre-doctoral fellowship from the Spanish Ministry of Science and Education.; Recipient of a Juan de La Cierva contract from the Spanish Ministry of Science and Education with support from the Fondo Social Europeo.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Cosgriff AJ, 1997, J BACTERIOL, V179, P3317, DOI 10.1128/jb.179.10.3317-3323.1997; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; ELLIS J, 1995, MICROBIOL-UK, V141, P1927, DOI 10.1099/13500872-141-8-1927; Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Heymann JAW, 2001, EMBO J, V20, P4408, DOI 10.1093/emboj/20.16.4408; Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731; Hu LA, 1998, BIOCHEM J, V336, P69, DOI 10.1042/bj3360069; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Jimenez-Vidal M, 2004, J BIOL CHEM, V279, P11214, DOI 10.1074/jbc.M309866200; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032; Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Stahlberg H, 2001, FEBS LETT, V504, P166, DOI 10.1016/S0014-5793(01)02746-6; Subramaniam S, 2002, PHILOS T ROY SOC A, V360, P859, DOI 10.1098/rsta.2001.0971; Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445; Xie H, 2004, MOL MEMBR BIOL, V21, P323, DOI 10.1080/09687860400003941; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yeramian A, 2006, J IMMUNOL, V176, P5918, DOI 10.4049/jimmunol.176.10.5918; Yeramian A, 2006, EUR J IMMUNOL, V36, P1516, DOI 10.1002/eji.200535694; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	42	34	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33240	33248		10.1074/jbc.M806917200	http://dx.doi.org/10.1074/jbc.M806917200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18819925	Green Published, hybrid			2022-12-27	WOS:000261183700027
J	He, PJ; Zhang, HC; Yun, CC				He, Peijian; Zhang, Huanchun; Yun, C. Chris			IRBIT, Inositol 1,4,5-Triphosphate (IP3) Receptor-binding Protein Released with IP3, Binds Na+/H+ Exchanger NHE3 and Activates NHE3 Activity in Response to Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; C-TERMINAL DOMAINS; BRUSH-BORDER; 1,4,5-TRISPHOSPHATE RECEPTOR; PROXIMAL TUBULE; KINASE-C; INHIBITION; REQUIRES; E3KARP; SGK1	Calcium (Ca2+) is a highly versatile second messenger that regulates various cellular processes. Previous studies showed that elevation of intracellular Ca2+ regulates the activity of Na+/H+ exchanger 3 ( NHE3). However, the effect of Ca2+-dependent signaling on NHE3 activity varies depending on cell types. In this study, we report the identification of IP3 receptor-binding protein released with IP3 (IRBIT) as a NHE3 interacting protein and its role in regulation of NHE3 activity. IRBIT bound to the carboxyl-terminal domain of NHE3, which is necessary for acute regulation of NHE3. Ectopic expression of IRBIT resulted in Ca2+-dependent activation of NHE3 activity, whereas silencing of endogenous IRBIT resulted in inhibition of NHE3 activity. Ca2+-dependent stimulation of NHE3 activity was dependent on the binding of IRBIT to NHE3. Previously Ca2+-dependent inhibition of NHE3 was demonstrated in the presence of NHERF2. Co-expression of IRBIT was able to reverse the NHERF2-dependent inhibition of NHE3. We also showed that IRBIT-dependent activation of NHE3 involves exocytic trafficking of NHE3 to the plasma membrane and this activation was blocked by inhibition of calmodulin (CaM) or CaM-dependent kinase II. These results suggest that the overall effect of Ca2+ on NHE3 activity is balanced by IRBIT-dependent activation and NHERF2-dependent inhibition.	[He, Peijian; Zhang, Huanchun; Yun, C. Chris] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Yun, CC (corresponding author), Whitehead Bldg,Rm 201,615 Michael St, Atlanta, GA 30322 USA.	ccyun@emory.edu	He, Peijian/F-4790-2011	He, Peijian/0000-0002-9526-8004	National Institutes of Health [DK061418]; Emory Digestive Disease Research Development Center [DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, R01DK061418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Digestive Disease Research Development Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK061418. This work was also supported by Emory Digestive Disease Research Development Center Grant DK064399. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Choi JW, 2004, BBA-MOL CELL BIOL L, V1683, P59, DOI 10.1016/j.bbalip.2004.04.005; Chu TS, 1996, J CLIN INVEST, V97, P1454, DOI 10.1172/JCI118567; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; COHEN ME, 1990, P NATL ACAD SCI USA, V87, P8990, DOI 10.1073/pnas.87.22.8990; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; Cooper BJ, 2006, J BIOL CHEM, V281, P22471, DOI 10.1074/jbc.M602520200; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Dekker JW, 2002, IMMUNOGENETICS, V53, P993, DOI 10.1007/s00251-001-0402-z; Devogelaere B, 2006, BIOCHEM BIOPH RES CO, V343, P49, DOI 10.1016/j.bbrc.2006.02.119; Devogelaere B, 2007, BIOCHEM J, V407, P303, DOI 10.1042/BJ20070361; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; DONOWITZ M, 1989, J CLIN INVEST, V83, P1953, DOI 10.1172/JCI114104; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Kloor D, 2004, TRENDS PHARMACOL SCI, V25, P294, DOI 10.1016/j.tips.2004.04.004; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Wang T, 1999, AM J PHYSIOL-RENAL, V277, pF298, DOI 10.1152/ajprenal.1999.277.2.F298; Yun CC, 2003, CELL PHYSIOL BIOCHEM, V13, P29, DOI 10.1159/000070247; Yun CC, 2002, J AM SOC NEPHROL, V13, P2823, DOI 10.1097/01.ASN.0000035085.54451.81; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; YUN CHC, 1995, P NATL ACAD SCI USA, V92, P10723, DOI 10.1073/pnas.92.23.10723; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	41	49	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33544	33553		10.1074/jbc.M805534200	http://dx.doi.org/10.1074/jbc.M805534200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829453	hybrid, Green Published			2022-12-27	WOS:000261183700059
J	Kim, SY; Jo, HY; Kim, MH; Cha, YY; Choi, SW; Shim, JH; Kim, TJ; Lee, KY				Kim, So Yong; Jo, Hee-Yeon; Kim, Mi Hye; Cha, Yun-Yi; Choi, Sung Won; Shim, Jae-Hyuck; Kim, Tae Jin; Lee, Ki-Young			H2O2-dependent Hyperoxidation of Peroxiredoxin 6 (Prdx6) Plays a Role in Cellular Toxicity via Up-regulation of iPLA2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; INDEPENDENT PHOSPHOLIPASE A(2); OXIDATIVE STRESS; SITE CYSTEINE; 1-CYS PEROXIREDOXIN; G2/M ARREST; IN-VIVO; CELLS; OVEROXIDATION; INACTIVATION	Peroxiredoxin 6 (Prdx6) is a bifunctional enzyme with peroxidase activity and Ca2+-independent phospholipase A2 (iPLA2) activity. Here, we report that H2O2-induced cellular toxicity acts through Prdx6 hyperoxidation. Under high concentrations of H2O2 (> 100 mu M), Prdx6, and 2-Cys Prdxs were hyperoxidized. Contrary to hyperoxidation of 2-Cys Prdxs, hyperoxidation of Prdx6 was irreversible in vivo. Surprisingly, H2O2-induced cell cycle arrest at the G2/M transition correlated with hyperoxidation and increased iPLA2 activity of Prdx6. This arrest was also associated with up-regulation of p53 and p21 and with down-regulation of cyclin B1. Furthermore, the H2O2-mediated increase in iPLA2 activity was dramatically abolished in a hyperoxidation mutant (C47A), an iPLA2 mutant (S32A), and a double mutant (C47A/S32A) of Prdx6, demonstrating the essential requirement of Prdx6 C47 hyperoxidation for its iPLA2 activity. Together, our results demonstrate that H2O2-mediated hyperoxidation of Prdx6 induces cell cycle arrest at the G2/M transition through up-regulation of iPLA2 activity.	[Kim, So Yong; Jo, Hee-Yeon; Kim, Mi Hye; Cha, Yun-Yi; Kim, Tae Jin; Lee, Ki-Young] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea; [Choi, Sung Won] Cornell Univ, Sch Arts & Sci, Dept Mol Biol, New York, NY 10021 USA; [Shim, Jae-Hyuck] Harvard Univ, Sch Med, Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Sungkyunkwan University (SKKU); Cornell University; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health	Lee, KY (corresponding author), 300 Cheoncheon Dong, Suwon 440746, Gyeonggi Do, South Korea.	thylee@med.skku.ac.kr	Kim, Tae Jin/D-6544-2011	Kim, Tae Jin/0000-0001-9802-0568; Shim, Jae-Hyuck/0000-0002-4947-3293	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A080250]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A080250). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Dona F, 2008, INT J ONCOL, V33, P613, DOI 10.3892/ijo_00000047; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lee SM, 2008, PHYTOTHER RES, V22, P752, DOI 10.1002/ptr.2355; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Saigusa K, 2007, ONCOGENE, V26, P1110, DOI 10.1038/sj.onc.1210148; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wang Y, 2006, AM J RESP CELL MOL, V34, P481, DOI 10.1165/rcmb.2005-0333OC; Wang Y, 2004, AM J PHYSIOL-LUNG C, V286, pL1188, DOI 10.1152/ajplung.00288.2003; Wang Y, 2008, J CELL BIOCHEM, V104, P1274, DOI 10.1002/jcb.21703; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	24	85	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33563	33568		10.1074/jbc.M806578200	http://dx.doi.org/10.1074/jbc.M806578200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826942	hybrid, Green Published			2022-12-27	WOS:000261183700061
J	Qin, DJ; Gan, Y; Shao, KF; Wang, H; Li, W; Wang, T; He, WZ; Xu, JY; Zhang, Y; Kou, ZH; Zeng, LW; Sheng, GQ; Esteban, MA; Gao, SR; Pei, DQ				Qin, Dajiang; Gan, Yi; Shao, Kaifeng; Wang, Hao; Li, Wen; Wang, Tao; He, Wenzhi; Xu, Jianyong; Zhang, Yu; Kou, Zhaohui; Zeng, Lingwen; Sheng, Guoqing; Esteban, Miguel A.; Gao, Shaorong; Pei, Duanqing			Mouse Meningiocytes Express Sox2 and Yield High Efficiency of Chimeras after Nuclear Reprogramming with Exogenous Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; FIBROBLASTS; ADULT; INDUCTION	Induced pluripotent stem cell technology, also termed iPS, is an emerging approach to reprogram cells into an embryonic stem cell-like state by viral transduction with defined combinations of factors. iPS cells share most characteristics of embryonic stem cells, counting pluripotency and self-renewal, and have so far been obtained from mouse and humans, including patients with genetic diseases. Remarkably, autologous transplantation of cell lineages derived from iPS cells will eliminate the possibility of immunological rejection, as well as current ethical issues surrounding human embryonic stem cell research. However, before iPS can be used for clinical purposes, technical problems must be overcome. Among other considerations, full and homogeneous iPS reprogramming is an important prerequisite. However, despite the fact that cells from several mouse tissues can be successfully induced to iPS, the overall efficiency of chimera formation of these clones remains low even if selection for Oct4 or Nanog expression is applied. In this report, we demonstrate that cells from the mouse meningeal membranes express elevated levels of the embryonic master regulator Sox2 and are highly amenable to iPS. Meningeal iPS clones, generated without selection, are fully and homogeneously reprogrammed based on DNA methylation analysis and 100% chimera competent. Our results define a population of somatic cells that are ready to undergo iPS, thus highlighting a very attractive cell type for iPS research and application.	[Qin, Dajiang; Gan, Yi; Shao, Kaifeng; Wang, Hao; Li, Wen; Wang, Tao; He, Wenzhi; Xu, Jianyong; Zeng, Lingwen; Sheng, Guoqing; Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Stem Cell & Canc Biol Grp, Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Guangdong, Peoples R China; [Zhang, Yu; Kou, Zhaohui; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Chinese Academy of Sciences; National Institute of Biological Sciences, Beijing	Pei, DQ (corresponding author), Chinese Acad Sci, Stem Cell & Canc Biol Grp, Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Shao, Kaifeng/T-3547-2018; zhou, xingru/G-4442-2012	Shao, Kaifeng/0000-0003-2066-9054; 	National Natural Science Foundation of China [30725012, 30630039]; Chinese Academy of Sciences [KSCX2-YW-R-48]; Guangzhou Science and Technology [2006A50104002]; Ministry of Science and Technology 973 [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804]; National High Technology [2005AA210930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Guangzhou Science and Technology; Ministry of Science and Technology 973(National Basic Research Program of China); National High Technology(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30725012 and 30630039; Chinese Academy of Sciences Grant KSCX2-YW-R-48; Guangzhou Science and Technology Grant 2006A50104002; Ministry of Science and Technology 973 Grants 2006CB701504, 2006CB943600, 2007CB948002, and 2007CB947804; and National High Technology Project 863 Grant 2005AA210930. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gagan Jeffrey R., 2007, Birth Defects Research, V81, P297, DOI 10.1002/bdrc.20104; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qin DJ, 2007, CELL RES, V17, P959, DOI 10.1038/cr.2007.92; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	22	42	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33730	33735		10.1074/jbc.M806788200	http://dx.doi.org/10.1074/jbc.M806788200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826945	Green Published, hybrid			2022-12-27	WOS:000261183700079
J	Hirota, K; Sakamaki, J; Ishida, J; Shimamoto, Y; Nishihara, S; Kodama, N; Ohta, K; Yamamoto, M; Tanimoto, K; Fukamizu, A				Hirota, Keiko; Sakamaki, Jun-ichi; Ishida, Junji; Shimamoto, Yoko; Nishihara, Shigeki; Kodama, Norio; Ohta, Kazuhide; Yamamoto, Masayuki; Tanimoto, Keiji; Fukamizu, Akiyoshi			A Combination of HNF-4 and Foxo1 Is Required for Reciprocal Transcriptional Regulation of Glucokinase and Glucose-6-phosphatase Genes in Response to Fasting and Feeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR 4-ALPHA; FACTOR FKHR; PROMOTER ACTIVITY; CYCLIC-AMP; IN-VIVO; INSULIN; EXPRESSION; LIVER; RECEPTOR; PROTEIN	Glucokinase (GK) and glucose-6-phosphatase (G6Pase) regulate rate-limiting reactions in the physiologically opposed metabolic cascades, glycolysis and gluconeogenesis, respectively. Expression of these genes is conversely regulated in the liver in response to fasting and feeding. We explored the mechanism of transcriptional regulation of these genes by nutritional condition and found that reciprocal function of HNF-4 and Foxo1 plays an important role in this process. In the GK gene regulation, Foxo1 represses HNF-4-potentiated transcription of the gene, whereas it synergizes with HNF-4 in activating the G6Pase gene transcription. These opposite actions of Foxo1 concomitantly take place in the cells under no insulin stimulus, and such gene-specific action was promoter context-dependent. Interestingly, HNF-4-binding elements (HBEs) in the GK and G6Pase promoters were required both for the insulin-stimulated GK gene activation and insulin-mediated G6Pase gene repression. Indeed, mouse in vivo imaging showed that mutating the HBEs in the GK and G6Pase promoters significantly impaired their reactivity to the nutritional states, even in the presence of intact Foxo1-binding sites (insulin response sequences). Thus, in the physiological response of the GK and G6Pase genes to fasting/feeding conditions, Foxo1 distinctly decodes the promoter context of these genes and differently modulates the function of HBE, which then leads to opposite outcomes of gene transcription.	[Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Nishihara, Shigeki; Kodama, Norio; Ohta, Kazuhide] Otsuka Pharmaceut Co Ltd, Otsuka GEN Res Inst, Tokushima 7710192, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan	University of Tsukuba; Otsuka Pharmaceutical; Tohoku University	Fukamizu, A (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ctr Tsukuba Adv Res Alliance, Tennoudai 1-1-1, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp	Tanimoto, Keiji/B-2600-2014; Yamamoto, Masayuki/A-4873-2010; fukamizu, akiyoshi/J-5350-2012	Yamamoto, Masayuki/0000-0002-9073-9436; fukamizu, akiyoshi/0000-0002-8786-6020; Tanimoto, Keiji/0000-0003-1971-6546; Sakamaki, Jun-ichi/0000-0003-3361-6314	Ministry of Education, Culture, Sports, Science and Technology of Japan; Fumi Yamamura Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fumi Yamamura Memorial Foundation	This work was supported by a grant-in-aid for scientific research on priority areas and a grant-in-aid for young scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Fumi Yamamura Memorial Foundation for Female Natural Scientists. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Arizmendi C, 1999, J BIOL CHEM, V274, P13033, DOI 10.1074/jbc.274.19.13033; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Chatelain F, 1998, DIABETES, V47, P882, DOI 10.2337/diabetes.47.6.882; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Drewes T, 1996, MOL CELL BIOL, V16, P925; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gautier-Stein A, 2005, MOL ENDOCRINOL, V19, P163, DOI 10.1210/me.2004-0105; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hirota K, 2005, INT J MOL MED, V15, P487; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; HROMAS R, 1995, CRIT REV ONCOL HEMAT, V20, P129, DOI 10.1016/1040-8428(94)00151-I; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Rajas F, 2002, J BIOL CHEM, V277, P15736, DOI 10.1074/jbc.M200971200; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Roth U, 2002, BIOCHEM J, V365, P223, DOI 10.1042/BJ20020340; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taylor DG, 1996, NUCLEIC ACIDS RES, V24, P2930, DOI 10.1093/nar/24.15.2930; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Yoshida E, 1997, BIOCHEM BIOPH RES CO, V241, P664, DOI 10.1006/bbrc.1997.7871; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	44	95	98	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32432	32441		10.1074/jbc.M806179200	http://dx.doi.org/10.1074/jbc.M806179200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805788	hybrid			2022-12-27	WOS:000260893700031
J	Kaeser, MD; Aslanian, A; Dong, MQ; Yates, JR; Emerson, BM				Kaeser, Matthias D.; Aslanian, Aaron; Dong, Meng-Qiu; Yates, John R., III; Emerson, Beverly M.			BRD7, a Novel PBAF-specific SWI/SNF Subunit, Is Required for Target Gene Activation and Repression in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTIONAL REGULATION; LENTIVIRAL VECTORS; CYCLE CONTROL; HORMONE GENE; SNF COMPLEX; DIFFERENTIATION; BINDING; BRG1; PLURIPOTENCY	The composition of chromatin-remodeling complexes dictates how these enzymes control transcriptional programs and cellular identity. In the present study we investigated the composition of SWI/SNF complexes in embryonic stem cells (ESCs). In contrast to differentiated cells, ESCs have a biased incorporation of certain paralogous SWI/SNF subunits with low levels of BRM, BAF170, and ARID1B. Upon differentiation, the expression of these subunits increases, resulting in a higher diversity of compositionally distinct SWI/SNF enzymes. We also identified BRD7 as a novel component of the Polybromo-associated BRG1-associated factor (PBAF) complex in both ESCs and differentiated cells. Using short hairpin RNA-mediated depletion of BRG1, we showed that SWI/SNF can function as both a repressor and an activator in pluripotent cells, regulating expression of developmental modifiers and signaling components such as Nodal, ADAMTS1, BMI-1, CRABP1, and thyroid releasing hormone. Knockdown studies of PBAF-specific BRD7 and of a signature subunit within the BAF complex, ARID1A, showed that these two subcomplexes affect SWI/SNF target genes differentially, in some cases even antagonistically. This may be due to their different biochemical properties. Finally we examined the role of SWI/SNF in regulating its target genes during differentiation. We found that SWI/SNF affects recruitment of components of the preinitiation complex in a promoter-specific manner to modulate transcription positively or negatively. Taken together, our results provide insight into the function of compositionally diverse SWI/SNF enzymes that underlie their inherent gene-specific mode of action.	[Kaeser, Matthias D.; Emerson, Beverly M.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Aslanian, Aaron; Dong, Meng-Qiu; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Salk Institute; Scripps Research Institute	Emerson, BM (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	emerson@salk.edu		Kaeser, Matthias/0000-0003-0050-9408	National Institutes of Health [GM038760]; Swiss National Science Foundation; European Molecular Biology Organization; Roche Research Foundation; Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Roche Research Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM038760 (to B. M. E.). This work was also supported by fellowships from the Swiss National Science Foundation, European Molecular Biology Organization, and Roche Research Foundation (to M. D. K.) and by the Ruth L. Kirschstein National Research Service Award (to A. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; D Kaeser M, 2006, CURR OPIN GENET DEV, V16, P508, DOI 10.1016/j.gde.2006.08.001; Dauvillier S, 2001, MECH DEVELOP, V101, P221, DOI 10.1016/S0925-4773(00)00560-8; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gunawardena RW, 2007, J BIOL CHEM, V282, P20116, DOI 10.1074/jbc.M701406200; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Klochendler-Yeivin A, 2006, MOL CELL BIOL, V26, P2661, DOI 10.1128/MCB.26.7.2661-2674.2006; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Logie C, 1999, METHOD ENZYMOL, V304, P726; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mitra D, 2006, MOL CELL BIOL, V26, P4095, DOI 10.1128/MCB.01849-05; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Moreira JMA, 1999, EMBO J, V18, P2836, DOI 10.1093/emboj/18.10.2836; Moshkin YM, 2007, MOL CELL BIOL, V27, P651, DOI 10.1128/MCB.01257-06; Motoyama A, 2007, ANAL CHEM, V79, P3623, DOI 10.1021/ac062292d; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Peng C, 2006, J CELL BIOCHEM, V97, P882, DOI 10.1002/jcb.20645; Ren Y, 1998, ENDOCRINOLOGY, V139, P195, DOI 10.1210/en.139.1.195; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Staal A, 2000, J CELL PHYSIOL, V185, P269, DOI 10.1002/1097-4652(200011)185:2<269::AID-JCP12>3.0.CO;2-L; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Zani VJ, 1996, BLOOD, V87, P3124, DOI 10.1182/blood.V87.8.3124.bloodjournal8783124	59	160	162	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32254	32263		10.1074/jbc.M806061200	http://dx.doi.org/10.1074/jbc.M806061200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809673	Green Published, hybrid			2022-12-27	WOS:000260893700012
J	Sudhamsu, J; Lee, GI; Klessig, DF; Crane, BR				Sudhamsu, Jawahar; Lee, Gyu In; Klessig, Daniel F.; Crane, Brian R.			The Structure of YqeH AN AtNOS1/AtNOA1 ORTHOLOG THAT COUPLES GTP HYDROLYSIS TO MOLECULAR RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; NUCLEAR EXPORT RECEPTOR; MESSENGER-RNA STABILITY; HIPPEL-LINDAU PROTEIN; BACILLUS-SUBTILIS; BINDING-PROTEINS; ARABIDOPSIS-THALIANA; ATTENUATION PROTEIN; RIBOSOMAL-SUBUNIT; CELL-DIVISION	AtNOS1/AtNOA1 was identified as a nitric oxide-generating enzyme in plants, but that function has recently been questioned. To resolve issues surrounding AtNOA1 activity, we report the biochemical properties and a 2.36 angstrom resolution crystal structure of a bacterial AtNOA1 ortholog (YqeH). Geobacillus YqeH fused to a putative AtNOA1 leader peptide complements growth and morphological defects of Atnoa1 mutant plants. YqeH does not synthesize nitric oxide from L-arginine but rather hydrolyzes GTP. The YqeH structure reveals a circularly permuted GTPase domain and an unusual C-terminal beta-domain. A small N-terminal domain, disordered in the structure, binds zinc. Structural homology among the C-terminal domain, the RNA-binding regulator TRAP, and the hypoxia factor pVHL define a recognition module for peptides and nucleic acids. TRAP residues important for RNA binding are conserved by the YqeH C-terminal domain, whose positioning is coupled to GTP hydrolysis. YqeH and AtNOA1 probably act as G-proteins that regulate nucleic acid recognition and not as nitric-oxide synthases.	[Sudhamsu, Jawahar; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Lee, Gyu In; Klessig, Daniel F.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Cornell University; Boyce Thompson Institute for Plant Research	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, G60 ST OLIN, Ithaca, NY 14853 USA.	bc69@cornell.edu	Sudhamsu, Jawahar/A-8751-2012		National Institutes of Health [5R01GM067011]; National Science Foundation [CHE-0749996]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM067011 ( to D. F. K.). This work was also supported by National Science Foundation Grant CHE-0749996 ( to B. R. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; Cheng G, 2005, NUCLEIC ACIDS RES, V33, P5861, DOI 10.1093/nar/gki894; Cohen HT, 1999, BIOCHEM BIOPH RES CO, V266, P43, DOI 10.1006/bbrc.1999.1767; Comartin DJ, 2006, CURR OPIN PHARMACOL, V6, P453, DOI 10.1016/j.coph.2006.05.005; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Crawford NM, 2006, J EXP BOT, V57, P471, DOI 10.1093/jxb/erj050; Crawford NM, 2005, TRENDS PLANT SCI, V10, P195, DOI 10.1016/j.tplants.2005.02.008; Cueto M, 1996, FEBS LETT, V398, P159, DOI 10.1016/S0014-5793(96)01232-X; Datta K, 2005, ONCOGENE, V24, P7850, DOI 10.1038/sj.onc.1208912; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; FLORESPEREZ U, 2008, PLANT CELL IN PRESS; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fridell RA, 1997, J CELL SCI, V110, P1325; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P1703, DOI 10.1093/nar/29.8.1703; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang S, 1997, J NEUROCHEM, V69, P2516; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kaiser WM, 2004, NITRIC OXIDE-BIOL CH, V11, P37; Kent HM, 1999, J MOL BIOL, V289, P565, DOI 10.1006/jmbi.1999.2775; Klessig Daniel F, 2004, Proc Natl Acad Sci U S A, V101, P16081, DOI 10.1073/pnas.0406996101; Klessig DF, 2004, CELL, V119, P445, DOI 10.1016/j.cell.2004.10.007; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Lamotte O, 2004, PLANT PHYSIOL, V135, P516, DOI 10.1104/pp.104.038968; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Mur LAJ, 2006, J EXP BOT, V57, P489, DOI 10.1093/jxb/erj052; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petersen C, 2000, J BIOL CHEM, V275, P4081, DOI 10.1074/jbc.275.6.4081; Pioli PA, 2001, J BIOL CHEM, V276, P40346, DOI 10.1074/jbc.M105391200; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Reynaud EG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-21; Ribeiro EA, 1999, FEBS LETT, V445, P283, DOI 10.1016/S0014-5793(99)00138-6; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3; Yang M, 1997, J MOL BIOL, V270, P696, DOI 10.1006/jmbi.1997.1149; Yona G, 2005, J COMPUT BIOL, V12, P12, DOI 10.1089/cmb.2005.12.12; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zemojtel T, 2006, FEBS LETT, V580, P455, DOI 10.1016/j.febslet.2005.12.038; Zemojtel T, 2004, TRENDS BIOCHEM SCI, V29, P224, DOI 10.1016/j.tibs.2004.03.005; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	85	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32968	32976		10.1074/jbc.M804837200	http://dx.doi.org/10.1074/jbc.M804837200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801747	Green Published, hybrid			2022-12-27	WOS:000260893700085
J	Iyengar, R				Iyengar, Ravi			Computational Biochemistry: Systems Biology Minireview Series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ENZYME-CATALYZED REACTIONS; PROTEINS; MODE		Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, R01GM054508] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM071558, R01 GM054508, P50 GM071558-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adair GS, 1925, J BIOL CHEM, V63, P529; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; CHA S, 1968, J BIOL CHEM, V243, P820; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hill AV, 1910, J PHYSIOL-LONDON, V40, P190; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; KHOLODENKO BN, 1993, FEBS LETT, V320, P71, DOI 10.1016/0014-5793(93)81660-R; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Segel I.H., 1975, ENZYME KINETICS; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020	14	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5425	5426		10.1074/jbc.R800066200	http://dx.doi.org/10.1074/jbc.R800066200			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	18940804	Green Published, hybrid			2022-12-27	WOS:000263560600001
J	Neves, SR; Iyengar, R				Neves, Susana R.; Iyengar, Ravi			Models of Spatially Restricted Biochemical Reaction Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE; SPATIOTEMPORAL REGULATION; SIGNALING NETWORKS; LIVING CELLS; TROPONIN-I; ACTIVATION; RAS; DYNAMICS; CALCIUM; PHOSPHORYLATION	Many reactions within the cell occur only in specific intracellular regions. Such local reaction networks give rise to microdomains of activated signaling components. The dynamics of microdomains can be visualized by live cell imaging. Computational models using partial differential equations provide mechanistic insights into the interacting factors that control microdomain dynamics. The mathematical models show that, for membrane-initiated signaling, the ratio of the surface area of the plasma membrane to the volume of the cytoplasm, the topology of the signaling network, the negative regulators, and kinetic properties of key components together define microdomain dynamics. Thus, patterns of locally restricted signaling reaction systems can be considered an emergent property of the cell.	[Neves, Susana R.; Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu			National Institutes of Health [GM 072853]; Systems Biology Center [P50 GM 065085]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065085, R01GM072853, R01GM054508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Systems Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 072853 and Systems Biology Center Grant P50 GM 065085.	Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; BRUNTON LL, 1981, ADV CYCL NUCL RES<D>, V14, P391; BRUNTON LL, 1979, NATURE, V280, P78, DOI 10.1038/280078a0; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Craske ML, 2005, J CELL BIOL, V170, P1147, DOI 10.1083/jcb.200503118; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Eungdamrong NJ, 2004, TRENDS CELL BIOL, V14, P661, DOI 10.1016/j.tcb.2004.10.007; Filipp D, 2003, J EXP MED, V197, P1221, DOI 10.1084/jem.20022112; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Honda A, 2001, P NATL ACAD SCI USA, V98, P2437, DOI 10.1073/pnas.051631298; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Loew LM, 2001, TRENDS BIOTECHNOL, V19, P401, DOI 10.1016/S0167-7799(01)01740-1; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; MORIN JG, 1971, J CELL PHYSIOL, V77, P305, DOI 10.1002/jcp.1040770304; MORISE H, 1974, BIOCHEMISTRY-US, V13, P2656, DOI 10.1021/bi00709a028; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Rios E, 1997, ANNU REV BIOPH BIOM, V26, P47, DOI 10.1146/annurev.biophys.26.1.47; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982	43	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5445	5449		10.1074/jbc.R800058200	http://dx.doi.org/10.1074/jbc.R800058200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	18940805	Green Published, hybrid			2022-12-27	WOS:000263560600005
J	Kato, S; Ding, JX; Pisck, E; Jhala, US; Du, KY				Kato, Satomi; Ding, Jixin; Pisck, Evan; Jhala, Ulupi S.; Du, Keyong			COP1 Functions as a FoxO1 Ubiquitin E3 Ligase to Regulate FoxO1-mediated Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; PHOSPHOENOLPYRUVATE CARBOXYKINASE; HEPATIC GLUCONEOGENESIS; INSULIN SENSITIVITY; GLUCOSE-PRODUCTION; NUCLEAR EXCLUSION; MAMMALIAN HOMOLOG; TUMOR SUPPRESSION; AKT ACTIVATION; C-JUN	COP1 is a Ring-Finger E3 ubiquitin ligase that is involved in plant development, mammalian cell survival, growth, and metabolism. Here we report that COP1, whose expression is enhanced by insulin, regulates FoxO1 protein stability. We found that in Fao hepatoma cells, ectopic expression of COP1 decreased, whereas knockdown of COP1 expression increased the level of endogenous FoxO1 protein without impacting other factors such as C/EBP alpha and CREB (cAMP-response element-binding protein). We further showed that COP1 binds FoxO1, enhances its ubiquitination, and promotes its degradation via the ubiquitin-proteasome pathway. To determine the biological significance of COP1-mediated FoxO1 protein degradation, we have examined the impact of COP1 on FoxO1-mediated gene expression and found that COP1 suppressed FoxO1 reporter gene as well as FoxO1 target genes such as glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, two key targets for FoxO1 in the regulation of gluconeogenesis, with corresponding changes of hepatic glucose production in Fao cells. We suggest that by functioning as a FoxO1 E3 ligase, COP1 may play a role in the regulation of hepatic glucose metabolism.	[Kato, Satomi; Ding, Jixin; Pisck, Evan; Du, Keyong] Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Jhala, Ulupi S.] Univ Calif San Diego, Whittier Inst, Islet Res Lab, La Jolla, CA 92037 USA	Tufts Medical Center; University of California System; University of California San Diego	Du, KY (corresponding author), Tufts Univ New England Med Ctr, Mol Oncol Res Inst, 750 Washington St, Boston, MA 02111 USA.	kdu@tufts-nemc.org			National Institutes of Health [DK08147]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK08147 ( to U. S. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Cho CY, 2006, CELL METAB, V3, P367, DOI 10.1016/j.cmet.2006.03.006; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Duong DT, 2002, J BIOL CHEM, V277, P32234, DOI 10.1074/jbc.M204873200; FEHLMANN M, 1983, BIOCHEM J, V214, P845, DOI 10.1042/bj2140845; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; KAHN CR, 1981, NATURE, V290, P717, DOI 10.1038/290717a0; Kato S, 2007, BIOCHEM BIOPH RES CO, V353, P933, DOI 10.1016/j.bbrc.2006.12.161; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; SASAKI K, 1984, J BIOL CHEM, V259, P5242; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Subramanian C, 2004, P NATL ACAD SCI USA, V101, P6798, DOI 10.1073/pnas.0307964101; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; VINITSKY A, 1992, BIOCHEMISTRY-US, V31, P9421, DOI 10.1021/bi00154a014; Wang HY, 1999, CURR BIOL, V9, P711, DOI 10.1016/S0960-9822(99)80314-5; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yamamoto N, 1999, GENES CELLS, V4, P489, DOI 10.1046/j.1365-2443.1999.00282.x; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Yi CL, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-30	51	71	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35464	35473		10.1074/jbc.M801011200	http://dx.doi.org/10.1074/jbc.M801011200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18815134	hybrid, Green Published			2022-12-27	WOS:000261687900018
J	Sekiyama, N; Ikegami, T; Yamane, T; Ikeguchi, M; Uchimura, Y; Baba, D; Ariyoshi, M; Tochio, H; Saitoh, H; Shirakawa, M				Sekiyama, Naotaka; Ikegami, Takahisa; Yamane, Tsutomu; Ikeguchi, Mitsunori; Uchimura, Yasuhiro; Baba, Daichi; Ariyoshi, Mariko; Tochio, Hidehito; Saitoh, Hisato; Shirakawa, Masahiro			Structure of the Small Ubiquitin-like Modifier (SUMO)-interacting Motif of MBD1-containing Chromatin-associated Factor 1 Bound to SUMO-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-DNA GLYCOSYLASE; PROTEIN MODIFICATION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TOPOISOMERASE-II; NMR; INSIGHTS; SYSTEM; NUCLEAR; DOMAIN	Post-translational modification by small ubiquitin-like modifier (SUMO) proteins has been implicated in the regulation of a variety of cellular events. The functions of sumoylation are often mediated by downstream effector proteins harboring SUMO interacting motifs (SIMs) that are composed of a hydrophobic core and a stretch of acidic residues. MBD1-containing chromatin-associated factor 1 (MCAF1), a transcription repressor, interacts with SUMO-2/3 and SUMO-1, with a preference for SUMO-2/3. We used NMR spectroscopy to solve the solution structure of the SIM of MCAF1 bound to SUMO-3. The hydrophobic core of the SIM forms a parallel beta-sheet pairing with strand beta 2 of SUMO-3, whereas its C-terminal acidic stretch seems to mediate electrostatic interactions with a surface area formed by basic residues of SUMO-3. The significance of these electrostatic interactions was shown by mutations of both SUMO- 3 and MCAF1. The present structural and biochemical data suggest that the acidic stretch of the SIM of MCAF1 plays an important role in the binding to SUMO-3.	[Sekiyama, Naotaka; Baba, Daichi; Ariyoshi, Mariko; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Yamane, Tsutomu; Ikeguchi, Mitsunori] Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan; [Uchimura, Yasuhiro] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Saitoh, Hisato] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Shirakawa, Masahiro] Japan Sci & Technol Corp, CREST, Saitama 3320012, Japan; [Shirakawa, Masahiro] RIKEN, Genome Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Kyoto University; Osaka University; Yokohama City University; Kumamoto University; Kumamoto University; Japan Science & Technology Agency (JST); RIKEN	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan.	shirakawa@moleng.kyoto-u.ac.jp	Ikegami, Takahisa/I-9626-2017; Tochio, Hidehito/F-6109-2011; Tochio, Hidehito/GWV-0429-2022	Ikegami, Takahisa/0000-0002-1429-1844; Tochio, Hidehito/0000-0003-3843-3330; Sekiyama, Naotaka/0000-0003-4537-6565; Ariyoshi, Mariko/0000-0002-1361-2642	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency; Global COE Program; MEXT of Japan [B-09]; Japan Society for the Promotion of Science; Global COE Program [B-09]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants (to M. S.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the Japan Science and Technology Agency; by the Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" (No. B-09) of MEXT of Japan, administrated by the Japan Society for the Promotion of Science; and by the Global COE Program "Integrated Materials Science" (# B-09). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Chupreta S, 2007, J BIOL CHEM, V282, P36155, DOI 10.1074/jbc.M708130200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Goddard T. D. and Kneller D. G ., 2002, SPARKY; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huang WC, 2004, EUR J BIOCHEM, V271, P4114, DOI 10.1111/j.1432-1033.2004.04349.x; Ikegami T, 1999, J BIOCHEM, V125, P495, DOI 10.1093/oxfordjournals.jbchem.a022313; Ikeguchi M, 2004, J COMPUT CHEM, V25, P529, DOI 10.1002/jcc.10402; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kurepa J, 2003, J BIOL CHEM, V278, P6862, DOI 10.1074/jbc.M209694200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Sternsdorf T, 1999, MOL CELL BIOL, V19, P5170; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Yamane T, 2008, PROTEINS, V71, P1970, DOI 10.1002/prot.21874	35	62	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35966	35975		10.1074/jbc.M802528200	http://dx.doi.org/10.1074/jbc.M802528200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18842587	hybrid			2022-12-27	WOS:000261687900071
J	Koh, YK; Lee, MY; Kim, JW; Kim, M; Moon, JS; Lee, YJ; Ahn, YH; Kim, KS				Koh, Yoo-Kyung; Lee, Min-Young; Kim, Jae-Woo; Kim, Minji; Moon, Jong-Seok; Lee, Yoo-Jung; Ahn, Yong-Ho; Kim, Kyung-Sup			Lipin1 Is a Key Factor for the Maturation and Maintenance of Adipocytes in the Regulatory Network with CCAAT/Enhancer-binding Protein alpha and Peroxisome Proliferator-activated Receptor gamma(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; C/EBP-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; DISEASE BURDEN; PPAR-GAMMA; EXPRESSION; OBESITY; ADIPOGENESIS; MUTATION	Lipin1 expression was induced at a late stage of differentiation of 3T3-L1 preadipocytes and maintained at high levels in mature adipocytes. Knockdown of expression of lipin1 by small interfering RNA in 3T3-L1 preadipocytes almost completely inhibited differentiation into adipocytes, whereas overexpression of lipin1 accelerated adipocyte differentiation, demonstrating that lipin1 is required for adipocyte differentiation. In mature adipocytes, transfection of lipin1-small interfering RNA decreased the expression of adipocyte functional genes, indicating the involvement of lipin1 in the maintenance of adipocyte function. Lipin1 increases the transcription-activating function of peroxisome proliferator-activated receptor gamma(2) (PPAR gamma(2)) via direct physical interaction, whereas lipin1 did not affect the function of other adipocyte-related transcription factors such as C/EBP alpha, liver X-activated receptor alpha, or sterol regulatory element binding protein 1c. In mature adipocytes, lipin1 was specifically recruited to the PPAR gamma-response elements of the phosphoenolpyruvate carboxykinase gene, an adipocyte-specific gene. C/EBP alpha up-regulates lipin1 transcription by directly binding to the lipin1 promoter. Based on the existence of a positive feedback loop between C/EBP alpha and PPAR gamma(2), we propose that lipin1 functions as an amplifier of the network between these factors, resulting in the maintenance of high levels of the specific gene expression that are required for adipogenesis and mature adipocyte functions.	[Koh, Yoo-Kyung; Lee, Min-Young; Kim, Jae-Woo; Kim, Minji; Moon, Jong-Seok; Lee, Yoo-Jung; Ahn, Yong-Ho; Kim, Kyung-Sup] Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res,Inst Genet Sci, Dept Biochem & Mol Biol,Brain Korea Project Med S, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System	Kim, KS (corresponding author), 134 Shinchon Dong, Seoul 120752, South Korea.	kyungsup59@yuhs.ac	AHN, Yong Ho/H-6712-2017	AHN, Yong Ho/0000-0002-4133-0757; Kim, Kyung-sup/0000-0001-8483-8537; Kim, Jae-woo/0000-0001-5456-9495	Korea Science and Engineering Foundation [R13-2002-054-03001-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation Grant R13-2002-054-03001-0. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Beale EG, 2003, BIOCHIMIE, V85, P1207, DOI 10.1016/j.biochi.2003.10.012; Bogacka I, 2004, DIABETES CARE, V27, P1660, DOI 10.2337/diacare.27.7.1660; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Duplus E, 2003, BIOCHIMIE, V85, P1257, DOI 10.1016/j.biochi.2003.10.016; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hegele RA, 2003, TRENDS ENDOCRIN MET, V14, P371, DOI 10.1016/S1043-2760(03)00142-5; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kress AA, 2005, PREV MED, V41, P63, DOI 10.1016/j.ypmed.2004.10.012; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LEE MY, 2008, BIOCH J IN PRESS; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nowicki EM, 2003, MIL MED, V168, P252, DOI 10.1093/milmed/168.3.252; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Pedersen TA, 2007, EMBO J, V26, P1081, DOI 10.1038/sj.emboj.7601563; Peet DJ, 1998, CURR OPIN GENET DEV, V8, P571, DOI 10.1016/S0959-437X(98)80013-0; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Reitman ML, 2000, TRENDS ENDOCRIN MET, V11, P410, DOI 10.1016/S1043-2760(00)00309-X; Reue K, 2000, Curr Atheroscler Rep, V2, P390, DOI 10.1007/s11883-000-0077-1; Reue K, 2000, J LIPID RES, V41, P1067; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Scavello GS, 2005, MOL VIS, V11, P97; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Schott M, 2004, NEW ENGL J MED, V351, P103; Scott CL, 2003, AM J CARDIOL, V92, p35I, DOI 10.1016/S0002-9149(03)00507-1; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Tange Y, 2002, J CELL SCI, V115, P4375, DOI 10.1242/jcs.00135; van Harmelen V, 2007, J LIPID RES, V48, P201, DOI 10.1194/jlr.M600272-JLR200; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yubero P, 2004, ENDOCRINOLOGY, V145, P4268, DOI 10.1210/en.2004-0099	41	101	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34896	34906		10.1074/jbc.M804007200	http://dx.doi.org/10.1074/jbc.M804007200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930917	Green Published, hybrid			2022-12-27	WOS:000261469100046
J	Shankaranarayanan, A; Thal, DM; Tesmer, VM; Roman, DL; Neubig, RR; Kozasa, T; Tesmer, JJG				Shankaranarayanan, Aruna; Thal, David M.; Tesmer, Valerie M.; Roman, David L.; Neubig, Richard R.; Kozasa, Tohru; Tesmer, John J. G.			Assembly of High Order G alpha(q)-Effector Complexes with RGS Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; COUPLED RECEPTOR KINASE-2; G-ALPHA SUBUNITS; HETEROTRIMERIC G-PROTEINS; SIGNALING IN-VIVO; PHOSPHOLIPASE-C; GQ-ALPHA; ADENYLYL-CYCLASE; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURE	Transmembrane signaling through G alpha(q)-coupled receptors is linked to physiological processes such as cardiovascular development and smooth muscle function. Recent crystallographic studies have shown how G alpha(q) interacts with two activation-dependent targets, p63RhoGEF and G protein-coupled receptor kinase 2 (GRK2). These proteins bind to the effector-binding site of G alpha(q) in a manner that does not appear to physically overlap with the site on G alpha(q) bound by regulator of G-protein signaling (RGS) proteins, which function as GTPase-activating proteins ( GAPs). Herein we confirm the formation of RGS-G alpha(q)-GRK2/p63RhoGEF ternary complexes using flow cytometry protein interaction and GAP assays. RGS2 and, to a lesser extent, RGS4 are negative allosteric modulators of G alpha(q) binding to either p63RhoGEF or GRK2. Conversely, GRK2 enhances the GAP activity of RGS4 but has little effect on that of RGS2. Similar but smaller magnitude responses are induced by p63RhoGEF. The fact that GRK2 and p63RhoGEF respond similarly to these RGS proteins supports the hypothesis that GRK2 is a bona fide G alpha(q) effector. The results also suggest that signal transduction pathways initiated by GRK2, such as the phosphorylation of G protein-coupled receptors, and by p63RhoGEF, such as the activation of gene transcription, can be regulated by RGS proteins via both allosteric and GAP mechanisms.	[Shankaranarayanan, Aruna; Thal, David M.; Tesmer, Valerie M.; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Shankaranarayanan, Aruna] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Thal, David M.; Tesmer, John J. G.] Univ Michigan, Chem Biol Program, Ann Arbor, MI 48109 USA; [Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Roman, David L.; Neubig, Richard R.; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	johntesmer@umich.edu	Roman, David/G-2637-2010; Thal, David/GXH-4911-2022	Roman, David/0000-0002-8250-0337; Tesmer, John/0000-0003-1125-3727; Thal, David/0000-0002-0325-2524; Neubig, Richard/0000-0003-0501-0008	National Institutes of Health [HL086865, HL071818, GM61454]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086865, R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076821, R01GM061454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL086865 and HL071818 ( to J. J. G. T.), GM61454 ( to T. K.), DA23252 ( to R. R. N.), and GM076821 ( to D. L. R.). This work was also supported by an American Heart Association Greater Midwest Affiliate grant-in-aid ( to T. K.) and a predoctoral fellowship from the Midwest Affiliate of the American Heart Association ( to A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen CH, 1999, J BIOL CHEM, V274, P19799, DOI 10.1074/jbc.274.28.19799; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Cook B, 2000, NAT CELL BIOL, V2, P296, DOI 10.1038/35010571; Day PW, 2003, BIOCHEMISTRY-US, V42, P9176, DOI 10.1021/bi034442+; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gu S, 2007, J BIOL CHEM, V282, P33064, DOI 10.1074/jbc.M702685200; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; Harris DM, 2007, AM J PHYSIOL-HEART C, V293, pH3072, DOI 10.1152/ajpheart.00880.2007; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2004, METHOD ENZYMOL, V390, P65; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Ingi T, 1998, J NEUROSCI, V18, P7178; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Karakoula A, 2008, EUR J PHARMACOL, V587, P16, DOI 10.1016/j.ejphar.2008.03.047; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kristelly R, 2003, ACTA CRYSTALLOGR D, V59, P1859, DOI 10.1107/S0907444903018067; Lodowski DT, 2003, ACTA CRYSTALLOGR D, V59, P936, DOI 10.1107/S0907444903002622; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; McEntaffer RL, 1999, BIOCHEMISTRY-US, V38, P4931, DOI 10.1021/bi982636x; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Natochin M, 1998, J BIOL CHEM, V273, P6731, DOI 10.1074/jbc.273.12.6731; Natochin M, 1997, J BIOL CHEM, V272, P17444, DOI 10.1074/jbc.272.28.17444; Nekrasova ER, 1997, BIOCHEMISTRY-US, V36, P7638, DOI 10.1021/bi970427r; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Offermanns S, 1998, ONCOGENE, V17, P1375, DOI 10.1038/sj.onc.1202173; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Schoeber JP, 2006, J BIOL CHEM, V281, P29669, DOI 10.1074/jbc.M606233200; Skiba NP, 1999, J BIOL CHEM, V274, P8770, DOI 10.1074/jbc.274.13.8770; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Theilade J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P139, DOI 10.2174/1568008013341352; Usui I, 2005, MOL ENDOCRINOL, V19, P2760, DOI 10.1210/me.2004-0429; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wieland T, 1997, J BIOL CHEM, V272, P8853; Willets JM, 2004, J NEUROSCI, V24, P4157, DOI 10.1523/JNEUROSCI.5506-03.2004; Willets JM, 2005, J BIOL CHEM, V280, P18950, DOI 10.1074/jbc.M412682200; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	77	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34923	34934		10.1074/jbc.M805860200	http://dx.doi.org/10.1074/jbc.M805860200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936096	Green Published, hybrid			2022-12-27	WOS:000261469100049
J	Shemesh, R; Toporik, A; Levine, Z; Hecht, I; Rotman, G; Wool, A; Dahary, D; Gofer, E; Kliger, Y; Soffer, MA; Rosenberg, A; Eshel, D; Cohen, Y				Shemesh, Ronen; Toporik, Amir; Levine, Zurit; Hecht, Iris; Rotman, Galit; Wool, Assaf; Dahary, Dvir; Gofer, Eyal; Kliger, Yossef; Soffer, Michal Ayalon; Rosenberg, Avi; Eshel, Dani; Cohen, Yossi			Discovery and Validation of Novel Peptide Agonists for G-protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREDICTING LIGANDS; TARGETS; BIOLOGY; FAMILY	G-protein-coupled receptors (GPCRs) represent an important group of targets for pharmaceutical therapeutics. The completion of the human genome revealed a large number of putative GPCRs. However, the identification of their natural ligands, and especially peptides, suffers from low discovery rates, thus impeding development of therapeutics based on these potential drug targets. We describe the discovery of novel GPCR ligands encrypted in the human proteome. Hundreds of potential peptide ligands were predicted by machine learning algorithms. In vitro screening of selected 33 peptides on a set of 152 GPCRs, including a group of designated orphan receptors, was conducted by intracellular calcium measurements and cAMP assays. The screening revealed eight novel peptides as potential agonists that specifically activated six different receptors in a dose-dependent manner. Most of the peptides showed distinct stimulatory patterns targeted at designated and orphan GPCRs. Further analysis demonstrated a significant in vivo effect for one of the peptides in a mouse inflammation model.	[Shemesh, Ronen; Toporik, Amir; Levine, Zurit; Hecht, Iris; Rotman, Galit; Wool, Assaf; Dahary, Dvir; Gofer, Eyal; Kliger, Yossef; Soffer, Michal Ayalon; Rosenberg, Avi; Eshel, Dani; Cohen, Yossi] Compugen Ltd, IL-69512 Tel Aviv, Israel		Shemesh, R (corresponding author), Compugen Ltd, 72 Pinchas Rosen St, IL-69512 Tel Aviv, Israel.	ronens@compugen.co.il	Dahary, Dvir/AAR-4534-2020; Eshel, Dani/AAH-8174-2020					Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bock JR, 2005, J CHEM INF MODEL, V45, P1402, DOI 10.1021/ci050006d; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Eglen RM, 2005, COMB CHEM HIGH T SCR, V8, P311, DOI 10.2174/1386207054020813; Halls ML, 2006, MOL PHARMACOL, V70, P214, DOI 10.1124/mol.105.021691; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Huang ES, 2005, DRUG DISCOV TODAY, V10, P69, DOI 10.1016/S1359-6446(04)03349-5; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Iribarren P, 2005, IMMUNOL RES, V31, P165, DOI 10.1385/IR:31:3:165; Jiang ZR, 2006, CURR PROTEIN PEPT SC, V7, P459, DOI 10.2174/138920306778559359; Joost P, 2002, GENOME BIOL, V3; Katugampola S, 2003, TRENDS PHARMACOL SCI, V24, P30, DOI 10.1016/S0165-6147(02)00007-X; Kliger Y, 2008, BIOINFORMATICS, V24, P1049, DOI 10.1093/bioinformatics/btn084; Kutzleb C, 2005, CURR PROTEIN PEPT SC, V6, P265, DOI 10.2174/1389203054065419; Leifert WR, 2005, J BIOMOL SCREEN, V10, P765, DOI 10.1177/1087057105280517; Lin SH, 2004, ANN MED, V36, P204, DOI 10.1080/07853890310024668; Liu AMF, 2003, J BIOMOL SCREEN, V8, P39, DOI 10.1177/1087057102239665; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Perretti Mauro, 2006, Inflammation & Allergy Drug Targets, V5, P107, DOI 10.2174/187152806776383170; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Wollemann M, 2004, LIFE SCI, V75, P257, DOI 10.1016/j.lfs.2003.12.005	27	60	63	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34643	34649		10.1074/jbc.M805181200	http://dx.doi.org/10.1074/jbc.M805181200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18854305	Green Published, hybrid			2022-12-27	WOS:000261469100019
J	Stuart, HC; Jia, ZJ; Messenberg, A; Joshi, B; Underhill, TM; Moukhles, H; Nabi, IR				Stuart, Heather C.; Jia, Zongjian; Messenberg, Anat; Joshi, Bharat; Underhill, T. Michael; Moukhles, Hakima; Nabi, Ivan R.			Localized Rho GTPase Activation Regulates RNA Dynamics and Compartmentalization in Tumor Cell Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN MESSENGER-RNA; FOCAL ADHESION DYNAMICS; M-RAS; TRANSLATION INITIATION; SPATIAL REGULATION; KINASE; MIGRATION; EXPRESSION; MEMBRANE; GROWTH	mRNA trafficking and local protein translation are associated with protrusive cellular domains, such as neuronal growth cones, and deregulated control of protein translation is associated with tumor malignancy. We show here that activated RhoA, but not Rac1, is enriched in pseudopodia of MSV-MDCK-INV tumor cells and that Rho, Rho kinase ( ROCK), and myosin II regulate the microtubule-independent targeting of RNA to these tumor cell domains. ROCK inhibition does not affect pseudopodial actin turnover but significantly reduces the dynamics of pseudopodial RNA turnover. Gene array analysis shows that 7.3% of the total genes analyzed exhibited a greater than 1.6-fold difference between the pseudopod and cell body fractions. Of these, only 13.2% ( 261 genes) are enriched in pseudopodia, suggesting that only a limited number of total cellular mRNAs are enriched in tumor cell protrusions. Comparison of the tumor pseudopod mRNA cohort and a cohort of mRNAs enriched in neuronal processes identified tumor pseudopod-specific signaling networks that were defined by expression of M-Ras and the Shp2 protein phosphatase. Pseudopod expression of M-Ras and Shp2 mRNA were diminished by ROCK inhibition linking pseudopodial Rho/ROCK activation to the localized expression of specific mRNAs. Pseudopodial enrichment for mRNAs involved in protein translation and signaling suggests that local mRNA translation regulates pseudopodial expression of less stable signaling molecules as well as the cellular machinery to translate these mRNAs. Pseudopodial Rho/ROCK activation may impact on tumor cell migration and metastasis by stimulating the pseudopodial translocation of mRNAs and thereby regulating the expression of local signaling cascades.	[Stuart, Heather C.; Jia, Zongjian; Messenberg, Anat; Joshi, Bharat; Underhill, T. Michael; Moukhles, Hakima; Nabi, Ivan R.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Nabi, IR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	irnabi@interchange.ubc.ca	Nabi, Ivan/GWZ-5144-2022; Nabi, Ivan R/C-5493-2009	Nabi, Ivan/0000-0002-0670-0513; 	Metastatic Cancer from the Cancer Research Society Inc	Metastatic Cancer from the Cancer Research Society Inc	This work was supported by a Strategic Research Grant on Genomics and Proteomics of Metastatic Cancer from the Cancer Research Society Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; BASSELL GJ, 1994, NEURON, V12, P571, DOI 10.1016/0896-6273(94)90213-5; Cardone RA, 2005, MOL BIOL CELL, V16, P3117, DOI 10.1091/mbc.e04-10-0945; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Duan HF, 2006, CELL SIGNAL, V18, P2049, DOI 10.1016/j.cellsig.2006.04.002; Eberwine J, 2001, P NATL ACAD SCI USA, V98, P7080, DOI 10.1073/pnas.121146698; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jia ZJ, 2005, J BIOL CHEM, V280, P30564, DOI 10.1074/jbc.M501754200; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Le PU, 1998, CANCER RES, V58, P1631; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Matsumoto K, 1997, ONCOGENE, V15, P2409, DOI 10.1038/sj.onc.1201416; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Muschler J, 2002, CANCER RES, V62, P7102; Nabi IR, 1999, J CELL SCI, V112, P1803; Nguyen TN, 2000, EXP CELL RES, V258, P171, DOI 10.1006/excr.2000.4929; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Poon MM, 2006, J NEUROSCI, V26, P13390, DOI 10.1523/JNEUROSCI.3432-06.2006; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Shestakova EA, 1999, CANCER RES, V59, P1202; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Vadnais J, 2002, J BIOL CHEM, V277, P48342, DOI 10.1074/jbc.M209481200; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang YC, 2006, J PROTEOME RES, V5, P907, DOI 10.1021/pr050390u; Wang YC, 2007, P NATL ACAD SCI USA, V104, P8328, DOI 10.1073/pnas.0701103104; Ward KR, 2004, ONCOGENE, V23, P1187, DOI 10.1038/sj.onc.1207226; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zhang KX, 2004, MOL CANCER RES, V2, P242; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	58	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34785	34795		10.1074/jbc.M804014200	http://dx.doi.org/10.1074/jbc.M804014200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845542	Green Published, hybrid			2022-12-27	WOS:000261469100035
J	Von Lohneysen, K; Noack, D; Jesaitis, AJ; Dinauer, MC; Knaus, UG				Von Loehneysen, Katharina; Noack, Deborah; Jesaitis, Algirdas J.; Dinauer, Mary C.; Knaus, Ulla G.			Mutational Analysis Reveals Distinct Features of the Nox4-p22(phox) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; GENE-ENCODING P22(PHOX); NADPH OXIDASE ACTIVITY; MONOCLONAL-ANTIBODIES; FLAVOCYTOCHROME-B; NOX FAMILY; SUPEROXIDE; MATURATION; SUBUNIT; CELLS	The integral membrane protein p22(phox) forms a heterodimeric enzyme complex with NADPH oxidases (Noxs) and is required for their catalytic activity. Nox4, a Nox linked to cardiovascular disease, angiogenesis, and insulin signaling, is unique in its ability to produce hydrogen peroxide constitutively. To date, p22phox constitutes the only identified regulatory component for Nox4 function. To delineate structural elements in p22phox essential for formation and localization of the Nox4-p22(phox) complex and its enzymatic function, truncation and point mutagenesis was used. Human lung carcinoma cells served as a heterologous expression system, since this cell type is p22(phox)-deficient and promotes cell surface expression of the Nox4-p22(phox) heterodimer. Expression of p22(phox) truncation mutants indicates that the dual tryptophan motif contained in the N-terminal amino acids 6-11 is essential, whereas the C terminus (amino acids 130-195) is dispensable for Nox4 activity. Introduction of charged residues in domains predicted to be extracellular by topology modeling was mostly tolerated, whereas the exchange of amino acids in predicted membrane-spanning domains caused loss of function or showed distinct differences in p22phox interaction with various Noxs. For example, the substitution of tyrosine 121 with histidine in p22(phox), which abolished Nox2 and Nox3 function in vivo, preserved Nox4 activity when expressed in lung cancer cells. Many of the examined p22(phox) mutations inhibiting Nox1 to -3 maturation did not alter Nox4-p22(phox) association, further accenting the differences between Noxs. These studies highlight the distinct interaction of the key regulatory p22(phox) subunit with Nox4, a feature which could provide the basis for selective inhibitor development.	[Von Loehneysen, Katharina; Noack, Deborah; Knaus, Ulla G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Jesaitis, Algirdas J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Dinauer, Mary C.] James Whitcomb Riley Hosp Children, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Scripps Research Institute; Montana State University System; Montana State University Bozeman; James Whitcomb Riley Hospital Children	Knaus, UG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	uknaus@scripps.edu		Jesaitis, Algirdas/0000-0001-9001-5617	National Institutes of Health [R01 AI024838, P01 CI000095, R01 AI026711, R01 HL045635]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [P01CI000095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024838, R01AI026711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI024838 and P01 CI000095 ( to U. G. K.), R01 AI026711 ( to A. J. J.), and R01 HL045635 ( to M. C. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Burritt JB, 1998, J BIOL CHEM, V273, P24847, DOI 10.1074/jbc.273.38.24847; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Dahan I, 2002, J BIOL CHEM, V277, P8421, DOI 10.1074/jbc.M109778200; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kuroda J, 2007, EUR J NEUROL, V14, P1091, DOI 10.1111/j.1468-1331.2007.01904.x; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Nakano Y, 2008, J CLIN INVEST, V118, P1176, DOI 10.1172/JCI33835; Nakano Y, 2007, BIOCHEM J, V403, P97, DOI 10.1042/BJ20060819; Rae J, 2000, BLOOD, V96, P1106, DOI 10.1182/blood.V96.3.1106.015k44_1106_1112; Roos D, 1996, BLOOD, V87, P1663; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; VERHOEVEN AJ, 1989, BLOOD, V73, P1686; Werner Erica, 2003, Sci STKE, V2003, pPL3, DOI 10.1126/stke.2003.168.pl3; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	29	79	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35273	35282		10.1074/jbc.M804200200	http://dx.doi.org/10.1074/jbc.M804200200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18849343	hybrid, Green Published			2022-12-27	WOS:000261469100083
J	Gazi, AD; Bastaki, M; Charova, SN; Gkougkoulia, EA; Kapellios, EA; Panopoulos, NJ; Kokkinidis, M				Gazi, Anastasia D.; Bastaki, Marina; Charova, Spyridoula N.; Gkougkoulia, Eirini A.; Kapellios, Efthymios A.; Panopoulos, Nicholas J.; Kokkinidis, Michael			Evidence for a Coiled-coil Interaction Mode of Disordered Proteins from Bacterial Type III Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; CIRCULAR-DICHROISM SPECTROSCOPY; 4-ALPHA-HELIX BUNDLE; INTRINSIC DISORDER; MOLECULAR-BASIS; LEUCINE-ZIPPER; EXPORT; MECHANISM; BINDING; ATPASE	Gene clusters encoding various type III secretion system (T3SS) injectisomes, frequently code downstream of the conserved atpase gene for small hydrophilic proteins whose amino acid sequences display a propensity for intrinsic disorder and coiled-coil formation. These properties were confirmed experimentally for a member of this class, the HrpO protein from the T3SS of Pseudomonas syringae pv phaseolicola: HrpO exhibits high alpha-helical content with coiled-coil characteristics, strikingly low melting temperature, structural properties that are typical for disordered proteins, and a pronounced self-association propensity, most likely via coiled-coil interactions, resulting in heterogeneous populations of quaternary complexes. HrpO interacts in vivo with HrpE, a T3SS protein for which coiled-coil formation is also strongly predicted. Evidence from HrpO analogues from all T3SS families and the flagellum suggests that the extreme flexibility and propensity for coiled-coil interactions of this diverse class of small, intrinsically disordered proteins, whose structures may alter as they bind to their cognate folded protein targets, might be important elements in the establishment of protein-protein interaction networks required for T3SS function.	[Gazi, Anastasia D.; Bastaki, Marina; Panopoulos, Nicholas J.; Kokkinidis, Michael] Univ Crete, Inst Mol Biol & Biotechnol, Fdn Res & Technol, GR-71409 Iraklion, Crete, Greece; [Gazi, Anastasia D.; Bastaki, Marina; Charova, Spyridoula N.; Gkougkoulia, Eirini A.; Kapellios, Efthymios A.; Panopoulos, Nicholas J.; Kokkinidis, Michael] Univ Crete, Dept Biol, GR-71409 Iraklion, Crete, Greece	University of Crete; University of Crete	Kokkinidis, M (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Crete, Greece.	kokkinid@imbb.forth.gr	Gazi, Anastasia/ABD-8988-2021; Gkougkoulia, Eirini/AAY-9789-2020	Gazi, Anastasia/0000-0002-2922-3625; Gkougkoulia, Eirini/0000-0003-0112-5449	PENED; PYTHAGORAS; PEP; GSRT; EPEAEK-Plant Molecular Biology and Biotechnology graduate program; EMBL/Hamburg Outstation; EU [RII3/CT/2004/5060008]	PENED(Greek Ministry of Development-GSRT); PYTHAGORAS; PEP; GSRT(Greek Ministry of Development-GSRT); EPEAEK-Plant Molecular Biology and Biotechnology graduate program; EMBL/Hamburg Outstation; EU(European Commission)	This work was supported by PENED, PYTHAGORAS, and PEP (KP-15) Grants from the Greek Ministry of Education, GSRT, and the EPEAEK-Plant Molecular Biology and Biotechnology graduate program. This work was also supported by the EMBL/Hamburg Outstation and the EU through the EU-I3 access grant from the EU Research Infrastructure Action under the FP6 "Structuring the European Research Area Programme,"Contract Number RII3/CT/2004/5060008. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; DUNKER AK, 2002, PROTEIN-STRUCT FUNCT, V41, P6573; Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103; Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101; FISCHETTI VA, 1993, INFORM PROCESS LETT, V45, P11, DOI 10.1016/0020-0190(93)90245-5; Fraser GM, 2003, J BACTERIOL, V185, P5546, DOI 10.1128/JB.185.18.5546-5554.2003; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guinier A, 1955, SMALL ANGLE XRAY SCA; Hagihara Y, 1998, FOLD DES, V3, P195, DOI 10.1016/S1359-0278(98)00027-3; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Holtzer ME, 2000, BIOPHYS J, V78, P2037, DOI 10.1016/S0006-3495(00)76751-8; HOLTZER ME, 1995, BIOPOLYMERS, V36, P365, DOI 10.1002/bip.360360310; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; ISHIMURO Y, 1979, J POLYM SCI POL CHEM, V17, P1811, DOI 10.1002/pol.1979.170170623; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lane MC, 2006, J BIOL CHEM, V281, P508, DOI 10.1074/jbc.M507238200; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Matsuo K, 2004, J BIOCHEM, V135, P405, DOI 10.1093/jb/mvh048; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Muskotal A, 2006, FEBS LETT, V580, P3916, DOI 10.1016/j.febslet.2006.06.024; PALIAKASIS CD, 1992, PROTEIN ENG, V5, P739, DOI 10.1093/protein/5.8.739; Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Perez J, 2001, J MOL BIOL, V308, P721, DOI 10.1006/jmbi.2001.4611; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ramos AR, 2007, J BACTERIOL, V189, P5773, DOI 10.1128/JB.00435-07; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 1999, PROTEIN SCI, V8, P161; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; VLASSI M, 1994, NAT STRUCT BIOL, V1, P706, DOI 10.1038/nsb1094-706; Wall MichaelE., 2003, SINGULAR VALUE DECOM; YOSHIDA K, 1993, BIOCHEMISTRY-US, V32, P2162, DOI 10.1021/bi00060a006; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	57	34	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34062	34068		10.1074/jbc.M803408200	http://dx.doi.org/10.1074/jbc.M803408200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18836182	Green Published, hybrid			2022-12-27	WOS:000261277700034
J	Sangwan, V; Paliouras, GN; Abella, JV; Dube, N; Monast, A; Tremblay, ML; Park, M				Sangwan, Veena; Paliouras, Grigorios N.; Abella, Jasmine V.; Dube, Nadia; Monast, Anie; Tremblay, Michel L.; Park, Morag			Regulation of the Met Receptor-tyrosine Kinase by the Protein-tyrosine Phosphatase 1B and T-cell Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SCATTER FACTOR-RECEPTOR; INSULIN-RECEPTOR; ENDOPLASMIC-RETICULUM; SELECTIVE REGULATION; SIGNAL-TRANSDUCTION; LIVER-REGENERATION; NEGATIVE REGULATOR; TERMINAL SEQUENCE; TPR-MET	The non-receptor protein-tyrosine phosphatases (PTPs) 1B and T-cell phosphatase ( TCPTP) have been implicated as negative regulators of multiple signaling pathways including receptor-tyrosine kinases. We have identified PTP1B and TCPTP as negative regulators of the hepatocyte growth factor receptor, the Met receptor-tyrosine kinase. In vivo, loss of PTP1B or TCPTP enhances hepatocyte growth factor-mediated phosphorylation of Met. Using substrate trapping mutants of PTP1B or TCPTP, we have demonstrated that both phosphatases interact with Met and that these interactions require phosphorylation of twin tyrosines (Tyr-1234/1235) in the activation loop of the Met kinase domain. Using confocal microscopy, we show that trapping mutants of both PTP1B and the endoplasmic reticulum-targeted TCPTP isoform, TC48, colocalize with Met and that activation of Met enables the nuclear-localized isoform of TCPTP, TC45, to exit the nucleus. Using small interfering RNA against PTP1B and TCPTP, we demonstrate that phosphorylation of Tyr-1234/1235 in the activation loop of the Met receptor is elevated in the absence of either PTP1B or TCPTP and further elevated upon loss of both phosphatases. This enhanced phosphorylation of Met corresponds to enhanced biological activity and cellular invasion. Our data demonstrate that PTP1B and TCPTP play distinct and non-redundant roles in the regulation of the Met receptor-tyrosine kinase.	[Sangwan, Veena; Paliouras, Grigorios N.; Abella, Jasmine V.; Monast, Anie; Park, Morag] McGill Univ, Ctr Hlth, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; [Abella, Jasmine V.; Dube, Nadia; Tremblay, Michel L.; Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; [Sangwan, Veena; Paliouras, Grigorios N.; Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; [Dube, Nadia; Tremblay, Michel L.] McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Park, M (corresponding author), McGill Univ, Ctr Hlth, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada.	morag.park@mcgill.ca			Cancer Research Society, Inc.; Terry Fox Foundation (National Cancer Institute of Canada); McGill University Health Center and Faculty of Medicine, McGill University; United States Department of Defense Breast Cancer Research Initiative [AMD17-99-1-9284]; Canadian Institutes of Health Research Doctoral Award and Alexander McFee Memorial Fellowship; Cancer Research Society, Inc. and Canadian Institutes of Health Research Operating [MOP-62887]; Canadian Institutes of Health Research [MOP-1154]	Cancer Research Society, Inc.; Terry Fox Foundation (National Cancer Institute of Canada); McGill University Health Center and Faculty of Medicine, McGill University; United States Department of Defense Breast Cancer Research Initiative(United States Department of Defense); Canadian Institutes of Health Research Doctoral Award and Alexander McFee Memorial Fellowship(Canadian Institutes of Health Research (CIHR)); Cancer Research Society, Inc. and Canadian Institutes of Health Research Operating; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a fellowship from Cancer Research Society, Inc. and the Terry Fox Foundation (National Cancer Institute of Canada) (to V. S.), by the McGill University Health Center and Faculty of Medicine, McGill University (to G. P.), by United States Department of Defense Breast Cancer Research Initiative Grant DAMD17-99-1-9284 (to J. A.), and by a Canadian Institutes of Health Research Doctoral Award and Alexander McFee Memorial Fellowship (to N. D.). This work was also supported by the Cancer Research Society, Inc. and Canadian Institutes of Health Research Operating Grant MOP-62887 (to M. L. T.) and by Canadian Institutes of Health Research operating Grant MOP-1154 (to M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cook WS, 2002, DEV CELL, V2, P385, DOI 10.1016/S1534-5807(02)00158-2; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FIXMAN ED, 1995, ONCOGENE, V10, P237; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Iversen LF, 2002, J BIOL CHEM, V277, P19982, DOI 10.1074/jbc.M200567200; Kakazu A, 2008, INVEST OPHTH VIS SCI, V49, P2927, DOI 10.1167/iovs.07-0709; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kulas DT, 1996, J BIOL CHEM, V271, P748, DOI 10.1074/jbc.271.2.748; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; Li SQ, 2005, STRUCTURE, V13, P1643, DOI 10.1016/j.str.2005.07.019; Liu F, 1998, MOL CELL BIOL, V18, P250, DOI 10.1128/MCB.18.1.250; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakagawa Y, 2005, ZOOL SCI, V22, P169, DOI 10.2108/zsj.22.169; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Pestana ES, 1999, ONCOGENE, V18, P4069, DOI 10.1038/sj.onc.1202794; PONZETTO C, 1993, MOL CELL BIOL, V13, P4600, DOI 10.1128/MCB.13.8.4600; RODRIGUES GA, 1994, ONCOGENE, V9, P2019; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Sangwan V, 2006, J BIOL CHEM, V281, P221, DOI 10.1074/jbc.M507858200; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Villa-Moruzzi E, 1998, BIOCHEM J, V336, P235, DOI 10.1042/bj3360235; Xie LP, 2002, BIOCHEMISTRY-US, V41, P4032, DOI 10.1021/bi015904r; Xu JF, 2007, CELL BIOL INT, V31, P88, DOI 10.1016/j.cellbi.2006.09.010; Yang HP, 2007, J CELL PHYSIOL, V210, P766, DOI 10.1002/jcp.20891; YANG XM, 1993, DEV BIOL, V157, P308, DOI 10.1006/dbio.1993.1137; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; ZHU H, 1994, CELL GROWTH DIFFER, V5, P359	68	77	81	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34374	34383		10.1074/jbc.M805916200	http://dx.doi.org/10.1074/jbc.M805916200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819921	hybrid, Green Published			2022-12-27	WOS:000261277700065
J	Zhang, LP; Zhang, Y; Ten Hagen, KG				Zhang, Liping; Zhang, Ying; Ten Hagen, Kelly G.			A Mucin-type O-Glycosyltransferase Modulates Cell Adhesion during Drosophila Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; UDP-GALNAC; GENETIC-ANALYSIS; PS2 INTEGRIN; NOTCH; EXPRESSION; PROTEIN; FAMILY; LIGAND; GLYCOSYLATION	Cell-cell and cell-matrix adhesion are crucial during many stages of eukaryotic development. Here, we provide the first example that mucin-type O-linked glycosylation is involved in a developmentally regulated cell adhesion event in Drosophila melanogaster. Mutations in one member of the evolutionarily conserved family of enzymes that initiates O-linked glycosylation alter epithelial cell adhesion in the Drosophila wing blade. A transposon insertion mutation in pgant3 or RNA interference to pgant3 resulted in blistered wings, a phenotype characteristic of genes involved in integrin-mediated cell interactions. Expression of wild type pgant3 in the mutant background rescued the wing blistering phenotype, whereas expression of another family member (pgant35A) did not, revealing a unique requirement for pgant3. pgant3 mutants displayed reduced O-glycosylation along the basal surface of larval wing imaginal discs, which was restored with wild type pgant3 expression, suggesting that reduced glycosylation of basal proteins is responsible for disruption of adhesion in the adult wing blade. Glycosylation reactions demonstrated that PGANT3 glycosylates certain extracellular matrix (ECM) proteins. Immunoprecipitation experiments revealed that PGANT3 glycosylates tiggrin, an ECM protein known to bind integrin. We propose that this glycosyltransferase is uniquely responsible for glycosylating tiggrin in the wing disc, thus modulating proper cell adhesion through integrin-ECM interactions. This study provides the first evidence for the role of O-glycosylation in a developmentally regulated, integrin-mediated, cell adhesion event and reveals a novel player in wing blade formation during Drosophila development.	[Zhang, Liping; Zhang, Ying; Ten Hagen, Kelly G.] NIH, Dev Glycobiol Unit, NIDCR, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by the National Institutes of Health (the Intramural Research Program of the NIDCR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; Araujo H, 2003, DEVELOPMENT, V130, P3851, DOI 10.1242/dev.00613; Avichezer D, 1997, INT J CANCER, V72, P119, DOI 10.1002/(SICI)1097-0215(19970703)72:1<119::AID-IJC17>3.3.CO;2-5; Bloor JW, 1998, GENETICS, V148, P1127; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWER DL, 1995, DEVELOPMENT, V121, P1311; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Bunch TA, 1998, DEVELOPMENT, V125, P1679; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; FOGERTY FJ, 1994, DEVELOPMENT, V120, P1747; Gauguet JM, 2004, BLOOD, V104, P4104, DOI 10.1182/blood-2004-05-1986; Graner MW, 1998, J BIOL CHEM, V273, P18235, DOI 10.1074/jbc.273.29.18235; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; Pratt MR, 2004, CHEM BIOL, V11, P1009, DOI 10.1016/j.chembiol.2004.05.009; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Prout M, 1997, GENETICS, V146, P275; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Subramanian A, 2007, DEVELOPMENT, V134, P1269, DOI 10.1242/dev.000406; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Walsh EP, 1998, GENETICS, V150, P791; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112	49	40	42	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34076	34086		10.1074/jbc.M804267200	http://dx.doi.org/10.1074/jbc.M804267200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835818	Green Published, hybrid			2022-12-27	WOS:000261277700036
J	Biddick, RK; Law, GL; Chin, KKB; Young, ET				Biddick, Rhiannon K.; Law, G. Lynn; Chin, Kevin Khaw Beng; Young, Elton T.			The Transcriptional Coactivators SAGA, SWI/SNF, and Mediator Make Distinct Contributions to Activation of Glucose-repressed Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; PROMOTERS IN-VIVO; SACCHAROMYCES-CEREVISIAE; PHO5 PROMOTER; HISTONE ACETYLATION; ADH2 EXPRESSION; SWI-SNF; CHROMATIN; YEAST	The paradigm of activation via ordered recruitment has evolved into a complicated picture as the influence of coactivators and chromatin structures on gene regulation becomes understood. We present here a comprehensive study of many elements of activation of ADH2 and FBP1, two glucose-regulated genes. We identify SWI/SNF as the major chromatin-remodeling complex at these genes, whereas SAGA (Spt-Ada-Gcn5-acetyltransferase complex) is required for stable recruitment of other coactivators. Mediator plays a crucial role in expression of both genes but does not affect chromatin remodeling. We found that Adr1 bound unaided by coactivators to ADH2, but Cat8 binding depended on coactivators at FBP1. Taken together, our results suggest that commonly regulated genes share many aspects of activation, but that gene-specific regulators or elements of promoter architecture may account for small differences in the mechanism of activation. Finally, we found that activator overexpression can compensate for the loss of SWI/SNF but not for the loss of SAGA.	[Biddick, Rhiannon K.; Law, G. Lynn; Chin, Kevin Khaw Beng; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98105 USA.	ety@u.washington.edu			National Institutes of Health [GM26079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM026079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM26079 (to E.T.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Agricola E, 2004, BIOCHEMISTRY-US, V43, P8878, DOI 10.1021/bi049577+; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Burns LG, 1997, MOL CELL BIOL, V17, P4811, DOI 10.1128/MCB.17.8.4811; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; DELOLMO ML, 1993, YEAST, V9, P1229, DOI 10.1002/yea.320091110; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; IRANI M, 1987, MOL CELL BIOL, V7, P1233, DOI 10.1128/MCB.7.3.1233; Kim SJ, 2005, MOL CELL BIOL, V25, P11171, DOI 10.1128/MCB.25.24.11171-11183.2005; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Lemieux K, 2004, EMBO J, V23, P4040, DOI 10.1038/sj.emboj.7600416; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; Mitra D, 2006, MOL CELL BIOL, V26, P4095, DOI 10.1128/MCB.01849-05; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reinke H, 2001, MOL CELL, V7, P529, DOI 10.1016/S1097-2765(01)00200-3; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; Verdone L, 1997, J BIOL CHEM, V272, P30828, DOI 10.1074/jbc.272.49.30828; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Young ET, 2008, MOL CELL BIOL, V28, P2509, DOI 10.1128/MCB.00658-07; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000; Zaragoza O, 2001, BIOCHEM J, V359, P193, DOI 10.1042/0264-6021:3590193	48	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33101	33109		10.1074/jbc.M805258200	http://dx.doi.org/10.1074/jbc.M805258200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826948	Green Published, hybrid			2022-12-27	WOS:000261183700011
J	Codutti, L; van Ingen, H; Vascotto, C; Fogolari, F; Corazza, A; Tell, G; Quadrifoglio, F; Viglino, P; Boelens, R; Esposito, G				Codutti, Luca; van Ingen, Hugo; Vascotto, Carlo; Fogolari, Federico; Corazza, Alessandra; Tell, Gianluca; Quadrifoglio, Franco; Viglino, Paolo; Boelens, Rolf; Esposito, Gennaro			The Solution Structure of DNA-free Pax-8 Paired Box Domain Accounts for Redox Regulation of Transcriptional Activity in the Pax Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE H-1-N-15 CORRELATIONS; ISOTOPICALLY ENRICHED PROTEINS; CONGENITAL HYPOTHYROIDISM; CHEMICAL-SHIFTS; BINDING ACTIVITY; C-13-ENRICHED PROTEINS; THYROID HYPOPLASIA; C-13 MAGNETIZATION; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE	Pax-8 is a transcription factor belonging to the PAX genes superfamily and its crucial role has been proven both in embryo and in the adult organism. Pax-8 activity is regulated via a redox-based mechanism centered on the glutathionylation of specific cysteines in the N-terminal region (Cys(45) and Cys(57)). These residues belong to a highly evolutionary conserved DNA binding site: the Paired Box (Prd) domain. Crystallographic protein-DNA complexes of the homologues Pax-6 and Pax-5 showed a bipartite Prd domain consisting of two helix-turn-helix (HTH) motifs separated by an extended linker region. Here, by means of nuclear magnetic resonance, we show for the first time that the HTH motifs are largely defined in the unbound Pax-8 Prd domain. Our findings contrast with previous induced fit models, in which Pax-8 is supposed to largely fold upon DNA binding. Importantly, our data provide the structural basis for the enhanced chemical reactivity of residues Cys45 and Cys57 and explain clinical missense mutations that are not obviously related to the DNA binding interface of the paired box domain. Finally, sequence conservation suggests that our findings could be a general feature of the Pax family transcription factors.	[Codutti, Luca; Vascotto, Carlo; Fogolari, Federico; Corazza, Alessandra; Tell, Gianluca; Quadrifoglio, Franco; Viglino, Paolo; Esposito, Gennaro] Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy; [van Ingen, Hugo; Boelens, Rolf] Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Fogolari, Federico; Corazza, Alessandra; Viglino, Paolo; Esposito, Gennaro] INBB, I-00100 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Esposito, G (corresponding author), Univ Udine, Dipartimento Sci & Tecnol Biomed, P Le Kolbe 4, I-33100 Udine, Italy.	gesposito@mail.dstb.uniud.it	Corazza, Alessandra/AGB-1457-2022; Boelens, Rolf/B-4702-2009; van Ingen, Hugo/Q-2883-2016	Corazza, Alessandra/0000-0003-2272-1928; Boelens, Rolf/0000-0002-6939-8913; van Ingen, Hugo/0000-0002-0808-3811; Fogolari, Federico/0000-0001-9862-250X; vascotto, carlo/0000-0003-4431-029X; Tell, Gianluca/0000-0001-8845-6448	Italian Ministry for University and Research Grants [COFIN 2006058958, FIRB RBNE03PX83, FIRB RBNE03B8KK]; European Union [LSHM-CT-2005-037525, 026145]	Italian Ministry for University and Research Grants; European Union(European Commission)	This work was supported by Italian Ministry for University and Research Grants COFIN 2006058958, FIRB RBNE03PX83, and FIRB RBNE03B8KK, European Union Grant LSHM-CT-2005-037525, and European Union project "EU-NMR-European Network of Research Infrastructures for Providing Access & Technological Advancement in Bio-NMR" FP-2005-RII3 Contract 026145. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Apuzzo S, 2006, BIOCHEMISTRY-US, V45, P7154, DOI 10.1021/bi060009z; Balczarek KA, 1997, MOL BIOL EVOL, V14, P829, DOI 10.1093/oxfordjournals.molbev.a025824; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Cao X, 2005, J BIOL CHEM, V280, P25901, DOI 10.1074/jbc.M411443200; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Congdon T, 2001, J CLIN ENDOCR METAB, V86, P3962, DOI 10.1210/jc.86.8.3962; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAMANTE G, 1994, BBA-GENE STRUCT EXPR, V1218, P255, DOI 10.1016/0167-4781(94)90176-7; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; DeLano W.L, PYMOL MOL GRAPHICS S; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Espinoza CR, 2001, J MOL ENDOCRINOL, V27, P59, DOI 10.1677/jme.0.0270059; Fogolari F, 2000, PROTEINS, V39, P317, DOI 10.1002/(SICI)1097-0134(20000601)39:4<317::AID-PROT50>3.0.CO;2-W; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Grasberger H, 2005, MOL ENDOCRINOL, V19, P1779, DOI 10.1210/me.2004-0426; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; IKURA M, 1991, J BIOMOL NMR, V1, P99; ISRAELACHVILI J, 1982, NATURE, V300, P341, DOI 10.1038/300341a0; Jun S, 1996, DEVELOPMENT, V122, P2639; Kambe F, 1996, MOL ENDOCRINOL, V10, P801, DOI 10.1210/me.10.7.801; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KAY MD, 1988, J AM CHEM SOC, V111, P1515; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Meeus L, 2004, J CLIN ENDOCR METAB, V89, P4285, DOI 10.1210/jc.2004-0166; Ohno M, 1999, MOL CELL BIOL, V19, P2051; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Pellizzari L, 1999, BIOCHEM J, V337, P253, DOI 10.1042/0264-6021:3370253; POLEEV A, 1992, DEVELOPMENT, V116, P611; Santisteban P, 2005, REV ENDOCR METAB DIS, V6, P217, DOI 10.1007/s11154-005-3053-9; Schubert M, 1999, J MAGN RESON, V141, P34, DOI 10.1006/jmre.1999.1881; Schubert M, 2001, J MAGN RESON, V148, P61, DOI 10.1006/jmre.2000.2222; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Tell G, 1998, BIOCHEM BIOPH RES CO, V252, P178, DOI 10.1006/bbrc.1998.9548; Tell G, 1998, J BIOL CHEM, V273, P25062, DOI 10.1074/jbc.273.39.25062; Tell G, 1999, BIOCHEM J, V341, P89, DOI 10.1042/0264-6021:3410089; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilain C, 2001, J CLIN ENDOCR METAB, V86, P234, DOI 10.1210/jc.86.1.234; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Wang YJ, 2002, J AM CHEM SOC, V124, P14075, DOI 10.1021/ja026811f; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230	68	19	21	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33321	33328		10.1074/jbc.M805717200	http://dx.doi.org/10.1074/jbc.M805717200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829450	Green Published, hybrid			2022-12-27	WOS:000261183700036
J	Fukui, K; Nakagawa, N; Kitamura, Y; Nishida, Y; Masui, R; Kuramitsu, S				Fukui, Kenji; Nakagawa, Noriko; Kitamura, Yoshiaki; Nishida, Yuya; Masui, Ryoji; Kuramitsu, Seiki			Crystal Structure of MutS2 Endonuclease Domain and the Mechanism of Homologous Recombination Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS MUTS2; MISMATCH REPAIR; HOLLIDAY JUNCTION; CATALYTIC DOMAIN; PROTEIN; BACTERIAL; MUTATIONS; MARKER; TOOLS; GENE	DNA recombination events need to be strictly regulated, because an increase in the recombinational frequency causes unfavorable alteration of genetic information. Recent studies revealed the existence of a novel anti-recombination enzyme, MutS2. However, the mechanism by which MutS2 inhibits homologous recombination has been unknown. Previously, we found that Thermus thermophilus MutS2 (ttMutS2) harbors an endonuclease activity and that this activity is confined to the C-terminal domain, whose amino acid sequence is widely conserved in a variety of proteins with unknown function from almost all organisms ranging from bacteria to man. In this study, we determined the crystal structure of the ttMutS2 endonuclease domain at 1.7-angstrom resolution, which resembles the structure of the DNase I-like catalytic domain of Escherichia coli RNase E, a sequence-nonspecific endonuclease. The N-terminal domain of ttMutS2, however, recognized branched DNA structures, including the Holliday junction and D-loop structure, a primary intermediate in homologous recombination. The full-length of ttMutS2 digested the branched DNA structures at the junction. These results indicate that ttMutS2 suppresses homologous recombination through a novel mechanism involving resolution of early intermediates.	[Fukui, Kenji; Nakagawa, Noriko; Kitamura, Yoshiaki; Nishida, Yuya; Masui, Ryoji; Kuramitsu, Seiki] RIKEN, Ctr SPring 8, Harima Inst, Sayo, Hyogo 6795148, Japan; [Nakagawa, Noriko; Masui, Ryoji; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan	RIKEN; Osaka University	Kuramitsu, S (corresponding author), RIKEN, Ctr SPring 8, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	kuramitu@spring8.or.jp		Fukui, Kenji/0000-0003-2463-7578; nishida, yuya/0000-0002-1994-0807	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20870042, 20570131]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (Grant 20870042 to K. F. and Grant 20570131 to R. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berthiau AS, 2006, EMBO J, V25, P846, DOI 10.1038/sj.emboj.7600975; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fukui K, 2004, J BIOCHEM, V135, P375, DOI 10.1093/jb/mvh045; Fukui K, 2007, NUCLEIC ACIDS RES, V35, P850, DOI 10.1093/nar/gkl735; Fukui K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm575; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3; Guan C, 2005, NUCLEIC ACIDS RES, V33, P6225, DOI 10.1093/nar/gki921; Hadden JM, 2007, NATURE, V449, P621, DOI 10.1038/nature06158; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Ishino Y, 2006, CHEM REV, V106, P324, DOI 10.1021/cr0404803; Jiricny J, 1998, MUTAT RES-DNA REPAIR, V409, P107, DOI 10.1016/S0921-8777(98)00056-1; Kang J, 2005, J BACTERIOL, V187, P3528, DOI 10.1128/JB.187.10.3528-3537.2005; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kitazono AA, 2002, YEAST, V19, P141, DOI 10.1002/yea.806; Kumarathasan P, 2005, ANAL BIOCHEM, V346, P85, DOI 10.1016/j.ab.2005.06.004; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lilley DMJ, 2000, P NATL ACAD SCI USA, V97, P9351, DOI 10.1073/pnas.97.17.9351; Malik HS, 2000, TRENDS BIOCHEM SCI, V25, P414, DOI 10.1016/S0968-0004(00)01623-6; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Moreira D, 1999, TRENDS BIOCHEM SCI, V24, P298, DOI 10.1016/S0968-0004(99)01419-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pinto AV, 2005, MOL CELL, V17, P113, DOI 10.1016/j.molcel.2004.11.035; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHINOHARA A, 1995, TRENDS BIOCHEM SCI, V20, P387, DOI 10.1016/S0968-0004(00)89085-4; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; SOLARO PC, 1993, J MOL BIOL, V230, P868, DOI 10.1006/jmbi.1993.1207; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Takamatsu S, 1996, NUCLEIC ACIDS RES, V24, P640, DOI 10.1093/nar/24.4.640; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Watanabe N, 2003, J BIOL CHEM, V278, P26102, DOI 10.1074/jbc.M303518200; WEAVER DT, 1995, TRENDS GENET, V11, P388, DOI 10.1016/S0168-9525(00)89121-0; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238	55	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33417	33427		10.1074/jbc.M806755200	http://dx.doi.org/10.1074/jbc.M806755200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838375	Green Published, hybrid			2022-12-27	WOS:000261183700046
J	Jakob, S; Schroeder, P; Lukosz, M; Buchner, N; Spyridopoulos, I; Altschmied, J; Haendeler, J				Jakob, Sascha; Schroeder, Peter; Lukosz, Margarete; Buechner, Nicole; Spyridopoulos, Ioakim; Altschmied, Joachim; Haendeler, Judith			Nuclear Protein Tyrosine Phosphatase Shp-2 Is One Important Negative Regulator of Nuclear Export of Telomerase Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; TUMOR-CELLS; KINASE; APOPTOSIS; GENE; EXPRESSION; PHOSPHORYLATION; ACTIVATION	Aging is one major risk factor for numerous diseases. The enzyme telomerase reverse transcriptase ( TERT) plays an important role for aging and apoptosis. Previously, we demonstrated that inhibition of oxidative stress-induced Src kinase family-dependent nuclear export of TERT results in delayed replicative senescence and reduced apoptosis sensitivity. Therefore, the aim of this study was to investigate mechanisms inhibiting nuclear export of TERT. First, we demonstrated that H2O2 induced nuclear export of TERT was abolished in Src, Fyn, and Yes-deficient embryonic fibroblasts. Next, we wanted to identify one potential negative regulator of this export process. One candidate is the protein tyrosine phosphatase Shp-2 (Shp-2), which can counteract activities of the Src kinase family. Indeed, Shp-2 was evenly distributed between the nucleus and cytosol. Nuclear Shp-2 associates with TERT in endothelial cells and dissociates from TERT prior to its nuclear export. Overexpression of Shp-2 wt inhibited H2O2-induced export of TERT. Overexpression of the catalytically inactive, dominant negative Shp-2 mutant (Shp2(C459S)) reduced endogenous as well as overexpressed nuclear TERT protein and telomerase activity, whereas it had no influence on TERT(Y707F). Binding of TERT( Y707F) to Shp-2 is reduced compared with TERTwt. Ablation of Shp-2 expression led only to an increased tyrosine phosphorylation of TERTwt, but not of TERT( Y707F). Moreover, reduced Shp-2 expression decreased nuclear telomerase activity, whereas nuclear telomerase activity was increased in Shp-2-overexpressing endothelial cells. Inconclusion, Shp-2 retains TERT in the nucleus by regulating tyrosine 707 phosphorylation.	[Jakob, Sascha; Schroeder, Peter; Lukosz, Margarete; Buechner, Nicole; Altschmied, Joachim; Haendeler, Judith] Univ Duesseldorf gGmbH, IUF, Dept Mol Cell & Aging Res, D-40225 Dusseldorf, Germany; [Spyridopoulos, Ioakim] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Newcastle University - UK	Altschmied, J (corresponding author), Univ Duesseldorf gGmbH, IUF, Dept Mol Cell & Aging Res, Aufm Hennekamp 50, D-40225 Dusseldorf, Germany.	joalt001@uni-duesseldorf.de; juhae001@uni-duesseldorf.de		Spyridopoulos, Ioakim/0000-0002-2750-2444; Haendeler, Judith/0000-0001-8507-4540	Deutsche Forschungsgemeinschaft [SFB728/B5, HA2868/2-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (SFB728/B5 and HA2868/2-3, to J.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chughtai N, 2002, J BIOL CHEM, V277, P31107, DOI 10.1074/jbc.M200156200; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; de Lange T, 1998, NATURE, V392, P753, DOI 10.1038/33790; Dimmeler S, 1996, FEBS LETT, V399, P71, DOI 10.1016/S0014-5793(96)01289-6; Geserick C, 2006, MECH AGEING DEV, V127, P579, DOI 10.1016/j.mad.2006.01.017; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Haendeler J, 2003, FEBS LETT, V536, P180, DOI 10.1016/S0014-5793(03)00058-9; Haendeler J, 1997, NITRIC OXIDE-BIOL CH, V1, P282, DOI 10.1006/niox.1997.0134; Haendeler J, 2000, CIRC RES, V86, P729, DOI 10.1161/01.RES.86.7.729; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Huang QH, 2002, J BIOL CHEM, V277, P29330, DOI 10.1074/jbc.M112450200; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Kharbanda S, 2000, CURR BIOL, V10, P568, DOI 10.1016/S0960-9822(00)00483-8; Li H, 1998, J BIOL CHEM, V273, P33436, DOI 10.1074/jbc.273.50.33436; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; Mattson MP, 2001, J NEUROSCI RES, V63, P1; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Osawa M, 2004, J BIOL CHEM, V279, P29691, DOI 10.1074/jbc.M309371200; Qu CK, 2002, BBA-MOL CELL RES, V1592, P297, DOI 10.1016/S0167-4889(02)00322-1; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Seimiya H, 1999, BIOCHEM BIOPH RES CO, V260, P365, DOI 10.1006/bbrc.1999.0910; Tran KT, 2003, EXP CELL RES, V289, P359, DOI 10.1016/S0014-4827(03)00287-8; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; Wang JF, 2004, J BIOL CHEM, V279, P27088, DOI 10.1074/jbc.M314015200; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664, DOI 10.1073/pnas.92.3.664; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	39	67	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33155	33161		10.1074/jbc.M805138200	http://dx.doi.org/10.1074/jbc.M805138200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829466	hybrid, Green Published			2022-12-27	WOS:000261183700017
J	Lawrence, R; Olson, SK; Steele, RE; Wang, LC; Warrior, R; Cummings, RD; Esko, JD				Lawrence, Roger; Olson, Sara K.; Steele, Robert E.; Wang, Lianchun; Warrior, Rahul; Cummings, Richard D.; Esko, Jeffrey D.			Evolutionary Differences in Glycosaminoglycan Fine Structure Detected by Quantitative Glycan Reductive Isotope Labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-UNSUBSTITUTED GLUCOSAMINE; TANDEM MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; CHONDROITIN-SULFATE-E; HEPARAN-SULFATE; CAENORHABDITIS-ELEGANS; GLUCURONIC-ACID; AMINO-GROUPS; TOUT-VELU; OLIGOSACCHARIDES	To facilitate qualitative and quantitative analysis of glycosaminoglycans, we tagged the reducing end of lyase-generated disaccharides with aniline-containing stable isotopes (C-12(6) and C-13(6)). Because different isotope tags have no effect on chromatographic retention times but can be discriminated by a mass detector, differentially isotope-tagged samples can be compared simultaneously by liquid chromatography/mass spectrometry and quantified by admixture with known amounts of standards. The technique is adaptable to all types of glycosaminoglycans, and its sensitivity is only limited by the type of mass spectrometer available. We validated the method using commercial heparin and keratan sulfate as well as heparan sulfate isolated from mutant and wild-type Chinese hamster ovary cells, and select tissues from mutant and wild-type mice. This new method provides more robust, reliable, and sensitive means of quantitative evaluation of glycosaminoglycan disaccharide compositions than existing techniques allowing us to compare the chondroitin and heparan sulfate compositions of Hydra vulgaris, Drosophila melanogaster, Caenorhabditis elegans, and mammalian cells. Our results demonstrate significant differences in glycosaminoglycan structure among these organisms that might represent evolutionarily distinct functional motifs.	[Lawrence, Roger; Olson, Sara K.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Steele, Robert E.; Warrior, Rahul] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Steele, Robert E.; Warrior, Rahul] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; [Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Cummings, Richard D.] Emory Univ, Sch Med Ctr, Dept Biochem, Atlanta, GA 30322 USA	University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine; University System of Georgia; University of Georgia; Emory University	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu			National Institutes of Health [GM33063, HL57345]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33063 and HL57345 ( to J. D. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Barroso B, 2005, J CHROMATOGR A, V1080, P43, DOI 10.1016/j.chroma.2005.03.020; Behr JR, 2005, RAPID COMMUN MASS SP, V19, P2553, DOI 10.1002/rcm.2079; Bowman MJ, 2007, ANAL CHEM, V79, P5777, DOI 10.1021/ac070581b; Cesaretti M, 2004, GLYCOBIOLOGY, V14, P1275, DOI 10.1093/glycob/cwh128; Desaire H, 2000, J AM SOC MASS SPECTR, V11, P916, DOI 10.1016/S1044-0305(00)00168-9; Ding K, 2001, J BIOL CHEM, V276, P3885, DOI 10.1074/jbc.M005238200; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; GUO YC, 1988, ANAL BIOCHEM, V168, P54, DOI 10.1016/0003-2697(88)90009-7; Hitchcock AM, 2007, GLYCOBIOLOGY, V17, P25, DOI 10.1093/glycob/cwl046; Hitchcock AM, 2008, PROTEOMICS, V8, P1384, DOI 10.1002/pmic.200700787; Hitchcock AM, 2006, BIOCHEMISTRY-US, V45, P2350, DOI 10.1021/bi052100t; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Karlsson NG, 2005, J CHROMATOGR B, V824, P139, DOI 10.1016/j.jchromb.2005.07.014; Kim YS, 1998, GLYCOBIOLOGY, V8, P869, DOI 10.1093/glycob/8.9.869; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita-Toyoda A, 2004, BIOCHEMISTRY-US, V43, P11063, DOI 10.1021/bi049622d; Korir AK, 2008, ANAL CHEM, V80, P1297, DOI 10.1021/ac702235u; Kuberan B, 2002, J AM CHEM SOC, V124, P8707, DOI 10.1021/ja0178867; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; Manzi AE, 2000, GLYCOBIOLOGY, V10, P669, DOI 10.1093/glycob/10.7.669; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; NADER HB, 1984, J BIOL CHEM, V259, P1431; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; Saad OM, 2005, ANAL CHEM, V77, P5902, DOI 10.1021/ac050793d; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Saad OM, 2004, J AM SOC MASS SPECTR, V15, P1274, DOI 10.1016/j.jasms.2004.05.008; Saad OM, 2003, ANAL CHEM, V75, P2985, DOI 10.1021/ac0340455; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Tai GH, 1996, J BIOL CHEM, V271, P23535, DOI 10.1074/jbc.271.38.23535; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; Toyoda H, 1997, J CHROMATOGR B, V704, P19, DOI 10.1016/S0378-4347(97)00478-7; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Wilson VA, 2002, GLYCOCONJUGATE J, V19, P347, DOI 10.1023/A:1025325222530; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Yang HO, 2000, GLYCOBIOLOGY, V10, P1033, DOI 10.1093/glycob/10.10.1033; Yuan J, 2005, J CHROMATOGR A, V1067, P145, DOI 10.1016/j.chroma.2004.11.070; Zhang YT, 2005, INVEST OPHTH VIS SCI, V46, P1604, DOI 10.1167/iovs.04-1453	49	149	157	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33674	33684		10.1074/jbc.M804288200	http://dx.doi.org/10.1074/jbc.M804288200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18818196	Green Published, hybrid			2022-12-27	WOS:000261183700074
J	Kalie, E; Jaitin, DA; Podoplelova, Y; Piehler, J; Schreiber, G				Kalie, Eyal; Jaitin, Diego A.; Podoplelova, Yulia; Piehler, Jacob; Schreiber, Gideon			The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-BETA; LIGAND-BINDING; ALPHA RECEPTOR; MUTATIONAL ANALYSIS; DOWN-REGULATION; PHAGE DISPLAY; CELLS; MUTANT; IFN-ALPHA-2; ACTIVATION	Type I interferons (IFNs) signal for their diverse biological effects by binding a common receptor on target cells, composed of the two transmembrane IFNAR1 and IFNAR2 proteins. We have previously differentially enhanced the antiproliferative activity of IFN by increasing the weak binding affinity of IFN to IFNAR1. In this study, we further explored the affinity interdependencies between the two receptor subunits and the role of IFNAR1 in differential IFN activity. For this purpose, we generated a panel of mutations targeting the IFNAR2 binding site on the background of the IFN alpha 2 YNS mutant, which increases the affinity to IFNAR1 by 60-fold, resulting in IFNAR2-to-IFNAR1 binding affinity ratios ranging from 1000:1 to 1:1000. Both the antiproliferative and antiviral potencies of the interferon mutants clearly correlated to the in situ binding IC50 values, independently of the relative contributions of the individual receptors, thus relating to the integral lifetime of the complex. However, the antiproliferative potency correlated throughout the entire range of affinities, as well as with prolonged IFNAR1 receptor down-regulation, whereas the antiviral potency reached a maximum at binding affinities equivalent to that of wild-type IFN alpha 2. Our data suggest that (i) the specific activity of interferon is related to the ternary complex binding affinity and not to affinity toward individual receptor components and (ii) although the antiviral pathway is strongly dependent on pSTAT1 activity, the cytostatic effect requires additional mechanisms that may involve IFNAR1 down-regulation. This differential interferon response is ultimately mediated through distinct gene expression profiling.	[Kalie, Eyal; Jaitin, Diego A.; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Podoplelova, Yulia; Piehler, Jacob] Univ Frankfurt, Inst Biochem, D-60438 Frankfurt, Germany; [Podoplelova, Yulia; Piehler, Jacob] Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany	Weizmann Institute of Science; Goethe University Frankfurt; Goethe University Frankfurt	Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	gideon.schreiber@weizmann.ac.il	Schreiber, Gideon/C-7332-2008		Israel Science Foundation [633/06]; Deutsche Forschungsgemeinschaft [PI 405/4, EXC 115]	Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Israel Science Foundation (founded by the Israel Academy of Sciences and Humanities) Grant 633/06 (to G. S.) and Deutsche Forschungsgemeinschaft Grants PI 405/4 and EXC 115 (to J.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed CMI, 2006, J IMMUNOL, V177, P315, DOI 10.4049/jimmunol.177.1.315; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Cajean-Feroldi C, 2004, BIOCHEMISTRY-US, V43, P12498, DOI 10.1021/bi049111r; Chill JH, 2003, STRUCTURE, V11, P791, DOI 10.1016/S0969-2126(03)00120-5; Claudinon J, 2007, BIOCHIMIE, V89, P735, DOI 10.1016/j.biochi.2007.03.014; Damdinsuren B, 2007, HEPATOL RES, V37, P77, DOI 10.1111/j.1872-034X.2007.00007.x; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Gakovic M, 2008, J BIOL CHEM, V283, P18522, DOI 10.1074/jbc.M801427200; Gavutis M, 2006, BIOPHYS J, V90, P3345, DOI 10.1529/biophysj.105.072546; Gavutis M, 2005, BIOPHYS J, V88, P4289, DOI 10.1529/biophysj.104.055855; Grumbach IM, 1999, J INTERF CYTOK RES, V19, P797, DOI 10.1089/107999099313659; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Ito K, 2004, EUR J HAEMATOL, V73, P191, DOI 10.1111/j.1600-0609.2004.00275.x; JACOBS S, 1979, P NATL ACAD SCI USA, V76, P4918, DOI 10.1073/pnas.76.10.4918; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaitin DA, 2007, J INTERF CYTOK RES, V27, P653, DOI 10.1089/jir.2006.0162; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; Lata S, 2006, J AM CHEM SOC, V128, P6, DOI 10.1021/ja054700l; Li ZL, 2008, J MOL BIOL, V377, P715, DOI 10.1016/j.jmb.2007.12.005; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; LUTFALLA G, 1995, EMBO J, V14, P5100, DOI 10.1002/j.1460-2075.1995.tb00192.x; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Piehler J, 1999, J MOL BIOL, V289, P57, DOI 10.1006/jmbi.1999.2726; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rani MRS, 1996, J BIOL CHEM, V271, P22878, DOI 10.1074/jbc.271.37.22878; Reichel A, 2007, ANAL CHEM, V79, P8590, DOI 10.1021/ac0714922; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Roisman LC, 2001, P NATL ACAD SCI USA, V98, P13231, DOI 10.1073/pnas.221290398; ROSENBLUM MG, 1990, J INTERFERON RES, V10, P141, DOI 10.1089/jir.1990.10.141; Rubinstein M, 1981, Methods Enzymol, V78, P464; Saleh AZM, 2004, ONCOGENE, V23, P7076, DOI 10.1038/sj.onc.1207955; Severa M, 2006, J LEUKOCYTE BIOL, V79, P1286, DOI 10.1189/jlb.1205742; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Subramaniam PS, 2004, FEBS LETT, V578, P207, DOI 10.1016/j.febslet.2004.10.085; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Wagner TC, 2004, INT J CANCER, V111, P32, DOI 10.1002/ijc.20236	51	86	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32925	32936		10.1074/jbc.M806019200	http://dx.doi.org/10.1074/jbc.M806019200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801736	hybrid			2022-12-27	WOS:000260893700081
J	McMahon, MA; Siliciano, JD; Lai, J; Liu, JO; Stivers, JT; Siliciano, RF; Kohli, RM				McMahon, Moira A.; Siliciano, Janet D.; Lai, Jun; Liu, Jun O.; Stivers, James T.; Siliciano, Robert F.; Kohli, Rahul M.			The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX-VIRUS; NUCLEOSIDE ANALOGS; DNA-POLYMERASE; DOUBLE-BLIND; TYPE-1; SUPPRESSION; INFECTION; THERAPY; PLASMA	The antiviral drug acyclovir is a guanosine nucleoside analog that potently inhibits herpes simplex virus (HSV) replication. Acyclovir treatment in patients coinfected with HSV and human immunodeficiency virus (HIV) has been observed to alter disease course and decrease HIV viral load, a finding that has been attributed to indirect effects of HSV suppression on HIV replication. Based on this hypothesis, several clinical studies have recently investigated the use of acyclovir for treatment of patients coinfected with HSV and HIV or for prophylaxis against HIV transmission. In this report, we use a single round HIV infectivity assay to show that acyclovir directly inhibits HIV infection with an IC50 of similar to 5 mu M. The target of acyclovir in HIV-infected cells is validated as HIV reverse transcriptase (RT) by the emergence of the RT variant V75I under the selective pressure of acyclovir. The V75I mutation is part of the multidrug resistance pathway that enhances viral resistance to many of the best RT inhibitors approved for the treatment of HIV. Biochemical analyses demonstrate that acyclovir triphosphate is a chain terminator substrate for HIV RT and can compete with dGTP for incorporation into DNA. Although acyclovir may prove a useful lead for development of new HIV treatments, the selection of resistant mutants raises a cautionary note to the use of acyclovir monotherapy in patients coinfected with HSV and HIV.	[Kohli, Rahul M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [McMahon, Moira A.; Liu, Jun O.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Lai, Jun; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Kohli, RM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, 1830 Monument St, Baltimore, MD 21205 USA.	rkohli2@jhmi.edu		Kohli, Rahul/0000-0002-7689-5678; McMahon, Moira/0000-0001-9810-8623	National Institutes of Health [AI43222, GM56834-12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI43222 (to R. F. S.) and GM56834-12 (to J. T. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Ferguson NM, 2001, TRENDS PHARMACOL SCI, V22, P97, DOI 10.1016/S0165-6147(00)01615-1; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; GAO Q, 1993, ANTIMICROB AGENTS CH, V37, P1390, DOI 10.1128/AAC.37.6.1390; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBSON MA, 1993, J MED VIROL, P150; Johnson Victoria A, 2008, Top HIV Med, V16, P62; KELLER PM, 1981, BIOCHEM PHARMACOL, V30, P3071, DOI 10.1016/0006-2952(81)90495-0; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Krone MR, 2000, CLIN INFECT DIS, V30, P261, DOI 10.1086/313647; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; Lisco A, 2008, NEW ENGL J MED, V359, P535, DOI 10.1056/NEJMc081075; MARGOLIS DM, 1992, VIROLOGY, V186, P788, DOI 10.1016/0042-6822(92)90048-T; Matamoros T, 2008, J MOL BIOL, V375, P1234, DOI 10.1016/j.jmb.2007.11.021; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MOSCA JD, 1987, P NATL ACAD SCI USA, V84, P7408, DOI 10.1073/pnas.84.21.7408; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; REARDON JE, 1989, J BIOL CHEM, V264, P19039; REARDON JE, 1989, J BIOL CHEM, V264, P7405; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Schacker T, 1998, ANN INTERN MED, V128, P21, DOI 10.7326/0003-4819-128-1-199801010-00004; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Winters MA, 2001, ANTIMICROB AGENTS CH, V45, P2276, DOI 10.1128/AAC.45.8.2276-2279.2001; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	37	68	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31289	31293		10.1074/jbc.C800188200	http://dx.doi.org/10.1074/jbc.C800188200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18818198	Green Published, hybrid			2022-12-27	WOS:000260760800005
J	Schellenberger, J; Palsson, BO				Schellenberger, Jan; Palsson, Bernhard O.			Use of Randomized Sampling for Analysis of Metabolic Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI; STEADY-STATE; INVIVO MEASUREMENT; OPTIMAL SELECTION; SCALE; PATHWAYS; MODELS; FLUXES; CAPABILITIES; CONSTRAINTS	Genome-scale metabolic network reconstructions in microorganisms have been formulated and studied for about 8 years. The constraint-based approach has shown great promise in analyzing the systemic properties of these network reconstructions. Notably, constraint-based models have been used successfully to predict the phenotypic effects of knock-outs and for metabolic engineering. The inherent uncertainty in both parameters and variables of large-scale models is significant and is well suited to study by Monte Carlo sampling of the solution space. These techniques have been applied extensively to the reaction rate (flux) space of networks, with more recent work focusing on dynamic/kinetic properties. Monte Carlo sampling as an analysis tool has many advantages, including the ability to work with missing data, the ability to apply post-processing techniques, and the ability to quantify uncertainty and to optimize experiments to reduce uncertainty. We present an overview of this emerging area of research in systems biology.	[Schellenberger, Jan] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Palsson, BO (corresponding author), Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA.	palsson@ucsd.edu	damiani, chiara/R-4256-2016	Palsson, Bernhard/0000-0003-2357-6785				Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Barrett CL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-132; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Braunstein A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-240; Calvetti D, 2006, MULTISCALE MODEL SIM, V5, P1333, DOI 10.1137/050644860; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Famili I, 2005, BIOPHYS J, V88, P1616, DOI 10.1529/biophysj.104.050385; Gianchandani EP, 2006, PLOS COMPUT BIOL, V2, P902, DOI 10.1371/journal.pcbi.0020101; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Jamshidi N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100077; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Kim HU, 2008, MOL BIOSYST, V4, P113, DOI 10.1039/b712395g; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Liebermeister W, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-42; Occhipinti R, 2007, ANN BIOMED ENG, V35, P886, DOI 10.1007/s10439-007-9270-5; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Price ND, 2006, BIOPHYS J, V90, P3919, DOI 10.1529/biophysj.105.072645; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; SAVINELL JM, 1992, J THEOR BIOL, V155, P215, DOI 10.1016/S0022-5193(05)80596-X; SAVINELL JM, 1992, J THEOR BIOL, V155, P201, DOI 10.1016/S0022-5193(05)80595-8; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Steuer R, 2007, PHYTOCHEMISTRY, V68, P2139, DOI 10.1016/j.phytochem.2007.04.041; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006; Yeung M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-363; [No title captured], DOI DOI 10.1142/S0218339094000131	34	159	162	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5457	5461		10.1074/jbc.R800048200	http://dx.doi.org/10.1074/jbc.R800048200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	18940807	hybrid			2022-12-27	WOS:000263560600007
J	Viegas, CSB; Simes, DC; Laize, V; Williamson, MK; Price, PA; Cancela, ML				Viegas, Carla S. B.; Simes, Dina C.; Laize, Vincent; Williamson, Matthew K.; Price, Paul A.; Cancela, M. Leonor			Gla-rich Protein (GRP), A New Vitamin K-dependent Protein Identified from Sturgeon Cartilage and Highly Conserved in Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; GLUTAMYL CARBOXYLASE; SEQUENCE ALIGNMENT; TELEOST FISH; BINDING-SITE; BONE; MATRIX; PROTHROMBIN; EXPRESSION; RESIDUES	We report the isolation of a novel vitamin K-dependent protein from the calcified cartilage of Adriatic sturgeon ( Acipenser nacarii). This 10.2-kDa secreted protein contains 16 gamma-carboxyglutamic acid (Gla) residues in its 74-residue sequence, the highest Gla percent of any known protein, and we have therefore termed it Gla-rich protein (GRP). GRP has a high charge density (36 negative + 16 positive = 20 net negative) yet is insoluble at neutral pH. GRP has orthologs in all taxonomic groups of vertebrates, and a paralog (GRP2) in bony fish; no GRP homolog was found in invertebrates. There is no significant sequence homology between GRP and the Gla-containing region of any presently known vitamin K-dependent protein. Forty-seven GRP sequences were obtained by a combination of cDNA cloning and comparative genomics: all 47 have a propeptide that contains a gamma-carboxylase recognition site and a mature protein with 14 highly conserved Glu residues, each of them being gamma-carboxylated in sturgeon. The protein sequence of GRP is also highly conserved, with 78% identity between sturgeon and human GRP. Analysis of the corresponding gene structures suggests a highly constrained organization, particularly for exon 4, which encodes the core Gla domain. GRP mRNA is found in virtually all rat and sturgeon tissues examined, with the highest expression in cartilage. Cells expressing GRP include chondrocytes, chondroblasts, osteoblasts, and osteocytes. Because of its potential to bind calcium through Gla residues, we suggest that GRP may regulate calcium in the extracellular environment.	[Viegas, Carla S. B.; Simes, Dina C.; Laize, Vincent; Cancela, M. Leonor] Univ Algarve, Ctr Marine Sci CCMAR, P-8005139 Faro, Portugal; [Williamson, Matthew K.; Price, Paul A.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	Universidade do Algarve; University of California System; University of California San Diego	Cancela, ML (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, P-8005139 Faro, Portugal.	lcancela@ualg.pt	Viegas, Carla/N-6314-2019; Laizé, Vincent/B-4463-2008; Viegas, Carla CSB/N-6695-2014; Cancela, M. Leonor/F-4665-2012; Simes, Dina Costa/N-2789-2014	Viegas, Carla/0000-0002-5765-3665; Laizé, Vincent/0000-0001-9565-9198; Viegas, Carla CSB/0000-0002-5765-3665; Cancela, M. Leonor/0000-0003-3114-6662; Simes, Dina Costa/0000-0002-5145-4753	National Institutes of Health [HL58090]; Centre of Marine Sciences; Portuguese Science and Technology Foundation [POCTI/MAR/57921/2004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre of Marine Sciences; Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58090 (to P.A.P.) and a grant from the Centre of Marine Sciences (to M.L.C., V.L ., and D.C.S.) and Project POCTI/MAR/57921/2004 from the Portuguese Science and Technology Foundation (including funds from FEDER and OE) (to D.C.S. and M.L.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; Brown MA, 2002, TOXICON, V40, P447, DOI 10.1016/S0041-0101(01)00233-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Cranenburg ECM, 2007, THROMB HAEMOSTASIS, V98, P120, DOI 10.1160/TH07-04-0266; DEBOERVANDENBERG MAG, 1986, J INVEST DERMATOL, V87, P377, DOI 10.1111/1523-1747.ep12524848; Funari VA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-165; Hallgren KW, 2006, BIOCHEMISTRY-US, V45, P5587, DOI 10.1021/bi051986y; Hansson K, 2006, BIOCHEMISTRY-US, V45, P12828, DOI 10.1021/bi061311a; HAUSCHKA PV, 1975, P NATL ACAD SCI USA, V72, P3925, DOI 10.1073/pnas.72.10.3925; JIE KSG, 1995, ANAL BIOCHEM, V224, P163, DOI 10.1006/abio.1995.1023; Kulman JD, 1997, P NATL ACAD SCI USA, V94, P9058, DOI 10.1073/pnas.94.17.9058; Kulman JD, 2001, P NATL ACAD SCI USA, V98, P1370, DOI 10.1073/pnas.98.4.1370; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Laize V, 2005, J BIOL CHEM, V280, P26659, DOI 10.1074/jbc.M500257200; Laize V, 2006, J BIOL CHEM, V281, P15037, DOI 10.1074/jbc.M600373200; Lin PJ, 2002, J BIOL CHEM, V277, P28584, DOI 10.1074/jbc.M202292200; Lingenfelter SE, 1996, BIOCHEMISTRY-US, V35, P8234, DOI 10.1021/bi9523318; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; NIELSO H, 1997, PROT ENG, V1, P1; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; Pinto JP, 2001, GENE, V270, P77, DOI 10.1016/S0378-1119(01)00426-7; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; RATCLIFFE JV, 1993, J BIOL CHEM, V268, P24339; REHEMTULLA A, 1993, P NATL ACAD SCI USA, V90, P4611, DOI 10.1073/pnas.90.10.4611; Roest Crollius H, 2005, GENOME RES, V15, P1675, DOI 10.1101/gr.3735805; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Simes DC, 2003, J BONE MINER RES, V18, P244, DOI 10.1359/jbmr.2003.18.2.244; SIMES DC, 2008, Patent No. 61136315; SPERLING R, 1978, J BIOL CHEM, V253, P3898; Stanley TB, 1999, J BIOL CHEM, V274, P16940, DOI 10.1074/jbc.274.24.16940; STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730; Surmann-Schmitt C, 2008, J BIOL CHEM, V283, P7082, DOI 10.1074/jbc.M702792200; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; Tagariello A, 2008, MATRIX BIOL, V27, P3, DOI 10.1016/j.matbio.2007.07.004; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; VERMEER C, 1990, BIOCHEM J, V266, P625, DOI 10.1042/bj2660625; Walker CS, 2001, J BIOL CHEM, V276, P7769, DOI 10.1074/jbc.M009576200; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; ZHANG L, 1993, J BIOL CHEM, V268, P12040	41	84	91	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36655	36664		10.1074/jbc.M802761200	http://dx.doi.org/10.1074/jbc.M802761200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18836183	hybrid, Green Published			2022-12-27	WOS:000261840500064
J	Robichaud, JC; Francis, GA; Vance, DE				Robichaud, Julie C.; Francis, Gordon A.; Vance, Dennis E.			A Role for Hepatic Scavenger Receptor Class B, Type I in Decreasing High Density Lipoprotein Levels in Mice That Lack Phosphatidylethanolamine N-Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA HIGH-DENSITY; APOLIPOPROTEIN-A-I; BINDING CASSETTE TRANSPORTERS; CELLULAR CHOLESTEROL EFFLUX; SR-BI; HORMONAL-REGULATION; SECRETION; PROTEIN; GENE; HDL	Phosphatidylethanolamine N-methyltransferase (PEMT) is a liver-specific enzyme that converts phosphatidylethanolamine to phosphatidylcholine (PC). Mice that lack PEMT have reduced plasma levels of PC and cholesterol in high density lipoproteins (HDL). We have investigated the mechanism responsible for this reduction with experiments designed to distinguish between a decreased formation of HDL particles by hepatocytes or an increased hepatic uptake of HDL lipids. Therefore, we analyzed lipid efflux to apoA-I and HDL lipid uptake using primary cultured hepatocytes isolated from Pemt(+/+) and Pemt(+/+) mice. Hepatic levels of the ATP-binding cassette transporter A1 are not significantly different between Pemt genotypes. Moreover, hepatocytes isolated from Pemt(+/+) mice released cholesterol and PC into the medium as efficiently as did hepatocytes from Pemt(+/+) mice. Immunoblotting of liver homogenates showed a 1.5-fold increase in the amount of the scavenger receptor, class B, type 1 (SR-BI) in Pemt(+/+) compared with Pemt(+/+) livers. In addition, there was a 1.5-fold increase in the SR-BI-interacting protein PDZK1. Lipid uptake experiments using radiolabeled HDL particles revealed a greater uptake of [H-3] cholesteryl ethers and [H-3] PC by hepatocytes derived from Pemt(+/+) compared with Pemt(+/+) mice. Furthermore, we observed an increased association of [H-3] cholesteryl ethers in livers of Pemt(+/+) compared with Pemt(+/+)mice after tail vein injection of [H-3] HDL. These results strongly suggest that PEMT is involved in the regulation of plasma HDL levels in mice, mainly via HDL lipid uptake by SR-BI.	[Robichaud, Julie C.; Francis, Gordon A.; Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Robichaud, Julie C.; Francis, Gordon A.; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Francis, Gordon A.] Univ British Columbia, Dept Med, Vancouver, BC V6Z 1Y6, Canada	University of Alberta; University of Alberta; University of British Columbia	Vance, DE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca			Canadian Institutes of Health Research [89793, 12660, 64520, 63605]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by Canadian Institutes of Health Research Grants MOP: 89793, MOP: 12660, MGC: 64520, and STR 63605. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe-Dohmae S, 2006, FEBS LETT, V580, P1178, DOI 10.1016/j.febslet.2005.12.029; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Agellon LB, 1999, HEPATOLOGY, V30, P725, DOI 10.1002/hep.510300305; Ahras M, 2008, J LIPID RES, V49, P1569, DOI 10.1194/jlr.M800055-JLR200; Azhar S, 2002, J LIPID RES, V43, P861; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; BREMER J, 1960, BIOCHIM BIOPHYS ACTA, V37, P173, DOI 10.1016/0006-3002(60)90104-9; CHUNG BH, 1980, J LIPID RES, V21, P284; Cohen DE, 1999, CURR OPIN LIPIDOL, V10, P295, DOI 10.1097/00041433-199908000-00002; Fielding CJ, 2008, N COMP BIOC, P533, DOI 10.1016/B978-044453219-0.50021-0; FIELDING CJ, 1977, ARCH PATHOL LAB MED, V101, P225; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; Folch J., 1959, J BIOL CHEM, V226, P495; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GLASS C, 1985, J BIOL CHEM, V260, P744; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Harder CJ, 2007, J BIOL CHEM, V282, P1445, DOI 10.1074/jbc.M604627200; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kiss RS, 2003, J BIOL CHEM, V278, P10119, DOI 10.1074/jbc.M300137200; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Krieger M, 1999, CURR OPIN LIPIDOL, V10, P491, DOI 10.1097/00041433-199912000-00003; Li ZY, 2007, BBA-MOL CELL BIOL L, V1771, P486, DOI 10.1016/j.bbalip.2007.01.003; Li ZY, 2007, J BIOL CHEM, V282, P10283, DOI 10.1074/jbc.M611726200; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Reaven E, 2004, J LIPID RES, V45, P513, DOI 10.1194/jlr.M300370-JLR200; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P818, DOI 10.1016/j.bbalip.2007.04.019; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P807, DOI 10.1016/j.bbalip.2006.03.003; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider WJ, 2008, N COMP BIOC, P555, DOI 10.1016/B978-044453219-0.50022-2; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Silver DL, 2004, REV ENDOCR METAB DIS, V5, P327, DOI 10.1023/B:REMD.0000045104.38104.8e; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Silver DL, 2001, CURR OPIN LIPIDOL, V12, P497, DOI 10.1097/00041433-200110000-00004; Sporstol M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-5; Stangl H, 2002, J ENDOCRINOL, V175, P663, DOI 10.1677/joe.0.1750663; Sun B, 2006, J LIPID RES, V47, P1700, DOI 10.1194/jlr.M500450-JLR200; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Trigatti B, 2004, BIOCHEM SOC T, V32, P116, DOI 10.1042/BST0320116; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; VANCE DE, 1979, TRENDS BIOCHEM SCI, V4, P145, DOI 10.1016/0968-0004(79)90001-X; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1986, BIOCHIM BIOPHYS ACTA, V875, P501, DOI 10.1016/0005-2760(86)90070-6; VANCE JE, 1990, ANNU REV NUTR, V10, P337, DOI 10.1146/annurev.nu.10.070190.002005; Vance JE, 2008, N COMP BIOC, P507, DOI 10.1016/B978-044453219-0.50020-9; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Waite KA, 2004, BBA-MOL CELL BIOL L, V1636, P175, DOI 10.1016/j.bbalip.2003.10.014; Waite KA, 2002, J NUTR, V132, P68, DOI 10.1093/jn/132.1.68; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; YOKOYAMA S, 1982, J BIOCHEM, V91, P1267, DOI 10.1093/oxfordjournals.jbchem.a133811; Yokoyama S, 2006, ARTERIOSCL THROM VAS, V26, P20, DOI 10.1161/01.ATV.0000195789.39418.e8; Zhang WW, 2003, CIRCULATION, V108, P2258, DOI 10.1161/01.CIR.0000093189.97429.9D	75	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35496	35506		10.1074/jbc.M807433200	http://dx.doi.org/10.1074/jbc.M807433200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18842588	hybrid			2022-12-27	WOS:000261687900021
J	Tanowitz, M; Hislop, JN; von Zastrow, M				Tanowitz, Michael; Hislop, James N.; von Zastrow, Mark			Alternative Splicing Determines the Post-endocytic Sorting Fate of G-protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU-OPIOID-RECEPTOR; MEMBRANE TRAFFICKING; DOWN-REGULATION; DESENSITIZATION; INTERNALIZATION; RESENSITIZATION; EXPRESSION; TOLERANCE; RESPONSES; BRAIN	Mu-type opioid receptors are physiologically important G-protein-coupled receptors that are generally thought to recycle after agonist-induced endocytosis. Here we show that several alternatively spliced receptor variants fail to do so efficiently because of splice-mediated removal of an endocytic sorting sequence that is present specifically in the MOR1 variant. All of the recycling-impaired receptor variants were found to undergo proteolytic down-regulation more rapidly than MOR1, irrespective of moderate differences in endocytic rate, indicating that alternative splicing plays a specific role in distinguishing the trafficking itinerary of receptors after endocytosis. The recycling-impaired MOR1B variant was similar to MOR1 in its ability to mediate opioid-dependent inhibition of adenylyl cyclase, and to undergo opioid-induced desensitization in intact cells. Functional recovery (resensitization) of MOR1B-mediated cellular responsiveness after opioid removal, however, was significantly impaired (4-fold reduction in rate) compared with MOR1. To our knowledge the present results are the first to establish a role of alternative RNA processing in specifying the post-endocytic sorting of G-protein-coupled receptors between divergent and functionally distinct membrane pathways.	[von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), MC 2140,600 16th St, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu			National Institutes of Health; National Institute on Drug Abuse	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health grants (to M.Z.) from the National Institute on Drug Abuse. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; BARE LA, 1994, FEBS LETT, V354, P213, DOI 10.1016/0014-5793(94)01129-X; Bockaert J, 2006, CELL TISSUE RES, V326, P553, DOI 10.1007/s00441-006-0286-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Evangelisti S, 2004, HIST J, V47, P1, DOI 10.1017/S0018246X03003480; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Haberstock-Debic H, 2003, J NEUROSCI, V23, P4324; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; LAW PY, 1982, MOL PHARMACOL, V72, P1; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Narita M, 2003, EUR J NEUROSCI, V18, P3193, DOI 10.1111/j.1460-9568.2003.03052.x; NESTLER EJ, 1993, CRIT REV NEUROBIOL, V7, P23; Pan YX, 1999, MOL PHARMACOL, V56, P396, DOI 10.1124/mol.56.2.396; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Pasternak GW, 2001, TRENDS PHARMACOL SCI, V22, P67, DOI 10.1016/S0165-6147(00)01616-3; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; SHARMA SK, 1977, P NATL ACAD SCI USA, V74, P3365, DOI 10.1073/pnas.74.8.3365; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sternini C, 2000, NEUROSCIENCE, V98, P233, DOI 10.1016/S0306-4522(00)00118-4; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Trafton JA, 2000, J NEUROSCI, V20, P8578; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; ZIMPRICH A, 1995, FEBS LETT, V359, P142, DOI 10.1016/0014-5793(95)00028-8	41	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35614	35621		10.1074/jbc.M806588200	http://dx.doi.org/10.1074/jbc.M806588200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18936093	Green Published, hybrid			2022-12-27	WOS:000261687900034
J	Ryan, TM; Howlett, GJ; Bailey, MF				Ryan, Timothy M.; Howlett, Geoffrey J.; Bailey, Michael F.			Fluorescence Detection of a Lipid-induced Tetrameric Intermediate in Amyloid Fibril Formation by Apolipoprotein C-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDIZED CHOLESTEROL METABOLITES; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; AGGREGATION; MEMBRANES; OLIGOMERS; ATHEROMA; TRIGGER; PLASMA; FORMS	The misfolding and self-assembly of proteins into amyloid fibrils that occurs in several debilitating and age-related diseases is affected by common components of amyloid deposits, notably lipids and lipid complexes. We have examined the effect of the short-chain phospholipids, dihexanoylphosphatidylcholine (DHPC) and dihexanoylphosphatidylserine (DHPS), on amyloid fibril formation by human apolipoprotein C-II (apoC-II). Micellar DHPC and DHPS strongly inhibited apoC-II fibril formation, whereas submicellar levels of these lipids accelerated apoC-II fibril formation to a similar degree. These results indicate that the net negative charge on DHPS, compared with the neutrally charged DHPC, is not critical for either the inhibition or activation process. We also investigated the mechanism for the submicellar, lipid-induced activation of fibril formation. Emission data for fluorescently labeled apoC-II indicated that DHPC and DHPS stimulate the early formation and accumulation of oligomeric species. Sedimentation velocity and equilibrium experiments using a new fluorescence detection system identified a discrete lipid-induced tetramer formed at low apoC-II concentrations in the absence of significant fibril formation. Seeding experiments showed that this tetramer was on the fibril-forming pathway. Fluorescence resonance energy transfer experiments established that this tetramer forms rapidly and is stabilized by submicellar, but not micellar, concentrations of DHPC and DHPS. Several recent studies show that oligomeric intermediates in amyloid fibril formation are toxic. Our results indicate that lipids promote on-pathway intermediates of apoC-II fibril assembly and that the accumulation of a discrete tetrameric intermediate depends on the molecular state of the lipid.	[Ryan, Timothy M.; Howlett, Geoffrey J.; Bailey, Michael F.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Melbourne	Howlett, GJ (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	ghowlett@unimelb.edu.au			Australian Research Council [DP0449510]; National Health and Medical Research Council of Australia [350229]	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant DP0449510 and National Health and Medical Research Council of Australia Grant 350229. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Atcliffe BW, 2001, EUR J BIOCHEM, V268, P2838, DOI 10.1046/j.1432-1327.2001.02164.x; Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Edelstein S J, 1973, Methods Enzymol, V27, P82; EDWARDS K, 1994, BIOCHEMISTRY-US, V33, P13304, DOI 10.1021/bi00249a017; Griffin MDW, 2008, J MOL BIOL, V375, P240, DOI 10.1016/j.jmb.2007.10.038; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hatters DM, 2001, FEBS LETT, V494, P220, DOI 10.1016/S0014-5793(01)02355-9; Hatters DM, 2002, EUR BIOPHYS J BIOPHY, V31, P2, DOI 10.1007/s002490100172; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; JOHNSON RE, 1981, BIOCHEMISTRY-US, V20, P4239, DOI 10.1021/bi00517a044; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Kokalj SJ, 2007, J MOL BIOL, V366, P1569, DOI 10.1016/j.jmb.2006.12.025; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l; MacRaild CA, 2001, BIOCHEMISTRY-US, V40, P5414, DOI 10.1021/bi002821m; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Olofsson A, 2007, J MOL BIOL, V374, P186, DOI 10.1016/j.jmb.2007.08.064; Sanders A, 2004, J MOL BIOL, V336, P165, DOI 10.1016/j.jmb.2003.12.011; Schlame M, 1996, J LIPID RES, V37, P2608; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stewart CR, 2007, J LIPID RES, V48, P2162, DOI 10.1194/jlr.M700098-JLR200; Stewart CR, 2007, BIOCHEMISTRY-US, V46, P5552, DOI 10.1021/bi602554z; TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Zhang QH, 2004, P NATL ACAD SCI USA, V101, P4752, DOI 10.1073/pnas.0400924101; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	41	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35118	35128		10.1074/jbc.M804004200	http://dx.doi.org/10.1074/jbc.M804004200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18852267	Green Published, hybrid			2022-12-27	WOS:000261469100069
J	Feelisch, M; Fernandez, BO; Bryan, NS; Garcia-Saura, MF; Bauer, S; Whitlock, DR; Ford, PC; Janero, DR; Rodriguez, J; Ashrafian, H				Feelisch, Martin; Fernandez, Bernadette O.; Bryan, Nathan S.; Garcia-Saura, Maria Francisca; Bauer, Selena; Whitlock, David R.; Ford, Peter C.; Janero, David R.; Rodriguez, Juan; Ashrafian, Houman			Tissue Processing of Nitrite in Hypoxia AN INTRICATE INTERPLAY OF NITRIC OXIDE-GENERATING AND-SCAVENGING SYSTEMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; MITOCHONDRIAL RESPIRATION; REDUCTASE; NO; DEOXYHEMOGLOBIN; VASODILATION; HEMOGLOBIN; METABOLISM; MODULATION; PHYSIOLOGY	Although nitrite (NO2-) and nitrate (NO3-) have been considered traditionally inert byproducts of nitric oxide (NO) metabolism, recent studies indicate that NO2- represents an important source of NO for processes ranging from angiogenesis through hypoxic vasodilation to ischemic organ protection. Despite intense investigation, the mechanisms through which NO2- exerts its physiological/pharmacological effects remain incompletely understood. We sought to systematically investigate the fate of NO2- in hypoxia from cellular uptake in vitro to tissue utilization in vivo using the Wistar rat as a mammalian model. We find that most tissues (except erythrocytes) produce free NO at rates that are maximal under hypoxia and that correlate robustly with each tissue's capacity for mitochondrial oxygen consumption. By comparing the kinetics of NO release before and after ferricyanide addition in tissue homogenates to mathematical models of NO2- reduction/NO scavenging, we show that the amount of nitrosylated products formed greatly exceeds what can be accounted for by NO trapping. This difference suggests that such products are formed directly from NO2-, without passing through the intermediacy of free NO. Inhibitor and subcellular fractionation studies indicate that NO2- reductase activity involves multiple redundant enzymatic systems (i.e. heme, iron-sulfur cluster, and molybdenum-based reductases) distributed throughout different cellular compartments and acting in concert to elicit NO signaling. These observations hint at conserved roles for the NO2--NO pool in cellular processes such as oxygen-sensing and oxygen-dependent modulation of intermediary metabolism.	[Feelisch, Martin; Fernandez, Bernadette O.] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Feelisch, Martin; Fernandez, Bernadette O.; Bryan, Nathan S.; Garcia-Saura, Maria Francisca; Bauer, Selena; Janero, David R.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Univ Texas Houston, Hlth Sci Ctr, Brown Fdn, Inst Mol Med, Houston, TX 77030 USA; [Whitlock, David R.] Nitroceutic LLC, Dover, MA 02030 USA; [Ford, Peter C.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Janero, David R.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Rodriguez, Juan] Centenary Coll Louisiana, Dept Phys, Shreveport, LA 71134 USA; [Ashrafian, Houman] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Warwick; Boston University; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Santa Barbara; Northeastern University; University of Oxford	Feelisch, M (corresponding author), Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	mf@warwick.ac.uk	Ford, Peter C/D-1826-2011; Fernandez, Bernadette/AAG-7202-2020; Feelisch, Martin/C-3042-2008	Ford, Peter C/0000-0002-5509-9912; Fernandez, Bernadette/0000-0001-6337-0381; Feelisch, Martin/0000-0003-2320-1158; Ashrafian, Houman/0000-0003-3988-378X	National Institutes of Health [HL 69029]; Kirschstein National Research Service; Medical Research Council (MRC Strategic Appointment Scheme); Wellcome Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069029] Funding Source: NIH RePORTER; Medical Research Council [G0701115] Funding Source: researchfish; MRC [G0701115] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (MRC Strategic Appointment Scheme)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 69029 (to M. F.) and the Kirschstein National Research Service Award Cardiovascular Training Grant (to B. O. F. and N. S. B.). This work was also supported by the Medical Research Council (MRC Strategic Appointment Scheme, to M. F.), and a Wellcome Trust CVRI Fellowship (to H. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Alzawahra WF, 2008, AM J PHYSIOL-HEART C, V295, pH499, DOI 10.1152/ajpheart.00374.2008; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Benamar A, 2008, BBA-BIOENERGETICS, V1777, P1268, DOI 10.1016/j.bbabio.2008.06.002; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Castillo L, 1996, P NATL ACAD SCI USA, V93, P11460, DOI 10.1073/pnas.93.21.11460; COHEN JJ, 1979, AM J PHYSIOL, V236, pF423, DOI 10.1152/ajprenal.1979.236.5.F423; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Edmunds NJ, 2003, J PHYSIOL-LONDON, V546, P521, DOI 10.1113/jphysiol.2002.023663; Erusalimsky JD, 2007, ARTERIOSCL THROM VAS, V27, P2524, DOI 10.1161/ATVBAHA.107.151167; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Gladwin MT, 2002, J BIOL CHEM, V277, P27818, DOI 10.1074/jbc.M203236200; Gonzalez FM, 2008, CIRCULATION, V117, P2986, DOI 10.1161/CIRCULATIONAHA.107.748814; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; HULBERT AJ, 1989, AM J PHYSIOL, V256, pR63, DOI 10.1152/ajpregu.1989.256.1.R63; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Kozlov AV, 2003, BRIT J PHARMACOL, V139, P989, DOI 10.1038/sj.bjp.0705323; Kumar D, 2008, P NATL ACAD SCI USA, V105, P7540, DOI 10.1073/pnas.0711480105; Lancaster JR, 2006, CANCER RES, V66, P6459, DOI 10.1158/0008-5472.CAN-05-2900; Li CQ, 2005, CANCER LETT, V226, P1, DOI 10.1016/j.canlet.2004.10.021; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Li HT, 2006, J BIOL CHEM, V281, P12546, DOI 10.1074/jbc.M511803200; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Maher AR, 2008, CIRCULATION, V117, P670, DOI 10.1161/CIRCULATIONAHA.107.719591; Mazzone M, 2008, NATURE, V453, P1194, DOI 10.1038/4531194a; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; PARKS DA, 1986, ACTA PHYSIOL SCAND, V126, P87; RICKWOOD D, 1993, PREPARATIVE CENTRIFU; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Zhou SF, 2005, CLIN PHARMACOKINET, V44, P279, DOI 10.2165/00003088-200544030-00005	39	167	177	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33927	33934		10.1074/jbc.M806654200	http://dx.doi.org/10.1074/jbc.M806654200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835812	Green Published, hybrid			2022-12-27	WOS:000261277700019
J	Ferrari, E; He, ZQ; Palermo, RE; Huang, HC				Ferrari, Eric; He, Zhiqing; Palermo, Robert E.; Huang, H. -C.			Hepatitis C Virus NS5B Polymerase Exhibits Distinct Nucleotide Requirements for Initiation and Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; DE-NOVO INITIATION; NONSTRUCTURAL PROTEIN; IN-VITRO; CRYSTAL-STRUCTURE; STEADY-STATE; HCV RNA; REPLICATION; BINDING; INHIBITORS	The hepatitis C virus (HCV) NS5B protein is an RNA-dependent RNA polymerase (RdRp) essential for replication of the viral RNA genome. Purified NS5B has been reported to exhibit multiple activities in vitro. Using a synthetic heteropolymeric RNA template with dideoxycytidine at its 3'-end, we examined de novo initiation and primer extension in a system devoid of self-priming and terminal nucleotide transferase activities. Products predominantly of template size and its multiples were detected. High concentrations of nucleoside triphosphates (K-m(app) similar to 100 - 400 mu M) corresponding to the first three incorporated nucleotides were found to be required for efficient de novo RNA synthesis. In the presence of initiating di- or trinucleotides, however, the amount of NTP needed to achieve maximal activity dropped 10(3)- to 10(4)-fold, revealing a much reduced nucleotide requirement for elongation (K-m(app) similar to 0.03-0.09 mu M). Accordingly, single round extension from an exogenous primer following preincubation of the enzyme with template and primer could also be supported by <0.1 mu M levels of NTP. De novo synthesis at high NTP concentrations was shown to be preferred over primer extension. On a dideoxycytidine-blocked synthetic RNA template derived from the 3'-end of the HCV(-)UTR, the addition of the corresponding initiating trinucleotide also dramatically reduced the NTP levels needed to achieve efficient RNA synthesis. Thus, distinct nucleotide requirements exist for initiation and elongation steps catalyzed by the HCV NS5B polymerase.	[Ferrari, Eric; He, Zhiqing; Palermo, Robert E.; Huang, H. -C.] Schering Plough Res Inst, Dept Virol, Kenilworth, NJ 07033 USA	Merck & Company; Schering-Plough Research Institute	Huang, HC (corresponding author), Schering Plough Res Inst, Dept Virol, K15-4945,2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	hsueh-cheng.huang@spcorp.com						Ali N, 2002, J VIROL, V76, P12001, DOI 10.1128/JVI.76.23.12001-12007.2002; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Amiott EA, 2006, J BIOL CHEM, V281, P34982, DOI 10.1074/jbc.M608638200; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Arnold JJ, 1999, J BIOL CHEM, V274, P2706, DOI 10.1074/jbc.274.5.2706; Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Cai ZH, 2005, J VIROL, V79, P11607, DOI 10.1128/JVI.79.18.11607-11617.2005; Carroll S. S., 2006, Infectious Disorders - Drug Targets, V6, P17, DOI 10.2174/187152606776056698; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Cheng CP, 2003, J VIROL, V77, P12033, DOI 10.1128/JVI.77.22.12033-12047.2003; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; Hardy RW, 2003, J VIROL, V77, P2029, DOI 10.1128/JVI.77.3.2029-2037.2003; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; Jia YP, 1997, J BIOL CHEM, V272, P30147, DOI 10.1074/jbc.272.48.30147; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; Kim MJ, 2000, J VIROL, V74, P10312, DOI 10.1128/JVI.74.22.10312-10322.2000; Kim MJ, 2001, P NATL ACAD SCI USA, V98, P4972, DOI 10.1073/pnas.081077198; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lai VCH, 2003, J VIROL, V77, P2295, DOI 10.1128/JVI.77.3.2295-2300.2003; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1998, VIROLOGY, V249, P108, DOI 10.1006/viro.1998.9311; Lohmann V, 1999, J BIOL CHEM, V274, P10807, DOI 10.1074/jbc.274.16.10807; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Nelson HB, 2006, J VIROL, V80, P1181, DOI 10.1128/JVI.80.3.1181-1190.2006; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; Ranjith-Kumar CT, 2001, J VIROL, V75, P8615, DOI 10.1128/JVI.75.18.8615-8623.2001; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Shim JH, 2002, J VIROL, V76, P7030, DOI 10.1128/JVI.76.14.7030-7039.2002; Tomei L, 2000, J GEN VIROL, V81, P759, DOI 10.1099/0022-1317-81-3-759; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vo NV, 2004, BIOCHEMISTRY-US, V43, P10579, DOI 10.1021/bi049773g; Vreede FT, 2008, J VIROL, V82, P6902, DOI 10.1128/JVI.00627-08; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	54	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33893	33901		10.1074/jbc.M803094200	http://dx.doi.org/10.1074/jbc.M803094200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840605	hybrid, Green Published			2022-12-27	WOS:000261277700015
J	Jayakumar, AR; Liu, ML; Moriyama, M; Ramakrishnan, R; Forbush, B; Reddy, PVB; Norenberg, MD				Jayakumar, Arumugam R.; Liu, Mingli; Moriyama, Mitsuaki; Ramakrishnan, Ramugounder; Forbush, Bliss, III; Reddy, Pichili V. B.; Norenberg, Michael D.			Na-K-Cl Cotransporter-1 in the Mechanism of Ammonia-induced Astrocyte Swelling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; ION-TRANSPORT; NA+-K+-2CL(-) COTRANSPORTER; HEPATIC-ENCEPHALOPATHY; PRIMARY CULTURES; BENZODIAZEPINE-RECEPTOR; GLUTAMATE TRANSPORTER; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; TYROSINE KINASE	Brain edema and the consequent increase in intracranial pressure and brain herniation are major complications of acute liver failure (fulminant hepatic failure) and a major cause of death in this condition. Ammonia has been strongly implicated as an important factor, and astrocyte swelling appears to be primarily responsible for the edema. Ammonia is known to cause cell swelling in cultured astrocytes, although the means by which this occurs has not been fully elucidated. A disturbance in one or more of these systems may result in loss of ion homeostasis and cell swelling. In particular, activation of the Na-K-Cl cotransporter (NKCC1) has been shown to be involved in cell swelling in several neurological disorders. We therefore examined the effect of ammonia on NKCC activity and its potential role in the swelling of astrocytes. Cultured astrocytes were exposed to ammonia (NH4Cl; 5 mM), and NKCC activity was measured. Ammonia increased NKCC activity at 24 h. Inhibition of this activity by bumetanide diminished ammonia-induced astrocyte swelling. Ammonia also increased total as well as phosphorylated NKCC1. Treatment with cyclohexamide, a potent inhibitor of protein synthesis, diminished NKCC1 protein expression and NKCC activity. Since ammonia is known to induce oxidative/nitrosative stress, and antioxidants and nitric-oxide synthase inhibition diminish astrocyte swelling, we also examined whether ammonia caused oxidation and/or nitration of NKCC1. Cultures exposed to ammonia increased the state of oxidation and nitration of NKCC1, whereas the antioxidants N-nitro-L-arginine methyl ester and uric acid all significantly diminished NKCC activity. These agents also reduced phosphorylated NKCC1 expression. These results suggest that activation of NKCC1 is an important factor in the mediation of astrocyte swelling by ammonia and that such activation appears to be mediated by NKCC1 abundance as well as by its oxidation/nitration and phosphorylation.	[Jayakumar, Arumugam R.; Liu, Mingli; Moriyama, Mitsuaki; Ramakrishnan, Ramugounder; Reddy, Pichili V. B.; Norenberg, Michael D.] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33101 USA; [Norenberg, Michael D.] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA; [Norenberg, Michael D.] Vet Affairs Med Ctr, Miami, FL 33101 USA; [Moriyama, Mitsuaki] Osaka Prefecture Univ, Lab Integrat Physiol Vet Sci, Osaka 5998531, Japan; [Forbush, Bliss, III] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	University of Miami; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); Osaka Metropolitan University; Yale University	Norenberg, MD (corresponding author), Univ Miami, Sch Med, Dept Pathol D33, POB 016960, Miami, FL 33101 USA.	mnorenbe@med.miami.edu	Rajadas, Jayakumar/AHC-0630-2022	Moriyama, Mitsuaki/0000-0001-8123-8835	National Institutes of Health [DK063311]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK063311. This work was also supported by a Merit Review from the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbruscato TJ, 2004, J PHARMACOL EXP THER, V310, P459, DOI 10.1124/jpet.104.066274; Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Bender AS, 1996, NEUROCHEM RES, V21, P567, DOI 10.1007/BF02527755; Bender AS, 1998, J NEUROSCI RES, V54, P673, DOI 10.1002/(SICI)1097-4547(19981201)54:5<673::AID-JNR12>3.3.CO;2-G; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Chin SS, 1999, CURR EYE RES, V18, P254, DOI 10.1076/ceyr.18.4.254.5359; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; DUCIS I, 1990, BRAIN RES, V531, P318, DOI 10.1016/0006-8993(90)90793-B; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V271, pF619, DOI 10.1152/ajprenal.1996.271.3.F619; ELLIOTT SJ, 1992, AM J PHYSIOL, V263, pH96, DOI 10.1152/ajpheart.1992.263.1.H96; GREGORIOS JB, 1985, J NEUROPATH EXP NEUR, V44, P404, DOI 10.1097/00005072-198507000-00004; GREGORIOS JB, 1985, J NEUROPATH EXP NEUR, V44, P397, DOI 10.1097/00005072-198507000-00003; HAAS M, 1994, AM J PHYSIOL-CELL PH, V267, pC869, DOI 10.1152/ajpcell.1994.267.4.C869; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; HANSSON E, 1986, NEUROCHEM RES, V11, P759, DOI 10.1007/BF00965202; Hazell AS, 1999, P SOC EXP BIOL MED, V222, P99, DOI 10.1046/j.1525-1373.1999.d01-120.x; Hertz L, 1994, HDB NEUROCHEMISTRY, P603; Hoffmann EK, 1995, INT REV CYTOL, V161, P173; Isaacks RE, 1999, NEUROCHEM RES, V24, P51, DOI 10.1023/A:1020928029845; ITZHAK Y, 1994, NEUROSCI LETT, V177, P35, DOI 10.1016/0304-3940(94)90038-8; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; Juncos R, 2005, AM J PHYSIOL-RENAL, V288, pF982, DOI 10.1152/ajprenal.00348.2004; JUURLINK BHJ, 1985, DEV NEUROSCI-BASEL, V7, P263, DOI 10.1159/000112295; Kaplan MR, 1996, ANNU REV PHYSIOL, V58, P649, DOI 10.1146/annurev.ph.58.030196.003245; KIMELBERG HK, 1983, CELL MOL NEUROBIOL, V3, P1, DOI 10.1007/BF00734994; KIMELBERG HK, 1985, BRAIN RES, V361, P125, DOI 10.1016/0006-8993(85)91282-X; KIMELBERG HK, 1987, J PHYSIOL-PARIS, V82, P294; Kintner DB, 2007, AM J PHYSIOL-CELL PH, V292, pC1113, DOI 10.1152/ajpcell.00412.2006; Kintner DB, 2007, FRONT BIOSCI-LANDMRK, V12, P762, DOI 10.2741/2099; KLETZIEN RF, 1975, ANAL BIOCHEM, V68, P537, DOI 10.1016/0003-2697(75)90649-1; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; LYTLE C, 1992, J BIOL CHEM, V267, P25438; MacMillan-Crow LA, 2000, ARCH BIOCHEM BIOPHYS, V377, P350, DOI 10.1006/abbi.2000.1799; MacVicar BA, 2002, GLIA, V37, P114, DOI 10.1002/glia.10023; Mallozzi C, 2001, FEBS LETT, V503, P189, DOI 10.1016/S0014-5793(01)02726-0; MARTINEZ A, 1968, ACTA NEUROPATHOL, V11, P82, DOI 10.1007/BF00692797; Mobasheri A, 1998, HISTOL HISTOPATHOL, V13, P893, DOI 10.14670/HH-13.893; Murthy CRK, 2001, J NEUROSCI RES, V66, P282, DOI 10.1002/jnr.1222; Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883, DOI 10.1152/ajpcell.1998.274.4.C883; Norenberg MD, 2007, METAB BRAIN DIS, V22, P219, DOI 10.1007/s11011-007-9062-5; NORENBERG MD, 1990, J NEUROPATH EXP NEUR, V49, P399, DOI 10.1097/00005072-199007000-00004; Norenberg MD, 1996, SEMIN LIVER DIS, V16, P245, DOI 10.1055/s-2007-1007237; Norenberg MD, 2004, METAB BRAIN DIS, V19, P313, DOI 10.1023/B:MEBR.0000043978.91675.79; Norenberg MD, 1997, GLIA, V21, P124; NORENBERG MD, 1991, NEUROCHEM RES, V16, P833, DOI 10.1007/BF00965694; Norenberg MD, 2003, HEPATOLOGY, V37, P245, DOI 10.1053/jhep.2003.50087; Norenberg MD, 1998, METAB BRAIN DIS, V13, P319, DOI 10.1023/A:1020688925901; NORENBERG MD, 1977, LAB INVEST, V36, P618; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; NORENBERG MD, 1987, NEUROCHEM PATHOL, V6, P13, DOI 10.1007/BF02833599; NORENBERG MD, 2001, ASTROCYTES AGING BRA, P477; O'Neill WC, 1999, AM J PHYSIOL-CELL PH, V276, pC995, DOI 10.1152/ajpcell.1999.276.5.C995; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Pichili VBR, 2007, GLIA, V55, P801, DOI 10.1002/glia.20499; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Rao KVR, 2003, J NEUROSCI RES, V74, P891, DOI 10.1002/jnr.10755; Rose CR, 1996, J PHYSIOL-LONDON, V491, P291, DOI 10.1113/jphysiol.1996.sp021216; Rose CR, 1998, J NEUROSCI, V18, P3554; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schomberg SL, 2003, J NEUROPHYSIOL, V89, P159, DOI 10.1152/jn.00229.2002; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; STAUB F, 1994, J NEUROTRAUM, V11, P679, DOI 10.1089/neu.1994.11.679; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1136, DOI 10.1152/ajpcell.00478.2001; Su G, 2002, AM J PHYSIOL-CELL PH, V282, pC1147, DOI 10.1152/ajpcell.00538.2001; Su G, 2000, AM J PHYSIOL-CELL PH, V279, pC1710; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939, DOI 10.1152/jn.1999.81.4.1939; SWAIN M, 1992, HEPATOLOGY, V15, P449, DOI 10.1002/hep.1840150316; TAS PWL, 1987, BIOCHIM BIOPHYS ACTA, V903, P411, DOI 10.1016/0005-2736(87)90047-2; TAS PWL, 1986, NEUROSCI LETT, V70, P369, DOI 10.1016/0304-3940(86)90581-1; TRABER P, 1989, GASTROENTEROLOGY, V96, P885; Vaquero Javier, 2003, Ann Hepatol, V2, P12; WALZ W, 1992, CAN J PHYSIOL PHARM, V70, pS260, DOI 10.1139/y92-270; XIE YX, 1994, BRAIN RES, V652, P216, DOI 10.1016/0006-8993(94)90230-5; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201; Yan YP, 2001, BRAIN RES, V911, P43, DOI 10.1016/S0006-8993(01)02649-X; Zhou BG, 1999, NEUROSCI LETT, V276, P145, DOI 10.1016/S0304-3940(99)00816-2	84	99	108	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33874	33882		10.1074/jbc.M804016200	http://dx.doi.org/10.1074/jbc.M804016200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18849345	Green Published, hybrid			2022-12-27	WOS:000261277700012
J	Juarez, O; Nilges, MJ; Gillespie, P; Cotton, J; Barquera, B				Juarez, Oscar; Nilges, Mark J.; Gillespie, Portia; Cotton, Jennifer; Barquera, Blanca			Riboflavin Is an Active Redox Cofactor in the Na+-pumping NADH: Quinone Oxidoreductase (Na+-NQR) from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; REDUCTASE; FLAVIN; MUTAGENESIS; SUBUNITS; PURIFICATION; BINDING; ENDOR; SITE	Here we present new evidence that riboflavin is present as one of four flavins in Na+-NQR. In particular, we present conclusive evidence that the source of the neutral radical is not one of the FMNs and that riboflavin is the center that gives rise to the neutral flavosemiquinone. The riboflavin is a bona fide redox cofactor and is likely to be the last redox carrier of the enzyme, from which electrons are donated to quinone. We have constructed a double mutant that lacks both covalently bound FMN cofactors (NqrB-T236Y/NqrC-T225Y) and have studied this mutant together with the two single mutants (NqrB-T236Y and NqrC-T225Y) and a mutant that lacks the noncovalently bound FAD in NqrF (NqrF-S246A). The double mutant contains riboflavin and FAD in a 0.6:1 ratio, as the only flavins in the enzyme; noncovalently bound flavins were detected. In the oxidized form, the double mutant exhibits an EPR signal consistent with a neutral flavosemiquinone radical, which is abolished on reduction of the enzyme. The same radical can be observed in the FAD deletion mutant. Furthermore, when the oxidized enzyme reacts with ubiquinol (the reduced form of the usual electron acceptor) in a process that reverses the physiological direction of the electron flow, a single kinetic phase is observed. The kinetic difference spectrum of this process is consistent with one-electron reduction of a neutral flavosemiquinone. The presence of riboflavin in the role of a redox cofactor is thus far unique to Na+-NQR.	[Juarez, Oscar; Gillespie, Portia; Cotton, Jennifer; Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Juarez, Oscar; Gillespie, Portia; Cotton, Jennifer; Barquera, Blanca] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Nilges, Mark J.] Univ Illinois, Illinois EPR Res Ctr, Urbana, IL 61801 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Illinois System; University of Illinois Urbana-Champaign	Barquera, B (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Rm 2239,110 8 St, Troy, NY 12180 USA.	barqub@rpi.edu		Cotton, Jennifer/0000-0003-0106-1801; Juarez, Oscar/0000-0002-2915-8413	National Institutes of Health [R01GM 069936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM 069936. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Bogachev AV, 2007, BIOCHEMISTRY-US, V46, P10186, DOI 10.1021/bi700440w; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Duran-Pinedo AE, 2007, MOL MICROBIOL, V64, P1061, DOI 10.1111/j.1365-2958.2007.05717.x; Fadeeva MS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P123, DOI 10.1134/S0006297908020028; Fadeeva MS, 2008, FEMS MICROBIOL LETT, V279, P116, DOI 10.1111/j.1574-6968.2007.01015.x; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; Kay CWM, 1999, BIOCHEMISTRY-US, V38, P16740, DOI 10.1021/bi991442u; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Tao ML, 2006, ACTA CRYSTALLOGR F, V62, P110, DOI 10.1107/S174430910504306X; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697	25	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33162	33167		10.1074/jbc.M806913200	http://dx.doi.org/10.1074/jbc.M806913200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832377	Green Published, hybrid			2022-12-27	WOS:000261183700018
J	Park, E; Lee, JW; Eom, SH; Seol, JH; Chung, CH				Park, Eunyong; Lee, Jung Wook; Eom, Soo Hyun; Seol, Jae Hong; Chung, Chin Ha			Binding of MG132 or Deletion of the Thr Active Sites in HslV Subunits Increases the Affinity of HslV Protease for HslU ATPase and Makes This Interaction Nucleotide-independent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HOMOLOG; DEPENDENT PROTEASE; 20S PROTEASOME; EUKARYOTIC PROTEASOME; PROTEOLYTIC ACTIVITY; CRYSTAL-STRUCTURE; DEGRADATION; COMPLEX; HSIU; INHIBITORS	HslVU is an ATP-dependent protease in bacteria consisting of HslV dodecamer and HslU hexamer. Upon ATP binding, HslU ATPase allosterically activates the catalytic function of HslV protease by 1-2 orders of magnitude. However, relatively little is known about the role of HslV in the control of HslU function. Here we describe the involvement of the N-terminal Thr active sites (Thr-1) of HslV in the communication between HslV and HslU. Binding of proteasome inhibitors to Thr-1 led to a dramatic increase in the interaction between HslV and HslU with a marked increase in ATP hydrolysis by HslU. Moreover, carbobenzoxyleucyl-leucyl-leucinal (MG132) could bind to Thr-1 of free HslV, and this binding induced a tight interaction between HslV and HslU with the activation of HslU ATPase, suggesting that substrate-bound HslV can allosterically regulate HslU function. Unexpectedly, the deletion of Thr-1 also caused a dramatic increase in the affinity between HslV and HslU even in the absence of ATP. Furthermore, the increase in the number of the Thr-1 deletion mutant subunit in place of HslV subunit in a dodecamer led to a proportional increase in the affinity between HslV and HslU with gradual activation of HslU ATPase. Although the molecular mechanism elucidating how the Thr-1 deletion influences the interaction between HslV and HslU remains unknown, these results suggest an additional allosteric mechanism for the control of HslU function by HslV. Taken together, our findings indicate a critical involvement of Thr-1 of HslV in the reciprocal control of HslU function and, thus, for their communication.	[Park, Eunyong; Lee, Jung Wook; Seol, Jae Hong; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Eom, Soo Hyun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST)	Seol, JH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	jhseol@snu.ac.kr; chchung@snu.ac.kr			Korea Research Foundation [KRF-2005-084]; Korea Science and Engineering Foundation [M10533010001]; BK21 Program	Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); BK21 Program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by grants from the Korea Research Foundation Grant KRF-2005-084 and Korea Science and Engineering Foundation Grant M10533010001. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; These two authors were recipients of a fellowship from the BK21 Program and contributed equally to this work.	Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Huang HC, 1997, J BIOL CHEM, V272, P21364, DOI 10.1074/jbc.272.34.21364; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kwon AR, 2003, J MOL BIOL, V330, P185, DOI 10.1016/S0022-2836(03)00580-1; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; Neuwald AF, 1999, GENOME RES, V9, P27; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Seemuller E, 1996, NATURE, V382, P468, DOI 10.1038/382468a0; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Seong IS, 2002, J BIOL CHEM, V277, P25976, DOI 10.1074/jbc.M202793200; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Sousa MC, 2002, J MOL BIOL, V318, P779, DOI 10.1016/S0022-2836(02)00145-6; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yoo SJ, 1997, FEBS LETT, V412, P57, DOI 10.1016/S0014-5793(97)00742-4; Yoo SJ, 1997, BIOCHEM BIOPH RES CO, V238, P581, DOI 10.1006/bbrc.1997.7341; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035	37	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33258	33266		10.1074/jbc.M805411200	http://dx.doi.org/10.1074/jbc.M805411200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838376	Green Published, hybrid			2022-12-27	WOS:000261183700029
J	Goldman, D; Lavid, N; Schwartz, A; Shoham, G; Danino, D; Shoham, Y				Goldman, Dan; Lavid, Noa; Schwartz, Alon; Shoham, Gil; Danino, Dganit; Shoham, Yuval			Two Active Forms of Zymomonas mobilis Levansucrase AN ORDERED MICROFIBRIL STRUCTURE OF THE ENZYME PROMOTES LEVAN POLYMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS LEVANSUCRASE; EXTRACELLULAR LEVANSUCRASE; ACID; PURIFICATION; FRUCTOSYLTRANSFERASE; RESIDUES; IDENTIFICATION; DIAZOTROPHICUS; INVERTASE; SEQUENCE	Fructansucrases, members of glycoside hydrolase family 68, catalyze both sucrose hydrolysis and the polymerization of fructose to beta-D-fructofuranose polymers. The resulting fructan polymers are distinguished by the nature of the glycosidic bond: inulin (beta-(2-1)-fructofuranose) and levan (beta-(2-6)-fructofuranose). In this study we demonstrate that Zymomonas mobilis levansucrase exists in two active forms, depending on the pH and ionic strength. At pH values above 7.0, the enzyme is mainly a dimer, whereas at pH values below 6.0, the protein forms well ordered microfibrils that precipitate out of the solution. These two forms are readily interchangeable simply by changing the pH. Surprisingly the manner in which the enzyme is arranged strongly affects its product specificity and kinetic properties. At pH values above 7.0, the activity of the enzyme as a dimer is mainly sucrose hydrolysis and the synthesis of short fructosaccharides (degree of polymerization, 3). At pH values below 6.0, in its microfibril form, the enzyme catalyzes almost exclusively the synthesis of levan (a degree of polymerization greater than 20,000). This difference in product specificity appears to depend on the form of the enzyme, dimer versus microfibril, and not directly on the pH. Images made by negative stain transmission electron microscopy reveal that the enzyme forms a very ordered structure of long fibrils that appear to be composed of repeating rings of six to eight protein units. A single amino acid replacement of H296R abolished the ability of the enzyme to form microfibrils with organized fibril networks and to synthesize levan at pH 6.0.	[Goldman, Dan; Lavid, Noa; Schwartz, Alon; Danino, Dganit; Shoham, Yuval] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel; [Shoham, Gil] Hebrew Univ Jerusalem, Dept Inorgan Chem, IL-91904 Jerusalem, Israel; [Shoham, Gil] Hebrew Univ Jerusalem, Lab Struct Chem & Biol, IL-91904 Jerusalem, Israel	Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shoham, Y (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel.	yshoham@tx.technion.ac.il	Danino, Dganit/D-6832-2016; Shoham, Yuval/M-4409-2013	Danino, Dganit/0000-0002-9782-4940; 	Otto Meyerhof Center for Biotechnology, Technion	Otto Meyerhof Center for Biotechnology, Technion	This work was supported in part by the Otto Meyerhof Center for Biotechnology, Technion, established by the Minerva Foundation (Munich, Germany). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albenne C, 2007, PROTEINS, V66, P118, DOI 10.1002/prot.21083; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arrieta JG, 2004, J BACTERIOL, V186, P5031, DOI 10.1128/jb.186.15.5031-5039.2004; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; BARROW KD, 1984, EUR J BIOCHEM, V145, P173, DOI 10.1111/j.1432-1033.1984.tb08537.x; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; CHAMBERT R, 1974, EUR J BIOCHEM, V41, P285, DOI 10.1111/j.1432-1033.1974.tb03269.x; CHAMBERT R, 1991, BIOCHEM J, V279, P35, DOI 10.1042/bj2790035; CRITTENDEN RG, 1994, APPL MICROBIOL BIOT, V41, P302, DOI [10.1007/s002530050148, 10.1007/BF00221223]; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Johnson JL, 1981, MANUAL METHODS GENER, P450; KYONO K, 1995, BIOSCI BIOTECH BIOCH, V59, P289, DOI 10.1271/bbb.59.289; L'Hocine L, 2000, J BIOTECHNOL, V81, P73, DOI 10.1016/S0168-1656(00)00277-7; Li SY, 2008, ACTA BIOCHIM POL, V55, P201, DOI 10.18388/abp.2008_3217; LYNESS EW, 1983, BIOTECHNOL LETT, V5, P345, DOI 10.1007/BF01141136; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Meng G, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-16; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seibel J, 2006, CARBOHYD RES, V341, P2335, DOI 10.1016/j.carres.2006.07.001; Seo JS, 2005, NAT BIOTECHNOL, V23, P63, DOI 10.1038/nbt1045; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SONG KB, 1994, BIOTECHNOL LETT, V16, P1305; SWINGS J, 1977, BACTERIOL REV, V41, P1; TANRISEVEN A, 1993, CARBOHYD RES, V245, P97, DOI 10.1016/0008-6215(93)80062-J; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Hijum SAFT, 2003, FEBS LETT, V534, P207, DOI 10.1016/S0014-5793(02)03841-3; Vigants A, 2003, CURR MICROBIOL, V47, P198, DOI 10.1007/s00284-002-3984-2; Vigants A, 2001, CURR MICROBIOL, V42, P415, DOI 10.1007/s002840010239; Vigants A, 1998, BIOTECHNOL LETT, V20, P1017, DOI 10.1023/A:1005454921301; YANASE H, 1992, BIOSCI BIOTECH BIOCH, V56, P1335, DOI 10.1271/bbb.56.1335; Yanase H, 2002, J BIOCHEM, V132, P565, DOI 10.1093/oxfordjournals.jbchem.a003258	35	48	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32209	32217		10.1074/jbc.M805985200	http://dx.doi.org/10.1074/jbc.M805985200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809687	hybrid			2022-12-27	WOS:000260893700007
J	Kanters, E; van Rijssel, J; Hensbergen, PJ; Hondius, D; Mul, FPJ; Deelder, AM; Sonnenberg, A; van Buul, JD; Hordijk, PL				Kanters, Edwin; van Rijssel, Jos; Hensbergen, Paul J.; Hondius, David; Mul, Frederik P. J.; Deelder, Andre M.; Sonnenberg, Arnoud; van Buul, Jaap D.; Hordijk, Peter L.			Filamin B Mediates ICAM-1-driven Leukocyte Transendothelial Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; BRAIN ENDOTHELIAL-CELLS; INTRACELLULAR DOMAIN; ACTIN CYTOSKELETON; ALPHA-ACTININ; IN-VITRO; T-CELLS; ICAM-1; TRANSMIGRATION; ACTIVATION	During inflammation, the endothelium mediates rolling and firm adhesion of activated leukocytes. Integrin-mediated adhesion to endothelial ligands of the Ig-superfamily induces intracellular signaling in endothelial cells, which promotes leukocyte transendothelial migration. We identified the actin cross-linking molecule filamin B as a novel binding partner for intracellular adhesion molecule-1 (ICAM-1). Immune precipitation as well as laser scanning confocal microscopy confirmed the specific interaction and co-localization of endogenous filamin B with ICAM-1. Importantly, clustering of ICAM-1 promotes the ICAM-1-filamin B interaction. To investigate the functional consequences of filamin B binding to ICAM-1, we used small interfering RNA to reduce filamin B expression in ICAM-1-GFP expressing HeLa cells. We found that filamin B is required for the lateral mobility of ICAM-1 and for ICAM-1-induced transmigration of leukocytes. Reducing filamin B expression in primary human endothelial cells resulted in reduced recruitment of ICAM-1 to endothelial docking structures, reduced firm adhesion of the leukocytes to the endothelium, and inhibition of transendothelial migration. In conclusion, this study identifies filamin B as a molecular linker that mediates ICAM-1-driven transendothelial migration.	[Kanters, Edwin; van Rijssel, Jos; Hondius, David; Mul, Frederik P. J.; van Buul, Jaap D.; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Hensbergen, Paul J.; Deelder, Andre M.] Leiden Univ, Biomol Mass Spectrometry Unit, Dept Parasitol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute	Hordijk, PL (corresponding author), Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	p.hordijk@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021	van Buul, Jaap D/0000-0003-0054-7949; Hordijk, Peter/0000-0002-3348-078X; van Rijssel, Jos/0000-0001-8077-1371; Hensbergen, Paul/0000-0002-3193-5445; Mul, FPJ/0000-0002-8234-9972	Dutch Heart Foundation [2003B012]	Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported in part by Dutch Heart Foundation Grant 2003B012.	Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; Celli L, 2006, J IMMUNOL, V177, P4113, DOI 10.4049/jimmunol.177.6.4113; Cunningham CC, 1997, J CELL BIOL, V136, P845, DOI 10.1083/jcb.136.4.845; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P12536; Etienne S, 1998, J IMMUNOL, V161, P5755; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; GREENWOOD J, 1995, IMMUNOLOGY, V86, P408; Greenwood J, 2003, J IMMUNOL, V171, P2099, DOI 10.4049/jimmunol.171.4.2099; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Nyman-Huttunen H, 2006, J CELL SCI, V119, P3057, DOI 10.1242/jcs.03045; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913; Rauch BH, 2007, EUR J PHARMACOL, V577, P54, DOI 10.1016/j.ejphar.2007.08.041; Reiss Y, 1998, EUR J IMMUNOL, V28, P3086, DOI 10.1002/(SICI)1521-4141(199810)28:10<3086::AID-IMMU3086>3.3.CO;2-Q; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Romero IA, 2002, MOL BRAIN RES, V105, P47, DOI 10.1016/S0169-328X(02)00392-3; Sans E, 2001, J IMMUNOL, V166, P544, DOI 10.4049/jimmunol.166.1.544; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; STEEN H, 2002, SCI STKE, pL16, DOI DOI 10.1126/STKE.2002.154.PL16; STEMME S, 1994, ANN MED, V26, P141, DOI 10.3109/07853899409147881; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; van Buul JD, 2007, ARTERIOSCL THROM VAS, V27, P1870, DOI 10.1161/ATVBAHA.107.145821; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Yang L, 2006, J IMMUNOL, V177, P6440, DOI 10.4049/jimmunol.177.9.6440	42	67	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31830	31839		10.1074/jbc.M804888200	http://dx.doi.org/10.1074/jbc.M804888200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18809679	hybrid			2022-12-27	WOS:000260760800066
J	Morrissette, DA; Parachikova, A; Green, KN; LaFerla, FM				Morrissette, Debbi A.; Parachikova, Anna; Green, Kim N.; LaFerla, Frank M.			Relevance of Transgenic Mouse Models to Human Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMYLOID PRECURSOR PROTEIN; A-BETA OLIGOMERS; SYNAPTIC DYSFUNCTION; TAU PATHOLOGY; COGNITIVE DEFICITS; MICE; CALCIUM; PLAQUES; BRAIN; INFLAMMATION	During the past 2 decades, the elucidation of susceptibility and causative genes for Alzheimer disease as well as proteins involved in the pathogenic process has greatly facilitated the development of genetically altered mouse models. These models have played a major role in defining critical disease-related mechanisms and in evaluating novel therapeutic approaches, with many treatments currently in clinical trial owing their origins to studies initially performed in mice. This review discusses the utility of transgenic mice as a research tool and their contributions to our understanding of Alzheimer disease.	[LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	laferla@uci.edu	Morrissette, Debbi/AAR-3442-2021					Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Bell KFS, 2006, EUR J PHARMACOL, V545, P11, DOI 10.1016/j.ejphar.2006.06.045; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Eriksen JL, 2007, BEHAV GENET, V37, P79, DOI 10.1007/s10519-006-9118-z; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Green K. N., 2007, V45, P507; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Iqbal K, 2005, ACTA NEUROPATHOL, V109, P25, DOI 10.1007/s00401-004-0951-y; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lehman EJH, 2003, HUM MOL GENET, V12, P2949, DOI 10.1093/hmg/ddg322; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Morgan D, 2006, J ALZHEIMERS DIS, V9, P425; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Schauwecker PE, 2002, EXP NEUROL, V178, P219, DOI 10.1006/exnr.2002.8038; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shuttleworth CWR, 2001, J NEUROSCI, V21, P4225, DOI 10.1523/JNEUROSCI.21-12-04225.2001; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Steele M, 2007, EXP GERONTOL, V42, P28, DOI 10.1016/j.exger.2006.06.002; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Webster SD, 1999, NEUROBIOL AGING, V20, P297, DOI 10.1016/S0197-4580(99)00020-2; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Xie CW, 2004, NEUROMOL MED, V6, P53, DOI 10.1385/NMM:6:1:053; Yang FS, 2000, BRAIN RES, V853, P381, DOI 10.1016/S0006-8993(99)02207-6; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	56	113	118	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6033	6037		10.1074/jbc.R800030200	http://dx.doi.org/10.1074/jbc.R800030200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	18948253	hybrid			2022-12-27	WOS:000263742700003
J	Yang, JH; Yang, L; Qu, ZL; Weiss, JN				Yang, Jun-Hai; Yang, Ling; Qu, Zhilin; Weiss, James N.			Glycolytic Oscillations in Isolated Rabbit Ventricular Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; MYOCARDIAL SUBSTRATE METABOLISM; (ROS)-INDUCED ROS RELEASE; CARDIAC MYOCYTES; CREATINE-KINASE; ATP HYDROLYSIS; FREE-RADICALS; HEART-CELLS; RAT HEARTS; ISCHEMIA	Previous studies have shown that glycolysis can oscillate periodically, driven by feedback loops in regulation of key glycolytic enzymes by free ADP and other metabolites. Here we show both theoretically and experimentally in cardiac myocytes that when the capacity of oxidative phosphorylation and the creatine kinase system to buffer the cellular ATP/ADP ratio is suppressed, glycolysis can cause large scale periodic oscillations in cellular ATP levels (0.02-0.067 Hz), monitored from gliben-clamide-sensitive changes in action potential duration or intracellular free Mg2+. Action potential duration oscillations originate primarily from glycolysis, since they 1) occur in the presence of cyanide or rotenone, 2) are suppressed by iodoacetate, 3) are accompanied by at most very small mitochondrial membrane potential oscillations, and 4) exhibit an anti-phase relationship to NADH fluorescence. By uncoupling energy supply-demand balance, glycolytic oscillations may promote injury and electrophysiological heterogeneity during acute metabolic stresses, such as acute myocardial ischemia in which both oxidative phosphorylation and creatine kinase activity are inhibited.	[Qu, Zhilin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Cardiovasc Res Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Qu, ZL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Cardiol, Cardiovasc Res Lab, 675 Charles Young Dr S,3645 MRL, Los Angeles, CA 90095 USA.	zqu@mednet.ucla.edu	Yang, Ling/D-2368-2011		National Institutes of Health; NHLBI [P01 HL-080111, R01 HL-071870]; Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071870, P01HL080111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants P01 HL-080111 and R01 HL-071870. This work was also supported by the Laubisch and Kawata Endowments. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Brady NR, 2006, ANTIOXID REDOX SIGN, V8, P1651, DOI 10.1089/ars.2006.8.1651; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; CHANCE B, 1972, AM J PHYSIOL, V223, P207, DOI 10.1152/ajplegacy.1972.223.1.207; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Dolder M, 2001, BIOL SIGNAL RECEPT, V10, P93; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; Ferrero JM, 1996, CIRC RES, V79, P208, DOI 10.1161/01.RES.79.2.208; Geraldes CFGC, 1997, MOL CELL BIOCHEM, V170, P53, DOI 10.1023/A:1006899932108; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; GOLDHABER JI, 1989, J CLIN INVEST, V83, P1800, DOI 10.1172/JCI114085; HESS B, 1968, H-S Z PHYSIOL CHEM, V349, P1567, DOI 10.1515/bchm2.1968.349.2.1567; HIGGINS J, 1964, P NATL ACAD SCI USA, V51, P989, DOI 10.1073/pnas.51.6.989; ICHIHARA K, 1984, AM J PHYSIOL, V246, pH652, DOI 10.1152/ajpheart.1984.246.5.H652; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; KUNZ WS, 1993, BIOCHEM MED METAB B, V50, P103, DOI 10.1006/bmmb.1993.1051; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Mekhfi H, 1996, CIRC RES, V78, P1016, DOI 10.1161/01.RES.78.6.1016; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Rehring TF, 1998, AM J PHYSIOL-HEART C, V275, pH805, DOI 10.1152/ajpheart.1998.275.3.H805; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Ryu SY, 2005, J MOL CELL CARDIOL, V39, P874, DOI 10.1016/j.yjmcc.2005.08.011; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; Sasaki N, 2001, AM J PHYSIOL-HEART C, V280, pH1882, DOI 10.1152/ajpheart.2001.280.4.H1882; Schaefer S, 1997, CARDIOVASC RES, V35, P90, DOI 10.1016/S0008-6363(97)00087-4; SCOTT ID, 1980, BIOCHEM J, V186, P21, DOI 10.1042/bj1860021; Silva AS, 2006, GENET MOL RES, V5, P525; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; van Beek JHGM, 2007, AM J PHYSIOL-CELL PH, V293, pC815, DOI 10.1152/ajpcell.00355.2006; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Weiss RG, 1996, CIRC RES, V79, P435, DOI 10.1161/01.RES.79.3.435; Westermark PO, 2003, BIOPHYS J, V85, P126, DOI 10.1016/S0006-3495(03)74460-9; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; YANG WCT, 1977, LIFE SCI, V21, P1171, DOI 10.1016/0024-3205(77)90117-5; Zhou LF, 2006, AM J PHYSIOL-HEART C, V291, pH1036, DOI 10.1152/ajpheart.01382.2005; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	42	38	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36321	36327		10.1074/jbc.M804794200	http://dx.doi.org/10.1074/jbc.M804794200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18948270	Green Published, hybrid			2022-12-27	WOS:000261840500028
J	Ren, KH; Jin, HX; Bian, CJ; He, HW; Liu, X; Zhang, SH; Wang, YG; Shao, RG				Ren, Kaihuan; Jin, Haixia; Bian, Chunjing; He, Hongwei; Liu, Xia; Zhang, Shenghua; Wang, Yiguang; Shao, Rong-Guang			MR-1 Modulates Proliferation and Migration of Human Hepatoma HepG2 Cells through Myosin Light Chains-2 (MLC2)/Focal Adhesion Kinase (FAK)/Akt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; RHO-KINASE; REGULATED KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; FOCAL ADHESIONS; STRESS FIBERS; GROWTH-FACTOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION	The key of cell migration process on solid substrates is phosphorylation of myosin light chain-2 (MLC2), which is implicated in a variety of intracellular functions. The previous data show that MLC2 interacts with a novel human gene, myofibrillogenesis regulator 1 (MR-1). Here, we reported that MR-1 was specially overexpressed in human hepatoma HepG2 cells. Transient treatment of cells with small interfering RNA (siRNA) against MR-1 or stable transfection of cells with plasmid expressing MR-1-siRNA led to inhibitions of cell proliferation, migration, and adhesion. Following down-regulation of MR-1, the phosphorylations of MLC2, focal adhesion kinase (FAK), and Akt were dramatically decreased, and the formation of stress fiber was destroyed by MR-1-siRNAs in hepatoma HepG2 cells. In addition, exogenous MR-1-induced as well as inherent phosphorylations of FAK and Akt were decreased by MLC kinase (MLCK) inhibitor, and F-actin polymerization inhibitor also decreased phosphorylations of FAK and Akt. Correspondingly, MR-1-enhanced migration of cells was also inhibited by these two inhibitors. These indicated that MLC2 activation and intact actin cytoskeleton were pivotal for MR-1 function. In vivo data showed that MR-1-siRNA markedly inhibited growth of human HepG2. This study suggested that overexpression of MR-1 was associated with cancer cell proliferation and migration through MLC2 and that MR-1 might be a potential cancer therapeutic target.	[Ren, Kaihuan; Jin, Haixia; He, Hongwei; Liu, Xia; Zhang, Shenghua; Wang, Yiguang; Shao, Rong-Guang] Chinese Acad Med Sci, Inst Med Biotechnol, Dept Oncol, Beijing 100050, Peoples R China; [Bian, Chunjing] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Excellence Tissue Engn, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Shao, RG (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Dept Oncol, 1 Tiantan Xili, Beijing 100050, Peoples R China.	shaor@bbn.cn	jin, haixia/HGA-9179-2022; He, Hongwei/G-5759-2010	He, Hongwei/0000-0002-9159-091X	National Natural Science Foundation of China (NSFC) [30772583]; National 973 Program [2002CB513108]; Ministry of Education [20070023017]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China); Ministry of Education	This work was supported by National Natural Science Foundation of China (NSFC) Grant 30772583), National 973 Program Grant 2002CB513108, and Ministry of Education Grant 20070023017. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Acconcia F, 2006, CANCER RES, V66, P11030, DOI 10.1158/0008-5472.CAN-06-2676; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Connell LE, 2006, J CELL SCI, V119, P2269, DOI 10.1242/jcs.02926; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; Fazal F, 2005, MOL CELL BIOL, V25, P6259, DOI 10.1128/MCB.25.14.6259-6266.2005; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; Hakuma N, 2005, CANCER RES, V65, P10776, DOI 10.1158/0008-5472.CAN-05-0060; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Ilic D, 1998, J CELL BIOL, V143, P547; ILLC D, 1995, NATURE, V377, P539; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kaneko K, 2002, PANCREAS, V24, P34, DOI 10.1097/00006676-200201000-00005; Kassis J, 2001, SEMIN CANCER BIOL, V11, P105, DOI 10.1006/scbi.2000.0362; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Li TB, 2004, ACTA BIOCH BIOPH SIN, V36, P412, DOI 10.1093/abbs/36.6.412; Liu TG, 2004, CANCER GENE THER, V11, P748, DOI 10.1038/sj.cgt.7700753; Liu XH, 2006, AM J PHYSIOL-HEART C, V290, pH279, DOI 10.1152/ajpheart.00247.2005; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARRA F, 1995, FEBS LETT, V376, P141, DOI 10.1016/0014-5793(95)01261-0; Masuda T, 2005, CLIN CANCER RES, V11, P4012, DOI 10.1158/1078-0432.CCR-05-0087; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; Niggli V, 2006, BIOCHEM BIOPH RES CO, V343, P602, DOI 10.1016/j.bbrc.2006.03.022; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Roovers K, 2003, MOL CELL BIOL, V23, P4283, DOI 10.1128/MCB.23.12.4283-4294.2003; Roovers K, 2003, DEV CELL, V5, P273, DOI 10.1016/S1534-5807(03)00206-5; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Swant JD, 2005, J BIOL CHEM, V280, P23066, DOI 10.1074/jbc.M500636200; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Vasiliev JM, 2004, INT J DEV BIOL, V48, P425, DOI 10.1387/ijdb.041806jv; Wakatsuki T, 2003, J CELL SCI, V116, P1617, DOI 10.1242/jcs.00340; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; WILSON AK, 1992, CANCER METAST REV, V11, P79, DOI 10.1007/BF00047605; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	50	39	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35598	35605		10.1074/jbc.M802253200	http://dx.doi.org/10.1074/jbc.M802253200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948272	hybrid			2022-12-27	WOS:000261687900032
J	Chalupnikova, K; Lattmann, S; Selak, N; Iwamoto, F; Fujiki, Y; Nagamine, Y				Chalupnikova, Katerina; Lattmann, Simon; Selak, Nives; Iwamoto, Fumiko; Fujiki, Yukio; Nagamine, Yoshikuni			Recruitment of the RNA Helicase RHAU to Stress Granules via a Unique RNA-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CRYSTAL-STRUCTURE; PROCESSING BODIES; TERMINAL DOMAIN; PROTEIN; BOX; TRANSLATION; EXPORT; SITES; PHOSPHORYLATION	In response to environmental stress, the translation machinery of cells is reprogrammed. The majority of actively translated mRNAs are released from polysomes and driven to specific cytoplasmic foci called stress granules (SGs) where dynamic changes in protein-RNA interaction determine the subsequent fate of mRNAs. Here we show that the DEAH box RNA helicase RHAU is a novel SG-associated protein. Although RHAU protein was originally identified as an AU-rich element-associated protein involved in urokinase-type plasminogen activator mRNA decay, it was not clear whether RHAU could directly interact with RNA. We have demonstrated that RHAU physically interacts with RNA in vitro and in vivo through a newly identified N-terminal RNA-binding domain, which was found to be both essential and sufficient for RHAU localization in SGs. We have also shown that the ATPase activity of RHAU plays a role in the RNA interaction and in the regulation of protein retention in SGs. Thus, our results show that RHAU is the fourth RNA helicase detected in SGs, after rck/p54, DDX3, and eIF4A, and that its association with SGs is dynamic and mediated by an RHAU-specific RNA-binding domain.	[Chalupnikova, Katerina; Lattmann, Simon; Selak, Nives; Iwamoto, Fumiko; Nagamine, Yoshikuni] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Fujiki, Yukio] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Friedrich Miescher Institute for Biomedical Research; Novartis; Kyushu University	Nagamine, Y (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	Yoshikuni.nagamine@fmi.ch	Lattmann, Simon/G-2914-2010	Lattmann, Simon/0000-0002-4639-4602	The Science and Technology Agency of Japan	The Science and Technology Agency of Japan(Japan Science & Technology Agency (JST))	This work was supported in part by CREST grant (to Y.F.) from The Science and Technology Agency of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abdelhaleem M, 2003, GENOMICS, V81, P618, DOI 10.1016/S0888-7543(03)00049-1; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Askjaer P, 2000, J BIOL CHEM, V275, P11561, DOI 10.1074/jbc.275.16.11561; Baguet A, 2007, J CELL SCI, V120, P2774, DOI 10.1242/jcs.009225; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fujimura K, 2008, RNA, V14, P425, DOI 10.1261/rna.780708; Fujimura K, 2008, EXP CELL RES, V314, P543, DOI 10.1016/j.yexcr.2007.10.024; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Jankowsky E, 2000, NUCLEIC ACIDS RES, V28, P333, DOI 10.1093/nar/28.1.333; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; Jeong Euna, 2004, Genome Inform, V15, P105; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schneider S, 2002, J BIOL CHEM, V277, P15452, DOI 10.1074/jbc.M112473200; Schneider S, 2001, J BIOL CHEM, V276, P21184, DOI 10.1074/jbc.M101964200; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tong J, 2008, COMPUT METH PROG BIO, V90, P148, DOI 10.1016/j.cmpb.2007.12.003; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Valgardsdottir R, 2003, J BIOL CHEM, V278, P21146, DOI 10.1074/jbc.M300888200; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Wagner JDO, 1998, EMBO J, V17, P2926, DOI 10.1093/emboj/17.10.2926; Wang Y, 1998, RNA, V4, P1216, DOI 10.1017/S1355838298980992; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692	50	75	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35186	35198		10.1074/jbc.M804857200	http://dx.doi.org/10.1074/jbc.M804857200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18854321	Green Published, hybrid			2022-12-27	WOS:000261469100075
J	Colon-Gonzalez, F; Leskow, FC; Kazanietz, MG				Colon-Gonzalez, Francheska; Leskow, Federico Coluccio; Kazanietz, Marcelo G.			Identification of an Autoinhibitory Mechanism That Restricts C1 Domain-mediated Activation of the Rac-GAP alpha 2-Chimaerin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMALL-MOLECULE INHIBITOR; PHORBOL ESTER RECEPTORS; TYROSINE PHOSPHORYLATION; DIACYLGLYCEROL-BINDING; INDUCED TRANSLOCATION; NIH 3T3-CELLS; BETA-2-CHIMAERIN; GTPASES; FAMILY	Chimaerins are a family of GTPase activating proteins (GAPs) for the small G-protein Rac that have gained recent attention due to their important roles in development, cancer, neurito-genesis, and T-cell function. Like protein kinase C isozymes, chimaerins possess a C1 domain capable of binding phorbol esters and the lipid second messenger diacylglycerol (DAG) in vitro. Here we identified an autoinhibitory mechanism in alpha 2-chimaerin that restricts access of phorbol esters and DAG, thereby limiting its activation. Although phorbol 12-myristate 13-acetate (PMA) caused limited translocation of wild-type alpha 2-chimaerin to the plasma membrane, deletion of either N- or C-terminal regions greatly sensitize alpha 2-chimaerin for intracellular redistribution and activation. Based on modeling analysis that revealed an occlusion of the ligand binding site in the alpha 2-chimaerin C1 domain, we identified key amino acids that stabilize the inactive conformation. Mutation of these sites renders alpha 2-chimaerin hypersensitive to C1 ligands, as reflected by its enhanced ability to translocate in response to PMA and to inhibit Rac activity and cell migration. Notably, in contrast to PMA, epidermal growth factor promotes full translocation of alpha 2-chimaerin in a phospholipase C-dependent manner, but not of a C1 domain mutant with reduced affinity for DAG (P216A-alpha 2-chimaerin). Therefore, DAG generation and binding to the C1 domain are required but not sufficient for epidermal growth factor- induced alpha 2-chimaerin membrane association. Our studies suggest a role for DAG in anchoring rather than activation of alpha 2-chimaerin. Like other DAG/phorbol ester receptors, including protein kinase C isozymes, alpha 2-chimaerin is subject to auto-inhibition by intramolecular contacts, suggesting a highly regulated mechanism for the activation of this Rac-GAP.	[Colon-Gonzalez, Francheska; Kazanietz, Marcelo G.] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA; [Colon-Gonzalez, Francheska; Kazanietz, Marcelo G.] Univ Penn, Sch Med, ITMAT, Philadelphia, PA 19104 USA; [Leskow, Federico Coluccio] Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1053 Buenos Aires, DF, Argentina	University of Pennsylvania; University of Pennsylvania; University of Buenos Aires	Kazanietz, MG (corresponding author), 1256 Bioimed Res Bldg II-III,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu			National Institutes of Health [CA74197]; NATIONAL CANCER INSTITUTE [R01CA074197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA74197 (to M. G. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; ARECES LB, 1994, J BIOL CHEM, V269, P19553; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bogi K, 1999, FEBS LETT, V456, P27, DOI 10.1016/S0014-5793(99)00927-8; Budas GR, 2007, BIOCHEM SOC T, V35, P1021, DOI 10.1042/BST0351021; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Choi SH, 2008, J BIOL CHEM, V283, P10543, DOI 10.1074/jbc.M707463200; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Kai M, 2007, BBA-MOL CELL RES, V1773, P1407, DOI 10.1016/j.bbamcr.2007.05.004; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Leskow FC, 2006, P NATL ACAD SCI USA, V103, P5373, DOI 10.1073/pnas.0508585103; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Menna PL, 2003, CANCER RES, V63, P2284; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; ORR JW, 1994, J BIOL CHEM, V269, P8383; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Schechtman D, 2004, J BIOL CHEM, V279, P15831, DOI 10.1074/jbc.M310696200; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shen N, 2005, BIOCHEMISTRY-US, V44, P1089, DOI 10.1021/bi0476127; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Siliceo M, 2006, J CELL SCI, V119, P141, DOI 10.1242/jcs.02722; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Wang HB, 2002, J BIOL CHEM, V277, P4541, DOI 10.1074/jbc.M107150200; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yasuda S, 2008, BIOCHEM J, V409, P95, DOI 10.1042/BJ20070848	45	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35247	35257		10.1074/jbc.M806264200	http://dx.doi.org/10.1074/jbc.M806264200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18826946	hybrid, Green Published			2022-12-27	WOS:000261469100080
J	Lau, KF; Chan, WM; Perkinton, MS; Tudor, EL; Chang, RCC; Chan, HYE; McLoughlin, DM; Miller, CCJ				Lau, Kwok-Fai; Chan, Wing-Man; Perkinton, Michael S.; Tudor, Elizabeth L.; Chang, Raymond C. C.; Chan, H. -Y. Edwin; McLoughlin, Declan M.; Miller, Christopher C. J.			Dexras1 Interacts with FE65 to Regulate FE65-Amyloid Precursor Protein-dependent Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; GLYCOGEN-SYNTHASE KINASE-3; APP INTRACELLULAR DOMAIN; RAS-RELATED PROTEIN; AMYLOID-BETA; ALZHEIMERS-DISEASE; ADAPTER PROTEIN; PTB DOMAIN; MOUSE MODEL; EXPRESSION	FE65 is an adaptor protein that binds to and forms a transcriptionally active complex with the gamma-secretase-derived amyloid precursor protein (APP) intracellular domain. The regulatory mechanisms of FE65-APP-mediated transcription are still not clear. In this report, we demonstrate that Dexras1, a Ras family small G protein, binds to FE65 PTB2 domain and potently suppresses the FE65-APP-mediated transcription. The suppression is not via competition for binding of FE65 between Dexras1 and APP because the two proteins can simultaneously bind to the FE65 PTB2 domain. Phosphorylation of FE65 tyrosine 547 within the PTB2 domain has been shown to enhance FE65-APP-mediated transcription but not to influence binding to APP. Here we find that this phosphorylation event reduces the binding between Dexras1 and FE65. We also demonstrate that Dexras1 inhibits the FE65-APP-mediated transcription of glycogen synthase kinase 3 beta(GSK3 beta). Moreover, small interfering RNA knockdown of Dexras1 enhances GSK3 beta expression and increases phosphorylation of Tau, a GSK3 beta substrate. Thus, Dexras1 functions as a suppressor of FE65-APP-mediated transcription, and FE65 tyrosine 547 phosphorylation enhances FE65-APP-mediated transcription, at least in part, by modulating the interaction between FE65 and Dexras1. These findings reveal a novel regulatory mechanism for FE65-APP-mediated signaling.	[Lau, Kwok-Fai; Chan, Wing-Man; Chan, H. -Y. Edwin] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China; [Lau, Kwok-Fai; Chan, Wing-Man; Chan, H. -Y. Edwin] Chinese Univ Hong Kong, Mol Biotechnol Programme, Shatin, Hong Kong, Peoples R China; [Perkinton, Michael S.; Tudor, Elizabeth L.; McLoughlin, Declan M.; Miller, Christopher C. J.] Kings Coll London, Inst Psychiat, Dept Neurosci, MRC Ctr Neurodegenerat Res, London SE5 8AF, England; [Chang, Raymond C. C.] Univ Hong Kong, Dept Anat, Lab Neurodegenerat Dis, Pokfulam, Hong Kong, Peoples R China; [McLoughlin, Declan M.] St Patricks Hosp, Trinity Coll, Dept Psychiat, Dublin 8, Ireland	Chinese University of Hong Kong; Chinese University of Hong Kong; University of London; King's College London; University of Hong Kong; Trinity College Dublin	Lau, KF (corresponding author), Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China.	kflau@cuhk.edu.hk	Chan, Edwin/A-9478-2011; Chang, Raymond Chuen-Chung/C-1107-2009; Miller, Christopher/H-5733-2012	Chan, Edwin/0000-0003-4307-474X; Chang, Raymond Chuen-Chung/0000-0001-8538-7993; McLoughlin, Declan/0000-0003-4574-2799; Miller, Christopher/0000-0002-5130-1845; Lau, Kwok-Fai/0000-0002-0193-1152	Council Hong Kong, a Chinese University of Hong Kong; United Kingdom Medical Research Council, Biotechnology and Biological Sciences Research Council; European Union NeuroNE,; Alzheimer Society; MRC [G0000749, G0501573] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C506913/1] Funding Source: researchfish; Medical Research Council [G0501573, G0000749] Funding Source: researchfish	Council Hong Kong, a Chinese University of Hong Kong(Chinese University of Hong Kong); United Kingdom Medical Research Council, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union NeuroNE,; Alzheimer Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Research Grant Council Hong Kong, a Chinese University of Hong Kong direct grant scheme, the Wellcome Trust, United Kingdom Medical Research Council, Biotechnology and Biological Sciences Research Council, European Union NeuroNE, the Alzheimer Society, the Alzheimer Research Trust, and the Alzheimer Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amanatullah D F, 2002, Minerva Endocrinol, V27, P7; Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Brogan MD, 2001, NEUROENDOCRINOLOGY, V74, P244, DOI 10.1159/000054691; Brownlees J, 2000, J CELL SCI, V113, P401; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Chien CT, 1998, MOL CELL BIOL, V18, P598, DOI 10.1128/MCB.18.1.598; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Costello LC, 2002, HORM METAB RES, V34, P417, DOI 10.1055/s-2002-33598; Dai JP, 2004, BRIT J PHARMACOL, V143, P606, DOI 10.1038/sj.bjp.0705995; De Martino MU, 2004, ANN NY ACAD SCI, V1024, P72, DOI 10.1196/annals.1321.006; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Giubilei F, 2001, J NEUROSCI RES, V66, P262, DOI 10.1002/jnr.1219; Graham TE, 2001, ENDOCRINOLOGY, V142, P2631, DOI 10.1210/en.142.6.2631; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hoschl C, 2001, EUR ARCH PSY CLIN N, V251, P81; Jicha GA, 1997, J NEUROCHEM, V69, P2087; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Kesavapany S, 2002, NEUROSCIENCE, V115, P951, DOI 10.1016/S0306-4522(02)00422-0; Kesavapany S, 2001, EUR J NEUROSCI, V13, P241, DOI 10.1046/j.1460-9568.2001.01376.x; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kinoshita A, 2002, J NEUROCHEM, V82, P839, DOI 10.1046/j.1471-4159.2002.01016.x; Klein-Hitpass L, 1998, J MOL MED, V76, P490, DOI 10.1007/s001090050243; Kulstad JJ, 2005, J NEUROPATH EXP NEUR, V64, P139, DOI 10.1093/jnen/64.2.139; Lau KF, 1999, J PEPT RES, V54, P85, DOI 10.1034/j.1399-3011.1999.00083.x; Lau KF, 1999, GENOMICS, V60, P121, DOI 10.1006/geno.1999.5875; Lau KF, 2002, MOL CELL NEUROSCI, V20, P13, DOI 10.1006/mcne.2002.1108; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; MAEDA K, 1991, NEUROBIOL AGING, V12, P161, DOI 10.1016/0197-4580(91)90055-O; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; McLoughlin DM, 2001, J BIOL CHEM, V276, P9303, DOI 10.1074/jbc.M010023200; McLoughlin DM, 1996, FEBS LETT, V397, P197; Minopoli G, 2001, J BIOL CHEM, V276, P6545, DOI 10.1074/jbc.M007340200; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Pascualy M, 2000, BIOL PSYCHIAT, V48, P247, DOI 10.1016/S0006-3223(00)00879-9; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Peskind ER, 2001, NEUROLOGY, V56, P1094, DOI 10.1212/WNL.56.8.1094; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Santiard-Baron D, 2005, J NEUROCHEM, V93, P330, DOI 10.1111/j.1471-4159.2005.03026.x; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Standen CL, 2003, MOL CELL NEUROSCI, V24, P851, DOI 10.1016/j.mcn.2003.07.002; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; SWAAB DF, 1994, J NEUROENDOCRINOL, V6, P681, DOI 10.1111/j.1365-2826.1994.tb00635.x; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Thomas JE, 1996, J BIOL CHEM, V271, P28630, DOI 10.1074/jbc.271.45.28630; Touma C, 2004, NEUROBIOL AGING, V25, P893, DOI 10.1016/j.neurobiolaging.2003.09.004; Tu YZ, 1999, BBA-GENE STRUCT EXPR, V1489, P452, DOI 10.1016/S0167-4781(99)00197-9; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zambrano N, 2001, J BIOL CHEM, V276, P19787, DOI 10.1074/jbc.M100792200; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	69	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34728	34737		10.1074/jbc.M801874200	http://dx.doi.org/10.1074/jbc.M801874200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922798	Green Published, hybrid			2022-12-27	WOS:000261469100029
J	Lemke, T; Welling, A; Christel, CJ; Blaich, A; Bernhard, D; Lenhardt, P; Hofmann, F; Moosmang, S				Lemke, Toni; Welling, Andrea; Christel, Carl Johannes; Blaich, Anne; Bernhard, Dominik; Lenhardt, Peter; Hofmann, Franz; Moosmang, Sven			Unchanged beta-Adrenergic Stimulation of Cardiac L-type Calcium Channels in Ca(v)1.2 Phosphorylation Site S1928A Mutant Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; CAMP-DEPENDENT PHOSPHORYLATION; CA2+ CHANNELS; SIGNALING COMPLEX; SUBUNITS; LOCALIZATION; REQUIRES; PKA	Phosphorylation of serine 1928 ( Ser(1928)) of the cardiac Ca(v)1.2 subunit of L-type Ca2+ channels has been proposed as the mechanism for regulation of L-type Ca2+ channels by protein kinase A (PKA). To test this directly in vivo, we generated a knock-in mouse with targeted mutation of Ser(1928) to alanine. This mutation did not affect basal L-type current characteristics or regulation of the L-type current by PKA and the beta-adrenergic receptor, whereas the mutation abolished phosphorylation of Cav1.2 by PKA. Therefore, our data show that PKA phosphorylation of Ser(1928) of Ca(v)1.2 is not functionally involved in beta-adrenergic stimulation of Ca(v)1.2-mediated Ca2+ influx into the cardiomyocyte.	[Lemke, Toni; Welling, Andrea; Christel, Carl Johannes; Blaich, Anne; Bernhard, Dominik; Lenhardt, Peter; Hofmann, Franz; Moosmang, Sven] Tech Univ Munich, Inst Pharmakol, D-80802 Munich, Germany	Technical University of Munich	Moosmang, S (corresponding author), Tech Univ Munich, Inst Pharmakol, Biedersteiner Str 29, D-80802 Munich, Germany.	moosmang@ipt.med.tu-muenchen.de	Tuluc, Petronel/C-2527-2011; Welling, Andrea/K-6674-2017	Welling, Andrea/0000-0002-5364-4980	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by grants from Deutsche Forschungsgemeinschaft and Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 To whom correspondence should be addressed.	Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gui PC, 2006, J BIOL CHEM, V281, P14015, DOI 10.1074/jbc.M600433200; Haase H, 2005, FASEB J, V19, P1969, DOI 10.1096/fj.05-3997com; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; HARTZELL HC, 1991, NATURE, V351, P573, DOI 10.1038/351573a0; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ludwig A, 1997, J NEUROSCI, V17, P1339; Miriyala J, 2008, CIRC RES, V102, pE54, DOI 10.1161/CIRCRESAHA.108.171736; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; OSTERRIEDER W, 1982, NATURE, V298, P576, DOI 10.1038/298576a0; SCULPTOREANU A, 1993, P NATL ACAD SCI USA, V90, P10135, DOI 10.1073/pnas.90.21.10135; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; ZONG XG, 1995, PFLUG ARCH EUR J PHY, V430, P340, DOI 10.1007/BF00373908	26	90	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34738	34744		10.1074/jbc.M804981200	http://dx.doi.org/10.1074/jbc.M804981200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18829456	Green Published, hybrid			2022-12-27	WOS:000261469100030
J	Stith, CM; Sterling, J; Resnick, MA; Gordenin, DA; Burgers, PM				Stith, Carrie M.; Sterling, Joan; Resnick, Michael A.; Gordenin, Dmitry A.; Burgers, Peter M.			Flexibility of Eukaryotic Okazaki Fragment Maturation through Regulated Strand Displacement Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-DELTA; REPLICATION PROTEIN-A; CELL NUCLEAR ANTIGEN; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; FLAP ENDONUCLEASE-1; LIGATABLE NICK; YEAST; SUBUNIT; ROLES	Okazaki fragment maturation to produce continuous lagging strands in eukaryotic cells requires precise coordination of strand displacement synthesis by DNA polymerase delta (Pol delta) with 5'-flap cutting by FEN1(RAD27) endonuclease. Excessive strand displacement is normally prevented by the 3' -exonuclease activity of Pol delta. This core maturation machinery can be assisted by Dna2 nuclease/helicase that processes long flaps. Our genetic studies show that deletion of the POL32 (third subunit of Pol delta) or PIF1 helicase genes can suppress lethality or growth defects of rad27 Delta pol3-D520V mutants (defective for FEN1RAD27 and the 3' -exonuclease of Pol delta) that produce long flaps and of dna2 Delta mutants that are defective in cutting long flaps. On the contrary, pol32 Delta or pif1 Delta caused lethality of rad27 Delta exo1 Delta double mutants, suggesting that Pol32 and Pif1 are required to generate longer flaps that can be processed by Dna2 in the absence of the short flap processing activities of FEN1(RAD27) and Exo1. The genetic analysis reveals a remarkable flexibility of the Okazaki maturation machinery and is in accord with our biochemical analysis. In vitro, the generation of short flaps by Pol delta is not affected by the presence of Pol32; however, longer flaps only accumulate when Pol32 is present. The presence of FEN1(RAD27) during strand displacement synthesis curtails displacement in favor of flap cutting, thus suggesting an active hand-off mechanism from Pol delta to FEN1(RAD27). Finally, RNA-DNA hybrids are more readily displaced by Pol delta than DNA hybrids, thereby favoring degradation of initiator RNA during Okazaki maturation.	[Sterling, Joan; Resnick, Michael A.; Gordenin, Dmitry A.] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Stith, Carrie M.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Washington University (WUSTL)	Gordenin, DA (corresponding author), NIEHS, Mol Genet Lab, NIH, D3-01,101 TW Alexander Dr,POB 12233, Res Triangle Pk, NC 27709 USA.	gordenin@niehs.nih.gov; burgers@biochem.wustl.edu	Dmitry, Gordenin/C-3907-2018; Burgers, Peter M/AAW-6621-2021; resnick, Michael/F-1668-2019	Dmitry, Gordenin/0000-0002-8399-1836; resnick, Michael/0000-0002-8473-7506	National Institutes of Grant [GM32431]; National Institutes of Health [Z01 ES065073]; NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	National Institutes of Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Grant GM32431 (to P. M. B.) and by the Intramural Research Program of National Institutes of Health, Project 1 Z01 ES065073, of NIEHS (to J. M. A. R., and D. A. G.). The costs of publication of this article were in part by the payment of page charges. This article must therefore hereby marked "advertisement" in accordance with 18 U. S. C. Section solely to indicate this fact.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Garg P, 2005, CELL CYCLE, V4, P221; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Huang ME, 2002, GENETICS, V160, P1409; Huang ME, 1999, MOL GEN GENET, V260, P541, DOI 10.1007/s004380050927; Ii M, 2005, CURR GENET, V48, P213, DOI 10.1007/s00294-005-0014-5; Jin YH, 2005, MOL CELL BIOL, V25, P461, DOI 10.1128/MCB.25.1.461-471.2005; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3	41	100	100	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34129	34140		10.1074/jbc.M806668200	http://dx.doi.org/10.1074/jbc.M806668200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18927077	Green Published, hybrid			2022-12-27	WOS:000261277700041
J	Ohtsuji, M; Katsuoka, F; Kobayashi, A; Aburatani, H; Hayes, JD; Yamamoto, M				Ohtsuji, Makiko; Katsuoka, Fumiki; Kobayashi, Akira; Aburatani, Hiroyuki; Hayes, John D.; Yamamoto, Masayuki			Nrf1 and Nrf2 Play Distinct Roles in Activation of Antioxidant Response Element-dependent Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL MAF PROTEINS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; METALLOTHIONEIN-I; ENDOPLASMIC-RETICULUM; EMBRYONIC LETHALITY; EXPRESSION; INDUCTION; STEATOHEPATITIS; DEFICIENCY	Nrf1 is a member of the vertebrate Cap'n'Collar (CNC) transcription factor family that commonly contains a unique basic-leucine zipper domain. Among CNC family members, Nrf2 is known to regulate a battery of antioxidant and xenobiotic-metabolizing enzyme genes through the antioxidant response element (ARE). Although Nrf1 has also been shown to bind the ARE, it is unclear whether it plays a distinct role from Nrf2 in regulating genes with this element. To address this issue in vivo, we generated mice bearing a hepatocyte-specific disruption of the Nrf1 gene. Although Nrf2 knock-out mice did not exhibit liver damage when they were maintained in an unstressed condition, hepatocyte-specific deletion of Nrf1 caused liver damage resembling the human disease non-alcoholic steatohepatitis. Gene expression analysis revealed that the disruption of Nrf1 causes stress that activates a number of ARE-driven genes in an Nrf2-dependent manner, indicating that Nrf2 cannot compensate completely for loss of Nrf1 function in the liver. In contrast, expression of metallothionein-1 and -2 (MT1 and MT2) genes, each of which harbors at least one ARE in its regulatory region, was decreased in the Nrf1-null mutant mice. Whereas Nrf1 and Nrf2 bound the MT1 ARE with comparable affinity, Nrf1 preferentially activated the reporter gene expression through the MT1 ARE. This study has, thus, identified the first ARE-dependent gene that relies exclusively on Nrf1, suggesting that it plays a distinct functional role in regulating ARE-driven genes.	[Ohtsuji, Makiko; Katsuoka, Fumiki; Kobayashi, Akira; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Biochem Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ohtsuji, Makiko; Yamamoto, Masayuki] Japan Sci & Technol Corp, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Ohtsuji, Makiko; Yamamoto, Masayuki] Japan Sci & Technol Corp, Ctr Tsukuba Adv Res Alliance & Exploratory Res Ad, Tsukuba, Ibaraki 3058577, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; [Hayes, John D.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland	Tohoku University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; University of Dundee	Yamamoto, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem Med, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	masi@mail.tains.tohoku.ac.jp	Kobayashi, Akira/AAN-8003-2020; Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Katsuoka, Fumiki/0000-0003-0939-7887; Kobayashi, Akira/0000-0001-9727-1218; Hayes, John/0000-0002-2927-5548	Exploratory Research for Advanced Technology-Japan Science and Technology Agency; Ministry of Education, Science, Sports, and Culture	Exploratory Research for Advanced Technology-Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Exploratory Research for Advanced Technology-Japan Science and Technology Agency (to M. Y.) and the Ministry of Education, Science, Sports, and Culture (to F. K., A. K., and M. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Beattie JH, 1998, P NATL ACAD SCI USA, V95, P358, DOI 10.1073/pnas.95.1.358; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Daniels PJ, 2003, NUCLEIC ACIDS RES, V31, P6710, DOI 10.1093/nar/gkg913; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Kyo M, 2004, GENES CELLS, V9, P153, DOI 10.1111/j.1356-9597.2004.00711.x; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Onodera K, 1999, J BIOL CHEM, V274, P21162, DOI 10.1074/jbc.274.30.21162; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Suwabe N, 1998, BLOOD, V92, P4108, DOI 10.1182/blood.V92.11.4108.423k29_4108_4118; Suzuki T, 2008, J BIOL CHEM, V283, P2021, DOI 10.1074/jbc.M708352200; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Yeh CT, 2005, CARCINOGENESIS, V26, P2138, DOI 10.1093/carcin/bgi185; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhou ZX, 2002, AM J PATHOL, V160, P2267, DOI 10.1016/S0002-9440(10)61174-1	37	241	244	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33554	33562		10.1074/jbc.M804597200	http://dx.doi.org/10.1074/jbc.M804597200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826952	hybrid, Green Published			2022-12-27	WOS:000261183700060
J	Erb, TJ; Retey, J; Fuchs, G; Alber, BE				Erb, Tobias J.; Retey, Janos; Fuchs, Georg; Alber, Birgit E.			Ethylmalonyl-CoA Mutase from Rhodobacter sphaeroides Defines a New Subclade of Coenzyme B-12-dependent Acyl-CoA Mutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSERTIONAL INACTIVATION; ABSOLUTE-CONFIGURATION; MICROBIAL-METABOLISM; ACETATE ASSIMILATION; GLYOXYLATE CYCLE; C2 COMPOUNDS; PATHWAY; ETHANOL; GENE; PURIFICATION	Coenzyme B-12-dependent mutases are radical enzymes that catalyze reversible carbon skeleton rearrangement reactions. Here we describe Rhodobacter sphaeroides ethylmalonyl-CoA mutase (Ecm), a novel member of the family of coenzyme B-12-dependent acyl-CoA mutases, that operates in the recently discovered ethylmalonyl-CoA pathway for acetate assimilation. Ecm is involved in the central reaction sequence of this novel pathway and catalyzes the transformation of ethylmalonyl-CoA to methylsuccinyl-CoA in combination with a second enzyme that was further identified as promiscuous ethylmalonyl-CoA/methylmalonyl-CoA epimerase. In contrast to the epimerase, Ecm is highly specific for its substrate, ethylmalonyl-CoA, and accepts methylmalonyl-CoA only at 0.2% relative activity. Sequence analysis revealed that Ecm is distinct from (2R)-methylmalonylCoA mutase as well as isobutyryl-CoA mutase and defines a new subfamily of coenzyme B-12-dependent acyl-CoA mutases. In combination with molecular modeling, two signature sequences were identified that presumably contribute to the substrate specificity of these enzymes.	[Alber, Birgit E.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Erb, Tobias J.; Fuchs, Georg] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Retey, Janos] Univ Karlsruhe TH, Inst Organ Chem, D-76131 Karlsruhe, Germany	University System of Ohio; Ohio State University; University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology	Alber, BE (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	alber.8@osu.edu	Erb, Tobias/J-5214-2013	Erb, Tobias/0000-0003-3685-0894	Deutsche Forschungsgemeinschaft [AL677/1-1]; Evonik-Degussa GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evonik-Degussa GmbH	This work was supported by Deutsche Forschungsgemeinschaft Grant AL677/1-1 and by Evonik-Degussa GmbH. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABEND A, 1995, THESIS U KARLSRUHE; Alber BE, 2006, MOL MICROBIOL, V61, P297, DOI 10.1111/j.1365-2958.2006.05238.x; ALLEN SHG, 1963, J BIOL CHEM, V238, P1637; ANTHONY C, 1982, BIOCH METHYLOTROPHS, P103; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckel W, 2006, CHEM-EUR J, V12, P352, DOI 10.1002/chem.200501074; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova LV, 1996, MICROBIOL-UK, V142, P1459, DOI 10.1099/13500872-142-6-1459; DECKER K, 1959, AKTIVIERTE ESSIGSAUR, P84; DUNSTAN PM, 1973, BIOCHEM J, V132, P797, DOI 10.1042/bj1320797; DUNSTAN PM, 1972, BIOCHEM J, V128, P107, DOI 10.1042/bj1280107; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Han L, 1997, J BACTERIOL, V179, P5157, DOI 10.1128/jb.179.16.5157-5164.1997; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; KELLERMEYER RW, 1964, J BIOL CHEM, V239, P2562; KORNBERG HL, 1965, ANGEW CHEM INT EDIT, V4, P558, DOI 10.1002/anie.196505581; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEADLAY PF, 1981, BIOCHEM J, V197, P413, DOI 10.1042/bj1970413; Liu HB, 1999, J BACTERIOL, V181, P6806, DOI 10.1128/JB.181.21.6806-6813.1999; Mancia F, 1999, BIOCHEMISTRY-US, V38, P7999, DOI 10.1021/bi9903852; McCarthy AA, 2001, STRUCTURE, V9, P637, DOI 10.1016/S0969-2126(01)00622-0; Meister M, 2005, J BACTERIOL, V187, P1415, DOI 10.1128/JB.187.4.1415-1425.2005; Miyamoto E, 2003, ARCH MICROBIOL, V180, P151, DOI 10.1007/s00203-003-0570-3; PFENNIG N, 1978, INT J SYST BACTERIOL, V28, P283, DOI 10.1099/00207713-28-2-283; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; RETEY J, 1978, EUR J BIOCHEM, V83, P437, DOI 10.1111/j.1432-1033.1978.tb12110.x; RETEY J, 1964, BIOCHEM BIOPH RES CO, V16, P358, DOI 10.1016/0006-291X(64)90040-3; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Rutey J., 1990, ANGEW CHEM, V102, P373, DOI DOI 10.1039/C4EE03271C; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Smith LM, 1996, MICROBIOL-UK, V142, P675, DOI 10.1099/13500872-142-3-675; SPRECHER M, 1966, J BIOL CHEM, V241, P872; STABLER SP, 1985, ARCH BIOCHEM BIOPHYS, V241, P252, DOI 10.1016/0003-9861(85)90381-9; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; TAOKA S, 1994, J BIOL CHEM, V269, P31630; Thoma NH, 2000, BIOCHEMISTRY-US, V39, P9213, DOI 10.1021/bi0004302; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q; Vrijbloed JW, 1999, J BACTERIOL, V181, P5600, DOI 10.1128/JB.181.18.5600-5605.1999; Wu K, 2000, GENE, V251, P81, DOI 10.1016/S0378-1119(00)00171-2; Xue Q, 1999, P NATL ACAD SCI USA, V96, P11740, DOI 10.1073/pnas.96.21.11740; ZAGALAK B, 1974, EUR J BIOCHEM, V44, P529, DOI 10.1111/j.1432-1033.1974.tb03512.x; Zarzycki J, 2008, J BACTERIOL, V190, P1366, DOI 10.1128/JB.01621-07; Zerbe-Burkhardt K, 1998, J BIOL CHEM, V273, P6508, DOI 10.1074/jbc.273.11.6508	48	78	83	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32283	32293		10.1074/jbc.M805527200	http://dx.doi.org/10.1074/jbc.M805527200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819910	hybrid			2022-12-27	WOS:000260893700015
J	Friedrichs, J; Manninen, A; Muller, DJ; Helenius, J				Friedrichs, Jens; Manninen, Aki; Muller, Daniel J.; Helenius, Jonne			Galectin-3 Regulates Integrin alpha(2)beta(1)-mediated Adhesion to Collagen-I and -IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED EPITHELIAL-CELLS; FORCE SPECTROSCOPY; ENDOTHELIAL-CELLS; BINDING PROTEINS; MDCK CELLS; SINGLE; RECEPTOR; LAMININ; MATRIX; LECTIN	Galectins are a taxonomically widespread family of galactose-binding proteins of which galectin-3 is known to modulate cell adhesion. Using single cell force spectroscopy, the contribution of galectin-3 to the adhesion of Madin-Darby canine kidney (MDCK) cells to different extracellular matrix proteins was investigated. When adhering to collagen-I or-IV, some cells rapidly entered an enhanced adhesion state, marked by a significant increase in the force required for cell detachment. Galectin-3-depleted cells had an increased probability of entering the enhanced adhesion state. Adhesion enhancement was specific to integrin alpha(2)beta(1), as it was not observed when cells adhered to extracellular matrix substrates by other integrins. The adhesion phenotype of galectin-3-depleted cells was mimicked in a galactoside-deficient MDCK cell line and could be complemented by the addition of recombinant galectin-3. We propose that galectin-3 influences integrin alpha(2)beta(1)-mediated adhesion complex formation by altering receptor clustering.	[Friedrichs, Jens; Muller, Daniel J.; Helenius, Jonne] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Manninen, Aki] Univ Oulu, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Dept Med Biochem & Mol Biol, SF-90220 Oulu, Finland	Technische Universitat Dresden; University of Oulu	Helenius, J (corresponding author), Tatzberg 47-49, D-01307 Dresden, Germany.	jonne.helenius@biotec.tu-dresden.de	Müller, Daniel J./A-5967-2010; Manninen, Aki/AAC-8067-2019; Friedrichs, Jens/D-4833-2015	Müller, Daniel J./0000-0003-3075-0665; Manninen, Aki/0000-0002-6263-8101; 	Volkswagenstiftung; AO Research Fund; Deutsche Forschungsgemeinschaft (DFG); Sigrid Juselius Foundation; Academy of Finland	Volkswagenstiftung(Volkswagen); AO Research Fund; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work was supported by the Volkswagenstiftung, the AO Research Fund, the Deutsche Forschungsgemeinschaft (DFG), the Sigrid Juselius Foundation, and the Academy of Finland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; AUMAILLEY M, 1990, EXP CELL RES, V188, P55, DOI 10.1016/0014-4827(90)90277-H; Bao Q, 1999, GLYCOBIOLOGY, V9, P489, DOI 10.1093/glycob/9.5.489; BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; CARTER BZ, 1991, LAB INVEST, V65, P610; CHAN PY, 1991, J CELL BIOL, V115, P245, DOI 10.1083/jcb.115.1.245; Cisneros DA, 2006, J STRUCT BIOL, V154, P232, DOI 10.1016/j.jsb.2006.02.006; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; HSU DK, 1992, J BIOL CHEM, V267, P14167; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Hughes RC, 2002, GLYCOCONJUGATE J, V19, P621, DOI 10.1023/B:GLYC.0000014094.39168.fd; Hughes RC, 2001, BIOCHIMIE, V83, P667; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Mak GZ, 2006, MOL BIOL CELL, V17, P3664, DOI 10.1091/mbc.E05-11-1070; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; MEISS HK, 1982, MOL CELL BIOL, V2, P1287, DOI 10.1128/MCB.2.10.1287; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; VANDEWIELVANKEMENADE E, 1992, J CELL BIOL, V117, P461, DOI 10.1083/jcb.117.2.461; Weisel JW, 2003, CURR OPIN STRUC BIOL, V13, P227, DOI 10.1016/S0959-440X(03)00039-3; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zuk A, 1996, J CELL SCI, V109, P1875	45	74	76	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32264	32272		10.1074/jbc.M803634200	http://dx.doi.org/10.1074/jbc.M803634200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806266	hybrid			2022-12-27	WOS:000260893700013
J	Huang, YC; Misquitta, S; Blond, SY; Adams, E; Colman, RF				Huang, Yu-chu; Misquitta, Stephanie; Blond, Sylvie Y.; Adams, Elizabeth; Colman, Roberta F.			Catalytically Active Monomer of Glutathione S-Transferase pi and Key Residues Involved in the Electrostatic Interaction between Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING SITE; 3-DIMENSIONAL STRUCTURE; INTERFACE; STABILITY; COMPLEX; P1-1; HEXYLGLUTATHIONE; IDENTIFICATION; TYROSINE-7; ENZYME	Human glutathione transferase pi (GST pi) has been crystallized as a homodimer, with a subunit molecular mass of similar to 23 kDa; however, in solution the average molecular mass depends on protein concentration, approaching that of monomer at < 0.03 mg/ml, concentrations typically used to measure catalytic activity of the enzyme. Electrostatic interaction at the subunit interface greatly influences the dimer-monomer equilibrium of the enzyme and is an important force for holding subunits together. Arg-70, Arg-74, Asp-90, Asp-94, and Thr-67 were selected as target sites for mutagenesis, because they are at the subunit interface. R70Q, R74Q, D90N, D94N, and T67A mutant enzymes were constructed, expressed in Escherichia coli, and purified. The construct of N-terminal His tag enzyme facilitates the purification of GST pi, resulting in a high yield of enzyme, but does not alter the kinetic parameters or secondary structure of the enzyme. Our results indicate that these mutant enzymes show no appreciable changes in K-m for 1-chloro-2,4-dinitrobenzene and have similar CD spectra to that of wild-type enzyme. However, elimination of the charges of either Arg-70, Arg-74, Asp-90, or Asp-94 shifts the dimer-monomer equilibrium toward monomer. In addition, replacement of Asp-94 or Arg-70 causes a large increase in the K-m(GSH), whereas substitution for Asp-90 or Arg-74 primarily results in a marked decrease in V-max. The GST pi retains substantial catalytic activity as a monomer probably because the glutathione and electrophilic substrate sites (such as for 1-chloro-2,4-dinitrobenzene) are predominantly located within each subunit.	[Huang, Yu-chu; Misquitta, Stephanie; Colman, Roberta F.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Blond, Sylvie Y.] Univ Illinois, Coll Pharm, Ctr Pharmaceut Biotechnol, Chicago, IL 60607 USA; [Adams, Elizabeth] Delaware Biotechnol Inst, Newark, DE 19711 USA	University of Delaware; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colman, RF (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	rfcolman@udel.edu			National Institutes of Health [R01-CA66561]; NATIONAL CANCER INSTITUTE [R01CA066561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA66561 ( to R. F. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this work.	Abdalla AM, 2002, PROTEIN ENG, V15, P827, DOI 10.1093/protein/15.10.827; Adams EL, 2004, CARBOHYD RES, V339, P579, DOI 10.1016/j.carres.2003.11.023; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carey J, 2007, PROTEIN SCI, V16, P2317, DOI 10.1110/ps.072985007; Chang MS, 1999, PROTEIN EXPRES PURIF, V17, P443, DOI 10.1006/prep.1999.1149; DIRR H, 1994, J MOL BIOL, V243, P72, DOI 10.1006/jmbi.1994.1631; Erhardt J, 1996, FEBS LETT, V391, P313, DOI 10.1016/0014-5793(96)00768-5; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hearne JL, 2006, BIOCHEMISTRY-US, V45, P5974, DOI 10.1021/bi060249e; Hegazy UM, 2004, J BIOL CHEM, V279, P9586, DOI 10.1074/jbc.M312320200; Hornby JAT, 2002, BIOCHEMISTRY-US, V41, P14238, DOI 10.1021/bi020548d; Ji XH, 1997, BIOCHEMISTRY-US, V36, P9690, DOI 10.1021/bi970805s; Ji XH, 1999, BIOCHEMISTRY-US, V38, P10231, DOI 10.1021/bi990668u; KONG KH, 1992, BIOCHEM BIOPH RES CO, V184, P194, DOI 10.1016/0006-291X(92)91177-R; KONG KH, 1993, PROTEIN ENG, V6, P93, DOI 10.1093/protein/6.1.93; KONG KH, 1992, BIOCHEM BIOPH RES CO, V182, P1122, DOI 10.1016/0006-291X(92)91848-K; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357; MANOHARAN TH, 1992, J BIOL CHEM, V267, P18940; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Parraga A, 1998, BIOCHEM J, V333, P811, DOI 10.1042/bj3330811; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Ralat LA, 2004, J BIOL CHEM, V279, P50204, DOI 10.1074/jbc.M407445200; Ralat LA, 2003, PROTEIN SCI, V12, P2575, DOI 10.1110/ps.03249303; Ralat LA, 2008, ARCH BIOCHEM BIOPHYS, V474, P109, DOI 10.1016/j.abb.2008.02.043; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P12491, DOI 10.1021/bi061330k; Ramos CHI, 2002, PROTEIN SCI, V11, P1771, DOI 10.1110/ps.0205902; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; SOUNDAR S, 1993, J BIOL CHEM, V268, P5264; Stenberg G, 2000, BIOCHEM BIOPH RES CO, V271, P59, DOI 10.1006/bbrc.2000.2579; Stevens JM, 2000, BIOCHEM J, V347, P193, DOI 10.1042/0264-6021:3470193; Thompson LC, 2006, BIOCHEMISTRY-US, V45, P2267, DOI 10.1021/bi0519506; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vararattanavech A, 2006, BIOCHEM J, V393, P89, DOI 10.1042/BJ20050555; Vargo MA, 2004, BIOCHEMISTRY-US, V43, P3327, DOI 10.1021/bi030245z; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Winayanuwattikun P, 2007, BIOCHEM J, V402, P339, DOI 10.1042/BJ20061253	43	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32880	32888		10.1074/jbc.M805484200	http://dx.doi.org/10.1074/jbc.M805484200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18796433	Green Published, hybrid			2022-12-27	WOS:000260893700077
J	Jang, MS; Sul, JW; Choi, BJ; Lee, SJ; Suh, JH; Kim, NS; Kim, WH; Lim, DS; Lee, CW; Kim, E				Jang, Moon-Sun; Sul, Jee-Won; Choi, Byung-Jung; Lee, Su-Jin; Suh, Jee-Hee; Kim, Nam-Soon; Kim, Woo Ho; Lim, Dae-Sik; Lee, Chang-Woo; Kim, Eunhee			Negative Feedback Regulation of Aurora-A via Phosphorylation of Fas-associated Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; CENTROSOME AMPLIFICATION; INDUCED APOPTOSIS; FACTOR FAF1; KAPPA-B; OVEREXPRESSION; DEGRADATION; INTERACTS; PATHWAY; COMPLEX	This study reports that Aurora-A (Aur-A) phosphorylates Fas-associated factor-1 (FAF1) at Ser-289 and Ser-291. Forced expression of a FAF1 mutant mimicking phosphorylation at Ser-289 and Ser-291 (FAF1 DD), but not phosphorylation-deficient FAF1 (FAF1 AA), reduced Aur-A expression. However, transfection of FAF1 DD failed to reduce Aur-A expression in the presence of MG132 and MG115, indicating that this decrease is proteasome-mediated. Additionally, transfection of FAF1 DD suppressed the expression of Aur-A in ts20-BALB cells lacking E1 ubiquitin (Ub) activating enzyme activity at restrictive temperatures and also reduced the expression of Aur-A S51D, a mutant resistant to Ub-dependent degradation. Our data indicate that phosphorylated FAF1 mediates the ubiquitin-independent, proteasome-dependent degradation of Aur-A. Overexpression of FAF1 DD blocked Aur-A-induced centrosome amplification and accumulated cells in G(2)/M phase, representing cellular phenotypes consistent with the anticipated loss of Aur-A. Collectively, our findings support the negative feedback regulation of Aur-A via phosphorylation of the death-promoting protein, FAF1, and disclose the presence of molecular cross-talk between constituents of the cell cycle and cell death machinery.	[Jang, Moon-Sun; Sul, Jee-Won; Choi, Byung-Jung; Lee, Su-Jin; Kim, Eunhee] Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea; [Suh, Jee-Hee] Korea Res Inst Chem Technol, Ctr Metab Syndrome Therapeut, Taejon 305600, South Korea; [Kim, Nam-Soon] Korea Res Inst Biosci & Biotechnol, Lab Human Genom, Taejon 305806, South Korea; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Chang-Woo] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea	Chungnam National University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU)	Kim, E (corresponding author), Chungnam Natl Univ, Dept Biol, Taejon 305764, South Korea.	eunhee@cnu.ac.kr	Kim, Wooho/G-3703-2011; Lim, Dae-Sik/C-1599-2011; LEE, CHANG WOO/AAK-7567-2020	Lim, Dae-Sik/0000-0003-2356-7555; 	Ministry of Education, Science, and Technology in Korea and the Brain Korea 21 Project Fellowship [FG08-21-02]	Ministry of Education, Science, and Technology in Korea and the Brain Korea 21 Project Fellowship	This work was supported by FG08-21-02 of the 21C Frontier Functional Human Genome Project from the Ministry of Education, Science, and Technology in Korea and the Brain Korea 21 Project Fellowship. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bjorling-Poulsen M, 2003, INT J ONCOL, V23, P1015; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Goepfert TM, 2002, CANCER RES, V62, P4115; Guerra B, 2001, INT J ONCOL, V19, P1117; Horn V, 2007, MOL BIOL CELL, V18, P1233, DOI 10.1091/mbc.E06-12-1152; Jensen HH, 2001, INT J BIOCHEM CELL B, V33, P577, DOI 10.1016/S1357-2725(01)00039-5; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Kamada K, 2004, ONCOL REP, V12, P593; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Katayama H, 2007, J CELL BIOCHEM, V102, P1318, DOI 10.1002/jcb.21421; Kim HJ, 2005, J BIOL CHEM, V280, P8125, DOI 10.1074/jbc.M406297200; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Lim SK, 2007, BIOCHEM J, V403, P119, DOI 10.1042/BJ20061272; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Olsen BB, 2003, FEBS LETT, V546, P218, DOI 10.1016/S0014-5793(03)00575-1; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Park MY, 2005, INT J CANCER, V115, P412, DOI 10.1002/ijc.20857; Park MY, 2004, J BIOL CHEM, V279, P2544, DOI 10.1074/jbc.M304565200; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Ryu SW, 2001, BIOCHEM BIOPH RES CO, V286, P1027, DOI 10.1006/bbrc.2001.5505; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	33	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32344	32351		10.1074/jbc.M804199200	http://dx.doi.org/10.1074/jbc.M804199200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790738	hybrid			2022-12-27	WOS:000260893700021
J	Kim, TY; Healy, KD; Der, CJ; Sciaky, N; Bang, YJ; Juliano, RL				Kim, Tai Young; Healy, Kevin D.; Der, Channing J.; Sciaky, Noah; Bang, Yung-Jue; Juliano, Rudy L.			Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell Morphology and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; P190 RHOGAP; PLC-DELTA(1)-BINDING PROTEIN; TUMOR-SUPPRESSOR; FOCAL ADHESIONS; CANCER CELLS; GROWTH; DOMAIN; GENE; BINDING	DLC-1 encodes a Rho GTPase-activating protein (RhoGAP) and negative regulator of specific Rho family proteins (RhoA-C and Cdc42). DLC-1 is a multi-domain protein, with the RhoGAP catalytic domain flanked by an amino-terminal sterile alpha motif (SAM) and a carboxyl-terminal START domain. The roles of these domains in the regulation of DLC-1 function remain to be determined. We undertook a structure-function analysis involving truncation and missense mutants of DLC-1. We determined that the amino-terminal SAM domain functions as an autoinhibitory domain of intrinsic RhoGAP activity. Additionally, we determined that the SAM and START domains are dispensable for DLC-1 association with focal adhesions. We then characterized several mutants for their ability to regulate cell migration and identified constitutively activated and dominant negative mutants of DLC-1. We report that DLC-1 activation profoundly alters cell morphology, enhances protrusive activity, and can increase the velocity but reduce directionality of cell migration. Conversely, the expression of the amino-terminal domain of DLC-1 acts as a dominant negative and profoundly inhibits cell migration by displacing endogenous DLC-1 from focal adhesions.	[Kim, Tai Young; Healy, Kevin D.; Der, Channing J.; Sciaky, Noah; Juliano, Rudy L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Healy, Kevin D.; Der, Channing J.; Juliano, Rudy L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110744, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU)	Der, CJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu; arjay@med.unc.edu	Bang, Yung Jue/J-2759-2012	Bang, Yung Jue/0000-0001-6000-4597; KIM, TAI YOUNG/0000-0001-8086-2476; Der, Channing/0000-0002-7751-2747	National Institutes of Health [PO1 HL4500, CA063071, CA129610, CA67771]; NATIONAL CANCER INSTITUTE [R01CA129610, R01CA063071, U19CA067771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL4500 (to R.L.J.) and CA063071, CA129610, and CA67771 (to C.J.D.).	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Durkin ME, 2007, ONCOGENE, V26, P4580, DOI 10.1038/sj.onc.1210244; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawai K, 2004, BIOCHEM SOC T, V32, P1107, DOI 10.1042/BST0321107; Kawai K, 2007, BIOCHEM BIOPH RES CO, V364, P783, DOI 10.1016/j.bbrc.2007.10.052; Kim TY, 2003, ONCOGENE, V22, P3943, DOI 10.1038/sj.onc.1206573; Kwan JJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-34; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Li HY, 2007, PROTEINS, V67, P1154, DOI 10.1002/prot.21361; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Ng IOL, 2000, CANCER RES, V60, P6581; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sekimata M, 1999, J BIOL CHEM, V274, P17757, DOI 10.1074/jbc.274.25.17757; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yamaga M, 2004, GENES CELLS, V9, P25, DOI 10.1111/j.1356-9597.2004.00698.x; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	36	48	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32762	32770		10.1074/jbc.M800617200	http://dx.doi.org/10.1074/jbc.M800617200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18786931	Green Published, hybrid			2022-12-27	WOS:000260893700065
J	Stuck, BJ; Lenski, M; Bohm, M; Laufs, U				Stuck, Bettina Johanna; Lenski, Matthias; Boehm, Michael; Laufs, Ulrich			Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID OXIDATION; CARDIAC-HYPERTROPHY; GLUCOSE-UPTAKE; PRESSURE-OVERLOAD; RAT-HEART; MUSCLE; OVEREXPRESSION; ISCHEMIA; GLUT4	Angiotensin II induces cardiomyocyte hypertrophy, but its consequences on cardiomyocyte metabolism and energy supply are not completely understood. Here we investigate the effect of angiotensin II on glucose and fatty acid utilization and the modifying role of AMP-activated protein kinase (AMPK), a key regulator of metabolism and proliferation. Treatment of H9C2 cardiomyocytes with angiotensin II (Ang II, 1 mu M, 4 h) increased [H-3] leucine incorporation, up-regulated the mRNA expression of the hypertrophy marker genes MLC, ANF, BNP, and beta-MHC, and decreased the phosphorylation of the negative mTOR-regulator tuberin (TSC-2). Rat neonatal cardiomyocytes showed similar results. Western blot analysis revealed a time-and concentration-dependent down-regulation of AMPK-phosphorylation in the presence of angiotensin II, whereas the protein expression of the catalytic alpha-subunit remained unchanged. This was paralleled by membrane translocation of glucose-transporter type 4 (GLUT4), increased uptake of [H-3] glucose and transient down-regulation of phosphorylation of acetyl-CoA carboxylase (ACC), whereas fatty acid uptake remained unchanged. Similarly, short-term transaortic constriction in mice resulted in down-regulation of P-AMPK and P-ACC but up-regulation of GLUT4 membrane translocation in the heart. Preincubation of cardiomyocytes with the AMPK stimulator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR; 1mM, 4 h) completely prevented the angiotensin II-induced cardiomyocytes hypertrophy. In addition, AICAR reversed the metabolic effects of angiotensin II: GLUT4 translocation was reduced, but ACC phosphorylation and TSC phosphorylation were elevated. In summary, angiotensin II-induced hypertrophy of cardiomyocytes is accompanied by decreased activation of AMPK, increased glucose uptake, and decreased mTOR inhibition. Stimulation with the AMPK activator AICAR reverses these metabolic changes, increases fatty acid utilization, and inhibits cardiomyocyte hypertrophy.	[Stuck, Bettina Johanna; Lenski, Matthias; Boehm, Michael; Laufs, Ulrich] Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, D-66421 Homburg, Germany	Universitatsklinikum des Saarlandes	Stuck, BJ (corresponding author), Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Kirrberger Str, D-66421 Homburg, Germany.	bettina.stuck@web.de	Böhm, Michael/C-3638-2011		Ernst und Berta Grimmke-Foundation; Universitat des Saarlandes (HOMFOR); Deutsche Forschungsgemeinschaft [KFO 196]	Ernst und Berta Grimmke-Foundation; Universitat des Saarlandes (HOMFOR); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Ernst und Berta Grimmke-Foundation, the Universitat des Saarlandes (HOMFOR), and Deutsche Forschungsgemeinschaft KFO 196. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; BAYESGENIS A, 1995, AM J CARDIOL, V76, pD54, DOI 10.1016/S0002-9149(99)80493-7; Custodis F, 2006, CARDIOVASC RES, V71, P342, DOI 10.1016/j.cardiores.2006.04.005; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Frederich M, 2002, J BIOL CHEM, V277, P1928, DOI 10.1074/jbc.M107128200; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Grynberg A, 1996, J CARDIOVASC PHARM, V28, pS11; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; KRAEGEN EW, 1993, BIOCHEM J, V295, P287, DOI 10.1042/bj2950287; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Malhotra R, 1999, CIRC RES, V85, P137, DOI 10.1161/01.RES.85.2.137; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; NEELY JR, 1973, AM J PHYSIOL, V225, P651; Omar MA, 2008, AM J PHYSIOL-HEART C, V294, pH1266, DOI 10.1152/ajpheart.01087.2007; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Pellieux C, 2006, J MOL CELL CARDIOL, V41, P459, DOI 10.1016/j.yjmcc.2006.06.004; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Ritchie RH, 2006, CLIN EXP PHARMACOL P, V33, P159, DOI 10.1111/j.1440-1681.2006.04342.x; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; SADDIK M, 1993, J BIOL CHEM, V268, P25836; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; Serneri GGN, 2001, CIRC RES, V89, P977, DOI 10.1161/hh2301.100982; Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119; SUN DQ, 1994, CIRCULATION, V89, P793, DOI 10.1161/01.CIR.89.2.793; SUZUKI J, 1993, CIRC RES, V73, P439, DOI 10.1161/01.RES.73.3.439; Tomita T, 1990, Am J Cardiovasc Pathol, V3, P81; WEBER KT, 1993, BASIC RES CARDIOL, V88, P107; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	37	98	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32562	32569		10.1074/jbc.M801904200	http://dx.doi.org/10.1074/jbc.M801904200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790741	hybrid			2022-12-27	WOS:000260893700045
J	Wohlgemuth, I; Brenne, S; Beringer, M; Rodnina, MV				Wohlgemuth, Ingo; Brenne, Sibylle; Beringer, Malte; Rodnina, Marina V.			Modulation of the Rate of Peptidyl Transfer on the Ribosome by the Nature of Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; ACID SIDE-CHAIN; AMINOACYL-TRANSFER-RNA; PROLYL-TRANSFER-RNA; BOND FORMATION; STRUCTURAL BASIS; UNIFORM BINDING; IONIC-STRENGTH; A-SITE; MECHANISM	The ribosome catalyzes peptide bond formation between peptidyl-tRNA in the P site and aminoacyl-tRNA in the A site. Here, we show that the nature of the C-terminal amino acid residue in the P-site peptidyl-tRNA strongly affects the rate of peptidyl transfer. Depending on the C-terminal amino acid of the peptidyl-tRNA, the rate of reaction with the small A-site substrate puromycin varied between 100 and 0.14 s(-1), regardless of the tRNA identity. The reactivity decreased in the order Lys = Arg > Ala > Ser > Phe = Val > Asp >> Pro, with Pro being by far the slowest. However, when Phe-tRNAPhe was used as A-site substrate, the rate of peptide bond formation with any peptidyl-tRNA was similar to 7 s(-1), which corresponds to the rate of binding of Phe-tRNA(Phe) to the A site (accommodation). Because accommodation is rate-limiting for peptide bond formation, the reaction rate is uniform for all peptidyl-tRNAs, regardless of the variations of the intrinsic chemical reactivities. On the other hand, the 50-fold increase in the reaction rate for peptidyl-tRNA ending with Pro suggests that full-length aminoacyl-tRNA in the A site greatly accelerates peptide bond formation.	[Wohlgemuth, Ingo; Brenne, Sibylle; Beringer, Malte; Rodnina, Marina V.] Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany; [Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Witten Herdecke University; Max Planck Society	Rodnina, MV (corresponding author), Univ Witten Herdecke, Inst Phys Biochem, Stockumer Str 10, D-58448 Witten, Germany.	rodnina@uni-wh.de	Rodnina, Marina V./AAD-4667-2019; Beringer, Malte/AAC-5734-2020; Beringer, Malte/N-3766-2015	Rodnina, Marina V./0000-0003-0105-3879; Beringer, Malte/0000-0003-1958-9786; Wohlgemuth, Ingo/0000-0001-9121-7675	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Present address: Manchester Interdisciplinary Biocentre and Faculty of Life Sciences, University of Manchester, Manchester M1 7DN, UK.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bashan A, 2003, MOL CELL, V11, P91, DOI 10.1016/S1097-2765(03)00009-1; Beringer M, 2005, J BIOL CHEM, V280, P36065, DOI 10.1074/jbc.M507961200; Beringer M, 2008, RNA, V14, P795, DOI 10.1261/rna.980308; Beringer M, 2007, BIOL CHEM, V388, P687, DOI 10.1515/BC.2007.077; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; BHUTA A, 1981, BIOCHEMISTRY-US, V20, P8, DOI 10.1021/bi00504a002; Bieling P, 2006, NAT STRUCT MOL BIOL, V13, P423, DOI 10.1038/nsmb1091; BRUICE TC, 1970, J AM CHEM SOC, V92, P1370; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; BURGI HB, 1995, STRUCTURE CORRELATIO; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Che Y, 2006, BIOPOLYMERS, V81, P392, DOI 10.1002/bip.20431; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2007, J BACTERIOL, V189, P3140, DOI 10.1128/JB.01869-06; Daviter T, 2006, BIOCHIMIE, V88, P1001, DOI 10.1016/j.biochi.2006.04.013; DETAR DF, 1983, J AM CHEM SOC, V105, P2734, DOI 10.1021/ja00347a036; DMITRIEVA MG, 1965, RUSS CHEM B, V14, P1141; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Dwyer Donard S, 2005, BMC Chem Biol, V5, P2, DOI 10.1186/1472-6769-5-2; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; HENTZEN D, 1972, BIOCHIM BIOPHYS ACTA, V281, P228, DOI 10.1016/0005-2787(72)90174-8; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; KEMP DS, 1974, J ORG CHEM, V39, P3841, DOI 10.1021/jo00940a009; KEMP DS, 1986, J ORG CHEM, V51, P3320, DOI 10.1021/jo00367a013; KIER LB, 1987, QUANT STRUCT-ACT REL, V6, P117, DOI 10.1002/qsar.19870060305; Kingery DA, 2008, CHEM BIOL, V15, P493, DOI 10.1016/j.chembiol.2008.04.005; Kothe U, 2007, MOL CELL, V25, P167, DOI 10.1016/j.molcel.2006.11.014; Kothe U, 2006, ANAL BIOCHEM, V356, P148, DOI 10.1016/j.ab.2006.04.038; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; MONRO RE, 1968, P NATL ACAD SCI USA, V61, P1042, DOI 10.1073/pnas.61.3.1042; MottaguiTabar S, 1996, BIOCHIMIE, V78, P953, DOI 10.1016/S0300-9084(97)86717-X; Murakami H, 2003, CHEM BIOL, V10, P1077, DOI 10.1016/j.chembiol.2003.10.010; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; NADASDI L, 1983, PEPTIDES, V4, P137, DOI 10.1016/0196-9781(83)90103-1; NOVOGRODSKY A, 1971, BIOCHIM BIOPHYS ACTA, V228, P688, DOI 10.1016/0005-2787(71)90733-7; PANET A, 1970, EUR J BIOCHEM, V15, P222, DOI 10.1111/j.1432-1033.1970.tb00998.x; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; ROBERTSON SA, 1991, J AM CHEM SOC, V113, P2722, DOI 10.1021/ja00007a055; RODNINA MV, 1995, EMBO J, V14, P2613, DOI 10.1002/j.1460-2075.1995.tb07259.x; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; RYCHLIK I, 1970, EUR J BIOCHEM, V16, P136, DOI 10.1111/j.1432-1033.1970.tb01064.x; Saito H, 2001, EMBO J, V20, P1797, DOI 10.1093/emboj/20.7.1797; Saito H, 2001, J AM CHEM SOC, V123, P7178, DOI 10.1021/ja015756s; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Sardesai NY, 1999, BIOCHEMISTRY-US, V38, P12080, DOI 10.1021/bi991126f; SATTERTH.AC, 1974, J AM CHEM SOC, V96, P7018, DOI 10.1021/ja00829a034; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Schroeder GK, 2007, BIOCHEMISTRY-US, V46, P4037, DOI 10.1021/bi602600p; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Starck SR, 2003, J AM CHEM SOC, V125, P8090, DOI 10.1021/ja034817e; Steitz TA, 2005, FEBS LETT, V579, P955, DOI 10.1016/j.febslet.2004.11.053; STRICKLAND JE, 1972, BIOCHEMISTRY-US, V11, P2321, DOI 10.1021/bi00762a017; TAFT RW, 1952, J AM CHEM SOC, V74, P3120, DOI 10.1021/ja01132a049; Trobro S, 2005, P NATL ACAD SCI USA, V102, P12395, DOI 10.1073/pnas.0504043102; Trobro S, 2006, BIOCHEMISTRY-US, V45, P7049, DOI 10.1021/bi0605383; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Weinger JS, 2004, NAT STRUCT MOL BIOL, V11, P1101, DOI 10.1038/nsmb841; Wohlgemuth I, 2006, EMBO REP, V7, P699, DOI 10.1038/sj.embor.7400732; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; ZACHAU HG, 1960, CHEM BER-RECL, V93, P1822, DOI 10.1002/cber.19600930820; [No title captured]	74	107	110	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32229	32235		10.1074/jbc.M805316200	http://dx.doi.org/10.1074/jbc.M805316200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809677	Green Published, hybrid			2022-12-27	WOS:000260893700009
J	Tessmer, I; Yang, Y; Zhai, J; Du, CW; Hsieh, P; Hingorani, MM; Erie, DA				Tessmer, Ingrid; Yang, Yong; Zhai, Jie; Du, Chungwei; Hsieh, Peggy; Hingorani, Manju M.; Erie, Dorothy A.			Mechanism of MutS Searching for DNA Mismatches and Signaling Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MUTS; THERMUS-AQUATICUS; CRYSTAL-STRUCTURE; DAMAGE RECOGNITION; ATPASE ACTIVITY; PROTEIN MUTS; MINOR-GROOVE; BINDING; HYDROLYSIS; DOMAINS	DNA mismatch repair is initiated by the recognition of mismatches by MutS proteins. The mechanism by which MutS searches for and recognizes mismatches and subsequently signals repair remains poorly understood. We used single-molecule analyses of atomic force microscopy images of MutS-DNA complexes, coupled with biochemical assays, to determine the distributions of conformational states, the DNA binding affinities, and the ATPase activities of wild type and two mutants of MutS, with alanine substitutions in the conserved Phe-Xaa-Glu mismatch recognition motif. We find that on homoduplex DNA, the conserved Glu, but not the Phe, facilitates MutS-induced DNA bending, whereas at mismatches, both Phe and Glu promote the formation of an unbent conformation. The data reveal an unusual role for the Phe residue in that it promotes the unbending, not bending, of DNA at mismatch sites. In addition, formation of the specific unbent MutS-DNA conformation at mismatches appears to be required for the inhibition of ATP hydrolysis by MutS that signals initiation of repair. These results provide a structural explanation for the mechanism by which MutS searches for and recognizes mismatches and for the observed phenotypes of mutants with substitutions in the Phe-Xaa-Glu motif.	[Tessmer, Ingrid; Yang, Yong; Erie, Dorothy A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Erie, Dorothy A.] Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA; [Du, Chungwei; Hsieh, Peggy] NIDDK, NIH, Bethesda, MD 20892 USA; [Zhai, Jie; Hingorani, Manju M.] Wesleyan Univ, Dept Biochem & Mol Biol, Middletown, CT 06459 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wesleyan University	Erie, DA (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	derie@unc.edu	Tessmer, Ingrid/O-2810-2013	Tessmer, Ingrid/0000-0002-8353-6315	National Institutes of Health [GM079480]; American Cancer Society [RSG03- 047-04-GMC]; National Science Foundation [0448379]; Intramural Research Program of NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079480, R01GM080294, T32GM008271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM079480 (to D.A.E.). This work was also supported by Grant RSG03- 047-04-GMC from the American Cancer Society (to D.A.E.), National Science Foundation Grant MCB 0448379 (to M.M.H.), and the Intramural Research Program of NIDDK (to P.H. and C.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; ANDERA L, 1994, BIOCHIMIE, V76, P933, DOI 10.1016/0300-9084(94)90018-3; Antony E, 2004, BIOCHEMISTRY-US, V43, P13115, DOI 10.1021/bi049010t; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Biswas I, 1999, J BIOL CHEM, V274, P23673, DOI 10.1074/jbc.274.33.23673; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Drotschmann K, 2001, J BIOL CHEM, V276, P46225, DOI 10.1074/jbc.C100450200; ERIE DA, 1994, SCIENCE, V266, P1562, DOI 10.1126/science.7985026; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Hardwidge PR, 2002, BIOCHEMISTRY-US, V41, P7732, DOI 10.1021/bi020213w; Hardwidge PR, 2002, BIOCHEMISTRY-US, V41, P8277, DOI 10.1021/bi020185h; Holmes SF, 2007, DNA REPAIR, V6, P293, DOI 10.1016/j.dnarep.2006.10.023; Horton JR, 2006, NUCLEIC ACIDS RES, V34, P939, DOI 10.1093/nar/gkj484; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Isaacs RJ, 2004, DNA REPAIR, V3, P455, DOI 10.1016/j.dnarep.2004.01.004; Isaacs RJ, 2002, J MOL BIOL, V319, P191, DOI 10.1016/S0022-2836(02)00265-6; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Lebbink JHG, 2006, EMBO J, V25, P409, DOI 10.1038/sj.emboj.7600936; Leonard DA, 1997, P NATL ACAD SCI USA, V94, P4913, DOI 10.1073/pnas.94.10.4913; Malkov VA, 1997, J BIOL CHEM, V272, P23811, DOI 10.1074/jbc.272.38.23811; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pues H, 1999, BIOCHEMISTRY-US, V38, P1426, DOI 10.1021/bi9818016; Rajski SR, 2000, MUTAT RES-FUND MOL M, V447, P49, DOI 10.1016/S0027-5107(99)00195-5; Salsbury FR, 2006, NUCLEIC ACIDS RES, V34, P2173, DOI 10.1093/nar/gkl238; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; Schofield MJ, 2001, J BIOL CHEM, V276, P45505, DOI 10.1074/jbc.C100449200; Sixma TK, 2001, CURR OPIN STRUC BIOL, V11, P47, DOI 10.1016/S0959-440X(00)00169-X; Strauss-Soukup JK, 1998, BIOCHEMISTRY-US, V37, P1060, DOI 10.1021/bi972146p; Wang H, 2003, P NATL ACAD SCI USA, V100, P14822, DOI 10.1073/pnas.2433654100; Yamamoto A, 2000, NUCLEIC ACIDS RES, V28, P3564, DOI 10.1093/nar/28.18.3564; Yang W, 2000, COLD SPRING HARB SYM, V65, P225, DOI 10.1101/sqb.2000.65.225; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708	48	52	53	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36646	36654		10.1074/jbc.M805712200	http://dx.doi.org/10.1074/jbc.M805712200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18854319	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000261840500063
J	Deming, PB; Campbell, SL; Baldor, LC; Howe, AK				Deming, Paula B.; Campbell, Shirley L.; Baldor, Linda C.; Howe, Alan K.			Protein Kinase A Regulates 3-Phosphatidylinositide Dynamics during Platelet-derived Growth Factor-induced Membrane Ruffling and Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; CELL-MIGRATION; PHOSPHATIDYLINOSITOL 3-KINASE; NEUTROPHIL CHEMOTAXIS; ACTIN CYTOSKELETON; ANCHORING PROTEINS; HUMAN FIBROBLASTS; SIGNALING EVENTS; DISTINCT ROLES; FEEDBACK LOOP	Spatial regulation of the cAMP-dependent protein kinase (PKA) is required for chemotaxis in fibroblasts; however, the mechanism(s)by which PKA regulates the cell migration machinery remain largely unknown. Here we report that one function of PKA during platelet-derived growth factor (PDGF)-induced chemotaxis was to promote membrane ruffling by regulating phosphatidylinositol 3,4,5-trisphosphate (PIP3) dynamics. Inhibition of PKA activity dramatically altered membrane dynamics and attenuated formation of peripheral membrane ruffles in response to PDGF. PKA inhibition also significantly decreased the number and size of PIP3-rich membrane ruffles in response to uniform stimulation and to gradients of PDGF. This ruffling defect was quantified using a newly developed method, based on computer vision edge-detection algorithms. PKA inhibition caused a marked attenuation in the bulk accumulation of PIP3 following PDGF stimulation, without effects on PI3-kinase (PI3K) activity. The deficits in PIP3 dynamics correlated with a significant inhibition of growth factor-induced membrane recruitment of endogenous Akt and Rac activation in PKA-inhibited cells. Simultaneous inhibition of PKA and Rac had an additive inhibitory effect on growth factor-induced ruffling dynamics. Conversely, the expression of a constitutively active Rac allele was able to rescue the defect in membrane ruffling and restore the localization of a fluorescent PIP3 marker to membrane ruffles in PKA-inhibited cells, even in the absence of PI3K activity. These data demonstrate that, like Rac, PKA contributes to PIP3 and membrane dynamics independently of direct regulation of PI3K activity and suggest that modulation of PIP3/3-phosphatidylinositol (3-PI) lipids represents a major target for PKA in the regulation of PDGF-induced chemotactic events.	[Campbell, Shirley L.; Baldor, Linda C.; Howe, Alan K.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Deming, Paula B.] Univ Vermont, Dept Med Lab & Radiat Sci, Burlington, VT 05405 USA; [Campbell, Shirley L.; Baldor, Linda C.; Howe, Alan K.] Univ Vermont, Vermont Canc Ctr, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Howe, AK (corresponding author), Univ Vermont, Dept Pharmacol, 149 Beaumont Ave,HSRF 322, Burlington, VT 05405 USA.	alan.howe@uvm.edu		Deming, Paula/0000-0003-3278-1705	National Institutes of Health [GM-074204]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074204 (to A.K.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Barber Mark A, 2006, Bull Cancer, V93, pE44; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cockcroft S, 2007, BBA-MOL CELL BIOL L, V1771, P677, DOI 10.1016/j.bbalip.2007.03.009; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; DEBLAQUIERE J, 1994, J BIOL CHEM, V269, P4812; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; FUKUI Y, 1991, MOL CELL BIOL, V11, P1972, DOI 10.1128/MCB.11.4.1972; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Graves LM, 1996, J BIOL CHEM, V271, P505, DOI 10.1074/jbc.271.1.505; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Hafizi S, 2005, FASEB J, V19, P971, DOI 10.1096/fj.04-2532fje; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HEDBERG KM, 1995, EXP CELL RES, V219, P266, DOI 10.1006/excr.1995.1227; HEDBERG KM, 1993, CELL MOTIL CYTOSKEL, V24, P139, DOI 10.1002/cm.970240207; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Kanamarlapudi V, 2005, BIOCHEM SOC T, V33, P1279, DOI 10.1042/BST0331279; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Loovers HM, 2006, MOL BIOL CELL, V17, P1503, DOI 10.1091/mbc.E05-09-0825; Ma K, 2008, CELL SIGNAL, V20, P684, DOI 10.1016/j.cellsig.2007.12.004; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; NOBES CD, 1995, J CELL SCI, V108, P225; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Scott JD, 2003, BIOCHEM SOC T, V31, P87, DOI 10.1042/bst0310087; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; WYMANN M, 1994, BIOCHEM J, V298, P517, DOI 10.1042/bj2980517; Yi Q, 2006, BIOTECHNIQUES, V40, P745, DOI 10.2144/000112162	65	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35199	35211		10.1074/jbc.M804448200	http://dx.doi.org/10.1074/jbc.M804448200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936099	Green Published, hybrid			2022-12-27	WOS:000261469100076
J	Frielingsdorf, S; Jakob, M; Klosgen, RB				Frielingsdorf, Stefan; Jakob, Mario; Kloesgen, Ralf Bernd			A Stromal Pool of TatA Promotes Tat-dependent Protein Transport across the Thylakoid Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE SIGNAL PEPTIDE; CYTOCHROME B(6)/F COMPLEX; RIESKE FE/S PROTEIN; ESCHERICHIA-COLI; TRANSLOCATION PATHWAY; ARABIDOPSIS-THALIANA; BACILLUS-SUBTILIS; CHLOROPLASTS; SEC; SYSTEM	In chloroplasts and bacteria, the Tat (twin-arginine translocation) system is engaged in transporting folded passenger proteins across the thylakoid and cytoplasmic membranes, respectively. To date, three membrane proteins (TatA, TatB, and TatC) have been identified to be essential for Tat-dependent protein translocation in the plant system, whereas soluble factors seem not to be required. In contrast, in the bacterial system, several cytosolic chaperones were described to be involved in Tat transport processes. Therefore, we have examined whether stromal or peripherally associated membrane proteins also play a role in Tat transport across the thylakoid membrane. Analyzing both authentic precursors as well as the chimeric 16/23 protein, which allows us to study each step of the translocation process individually, we demonstrate that a soluble form of TatA is present in the chloroplast stroma, which significantly improves the efficiency of Tat-dependent protein transport. Furthermore, this soluble TatA is able to reconstitute the Tat transport properties of thylakoid membranes that are transport-incompetent due to extraction with solutions of chaotropic salts.	[Frielingsdorf, Stefan; Jakob, Mario; Kloesgen, Ralf Bernd] Univ Halle Wittenberg, Inst Biol, D-06120 Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Klosgen, RB (corresponding author), Univ Halle Wittenberg, Inst Biol, Weinbergweg 10, D-06120 Halle, Saale, Germany.	klosgen@pflanzenphys.uni-halle.de	Frielingsdorf, Stefan/AAD-8065-2019	Frielingsdorf, Stefan/0000-0002-4141-7836	state Sachsen-Anhalt (Exzellenzcluster Biowissenschaften, Research Cluster B); Deutsche Forschungsgemeinschaft [KL 862/2-1]	state Sachsen-Anhalt (Exzellenzcluster Biowissenschaften, Research Cluster B); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the state Sachsen-Anhalt (Exzellenzcluster Biowissenschaften, Research Cluster B) and the Deutsche Forschungsgemeinschaft (KL 862/2-1). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Berghofer J, 1999, FEBS LETT, V460, P328, DOI 10.1016/S0014-5793(99)01365-4; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Braun NA, 2007, BIOPHYS J, V93, P1993, DOI 10.1529/biophysj.106.098731; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; De Keersmaeker S, 2005, FEBS LETT, V579, P797, DOI 10.1016/j.febslet.2004.12.059; Fincher V, 2003, EUR J BIOCHEM, V270, P4930, DOI 10.1046/j.1432-1033.2003.03894.x; Frielingsdorf S, 2007, J BIOL CHEM, V282, P24455, DOI 10.1074/jbc.M702630200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Jakob M, 2009, BBA-MOL CELL RES, V1793, P388, DOI 10.1016/j.bbamcr.2008.09.006; Karnauchov I, 1997, FEBS LETT, V408, P206, DOI 10.1016/S0014-5793(97)00427-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maillard J, 2007, P NATL ACAD SCI USA, V104, P15641, DOI 10.1073/pnas.0703967104; Marques JP, 2004, J EXP BOT, V55, P1697, DOI 10.1093/jxb/erh191; Marques JP, 2003, MOL GENET GENOMICS, V269, P381, DOI 10.1007/s00438-003-0846-y; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; Motohashi R, 2001, P NATL ACAD SCI USA, V98, P10499, DOI 10.1073/pnas.181304598; MOULD RM, 1991, J BIOL CHEM, V266, P17286; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Netzer WJ, 1998, TRENDS BIOCHEM SCI, V23, P68, DOI 10.1016/S0968-0004(97)01171-7; Perez-Rodriguez R, 2007, J MOL BIOL, V367, P715, DOI 10.1016/j.jmb.2007.01.027; Pop OI, 2003, J BIOL CHEM, V278, P38428, DOI 10.1074/jbc.M306516200; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; VACHEREAU A, 1989, ANAL BIOCHEM, V179, P206, DOI 10.1016/0003-2697(89)90227-3; Walker MB, 1999, J CELL BIOL, V147, P267, DOI 10.1083/jcb.147.2.267; Westermann M, 2006, BBA-BIOMEMBRANES, V1758, P443, DOI 10.1016/j.bbamem.2006.03.018	47	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33838	33845		10.1074/jbc.M806334200	http://dx.doi.org/10.1074/jbc.M806334200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18842584	Green Published, hybrid			2022-12-27	WOS:000261277700007
J	Huber, C; Martensson, A; Bokoch, GM; Nemazee, D; Gavin, AL				Huber, Christoph; Martensson, Annica; Bokoch, Gary M.; Nemazee, David; Gavin, Amanda L.			FGD2, a CDC42-specific Exchange Factor Expressed by Antigen-presenting Cells, Localizes to Early Endosomes and Active Membrane Ruffles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSION RATIO DISTORTION; FACIOGENITAL DYSPLASIA FGD1; DBL HOMOLOGY DOMAIN; MOUSE BONE-MARROW; DENDRITIC CELLS; RHO-GTPASES; SYNDROME GENE; SELECTIVE ACTIVATION; GDP/GTP EXCHANGE; STRUCTURAL BASIS	Members of the Fgd (faciogenital dysplasia) gene family encode a group of critical guanine nucleotide exchange factors (GEFs), which, by specifically activating Cdc42, control cytoskeleton-dependent membrane rearrangements. In its first characterization, we find that FGD2 is expressed in antigen-presenting cells, including B lymphocytes, macrophages, and dendritic cells. In the B lymphocyte lineage, FGD2 levels change with developmental stage. In both mature splenic B cells and immature bone marrow B cells, FGD2 expression is suppressed upon activation through the B cell antigen receptor. FGD2 has a complex intracellular localization, with concentrations found in membrane ruffles and early endosomes. Although endosomal localization of FGD2 is dependent on a conserved FYVE domain, its C-terminal pleckstrin homology domain mediates recruitment to membrane ruffles. FGD2 overexpression promotes the activation of Cdc42 and leads to elevated JNK1 activity in a Cdc42-but not Rac1-dependent fashion. These findings are consistent with a role of FGD2 in leukocyte signaling and vesicle trafficking in cells specialized to present antigen in the immune system.	[Huber, Christoph; Martensson, Annica; Bokoch, Gary M.; Nemazee, David; Gavin, Amanda L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Gavin, AL (corresponding author), 10550 N Torrey Pines Rd,IMM-29, La Jolla, CA 92037 USA.	agavin@scripps.edu			National Institutes of Health [R01AI033608, R01AI067403]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067403, R01AI033608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI033608 and R01AI067403. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bauer H, 2007, GENE DEV, V21, P143, DOI 10.1101/gad.414807; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Delague V, 2007, AM J HUM GENET, V81, P1, DOI 10.1086/518428; Deruytter N, 2004, DIABETES, V53, P3323, DOI 10.2337/diabetes.53.12.3323; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Ducummon CC, 2006, ZYGOTE, V14, P249, DOI 10.1017/S0967199406003790; Egami Y, 2008, EXP CELL RES, V314, P729, DOI 10.1016/j.yexcr.2007.11.018; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; Hou P, 2003, HUM MOL GENET, V12, P1981, DOI 10.1093/hmg/ddg209; Kim Y, 2002, GENES CELLS, V7, P413, DOI 10.1046/j.1365-2443.2002.00524.x; Kjeken R, 2001, BIOCHEM J, V357, P497, DOI 10.1042/0264-6021:3570497; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lyon MF, 2005, NAT GENET, V37, P924, DOI 10.1038/ng0905-924; Muller O, 2001, EMBO J, V20, P5657, DOI 10.1093/emboj/20.20.5657; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Nobes C, 2000, CURR BIOL, V10, pR739, DOI 10.1016/S0960-9822(00)00736-3; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Obaishi H, 1998, J BIOL CHEM, V273, P18697, DOI 10.1074/jbc.273.30.18697; Ono Y, 2000, ONCOGENE, V19, P3050, DOI 10.1038/sj.onc.1203631; Pasteris NG, 1999, GENOMICS, V60, P57, DOI 10.1006/geno.1999.5903; Pasteris NG, 2000, GENE, V242, P237, DOI 10.1016/S0378-1119(99)00518-1; PASTERIS NG, 1994, CELL, V79, P669; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Sanna MG, 1998, P NATL ACAD SCI USA, V95, P6015, DOI 10.1073/pnas.95.11.6015; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Stendel C, 2007, AM J HUM GENET, V81, P158, DOI 10.1086/518770; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stofega Mary, 2006, V332, P269; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sutcliffe JG, 2000, P NATL ACAD SCI USA, V97, P1976, DOI 10.1073/pnas.040537997; VAIRO G, 1985, BIOCHEM BIOPH RES CO, V132, P430, DOI 10.1016/0006-291X(85)91040-X; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169; Zhou KM, 1998, J BIOL CHEM, V273, P16782, DOI 10.1074/jbc.273.27.16782; Zhu KJ, 2000, J BIOL CHEM, V275, P25993, DOI 10.1074/jbc.M003780200	56	38	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34002	34012		10.1074/jbc.M803957200	http://dx.doi.org/10.1074/jbc.M803957200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18838382	Green Published, hybrid			2022-12-27	WOS:000261277700027
J	Isono, O; Ohshima, T; Saeki, Y; Matsumoto, J; Hijikata, M; Tanaka, K; Shimotohno, K				Isono, Osamu; Ohshima, Takayuki; Saeki, Yasushi; Matsumoto, Jun; Hijikata, Makoto; Tanaka, Keiji; Shimotohno, Kunitada			Human T-cell Leukemia Virus Type 1 HBZ Protein Bypasses the Targeting Function of Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; TRANSCRIPTIONAL ACTIVITY; ORNITHINE-DECARBOXYLASE; INDEPENDENT DEGRADATION; RETINOBLASTOMA PROTEIN; PROTEASOMAL TURNOVER; NEGATIVE REGULATOR; 20S PROTEASOME; IN-VIVO; P53	Human T-cell leukemia virus type 1 (HTLV-1) encodes an antisense viral gene product termed HTLV-1 basic leucine-zipper factor (HBZ). HBZ forms heterodimers with c-Jun, a member of the AP-1 family, and promotes its proteasomal degradation. Although most proteasomal substrates are targeted for degradation via conjugation of polyubiquitin chains, we show that ubiquitination is not required for HBZ-mediated proteasomal degradation of c-Jun. We demonstrate that HBZ directly interacts with both the 26 S proteasome and c-Jun and facilitates the delivery of c-Jun to the proteasome without ubiquitination. HBZ acts as a tethering factor between the 26 S proteasome and its substrate, thereby bypassing the targeting function of ubiquitination. These findings disclose a novel viral strategy to utilize the cellular proteolytic system for viral propagation.	[Isono, Osamu; Ohshima, Takayuki; Matsumoto, Jun; Hijikata, Makoto; Shimotohno, Kunitada] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Human Tumor Viruses,Sakyo Ku, Kyoto 6068507, Japan; [Ohshima, Takayuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa 7692193, Japan; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Core Technol & Res Ctr, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Shimotohno, Kunitada] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Chiba 2750016, Japan	Kyoto University; Tokushima Bunri University; Tokyo Metropolitan Institute of Medical Science; Keio University; Chiba Institute of Technology	Shimotohno, K (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Lab Human Tumor Viruses,Sakyo Ku, Kyoto 6068507, Japan.	shimkuni@z8.keio.jp	Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; OHSHIMA, Takayuki/0000-0002-1501-6430	Ministry of Health, Labour and Welfare; Takeda Science Foundation; Suzuken Memorial Foundation; Japanese Leukemia Research Foundation	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Japanese Leukemia Research Foundation	This work was supported by grants-in-aid for cancer research and for the second-term comprehensive 10-year strategy for cancer control from the Ministry of Health, Labour and Welfare as well as by grants-in-aid for Scientific Research on Priority Areas "Integrative Research Toward the Conquest of Cancer" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. In addition, this work was supported by research funds from the Takeda Science Foundation, the Suzuken Memorial Foundation, and the Japanese Leukemia Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; FUJII M, 1991, ONCOGENE, V6, P1023; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; INOUE J, 1987, P NATL ACAD SCI USA, V84, P3653, DOI 10.1073/pnas.84.11.3653; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; KANNAGI M, 1991, INT IMMUNOL, V3, P761, DOI 10.1093/intimm/3.8.761; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Lemasson I, 2007, J VIROL, V81, P1543, DOI 10.1128/JVI.00480-06; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; Mori N, 2000, BLOOD, V95, P3915; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murata K, 2006, J VIROL, V80, P2495, DOI 10.1128/JVI.80.5.2495-2505.2006; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nicot C, 2004, NAT MED, V10, P197, DOI 10.1038/nm984; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shackelford J, 2005, ESSAYS BIOCHEM, V41, P139, DOI 10.1042/EB0410139; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	46	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34273	34282		10.1074/jbc.M802527200	http://dx.doi.org/10.1074/jbc.M802527200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18805793	Green Published, hybrid			2022-12-27	WOS:000261277700055
J	Lim, YB; Park, TJ; Lim, IK				Lim, Young-Bin; Park, Tae Jun; Lim, In Kyoung			B Cell Translocation Gene 2 Enhances Susceptibility of HeLa Cells to Doxorubicin-induced Oxidative Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MESSENGER-RNA; UP-REGULATION; DNA-DAMAGE; EXPRESSION; GROWTH; TIS21; BTG2; CARDIOTOXICITY; OVEREXPRESSION	BTG2(/TIS21/PC3) (B cell translocation gene 2) has been known as a p53 target gene and functions as a tumor suppressor in carcinogenesis of thymus, prostate, kidney, and liver. Although it has been known that the expression of BTG2(/TIS21/PC3) is induced during chemotherapy-mediated apoptosis in cancer cells, a role of BTG2(/TIS21/PC3) in cell death remains to be elucidated. In this study, the mechanism and role of BTG2 involved in the enhancement of doxorubicin (DOXO)-induced cell death were examined. Treatment of HeLa cells with DOXO revealed apoptotic phenomena, such as chromatin condensation and cleavage of poly(ADP-ribose) polymerase and lamin A/C with concomitant increase of BTG2(/TIS21/PC3) expression. Employing infections of Ad-TIS21 virus and lentivirus with short hairpin RNA to BTG2, the effect of BTG2(/TIS21/PC3) on the DOXO-induced apoptosis of HeLa cells and liver cancer cells was evaluated. Not only short hairpin RNA-BTG2 but also N-acetyl-Lcysteine significantly reduced the DOXO-induced HeLa cell death and generation of H2O2. Moreover, forced expression of BTG2(/TIS21/PC3) using adenoviral vector augmented DOXO-induced cancer cell death concomitantly with increase of manganese-superoxide dismutase but not catalase, CuZnSOD, and glutathione peroxidase 1. The increased apoptosis by forced expression of BTG2(/TIS21/PC3) could be inhibited by N-acetyl-Lcysteine and polyethylene glycol-catalase. These results therefore suggest that BTG2(/TIS21/PC3) works as an enhancer of DOXO-induced cell death via accumulation of H2O2 by up-regulating manganese-superoxide dismutase without any other antioxidant enzymes. In summary, BTG2(/TIS21/PC3) enhances cancer cell death by accumulating H2O2 via imbalance of the antioxidant enzymes in response to chemotherapy.	[Lim, Young-Bin; Park, Tae Jun; Lim, In Kyoung] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea	Ajou University	Lim, IK (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea.	iklim@ajou.ac.kr			Korea Science and Engineering Foundation [R01-2006-000-10311-0, M10756040001-07N5604-00110]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Research Grants R01-2006-000-10311-0 and M10756040001-07N5604-00110 from the Korea Science and Engineering Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Bernard D, 2002, ONCOGENE, V21, P4392, DOI 10.1038/sj.onc.1205536; Bernard D, 2001, CANCER RES, V61, P2656; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Buettner GR, 2006, FREE RADICAL BIO MED, V41, P1338, DOI 10.1016/j.freeradbiomed.2006.07.015; Chen JG, 2003, CANCER RES, V63, P7891; Cortes U, 2000, MOL CARCINOGEN, V27, P57, DOI 10.1002/(SICI)1098-2744(200002)27:2<57::AID-MC1>3.3.CO;2-9; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELIOT H, 1984, BIOCHEMISTRY-US, V23, P928, DOI 10.1021/bi00300a021; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gardner R, 2002, FREE RADICAL BIO MED, V32, P1351, DOI 10.1016/S0891-5849(02)00861-4; Hong JW, 2005, J BIOL CHEM, V280, P21256, DOI 10.1074/jbc.M500318200; Islaih M, 2005, MUTAT RES-FUND MOL M, V578, P100, DOI 10.1016/j.mrfmmm.2005.04.012; Kim BC, 2008, STEM CELLS, V26, P2339, DOI 10.1634/stemcells.2008-0327; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kim SW, 2008, MOL CARCINOGEN, V47, P114, DOI 10.1002/mc.20369; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Lee YJ, 1997, BLOOD, V89, P4480, DOI 10.1182/blood.V89.12.4480; Li N, 1998, PROSTATE, V35, P221, DOI 10.1002/(SICI)1097-0045(19980515)35:3<221::AID-PROS8>3.0.CO;2-J; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LIM IK, 1995, J CANCER RES CLIN, V121, P279, DOI 10.1007/BF01209594; Lim IK, 1998, MOL CARCINOGEN, V23, P25, DOI 10.1002/(SICI)1098-2744(199809)23:1<25::AID-MC4>3.0.CO;2-G; LIM RW, 1987, ONCOGENE, V1, P263; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Minotti G, 1999, FASEB J, V13, P199, DOI 10.1096/fasebj.13.2.199; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Pani G, 2000, CANCER RES, V60, P4654; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Park TJ, 2008, HEPATOLOGY, V47, P1533, DOI 10.1002/hep.22212; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Ryu MS, 2004, EXP CELL RES, V299, P159, DOI 10.1016/j.yexcr.2004.05.014; SCOTT MD, 1989, J BIOL CHEM, V264, P2498; SCOTT MD, 1987, J BIOL CHEM, V262, P3640; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tokarska-Schlattner M, 2006, J MOL CELL CARDIOL, V41, P389, DOI 10.1016/j.yjmcc.2006.06.009; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; ZALESKIS G, 1994, MOL PHARMACOL, V46, P901; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	44	33	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33110	33118		10.1074/jbc.M804255200	http://dx.doi.org/10.1074/jbc.M804255200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18840609	hybrid, Green Published			2022-12-27	WOS:000261183700012
J	Panahandeh, S; Maurer, C; Moser, M; DeLisa, MP; Muller, M				Panahandeh, Sascha; Maurer, Carlo; Moser, Michael; DeLisa, Matthew P.; Mueller, Matthias			Following the Path of a Twin-arginine Precursor along the TatABC Translocase of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; SEC-INDEPENDENT PROTEIN; FOLDING QUALITY-CONTROL; SIGNAL PEPTIDE BINDING; IN-VIVO; TRANSPORT COMPLEXES; TATC FORM; SYSTEM; COMPONENT; EXPORT	The twin-arginine translocation (Tat) machinery present in bacterial and thylakoidal membranes is able to transport fully folded proteins. Consistent with previous in vivo data, we show that the model Tat substrate TorA-PhoA is translocated by the TatABC translocase of Escherichia coli inner membrane vesicles, only if the PhoA moiety was allowed to fold by disulfide bond formation. Although even unfolded TorA-PhoA was found to physically associate with the Tat translocase of the vesicles, site-specific cross-linking revealed a perturbed interaction of the signal sequence of unfolded TorA-PhoA with the TatBC receptor site. Some of the folded TorA-PhoA precursor accumulated in a partially protease-protected membrane environment, from where it could be translocated into the lumen of the vesicles upon re-installation of an H+-gradient. Translocation arrest occurred in immediate vicinity to TatA. Consistent with a neighborhood to TatA, TorA-PhoA remained protease-resistant in the presence of detergents that are known to preserve the oligomeric structures of TatA. Moreover, entry of TorA-PhoA to the protease-protected environment strictly required the presence of TatA. Collectively, our results are consistent with some degree of quality control by TatBC and a recruitment of TatA to a folded substrate that has functionally engaged the twin-arginine translocase.	[Panahandeh, Sascha] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	University of Freiburg; Cornell University		matthias.mueller@biochemie.uni-freiburg.de	DeLisa, Matthew/AAE-7361-2019	Maurer, H. Carlo/0000-0002-2193-6014; DeLisa, Matthew/0000-0003-3226-1566	European Union [LSHG-CT-2004-005257]; Deutsche Forschungsgemeinschaft; University of Freiburg; NSF [0449080]; NYSTAR James D. Watson Award	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Freiburg; NSF(National Science Foundation (NSF)); NYSTAR James D. Watson Award	This work was supported by Grant LSHG-CT-2004-005257 of the European Union (to S. P. and M. M.), grants from the Deutsche Forschungsgemeinschaft (Collaborative Research Centres 388 and 746, to M. M.), an F. F. Nord fellowship of the University of Freiburg (to C. M.), and an NSF Career Award (CBET 0449080) and a NYSTAR James D. Watson Award (both to M. P. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alder NN, 2003, FEBS LETT, V540, P96, DOI 10.1016/S0014-5793(03)00231-X; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Barrett CML, 2007, J BIOL CHEM, V282, P36206, DOI 10.1074/jbc.M704127200; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Di Cola A, 2005, J CELL BIOL, V171, P281, DOI 10.1083/jcb.200502067; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hatzixanthis K, 2005, P NATL ACAD SCI USA, V102, P8460, DOI 10.1073/pnas.0500737102; Hoffmann JH, 2004, EMBO J, V23, P160, DOI 10.1038/sj.emboj.7600016; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; McDevitt CA, 2005, BIOCHEM BIOPH RES CO, V329, P693, DOI 10.1016/j.bbrc.2005.02.038; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mendel S, 2008, J MOL BIOL, V375, P661, DOI 10.1016/j.jmb.2007.09.087; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Moser Michael, 2007, V390, P63; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	52	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33267	33275		10.1074/jbc.M804225200	http://dx.doi.org/10.1074/jbc.M804225200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18836181	hybrid, Green Published			2022-12-27	WOS:000261183700030
J	Sato, H; Kato, R; Isogai, Y; Saka, G; Ohtsuki, M; Taketomi, Y; Yamamoto, K; Tsutsumi, K; Yamada, J; Masuda, S; Ishikawa, Y; Ishii, T; Kobayashi, T; Ikeda, K; Taguchi, R; Hatakeyama, S; Hara, S; Kudo, I; Itabe, H; Murakami, M				Sato, Hiroyasu; Kato, Rina; Isogai, Yuki; Saka, Go-ichi; Ohtsuki, Mitsuhiro; Taketomi, Yoshitaka; Yamamoto, Kei; Tsutsumi, Kae; Yamada, Joe; Masuda, Seiko; Ishikawa, Yukio; Ishii, Toshiharu; Kobayashi, Tetsuyuki; Ikeda, Kazutaka; Taguchi, Ryo; Hatakeyama, Shinji; Hara, Shuntaro; Kudo, Ichiro; Itabe, Hiroyuki; Murakami, Makoto			Analyses of Group III Secreted Phospholipase A(2) Transgenic Mice Reveal Potential Participation of This Enzyme in Plasma Lipoprotein Modification, Macrophage Foam Cell Formation, and Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ARACHIDONATE-RELEASING FUNCTION; MOUSE PERITONEAL-MACROPHAGES; GROUP-V; GROUP-X; EXPRESSION; GENE; ACID; ACTIVATION; LYSOPHOSPHATIDYLCHOLINE	Among the many mammalian secreted phospholipase A(2) (sPLA(2)) enzymes, PLA2G3 ( group III secreted phospholipase A2) is unique in that it possesses unusual N- and C-terminal domains and in that its central sPLA(2) domain is homologous to bee venom PLA(2) rather than to other mammalian sPLA(2)s. To elucidate the in vivo actions of this atypical sPLA(2), we generated transgenic (Tg) mice overexpressing human PLA2G3. Despite marked increases in PLA(2) activity and mature 18-kDa PLA2G3 protein in the circulation and tissues, PLA2G3 Tg mice displayed no apparent abnormality up to 9 months of age. However, alterations in plasma lipoproteins were observed in PLA2G3 Tg mice compared with control mice. In vitro incubation of low density (LDL) and high density (HDL) lipoproteins with several sPLA(2)s showed that phosphatidylcholine was efficiently converted to lysophosphatidylcholine by PLA2G3 as well as by PLA2G5 and PLA2G10, to a lesser extent by PLA2G2F, and only minimally by PLA2G2A and PLA2G2E. PLA2G3-modified LDL, like PLA2G5- or PLA2G10-treated LDL, facilitated the formation of foam cells from macrophages ex vivo. Accumulation of PLA2G3 was detected in the atherosclerotic lesions of humans and apoE-deficient mice. Furthermore, following an atherogenic diet, aortic atherosclerotic lesions were more severe in PLA2G3 Tg mice than in control mice on the apoE-null background, in combination with elevated plasma lysophosphatidylcholine and thromboxane A(2) levels. These results collectively suggest a potential functional link between PLA2G3 and atherosclerosis, as has recently been proposed for PLA2G5 and PLA2G10.	[Sato, Hiroyasu; Isogai, Yuki; Yamamoto, Kei; Masuda, Seiko; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Biomembrane Signaling Project, Bunkyo Ku, Tokyo 1138613, Japan; [Sato, Hiroyasu; Ohtsuki, Mitsuhiro; Taketomi, Yoshitaka; Masuda, Seiko; Kudo, Ichiro; Murakami, Makoto] Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Kato, Rina; Saka, Go-ichi; Itabe, Hiroyuki] Showa Univ, Sch Pharmaceut Sci, Dept Biol Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Taketomi, Yoshitaka] Showa Univ, Ctr Biotechnol, Shinagawa Ku, Tokyo 1428555, Japan; [Isogai, Yuki; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo 1128610, Japan; [Tsutsumi, Kae; Yamada, Joe; Hatakeyama, Shinji] Novartis Inst BioMed Res, Tsukuba, Ibaraki 3002611, Japan; [Ishikawa, Yukio; Ishii, Toshiharu] Toho Univ, Sch Med, Dept Pathol, Ohta Ku, Tokyo 1438540, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Fac Med, Dept Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Murakami, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Showa University; Showa University; Showa University; Ochanomizu University; Novartis; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Biomembrane Signaling Project, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	murakami-mk@igakuken.or.jp	Kobayashi, Tetsuyuki/AAH-2985-2020; Hatakeyama, Shinji/I-8873-2019; 板部板部, 洋之/ABC-7746-2020	Kobayashi, Tetsuyuki/0000-0002-9285-0859; Hatakeyama, Shinji/0000-0002-0166-2773; 	Ministry of Education, Science, Culture, Sports and Technology of Japan	Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, Sports and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Boyanovsky BB, 2005, J BIOL CHEM, V280, P32746, DOI 10.1074/jbc.M502067200; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Chen YJ, 1998, BBA-LIPID LIPID MET, V1394, P57, DOI 10.1016/S0005-2760(98)00098-8; Curfs DMJ, 2008, J BIOL CHEM, V283, P21640, DOI 10.1074/jbc.M710584200; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Deregnaucourt C, 2000, J BIOL CHEM, V275, P39973, DOI 10.1074/jbc.M006712200; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Fox N, 1996, EUR J PHARMACOL, V308, P195, DOI 10.1016/0014-2999(96)00257-9; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; HEIDER JG, 1978, J LIPID RES, V19, P514; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Houjou T, 2004, RAPID COMMUN MASS SP, V18, P3123, DOI 10.1002/rcm.1737; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Hurt-Camejo E, 2001, CIRC RES, V89, P298, DOI 10.1161/hh1601.095598; Hurt-Camejo E, 2001, ARTHRITIS RHEUM, V44, P2761, DOI 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5; Ishimoto Y, 2003, BBA-MOL CELL RES, V1642, P129, DOI 10.1016/S0167-4889(03)00120-4; ITABE H, 1994, J BIOL CHEM, V269, P15274; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Kimura-Matsumoto M, 2008, ATHEROSCLEROSIS, V196, P81, DOI 10.1016/j.atherosclerosis.2006.08.062; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Masuda S, 2008, BIOCHEM J, V409, P429, DOI 10.1042/BJ20070844; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Mitsuishi M, 2007, BBA-MOL CELL BIOL L, V1771, P1389, DOI 10.1016/j.bbalip.2007.09.006; Mounier CM, 2008, BRIT J CANCER, V98, P587, DOI 10.1038/sj.bjc.6604184; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Murakami M, 2005, J BIOL CHEM, V280, P24987, DOI 10.1074/jbc.M502088200; Murakami M, 2003, J BIOL CHEM, V278, P10657, DOI 10.1074/jbc.M211325200; Murakami M, 2002, J BIOL CHEM, V277, P19145, DOI 10.1074/jbc.M112385200; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Neuzil J, 1998, BIOCHEMISTRY-US, V37, P9203, DOI 10.1021/bi9730745; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; POSTON RN, 1992, AM J PATHOL, V140, P665; Pruzanski W, 2005, BBA-MOL CELL BIOL L, V1736, P38, DOI 10.1016/j.bbalip.2005.07.005; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Romano M, 1998, ARTERIOSCL THROM VAS, V18, P519, DOI 10.1161/01.ATV.18.4.519; Rosengren B, 2006, ARTERIOSCL THROM VAS, V26, P1579, DOI 10.1161/01.ATV.0000221231.56617.67; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sartipy P, 1996, J BIOL CHEM, V271, P26307, DOI 10.1074/jbc.271.42.26307; Sartipy P, 2000, CIRC RES, V86, P707, DOI 10.1161/01.RES.86.6.707; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492; VANZANTEN GH, 1994, J CLIN INVEST, V93, P615, DOI 10.1172/JCI117014; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1439, P1, DOI 10.1016/S1388-1981(99)00063-3; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5; Weinrauch Y, 1996, J CLIN INVEST, V97, P250, DOI 10.1172/JCI118399; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Wootton PTE, 2007, HUM MOL GENET, V16, P1437, DOI 10.1093/hmg/ddm094; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Yanaru-Fujisawa R, 2007, DIS COLON RECTUM, V50, P223, DOI 10.1007/s10350-006-0780-2; YOKODE M, 1988, J CLIN INVEST, V81, P720, DOI 10.1172/JCI113377; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	77	93	101	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33483	33497		10.1074/jbc.M804628200	http://dx.doi.org/10.1074/jbc.M804628200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18801741	hybrid, Green Published			2022-12-27	WOS:000261183700053
J	Walker, A; Skamel, C; Vorreiter, J; Nassal, M				Walker, Andreas; Skamel, Claudia; Vorreiter, Jolanta; Nassal, Michael			Internal Core Protein Cleavage Leaves the Hepatitis B Virus Capsid Intact and Enhances Its Capacity for Surface Display of Heterologous Whole Chain Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ELECTRON CRYOMICROSCOPY; 3-DIMENSIONAL STRUCTURE; ANTIGENIC DETERMINANTS; MONOCLONAL-ANTIBODIES; STRUCTURAL MODEL; LYME BORRELIOSIS; PARTICLES CLPS; CELL EPITOPES; WILD-TYPE	Virus capsids find increasing use as nanoparticulate platforms for the surface display of heterologous ligands, including as multivalent vaccine carriers. Presentation on the icosahedral hepatitis B virus capsid (HBcAg) is known to strongly enhance immunogenicity of foreign sequences, most efficiently if they are inserted into the dominant c/el B cell epitope, a surface-exposed loop in the center of the constituent core protein primary sequence. Even some complete proteins were successfully inserted but others, e. g. the outer surface protein A (OspA) of the Lyme disease agent Borrelia burgdorferi, impaired formation of capsid-like particles (CLPs). This difference can be rationalized by the requirement for the termini of the insert to fit into the predetermined geometry of the two acceptor sites in the carrier. We reasoned that cleavage of one of the two bonds connecting insert and carrier should relieve these constraints, provided the cleaved protein fragments remain competent to support the particle structure. Indeed, HBcAg CLPs containing a recognition site for tobacco etch virus (TEV) protease in the c/el loop remained intact after cleavage, as did CLPs carrying a 65-residue peptide insertion. Most importantly, in situ cleavage of a core-OspA fusion protein by coexpressed TEV protease strongly enhanced CLP formation compared with the uncleaved protein. These data attest to the high structural stability of the HBcAg CLP and they significantly widen its applicability as a carrier for heterologous proteins. This approach should be adaptable to any protein-based particle with surface-exposed yet sequence-internal loops.	[Walker, Andreas; Skamel, Claudia; Vorreiter, Jolanta; Nassal, Michael] Univ Hosp Freiburg, Dept Internal Med, D-79106 Freiburg, Germany; [Walker, Andreas] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Nassal, M (corresponding author), Univ Hosp Freiburg, Dept Internal Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	nassal2@ukl.uni-freiburg.de	Nassal, Michael/U-4529-2019	Nassal, Michael/0000-0003-2204-9158; Walker, Andreas/0000-0002-8736-0863	Deutsche Forschungsgemeinschaft [NA 154/6-2, 154/8-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (NA 154/6-2 and 154/8-3 within the Priority program SPP 1089 Novel Vaccination Strategies). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amexis G, 2006, J INFECT DIS, V194, P790, DOI 10.1086/506361; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Belnap DM, 2003, P NATL ACAD SCI USA, V100, P10884, DOI 10.1073/pnas.1834404100; BICHKO V, 1993, MOL IMMUNOL, V30, P221, DOI 10.1016/0161-5890(93)90051-C; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bottcher B, 2006, J MOL BIOL, V356, P812, DOI 10.1016/j.jmb.2005.11.053; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Bourne CR, 2006, J VIROL, V80, P11055, DOI 10.1128/JVI.00933-06; Chatterji A, 2002, INTERVIROLOGY, V45, P362, DOI 10.1159/000067929; Conway JF, 1998, J MOL BIOL, V279, P1111, DOI 10.1006/jmbi.1998.1845; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; Ding W, 2000, J MOL BIOL, V302, P1153, DOI 10.1006/jmbi.2000.4119; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Fehr T, 1998, P NATL ACAD SCI USA, V95, P9477, DOI 10.1073/pnas.95.16.9477; Freivalds J, 2006, J BIOTECHNOL, V123, P297, DOI 10.1016/j.jbiotec.2005.11.013; Harris A, 2006, J MOL BIOL, V355, P562, DOI 10.1016/j.jmb.2005.10.035; Hilmer JK, 2008, J MOL BIOL, V375, P581, DOI 10.1016/j.jmb.2007.10.044; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KENNEY JM, 1995, STRUCTURE, V3, P1009, DOI 10.1016/S0969-2126(01)00237-4; Kondo K, 2008, J MED VIROL, V80, P841, DOI 10.1002/jmv.21124; Konig S, 1998, J VIROL, V72, P4997; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; Manayani DJ, 2007, PLOS PATHOG, V3, P1422, DOI 10.1371/journal.ppat.0030142; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Nassal M, 2005, EUR J IMMUNOL, V35, P655, DOI 10.1002/eji.200425449; NASSAL M, 1988, GENE, V66, P279, DOI 10.1016/0378-1119(88)90364-2; NASSAL M, 1992, J MOL BIOL, V225, P1013, DOI 10.1016/0022-2836(92)90101-O; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2008, INT J MED MICROBIOL, V298, P135, DOI 10.1016/j.ijmm.2007.08.002; Nassal M, 2007, J VIROL, V81, P13218, DOI 10.1128/JVI.00846-07; Newman M, 2003, J VIROL, V77, P12950, DOI 10.1128/JVI.77.24.12950-12960.2003; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; PUSHKO P, 1994, VIROLOGY, V202, P912, DOI 10.1006/viro.1994.1413; Rai P, 2006, NAT BIOTECHNOL, V24, P582, DOI 10.1038/nbt1204; Roseman AM, 2005, P NATL ACAD SCI USA, V102, P15821, DOI 10.1073/pnas.0504874102; Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; SCHAIBLE UE, 1990, P NATL ACAD SCI USA, V87, P3768, DOI 10.1073/pnas.87.10.3768; SERWER P, 1995, J CHROMATOGR A, V698, P251, DOI 10.1016/0021-9673(94)01259-H; Singh P, 2006, DRUG DEVELOP RES, V67, P23, DOI 10.1002/ddr.20064; Singh S, 2003, J BIOL CHEM, V278, P18249, DOI 10.1074/jbc.M211408200; Skamel C, 2006, J BIOL CHEM, V281, P17474, DOI 10.1074/jbc.M513571200; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; Taylor KM, 2000, J MOL RECOGNIT, V13, P71; Ulrich R, 1998, ADV VIRUS RES, V50, P141, DOI 10.1016/S0065-3527(08)60808-8; Vogel M, 2005, FEBS LETT, V579, P5211, DOI 10.1016/j.febslet.2005.08.044; Vogel M, 2005, PROTEINS, V58, P478, DOI 10.1002/prot.20312; Voronkova T, 2002, VIRAL IMMUNOL, V15, P627, DOI 10.1089/088282402320914557; Watts NR, 2002, EMBO J, V21, P876, DOI 10.1093/emboj/21.5.876; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zlotnick A, 2003, VIROLOGY, V315, P269, DOI 10.1016/S0042-6822(03)00586-5	61	22	24	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33508	33515		10.1074/jbc.M805211200	http://dx.doi.org/10.1074/jbc.M805211200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826949	hybrid, Green Published			2022-12-27	WOS:000261183700055
J	Wu, XL; Lemon, B; Li, XF; Gupte, J; Weiszmann, J; Stevens, J; Hawkins, N; Shen, WY; Lindberg, R; Chen, JL; Tian, H; Li, Y				Wu, Xinle; Lemon, Bryan; Li, XiaoFan; Gupte, Jamila; Weiszmann, Jennifer; Stevens, Jennitte; Hawkins, Nessa; Shen, Wenyan; Lindberg, Richard; Chen, Jin-Long; Tian, Hui; Li, Yang			C-terminal Tail of FGF19 Determines Its Specificity toward Klotho Co-receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-KLOTHO; METABOLIC-ACTIVITY; STRUCTURAL BASIS; FIBROBLAST; EXPRESSION; MICE; FIBROBLAST-GROWTH-FACTOR-21; PHOSPHATE; FAMILY; GENE	FGF19 subfamily proteins (FGF19, FGF21, and FGF23) are unique members of fibroblast growth factors (FGFs) that regulate energy, bile acid, glucose, lipid, phosphate, and vitamin D homeostasis in an endocrine fashion. Their activities require the presence of alpha or beta Klotho, two related single-pass transmembrane proteins, as co-receptors in relevant target tissues. We previously showed that FGF19 can bind to both alpha and beta Klotho, whereas FGF21 and FGF23 can bind only to either beta Klotho or alpha Klotho, respectively in vitro. To determine the mechanism regulating the binding and specificity among FGF19 subfamily members to Klotho family proteins, chimeric proteins between FGF19 subfamily members or chimeric proteins between Klotho family members were constructed to probe the interaction between those two families. Our results showed that a chimera of FGF19 with the FGF21 C-terminal tail interacts only with beta Klotho and a chimera with the FGF23 C-terminal tail interacts only with alpha Klotho. FGF signaling assays also reflected the change of specificity we observed for the chimeras. These results identified the C-terminal tail of FGF19 as a region necessary for its recognition of Klotho family proteins. In addition, chimeras between alpha and beta Klotho were also generated to probe the regions in Klotho proteins that are important for signaling by this FGF subfamily. Both FGF23 and FGF21 require intact alpha or beta Klotho for signaling, respectively, whereas FGF19 can signal through a Klotho chimera consisting of the N terminus of alpha Klotho and the C terminus of beta Klotho. Our results provide the first glimpse of the regions that regulate the binding specificity between this unique family of FGFs and their co-receptors.	[Wu, Xinle; Lemon, Bryan; Li, XiaoFan; Gupte, Jamila; Weiszmann, Jennifer; Shen, Wenyan; Chen, Jin-Long; Tian, Hui; Li, Yang] Amgen Inc, San Francisco, CA 94080 USA; [Stevens, Jennitte; Hawkins, Nessa; Lindberg, Richard] Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Li, Y (corresponding author), Amgen Inc, San Francisco, CA 94080 USA.	yangl@amgen.com						Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683	18	68	122	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33304	33309		10.1074/jbc.M803319200	http://dx.doi.org/10.1074/jbc.M803319200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829467	Green Published, hybrid			2022-12-27	WOS:000261183700034
J	Abu-Elneel, K; Ochiishi, T; Medina, M; Remedi, M; Gastaldi, L; Caceres, A; Kosik, KS				Abu-Elneel, Kawther; Ochiishi, Tomoyo; Medina, Miguel; Remedi, Monica; Gastaldi, Laura; Caceres, Alfredo; Kosik, Kenneth S.			A delta-Catenin Signaling Pathway Leading to Dendritic Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; REGULATES SPINE MORPHOGENESIS; CULTURED HIPPOCAMPAL-NEURONS; X MENTAL-RETARDATION; P120 CATENIN; E-CADHERIN; DESMOSOMAL PLAQUE; COFILIN PHOSPHORYLATION; SYNAPTIC PLASTICITY; CONTACT FORMATION	delta-Catenin is a synaptic adherens junction protein pivotally positioned to serve as a signaling sensor and integrator. Expression of delta-catenin induces filopodia-like protrusions in neurons. Here we show that the small GTPases of the Rho family act coordinately as downstream effectors of delta-catenin. A dominant negative Rac prevented delta-catenin-induced protrusions, and Cdc42 activity was dramatically increased by delta-catenin expression. A kinase dead LIMK (LIM kinase) and a mutant Cofilin also prevented delta-catenin-induced protrusions. To link the effects of delta-catenin to a physiological pathway, we noted that (S)-3,5-dihydroxyphenylglycine (DHPG) activation of metabotropic glutamate receptors induced dendritic protrusions that are very similar to those induced by delta-catenin. Furthermore, delta-catenin RNA-mediated interference can block the induction of dendritic protrusions by DHPG. Interestingly, DHPG dissociated PSD-95 and N-cadherin from the delta-catenin complex, increased the association of delta-catenin with Cortactin, and induced the phosphorylation of delta-catenin within the sites that bind to these protein partners.	[Ochiishi, Tomoyo] Natl Inst Adv Ind Sci & Technol, Mol Neurobiol Grp, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Abu-Elneel, Kawther; Medina, Miguel; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Abu-Elneel, Kawther; Medina, Miguel; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Remedi, Monica; Gastaldi, Laura; Caceres, Alfredo] Consejo Nacl Invest Cient & Tecn, Inst Invest Med Mercedes & Martin Ferreya, RA-5000 Cordoba, Argentina	National Institute of Advanced Industrial Science & Technology (AIST); University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Ochiishi, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Mol Neurobiol Grp, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan.	tomoyo.ochiishi@aist.go.jp; kosik@lifesci.ucsb.edu	Ochiishi, Tomoyo/L-7041-2018; Medina, Miguel/I-7135-2019; Medina, Miguel/J-1642-2019; Medina, Miguel/H-5676-2012	Ochiishi, Tomoyo/0000-0001-6290-6471; Medina, Miguel/0000-0002-7016-5340	W.M. Keck Foundation	W.M. Keck Foundation(W.M. Keck Foundation)	Support for this work was provided by the W.M. Keck Foundation.	Ahmed SH, 2005, P NATL ACAD SCI USA, V102, P11533, DOI 10.1073/pnas.0504438102; Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fiala JC, 1998, J NEUROSCI, V18, P8900; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Grosheva I, 2001, J CELL SCI, V114, P695; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; HEID HW, 1994, DIFFERENTIATION, V58, P113; Hering H, 2003, J NEUROSCI, V23, P11759; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hoogenraad SC, 2004, BIOESSAYS, V26, P141, DOI 10.1002/bies.10402; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; KAPPRELL HP, 1988, J CELL BIOL, V106, P1679, DOI 10.1083/jcb.106.5.1679; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; PAPA M, 1995, J NEUROSCI, V15, P1; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Sirotkin H, 1997, GENOMICS, V41, P75, DOI 10.1006/geno.1997.4627; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	65	52	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32781	32791		10.1074/jbc.M804688200	http://dx.doi.org/10.1074/jbc.M804688200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809680	hybrid			2022-12-27	WOS:000260893700067
J	Shen, H; Walters, DE; Mueller, DM				Shen, Hong; Walters, D. Eric; Mueller, David M.			Introduction of the Chloroplast Redox Regulatory Region in the Yeast ATP Synthase Impairs Cytochrome c Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL CRISTAE MORPHOLOGY; BOVINE HEART-MITOCHONDRIA; SACCHAROMYCES-CEREVISIAE; GAMMA-SUBUNIT; F1F0-ATP SYNTHASE; PERIPHERAL STALK; EPSILON-SUBUNIT; DISULFIDE BOND; P-I; F-1-ATPASE	The ATP synthase is under a number of mechanisms of regulation. The chloroplast ATPase has a unique mode of regulation in which activity is controlled by the redox state in the organelle. This mode of regulation is determined by a small unique region within the gamma-subunit and this region contains two cysteine residues. Introduction of this region within the yeast gamma-subunit causes a defect in oxidative phosphorylation. Oxidative phosphorylation is restored if the cysteine residues are replaced with serine. Biochemical analysis of the chimeric mitochondrial ATPase indicates that the ATP synthase is not largely altered with the cysteine residues in either the oxidized or reduced states. However, the level and activity of cytochrome c oxidase are decreased by about 90%, whereas that of NADH dehydrogenase and cytochrome c reductase are unchanged as compared with the wild-type enzymes. The level and activity of cytochrome c oxidase are restored with replacement of the cysteine residues with serine in the regulatory region. These results indicate that the chimeric ATP synthase containing cysteine, but not serine, decreases the expression or assembly of cytochrome c oxidase with little effect on the activity of the ATP synthase.	[Shen, Hong; Walters, D. Eric; Mueller, David M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Mueller, DM (corresponding author), 3333 Green Bay Rd, N Chicago, IL 60064 USA.	david.mueller@RosalindFranklin.edu	Walters, D. Eric/C-9626-2010	Walters, D. Eric/0000-0002-1513-3522	National Institutes of Health [R01-GM067091, R01-GM066223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067091, R01GM066223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM067091 and R01-GM066223 (to D. M. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact..	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Bakhtiari N, 1999, J BIOL CHEM, V274, P16363, DOI 10.1074/jbc.274.23.16363; Bald D, 2000, J BIOL CHEM, V275, P12757, DOI 10.1074/jbc.275.17.12757; Boyle GM, 1999, EUR J BIOCHEM, V262, P315, DOI 10.1046/j.1432-1327.1999.00345.x; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Chiadmi M, 1999, EMBO J, V18, P6809, DOI 10.1093/emboj/18.23.6809; DeLano W.L, PYMOL MOL GRAPHICS S; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Jie LZ, 1999, EMBO J, V18, P58, DOI 10.1093/emboj/18.1.58; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Knowles AF, 1997, BBA-BIOMEMBRANES, V1329, P311, DOI 10.1016/S0005-2736(97)00123-5; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Krenn BE, 1995, BIOCHEM SOC T, V23, P757, DOI 10.1042/bst0230757; KUKI M, 1988, J BIOL CHEM, V263, P17437; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai-Zhang J, 2000, EUR J BIOCHEM, V267, P2409, DOI 10.1046/j.1432-1327.2000.01253.x; MACKLER B, 1967, METHOD ENZYMOL, V10, P295; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; MUELLER DM, 1988, J BIOL CHEM, V263, P5634; MUKHOPADHYAY A, 1994, FEBS LETT, V343, P160, DOI 10.1016/0014-5793(94)80310-2; NALIN CM, 1984, J BIOL CHEM, V259, P7275; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pedersen PL, 1996, J BIOENERG BIOMEMBR, V28, P389, DOI 10.1007/BF02113979; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; QIU ZH, 1992, BIOCHEMISTRY-US, V31, P3297, DOI 10.1021/bi00127a036; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; Samra HS, 2006, J BIOL CHEM, V281, P31041, DOI 10.1074/jbc.M603315200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, J BIOL CHEM, V276, P37861; Silvester JA, 2006, ACTA CRYSTALLOGR F, V62, P530, DOI 10.1107/S1744309106015338; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i	44	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32937	32943		10.1074/jbc.M805310200	http://dx.doi.org/10.1074/jbc.M805310200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819926	hybrid, Green Published			2022-12-27	WOS:000260893700082
J	Thelen, K; Georg, T; Bertuch, S; Zelina, P; Pollerberg, GE				Thelen, Karsten; Georg, Tanja; Bertuch, Stefanie; Zelina, Pavol; Pollerberg, G. Elisabeth			Ubiquitination and Endocytosis of Cell Adhesion Molecule DM-GRASP Regulate Its Cell Surface Presence and Affect Its Role for Axon Navigation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; GROWTH CONE; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR TRAFFICKING; CYTOPLASMIC DOMAIN; NERVOUS-SYSTEM; PROTEIN-KINASE; GANGLION-CELLS; COATED PITS	DM-GRASP, cell adhesion molecule of the immunoglobulin superfamily, has been shown to promote growth and navigation of axons. We here demonstrate that clustering of DM-GRASP in the plasma membrane induces its rapid internalization via dynamin-and clathrin-dependent endocytosis, which is controlled by phosphatidylinositol 3-kinase and mitogen-activated protein kinase ERK. The clustering of DM-GRASP activates ERK; the intensity and duration of ERK activation by DM-GRASP do not depend on rapid clathrin-mediated internalization of DM-GRASP. Moreover, the preference of retinal ganglion cell axons for DM-GRASP-coated micro-lanes requires clathrin-mediated endocytosis for the appropriate axonal turning reactions at substrate borders. Because the intracellular domain of DM-GRASP does not contain motifs for direct interactions with the endocytosis machinery, we performed a yeast two-hybrid screen to identify intracellular proteins mediating the uptake of DM-GRASP and isolated ubiquitin. Immunoprecipitation of DM-GRASP coexpressed with ubiquitin revealed that one or two ubiquitin(s) are attached to the intracellular domain of cell surface-resident DM-GRASP. Furthermore, elevated ubiquitination levels result in a decrease of cell surface-resident DM-GRASP as well as in the amount of total DM-GRASP. The endocytosis rate is not affected, but the delivery to multivesicular bodies is increased, indicating that DM-GRASP ubiquitination enhances its sorting into the degradation pathway. Together, our data show that ubiquitination and endocytosis of DM-GRASP in concert regulate its cell surface concentration, which is crucial for its function in axon navigation.	[Thelen, Karsten; Georg, Tanja; Bertuch, Stefanie; Zelina, Pavol; Pollerberg, G. Elisabeth] Univ Heidelberg, Dept Dev Neurobiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Pollerberg, GE (corresponding author), Neuenheimer Feld 232, D-69120 Heidelberg, Germany.	G.E.Pollerberg@urz.uni-heidelberg.de	Zelina, Pavol/AAO-7851-2021		 [SFB488];  [GRK484];  [GRK791]	; ; 	The work was supported by Grants SFB488, GRK484, and GRK791.	Aguilar RC, 2003, J BIOL CHEM, V278, P10737, DOI 10.1074/jbc.M211622200; Avci HX, 2004, DEV BIOL, V271, P291, DOI 10.1016/j.ydbio.2004.03.035; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Caruso-Neves C, 2005, P NATL ACAD SCI USA, V102, P17513, DOI 10.1073/pnas.0507255102; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; Chedotal A, 1996, J NEUROSCI, V16, P3296; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; DEBERNARDO AP, 1995, DEV BIOL, V169, P65, DOI 10.1006/dbio.1995.1127; DeBernardo AP, 1996, J CELL BIOL, V133, P657, DOI 10.1083/jcb.133.3.657; ELDEEB S, 1992, DEV BIOL, V149, P213, DOI 10.1016/0012-1606(92)90278-O; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gommerman JL, 1997, J BIOL CHEM, V272, P30519, DOI 10.1074/jbc.272.48.30519; Gu F, 1999, FEBS LETT, V452, P61, DOI 10.1016/S0014-5793(99)00561-X; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Heffron DS, 2000, J NEUROSCI, V20, P2287; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Holbrook MR, 1999, BIOCHEMISTRY-US, V38, P9348, DOI 10.1021/bi990195r; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; KANKI JP, 1994, J NEUROBIOL, V25, P831, DOI 10.1002/neu.480250708; KAYYEM JF, 1992, EUR J BIOCHEM, V208, P1, DOI 10.1111/j.1432-1033.1992.tb17152.x; Khundmiri SJ, 2004, J BIOL CHEM, V279, P17418, DOI 10.1074/jbc.M311715200; Konno A, 2001, J LEUKOCYTE BIOL, V69, P944; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; LAMAZE C, 1995, J CELL BIOL, V129, P47, DOI 10.1083/jcb.129.1.47; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Long KE, 2001, J BIOL CHEM, V276, P1285, DOI 10.1074/jbc.M006658200; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Minana R, 2001, EUR J NEUROSCI, V13, P749, DOI 10.1046/j.0953-816x.2000.01439.x; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; POLLERBERG EG, 1985, J CELL BIOL, V101, P1921, DOI 10.1083/jcb.101.5.1921; POLLERBERG GE, 1994, DEV BIOL, V165, P670, DOI 10.1006/dbio.1994.1284; POURQUIE O, 1990, DEVELOPMENT, V109, P743; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schmid RS, 2000, J NEUROSCI, V20, P4177; Sekine-Aizawa Y, 1998, EUR J NEUROSCI, V10, P2810, DOI 10.1111/j.1460-9568.1998.00288.x; Stephan JP, 1999, DEV BIOL, V212, P264, DOI 10.1006/dbio.1999.9348; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; Thelen K, 2007, SOFT MATTER, V3, P1486, DOI 10.1039/b707250c; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; VOJTEK AB, 1997, YEAST 2 HYBRID SYSTE, P29; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yang PZ, 2002, INVEST OPHTH VIS SCI, V43, P1488; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zelina P, 2005, DEVELOPMENT, V132, P3609, DOI 10.1242/dev.01934; Zimmerman AW, 2004, J CELL SCI, V117, P2841, DOI 10.1242/jcs.01139	67	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32792	32801		10.1074/jbc.M805896200	http://dx.doi.org/10.1074/jbc.M805896200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790729	hybrid			2022-12-27	WOS:000260893700068
J	Ohne, Y; Takahara, T; Hatakeyama, R; Matsuzaki, T; Noda, M; Mizushima, N; Maeda, T				Ohne, Yoichiro; Takahara, Terunao; Hatakeyama, Riko; Matsuzaki, Tomoko; Noda, Makoto; Mizushima, Noboru; Maeda, Tatsuya			Isolation of Hyperactive Mutants of Mammalian Target of Rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICTOR-MTOR COMPLEX; CELL-GROWTH CONTROL; SIGNALING PATHWAYS; BINDING PARTNER; KINASE; TOR; YEAST; NUTRIENT; RAPTOR; PHOSPHORYLATION	The mammalian target of rapamycin(mTOR) is a Ser/Thr kinase that plays essential roles in the regulation of a wide array of growth-related processes such as protein synthesis, cell sizing, and autophagy. mTOR forms two functionally distinct complexes, termed the mTOR complex 1(mTORC1) and 2 (mTORC2); only the former of which is inhibited by rapamycin. Based on the similarity between the cellular responses caused by rapamycin treatment and by nutrient starvation, it has been widely accepted that modulation in the mTORC1 activity in response to nutrient status directs these cellular responses, although direct evidence has been scarce. Here we report isolation of hyperactive mutants of mTOR. The isolated mTOR mutants exhibited enhanced kinase activity in vitro and rendered cells refractory to the dephosphorylation of the mTORC1 substrates upon amino acid starvation. Cells expressing the hyperactive mTOR mutant displayed larger cell size in a normal growing condition and were resistant to cell size reduction and autophagy induction in an amino acid-starved condition. These results indicate that the activity of mTORC1 actually directs these cellular processes in response to nutrient status and confirm the biological functions of mTORC1, which had been proposed solely from loss-of-function analyses using rapamycin and(molecular) genetic techniques. Additionally, the hyperactive mTOR mutant did not induce cellular transformation of NIH/3T3 cells, suggesting that concomitant activation of additional pathways is required for tumorigenesis. This hyperactive mTOR mutant will be a valuable tool for establishing physiological consequences of mTOR activation in cells as well as in organisms.	[Ohne, Yoichiro; Takahara, Terunao; Hatakeyama, Riko; Maeda, Tatsuya] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Matsuzaki, Tomoko; Noda, Makoto] Kyoto Univ, Dept Mol Oncol, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan	University of Tokyo; Kyoto University; Tokyo Medical & Dental University (TMDU)	Maeda, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	maeda@iam.u-tokyo.ac.jp	Ohne, Yoichiro/AGE-6061-2022; Mizushima, Noboru/C-3635-2009; Maeda, Tatsuya/L-5540-2019	Mizushima, Noboru/0000-0002-6258-6444; Hatakeyama, Riko/0000-0002-3065-6639; Matsuzaki, Tomoko/0000-0002-9878-0433	Japan Society for the Promotion of Science [KAKENHI 20658027]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Welfide Medicinal Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Welfide Medicinal Research Foundation	This work was supported in part by a Grant-in-aid for Exploratory Research KAKENHI 20658027 from the Japan Society for the Promotion of Science and grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Naito Foundation, and the Welfide Medicinal Research Foundation (all to T. Maeda).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Alarcon CM, 1996, GENE DEV, V10, P279, DOI 10.1101/gad.10.3.279; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; SIKORSKI RS, 1989, GENETICS, V122, P19; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979	48	59	59	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31861	31870		10.1074/jbc.M801546200	http://dx.doi.org/10.1074/jbc.M801546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18812319	hybrid			2022-12-27	WOS:000260760800069
J	Hakobyan, S; Harris, CL; van den Berg, CW; Fernandez-Alonso, MC; de Jorge, EG; de Cordoba, SR; Rivas, G; Mangione, P; Pepys, MB; Morgan, BP				Hakobyan, Svetlana; Harris, Claire L.; van den Berg, Carmen W.; Carmen Fernandez-Alonso, Maria; Goicoechea de Jorge, Elena; Rodriguez de Cordoba, Santiago; Rivas, German; Mangione, Palma; Pepys, Mark B.; Morgan, B. Paul			Complement Factor H Binds to Denatured Rather than to Native Pentameric C-reactive Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED FORM; MACULAR DEGENERATION; ALTERNATIVE PATHWAY; POLYMORPHISM; ACTIVATION; VARIANT; COMPONENT; SITE; CRP; INDIVIDUALS	Binding of the complement regulatory protein, factor H, to C-reactive protein has been reported and implicated as the biological basis for association of the H402 polymorphic variant of factor H with macular degeneration. Published studies utilize solid-phase or fluid-phase binding assays to show that the factor H Y402 variant binds C-reactive protein more strongly than H402. Diminished binding of H402 variant to C-reactive protein in retinal drusen is posited to permit increased complement activation, driving inflammation and pathology. We used well validated native human C-reactive protein and pure factor H Y402H variants to test interactions. When factor H variants were incubated with C-reactive protein in the fluid phase at physiological concentrations, no association occurred. When C-reactive protein was immobilized on plastic, either non-specifically by adsorption in the presence of Ca2+ to maintain its native fold and pentameric subunit assembly or by specific Ca2+-dependent binding to immobilized natural ligands, no specific binding of either factor H variant from the fluid phase was observed. In contrast, both factor H variants reproducibly bound to C-reactive protein immobilized in the absence of Ca2+, conditions that destabilize the native fold and pentameric assembly. Both factor H variants strongly bound C-reactive protein that was denatured by heat treatment before immobilization, confirming interaction with denatured but not native C-reactive protein. We conclude that the reported binding of factor H to C-reactive protein results from denaturation of the C-reactive protein during immobilization. Differential binding to C-reactive protein, thus, does not explain association of the Y402H polymorphism with macular degeneration.	[Hakobyan, Svetlana; Harris, Claire L.; Morgan, B. Paul] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff CF14 4XN, Wales; [van den Berg, Carmen W.] Cardiff Univ, Sch Med, Dept Pharmacol, Cardiff CF14 4XN, Wales; [Carmen Fernandez-Alonso, Maria; Goicoechea de Jorge, Elena; Rodriguez de Cordoba, Santiago; Rivas, German] Ctr Invest Biol & Ciber Enfermedades Raras, Dept Mol & Cellular Physiopathol, Madrid 28040, Spain; [Carmen Fernandez-Alonso, Maria; Goicoechea de Jorge, Elena; Rodriguez de Cordoba, Santiago; Rivas, German] Ctr Invest Biol & Ciber Enfermedades Raras, Dept Prot Sci, Madrid 28040, Spain; [Mangione, Palma] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy; [Mangione, Palma; Pepys, Mark B.] Royal Free & Univ Coll Med Sch, Div Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England	Cardiff University; Cardiff University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Pavia; University of London; University College London	Morgan, BP (corresponding author), Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Henry Wellcome Bldg,Heath Pk, Cardiff CF14 4XN, Wales.	morganbp@cardiff.ac.uk	Rivas, German/AAG-7458-2022; de Jorge, Elena Goicoechea/L-4580-2016; Rivas, German/AFL-7528-2022; de Cordoba, Santiago Rodriguez/K-6727-2014	Rivas, German/0000-0003-3450-7478; de Jorge, Elena Goicoechea/0000-0002-4978-2483; Rivas, German/0000-0003-3450-7478; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Mangione, Palma/0000-0003-0260-1400; Morgan, Paul/0000-0003-4075-7676	Wellcome Trust Programme [068590]; Wellcome Trust University [068823]; Spanish Ministerio de Educacion y Cultura [SAF2005-00913]; Medical Research Council [G7900510] Funding Source: researchfish; MRC [G7900510] Funding Source: UKRI	Wellcome Trust Programme(Wellcome Trust); Wellcome Trust University(Wellcome Trust); Spanish Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by Wellcome Trust Programme Grant 068590 (to B. P. M.), Wellcome Trust University Award 068823 (to C. L. H.), and Spanish Ministerio de Educacion y Cultura Grant SAF2005-00913 (to S. R. d.-C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Boguslawski G, 2007, J HEART LUNG TRANSPL, V26, P705, DOI 10.1016/j.healun.2007.04.006; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; DEBEER FC, 1982, IMMUNOLOGY, V45, P55; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gasque P, 2002, MOL NEUROBIOL, V25, P1, DOI 10.1385/MN:25:1:001; Gerl VB, 2002, INVEST OPHTH VIS SCI, V43, P1104; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; HAAPASALO K, 2008, MOL MICROBI IN PRESS; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Jarva H, 1999, J IMMUNOL, V163, P3957; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Kemp P A, 1992, J Clin Lab Immunol, V37, P147; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; MOLD C, 1984, J IMMUNOL, V133, P882; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; POTEMPA LA, 1987, MOL IMMUNOL, V24, P531, DOI 10.1016/0161-5890(87)90028-9; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Prosser BE, 2007, ACTA CRYSTALLOGR F, V63, P480, DOI 10.1107/S1744309107020052; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; SANCHEZCORRAL P, 1989, J IMMUNOL METHODS, V122, P105, DOI 10.1016/0022-1759(89)90340-2; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; VIGUSHIN DM, 1993, J CLIN INVEST, V91, P1351, DOI 10.1172/JCI116336; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; VOLANAKIS JE, 1974, J IMMUNOL, V113, P9; WHO Expert Committee on Biological Standardization, 1987, WHO TECHN REP SER, V760, P21; YING SC, 1989, J IMMUNOL, V143, P221; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	44	78	80	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30451	30460		10.1074/jbc.M803648200	http://dx.doi.org/10.1074/jbc.M803648200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18786923	Green Published, hybrid			2022-12-27	WOS:000260544800003
J	Tsutsui, Y; Kuri, B; Sengupta, T; Wintrode, PL				Tsutsui, Yuko; Kuri, Barbara; Sengupta, Tanusree; Wintrode, Patrick L.			The Structural Basis of Serpin Polymerization Studied by Hydrogen/Deuterium Exchange and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-EXCHANGE; CONFORMATIONAL-CHANGES; METASTABLE SERPIN; REACTIVE LOOP; BETA-SHEET; ALPHA(1)-ANTITRYPSIN; MECHANISM; POLYMERS; INHIBITOR; DYNAMICS	The serpinopathies are a group of inherited disorders that share as their molecular basis the misfolding and polymerization of serpins, an important class of protease inhibitors. Depending on the identity of the serpin, conditions arising from polymerization include emphysema, thrombosis, and dementia. The structure of serpin polymers is thus of considerable medical interest. Wild-type alpha(1)-antitrypsin will form polymers upon incubation at moderate temperatures and has been widely used as a model system for studying serpin polymerization. Using hydrogen/deuterium exchange and mass spectrometry, we have obtained molecular level structural information on the alpha(1)-antitrypsin polymer. We found that the flexible reactive center loop becomes strongly protected upon polymerization. We also found significant increases in protection in the center of beta-sheet A and in helix F. These results support a model in which linkage between serpins is achieved through insertion of the reactive center loop of one serpin into beta-sheet A of another. We have also examined the heat-induced conformational changes preceding polymerization. We found that polymerization is preceded by significant destabilization of beta-sheet C. On the basis of our results, we propose a mechanism for polymerization in which beta-strand 1C is displaced from the rest of beta-sheet C through a binary serpin/serpin interaction. Displacement of strand 1C triggers further conformational changes, including the opening of beta-sheet A, and allows for subsequent polymerization.	[Tsutsui, Yuko; Kuri, Barbara; Sengupta, Tanusree; Wintrode, Patrick L.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Wintrode, PL (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	patrick.wintrode@case.edu	S, Tanusree/AAI-8680-2021	S, Tanusree/0000-0002-6828-667X	National Institutes of Health [RO1-HL085469]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-HL085469. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cabrita LD, 2004, BIOCHEMISTRY-US, V43, P9834, DOI 10.1021/bi0491346; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Chang WSW, 1997, PROTEIN SCI, V6, P89; Crowther DC, 2003, BIOCHEMISTRY-US, V42, P2355, DOI 10.1021/bi0259305; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Deng YZ, 1999, ANAL BIOCHEM, V276, P150, DOI 10.1006/abio.1999.4347; Dunstone MA, 2000, PROTEIN SCI, V9, P417; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Englander SW, 1997, PROTEIN SCI, V6, P1101, DOI 10.1002/pro.5560060517; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Kheterpal I, 2006, METHOD ENZYMOL, V413, P140, DOI 10.1016/S0076-6879(06)13008-6; Koloczek H, 1996, J PROTEIN CHEM, V15, P447, DOI 10.1007/BF01886851; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; LOMAS DA, 1995, J BIOL CHEM, V270, P16864, DOI 10.1074/jbc.270.28.16864; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Marszal E, 2003, J BIOL CHEM, V278, P19611, DOI 10.1074/jbc.M210720200; Purkayastha P, 2005, BIOCHEMISTRY-US, V44, P2642, DOI 10.1021/bi048662e; Redeker V, 2007, J MOL BIOL, V369, P1113, DOI 10.1016/j.jmb.2007.04.018; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; Tsutsui Y, 2006, BIOCHEMISTRY-US, V45, P6561, DOI 10.1021/bi060431f; Tsutsui Y, 2007, J MOL BIOL, V371, P245, DOI 10.1016/j.jmb.2007.05.039; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Zhang QW, 2008, J MOL BIOL, V376, P1348, DOI 10.1016/j.jmb.2007.12.050; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055; Zhou AW, 2003, J BIOL CHEM, V278, P15116, DOI 10.1074/jbc.M211663200	29	34	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30804	30811		10.1074/jbc.M804048200	http://dx.doi.org/10.1074/jbc.M804048200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18794298	Green Published, hybrid			2022-12-27	WOS:000260544800035
J	Bajaj, G; Zhang, Y; Schimerlik, MI; Hau, AM; Yang, J; Filtz, TM; Kioussi, C; Ishmael, JE				Bajaj, Gaurav; Zhang, Yong; Schimerlik, Michael I.; Hau, Andrew M.; Yang, Jing; Filtz, Theresa M.; Kioussi, Chrissa; Ishmael, Jane E.			N-Methyl-D-aspartate Receptor Subunits Are Non-myosin Targets of Myosin Regulatory Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-DEPENDENT INACTIVATION; ERM-LIKE PROTEIN; NONMUSCLE MYOSIN; NMDA RECEPTOR; ENDOPLASMIC-RETICULUM; FUNCTIONAL-ANALYSIS; ALPHA-ACTININ; C-TERMINUS; RAT-BRAIN; II MYOSIN	Excitatory synapses contain multiple members of the myosin superfamily of molecular motors for which functions have not been assigned. In this study we characterized the molecular determinants of myosin regulatory light chain (RLC) binding to two major subunits of the N-methyl-D-aspartate receptor (NR). Myosin RLC bound to NR subunits in a manner that could be distinguished from the interaction of RLC with the neck region of non-muscle myosin II-B (NMII-B) heavy chain; NR-RLC interactions did not require the addition of magnesium, were maintained in the absence of the fourth EF-hand domain of the light chain, and were sensitive to RLC phosphorylation. Equilibrium fluorescence spectroscopy experiments indicate that the affinity of myosin RLC for NR1 is high (30 nM) in the context of the isolated light chain. Binding was not favored in the context of a recombinant NMII-B subfragment one, indicating that if the RLC is already bound to NMII-B it is unlikely to form a bridge between two binding partners. We report that sequence similarity in the "GXXXR" portion of the incomplete IQ2 motif found in NMII heavy chain isoforms likely contributes to recognition of NR2A as a non-myosin target of the RLC. Using site-directed mutagenesis to disrupt NR2A-RLC binding in intact cells, we find that RLC interactions facilitate trafficking of NR1/NR2A receptors to the cell membrane. We suggest that myosin RLC can adopt target-dependent conformations and that a role for this light chain in protein trafficking may be independent of the myosin II complex.	[Bajaj, Gaurav; Zhang, Yong; Hau, Andrew M.; Yang, Jing; Filtz, Theresa M.; Kioussi, Chrissa; Ishmael, Jane E.] Oregon State Univ, Dept Pharmaceut Sci, Coll Pharm, Corvallis, OR 97331 USA; [Schimerlik, Michael I.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Ishmael, JE (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Coll Pharm, Corvallis, OR 97331 USA.	jane.ishmael@oregonstate.edu		Kioussi, Chrissa/0000-0001-8226-9908; Filtz, Theresa/0000-0002-5348-1114	National Institutes of Health [R01AR054406, P30-ES000210]; American Heart Association Award [P30-ES000210, 0060435Z]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Award(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in part, by National Institutes of Health Grants R01AR054406 and P30-ES000210. This work was also supported by American Heart Association Award 0060435Z, P30-ES000210.	Akyol Z, 2004, J BIOL CHEM, V279, P2166, DOI 10.1074/jbc.M302542200; Amparan D, 2005, J NEUROCHEM, V92, P349, DOI 10.1111/j.1471-4159.2004.02869.x; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bezanilla M, 1997, MOL BIOL CELL, V8, P2693, DOI 10.1091/mbc.8.12.2693; Bornhauser BC, 2003, FEBS LETT, V553, P195, DOI 10.1016/S0014-5793(03)01010-X; Boyne JR, 2000, J CELL SCI, V113, P4533; Chan W, 2005, J BIOL CHEM, V280, P23741, DOI 10.1074/jbc.M502767200; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Fath KR, 2005, CELL MOTIL CYTOSKEL, V60, P222, DOI 10.1002/cm.20060; FEINSTEIN DL, 1991, MOL BRAIN RES, V10, P97, DOI 10.1016/0169-328X(91)90099-J; Franke JD, 2006, CELL MOTIL CYTOSKEL, V63, P604, DOI 10.1002/cm.20148; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Guillaud L, 2003, J NEUROSCI, V23, P131; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; HENG D, 2006, MOL CELL PROTEOMICS, V5, P1158; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ishmael JE, 2007, BRAIN RES, V1143, P46, DOI 10.1016/j.brainres.2007.01.061; Ishmael JE, 1996, J NEUROCHEM, V67, P1500; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kioussi C, 2007, BRAIN RES BULL, V74, P439, DOI 10.1016/j.brainresbull.2007.07.024; Knowlton MN, 2004, ZEBRAFISH, V1, P133, DOI 10.1089/zeb.2004.1.133; Knowlton MN, 2003, DEV BIOL, V264, P407, DOI 10.1016/j.ydbio.2003.09.001; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Lei SB, 2001, J NEUROSCI, V21, P8464, DOI 10.1523/JNEUROSCI.21-21-08464.2001; Luo JY, 2004, J CELL BIOL, V165, P843, DOI 10.1083/jcb.200401040; Maeda M, 2000, DEV BIOL, V223, P114, DOI 10.1006/dbio.2000.9736; MALENCIK DA, 1988, BIOCHEMISTRY-US, V27, P1941, DOI 10.1021/bi00406a021; MALENCIK DA, 1982, BIOCHEMISTRY-US, V21, P3480, DOI 10.1021/bi00257a035; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nagano K, 2006, EMBO J, V25, P1871, DOI 10.1038/sj.emboj.7601059; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Olsson PA, 2000, BIOCHEM BIOPH RES CO, V279, P879, DOI 10.1006/bbrc.2000.4028; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; Shannon KB, 2000, CURR BIOL, V10, P727, DOI 10.1016/S0960-9822(00)00539-X; Stevens RC, 1998, J CELL BIOL, V142, P711, DOI 10.1083/jcb.142.3.711; Szymanski PT, 1999, BIOCHEMISTRY-US, V38, P3778, DOI 10.1021/bi981394y; Szymanski PT, 2004, J MUSCLE RES CELL M, V25, P7, DOI 10.1023/B:JURE.0000021349.47697.bf; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; TAUBMAN MB, 1987, J CELL BIOL, V104, P1505, DOI 10.1083/jcb.104.6.1505; Terrak M, 2003, EMBO J, V22, P362, DOI 10.1093/emboj/cdg058; Terrak M, 2002, ACTA CRYSTALLOGR D, V58, P1882, DOI 10.1107/S0907444902013951; Vissel B, 2002, MOL PHARMACOL, V61, P595, DOI 10.1124/mol.61.3.595; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wakabayashi Y, 2006, J BIOL CHEM, V281, P27669, DOI 10.1074/jbc.R600013200; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; WANG YL, 1994, FEBS LETT, V348, P244, DOI 10.1016/0014-5793(94)00613-X; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; ZAVODNY PJ, 1988, NUCLEIC ACIDS RES, V16, P1214, DOI 10.1093/nar/16.3.1214; Zegers MMP, 1998, BIOCHEM J, V336, P257, DOI 10.1042/bj3360257; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhang Y, 2006, MOL PHARMACOL, V70, P860, DOI 10.1124/mol.105.021923	68	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1252	1266		10.1074/jbc.M801861200	http://dx.doi.org/10.1074/jbc.M801861200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18945678	Green Published, hybrid			2022-12-27	WOS:000262122900061
J	Coudevylle, N; Montaville, P; Leonov, A; Zweckstetter, M; Becker, S				Coudevylle, Nicolas; Montaville, Pierre; Leonov, Andrei; Zweckstetter, Markus; Becker, Stefan			Structural Determinants for Ca2+ and Phosphatidylinositol 4,5-Bisphosphate Binding by the C2A Domain of Rabphilin-3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NMR STRUCTURE DETERMINATION; CORE VESICLE EXOCYTOSIS; PIP2 BINDING; PC12 CELLS; PHOSPHOINOSITIDE REGULATION; DIPOLAR COUPLINGS; MEMBRANE-BINDING; PLASMA-MEMBRANE; PKC-ALPHA	Rabphilin-3A is a neuronal C2 domain tandem containing protein involved in vesicle trafficking. Both its C2 domains (C2A and C2B) are able to bind phosphatidylinositol 4,5-bisphosphate, a key player in the neurotransmitter release process. The rabphilin-3A C2A domain has previously been shown to bind inositol-1,4,5-trisphosphate (IP3; phosphatidylinositol 4,5-bisphosphate headgroup) in a Ca2+-dependent manner with a relatively high affinity (50 mu M) in the presence of saturating concentrations of Ca2+. Moreover, IP3 and Ca2+ binding to the C2A domain mutually enhance each other. Here we present the Ca2+-bound solution structure of the C2A domain. Structural comparison with the previously published Ca2+-free crystal structure revealed that Ca2+ binding induces a conformational change of Ca2+ binding loop 3(CBL3). Our IP3 binding studies as well as our IP3-C2A docking model show the active involvement of CBL3 in IP3 binding, suggesting that the conformational change on CBL3 upon Ca2+ binding enables the interaction with IP3 and vice versa, in line with a target-activated messenger affinity mechanism. Our data provide detailed structural insight into the functional properties of the rabphilin-3A C2A domain and reveal for the first time the structural determinants of a target-activated messenger affinity mechanism.	[Coudevylle, Nicolas; Montaville, Pierre; Leonov, Andrei; Zweckstetter, Markus; Becker, Stefan] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany	Max Planck Society	Becker, S (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany.	sabe@nmr.mpibpc.mpg.de		montaville, Pierre/0000-0002-9931-3482; Zweckstetter, Markus/0000-0002-2536-6581	MaxPlanck Society	MaxPlanck Society(Max Planck Society)	This work was supported by the MaxPlanck Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200; Auguin D, 2004, J BIOL CHEM, V279, P35890, DOI 10.1074/jbc.M400364200; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Biadene M, 2006, ACTA CRYSTALLOGR D, V62, P793, DOI 10.1107/S0907444906017537; Bolsover SR, 2003, J BIOL CHEM, V278, P10282, DOI 10.1074/jbc.M212145200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Corbin JA, 2007, BIOCHEMISTRY-US, V46, P4322, DOI 10.1021/bi062140c; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cremona O, 2001, J CELL SCI, V114, P1041; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Keller R., 2004, COMPUTER AIDED RESON, V1; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; McKiernan CJ, 1996, MOL CELL BIOL, V16, P4985; MIYAZAKI M, 1994, BIOCHEM BIOPH RES CO, V205, P460, DOI 10.1006/bbrc.1994.2688; Montaville P, 2008, PROTEIN SCI, V17, P1025, DOI 10.1110/ps.073326608; Montaville P, 2007, J BIOL CHEM, V282, P5015, DOI 10.1074/jbc.M606746200; Montaville P, 2006, J BIOMOL NMR, V36, P20, DOI 10.1007/s10858-005-6051-z; Nalefski EA, 1998, BIOCHEMISTRY-US, V37, P17642, DOI 10.1021/bi982372e; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Osborne SL, 2006, J NEUROCHEM, V98, P336, DOI 10.1111/j.1471-4159.2006.03892.x; Ottiger M, 1998, J BIOMOL NMR, V12, P361, DOI 10.1023/A:1008366116644; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rodriguez-Alfaro JA, 2004, J MOL BIOL, V335, P1117, DOI 10.1016/j.jmb.2003.10.080; Rufener E, 2005, BIOCHEMISTRY-US, V44, P18, DOI 10.1021/bi048370d; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Selvan S, 2007, IEEE T IMAGE PROCESS, V16, P2688, DOI 10.1109/TIP.2007.908082; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Willshaw A, 2004, FEBS LETT, V559, P13, DOI 10.1016/S0014-5793(03)01513-8; Zhang Y, 2001, FEBS LETT, V497, P99, DOI 10.1016/S0014-5793(01)02450-4; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	53	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35918	35928		10.1074/jbc.M804094200	http://dx.doi.org/10.1074/jbc.M804094200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945677	Green Published, hybrid			2022-12-27	WOS:000261687900067
J	Faridmoayer, A; Fentabil, MA; Haurat, MF; Yi, W; Woodward, R; Wang, PG; Feldman, MF				Faridmoayer, Amirreza; Fentabil, Messele A.; Haurat, M. Florencia; Yi, Wen; Woodward, Robert; Wang, Peng George; Feldman, Mario F.			Extreme Substrate Promiscuity of the Neisseria Oligosaccharyl Transferase Involved in Protein O-Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; PSEUDOMONAS-AERUGINOSA 1244-PILIN; ESCHERICHIA-COLI; PILIN GLYCOSYLATION; BACTERIAL OLIGOSACCHARYLTRANSFERASE; PSEUDOMONAS-AERUGINOSA-1244 PILIN; CAMPYLOBACTER-JEJUNI; SURFACE EXPRESSION; ANTIGEN; LIPOPOLYSACCHARIDE	Neisseria meningitidis PglL belongs to a novel family of bacterial oligosaccharyltransferases (OTases) responsible for O-glycosylation of type IV pilins. Although members of this family are widespread among pathogenic bacteria, there is little known about their mechanism. Understanding the O-glycosylation process may uncover potential targets for therapeutic intervention, and can open new avenues for the exploitation of these pathways for biotechnological purposes. In this work, we demonstrate that PglL is able to transfer virtually any glycan from the undecaprenyl pyrophosphate (UndPP) carrier to pilin in engineered Escherichia coli and Salmonella cells. Surprisingly, PglL was also able to interfere with the peptidoglycan biosynthetic machinery and transfer peptidoglycan subunits to pilin. This represents a previously unknown post-translational modification in bacteria. Given the wide range of glycans transferred by PglL, we reasoned that substrate specificity of PglL lies in the lipid carrier. To test this hypothesis we developed an in vitro glycosylation system that employed purified PglL, pilin, and the lipid farnesyl pyrophosphate (FarPP) carrying a pentasaccharide that had been synthesized by successive chemical and enzymatic steps. Although FarPP has different stereochemistry and a significantly shorter aliphatic chain than the natural lipid substrate, the pentasaccharide was still transferred to pilin in our system. We propose that the primary roles of the lipid carrier during O-glycosylation are the translocation of the glycan into the periplasm, and the positioning of the pyrophosphate linker and glycan adjacent to PglL. The unique characteristics of PglL make this enzyme a promising tool for glycoengineering novel glycan-based vaccines and therapeutics.	[Faridmoayer, Amirreza; Haurat, M. Florencia; Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Fentabil, Messele A.] Univ Alberta, Dept Chem, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB T6G 2E9, Canada; [Yi, Wen; Woodward, Robert; Wang, Peng George] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Yi, Wen; Woodward, Robert; Wang, Peng George] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University of Alberta; University of Alberta; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Feldman, MF (corresponding author), Univ Alberta, Dept Biol Sci, CW405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mfeldman@ualberta.ca	Haurat, M Florencia/ABA-2634-2020; Yi, Wen/M-5905-2014; Feldman, Mario/A-2637-2014; Yi, Wen/C-8756-2009; WANG, Peng/GSN-5263-2022	Haurat, M Florencia/0000-0001-7569-2783; Feldman, Mario/0000-0003-4497-0976; 	Alberta Ingenuity Centre for Carbohydrate Science (AICCS); Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation (CFI); University of Alberta, the Alberta Ingenuity Fund; Alberta Heritage Foundation for Medical Research (AHFMR)	Alberta Ingenuity Centre for Carbohydrate Science (AICCS); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); University of Alberta, the Alberta Ingenuity Fund(University of Alberta); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	This work was supported by grants from the Alberta Ingenuity Centre for Carbohydrate Science (AICCS), the Natural Sciences and Engineering Research Council (NSERC), the Canada Foundation for Innovation (CFI), the University of Alberta, the Alberta Ingenuity Fund, and the Alberta Heritage Foundation for Medical Research (AHFMR) (to M. F. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; BUNDLE DR, 1994, BIOCHEMISTRY-US, V33, P5172, DOI 10.1021/bi00183a022; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Chen MM, 2007, BIOCHEMISTRY-US, V46, P14342, DOI 10.1021/bi701956x; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Drummelsmith J, 1999, MOL MICROBIOL, V31, P1321, DOI 10.1046/j.1365-2958.1999.01277.x; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; GOLDBERG JB, 1992, P NATL ACAD SCI USA, V89, P10716, DOI 10.1073/pnas.89.22.10716; Guan ZQ, 2005, ANAL BIOCHEM, V345, P336, DOI 10.1016/j.ab.2005.07.002; Hoare A, 2006, INFECT IMMUN, V74, P1555, DOI 10.1128/IAI.74.3.1555-1564.2006; Horzempa J, 2008, CLIN VACCINE IMMUNOL, V15, P590, DOI 10.1128/CVI.00476-07; IELPI L, 1993, J BACTERIOL, V175, P2490, DOI 10.1128/JB.175.9.2490-2500.1993; JANSSON PE, 1987, CARBOHYD RES, V161, P273, DOI 10.1016/S0008-6215(00)90084-3; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; NEAL BL, 1993, J BACTERIOL, V175, P7115, DOI 10.1128/jb.175.21.7115-7118.1993; Power PM, 2006, BIOCHEM BIOPH RES CO, V347, P904, DOI 10.1016/j.bbrc.2006.06.182; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Qutyan M, 2007, MOL MICROBIOL, V66, P1444, DOI 10.1111/j.1365-2958.2007.06001.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Templin MF, 1999, EMBO J, V18, P4108, DOI 10.1093/emboj/18.15.4108; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Yi W, 2005, J AM CHEM SOC, V127, P2040, DOI 10.1021/ja045021y	33	93	104	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34596	34604		10.1074/jbc.M807113200	http://dx.doi.org/10.1074/jbc.M807113200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930921	Green Published, hybrid			2022-12-27	WOS:000261469100014
J	Lammers, M; Meyer, S; Kuhlmann, D; Wittinghofer, A				Lammers, Michael; Meyer, Simon; Kuehlmann, Dorothee; Wittinghofer, Alfred			Specificity of Interactions between mDia Isoforms and Rho Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAPHANOUS-RELATED FORMIN; ACTIN NUCLEATION FACTOR; PROLINE-RICH LIGANDS; HOMOLOGY-2 DOMAIN; STRUCTURAL BASIS; BINDING PROTEIN; CAPPING PROTEIN; BARBED-END; CELLULAR-TRANSFORMATION; MAMMALIAN HOMOLOG	Formins are key regulators of actin nucleation and polymerization. They contain formin homology 1 (FH1) and 2 (FH2) domains as the catalytic machinery for the formation of linear actin cables. A subclass of formins constitutes the Diaphanous-related formins, members of which are regulated by the binding of a small GTP-binding protein of the Rho subfamily. Binding of these molecular switch proteins to the regulatory N-terminal mDia(N), including the GTPase-binding domain, leads to the release of auto-inhibition. From the three mDia isoforms, mDia1 is activated only by Rho (RhoA, -B, and -C), in contrast to mDia2 and -3, which is also activated by Rac and Cdc42. Little is known about the determinants of specificity. Here we report on the interactions of RhoA, Rac1, and Cdc42 with mDia1 and an mDia1 mutant (mDia(N)-Thr-Ser-His (TSH)), which based on structural information should mimic mDia2 and -3. Specificity is analyzed by biochemical studies and a structural analysis of a complex between Cdc42 center dot Gpp(NH)p and mDia(N)-TSH. A triple NNN motif in mDia1 (amino acids 164-166), corresponding to the TSH motif in mDia2/3 (amino acids 183-185 and 190-192), and the epitope interacting with the Rho insert helix are essential for high affinity binding. The triple N motif of mDia1 allows tight interaction with Rho because of the presence of Phe-106, whereas the corresponding His-104 in Rac and Cdc42 forms a complementary interface with the TSH motif in mDia2/3. We also show that the F106H and H104F mutations drastically alter the affinities and thermodynamics of mDia interactions.	[Lammers, Michael; Meyer, Simon; Kuehlmann, Dorothee; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Dept Biol Struct, Otto Hahn Str 11, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Lammers, Michael/AAX-1164-2020	Lammers, Michael/0000-0003-4168-4640				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Arai R, 2002, J CELL SCI, V115, P887; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; DeLano WL, 2002, PYMOL USERS MANUAL; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karnoub AE, 2001, MOL CELL BIOL, V21, P2847, DOI 10.1128/MCB.21.8.2847-2857.2001; Kato T, 2001, J CELL SCI, V114, P775; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, NAT CELL BIOL, V6, P1158, DOI 10.1038/ncb1204-1158; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Leung DW, 2005, P NATL ACAD SCI USA, V102, P5685, DOI 10.1073/pnas.0406472102; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, ACTA CRYSTALLOGR F, V61, P225, DOI 10.1107/S1744309105001065; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VAN AL, 1997, GENE DEV, V11, P2295; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WITTINGHOFER A, 1991, TRENDS BIOCHEM SCI, V16, P382, DOI 10.1016/0968-0004(91)90156-P; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019; Zong H, 2001, MOL CELL BIOL, V21, P5287, DOI 10.1128/MCB.21.16.5287-5298.2001	75	76	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35236	35246		10.1074/jbc.M805634200	http://dx.doi.org/10.1074/jbc.M805634200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18829452	Green Published, hybrid			2022-12-27	WOS:000261469100079
J	Cao, Y; Siegel, D; Oswald, F; Knochel, W				Cao, Ying; Siegel, Doreen; Oswald, Franz; Knoechel, Walter			Oct25 Represses Transcription of Nodal/Activin Target Genes by Interaction with Signal Transducers during Xenopus Gastrulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; NODAL-RELATED SIGNALS; HOMEOBOX GENE; DEVELOPMENTAL REGULATORS; MOLECULAR-MECHANISMS; HISTONE DEACETYLASE; SPEMANNS ORGANIZER; AXIS FORMATION; MESODERM; INDUCTION	The balance between differentiation signals and signals maintaining the undifferentiated state of embryonic cells ensures proper formation of germ layers. The nodal/activin pathway represents one of the major signaling chains responsible for the differentiation of embryonic cells into mesodermal and endodermal germ layers, while Oct4 is one of the major players in the maintenance of an undifferentiated state. Here we show that Oct25, an Oct4 homologue in Xenopus, antagonizes the activity of nodal/activin signaling by inhibiting the transcription of its target genes, Gsc and Mix2. The inhibitory effect is achieved by forming repression complexes on the promoters of Gsc and Mix2 between Oct25 and the signal transducers of the nodal/activin pathway, WBSCR11, FAST1, and Smad2. We have analyzed the significance of the Oct binding site for its inhibitory effect within the Gsc promoter. Albeit VP16-Oct25 fusion protein demonstrated a stimulating effect and EVE-Oct25 revealed a repression effect on an artificial reporter that is composed of eight repeats of Oct binding motifs, both fusions, like wild-type Oct25, inhibited mesendoderm formation and the activity of Gsc and Mix2 promoters. These results suggest that the regulatory effect of Oct25 on the expression of Gsc and Mix2 is mediated by specific protein/protein interactions. Furthermore, we demonstrate that histone deacetylase activities are not required for the inhibitory effect of Oct25. Our results provide a novel view in that Oct25 controls the nodal/activin pathway and thus maintains the undifferentiated state of embryonic cells in preventing them from premature differentiation.	[Cao, Ying; Siegel, Doreen; Knoechel, Walter] Univ Ulm, Inst Biochem, D-89091 Ulm, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med 1, D-89091 Ulm, Germany	Ulm University; Ulm University	Knochel, W (corresponding author), Univ Ulm, Inst Biochem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	walter.knoechel@uni-ulm.de	Oswald, Franz/AAO-9584-2020	Cao, Ying/0000-0001-8286-9591	Deutsche Forschungsgemeinschaft [SFB497/A1, SFB497/B9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants (SFB497/A1)( to W. K.) and (SFB497/B9) (to F.O.) from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agius E, 2000, DEVELOPMENT, V127, P1173; ARIIZUMI T, 1991, International Journal of Developmental Biology, V35, P407; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Cao Y, 2007, EMBO J, V26, P2942, DOI 10.1038/sj.emboj.7601736; Cao Y, 2006, MECH DEVELOP, V123, P614, DOI 10.1016/j.mod.2006.06.004; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HINKLEY CS, 1992, MOL CELL BIOL, V12, P638, DOI 10.1128/MCB.12.2.638; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; JONES CM, 1995, DEVELOPMENT, V121, P3651; Joseph EM, 1997, DEV BIOL, V184, P367, DOI 10.1006/dbio.1997.8510; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Laurent MN, 1997, DEVELOPMENT, V124, P4905; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemaire P, 1998, DEVELOPMENT, V125, P2371; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; NIEHRS C, 1993, CELL, V72, P491, DOI 10.1016/0092-8674(93)90069-3; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Ramsdell AF, 1998, TRENDS GENET, V14, P459, DOI 10.1016/S0168-9525(98)01599-6; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; STEINBEISSER H, 1993, DEVELOPMENT, V118, P499; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vize PD, 1996, DEV BIOL, V177, P226, DOI 10.1006/dbio.1996.0158; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	45	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34168	34177		10.1074/jbc.M803532200	http://dx.doi.org/10.1074/jbc.M803532200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922797	hybrid, Green Published			2022-12-27	WOS:000261277700045
J	Jones, CN; Jones, CI; Graham, WD; Agris, PF; Spremulli, LL				Jones, Christie N.; Jones, Christopher I.; Graham, William D.; Agris, Paul F.; Spremulli, Linda L.			A Disease-causing Point Mutation in Human Mitochondrial tRNA(Met) Results in tRNA Misfolding Leading to Defects in Translational Initiation and Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNAS; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; HIGHER-ORDER STRUCTURE; STEADY-STATE LEVELS; FACTOR TU; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; DNA	The mitochondrial tRNA genes are hot spots for mutations that lead to human disease. A single point mutation (T4409C) in the gene for human mitochondrial tRNAMet (hmtRNA(Met)) has been found to cause mitochondrial myopathy. This mutation results in the replacement of U8 in hmtRNA(Met) with a C8. The hmtRNAMet serves both in translational initiation and elongation in human mitochondria making this tRNA of particular interest in mitochondrial protein synthesis. Here we show that the single 8U -> C mutation leads to a failure of the tRNA to respond conformationally to Mg2+. This mutation results in a drastic disruption of the structure of the hmtRNAMet, which significantly reduces its aminoacylation. The small fraction of hmtRNAMet that can be aminoacylated is not formylated by the mitochondrial Met-tRNA transformylase preventing its function in initiation, and it is unable to form a stable ternary complex with elongation factor EF-Tu preventing any participation in chain elongation. We have used structural probing and molecular reconstitution experiments to examine the structures formed by the normal and mutated tRNAs. In the presence of Mg2+, the normal tRNA displays the structural features expected of a tRNA. However, even in the presence of Mg2+, the mutated tRNA does not form the cloverleaf structure typical of tRNAs. Thus, we believe that this mutation has disrupted a critical Mg2+-binding site on the tRNA required for formation of the biologically active structure. This work establishes a foundation for understanding the physiological consequences of the numerous mitochondrial tRNA mutations that result in disease in humans.	[Jones, Christopher I.; Graham, William D.; Agris, Paul F.] N Carolina State Univ, Dept Struct & Mol Biol, Raleigh, NC 27695 USA; [Jones, Christie N.; Spremulli, Linda L.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Agris, PF (corresponding author), N Carolina State Univ, Dept Struct & Mol Biol, Campus Box 7622, Raleigh, NC 27695 USA.	Paul_Agris@ncsu.edu; Linda_Spremulli@unc.edu			National Institutes of Health [GM32734, GM23037]; United Mitochondrial Disease Foundation; National Science Foundation [MCB 548602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023037, R01GM032734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32734 (to L. L. S.) and GM23037. This work was also supported by a United Mitochondrial Disease Foundation grant (to L. L. S. and P. F. A.) and National Science Foundation Grant MCB 548602 (to P. F. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Ashraf SS, 2000, CELL BIOCHEM BIOPHYS, V33, P241, DOI 10.1385/CBB:33:3:241; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; Bacman SR, 2003, BIOCHEM J, V374, P131, DOI 10.1042/BJ20030222; Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k; BAEYENS KJ, 1995, NAT STRUCT BIOL, V2, P56, DOI 10.1038/nsb0195-56; Bonnefond L, 2008, RNA, V14, P641, DOI 10.1261/rna.938108; Bullard JM, 1999, BBA-GENE STRUCT EXPR, V1446, P102, DOI 10.1016/S0167-4781(99)00077-9; Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200; CENATIEMPO Y, 1987, BIOCHEMISTRY-US, V26, P5070, DOI 10.1021/bi00390a028; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Dirheimer G., 1995, P93; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Hao HL, 1997, MOL CELL BIOL, V17, P6831, DOI 10.1128/MCB.17.12.6831; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Hunter S.E., 2004, RNA BIOL, V2, P95; Hunter SE, 2004, MITOCHONDRION, V4, P21, DOI 10.1016/j.mito.2004.04.003; Jones CI, 2006, J MOL BIOL, V362, P771, DOI 10.1016/j.jmb.2006.07.036; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Levinger L, 2001, NUCLEIC ACIDS RES, V29, P4334, DOI 10.1093/nar/29.21.4334; Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104; Lombes A, 1998, HUM MUTAT, pS175; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; Schwartzbach C J, 1996, Methods Enzymol, V264, P248, DOI 10.1016/S0076-6879(96)64025-7; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Spencer AC, 2004, NUCLEIC ACIDS RES, V32, P5464, DOI 10.1093/nar/gkh886; Spencer AC, 2004, BIOCHEMISTRY-US, V43, P9743, DOI 10.1021/bi049639w; SPRINZL M, 1980, NUCLEIC ACIDS RES, V8, P4737, DOI 10.1093/nar/8.20.4737; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; STEIN A, 1976, BIOCHEMISTRY-US, V15, P160, DOI 10.1021/bi00646a025; Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Vissing J, 1998, NEUROLOGY, V50, P1875, DOI 10.1212/WNL.50.6.1875; WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347; WATANABE Y, 1994, NUCLEIC ACIDS RES, V22, P5378, DOI 10.1093/nar/22.24.5378; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006; Wittenhagen LM, 2003, NUCLEIC ACIDS RES, V31, P596, DOI 10.1093/nar/gkg131; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543; YOKOGAWA T, 1991, NUCLEIC ACIDS RES, V19, P6101, DOI 10.1093/nar/19.22.6101; Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548	53	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34445	34456		10.1074/jbc.M806992200	http://dx.doi.org/10.1074/jbc.M806992200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835817	Green Published, hybrid			2022-12-27	WOS:000261277700072
J	Parastatidis, I; Thomson, L; Burke, A; Chernysh, I; Nagaswami, C; Visser, J; Stamer, S; Liebler, DC; Koliakos, G; Heijnen, HFG; FitzGerald, GA; Weisel, JW; Ischiropoulos, H				Parastatidis, Ioannis; Thomson, Leonor; Burke, Anne; Chernysh, Irina; Nagaswami, Chandrasekaran; Visser, Jetze; Stamer, Sheryl; Liebler, Daniel C.; Koliakos, George; Heijnen, Harry F. G.; FitzGerald, Garret A.; Weisel, John W.; Ischiropoulos, Harry			Fibrinogen beta-Chain Tyrosine Nitration Is a Prothrombotic Risk Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ARG-PRO-AMIDE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; PLATELET REACTIVITY; VENOUS THROMBOSIS; PLASMA-FIBRINOGEN; DEFICIENT MICE; CLOT STRUCTURE; HEART-DISEASE	Elevated levels of circulating fibrinogen are associated with an increased risk of atherothrombotic diseases although a causative correlation between high levels of fibrinogen and cardiovascular complications has not been established. We hypothesized that a potential mechanism for an increased prothrombotic state is the post-translational modification of fibrinogen by tyrosine nitration. Mass spectrometry identified tyrosine residues 292 and 422 at the carboxyl terminus of the beta-chain as the principal sites of fibrinogen nitration in vivo. Immunoelectron microscopy confirmed the incorporation of nitrated fibrinogen molecules in fibrin fibers. The nitration of fibrinogen in vivo resulted in four distinct functional consequences: increased initial velocity of fibrin clot formation, altered fibrin clot architecture, increased fibrin clot stiffness, and reduced rate of clot lysis. The rate of fibrin clot formation and clot architecture was restored upon depletion of the tyrosine-nitrated fibrinogen molecules. An enhanced response to the knob "B" mimetic peptides Gly-His-Arg-Pro(am) and Ala-His-Arg-Pro(am) suggests that incorporation of nitrated fibrinogen molecules accelerates fibrin lateral aggregation. The data provide a novel biochemical risk factor that could explain epidemiological associations of oxidative stress and inflammation with thrombotic complications.	[Parastatidis, Ioannis; Thomson, Leonor; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Stokes Res Inst, Philadelphia, PA 19104 USA; [Parastatidis, Ioannis; Thomson, Leonor; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Parastatidis, Ioannis; Thomson, Leonor; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA 19104 USA; [Parastatidis, Ioannis; Koliakos, George] Aristotle Univ Thessaloniki, Sch Med, Dept Biol Chem, Thessaloniki 54210, Greece; [Burke, Anne; FitzGerald, Garret A.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Chernysh, Irina; Nagaswami, Chandrasekaran; Visser, Jetze; Weisel, John W.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Stamer, Sheryl; Liebler, Daniel C.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Heijnen, Harry F. G.] Univ Med Ctr Utrecht, Dept Cell Biol, Thrombosis & Haemostasis Lab, NL-3584 CX Utrecht, Netherlands; [Heijnen, Harry F. G.] Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; [Thomson, Leonor] Univ Republica, Fac Ciencias, Montevideo, Uruguay	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Aristotle University of Thessaloniki; University of Pennsylvania; University of Pennsylvania; Vanderbilt University; Utrecht University; Utrecht University Medical Center; Universidad de la Republica, Uruguay	Ischiropoulos, H (corresponding author), 417 Abramson Res Ctr, 34th St,Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ischirop@mail.med.upenn.edu	FitzGerald, Garret A/A-4222-2010; Koliakos, George/AAC-8888-2021; Visser, Jetze/ABE-2738-2021; Thomson, Leonor/C-4684-2008	Thomson, Leonor/0000-0002-2574-8520; Liebler, Daniel/0000-0002-7873-3031	National Institutes of Health [P50 HL70128, RO1 HL54926]; NIEHS Center of Excellence in Environmental Toxicology [ES013508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL070128, R01HL054926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Center of Excellence in Environmental Toxicology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 HL70128 (to G. F. and H. I.), RO1 HL54926 (to H. I.), and ES013508 from the NIEHS Center of Excellence in Environmental Toxicology (to H. I.).	Afeltra A, 2005, ARTHRIT RHEUM-ARTHR, V53, P452, DOI 10.1002/art.21172; ALPERT JS, 1976, JAMA-J AM MED ASSOC, V236, P1477, DOI 10.1001/jama.236.13.1477; Blake GJ, 2001, EUR HEART J, V22, P2262, DOI 10.1053/euhj.2001.2692; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Carter AM, 2000, BLOOD, V96, P1177, DOI 10.1182/blood.V96.3.1177.015k25_1177_1179; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Doolittle RF, 2006, BIOCHEMISTRY-US, V45, P13962, DOI 10.1021/bi061219e; DOTEVALL A, 1987, EUR J HAEMATOL, V38, P55; Everse SJ, 1999, BIOCHEMISTRY-US, V38, P2941, DOI 10.1021/bi982626w; FATAH K, 1992, THROMB HAEMOSTASIS, V68, P130; Fatah K, 1996, THROMB HAEMOSTASIS, V76, P535; Ferro D, 1997, CIRCULATION, V95, P1425; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Heijnen HFG, 2006, FREE RADICAL BIO MED, V40, P1903, DOI 10.1016/j.freeradbiomed.2005.09.006; INADA Y, 1978, BIOCHIM BIOPHYS ACTA, V532, P161, DOI 10.1016/0005-2795(78)90459-2; KANNEL WB, 1987, AM HEART J, V113, P1006, DOI 10.1016/0002-8703(87)90063-9; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; KAZAL LA, 1963, P SOC EXP BIOL MED, V113, P989; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Parastatidis I, 2007, CIRC RES, V101, P368, DOI 10.1161/CIRCRESAHA.107.157537; Pignatelli B, 2001, CANCER RES, V61, P778; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Reilly M, 1996, CIRCULATION, V94, P19, DOI 10.1161/01.CIR.94.1.19; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; WEISEL JW, 1993, J MOL BIOL, V232, P285, DOI 10.1006/jmbi.1993.1382; WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804	41	65	67	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33846	33853		10.1074/jbc.M805522200	http://dx.doi.org/10.1074/jbc.M805522200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818200	Green Published, hybrid			2022-12-27	WOS:000261277700008
J	Dweck, D; Hus, N; Potter, JD				Dweck, David; Hus, Nir; Potter, James D.			Challenging Current Paradigms Related to Cardiomyopathies ARE CHANGES IN THE Ca2+ SENSITIVITY OF MYOFILAMENTS CONTAINING CARDIAC TROPONIN C MUTATIONS (G159D AND L29Q) GOOD PREDICTORS OF THE PHENOTYPIC OUTCOMES?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNESIUM BINDING-SITES; DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; ALPHA-TROPOMYOSIN; CALCIUM-BINDING; ATPASE ACTIVITY; FUNCTIONAL CONSEQUENCES; T MUTATIONS; N-TERMINUS; AFFINITY	Two novel mutations (G159D and L29Q) in cardiac troponin C (CTnC) associate their phenotypic outcomes with dilated (DCM) and hypertrophic cardiomyopathy (HCM), respectively. Current paradigms propose that sarcomeric mutations associated with DCM decrease the myofilament Ca2+ sensitivity, whereas those associated with HCM increase it. Therefore, we incorporated the mutant CTnCs into skinned cardiac muscle in order to determine if their effects on the Ca2+ sensitivities of tension and ATPase activity coincide with the current paradigms and phenotypic outcomes. The G159D-CTnC decreases the Ca2+ sensitivity of tension and ATPase activation and reduces the maximal ATPase activity when incorporated into regulated actomyosin filaments. Under the same conditions, the L29Q-CTnC has no effect. Surprisingly, changes in the apparent G159D-CTnC Ca2+ affinity measured by tension in fibers do not occur in the isolated CTnC, and large changes measured in the isolated L29Q-CTnC do not manifest in the fiber. These counterintuitive findings are justified through a transition in Ca2+ affinity occurring at the level of cardiac troponin and higher, implying that the true effects of these mutations become apparent as the hierarchical level of the myofilament increases. Therefore, the contractile apparatus, representing a large cooperative machine, can provide the potential for a change ( G159D) or no change ( L29Q) in the Ca2+ regulation of contraction. In accordance with the clinical outcomes and current paradigms, the desensitization of myofilaments from G159D-CTnC is expected to weaken the contractile force of the myocardium, whereas the lack of myofilament changes from L29Q-CTnC may preserve diastolic and systolic function.	[Dweck, David; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Hus, Nir] Mt Sinai Med Ctr, Dept Surg, Miami Beach, FL 33141 USA	University of Miami; Mount Sinai Medical Center	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave R-189, Miami, FL 33136 USA.	jdpotter@miami.edu			National Institutes of Health [HL67415, HL42325, HL07188]; American Heart Association [AHA 0315164B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R01HL067415, T32HL007188, R37HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67415 and HL42325 (to J.D.P.) and T32-HL07188. This work was also supported by American Heart Association Grant AHA 0315164B (to D. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; de Simone G, 2005, EUR HEART J, V26, P1039, DOI 10.1093/eurheartj/ehi019; de Simone G, 2005, AM J HYPERTENS, V18, P191, DOI 10.1016/j.amjhyper.2004.08.032; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Dweck D, 2005, BIOPHYS J, V88, p317A; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GRIFFIN BP, 2004, MANUAL CARDIOVASCULA, P101; GULATI J, 1991, J PHYSIOL-LONDON, V441, P305, DOI 10.1113/jphysiol.1991.sp018753; GUTH K, 1987, J BIOL CHEM, V262, P13627; Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200; Heller MJ, 2003, J BIOL CHEM, V278, P41742, DOI 10.1074/jbc.M303408200; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Jain M, 1998, CIRCULATION, V98, P179; JAQUET K, 1987, BIOCHEM BIOPH RES CO, V145, P1390, DOI 10.1016/0006-291X(87)91592-0; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; Karibe A, 2001, CIRCULATION, V103, P65; Kaski JP, 2007, CARDIOL YOUNG, V17, P675, DOI 10.1017/S1047951107001291; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Lilly L., 2006, PATHOPHYSIOLOGY HEAR; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; MORIMOTO S, 1987, J BIOCHEM-TOKYO, V101, P291, DOI 10.1093/oxfordjournals.jbchem.a121913; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; MURAKAMI U, 1976, J BIOCHEM, V80, P611, DOI 10.1093/oxfordjournals.jbchem.a131316; Palmieri V, 2001, AM J CARDIOL, V88, P1163, DOI 10.1016/S0002-9149(01)02054-9; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Preston LC, 2007, BIOCHEM BIOPH RES CO, V360, P27, DOI 10.1016/j.bbrc.2007.05.221; Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; SOLARO RJ, 1971, BIOCHIM BIOPHYS ACTA, V245, P259, DOI 10.1016/0005-2728(71)90033-8; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Venkatraman G, 2005, J BIOL CHEM, V280, P17584, DOI 10.1074/jbc.M409337200; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773	61	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33119	33128		10.1074/jbc.M804070200	http://dx.doi.org/10.1074/jbc.M804070200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18820258	Green Published, hybrid			2022-12-27	WOS:000261183700013
J	England, P; Westblade, LF; Karimova, G; Robbe-Saule, V; Norel, F; Kolb, A				England, Patrick; Westblade, Lars F.; Karimova, Gouzel; Robbe-Saule, Veronique; Norel, Francoise; Kolb, Annie			Binding of the Unorthodox Transcription Activator, Crl, to the Components of the Transcription Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE HOLOENZYME; PROTEIN-PROTEIN INTERACTION; ESCHERICHIA-COLI REGULATOR; GENERAL STRESS-RESPONSE; PHASE SIGMA-FACTOR; STATIONARY-PHASE; CRYSTAL-STRUCTURE; CORE ENZYME; SIGMA(S)-DEPENDENT GENES; SIGNAL-TRANSDUCTION	The small regulatory protein Crl binds to sigma(S), the RNA polymerase stationary phase sigma factor. Crl facilitates the formation of the sigma(S)-associated holoenzyme (E sigma(S)) and thereby activates sigma(S)-dependent genes. Using a real time surface plasmon resonance biosensor, we characterized in greater detail the specificity and mode of action of Crl. Crl specifically forms a 1: 1 complex with sigma(S), which results in an increase of the association rate of sigma(S) to core RNA polymerase without any effect on the dissociation rate of E sigma(S). Crl is also able to associate with preformed E sigma(S) with a higher affinity than with sigma(S) alone. Furthermore, even at saturating sigma(S) concentrations, Crl significantly increases E sigma(S) association with the katN promoter and the productive isomerization of the E sigma(S)-katN complex, supporting a direct role of Crl in transcription initiation. Finally, we show that Crl does not bind to sigma(70) itself but is able at high concentrations to form a weak and transient 1:1 complex with both core RNA polymerase and the sigma(70)-associated holoenzyme, leaving open the possibility that Crl might also exert a side regulatory role in the transcriptional activity of additional non-sigma(S) holoenzymes.	[England, Patrick] Inst Pasteur, F-75015 Paris, France; [Karimova, Gouzel] Unite Biochim Interact Macromol, F-75015 Paris, France; [Robbe-Saule, Veronique; Norel, Francoise; Kolb, Annie] Mol Genet Unit, F-75015 Paris, France; [England, Patrick; Karimova, Gouzel] CNRS, URA2185, F-75015 Paris, France; [Robbe-Saule, Veronique; Norel, Francoise; Kolb, Annie] CNRS, URA2172, F-75015 Paris, France; [Westblade, Lars F.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Rockefeller University	England, P (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75724 Paris 15, France.	england@pasteur.fr; akolb@pasteur.fr	, KARIMOVA/W-4225-2018	, KARIMOVA/0000-0003-4279-186X; ENGLAND, Patrick/0000-0001-6410-5918	National Institutes of Health [GM53759]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53759 (in support of L. F. W.; awarded to Seth A. Darst). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; ARNQVIST A, 1992, MOL MICROBIOL, V6, P2443; Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439; Bougdour A, 2004, J BIOL CHEM, V279, P19540, DOI 10.1074/jbc.M314145200; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Colland F, 1999, EMBO J, V18, P4049, DOI 10.1093/emboj/18.14.4049; Colland F, 2002, GENES CELLS, V7, P233, DOI 10.1046/j.1365-2443.2002.00517.x; DEHASETH P L, 1978, Biochemistry, V17, P1612, DOI 10.1021/bi00602a006; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; Ferguson AL, 2000, FEBS LETT, V481, P281, DOI 10.1016/S0014-5793(00)02028-7; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gaal T, 2006, J BACTERIOL, V188, P7966, DOI 10.1128/JB.01266-06; Gildehaus N, 2007, NUCLEIC ACIDS RES, V35, P1885, DOI 10.1093/nar/gkm085; Gourse RL, 2006, J BACTERIOL, V188, P4589, DOI 10.1128/JB.00499-06; Gowrishankar J, 2003, J BACTERIOL, V185, P2673, DOI 10.1128/JB.185.8.2673-2679.2003; Greive SJ, 2008, P NATL ACAD SCI USA, V105, P3315, DOI 10.1073/pnas.0712074105; GRIBSKOV M, 1983, GENE, V26, P109, DOI 10.1016/0378-1119(83)90180-4; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gruber TM, 2001, MOL CELL, V8, P21, DOI 10.1016/S1097-2765(01)00292-1; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Klauck Eberhard, 2007, Science Progress, V90, P103, DOI 10.3184/003685007X215922; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; LEDERER H, 1991, J MOL BIOL, V219, P747, DOI 10.1016/0022-2836(91)90669-W; Lee DJ, 2008, J BACTERIOL, V190, P1284, DOI 10.1128/JB.01599-07; Lelong C, 2007, MOL CELL PROTEOMICS, V6, P648, DOI 10.1074/mcp.M600191-MCP200; Lelong C, 2007, MOL CELL PROTEOMICS, V6, P660, DOI 10.1074/mcp.M600192-MCP200; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; MELANCON P, 1983, BIOCHEMISTRY-US, V22, P5169, DOI 10.1021/bi00291a017; Miller J. H, 1972, EXPT MOL GENETICS; Mitchell JE, 2007, J BACTERIOL, V189, P3489, DOI 10.1128/JB.00019-07; Mooney RA, 2003, GENE DEV, V17, P2839, DOI 10.1101/gad.1142203; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Patikoglou GA, 2007, J MOL BIOL, V372, P649, DOI 10.1016/j.jmb.2007.06.081; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Pemberton IK, 1999, J MOL RECOGNIT, V12, P322, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<322::AID-JMR471>3.0.CO;2-W; Pratt LA, 1998, MOL MICROBIOL, V29, P1225, DOI 10.1046/j.1365-2958.1998.01007.x; Robbe-Saule V, 2001, MOL MICROBIOL, V39, P1533, DOI 10.1046/j.1365-2958.2001.02340.x; Robbe-Saule V, 2008, J BACTERIOL, V190, P4453, DOI 10.1128/JB.00154-08; Robbe-Saule V, 2007, J BACTERIOL, V189, P2976, DOI 10.1128/JB.01919-06; Robbe-Saule V, 2006, J BACTERIOL, V188, P3983, DOI 10.1128/JB.00033-06; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; Schnetz K, 2002, MICROBIOL-SGM, V148, P2573, DOI 10.1099/00221287-148-8-2573; Sorenson MK, 2006, P NATL ACAD SCI USA, V103, P16722, DOI 10.1073/pnas.0606482103; Sorenson MK, 2004, MOL CELL, V14, P127, DOI 10.1016/S1097-2765(04)00150-9; Stockley PG, 1998, BIOSENS BIOELECTRON, V13, P637, DOI 10.1016/S0956-5663(98)00019-0; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Westblade LF, 2004, J MOL BIOL, V335, P685, DOI 10.1016/j.jmb.2003.11.004; WU FYH, 1976, BIOCHEMISTRY-US, V15, P3254, DOI 10.1021/bi00660a014; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhi HJ, 2003, METHOD ENZYMOL, V370, P174; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	72	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33455	33464		10.1074/jbc.M807380200	http://dx.doi.org/10.1074/jbc.M807380200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18818199	hybrid, Green Published			2022-12-27	WOS:000261183700050
J	Panopoulos, P; Mauro, VP				Panopoulos, Panagiotis; Mauro, Vincent P.			Antisense Masking Reveals Contributions of mRNA- rRNA Base Pairing to Translation of Gtx and FGF2 mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; MOLECULAR-WEIGHT FORMS; AUG-INITIATED FORMS; ALTERNATIVE TRANSLATION; ESCHERICHIA-COLI; GENE-EXPRESSION; ENTRY SITE; CODONS; CUG; DNA	We previously showed that a 9-nucleotide sequence from the 5' leader of the Gtx homeodomain mRNA facilitates translation initiation by base pairing to 18S rRNA. These earlier studies tested the Gtx element in isolation; we now assess the physiological relevance of this element in the context of two natural mRNAs that contain this sequence in their 5' leaders, Gtx itself and FGF2(fibroblast growth factor 2). 2'-O-Methyl-modified RNA oligonucleotides were employed to block mRNA-rRNA base pairing by targeting either the Gtx-binding site in 18S rRNA or Gtx elements in recombinant mRNAs containing the Gtx or FGF2 5' leaders linked to a reporter cistron. Studies in cell-free lysates and transfected COS-7 cells showed that translation of mRNAs containing the Gtx or FGF2 5' leaders was decreased by > 50% when oligonucleotides targeting either the rRNA or mRNA were used. Specificity was demonstrated by showing that translation of the recombinant mRNAs was unaffected by control oligonucleotides. In addition, the specific oligonucleotides did not affect the translation of recombinant mRNAs in which the Gtx elements were mutated. Experiments performed using constructs containing Gtx and FGF2 5' leader and coding sequences ruled out possible effects of the reporter cistron. Furthermore, two-dimensional gel electrophoresis revealed that the oligonucleotides used in this study had little overall effect on the proteomes of cells transfected with these oligonucleotides. This study demonstrates that mRNA-rRNA base pairing affects the expression of two cellularm RNAs and describes a new approach for investigating putative mRNA-rRNA base pairing interactions in mammalian cells.	Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Mauro, VP (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	vmauro@scripps.edu			National Institutes of Health [GM078071]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078071 (to V. P. M.). This work was also supported by the Skaggs Institute for Chemical Biology ( to P. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnaud E, 1999, MOL CELL BIOL, V19, P505; Awatramani R, 1997, J NEUROSCI, V17, P6657; BIKFALVI A, 1995, J CELL BIOL, V129, P233, DOI 10.1083/jcb.129.1.233; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2004, P NATL ACAD SCI USA, V101, P9590, DOI 10.1073/pnas.0308759101; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P18077, DOI 10.1073/pnas.0608212103; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; COUDERC B, 1991, CELL REGUL, V2, P709, DOI 10.1091/mbc.2.9.709; CUMMINS LL, 1995, NUCLEIC ACIDS RES, V23, P2019, DOI 10.1093/nar/23.11.2019; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; HOGREFE HH, 1990, J BIOL CHEM, V265, P5561; Hu MCY, 1999, P NATL ACAD SCI USA, V96, P1339, DOI 10.1073/pnas.96.4.1339; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; MATVEEVA OV, 1993, NUCLEIC ACIDS RES, V21, P1007, DOI 10.1093/nar/21.4.1007; Mauro VP, 1997, P NATL ACAD SCI USA, V94, P422, DOI 10.1073/pnas.94.2.422; Mignone Flavio, 2002, Appl Bioinformatics, V1, P145; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; QUARTO N, 1991, J CELL PHYSIOL, V147, P311, DOI 10.1002/jcp.1041470217; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SCHEPER GC, 1994, FEBS LETT, V352, P271, DOI 10.1016/0014-5793(94)00975-9; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Stein D, 1997, ANTISENSE NUCLEIC A, V7, P151, DOI 10.1089/oli.1.1997.7.151; Vagner S, 1996, J CELL BIOL, V135, P1391, DOI 10.1083/jcb.135.5.1391; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116	30	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33087	33093		10.1074/jbc.M804904200	http://dx.doi.org/10.1074/jbc.M804904200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832380	Green Published, hybrid			2022-12-27	WOS:000261183700009
J	Basu, S; Azarova, NA; Font, MD; King, SB; Hogg, N; Gladwin, MT; Shiva, S; Kim-Shapiro, DB				Basu, Swati; Azarova, Natalia A.; Font, Michael D.; King, S. Bruce; Hogg, Neil; Gladwin, Mark T.; Shiva, Sruti; Kim-Shapiro, Daniel B.			Nitrite Reductase Activity of Cytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL TRANSITIONS; TYROSINE NITRATION; HYPOXIC CONDITIONS; S-NITROSATION; OXIDE; OXYGEN; CARDIOLIPIN; SUPEROXIDE; KINETICS; CELL	Small increases in physiological nitrite concentrations have now been shown to mediate a number of biological responses, including hypoxic vasodilation, cytoprotection after ischemia/reperfusion, and regulation of gene and protein expression. Thus, while nitrite was until recently believed to be biologically inert, it is now recognized as a potentially important hypoxic signaling molecule and therapeutic agent. Nitrite mediates signaling through its reduction to nitric oxide, via reactions with several heme-containing proteins. In this report, we show for the first time that the mitochondrial electron carrier cytochrome c can also effectively reduce nitrite to NO. This nitrite reductase activity is highly regulated as it is dependent on pentacoordination of the heme iron in the protein and occurs under anoxic and acidic conditions. Further, we demonstrate that in the presence of nitrite, pentacoordinate cytochrome c generates bioavailable NO that is able to inhibit mitochondrial respiration. These data suggest an additional role for cytochrome c as a nitrite reductase that may play an important role in regulating mitochondrial function and contributing to hypoxic, redox, and apoptotic signaling within the cell.	[Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Gladwin, Mark T.; Shiva, Sruti] Univ Pittsburgh, Hemostasis & Vasc Biol Res Inst, Pittsburgh, PA 15213 USA; [Basu, Swati; Azarova, Natalia A.; Font, Michael D.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [King, S. Bruce] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Hogg, Neil] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Hogg, Neil] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Gladwin, Mark T.] Univ Pittsburgh, Med Ctr, Pulm Allergy & Crit Care Med Div, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Wake Forest University; Medical College of Wisconsin; Medical College of Wisconsin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shiva, S (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	shivas@upmc.edu; shapiro@wfu.edu	Kim-Shapiro, Daniel/HGA-2682-2022		National Institutes of Health [HL058091, HL078706]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058091, R37HL058091, K02HL078706, R01HL058091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058091 and HL078706. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASCENZI P, 1994, J INORG BIOCHEM, V53, P273, DOI 10.1016/0162-0134(94)85114-X; Batthyany C, 2005, BIOCHEMISTRY-US, V44, P8038, DOI 10.1021/bi0474620; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Boyd CS, 2002, BIOL CHEM, V383, P411, DOI 10.1515/BC.2002.045; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; BUTT WD, 1962, PROC R SOC SER B-BIO, V156, P429, DOI 10.1098/rspb.1962.0049; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Castello PR, 2008, P NATL ACAD SCI USA, V105, P8203, DOI 10.1073/pnas.0709461105; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Castro L, 2004, ARCH BIOCHEM BIOPHYS, V421, P99, DOI 10.1016/j.abb.2003.08.033; Chen YR, 2002, J BIOL CHEM, V277, P29781, DOI 10.1074/jbc.M200709200; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Estevam ML, 2004, J BIOL CHEM, V279, P39214, DOI 10.1074/jbc.M402093200; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; Frost MT, 2005, AM J PHYSIOL-REG I, V288, pR394, DOI 10.1152/ajpregu.00504.2004; Galkin A, 2007, ESSAYS BIOCHEM, V43, P29, DOI 10.1042/bse0430029; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Godoy LC, 2007, FREE RADICAL BIO MED, V43, pS31; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; HOGG N, 1993, FEBS LETT, V326, P199, DOI 10.1016/0014-5793(93)81790-7; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lee VY, 2002, J BIOL CHEM, V277, P16067, DOI 10.1074/jbc.M111177200; Li CQ, 2005, CANCER LETT, V226, P1, DOI 10.1016/j.canlet.2004.10.021; Li HT, 2004, J BIOL CHEM, V279, P16939, DOI 10.1074/jbc.M314336200; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Nadtochiy SM, 2007, J MOL CELL CARDIOL, V42, P812, DOI 10.1016/j.yjmcc.2007.01.010; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nantes IL, 2001, J BIOL CHEM, V276, P153, DOI 10.1074/jbc.M006338200; Osipov AN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1491, DOI 10.1134/S0006297907130068; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Schonhoff CM, 2003, J BIOL CHEM, V278, P18265, DOI 10.1074/jbc.M212459200; Shen YH, 1998, FEBS LETT, V433, P125, DOI 10.1016/S0014-5793(98)00844-8; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; SPOONER PJR, 1992, BIOCHEMISTRY-US, V31, P10129, DOI 10.1021/bi00156a037; Thomas DD, 2002, P NATL ACAD SCI USA, V99, P12691, DOI 10.1073/pnas.202312699; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169; Tuominen EKJ, 2002, J BIOL CHEM, V277, P8822, DOI 10.1074/jbc.M200056200; van Beek-Harmsen BJ, 2005, J HISTOCHEM CYTOCHEM, V53, P803, DOI 10.1369/jhc.4C6527.2005; Xu XL, 2002, J BIOL CHEM, V277, P36787, DOI 10.1074/jbc.M205350200; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	60	154	157	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32590	32597		10.1074/jbc.M806934200	http://dx.doi.org/10.1074/jbc.M806934200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18820338	Green Published, hybrid			2022-12-27	WOS:000260893700048
J	Wolfe, MS				Wolfe, Michael S.			Tau Mutations in Neurodegenerative Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MICROTUBULE-ASSOCIATED PROTEIN; INHERITED DEMENTIA FTDP-17; PAIRED HELICAL FILAMENT; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; EXON 10; MOUSE MODEL; NEUROFIBRILLARY TANGLES; TRANSGENIC MICE; GENE	Tau deposition is found in a variety of neurodegenerative brain diseases. The identification of tau mutations that cause familial dementia demonstrated that aberrant Tau alone could cause neurodegenerative disease and suggested that Tau likely plays a role in other cases in which Tau deposits are found, most notably Alzheimer disease. The mechanisms by which tau mutations cause neurodegeneration vary and are unclear to some degree, but evidence supports changes in alternative splicing, phosphorylation state, interaction with tubulin, and self-association into filaments as important contributing factors.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wolfe, MS (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu						Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; D'Souza I, 2000, J BIOL CHEM, V275, P17700, DOI 10.1074/jbc.M909470199; D'Souza I, 2002, J BIOL CHEM, V277, P26587, DOI 10.1074/jbc.M203794200; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; DeTure M, 2002, AM J PATHOL, V161, P1711, DOI 10.1016/S0002-9440(10)64448-3; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Donahue CP, 2006, J BIOL CHEM, V281, P23302, DOI 10.1074/jbc.C600143200; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Goedert M, 2000, J NEUROCHEM, V75, P2155, DOI 10.1046/j.1471-4159.2000.0752155.x; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Grover A, 2003, EXP NEUROL, V184, P131, DOI 10.1016/S0014-4886(03)00393-5; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; Jiang ZH, 2000, MOL CELL BIOL, V20, P4036, DOI 10.1128/MCB.20.11.4036-4048.2000; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Neumann M, 2005, NEUROGENETICS, V6, P91, DOI 10.1007/s10048-005-0210-y; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Nicholl DJ, 2003, ANN NEUROL, V54, P682, DOI 10.1002/ana.10747; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Pickering-Brown SM, 2004, BRAIN, V127, P1415, DOI 10.1093/brain/awh147; Pittman AM, 2006, HUM MOL GENET, V15, pR188, DOI 10.1093/hmg/ddl190; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stanford PM, 2003, BRAIN, V126, P814, DOI 10.1093/brain/awg090; Varani L, 1999, P NATL ACAD SCI USA, V96, P8229, DOI 10.1073/pnas.96.14.8229; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	61	117	129	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6021	6025		10.1074/jbc.R800013200	http://dx.doi.org/10.1074/jbc.R800013200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	18948254	hybrid			2022-12-27	WOS:000263742700001
J	Dagda, RK; Merrill, RA; Cribbs, JT; Chen, YC; Hell, JW; Usachev, YM; Strack, S				Dagda, Ruben K.; Merrill, Ronald A.; Cribbs, J. Thomas; Chen, Yucui; Hell, Johannes W.; Usachev, Yuriy M.; Strack, Stefan			The Spinocerebellar Ataxia 12 Gene Product and Protein Phosphatase 2A Regulatory Subunit B beta 2 Antagonizes Neuronal Survival by Promoting Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED GTPASE; CYTOCHROME-C RELEASE; NITRIC-OXIDE; CELL-DEATH; APOPTOSIS; PHOSPHORYLATION; DRP1; FAMILY; DEPHOSPHORYLATION	The neurodegenerative disorder spinocerebellar ataxia 12 (SCA12) is caused by CAG repeat expansion in the non-coding region of the PPP2R2B gene. PPP2R2B encodes B beta 1 and B beta 2, alternatively spliced and neuron-specific regulatory subunits of the protein phosphatase 2A (PP2A) holoenzyme. We show here that in PC12 cells and hippocampal neurons, cell stressors induced a rapid translocation of PP2A/B beta 2 to mitochondria to promote apoptosis. Conversely, silencing of PP2A/B beta 2 protected hippocampal neurons against free radical-mediated, excitotoxic, and ischemic insults. Evidence is accumulating that the mitochondrial fission/fusion equilibrium is an important determinant of cell survival. Accordingly, we found that B beta 2 expression induces mitochondrial fragmentation, whereas B beta 2 silencing or inhibition resulted in mitochondrial elongation. Based on epistasis experiments involving Bcl2 and core components of the mitochondrial fission machinery (Fis1 and dynamin-related protein 1), mitochondrial fragmentation occurs upstream of apoptosis and is both necessary and sufficient for hippocampal neuron death. Our data provide the first example of a proapoptotic phosphatase that predisposes to neuronal death by promoting mitochondrial division and point to a possible imbalance of the mitochondrial morphogenetic equilibrium in the pathogenesis of SCA12.	[Strack, Stefan] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Strack, S (corresponding author), Univ Iowa, Carver Coll Med, Dept Pharmacol, 2-432 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu	Hell, Johannes W./P-5085-2019	Usachev, Yuriy/0000-0002-6948-4627; Merrill, Ronald/0000-0002-5276-4163; Dagda, Ruben/0000-0002-9946-9591; Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [NS043254, NS056244, NS054614, NS046450]; American Heart Association [0455653Z]; United Mitochondrial Disease Foundation [04-65]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054614, R01NS043254, R01NS046450, R01NS035563, R56NS056244, F31NS049659, R01NS056244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United Mitochondrial Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS043254, NS056244 (to S. S.), NS054614 (to Y. M. U.), and NS046450 (to Y. W. H.). This work was also supported by American Heart Association Grant-in-Aid 0455653Z (to S. S.) and United Mitochondrial Disease Foundation Grant 04-65 (to S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Cheung ECC, 2007, APOPTOSIS, V12, P979, DOI 10.1007/s10495-007-0745-5; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Dagda RK, 2005, J BIOL CHEM, V280, P27375, DOI 10.1074/jbc.M503693200; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Dimmer KS, 2006, PHYSIOLOGY, V21, P233, DOI 10.1152/physiol.00010.2006; Dobson S, 2003, MOL BIOCHEM PARASIT, V126, P239, DOI 10.1016/S0166-6851(02)00293-1; Gonzalez-Alegre P, 2005, J NEUROSCI, V25, P10502, DOI 10.1523/JNEUROSCI.3016-05.2005; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; HOLMES SE, 2006, GENETIC INSTABILITIE, P461; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; James DI, 2008, DEV CELL, V15, P341, DOI 10.1016/j.devcel.2008.08.011; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lim IA, 2003, NEUROPHARMACOLOGY, V45, P738, DOI 10.1016/S0028-3908(03)00276-4; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Schmidt K, 2002, EUR J NEUROSCI, V16, P2039, DOI 10.1046/j.1460-9568.2002.02274.x; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Yuan H, 2007, CELL DEATH DIFFER, V14, P462, DOI 10.1038/sj.cdd.4402046; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	40	61	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36241	36248		10.1074/jbc.M800989200	http://dx.doi.org/10.1074/jbc.M800989200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940801	hybrid, Green Published			2022-12-27	WOS:000261840500019
J	Sauna, ZE; Bohn, SS; Rutledge, R; Dougherty, MP; Cronin, S; May, L; Xia, D; Ambudkar, SV; Golin, J				Sauna, Zuben E.; Bohn, Sherry Supernavage; Rutledge, Robert; Dougherty, Michael P.; Cronin, Susan; May, Leopold; Xia, Di; Ambudkar, Suresh V.; Golin, John			Mutations Define Cross-talk between the N-terminal Nucleotide-binding Domain and Transmembrane Helix-2 of the Yeast Multidrug Transporter Pdr5 POSSIBLE CONSERVATION OF A SIGNALING INTERFACE FOR COUPLING ATP HYDROLYSIS TO DRUG TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; CANDIDA-ALBICANS; ENCODING GENE; RESISTANCE; PROTEIN; MECHANISM; PUMP; ARCHITECTURE; EXPRESSION; ENERGY	The yeast Pdr5 multidrug transporter is an important member of the ATP-binding cassette superfamily of proteins. We describe a novel mutation (S558Y) in transmembrane helix 2 of Pdr5 identified in a screen for suppressors that eliminated Pdr5-mediated cycloheximide hyper-resistance. Nucleotides as well as transport substrates bind to the mutant Pdr5 with an affinity comparable with that for wild-type Pdr5. Wild-type and mutant Pdr5s show ATPase activity with comparable K-m(ATP) values. Nonetheless, drug sensitivity is equivalent in the mutant pdr5 and the pdr5 deletion. Finally, the transport substrate clotrimazole, which is a noncompetitive inhibitor of Pdr5 ATPase activity, has a minimal effect on ATP hydrolysis by the S558Y mutant. These results suggest that the drug sensitivity of the mutant Pdr5 is attributable to the uncoupling of NTPase activity and transport. We screened for amino acid alterations in the nucleotide-binding domains that would reverse the phenotypic effect of the S558Y mutation. A second-site mutation, N242K, located between the Walker A and signature motifs of the N-terminal nucleotide-binding domain, restores significant function. This region of the nucleotide-binding domain interacts with the transmembrane domains via the intracellular loop-1 (which connects transmembrane helices 2 and 3) in the crystal structure of Sav1866, a bacterial ATP-binding cassette drug transporter. These structural studies are supported by biochemical and genetic evidence presented here that interactions between transmembrane helix 2 and the nucleotide-binding domain, via the intracellular loop-1, may define at least part of the translocation pathway for coupling ATP hydrolysis to drug transport.	[Bohn, Sherry Supernavage; Dougherty, Michael P.; Golin, John] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA; [May, Leopold] Catholic Univ Amer, Dept Chem, Washington, DC 20064 USA; [Sauna, Zuben E.; Rutledge, Robert; Xia, Di; Ambudkar, Suresh V.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Cronin, Susan] Immaculata Univ, Dept Biol, Immaculata, PA 19345 USA	Catholic University of America; Catholic University of America; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Golin, J (corresponding author), Catholic Univ Amer, Dept Biol, McCort Ward Bldg 103, Washington, DC 20064 USA.	golin@cua.edu	Ambudkar, Suresh V/L-1317-2016; Sauna, Zuben E./AAA-7149-2019		National Institutes of Health (Intramural Research Program, Center for Cancer Research, NCI); National Institutes of Health [GM07721]; NATIONAL CANCER INSTITUTE [ZIABC010319, ZIABC010030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007721] Funding Source: NIH RePORTER	National Institutes of Health (Intramural Research Program, Center for Cancer Research, NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health (Intramural Research Program, Center for Cancer Research, NCI). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant GM07721.	AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Thozee CP, 2007, MOL MICROBIOL, V63, P811, DOI 10.1111/j.1365-2958.2006.05562.x; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Golin J, 2003, J BIOL CHEM, V278, P5963, DOI 10.1074/jbc.M210908200; Golin J, 2007, BIOCHEMISTRY-US, V46, P13109, DOI 10.1021/bi701414f; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hanson L, 2005, BIOCHEMISTRY-US, V44, P9703, DOI 10.1021/bi0502994; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Nakamura K, 2001, ANTIMICROB AGENTS CH, V45, P3366, DOI 10.1128/AAC.45.12.3366-3374.2001; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Posteraro B, 2003, MOL MICROBIOL, V47, P357, DOI 10.1046/j.1365-2958.2003.03281.x; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Rutledge RM, 2008, MOL GENET GENOMICS, V279, P573, DOI 10.1007/s00438-008-0334-5; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Schumacher MA, 2003, RES MICROBIOL, V154, P69, DOI 10.1016/S0923-2508(02)00013-X; Shukla S, 2006, BIOCHEMISTRY-US, V45, P2425, DOI 10.1021/bi0519147; Shukla S, 2003, EUKARYOT CELL, V2, P1361, DOI 10.1128/EC.2.6.1361-1375.2003; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	36	51	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35010	35022		10.1074/jbc.M806446200	http://dx.doi.org/10.1074/jbc.M806446200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842589	hybrid, Green Published			2022-12-27	WOS:000261469100058
J	Siegel, C; Schreiber, J; Haupt, K; Skerka, C; Brade, V; Simon, MM; Stevenson, B; Wallich, R; Zipfel, PF; Kraiczy, P				Siegel, Corinna; Schreiber, Johanna; Haupt, Katrin; Skerka, Christine; Brade, Volker; Simon, Markus M.; Stevenson, Brian; Wallich, Reinhard; Zipfel, Peter F.; Kraiczy, Peter			Deciphering the Ligand-binding Sites in the Borrelia burgdorferi Complement Regulator-acquiring Surface Protein 2 Required for Interactions with the Human Immune Regulators Factor H and Factor H-like Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR FACTOR-H; SERUM RESISTANCE; FUNCTIONAL-CHARACTERIZATION; VIRULENCE FACTOR; RELAPSING FEVER; HERMSII FHBA; EXPRESSION; EVASION; IDENTIFICATION; INFECTION	Borrelia burgdorferi, the etiologic agent of Lyme disease, employs sophisticated means to evade killing by its mammalian hosts. One important immune escape mechanism is the inhibition of complement activation mediated by interactions of the host-derived immune regulators factor H (CFH) and factor H-like protein 1 (CFHL1) with borrelial complement regulator-acquiring surface proteins (BbCRASPs). BbCRASP-2 is a distinctive CFH- and CFHL1-binding protein that is produced by serum-resistant B. burgdorferi strains. Here we show that binding of CFH by BbCRASP-2 is due to electrostatic as well as hydrophobic forces. In addition, 14 individual amino acid residues of BbCRASP-2 were identified as being involved in CFH and CFHL1 binding. Alanine substitutions of most of those residues significantly inhibited binding of CFH and/or CFHL1 by recombinant BbCRASP-2 proteins. To conclusively define the effects of BbCRASP-2 residue substitutions on serum sensitivity in the bacterial context, a serum-sensitive Borrelia garinii strain was transformed with plasmids that directed production of either wildtype or mutated BbCRASP-2 proteins. Critical amino acid residues within BbCRASP-2 were identified, with bacteria producing distinct mutant proteins being unable to bind either CFH or CFHL1, showing high levels of complement components C3, C6, and C5b-9 deposited on their surfaces and being highly sensitive to killing by normal serum. Collectively, we mapped a structurally sensitive CFH/CFHL1 binding site within borrelial BbCRASP-2 and identified single amino acid residues potentially involved in the interaction with both complement regulators.	[Siegel, Corinna; Schreiber, Johanna; Brade, Volker; Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, D-60596 Frankfurt, Germany; [Haupt, Katrin; Skerka, Christine; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, D-79108 Freiburg, Germany; [Stevenson, Brian] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany; [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hans Knoll Institute (HKI); Max Planck Society; University of Kentucky; Ruprecht Karls University Heidelberg; Friedrich Schiller University of Jena	Kraiczy, P (corresponding author), Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	Kraiczy@em.uni-frankfurt.de			Deutsche Forschungsgemeinschaft [Kr3383/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft ( Grant Kr3383/1-1 to P. K.). This work forms part of the doctoral theses of C. S. and J. S. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alitalo A, 2004, J IMMUNOL, V172, P6195, DOI 10.4049/jimmunol.172.10.6195; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; BRADE V, 1992, IMMUNOBIOLOGY, V185, P453, DOI 10.1016/S0171-2985(11)80087-2; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Bykowski T, 2008, INT J MED MICROBIOL, V298, P249, DOI 10.1016/j.ijmm.2007.10.002; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Coleman AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003010; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Embers ME, 2004, MICROBES INFECT, V6, P312, DOI 10.1016/j.micinf.2003.11.014; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Hauser U, 1999, J CLIN MICROBIOL, V37, P2241, DOI 10.1128/JCM.37.7.2241-2247.1999; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Herzberger P, 2007, INFECT IMMUN, V75, P4817, DOI 10.1128/IAI.00532-07; Hovis KM, 2008, INFECT IMMUN, V76, P2113, DOI 10.1128/IAI.01266-07; Hovis KM, 2006, INFECT IMMUN, V74, P2007, DOI 10.1128/IAI.74.4.2007-2014.2006; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001; Jarva H, 2004, J IMMUNOL, V172, P3111, DOI 10.4049/jimmunol.172.5.3111; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Johnsson E, 1998, J IMMUNOL, V161, P4894; KOLLMAN PA, 1994, CURR OPIN STRUC BIOL, V4, P240, DOI 10.1016/S0959-440X(94)90315-8; Kotarsky H, 1998, J IMMUNOL, V160, P3349; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; Kraiczy P, 2000, IMMUNOBIOLOGY, V201, P406, DOI 10.1016/S0171-2985(00)80094-7; Kraiczy P, 2008, CLIN VACCINE IMMUNOL, V15, P484, DOI 10.1128/CVI.00415-07; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; Kuhn S, 1996, EUR J IMMUNOL, V26, P2383, DOI 10.1002/eji.1830261017; KUHN S, 1995, J IMMUNOL, V155, P5663; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lu L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/jbc.M602404200; McDowell JV, 2003, J CLIN MICROBIOL, V41, P3905, DOI 10.1128/JCM.41.8.3905-3910.2003; Metts MS, 2003, INFECT IMMUN, V71, P3587, DOI 10.1128/IAI.71.6.3587-3596.2003; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Miller JC, 2006, INT J MED MICROBIOL, V296, P185, DOI 10.1016/j.ijmm.2006.01.010; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Prodinger WM, 1998, BIOCHEM J, V331, P41, DOI 10.1042/bj3310041; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; Rogers EA, 2007, INFECT IMMUN, V75, P5272, DOI 10.1128/IAI.00850-07; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; SAMUELS SD, 1995, ELECTROPORATION PROT, V47; Siegel C, 2008, INT J MED MICROBIOL, V298, P292, DOI 10.1016/j.ijmm.2007.12.007; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; VanDam AP, 1997, INFECT IMMUN, V65, P1228, DOI 10.1128/IAI.65.4.1228-1236.1997; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; von Lackum K, 2005, INFECT IMMUN, V73, P7398, DOI 10.1128/IAI.73.11.7398-7405.2005; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Zipfel PF, 1999, IMMUNOL TODAY, V20, P135, DOI 10.1016/S0167-5699(98)01432-7	63	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34855	34863		10.1074/jbc.M805844200	http://dx.doi.org/10.1074/jbc.M805844200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18824548	Green Published, hybrid			2022-12-27	WOS:000261469100041
J	Song, JJ; Kingston, RE				Song, Ji-Joon; Kingston, Robert E.			WDR5 Interacts with Mixed Lineage Leukemia (MLL) Protein via the Histone H3-binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MOLECULAR RECOGNITION; H3; COMPLEX	WDR5 is a component of the mixed lineage leukemia (MLL) complex, which methylates lysine 4 of histone H3, and was identified as a methylated Lys-4 histone H3-binding protein. Here, we present a crystal structure of WDR5 bound to an MLL peptide. Surprisingly, we find that WDR5 utilizes the same pocket shown to bind histone H3 for this MLL interaction. Furthermore, the WDR5-MLL interaction is disrupted preferentially by mono- and di-methylated Lys-4 histone H3 over unmodified and tri-methylated Lys-4 histone H3. These data implicate a delicate interplay between the effector, WDR5, the catalytic subunit, MLL, and the substrate, histone H3, of the MLL complex. We suggest that the activity of the MLL complex might be regulated through this interplay.	[Kingston, Robert E.] Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kingston, RE (corresponding author), Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu	Song, Ji-Joon/C-1721-2011		National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by grants from the National Institutes of Health (to R. E. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	10	135	147	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35258	35264		10.1074/jbc.M806900200	http://dx.doi.org/10.1074/jbc.M806900200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18840606	Green Published, hybrid			2022-12-27	WOS:000261469100081
J	Su, N; Kilberg, MS				Su, Nan; Kilberg, Michael S.			C/EBP Homology Protein (CHOP) Interacts with Activating Transcription Factor 4 (ATF4) and Negatively Regulates the Stress-dependent Induction of the Asparagine Synthetase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DEPRIVATION; ENDOPLASMIC-RETICULUM STRESS; MAMMALIAN-CELLS; ARGININE/LYSINE TRANSPORTER; TRANSLATIONAL REGULATION; EIF2-ALPHA KINASE; RESPONSE ELEMENTS; BINDING PROTEINS; NUCLEAR-PROTEIN; EXPRESSION	C/EBP homology protein (CHOP), a stress-induced transcription factor, is involved in transcriptional regulation, cell cycle, and apoptosis. The present studies identified CHOP as an interacting partner of activating transcription factor (ATF) 4 in a yeast two-hybrid screen and confirmed their interaction in HEK293T cells. CHOP protein levels rose modestly and transiently during amino acid deprivation, whereas endoplasmic reticulum stress caused a much higher and sustained expression of CHOP protein. Exogenous CHOP expression enhanced the TRB3 gene induction by amino acid deprivation. Conversely, CHOP suppressed the induction of the endogenous asparagine synthetase (ASNS) gene and inhibited transcription from a reporter gene driven by the ASNS promoter following activation by ATF4 or amino acid deprivation. Short interfering RNA-mediated knockdown of CHOP further enhanced the induction of ASNS by either amino acid deprivation or endoplasmic reticulum stress. The CHOP-dependent repression of the ASNS gene required the entire CHOP protein, arguing against the possibility of simple sequestration of ATF4 by the CHOP leucine zipper domain, and chromatin immunoprecipitation analysis showed association of CHOP with the ASNS and TRB3 promoters. Interestingly, chromatin immunoprecipitation also showed that CHOP was associated with the C/EBP-ATF composite site regions of the SNAT2, VEGF, and CAT-1 genes, despite no significant effect on their expression after exogenous CHOP overexpression. Collectively, the results document that CHOP is a member of the transcription factor network that controls the stress-induced regulation of specific C/EBP-ATF-containing genes, such as ASNS.	[Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	su, nan/GRS-5213-2022		National Institutes of Health [DK-52064, DK70647]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052064, R01DK070647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-52064 and DK70647 (NIDDK) (to M.S.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; Al Sarraj J, 2005, BIOL CHEM, V386, P873, DOI 10.1515/BC.2005.102; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Barber GN, 2005, CELL DEATH DIFFER, V12, P563, DOI 10.1038/sj.cdd.4401643; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Gachon F, 2001, FEBS LETT, V502, P57, DOI 10.1016/S0014-5793(01)02646-1; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mazumder Suparna, 2008, V414, P13; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sood R, 2000, GENETICS, V154, P787; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yoon S, 2004, P NATL ACAD SCI USA, V101, P11713, DOI 10.1073/pnas.0404652101; Yu VWC, 2005, J CELL BIOL, V169, P591, DOI 10.1083/jcb.200412139; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	121	127	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35106	35117		10.1074/jbc.M806874200	http://dx.doi.org/10.1074/jbc.M806874200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940792	Green Published, hybrid			2022-12-27	WOS:000261469100068
J	Yang, L; Zhang, L; Wu, QY; Boyd, DD				Yang, Lin; Zhang, Li; Wu, Qiuyu; Boyd, Douglas D.			Unbiased Screening for Transcriptional Targets of ZKSCAN3 Identifies Integrin beta 4 and Vascular Endothelial Growth Factor as Downstream Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER PROGRESSION; WIDE ASSOCIATION SCAN; CARCINOMA-CELLS; TYROSINE KINASE; HUMAN BREAST; SIGNALING PATHWAY; TUMOR PROGRESSION; BINDING DOMAIN; IN-VIVO; K-RAS	We previously described the novel zinc finger protein ZKSCAN3 as a new "driver" of colon cancer progression. To investigate the underlying mechanism and because the predicted structural features (tandem zinc fingers) are often present in transcription factors, we hypothesized that ZKSCAN3 regulates the expression of a gene(s) favoring tumor progression. We employed unbiased screening to identify a DNA binding motif and candidate downstream genes. Cyclic amplification and selection of targets using a random oligonucleotide library and ZKSCAN3 protein identified KRDGGG as the DNA recognition motif. In expression profiling, 204 genes were induced 2-29-fold, and 76 genes reduced 2-5-fold by ZKSCAN3. To enrich for direct targets, we eliminated genes under-represented (< 3) for the ZKSCAN3 binding motif (identified by CAST-ing) in 2 kilobases of regulatory sequence. Up-regulated putative downstream targets included genes contributing to growth (c-Met-related tyrosine kinase (MST1R), MEK2; the guanine nucleotide exchanger RasGRP2, insulin-like growth factor-2, integrin beta 4), cell migration (MST1R), angiogenesis (vascular endothelial growth factor), and proteolysis (MMP26; cathepsin D; PRSS3 (protease serine 3)). We pursued integrin beta 4 (induced up to 6-fold) as a candidate target because it promotes breast cancer tumorigenicity and stimulates phosphatidyl 3-kinase implicated in colorectal cancer progression. ZKSCAN3 overexpression/silencing modulated integrin beta 4 expression, confirming the array analysis. Moreover, ZKSCAN3 bound to the integrin beta 4 promoter in vitro and in vivo, and the integrin beta 4-derived ZKSCAN3 motif fused upstream of a tk-Luc reporter conferred ZKSCAN3 sensitivity. Integrin beta 4 knockdown by short hairpin RNA countered ZKSCAN3-augmented anchorage-independent colony formation. We also demonstrate vascular endothelial growth factor as a direct ZKSCAN3 target. Thus, ZKSCAN3 regulates the expression of several genes favoring tumor progression including integrin beta 4.	[Yang, Lin; Wu, Qiuyu; Boyd, Douglas D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Zhang, Li] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Boyd, DD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	dboyd@mdanderson.org		Zhang, Li/0000-0003-0517-7860	National Institutes of Health Grants [CA58311, DE10845]; NATIONAL CANCER INSTITUTE [R01CA058311, R56CA058311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010845] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA58311 and DE10845 (to D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahnen DJ, 1998, CANCER RES, V58, P1149; Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Bernet A, 2007, GASTROENTEROLOGY, V133, P1840, DOI 10.1053/j.gastro.2007.08.009; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Calistri D, 2005, J CELL PHYSIOL, V204, P484, DOI 10.1002/jcp.20310; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Chao C, 1996, CANCER RES, V56, P4811; CHOWDHURY K, 1992, MECH DEVELOP, V39, P129, DOI 10.1016/0925-4773(92)90040-Q; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Chung SK, 2007, GASTROENTEROLOGY, V132, P2459, DOI 10.1053/j.gastro.2007.04.024; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Delfino FJ, 2006, J BIOL CHEM, V281, P8829, DOI 10.1074/jbc.M507331200; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Fenton JI, 2005, CANCER EPIDEM BIOMAR, V14, P1646, DOI 10.1158/1055-9965.EPI-04-0916; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Heyer J, 1999, ONCOGENE, V18, P5325, DOI 10.1038/sj.onc.1203036; Hoffmann A, 2008, MOL CELL BIOL, V28, P6078, DOI 10.1128/MCB.00842-08; Huang CX, 2007, EXP CELL RES, V313, P254, DOI 10.1016/j.yexcr.2006.10.009; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Izumi Y, 2005, ARTERIOSCL THROM VAS, V25, P1877, DOI 10.1161/01.ATV.0000174801.76234.bd; Johansen KA, 2003, MECH DEVELOP, V120, P1139, DOI 10.1016/j.mod.2003.08.001; Kawamoto K, 1998, ONCOLOGY-BASEL, V55, P242, DOI 10.1159/000011858; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li JN, 2005, GASTROENTEROLOGY, V128, P1907, DOI 10.1053/j.gastro.2005.02.067; Li YQ, 2006, MOL BIOL REP, V33, P287, DOI 10.1007/s11033-006-9019-5; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; LU H, 2004, BIOCHEM BIOPH RES CO, V320, P45; Luo KT, 2006, GENE, V367, P89, DOI 10.1016/j.gene.2005.09.023; Ma X, 2007, LIFE SCI, V81, P1141, DOI 10.1016/j.lfs.2007.08.006; MORIKAWA K, 1988, CANCER RES, V48, P1943; Ni HH, 2005, ONCOGENE, V24, P6820, DOI 10.1038/sj.onc.1208848; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sebzda T, 2005, J EXP THER ONCOL, V5, P145; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Spensberger D, 2008, BIOCHEMISTRY-US, V47, P6418, DOI 10.1021/bi800267f; Sum EYM, 2005, P NATL ACAD SCI USA, V102, P7659, DOI 10.1073/pnas.0502990102; Takaoka AS, 1998, J BIOL CHEM, V273, P33848, DOI 10.1074/jbc.273.50.33848; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu XM, 2004, ONCOGENE, V23, P8464, DOI 10.1038/sj.onc.1207907; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2008, CANCER RES, V68, P4321, DOI 10.1158/0008-5472.CAN-08-0407; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	59	39	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35295	35304		10.1074/jbc.M806965200	http://dx.doi.org/10.1074/jbc.M806965200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940803	Green Published, hybrid			2022-12-27	WOS:000261469100085
J	Geraldes, P; Yagi, K; Ohshiro, Y; He, ZH; Maeno, Y; Yamamoto-Hiraoka, J; Rask-Madsen, C; Chung, SW; Perrella, MA; King, GL				Geraldes, Pedro; Yagi, Kunimasa; Ohshiro, Yuzuru; He, Zhiheng; Maeno, Yasuhiro; Yamamoto-Hiraoka, Junko; Rask-Madsen, Christian; Chung, Su Wol; Perrella, Mark A.; King, George L.			Selective Regulation of Heme Oxygenase-1 Expression and Function by Insulin through IRS1/Phosphoinositide 3-Kinase/Akt-2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NRF2 TRANSCRIPTION FACTOR; PROTEIN-KINASE-C; OXIDATIVE STRESS; EPITHELIAL-CELLS; NITRIC-OXIDE; GENE; ANTIOXIDANT; ACTIVATION; RESISTANCE; APOPTOSIS	Heme oxygenase 1 (HO-1) is a representative mediator of antioxidants and cytoprotectants against various stress stimuli including oxidants in vascular cells. Intensive insulin treatment can delay the onset and progression of diabetic retinopathy and other vascularopathies, yet little is known about insulin regulation of anti-apoptotic and antioxidant molecules such as HO-1 in vascular cells. Intravitreous injection or in vitro addition of insulin increased HO-1 protein expression in rat retina and in cultured bovine retinal pericytes, retinal endothelial cells, and retinal pigment epithelial cells. In bovine retinal pericytes, insulin induced mRNA and protein expression of HO-1 in a time- and concentration-dependent manner. Using HO-1 promoter analysis, the luciferase reporter assay showed that induction of HO-1 expression by insulin is mediated by additional response elements in the ho-1 promoter gene, which was not responsive to antioxidants. Insulin-induced HO-1 mRNA expression through activation of PI3-kinase/Akt pathway without affecting ERK and p38 MAPK. Overexpression of an adenoviral vector of native IRS1, IRS2, and Akt dominant negative or small interfering RNA transfection of Akt1 and Akt2 targeted gene demonstrated that insulin regulated HO-1 expression via IRS1 and Akt2 pathway, selectively. Further, insulin treatment prevented H2O2-induced NF-kappa B and caspase-8 activation and apoptosis via the IRS1/PI3K/Akt2/HO-1 pathway in the pericytes. In conclusion, we suggest that the anti-apoptotic properties of insulin are mediated partly by increasing HO-1 expression at transcriptional level via IRS1/PI3K/Akt2 activation, a potential explanation for how insulin is retarding the progression of microvascular complications induced by diabetes.	[Geraldes, Pedro; Yagi, Kunimasa; Ohshiro, Yuzuru; He, Zhiheng; Maeno, Yasuhiro; Yamamoto-Hiraoka, Junko; Rask-Madsen, Christian; King, George L.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Chung, Su Wol] Univ Ulsan, Coll Nat Sci, Sch Biol Sci & Technol, Ulsan 630749, South Korea; [Chung, Su Wol; Perrella, Mark A.] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02215 USA; [King, George L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; University of Ulsan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	King, GL (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	George.King@joslin.harvard.edu	Ohshiro, Yuzuru/HHS-7520-2022; Yagi, Kunimasa/AAA-8666-2021	Ohshiro, Yuzuru/0000-0002-9345-3759; Yagi, Kunimasa/0000-0002-6805-6428; Rask-Madsen, Christian/0000-0002-8548-466X	National Institutes of Health [5 R01 DK053105-09A1, NEI 5 R01 EY016150-02, P30 DK36836, R01HL60788]; American Diabetes Association Research [1-08-RA-93]; NATIONAL EYE INSTITUTE [R01EY016150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK053105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research(American Diabetes Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 R01 DK053105-09A1 and NEI 5 R01 EY016150-02 (to G. L. K.), Grant P30 DK36836, and Grant R01HL60788 (to M. A. P.). This work was also supported by American Diabetes Association Research Grant 1-08-RA-93. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Aikawa R, 2002, CYTOKINE, V18, P179, DOI 10.1006/cyto.2001.1007; Alam J, 2000, J BIOL CHEM, V275, P27694; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; AUTHOR AB, 1993, NEW ENGL J MED, V329, P977; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bronson SK, 2003, J CLIN INVEST, V111, P1817, DOI 10.1172/JCI200318927; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Camhi SL, 1998, AM J RESP CELL MOL, V18, P226, DOI 10.1165/ajrcmb.18.2.2910; Chung SW, 2005, J BIOL CHEM, V280, P4578, DOI 10.1074/jbc.M409125200; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; Cukiernik M, 2003, CURR EYE RES, V27, P301, DOI 10.1076/ceyr.27.5.301.17227; Duckworth W C, 2001, Curr Atheroscler Rep, V3, P383, DOI 10.1007/s11883-001-0076-x; Egan BM, 2001, AM J HYPERTENS, V14, p116S, DOI 10.1016/S0895-7061(01)02078-7; Farhangkhoee H, 2003, J MOL CELL CARDIOL, V35, P1439, DOI 10.1016/j.yjmcc.2003.09.007; Gerstein HC, 1996, DIABETES CARE, V19, P1225, DOI 10.2337/diacare.19.11.1225; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Gong PF, 2004, ARCH BIOCHEM BIOPHYS, V432, P252, DOI 10.1016/j.abb.2004.09.024; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hara E, 1999, BIOCHEM PHARMACOL, V58, P227, DOI 10.1016/S0006-2952(99)00097-0; Harrison EM, 2006, FEBS J, V273, P2345, DOI 10.1111/j.1742-4658.2006.05224.x; Hayashi K, 2001, DIABETES RES CLIN PR, V52, P85, DOI 10.1016/S0168-8227(01)00218-2; Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim J, 2002, BIOCHEM BIOPH RES CO, V292, P1010, DOI 10.1006/bbrc.2002.6751; KING GL, 1987, DIABETES, V36, P1460, DOI 10.2337/diabetes.36.12.1460; KING GL, 1985, J CLIN INVEST, V75, P1028, DOI 10.1172/JCI111764; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Kobayashi T, 2007, INVEST OPHTH VIS SCI, V48, P2350, DOI 10.1167/iovs.06-1357; Kowluru RA, 2001, ACTA DIABETOL, V38, P179, DOI 10.1007/s592-001-8076-6; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; KUTTY RK, 1994, J CELL PHYSIOL, V159, P371; KUWABARA T, 1963, ARCH OPHTHALMOL-CHIC, V69, P492, DOI 10.1001/archopht.1963.00960040498013; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Masuya Y, 1998, J BIOCHEM-TOKYO, V124, P628; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MOTTERLINI R, 1993, J APPL PHYSIOL, V75, P2224, DOI 10.1152/jappl.1993.75.5.2224; Mustata GT, 2005, DIABETES, V54, P517, DOI 10.2337/diabetes.54.2.517; Pugazhenthi S, 2007, AM J PHYSIOL-ENDOC M, V293, pE645, DOI 10.1152/ajpendo.00111.2007; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sekine O, 2002, J BIOL CHEM, V277, P36631, DOI 10.1074/jbc.M206266200; SELBY JV, 1990, JAMA-J AM MED ASSOC, V263, P1954, DOI 10.1001/jama.263.14.1954; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Shannon H, 2000, NEW ENGL J MED, V342, P381; SHIBAHARA S, 1988, SEMIN HEMATOL, V25, P370; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Wagner M, 2003, KIDNEY INT, V63, P1564, DOI 10.1046/j.1523-1755.2003.00897.x; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87	54	49	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34327	34336		10.1074/jbc.M807036200	http://dx.doi.org/10.1074/jbc.M807036200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854316	hybrid, Green Published			2022-12-27	WOS:000261277700060
J	Li, JX; Niu, XL; Madamanchi, NR				Li, Juxiang; Niu, Xi-Lin; Madamanchi, Nageswara R.			Leukocyte Antigen-related Protein Tyrosine Phosphatase Negatively Regulates Hydrogen Peroxide-induced Vascular Smooth Muscle Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; OXIDATIVE-STRESS; INSULIN-RECEPTOR; REVERSIBLE INACTIVATION; SIGNAL-TRANSDUCTION; CASPASE ACTIVATION; NEURITE OUTGROWTH; REDOX REGULATION; DOWN-REGULATION; JNK ACTIVATION	Reactive oxygen species (ROS) have been implicated in vascular smooth muscle cell (VSMC) apoptosis, a hallmark of advanced atherosclerotic lesions. Transient oxidation and inactivation of protein-tyrosine phosphatases play a critical role in cellular response to ROS production. However, the function of leukocyte antigen-related (LAR) protein-tyrosine phosphatase in ROS signaling is not known. To determine the expression of LAR in ROS-induced apoptosis, we investigated hydrogen peroxide-induced cell death and signaling in aortic VSMCs from wild-type and LAR(-/-) mice. Histone- associated DNA fragmentation and caspase-3/7 activity were significantly enhanced, mitochondrial membrane integrity was compromised, and cell viability was significantly decreased following H2O2 treatment in LAR(-/-) VSMCs compared with wild-type cells. Stronger and sustained increase in autophosphorylation and activity of Fyn, an Src family tyrosine kinase, was observed in LAR(-/-) cells compared with wild-type cells following H2O2 treatment. LAR binds to activated Fyn in H2O2-treated VSMCs, and recombinant LAR dephosphorylates phosphorylated-Fyn in vitro. In addition, LAR deficiency enhanced H2O2-induced phosphorylation of Janus kinase 2 (JAK2), signal transducer and activator of transcription 3 (STAT3), and p38 mitogen-activated protein kinase (MAPK). PP2, a Fyn-specific inhibitor, blocked JAK2, STAT3, and p38 MAPK activation and significantly attenuated apoptosis induced by H2O2. AG490, a JAK2-specific inhibitor, significantly attenuated H2O2-induced apoptosis, and blocked H2O2-induced activation of STAT3, but not p38 MAPK in both wild-type and LAR(-/-) VSMCs. Attenuation of Fyn expression by short hairpin RNA significantly decreased H2O2-induced downstream signaling and apoptosis in VSMCs. Together, these data indicate that LAR regulates Fyn/JAK2/STAT3 and Fyn/p38 MAPK pathways involved in ROS-induced apoptosis.	[Li, Juxiang; Niu, Xi-Lin; Madamanchi, Nageswara R.] Univ N Carolina, Dept Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Madamanchi, NR (corresponding author), Univ N Carolina, Dept Med, Carolina Cardiovasc Biol Ctr, 7312B Med Biomol Res Bldg, Chapel Hill, NC 27599 USA.	nrmadama@med.unc.edu		Madamanchi, Nageswara/0000-0003-0590-0908	National Institutes of Health [HL-5735]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant HL-5735. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003; Abe JI, 2000, J BIOL CHEM, V275, P1739, DOI 10.1074/jbc.275.3.1739; Ahmad F, 1997, J BIOL CHEM, V272, P448; Ahmed-Choudhury J, 2006, CELL SIGNAL, V18, P456, DOI 10.1016/j.cellsig.2005.05.015; Amiri F, 1999, J BIOL CHEM, V274, P32382, DOI 10.1074/jbc.274.45.32382; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bauriedel G, 1999, CARDIOVASC RES, V41, P480, DOI 10.1016/S0008-6363(98)00318-6; Channon KM, 1996, CARDIOVASC RES, V32, P962; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Diep QN, 2000, HYPERTENSION, V36, P851, DOI 10.1161/01.HYP.36.5.851; GENG YJ, 1995, AM J PATHOL, V147, P251; Grethe S, 2004, EXP CELL RES, V298, P632, DOI 10.1016/j.yexcr.2004.05.007; Groen A, 2005, J BIOL CHEM, V280, P10298, DOI 10.1074/jbc.M412424200; Guo ZM, 2002, MECH AGEING DEV, V123, P1121, DOI 10.1016/S0047-6374(02)00008-8; HAN DKM, 1995, AM J PATHOL, V147, P267; Hao Q, 2006, FREE RADICAL BIO MED, V41, P302, DOI 10.1016/j.freeradbiomed.2006.04.011; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kappert K, 2006, ARTERIOSCL THROM VAS, V26, P2644, DOI 10.1161/01.ATV.0000246777.30819.85; KULAS DT, 1995, J BIOL CHEM, V270, P2435, DOI 10.1074/jbc.270.6.2435; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lee CK, 2006, PROTEOMICS, V6, P6455, DOI 10.1002/pmic.200600124; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; LONGO FM, 1993, J BIOL CHEM, V268, P26503; Lu Y, 2006, J BIOL CHEM, V281, P36683, DOI 10.1074/jbc.M607374200; Madamanchi NR, 2001, J BIOL CHEM, V276, P18915, DOI 10.1074/jbc.M008802200; Mascareno E, 2001, CIRCULATION, V104, P325, DOI 10.1161/01.CIR.104.3.325; Mayer BJ, 1997, CURR BIOL, V7, pR295, DOI 10.1016/S0960-9822(06)00141-2; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Moon SK, 2001, AM J PHYSIOL-HEART C, V280, pH2779, DOI 10.1152/ajpheart.2001.280.6.H2779; Mori-Abe A, 2003, J ENDOCRINOL, V178, P417, DOI 10.1677/joe.0.1780417; Niu XL, 2007, J BIOL CHEM, V282, P19808, DOI 10.1074/jbc.M610452200; Pollman MJ, 1999, CIRC RES, V84, P113; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Ren JM, 1998, DIABETES, V47, P493, DOI 10.2337/diabetes.47.3.493; Ricci JE, 2001, FASEB J, V15, P1777, DOI 10.1096/fj.00-0665fje; Rosini P, 2004, J BIOL CHEM, V279, P14016, DOI 10.1074/jbc.M305356200; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Sandberg EM, 2004, J BIOL CHEM, V279, P34547, DOI 10.1074/jbc.M405045200; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Schaapveld RQJ, 1997, DEV BIOL, V188, P134, DOI 10.1006/dbio.1997.8630; Sgorbissa A, 1999, J CELL SCI, V112, P4475; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; SMITH C, 1992, BIOCHEM J, V286, P901, DOI 10.1042/bj2860901; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tang H, 2005, J BIOL CHEM, V280, P23918, DOI 10.1074/jbc.M503498200; Tisi MA, 2000, J NEUROBIOL, V42, P477, DOI 10.1002/(SICI)1097-4695(200003)42:4<477::AID-NEU8>3.0.CO;2-B; Tsujikawa K, 2002, MOL CANCER RES, V1, P155; Tsujikawa K, 2001, MOL ENDOCRINOL, V15, P271, DOI 10.1210/me.15.2.271; Uddin S, 1997, BIOCHEM BIOPH RES CO, V235, P83, DOI 10.1006/bbrc.1997.6741; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; von der Thusen JH, 2002, CIRCULATION, V105, P2064, DOI 10.1161/01.CIR.0000015502.97828.93; Weng LP, 1998, CURR BIOL, V8, P247, DOI 10.1016/S0960-9822(98)70106-X; Weng LP, 1999, GENES CELLS, V4, P185, DOI 10.1046/j.1365-2443.1999.00251.x; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang T, 2003, J NEUROSCI, V23, P3353; Yeo TT, 1997, J NEUROSCI RES, V47, P348, DOI 10.1002/(SICI)1097-4547(19970201)47:3<348::AID-JNR13>3.0.CO;2-Y; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; YU Q, 1992, ONCOGENE, V7, P1051	71	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34260	34272		10.1074/jbc.M806087200	http://dx.doi.org/10.1074/jbc.M806087200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854310	Green Published, hybrid			2022-12-27	WOS:000261277700054
J	Muller, M; Essin, K; Hill, K; Beschmann, H; Rubant, S; Schempp, CM; Gollasch, M; Boehncke, WH; Harteneck, C; Muller, WE; Leuner, K				Mueller, Margarethe; Essin, Kirill; Hill, Kerstin; Beschmann, Heike; Rubant, Simone; Schempp, Christoph M.; Gollasch, Maik; Boehncke, W. Henning; Harteneck, Christian; Mueller, Walter E.; Leuner, Kristina			Specific TRPC6 Channel Activation, a Novel Approach to Stimulate Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ST-JOHNS-WORT; CALCIUM-INDUCED DIFFERENTIATION; HUMAN GINGIVAL KERATINOCYTES; ATOPIC-DERMATITIS; EPIDERMAL DIFFERENTIATION; ULTRASTRUCTURAL-LOCALIZATION; SENSING RECEPTOR; HYPERFORIN; PSORIASIS; BARRIER	The protective epithelial barrier in our skin undergoes constant regulation, whereby the balance between differentiation and proliferation of keratinocytes plays a major role. Impaired keratinocyte differentiation and proliferation are key elements in the pathophysiology of several important dermatological diseases, including atopic dermatitis and psoriasis. Ca2+ influx plays an essential role in this process presumably mediated by different transient receptor potential (TRP) channels. However, investigating their individual role was hampered by the lack of specific stimulators or inhibitors. Because we have recently identified hyperforin as a specific TRPC6 activator, we investigated the contribution of TRPC6 to keratinocyte differentiation and proliferation. Like the endogenous differentiation stimulus high extracellular Ca2+ concentration ([Ca2+](o)), hyperforin triggers differentiation in HaCaT cells and in primary cultures of human keratinocytes by inducing Ca2+ influx via TRPC6 channels and additional inhibition of proliferation. Knocking down TRPC6 channels prevents the induction of Ca2+- and hyperforin-induced differentiation. Importantly, TRPC6 activation is sufficient to induce keratinocyte differentiation similar to the physiological stimulus [Ca2+](o). Therefore, TRPC6 activation by hyperforin may represent a new innovative therapeutic strategy in skin disorders characterized by altered keratinocyte differentiation.	[Mueller, Margarethe; Mueller, Walter E.; Leuner, Kristina] Univ Frankfurt, Bioctr Niederursel, Inst Pharmacol, D-60439 Frankfurt, Germany; [Essin, Kirill; Gollasch, Maik] Charite Univ Med Berlin, Sect Nephrol Intens Care, D-13353 Berlin, Germany; [Essin, Kirill; Gollasch, Maik] Max Delbruck Ctr Berlin Buch, Franz Volhard Clin, D-13353 Berlin, Germany; [Hill, Kerstin; Harteneck, Christian] Charite Univ Med Berlin, D-14195 Berlin, Germany; [Beschmann, Heike; Rubant, Simone; Boehncke, W. Henning] Univ Frankfurt, Dept Dermatol, D-60590 Frankfurt, Germany; [Schempp, Christoph M.] Univ Med Ctr Freiburg, Dept Dermatol, D-79104 Freiburg, Germany	Goethe University Frankfurt; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Franz-Volhard Clinical Research Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; University of Freiburg	Leuner, K (corresponding author), Univ Frankfurt, Bioctr Niederursel, Inst Pharmacol, Max Von Laue Str 9, D-60439 Frankfurt, Germany.	Leuner@em.uni-frankfurt.de	Friedland, Kristina/G-4651-2015	Friedland, Kristina/0000-0001-8603-5957; Muller, Werner E.G./0000-0002-8223-3689	Casella Med GmbH & Co. KG(Cologne, Germany); German Research Foundation	Casella Med GmbH & Co. KG(Cologne, Germany); German Research Foundation(German Research Foundation (DFG))	This work was supported by a research grant from Casella Med GmbH & Co. KG(Cologne, Germany) and the German Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck B, 2008, CELL CALCIUM, V43, P492, DOI 10.1016/j.ceca.2007.08.005; Beck B, 2006, J INVEST DERMATOL, V126, P1982, DOI 10.1038/sj.jid.5700352; Bikle DD, 1996, J CLIN INVEST, V97, P1085, DOI 10.1172/JCI118501; Bovenschen HJ, 2005, BRIT J DERMATOL, V153, P72, DOI 10.1111/j.1365-2133.2005.06538.x; Cai SW, 2006, PFLUG ARCH EUR J PHY, V452, P43, DOI 10.1007/s00424-005-0001-1; Cai SW, 2005, J DERMATOL SCI, V40, P21, DOI 10.1016/j.jdermsci.2005.06.005; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; Fatherazi S, 2007, PFLUG ARCH EUR J PHY, V453, P879, DOI 10.1007/s00424-006-0156-4; Forslind B, 1987, Acta Derm Venereol Suppl (Stockh), V134, P1; GERDES J, 1984, J IMMUNOL, V133, P1710; GUREVICH AI, 1971, ANTIBIOT MED BIOTEK, V16, P510; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hwang SM, 2001, INT J DERMATOL, V40, P223, DOI 10.1046/j.1365-4362.2001.01158.x; Jensen JM, 2004, J INVEST DERMATOL, V122, P1423, DOI 10.1111/j.0022-202X.2004.22621.x; Lehen'kyi V, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611398200; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MAISENBACHER P, 1992, PLANTA MED, V58, P351, DOI 10.1055/s-2006-961483; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Muller WE, 2003, PHARMACOL RES, V47, P101, DOI 10.1016/S1043-6618(02)00266-9; Pallon J, 1996, CELL MOL BIOL, V42, P111; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Proksch E, 2006, J DERMATOL SCI, V43, P159, DOI 10.1016/j.jdermsci.2006.06.003; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; Schempp CA, 2003, PHYTOMEDICINE, V10, P31, DOI 10.1078/1433-187X-00306; Schempp CM, 2005, PLANTA MED, V71, P999, DOI 10.1055/s-2005-871303; Schempp CM, 1999, LANCET, V353, P2129, DOI 10.1016/S0140-6736(99)00214-7; Schempp CM, 2000, BRIT J DERMATOL, V142, P979, DOI 10.1046/j.1365-2133.2000.03482.x; SHARPE GR, 1989, FEBS LETT, V254, P25, DOI 10.1016/0014-5793(89)81002-6; Treiber K, 2005, BRIT J PHARMACOL, V145, P75, DOI 10.1038/sj.bjp.0706155; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	39	82	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33942	33954		10.1074/jbc.M801844200	http://dx.doi.org/10.1074/jbc.M801844200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818211	hybrid, Green Published			2022-12-27	WOS:000261277700021
J	Rigoni, M; Paoli, M; Milanesi, E; Caccin, P; Rasola, A; Bernardi, P; Montecucco, C				Rigoni, Michela; Paoli, Marco; Milanesi, Eva; Caccin, Paola; Rasola, Andrea; Bernardi, Paolo; Montecucco, Cesare			Snake Phospholipase A(2) Neurotoxins Enter Neurons, Bind Specifically to Mitochondria, and Open Their Transition Pores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BUNGAROTOXIN; PERMEABILITY TRANSITION; NEUROMUSCULAR-JUNCTION; PRESYNAPTIC NEUROTOXINS; SYNAPTIC VESICLES; CELL-DEATH; TAIPOXIN; VENOM; NERVE; INHIBITION	Snake presynaptic neurotoxins with phospholipase A(2) activity are potent inducers of paralysis through inhibition of the neuromuscular junction. These neurotoxins were recently shown to induce exocytosis of synaptic vesicles following the production of lysophospholipids and fatty acids and a sustained influx of Ca2+ from the medium. Here, we show that these toxins are able to penetrate spinal cord motor neurons and cerebellar granule neurons and selectively bind to mitochondria. As a result of this interaction, mitochondria depolarize and undergo a profound shape change from elongated and spaghetti-like to round and swollen. We show that snake presynaptic phospholipase A(2) neurotoxins facilitate opening of the mitochondrial permeability transition pore, an inner membrane high-conductance channel. The relative potency of the snake neurotoxins was similar for the permeability transition pore opening and for the phospholipid hydrolysis activities, suggesting a causal relationship, which is also supported by the effect of phospholipid hydrolysis products, lysophospholipids and fatty acids, on mitochondrial pore opening. These findings contribute to define the cellular events that lead to intoxication of nerve terminals by these snake neurotoxins and suggest that mitochondrial impairment is an important determinant of their toxicity.	[Rigoni, Michela; Paoli, Marco; Caccin, Paola; Rasola, Andrea; Bernardi, Paolo; Montecucco, Cesare] Univ Padua, Dipartimento Sci Biomed Sperimentali, I-35121 Padua, Italy; [Rigoni, Michela; Paoli, Marco; Caccin, Paola; Rasola, Andrea; Bernardi, Paolo; Montecucco, Cesare] CNR, Ist Neurosci, I-35121 Padua, Italy; [Milanesi, Eva] Congenia Srl, I-20139 Milan, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Montecucco, C (corresponding author), Univ Padua, Dipartimento Sci Biomed Sperimentali, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	cesare.montecucco@unipd.it	Paoli, Marco/HDO-6474-2022; Bernardi, Paolo/C-3656-2008	Bernardi, Paolo/0000-0001-9187-3736; Paoli, Marco/0000-0001-5672-1403; Rasola, Andrea/0000-0003-4522-3008	Telethon [GGP06133, GGP04113]; Fondazione Cariparo Progetto "Physiopathology of the Synapse: Neurotransmitters, Neurotoxins and Novel Therapies; Ministero dell' Universita e della Ricerca	Telethon(Fondazione Telethon); Fondazione Cariparo Progetto "Physiopathology of the Synapse: Neurotransmitters, Neurotoxins and Novel Therapies(Fondazione Cariparo); Ministero dell' Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by Telethon Grants GGP06133 and GGP04113, the Fondazione Cariparo Progetto "Physiopathology of the Synapse: Neurotransmitters, Neurotoxins and Novel Therapies" (to C. M.), and by the Ministero dell' Universita e della Ricerca (to P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Bonanomi D, 2005, MOL PHARMACOL, V67, P1901, DOI 10.1124/mol.104.005678; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; CHEN I, 1970, VIRCHOWS ARCH B, V6, P318; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Connolly S, 1995, ANN NEUROL, V38, P916, DOI 10.1002/ana.410380612; CULLCANDY SG, 1976, NEUROSCIENCE, V1, P175, DOI 10.1016/0306-4522(76)90074-9; Dixon RW, 1999, AM J PATHOL, V154, P447, DOI 10.1016/S0002-9440(10)65291-1; DODDS D, 1995, J NEUROCHEM, V64, P2339; FOHLMAN J, 1979, EUR J BIOCHEM, V94, P531, DOI 10.1111/j.1432-1033.1979.tb12922.x; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; GOPALAKRISHNAKONE P, 1984, TOXICON, V22, P791, DOI 10.1016/0041-0101(84)90162-4; HALPERT J, 1976, FEBS LETT, V61, P72, DOI 10.1016/0014-5793(76)80174-3; Herkert M, 2001, EUR J NEUROSCI, V14, P821, DOI 10.1046/j.0953-816x.2001.01699.x; LEE CY, 1984, ARCH INT PHARMACOD T, V268, P313; LEVI G, 1984, BRAIN RES, V290, P77, DOI 10.1016/0006-8993(84)90737-6; Means G.E., 1971, CHEM MODIFICATION PR, P214; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Neco P, 2003, J NEUROCHEM, V85, P329, DOI 10.1046/j.1471-4159.2003.01682.x; NG RH, 1980, P NATL ACAD SCI-BIOL, V77, P1346, DOI 10.1073/pnas.77.3.1346; PAPINI E, 1989, J BIOL CHEM, V264, P12385; Petrovic U, 2004, BIOCHEM BIOPH RES CO, V324, P981, DOI 10.1016/j.bbrc.2004.09.144; Prasarnpun S, 2005, BRAIN, V128, P2987, DOI 10.1093/brain/awh642; Prasarnpun S, 2004, NEUROPHARMACOLOGY, V47, P304, DOI 10.1016/j.neuropharm.2004.04.012; Praznikar ZJ, 2008, BBA-MOL CELL RES, V1783, P1129, DOI 10.1016/j.bbamcr.2008.01.011; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Rigoni M, 2004, J CELL SCI, V117, P3561, DOI 10.1242/jcs.01218; Rigoni M, 2007, J BIOL CHEM, V282, P11238, DOI 10.1074/jbc.M610176200; Rossetto Ornella, 2008, V184, P129; Rossetto O, 2006, J NEUROCHEM, V97, P1534, DOI 10.1111/j.1471-4159.2006.03965.x; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; SIMPSON LL, 1994, J PHARMACOL EXP THER, V269, P256; Sribar J, 2003, FEBS LETT, V553, P309, DOI 10.1016/S0014-5793(03)01035-4; Sribar J, 2003, BIOCHEM BIOPH RES CO, V302, P691, DOI 10.1016/S0006-291X(03)00228-6; Sribar J, 2001, J BIOL CHEM, V276, P12493, DOI 10.1074/jbc.C100048200; WAGNER GM, 1974, BIOCHEM BIOPH RES CO, V58, P475, DOI 10.1016/0006-291X(74)90389-1; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	42	74	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34013	34020		10.1074/jbc.M803243200	http://dx.doi.org/10.1074/jbc.M803243200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18809685	Green Published, hybrid			2022-12-27	WOS:000261277700028
J	Stoddart, CA; Nault, G; Galkina, SA; Thibaudeau, K; Bakis, P; Bousquet-Gagnon, N; Robitaille, M; Bellomo, M; Paradis, V; Liscourt, P; Lobach, A; Rivard, ME; Ptak, RG; Mankowski, MK; Bridon, D; Quraishi, O				Stoddart, Cheryl A.; Nault, Genevieve; Galkina, Sofiya A.; Thibaudeau, Karen; Bakis, Peter; Bousquet-Gagnon, Nathalie; Robitaille, Martin; Bellomo, Maryanne; Paradis, Veronique; Liscourt, Patricia; Lobach, Alexandra; Rivard, Marie-Eve; Ptak, Roger G.; Mankowski, Marie K.; Bridon, Dominique; Quraishi, Omar			Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor EQUIPOTENT TO C34 AND T-20 IN VITRO WITH SUSTAINED ACTIVITY IN SCID-HU THY/LIV MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INJECTION SITE REACTIONS; HUMAN SERUM ALBUMINS; ENVELOPE GLYCOPROTEIN; ENFUVIRTIDE T-20; COILED-COIL; HTLV-III; GP41; POTENT; ENTRY	Entry inhibitors of human immunodeficiency virus, type 1 (HIV-1) have been the focus of much recent research. C34, a potent fusion inhibitor derived from the HR2 region of gp41, was engineered into a 1:1 human serum albumin conjugate through stable covalent attachment of a maleimido-C34 analog onto cysteine 34 of albumin. This bioconjugate, PC-1505, was designed to require less frequent dosing and less peptide than T-20 and was assessed for its antifusogenic activity both in vitro and in vivo in the SCID-hu Thy/Liv mouse model. PC-1505 was essentially equipotent to the original C34 peptide and to T-20 in vitro. In HIV-1-infected SCID-hu Thy/Liv mice, T-20 lost activity with infrequent dosing, whereas the antiviral potency of PC-1505 was sustained, and PC-1505 was active against T-20-resistant ("DIV") virus with a G36D substitution in gp41. The in vivo results are the direct result of a significantly improved pharmacokinetic profile for the C34 peptide following albumin conjugation. Contrary to previous reports that the gp41 NHR trimer is poorly accessible to C34 fused to protein cargoes of increasing size (Hamburger, A. E., Kim, S., Welch, B. D., and Kay, M. S. (2005) J. Biol. Chem. 280, 12567-12572), these results are the first demonstration of the capacity for a large, endogenous serum protein to gain unobstructed access to the transient gp41 intermediates that exist during the HIV fusion process, and it supports further development of albumin conjugation as a promising approach to inhibit HIV-1 entry.	[Stoddart, Cheryl A.; Galkina, Sofiya A.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Expt Med, Dept Med, San Francisco, CA 94110 USA; [Nault, Genevieve; Thibaudeau, Karen; Bakis, Peter; Bousquet-Gagnon, Nathalie; Robitaille, Martin; Bellomo, Maryanne; Paradis, Veronique; Liscourt, Patricia; Lobach, Alexandra; Rivard, Marie-Eve; Bridon, Dominique; Quraishi, Omar] Conjuchem Biotechnol Inc, Montreal, PQ H2X 3Y8, Canada; [Ptak, Roger G.; Mankowski, Marie K.] So Res Inst, Infect Dis Res Dept, Frederick, MD 21701 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Stoddart, CA (corresponding author), Box 1234, San Francisco, CA 94143 USA.	cheryl.stoddart@.ucsf.edu; quraishi@conjuchem.com			National Institutes of Health [N01-AI-05418, N01-AI-70002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Contracts N01-AI-05418 and N01-AI-70002. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ball RA, 2003, J AM ACAD DERMATOL, V49, P826, DOI 10.1016/S0190-9622(03)02099-1; BENTHANSEN L, 1991, ACTA PHYSIOL SCAND, V143, P5; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gilden D, 1998, GMHC Treat Issues, V12, P6; Golding H, 2002, J VIROL, V76, P6780, DOI 10.1128/JVI.76.13.6780-6790.2002; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Groenink M, 1997, AIDS RES HUM RETROV, V13, P179, DOI 10.1089/aid.1997.13.179; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; Holmes DL, 2000, BIOCONJUGATE CHEM, V11, P439, DOI 10.1021/bc0000233; Jacobs A, 2007, J BIOL CHEM, V282, P32406, DOI 10.1074/jbc.M705577200; JANSEN RW, 1993, MOL PHARMACOL, V44, P1003; Jette L, 2005, ENDOCRINOLOGY, V146, P3052, DOI 10.1210/en.2004-1286; Kliger Y, 2000, J MOL BIOL, V295, P163, DOI 10.1006/jmbi.1999.3368; Kliger Y, 2001, J BIOL CHEM, V276, P1391, DOI 10.1074/jbc.M004113200; Leger R, 2004, BIOORG MED CHEM LETT, V14, P4395, DOI 10.1016/j.bmcl.2004.06.066; Leger R, 2004, BIOORG MED CHEM LETT, V14, P841, DOI 10.1016/j.bmcl.2003.12.025; Leger R, 2003, BIOORG MED CHEM LETT, V13, P3571, DOI 10.1016/S0960-894X(03)00790-X; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Maggi P, 2004, J ANTIMICROB CHEMOTH, V53, P678, DOI 10.1093/jac/dkh141; Manfredi R, 2006, CURR MED CHEM, V13, P2369, DOI 10.2174/092986706777935069; Meanwell NA, 2003, CURR OPIN DRUG DISC, V6, P451; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Olson W. C., 2003, Current Drug Targets - Infectious Disorders, V3, P283, DOI 10.2174/1568005033481015; Opalka D, 2004, J IMMUNOL METHODS, V287, P49, DOI 10.1016/j.jim.2004.01.016; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Petersen S, 1996, J CONSTR PSYCHOL, V9, P75; POPOVIC M, 1984, LANCET, V2, P1472; Porter CJH, 2000, J PHARM SCI-US, V89, P297, DOI 10.1002/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; Rabin L, 1996, ANTIMICROB AGENTS CH, V40, P755, DOI 10.1128/AAC.40.3.755; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Roman F, 2003, JAIDS-J ACQ IMM DEF, V33, P134, DOI 10.1097/00126334-200306010-00003; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Stoddart CA, 2000, ANTIMICROB AGENTS CH, V44, P783, DOI 10.1128/AAC.44.3.783-786.2000; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001251; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000655; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Swart PJ, 1996, J DRUG TARGET, V4, P109, DOI 10.3109/10611869609046269; TAKAMI M, 1992, BIOCHIM BIOPHYS ACTA, V1180, P180, DOI 10.1016/0925-4439(92)90066-V; Thibaudeau K, 2005, BIOCONJUGATE CHEM, V16, P1000, DOI 10.1021/bc050102k; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weiss Carol D, 2003, AIDS Rev, V5, P214	47	60	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34045	34052		10.1074/jbc.M805536200	http://dx.doi.org/10.1074/jbc.M805536200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18809675	hybrid, Green Published			2022-12-27	WOS:000261277700032
J	van den Bogaart, G; Guzman, JV; Mika, JT; Poolman, B				van den Bogaart, Geert; Guzman, Jeanette Velasquez; Mika, Jacek T.; Poolman, Bert			On the Mechanism of Pore Formation by Melittin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE-BURST ANALYSIS; ANTIMICROBIAL PEPTIDES; PHOSPHOLIPID-BILAYERS; ELECTRON-MICROSCOPY; LIPID-BILAYERS; MEMBRANE PORES; BEE VENOM; VESICLES; BINDING; PROTEIN	The mechanism of pore formation of lytic peptides, such as melittin from bee venom, is thought to involve binding to the membrane surface, followed by insertion at threshold levels of bound peptide. We show that in membranes composed of zwitterionic lipids, i.e. phosphatidylcholine, melittin not only forms pores but also inhibits pore formation. We propose that these two modes of action are the result of two competing reactions: direct insertion into the membrane and binding parallel to the membrane surface. The direct insertion of melittin leads to pore formation, whereas the parallel conformation is inactive and prevents other melittin molecules from inserting, hence preventing pore formation.	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Poolman, B (corresponding author), Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	van den Bogaart, Geert/GLV-3283-2022; Poolman, Bert/D-1882-2012; van den Bogaart, Geert/A-1089-2014; Institute, Zernike/W-7033-2019	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; 	Dutch Science Foundation (NWO) [ALW-814.02.002]; Zernike Institute for Advanced Materials	Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO)); Zernike Institute for Advanced Materials	This work was supported by the Dutch Science Foundation (NWO, Grant ALW-814.02.002) and the Zernike Institute for Advanced Materials. The costs of publication of this article were defrayed in part by the payment of page charges.	ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; BENACHIR T, 1995, BBA-BIOMEMBRANES, V1235, P452, DOI 10.1016/0005-2736(95)80035-E; BESCHIASCHVILI G, 1991, BIOCHIM BIOPHYS ACTA, V1068, P195, DOI 10.1016/0005-2736(91)90210-Y; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BROWN LR, 1980, BIOCHIM BIOPHYS ACTA, V622, P231, DOI 10.1016/0005-2795(80)90034-3; DUFOURCQ J, 1977, BIOCHIM BIOPHYS ACTA, V467, P1, DOI 10.1016/0005-2736(77)90236-X; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j; GOTO Y, 1992, BIOCHEMISTRY-US, V31, P732, DOI 10.1021/bi00118a014; He K, 1996, BIOPHYS J, V71, P2669, DOI 10.1016/S0006-3495(96)79458-4; Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; HUANG HW, 1995, J PHYS II, V5, P1427, DOI 10.1051/jp2:1995103; Kleinschmidt JH, 1997, BIOPHYS J, V72, P767, DOI 10.1016/S0006-3495(97)78711-3; Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760; KUBOTA S, 1986, BIOPOLYMERS, V25, P1493, DOI 10.1002/bip.360250808; Ladokhin AS, 1997, BIOPHYS J, V72, P1762, DOI 10.1016/S0006-3495(97)78822-2; Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Lee TH, 2001, J PEPT RES, V58, P464, DOI 10.1034/j.1399-3011.2001.10974.x; Lin JJ, 2007, ANAL BIOCHEM, V367, P49, DOI 10.1016/j.ab.2007.04.039; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Park SC, 2006, BIOCHEM BIOPH RES CO, V343, P222, DOI 10.1016/j.bbrc.2006.02.090; Popplewell JF, 2007, BBA-BIOMEMBRANES, V1768, P13, DOI 10.1016/j.bbamem.2006.05.016; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Schumann M, 1997, BIOCHEMISTRY-US, V36, P4345, DOI 10.1021/bi962304x; SCHWARZ G, 1989, BIOCHIM BIOPHYS ACTA, V979, P82, DOI 10.1016/0005-2736(89)90526-9; Son DJ, 2007, PHARMACOL THERAPEUT, V115, P246, DOI 10.1016/j.pharmthera.2007.04.004; STEINER H, 1988, BIOCHIM BIOPHYS ACTA, V939, P260, DOI 10.1016/0005-2736(88)90069-7; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; van den Bogaart G, 2007, BIOPHYS J, V93, P154, DOI 10.1529/biophysj.107.106005; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X	35	133	137	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33854	33857		10.1074/jbc.M805171200	http://dx.doi.org/10.1074/jbc.M805171200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819911	Green Published, hybrid			2022-12-27	WOS:000261277700009
J	Lund, IK; Jogi, A; Rono, B; Rasch, MG; Lund, LR; Almholt, K; Gardsvoll, H; Behrendt, N; Romer, J; Hoyer-Hansen, G				Lund, Ida K.; Joegi, Annika; Rono, Birgitte; Rasch, Morten G.; Lund, Leif R.; Almholt, Kasper; Gardsvoll, Henrik; Behrendt, Niels; Romer, John; Hoyer-Hansen, Gunilla			Antibody-mediated Targeting of the Urokinase-type Plasminogen Activator Proteolytic Function Neutralizes Fibrinolysis in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-DEFICIENT MICE; MONOCLONAL-ANTIBODIES; BREAST-CANCER; TUMOR-GROWTH; BINDING REGION; U937 MONOCYTES; ANTHRAX TOXIN; RECEPTOR; METASTASIS; SYSTEM	Urokinase-type plasminogen activator (uPA) plays a central role in tissue remodeling processes. Most of our understanding of the role of uPA in vivo is derived from studies using gene-targeted uPA-deficient mice. To enable in vivo studies on the specific interference with uPA functionality in mouse models, we have now developed murine monoclonal antibodies (mAbs) directed against murine uPA by immunization of uPA-deficient mice with the recombinant protein. Guided by enzyme-linked immunosorbent assay, Western blotting, surface plasmon resonance, and enzyme kinetic analyses, we have selected two highly potent and inhibitory anti-uPA mAbs (mU1 and mU3). Both mAbs recognize epitopes located on the B-chain of uPA that encompasses the catalytic site. In enzyme activity assays in vitro, mU1 blocked uPA-catalyzed plasminogen activation as well as plasmin-mediated pro-uPA activation, whereas mU3 only was directed against the first of these reactions. We additionally provide evidence that mU1, but not mU3, successfully targets uPA-dependent processes in vivo. Hence, systemic administration of mU1 (i) rescued mice treated with a uPA-activable anthrax protoxin and (ii) impaired uPA-mediated hepatic fibrinolysis in tissue-type plasminogen activator (tPA)-deficient mice, resulting in a phenotype mimicking that of uPA; tPA double deficient mice. Importantly, this is the first report demonstrating specific antagonist-directed targeting of mouse uPA at the enzyme activity level in a normal physiological process in vivo.	[Lund, Ida K.; Joegi, Annika; Rono, Birgitte; Rasch, Morten G.; Lund, Leif R.; Almholt, Kasper; Gardsvoll, Henrik; Behrendt, Niels; Romer, John; Hoyer-Hansen, Gunilla] Rigshosp, Finsen Lab, Copenhagen BioCtr, DK-2200 Copenhagen N, Denmark	Rigshospitalet	Lund, IK (corresponding author), Rigshosp, Finsen Lab, Copenhagen BioCtr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	ikl@finsenlab.dk	Almholt, Kasper/D-6133-2013	Almholt, Kasper/0000-0002-9250-514X; Behrendt, Niels/0000-0003-1833-3922; Jogi, Annika/0000-0003-1697-8030	H:S Copenhagen Hospital Corpation; European Union [LSHC-CT-2003-503297, 201279]; MICROENVIMET; Danish Cancer Society; Danish Cancer Research Foundation; Dagmar Marshall's Foundation; Fru Astrid Thaysen's Legat for Laegevidenskabelig Grundforskning; Swedish Society for Medical Research	H:S Copenhagen Hospital Corpation; European Union(European Commission); MICROENVIMET; Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; Dagmar Marshall's Foundation; Fru Astrid Thaysen's Legat for Laegevidenskabelig Grundforskning; Swedish Society for Medical Research	This work was supported by the H:S Copenhagen Hospital Corpation, European Union Grants LSHC-CT-2003-503297 and Grant 201279, MICROENVIMET, the Danish Cancer Society, the Danish Cancer Research Foundation, Dagmar Marshall's Foundation, Fru Astrid Thaysen's Legat for Laegevidenskabelig Grundforskning, and the Swedish Society for Medical Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Almholt K, 2005, INT J CANCER, V113, P525, DOI 10.1002/ijc.20631; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Behrendt N, 2003, BIOCHEM J, V371, P277, DOI 10.1042/BJ20021508; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Carmeliet P, 1998, J CELL BIOL, V140, P233, DOI 10.1083/jcb.140.1.233; Collen D, 2005, THROMB HAEMOSTASIS, V93, P627, DOI 10.1160/TH04-11-0724; DANO K, 1980, BIOCHIM BIOPHYS ACTA, V613, P542, DOI 10.1016/0005-2744(80)90110-2; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DECLERCK PJ, 1995, J BIOL CHEM, V270, P8397, DOI 10.1074/jbc.270.15.8397; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; ELLIS V, 1991, J BIOL CHEM, V266, P12752; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Green KA, 2005, BIOESSAYS, V27, P894, DOI 10.1002/bies.20281; Groner B, 2004, CURR MOL MED, V4, P539, DOI 10.2174/1566524043360483; Guo YJ, 2002, CANCER RES, V62, P4678; Guo YJ, 2000, FASEB J, V14, P1400, DOI 10.1096/fj.14.10.1400; Harbeck N, 2004, THROMB HAEMOSTASIS, V91, P450, DOI 10.1160/TH03-12-0798; Jogi A, 2007, J THROMB HAEMOST, V5, P1936, DOI 10.1111/j.1538-7836.2007.02653.x; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Mishima K, 2000, P NATL ACAD SCI USA, V97, P8484, DOI 10.1073/pnas.150239497; Pass J, 2007, THROMB HAEMOSTASIS, V97, P1013, DOI 10.1160/TH06-11-0644; PETERSEN LC, 1988, J BIOL CHEM, V263, P11189; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Schmitt M, 1997, THROMB HAEMOSTASIS, V78, P285; Scott KA, 2003, MOL CANCER THER, V2, P445; Setyono-Han B, 2005, THROMB HAEMOSTASIS, V93, P779, DOI 10.1160/TH04-11-0712; Shanmukhappa K, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-40; Solberg H, 2003, DEVELOPMENT, V130, P4439, DOI 10.1242/dev.00642; STOPPELLI MP, 1985, P NATL ACAD SCI USA, V82, P4939, DOI 10.1073/pnas.82.15.4939	40	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32506	32515		10.1074/jbc.M801924200	http://dx.doi.org/10.1074/jbc.M801924200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18799467	hybrid			2022-12-27	WOS:000260893700039
J	Moreau, M; Lee, GI; Wang, Y; Crane, BR; Klessig, DF				Moreau, Magali; Lee, Gyu In; Wang, Yongzeng; Crane, Brian R.; Klessig, Daniel F.			AtNOS/AtNOA1 Is a Functional Arabidopsis thaliana cGTPase and Not a Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; PLANT NITRATE REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; RNA-BINDING; PROTEIN; NO; SUBUNIT; GTPASES	AtNOS1 was previously identified as a potential nitric-oxide synthase (NOS) in Arabidopsis thaliana, despite lack of sequence similarity to animal NOSs. Although the dwarf and yellowish leaf phenotype of Atnos1 knock-out mutant plants can be rescued by treatment with exogenous NO, doubts have recently been raised as to whether AtNOS1 is a true NOS. Moreover, depending on the type of physiological responses studied, Atnos1 is not always deficient in NO induction and/or detection, as previously reported. Here, we present experimental evidence showing that AtNOS1 is unable to bind and oxidize arginine to NO. These results support the argument that AtNOS1 is not a NOS. We also show that the renamed NO-associated protein 1 (AtNOA1) is a member of the circularly permuted GTPase family (cGTPase). AtNOA1 specifically binds GTP and hydrolyzes it. Complementation experiments of Atnoa1 mutant plants with different constructs of AtNOA1 show that GTP hydrolysis is necessary but not sufficient for the physiological function of AtNOA1. Mutant AtNOA1 lacking the C-terminal domain, although retaining GTPase activity, failed to complement Atnoa1, suggesting that this domain plays a crucial role in planta. cGTPases appear to be RNA-binding proteins, and the closest homolog of AtNOA1, the Bacillus subtilis YqeH, has been shown to participate in ribosome assembly and stability. We propose a similar function for AtNOA1 and discuss it in the light of its potential role in NO accumulation and plant development.	[Moreau, Magali; Lee, Gyu In; Wang, Yongzeng; Klessig, Daniel F.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Moreau, Magali; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Klessig, DF (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	dfk8@cornell.edu			National Institutes of Health [5R01GM067011]; National Science Foundation [CHE-0749996]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM067011 (to D. F. K.). This work was also supported by National Science Foundation Grant CHE-0749996 (to B. R. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Bassler J, 2006, J BIOL CHEM, V281, P24737, DOI 10.1074/jbc.M604261200; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bethke PC, 2006, J EXP BOT, V57, P517, DOI 10.1093/jxb/erj060; Bethke PC, 2004, PLANT CELL, V16, P332, DOI 10.1105/tpc.017822; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Campbell TL, 2008, J BACTERIOL, V190, P2537, DOI 10.1128/JB.01744-07; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; Cladiere L, 2006, MOL GENET GENOMICS, V275, P409, DOI 10.1007/s00438-006-0097-9; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Cueto M, 1996, FEBS LETT, V398, P159, DOI 10.1016/S0014-5793(96)01232-X; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Daigle DM, 2002, BIOCHEMISTRY-US, V41, P11109, DOI 10.1021/bi020355q; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; Flores-Perez U, 2008, PLANT CELL, V20, P1303, DOI 10.1105/tpc.108.058768; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P1703, DOI 10.1093/nar/29.8.1703; Guo FG, 2006, TRENDS PLANT SCI, V11, P527, DOI 10.1016/j.tplants.2006.09.006; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; HALL A, 1986, J BIOL CHEM, V261, P963; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; HEVEL JM, 1994, METHOD ENZYMOL, V233, P250; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Huang S, 1997, J NEUROCHEM, V69, P2516; KILBY NJ, 1992, PLANT MOL BIOL, V20, P103, DOI 10.1007/BF00029153; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kolbert Z, 2008, J PLANT PHYSIOL, V165, P967, DOI 10.1016/j.jplph.2007.07.019; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lamotte O, 2004, PLANT PHYSIOL, V135, P516, DOI 10.1104/pp.104.038968; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Levdikov VM, 2004, J MOL BIOL, V340, P767, DOI 10.1016/j.jmb.2004.05.029; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; Majumdar S, 2004, J BIOL CHEM, V279, P40137, DOI 10.1074/jbc.M405420200; Martinez-Vicente M, 2005, J BIOL CHEM, V280, P30660, DOI 10.1074/jbc.M503223200; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Mishra R, 2005, PROTEINS, V59, P332, DOI 10.1002/prot.20413; Moreau M, 2004, J INORG BIOCHEM, V98, P1200, DOI 10.1016/j.jinorgbio.2004.03.015; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Mur LAJ, 2006, J EXP BOT, V57, P489, DOI 10.1093/jxb/erj052; MURPHY ME, 1994, METHOD ENZYMOL, V233, P240; Neill SJ, 2002, PLANT PHYSIOL, V128, P13, DOI 10.1104/pp.010707; Ninnemann H, 1996, PHOTOCHEM PHOTOBIOL, V64, P393, DOI 10.1111/j.1751-1097.1996.tb02477.x; Pan JY, 1998, BIOESSAYS, V20, P516, DOI 10.1002/(SICI)1521-1878(199806)20:6<516::AID-BIES11>3.0.CO;2-3; Planchet E, 2005, PLANT J, V41, P732, DOI 10.1111/j.1365-313X.2005.02335.x; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Rockel P, 2002, J EXP BOT, V53, P103, DOI 10.1093/jexbot/53.366.103; Rutthard H, 2001, J BIOL CHEM, V276, P18728, DOI 10.1074/jbc.M102122200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Shi FM, 2008, BMB REP, V41, P79, DOI 10.5483/BMBRep.2008.41.1.079; Shin DH, 2004, P NATL ACAD SCI USA, V101, P13198, DOI 10.1073/pnas.0405202101; Stohr C, 2006, J EXP BOT, V57, P463, DOI 10.1093/jxb/erj058; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Travis J, 2004, SCIENCE, V306, P960; Tun NN, 2008, NEW PHYTOL, V178, P515, DOI 10.1111/j.1469-8137.2008.02383.x; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Wink DA, 2001, ANTIOXID REDOX SIGN, V3, P203, DOI 10.1089/152308601300185179; Yamasaki H, 2000, FEBS LETT, V468, P89, DOI 10.1016/S0014-5793(00)01203-5; Yang M, 1997, J MOL BIOL, V270, P696, DOI 10.1006/jmbi.1997.1149; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zemojtel T, 2006, FEBS LETT, V580, P455, DOI 10.1016/j.febslet.2005.12.038; Zemojtel T, 2004, TRENDS BIOCHEM SCI, V29, P224, DOI 10.1016/j.tibs.2004.03.005; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao MG, 2007, PLANT PHYSIOL, V144, P206, DOI 10.1104/pp.107.096842; Zhao MG, 2007, J PLANT PHYSIOL, V164, P737, DOI 10.1016/j.jplph.2006.03.002; Zottini M, 2007, J EXP BOT, V58, P1397, DOI 10.1093/jxb/erm001	82	227	249	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32957	32967		10.1074/jbc.M804838200	http://dx.doi.org/10.1074/jbc.M804838200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801746	hybrid, Green Published			2022-12-27	WOS:000260893700084
J	Stoddart, LA; Smith, NJ; Jenkins, L; Brown, AJ; Milligan, G				Stoddart, Leigh A.; Smith, Nicola J.; Jenkins, Laura; Brown, Andrew J.; Milligan, Graeme			Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; G-ALPHA PROTEINS; DRUG DISCOVERY; INSULIN-SECRETION; CONSTITUTIVE ACTIVITY; AGONIST RECOGNITION; LIGAND-BINDING; C-TERMINUS; GPR40; ACTIVATION	FFA2 and FFA3 are closely related G protein-coupled receptors that bind and respond to short chain fatty acids. (FFA2 and FFA3 are the provisional International Union of Pharmacology designations for the receptors previously called GPR43 and GPR41, respectively.) Sequence comparisons between these two receptors and alignments with the related G protein-coupled receptor FFA1, linked to homology modeling based on the atomic level structure of bovine rhodopsin, indicated the potential for polar residues within the transmembrane helix bundle to play important roles in ligand recognition and function. In both FFA2 and FFA3, mutation of either an arginine at the top of transmembrane domain V or a second arginine at the top of transmembrane domain VII eliminated the function of a range of short chain fatty acids. Mutation of a histidine in transmembrane domain VI, predicted to be in proximity to both the arginine residues, also eliminated function in many but not all assay formats. By contrast, mutation of a histidine in transmembrane domain IV, predicted to be lower in the binding pocket, modulated function in some assays of FFA3 function but had limited effects on the function of acetate and propionate at FFA2. Interestingly, wild type FFA3 responded to caproate, whereas FFA2 did not. Mutation of the transmembrane domain IV histidine eliminated responses of FFA3 to caproate but resulted in a gain of function of FFA2 to this six-carbon fatty acid. These data demonstrate the importance of positively charged residues in the recognition and/or function of short chain fatty acids in both FFA2 and FFA3. The development of small molecule ligands that interact selectively with these receptors will allow further details of the binding pockets to be elucidated.	[Stoddart, Leigh A.; Smith, Nicola J.; Jenkins, Laura; Milligan, Graeme] Univ Glasgow, Fac Biomed & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Brown, Andrew J.] GlaxoSmithKline, Dept Screening & Compound Profiling, Harlow CM19 5AW, Essex, England	University of Glasgow; GlaxoSmithKline	Milligan, G (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Mol Pharmacol Grp, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	g.milligan@bio.gla.ac.uk	Brown, Andrew J/G-6403-2013; Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519; Stoddart, Leigh/0000-0002-4469-0600; Brown, Andrew James/0000-0002-5616-3664; Smith, Nicola J/0000-0002-7247-9562	Biotechnology and Biosciences Research Council [BB/E019455/1]; BBSRC [BB/E019455/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E019455/1] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biosciences Research Council Grant BB/E019455/1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berkhout TA, 2003, J MED CHEM, V46, P4070, DOI 10.1021/jm030862l; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2005, DNA CELL BIOL, V24, P54, DOI 10.1089/dna.2005.24.54; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Canals M, 2008, J BIOL CHEM, V283, P11424, DOI 10.1074/jbc.M710300200; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Costanzi S, 2008, J BIOL CHEM, V283, P16269, DOI 10.1074/jbc.R800014200; Covington DK, 2006, BIOCHEM SOC T, V34, P770, DOI 10.1042/BST0340770; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Garrido DM, 2006, BIOORG MED CHEM LETT, V16, P1840, DOI 10.1016/j.bmcl.2006.01.007; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kenakin T, 2008, J RECEPT SIG TRANSD, V28, P109, DOI 10.1080/10799890801946318 ; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; Kostenis E, 2005, J PHARMACOL EXP THER, V313, P78, DOI 10.1124/jpet.104.080424; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Liu S, 2002, J BIOL CHEM, V277, P25707, DOI 10.1074/jbc.M201015200; MCCLUE SJ, 1992, BIOCHEM J, V284, P565, DOI 10.1042/bj2840565; Milasta S, 2006, MOL PHARMACOL, V69, P479, DOI 10.1124/mol.105.018788; Milligan G, 1999, TRENDS PHARMACOL SCI, V20, P118, DOI 10.1016/S0165-6147(99)01320-6; Milligan G, 2006, CELL SIGNAL, V18, P1360, DOI 10.1016/j.cellsig.2006.03.011; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Sabirsh A, 2006, BIOCHEMISTRY-US, V45, P5733, DOI 10.1021/bi060076t; Song FB, 2007, J MED CHEM, V50, P2807, DOI 10.1021/jm070130j; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stitham J, 2003, J BIOL CHEM, V278, P4250, DOI 10.1074/jbc.M207420200; STODDART LA, 2008, PHARM REV IN PRESS; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tikhonova IG, 2008, J MED CHEM, V51, P625, DOI 10.1021/jm7012425; Tikhonova IG, 2007, J MED CHEM, V50, P2981, DOI 10.1021/jm0614782; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Wise A, 1999, BIOCHEMISTRY-US, V38, P2272, DOI 10.1021/bi982054f	39	82	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32913	32924		10.1074/jbc.M805601200	http://dx.doi.org/10.1074/jbc.M805601200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801738	hybrid			2022-12-27	WOS:000260893700080
J	Hasan, MR; Tosha, T; Theil, EC				Hasan, Mohammad R.; Tosha, Takehiko; Theil, Elizabeth C.			Ferritin Contains Less Iron (Fe-59) in Cells When the Protein Pores Are Unfolded by Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL; RELEASE; MOBILIZATION; MECHANISM; STORAGE	Ferric minerals in ferritins are protected from cytoplasmic reductants and Fe2+ release by the protein nanocage until iron need is signaled. Deletion of ferritin genes is lethal; two critical ferritin functions are concentrating iron and oxidant protection (consuming cytoplasmic iron and oxygen in the mineral). In solution, opening/closing (gating) of eight ferritin protein pores controls reactions between external reductant and the ferritin mineral; pore gating is altered by mutation, low heat, and physiological urea (1 mM) and monitored by CD spectroscopy, protein crystallography, and Fe2+ release rates. To study the effects of a ferritin pore gating mutation in living cells, we cloned/expressed human ferritin H and H L138P, homologous to the frog open pore model that was unexpressable in human cells. Human ferritin H L138P behaved like the open pore ferritin model in vitro as follows: (i) normal protein cage assembly and mineralization, (ii) increased iron release (t(1/2) decreased 17-fold), and (iii) decreased alpha-helix (8%). Overexpression (>4-fold), in HeLa cells, showed for ferritin H L138P equal protein expression and total cell Fe-59 but increased chelatable iron, 16%, p < 0.01 (Fe-59 in the deferoxamine-containing medium), and decreased Fe-59 in ferritin, 28%, p < 0.01, compared with wild type. The coincidence of decreased Fe-59 in open pore ferritin with increased chelatable Fe-59 in cells expressing the ferritin open pore mutation suggests that ferritin pore gating influences to the amount of iron (Fe-59) in ferritin in vivo.	[Theil, Elizabeth C.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Univ Calif Berkeley, Dept Nutrit Sci & Toxicol, Berkeley, CA 94609 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Theil, EC (corresponding author), Childrens Hosp, Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	etheil@chori.org	Hasan, Mohammad/AAR-2093-2020; Tosha, Takehiko/AAR-2404-2020	Hasan, Mohammad/0000-0002-4658-7949; Tosha, Takehiko/0000-0002-8971-0759	National Institutes of Health [DK20251]; Children's Hospital Oakland Research Institute Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK020251, R37DK020251, R01DK020251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Oakland Research Institute Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK20251 (to E. C. T., M. R. H., and T. T.). This work was also supported by Children's Hospital Oakland Research Institute Foundation (to E. C. T.) and Japan Society for the Promotion of Science fellowship for research abroad (to T. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BOTHWELL TH, 1979, IRON BIOCH MED, P564; BRADY MC, 1989, J INORG BIOCHEM, V35, P9, DOI 10.1016/0162-0134(89)84002-4; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; CRICHTON RR, 1980, J INORG BIOCHEM, V13, P305, DOI 10.1016/S0162-0134(00)80251-2; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Harrison P.M., 1989, IRON CARRIERS IRON P, P123; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; IHARA K, 1984, J BIOL CHEM, V259, P278; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Kurz T, 2007, ARCH BIOCHEM BIOPHYS, V462, P220, DOI 10.1016/j.abb.2007.01.013; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; LIPSCHITZ DA, 1971, BRIT J HAEMATOL, V21, P289, DOI 10.1111/j.1365-2141.1971.tb03441.x; LISTOWSKY I, 1972, BIOCHEMISTRY-US, V11, P2176, DOI 10.1021/bi00761a026; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XS, 2007, J BIOL CHEM, V282, P31821, DOI 10.1074/jbc.C700153200; McDonough SI, 2007, TOXICON, V49, P202, DOI 10.1016/j.toxicon.2006.09.018; MERTZ JR, 1983, J BIOL CHEM, V258, P1719; Porter JB, 2007, AM J HEMATOL, V82, P1136, DOI 10.1002/ajh.21100; SCHLABACH MR, 1975, J BIOL CHEM, V250, P2182; Schwartz JK, 2008, J AM CHEM SOC, V130, P9441, DOI 10.1021/ja801251q; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; Theil EC, 2008, INORG CHIM ACTA, V361, P868, DOI 10.1016/j.ica.2007.08.025; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; WALDO GS, 1993, BIOCHEMISTRY-US, V32, P13262, DOI 10.1021/bi00211a039	36	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31394	31400		10.1074/jbc.M806025200	http://dx.doi.org/10.1074/jbc.M806025200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18805796	Green Published, hybrid			2022-12-27	WOS:000260760800018
J	Lima, CD; Reverter, D				Lima, Christopher D.; Reverter, David			Structure of the Human SENP7 Catalytic Domain and Poly-SUMO Deconjugation Activities for SENP6 and SENP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEASE; UBIQUITIN; PROTEINS; COMPLEX; NEDD8; PML; STABILIZATION; LOCALIZATION; SUMOYLATION	Small ubiquitin-like modifier (SUMO) proteases regulate the abundance and lifetime of SUMO-conjugated substrates by antagonizing reactions catalyzed by SUMO-conjugating enzymes. Six SUMO proteases constitute the human SENP/ULP protease family (SENP1-3 and SENP5-7). SENP6 and SENP7 include the most divergent class of SUMO proteases, which also includes the yeast enzyme ULP2. We present the crystal structure of the SENP7 catalytic domain at a resolution of 2.4 angstrom. Comparison with structures of human SENP1 and SENP2 reveals unique elements that differ from previously characterized structures of SUMO-deconjugating enzymes. Biochemical assays show that SENP6 and SENP7 prefer SUMO2 or SUMO3 in deconjugation reactions with rates comparable with those catalyzed by SENP2, particularly during cleavage of di-SUMO2, di-SUMO3, and poly-SUMO chains composed of SUMO2 or SUMO3. In contrast, SENP6 and SENP7 exhibit lower rates for processing pre-SUMO1, pre-SUMO2, or pre-SUMO3 in comparison with SENP2. Structure-guided mutational analysis reveals elements unique to the SENP6 and SENP7 subclass of SENP/ULP proteases that contribute to protease function during deconjugation of poly-SUMO chains.	[Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA; [Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain	Memorial Sloan Kettering Cancer Center; Autonomous University of Barcelona	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	limac@mskcc.org; david.reverter@uab.cat	Reverter, David/H-5360-2015	Reverter, David/0000-0002-5347-0992; Lima, Christopher/0000-0002-9163-6092	National Institutes of Health [GM65872]; European Community [MIRG-CT-2007-200346]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM65872 (to C. D. L.). This work was also supported by European Community Grant MIRG-CT-2007-200346 (to D. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L, 2002, PYMOL VERSION 0 99RC; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li YH, 2003, P NATL ACAD SCI USA, V100, P259, DOI 10.1073/pnas.0235361100; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Reverter D, 2005, J MOL BIOL, V345, P141, DOI 10.1016/j.jmb.2004.10.022; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Xu Z, 2006, BIOCHEM J, V398, P345, DOI 10.1042/BJ20060526; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	48	95	101	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32045	32055		10.1074/jbc.M805655200	http://dx.doi.org/10.1074/jbc.M805655200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799455	Green Published, hybrid			2022-12-27	WOS:000260760800086
J	Takechi, M; Seno, S; Kawamura, S				Takechi, Masaki; Seno, Sadayoshi; Kawamura, Shoji			Identification of cis-Acting Elements Repressing Blue Opsin Expression in Zebrafish UV Cones and Pineal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; VISUAL PIGMENTS; PHOTORECEPTOR DEVELOPMENT; TRANSGENIC ZEBRAFISH; GENE-EXPRESSION; SENSITIVE OPSIN; HOMEOBOX GENE; HUMAN RED; ROD; RECEPTOR	Opsin genes are expressed in a cell type-specific manner in the retina and the pineal organ for visual and nonvisual photoreceptive purposes, but the regulatory mechanism behind the tissue and cell selectivity is not well understood. In this study, we focus on the expression regulation of the blue-sensitive opsin gene SWS2 of zebrafish by taking a transgenic approach using the green fluorescence protein as an expression reporter. The zebrafish SWS2 is a single-copy gene and is expressed specifically in the "long single cones" in the retina. We found the following. 1)A0.3-kb region between 0.6 and 0.3 kb 5' of the SWS2 initiation codon, encompassing four cone-rod homeobox-binding sites (OTX sequences), contains the region necessary and sufficient to drive gene expression in long single cones. 2) A 15-bp portion (-341 to -327) in the 0.3-kb region represses the gene expression in the "short single cones," which are dedicated to the UV-sensitive opsin gene SWS1. 3) An 11-bp sequence TAACTGCCAGT (-441 to -431) in the 0.3-kb region, with its adjacent OTX element, also works as a repressor for gene expression in the pineal cells. 4) Finally, this OTX site is necessary for expression repression in the bipolar cells in the retina. These findings open a way for understanding the complex interaction of positive and negative regulatory factors that govern the cell type specificity of the opsin gene expression in the photoreceptive cells in the retina and the pineal organ. We termed the novel 11-bp sequence as the pineal negative regulatory element, PINE.	[Takechi, Masaki; Seno, Sadayoshi; Kawamura, Shoji] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	University of Tokyo	Kawamura, S (corresponding author), Seimeitou 502,5-1-5 Kashiwanoha, Chiba 2778562, Japan.	Kawamura@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20017008]; Japan Society for the Promotion of Science (JSPS) [19207018, 16-11736]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research on Priority Areas "Comparative Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan 20017008 (to S. K.), Grant-in-Aid for Scientific Research A from Japan Society for the Promotion of Science (JSPS) 19207018 (to S. K.), and JSPS Fellowship 16-11736 (to M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Appelbaum L, 2005, J BIOL CHEM, V280, P11544, DOI 10.1074/jbc.M412935200; Asaoka Y, 2002, P NATL ACAD SCI USA, V99, P15456, DOI 10.1073/pnas.232444199; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng CL, 2007, J EXP BIOL, V210, P4123, DOI 10.1242/jeb.009217; Chinen A, 2003, GENETICS, V163, P663; Davies WL, 2007, CURR BIOL, V17, pR161, DOI 10.1016/j.cub.2007.01.037; Forsell J, 2001, J EXP BIOL, V204, P2517; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Hamaoka T, 2002, GENESIS, V34, P215, DOI 10.1002/gene.10155; Kawamura S, 1997, VISION RES, V37, P1867, DOI 10.1016/S0042-6989(96)00309-4; Kawamura S, 1999, GENETICS, V153, P1839; Kennedy BN, 2001, J BIOL CHEM, V276, P14037, DOI 10.1074/jbc.M010490200; Li XD, 1998, P NATL ACAD SCI USA, V95, P1876, DOI 10.1073/pnas.95.4.1876; Luo WQ, 2004, J BIOL CHEM, V279, P19286, DOI 10.1074/jbc.M400161200; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Meissl H, 1997, BIOL CELL, V89, P549, DOI 10.1016/S0248-4900(98)80158-5; Muller F, 1997, MOL REPROD DEV, V47, P404, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;404::AID-MRD6&gt;3.0.CO;2-O; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Okano T, 1997, MOL BRAIN RES, V50, P190, DOI 10.1016/S0169-328X(97)00184-8; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; OKSCHE A, 1984, OPHTHALMIC RES, V16, P88, DOI 10.1159/000265300; Prabhudesai SN, 2005, DEV BIOL, V287, P157, DOI 10.1016/j.ydbio.2005.08.045; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Smallwood PM, 2002, P NATL ACAD SCI USA, V99, P1008, DOI 10.1073/pnas.022629799; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; TAKAHASHI JS, 1993, CURR OPIN GENET DEV, V3, P301, DOI 10.1016/0959-437X(93)90038-Q; Takechi M, 2005, J EXP BIOL, V208, P1337, DOI 10.1242/jeb.01532; Takechi M, 2003, FEBS LETT, V553, P90, DOI 10.1016/S0014-5793(03)00977-3; Tsujimura T, 2007, P NATL ACAD SCI USA, V104, P12813, DOI 10.1073/pnas.0704061104; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Wakefield MJ, 2008, VISUAL NEUROSCI, V25, P257, DOI 10.1017/S0952523808080255; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; YOKOYAMA R, 1993, FEBS LETT, V334, P27, DOI 10.1016/0014-5793(93)81673-N; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Ziv L, 2007, EXP EYE RES, V84, P92, DOI 10.1016/j.exer.2006.09.004	41	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31625	31632		10.1074/jbc.M806226200	http://dx.doi.org/10.1074/jbc.M806226200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18796431	hybrid			2022-12-27	WOS:000260760800043
J	McConnell, BK; Popovic, Z; Mal, N; Lee, K; Bautista, J; Forudi, F; Schwartzman, R; Jin, JP; Penn, M; Bond, M				McConnell, Bradley K.; Popovic, Zoran; Mal, Niladri; Lee, Kwangdeok; Bautista, James; Forudi, Farhad; Schwartzman, Raul; Jin, J. -P.; Penn, Marc; Bond, Meredith			Disruption of Protein Kinase A Interaction with A-kinase-anchoring Proteins in the Heart in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-I; DILATED CARDIOMYOPATHY; RYANODINE-RECEPTOR; MU-CALPAIN; RAT HEART; PHOSPHORYLATION; COMPLEX; DEGRADATION; ISCHEMIA; BINDING	Protein kinase A (PKA)-dependent phosphorylation is regulated by targeting of PKA to its substrate as a result of binding of regulatory subunit, R, to A-kinase-anchoring proteins (AKAPs). We investigated the effects of disrupting PKA targeting to AKAPs in the heart by expressing the 24-amino acid regulatory subunit RII-binding peptide, Ht31, its inactive analog, Ht31P, or enhanced green fluorescent protein by adenoviral gene transfer into rat hearts in vivo. Ht31 expression resulted in loss of the striated staining pattern of type II PKA (RII), indicating loss of PKA from binding sites on endogenous AKAPs. In the absence of isoproterenol stimulation, Ht31-expressing hearts had decreased +dP/dt(max) and -dP/dt(min) but no change in left ventricular ejection fraction or stroke volume and decreased end diastolic pressure versus controls. This suggests that cardiac output is unchanged despite decreased +dP/dt and -dP/dt. There was also no difference in PKA phosphorylation of cardiac troponin I (cTnI), phospholamban, or ryanodine receptor (RyR(2)). Upon isoproterenol infusion, +dP/dt(max) and -dP/dt(min) did not differ between Ht31 hearts and controls. At higher doses of isoproterenol, left ventricular ejection fraction and stroke volume increased versus isoproterenol-stimulated controls. This occurred in the context of decreased PKA phosphorylation of cTnI, RyR2, and phospholamban versus controls. We previously showed that expression of N-terminal-cleaved cTnI (cTnIND) in transgenic mice improves cardiac function. Increased cTnI N-terminal truncation was also observed in Ht31-expressing hearts versus controls. Increased cTnI-ND may help compensate for reduced PKA phosphorylation as occurs in heart failure.	[McConnell, Bradley K.; Bond, Meredith] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Bond, Meredith] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Mal, Niladri; Schwartzman, Raul; Penn, Marc] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Popovic, Zoran; Lee, Kwangdeok; Forudi, Farhad; Penn, Marc] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Bautista, James; Jin, J. -P.] Northwestern Univ, Fienberg Sch Med, Evanston, IL 60201 USA; [Bautista, James; Jin, J. -P.] Evanston NW Healthcare, Sect Mol Cardiol, Evanston, IL 60201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Northwestern University; Feinberg School of Medicine; NorthShore University Health System	McConnell, BK (corresponding author), Univ Houston, Dept Pharmacol & Pharmaceut Sci, Coll Pharm, 4800 Calhoun Rd,Bldg SR-2,Rm 460, Houston, TX 77204 USA.	bkmcconn@central.uh.edu	Jin, Jian-Ping/AAD-1149-2020	popovic, zoran/0000-0001-5692-2299; Jin, JP/0000-0001-9932-1063	National Institutes of Health [HL085487, HL56256, AG16613, HL074400, HL76491, HL078773]; National Aeronautics and Space Administration [NNA04CK26G]; American Heart Association [0465470U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085487, R01HL078773, R01HL056256, P01HL076491, R01HL074400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085487 (to B. M.), HL56256 and AG16613 (to M. B.), HL074400 and HL76491 (to M. P.), and HL078773 (to J.-P. Jin). This work was also supported by National Aeronautics and Space Administration Grant NNA04CK26G (to J.-P. Jin) and by the American Heart Association, midAtlantic affiliate, Beginning Grant-in-aid 0465470U (to B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Askari A, 2004, J AM COLL CARDIOL, V43, P1908, DOI 10.1016/j.jacc.2003.12.045; Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Barta J, 2003, MOL CELL BIOCHEM, V251, P83, DOI 10.1023/A:1025485916872; CARR DW, 1991, J BIOL CHEM, V266, P14188; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; del Monte Federica, 2003, Methods Mol Biol, V219, P179; DILISA F, 1995, BIOCHEM J, V308, P57, DOI 10.1042/bj3080057; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6745, DOI 10.1021/bi962226d; ELVIRA M, 1993, J BIOL CHEM, V268, P14294; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Feng J, 2001, CIRCULATION, V103, P2035; GAASCH WH, 1990, CIRCULATION, V81, P1644, DOI 10.1161/01.CIR.81.5.1644; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Kockskamper J, 2001, PFLUG ARCH EUR J PHY, V441, P807, DOI 10.1007/s004240000485; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; LITERSKY JM, 1992, J BIOL CHEM, V267, P1563; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Matsui T, 2001, CIRCULATION, V104, P330; McConnell BK, 1997, AM J PHYSIOL-HEART C, V273, pH1440, DOI 10.1152/ajpheart.1997.273.3.H1440; McConnell BK, 1998, AM J PHYSIOL-HEART C, V274, pH385, DOI 10.1152/ajpheart.1998.274.2.H385; McConnell BK, 1999, J CLIN INVEST, V104, P1235, DOI 10.1172/JCI7377; McDonough JL, 1999, CIRC RES, V84, P9; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Popovic ZB, 2006, AM J PHYSIOL-HEART C, V291, pH762, DOI 10.1152/ajpheart.00081.2006; Potet F, 2001, AM J PHYSIOL-HEART C, V280, pH2038, DOI 10.1152/ajpheart.2001.280.5.H2038; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Sumandea CA, 2007, CIRCULATION, V116, P189; Thijssen VLJL, 2004, CIRCULATION, V110, P770, DOI 10.1161/01.CIR.0000138849.03311.C6; Yang JC, 1998, J CELL BIOL, V142, P511, DOI 10.1083/jcb.142.2.511; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Zakhary DR, 2000, CIRCULATION, V101, P1459, DOI 10.1161/01.CIR.101.12.1459; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505	42	51	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1583	1592		10.1074/jbc.M806321200	http://dx.doi.org/10.1074/jbc.M806321200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18945669	hybrid, Green Published			2022-12-27	WOS:000262330100026
J	Molnar, A; Borbely, A; Czuriga, D; Ivetta, SM; Szilagyi, S; Hertelendi, Z; Pasztor, ET; Balogh, A; Galajda, Z; Szerafin, T; Jaquet, K; Papp, Z; Edes, I; Toth, A				Molnar, Andrea; Borbely, Attila; Czuriga, Daniel; Ivetta, Siket M.; Szilagyi, Szabolcs; Hertelendi, Zita; Pasztor, Eniko T.; Balogh, Agnes; Galajda, Zoltan; Szerafin, Tamas; Jaquet, Kornelia; Papp, Zoltan; Edes, Istvan; Toth, Attila			Protein Kinase C Contributes to the Maintenance of Contractile Force in Human Ventricular Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-I; CONGESTIVE-HEART-FAILURE; MYOFILAMENT DYSFUNCTION; MOLECULAR HETEROGENEITY; PHOSPHORYLATION SITES; ACTOMYOSIN MGATPASE; PKC PHOSPHORYLATION; ANCHORING PROTEINS; MYOCARDIAL-CELLS; MOUSE HEARTS	Prolonged Ca2+ stimulations often result in a decrease in contractile force of isolated, demembranated human ventricular cardiomyocytes, whereas intact cells are likely to be protected from this deterioration. We hypothesized that cytosolic protein kinase C (PKC) contributes to this protection. Prolonged contracture (10 min) of demembranated human cardiomyocytes at half-maximal Ca2+ resulted in a 37 +/- 5% reduction of active force (p < 0.01), whereas no decrease (2 +/- 3% increase) was observed in the presence of the cytosol (reconstituted myocytes). The PKC inhibitors GF109203X and Go6976 (10 mu mol/liter) partially antagonized the cytosol-mediated protection (15 +/- 5 and 9 +/- 2% decrease in active force, p < 0.05). Quantitation of PKC isoform expression revealed the dominance of the Ca2+-dependent PKC alpha over PKC delta and PKC epsilon (189 +/- 31, 7 +/- 3, and 7 +/- 2 ng/mg protein, respectively). Ca2+ stimulations of reconstituted human cardiomyocytes resulted in the translocation of endogenous PKC alpha, but not PKC beta 1, delta, and epsilon from the cytosol to the contractile system (PKC alpha association: control, 5 +/- 3 arbitrary units; +Ca2+, 39 +/- 8 arbitrary units; p < 0.01, EC50,Ca = 645 nmol/liter). One of the PKC alpha-binding proteins were identified as the thin filament regulatory protein cardiac troponin I (TnI). Finally, the Ca2+-dependent interaction between PKC alpha and TnI was confirmed using purified recombinant proteins (binding without Ca2+ was only 28 +/- 18% of that with Ca2+). Our data suggest that PKC alpha translocates to the contractile system and anchors to TnI in a Ca2+-dependent manner in the human heart, contributing to the maintenance of contractile force.	[Molnar, Andrea; Borbely, Attila; Czuriga, Daniel; Ivetta, Siket M.; Szilagyi, Szabolcs; Hertelendi, Zita; Pasztor, Eniko T.; Balogh, Agnes; Papp, Zoltan; Edes, Istvan; Toth, Attila] Univ Debrecen, Fac Med, Med & Hlth Sci Ctr, Div Clin Physiol,Inst Cardiol, H-4032 Debrecen, Hungary; [Galajda, Zoltan; Szerafin, Tamas] Univ Debrecen, Ctr Cardiac Surg, Inst Cardiol, H-4032 Debrecen, Hungary; [Jaquet, Kornelia] Ruhr Univ Kliniken, St Josef Hosp Bergmannsheil, Forsch Labor Mol Kardiol, D-44791 Bochum, Germany	University of Debrecen; University of Debrecen; Ruhr University Bochum	Toth, A (corresponding author), Univ Debrecen, Fac Med, Med & Hlth Sci Ctr, Div Clin Physiol,Inst Cardiol, 22 Moricz Zs Krt, H-4032 Debrecen, Hungary.	atitoth@dote.hu	Czuriga, Daniel/AAL-5090-2020; Édes, István/B-8795-2011; Papp, Zoltán/HDO-3347-2022; Tóth, Attila/F-4859-2010	Tóth, Attila/0000-0001-6503-3653; Czuriga, Daniel/0000-0002-6972-0781	OTKA [F048873, K68077, K68363]; ETT [430/2006]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ETT	This work was supported by Hungarian Research Fund Grants OTKA F048873 and K68077 (to A. T.) and K68363 (to Z. P.) and by Hungarian Ministry of Health Grant ETT 430/2006 (to A. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288; Belin RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2344, DOI 10.1152/ajpheart.00541.2006; BILCHICK KC, 2006, AM J PHYSIOL, V292, pH318; Borbely A, 2005, CARDIOVASC RES, V67, P225, DOI 10.1016/j.cardiores.2005.03.025; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Braun MU, 2003, CARDIOVASC RES, V59, P658, DOI 10.1016/S0008-6363(03)00470-X; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; DAMRON DS, 1995, CIRC RES, V76, P1011, DOI 10.1161/01.RES.76.6.1011; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Goldberg M, 1996, BIOCHEM PHARMACOL, V51, P1089, DOI 10.1016/0006-2952(96)00046-9; Goldspink PH, 2004, CIRC RES, V95, P424, DOI 10.1161/01.RES.0000138299.85648.92; GU X, 1994, CIRC RES, V75, P926, DOI 10.1161/01.RES.75.5.926; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Huang XP, 2004, J CELL SCI, V117, P1971, DOI 10.1242/jcs.01044; Huang XP, 2002, EXP BIOL MED, V227, P1039, DOI 10.1177/153537020222701113; Jalili T, 1999, AM J PHYSIOL-HEART C, V277, pH2298, DOI 10.1152/ajpheart.1999.277.6.H2298; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Jonjev ZS, 2003, J THORAC CARDIOV SUR, V126, P1880, DOI 10.1016/S0022-5223(03)01326-6; KARMAZYN M, 1993, CARDIOVASC RES, V27, P915, DOI 10.1093/cvr/27.6.915; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; Maasch C, 2000, FASEB J, V14, P1653, DOI 10.1096/fj.14.11.1653; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Mochly-Rosen D, 1998, FASEB J, V12, P35; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Montgomery DE, 2002, AM J PHYSIOL-HEART C, V282, pH2397, DOI 10.1152/ajpheart.00714.2001; Murphy Stephen, 2005, Cardiol Rev, V13, P3; Narolska NA, 2006, CIRC RES, V99, P1012, DOI 10.1161/01.RES.0000248753.30340.af; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Noguchi T, 2004, CIRCULATION, V110, P982, DOI 10.1161/01.CIR.0000139334.43109.F9; NOLAND TA, 1995, J BIOL CHEM, V270, P25445, DOI 10.1074/jbc.270.43.25445; NOLAND TA, 1989, J BIOL CHEM, V264, P20778; NOLAND TA, 1992, BIOCHEM J, V288, P123, DOI 10.1042/bj2880123; Pyle WG, 2002, AM J PHYSIOL-HEART C, V283, pH1215, DOI 10.1152/ajpheart.00128.2002; Roman BB, 2004, AM J PHYSIOL-HEART C, V286, pH2089, DOI 10.1152/ajpheart.00582.2003; RYBIN VO, 1994, CIRC RES, V74, P299, DOI 10.1161/01.RES.74.2.299; Sakthivel S, 2005, J BIOL CHEM, V280, P703, DOI 10.1074/jbc.M409513200; Scruggs SB, 2006, J MOL CELL CARDIOL, V40, P465, DOI 10.1016/j.yjmcc.2005.12.009; Shin HG, 2000, CARDIOVASC RES, V48, P285, DOI 10.1016/S0008-6363(00)00185-1; Simonis G, 2007, MOL CELL BIOCHEM, V305, P103, DOI 10.1007/s11010-007-9533-3; Takeishi Y, 1998, J CLIN INVEST, V102, P72, DOI 10.1172/JCI2709; van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021; VENEMA RC, 1993, J BIOL CHEM, V268, P2705; VENEMA RC, 1993, BIOCHEM J, V294, P401, DOI 10.1042/bj2940401	46	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1031	1039		10.1074/jbc.M807600200	http://dx.doi.org/10.1074/jbc.M807600200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18854307	hybrid			2022-12-27	WOS:000262122900039
J	Agopian, A; Gros, E; Aldrian-Herrada, G; Bosquet, N; Clayette, P; Divita, G				Agopian, Audrey; Gros, Edwige; Aldrian-Herrada, Gudrun; Bosquet, Nathalie; Clayette, Pascal; Divita, Gilles			A New Generation of Peptide-based Inhibitors Targeting HIV-1 Reverse Transcriptase Conformational Flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANGSTROM RESOLUTION; SYNTHETIC PEPTIDES; CRYSTAL-STRUCTURE; DNA-SYNTHESIS; PRIMER GRIP; DIMERIZATION; SUBUNIT; P66; TEMPLATE	The biologically active form of human immunodeficiency virus (HIV) type 1 reverse transcriptase (RT) is a heterodimer. The formation of RT is a two-step mechanism, including a rapid protein-protein interaction "the dimerization step,"followed by conformational changes "the maturation step,"yielding the biologically active form of the enzyme. We have previously proposed that the heterodimeric organization of RT constitutes an interesting target for the design of new inhibitors. Here, we propose a new class of RT inhibitors that targets protein-protein interactions and conformational changes involved in the maturation of heterodimeric reverse transcriptase. Based on a screen of peptides derived from the thumb domain of this enzyme, we have identified a short peptide PAW that inhibits the maturation step and blocks viral replication at subnano-molar concentrations. PAW only binds dimeric RT and stabilizes it in an inactive/non-processive conformation. From a mechanistic point of view, PAW prevents proper binding of primer/template by affecting the structural dynamics of the thumb/fingers of p66 subunit. Taken together, these results demonstrate that HIV-1 RT maturation constitutes an attractive target for AIDS chemotherapeutics.	[Agopian, Audrey; Gros, Edwige; Aldrian-Herrada, Gudrun; Divita, Gilles] UM1, UM2, CNRS,UMR 5237, Dept Mol Biophys & Therapeut,Ctr Rech Biochim Mac, F-34293 Montpellier, France; [Bosquet, Nathalie; Clayette, Pascal] SPI BIO Commissariat Energie Atom, F-9226 Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; CEA; UDICE-French Research Universities; Universite Paris Saclay	Divita, G (corresponding author), UM1, UM2, CNRS,UMR 5237, Dept Mol Biophys & Therapeut,Ctr Rech Biochim Mac, 1919 Route Mende, F-34293 Montpellier, France.	gilles.divita@crbm.cnrs.fr	DIVITA, GILLES/AAV-9214-2021	Aldrian, Gudrun/0000-0002-7899-0572	CNRS; Agence Nationale de Recherche sur le SIDA and SIDACTION; Targeting Replication and Integration of HIV HIV; European Community [LSHB-CT-2003-503480]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de Recherche sur le SIDA and SIDACTION(ANRS); Targeting Replication and Integration of HIV HIV; European Community(European Commission)	This work was supported in part by the CNRS and by a grant from the Agence Nationale de Recherche sur le SIDA and SIDACTION. This work is part of the program "Targeting Replication and Integration of HIV HIV" supported by the European Community (EC, Grant LSHB-CT-2003-503480).	Agopian A, 2007, J MOL BIOL, V373, P127, DOI 10.1016/j.jmb.2007.07.044; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BECERRA SP, 1991, BIOCHEMISTRY-US, V30, P11707, DOI 10.1021/bi00114a015; Cabodevilla JF, 2001, EUR J BIOCHEM, V268, P1163, DOI 10.1046/j.1432-1327.2001.01939.x; Camarasa MJ, 2006, ANTIVIR RES, V71, P260, DOI 10.1016/j.antiviral.2006.05.021; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Depollier J, 2005, BIOCHEMISTRY-US, V44, P1909, DOI 10.1021/bi0484264; DIVITA G, 1993, BIOCHEMISTRY-US, V32, P7966, DOI 10.1021/bi00082a018; DIVITA G, 1994, J BIOL CHEM, V269, P13080; Divita G, 1995, BIOCHEMISTRY-US, V34, P16337, DOI 10.1021/bi00050a014; DIVITA G, 1995, J MOL BIOL, V245, P508, DOI 10.1006/jmbi.1994.0042; DIVITA G, 1995, J BIOL CHEM, V270, P28642, DOI 10.1074/jbc.270.48.28642; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Figueiredo A, 2006, PLOS PATHOG, V2, P1051, DOI 10.1371/journal.ppat.0020119; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; Ghosh M, 1996, BIOCHEMISTRY-US, V35, P8553, DOI 10.1021/bi952773j; Gros E, 2006, BBA-BIOMEMBRANES, V1758, P384, DOI 10.1016/j.bbamem.2006.02.006; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUANG SC, 1992, BIOCHEM BIOPH RES CO, V184, P986, DOI 10.1016/0006-291X(92)90688-H; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Morris MC, 1999, J BIOL CHEM, V274, P24941, DOI 10.1074/jbc.274.35.24941; Morris MC, 1999, BIOCHEMISTRY-US, V38, P15097, DOI 10.1021/bi9914558; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mulky A, 2004, J VIROL, V78, P7089, DOI 10.1128/JVI.78.13.7089-7096.2004; MULLER B, 1989, J BIOL CHEM, V264, P13975; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; RESTLE T, 1990, J BIOL CHEM, V265, P8986; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Roisin A, 2004, J BIOL CHEM, V279, P9208, DOI 10.1074/jbc.M311594200; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Sluis-Cremer N, 2002, MOL PHARMACOL, V62, P398, DOI 10.1124/mol.62.2.398; Sluis-Cremer N, 2002, EUR J BIOCHEM, V269, P5103, DOI 10.1046/j.1432-1033.2002.03216.x; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Tachedjian G, 2005, FEBS LETT, V579, P379, DOI 10.1016/j.febslet.2004.11.099; Tachedjian G, 2001, P NATL ACAD SCI USA, V98, P7188, DOI 10.1073/pnas.121055998; Tachedjian Gilda, 2003, Curr Opin Investig Drugs, V4, P966; Venezia CF, 2006, BIOCHEMISTRY-US, V45, P2779, DOI 10.1021/bi051915z; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Wohrl BM, 1997, J BIOL CHEM, V272, P17581, DOI 10.1074/jbc.272.28.17581	48	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					254	264		10.1074/jbc.M802199200	http://dx.doi.org/10.1074/jbc.M802199200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952602	Green Submitted, hybrid			2022-12-27	WOS:000261974800029
J	Li, W; Danilenko, DM; Bunting, S; Ganesan, R; Sa, S; Ferrando, R; Wu, TD; Kolumam, GA; Ouyang, W; Kirchhofer, D				Li, Wei; Danilenko, Dimitry M.; Bunting, Stuart; Ganesan, Rajkumar; Sa, Susan; Ferrando, Ronald; Wu, Thomas D.; Kolumam, Ganesh A.; Ouyang, Wenjun; Kirchhofer, Daniel			The Serine Protease Marapsin Is Expressed in Stratified Squamous Epithelia and Is Up-regulated in the Hyperproliferative Epidermis of Psoriasis and Regenerating Wounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE KALLIKREINS; GENE-EXPRESSION; ADAPTIVE IMMUNITY; POTENTIAL ROLE; MESSENGER-RNA; SKIN; CELLS; RECEPTORS; CYTOKINE; PANCREAS	The trypsin-like serine protease marapsin is a member of the large protease gene cluster at human chromosome 16p13.3, which also contains the structurally related proteases testisin, tryptase epsilon, tryptase gamma, and EOS. To gain insight into the biological functions of marapsin, we undertook a detailed gene expression analysis. It showed that marapsin expression was restricted to tissues containing stratified squamous epithelia and was absent or only weakly expressed in all other tissues, including the pancreas. Marapsin was constitutively expressed in nonkeratinizing stratified squamous epithelia of human esophagus, tonsil, cervix, larynx, and cornea. In the keratinizing stratified squamous epidermis of skin, however, its expression was induced only during epidermal hyperproliferation, such as in psoriasis and in murine wound healing. In fact, marapsin was the second most strongly up-regulated protease in psoriatic lesions, where expression was localized to the upper region of the hyperplastic epidermis. Similarly, in the hyperproliferative epithelium of regenerating murine skin wounds, marapsin localized to the suprabasal layers, where keratinocytes undergo squamous differentiation. The transient up-regulation of marapsin, which closely correlated with re-epithelialization, was virtually absent in a genetic mouse model of delayed wound closure. These results suggested a function during the process of re-epithelialization. Furthermore, in reconstituted human epidermis, a model system of epidermal differentiation, members of the IL-20 subfamily of cytokines, such as IL-22, induced marapsin expression. Consistent with a physiologic role in marapsin regulation, IL-22 was also strongly expressed in re-epithelializing skin wounds. Marapsin's restricted expression, localization, and cytokine-inducible expression suggest a role in the terminal differentiation of keratinocytes in hyperproliferating squamous epithelia.	[Li, Wei; Ganesan, Rajkumar; Kirchhofer, Daniel] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Danilenko, Dimitry M.; Sa, Susan; Ferrando, Ronald] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Bunting, Stuart; Kolumam, Ganesh A.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Wu, Thomas D.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kirchhofer, D (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	dak@gene.com	Ouyang, Wenjun/ABA-8763-2020; Ganesan, Rajkumar/B-1093-2008	Ganesan, Rajkumar/0000-0002-3431-9664; Ouyang, Wenjun/0000-0002-1811-5864; Danilenko, Dimitry/0000-0002-8326-1921				Adachi W, 2006, INVEST OPHTH VIS SCI, V47, P3801, DOI 10.1167/iovs.06-0216; Bhagwandin VJ, 2003, J BIOL CHEM, V278, P3363, DOI 10.1074/jbc.M209353200; Borgono CA, 2004, MOL CANCER RES, V2, P257; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Fitch PM, 2006, BIOCHEM SOC T, V34, P279, DOI 10.1042/BST0340279; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Hendrixson DR, 2003, MOL MICROBIOL, V47, P607, DOI 10.1046/j.1365-2958.2003.03327.x; Inoue N, 1998, J INVEST DERMATOL, V110, P923, DOI 10.1046/j.1523-1747.1998.00212.x; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; KAWASHIMA I, 1987, DNA-J MOLEC CELL BIO, V6, P163, DOI 10.1089/dna.1987.6.163; Kishibe M, 2007, J BIOL CHEM, V282, P5834, DOI 10.1074/jbc.M607998200; Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Kuwae K, 2002, J CLIN PATHOL-MOL PA, V55, P235, DOI 10.1136/mp.55.4.235; Layfield LJ, 2001, DIAGN CYTOPATHOL, V25, P38, DOI 10.1002/dc.1099; Ling JML, 2006, BIOCHEM CELL BIOL, V84, P275, DOI 10.1139/O06-044; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Otkjaer K, 2005, BRIT J DERMATOL, V153, P911, DOI 10.1111/j.1365-2133.2005.06800.x; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pfundt R, 1996, J CLIN INVEST, V98, P1389, DOI 10.1172/JCI118926; Renauld JC, 2003, NAT REV IMMUNOL, V3, P667, DOI 10.1038/nri1153; Robbins, 1999, PATHOLOGIC BASIS DIS; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Szepessy E, 2006, PANCREATOLOGY, V6, P117, DOI 10.1159/000090031; Tanaka N, 2000, BRIT J DERMATOL, V143, P728, DOI 10.1046/j.1365-2133.2000.03766.x; TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; vanBergen BH, 1996, ARCH DERMATOL RES, V288, P458, DOI 10.1007/s004030050083; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wong GW, 2005, BIOCHEM BIOPH RES CO, V336, P579, DOI 10.1016/j.bbrc.2005.08.137; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Wong GW, 2001, J BIOL CHEM, V276, P49169, DOI 10.1074/jbc.M108677200; Yasuda S, 2005, BLOOD, V105, P3893, DOI 10.1182/blood-2003-10-3501; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	44	28	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					218	228		10.1074/jbc.M806267200	http://dx.doi.org/10.1074/jbc.M806267200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18948266	hybrid			2022-12-27	WOS:000261974800025
J	Chi, YH; Haller, K; Ward, MD; Semmes, OJ; Li, Y; Jeang, KT				Chi, Ya-Hui; Haller, Kerstin; Ward, Michael D.; Semmes, O. John; Li, Yan; Jeang, Kuan-Teh			Requirements for Protein Phosphorylation and the Kinase Activity of Polo-like Kinase 1 (Plk1) for the Kinetochore Function of Mitotic Arrest Deficiency Protein 1 (Mad1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; YEAST SACCHAROMYCES-CEREVISIAE; SMALL-MOLECULE INHIBITOR; BUDDING YEAST; BOX DOMAIN; CELLULAR-TRANSFORMATION; MPS1 KINASE; HUMAN LUNG; IN-VITRO	Mitotic arrest deficiency protein 1 (Mad1) is associated with microtubule-unattached kinetochores in mitotic cells and is a component of the spindle assembly checkpoint (SAC). Here, we have studied the phosphorylation of Mad1 and mapped using liquid chromatography-tandem mass spectrometry several phosphorylated amino acids in this protein. One phosphorylated residue, Thr(680), was characterized to be important for the kinetochore localization of Mad1 and its SAC function. We also found that in mitotic cells Mad1 co-immunoprecipitated with Plk1. Depletion of cellular Plk1 using small interfering RNAs and inhibition of the kinase activity of Plk1 using a kinase-dead mutant or a small molecule inhibitor attenuated Mad1 phosphorylation and its association with kinetochores. Collectively, these findings indicate mechanistic roles contributed by protein phosphorylation and Plk1 to the SAC activity of Mad1.	[Chi, Ya-Hui; Haller, Kerstin; Li, Yan; Jeang, Kuan-Teh] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Ward, Michael D.; Semmes, O. John] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Ctr Biomed Proteom, Norfolk, VA 23501 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Eastern Virginia Medical School	Jeang, KT (corresponding author), Bldg 4,Rm 306,9000 Rockville Pike, Bethesda, MD 20892 USA.	kj7e@nih.gov	Jeang, Kuan-Teh/A-2424-2008; Chi, Ya-Hui/B-1080-2010; Semmes, Oliver/GQA-5179-2022; Chi, Ya-Hui/ABE-8550-2020	Chi, Ya-Hui/0000-0002-9216-0938	National Institutes of Health; NIAID; NATIONAL CANCER INSTITUTE [R01CA076595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported through intramural funding from the NIAID, National Institutes of Health. To whom correspondence should be addressed: Bldg. 4, Rm. 306, 9000 Rockville Pike, Bethesda, MD 20892-0460. Tel.: 301-496-6680; Fax: 301-480-3686; E- mail: kj7e@ nih. gov.	Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Campbell MS, 2001, J CELL SCI, V114, P953; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Chi YH, 2007, J CELL BIOCHEM, V102, P531, DOI 10.1002/jcb.21484; Chung EN, 2002, MOL BIOL CELL, V13, P1501, DOI 10.1091/mbc.02-01-0003; Coe BR, 2006, GENE CHROMOSOME CANC, V45, P11, DOI 10.1002/gcc.20260; Dai W, 2003, FRONT BIOSCI-LANDMRK, V8, pD1128, DOI 10.2741/1129; Eckerdt F, 2006, CANCER RES, V66, P6895, DOI 10.1158/0008-5472.CAN-06-0358; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Gaillard S, 2001, J VIROL, V75, P9799, DOI 10.1128/JVI.75.20.9799-9807.2001; Gemma A, 2001, LUNG CANCER-J IASLC, V32, P289, DOI 10.1016/S0169-5002(00)00223-3; Haller K, 2006, ONCOGENE, V25, P2137, DOI 10.1038/sj.onc.1209259; Hardwick KG, 1999, GENETICS, V152, P509; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068; Iwanaga Y, 2002, J BIOL CHEM, V277, P31005, DOI 10.1074/jbc.M110666200; Iwanaga Y, 2007, CANCER RES, V67, P160, DOI 10.1158/0008-5472.CAN-06-3326; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kasai T, 2002, J BIOL CHEM, V277, P5187, DOI 10.1074/jbc.M110295200; Kienitz A, 2005, ONCOGENE, V24, P4301, DOI 10.1038/sj.onc.1208589; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Lowery DM, 2004, CELL CYCLE, V3, P128; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Osaka F, 1997, MOL CELL BIOL, V17, P3388, DOI 10.1128/MCB.17.6.3388; Osaki M, 2007, VIRCHOWS ARCH, V451, P771, DOI 10.1007/s00428-007-0470-z; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; SCARANO FJ, 1994, J VIROL, V68, P2355, DOI 10.1128/JVI.68.4.2355-2361.1994; Seeley TW, 1999, BIOCHEM BIOPH RES CO, V257, P589, DOI 10.1006/bbrc.1999.0514; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Takahashi T, 1999, ONCOGENE, V18, P4295, DOI 10.1038/sj.onc.1202807; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; WANG YC, 1995, MOL CELL BIOL, V15, P6838; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Weinstein J, 1997, J BIOL CHEM, V272, P28501, DOI 10.1074/jbc.272.45.28501; Wong OK, 2006, MOL BIOL CELL, V17, P4390, DOI 10.1091/mbc.E06-04-0346; Wong OK, 2005, J CELL BIOL, V170, P709, DOI 10.1083/jcb.200502163; Wu HY, 2000, ONCOGENE, V19, P4557, DOI 10.1038/sj.onc.1203803; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	74	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35834	35844		10.1074/jbc.M804967200	http://dx.doi.org/10.1074/jbc.M804967200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18922800	hybrid, Green Published			2022-12-27	WOS:000261687900058
J	Gao, X; Wen, J; Zhang, L; Li, X; Ning, YH; Meng, AM; Chen, YG				Gao, Xia; Wen, Jun; Zhang, Long; Li, Xiang; Ning, Yuanheng; Meng, Anming; Chen, Ye-Guang			Dapper1 Is a Nucleocytoplasmic Shuttling Protein That Negatively Modulates Wnt Signaling in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APC TUMOR-SUPPRESSOR; BETA-CATENIN; SUBCELLULAR-LOCALIZATION; FUNCTIONAL INTERACTION; REGULATOR; PATHWAY; COMPLEX; TARGET; AXIN; TCF	Wnt signaling, via the activation of the canonical beta-catenin and lymphoid enhancer factor (LEF)/T-cell factor pathway, plays an important role in embryogenesis and cancer development by regulating the expression of genes involved in cell proliferation, differentiation, and survival. Dapper (Dpr), as a Dishevelled interactor, has been suggested to modulate Wnt signaling by promoting Dishevelled degradation. Here, we provide evidence that Dpr1 shuttles between the cytoplasm and the nucleus. Although overexpressed Dpr1 was mainly found in the cytoplasm, endogenous Dpr1 was localized over the cell, and Wnt1 induced its nuclear export. Treatment with leptomycin B induced nuclear accumulation of both endogenous and overexpressed Dpr1. We further identified the nuclear localization signal and the nuclear export signal within Dpr1. Using reporter assay and in vivo zebrafish embryo assay, we demonstrated that the forced nuclearly localized Dpr1 possessed the ability to antagonize Wnt signaling. Dpr1 interacted with beta-catenin and LEF1 and disrupted their complex formation. Furthermore, Dpr1 could associate with histone deacetylase 1 (HDAC1) and enhance the LEF1-HDAC1 interaction. Together, our findings suggest that Dpr1 negatively modulates the basal activity of Wnt/beta-catenin signaling in the nucleus by keeping LEF1 in the repressive state. Thus, Dpr1 controls Wnt/beta-catenin signaling in both the cytoplasm and the nucleus.	[Gao, Xia; Wen, Jun; Zhang, Long; Li, Xiang; Ning, Yuanheng; Meng, Anming; Chen, Ye-Guang] Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Chen, YG (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Meng, Anming/A-4785-2012; Zhang, Long/AAT-6571-2021	Zhang, Long/0000-0001-8139-0474; Meng, Anming/0000-0001-7228-3431	National Natural Science Foundation of China [30430360, 30671033]; 973 Program [2004CB720002, 2006CB943401, 2006CB910102]; 863 Program [2006AA02Z172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30430360 and 30671033, 973 Program Grant 2004CB720002, 2006CB943401, and 2006CB910102, and 863 Program Grant 2006AA02Z172 ( to Y.-G.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Brott BK, 2005, DEV CELL, V8, P703, DOI 10.1016/j.devcel.2005.02.012; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Katoh M, 2003, INT J ONCOL, V22, P907; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yau TO, 2005, ONCOGENE, V24, P1607, DOI 10.1038/sj.onc.1208340; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	53	47	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35679	35688		10.1074/jbc.M804088200	http://dx.doi.org/10.1074/jbc.M804088200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18936100	hybrid			2022-12-27	WOS:000261687900042
J	Garcia-Roves, PM; Osler, ME; Holmstrom, MH; Zierath, JR				Garcia-Roves, Pablo M.; Osler, Megan E.; Holmstrom, Maria H.; Zierath, Juleen R.			Gain-of-function R225Q Mutation in AMP-activated Protein Kinase gamma 3 Subunit Increases Mitochondrial Biogenesis in Glycolytic Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-METABOLISM; GENE-EXPRESSION; GLYCOGEN-CONTENT; ENHANCER FACTOR; EXERCISE; ADAPTATION; GLUCOSE; GLUT4; TRANSCRIPTION; HOMEOSTASIS	AMP-activated protein kinase (AMPK) is a heterotrimeric complex, composed of a catalytic subunit (alpha) and two regulatory subunits (beta and gamma), that works as a cellular energy sensor. The existence of multiple heterotrimeric complexes provides a molecular basis for the multiple roles of this highly conserved signaling system. The AMPK gamma 3 subunit is predominantly expressed in skeletal muscle, mostly in type II glycolytic fiber types. We determined whether the AMPK gamma 3 subunit has a role in signaling pathways that mediate mitochondrial biogenesis in skeletal muscle. We provide evidence that overexpression or ablation of the AMPK gamma 3 subunit does not appear to play a critical role in defining mitochondrial content in resting skeletal muscle. However, overexpression of a mutant form (R225Q) of the AMPK gamma 3 subunit (Tg-AMPK gamma 3(225Q)) increases mitochondrial biogenesis in glycolytic skeletal muscle. These adaptations are associated with an increase in expression of the co-activator PGC-1 alpha and several transcription factors that regulate mitochondrial biogenesis, including NRF-1, NRF-2, and TFAM. Succinate dehydrogenase staining, a marker of the oxidative profile of individual fibers, was also increased in transversal skeletal muscle sections of white gastrocnemius muscle from Tg-AMPK gamma 3(225Q) mice, independent of changes in fiber type composition. In conclusion, a single nucleotide mutation (R225Q) in the AMPK gamma 3 subunit is associated with mitochondrial biogenesis in glycolytic skeletal muscle, concomitant with increased expression of the co-activator PGC-1 alpha and several transcription factors that regulate mitochondrial proteins, without altering fiber type composition.	[Garcia-Roves, Pablo M.; Osler, Megan E.; Holmstrom, Maria H.; Zierath, Juleen R.] Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, S-17177 Stockholm, Sweden	Karolinska Institutet	Zierath, JR (corresponding author), Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, Von Eulers Vag 4,4th Floor, S-17177 Stockholm, Sweden.	Juleen.Zierath@ki.se	Roves, Pablo Garcia/A-7113-2015; Garcia-Roves, Pablo M./X-4585-2018	Zierath, Juleen/0000-0001-6891-7497; Garcia-Roves, Pablo M./0000-0002-8371-2067	European Foundation for the Study of Diabetes; Swedish Research Council; Swedish Diabetes Association; Strategic Research Foundation; Knut and Alice Wallenberg Foundation; Novo Nordisk Research Foundation; Research and Education, Karolinska University Hospital; Commission of the European Communities [LSHM-CT-2004-005272]; EXGENESIS [LSHM-CT-2004-512013]	European Foundation for the Study of Diabetes; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Strategic Research Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Research and Education, Karolinska University Hospital; Commission of the European Communities(European Commission); EXGENESIS(European Commission)	This work was supported by the European Foundation for the Study of Diabetes, Swedish Research Council, Swedish Diabetes Association, Strategic Research Foundation (INGVAR II and Center for Functional Genetics), Knut and Alice Wallenberg Foundation, Novo Nordisk Research Foundation, Research and Education, Karolinska University Hospital, and Commission of the European Communities Contract LSHM-CT-2004-005272 EXGENESIS and Contract LSHM-CT-2004-512013 EUGENE2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Al-Khalili L, 2004, AM J PHYSIOL-CELL PH, V286, pC1410, DOI 10.1152/ajpcell.00444.2003; Athea Y, 2007, DIABETES, V56, P786, DOI 10.2337/db06-0187; Barnes BR, 2005, DIABETES, V54, P3484, DOI 10.2337/diabetes.54.12.3484; Barnes BR, 2005, FASEB J, V19, P773, DOI 10.1096/fj.04-3221com; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Costford SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000903; Fitts RH, 2003, AM J PHYS MED REHAB, V82, P320, DOI 10.1097/01.PHM.0000059336.40487.9C; Gao G, 1996, J BIOL CHEM, V271, P8675, DOI 10.1074/jbc.271.15.8675; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hodgson JA, 2005, J EXP BIOL, V208, P3761, DOI 10.1242/jeb.01825; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004; Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016; JAGER S, 2007, P NATL ACAD SCI USA; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Ju JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE347, DOI 10.1152/ajpendo.00238.2004; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Long YC, 2005, DIABETOLOGIA, V48, P2354, DOI 10.1007/s00125-005-1962-5; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nilsson EC, 2006, J BIOL CHEM, V281, P7244, DOI 10.1074/jbc.M510461200; Ojuka EO, 2002, AM J PHYSIOL-ENDOC M, V283, pE1040, DOI 10.1152/ajpendo.00242.2002; Putman CT, 2003, J PHYSIOL-LONDON, V551, P169, DOI 10.1113/jphysiol.2003.04069; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; SCHANTZ P, 1982, MUSCLE NERVE, V5, P628, DOI 10.1002/mus.880050807; SCHANTZ P, 1983, CLIN PHYSIOL, V3, P141, DOI 10.1111/j.1475-097X.1983.tb00685.x; SCHIAFFINO S, 1973, J HISTOCHEM CYTOCHEM, V21, P142, DOI 10.1177/21.2.142; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Weyrich P, 2007, DIABETOLOGIA, V50, P2097, DOI 10.1007/s00125-007-0788-8; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	54	131	134	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35724	35734		10.1074/jbc.M805078200	http://dx.doi.org/10.1074/jbc.M805078200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18838377	Green Published, hybrid			2022-12-27	WOS:000261687900046
J	Rofougaran, R; Crona, M; Vodnala, M; Sjoberg, BM; Hofer, A				Rofougaran, Reza; Crona, Mikael; Vodnala, Munender; Sjoberg, Britt-Marie; Hofer, Anders			Oligomerization Status Directs Overall Activity Regulation of the Escherichia coli Class Ia Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHATE REDUCTASE; PROTEIN R1; ALLOSTERIC REGULATION; TRYPANOSOMA-BRUCEI; ELECTROPHORETIC MOBILITY; SUBUNIT INTERACTION; ENZYMATIC SYNTHESIS; RECOMBINANT MOUSE; EFFECTOR-BINDING; ATP-CONE	Ribonucleotide reductase (RNR) is a key enzyme for the synthesis of the four DNA building blocks. Class Ia RNRs contain two subunits, denoted R1 (alpha) and R2 (beta). These enzymes are regulated via two nucleotide-binding allosteric sites on the R1 subunit, termed the specificity and overall activity sites. The specificity site binds ATP, dATP, dTTP, or dGTP and determines the substrate to be reduced, whereas the overall activity site binds dATP (inhibitor) or ATP. By using gas-phase electrophoretic mobility macromolecule analysis and enzyme assays, we found that the Escherichia coli class Ia RNR formed an inhibited alpha(4)beta(4) complex in the presence of dATP and an active alpha(2)beta(2) complex in the presence of ATP (main substrate: CDP), dTTP (substrate: GDP) or dGTP (substrate: ADP). The R1-R2 interaction was 30-50 times stronger in the alpha(4)beta(4) complex than in the alpha(4)beta(4) complex, which was in equilibrium with free alpha(2) and beta(2) subunits. Studies of a known E. coli R1 mutant (H59A) showed that deficient dATP inhibition correlated with reduced ability to form alpha(4)beta(4) complexes. ATP could also induce the formation of a generally inhibited alpha(4)beta(4) complex in the E. coli RNR but only when used in combination with high concentrations of the specificity site effectors, dTTP/dGTP. Both allosteric sites are therefore important for alpha(4)beta(4) formation and overall activity regulation. The E. coli RNR differs from the mammalian enzyme, which is stimulated by ATP also in combination with dGTP/dTTP and forms active and inactive alpha(6)beta(2) complexes.	[Rofougaran, Reza; Vodnala, Munender; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Crona, Mikael; Sjoberg, Britt-Marie] Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden	Umea University; Stockholm University	Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	anders.hofer@medchem.umu.se		Hofer, Anders/0000-0003-2890-2957; Vodnala, Munender/0000-0002-6219-6243; Crona, Mikael/0000-0002-6420-6097; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Cancer Foundation; Swedish Research Council; Kempe Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation	This work was supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, and the Kempe Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravind L, 2000, J MOL MICROB BIOTECH, V2, P191; Bacher G, 2001, J MASS SPECTROM, V36, P1038, DOI 10.1002/jms.208; Berg J, 2002, BIOCHEMISTRY-US, P702; Birgander PL, 2005, J BIOL CHEM, V280, P14997, DOI 10.1074/jbc.M500565200; Birgander PL, 2004, J BIOL CHEM, V279, P14496, DOI 10.1074/jbc.M310142200; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BROWN NC, 1969, J MOL BIOL, V46, P25, DOI 10.1016/0022-2836(69)90055-2; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; CARAS IW, 1988, MOL CELL BIOL, V8, P2698, DOI 10.1128/MCB.8.7.2698; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; CORY JG, 1985, J BIOL CHEM, V260, P2001; DAVIS R, 1994, J BIOL CHEM, V269, P23171; Ekberg M, 1996, J BIOL CHEM, V271, P20655, DOI 10.1074/jbc.271.34.20655; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; ERIKSSON S, 1977, J BIOL CHEM, V252, P6132; ERIKSSON S, 1989, ALLOSTERIC ENZYMES, P189; Hendricks SP, 1997, J BIOL CHEM, V272, P2861, DOI 10.1074/jbc.272.5.2861; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Ingemarson R, 1996, BIOCHEMISTRY-US, V35, P8603, DOI 10.1021/bi960184n; Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Kasrayan A, 2004, J BIOL CHEM, V279, P31050, DOI 10.1074/jbc.M400693200; Kaufman SL, 1996, ANAL CHEM, V68, P1895, DOI 10.1021/ac951128f; Kaufman SL, 2000, ANAL CHIM ACTA, V406, P3, DOI 10.1016/S0003-2670(99)00597-8; LARSSON A, 1966, J BIOL CHEM, V241, P2540; LARSSON A, 1966, J BIOL CHEM, V241, P2533; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; ORMO M, 1990, ANAL BIOCHEM, V189, P138, DOI 10.1016/0003-2697(90)90059-I; Reichard P, 2000, J BIOL CHEM, V275, P33021, DOI 10.1074/jbc.M005337200; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; SJOBERG BM, 1986, J BIOL CHEM, V261, P5658; SJOBERG BM, 1987, J BIOL CHEM, V262, P9736; Thelander L, 1978, Methods Enzymol, V51, P227; THELANDER L, 1973, J BIOL CHEM, V248, P4591; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; WEINBERG G, 1981, P NATL ACAD SCI-BIOL, V78, P2447, DOI 10.1073/pnas.78.4.2447	44	65	66	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35310	35318		10.1074/jbc.M806738200	http://dx.doi.org/10.1074/jbc.M806738200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18835811	hybrid			2022-12-27	WOS:000261687900002
J	Jung, H; Seong, HA; Ha, H				Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung			Murine Protein Serine/Threonine Kinase 38 Activates Apoptosis Signal-regulating Kinase 1 via Thr(838) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NM23-H1 TUMOR-SUPPRESSOR; SERINE-THREONINE KINASE; HEMATOPOIETIC-CELLS; ASK1; INHIBITOR; DISSOCIATION; THIOREDOXIN; PROTEASES; CLONING; PATHWAY	Murine protein serine/threonine kinase 38 (MPK38) is a member of the AMP-activated protein kinase-related serine/threonine kinase family that plays an important role in various cellular processes, including cell cycle, signaling pathways, and self-renewal of stem cells. Here we demonstrate a functional association between MPK38 and apoptosis signal-regulating kinase 1 (ASK1). The physical association between MPK38 and ASK1 was mediated through their carboxyl-terminal regulatory domains and was increased by H2O2 or tumor necrosis factor alpha treatment. The use of kinase-dead MPK38 and ASK1 mutants revealed that MPK38-ASK1 complex formation was dependent on the activities of both kinases. Ectopic expression of wild-type MPK38, but not kinase-dead MPK38, stimulated ASK1 activity by Thr(838) phosphorylation and enhanced ASK1-mediated signaling to both JNK and p38 kinases. However, the phosphorylation of MKK6 and p38 by MPK38 was not detectable. In addition, MPK38-mediated ASK1 activation was induced through the increased interaction between ASK1 and its substrate MKK3. MPK38 also stimulated H2O2-mediated apoptosis by enhancing the ASK1 activity through Thr(838) phosphorylation. These results suggest that MPK38 physically interacts with ASK1 in vivo and acts as a positive upstream regulator of ASK1.	[Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Biotechnol Res Inst, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Biotechnol Res Inst, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr			Korea Science and Engineering Foundation [R0A-2007-000-20006-0]; Chungbuk National University	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Chungbuk National University	This work was supported by Korea Science and Engineering Foundation Grant R0A-2007-000-20006-0 and in part by Chungbuk National University Grant 2007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beullens M, 2005, J BIOL CHEM, V280, P40003, DOI 10.1074/jbc.M507274200; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; Fujii K, 2004, ONCOGENE, V23, P5099, DOI 10.1038/sj.onc.1207668; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002; Patel T, 1996, FASEB J, V10, P587, DOI 10.1096/fasebj.10.5.8621058; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Seong HA, 2002, BIOCHEM J, V361, P597, DOI 10.1042/0264-6021:3610597; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Yang Y, 1999, APPL BIOCHEM BIOTECH, V80, P13, DOI 10.1385/ABAB:80:1:13; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	35	55	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34541	34553		10.1074/jbc.M807219200	http://dx.doi.org/10.1074/jbc.M807219200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18948261	Green Published, hybrid			2022-12-27	WOS:000261469100008
J	Maehama, T; Tanaka, M; Nishina, H; Murakami, M; Kanaho, Y; Hanada, K				Maehama, Tomohiko; Tanaka, Masahiko; Nishina, Hiroshi; Murakami, Makoto; Kanaho, Yasunori; Hanada, Kentaro			RalA Functions as an Indispensable Signal Mediator for the Nutrient-sensing System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUFFICIENCY; MAMMALIAN TARGET; EXOCYST COMPLEX; DEPENDENT MANNER; RHEB GTPASE; PHOSPHORYLATION SITE; RAPAMYCIN MTOR; S6 KINASE-1; RAG GTPASES; TSC2	Cells sense nutrients present in the extracellular environment and modulate the activities of intracellular signaling systems in response to nutrient availability. This study demonstrates that RalA and its activator RalGDS participate in nutrient sensing and are indispensable for activation of mammalian target of rapamycin complex 1 (mTORC1) induced by extracellular nutrients. Knockdown of RalA or RalGDS abolished amino acid- and glucose-induced mTORC1 activation, as judged by phosphorylation of S6 kinase and eukaryotic translation initiation factor 4E-binding protein 1. The amount of GTP-bound RalA increased in response to increased amino acid availability. In addition, RalA knockdown suppressed Rheb-induced S6 kinase phosphorylation, and the constitutively active form of RalA induced mTORC1 activation in the absence of Rheb. These results collectively suggest that RalGDS and RalA act downstream of Rheb and that RalA activation is a crucial step in nutrient-induced mTORC1 activation.	[Maehama, Tomohiko; Tanaka, Masahiko; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Tanaka, Masahiko; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo 1138510, Japan; [Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Biomembrane Signaling Project, Tokyo 1138613, Japan; [Murakami, Makoto] Japan Sci & Technol Corp, PRESTO, Saitama 3320012, Japan; [Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Kanaho, Yasunori] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Physiol Chem, Tsukuba, Ibaraki 3058575, Japan	National Institute of Infectious Diseases (NIID); Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba	Maehama, T (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	tmaehama@nih.go.jp	Maehama, Tomohiko/AAX-8926-2020; Maehama, Tomohiko/HGB-4896-2022	Maehama, Tomohiko/0000-0002-9685-2317; Hanada, Kentaro/0000-0003-1383-2781	Japanese Ministry of Education, Culture, Sports, Science, and Technology [18057028, 20054024, 19370058, 19657044]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research 18057028, 20054024, 19370058, and 19657044 from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan LJ, 2006, J BIOL CHEM, V281, P19793, DOI 10.1074/jbc.C600028200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	46	64	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35053	35059		10.1074/jbc.M805822200	http://dx.doi.org/10.1074/jbc.M805822200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18948269	Green Published, hybrid			2022-12-27	WOS:000261469100062
J	Stokasimov, E; McKane, M; Rubenstein, PA				Stokasimov, Ema; McKane, Melissa; Rubenstein, Peter A.			Role of Intermonomer Ionic Bridges in the Stabilization of the Actin Filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN; F-ACTIN; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL MOVEMENT; DEPOLYMERIZING FACTOR; INTERACTING PROTEIN-1; REGULATORY PROTEINS; CELLULAR FUNCTION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS	Filament formation is required for most of the functions of actin. However, the intermonomer interactions that stabilize F-actin have not been elucidated because of a lack of an F-actin crystal structure. The Holmes muscle actin model suggests that an ionic interaction between Arg-39 of one monomer and Glu-167 of an adjacent monomer in the same strand contributes to this stabilization. Yeast actin has an Ala-167 instead. F-actin molecular dynamics modeling predicts another interaction between Arg-39 of one monomer and Asp-275 of an opposing strand monomer. In Toxoplasma gondii actin, which forms short stubby filaments, the Asp-275 equivalent is replaced by Arg leading to a potential filament-destabilizing charge-charge repulsion. Using yeast actin, we tested the effect of A167E as a potential stabilizer and A167R and D275R as potential filament disruptors. All mutations caused abnormal growth and mitochondrial malfunction. A167E and D275R actins polymerize normally and form relatively normal appearing filaments. A167R nucleates filaments more slowly and forms filament bundles. The R39D/A167R double mutant, which re-establishes an ionic bond in the opposite orientation, reverses this polymerization and bundling defect. Stoichiometric amounts of yeast cofilin have little effect on wild-type and A167E filaments. However, D275R and A167R actin depolymerization is profound with cofilin. Although our results suggest that disruption of an interaction between Arg-39 and Asp-275 is not sufficient to cause fragmentation, it suggests that it changes filament stability thereby disposing it for enhanced cofilin depolymerizing effects. Ala-167 results demonstrate the in vivo and in vitro importance of another potential Arg-39 ionic interaction.	[Stokasimov, Ema; McKane, Melissa; Rubenstein, Peter A.] Univ Iowa Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [GM33689]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33689 ( to P. A. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benchaar SA, 2007, BIOCHEMISTRY-US, V46, P225, DOI 10.1021/bi0610754; Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Bryan KE, 2006, J BIOL CHEM, V281, P20129, DOI 10.1074/jbc.M601514200; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; CHEN X, 1993, J CELL BIOL, V123, P1185, DOI 10.1083/jcb.123.5.1185; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Conchaudron AP, 2006, J BIOL CHEM, V281, P24036, DOI 10.1074/jbc.M602747200; COOK RK, 1992, J BIOL CHEM, V267, P9430; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; GANCEDO C, 1968, EUR J BIOCHEM, V5, P165, DOI 10.1111/j.1432-1033.1968.tb00353.x; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; IIDA K, 1993, GENE, V124, P115; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kamal JKA, 2007, P NATL ACAD SCI USA, V104, P7910, DOI 10.1073/pnas.0611283104; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; KLINGENBERG M, 1970, EUR J BIOCHEM, V13, P247, DOI 10.1111/j.1432-1033.1970.tb00924.x; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; McKane M, 2005, J BIOL CHEM, V280, P36494, DOI 10.1074/jbc.M506970200; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Mohri K, 2006, MOL BIOL CELL, V17, P2190, DOI 10.1091/mbc.E05-11-1016; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Ojala PJ, 2001, BIOCHEMISTRY-US, V40, P15562, DOI 10.1021/bi0117697; Okada K, 2006, MOL BIOL CELL, V17, P2855, DOI 10.1091/mbc.e06-02-0135; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; POLLARD TD, 1984, FEBS LETT, V170, P94, DOI 10.1016/0014-5793(84)81376-9; RICKARD JE, 1986, J MOL BIOL, V191, P273, DOI 10.1016/0022-2836(86)90264-0; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; SIKORSKI RS, 1989, GENETICS, V122, P19; Slaninova I, 2000, ARCH MICROBIOL, V173, P245, DOI 10.1007/s002030000136; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Yang HC, 2001, METHOD CELL BIOL, V65, P333, DOI 10.1016/S0091-679X(01)65020-9; Yao XY, 2002, J BIOL CHEM, V277, P22875, DOI 10.1074/jbc.M201685200; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200	53	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34844	34854		10.1074/jbc.M804419200	http://dx.doi.org/10.1074/jbc.M804419200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945676	Green Published, hybrid			2022-12-27	WOS:000261469100040
J	Coba, MP; Valor, LM; Kopanitsa, MV; Afinowi, NO; Grant, SGN				Coba, Marcelo P.; Valor, Luis M.; Kopanitsa, Maksym V.; Afinowi, Nurudeen O.; Grant, Seth G. N.			Kinase Networks Integrate Profiles of N-Methyl-D-aspartate Receptor-mediated Gene Expression in Hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA RECEPTOR; POSTSYNAPTIC DENSITY-95; SYNAPTIC PLASTICITY; IN-VIVO; PHOSPHORYLATION; NEUROSCIENCE; INDUCTION; PATHWAYS; COMPLEX	The postsynaptic N-methyl-D-aspartate (NMDA) receptor activates multiple kinases and changes the phosphorylation of many postsynaptic proteins organized in signaling networks. Because the NMDA receptor is known to regulate gene expression, it is important to examine whether networks of kinases control signaling to gene expression. We examined the requirement of multiple kinases and NMDA receptor-interacting proteins for gene expression in mouse hippocampal slices. Protocols that induce long-term depression (LTD) and long-term potentiation (LTP) activated common kinases and overlapping gene expression profiles. Combinations of kinases were required for induction of each gene. Distinct combinations of kinases were required to up-regulate Arc, Npas4, Egr2, and Egr4 following either LTP or LTD protocols. Consistent with the combinatorial data, a mouse mutant model of the human cognition disease gene SAP102, which couples ERK kinase to the NMDA receptor, showed deregulated expression of specific genes. These data support a network model of postsynaptic integration where kinase signaling networks are recruited by differential synaptic activity and control both local synaptic events and activity-dependent gene expression.	[Coba, Marcelo P.; Valor, Luis M.; Kopanitsa, Maksym V.; Afinowi, Nurudeen O.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Valor, Luis M.] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante 03550, Spain	Wellcome Trust Sanger Institute; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Grant, SGN (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	sg3@sanger.ac.uk	Kopanitsa, Maksym/I-4668-2019; Kopanitsa, Maksym/G-6266-2011; Valor, Luis/ABG-1754-2020	Grant, Seth/0000-0001-8732-8735; Valor, Luis M./0000-0002-1229-0565				Bloomer WAC, 2008, J BIOL CHEM, V283, P582, DOI 10.1074/jbc.M702451200; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Dadgostar H, 2002, P NATL ACAD SCI USA, V99, P1497, DOI 10.1073/pnas.032665099; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Grant SGN, 2005, HUM MOL GENET, V14, pR225, DOI 10.1093/hmg/ddi330; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kopanitsa MV, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-61; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Opazo P, 2003, J NEUROSCI, V23, P3679; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Watanabe T, 2005, DEV BIOL, V277, P508, DOI 10.1016/j.ydbio.2004.08.051; Winstanley CA, 2007, J NEUROSCI, V27, P10497, DOI 10.1523/JNEUROSCI.2566-07.2007; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	30	34	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34101	34107		10.1074/jbc.M804951200	http://dx.doi.org/10.1074/jbc.M804951200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18815127	Green Published, hybrid			2022-12-27	WOS:000261277700038
J	Oliveira, TF; Vonrhein, C; Matias, PM; Venceslau, SS; Pereira, IAC; Archer, M				Oliveira, Tania F.; Vonrhein, Clemens; Matias, Pedro M.; Venceslau, Sofia S.; Pereira, Ines A. C.; Archer, Margarida			The Crystal Structure of Desulfovibrio vulgaris Dissimilatory Sulfite Reductase Bound to DsrC Provides Novel Insights into the Mechanism of Sulfate Respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR; PROSTHETIC GROUPS; DSRMKJOP COMPLEX; SIROHEME; PURIFICATION; CLUSTER; SUBUNIT; PROTEIN; HILDENBOROUGH; EVOLUTION	Sulfate reduction is one of the earliest types of energy metabolism used by ancestral organisms to sustain life. Despite extensive studies, many questions remain about the way respiratory sulfate reduction is associated with energy conservation. A crucial enzyme in this process is the dissimilatory sulfite reductase (dSiR), which contains a unique siroheme-[4Fe4S] coupled cofactor. Here, we report the structure of desulfoviridin from Desulfovibrio vulgaris, in which the dSiR DsrAB (sulfite reductase) subunits are bound to the DsrC protein. The alpha(2)beta(2)gamma(2) assembly contains two siroheme-[4Fe4S] cofactors bound by DsrB, two sirohydrochlorins and two [4Fe4S] centers bound by DsrA, and another four [4Fe4S] centers in the ferredoxin domains. A sulfite molecule, coordinating the siroheme, is found at the active site. The DsrC protein is bound in a cleft between DsrA and DsrB with its conserved C-terminal cysteine reaching the distal side of the siroheme. We propose a novel mechanism for the process of sulfite reduction involving DsrAB, DsrC, and the DsrMKJOP membrane complex (a membrane complex with putative disulfide/thiol reductase activity), in which two of the six electrons for reduction of sulfite derive from the membrane quinone pool. These results show that DsrC is involved in sulfite reduction, which changes the mechanism of sulfate respiration. This has important implications for models used to date ancient sulfur metabolism based on sulfur isotope fractionations.	[Oliveira, Tania F.; Matias, Pedro M.; Venceslau, Sofia S.; Pereira, Ines A. C.; Archer, Margarida] Univ Nova Lisboa, ITQB, P-2780157 Oeiras, Portugal; [Vonrhein, Clemens] Global Phasing Ltd, Cambridge CB3 0AX, England	Universidade Nova de Lisboa; Global Phasing Limited	Pereira, IAC (corresponding author), Univ Nova Lisboa, ITQB, Av Republ EAN, P-2780157 Oeiras, Portugal.	ipereira@itqb.unl.pt; archer@itqb.unl.pt	Matias, Pedro M/B-7180-2008; Pereira, Inês/C-2748-2009; Venceslau, Sofia/M-2882-2016	Matias, Pedro M/0000-0001-6170-451X; Pereira, Inês/0000-0003-3283-4520; Venceslau, Sofia/0000-0001-8774-1351; Oliveira, Tania/0000-0003-0843-7541; Archer, Margarida/0000-0001-8419-5420	Fundacao para a Ciencia e Tecnologia (Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal) [PTDC/QUI/68368/06, PPCDT/BIA-PRO/55621/2004]; Fundo Europeu de Desenvolvimento Regional program; Fundacao para a Ciencia e Tecnologia-Programa Operacional Ciencia, Tecnologia, Inovacao fellowships [SFRH/BD/29519/2006, SFRH/BD/30648/2006]	Fundacao para a Ciencia e Tecnologia (Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal)(Portuguese Foundation for Science and Technology); Fundo Europeu de Desenvolvimento Regional program; Fundacao para a Ciencia e Tecnologia-Programa Operacional Ciencia, Tecnologia, Inovacao fellowships(Portuguese Foundation for Science and Technology)	This work was supported by the Research Grants PTDC/QUI/68368/06 and PPCDT/BIA-PRO/55621/2004 funded by Fundacao para a Ciencia e Tecnologia (Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal) and Fundo Europeu de Desenvolvimento Regional program and by Fundacao para a Ciencia e Tecnologia-Programa Operacional Ciencia, Tecnologia, Inovacao fellowships SFRH/BD/29519/2006 (to T. F. O.) and SFRH/BD/30648/2006 (to S. S. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akagi J.M, 1995, BIOTECH HAN, P89; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; ARENDSEN AF, 1993, BIOCHEMISTRY-US, V32, P10323, DOI 10.1021/bi00090a007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; CHANG CK, 1981, P NATL ACAD SCI USA, V78, P2652, DOI 10.1073/pnas.78.5.2652; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; Cort JR, 2001, EUR J BIOCHEM, V268, P5842, DOI 10.1046/j.0014-2956.2001.02529.x; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; DAHL C, 1993, J GEN MICROBIOL, V139, P1817, DOI 10.1099/00221287-139-8-1817; DeLano W.L, PYMOL MOL GRAPHICS S; Dhillon A, 2005, ASTROBIOLOGY, V5, P18, DOI 10.1089/ast.2005.5.18; DRAKE HL, 1978, J BACTERIOL, V136, P916, DOI 10.1128/JB.136.3.916-923.1978; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; FAUQUE G, 1990, BIOCHIM BIOPHYS ACTA, V1040, P112, DOI 10.1016/0167-4838(90)90154-8; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hamann N, 2007, BIOCHEMISTRY-US, V46, P12875, DOI 10.1021/bi700679u; Haveman SA, 2003, J BACTERIOL, V185, P4345, DOI 10.1128/JB.185.15.4345-4353.2003; Hipp WM, 1997, MICROBIOL-UK, V143, P2891, DOI 10.1099/00221287-143-9-2891; Hoek J, 2008, MICROBIAL SULFUR METABOLISM, P273, DOI 10.1007/978-3-540-72682-1_21; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; JANICK PA, 1982, BIOCHEMISTRY-US, V21, P3538, DOI 10.1021/bi00258a003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KARKHOFFSCHWEIZER RAR, 1993, EUR J BIOCHEM, V211, P501, DOI 10.1111/j.1432-1033.1993.tb17576.x; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; KOBAYASHI K, 1982, FEBS LETT, V142, P235, DOI 10.1016/0014-5793(82)80142-7; Loy A, 2008, MICROBIAL SULFUR METABOLISM, P46, DOI 10.1007/978-3-540-72682-1_5; Mander GJ, 2005, FEBS LETT, V579, P4600, DOI 10.1016/j.febslet.2005.07.029; Marritt SJ, 1996, EUR J BIOCHEM, V238, P724, DOI 10.1111/j.1432-1033.1996.0724w.x; MATTHEWS JC, 1995, BIOCHEMISTRY-US, V34, P5248, DOI 10.1021/bi00015a039; Molitor M, 1998, MICROBIOL-SGM, V144, P529, DOI 10.1099/00221287-144-2-529; MOURA I, 1988, J AM CHEM SOC, V110, P1075, DOI 10.1021/ja00212a013; MURPHY MJ, 1973, J BIOL CHEM, V248, P6911; Oliveira TF, 2008, J STRUCT BIOL, V164, P236, DOI 10.1016/j.jsb.2008.07.007; OSTROWSKI J, 1989, J BIOL CHEM, V264, P15726; Pearson AR, 2007, BIOCHEMISTRY-US, V46, P8340, DOI 10.1021/bi700086r; PECK HD, 1982, PHILOS T R SOC B, V298, P443, DOI 10.1098/rstb.1982.0091; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; PIERIK AJ, 1991, EUR J BIOCHEM, V195, P505, DOI 10.1111/j.1432-1033.1991.tb15731.x; PIERIK AJ, 1992, EUR J BIOCHEM, V205, P111, DOI 10.1111/j.1432-1033.1992.tb16757.x; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; POSTGATE J, 1959, NATURE, V183, P481, DOI 10.1038/183481b0; Sander J, 2006, ARCH MICROBIOL, V186, P357, DOI 10.1007/s00203-006-0156-y; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schiffer A, 2008, J MOL BIOL, V379, P1063, DOI 10.1016/j.jmb.2008.04.027; Schnell R, 2005, J BIOL CHEM, V280, P27319, DOI 10.1074/jbc.M502560200; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; STEUBER J, 1994, ARCH MICROBIOL, V162, P255, DOI 10.1007/s002030050134; Swamy U, 2005, BIOCHEMISTRY-US, V44, P16054, DOI 10.1021/bi050981y; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; Whittaker MM, 2003, J BIOL CHEM, V278, P22090, DOI 10.1074/jbc.M300112200; WOLFE BM, 1994, EUR J BIOCHEM, V223, P79, DOI 10.1111/j.1432-1033.1994.tb18968.x; YOUNG LJ, 1988, BIOCHEMISTRY-US, V27, P5984, DOI 10.1021/bi00416a023	60	118	122	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34141	34149		10.1074/jbc.M805643200	http://dx.doi.org/10.1074/jbc.M805643200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18829451	Green Published, hybrid			2022-12-27	WOS:000261277700042
J	Tchesnokov, EP; Obikhod, A; Schinazi, RF; Gotte, M				Tchesnokov, Egor P.; Obikhod, Aleksandr; Schinazi, Raymond F.; Gotte, Matthias			Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE TRANSLOCATION; MOLECULAR-MECHANISMS; NUCLEOSIDE ANALOGS; PRIMER UNBLOCKING; INFECTED PATIENTS; NAIVE PATIENTS; RATCHET MODEL; IN-VITRO; RESISTANCE	Entecavir (ETV) is a potent antiviral nucleoside analogue that is used to treat hepatitis B virus (HBV) infection. Recent clinical studies have demonstrated that ETV is also active against the human immunodeficiency virus type 1 (HIV-1). Unlike all approved nucleoside analogue reverse transcriptase RT) inhibitors (NRTIs), ETV contains a 3'-hydroxyl group that allows further nucleotide incorporation events to occur. Thus, the mechanism of inhibition probably differs from classic chain termination. Here, we show that the incorporated ETV-monophosphate (MP) can interfere with three distinct stages of DNA synthesis. First, incorporation of the next nucleotide at position n + 1 following ETV-MP is compromised, although DNA synthesis eventually continues. Second, strong pausing at position n + 3 suggests a long range effect, referred to as "delayed chain-termination." Third, the incorporated ETV-MP can also act as a "base pair confounder" during synthesis of the second DNA strand, when the RT enzyme needs to pass the inhibitor in the template. Enzyme kinetics revealed that delayed chain termination is the dominant mechanism of action. High resolution foot-printing experiments suggest that the incorporated ETV-MP "repels" the 3'-end of the primer from the active site of HIV-1 RT, which, in turn, diminishes incorporation of the natural nucleotide substrate at position n + 4. Most importantly, delayed chain termination protects ETV-MP from phosphorolytic excision, which represents a major resistance mechanism for approved NRTIs. Collectively, these findings provide a rationale and important tools for the development of novel, more potent delayed chain terminators as anti-HIV agents.	[Tchesnokov, Egor P.; Gotte, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Obikhod, Aleksandr; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res, Atlanta, GA 30322 USA; [Obikhod, Aleksandr; Schinazi, Raymond F.] Vet Affairs Med Res, Atlanta, GA 30322 USA	McGill University; Emory University	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca			National Institutes of Health [5R37-AI-041980, 4R37-AI-025899, 5P30-AI-50409]; Canadian Institutes for Health Research (CIHR); United States Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI025899, P30AI050409, R37AI041980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R37-AI-041980, 4R37-AI-025899, and 5P30-AI-50409 (CFAR) (to R. F. S.). This study was also supported by the Canadian Institutes for Health Research (CIHR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. Supported in part by the United States Department of Veterans Affairs.	Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; Benhamou Y, 2003, NEW ENGL J MED, V348, P177, DOI 10.1056/NEJM200301093480218; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Colonno RJ, 2006, HEPATOLOGY, V44, P1656, DOI 10.1002/hep.21422; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Deval J, 2007, ANTIMICROB AGENTS CH, V51, P2920, DOI 10.1128/AAC.00186-07; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Domaoal RA, 2008, J BIOL CHEM, V283, P5452, DOI 10.1074/jbc.M707834200; Fontaine H, 1999, ANN INTERN MED, V131, P716, DOI 10.7326/0003-4819-131-9-199911020-00027; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; GOTTE M, 1995, EMBO J, V14, P833, DOI 10.1002/j.1460-2075.1995.tb07061.x; Gutfreund KS, 2000, J HEPATOL, V33, P469, DOI 10.1016/S0168-8278(00)80284-6; Hirsch MS, 2007, NEW ENGL J MED, V356, P2641, DOI 10.1056/NEJMe078045; Isel C, 2001, J BIOL CHEM, V276, P48725, DOI 10.1074/jbc.M108352200; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; Lin PF, 2008, ANTIMICROB AGENTS CH, V52, P1759, DOI 10.1128/AAC.01313-07; Ling R, 1996, HEPATOLOGY, V24, P711, DOI 10.1053/jhep.1996.v24.pm0008781347; Manalakopoulos S, 2008, ALIMENT PHARM THER, V27, P266, DOI 10.1111/j.1365-2036.2007.03567.x; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Marquez VE, 2004, J AM CHEM SOC, V126, P543, DOI 10.1021/ja037929e; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Miller MD, 2001, NUCLEOS NUCLEOT NUCL, V20, P1025, DOI 10.1081/NCN-100002483; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nunez M, 2002, AIDS, V16, P2352, DOI 10.1097/00002030-200211220-00023; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sasadeusz J, 2008, AIDS, V22, P947, DOI 10.1097/QAD.0b013e3282ffde91; Sasadeusz Joe, 2007, J Hepatol, V47, P872, DOI 10.1016/j.jhep.2007.09.002; SCHINAZI RF, 1992, ANTIMICROB AGENTS CH, V36, P2423, DOI 10.1128/AAC.36.11.2423; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Seifer M, 1998, ANTIMICROB AGENTS CH, V42, P3200, DOI 10.1128/AAC.42.12.3200; SEVERINI A, 1995, ANTIMICROB AGENTS CH, V39, P1430, DOI 10.1128/AAC.39.7.1430; Sherman M, 2006, GASTROENTEROLOGY, V130, P2039, DOI 10.1053/j.gastro.2006.04.007; Soriano V, 2008, AIDS, V22, P911, DOI 10.1097/QAD.0b013e3282f82b96; Sulkowski MS, 2008, J INFECT DIS, V197, pS279, DOI 10.1086/533414; Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009; Telesnitsky A., 1997, P121; Tenney DJ, 2007, ANTIMICROB AGENTS CH, V51, P902, DOI 10.1128/AAC.00833-06; Tenney DJ, 2004, ANTIMICROB AGENTS CH, V48, P3498, DOI 10.1128/AAC.48.9.3498-3507.2004; Thibault V, 1999, J CLIN MICROBIOL, V37, P3013, DOI 10.1128/JCM.37.9.3013-3016.1999; van Bommel F, 2002, HEPATOLOGY, V36, P507, DOI 10.1053/jhep.2002.35328; Villet S, 2006, GASTROENTEROLOGY, V131, P1253, DOI 10.1053/j.gastro.2006.08.013; WAINBERG MA, 1995, AIDS, V9, P351, DOI 10.1097/00002030-199509040-00006; Yuan HJ, 2007, CURR MOL MED, V7, P185, DOI 10.2174/156652407780059159	57	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34218	34228		10.1074/jbc.M806797200	http://dx.doi.org/10.1074/jbc.M806797200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18940786	Green Published, hybrid			2022-12-27	WOS:000261277700050
J	Willer, M; Forte, GMA; Stirling, CJ				Willer, Martin; Forte, Gabriella M. A.; Stirling, Colin J.			Sec61p Is Required for ERAD-L GENETIC DISSECTION OF THE TRANSLOCATION AND ERAD-L FUNCTIONS OF Sec61P USING NOVEL DERIVATIVES OF CPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN TRANSLOCATION; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; UBIQUITIN-LIGASE; QUALITY-CONTROL; YEAST SEC61P; DEGRADATION; COMPLEX; REVEALS	Misfolded proteins in the endoplasmic reticulum (ER) are exported to the cytosol for degradation by the proteasome in a process known as ER-associated degradation (ERAD). CPY* is a well characterized ERAD substrate whose degradation is dependent upon the Hrd1 complex. However, although the functions of some of the components of this complex are known, the nature of the protein dislocation channel remains obscure. Sec61p has been suggested as an obvious candidate because of its role as a protein-conducting channel through which polypeptides are initially translocated into the ER. However, it has not yet been possible to functionally dissect any role for Sec61p in dislocation from its essential function in translocation. By changing the translocation properties of a series of novel ERAD substrates, we are able to separate these two events and find that functional Sec61p is essential for the ERAD-L pathway.	[Willer, Martin; Forte, Gabriella M. A.; Stirling, Colin J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Stirling, CJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	colin.stirling@manchester.ac.uk			Wellcome Trust [074149]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant 074149. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hitt R, 2004, FEMS YEAST RES, V4, P815, DOI 10.1016/j.femsyr.2004.04.002; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Robson A, 2006, EMBO REP, V7, P1099, DOI 10.1038/sj.embor.7400832; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; SILBERSTEIN S, 1995, J CELL BIOL, V128, P525, DOI 10.1083/jcb.128.4.525; STIRLING CJ, 1992, NATURE, V356, P534, DOI 10.1038/356534a0; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Willer M, 2003, YEAST, V20, P133, DOI 10.1002/yea.954; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	31	63	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33883	33888		10.1074/jbc.M803054200	http://dx.doi.org/10.1074/jbc.M803054200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819915	Green Published, hybrid			2022-12-27	WOS:000261277700013
J	Moncrieffe, MC; Grossmann, JG; Gay, NJ				Moncrieffe, Martin C.; Grossmann, J. Guenter; Gay, Nicholas J.			Assembly of Oligomeric Death Domain Complexes during Toll Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REL PROTEIN DORSAL; DROSOPHILA MYD88; PELLE KINASE; ADAPTER; TOLL-LIKE-RECEPTOR-4; SUPERFAMILY; ACTIVATION; MECHANISM; POLARITY; PATHWAY	The Drosophila Toll receptor is activated by the endogenous protein ligand Spatzle in response to microbial stimuli in immunity and spatial cues during embryonic development. Downstream signaling is mediated by the adaptor proteins Tube, the kinase Pelle, and the Drosophila homologue of myeloid differentiation primary response protein (dMyD88). Here we have characterized heterodimeric (dMyD88-Tube) and heterotrimeric (dMyD88-Tube-Pelle) death domain complexes. We show that both the heterodimeric and heterotrimeric complexes form kidney-shaped structures and that Tube is bivalent and has separate high affinity binding sites for dMyD88 and Pelle. Additionally we found no interaction between the isolated death domains of Pelle and dMyD88. These results indicate that the mode of assembly of the heterotrimeric dMyD88-Tube-Pelle complex downstream of the activated Toll receptor is unique. The measured dissociation constants for the interaction between the death domains of dMyD88 and Tube and of Pelle and a preformed dMyD88-Tube complex are used to propose a model of the early postreceptor events in Drosophila Toll receptor signaling.	[Moncrieffe, Martin C.; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Grossmann, J. Guenter] Univ Liverpool, Sch Biol Sci, Mol Biophys Grp, Liverpool L69 7ZB, Merseyside, England	University of Cambridge; University of Liverpool	Moncrieffe, MC (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Ct Rd, Cambridge CB2 1GA, England.	mcm35@cam.ac.uk			UK Biotechnology and Biological Sciences Research Council (BBSRC); MRC [G0400007] Funding Source: UKRI; Medical Research Council [G0400007] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from the UK Biotechnology and Biological Sciences Research Council (BBSRC) (to N. J. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; Chen LY, 2006, CURR BIOL, V16, P1183, DOI 10.1016/j.cub.2006.05.050; Drier EA, 1999, GENE DEV, V13, P556, DOI 10.1101/gad.13.5.556; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Edwards DN, 1997, DEVELOPMENT, V124, P3855; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; ISODA K, 1994, P NATL ACAD SCI USA, V91, P5350, DOI 10.1073/pnas.91.12.5350; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Moncrieffe MC, 2005, FEBS LETT, V579, P3920, DOI 10.1016/j.febslet.2005.06.009; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; RAY RP, 1991, DEVELOPMENT, V113, P35; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Schiffmann DA, 1999, BIOCHEMISTRY-US, V38, P11722, DOI 10.1021/bi9904252; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; Shen BH, 1998, DEVELOPMENT, V125, P4719; Shen BH, 2002, DEVELOPMENT, V129, P1925; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Weber CH, 2001, FEBS LETT, V492, P171, DOI 10.1016/S0014-5793(01)02162-7; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	44	53	54	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33447	33454		10.1074/jbc.M805427200	http://dx.doi.org/10.1074/jbc.M805427200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829464	Green Published, hybrid			2022-12-27	WOS:000261183700049
J	Heng, BC; Gribbon, PM; Day, AJ; Hardingham, TE				Heng, Boon Chin; Gribbon, Philip M.; Day, Anthony J.; Hardingham, Timothy E.			Hyaluronan Binding to Link Module of TSG-6 and to G1 Domain of Aggrecan Is Differently Regulated by pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFOCAL FLUORESCENCE RECOVERY; INTER-ALPHA-INHIBITOR; CARTILAGE PROTEOGLYCAN; PROTEIN TSG-6; EXTRACELLULAR-MATRIX; INDUCED ARTHRITIS; STIMULATED GENE-6; MOLECULAR-BASIS; UP-REGULATION; IN-VIVO	The physiological functions of hyaluronan (HA) in the extracellular matrix of vertebrate tissues involve a range of specific protein interactions. In this study, the interaction of HA with the Link module from TSG-6 (Link_TSG6) and G1 domain of aggrecan (G1), were investigated by a biophysical analysis of translational diffusion in dilute solution using confocal fluorescence recovery after photobleaching (confocal FRAP). Both Link_TSG6 and G1 were shown to bind to polymeric HA and these interactions could be competed with HA(8) and HA(10) oligosaccharides, respectively. Equilibrium experiments showed that the binding affinity of Link_TSG6 to HA was maximal at pH 6.0, and reduced dramatically above and below this pH. In contrast, G1 had maximum binding at pH 7.0-8.0 and moderate to strong binding affinity over a much broader pH range (5.5-8.0). The K-D determined for Link_TSG6 binding to HA showed a 100-fold increase in binding affinity between pH 7.4 and 6.0, whereas G1 showed a 75-fold decrease in binding affinity over the same pH range. The sharp difference observed in their pH binding suggests that pH controls the physiological function of TSG-6, with a low affinity for HA at neutral pH, but with increased affinity as the pH falls below pH 7. TSG-6 and aggrecan interact with HA through structurally homologous domains and the difference in pH-dependent binding can be understood in terms of differences in the presence and topographical distribution of key regulatory amino acids in Link_TSG6 and in the related tandem Link domains in aggrecan G1.	[Heng, Boon Chin; Gribbon, Philip M.; Day, Anthony J.; Hardingham, Timothy E.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Heng, Boon Chin] Abbott Vasc Inc, Santa Clara, CA 95054 USA; [Gribbon, Philip M.] GlaxoSmithKline Res & Dev Ltd, Med Res Ctr, Stevenage SG1 2NY, Herts, England	University of Manchester; GlaxoSmithKline	Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk; timothy.e.hardingham@manchester.ac.uk	Heng, Boon Chin/E-5462-2016; Day, Anthony/O-1658-2015; Gribbon, Philip/ABC-7807-2020	Heng, Boon Chin/0000-0003-2541-3699; Day, Anthony/0000-0002-1415-3134; Hardingham, Timothy/0000-0001-8271-6763; Gribbon, Philip/0000-0001-7655-2459	Seikagaku Corporation (Tokyo, Japan); Arthritis Research Campaign [D0540, 16539]; Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK	Seikagaku Corporation (Tokyo, Japan); Arthritis Research Campaign(Versus Arthritis); Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK(Wellcome Trust)	This work was supported by the Seikagaku Corporation (Tokyo, Japan), Arthritis Research Campaign Grants D0540 and 16539 (to A. J. D.), and the Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, UK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Blundell C. D., 2002, HYALURONAN, P161; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Blundell CD, 2007, J BIOL CHEM, V282, P12976, DOI 10.1074/jbc.M611713200; BONNET F, 1985, BIOCHEM J, V228, P77, DOI 10.1042/bj2280077; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; COWMAN MK, 1984, ARCH BIOCHEM BIOPHYS, V230, P203, DOI 10.1016/0003-9861(84)90101-2; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; Gribbon P, 1999, BIOPHYS J, V77, P2210, DOI 10.1016/S0006-3495(99)77061-X; Gribbon P, 2001, Methods Mol Biol, V171, P487; Gribbon P, 1998, BIOPHYS J, V75, P1032, DOI 10.1016/S0006-3495(98)77592-7; Gribbon P, 2000, BIOCHEM J, V350, P329, DOI 10.1042/0264-6021:3500329; Han L, 2007, BIOPHYS J, V93, pL23, DOI 10.1529/biophysj.107.114025; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; HARDINGHAM TE, 1994, EUR J CLIN CHEM CLIN, V32, P249; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HARDINGHAM TE, 1973, BIOCHEM J, V135, P905, DOI 10.1042/bj1350905; Hardingham T, 1981, BIOCHEM SOC T, V9, P489, DOI 10.1042/bst0090489; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; KUBITSCHECK U, 1994, BIOPHYS J, V67, P948, DOI 10.1016/S0006-3495(94)80596-X; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Maroudas A., 1980, JOINTS SYNOVIAL FLUI, P239; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; MORGELIN M, 1995, BIOCHEM J, V307, P595; NIEDUSZYNSKI IA, 1980, BIOCHEM J, V185, P107, DOI 10.1042/bj1850107; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Rodriguez E, 2006, J BIOL CHEM, V281, P18444, DOI 10.1074/jbc.M512531200; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; SIMKIN PA, 1992, J RHEUMATOL, V19, P1017; SMEDSROD B, 1985, CELL TISSUE RES, V241, P639; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; TENGBLAD A, 1981, BIOCHEM J, V199, P297, DOI 10.1042/bj1990297; Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057; WEISSMANN B, 1954, J AM CHEM SOC, V76, P1753, DOI 10.1021/ja01636a010; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; Wisniewski HG, 1996, J IMMUNOL, V156, P1609	52	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32294	32301		10.1074/jbc.M804155200	http://dx.doi.org/10.1074/jbc.M804155200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806261	hybrid			2022-12-27	WOS:000260893700016
J	Sethi, AA; Stonik, JA; Thomas, F; Demosky, SJ; Amar, M; Neufeld, E; Brewer, HB; Davidson, WS; D'Souza, W; Sviridov, D; Remaley, AT				Sethi, Amar A.; Stonik, John A.; Thomas, Fairwell; Demosky, Steve J.; Amar, Marcelo; Neufeld, Edward; Brewer, H. Bryan; Davidson, W. Sean; D'Souza, Wilissa; Sviridov, Dmitri; Remaley, Alan T.			Asymmetry in the Lipid Affinity of Bihelical Amphipathic Peptides A STRUCTURAL DETERMINANT FOR THE SPECIFICITY OF ABCA1-DEPENDENT CHOLESTEROL EFFLUX BY PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; CASSETTE TRANSPORTER A1; CELLULAR CHOLESTEROL; HELICAL PEPTIDES; APOA-I; MIMETIC PEPTIDES; ALPHA-HELICES; DOMAIN-STRUCTURE; TANGIER DISEASE; BINDING	ApoA-I contains a tandem array of amphipathic helices with varying lipid affinity, which are critical in its ability to bind and remove lipids from cells by the ABCA1 transporter. In this study, the effect of asymmetry in the lipid affinity of amphipathic helices in a bihelical apoA-I mimetic peptide, 37pA, on lipid efflux by the ABCA1 transporter was examined. Seven peptide variants of 37pA were produced by substituting a varying number of hydrophobic amino acids for alanine on either one or both helices. The 5A peptide with five alanine substitutions in the second helix had decreased helical content compared with 37pA (5A, 12 +/- 1% helicity; 37pA, 28 +/- 2% helicity) and showed less self-association but, similar to the parent peptide, was able to readily solubilize phospholipid vesicles. Furthermore, 5A, unlike the parent peptide 37pA, was not hemolytic (37pA, 27 +/- 2% RBC lysis, 2 h, 18 mu M). Finally, the 5A peptide stimulated cholesterol and phospholipid efflux by the ABCA1 transporter with higher specificity (ABCA1-transfected versus untransfected cells) than 37pA(5A, 9.7 +/- 0.77%, 18 h, 18 mu M versus 1.5 +/- 0.27%, 18 h, 18 mu M (p < 0.0001); 37pA, 7.4 +/- 0.85%, 18h, 18 mu M versus 5.8 +/- 0.20%, 18h, 18 mu M(p = 0.03)). In summary, we describe a novel bihelical peptide with asymmetry in the lipid affinity of its helices and properties similar to apoA-I in terms of specificity for cholesterol efflux by the ABCA1 transporter and low cytotoxicity.	[Neufeld, Edward] NHLBI, NIH, Bethesda, MD 20892 USA; [Sethi, Amar A.; Stonik, John A.; Thomas, Fairwell; Demosky, Steve J.; Amar, Marcelo; Remaley, Alan T.] NHLBI, Lipoprot Metab Sect, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Brewer, H. Bryan] Washington Hosp Ctr, Cardiovasc Res Inst, MedStar Res Inst, Washington, DC 20010 USA; [Davidson, W. Sean] Univ Cincinnati, Ctr Lipid & Arteriosclerosis Studies, Cincinnati, OH 45221 USA; [D'Souza, Wilissa; Sviridov, Dmitri] Baker Heart Res Inst, Melbourne, Vic, Australia	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); MedStar Washington Hospital Center; University System of Ohio; University of Cincinnati; Baker Heart and Diabetes Institute	Remaley, AT (corresponding author), NHLBI, NIH, Bldg 10,Rm 7N-115,10 Ctr Dr, Bethesda, MD 20892 USA.	aremaley@cc.nih.gov	Neufeld, Edward/R-3819-2019; Amar, Marcelo/AAD-5599-2019; Sviridov, Dmitri/E-7943-2010	Davidson, William/0000-0003-2756-2989	National Institutes of Health; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062542, R01HL067093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by intramural funds from the National Institutes of Health, NHLBI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Bielicki JK, 2002, BIOCHEMISTRY-US, V41, P2089, DOI 10.1021/bi011716p; Boggs JM, 2001, BBA-BIOMEMBRANES, V1511, P28, DOI 10.1016/S0005-2736(00)00379-5; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; CALABRESI L, 1994, J BIOL CHEM, V269, P32168; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Costet P, 2000, J BIOL CHEM, V275, P28240; Dashti N, 2004, J LIPID RES, V45, P1919, DOI 10.1194/jlr.M400251-JLR200; Datta G, 2004, J BIOL CHEM, V279, P26509, DOI 10.1074/jbc.M314276200; Datta G, 2001, J LIPID RES, V42, P1096; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; Gazzara JA, 1997, J LIPID RES, V38, P2134; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Handattu SP, 2007, J BIOL CHEM, V282, P1980, DOI 10.1074/jbc.M606231200; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; MISHRA VK, 1995, J BIOL CHEM, V270, P1602, DOI 10.1074/jbc.270.4.1602; Mukhamedova N, 2007, BIOCHEMISTRY-US, V46, P9388, DOI 10.1021/bi700473t; Natarajan P, 2004, J BIOL CHEM, V279, P24044, DOI 10.1074/jbc.M400561200; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Nicholls SJ, 2006, J AM COLL CARDIOL, V47, P992, DOI 10.1016/j.jacc.2005.11.040; Nofer JR, 2005, CELL MOL LIFE SCI, V62, P2150, DOI 10.1007/s00018-005-5125-0; Oram JF, 1996, J LIPID RES, V37, P2473; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Phoenix DA, 2002, CURR PROTEIN PEPT SC, V3, P201, DOI 10.2174/1389203024605368; Pownall HJ, 2006, CURR OPIN LIPIDOL, V17, P209, DOI 10.1097/01.mol.0000226110.66942.e8; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Remaley AT, 1997, ARTERIOSCL THROM VAS, V17, P1813, DOI 10.1161/01.ATV.17.9.1813; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SEGREST JP, 1992, J LIPID RES, V33, P141; Sethi AA, 2007, CURR OPIN INVEST DR, V8, P201; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sugar IP, 2005, BIOPHYS J, V89, P3997, DOI 10.1529/biophysj.105.061952; Tanaka M, 2005, BIOCHEMISTRY-US, V44, P10689, DOI 10.1021/bi050853+; UEDA M, 2005, J CLIN LIGAND ASSAY, V4, P216; VEDHACHALAM C, 2007, J BIOL CHEM; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Victor K, 1999, BIOCHEMISTRY-US, V38, P12527, DOI 10.1021/bi990847b; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021	49	83	89	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32273	32282		10.1074/jbc.M804461200	http://dx.doi.org/10.1074/jbc.M804461200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805791	Green Published, hybrid			2022-12-27	WOS:000260893700014
J	Knowles, LM; Yang, C; Osterman, A; Smith, JW				Knowles, Lynn M.; Yang, Chen; Osterman, Andrei; Smith, Jeffrey W.			Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ATP CITRATE LYASE; PROSTATE-CANCER; SELECTIVE-INHIBITION; SYNTHESIS PATHWAY; NUDE-MICE; EXPRESSION; CARCINOMA; TARGET; GROWTH	Fatty-acid synthase (FAS) is up-regulated in a broad range of cancers, including those of the breast, prostate, and ovaries. In tumor cells, the inhibition of FAS elicits cell cycle arrest and apoptosis, so it is considered a potential drug target for oncology. Results from this study show that inhibition of FAS, by either knockdown with small interfering RNA or inhibition with the small molecule drug orlistat, leads to activation of the receptor-mediated apoptotic cascade (caspase-8-mediated) and ultimately to cell death. However, knockdown of two enzymes upstream of FAS, acetyl-CoA carboxylase-alpha and ATP-citrate lyase, fails to activate caspase-8 or to elicit apoptosis in tumor cells, even though palmitate synthesis was suppressed. Using differential gene analysis, we traced the unique apoptotic effect of FAS inhibition to up-regulation of DDIT4 (DNA damage-inducible transcript 4), a stress-response gene that negatively regulates the mTOR pathway. These findings indicate that suppression of palmitate synthesis is not sufficient for eliciting tumor cell death and suggest that the unique effect of inhibition of FAS results from negative regulation of the mTOR pathway via DDIT4.	[Knowles, Lynn M.] Burnham Inst Med Res, Canc Res Ctr, La Jolla, CA 92037 USA; [Yang, Chen; Osterman, Andrei; Smith, Jeffrey W.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Smith, JW (corresponding author), Burnham Inst Med Res, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jsmith@burnham.org		Knowles, Lynn/0000-0002-6250-9289	National Institutes of Health [CA108959, RR020843, HL080718]; Department of Defense [DAMD17-02-0693]; California Breast Cancer Research Program [CA6982713, CA69306, 8FB-0107]; NATIONAL CANCER INSTITUTE [R01CA069306, R01CA108959] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA108959, RR020843, and HL080718. This work was also supported by Department of Defense Grant DAMD17-02-0693 and California Breast Cancer Research Program Grants CA6982713 and CA69306 (to J. W. S.) and Grant 8FB-0107 (to L. M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Carlo-Stella C, 2007, CLIN CANCER RES, V13, P2313, DOI 10.1158/1078-0432.CCR-06-2774; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; De Schrijver E, 2003, CANCER RES, V63, P3799; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Innocenzi D, 2003, J CUTAN PATHOL, V30, P23, DOI 10.1034/j.1600-0560.2003.300104.x; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Koshida K, 2004, INT J UROL, V11, P1114, DOI 10.1111/j.1442-2042.2004.00961.x; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; KUREBAYASHI J, 1993, CANCER RES, V53, P2178; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Little JL, 2007, CANCER RES, V67, P1262, DOI 10.1158/0008-5472.CAN-06-1794; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Orita H, 2007, CLIN CANCER RES, V13, P7139, DOI 10.1158/1078-0432.CCR-07-1186; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Pizer ES, 1996, CANCER RES, V56, P745; Pizer ES, 1996, CANCER RES, V56, P1189; Pizer ES, 2000, CANCER RES, V60, P213; Pizer ES, 1998, CANCER RES, V58, P4611; PRICE JE, 1990, CANCER RES, V50, P717; Rashid A, 1997, AM J PATHOL, V150, P201; SHAFIE SM, 1980, CANCER LETT, V11, P81, DOI 10.1016/0304-3835(80)90097-X; Siegmund D, 2002, MOL MED, V8, P725, DOI 10.1007/BF03402036; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Swinnen JV, 2000, INT J CANCER, V88, P176, DOI 10.1002/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; SZUTOWICZ A, 1979, BRIT J CANCER, V39, P681, DOI 10.1038/bjc.1979.120; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; Turyn J, 2003, HORM METAB RES, V35, P565, DOI 10.1055/s-2003-43500; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wittmann C, 1999, BIOTECHNOL BIOENG, V62, P739, DOI 10.1002/(SICI)1097-0290(19990320)62:6<739::AID-BIT13>3.0.CO;2-E; Zhou WB, 2003, CANCER RES, V63, P7330	53	79	85	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31378	31384		10.1074/jbc.M803384200	http://dx.doi.org/10.1074/jbc.M803384200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18796435	Green Published, hybrid			2022-12-27	WOS:000260760800016
J	Schoijet, AC; Miranda, K; Girard-Dias, W; de Souza, W; Flawia, MM; Torres, HN; Docampo, R; Alonso, GD				Schoijet, Alejandra C.; Miranda, Kildare; Girard-Dias, Wendell; de Souza, Wanderley; Flawia, Mirtha M.; Torres, Hector N.; Docampo, Roberto; Alonso, Guillermo D.			A Trypanosoma cruzi Phosphatidylinositol 3-Kinase (TcVps34) Is Involved in Osmoregulation and Receptor-mediated Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE VACUOLE COMPLEX; CAMP-SPECIFIC PHOSPHODIESTERASE; PROTON-PUMPING PYROPHOSPHATASE; PHOSPHOINOSITIDE 3-KINASES; H+-ATPASE; CANDIDA-ALBICANS; MEMBRANE TRAFFICKING; DISTINCT CLASSES; PLASMA-MEMBRANE; PROTEIN-KINASE	Trypanosoma cruzi, the etiological agent of Chagas disease, has the ability to respond to a variety of environmental changes during its life cycle both in the insect vector and in the vertebrate host. Because regulation of transcription initiation seems to be nonfunctional in this parasite, it is important to investigate other regulatory mechanisms of adaptation. Regulatory mechanisms at the level of signal transduction pathways involving phosphoinositides are good candidates for this purpose. Here we report the identification of the first phosphatidylinositol 3-kinase (PI3K) in T. cruzi, with similarity with its yeast counterpart, Vps34p. TcVps34 specifically phosphorylates phosphatidylinositol to produce phosphatidylinositol 3-phosphate, thus confirming that it belongs to class III PI3K family. Overexpression of TcVps34 resulted in morphological and functional alterations related to vesicular trafficking. Although inhibition of TcVps34 with specific PI3K inhibitors, such as wortmannin and LY294,000, resulted in reduced regulatory volume decrease after hyposmotic stress, cells overexpressing this enzyme were resistant to these inhibitors. Furthermore, these cells were able to recover their original volume faster than wild type cells when they were submitted to severe hyposmotic stress. In addition, in TcVps34-overexpressing cells, the activities of vacuolar-H+-ATPase and vacuolar H+-pyrophosphatase were altered, suggesting defects in the acidification of intracellular compartments. Furthermore, receptor-mediated endocytosis was partially blocked although fluid phase endocytosis was not affected, confirming a function for TcVps34 in membrane trafficking. Taken together, these results strongly support that TcVps34 plays a prominent role in vital processes for T. cruzi survival such as osmoregulation, acidification, and vesicular trafficking.	[Schoijet, Alejandra C.; Flawia, Mirtha M.; Torres, Hector N.; Alonso, Guillermo D.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina; [Schoijet, Alejandra C.; Flawia, Mirtha M.; Torres, Hector N.; Alonso, Guillermo D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, RA-1428 Buenos Aires, DF, Argentina; [Schoijet, Alejandra C.; Miranda, Kildare; Docampo, Roberto; Alonso, Guillermo D.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Schoijet, Alejandra C.; Miranda, Kildare; Docampo, Roberto; Alonso, Guillermo D.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Miranda, Kildare; Girard-Dias, Wendell; de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Universidade Federal do Rio de Janeiro	Docampo, R (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	rdocampo@uga.edu; galonso@dna.uba.ar	Torres, Héctor/GXG-1780-2022; Alonso, Guillermo Daniel/AAI-6674-2020	Alonso, Guillermo Daniel/0000-0001-9386-9431; Schoijet, Alejandra/0000-0002-4999-7169	National Institutes of Health [AI-68647]; Consejo Nacional de Investigaciones CientIficas y Te cnicas (CONICET, Argentina); Departamento de Fisiologia; Biologia Molecular y Celular; Facultad de Ciencias Exactas y Naturales; University of Buenos Aires (Argentina); Agencia Nacional de Promocion Cientifica y Tecnolo gica (Argentina); Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases; MCT-CNPq; FAPERJ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones CientIficas y Te cnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Departamento de Fisiologia; Biologia Molecular y Celular; Facultad de Ciencias Exactas y Naturales; University of Buenos Aires (Argentina)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnolo gica (Argentina)(ANPCyT); Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases(Lawrence Ellison Foundation); MCT-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, by National Institutes of Health Grant AI-68647 (to R. D.). This work was also supported by Consejo Nacional de Investigaciones CientIficas y Te cnicas (CONICET, Argentina), Departamento de Fisiologia, Biologia Molecular y Celular, Facultad de Ciencias Exactas y Naturales, University of Buenos Aires (Argentina), and Agencia Nacional de Promocion Cientifica y Tecnolo gica (Argentina). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Fellow of CONICET and supported in part by a training grant of the Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases.; Supported by MCT-CNPq and FAPERJ.	Alonso GD, 2006, MOL BIOCHEM PARASIT, V145, P40, DOI 10.1016/j.molbiopara.2005.09.005; Alonso GD, 2007, MOL BIOCHEM PARASIT, V152, P72, DOI 10.1016/j.molbiopara.2006.12.002; Benchimol M, 1998, BIOCHEM J, V332, P695, DOI 10.1042/bj3320695; Braga MV, 2006, FEMS MICROBIOL LETT, V256, P209, DOI 10.1111/j.1574-6968.2006.00125.x; Brown RA, 2001, BIOCHEM SOC T, V29, P535, DOI 10.1042/BST0290535; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Corvera S, 2001, TRAFFIC, V2, P859, DOI 10.1034/j.1600-0854.2001.21201.x; Eck R, 2000, YEAST, V16, P933, DOI 10.1002/1097-0061(200007)16:10&lt;933::AID-YEA591&gt;3.0.CO;2-C; Eck R, 2005, INT J MED MICROBIOL, V295, P57, DOI 10.1016/j.ijmm.2004.12.007; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; FRY MJ, 1994, BBA-MOL BASIS DIS, V1226, P237, DOI 10.1016/0925-4439(94)90036-1; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; GUHL F, 2007, REPORT SCI WORKING G; Gunther J, 2005, MICROBIOL-SGM, V151, P81, DOI 10.1099/mic.0.27333-0; Hall BS, 2006, J BIOL CHEM, V281, P27600, DOI 10.1074/jbc.M602183200; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kollien AH, 2001, J INSECT PHYSIOL, V47, P739, DOI 10.1016/S0022-1910(00)00170-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Martinez R, 2002, MOL BIOCHEM PARASIT, V120, P205, DOI 10.1016/S0166-6851(01)00456-X; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Ono F, 1998, J BIOL CHEM, V273, P7731, DOI 10.1074/jbc.273.13.7731; Pereira CA, 2000, J BIOL CHEM, V275, P1495, DOI 10.1074/jbc.275.2.1495; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Porto-Carreiro I, 2000, EUR J CELL BIOL, V79, P858, DOI 10.1078/0171-9335-00112; Rog O, 2005, CURR GENET, V47, P18, DOI 10.1007/s00294-004-0548-y; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Rohloff P, 2008, EXP PARASITOL, V118, P17, DOI 10.1016/j.exppara.2007.04.013; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Scott DA, 1998, BIOCHEM J, V331, P583, DOI 10.1042/bj3310583; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Soares MJ, 2006, PARASITOL RES, V99, P321, DOI 10.1007/s00436-006-0189-9; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; Van der Kaay J, 1999, J BIOL CHEM, V274, P35963, DOI 10.1074/jbc.274.50.35963; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Vieira M, 2005, BIOCHEM J, V392, P467, DOI 10.1042/BJ20051319; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7	50	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31541	31550		10.1074/jbc.M801367200	http://dx.doi.org/10.1074/jbc.M801367200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801733	Green Published, hybrid			2022-12-27	WOS:000260760800033
J	Pan, HL; Yu, J; Zhang, LH; Carpenter, A; Zhu, H; Li, L; Ma, DW; Yuan, JY				Pan, Heling; Yu, Jia; Zhang, Lihong; Carpenter, Anne; Zhu, Hong; Li, Li; Ma, Dawei; Yuan, Junying			A Novel Small Molecule Regulator of Guanine Nucleotide Exchange Activity of the ADP-ribosylation Factor and Golgi Membrane Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREFELDIN-A; ENDOPLASMIC-RETICULUM; CIS-GOLGI; INTERMEDIATE COMPARTMENT; PROTEIN-TRANSPORT; SEC7 DOMAIN; FACTOR GBF1; MDCK CELLS; ARF; INHIBITION	An image-based phenotypic screen was developed to identify small molecule regulators of intracellular traffic. Using this screen we found that AG1478, a previously known inhibitor of epidermal growth factor receptor, had epidermal growth factor receptor-independent activity in inducing the disassembly of the Golgi in human cells. Similar to brefeldin A (BFA), a known disrupter of the Golgi, AG1478 inhibits the activity of small GTPase ADP-ribosylation factor. Unlike BFA, AG1478 exhibits low cytotoxicity and selectively targets the cis-Golgi without affecting endosomal compartment. We show that AG1478 inhibits GBF1, a large nucleotide exchange factor for the ADP-ribosylation factor, in a Sec7 domain-dependent manner and mimics the phenotype of a GBF1 mutant that has an inactive mutation. The treatment with AG1478 leads to the recruitment of GBF1 to the vesicular-tubular clusters adjacent to the endoplasmic reticulum exit sites, a step only transiently observed previously in the presence of BFA. We propose that the treatment with AG1478 delineates a membrane trafficking intermediate step that depends upon the Sec7 domain.	[Pan, Heling; Yu, Jia; Zhang, Lihong; Li, Li; Ma, Dawei] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Carpenter, Anne] MIT, Cambridge, MA 02142 USA; [Carpenter, Anne] Broad Inst Harvard, Cambridge, MA 02142 USA; [Zhu, Hong; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Ma, DW (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 354 Fenglin Rd, Shanghai 200032, Peoples R China.	madw@pub.sioc.ac.cn; jyuan@hms.harvard.edu	Carpenter, Anne/C-4982-2008	Carpenter, Anne/0000-0003-1555-8261; Zhu, Hong/0000-0002-2575-4031; LI, LI/0000-0003-2064-2177	National Institutes of Health [R37 AG12859]; National Natural Science Foundation of China [20321202]; Chinese Academy of Science [KGCX2-SW-209]; NATIONAL INSTITUTE ON AGING [R37AG012859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 AG12859 (to J.Y.). This work was also supported by National Natural Science Foundation of China Grant 20321202 and Chinese Academy of Science Grant KGCX2-SW-209 (to D.M.).	Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; BREWER CB, 1995, J CELL SCI, V108, P789; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; FINAZZI D, 1994, J BIOL CHEM, V269, P13325; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Gleeson PA, 1996, J CELL SCI, V109, P2811; Guo H, 1998, EXP CELL RES, V245, P57, DOI 10.1006/excr.1998.4235; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Hauri HP, 2000, J CELL SCI, V113, P587; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LOW SH, 1991, J BIOL CHEM, V266, P17729; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; ORCI L, 1993, P NATL ACAD SCI USA, V90, P11089, DOI 10.1073/pnas.90.23.11089; Puri S, 2003, MOL BIOL CELL, V14, P5011, DOI 10.1091/mbc.E03-06-0437; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; STEPHEN GM, 1992, J CELL BIOL, V118, P267; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Tang BL, 1997, MOL CELL BIOL, V17, P256, DOI 10.1128/MCB.17.1.256; TSAI SC, 1993, J BIOL CHEM, V268, P10820; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	53	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31087	31096		10.1074/jbc.M806592200	http://dx.doi.org/10.1074/jbc.M806592200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18799457	Green Published, hybrid			2022-12-27	WOS:000260544800063
J	Miallau, L; Faller, M; Chiang, J; Arbing, M; Guo, F; Cascio, D; Eisenberg, D				Miallau, Linda; Faller, Michael; Chiang, Janet; Arbing, Mark; Guo, Feng; Cascio, Duilio; Eisenberg, David			Structure and Proposed Activity of a Member of the VapBC Family of Toxin-Antitoxin Systems VapBC-5 FROM MYCOBACTERIUM TUBERCULOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PIN DOMAINS; DNA; ANTIDOTE; BACTERIA; COMPLEX; MODULES; STRESS	In prokaryotes, cognate toxin-antitoxin pairs have long been known, but no three-dimensional structure has been available for any given complex from Mycobacterium tuberculosis. Here we report the crystal structure and activity of a member of the VapBC family of complexes from M. tuberculosis. The toxin VapC-5 is a compact, 150 residues, two domain alpha/beta protein. Bent around the toxin is the VapB-5 antitoxin, a 33-residue alpha-helix. Assays suggest that the toxin is an Mg-enabled endoribonuclease, inhibited by the antitoxin. The lack of DNase activity is consistent with earlier suggestions that the complex represses its own operon. Furthermore, analysis of the interactions in the binding of the antitoxin to the toxin suggest that exquisite control is required to protect the bacteria cell from toxic VapC-5.	[Miallau, Linda; Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Faller, Michael; Guo, Feng; Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Cascio, Duilio; Eisenberg, David] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, 611 Charles Young E Dr, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Guo, Feng/HIK-3259-2022; Miallau, linda/G-9804-2011		National Institutes of Health [23616-002-06 F3:02, TBSGC R01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 23616-002-06 F3:02 and TBSGC R01.	Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Bahassi EM, 1999, J BIOL CHEM, V274, P10936, DOI 10.1074/jbc.274.16.10936; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Wilbur JS, 2005, BIOCHEMISTRY-US, V44, P12515, DOI 10.1021/bi0511080	36	106	109	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					276	283		10.1074/jbc.M805061200	http://dx.doi.org/10.1074/jbc.M805061200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952600	Green Published, hybrid			2022-12-27	WOS:000261974800031
J	Mallappa, C; Singh, A; Ram, H; Chattopadhyay, S				Mallappa, Chandrashekara; Singh, Aparna; Ram, Hathi; Chattopadhyay, Sudip			GBF1, a Transcription Factor of Blue Light Signaling in Arabidopsis, Is Degraded in the Dark by a Proteasome-mediated Pathway Independent of COP1 and SPA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOCHROME-A; BZIP PROTEINS; GENE-EXPRESSION; HIGHER-PLANTS; PHOTOMORPHOGENIC GROWTH; G-BOX; HY5; TRANSDUCTION; RECEPTORS; ELEMENTS	Arabidopsis GBF1/ZBF2 is a bZIP transcription factor that plays dual but opposite regulatory roles in cryptochrome-mediated blue light signaling. Here, we show the genetic and molecular interrelation of GBF1 with two well characterized negative regulators of light signaling, COP1 and SPA1, in photomorphogenic growth and light-regulated gene expression. Our results further reveal that GBF1 protein is less abundant in the dark-grown seedlings and is degraded by a proteasome-mediated pathway independent of COP1 and SPA1. Furthermore, COP1 physically interacts with GBF1 and is required for the optimum accumulation of GBF1 protein in light-grown seedlings. Taken together, this study provides a mechanistic view of concerted function of three important regulators in Arabidopsis seedling development.	[Mallappa, Chandrashekara; Singh, Aparna; Ram, Hathi; Chattopadhyay, Sudip] Natl Inst Plant Genome Res, Lab 101, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, S (corresponding author), Natl Inst Plant Genome Res, Lab 101, Aruna Asaf Ali Marg, New Delhi 110067, India.	sudipchatto@yahoo.com	Singh, Aparna/D-3237-2011; Chattopadhyay, Sudip/P-8491-2014	Ram, Dr Hasthi/0000-0003-0893-3895	Dept. of Science and Technology, Government of India	Dept. of Science and Technology, Government of India	This work is supported in part by a Ramanna Fellowship grant from the Dept. of Science and Technology, Government of India (to S. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Baumgardt RL, 2002, PLANTA, V215, P745, DOI 10.1007/s00425-002-0801-x; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chattopadhyay S, 1998, PLANT J, V15, P69, DOI 10.1046/j.1365-313X.1998.00180.x; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Fittinghoff K, 2006, PLANT J, V47, P577, DOI 10.1111/j.1365-313X.2006.02812.x; FOSTER R, 1994, FASEB J, V8, P192, DOI 10.1096/fasebj.8.2.8119490; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; Hoecker U, 1999, SCIENCE, V284, P496, DOI 10.1126/science.284.5413.496; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Huq E, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P151, DOI 10.1002/352760510X.ch7; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; Laubinger S, 2004, PLANT CELL, V16, P2293, DOI 10.1105/tpc.104.024216; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Mallappa C, 2006, J BIOL CHEM, V281, P22190, DOI 10.1074/jbc.M601172200; MCNELLIS TW, 1994, PLANT CELL, V6, P487, DOI 10.1105/tpc.6.4.487; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Moller SG, 2003, PLANT CELL, V15, P1111, DOI 10.1105/tpc.008649; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Puente P, 1996, EMBO J, V15, P3732, DOI 10.1002/j.1460-2075.1996.tb00743.x; Saijo Y, 2003, GENE DEV, V17, P2642, DOI 10.1101/gad.1122903; Schepens I, 2004, CURR OPIN PLANT BIOL, V7, P564, DOI 10.1016/j.pbi.2004.07.004; SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Terzaghi WB, 1997, PLANT J, V11, P967, DOI 10.1046/j.1365-313X.1997.11050967.x; Wang H., 2004, ARXIVCS010056V2, P1; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yang JP, 2005, PLANT J, V43, P131, DOI 10.1111/j.1365-313X.2005.02433.x; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205	48	33	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35772	35782		10.1074/jbc.M803437200	http://dx.doi.org/10.1074/jbc.M803437200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18930926	hybrid			2022-12-27	WOS:000261687900051
J	Li, HY; Das, A; Sibhatu, H; Jamal, J; Sligar, SG; Poulos, TL				Li, Huiying; Das, Aditi; Sibhatu, Hiruy; Jamal, Joumana; Sligar, Stephen G.; Poulos, Thomas L.			Exploring the Electron Transfer Properties of Neuronal Nitric-oxide Synthase by Reversal of the FMN Redox Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-REDUCTION POTENTIALS; FLAVOPROTEIN DOMAIN; FUNCTIONAL INTERACTIONS; FLAVIN MONONUCLEOTIDE; BACILLUS-MEGATERIUM; OUTPUT STATE; CALMODULIN; HEME; FLAVODOXIN; MECHANISM	In nitric-oxide synthase ( NOS) the FMN can exist as the fully oxidized ( ox), the one-electron reduced semiquinone (sq), or the two-electron fully reduced hydroquinone (hq). InNOS and microsomal cytochrome P450 reductase the sq/hq redox potential is lower than that of the ox/sq couple, and hence it is the hq form of FMN that delivers electrons to the heme. Like NOS, cytochrome P450BM3 has the FAD/FMN reductase fused to the C-terminal end of the heme domain, but in P450BM3 the ox/sq and sq/hq redox couples are reversed, so it is the sq that transfers electrons to the heme. This difference is due to an extra Gly residue found in the FMN binding loop in NOS compared with P450BM3. We have deleted residue Gly-810 from the FMN binding loop in neuronal NOS ( nNOS) to give Delta G810 so that the shorter binding loop mimics that in cytochrome P450BM3. As expected, the ox/sq redox potential now is lower than the sq/ hq couple. Delta G810 exhibits lower NO synthase activity but normal levels of cytochrome c reductase activity. However, unlike the wild-type enzyme, the cytochrome c reductase activity of Delta G810 is insensitive to calmodulin binding. In addition, calmodulin binding to Delta G810 does not result in a large increase in FMN fluorescence as in wild-type nNOS. These results indicate that the FMN domain in Delta G810 is locked in a unique conformation that is no longer sensitive to calmodulin binding and resembles the "on" output state of the calmodulin-boundwild-type nNOS with respect to the cytochrome c reduction activity.	[Li, Huiying; Sibhatu, Hiruy; Jamal, Joumana; Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Li, Huiying; Sibhatu, Hiruy; Jamal, Joumana; Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Li, Huiying; Sibhatu, Hiruy; Jamal, Joumana; Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Das, Aditi; Sligar, Stephen G.] Univ Illinois, Dept Biochem, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Das, Aditi; Sligar, Stephen G.] Univ Illinois, Dept Chem, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Das, Aditi; Sligar, Stephen G.] Univ Illinois, Coll Med, Urbana, IL 61801 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	poulos@uci.edu	Li, HY/G-3987-2010		National Institutes of Health [GM31756]; National Science Foundation [EEC-0647560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031756, R37GM031756, R01GM057353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31756 ( to S. G. S.) and GM57353 ( to T. L. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.Supported by National Science Foundation postdoctoral Grant EEC-0647560.	ABU SH, 1993, P NATL ACAD SCI USA, V90, P10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; ANDERSON RF, 1983, BIOCHIM BIOPHYS ACTA, V722, P158, DOI 10.1016/0005-2728(83)90169-X; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Du M, 2003, J BIOL CHEM, V278, P6002, DOI 10.1074/jbc.M209606200; DUBOURDIEU M, 1975, BIOCHIM BIOPHYS ACTA, V376, P519, DOI 10.1016/0005-2728(75)90172-3; Dutton P L, 1978, Methods Enzymol, V54, P411; EDMONDSO.DE, 1972, BIOCHEMISTRY-US, V11, P1133, DOI 10.1021/bi00757a003; ENTSCH B, 1972, ARCH BIOCHEM BIOPHYS, V151, P378, DOI 10.1016/0003-9861(72)90512-7; Feng CJ, 2006, BIOCHEMISTRY-US, V45, P6354, DOI 10.1021/bi060223n; FULCO AJ, 1991, ANNU REV PHARMACOL, V31, P177; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garnaud PE, 2004, BIOCHEMISTRY-US, V43, P11035, DOI 10.1021/bi049312v; GHISLA S, 1986, BIOCHEM J, V239, P1; Ghosh DK, 2006, J BIOL CHEM, V281, P14173, DOI 10.1074/jbc.M509937200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Hanley SC, 2004, BIOCHEM BIOPH RES CO, V325, P1418, DOI 10.1016/j.bbrc.2004.10.189; HEVEL JM, 1991, J BIOL CHEM, V266, P22789; Hoover DM, 1999, J MOL BIOL, V294, P725, DOI 10.1006/jmbi.1999.3152; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Li HY, 2006, J BIOL INORG CHEM, V11, P753, DOI 10.1007/s00775-006-0123-8; Li HY, 2002, BIOCHEMISTRY-US, V41, P13868, DOI 10.1021/bi020417c; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MATSUOKA A, 1994, J BIOL CHEM, V269, P20335; Mayhew SG, 1999, EUR J BIOCHEM, V265, P698, DOI 10.1046/j.1432-1327.1999.00767.x; MAYHEW SG, 1971, BIOCHIM BIOPHYS ACTA, V235, P289, DOI 10.1016/0005-2744(71)90207-5; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Murataliev MB, 1996, BIOCHEMISTRY-US, V35, P15029, DOI 10.1021/bi961667u; Murataliev MB, 1997, BIOCHEMISTRY-US, V36, P8401, DOI 10.1021/bi970026b; MURPHY ME, 1994, METHOD ENZYMOL, V233, P240; Narayanasami R, 1997, NITRIC OXIDE-BIOL CH, V1, P39, DOI 10.1006/niox.1996.0103; NARHI LO, 1986, J BIOL CHEM, V261, P7160; NARHI LO, 1987, J BIOL CHEM, V262, P6683; Nishida CR, 2001, J BIOL CHEM, V276, P20116, DOI 10.1074/jbc.M101548200; Nishino Y, 2007, ARCH BIOCHEM BIOPHYS, V465, P254, DOI 10.1016/j.abb.2007.05.021; PACE C, 1986, BIOCHEMISTRY-US, V25, P2516, DOI 10.1021/bi00357a035; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; RAMAN CS, 2000, PORPHYRIN HDB, V4, P293; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Schrammel A, 1998, BBA-PROTEIN STRUCT M, V1387, P257, DOI 10.1016/S0167-4838(98)00138-1; Sevrioukova I, 1996, BIOCHEMISTRY-US, V35, P7058, DOI 10.1021/bi960060a; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; WATT W, 1991, J MOL BIOL, V218, P195, DOI 10.1016/0022-2836(91)90884-9; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804	65	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34762	34772		10.1074/jbc.M806949200	http://dx.doi.org/10.1074/jbc.M806949200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18852262	Green Published, hybrid			2022-12-27	WOS:000261469100033
J	Ritter, E; Stehfest, K; Berndt, A; Hegemann, P; Bartl, FJ				Ritter, Eglof; Stehfest, Katja; Berndt, Andre; Hegemann, Peter; Bartl, Franz J.			Monitoring Light-induced Structural Changes of Channelrhodopsin-2 by UV-visible and Fourier Transform Infrared Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FTIR DIFFERENCE SPECTROSCOPY; VIBRATIONAL SPECTROSCOPY; PHOTOPHOBIC RESPONSES; SENSORY RHODOPSIN; PROTON-TRANSFER; SCHIFF-BASE; CHLAMYDOMONAS-REINHARDTII; BACTERIORHODOPSIN MUTANTS; CONFORMATIONAL-CHANGES; DROSOPHILA LARVAE	Channelrhodopsin-2 (ChR2) is a microbial type rhodopsin and a light-gated cation channel that controls phototaxis in Chlamydomonas. We expressed ChR2 in COS-cells, purified it, and subsequently investigated this unusual photoreceptor by flash photolysis and UV-visible and Fourier transform infrared difference spectroscopy. Several transient photoproducts of the wild type ChR2 were identified, and their kinetics and molecular properties were compared with those of the ChR2 mutant E90Q. Based on the spectroscopic data we developed a model of the photocycle comprising six distinguishable intermediates. This photocycle shows similarities to the photocycle of the ChR2-related Channelrhodopsin of Volvox but also displays significant differences. We show that molecular changes include retinal isomerization, changes in hydrogen bonding of carboxylic acids, and large alterations of the protein backbone structure. These alterations are stronger than those observed in the photocycle of other microbial rhodopsins like bacteriorhodopsin and are related to those occurring in animal rhodopsins. UV-visible and Fourier transform infrared difference spectroscopy revealed two late intermediates with different time constants of tau=6 and 40 s that exist during the recovery of the dark state. The carboxylic side chain of Glu(90) is involved in the slow transition. The molecular changes during the ChR2 photocycle are discussed with respect to other members of the rhodopsin family.	[Ritter, Eglof; Bartl, Franz J.] Charite Univ Med Berlin, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Stehfest, Katja; Berndt, Andre; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Hegemann, Peter; Bartl, Franz J.] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Bartl, FJ (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys, Charite Pl 1, D-10117 Berlin, Germany.	franz.bartl@charite.de		Berndt, Andre/0000-0003-4758-5598; Hegemann, Peter/0000-0003-3589-6452	Deutsche Forschungsgemeinschaft [SFB 498]; Cluster of Excellence: Unifying Concepts in Catalysis	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence: Unifying Concepts in Catalysis(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 498 and funds from Cluster of Excellence: Unifying Concepts in Catalysis (to P.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; BOUSCHE O, 1991, BIOCHEMISTRY-US, V30, P5395, DOI 10.1021/bi00236a010; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Eaton J.W., 2002, GNU OCTAVE MANUAL; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Garczarek F, 2004, BIOPHYS J, V87, P2676, DOI 10.1529/biophysj.104.046433; GERWERT K, 1986, EMBO J, V5, P805, DOI 10.1002/j.1460-2075.1986.tb04285.x; Govorunova EG, 2004, BIOPHYS J, V86, P2342, DOI 10.1016/S0006-3495(04)74291-5; Heberle J, 2000, BIOPHYS CHEM, V85, P229, DOI 10.1016/S0301-4622(99)00154-4; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HEGEMANN P, 1991, BIOPHYS J, V60, P1477, DOI 10.1016/S0006-3495(91)82183-X; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kandori H, 2002, BIOCHEMISTRY-US, V41, P4554, DOI 10.1021/bi0120749; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; LAWSON MA, 1991, BIOPHYS J, V60, P1490, DOI 10.1016/S0006-3495(91)82184-1; LECOUTRE J, 1995, P NATL ACAD SCI USA, V92, P4962, DOI 10.1073/pnas.92.11.4962; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Maeda A, 1999, BIOCHEMISTRY-US, V38, P8800, DOI 10.1021/bi9907072; MAEDA A, 1994, BIOCHEMISTRY-US, V33, P1713, DOI 10.1021/bi00173a013; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nikolic Konstantin, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1626; OESTERHELT D, 1973, EUR J BIOCHEM, V37, P316, DOI 10.1111/j.1432-1033.1973.tb02990.x; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Patzelt H, 2002, P NATL ACAD SCI USA, V99, P9765, DOI 10.1073/pnas.132253899; PFEFFERLE JM, 1991, BIOCHEMISTRY-US, V30, P6548, DOI 10.1021/bi00240a027; Ritter E, 2007, J BIOL CHEM, V282, P10720, DOI 10.1074/jbc.M610658200; ROTHSCHILD KJ, 1992, J BIOL CHEM, V267, P1615; ROTHSCHILD KJ, 1992, J BIOENERG BIOMEMBR, V24, P147, DOI 10.1007/BF00762674; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Siebert F, 1995, ISRAEL J CHEM, V35, P309; SIEBERT F, 1995, METHOD ENZYMOL, V246, P501; SIEBERT F, 1983, EUR J BIOCHEM, V136, P119, DOI 10.1111/j.1432-1033.1983.tb07714.x; Siebert F., 2008, VIBRATIONAL SPECTROS; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tittor J, 2002, J MOL BIOL, V319, P555, DOI 10.1016/S0022-2836(02)00307-8; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	53	136	168	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35033	35041		10.1074/jbc.M806353200	http://dx.doi.org/10.1074/jbc.M806353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18927082	Green Published, hybrid			2022-12-27	WOS:000261469100060
J	Toschi, A; Lee, E; Gadir, N; Ohh, M; Foster, DA				Toschi, Alfredo; Lee, Evan; Gadir, Noga; Ohh, Michael; Foster, David A.			Differential Dependence of Hypoxia-inducible Factors 1 alpha and 2 alpha on mTORC1 and mTORC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU PROTEIN; PHOSPHOLIPASE-D; PHOSPHATIDIC-ACID; MAMMALIAN TARGET; SURVIVAL SIGNAL; KIDNEY CANCER; RAPAMYCIN; HIF	Constitutive expression of hypoxia-inducible factor (HIF) has been implicated in several proliferative disorders. Constitutive expression of HIF1 alpha and HIF2 alpha has been linked to a number of human cancers, especially renal cell carcinoma (RCC), in which HIF2 alpha expression is the more important contributor. Expression of HIF1 alpha is dependent on the mammalian target of rapamycin (mTOR) and is sensitive to rapamycin. In contrast, there have been no reports linking HIF2 alpha expression with mTOR. mTOR exists in two complexes, mTORC1 and mTORC2, which are differentially sensitive to rapamycin. We report here that although there are clear differences in the sensitivity of HIF1 alpha and HIF2 alpha to rapamycin, both HIF1 alpha and HIF2 alpha expression is dependent on mTOR. HIF1 alpha expression was dependent on both Raptor (a constituent of mTORC1) and Rictor (a constitutive of mTORC2). In contrast, HIF2 alpha was dependent only on the mTORC2 constituent Rictor. These data indicate that although HIF1 alpha is dependent on both mTORC1 and mTORC2, HIF2 alpha is dependent only on mTORC2. We also examined the dependence of HIF alpha expression on the mTORC2 substrate Akt, which exists as three different isoforms, Akt1, Akt2, and Akt3. Interestingly, the expression of HIF2 alpha was dependent on Akt2, whereas that of HIF1 alpha was dependent on Akt3. Because HIF2 alpha is apparently more critical in RCC, this study underscores the importance of targeting mTORC2 and perhaps Akt2 signaling in RCC and other proliferative disorders in which HIF2 alpha has been implicated.	[Toschi, Alfredo; Lee, Evan; Gadir, Noga; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Ohh, Michael] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	City University of New York (CUNY) System; Hunter College (CUNY); University of Toronto	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu			National Institutes of Health [CA46677]; NCl and SCORE [GM60654]; Research Centers in Minority Institutions Award [RR-03037]; Department of Biological Sciences at Hunter College; Canadian Cancer Society of the National Cancer Institute of Canada; NATIONAL CANCER INSTITUTE [R01CA046677, R29CA046677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM060654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCl and SCORE; Research Centers in Minority Institutions Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Biological Sciences at Hunter College; Canadian Cancer Society of the National Cancer Institute of Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA46677 from NCl and SCORE Grant GM60654 (to D. A. F.) and by Research Centers in Minority Institutions Award RR-03037 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Department of Biological Sciences at Hunter College. This work was also supported by grants from the Canadian Cancer Society of the National Cancer Institute of Canada (to M.O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Foster David A, 2004, Expert Rev Anticancer Ther, V4, P691, DOI 10.1586/14737140.4.4.691; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; Gadir N, 2007, CELL CYCLE, V6, P2840, DOI 10.4161/cc.6.22.4921; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hickey MM, 2006, CURR TOP DEV BIOL, V76, P217, DOI 10.1016/S0070-2153(06)76007-0; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; Maynard MA, 2004, AM J NEPHROL, V24, P1, DOI 10.1159/000075346; Ohh M, 2006, NEOPLASIA, V8, P623, DOI 10.1593/neo.06442; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Toschi A, 2008, ONCOGENE, V27, P2746, DOI 10.1038/sj.onc.1210927; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	38	231	237	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34495	34499		10.1074/jbc.C800170200	http://dx.doi.org/10.1074/jbc.C800170200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945681	Green Published, hybrid			2022-12-27	WOS:000261469100003
J	Weinstein, MM; Yin, L; Beigneux, AP; Davies, BSJ; Gin, P; Estrada, K; Melford, K; Bishop, JR; Esko, JD; Dallinga-Thie, GM; Fong, LG; Bensadoun, A; Young, SG				Weinstein, Michael M.; Yin, Liya; Beigneux, Anne P.; Davies, Brandon S. J.; Gin, Peter; Estrada, Kristine; Melford, Kristan; Bishop, Joseph R.; Esko, Jeffrey D.; Dallinga-Thie, Geesje M.; Fong, Loren G.; Bensadoun, Andre; Young, Stephen G.			Abnormal Patterns of Lipoprotein Lipase Release into the Plasma in GPIHBP1-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; HEPARAN-SULFATE PROTEOGLYCANS; ENDOTHELIAL-CELLS; BINDING; RECEPTOR; CHYLOMICRONS; DEFICIENCY; IDENTIFICATION; LIPOLYSIS; PROTEINS	GPIHBP1-deficient mice (Gpihbp1(-/-)) exhibit severe chylomicronemia. GPIHBP1 is located within capillaries of muscle and adipose tissue, and expression of GPIHBP1 in Chinese hamster ovary cells confers upon those cells the ability to bind lipoprotein lipase (LPL). However, there has been absolutely no evidence that GPIHBP1 actually interacts with LPL in vivo. Heparin is known to release LPL from its in vivo binding sites, allowing it to enter the plasma. After an injection of heparin, we reasoned that LPL bound to GPIHBP1 in capillaries would be released very quickly, and we hypothesized that the kinetics of LPL entry into the plasma would differ in Gpihbp1(-/-) and control mice. Indeed, plasma LPL levels peaked very rapidly (within 1 min) after heparin in control mice. In contrast, plasma LPL levels in Gpihbp1(-/-) mice were much lower 1 min after heparin and increased slowly over 15 min. In keeping with that result, plasma triglycerides fell sharply within 10 min after heparin in wild-type mice, but were negligibly altered in the first 15 min after heparin in Gpihbp1(-/-) mice. Also, an injection of Intralipid released LPL into the plasma of wild-type mice but was ineffective in releasing LPL in Gpihbp1(-/-) mice. The observed differences in LPL release cannot be ascribed to different tissue stores of LPL, as LPL mass levels in tissues were similar in Gpihbp1(-/-) and control mice. The differences in LPL release after intravenous heparin and Intralipid strongly suggest that GPIHBP1 represents an important binding site for LPL in vivo.	[Weinstein, Michael M.; Yin, Liya; Beigneux, Anne P.; Davies, Brandon S. J.; Gin, Peter; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Weinstein, Michael M.; Estrada, Kristine; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Melford, Kristan; Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Bishop, Joseph R.; Dallinga-Thie, Geesje M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of California System; University of California San Diego	Fong, LG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	lfong@mednet.ucla.edu; ab55@cornell.edu; sgyoung@mednet.ucla.edu		dallinga-thie, geesje/0000-0001-5412-5923; Davies, Brandon/0000-0002-7168-8522; Young, Stephen/0000-0001-7270-3176	National Institutes of Health Postdoctoral Fellowship Awards [HL66621, HL66600, 5P01HL090553, HL087228, GM33063]; American Heart Association's National Office and Ruth L. Kirschstein Grant [0735026N, NRSA T32HL69766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, U01HL066600, U01HL066621, T32HL069766, R01HL087228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033063, R01GM033063] Funding Source: NIH RePORTER	National Institutes of Health Postdoctoral Fellowship Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association's National Office and Ruth L. Kirschstein Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Postdoctoral Fellowship Awards HL66621, HL66600, 5P01HL090553 (to P. G.), HL087228 (to S. G. Y.), and GM33063 (to J. D. E.). This work was also supported by Scientist Development Award 0735026N (to A. P. B.) from the American Heart Association's National Office and Ruth L. Kirschstein Grant NRSA T32HL69766 (to M. M. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; BENSADOU.A, 1974, J BIOL CHEM, V249, P2220; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BENSADOUN A, 2007, ADIPOSE TISSUE HLTH; BRUNZELL JD, 1980, METABOLISM, V29, P624, DOI 10.1016/0026-0495(80)90106-7; BRUNZELL JD, 2001, METABOLIC MOL BASES, P2789; CARDIN AD, 1984, THROMB RES, V34, P541, DOI 10.1016/0049-3848(84)90258-5; CARDIN AD, 1987, BIOCHEMISTRY-US, V26, P5513, DOI 10.1021/bi00391a045; CHENG CF, 1981, J BIOL CHEM, V256, P2893; Gin P, 2007, BBA-MOL CELL BIOL L, V1771, P1464, DOI 10.1016/j.bbalip.2007.10.005; Goldberg IJ, 1996, J LIPID RES, V37, P693; HANSEN LM, 1976, ANN SURG, V184, P80, DOI 10.1097/00000658-197607000-00014; HAVEL RJ, 2001, METABOLIC MOL BASES, P2705; Hocquette JF, 1998, COMP BIOCHEM PHYS B, V121, P201, DOI 10.1016/S0305-0491(98)10090-1; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; KORN ED, 1955, J BIOL CHEM, V215, P15; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Obunike JC, 2001, J BIOL CHEM, V276, P8934, DOI 10.1074/jbc.M008813200; Page S, 2006, J BIOL CHEM, V281, P13931, DOI 10.1074/jbc.M600995200; Peterfy M, 2007, NAT GENET, V39, P1483, DOI 10.1038/ng.2007.24; SAXENA U, 1991, J BIOL CHEM, V266, P17516; SAXENA U, 1991, P NATL ACAD SCI USA, V88, P2254, DOI 10.1073/pnas.88.6.2254; Sendak RA, 1998, J LIPID RES, V39, P1310; Strauss JG, 2001, J BIOL CHEM, V276, P36083, DOI 10.1074/jbc.M104430200; VENIANT MM, 2007, MURINE ATHEROSCLEROS; Wang J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-23; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wu GS, 2003, J BIOL CHEM, V278, P11925, DOI 10.1074/jbc.M212736200; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	29	62	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34511	34518		10.1074/jbc.M806067200	http://dx.doi.org/10.1074/jbc.M806067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845532	Green Published, hybrid			2022-12-27	WOS:000261469100005
J	Wilkins, ME; Li, XY; Smart, TG				Wilkins, Megan E.; Li, Xinyan; Smart, Trevor G.			Tracking Cell Surface GABA(B) Receptors Using an alpha-Bungarotoxin Tag	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; INHIBITORY SYNAPSES; BINDING-SITE; A RECEPTORS; TRAFFICKING; PHOSPHORYLATION; SUBUNIT; DESENSITIZATION; ENDOCYTOSIS; MODULATION	GABA(B) receptors mediate slow synaptic inhibition in the central nervous system and are important for synaptic plasticity as well as being implicated in disease. Located at pre- and postsynaptic sites, GABAB receptors will influence cell excitability, but their effectiveness in doing so will be dependent, in part, on their trafficking to, and stability on, the cell surface membrane. To examine the dynamic behavior of GABA(B) receptors in GIRK cells and neurons, we have devised a method that is based on tagging the receptor with the binding site components for the neurotoxin, alpha-bungarotoxin. By using the alpha-bungarotoxin binding site-tagged GABA(B) R1a subunit (R1a(BBS)), co-expressed with the R2 subunit, we can track receptor mobility using the small reporter, alpha-bungarotoxin-conjugated rhodamine. In this way, the rates of internalization and membrane insertion for these receptors could be measured with fixed and live cells. The results indicate that GABAB receptors rapidly turnover in the cell membrane, with the rate of internalization affected by the state of receptor activation. The bungarotoxin-based method of receptor-tagging seems ideally suited to follow the dynamic regulation of other G-protein-coupled receptors.	[Wilkins, Megan E.; Li, Xinyan; Smart, Trevor G.] UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Smart, TG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	t.smart@ucl.ac.uk		Wilkins, Megan/0000-0003-0150-4457	MRC; Wellcome Trust; MRC [G0601529] Funding Source: UKRI; Medical Research Council [G0601529] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Caputi L, 2003, SYNAPSE, V47, P236, DOI 10.1002/syn.10164; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Enna SJ, 2004, BIOCHEM PHARMACOL, V68, P1541, DOI 10.1016/j.bcp.2004.06.037; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Fritschy JM, 2004, J COMP NEUROL, V477, P235, DOI 10.1002/cne.20188; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Gonzalez-Maeso J, 2003, EUR J PHARMACOL, V481, P15, DOI 10.1016/j.ejphar.2003.09.002; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Pooler AM, 2007, J BIOL CHEM, V282, P25349, DOI 10.1074/jbc.M702358200; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Wilkins ME, 2005, J PHYSIOL-LONDON, V567, P365, DOI 10.1113/jphysiol.2005.088823	33	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34745	34752		10.1074/jbc.M803197200	http://dx.doi.org/10.1074/jbc.M803197200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18812318	Green Published, hybrid			2022-12-27	WOS:000261469100031
J	Hudson, BI; Kalea, AZ; Arriero, MD; Harja, E; Boulanger, E; D'Agati, V; Schmidt, AM				Hudson, Barry I.; Kalea, Anastasia Z.; Arriero, Maria del Mar; Harja, Evis; Boulanger, Eric; D'Agati, Vivette; Schmidt, Ann Marie			Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; NEURITE OUTGROWTH; ACTIN NUCLEATION; SURFACE RECEPTOR; SMALL GTPASE; RHO-GTPASE; PROTEIN; FORMIN; PATHWAY; BINDING	Cellular migration is a fundamental process linked to diverse pathological states such as diabetes and its complications, atherosclerosis, inflammation, and cancer. The receptor for advanced glycation end products ( RAGE) is a multiligand cell surface macromolecule which binds distinct ligands that accumulate in these settings. RAGE-ligand interaction evokes central changes in key biological properties of cells, including proliferation, generation of inflammatory mediators, and migration. Although RAGE-dependent signal transduction is critically dependent on its short cytoplasmic domain, to date the proximate mechanism by which this RAGE domain engages and stimulates cytoplasmic signaling pathways has yet to be identified. Here we show that the RAGE cytoplasmic domain interacts with Diaphanous-1 (Dia-1) both in vitro and in vivo. We employed the human RAGE cytoplasmic domain as "bait" in the yeast two-hybrid assay and identified the formin homology (FH1) domain of Dia-1 as a potential binding partner of this RAGE domain. Immunoprecipitation studies revealed that the RAGE cytoplasmic domain interacts with the FH1 domain of Dia-1. Down-regulation of Dia-1 expression by RNA interference blocks RAGE-mediated activation of Rac-1 and Cdc42 and, in parallel, RAGE ligand-stimulated cellular migration. Taken together, these findings indicate that the interaction of the RAGE cytoplasmic domain with Dia-1 is required to transduce extracellular environmental cues evoked by binding of RAGE ligands to their cell surface receptor, a chief consequence of which is Rac-1 and Cdc42 activation and cellular migration. Because RAGE and Dia-1 are implicated in the regulation of inflammatory, vascular, and transformed cell migration, these findings highlight this interaction as a novel target for therapeutic intervention in inflammation, atherosclerosis, diabetes, and cancer.	[Hudson, Barry I.; Kalea, Anastasia Z.; Arriero, Maria del Mar; Harja, Evis; Boulanger, Eric; Schmidt, Ann Marie] Columbia Univ, Med Ctr, Div Surg Sci, Dept Surg, New York, NY 10032 USA; [D'Agati, Vivette] Columbia Univ, Med Ctr, Div Surg Sci, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Schmidt, AM (corresponding author), Columbia Univ, Coll Phys & Surg, Div Surg Sci, Dept Surg, 630 W 168th St,P&S 17-401, New York, NY 10032 USA.	ams11@columbia.edu	Kalea, Anastasia Z./G-4053-2010; Hudson, Barry/B-3122-2009	Hudson, Barry/0000-0001-7647-8121; Kalea, Anastasia Z./0000-0001-5775-3984; BOULANGER, Eric/0000-0002-5204-2849	National Institutes of Health [HL60901, CA 087677]; Juvenile Diabetes Research Foundation; Surgical Research Fund; NATIONAL CANCER INSTITUTE [R01CA087677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Surgical Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60901 and CA 087677 (United States Public Health Service). This work was also funded by the Juvenile Diabetes Research Foundation and by the Surgical Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Bai CX, 2008, EMBO J, V27, P1345, DOI 10.1038/emboj.2008.70; Barbieri MA, 2004, CURR TOP MICROBIOL, V286, P1; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Gill MB, 2004, J CELL SCI, V117, P2709, DOI 10.1242/jcs.01113; Goulimari P, 2008, MOL BIOL CELL, V19, P30, DOI 10.1091/mbc.E06-11-1045; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huang JS, 2001, J CELL BIOCHEM, V81, P102, DOI 10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kislinger T, 2001, ARTERIOSCL THROM VAS, V21, P905, DOI 10.1161/01.ATV.21.6.905; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Krebs A, 2001, J CELL SCI, V114, P3663; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Satoh S, 2001, J BIOL CHEM, V276, P39290, DOI 10.1074/jbc.M107026200; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SCHMIDT AM, 1993, J CLIN INVEST, V91, P2155, DOI 10.1172/JCI116442; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wang LY, 2008, J NEUROSCI RES, V86, P1254, DOI 10.1002/jnr.21578; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23	45	243	253	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34457	34468		10.1074/jbc.M801465200	http://dx.doi.org/10.1074/jbc.M801465200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922799	hybrid, Green Published			2022-12-27	WOS:000261277700073
J	Veiga-da-Cunha, M; Vleugels, W; Maliekal, P; Matthijs, G; Van Schaftingen, E				Veiga-da-Cunha, Maria; Vleugels, Wendy; Maliekal, Pushpa; Matthijs, Gert; Van Schaftingen, Emile			Mammalian Phosphomannomutase PMM1 Is the Brain IMP-sensitive Glucose-1,6-bisphosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; GLUCOSE 1,6-BISPHOSPHATE; KINETIC-PROPERTIES; PHOSPHOGLUCOMUTASE; PHOSPHOFRUCTOKINASE; HEXOKINASE; GENE; 1,6-DIPHOSPHATE; BISPHOSPHATASE; DEHYDROGENASE	Glucose 1,6-bisphosphate (Glc-1,6-P-2) concentration in brain is much higher than what is required for the functioning of phosphoglucomutase, suggesting that this compound has a role other than as a cofactor of phosphomutases. In cell-free systems, Glc-1,6-P-2 is formed from 1,3-bisphosphoglycerate and Glc-6-P by two related enzymes: PGM2L1 (phosphoglucomutase 2-like 1) and, to a lesser extent, PGM2 (phosphoglucomutase 2). It is hydrolyzed by the IMP-stimulated brain Glc-1,6-bisphosphatase of still unknown identity. Our aim was to test whether Glc-1,6-bisphosphatase corresponds to the phosphomannomutase PMM1, an enzyme of mysterious physiological function sharing several properties with Glc1,6- bisphosphatase. We show that IMP, but not other nucleotides, stimulated by > 100-fold (K-a approximate to 20 mu M) the intrinsic Glc-1,6-bisphosphatase activity of recombinant PMM1 while inhibiting its phosphoglucomutase activity. No such effects were observed with PMM2, an enzyme paralogous to PMM1 that physiologically acts as a phosphomannomutase in mammals. Transfection of HEK293T cells with PGM2L1, but not the related enzyme PGM2, caused an approximate to 20-fold increase in the concentration of Glc-1,6-P-2. Transfection with PMM1 caused a profound decrease (> 5-fold) in Glc-1,6-P-2 in cells that were or were not cotransfected with PGM2L1. Furthermore, the concentration of Glc-1,6-P-2 in wild type mouse brain decreased with time after ischemia, where as it did not change in PMM1-deficient mouse brain. Taken together, these data show that PMM1 corresponds to the IMP-stimulated Glc-1,6-bisphosphatase and that this enzyme is responsible for the degradation of Glc- 1,6-P-2 in brain. In addition, the role of PGM2L1 as the enzyme responsible for the synthesis of the elevated concentrations of Glc- 1,6-P-2 in brain is established.	[Veiga-da-Cunha, Maria] Catholic Univ Louvain, de Duve Inst, Physiol Chem Lab, Grp Rech Metab, B-1200 Brussels, Belgium; [Vleugels, Wendy; Matthijs, Gert] Univ Leuven, Ctr Human Genet, Mol Diagnost Lab, B-3000 Louvain, Belgium	Universite Catholique Louvain; KU Leuven	Veiga-da-Cunha, M (corresponding author), Catholic Univ Louvain, de Duve Inst, Physiol Chem Lab, Grp Rech Metab, Ave Hippocrate 75, B-1200 Brussels, Belgium.	maria.veiga@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Van Schaftingen, Emile/0000-0002-6199-7647; Matthijs, Gert/0000-0001-6710-1912				ACCORSI A, 1986, MECH AGEING DEV, V36, P133, DOI 10.1016/0047-6374(86)90014-X; ACCORSI A, 1989, PREP BIOCHEM, V19, P251, DOI 10.1080/10826068908544915; BEITNER R, 1975, BIOCHIM BIOPHYS ACTA, V397, P355, DOI 10.1016/0005-2744(75)90125-4; BEITNER R, 1979, BIOCHIM BIOPHYS ACTA, V583, P266, DOI 10.1016/0304-4165(79)90434-3; BONTEMPS F, 1993, BIOCHEM J, V290, P679, DOI 10.1042/bj2900679; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Cromphout K, 2006, MOL CELL BIOL, V26, P5621, DOI 10.1128/MCB.02357-05; Cromphout K, 2005, EUR J NEUROSCI, V22, P991, DOI 10.1111/j.1460-9568.2005.04266.x; Gemayel R, 2007, FEBS J, V274, P4360, DOI 10.1111/j.1742-4658.2007.05948.x; GERBER G, 1974, EUR J BIOCHEM, V45, P39, DOI 10.1111/j.1432-1033.1974.tb03527.x; GUHA SK, 1982, J BIOL CHEM, V257, P6634; GUHA SK, 1983, BIOCHEMISTRY-US, V22, P1356, DOI 10.1021/bi00275a006; KOSTER JF, 1972, BIOCHIM BIOPHYS ACTA, V258, P763, DOI 10.1016/0005-2744(72)90177-5; KRZANOWS.J, 1969, BIOCHEM BIOPH RES CO, V34, P816, DOI 10.1016/0006-291X(69)90253-8; LELOIR LF, 1948, ARCH BIOCHEM, V19, P339; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; MARCUS CJ, 1976, J BIOL CHEM, V251, P2963; Matthijs G, 1997, NAT GENET, V16, P316, DOI 10.1038/ng0797-316; Matthijs G, 1997, GENOMICS, V40, P41, DOI 10.1006/geno.1996.4536; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Messana I, 1998, J BIOL CHEM, V273, P15329, DOI 10.1074/jbc.273.25.15329; PASSONNEAU JV, 1969, J BIOL CHEM, V244, P902; PIATTI E, 1992, ARCH BIOCHEM BIOPHYS, V293, P117, DOI 10.1016/0003-9861(92)90373-5; Pirard M, 1999, BIOCHEM J, V339, P201, DOI 10.1042/0264-6021:3390201; Pirard M, 1997, FEBS LETT, V411, P251, DOI 10.1016/S0014-5793(97)00704-7; RIJKSEN G, 1977, FEBS LETT, V80, P61, DOI 10.1016/0014-5793(77)80407-9; ROSE IA, 1975, J BIOL CHEM, V250, P3466; ROSE IA, 1974, BIOCHEM BIOPH RES CO, V59, P1333, DOI 10.1016/0006-291X(74)90460-4; ROSE ZB, 1986, TRENDS BIOCHEM SCI, V11, P253, DOI 10.1016/0968-0004(86)90188-X; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1	34	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33988	33993		10.1074/jbc.M805224200	http://dx.doi.org/10.1074/jbc.M805224200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18927083	Green Published, hybrid			2022-12-27	WOS:000261277700025
J	Chee, MJS; Morl, K; Lindner, D; Merten, N; Zamponi, GW; Light, PE; Beck-Sickinger, AG; Colmers, WF				Chee, Melissa J. S.; Moerl, Karin; Lindner, Diana; Merten, Nicole; Zamponi, Gerald W.; Light, Peter E.; Beck-Sickinger, Annette G.; Colmers, William F.			The Third Intracellular Loop Stabilizes the Inactive State of the Neuropeptide Y1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; RESONANCE ENERGY-TRANSFER; MU-OPIOID RECEPTOR; CONSTITUTIVE ACTIVATION; ADENYLYL-CYCLASE; INVERSE AGONIST; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSTABILITY; THYROTROPIN RECEPTOR	Constitutively active G-protein-coupled receptors (GPCRs) can signal even in the absence of ligand binding. Most Class I GPCRs are stabilized in the resting conformation by intramolecular interactions involving transmembrane domain (TM) 3 and TM6, particularly at loci 6.30 and 6.34 of TM6. Signaling by G(i)/G(o)-coupled receptors such as the Neuropeptide Y1 receptor decreases already low basal metabolite levels. Thus, we examined constitutive activity using a biochemical assay mediated by a G(i)/G(q) chimeric protein and a more direct electrophysiological assay. Wild-type (WT-Y1) receptors express no measurable, agonist-independent activation, while mu-opioid receptors (MOR) and P2Y(12) purinoceptors showed clear evidence of constitutive activation, especially in the electrophysiological assay. Neither point mutations at TM6 (T(6.30)A or N(6.34)A) nor substitution of the entire TM3 and TM6 regions from the MOR into the Y1 receptor increased basal WT-Y1 activation. By contrast, chimeric substitution of the third intracellular loop (ICL3) generated a constitutively active, Y1-ICL3-MOR chimera. Furthermore, the loss of stabilizing interactions from the native ICL3 enhanced the role of surrounding residues to permit basal receptor activation; because constitutive activity of the Y1-ICL3-MOR chimera was further increased by point mutation at locus 6.34, which did not alter WT-Y1 receptor activity. Our results indicate that the ICL3 stabilizes the Y1 receptor in the inactive state and confers structural properties critical for regulating Y receptor activation and signal transduction. These studies reveal the active participation of the ICL3 in the stabilization and activation of Class I GPCRs.	[Chee, Melissa J. S.; Light, Peter E.; Colmers, William F.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; [Chee, Melissa J. S.; Colmers, William F.] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2H7, Canada; [Moerl, Karin; Lindner, Diana; Merten, Nicole; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, D-041033 Leipzig, Germany; [Zamponi, Gerald W.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada	University of Alberta; University of Alberta; Leipzig University; University of Calgary	Colmers, WF (corresponding author), Univ Alberta, Dept Pharmacol, 9-36 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	william.colmers@ualberta.ca	Colmers, William/C-3106-2013; Lindner, Diana/AAL-9856-2021; Chee, Melissa/G-4150-2014	Colmers, William/0000-0001-7902-3560; Lindner, Diana/0000-0001-5477-769X; Chee, Melissa/0000-0003-3815-9095; Zamponi, Gerald W./0000-0002-0644-9066	Canadian Institutes of Health Research (CIHR) [MT10520]; German Research Foundation [DFG SFB610, TP A1]; Saxonian Ministry for Science and Culture [4-7531.50-02-0361-05/1]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); German Research Foundation(German Research Foundation (DFG)); Saxonian Ministry for Science and Culture	The work was supported by the Canadian Institutes of Health Research (CIHR) Grant MT10520, the German Research Foundation (DFG SFB610, TP A1), and the Saxonian Ministry for Science and Culture (SMWK, Saxonia/Alberta-collaboration 4-7531.50-02-0361-05/1). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Bakker RA, 2004, J BIOL CHEM, V279, P5152, DOI 10.1074/jbc.M309200200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Burford NT, 2000, BIOCHEM J, V348, P531, DOI 10.1042/0264-6021:3480531; Chalmers DT, 2002, NAT REV DRUG DISCOV, V1, P599, DOI 10.1038/nrd872; Chan KYY, 2001, ENDOCRINOLOGY, V142, P3926, DOI 10.1210/en.142.9.3926; Chen G, 2000, MOL PHARMACOL, V57, P125; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conner AC, 2006, BIOCHEMISTRY-US, V45, P12976, DOI 10.1021/bi0615801; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; Couvineau A, 2003, J BIOL CHEM, V278, P24759, DOI 10.1074/jbc.M301916200; Ding ZG, 2006, MOL PHARMACOL, V69, P338, DOI 10.1124/mol.105.014654; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Egan CT, 1998, J PHARMACOL EXP THER, V286, P85; El Bahh B, 2005, EUR J NEUROSCI, V22, P1417, DOI 10.1111/j.1460-9568.2005.04338.x; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fuhrer D, 1997, J CLIN ENDOCR METAB, V82, P4234, DOI 10.1210/jc.82.12.4234; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HillEubanks D, 1996, J BIOL CHEM, V271, P3058, DOI 10.1074/jbc.271.6.3058; HOLST B, 2003, ANN NY ACAD SCI, P9941; Huang P, 2002, BIOCHEMISTRY-US, V41, P11972, DOI 10.1021/bi026067b; Huang P, 2001, BIOCHEMISTRY-US, V40, P13501, DOI 10.1021/bi010917q; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jackson DN, 2005, J PHYSIOL-LONDON, V568, P573, DOI 10.1113/jphysiol.2005.092700; Janovick JA, 2003, J PHARMACOL EXP THER, V305, P608, DOI 10.1124/jpet.102.048454; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kostenis E, 1997, J BIOL CHEM, V272, P19107, DOI 10.1074/jbc.272.31.19107; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; KOSUGI S, 1994, FEBS LETT, V356, P291, DOI 10.1016/0014-5793(94)01286-5; Kosugi S, 1998, MOL PHARMACOL, V53, P894; Larhammar D, 2001, PEPTIDES, V22, P295, DOI 10.1016/S0196-9781(01)00331-X; Larhammar D, 1996, REGUL PEPTIDES, V65, P165, DOI 10.1016/0167-0115(96)00110-3; LATRONICO AC, 1995, J CLIN ENDOCR METAB, V80, P2490, DOI 10.1210/jc.80.8.2490; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Lindner D, 2008, BIOCHEMISTRY-US, V47, P5905, DOI 10.1021/bi800181k; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; Menzaghi F, 2002, CNS NEUROL DISORD-DR, V1, P105, DOI 10.2174/1568007023339508; Miura S, 2000, FEBS LETT, V470, P331, DOI 10.1016/S0014-5793(00)01346-6; NELSON CP, 2002, J PHARMACOL EXP THER, V316, P279; Niswender CM, 2008, MOL PHARMACOL, V73, P1213, DOI 10.1124/mol.107.041053; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pan XH, 1998, MOL PHARMACOL, V54, P1064, DOI 10.1124/mol.54.6.1064; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schulz A, 2003, J BIOL CHEM, V278, P35531, DOI 10.1074/jbc.M303346200; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; Straiker AJ, 2002, J NEUROSCI, V22, P2460, DOI 10.1523/JNEUROSCI.22-07-02460.2002; Takhar S, 1996, ENDOCRINOLOGY, V137, P2175, DOI 10.1210/en.137.5.2175; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timossi C, 2004, MOL CELL ENDOCRINOL, V223, P17, DOI 10.1016/j.mce.2004.06.004; Tu B, 2005, J NEUROSCI, V25, P1718, DOI 10.1523/JNEUROSCI.4835-04.2005; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wonerow P, 1998, J BIOL CHEM, V273, P7900, DOI 10.1074/jbc.273.14.7900; Yao LN, 2002, CELL, V109, P733, DOI 10.1016/S0092-8674(02)00763-8; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang M, 2000, J BIOL CHEM, V275, P15782, DOI 10.1074/jbc.M000198200	70	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33337	33346		10.1074/jbc.M804671200	http://dx.doi.org/10.1074/jbc.M804671200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18812316	Green Published, hybrid			2022-12-27	WOS:000261183700038
J	Frasch, SC; Berry, KZ; Fernandez-Boyanapalli, R; Jin, HS; Leslie, C; Henson, PM; Murphy, RC; Bratton, DL				Frasch, S. Courtney; Berry, Karin Zemski; Fernandez-Boyanapalli, Ruby; Jin, Hyun-Sun; Leslie, Christina; Henson, Peter M.; Murphy, Robert C.; Bratton, Donna L.			NADPH Oxidase-dependent Generation of Lysophosphatidylserine Enhances Clearance of Activated and Dying Neutrophils via G2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); SOLID-PHASE EXTRACTION; APOPTOTIC CELLS INDUCE; PERITONEAL MAST-CELLS; PHOSPHATIDYLSERINE RECEPTOR; IN-VIVO; FACTOR ACETYLHYDROLASE; PROTEIN-KINASE; UNSATURATED PHOSPHATIDYLCHOLINES; BACTERIAL LIPOPOLYSACCHARIDE	Exofacial phosphatidylserine (PS) is an important ligand mediating apoptotic cell clearance by phagocytes. Oxidation of PS fatty acyl groups (oxPS) during apoptosis reportedly mediates recognition through scavenger receptors. Given the oxidative capacity of the neutrophil NADPH oxidase, we sought to identify oxPS signaling species in stimulated neutrophils. Using mass spectrometry analysis, only trace amounts of previously characterized oxPS species were found. Conversely, 18: 1 and 18: 0 lysophosphatidylserine (lysoPS), known bioactive signaling phospholipids, were identified as abundant modified PS species following activation of the neutrophil oxidase. NADPH oxidase inhibitors blocked the production of lyso-PS in vitro, and accordingly, its generation in vivo by activated, murine neutrophils during zymosan-induced peritonitis was absent in mice lacking a functional NADPH oxidase (gp91(phox-/-)). Treatment of macrophages with lyso-PS enhanced the uptake of apoptotic cells in vitro, an effect that was dependent on signaling via the macrophage G2A receptor. Similarly, endogenously produced lyso-PS also enhanced the G2A-mediated uptake of activated PS-exposing (but non-apoptotic) neutrophils, raising the possibility of non-apoptotic mechanisms for removal of inflammatory cells during resolution. Finally, antibody blockade of G2A signaling in vivo prolonged zymosan-induced neutrophilia in wild-type mice, whereas having no effect in gp91(phox-/-) mice where lyso-PS are not generated. Taken together, we show that lyso-PS are modified PS species generated following activation of the NADPH oxidase and lyso-PS signaling through the macrophage G2A functions to enhance existing receptor/ligand systems for optimal resolution of neutrophilic inflammation.	[Berry, Karin Zemski; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby; Jin, Hyun-Sun; Leslie, Christina; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leslie, Christina; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Cell Biol Program, Denver, CO 80206 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; National Jewish Health	Frasch, SC (corresponding author), 1400 Jackson St, Denver, CO 80206 USA.	fraschc@njc.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [AI058228, HL34303, GM61031, HL81151]; Immunodeficiency Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081151, P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058228, R01AI058228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Immunodeficiency Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058228 (to D. L. B.), HL34303 (to D. L. B., C. C. L., and R. C. M.), and GM61031 and HL81151 (to P. M. H.). This work was also supported by a grant from the Immunodeficiency Foundation (to D. L. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Berry KAZ, 2005, ANTIOXID REDOX SIGN, V7, P157, DOI 10.1089/ars.2005.7.157; Bodennec J, 2003, J LIPID RES, V44, P218, DOI 10.1194/jlr.D200026-JLR200; Bratton DL, 2008, CURR BIOL, V18, pR76, DOI 10.1016/j.cub.2007.11.024; Campbell EL, 2007, FASEB J, V21, P3162, DOI 10.1096/fj.07-8473com; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Elliott JI, 2006, BLOOD, V108, P1611, DOI 10.1182/blood-2005-11-012328; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frasch SC, 2007, J IMMUNOL, V178, P6540, DOI 10.4049/jimmunol.178.10.6540; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; Guzik K, 2008, BIOCHIMIE, V90, P405, DOI 10.1016/j.biochi.2007.09.008; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hallett JM, 2008, TRENDS PHARMACOL SCI, V29, P250, DOI 10.1016/j.tips.2008.03.002; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HASLETT C, 1985, AM J PATHOL, V119, P101; Hazan I, 1997, BIOCHEM J, V326, P867, DOI 10.1042/bj3260867; Hoffmann PR, 2005, J IMMUNOL, V174, P1393, DOI 10.4049/jimmunol.174.3.1393; Hosono H, 2001, J BIOL CHEM, V276, P29664, DOI 10.1074/jbc.M104597200; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kawamoto K, 2002, J IMMUNOL, V168, P6412, DOI 10.4049/jimmunol.168.12.6412; KIM HY, 1990, J LIPID RES, V31, P2285; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Kriska T, 2007, J BIOL CHEM, V282, P100, DOI 10.1074/jbc.M608135200; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; MUELLER HW, 1984, J LIPID RES, V25, P383; Panasenko OM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P571, DOI 10.1134/S0006297906050178; Panasenko OM, 2003, FREE RADICAL BIO MED, V34, P553, DOI 10.1016/S0891-5849(02)01358-8; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rossi AG, 2007, BIOCHEM SOC T, V35, P288, DOI 10.1042/BST0350288; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SMITH GA, 1979, FEBS LETT, V105, P58, DOI 10.1016/0014-5793(79)80887-X; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; VANHOEVEN RP, 1975, BIOCHIM BIOPHYS ACTA, V380, P1, DOI 10.1016/0005-2760(75)90039-9; Yamamori T, 2002, BIOCHEM BIOPH RES CO, V293, P1571, DOI 10.1016/S0006-291X(02)00418-7; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Zhao XX, 2002, J BIOL CHEM, V277, P25385, DOI 10.1074/jbc.M203630200	68	76	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33736	33749		10.1074/jbc.M807047200	http://dx.doi.org/10.1074/jbc.M807047200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824544	Green Published, hybrid			2022-12-27	WOS:000261183700080
J	Matsui, C; Kaieda, S; Ikegami, T; Mimori-Kiyosue, Y				Matsui, Chiyuki; Kaieda, Shuji; Ikegami, Takahisa; Mimori-Kiyosue, Yuko			Identification of a Link between the SAMP Repeats of Adenomatous Polyposis Coli Tumor Suppressor and the Src Homology 3 Domain of DDEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; FOCAL ADHESION KINASE; PAXILLIN-BINDING PROTEIN; WNT SIGNALING PATHWAY; CELL-MIGRATION; BETA-CATENIN; SH3 DOMAIN; MICROTUBULE DYNAMICS; NEGATIVE REGULATOR; STRUCTURAL BASIS	The adenomatous polyposis coli (APC) tumor suppressor protein is a multifunctional protein with a well characterized role in the Wnt signal transduction pathway and in cytoskeletal regulation. The SAMP repeats region of APC, an Axin-binding site, is known to be important for tumor suppression and for the developmental function of APC. We performed a yeast two-hybrid screening using the first SAMP motif-containing region of Xenopus APC as bait and obtained several SAMP binding candidates including DDEF2 (development and differentiation enhancing factor 2), which is an ADP-ribosylation factor (Arf) GTPase-activating protein (GAP (ArfGAP)) involved in the regulation of focal adhesions. In vitro and in cells the Src homology 3 (SH3) domain of DDEF2 and its close homolog, DDEF1, are associated with the SAMP motif of APC competitively with Axin1. Moreover, NMR chemical shift perturbation experiments revealed that the SAMP motif interacts at the same surface of the SH3 domain of DDEF as the known SH3 binding motif, PXXP. When fluorescent protein-tagged APC and DDEF are expressed in Xenopus A6 cells, co-localization at microtubule ends is observed. Overexpression and RNA interference experiments indicate that APC and DDEFs cooperatively regulate the distributions of microtubules and focal adhesions. Our findings reveal that the SAMP motif of APC specifically binds to the SH3 domains of DDEFs, providing new insights into the functions of APC in cell migration.	[Matsui, Chiyuki; Mimori-Kiyosue, Yuko] KAN Res Inst Inc, Kobe MI R&D Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kaieda, Shuji; Ikegami, Takahisa] Osaka Univ, Lab Struct Prote, Inst Prot Res, Suita, Osaka 5650871, Japan	KAN Research Institute; Osaka University	Mimori-Kiyosue, Y (corresponding author), KAN Res Inst Inc, Kobe MI R&D Ctr, Chuo Ku, 3F,6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	y-kiyosue@kan.eisai.co.jp	Mimori-Kiyosue, Yuko/K-9158-2015; Ikegami, Takahisa/I-9626-2017	Mimori-Kiyosue, Yuko/0000-0003-3513-9072; Ikegami, Takahisa/0000-0002-1429-1844				Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Hamada F, 1999, GENES CELLS, V4, P465, DOI 10.1046/j.1365-2443.1999.00272.x; Hashimoto S, 2004, J BIOL CHEM, V279, P37677, DOI 10.1074/jbc.M404196200; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Kruljac-Letunic A, 2005, METHOD ENZYMOL, V404, P411, DOI 10.1016/S0076-6879(05)04036-X; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mimori-Kiyosue Y, 2007, GENES CELLS, V12, P219, DOI 10.1111/j.1365-2443.2007.01045.x; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; MUNEMITSU S, 1994, CANCER RES, V54, P3676; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nakamura K, 2000, J BIOL CHEM, V275, P27155; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Oshiro T, 2002, J BIOL CHEM, V277, P38618, DOI 10.1074/jbc.M203453200; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; POLAKIS P, 1995, CURR OPIN GENET DEV, V5, P66, DOI 10.1016/S0959-437X(95)90055-1; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Renner C, 1997, J IMMUNOL, V159, P1276; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; SMITH KJ, 1994, CANCER RES, V54, P3672; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Vaughan KT, 1999, J CELL SCI, V112, P1437; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104	61	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					33006	33020		10.1074/jbc.M800420200	http://dx.doi.org/10.1074/jbc.M800420200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18786926	hybrid			2022-12-27	WOS:000260893700089
J	Agren, D; Schnell, R; Oehlmann, W; Singh, M; Schneider, G				Agren, Daniel; Schnell, Robert; Oehlmann, Wulf; Singh, Mahavir; Schneider, Gunter			Cysteine Synthase (CysM) of Mycobacterium tuberculosis Is an O-Phosphoserine Sulfhydrylase EVIDENCE FOR AN ALTERNATIVE CYSTEINE BIOSYNTHESIS PATHWAY IN MYCOBACTERIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLSERINE SULFHYDRYLASE; 3-DIMENSIONAL STRUCTURE; SALMONELLA-TYPHIMURIUM; MECHANISM; ENZYME; IDENTIFICATION; REQUIREMENTS; MACROPHAGES; ADAPTATION; PERSISTENT	The biosynthesis of cysteine is a crucial metabolic pathway supplying a building block for de novo protein synthesis but also a reduced thiol as a component of the oxidative defense mechanisms that appear particularly vital in the dormant state of Mycobacterium tuberculosis. We here show that the cysteine synthase CysM is, in contrast to previous annotations, an O-phosphoserine-specific cysteine synthase. CysM belongs to the fold type II pyridoxal 5'-phosphate-dependent enzymes, as revealed by the crystal structure determined at 2.1-angstrom resolution. A model of O-phosphoserine bound to the enzyme suggests a hydrogen bonding interaction of the side chain of Arg(220) with the phosphate group as a key feature in substrate selectivity. Replacement of this residue results in a significant loss of specificity for O- phosphoserine. Notably, reactions with sulfur donors are not affected by the amino acid replacement. The specificity of CysM toward O- phosphoserine together with the previously established novel mode of sulfur delivery via thiocar-boxylated CysO (Burns, K. E., Baumgart, S., Dorrestein, P. C., Zhai, H., McLafferty, F. W., and Begley, T. P. (2005) J. Am. Chem. Soc. 127, 11602 - 11603) provide strong evidence for an O-phosphoserine-based cysteine biosynthesis pathway in M. tuberculosis that is independent of both O- acetylserine and the sulfate reduction pathway. The existence of an alternative biosynthetic pathway to cysteine in this pathogen has implications for the design strategy aimed at inhibition of this metabolic route.	[Agren, Daniel; Schnell, Robert; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Oehlmann, Wulf; Singh, Mahavir] LIONEX GmbH, D-38124 Braunschweig, Germany; [Singh, Mahavir] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Karolinska Institutet; Helmholtz Association; Helmholtz-Center for Infection Research	Schneider, G (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	Robert.Schnell@ki.se; Gunter.Schneider@ki.se		Schneider, Gunter/0000-0003-0622-5713; SCHNELL, ROBERT/0000-0001-7530-3629	European Commission [LSHP-CT-2005-018729]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Contract LSHP-CT-2005-018729. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Bornemann C, 1997, BIOCHEM J, V325, P623, DOI 10.1042/bj3250623; Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Chattopadhyay A, 2007, BIOCHEMISTRY-US, V46, P8315, DOI 10.1021/bi602603c; Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+; *COLL COMP PROJ, 1994, ACTA CRYSTALLOGR D, V53, P760; Cook PF, 1996, J BIOL CHEM, V271, P25842, DOI 10.1074/jbc.271.42.25842; Dey S, 2005, J BIOL CHEM, V280, P14884, DOI 10.1074/jbc.M414488200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenton MJ, 1996, INFECT IMMUN, V64, P683, DOI 10.1128/IAI.64.3.683-690.1996; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Hwang CC, 1996, BIOCHEMISTRY-US, V35, P6358, DOI 10.1021/bi9602472; Karsten WE, 2002, METHOD ENZYMOL, V354, P223; Kinsland C, 1998, PROTEIN SCI, V7, P1839, DOI 10.1002/pro.5560070821; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Maier THP, 2003, NAT BIOTECHNOL, V21, P422, DOI 10.1038/nbt807; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mino K, 2003, FEBS LETT, V551, P133, DOI 10.1016/S0014-5793(03)00913-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAMURA T, 1984, J BACTERIOL, V158, P1122, DOI 10.1128/JB.158.3.1122-1127.1984; Oda Y, 2005, J MOL BIOL, V351, P334, DOI 10.1016/j.jmb.2005.05.064; Rabeh WM, 2005, BIOCHEMISTRY-US, V44, P5541, DOI 10.1021/bi047479i; Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; White RH, 2003, BBA-GEN SUBJECTS, V1624, P46, DOI 10.1016/j.bbagen.2003.09.005; Williams SJ, 2002, J BIOL CHEM, V277, P32606, DOI 10.1074/jbc.M204613200; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291; Zocher G, 2007, FEBS J, V274, P5382, DOI 10.1111/j.1742-4658.2007.06063.x	44	42	55	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31567	31574		10.1074/jbc.M804877200	http://dx.doi.org/10.1074/jbc.M804877200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799456	hybrid			2022-12-27	WOS:000260760800036
J	Maa, MC; Chang, MY; Chen, YJ; Lin, CH; Yu, CJ; Yang, YL; Li, JR; Chen, PR; Tang, CH; Lei, HY; Leu, TH				Maa, Ming-Chei; Chang, Miao Ying; Chen, Yen-Jen; Lin, Chen-Hsuan; Yu, Chih Jen; Yang, Yi Lun; Li, Jiarung; Chen, Pei-Ru; Tang, Chih-Hsin; Lei, Huan-Yao; Leu, Tzeng-Horng			Requirement of Inducible Nitric-oxide Synthase in Lipopolysaccharide-mediated Src Induction and Macrophage Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROTEIN-TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELL MIGRATION; C-SRC; SIGNAL-TRANSDUCTION; GUANYLYL-CYCLASE; FAMILY KINASES; GROWTH-FACTOR; HUMAN CANCER; CYCLIC-GMP	Previously, we have demonstrated the induction of Src in lipopolysaccharide (LPS)-stimulated macrophages. In this study, we observed that pharmacological blockade or knockout of inducible nitric-oxide synthase (iNOS) reduced LPS-mediated Src induction and macrophage migration. Either SNAP (a NO donor) or 8-Br-cGMP (a cGMP analogue) could rescue these defects in iNOS-null macrophages, which indicated the participation of NO/cGMP in LPS-elicited Src expression and mobilization. In addition, Src family kinase (SFK)-specific inhibitor, PP2, inhibited SNAP- and 8-Br-cGMP-evoked motility implicating the involvement of SFKs downstream of NO/cGMP. Analysis of the expression of SFKs indicated LPS dramatically induced Src, which could be attributable to the increased level of the src transcript. Attenuation of Src by src-specific siRNA reduced LPS- and SNAP-evoked mobilization in Raw264.7 macrophages, and reintroduction of avian Src could rescue their motility. Furthermore, LPS- mediated Src induction led to increased FAK Pi-Tyr-397 and Pi-Tyr-861, which was also iNOS-dependent. With these findings, we concluded that iNOS was important for LPS-mediated macrophage locomotion and Src was a critical player in this process.	[Maa, Ming-Chei; Chang, Miao Ying] China Med Univ, Inst Med Sci, Taichung 40402, Taiwan; [Chen, Yen-Jen; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Inst Basic Med Sci, Dept Pharmacol, Coll Med, Tainan 70101, Taiwan; [Chen, Yen-Jen; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan; [Lin, Chen-Hsuan; Yu, Chih Jen; Yang, Yi Lun; Li, Jiarung] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung 40201, Taiwan; [Chen, Pei-Ru] Chung Shan Med Univ, Instrument Ctr, Taichung 40201, Taiwan; [Tang, Chih-Hsin] China Med Univ, Dept Pharmacol, Taichung 40402, Taiwan; [Lei, Huan-Yao] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan	China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University; Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan; National Cheng Kung University	Maa, MC (corresponding author), China Med Univ, Inst Med Sci, Taichung 40402, Taiwan.	mcmaa@mail.cmu.edu.tw; tzengleu@mail.ncku.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council (NSC) [NSC95-2311-B-039-001-MY3, NSC95-2320-B-006-074-MY2, NSC 94-3112-B-001-003, NSC 94-3112-B-001-018-Y]; National Health Research Institute [NHRI-EX-97-9517BI]; China Medical University [CMU95-306, CMU96-134]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); China Medical University(China Medical University)	This work was supported by the National Science Council (NSC) (Grant NSC95-2311-B-039-001-MY3 to M.-C. M. and Grant NSC95-2320-B-006-074-MY2 to T.-H. L.). Additional support came from National Health Research Institute (Grant NHRI-EX-97-9517BI) and China Medical University Grants CMU95-306 and CMU96-134 (to T.-H. L. and M.-C. M., respectively). The DNA construct pLKO.1-msrc (puro) was provided by the National RNAi Core Facility located at the institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by the National Research Program for Genomic Medicine Grants of NSC (Grants NSC 94-3112-B-001-003 and NSC 94-3112-B-001-018-Y). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Ajuebor MN, 1998, IMMUNOLOGY, V95, P625; Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; BELENKY SN, 1993, J LEUKOCYTE BIOL, V53, P498, DOI 10.1002/jlb.53.5.498; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Gerthoffer William T, 2008, Proc Am Thorac Soc, V5, P97, DOI 10.1513/pats.200704-051VS; Haase A, 2003, DEVELOPMENT, V130, P3977, DOI 10.1242/dev.00612; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Iwabuchi K, 1997, EUR J IMMUNOL, V27, P742, DOI 10.1002/eji.1830270324; Kamisato S, 1997, J BIOCHEM-TOKYO, V121, P862; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Korade-Mirnics Z, 2000, J LEUKOCYTE BIOL, V68, P603; Kox M, 2007, VASC PHARMACOL, V46, P195, DOI 10.1016/j.vph.2006.10.004; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; Kuo ML, 1997, MOL PHARMACOL, V52, P535, DOI 10.1124/mol.52.3.535; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lee JC, 2005, MOL CARCINOGEN, V43, P207, DOI 10.1002/mc.20117; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Leu TH, 2004, J BIOL CHEM, V279, P9875, DOI 10.1074/jbc.M309884200; Leu TH, 2003, BIOCHEM PHARMACOL, V66, P2323, DOI 10.1016/j.bcp.2003.08.017; Leu TH, 2002, ONCOGENE, V21, P6992, DOI 10.1038/sj.onc.1205904; Lin WC, 2000, MUTAT RES-GEN TOX EN, V466, P187, DOI 10.1016/S1383-5718(00)00018-8; Lucas KA, 2000, PHARMACOL REV, V52, P375; Maa MC, 1998, BIOCHEM BIOPH RES CO, V251, P344, DOI 10.1006/bbrc.1998.9464; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Obasanjo-Blackshire K, 2006, CARDIOVASC RES, V71, P672, DOI 10.1016/j.cardiores.2006.05.026; Orlicek SL, 1999, SHOCK, V12, P350, DOI 10.1097/00024382-199911000-00004; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Ridnour LA, 2007, P NATL ACAD SCI USA, V104, P16898, DOI 10.1073/pnas.0702761104; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Tanno T, 2007, FEBS LETT, V581, P1022, DOI 10.1016/j.febslet.2007.02.001; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Walpen S, 2001, FASEB J, V15, P571; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; WEINSTEIN SL, 1993, J IMMUNOL, V151, P3829; WILSON LK, 1989, MOL CELL BIOL, V9, P1536, DOI 10.1128/MCB.9.4.1536; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Yaroslavskiy BB, 2005, J CELL SCI, V118, P5479, DOI 10.1242/jcs.02655	49	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31408	31416		10.1074/jbc.M801158200	http://dx.doi.org/10.1074/jbc.M801158200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786925	hybrid			2022-12-27	WOS:000260760800020
J	Moore, KJ; Fillingame, RH				Moore, Kyle J.; Fillingame, Robert H.			Structural Interactions between Transmembrane Helices 4 and 5 of Subunit a and the Subunit c Ring of Escherichia coli ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS ACCESS PATHWAYS; CROSS-LINKING; ROTARY MOTOR; MEMBRANE; SECTOR; F-0; REACTIVITY	Subunit a plays a key role in promoting H+ transport and the coupled rotary motion of the subunit c ring in F1F0-ATP synthase. H+ binding and release occur at Asp-61 in the middle of the second transmembrane helix (TMH) of F-0 subunit c. H+ are thought to reach Asp-61 via aqueous pathways mapping to the surfaces of TMHs 2-5 of subunit a. TMH4 of subunit a is thought to pack close to TMH2 of subunit c based upon disulfide cross-link formation between Cys substitutions in both TMHs. Here we substituted Cys into the fifth TMH of subunit a and the second TMH of subunit c and tested for cross-linking using bismethanethiosulfonate (bis-MTS) reagents. A total of 62 Cys pairs were tested and 12 positive cross-links were identified with variable alkyl length linkers. Cross-linking was achieved near the middle of the bilayer for the Cys pairs a248C/c62C, a248C/c63C, a248C/c65C, a251C/c57C, a251C/c59C, a251C/c62C, a252C/c62C, and a252C/c65C. Cross-linking was achieved near the cytoplasmic side of the bilayer for Cys pairs a262C/c53C, a262C/c54C, a262C/c55C, and a263C/c54C. We conclude that both aTMH4 and aTMH5 pack proximately to cTMH2 of the c-ring. In other experiments we demonstrate that aTMH4 and aTMH5 can be simultaneously cross-linked to different subunit c monomers in the c-ring. Five mutants showed pH-dependent cross-linking consistent with a TMH5 changing conformation at lower pH values to facilitate cross-linking. We suggest that the pH-dependent conformational change may be related to the proposed role of a TMH5 in gating H+ access from the periplasm to the cAsp-61 residue in cTMH2.	[Moore, Kyle J.; Fillingame, Robert H.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu			National Institutes of Health [GM23105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23105.	Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Barik S, 1996, Methods Mol Biol, V57, P203; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; Ishmukhametov RR, 2008, BBA-BIOENERGETICS, V1777, P32, DOI 10.1016/j.bbabio.2007.11.004; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	30	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31726	31735		10.1074/jbc.M803848200	http://dx.doi.org/10.1074/jbc.M803848200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786930	hybrid, Green Published			2022-12-27	WOS:000260760800055
J	Kanter, DM; Bruck, I; Kaplan, DL				Kanter, Diane M.; Bruck, Irina; Kaplan, Daniel L.			Mcm Subunits Can Assemble into Two Different Active Unwinding Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; SINGLE-STRANDED-DNA; MINICHROMOSOME MAINTENANCE PROTEINS; HISTONE ACETYLTRANSFERASE HBO1; HELICASE ACTIVITY; HEXAMERIC HELICASE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; SCHIZOSACCHAROMYCES-POMBE; BIOCHEMICAL ACTIVITIES; MCM4/6/7 HELICASE	The replication fork helicase in eukaryotes is a large complex that is composed of Mcm2-7, Cdc45, and GINS. The Mcm2-7 proteins form a heterohexameric ring that hydrolyzes ATP and provide the motor function for this unwinding complex. A comprehensive study of how individual Mcm subunit biochemical activities relate to unwinding function has not been accomplished. We studied the mechanism of the Mcm4-Mcm6-Mcm7 complex, a useful model system because this complex has helicase activity in vitro. We separately purified each of three Mcm subunits until they were each nuclease-free, and we then examined the biochemical properties of different combinations of Mcm subunits. We found that Mcm4 and Mcm7 form an active unwinding assembly. The addition of Mcm6 to Mcm4/Mcm7 results in the formation of an active Mcm4/Mcm6/Mcm7 helicase assembly. The Mcm4-Mcm7 complex forms a ringed-shaped hexamer that unwinds DNA with 3' to 5' polarity by a steric exclusion mechanism, similar to Mcm4/Mcm6/Mcm7. The Mcm4-Mcm7 complex has a high level of ATPase activity that is further stimulated by DNA. The ability of different Mcm mixtures to form rings or exhibit DNA stimulation of ATPase activity correlates with the ability of these complexes to unwind DNA. The Mcm4/Mcm7 and Mcm4/Mcm6/Mcm7 assemblies can open to load onto circular DNA to initiate unwinding. We conclude that the Mcm subunits are surprisingly flexible and dynamic in their ability to interact with one another to form active unwinding complexes.	[Kanter, Diane M.; Bruck, Irina; Kaplan, Daniel L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, DL (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	Daniel.Kaplan@Vanderbilt.Edu		Kaplan, Daniel/0000-0003-2760-7745	Vanderbilt University; Vanderbilt Ingram Cancer Center; American Cancer Society Research Scholar [SG-08-124-01-CCG]	Vanderbilt University; Vanderbilt Ingram Cancer Center; American Cancer Society Research Scholar(American Cancer Society)	This work was supported by Vanderbilt University start-up funds (to D.L.K.), a Vanderbilt University discovery grant (to D.L.K.), a pilot grant from the Vanderbilt Ingram Cancer Center (to D.L.K.), and American Cancer Society Research Scholar Grant SG-08-124-01-CCG (to D.L.K. and I.B.).	Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2007, J BIOL CHEM, V282, P33795, DOI 10.1074/jbc.M703824200; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2006, NUCLEIC ACIDS RES, V34, P5829, DOI 10.1093/nar/gkl708; Coue M, 1998, EXP CELL RES, V245, P282, DOI 10.1006/excr.1998.4271; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; DAVEY MJ, 2003, CURR BIOL; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fitch MJ, 2003, J BIOL CHEM, V278, P25408, DOI 10.1074/jbc.M300699200; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Holthoff HP, 1998, J BIOL CHEM, V273, P7320, DOI 10.1074/jbc.273.13.7320; Honeycutt KA, 2006, ONCOGENE, V25, P4027, DOI 10.1038/sj.onc.1209435; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 2001, J BIOL CHEM, V276, P42744, DOI 10.1074/jbc.M106861200; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Krude T, 1996, J CELL SCI, V109, P309; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lei M, 1996, MOL CELL BIOL, V16, P5081; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MUSAHL C, 1995, EUR J BIOCHEM, V230, P1096, DOI 10.1111/j.1432-1033.1995.tb20660.x; Norcum MT, 2005, P NATL ACAD SCI USA, V102, P3623, DOI 10.1073/pnas.0500713102; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Rothenberg E, 2007, J BIOL CHEM, V282, P34229, DOI 10.1074/jbc.M706300200; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Sherman DA, 1998, NUCLEIC ACIDS RES, V26, P3955, DOI 10.1093/nar/26.17.3955; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Valle M, 2006, J MOL BIOL, V357, P1295, DOI 10.1016/j.jmb.2006.01.021; Yabuta N, 2003, GENES CELLS, V8, P413, DOI 10.1046/j.1365-2443.2003.00645.x; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Ying CY, 2005, EMBO J, V24, P4334, DOI 10.1038/sj.emboj.7600892; You Z, 2005, NUCLEIC ACIDS RES, V33, P3033, DOI 10.1093/nar/gki607; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576; You ZY, 1999, MOL CELL BIOL, V19, P8003; Yu ZL, 2004, J MOL BIOL, V340, P1197, DOI 10.1016/j.jmb.2004.05.024	65	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31172	31182		10.1074/jbc.M804686200	http://dx.doi.org/10.1074/jbc.M804686200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18801730	Green Published, hybrid			2022-12-27	WOS:000260544800071
J	Hamilton, SL; Serysheva, II				Hamilton, Susan L.; Serysheva, Irina I.			Ryanodine Receptor Structure: Progress and Challenges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CALCIUM-RELEASE CHANNEL; MUSCLE SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; CA2+ RELEASE; ELECTRON CRYOMICROSCOPY; 3-DIMENSIONAL STRUCTURE; PHOSPHORYLATION SITE; CALMODULIN-BINDING; POTASSIUM CHANNEL; MOLECULAR-BASIS		[Hamilton, Susan L.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Serysheva, Irina I.] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	susanh@bcm.tmc.edu		Hamilton, Susan/0000-0003-0241-9369	NIGMS NIH HHS [R01 GM072804-01, R01 GM072804-02, R01 GM072804-03, R01 GM072804-05S1, R01 GM072804-05, R01 GM072804-04, R01 GM072804] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072804] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Benkusky NA, 2007, CIRC RES, V101, P819, DOI 10.1161/CIRCRESAHA.107.153007; BLOCK BA, 1988, J CELL BIOL, V107, P1099, DOI 10.1083/jcb.107.3.1099; Carter S, 2006, CIRC RES, V98, P1506, DOI 10.1161/01.RES.0000227506.43292.df; CHEN SRW, 1994, J BIOL CHEM, V269, P22698; Dirksen RT, 2002, FRONT BIOSCI-LANDMRK, V7, pD659, DOI 10.2741/dirksen; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Durham W. J., 2007, V45, P273; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Feng W, 2002, J BIOL CHEM, V277, P44722, DOI 10.1074/jbc.M207675200; Fessenden JD, 2004, J BIOL CHEM, V279, P53028, DOI 10.1074/jbc.M411136200; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Galvan DL, 2002, J BIOL CHEM, V277, P48248, DOI 10.1074/jbc.M209990200; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jones PP, 2008, BIOCHEM J, V410, P261, DOI 10.1042/BJ20071257; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; MacDonnell SM, 2008, CIRC RES, V102, pE65, DOI 10.1161/CIRCRESAHA.108.174722; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Marks AR, 2002, TRENDS CARDIOVAS MED, V12, P166, DOI 10.1016/S1050-1738(02)00156-1; MEISSNER G, 2008, PROTEINS IN PRESS; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Moore CP, 1999, BIOCHEMISTRY-US, V38, P8532, DOI 10.1021/bi9907431; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; Paolini C, 2004, P NATL ACAD SCI USA, V101, P12748, DOI 10.1073/pnas.0404836101; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Serysheva II, 1999, BIOPHYS J, V77, P1936, DOI 10.1016/S0006-3495(99)77035-9; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Serysheva II, 2007, METHOD CELL BIOL, V79, P407, DOI 10.1016/S0091-679X(06)79016-1; Sharma MR, 2000, J BIOL CHEM, V275, P9485, DOI 10.1074/jbc.275.13.9485; Sheridan DC, 2006, P NATL ACAD SCI USA, V103, P19760, DOI 10.1073/pnas.0609473103; Stewart R, 2003, BIOCHEM J, V376, P795, DOI 10.1042/BJ20030597; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; TREVES S, 1993, BIOCHEM J, V291, P757, DOI 10.1042/bj2910757; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; Xiong H, 1998, BIOCHEMISTRY-US, V37, P4804, DOI 10.1021/bi971198b; Xiong LW, 2006, BIOPHYS J, V90, P173, DOI 10.1529/biophysj.105.066092; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yamaguchi N, 2005, BIOCHEMISTRY-US, V44, P15074, DOI 10.1021/bi051251t; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200; Zissimopoulos S, 2005, CELL BIOCHEM BIOPHYS, V43, P203, DOI 10.1385/CBB:43:2:203	51	67	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4047	4051		10.1074/jbc.R800054200	http://dx.doi.org/10.1074/jbc.R800054200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	18927076	Green Published, hybrid			2022-12-27	WOS:000263134400002
J	Studelska, DR; Mandik-Nayak, L; Zhou, XD; Pan, J; Weiser, P; McDowell, LM; Lu, H; Liapis, H; Allen, PM; Shih, FF; Zhang, LJ				Studelska, Daniel R.; Mandik-Nayak, Laura; Zhou, Xiaodong; Pan, Jing; Weiser, Peter; McDowell, Lynda M.; Lu, Hong; Liapis, Helen; Allen, Paul M.; Shih, Fei F.; Zhang, Lijuan			High Affinity Glycosaminoglycan and Autoantigen Interaction Explains Joint Specificity in a Mouse Model of Rheumatoid Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCURONIDASE ACTIVITY; HEPARAN-SULFATE; NEGATIVE ASSOCIATION; ARTICULAR-CARTILAGE; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; PREGNANCY; ISOMERASE; SERUM; SCHIZOPHRENIA	In the K/BxN mouse model of rheumatoid arthritis, autoantibodies specific for glucose-6-phosphate isomerase (GPI) can transfer joint-specific inflammation to most strains of normal mice. Binding of GPI and autoantibody to the joint surface is a prerequisite for joint-specific inflammation. However, how GPI localizes to the joint remains unclear. We show that glycosaminoglycans (GAGs) are the high affinity (83 nM) joint receptors for GPI. The binding affinity and structural differences between mouse paw/ankle GAGs and elbows/knee GAGs correlated with the distal to proximal disease severity in these joints. We found that cartilage surface GPI binding was greatly reduced by either chondroitinase ABC or beta-glucuronidase treatment. We also identified several inhibitors that inhibit both GPI/GAG interaction and GPI enzymatic activities, which suggests that the GPI GAG-binding domain overlaps with the active site of GPI enzyme. Our studies raise the possibility that GAGs are the receptors for other autoantigens involved in joint-specific inflammatory responses.	[Studelska, Daniel R.; Mandik-Nayak, Laura; Zhou, Xiaodong; Pan, Jing; Weiser, Peter; McDowell, Lynda M.; Lu, Hong; Liapis, Helen; Allen, Paul M.; Shih, Fei F.; Zhang, Lijuan] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shih, FF (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Fei.F.Shih@pfizer.com; ljzhang@wustl.edu	Zhou, Xiaodong/B-4017-2011		National Institutes of Health [GM069968, AI031238]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069968 (to L. Z.) and AI031238 (to P. M. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Barrett JH, 1999, ARTHRITIS RHEUM, V42, P1219, DOI 10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G; BIJLSMA JWJ, 1988, ANN RHEUM DIS, V47, P350, DOI 10.1136/ard.47.4.350-b; Carpintero A, 1996, CLIN CHIM ACTA, V255, P153, DOI 10.1016/0009-8981(96)06403-0; Coleman P, 1998, HISTOCHEM J, V30, P519, DOI 10.1023/A:1003291303380; Coleman PJ, 1998, J PHYSIOL-LONDON, V509, P695, DOI 10.1111/j.1469-7793.1998.695bm.x; Conrad H. E., 1998, HEPARIN BINDING PROT; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FERRARA M, 1979, ISRAEL J MED SCI, V15, P746; Godfrey RG, 2000, CLIN EXP RHEUMATOL, V18, P649; Gorwood P, 2004, SCHIZOPHR RES, V66, P21, DOI 10.1016/S0920-9964(03)00017-3; HAYDU G G, 1950, Rheumatism, V6, P133; HOWELL EE, 1981, MOL CELL BIOCHEM, V37, P101, DOI 10.1007/BF02354933; JENKINSON ML, 1989, BRIT J RHEUMATOL, V28, P86; Ji H, 2001, J EXP MED, V194, P321, DOI 10.1084/jem.194.3.321; KAHANA SE, 1960, J BIOL CHEM, V235, P2178; Kavanagh E, 1999, J HISTOCHEM CYTOCHEM, V47, P1603, DOI 10.1177/002215549904701212; KERR LD, 1991, J RHEUMATOL, V18, P1739; Kurup RKA, 2001, NEUROSCI RES COMMUN, V28, P95, DOI 10.1002/nrc.1009; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; Liu JJ, 2001, CHEM BIOL, V8, P701, DOI 10.1016/S1074-5521(01)00045-X; Mandik-Nayak L, 2002, P NATL ACAD SCI USA, V99, P14368, DOI 10.1073/pnas.182549099; MAROUDAS A, 1976, J ANAT, V122, P335; Matsumoto I, 2005, ARTHRITIS RES THER, V7, pR1183, DOI 10.1186/ar1802; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Matsumoto I, 2003, ARTHRITIS RHEUM-US, V48, P944, DOI 10.1002/art.10898; Mazzola JL, 2003, J NEUROSCI RES, V71, P279, DOI 10.1002/jnr.10484; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Mills JL, 1998, METABOLISM, V47, P1140, DOI 10.1016/S0026-0495(98)90290-6; Oken RJ, 1999, SCHIZOPHRENIA BULL, V25, P625, DOI 10.1093/oxfordjournals.schbul.a033407; PALMBLAD J, 1991, RHEUM DIS CLIN N AM, V17, P351; Rantapaa-Dahlqvist S, 2005, SCAND J RHEUMATOL, V34, P83, DOI 10.1080/03009740510017689; SAHA AK, 1991, CLIN CHIM ACTA, V199, P311, DOI 10.1016/0009-8981(91)90125-V; Schaller M, 2005, ANN RHEUM DIS, V64, P743, DOI 10.1136/ard.2004.025502; Schaller M, 2001, NAT IMMUNOL, V2, P746, DOI 10.1038/90696; SKOLDSTAM L, 1991, RHEUM DIS CLIN N AM, V17, P363; SNOWDEN JM, 1976, BIOCHIM BIOPHYS ACTA, V428, P726; SPECTOR TD, 1992, AM J REPROD IMMUNOL, V28, P222, DOI 10.1111/j.1600-0897.1992.tb00797.x; Stone WS, 2004, AM J MED GENET B, V127B, P5, DOI 10.1002/ajmg.b.20132; Studelska DR, 2006, GLYCOBIOLOGY, V16, P65, DOI 10.1093/glycob/cwj037; SVENSON KLG, 1988, METABOLISM, V37, P125, DOI 10.1016/S0026-0495(98)90005-1; VUORINENMARKKOLA H, 1994, J CLIN ENDOCR METAB, V78, P25, DOI 10.1210/jc.78.1.25; Watanabe H, 1996, CANCER RES, V56, P2960; WEITZNER H A, 1952, Perm Found Med Bull, V10, P119; Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Wu ZLL, 2002, FASEB J, V16, P539, DOI 10.1096/fj.01-0807com; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9	53	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2354	2362		10.1074/jbc.M806458200	http://dx.doi.org/10.1074/jbc.M806458200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	18948258	Green Published, hybrid			2022-12-27	WOS:000262545600044
J	Burkhead, JL; Morgan, CT; Shinde, U; Haddock, G; Lutsenko, S				Burkhead, Jason L.; Morgan, Clinton T.; Shinde, Ujwal; Haddock, Gabrielle; Lutsenko, Svetlana			COMMD1 Forms Oligomeric Complexes Targeted to the Endocytic Membranes via Specific Interactions with Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; N-TERMINAL DOMAIN; COPPER TOXICOSIS; PHOSPHOINOSITIDE-BINDING; MURR1; CHANNEL; CELLS; GENE; UBIQUITINATION; IDENTIFICATION	Copper metabolism Murr1 domain 1 (COMMD1) is a 21-kDa protein involved in copper export from the liver, NF-kappa B signaling, HIV infection, and sodium transport. The precise function of COMMD and the mechanism through which COMMD1 performs its multiple roles are not understood. Recombinant COMMD1 is a soluble protein, yet in cells COMMD1 is largely seen as targeted to cellular membranes. Using co-localization with organelle markers and cell fractionation, we determined that COMMD1 is located in the vesicles of the endocytic pathway, whereas little COMMD1 is detected in either the trans-Golgi network or lysosomes. The mechanism of COMMD1 recruitment to cell membranes was investigated using lipid-spotted arrays and liposomes. COMMD1 specifically binds phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) in the absence of other proteins and does not bind structural lipids; the phosphorylation of PtdIns at position 4 is essential for COMMD1 binding. Proteolytic sensitivity and molecular modeling experiments identified two distinct domains in the structure of COMMD1. The C-terminal domain appears sufficient for lipid binding, because both the full-length and C-terminal domain proteins bind to PtdIns(4,5)P-2. In native conditions, endogenous COMMD1 forms large oligomeric complexes both in the cytosol and at the membrane; interaction with PtdIns(4,5)P-2 increases the stability of oligomers. Altogether, our results suggest that COMMD1 is a scaffold protein in a distinct sub-compartment of endocytic pathway and offer first clues to its role as a regulator of structurally unrelated membrane transporters.	[Burkhead, Jason L.; Morgan, Clinton T.; Shinde, Ujwal; Haddock, Gabrielle; Lutsenko, Svetlana] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Lutsenko, S (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lutsenko@ohsu.edu	Burkhead, Jason/C-9612-2013; Morgan, Clinton/AAM-7410-2021	Burkhead, Jason/0000-0001-5457-311X; 	National Institutes of Health [R01 DK071865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK071865 ( to S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; de Bie P, 2006, BIOCHEM J, V398, P63, DOI 10.1042/BJ20051664; Huang Y, 2008, J BIOL CHEM, V283, P11453, DOI 10.1074/jbc.M708544200; JOHNSON GF, 1981, HEPATOLOGY, V1, P243, DOI 10.1002/hep.1840010309; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kawamura M, 2002, VET PATHOL, V39, P747, DOI 10.1354/vp.39-6-747; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Knodler A, 2005, BIOTECHNIQUES, V38, P858, DOI 10.2144/05386BM02; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; MAINE GN, 2008, BIOCH J IN PRESS; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Muller P, 2007, J BIOL INORG CHEM, V12, P495, DOI 10.1007/s00775-006-0201-y; Narindrasorasak S, 2007, BIOCHEMISTRY-US, V46, P3116, DOI 10.1021/bi0620656; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; Sommerhalter M, 2007, J MOL BIOL, V365, P715, DOI 10.1016/j.jmb.2006.10.030; SORMUNEN R, 1993, LAB INVEST, V68, P652; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; TWEDT DC, 1979, J AM VET MED ASSOC, V175, P269; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	37	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					696	707		10.1074/jbc.M804766200	http://dx.doi.org/10.1074/jbc.M804766200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18940794	Green Published, hybrid			2022-12-27	WOS:000261974800074
J	Franco, R; DeHaven, WI; Sifre, MI; Bortner, CD; Cidlowski, JA				Franco, Rodrigo; DeHaven, Wayne I.; Sifre, Maria I.; Bortner, Carl D.; Cidlowski, John A.			Glutathione Depletion and Disruption of Intracellular Ionic Homeostasis Regulate Lymphoid Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PLASMA-MEMBRANE DEPOLARIZATION; REDUCED GLUTATHIONE; VOLUME DECREASE; K+ CHANNELS; OXIDATIVE STRESS; NA+/K+-ATPASE; MEDIATED APOPTOSIS; POTASSIUM CHANNELS; CHLORIDE CHANNELS	Intracellular glutathione (GSH) depletion is an important hallmark of apoptosis. We have recently shown that GSH depletion by its extrusion regulates apoptosis independently of excessive reactive oxygen species accumulation. However, the mechanisms by which GSH depletion regulates apoptosis are still unclear. Because disruption of intracellular ionic homeostasis, associated with apoptotic volume decrease (AVD), is necessary for the progression of apoptotic cell death, we sought to evaluate the relationship between GSH transport and ionic homeostasis during Fas ligand (FasL)-induced apoptosis in Jurkat cells. GSH depletion in response to FasL was paralleled by distinct degrees of AVD identified by differences in cellular forward scatter and electronic impedance analysis. Inhibition of GSH efflux prevented AVD, K+ loss, and the activation of two distinct ionic conductances, mediated by Kv1.3 and outward rectifying Cl- channels. Reciprocally, stimulation of GSH loss accelerated the loss of K+, AVD, and consequently the progression of the execution phase of apoptosis. Although high extracellular K+ inhibited FasL-induced apoptosis, GSH depletion was largely independent of K+ loss. These results suggest that deregulation of GSH and ionic homeostasis converge in the regulation of apoptosis in lymphoid cells.	[Franco, Rodrigo; DeHaven, Wayne I.; Sifre, Maria I.; Bortner, Carl D.; Cidlowski, John A.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Lab Signal Transduct, NIH, POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	cidlows1@mail.nih.gov	Cidlowski, John A/G-2548-2019; Franco, Rodrigo/D-9470-2013	Cidlowski, John A/0000-0003-1420-0516; Franco, Rodrigo/0000-0003-3241-8615	National Institutes of Health grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102486, Z01ES090079, ZICES102486, ZIAES090079] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by a National Institutes of Health grant (intramural research program of the NIEHS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; BLOKZIJL H, 2008, J BIOL CHEM, V284; Bortner CD, 2008, J BIOL CHEM, V283, P7219, DOI 10.1074/jbc.M707809200; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bortner CD, 2007, METHOD ENZYMOL, V428, P161, DOI 10.1016/S0076-6879(07)28009-7; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; Bortner CD, 2003, J BIOL CHEM, V278, P39176, DOI 10.1074/jbc.M303516200; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Brunner T, 2003, SEMIN IMMUNOL, V15, P167, DOI 10.1016/S1044-5323(03)00035-6; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Cai S, 1997, J MEMBRANE BIOL, V158, P147, DOI 10.1007/s002329900252; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Chiba T, 1996, EUR J IMMUNOL, V26, P1164, DOI 10.1002/eji.1830260530; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Circu ML, 2009, BIOCHEM PHARMACOL, V77, P76, DOI 10.1016/j.bcp.2008.09.011; Cui YH, 2003, LAB INVEST, V83, P527, DOI 10.1097/01.LAB.0000065015.02412.48; Dallaporta B, 1998, J IMMUNOL, V160, P5605; Deas O, 1997, INT IMMUNOL, V9, P117, DOI 10.1093/intimm/9.1.117; Devadas S, 2003, FREE RADICAL BIO MED, V35, P648, DOI 10.1016/S0891-5849(03)00391-5; Ernest NJ, 2008, J CELL SCI, V121, P290, DOI 10.1242/jcs.017343; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Fico A, 2008, FREE RADICAL BIO MED, V45, P211, DOI 10.1016/j.freeradbiomed.2008.04.017; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Franklin CC, 2002, AM J PATHOL, V160, P1887, DOI 10.1016/S0002-9440(10)61135-2; Friend KB, 2004, DRUG-EDUC PREV POLIC, V11, P1, DOI 10.1080/0968763031000105038; GHIBELLI L, 1995, BIOCHEM BIOPH RES CO, V216, P313, DOI 10.1006/bbrc.1995.2626; Ghibelli L, 1998, FASEB J, V12, P479, DOI 10.1096/fasebj.12.6.479; Gilbert M, 1997, J CELL PHYSIOL, V171, P299, DOI 10.1002/(SICI)1097-4652(199706)171:3<299::AID-JCP8>3.0.CO;2-J; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Gulbins E, 1996, IMMUNOLOGY, V89, P205, DOI 10.1046/j.1365-2567.1996.d01-743.x; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hall AG, 1999, ADV EXP MED BIOL, V457, P199; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hammond CL, 2004, TOXICOL APPL PHARM, V195, P12, DOI 10.1016/j.taap.2003.10.008; Haouzi D, 2001, HEPATOLOGY, V33, P1181, DOI 10.1053/jhep.2001.24235; He YY, 2003, J BIOL CHEM, V278, P8058, DOI 10.1074/jbc.M207781200; HEDLEY DW, 1994, CYTOMETRY, V15, P349, DOI 10.1002/cyto.990150411; Heimlich G, 2006, J BIOL CHEM, V281, P2232, DOI 10.1074/jbc.M507367200; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Jiao JD, 2006, BIOCHEM BIOPH RES CO, V340, P277, DOI 10.1016/j.bbrc.2005.11.175; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Karki P, 2007, CELL DEATH DIFFER, V14, P2068, DOI 10.1038/sj.cdd.4402221; KLASSEN NV, 1993, INT J RADIAT BIOL, V64, P571, DOI 10.1080/09553009314551791; Kohno T, 1996, J IMMUNOL, V156, P4722; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Laberge RM, 2007, BIOCHEM PHARMACOL, V73, P1727, DOI 10.1016/j.bcp.2007.02.005; Lang F, 2006, CONTRIB NEPHROL, V152, P142, DOI 10.1159/000096321; Liuzzi F, 2003, ANN NY ACAD SCI, V1010, P441, DOI 10.1196/annals.1299.080; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Marchan R, 2008, BBA-BIOMEMBRANES, V1778, P2413, DOI 10.1016/j.bbamem.2008.06.011; Marzolini C, 2004, PHARMACOGENOMICS, V5, P273, DOI 10.1517/phgs.5.3.273.29831; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Merendino N, 2005, NUTR CANCER, V52, P225, DOI 10.1207/s15327914nc5202_12; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Nobel CSI, 2000, APOPTOSIS, V5, P153, DOI 10.1023/A:1009684713784; Oda T, 1999, J BIOCHEM-TOKYO, V126, P715, DOI 10.1093/oxfordjournals.jbchem.a022508; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Osbild S, 2006, ANTICANCER RES, V26, P3595; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Panayiotidis MI, 2006, ACTA PHYSIOL, V187, P205, DOI 10.1111/j.1748-1716.2006.01562.x; Patel AJ, 2004, PFLUG ARCH EUR J PHY, V448, P261, DOI 10.1007/s00424-004-1255-8; Pervaiz S, 2002, BIOCHEM BIOPH RES CO, V290, P1145, DOI 10.1006/bbrc.2001.6274; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Rozanski GJ, 2002, J MOL CELL CARDIOL, V34, P1623, DOI 10.1006/jmcc.2002.2112; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shiffer Z, 2001, BIOCHEM BIOPH RES CO, V289, P1320, DOI 10.1006/bbrc.2001.6127; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; SPENCER RH, 1993, BIOCHEM BIOPH RES CO, V191, P201, DOI 10.1006/bbrc.1993.1203; Storey NM, 2003, J BIOL CHEM, V278, P33319, DOI 10.1074/jbc.M300443200; Szabo I, 1996, J BIOL CHEM, V271, P20465, DOI 10.1074/jbc.271.34.20465; Szabo I, 1998, P NATL ACAD SCI USA, V95, P6169, DOI 10.1073/pnas.95.11.6169; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Trompier D, 2004, CANCER RES, V64, P4950, DOI 10.1158/0008-5472.CAN-04-0143; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Varghese J, 2003, APOPTOSIS, V8, P363, DOI 10.1023/A:1024121017841; Wang XQ, 2003, J CELL SCI, V116, P2099, DOI 10.1242/jcs.00420; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; William R, 1997, BLOOD, V89, P4175, DOI 10.1182/blood.V89.11.4175; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yin W, 2007, LEUKEMIA, V21, P1669, DOI 10.1038/sj.leu.2404791; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Zeidner G, 2001, J BIOL CHEM, V276, P35564, DOI 10.1074/jbc.M105189200	97	40	41	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36071	36087		10.1074/jbc.M807061200	http://dx.doi.org/10.1074/jbc.M807061200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940791	Green Published, hybrid			2022-12-27	WOS:000261840500003
J	Wong, KW; Mohammadi, S; Isberg, RR				Wong, Ka-Wing; Mohammadi, Sina; Isberg, Ralph R.			The Polybasic Region of Rac1 Modulates Bacterial Uptake Independently of Self-association and Membrane Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOTUBERCULOSIS INVASIN PROTEIN; RESONANCE ENERGY-TRANSFER; YERSINIA-PSEUDOTUBERCULOSIS; RHO GTPASES; MAMMALIAN-CELLS; NUCLEAR-LOCALIZATION; PLASMA-MEMBRANE; LIVE CELLS; N-WASP; INTEGRINS	The COOH-terminal polybasic region (PBR) of Rac1, a Rho family GTPase member, is required for Rac1 self-association, membrane localization, nuclear translocation, and interaction with downstream effectors. We previously demonstrated that phosphatidylinositol-4-phosphate 5-kinase, one of the effectors that requires the polybasic region for interaction, is necessary for efficient invasin-promoted uptake of Yersinia pseudotuberculosis by nonphagocytic cells. Here we further examined the role of this region in invasin-promoted uptake. Using fluorescence resonance energy transfer experiments (FRET), we determined that engagement of integrin receptors by invasin caused elevated levels of Rac1 self-association at the site of bacterial adhesion in a PBR-dependent fashion. Self-association could be disrupted using several strategies: translocation of the Yersinia YopT prenylcysteine protease into host cells, inactivation of the Rac1 isoprenylation signal that is required for membrane localization, and elimination of the PBR. Disruption in each case impaired invasin-promoted uptake. To determine if there is a role for the PBR in Rac1 effector signaling that was independent of its role in membrane localization or multimerization, we examined the effect of the PBR in the context of a Rac1 derivative that was targeted to the membrane via an NH2-terminal lipid tail. The membrane-targeted Rac1 derivative restored significant invasin-promoted bacterial uptake in a PBR-dependent manner and yet displayed no detectable self-association. This study indicates that, in addition to its role in promoting membrane localization, the PBR exerts a positive effect on Rac1-controlled bacterial uptake that is independent of Rac1 self-association, most likely due to signaling to downstream effectors.	[Wong, Ka-Wing; Mohammadi, Sina; Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Isberg, Ralph R.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA	Tufts University; Howard Hughes Medical Institute; Tufts University	Isberg, RR (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, 136 Harrison Ave, Boston, MA 02111 USA.	Ralph.Isberg@tufts.edu			National Institutes of Health [R37AI23538]; NIDDK [P30DK34928]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant R37AI23538 and NIDDK Program Project Award Grant P30DK34928. This work was also supported by the Howard Hughes Medical Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Anikovsky M, 2008, BIOPHYS J, V95, P1349, DOI 10.1529/biophysj.107.124313; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Gibson RM, 2001, BIOCHEM J, V359, P285, DOI 10.1042/0264-6021:3590285; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; LEONG JM, 1995, EMBO J, V14, P422, DOI 10.1002/j.1460-2075.1995.tb07018.x; Logsdon LK, 2006, INFECT IMMUN, V74, P1516, DOI 10.1128/IAI.74.3.1516-1527.2006; McGee K, 2001, FEBS LETT, V509, P59, DOI 10.1016/S0014-5793(01)03139-8; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Modha R, 2008, J BIOL CHEM, V283, P1492, DOI 10.1074/jbc.M706760200; NHIEU GTV, 1991, J BIOL CHEM, V266, P24367; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; TAKAI Y, 1995, METHOD ENZYMOL, V250, P122; Takenawa T, 2001, J CELL SCI, V114, P1801; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wong KW, 2006, J BIOL CHEM, V281, P40379, DOI 10.1074/jbc.M605387200; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Wong KW, 2003, J EXP MED, V198, P603, DOI 10.1084/jem.20021363; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang BL, 2001, J BIOL CHEM, V276, P8958, DOI 10.1074/jbc.M008720200	39	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35954	35965		10.1074/jbc.M804717200	http://dx.doi.org/10.1074/jbc.M804717200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18940795	Green Published, hybrid			2022-12-27	WOS:000261687900070
J	Tauskela, JS; Fang, H; Hewitt, M; Brunette, E; Ahuja, T; Thivierge, JP; Comas, T; Mealing, GAR				Tauskela, Joseph S.; Fang, Hung; Hewitt, Melissa; Brunette, Eric; Ahuja, Tarun; Thivierge, Jean-Philippe; Comas, Tanya; Mealing, Geoffrey A. R.			Elevated Synaptic Activity Preconditions Neurons against an in Vitro Model of Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; METHYL-D-ASPARTATE; EXTRASYNAPTIC NMDA RECEPTORS; CALCIUM OSCILLATIONS; CORTICAL-NEURONS; REGULATED KINASE; NUCLEAR CALCIUM; GENE-EXPRESSION; CELL-DEATH; TOLERANCE	Tolerance to otherwise lethal cerebral ischemia in vivo or to oxygen-glucose deprivation (OGD) in vitro can be induced by prior transient exposure to N-methyl-D-aspartic acid (NMDA): preconditioning in this manner activates extrasynaptic and synaptic NMDA receptors and can require bringing neurons to the "brink of death." We considered if this stressful requirement could be minimized by the stimulation of primarily synaptic NMDA receptors. Subjecting cultured cortical neurons to prolonged elevations in electrical activity induced tolerance to OGD. Specifically, exposing cultures to a K+-channel blocker, 4-aminopyridine (20-2500 mu M), and a GABA(A) receptor antagonist, bicuculline (50 mu M) (4-AP/bic), for 1-2 days resulted in potent tolerance to normally lethal OGD applied up to 3 days later. Preconditioning induced phosphorylation of ERK1/2 and CREB which, along with Ca2+ spiking and OGD tolerance, was eliminated by tetrodotoxin. Antagonists of NMDA receptors or L-type voltage-gated Ca2+ channels (L-VGCCs) applied during preconditioning decreased Ca2+ spiking, phosphorylation of ERK1/2 and CREB, and OGD tolerance more effectively when combined, particularly at the lowest 4-AP concentration. Inhibiting ERK1/2 or Ca2+/calmodulin-dependent protein kinases (CaMKs) also reduced Ca2+ spiking and OGD tolerance. Preconditioning resulted in altered neuronal excitability for up to 3 days following 4-AP/bic washout, based on field potential recordings obtained from neurons cultured on 64-channel multielectrode arrays. Taken together, the data are consistent with action potential-driven co-activation of primarily synaptic NMDA receptors and L-VGCCs, resulting in parallel phosphorylation of ERK1/2 and CREB and involvement of CaMKs, culminating in a potent, prolonged but reversible, OGD-tolerant phenotype.	[Tauskela, Joseph S.; Hewitt, Melissa; Brunette, Eric; Ahuja, Tarun; Comas, Tanya; Mealing, Geoffrey A. R.] Inst Biol Sci, Natl Res Council, Synapt Therapies & Devices Grp, Ottawa, ON K1A 0R6, Canada; [Fang, Hung] Inst Biol Sci, Natl Res Council, Glycosyltransferases & Neuroglyc Grp, Ottawa, ON K1A 0R6, Canada; [Thivierge, Jean-Philippe] Indiana Univ, Dept Physiol & Brain Sci, Bloomington, IN 47405 USA	National Research Council Canada; National Research Council Canada; Indiana University System; Indiana University Bloomington	Tauskela, JS (corresponding author), Inst Biol Sci, Natl Res Council, Synapt Therapies & Devices Grp, Bldg M 54,Montreal Rd Campus, Ottawa, ON K1A 0R6, Canada.	joe.tauskela@nrc-cnrc.gc.ca			Heart & Stroke Foundation of Ontario; Canadian Stroke Network	Heart & Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Stroke Network	This work was supported by the Heart & Stroke Foundation of Ontario (to Paul Morley) and the Canadian Stroke Network (to P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Baron C, 1996, J NEUROCHEM, V66, P1005; Bond A, 1999, EUR J PHARMACOL, V380, P91, DOI 10.1016/S0014-2999(99)00523-3; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Debanne D, 2006, EPILEPSIA, V47, P247, DOI 10.1111/j.1528-1167.2006.00416.x; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Duszczyk M, 2005, NEUROTOX RES, V7, P283, DOI 10.1007/BF03033886; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fujiki M, 2004, J NEUROTRAUM, V21, P459, DOI 10.1089/089771504323004601; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Grabb MC, 1999, J NEUROSCI, V19, P1657; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; KATO H, 1992, NEUROSCI LETT, V139, P118, DOI 10.1016/0304-3940(92)90871-4; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Lange-Asschenfeldt C, 2005, NEUROSCI LETT, V384, P87, DOI 10.1016/j.neulet.2005.04.053; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; MARTEL MA, 2008, NEUROSCIENC IN PRESS; Marunaka Y, 2003, BIOCHEM PHARMACOL, V66, P1083, DOI 10.1016/S0006-2952(03)00456-8; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Miao B, 2005, J BIOL CHEM, V280, P21693, DOI 10.1074/jbc.M500003200; Mulholland PJ, 2008, NEUROSCIENCE, V151, P419, DOI 10.1016/j.neuroscience.2007.11.001; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Nishimura M, 2008, NEUROBIOL DIS, V29, P267, DOI 10.1016/j.nbd.2007.08.018; Ogita K, 2005, NEUROPHARMACOLOGY, V48, P810, DOI 10.1016/j.neuropharm.2004.12.018; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pivovarova NB, 2008, J NEUROCHEM, V104, P1686, DOI 10.1111/j.1471-4159.2007.05080.x; Plamondon H, 1999, J CEREBR BLOOD F MET, V19, P1296, DOI 10.1097/00004647-199912000-00002; Raval AP, 2003, J NEUROSCI, V23, P384, DOI 10.1523/JNEUROSCI.23-02-00384.2003; ROGAWSKI MA, 1983, BRAIN RES, V280, P180, DOI 10.1016/0006-8993(83)91190-3; Semenov DG, 2002, NEUROSIGNALS, V11, P329, DOI 10.1159/000068255; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Tanaka M, 2007, NEUROCHEM RES, V32, P988, DOI 10.1007/s11064-006-9259-8; Tapia R, 1999, NEUROCHEM INT, V34, P23, DOI 10.1016/S0197-0186(98)00061-8; Tauskela JS, 2005, FASEB J, V19, P1734, DOI 10.1096/fj.05-3795fje; Tauskela JS, 2004, CEREBRAL ISCHEMIC TOLERANCE, P45; Tauskela JS, 2001, NEUROSCIENCE, V107, P571, DOI 10.1016/S0306-4522(01)00381-5; Tauskela JS, 1999, BRAIN RES, V827, P143, DOI 10.1016/S0006-8993(99)01322-0; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tremblay R, 2000, J NEUROSCI, V20, P7183; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; Wang XQ, 2003, J PHARMACOL EXP THER, V305, P502, DOI 10.1124/jpet.102.045013; Wrang ML, 2004, NEUROREPORT, V15, P1151, DOI 10.1097/00001756-200405190-00014; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	63	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34667	34676		10.1074/jbc.M805624200	http://dx.doi.org/10.1074/jbc.M805624200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845540	Green Published, hybrid			2022-12-27	WOS:000261469100022
J	Abalos, GC; Cruite, JT; Bellon, A; Hemmers, S; Akagi, J; Mastrianni, JA; Williamson, RA; Solforosi, L				Abalos, Gil C.; Cruite, Justin T.; Bellon, Anne; Hemmers, Saskia; Akagi, Junya; Mastrianni, James A.; Williamson, R. Anthony; Solforosi, Laura			Identifying Key Components of the PrPC-PrPSc Replicative Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-RESISTANT STATE; PRION PROTEIN; SCRAPIE ISOFORM; IN-VITRO; NEUROBLASTOMA-CELLS; MONOCLONAL-ANTIBODY; TRANSGENIC MICE; SPECIES BARRIER; CULTURED-CELLS; CELLULAR PRP	In prion disease, direct interaction between the cellular prion protein (PrPC) and its misfolded disease-associated conformer PrPSc is a crucial, although poorly understood step promoting the formation of nascent PrPSc and prion infectivity. Recently, we hypothesized that three regions of PrP (corresponding to amino acid residues 23-33, 98-110, and 136-158) interacting specifically and robustly with PrPSc, likely represent peptidic components of one flank of the prion replicative interface. In this study, we created epitope-tagged mouse PrPC molecules in which the PrP sequences 23-33, 98-110, and 136-158 were modified. These novel PrP molecules were individually expressed in the prion-infected neuroblastoma cell line (ScN2a) and the conversion of each mutated mouse PrPC substrate to PrPSc compared with that of the epitope-tagged wild-type mouse PrPC. Mutations within PrP 98-110, substituting all 4 wild-type lysine residues with alanine residues, prevented conversion to PrPSc. Furthermore, when residues within PrP 136 140 were collectively scrambled, changed to alanines, or amino acids at positions 136, 137, and 139 individually replaced by alanine, conversion to PrPSc was similarly halted. However, other PrP molecules containing mutations within regions 23-33 and 101-104 were able to readily convert to PrPSc. These results suggest that PrP sequence comprising residues 98-110 and 136-140 not only participates in the specific binding interaction between PrPC and PrPSc, but also in the process leading to conversion of PrPSc-sequestered PrPC into its disease-associated form.	[Abalos, Gil C.; Cruite, Justin T.; Bellon, Anne; Akagi, Junya; Williamson, R. Anthony; Solforosi, Laura] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Hemmers, Saskia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Akagi, Junya] KANEKA Corp, Takasago, Hyogo 6768688, Japan; [Mastrianni, James A.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	Scripps Research Institute; Scripps Research Institute; Kaneka Corporation; University of Chicago	Williamson, RA (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	williamson@calmune.com; lsolf@scripps.edu			National Institutes of Health [AG004243, NS053504, NS046037]; Department of Defense [DAMD 17-03-1-0511]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046037, R01NS053504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AG004243, NS053504, and NS046037, and the Department of Defense Grant DAMD 17-03-1-0511. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Billeter M, 1997, P NATL ACAD SCI USA, V94, P7281, DOI 10.1073/pnas.94.14.7281; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 2001, TRENDS BIOCHEM SCI, V26, P235, DOI 10.1016/S0968-0004(01)01792-3; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Lawson VA, 2004, J BIOL CHEM, V279, P13689, DOI 10.1074/jbc.M303697200; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Norstrom EM, 2006, J VIROL, V80, P8521, DOI 10.1128/JVI.00366-06; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r	37	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34021	34028		10.1074/jbc.M804475200	http://dx.doi.org/10.1074/jbc.M804475200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18826953	hybrid, Green Published			2022-12-27	WOS:000261277700029
J	Kim, AY; Bommelje, CC; Lee, BE; Yonekawa, Y; Choi, L; Morris, LG; Huang, GC; Kaufman, A; Ryan, RJH; Hao, B; Ramanathan, Y; Singh, B				Kim, Alexander Y.; Bommelje, Claire C.; Lee, Benjamin E.; Yonekawa, Yoshihiro; Choi, Lydia; Morris, Luc G.; Huang, Guochang; Kaufman, Andrew; Ryan, Russel J. H.; Hao, Bing; Ramanathan, Y.; Singh, Bhuvanesh			SCCRO (DCUN1D1) Is an Essential Component of the E3 Complex for Neddylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMAS; E2 CONJUGATING ENZYMES; CULLIN NEDDYLATION; NEDD8 MODIFICATION; UBIQUITIN LIGASES; COP9 SIGNALOSOME; STRUCTURAL BASIS; CUL1; SCF; AMPLIFICATION	Covalent modification of cullins by the ubiquitin-like protein NEDD8 (neddylation) regulates protein ubiquitination by promoting the assembly of cullin-RING ligase E3 complexes. Like ubiquitination, neddylation results from an enzymatic cascade involving the sequential activity of a dedicated E1 (APPBP1/Uba3), E2 (Ubc12), and an ill-defined E3. We show that SCCRO (also known as DCUN1D1) binds to the components of the neddylation pathway (Cullin-ROC1, Ubc12, and CAND1) and augments but is not required for cullin neddylation in reactions using purified recombinant proteins. We also show that SCCRO recruits Ubc12 similar to NEDD8 to the CAND1-Cul1-ROC1 complex but that this is not sufficient to dissociate or overcome the inhibitory effects of CAND1 on cullin neddylation in purified protein assays. In contrast to findings in cellular systems where no binding is seen, we show that SCCRO and CAND1 can bind to the neddylated Cul1-ROC1 complex in assays using purified recombinant proteins. Although neddylated (not unneddylated) Cul1-ROC1 is released from CAND1 upon incubation with testis lysate from SCCRO+/+ mice, the addition of recombinant SCCRO is required to achieve the same results in lysate from SCCRO-/- mice. Combined, these results suggest that SCCRO is an important component of the neddylation E3 complex that functions to recruit charged E2 and is involved in the release of inhibitory effects of CAND1 on cullin-RING ligase E3 complex assembly and activity.	[Kim, Alexander Y.; Bommelje, Claire C.; Lee, Benjamin E.; Yonekawa, Yoshihiro; Choi, Lydia; Morris, Luc G.; Huang, Guochang; Kaufman, Andrew; Ryan, Russel J. H.; Ramanathan, Y.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Lab Epithelial Canc Biol, Dept Surg, New York, NY 10065 USA; [Bommelje, Claire C.] Erasmus MC, Dept Otolaryngol, NL-3015 CE Rotterdam, Netherlands; [Hao, Bing] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; University of Connecticut	Ramanathan, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Epithelial Canc Biol, Dept Surg, 1275 York Ave, New York, NY 10065 USA.	ramanaty@mskcc.org; singhb@mskcc.org		Ryan, Russell/0000-0001-8174-3962	American College of Surgeons	American College of Surgeons	This work was supported in part a George H. A. Clowes Memorial Research Career Development Award from the American College of Surgeons (to B. S.), a Clinical Innovator Award from Flight Attendant Medical Research Institute ( to B. S. and Y.R.), the T.J. Martel Fund ( to B. S. and V. Rusch), the Falcone Fund (to B.S. and J. Shah), an National Institutes of Health training grant (to L.C.), and a Matheson Fellowship (to Y. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 S. C. Section 1734 solely to indicate this fact.	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Hwang JW, 2003, FEBS LETT, V541, P102, DOI 10.1016/S0014-5793(03)00321-1; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V303, P1209, DOI 10.1016/S0006-291X(03)00501-1; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Singh B, 2002, AM J PATHOL, V161, P365, DOI 10.1016/S0002-9440(10)64191-0; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Singh B, 2001, CANCER RES, V61, P4506; Sufan RI, 2006, NEOPLASIA, V8, P956, DOI 10.1593/neo.06520; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	36	66	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33211	33220		10.1074/jbc.M804440200	http://dx.doi.org/10.1074/jbc.M804440200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826954	Green Published, hybrid			2022-12-27	WOS:000261183700024
J	Park, KS; Wiederkehr, A; Kirkpatrick, C; Mattenberger, Y; Martinou, JC; Marchetti, P; Demaurex, N; Wollheim, CB				Park, Kyu-Sang; Wiederkehr, Andreas; Kirkpatrick, Clare; Mattenberger, Yves; Martinou, Jean-Claude; Marchetti, Piero; Demaurex, Nicolas; Wollheim, Claes B.			Selective Actions of Mitochondrial Fission/Fusion Genes on Metabolism-Secretion Coupling in Insulin-releasing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL; MAMMALIAN-CELLS; PANCREATIC-ISLETS; FUSION MEDIATORS; PROTEIN; APOPTOSIS; HFIS1; FIS1; CA2+; HETEROGENEITY	Mitochondria form filamentous networks that undergo continuous fission/fusion. In the pancreatic beta-cells, mitochondria are essential for the transduction of signals linking nutrient metabolism to insulin granule exocytosis. Here we have studied mitochondrial networks in the insulinoma cell line INS-1E, primary rat and human beta-cells. We have further investigated the impact of mitochondrial fission/fusion on metabolism-secretion coupling in INS-1E cells. Overexpression of hFis1 caused dramatic mitochondrial fragmentation, whereas Mfn1 evoked hyperfusion and the aggregation of mitochondria. Cells overexpressing hFis1 or Mfn1 showed reduced mitochondrial volume, lowered cellular ATP levels, and as a consequence, impaired glucose-stimulated insulin secretion. Decreased mitochondrial ATP generation was partially compensated for by enhanced glycolysis as indicated by increased lactate production in these cells. Dominant-negative Mfn1 elicited mitochondrial shortening and fragmentation of INS-1E cell mitochondria, similar to hFis1. However, the mitochondrial volume, cytosolic ATP levels, and glucose-stimulated insulin secretion were little affected. We conclude that mitochondrial fragmentation per se does not impair metabolism-secretion coupling. Through their impact on mitochondrial bioenergetics and distribution, hFis1 and Mfn1 activities influence mitochondrial signal generation thereby insulin exocytosis.	[Park, Kyu-Sang; Wiederkehr, Andreas; Kirkpatrick, Clare; Demaurex, Nicolas; Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Mattenberger, Yves; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, I-56126 Pisa, Italy	University of Geneva; University of Geneva; University of Pisa	Wollheim, CB (corresponding author), 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Claes.Wollheim@medecine.unige.ch	Kirkpatrick, Clare L/M-1890-2018; Marchetti, Piero/J-7439-2013	Kirkpatrick, Clare L/0000-0001-8564-8559; Marchetti, Piero/0000-0003-4907-0635; Mattenberger, Yves/0000-0002-1651-7691; Demaurex, Nicolas/0000-0002-9933-6772; martinou, Jean-claude/0000-0002-9847-2051; Park, Kyu-Sang/0000-0003-0322-9807	Swiss National Foundation; EuroDia [LSHM-CT-2006-518153]; European Community-funded project under framework program 6; Korea Research Foundation [KRF-2006-013-E00082]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); EuroDia; European Community-funded project under framework program 6(European Commission); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the Swiss National Foundation and EuroDia (Grant LSHM-CT-2006-518153), a European Community-funded project under framework program 6 (to C. B. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; A recipient of a fellowship from the Korea Research Foundation Grant (KRF-2006-013-E00082).	Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Brun T, 2004, J CELL BIOL, V167, P1123, DOI 10.1083/jcb.200405148; Celik M, 2001, DIABETIC MED, V18, P685, DOI 10.1046/j.1464-5491.2001.05302.x; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Frieden M, 2005, J BIOL CHEM, V280, P43198, DOI 10.1074/jbc.M510279200; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Iezzi M, 2004, J CELL SCI, V117, P3119, DOI 10.1242/jcs.01179; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Koc F, 2006, INT J NEUROSCI, V116, P103, DOI 10.1080/00207450500341431; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188; Maechler P, 1998, J BIOL CHEM, V273, P20770, DOI 10.1074/jbc.273.33.20770; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Noda M, 2002, J BIOL CHEM, V277, P41817, DOI 10.1074/jbc.M207690200; Noske AB, 2008, J STRUCT BIOL, V161, P298, DOI 10.1016/j.jsb.2007.09.015; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang YC, 2006, MOL PHARMACOL, V70, P1424, DOI 10.1124/mol.106.024323; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	47	92	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33347	33356		10.1074/jbc.M806251200	http://dx.doi.org/10.1074/jbc.M806251200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832378	Green Published, hybrid			2022-12-27	WOS:000261183700039
J	Seko, A; Yamashita, K				Seko, Akira; Yamashita, Katsuko			Activation of beta 1,3-N-Acetylglucosaminyltransferase-2(beta 3Gn-T2) by beta 3Gn-T8 POSSIBLE INVOLVEMENT OF beta 3Gn-T8 IN INCREASING POLY-N-ACETYLLACTOSAMINE CHAINS IN DIFFERENTIATED HL-60 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE-GLYCOPROTEINS; CHONDROITIN-POLYMERIZING FACTOR; HEPARAN-SULFATE POLYMERIZATION; O-MANNOSYLTRANSFERASE ACTIVITY; COMPLEX-FORMATION; LINKED OLIGOSACCHARIDES; GOLGI LOCALIZATION; ENZYMATIC-ACTIVITY; CYSTEINE RESIDUES; TUMOR SUPPRESSORS	Enzymatic activities of some glycosyltransferases are markedly increased via complex formation with other transferases or cofactor proteins. We previously showed that beta 1,3-N-acetylglucosaminyltransferase-2 (beta 3Gn-T2) and beta 3Gn-T8 can form a heterodimer in vitro and that the complex exhibits much higher enzymatic activity than either enzyme alone (Seko, A., and Yamashita, K. (2005) Glycobiology 15, 943-951). Here we examined this activation and the biological significance of complex formation in differentiated HL-60 cells. beta 3Gn-T2 and -T8 were co-immunoprecipitated from the lysates of both-transfected COS-7 cells, indicating their association in vivo. We prepared inactive mutants of both enzymes by destroying the DXD motifs. The mixture of mutated beta 3Gn-T2 and intact beta 3Gn-T8 did not exhibit any activation, whereas the mixture of intact beta 3Gn-T2 and mutated beta 3Gn-T8 had increased activity, indicating the activation of beta 3Gn-T2 via complex formation. Next, we compared expression levels of beta 3Gn-T1-T8 in HL-60 cells and DMSO-treated differentiated HL-60 cells, which produce larger poly-N-acetyllactosamine chains. The expression level of beta 3Gn-T8 in the differentiated cells was 2.6-fold higher than in the untreated cells. Overexpression of beta 3Gn-T8, but not beta 3Gn-T2, induced an increase in poly-N-acetyllactosamine chains in HL-60 cells. These results raise a possibility that up-regulation of beta 3Gn-T8 in differentiated HL-60 cells increases poly-Nacetyllactosamine chains by activating intrinsic beta 3Gn-T2.	[Seko, Akira; Yamashita, Katsuko] Tokyo Inst Technol, Innovat Res Initiat, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Yamashita, Katsuko] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Yamashita, K (corresponding author), Tokyo Inst Technol, Innovat Res Initiat, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	kyamashi@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [14082208]; New Energy and Industrial Technology Development Organization	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by Grant-in-Aid for Scientific Research on Priority Area(s) 14082208 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the New Energy and Industrial Technology Development Organization. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bieberich E, 2002, BIOCHEMISTRY-US, V41, P11479, DOI 10.1021/bi0259958; Borsig L, 1998, GLYCOBIOLOGY, V8, P259, DOI 10.1093/glycob/8.3.259; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; Chen C, 2000, J BIOL CHEM, V275, P13819, DOI 10.1074/jbc.275.18.13819; de Graffenried CL, 2004, J BIOL CHEM, V279, P40035, DOI 10.1074/jbc.M405709200; Gentzsch M, 1995, FEBS LETT, V377, P128, DOI 10.1016/0014-5793(95)01324-5; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; Izumikawa T, 2006, J BIOL CHEM, V281, P1929, DOI 10.1074/jbc.M509138200; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; LEE N, 1990, J BIOL CHEM, V265, P20476; Li JH, 2000, J BIOL CHEM, V275, P41476, DOI 10.1074/jbc.M007480200; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Nagai N, 2004, J CELL SCI, V117, P3331, DOI 10.1242/jcs.01191; Nilsson T, 1996, J CELL SCI, V109, P1975; Ouzzine M, 2000, J BIOL CHEM, V275, P28254; Qian R, 2001, J BIOL CHEM, V276, P28641, DOI 10.1074/jbc.M103664200; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Seko A, 2004, FEBS LETT, V556, P216, DOI 10.1016/S0014-5793(03)01440-6; Seko A, 2006, TRENDS GLYCOSCI GLYC, V18, P209, DOI 10.4052/tigg.18.209; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; Terada M, 2005, J BIOL CHEM, V280, P10897, DOI 10.1074/jbc.M413092200; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; VARKI A, 1999, ESSENTIALS GLYCOBIOL, P211; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; YAMASHITA K, 1981, J BIOL CHEM, V256, P4789	36	29	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33094	33100		10.1074/jbc.M806933200	http://dx.doi.org/10.1074/jbc.M806933200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826941	hybrid, Green Published			2022-12-27	WOS:000261183700010
J	Yoshioka, H; Kamitani, H; Watanabe, T; Eling, TE				Yoshioka, Hiroki; Kamitani, Hideki; Watanabe, Takashi; Eling, Thomas E.			Nonsteroidal Anti-inflammatory Drug-activated Gene (NAG-1/GDF15) Expression Is Increased by the Histone Deacetylase Inhibitor Trichostatin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER CELLS; SP1 SITES; CYCLOOXYGENASE INHIBITORS; BETA SUPERFAMILY; TUMOR-SUPPRESSOR; ASTROCYTE CELLS; NAG-1; TRANSCRIPTION; APOPTOSIS; P53	Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is a putative tumor suppressor whose expression can be increased by drug treatment. Glioblastoma is the most common central nervous system tumor, is associated with high morbidity and mortality, and responds poorly to surgical, chemical, and radiation therapy. The histone deacetylase inhibitors are under current consideration as therapeutic agents in treating glioblastoma. We investigated whether trichostatin A(TSA) would alter the expression of NAG-1 in glioblastoma cells. The DNA demethylating agent 5-aza-dC did not increase NAG-1 expression, but TSA up-regulated NAG-1 expression and acted synergistically with 5-aza-dC to induce NAG-1 expression. TSA indirectly increases NAG-1 promoter activity and increases NAG-1mRNA and protein expression in the T98G human glioblastoma cell line. TSA also increases the expression of transcription factors Sp-1 and Egr-1. Small interfering RNA experiments link NAG-1 expression to apoptosis induced by TSA. Reporter gene assays, specific inhibition by small interfering RNA transfections, and chromatin immunoprecipitation assays indicate that Egr-1 and Sp-1 mediate TSA-induced NAG-1 expression. TSA also increases the stability of NAG-1 mRNA. TSA-induced NAG-1 expression involves multiple mechanisms at the transcriptional and post-transcriptional levels.	[Yoshioka, Hiroki; Eling, Thomas E.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Yoshioka, Hiroki; Kamitani, Hideki; Watanabe, Takashi] Tottori Univ, Fac Med, Inst Neurol Sci, Div Neurosurg, Tottori 6838504, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tottori University	Eling, TE (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	eling@niehs.nih.gov			National Institutes of Health Intramural Program from the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES010016, ZIAES010016] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program from the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program from the NIEHS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Baek SJ, 2006, PROG LIPID RES, V45, P1, DOI 10.1016/j.plipres.2005.10.001; Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108; Baek SJ, 2004, J BIOL CHEM, V279, P6883, DOI 10.1074/jbc.M305295200; Baek SJ, 2002, J PHARMACOL EXP THER, V301, P1126, DOI 10.1124/jpet.301.3.1126; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baek SJ, 2001, J BIOL CHEM, V276, P33384, DOI 10.1074/jbc.M101814200; Camarero N, 2003, NUCLEIC ACIDS RES, V31, P1693, DOI 10.1093/nar/gkg262; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Condorelli F, 2008, BRIT J PHARMACOL, V153, P657, DOI 10.1038/sj.bjp.0707608; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Eling TE, 2006, J BIOCHEM MOL BIOL, V39, P649; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Habold C, 2008, J CELL MOL MED, V12, P607, DOI 10.1111/j.1582-4934.2007.00136.x; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; KIJIMA M, 1993, J BIOL CHEM, V268, P22429; Kim YB, 1999, ONCOGENE, V18, P2461, DOI 10.1038/sj.onc.1202564; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; Kim YK, 2003, ONCOGENE, V22, P6023, DOI 10.1038/sj.onc.1206875; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kwon HJ, 1998, P NATL ACAD SCI USA, V95, P3356, DOI 10.1073/pnas.95.7.3356; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Maehara K, 2002, BIOCHEM BIOPH RES CO, V295, P187, DOI 10.1016/S0006-291X(02)00646-0; Martinez JM, 2006, J PHARMACOL EXP THER, V318, P899, DOI 10.1124/jpet.105.100081; Moon Y, 2005, MOL CANCER THER, V4, P1551, DOI 10.1158/1535-7163.MCT-05-0213; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; Newman D, 2003, MOL PHARMACOL, V63, P557, DOI 10.1124/mol.63.3.557; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Omotehara F, 2002, BRIT J CANCER, V87, P1042, DOI 10.1038/sj.bjc.6600592; Pan LN, 2007, CANCER, V109, P1676, DOI 10.1002/cncr.22585; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Sasai K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-36; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Strelau J, 2000, J NEUROSCI, V20, P8597; Strelau J, 2008, CANCER LETT, V270, P30, DOI 10.1016/j.canlet.2008.04.042; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Taniura S, 2002, J BIOL CHEM, V277, P16823, DOI 10.1074/jbc.M200527200; Walton TJ, 2008, PROSTATE, V68, P210, DOI 10.1002/pros.20673; Wilson LC, 2003, INT J CANCER, V105, P747, DOI 10.1002/ijc.11173; Yamaguchi K, 2005, J BIOL CHEM, V280, P32569, DOI 10.1074/jbc.M503201200; Yamaguchi K, 2006, MOL CANCER THER, V5, P1352, DOI 10.1158/1535-7163.MCT-05-0528	47	36	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33129	33137		10.1074/jbc.M805248200	http://dx.doi.org/10.1074/jbc.M805248200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18801729	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000261183700014
J	Boudko, SP; Engel, J; Okuyama, K; Mizuno, K; Bachinger, HP; Schumacher, MA				Boudko, Sergei P.; Engel, Juergen; Okuyama, Kenji; Mizuno, Kazunori; Baechinger, Hans Peter; Schumacher, Maria A.			Crystal Structure of Human Type III Collagen Gly(991)-Gly(1032) Cystine Knot-containing Peptide Shows Both 7/2 and 10/3 Triple Helical Symmetries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE SCAVENGER RECEPTORS; AMINO-ACID SEQUENCE; MOLECULAR-STRUCTURE; ANGSTROM RESOLUTION; POLYPEPTIDE (PRO-PRO-GLY)10; ELECTROSTATIC INTERACTIONS; REPEATING SEQUENCE; MODEL PEPTIDES; PROLINE RING; XAA POSITION	Type III collagen is a critical collagen that comprises extensible connective tissue such as skin, lung, and the vascular system. Mutations in the type III collagen gene, COL3A1, are associated with the most severe forms of Ehlers-Danlos syndrome. A characteristic feature of type III collagen is the presence of a stabilizing C-terminal cystine knot. Crystal structures of collagen triple helices reported so far contain artificial sequences like (Gly-Pro-Pro)(n) or (Gly-Pro-Hyp)(n). To gain insight into the structural properties exhibited by the natural type III collagen triple helix, we synthesized, crystallized, and determined the structure of a 12-triplet repeating peptide containing the natural type III collagen sequence from residues 991 to 1032 including the C-terminal cystine knot region, to 2.3 angstrom resolution. This represents the longest collagen triple helical structure determined to date with a native sequence. Strikingly, the Gly(991)-Gly(1032) structure reveals that the central non-imino acid-containing region adopts 10/3 superhelical properties, whereas the imino acid rich N- and C-terminal regions adhere to a 7/2 superhelical conformation. The structure is consistent with two models for the cystine knot; however, the poor density for the majority of this region suggests that multiple conformations may be adopted. The structure shows that the multiple non-imino acids make several types of direct intrahelical as well as interhelical contacts. The looser superhelical structure of the non-imino acid region of collagen triple helices combined with the extra contacts afforded by ionic and polar residues likely play a role in fibrillar assembly and interactions with other extracellular components.	[Boudko, Sergei P.; Mizuno, Kazunori; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Okuyama, Kenji] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Osaka 5600043, Japan; [Schumacher, Maria A.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Basel; Osaka University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.	hbp@shcc.org; maschuma@mdanderson.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Boudko, Sergei/0000-0003-3856-4859	Shriners Hospital; Burroughs Wellcome Career Development Award [992863]; United States Department of Energy [DE-AC03-78SF00098]	Shriners Hospital; Burroughs Wellcome Career Development Award(Burroughs Wellcome Fund); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by a grant from the Shriners Hospital for Children, in part by Burroughs Wellcome Career Development Award 992863 ( to M. A. S.), and in part by United States Department of Energy Contract DE-AC03-78SF00098. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ACTON S, 1993, J BIOL CHEM, V268, P3530; ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; ALLMANN H, 1979, H-S Z PHYSIOL CHEM, V360, P861; Bachmann A, 2005, P NATL ACAD SCI USA, V102, P13897, DOI 10.1073/pnas.0505141102; Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054; Boulegue C, 2008, ANTIOXID REDOX SIGN, V10, P113, DOI 10.1089/ars.2007.1868; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNS RR, 1973, BIOCHEMISTRY-US, V12, P808, DOI 10.1021/bi00729a004; Bulleid NJ, 1996, BIOCHEM J, V317, P195, DOI 10.1042/bj3170195; Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7; COHEN H, 1953, Br J Phys Med, V16, P169; COWAN PM, 1955, NATURE, V176, P1062, DOI 10.1038/1761062a0; DeLano W.L, PYMOL MOL GRAPHICS S; DOI T, 1993, J BIOL CHEM, V268, P2126; DOYLE BB, 1974, PROC R SOC SER B-BIO, V187, P37, DOI 10.1098/rspb.1974.0059; Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Frankfurter D, 2003, J EARLY CHRISTIAN ST, V11, P339, DOI 10.1353/earl.2003.0043; HAUKIPURO K, 1987, ANN SURG, V206, P752, DOI 10.1097/00000658-198712000-00011; HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X; Hongo C, 2001, POLYM J, V33, P812; HOPPE HJ, 1994, PROTEIN SCI, V3, P1143, DOI 10.1002/pro.5560030801; HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawahara K, 2005, BIOCHEMISTRY-US, V44, P15812, DOI 10.1021/bi051619m; KIELTY ME, 1993, CONNECTIVE TISSUE IT; Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI ST, 1975, J MOL BIOL, V98, P835, DOI 10.1016/S0022-2836(75)80015-5; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nagarajan V, 1998, J BIOCHEM-TOKYO, V124, P1117, DOI 10.1093/oxfordjournals.jbchem.a022229; Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; Okuyama K, 2004, BIOPOLYMERS, V76, P367, DOI 10.1002/bip.20107; OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7; OKUYAMA K, 1972, J MOL BIOL, V72, P571, DOI 10.1016/0022-2836(72)90175-1; Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; Schumacher M, 2005, J BIOL CHEM, V280, P20397, DOI 10.1074/jbc.M501453200; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; SUGETA H, 1967, BIOPOLYMERS, V5, P673, DOI 10.1002/bip.1967.360050708; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TORCHIA DA, 1976, J MOL BIOL, V104, P315, DOI 10.1016/0022-2836(76)90018-8; TRUS BL, 1976, J MOL BIOL, V108, P705, DOI 10.1016/S0022-2836(76)80113-1; VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023	59	64	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32580	32589		10.1074/jbc.M805394200	http://dx.doi.org/10.1074/jbc.M805394200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805790	hybrid			2022-12-27	WOS:000260893700047
J	Ishii, M; Maeda, N				Ishii, Maki; Maeda, Nobuaki			Oversulfated Chondroitin Sulfate Plays Critical Roles in the Neuronal Migration in the Cerebral Cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-ASSOCIATED MOLECULE; RADIAL MIGRATION; HEPARAN-SULFATE; ZETA/RPTP-BETA; HYBRID CHAINS; NEURITE OUTGROWTH; RNA INTERFERENCE; DERMATAN SULFATE; AXON-GROWTH; BINDING	Chondroitin sulfate (CS) proteoglycans bind with various proteins through CS chains in a CS structure-dependent manner, in which oversulfated structures, such as iB (IdoA(2-O-sulfate) alpha 1-3GalNAc(4-O-sulfate)), D (GlcA(2-O-sulfate) beta 1-3GalNAc(6-O-sulfate)), and E (GlcA beta 1-3GalNAc(4,6-O-disulfate)) units constitute the critical functional module. In this study, we examined the expression and function of three CS sulfotransferases in the developing neocortex: uronyl 2-O-sulfotransferase (UST), N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase (4,6-ST) and dermatan 4-O-sulfotransferase-1 (D4-ST), which are responsible for the synthesis of oversulfated structures. The CS chains of the neocortex of mouse embryos contained significant amounts of D and E units that are generated by UST and 4,6-ST, respectively. UST and 4,6-ST mRNAs were expressed in the ventricular and subventricular zones, and their expression increased during late embryonic development. In utero electroporation experiments indicated that knockdown of UST and 4,6-ST resulted in the disturbed migration of cortical neurons. The neurons electroporated with the short hairpin RNA constructs of UST and 4,6-ST accumulated in the lower intermediate zone and in the subventricular zone, showing a multipolar morphology. The cDNA constructs of UST and 4,6-ST rescued the defects caused by the RNA interference, and the neurons were able to migrate radially. On the other hand, knockdown of D4-ST, which is involved in the biosynthesis of the iB unit, caused no migratory defects. These results revealed that specific oversulfated structures in CS chains play critical roles in the migration of neuronal precursors during cortical development.	[Ishii, Maki; Maeda, Nobuaki] Tokyo Metropolitan Inst Neurosci, Dept Dev Neurosci, Tokyo 1838526, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Maeda, N (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Dev Neurosci, Tokyo 1838526, Japan.	maeda-nb@igakuken.or.jp			Ministry of Education, Sports, and Culture of Japan; Naito Foundation	Ministry of Education, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This work was supported by grants from the Ministry of Education, Sports, and Culture of Japan and the Naito Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Corvetti L, 2005, J NEUROSCI, V25, P7150, DOI 10.1523/JNEUROSCI.0683-05.2005; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Ishii M, 2008, GLYCOBIOLOGY, V18, P602, DOI 10.1093/glycob/cwn040; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MATSUMOTO K, 1994, DEV BRAIN RES, V79, P229, DOI 10.1016/0165-3806(94)90127-9; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Ohtake S, 2001, J BIOL CHEM, V276, P43894, DOI 10.1074/jbc.M104922200; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Probstmeier R, 2000, BRAIN RES, V863, P42, DOI 10.1016/S0006-8993(00)02075-8; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Shimazaki Y, 2005, J NEUROSCI RES, V82, P172, DOI 10.1002/jnr.20639; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; SNOW DM, 1992, J NEUROBIOL, V23, P322, DOI 10.1002/neu.480230311; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takagaki K, 2002, J BIOL CHEM, V277, P8882, DOI 10.1074/jbc.M106479200; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; YAMAGATA M, 1987, J BIOL CHEM, V262, P4146; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	48	60	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32610	32620		10.1074/jbc.M806331200	http://dx.doi.org/10.1074/jbc.M806331200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819920	hybrid			2022-12-27	WOS:000260893700050
J	Wang, GS				Wang, Guangshun			Structures of Human Host Defense Cathelicidin LL-37 and Its Smallest Antimicrobial Peptide KR-12 in Lipid Micelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; NMR; EXPRESSION; PROTEIN; SYSTEM; DODECYLPHOSPHOCHOLINE; IDENTIFICATION; PURIFICATION; CONFORMATION	As a key component of the innate immunity system, human cathelicidin LL-37 plays an essential role in protecting humans against infectious diseases. To elucidate the structural basis for its targeting bacterial membrane, we have determined the high quality structure of C-13, N-15-labeled LL-37 by three-dimensional triple-resonance NMR spectroscopy, because two-dimensional H-1 NMR did not provide sufficient spectral resolution. The structure of LL-37 in SDS micelles is composed of a curved amphipathic helix-bend-helix motif spanning residues 2-31 followed by a disordered C-terminal tail. The helical bend is located between residues Gly-14 and Glu-16. Similar chemical shifts and N-15 nuclear Overhauser effect (NOE) patterns of the peptide in complex with dioctanoylphosphatidylglycerol (D8PG) micelles indicate a similar structure. The aromatic rings of Phe-5, Phe-6, Phe-17, and Phe-27 of LL-37, as well as arginines, showed intermolecular NOE cross-peaks with D8PG, providing direct evidence for the association of the entire amphipathic helix with anionic lipid micelles. The structure of LL-37 serves as a model for understanding the structure and function relationship of homologous primate cathelicidins. Using synthetic peptides, we also identified the smallest antibacterial peptide KR-12 corresponding to residues 18-29 of LL-37. Importantly, KR-12 displayed a selective toxic effect on bacteria but not human cells. NMR structural analysis revealed a short three-turn amphipathic helix rich in positively charged side chains, allowing for effective competition for anionic phosphatidylglycerols in bacterial membranes. KR-12 may be a useful peptide template for developing novel antimicrobial agents of therapeutic use.	[Wang, Guangshun] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Wang, GS (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, Rm EC13018,986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	gwang@unmc.edu			Nebraska Research Initiative (NRI)	Nebraska Research Initiative (NRI)	This work was supported in part by the Nebraska Research Initiative (NRI) ( to G. W.).	BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Epand RF, 2008, J MOL BIOL, V379, P38, DOI 10.1016/j.jmb.2008.03.047; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hong IP, 2007, BIOTECHNOL LETT, V29, P73, DOI 10.1007/s10529-006-9202-8; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875; Li X, 2008, AMINO ACIDS, V35, P531, DOI 10.1007/s00726-008-0079-9; Li YF, 2006, PROTEIN EXPRES PURIF, V47, P498, DOI 10.1016/j.pep.2005.10.022; Li YF, 2007, PROTEIN EXPRES PURIF, V54, P157, DOI 10.1016/j.pep.2007.02.003; Lia X, 2003, J BIOMOL NMR, V27, P401; Moon JY, 2006, BBA-BIOMEMBRANES, V1758, P1351, DOI 10.1016/j.bbamem.2006.02.003; Nell MJ, 2006, PEPTIDES, V27, P649, DOI 10.1016/j.peptides.2005.09.016; Neville F, 2006, BIOPHYS J, V90, P1275, DOI 10.1529/biophysj.105.067595; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Sambhara S, 2007, EXPERT REV ANTI-INFE, V5, P1, DOI 10.1586/14787210.5.1.1; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sigurdardottir T, 2006, ANTIMICROB AGENTS CH, V50, P2983, DOI 10.1128/AAC.01583-05; Wang G., 2008, OPEN MAGN RESON J, V1, P9; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Wang GS, 1996, BBA-LIPID LIPID MET, V1301, P174, DOI 10.1016/0005-2760(96)00037-9; Wang GS, 2005, J BIOL CHEM, V280, P5803, DOI 10.1074/jbc.M410116200; Wang GS, 2003, PROTEIN SCI, V12, P1087, DOI 10.1110/ps.0301503; Wang GS, 2008, ANTIMICROB AGENTS CH, V52, P3438, DOI 10.1128/AAC.00452-08; Wang GS, 2007, BBA-BIOMEMBRANES, V1768, P3271, DOI 10.1016/j.bbamem.2007.08.005; Wang GS, 2007, PROTEIN PEPTIDE LETT, V14, P57, DOI 10.2174/092986607779117182; Wang H, 2008, AMYOTROPH LATERAL SC, V9, P50, DOI 10.1080/17482960701791234; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, J BIOL CHEM, V281, P19861, DOI 10.1074/jbc.M511108200	47	310	328	3	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32637	32643		10.1074/jbc.M805533200	http://dx.doi.org/10.1074/jbc.M805533200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818205	hybrid			2022-12-27	WOS:000260893700053
J	Pollard, TD; Berro, J				Pollard, Thomas D.; Berro, Julien			Mathematical Models and Simulations of Cellular Processes Based on Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MOLECULAR-DYNAMICS SIMULATIONS; POLYMERIZATION KINETICS; SELF-ORGANIZATION; CONTRACTILE RING; MONOMERIC ACTIN; ARP2/3 COMPLEX; ADP-ACTIN; MECHANISM; FORMIN; NUCLEATION	Actin filaments help to maintain the physical integrity of cells and participate in many processes that produce cellular movements. Studies of the processes that depend on actin filaments have progressed to the point where mathematical models and computer simulations are an essential part of the experimental toolkit. These quantitative models integrate knowledge about the structures of the key proteins and the rate and equilibrium constants for the reactions for comparison with a growing body of quantitative measurements of dynamic processes in live cells. Models and simulations are essential because it is impossible to appreciate by intuition alone the properties that emerge from a network of coupled reactions, particularly when the system contains many components, and force is one of the parameters.	[Pollard, Thomas D.; Berro, Julien] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.; Berro, Julien] Yale Univ, Dept Cell Biol & Mol Biophys, New Haven, CT 06520 USA; [Pollard, Thomas D.; Berro, Julien] Yale Univ, Dept Biochem, New Haven, CT 06520 USA; [Berro, Julien] Univ Lyon 1, CNRS, UMR 5208, Inst Camille Jordan, F-69622 Villeurbanne, France; [Berro, Julien] Univ Lyon 1, CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France	Yale University; Yale University; Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu	Berro, Julien/G-5292-2010	Berro, Julien/0000-0002-9560-8646				Alberts JB, 2004, PLOS BIOL, V2, P2054, DOI 10.1371/journal.pbio.0020412; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Atilgan E, 2005, BIOPHYS J, V89, P3589, DOI 10.1529/biophysj.105.065383; Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Berro J, 2007, BIOPHYS J, V92, P2546, DOI 10.1529/biophysj.106.094672; Bindschadler M, 2004, BIOPHYS J, V86, P2720, DOI 10.1016/S0006-3495(04)74326-X; Boukellal H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061906; Burroughs NJ, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2087427; Carlsson AE, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051912; Carlsson AE, 2000, PHYS REV E, V62, P7082, DOI 10.1103/PhysRevE.62.7082; Carlsson AE, 2001, BIOPHYS J, V81, P1907, DOI 10.1016/S0006-3495(01)75842-0; Chu JW, 2005, P NATL ACAD SCI USA, V102, P13111, DOI 10.1073/pnas.0503732102; Dalhaimer P, 2008, J MOL BIOL, V376, P166, DOI 10.1016/j.jmb.2007.11.068; Dickinson RB, 2006, BIOPHYS J, V91, P1548, DOI 10.1529/biophysj.106.082362; FRIEDEN C, 1983, P NATL ACAD SCI-BIOL, V80, P6513, DOI 10.1073/pnas.80.21.6513; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Gerbal F, 2000, BIOPHYS J, V79, P2259, DOI 10.1016/S0006-3495(00)76473-3; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Maly IV, 2001, P NATL ACAD SCI USA, V98, P11324, DOI 10.1073/pnas.181338798; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Minehardt TJ, 2006, BIOPHYS J, V90, P2445, DOI 10.1529/biophysj.105.072900; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pollard T.D., 2017, CELL BIOL, P543; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Roland J, 2008, BIOPHYS J, V94, P2082, DOI 10.1529/biophysj.107.121988; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Schaus TE, 2007, P NATL ACAD SCI USA, V104, P7086, DOI 10.1073/pnas.0701943104; Sept D, 1999, J MOL BIOL, V294, P1181, DOI 10.1006/jmbi.1999.3332; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Shemesh T, 2007, BIOPHYS J, V92, P1512, DOI 10.1529/biophysj.106.098459; Shlomovitz R, 2008, BIOPHYS J, V94, P1155, DOI 10.1529/biophysj.107.111351; STUKALIN EB, 2006, BIOPHYS J, V87, P3679; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vavylonis D, 2005, P NATL ACAD SCI USA, V102, P8543, DOI 10.1073/pnas.0501435102; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	51	39	39	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5433	5437		10.1074/jbc.R800043200	http://dx.doi.org/10.1074/jbc.R800043200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	18940808	hybrid			2022-12-27	WOS:000263560600003
J	Bogacheva, O; Bogachev, O; Menon, M; Dev, A; Houde, E; Valoret, EI; Prosser, HM; Creasy, CL; Pickering, SJ; Grau, E; Rance, K; Livi, GP; Karur, V; Erickson-Miller, CL; Wojchowski, DM				Bogacheva, Olga; Bogachev, Oleg; Menon, Madhu; Dev, Arvind; Houde, Estelle; Valoret, Elizabeth I.; Prosser, Haydn M.; Creasy, Caretha L.; Pickering, Susan J.; Grau, Evelyn; Rance, Kim; Livi, George P.; Karur, Vinit; Erickson-Miller, Connie L.; Wojchowski, Don M.			DYRK3 Dual-specificity Kinase Attenuates Erythropoiesis during Anemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATES CELL-SURVIVAL; PROTEIN; PHOSPHORYLATION; FAMILY; ACTIVATION; MIRK/DYRK1B; MODULATION; RECEPTOR; GENES; PHENOTYPE	During anemia erythropoiesis is bolstered by several factors including KIT ligand, oncostatin-M, glucocorticoids, and erythropoietin. Less is understood concerning factors that limit this process. Experiments performed using dual-specificity tyrosine-regulated kinase-3 (DYRK3) knock-out and transgenic mice reveal that erythropoiesis is attenuated selectively during anemia. DYRK3 is restricted to erythroid progenitor cells and testes. DYRK3(-/-) mice exhibited essentially normal hematological profiles at steady state and reproduced normally. In response to hemolytic anemia, however, reticulocyte production increased severalfold due to DYRK3 deficiency. During 5-fluorouracil-induced anemia, both reticulocyte and red cell formation in DYRK3(-/-) mice were elevated. In short term transplant experiments, DYRK3(-/-) progenitors also supported enhanced erythroblast formation, and erythropoietic advantages due to DYRK3-deficiency also were observed in 5-fluorou-racil-treated mice expressing a compromised erythropoietin receptor EPOR-HM allele. As analyzed ex vivo, DYRK3(-/-) erythroblasts exhibited enhanced CD71(pos)Ter119(pos) cell formation and 3HdT incorporation. Transgenic pA2gata1-DYRK3 mice, in contrast, produced fewer reticulocytes during hemolytic anemia, and pA2gata1-DYRK3 progenitors were compromised in late pro-erythroblast formation ex vivo. Finally, as studied in erythroid K562 cells, DYRK3 proved to effectively inhibit NFAT (nuclear factor of activatedT cells) transcriptional response pathways and to co-immunoprecipitate with NFATc3. Findings indicate that DYRK3 attenuates (and possibly apportions) red cell production selectively during anemia.	[Bogacheva, Olga; Bogachev, Oleg; Menon, Madhu; Dev, Arvind; Houde, Estelle; Karur, Vinit; Wojchowski, Don M.] Maine Med Ctr Res Inst, Stem & Progenitor Cell Biol Program, Div Mol Med, Scarborough, ME 04074 USA; [Valoret, Elizabeth I.; Creasy, Caretha L.; Livi, George P.; Erickson-Miller, Connie L.] GlaxoSmithKline, Collegeville, PA 19426 USA; [Prosser, Haydn M.; Pickering, Susan J.; Grau, Evelyn; Rance, Kim] GlaxoSmithKline, Harlow CM19 5AW, Essex, England	Maine Medical Center; GlaxoSmithKline; GlaxoSmithKline	Wojchowski, DM (corresponding author), Maine Med Ctr Res Inst, Stem & Progenitor Cell Biol Program, Div Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	wojchd@mmc.org		menon, madhu/0000-0002-4075-4961	National Institutes of Health [RO1 DK059472, P20 RR18789]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK059472 and P20 RR18789 (in particular its core facility resources; National Center for Research Resources). E. Valoret, H. Prosser, C. Creasy, S. Pickering, E. Grau, K. Rance, G. Livi, and C. Erickson- Miller are ( or have been) employees of GlaxoSmithKline. The costs of publication of this article were defrayed in part by the of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adayev T, 2006, BIOCHEM BIOPH RES CO, V351, P1060, DOI 10.1016/j.bbrc.2006.10.169; Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Callero MA, 2007, CELL PHYSIOL BIOCHEM, V20, P319, DOI 10.1159/000107518; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; de Graaf K, 2004, J BIOL CHEM, V279, P4612, DOI 10.1074/jbc.M310794200; Deng XB, 2006, CANCER RES, V66, P4149, DOI 10.1158/0008-5472.CAN-05-3089; Epstein CJ, 2006, NATURE, V441, P582, DOI 10.1038/441582a; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Geiger JN, 2001, BLOOD, V97, P901, DOI 10.1182/blood.V97.4.901; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Jin K, 2007, CANCER RES, V67, P7247, DOI 10.1158/0008-5472.can-06-4099; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Li K, 2002, J BIOL CHEM, V277, P47052, DOI 10.1074/jbc.M205374200; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Longmore GD, 2006, J CLIN INVEST, V116, P626, DOI 10.1172/JCI27988; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Lyons BL, 2003, EXP HEMATOL, V31, P234, DOI 10.1016/S0301-472X(02)01031-7; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Mercer SE, 2006, CANCER RES, V66, P5143, DOI 10.1158/0008-5472.CAN-05-1539; Miller CP, 2002, BLOOD, V99, P898, DOI 10.1182/blood.V99.3.898; Mirandola P, 2006, BLOOD, V107, P508, DOI 10.1182/blood-2005-07-2676; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Pircher TJ, 2000, ONCOGENE, V19, P3684, DOI 10.1038/sj.onc.1203684; Pratt ZL, 2007, J MOL BIOL, V368, P30, DOI 10.1016/j.jmb.2007.01.046; Quinn J, 2007, CYTOM PART A, V71A, P612, DOI 10.1002/cyto.a.20416; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Sacher F, 2007, MOL CELL ENDOCRINOL, V267, P80, DOI 10.1016/j.mce.2006.12.041; Sarna MK, 2003, ONCOGENE, V22, P3221, DOI 10.1038/sj.onc.1206381; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, PLOS BIOL, V5, P2296, DOI 10.1371/journal.pbio.0050252; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; SYTKOWSKI AJ, 2007, SCI STKE, pPE38, DOI DOI 10.1126/STKE.3952007.PE38; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taminato A, 2002, MOL BIOL CELL, V13, P2266, DOI 10.1091/mbc.01-11-0555; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Zhang DY, 2005, GENOMICS, V85, P117, DOI 10.1016/j.ygeno.2004.08.021; Zhang DY, 2001, EXP HEMATOL, V29, P1278, DOI 10.1016/S0301-472X(01)00725-1	52	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36665	36675		10.1074/jbc.M807844200	http://dx.doi.org/10.1074/jbc.M807844200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18854306	Green Published, hybrid			2022-12-27	WOS:000261840500065
J	Shi, LH; Ko, S; Kim, S; Echchgadda, I; Oh, TS; Song, CS; Chatterjee, B				Shi, Liheng; Ko, Soyoung; Kim, Soyoung; Echchgadda, Ibtissam; Oh, Tae-Sung; Song, Chung S.; Chatterjee, Bandana			Loss of Androgen Receptor in Aging and Oxidative Stress through Myb Protooncoprotein-regulated Reciprocal Chromatin Dynamics of p53 and Poly(ADP-ribose) Polymerase PARP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION; GENE; EXPRESSION; COREPRESSOR; PROTEIN; FAMILY; LIVER; SPECIFICITY	Poly(ADP-ribosyl)ation of transcription factors and coregulators, mediated by the poly(ADP-ribose) polymerase PARP-1, has been emerging as an important epigenetic mechanism that controls transcriptional dynamics in response to diverse intra- and extracellular signals. PARP-1 activity is also implicated in the regulation of mammalian lifespan. Herein we show that transcriptional down-regulation of androgen receptor (AR) in the aging rat liver and in oxidatively stressed hepatoma cells involves exchange of a PARP-1-associated, p/CAF-containing coactivator assembly for a p53-interacting, Groucho/TLE1-, and mSin3A-induded corepressor complex at an age- and oxidant-responsive DNA element (age- dependent factor (ADF) element) in the AR promoter. The coregulator switch is mediated by B-Myb and c-Myb, which bind to the ADF element and physically associate with PARP-1 and the tumor suppressor p53. Heterogeneous nuclear ribonucleoprotein K, residing at the ADF element in association with PARP-1, may serve a platform role in stabilizing the activating complex. PARP-1 coactivated B-Myb- and c-Myb-mediated transactivation of the AR promoter, and p53 antagonized the B-Myb/c-Myb-induced AR promoter activation. PARP-1, heterogeneous nuclear ribonucleoprotein K, B-Myb, and c-Myb each serves as a positive regulator of cellular AR content, whereas p53 negatively regulates AR expression. Our results identify a shared, PARP-1-regulated sensing mechanism that coordinates transcriptional repression of AR during aging and in response to oxidative stress. This study may provide insights as to how advancing age and intracellular redox balance might influence androgen-regulated physiology.	[Shi, Liheng; Ko, Soyoung; Kim, Soyoung; Echchgadda, Ibtissam; Oh, Tae-Sung; Song, Chung S.; Chatterjee, Bandana] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [Chatterjee, Bandana] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Chatterjee, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	chatterjee@uthscsa.edu			National Institutes of Health [AG-10486, AG-19660]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG010486, R01AG010486, R01AG019660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG-10486 and AG-19660. This work was also supported by a merit review grant from Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alimirah F, 2007, NEOPLASIA, V9, P1152, DOI 10.1593/neo.07769; BOIX L, 1995, J HEPATOL, V22, P616, DOI 10.1016/0168-8278(95)80217-7; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bowerman B, 2005, SCIENCE, V308, P1119, DOI 10.1126/science.1113356; Cai Y, 2003, ENDOCRINOLOGY, V144, P2311, DOI 10.1210/en.2002-0129; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; KEMP CJ, 1989, P NATL ACAD SCI USA, V86, P7505, DOI 10.1073/pnas.86.19.7505; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Ko S, 2008, MOL ENDOCRINOL, V22, P273, DOI 10.1210/me.2007-0332; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Li XL, 2002, MOL CELL BIOL, V22, P3663, DOI 10.1128/MCB.22.11.3663-3673.2002; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Miglarese MR, 1996, J BIOL CHEM, V271, P22697, DOI 10.1074/jbc.271.37.22697; MOTICELLI S, 2001, MOL IMMUNOL, V38, P1129; Muiras ML, 1998, J MOL MED-JMM, V76, P346, DOI 10.1007/s001090050226; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nantermet P, 2008, ENDOCRINOLOGY, V149, P1551, DOI 10.1210/en.2007-1151; Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7; OCHI T, 1989, TOXICOLOGY, V55, P69, DOI 10.1016/0300-483X(89)90175-3; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Roy AK, 2002, AGEING RES REV, V1, P367, DOI 10.1016/S1568-1637(02)00006-5; Roy AK, 1996, EXP GERONTOL, V31, P83, DOI 10.1016/0531-5565(95)00020-8; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Seo YK, 2007, GENE, V386, P218, DOI 10.1016/j.gene.2006.10.006; Song CS, 1998, J BIOL CHEM, V273, P21856, DOI 10.1074/jbc.273.34.21856; SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349; Stains JP, 2005, BIOCHEM J, V385, P613, DOI 10.1042/BJ20040680; SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837; SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400; Supakar PC, 1996, BIOL SIGNAL, V5, P170; Tanikawa J, 2004, J BIOL CHEM, V279, P55393, DOI 10.1074/jbc.M411658200; Wang LG, 1999, BIOCHEM BIOPH RES CO, V259, P21, DOI 10.1006/bbrc.1999.0655; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; Yaklichkin S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-201; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001	53	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36474	36485		10.1074/jbc.M805980200	http://dx.doi.org/10.1074/jbc.M805980200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18945670	Green Published, hybrid			2022-12-27	WOS:000261840500045
J	Fukunaga, E; Inoue, Y; Komiya, S; Horiguchi, K; Goto, K; Saitoh, M; Miyazawa, K; Koinuma, D; Hanyu, A; Imamura, T				Fukunaga, Erina; Inoue, Yasumichi; Komiya, Setsuro; Horiguchi, Kana; Goto, Kouichiro; Saitoh, Masao; Miyazawa, Keiji; Koinuma, Daizo; Hanyu, Aki; Imamura, Takeshi			Smurf2 Induces Ubiquitin-dependent Degradation of Smurf1 to Prevent Migration of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; LIGASE SMURF2; UP-REGULATION; SMAD7; TARGETS; RHOA; PHOSPHORYLATION; INHIBITION; EXPRESSION; PLASTICITY	Ubiquitin-dependent protein degradation is involved in various biological processes, and accumulating evidence suggests that E3 ubiquitin ligases play important roles in cancer development. Smad ubiquitin regulatory factor 1 (Smurf1) and Smurf2 are E3 ubiquitin ligases, which suppress transforming growth factor-beta (TGF-beta) family signaling through degradation of Smads and receptors for TGF-beta and bone morphogenetic proteins. In addition, Smurf1 has been reported to promote RhoA ubiquitination and degradation and regulate cell motility, suggesting the involvement of Smurf1 in cancer progression. However, the regulation and biological function of Smurf1 and Smurf2 in cancer development remain to be elucidated. In the present study, we show the post-translational regulation of Smurf1 by Smurf2 and the functional differences between Smurf1 and Smurf2 in the progression of breast cancer cells. Smurf2 interacted with Smurf1 and induced its ubiquitination and degradation, whereas Smurf1 failed to induce degradation of Smurf2. Knockdown of Smurf2 in human breast cancer MDA-MB-231 cells resulted in increases in the levels of Smurf1 protein, and enhancement of cell migration in vitro and bone metastasis in vivo. Of note, knockdown of Smurf1, but not of Smurf2, enhanced TGF-beta signaling in MDA-MB-231 cells, suggesting that increased an protein level of Smurf1 offsets the effect of Smurf2 knockdown on TGF-beta signaling. These results indicate that two related E3 ubiquitin ligases, Smurf1 and Smurf2, act in the same direction in TGF-beta family signaling but play opposite roles in cell migration.	[Fukunaga, Erina; Inoue, Yasumichi; Koinuma, Daizo; Hanyu, Aki; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Tokyo 1358550, Japan; [Fukunaga, Erina; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent, Dept Neuromusculoskeletal Disorder Orthopaed Surg, Kagoshima 8908520, Japan; [Horiguchi, Kana; Goto, Kouichiro; Saitoh, Masao; Miyazawa, Keiji] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan	Japanese Foundation for Cancer Research; Kagoshima University; University of Tokyo	Imamura, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014; Koinuma, Daizo/Y-8716-2018	Koinuma, Daizo/0000-0001-5611-2122	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Space Forum	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum	This work was supported by grants-in-aid for scientific research (KAKENHI) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the "Ground-based Research Program for Space Utilization" promoted by the Japan Space Forum. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Boyer L, 2006, MOL BIOL CELL, V17, P2489, DOI 10.1091/mbc.E05-09-0876; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Ebisawa T, 1999, J CELL SCI, V112, P3519; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fukuchi M, 2002, CANCER RES, V62, P7162; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Tajima Y, 2003, J BIOL CHEM, V278, P10716, DOI 10.1074/jbc.M212663200; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhang H, 2004, GENE DEV, V18, P3028, DOI 10.1101/gad.1253004; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	33	71	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35660	35667		10.1074/jbc.M710496200	http://dx.doi.org/10.1074/jbc.M710496200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18927080	hybrid			2022-12-27	WOS:000261687900040
J	Meyer, P; Evrin, C; Briozzo, P; Joly, N; Barzu, O; Gilles, AM				Meyer, Philippe; Evrin, Cecile; Briozzo, Pierre; Joly, Nathalie; Barzu, Octavian; Gilles, Anne-Marie			Structural and Functional Characterization of Escherichia coli UMP Kinase in Complex with Its Allosteric Regulator GTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTP; SOFTWARE; BACTERIA; BINDING; SYSTEM; GENE	Bacterial UMP kinases are essential enzymes involved in the multistep synthesis of UTP. They are hexamers regulated by GTP (allosteric activator) and UTP (inhibitor). We describe here the 2.8 angstrom crystal structure of Escherichia coli UMP kinase bound to GTP. The GTP-binding site, situated at 15 angstrom from the UMP-binding site and at 24 angstrom from the ATP-binding site, is delineated by two contiguous dimers. The overall structure, as compared with those bound to UMP, UDP, or UTP, shows a rearrangement of its quaternary structure: GTP induces an 11 degrees opening of the UMP kinase dimer, resulting in a tighter dimer-dimer interaction. A nucleotide-free UMP kinase dimer has an intermediate opening. Superposition of our structure with that of archaeal UMP kinases, which are also hexamers, shows that a loop appears to hamper any GTP binding in archeal enzymes. This would explain the absence of activating effect of GTP on this group of UMP kinases. Among GTP-binding residues, the Asp-93 is the most conserved in bacterial UMP kinases. In the previously published structures of E. coli UMP kinase, this residue was shown to be involved in hydrogen bonds between the subunits of a dimer. Its substitution by an alanine decreases the cooperativity for UTP binding and suppresses the reversal by GTP of UTP inhibition. This demonstrates that the previously described mutual exclusion of these two nucleotides is mediated by Asp-93.	[Briozzo, Pierre; Joly, Nathalie] AgroParisTech, INRA, UMR Chim Biol 206, F-78550 Thiverval Grignon, France; [Meyer, Philippe; Briozzo, Pierre] CNRS, Lab Enzymol & Biochim Struct, UPR 3082, F-91198 Gif Sur Yvette, France; [Evrin, Cecile; Barzu, Octavian; Gilles, Anne-Marie] Inst Pasteur, CNRS, Unite Genet Genomes Bacteriens, URA2171, F-75724 Paris 15, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Briozzo, P (corresponding author), AgroParisTech, INRA, UMR Chim Biol 206, F-78550 Thiverval Grignon, France.	briozzo@grignon.inra.fr			Centre National de la Recherche Scientifique [UPR 9063, URA 2185, 2171]; Institut National de la Recherche Agronomique [UMR 206]; Institut Pasteur [AC02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique; Institut Pasteur(European Commission)	This work was supported by Centre National de la Recherche Scientifique Grants UPR 9063 and URA 2185 and 2171, Institut National de la Recherche Agronomique Grant UMR 206, and Institut Pasteur Grant AC02. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BLONDIN C, 1994, ANAL BIOCHEM, V220, P219, DOI 10.1006/abio.1994.1326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREED J, 2006, Patent No. 2006018618; Briozzo P, 2005, J BIOL CHEM, V280, P25533, DOI 10.1074/jbc.M501849200; BRUNGER A, 1992, NATURE, V355, P372; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bucurenci N, 1998, J BACTERIOL, V180, P473, DOI 10.1128/JB.180.3.473-477.1998; Crowe J, 1994, Methods Mol Biol, V31, P371; DeLano W.L, PYMOL MOL GRAPHICS S; Egeblad-Welin L, 2007, FEBS J, V274, P6403, DOI 10.1111/j.1742-4658.2007.06157.x; EVRIN C, 2006, THESIS U PARIS 7; Evrin C, 2007, J BIOL CHEM, V282, P7242, DOI 10.1074/jbc.M606963200; Fassy F, 2004, BIOCHEM J, V384, P619, DOI 10.1042/BJ20040440; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Jensen KS, 2007, BIOCHEMISTRY-US, V46, P2745, DOI 10.1021/bi0618159; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SE, 2007, INFECT IMMUN, V75, P2795, DOI 10.1128/IAI.01499-06; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x; Picard V, 1997, Methods Mol Biol, V67, P183; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Sakamoto H, 2004, MICROBIOL-SGM, V150, P2153, DOI 10.1099/mic.0.26996-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SERINA L, 1995, BIOCHEMISTRY-US, V34, P5066, DOI 10.1021/bi00015a018; Serina L, 1996, BIOCHEMISTRY-US, V35, P7003, DOI 10.1021/bi960062v; SMALLSHAW JD, 1992, LIFE SCI ADV, V11, P59; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YAMANAKA K, 1992, J BACTERIOL, V174, P7517, DOI 10.1128/JB.174.23.7517-7526.1992	35	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36011	36018		10.1074/jbc.M802614200	http://dx.doi.org/10.1074/jbc.M802614200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945668	hybrid			2022-12-27	WOS:000261687900075
J	Firth, JD; Uitto, VJ; Putnins, EE				Firth, James D.; Uitto, Veli-Jukka; Putnins, Edward E.			Mechanical Induction of an Epithelial Cell Chymase Associated with Wound Edge Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEUM CHYMOTRYPTIC ENZYME; NADPH OXIDASE ACTIVATION; SEROSAL MAST-CELLS; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; LINE HMC-1; DEGRANULATION; MACROPHAGES; GENERATION; INHIBITION	Chymase is a chymotrypsin-like serine protease predominantly produced by mast cells. In this study, human cutaneous and gingival keratinocytes, ovary surface epithelia, and a porcine epithelial cell line were assayed by homology-based cloning, and the amplified DNA fragment was identified as a chymase. In vitro, chymase could not be induced by serum or cytokine treatment alone. Chymase was activated 3-fold within 60 min in basal media by scratch wounding cultured monolayers and further potentiated over 10-fold at 18 h by additional serum and cytokine treatment. Chymase activity was cell-associated and found to peak within 24 h of wounding and then steadily decreased as cultures healed, reaching baseline levels before confluence was reestablished. Affinity column purified enzyme effectively degraded fibronectin and was found by Western blot analysis using a human chymase antibody to be of about 30 kDa. Immunostaining revealed chymase activation at the wound edge colocalizing with reactive oxygen species generation. Specifically, chymase activation was attenuated by inhibition of nitric oxide, superoxide, and peroxynitrite. Exogenous peroxynitrite but not hydrogen peroxide also resulted in chymase activation in unwounded monolayers. Disruption of cytoskeletal stress fibers by cytochalasin D attenuated both wound-activated chymase and reactive oxygen species generation. Chymase inhibitor chymostatin reduced the loss of cell-cell contacts and the onset of porcine and human skin epithelial cell migration at the wound edge. This shows that an epithelial chymase is rapidly activated by a ligand-independent mechanism following mechanical stress via cytoskeletal and reactive oxygen species signaling and is associated with the onset of epithelial cell migration.	[Firth, James D.; Putnins, Edward E.] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Uitto, Veli-Jukka] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Surg, FIN-00290 Helsinki, Finland	University of British Columbia; University of Helsinki; Helsinki University Central Hospital	Putnins, EE (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, 2199 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	putnins@interchange.ubc.ca			Canadian Institutes of Health Research [MOP-82830]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-82830 (to E.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Bankers-Fulbright JL, 2001, J CELL PHYSIOL, V189, P306, DOI 10.1002/jcp.10022; Bengtsson T, 2006, CELL BIOL INT, V30, P154, DOI 10.1016/j.cellbi.2005.10.017; Bidani A, 2000, LUNG, V178, P91, DOI 10.1007/s004080000012; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Cougnon M, 2002, AM J PHYSIOL-CELL PH, V282, pC1445, DOI 10.1152/ajpcell.00410.2001; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Ekholm E, 1998, ACTA DERM-VENEREOL, V78, P343; Firth JD, 2004, J INVEST DERMATOL, V122, P222, DOI 10.1046/j.0022-202X.2003.22124.x; Firth JD, 1996, J PERIODONTAL RES, V31, P345, DOI 10.1111/j.1600-0765.1996.tb00502.x; Freitas I, 2002, EXP GERONTOL, V37, P591, DOI 10.1016/S0531-5565(01)00226-1; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Guo CY, 2001, J CLIN INVEST, V107, P703, DOI 10.1172/JCI9997; HAN Z, 2007, AM J PHYSIOL, V92, pC1103; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Huttunen M, 2000, EXP DERMATOL, V9, P258, DOI 10.1034/j.1600-0625.2000.009004258.x; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Kadi A, 2007, CLIN HEMORHEOL MICRO, V37, P131; Kishi K, 2007, HYPERTENS RES, V30, P77, DOI 10.1291/hypres.30.77; KRUK PA, 1994, EXP CELL RES, V215, P97, DOI 10.1006/excr.1994.1320; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Lindstedt KA, 2001, FASEB J, V15, P1377, DOI 10.1096/fj.00-0273com; Lindstedt L, 2001, ATHEROSCLEROSIS, V155, P87, DOI 10.1016/S0021-9150(00)00544-X; Maruichi M, 2004, EXP EYE RES, V79, P111, DOI 10.1016/j.exer.2004.02.009; May RC, 2001, J CELL SCI, V114, P1061; Miyazaki M, 2000, J Renin Angiotensin Aldosterone Syst, V1, P23, DOI 10.3317/jraas.2000.004; Nikolic DL, 2006, AM J PHYSIOL-CELL PH, V291, pC68, DOI 10.1152/ajpcell.00411.2005; Nishikori Y, 1998, ARCH DERMATOL RES, V290, P553, DOI 10.1007/s004030050351; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Pernas-Sueiras O, 2006, J CELL BIOCHEM, V99, P1397, DOI 10.1002/jcb.21010; Qian Y, 2005, J BIOL CHEM, V280, P3875, DOI 10.1074/jbc.M403788200; Rajan S, 2000, AM J RESP CELL MOL, V23, P304, DOI 10.1165/ajrcmb.23.3.4098; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Rice DC, 2002, HYPERTENSION, V39, P502, DOI 10.1161/hy0202.102834; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; SCHICK B, 1984, J IMMUNOL, V132, P2571; Shan J, 2007, NITRIC OXIDE-BIOL CH, V17, P25, DOI 10.1016/j.niox.2007.05.001; Sheth PD, 2003, BIOCHEM PHARMACOL, V66, P2251, DOI 10.1016/j.bcp.2003.08.002; SONDELL B, 1994, J HISTOCHEM CYTOCHEM, V42, P459, DOI 10.1177/42.4.7510318; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Suzuki Y, 2005, CHEM IMMUNOL ALLERGY, V87, P32, DOI 10.1159/000087569; Swindle EJ, 2002, J IMMUNOL, V169, P5866, DOI 10.4049/jimmunol.169.10.5866; Tchougounova E, 2001, J BIOL CHEM, V276, P3772, DOI 10.1074/jbc.M008434200; URATA H, 1994, J HYPERTENS, V12, pS17; URATA H, 1991, J BIOL CHEM, V266, P17173; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; van Zyp JV, 2004, AM J SURG, V188, P467, DOI 10.1016/j.amjsurg.2004.07.005; Yoshimaru T, 2006, FREE RADICAL BIO MED, V40, P1949, DOI 10.1016/j.freeradbiomed.2006.01.023	51	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34983	34993		10.1074/jbc.M801975200	http://dx.doi.org/10.1074/jbc.M801975200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845543	Green Published, hybrid			2022-12-27	WOS:000261469100055
J	Qian, CM; Li, SD; Jakoncic, J; Zeng, L; Walsh, MJ; Zhou, MM				Qian, Chengmin; Li, Side; Jakoncic, Jean; Zeng, Lei; Walsh, Martin J.; Zhou, Ming-Ming			Structure and Hemimethylated CpG Binding of the SRA Domain from Human UHRF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; METHYL-CPG; PROTEIN; ICBP90; DNA; HETEROCHROMATINIZATION; FAMILY; CELLS; DNMT1	Human UHRF1((u) under bar biquitin-like P (H) under barD and (R) under bar ING (f) under bar inger (1) under bar) functions to maintain CpG DNA methylation patterns through DNA replication by co-localizing with the DNA methyltransferase DNMT1 at chromatin in mammals. Recent studies show that UHRF1 binds selectively to hemimethylated CpG via its conserved SRA ((S) under bar ET-and (R) under bar ING finger-(a) under bar ssociated) domain. However, the underlying molecular mechanism is not known. Here, we report a 1.95 angstrom resolution crystal structure of the SRA domain of human UHRF1. Using NMR structure-guided mutagenesis, electrophoretic mobility shift assay, and fluorescence anisotropy analysis, we determined key amino acid residues for methyl-DNA binding that are conserved in the SRA domain.	[Qian, Chengmin; Zeng, Lei; Zhou, Ming-Ming] New York Univ, Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Li, Side; Walsh, Martin J.] New York Univ, Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Jakoncic, Jean] Brookhaven Natl Lab, Upton, NY 11973 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; United States Department of Energy (DOE); Brookhaven National Laboratory	Zhou, MM (corresponding author), New York Univ, Mt Sinai Sch Med, Dept Struct & Chem Biol, 1425 Madison Ave,POB 1677, New York, NY 10029 USA.	ming-ming.zhou@mssm.edu	Qian, Chengmin/E-9881-2010	Qian, Chengmin/0000-0003-4491-4421	NMR; Brookhaven National Laboratory [X4C, X6A]; National Institutes of Health [GM073207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073207] Funding Source: NIH RePORTER	NMR; Brookhaven National Laboratory(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health, Grant GM073207 (to M.-M.Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. We acknowledge the use of the NMR facilities at the New York Structural Biology Center and thank the staff at the Brookhaven National Laboratory (beamlines X4C and X6A) for facilitating x-ray data collection. We also thank A. Plotnikov and G. Chai for helpful discussion.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; CITTERIO E, 2004, MOL CELL BIOL, V28, P705; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Hopfner R, 2002, ANTICANCER RES, V22, P3165; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Jones S, 2003, NUCLEIC ACIDS RES, V31, P7189, DOI 10.1093/nar/gkg922; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Liu SM, 2007, PLANT J, V52, P914, DOI 10.1111/j.1365-313X.2007.03286.x; Lorenzato M, 2005, HUM PATHOL, V36, P1101, DOI 10.1016/j.humpath.2005.07.016; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Oba-Shinjo SM, 2005, MOL BRAIN RES, V140, P25, DOI 10.1016/j.molbrainres.2005.06.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Schaaf GJ, 2005, FASEB J, V19, P404, DOI 10.1096/fj.04-2104fje; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005	28	68	70	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34490	34494		10.1074/jbc.C800169200	http://dx.doi.org/10.1074/jbc.C800169200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945682	hybrid, Green Published			2022-12-27	WOS:000261469100002
J	Zhao, HR; Sohail, A; Sun, Q; Shi, QZ; Kim, S; Mobashery, S; Fridman, R				Zhao, Huiren; Sohail, Anjum; Sun, Qing; Shi, Qicun; Kim, Seaho; Mobashery, Shahriar; Fridman, Rafael			Identification and Role of the Homodimerization Interface of the Glycosylphosphatidylinositol-anchored Membrane Type 6 Matrix Metalloproteinase (MMP25)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-MATRIX METALLOPROTEINASE; PROMMP-2 ACTIVATION; TISSUE INHIBITORS; CRYSTAL-STRUCTURE; BREAST-CARCINOMA; STRUCTURAL BASIS; CELL-SURFACE; HL60 CELLS; MT1-MMP; OLIGOMERIZATION	The membrane type (MT) 6 matrix metalloproteinase (MMP) (MMP25) is a glycosylphosphatidylinositol-anchored matrix metalloproteinase (MMP) that is highly expressed in leukocytes and in some cancer tissues. We previously showed that natural MT6-MMP is expressed on the cell surface as a major reduction-sensitive form of M-r 120, likely representing enzyme homodimers held by disulfide bridges. Among the membrane type-MMPs, the stem region of MT6-MMP contains three cysteine residues at positions 530, 532, and 534 which may contribute to dimerization. A systematic site-directed mutagenesis study of the Cys residues in the stem region shows that Cys(532) is involved in MT6-MMP dimerization by forming an intermolecular disulfide bond. The mutagenesis data also suggest that Cys(530) and Cys(534) form an intramolecular disulfide bond. The experimental observations on cysteines were also investigated by computational studies of the stem peptide, which validate these proposals. Dimerization is not essential for transport of MT6-MMP to the cell surface, partitioning into lipid rafts or cleavage of alpha-1-proteinase inhibitor. However, monomeric forms of MT6-MMP exhibited enhanced autolysis and metalloprotease-dependent degradation. Collectively, these studies establish the stem region of MT6-MMP as the dimerization interface, an event whose outcome imparts protease stability to the protein.	[Fridman, Rafael] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Zhao, Huiren; Sohail, Anjum; Sun, Qing; Kim, Seaho; Fridman, Rafael] Barbara Ann Karmanos Canc, Proteases & Canc Program, Detroit, MI 48201 USA; [Shi, Qicun; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Shi, Qicun; Mobashery, Shahriar] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; University of Notre Dame; University of Notre Dame; Walther Cancer Institute	Fridman, R (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 540 E Canfield Ave, Detroit, MI 48201 USA.	rfridman@med.wayne.edu		Sohail, Anjum/0000-0001-5567-9645	National Institutes of Health [CA-61986]; NATIONAL CANCER INSTITUTE [R01CA122417, R01CA061986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-61986 (to R.F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Cho JA, 2008, J BIOL CHEM, V283, P17391, DOI 10.1074/jbc.M708943200; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gorman JJ, 2002, MASS SPECTROM REV, V21, P183, DOI 10.1002/mas.10025; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Han GW, 2003, P NATL ACAD SCI USA, V100, P9214, DOI 10.1073/pnas.1533326100; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Jacob C, 2002, INT IMMUNOPHARMACOL, V2, P1647, DOI 10.1016/S1567-5769(02)00141-8; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1997, BIOL CHEM, V378, P151; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2007, TRAFFIC, V8, P251, DOI 10.1111/j.1600-0854.2006.00522.x; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Puente XS, 1996, CANCER RES, V56, P944; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Solomon KR, 1998, BIOCHEM J, V334, P325, DOI 10.1042/bj3340325; Sun Q, 2007, J BIOL CHEM, V282, P21998, DOI 10.1074/jbc.M701737200; Trayner ID, 1998, LEUKEMIA RES, V22, P537, DOI 10.1016/S0145-2126(98)00041-1; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; Zhang WL, 2007, BIOCHEMISTRY-US, V46, P10113, DOI 10.1021/bi700777x; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhuang LY, 2002, CANCER RES, V62, P2227; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	48	20	20	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35023	35032		10.1074/jbc.M806553200	http://dx.doi.org/10.1074/jbc.M806553200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936094	hybrid, Green Published			2022-12-27	WOS:000261469100059
J	Koussevitzky, S; Suzuki, N; Huntington, S; Armijo, L; Sha, W; Cortes, D; Shulaev, V; Mittler, R				Koussevitzky, Shai; Suzuki, Nobuhiro; Huntington, Serena; Armijo, Leigh; Sha, Wei; Cortes, Diego; Shulaev, Vladimir; Mittler, Ron			Ascorbate Peroxidase 1 Plays a Key Role in the Response of Arabidopsis thaliana to Stress Combination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRASSULACEAN ACID METABOLISM; OXYGEN GENE NETWORK; REACTIVE OXYGEN; OXIDATIVE STRESS; HEAT-STRESS; ENERGY-DISSIPATION; ELECTRON-TRANSPORT; DROUGHT STRESS; ABIOTIC STRESS; CELL-DEATH	Within their natural habitat plants are subjected to a combination of different abiotic stresses, each with the potential to exacerbate the damage caused by the others. One of the most devastating stress combinations for crop productivity, which frequently occurs in the field, is drought and heat stress. In this study we conducted proteomic and metabolic analysis of Arabidopsis thaliana plants subjected to a combination of drought and heat stress. We identified 45 different proteins that specifically accumulated in Arabidopsis in response to the stress combination. These included enzymes involved in reactive oxygen detoxification, malate metabolism, and the Calvin cycle. The accumulation of malic enzyme during the combined stress corresponded with enhanced malic enzyme activity, a decrease in malic acid, and lower amounts of oxaloacetate, suggesting that malate metabolism plays an important role in the response of Arabidopsis to the stress combination. Cytosolic ascorbate peroxidase 1 (APX1) protein and mRNA accumulated during the stress combination. When exposed to heat stress combined with drought, an APX1-deficient mutant (apx1) accumulated more hydrogen peroxide and was significantly more sensitive to the stress combination than wild type. In contrast, mutants deficient in thylakoid or stromal/mitochondrial APXs were not more sensitive to the stress combination than apx1 or wild type. Our findings suggest that cytosolic APX1 plays a key role in the acclimation of plants to a combination of drought and heat stress.	[Koussevitzky, Shai; Suzuki, Nobuhiro; Huntington, Serena; Armijo, Leigh; Mittler, Ron] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Sha, Wei; Cortes, Diego; Shulaev, Vladimir] Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Mittler, Ron] Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel	Nevada System of Higher Education (NSHE); University of Nevada Reno; Hebrew University of Jerusalem	Mittler, R (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Mail Stop 200, Reno, NV 89557 USA.	ronm@unr.edu	Mittler, Ron/ABE-6496-2020; Suzuki, Nobuhiro/Y-2851-2019	Suzuki, Nobuhiro/0000-0002-0225-1597	National Institutes of Health [RR-03-008, P20 RR16464-05]; National Science Foundation [IBN-0420033, NSF-0431327, IOS-0743954]; The Nevada Agricultural Experimental Station [03055517]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); The Nevada Agricultural Experimental Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants RR-03-008 and P20 RR16464-05 from the IDeA Network of Biomedical Research Excellence. This work was also supported by National Science Foundation Grants IBN-0420033, NSF-0431327, and IOS-0743954 and The Nevada Agricultural Experimental Station (Publication 03055517). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Carter C, 1998, PLANT MOL BIOL, V38, P929, DOI 10.1023/A:1006038117130; Chang CCC, 2004, PLANT J, V38, P499, DOI 10.1111/j.1365-313X.2004.02066.x; Cheng YX, 2007, BIOTECHNOL LETT, V29, P1129, DOI 10.1007/s10529-007-9347-0; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Cushman JC, 1999, ANNU REV PLANT PHYS, V50, P305, DOI 10.1146/annurev.arplant.50.1.305; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ishikawa A, 2003, PLANT CELL PHYSIOL, V44, P255, DOI 10.1093/pcp/pcg031; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Luhua S, 2008, PLANT PHYSIOL, V148, P280, DOI 10.1104/pp.108.124875; Maeda H, 2006, PLANT CELL, V18, P2710, DOI 10.1105/tpc.105.039404; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; MITTLER R, 1992, J BIOL CHEM, V267, P21802; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; MITTLER R, 1991, PLANT PHYSIOL, V97, P962, DOI 10.1104/pp.97.3.962; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mullineaux PM, 2006, PLANT PHYSIOL, V141, P346, DOI 10.1104/pp.106.078162; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Raines CA, 2006, PLANT CELL ENVIRON, V29, P331, DOI 10.1111/j.1365-3040.2005.01488.x; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Sheen J, 1999, ANNU REV PLANT PHYS, V50, P187, DOI 10.1146/annurev.arplant.50.1.187; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Spinola MC, 2008, PHYSIOL PLANTARUM, V133, P516, DOI 10.1111/j.1399-3054.2008.01088.x; Stenzel I, 2003, PLANT MOL BIOL, V51, P895, DOI 10.1023/A:1023049319723; STUHLFAUTH T, 1990, PLANT PHYSIOL, V92, P1053, DOI 10.1104/pp.92.4.1053; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; WINTER K, 1982, PLANT PHYSIOL, V69, P300, DOI 10.1104/pp.69.2.300	51	266	282	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34197	34203		10.1074/jbc.M806337200	http://dx.doi.org/10.1074/jbc.M806337200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18852264	hybrid, Green Published			2022-12-27	WOS:000261277700048
J	Rass, U; Ahel, I; West, SC				Rass, Ulrich; Ahel, Ivan; West, Stephen C.			Molecular Mechanism of DNA Deadenylation by the Neurological Disease Protein Aprataxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; HISTIDINE TRIAD SUPERFAMILY; NUCLEOTIDE-BINDING PROTEINS; SINGLE-STRAND; POLY(ADP-RIBOSE) POLYMERASE; LIGASE-III; NEURODEGENERATIVE DISEASE; 3-DIMENSIONAL STRUCTURE; ESCHERICHIA-COLI; TUMOR-SUPPRESSOR	The human neurological disease known as ataxia with oculomotor apraxia 1 is caused by mutations in the APTX gene that encodes Aprataxin (APTX) protein. APTX is a member of the histidine triad superfamily of nucleotide hydrolases and transferases but is distinct from other family members in that it acts upon DNA. The target of APTX is 5' -adenylates at DNA nicks or breaks that result from abortive DNA ligation reactions. In this work, we show that APTX acts as a nick sensor, which provides a mechanism to assess the adenylation status of unsealed nicks. When an adenylated nick is encountered by APTX, base pairing at the 5' terminus of the nick is disrupted as the adenylate is accepted into the active site of the enzyme. Adenylate removal occurs by a two-step process that proceeds through a transient AMP-APTX covalent intermediate. These results pinpoint APTX as the first protein to adopt canonical histidine triad-type reaction chemistry for the repair of DNA.	[Rass, Ulrich; Ahel, Ivan; West, Stephen C.] Canc Res UK, Clare Hall Labs, London Res Inst, S Mimms EN6 3LD, Herts, England	Cancer Research UK	West, SC (corresponding author), Canc Res UK, Clare Hall Labs, London Res Inst, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk		West, Stephen/0000-0001-8848-9418; Ahel, Ivan/0000-0002-9446-3756; Rass, Ulrich/0000-0001-9275-9062	Cancer Research UK; Louis-Jeantet Foundation; European Union DNA Repair Consortium	Cancer Research UK(Cancer Research UK); Louis-Jeantet Foundation; European Union DNA Repair Consortium(European Commission)	This work was supported by Cancer Research UK, the Louis-Jeantet Foundation, and the European Union DNA Repair Consortium. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1997, NAT STRUCT BIOL, V4, P231, DOI 10.1038/nsb0397-231; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Gu MG, 2004, MOL CELL, V14, P67, DOI 10.1016/S1097-2765(04)00180-7; Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122; Hirano M, 2007, ANN NEUROL, V61, P162, DOI 10.1002/ana.21078; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200; Lavin MF, 2008, DNA REPAIR, V7, P1061, DOI 10.1016/j.dnarep.2008.03.008; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; Lima CD, 1997, STRUCTURE, V5, P763, DOI 10.1016/S0969-2126(97)00231-1; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Mosesso P, 2005, CELL MOL LIFE SCI, V62, P485, DOI 10.1007/s00018-004-4441-0; OLSSON M, 1980, J BIOL CHEM, V255, P569; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200; Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808; Seraphin B., 1992, DNA Sequence, V3, P177, DOI 10.3109/10425179209034013; WEDEKIND JE, 1995, BIOCHEMISTRY-US, V34, P11049, DOI 10.1021/bi00035a010	34	35	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33994	34001		10.1074/jbc.M807124200	http://dx.doi.org/10.1074/jbc.M807124200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18836178	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000261277700026
J	Xu, K; Nowak, I; Kirchner, M; Xu, YJ				Xu, Ke; Nowak, Iwona; Kirchner, Michele; Xu, Yujia			Recombinant Collagen Studies Link the Severe Conformational Changes Induced by Osteogenesis Imperfecta Mutations to the Disruption of a Set of Interchain Salt Bridges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; I COLLAGEN; MOLECULAR-STRUCTURE; STABILITY; PEPTIDE; STABILIZATION; MECHANISM; BINDING; PROTEIN; STEP	The clinical severity of Osteogenesis Imperfecta (OI), also known as the brittle bone disease, relates to the extent of conformational changes in the collagen triple helix induced by Gly substitution mutations. The lingering question is why Gly substitutions at different locations of collagen cause different disruptions of the triple helix. Here, we describe markedly different conformational changes of the triple helix induced by two Gly substitution mutations placed only 12 residues apart. The effects of the Gly substitutions were characterized using a recombinant collagen fragment modeling the 63-residue segment of the alpha 1 chain of type I collagen containing no Hyp (residues 877-939) obtained from Escherichia coli. Two Gly -> Ser substitutions at Gly-901 and Gly-913 associated with, respectively, mild and severe OI variants were introduced by site-directed mutagenesis. Biophysical characterization and limited protease digestion experiments revealed that while the substitution at Gly-901 causes relatively minor destabilization of the triple helix, the substitution at Gly-913 induces large scale unfolding of an unstable region C-terminal to the mutation site. This extensive unfolding is caused by the intrinsic low stability of the C-terminal region of the helix and the mutation induced disruption of a set of salt bridges, which functions to lock this unstable region into the triple helical conformation. The extensive conformational changes associated with the loss of the salt bridges highlight the long range impact of the local interactions of triple helix and suggest a new mechanism by which OI mutations cause severe conformational damages in collagen.	[Xu, Ke; Nowak, Iwona; Kirchner, Michele; Xu, Yujia] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Xu, YJ (corresponding author), CUNY Hunter Coll, Dept Chem, 695 Pk Ave, New York, NY 10021 USA.	yujia.xu@hunter.cuny.edu	Xu, Ke/C-1253-2013		National Institutes of Health [3S06-GM060654-06S1]; National Science Foundation (NSF) [DBI0521709]; PSC-CUNY [60042-34 35, 67874-0036]; Gender Equity Program at Hunter (NSF Advanced Transformation Award); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM060654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); PSC-CUNY; Gender Equity Program at Hunter (NSF Advanced Transformation Award); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 3S06-GM060654-06S1. This work was also supported by National Science Foundation (NSF) Grant DBI0521709, PSC-CUNY Grants 60042-34 35 and 67874-0036, and the Gender Equity Program at Hunter (NSF Advanced Transformation Award). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; BYERS PH, 1993, OSTEOGENESIS IMPERFE, P317; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200; Kielty Cay M., 1993, P103; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Liu XY, 1998, BIOCHEMISTRY-US, V37, P15528, DOI 10.1021/bi981147u; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342; PRIVALOV PL, 1979, J MOL BIOL, V127, P203, DOI 10.1016/0022-2836(79)90240-7; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1771, DOI 10.1002/bip.1968.360061213; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023; Xu YJ, 2002, BIOCHEMISTRY-US, V41, P8143, DOI 10.1021/bi015952b; Yang W, 1997, BIOCHEMISTRY-US, V36, P6930, DOI 10.1021/bi970051h	28	28	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34337	34344		10.1074/jbc.M805485200	http://dx.doi.org/10.1074/jbc.M805485200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845533	Green Published, hybrid			2022-12-27	WOS:000261277700061
J	Chan, DI; Stockner, T; Tieleman, DP; Vogel, HJ				Chan, David I.; Stockner, Thomas; Tieleman, D. Peter; Vogel, Hans J.			Molecular Dynamics Simulations of the Apo-, Holo-, and Acyl-forms of Escherichia coli Acyl Carrier Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MACROMOLECULAR STRUCTURES; BINDING; REVEAL; BIOSYNTHESIS; THIOESTERS; REDUCTASE; RESIDUES; PROGRAM; PACKAGE	Acyl carrier protein (ACP) is an essential co-factor protein in fatty acid biosynthesis that shuttles covalently bound fatty acyl intermediates in its hydrophobic pocket to various enzyme partners. To characterize acyl chain-ACP interactions and their influence on enzyme interactions, we performed 19 molecular dynamics(MD) simulations of Escherichia coli apo-, holo-, andacyl-ACPs. The simulations were started with the acyl chain in either a solvent-exposed or a buried conformation. All four short-chain(<= C10) and one long-chain (C16) unbiased acyl-ACP MD simulation show the transition of the solvent-exposed acyl chain into the hydrophobic pocket of ACP, revealing its pathway of acyl chain binding. Although the acyl chain resides inside the pocket, Thr-39 and Glu-60 at the entrance stabilize the phosphopantetheine linker through hydrogen bonding. Comparisons of the different ACP forms indicate that the loop region between helices II and III and the prosthetic linker may aid in substrate recognition by enzymes of fatty acid synthase systems. The MD simulations consistently show that the hydrophobic binding pocket of ACP is best suited to accommodate an octanoyl group and is capable of adjusting in size to accommodate chain lengths as long as decanoic acid. The simulations also reveal a second, novel binding mode of the acyl chains inside the hydrophobic binding pocket directed toward helix I. This study provides a detailed dynamic picture of acyl-ACPs that is in excellent agreement with available experimental data and, thereby, provides a new understanding of enzyme-ACP interactions.	[Chan, David I.; Stockner, Thomas; Tieleman, D. Peter; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca	Tieleman, D. Peter/A-4790-2011; Stockner, Thomas/A-9509-2014	Tieleman, D. Peter/0000-0001-5507-0688; Stockner, Thomas/0000-0002-7071-8283	Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants from the Canadian Institute of Health Research ( to H. J. V. and D. P. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDREC M, 1995, PROTEIN SCI, V4, P983; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; CRONAN JE, 1982, J BIOL CHEM, V257, P5013; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Frisch M.J., 2016, GAUSSIAN16 REV B01; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Kandt C, 2006, BIOCHEMISTRY-US, V45, P13284, DOI 10.1021/bi061280j; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; ROCK CO, 1979, J BIOL CHEM, V254, P7123; ROCK CO, 1982, J BIOL CHEM, V257, P10759; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Wright HT, 2007, CURR OPIN MICROBIOL, V10, P447, DOI 10.1016/j.mib.2007.07.001; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2004, J BIOL CHEM, V279, P50969, DOI 10.1074/jbc.M409607200; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	44	40	40	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33620	33629		10.1074/jbc.M805323200	http://dx.doi.org/10.1074/jbc.M805323200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18809688	Green Published, hybrid			2022-12-27	WOS:000261183700068
J	Feng, HZ; Chen, M; Weinstein, LS; Jin, JP				Feng, Han-Zhong; Chen, Min; Weinstein, Lee S.; Jin, Jian-Ping			Removal of the N-terminal Extension of Cardiac Troponin I as a Functional Compensation for Impaired Myocardial beta-Adrenergic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE HEART; PHOSPHORYLATION; RECEPTOR; MYOSIN; PROTEIN; TRUNCATION; EXPRESSION; RESPONSES; FAILURE; PHOSPHOLAMBAN	Although beta-adrenergic stimuli are essential for myocardial contractility, beta-blockers have a proven beneficial effect on the treatment of heart failure, but the mechanism is not fully understood. The stimulatory G protein alpha-subunit (G(s)alpha) couples the beta-adrenoreceptor to adenylyl cyclase and the intracellular cAMP response. In a mouse model of conditional G(s)alpha deficiency in the cardiac muscle (G(s)alpha-DF), we demonstrated heart failure phenotypes accompanied by increases in the level of a truncated cardiac troponin I (cTnI-ND) from restricted removal of the cTnI-specific N-terminal extension. To investigate the functional significance of the increase of cTnI-ND in G(s)alpha-DF cardiac muscle, we generated double transgenic mice to overexpress cTnI-ND in G(s)alpha-DF hearts. The overexpression of cTnI-ND in G(s)alpha-DF failing hearts increased relaxation velocity and left ventricular end diastolic volume to produce higher left ventricle maximum pressure and stroke volume. Supporting the hypothesis that up-regulation of cTnI-ND is a compensatory rather than a destructive myocardial response to impaired beta-adrenergic signaling, the aberrant expression of beta-myosin heavy chain in adult G(s)alpha-DF but not control mouse hearts was reversed by cTnI overexpression. These data indicate that the up-regulation of cTnI-ND may partially compensate for the cardiac inefficiency in impaired beta-adrenergic signaling.	[Feng, Han-Zhong; Jin, Jian-Ping] Evanston NW Healthcare & NW Univ, Sect Mol Cardiol, Feinberg Sch Med, Evanston, IL 60201 USA; [Chen, Min; Weinstein, Lee S.] NIDDK, Signal Transduct Sect, Metab Dis Branch, NIH, Bethesda, MD 20892 USA	Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Jin, JP (corresponding author), Evanston NW Healthcare & NW Univ, Sect Mol Cardiol, Feinberg Sch Med, Evanston, IL 60201 USA.	jpjin@northwestern.edu	Jin, Jian-Ping/AAD-1149-2020; Weinstein, Lee S/I-5575-2015	Jin, JP/0000-0001-9932-1063; Weinstein, Lee/0000-0002-1899-5152	National Institutes of Health [HL-078773, AR-048816]; National Institutes of Health, NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-078773 and AR-048816 (to J.-P.J.) and by the Intramural Research Program of the National Institutes of Health, NIDDK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALPERT NR, 1983, MYOCARDIAL HYPERTROP, P619; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRISTOW MR, 1990, CIRCULATION, V82, P12; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; CAPPELLI V, 1989, CIRC RES, V65, P446, DOI 10.1161/01.RES.65.2.446; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; DILISA F, 1995, BIOCHEM J, V308, P57, DOI 10.1042/bj3080057; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Engelhardt Stefan, 2005, Heart Fail Clin, V1, P183, DOI 10.1016/j.hfc.2005.04.005; Feng HZ, 2008, J PHYSIOL-LONDON, V586, P3537, DOI 10.1113/jphysiol.2008.153577; Fitzsimons DP, 1998, J PHYSIOL-LONDON, V513, P171, DOI 10.1111/j.1469-7793.1998.171by.x; Gauthier NS, 1998, J MOL CELL CARDIOL, V30, P453, DOI 10.1006/jmcc.1997.0610; HARTZELL HC, 1984, J BIOL CHEM, V259, P5587; HOMCY CJ, 1991, ANNU REV PHYSIOL, V53, P137, DOI 10.1146/annurev.physiol.53.1.137; How OJ, 2005, AM J PHYSIOL-HEART C, V288, pH2979, DOI 10.1152/ajpheart.00084.2005; Hoyer K, 2007, J MOL CELL CARDIOL, V42, P214, DOI 10.1016/j.yjmcc.2006.08.116; Huang QQ, 2008, AM J PHYSIOL-CELL PH, V294, pC213, DOI 10.1152/ajpcell.00146.2007; JIN JP, 1990, HYBRIDOMA, V9, P597, DOI 10.1089/hyb.1990.9.597; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Kameyama T, 1998, CIRCULATION, V98, P2919, DOI 10.1161/01.CIR.98.25.2919; KATZ AM, 1973, CIRCULATION, V47, P1076, DOI 10.1161/01.CIR.47.5.1076; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; LOMPRE AM, 1981, DEV BIOL, V84, P286, DOI 10.1016/0012-1606(81)90396-1; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McConnell BK, 1998, AM J PHYSIOL-HEART C, V274, pH385, DOI 10.1152/ajpheart.1998.274.2.H385; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; RAPUNDALO ST, 1989, CIRC RES, V64, P104, DOI 10.1161/01.RES.64.1.104; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Sutherland FJ, 2003, CLIN EXP PHARMACOL P, V30, P879, DOI 10.1046/j.1440-1681.2003.03926.x; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; VANBUREN P, 1995, CIRC RES, V77, P439, DOI 10.1161/01.RES.77.2.439; Vatner SF, 2000, CIRC RES, V86, P502, DOI 10.1161/01.RES.86.5.502; Wang QD, 2002, ACTA PHYSIOL SCAND, V175, P279, DOI 10.1046/j.1365-201X.2002.01003.x; Wolska BM, 2002, CIRC RES, V90, P882, DOI 10.1161/01.RES.0000016962.36404.04; Yao A, 2003, CIRC J, V67, P83, DOI 10.1253/circj.67.83; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Yu ZB, 2007, AM J PHYSIOL-CELL PH, V292, pC1192, DOI 10.1152/ajpcell.00462.2006; Yurukova S, 2007, CARDIOVASC RES, V73, P678, DOI 10.1016/j.cardiores.2006.10.003; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773	51	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33384	33393		10.1074/jbc.M803302200	http://dx.doi.org/10.1074/jbc.M803302200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18815135	Green Published, hybrid			2022-12-27	WOS:000261183700043
J	Finn, RD; McLaughlin, LA; Ronseaux, S; Rosewell, I; Houston, JB; Henderson, CJ; Wolf, CR				Finn, Robert D.; McLaughlin, Lesley A.; Ronseaux, Sebastien; Rosewell, Ian; Houston, J. Brian; Henderson, Colin J.; Wolf, C. Roland			Defining the in Vivo Role for Cytochrome b(5) in Cytochrome P450 Function through the Conditional Hepatic Deletion of Microsomal Cytochrome b(5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIVER-MICROSOMES; ELECTRON-TRANSFER; ESCHERICHIA-COLI; NADPH-CYTOCHROME-P450 REDUCTASE; NADPH-P450 REDUCTASE; HEME OXYGENASE; P450 REDUCTASE; RAT-LIVER; MOUSE; EXPRESSION	In vitro, cytochrome b(5) modulates the rate of cytochrome P450-dependent mono-oxygenation reactions. However, the role of this enzyme in determining drug pharmacokinetics in vivo and the consequential effects on drug absorption distribution, metabolism, excretion, and toxicity are unclear. In order to resolve this issue, we have carried out the conditional deletion of microsomal cytochrome b(5) in the liver to create the hepatic microsomal cytochrome b(5) null mouse. These mice develop and breed normally and have no overt phenotype. In vitro studies using a range of substrates for different P450 enzymes showed that in hepatic microsomal cytochrome b(5) null NADH-mediated metabolism was essentially abolished for most substrates, and the NADPH-dependent metabolism of many substrates was reduced by 50-90%. This reduction in metabolism was also reflected in the in vivo elimination profiles of several drugs, including midazolam, metoprolol, and tolbutamide. In the case of chlorzoxazone, elimination was essentially unchanged. For some drugs, the pharmacokinetics were also markedly altered; for example, when administered orally, the maximum plasma concentration for midazolam was increased by 2.5-fold, and the clearance decreased by 3.6-fold in hepatic microsomal cytochrome b(5) null mice. These data indicate that microsomal cytochrome b(5) can play a major role in the in vivo metabolism of certain drugs and chemicals but in a P450- and substrate-dependent manner.	[Finn, Robert D.; McLaughlin, Lesley A.; Ronseaux, Sebastien; Henderson, Colin J.; Wolf, C. Roland] Ninewells Hosp, Canc Res UK Mol Pharmacol Unit, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Finn, Robert D.; McLaughlin, Lesley A.; Ronseaux, Sebastien; Henderson, Colin J.; Wolf, C. Roland] Sch Med, Dundee DD1 9SY, Scotland; [Rosewell, Ian] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK Transgen Serv, Potters Bar EN6 3LD, Herts, England; [Houston, J. Brian] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England	University of Dundee; University of Dundee; University of Manchester	Wolf, CR (corresponding author), Ninewells Hosp, Canc Res UK Mol Pharmacol Unit, Biomed Res Inst, Level 5, Dundee DD1 9SY, Scotland.	c.r.wolf@dundee.ac.uk	Henderson, Colin/AAE-7141-2019; Henderson, Colin J/A-6347-2009	Henderson, Colin/0000-0002-4764-639X; Wolf, Charles Roland/0000-0002-6969-0113	Cancer Research UK Programme [C4639/A5661]	Cancer Research UK Programme(Cancer Research UK)	This work was supported by Cancer Research UK Programme Grant C4639/A5661 (to C. R. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altuve A, 2001, BIOCHEMISTRY-US, V40, P9469, DOI 10.1021/bi010636i; Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; AOYAMA T, 1990, P NATL ACAD SCI USA, V87, P5425, DOI 10.1073/pnas.87.14.5425; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; BURKE MD, 1994, BIOCHEM PHARMACOL, V48, P923, DOI 10.1016/0006-2952(94)90363-8; Cannady EA, 2003, TOXICOL SCI, V73, P423, DOI 10.1093/toxsci/kfg077; Cooper MT, 2001, MUTAT RES-FUND MOL M, V484, P61, DOI 10.1016/S0027-5107(01)00236-6; Court MH, 1997, BIOPHARM DRUG DISPOS, V18, P213, DOI 10.1002/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO;2-0; DeLozier TC, 2004, J PHARMACOL EXP THER, V310, P845, DOI 10.1124/jpet.104.067819; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; EBERHART DC, 1991, ARCH BIOCHEM BIOPHYS, V291, P231, DOI 10.1016/0003-9861(91)90128-6; Emoto C, 2007, XENOBIOTICA, V37, P986, DOI 10.1080/00498250701620692; FORRESTER LM, 1992, BIOCHEM J, V281, P359, DOI 10.1042/bj2810359; Goosen TC, 2001, J PHARMACOL EXP THER, V296, P198; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Guryev OL, 2001, BIOCHEMISTRY-US, V40, P5018, DOI 10.1021/bi002305w; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; Hlavica P, 2001, EUR J BIOCHEM, V268, P4817, DOI 10.1046/j.1432-1327.2001.02412.x; Li L, 2007, ARCH BIOCHEM BIOPHYS, V461, P76, DOI 10.1016/j.abb.2007.02.010; Lofgren S, 2004, XENOBIOTICA, V34, P811, DOI 10.1080/00498250412331285463; Loughran PA, 2001, ARCH BIOCHEM BIOPHYS, V385, P311, DOI 10.1006/abbi.2000.2136; Masubuchi Y, 1997, J PHARMACOL EXP THER, V282, P1435; McLaughlin LA, 2008, DRUG METAB DISPOS, V36, P1322, DOI 10.1124/dmd.108.021261; MEEHAN RR, 1988, BIOCHEM J, V254, P789, DOI 10.1042/bj2540789; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Mokashi V, 2003, ARCH BIOCHEM BIOPHYS, V412, P147, DOI 10.1016/S0003-9861(03)00040-7; NERURKAR PV, 1993, BIOCHEM PHARMACOL, V46, P933, DOI 10.1016/0006-2952(93)90504-P; Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Pritchard MP, 1998, PHARMACOGENETICS, V8, P33, DOI 10.1097/00008571-199802000-00005; Pritchard MP, 1997, ARCH BIOCHEM BIOPHYS, V345, P342, DOI 10.1006/abbi.1997.0265; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; SHET MS, 1995, ARCH BIOCHEM BIOPHYS, V318, P314, DOI 10.1006/abbi.1995.1235; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Strobel H W, 1978, Methods Enzymol, V52, P89; Ueng YF, 2002, DRUG METAB DISPOS, V30, P349, DOI 10.1124/dmd.30.3.349; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Voice MW, 1999, ARCH BIOCHEM BIOPHYS, V366, P116, DOI 10.1006/abbi.1999.1192; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200; Yang MX, 1995, ARCH BIOCHEM BIOPHYS, V324, P282, DOI 10.1006/abbi.1995.0041; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P11594, DOI 10.1021/bi034968u; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200	49	70	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31385	31393		10.1074/jbc.M803496200	http://dx.doi.org/10.1074/jbc.M803496200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18805792	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000260760800017
J	Krasel, C; Zabel, U; Lorenz, K; Reiner, S; Al-Sabah, S; Lohse, MJ				Krasel, Cornelius; Zabel, Ulrike; Lorenz, Kristina; Reiner, Susanne; Al-Sabah, Suleiman; Lohse, Martin J.			Dual Role of the beta(2)-Adrenergic Receptor C Terminus for the Binding of beta-Arrestin and Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-2-ADRENERGIC RECEPTOR; INTRACELLULAR DOMAINS; ALPHA(2)-ADRENERGIC RECEPTORS; PHOSPHORYLATION SITES; ADRENERGIC-RECEPTOR; OPIOID RECEPTORS; DESENSITIZATION; BETA-ARRESTIN2; SPECIFICITY	Homologous desensitization of beta(2)-adrenergic and other G-protein-coupled receptors is a two-step process. After phosphorylation of agonist-occupied receptors by G-protein-coupled receptor kinases, they bind beta-arrestins, which triggers desensitization and internalization of the receptors. Because it is not known which regions of the receptor are recognized by beta-arrestins, we have investigated beta-arrestin interaction and internalization of a set of mutants of the human beta(2)-adrenergic receptor. Mutation of the four serine/threonine residues between residues 355 and 364 led to the loss of agonist-induced receptor-beta-arrestin2 interaction as revealed by fluorescence resonance energy transfer (FRET), translocation of beta-arrestin2 to the plasma membrane, and receptor internalization. Mutation of all seven serine/threonine residues distal to residue 381 did not affect agonist-induced receptor internalization and beta-arrestin2 translocation. A beta(2)-adrenergic receptor truncated distal to residue 381 interacted normally with beta-arrestin2, whereas its ability to internalize in an agonist-dependent manner was compromised. A similar impairment of internalization was observed when only the last eight residues of the C terminus were deleted. Our experiments show that the C terminus distal to residue 381 does not affect the initial interaction between receptor and beta-arrestin, but its last eight amino acids facilitate receptor internalization in concert with beta-arrestin2.	[Krasel, Cornelius; Al-Sabah, Suleiman] Univ Reading, Sch Pharm, Reading RG6 6AJ, Berks, England; [Krasel, Cornelius; Zabel, Ulrike; Lorenz, Kristina; Reiner, Susanne; Lohse, Martin J.] Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany	University of Reading	Krasel, C (corresponding author), Univ Reading, Sch Pharm, POB 228, Reading RG6 6AJ, Berks, England.	c.krasel@reading.ac.uk	Krasel, Cornelius/AAH-7074-2019; Lohse, Martin J/A-7160-2012; Lorenz, Kristina/F-3522-2016	Lohse, Martin J/0000-0002-0599-3510; Krasel, Cornelius/0000-0001-8309-8696; Al-Sabah, Suleiman/0000-0002-9808-7866; Lorenz, Kristina/0000-0002-5747-2207	DFG [SFB487]; Fonds der Chemischen Industrie; Biotechnology and Biological Sciences Research Council [BB/D012902/1] Funding Source: researchfish; BBSRC [BB/D012902/1] Funding Source: UKRI	DFG(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by SFB487 "Regulatory Membrane Proteins," by a Leibniz grant from the DFG, and by the Fonds der Chemischen Industrie.	BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cen B, 2001, MOL PHARMACOL, V59, P758, DOI 10.1124/mol.59.4.758; Cen B, 2001, J NEUROCHEM, V76, P1887, DOI 10.1046/j.1471-4159.2001.00204.x; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; Gabilondo AM, 1996, EUR J PHARMACOL, V307, P243, DOI 10.1016/0014-2999(96)00247-6; Gelber EI, 1999, J NEUROCHEM, V72, P2206, DOI 10.1046/j.1471-4159.1999.0722206.x; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; McDonald PH, 1999, J BIOL CHEM, V274, P10677, DOI 10.1074/jbc.274.16.10677; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu N, 2006, MOL PHARMACOL, V70, P249, DOI 10.1124/mol.105.018804; Zhang X, 2005, J NEUROCHEM, V95, P169, DOI 10.1111/j.1471-4159.2005.03352.x	35	37	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31840	31848		10.1074/jbc.M806086200	http://dx.doi.org/10.1074/jbc.M806086200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801735	hybrid			2022-12-27	WOS:000260760800067
J	Mayer, G; Poirier, S; Seidah, NG				Mayer, Gaetan; Poirier, Steve; Seidah, Nabil G.			Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PLASMINOGEN ACTIVATION; PROPROTEIN CONVERTASE PCSK9; CELL-SURFACE; LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; LIVER-REGENERATION; SECRETED PCSK9; II TETRAMER; MOUSE-LIVER; T-PA	The proprotein convertase subtilisin/kexin-type 9 (PCSK9), which promotes degradation of the hepatic low density lipoprotein receptor (LDLR), is now recognized as a major player in plasma cholesterol metabolism. Several gain-of-function mutations in PCSK9 cause hypercholesterolemia and premature atherosclerosis, and thus, inhibition of PCSK9-induced degradation of the LDLR may be used to treat this deadly disease. Herein, we discovered an endogenous PCSK9 binding partner by Far Western blotting, co-immunoprecipitation, and pull-down assays. Following two-dimensional gel electrophoresis and mass spectrometry analysis, we demonstrated that PCSK9 binds to a similar to 33-kDa protein identified as annexin A2 (AnxA2) but not to the closely related annexin A1. Furthermore, our functional LDLR assays and small hairpin RNA studies show that AnxA2 and the AnxA2.p11 complex could prevent PCSK9-directed LDLR degradation in HuH7, HepG2, and Chinese hamster ovary cells. Immunocytochemistry revealed that PCSK9 and AnxA2 co-localize at the cell surface, indicating a possible competition with the LDLR. Structure-function analyses demonstrated that the C-terminal cysteine-histidine-rich domain of PCSK9 interacts specifically with the N-terminal repeat R1 of AnxA2. Mutational analysis of this 70-amino acid-long repeat indicated that the RRTKK81 sequence of AnxA2 is implicated in this binding because its mutation to AATAA(81) prevents its interaction with PCSK9. To our knowledge, this work constitutes the first to show that PCSK9 activity on LDLR can be regulated by an endogenous inhibitor. The identification of the minimal inhibitory sequence of AnxA2 should pave the way toward the development of PCSK9 inhibitory lead molecules for the treatment of hypercholesterolemia.	[Mayer, Gaetan; Poirier, Steve; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research [MOP-36496, CTP-82946]; Canada Chair [201652]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Chair	This work was supported by Canadian Institutes of Health Research Grants MOP-36496 and CTP-82946 and Canada Chair 201652.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; CHUNG CY, 1994, J CELL BIOL, V126, P539, DOI 10.1083/jcb.126.2.539; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Kassam G, 1998, BIOCHEMISTRY-US, V37, P16958, DOI 10.1021/bi981713l; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; MA ASP, 1994, J CELL SCI, V107, P1973; Mai JX, 2000, BBA-PROTEIN STRUCT M, V1477, P215, DOI 10.1016/S0167-4838(99)00274-5; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Patchell BJ, 2007, AM J PHYSIOL-LUNG C, V293, pL354, DOI 10.1152/ajplung.00412.2006; Peterson AS, 2008, J LIPID RES, V49, P1152, DOI 10.1194/jlr.E800008-JLR200; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Sagot I, 1997, FEBS LETT, V410, P229, DOI 10.1016/S0014-5793(97)00594-2; Satish L, 2006, WOUND REPAIR REGEN, V14, P463, DOI 10.1111/j.1743-6109.2006.00135.x; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Siever DA, 1997, INT J BIOCHEM CELL B, V29, P1219, DOI 10.1016/S1357-2725(97)00057-5; Stahlhut M, 2000, EXP CELL RES, V261, P111, DOI 10.1006/excr.2000.4960; THIEL C, 1992, J CELL SCI, V103, P733; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; YEATMAN TJ, 1993, CLIN EXP METASTAS, V11, P37, DOI 10.1007/BF00880064; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zibouche M, 2008, J BIOL CHEM, V283, P22121, DOI 10.1074/jbc.M801000200	52	117	128	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31791	31801		10.1074/jbc.M805971200	http://dx.doi.org/10.1074/jbc.M805971200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799458	hybrid			2022-12-27	WOS:000260760800062
J	Mckee, CJ; Kessl, JJ; Shkriabai, N; Dar, MJ; Engelman, A; Kvaratskhelia, M				McKee, Christopher J.; Kessl, Jacques J.; Shkriabai, Nikolozi; Dar, Mohd Jamal; Engelman, Alan; Kvaratskhelia, Mamuka			Dynamic Modulation of HIV-1 Integrase Structure and Function by Cellular Lens Epithelium-derived Growth Factor (LEDGF) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-BINDING-DOMAIN; IN-VITRO; TYPE-1 INTEGRASE; PREINTEGRATION COMPLEXES; ENZYMATIC-ACTIVITY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; TERMINAL DOMAINS; CDNA INTEGRATION	The mandatory integration of the reverse-transcribed HIV-1 genome into host chromatin is catalyzed by the viral protein integrase (IN), and IN activity can be regulated by numerous viral and cellular proteins. Among these, LEDGF has been identified as a cellular cofactor critical for effective HIV-1 integration. The x-ray crystal structure of the catalytic core domain (CCD) of IN in complex with the IN binding domain (IBD) of LEDGF has furthermore revealed essential protein-protein contacts. However, mutagenic studies indicated that interactions between the full-length proteins were more extensive than the contacts observed in the co-crystal structure of the isolated domains. Therefore, we have conducted detailed biochemical characterization of the interactions between full-length IN and LEDGF. Our results reveal a highly dynamic nature of IN subunit-subunit interactions. LEDGF strongly stabilized these interactions and promoted IN tetramerization. Mass spectrometric protein footprinting and molecular modeling experiments uncovered novel intra- and inter-protein-protein contacts in the full-length IN-LEDGF complex that lay outside of the observable IBD-CCD structure. In particular, our studies defined the IN tetramer interface important for enzymatic activities and high affinity LEDGF binding. These findings provide new insight into how LEDGF modulates HIV-1 IN structure and function, and highlight the potential for exploiting the highly dynamic structure of multimeric IN as a novel therapeutic target.	[McKee, Christopher J.; Kessl, Jacques J.; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Retrovirus Res, Coll Pharm, Columbus, OH 43210 USA; [McKee, Christopher J.; Kessl, Jacques J.; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Comprehens Canc, Coll Pharm, Columbus, OH 43210 USA; [Dar, Mohd Jamal; Engelman, Alan] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; [Dar, Mohd Jamal; Engelman, Alan] Harvard Univ, Sch Med, Div Aids, Boston, MA 02115 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Kvaratskhelia, M (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Coll Pharm, 500 W 12th Ave,238 LM Pk Hall, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Kessl, Jacques/J-6073-2015; Kessl, Jacques/AAV-2526-2021		National Institutes of Health AIDS Research [118-D-24]; Reference Reagent Program; Division of AIDS; NIAID; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039394, R01AI039394] Funding Source: NIH RePORTER	National Institutes of Health AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reference Reagent Program; Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Jocelyn Norris for help with purifying LEDGF proteins. The integrase strand transfer inhibitor (118-D-24) was obtained through the National Institutes of Health AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, National Institutes of Health.	Al-Mawsawi LQ, 2008, FEBS LETT, V582, P1425, DOI 10.1016/j.febslet.2008.02.076; Al-Mawsawi LQ, 2006, P NATL ACAD SCI USA, V103, P10080, DOI 10.1073/pnas.0511254103; ANDRAKE MD, 1995, J BIOL CHEM, V270, P29299, DOI 10.1074/jbc.270.49.29299; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Berthoux L, 2007, VIROLOGY, V364, P227, DOI 10.1016/j.virol.2007.02.029; Bosserman MA, 2007, BIOCHEMISTRY-US, V46, P11231, DOI 10.1021/bi700197a; Brown P. O., 1997, P161; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; CANNON PM, 1994, J VIROL, V68, P4768, DOI 10.1128/JVI.68.8.4768-4775.1994; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 1999, NUCLEIC ACIDS RES, V27, P2202, DOI 10.1093/nar/27.10.2202; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Kvaratskhelia M, 2002, P NATL ACAD SCI USA, V99, P15988, DOI 10.1073/pnas.252550199; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; Petit C, 2000, J VIROL, V74, P7119, DOI 10.1128/JVI.74.15.7119-7126.2000; Raghavendra NK, 2007, VIROLOGY, V360, P1, DOI 10.1016/j.virol.2006.12.022; Rahman S, 2007, VIROLOGY, V357, P79, DOI 10.1016/j.virol.2006.08.011; Shell SM, 2005, BIOCHEMISTRY-US, V44, P971, DOI 10.1021/bi048208a; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Shkriabai N, 2004, P NATL ACAD SCI USA, V101, P6894, DOI 10.1073/pnas.0400873101; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Svarovskaia ES, 2004, J VIROL, V78, P3210, DOI 10.1128/JVI.78.7.3210-3222.2004; Tsurutani N, 2000, J VIROL, V74, P4795, DOI 10.1128/JVI.74.10.4795-4806.2000; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; VANGENT DC, 1991, NUCLEIC ACIDS RES, V19, P3821, DOI 10.1093/nar/19.14.3821; VINCENT KA, 1993, J VIROL, V67, P425, DOI 10.1128/JVI.67.1.425-437.1993; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Yu F, 2007, BIOCHEMISTRY-US, V46, P2899, DOI 10.1021/bi602387u; Zhang XC, 2003, BIOORG MED CHEM LETT, V13, P1215, DOI 10.1016/S0960-894X(03)00059-3; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	76	105	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31802	31812		10.1074/jbc.M805843200	http://dx.doi.org/10.1074/jbc.M805843200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801737	Green Published, hybrid			2022-12-27	WOS:000260760800063
J	Sawicki, A; Willows, RD				Sawicki, Artur; Willows, Robert D.			Kinetic Analyses of the Magnesium Chelatase Provide Insights into the Mechanism, Structure, and Formation of the Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRIN-IX METHYLTRANSFERASE; PHOSPHATE EXCHANGE ACTIVITIES; ADENOSYL-L-METHIONINE; MG-CHELATASE; RHODOBACTER-CAPSULATUS; ATPASE ACTIVITY; CHLOROPHYLL BIOSYNTHESIS; SYNECHOCYSTIS PCC6803; BARLEY MUTANTS; H-SUBUNIT	The metabolic pathway known as (bacterio) chlorophyll biosynthesis is initiated by magnesium chelatase (BchI, BchD, BchH). This first step involves insertion of magnesium into protoporphyrin IX (proto), a process requiring ATP hydrolysis. Structural information shows that the BchI and BchD subunits form a double hexameric enzyme complex, whereas BchH binds proto and can be purified as BchH-proto. We utilized the Rhodobacter capsulatus magnesium chelatase subunits using continuous magnesium chelatase assays and treated the BchD subunit as the enzyme with both BchI and BchH-proto as substrates. Michaelis-Menten kinetics was observed with the BchI subunit, whereas the BchH subunit exhibited sigmoidal kinetics (Hill coefficient of 1.85). The BchI.BchD complex had intrinsic ATPase activity, and addition of BchH greatly increased ATPase activity. This was concentration-dependent and gave sigmoidal kinetics, indicating there is more than one binding site for the BchH subunit on the BchI.BchD complex. ATPase activity was similar to 40-fold higher than magnesium chelatase activity and continued despite cessation of magnesium chelation, implying one or more secondary roles for ATP hydrolysis and possibly an as yet unknown switch required to terminate ATPase activity. One of the secondary roles for BchH-stimulated ATP hydrolysis by a BchI.BchD complex is priming of BchH to facilitate correct binding of proto to BchH in a form capable of participating in magnesium chelation. This porphyrin binding is the rate-limiting step in catalysis. These data suggest that ATP hydrolysis by the BchI.BchD complex causes a series of conformational changes in BchH to effect substrate binding, magnesium chelation, and product release.	[Sawicki, Artur; Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	Macquarie University	Willows, RD (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	rwillows@rna.bio.mq.edu.au	Willows, Robert/C-1537-2010; Sawicki, Artur/G-7984-2016	Willows, Robert/0000-0002-0731-2950; Sawicki, Artur/0000-0001-6187-042X; Sawicki, Artur/0000-0002-1469-0845				Alawady A, 2005, PLANT MOL BIOL, V57, P679, DOI 10.1007/s11103-005-1427-8; Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; GORCHEIN A, 1972, BIOCHEM J, V127, P97, DOI 10.1042/bj1270097; Grafe S, 1999, P NATL ACAD SCI USA, V96, P1941, DOI 10.1073/pnas.96.5.1941; Guo RB, 1998, PLANT PHYSIOL, V116, P605, DOI 10.1104/pp.116.2.605; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hansson A, 2002, P NATL ACAD SCI USA, V99, P13944, DOI 10.1073/pnas.212504499; Hansson M, 1997, P NATL ACAD SCI USA, V94, P13351, DOI 10.1073/pnas.94.24.13351; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Lake V, 2004, EUR J BIOCHEM, V271, P2182, DOI 10.1111/j.1432-1033.2004.04143.x; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Masuda T, 2008, PHOTOSYNTH RES, V96, P121, DOI 10.1007/s11120-008-9291-4; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Petersen BL, 1999, ARCH MICROBIOL, V171, P146, DOI 10.1007/s002030050692; Reid JD, 2003, BIOCHEMISTRY-US, V42, P6912, DOI 10.1021/bi034082q; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Reid JD, 2002, BIOCHEM SOC T, V30, P643, DOI 10.1042/bst0300643; RICHTER ML, 1982, BIOCHIM BIOPHYS ACTA, V717, P255, DOI 10.1016/0304-4165(82)90177-5; Sawicki A, 2007, BIOCHEM J, V406, P469, DOI 10.1042/BJ20070284; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Sirijovski N, 2006, BIOCHEM J, V400, P477, DOI 10.1042/BJ20061103; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; Walker CJ, 1997, BIOCHEM J, V327, P321; Willows R.D., 2003, PORPHYRIN HDB CHLORO, V13, P1, DOI [10.1016/B978-0-08-092387-1.50007-2, DOI 10.1016/B978-0-08-092387-1.50007-2]; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019; Willows RD, 1998, J BIOL CHEM, V273, P34206, DOI 10.1074/jbc.273.51.34206; Willows RD, 1996, EUR J BIOCHEM, V235, P438, DOI 10.1111/j.1432-1033.1996.00438.x; Willows RD, 2003, J BACTERIOL, V185, P3249, DOI 10.1128/JB.185.11.3249-3258.2003; Willows RD, 1999, ACTA CRYSTALLOGR D, V55, P689, DOI 10.1107/S0907444998014759	44	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31294	31302		10.1074/jbc.M805792200	http://dx.doi.org/10.1074/jbc.M805792200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18790730	hybrid			2022-12-27	WOS:000260760800006
J	Switzer, RL				Switzer, Robert L.			Discoveries in Bacterial Nucleotide Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; SUBTILIS ASPARTATE-TRANSCARBAMYLASE; SPORULATING BACILLUS-SUBTILIS; OXYGEN-DEPENDENT INACTIVATION; IRON-SULFUR CLUSTER; PYR GENE-CLUSTER; ESCHERICHIA-COLI; IN-VIVO; PYRIMIDINE BIOSYNTHESIS; DIPHOSPHATE SYNTHASE		Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Switzer, RL (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	rswitzer@illinois.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047112] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47112, R01 GM047112] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNVIG K, 1990, EUR J BIOCHEM, V192, P195, DOI 10.1111/j.1432-1033.1990.tb19214.x; AVERILL BA, 1980, J BIOL CHEM, V255, P6007; BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; BECKER MA, 1988, AM J MED, V85, P383, DOI 10.1016/0002-9343(88)90591-8; BERNLOHR DA, 1983, J BACTERIOL, V153, P937, DOI 10.1128/JB.153.2.937-949.1983; BERNLOHR DA, 1981, BIOCHEMISTRY-US, V20, P5675, DOI 10.1021/bi00523a006; BOND RW, 1984, J BACTERIOL, V158, P746, DOI 10.1128/JB.158.2.746-748.1984; BOND RW, 1983, J BACTERIOL, V153, P253, DOI 10.1128/JB.153.1.253-258.1983; BRABSON JS, 1975, J BIOL CHEM, V250, P8664; CARTER AT, 1994, YEAST, V10, P1031, DOI 10.1002/yea.320100805; Chen SH, 1999, BIOCHEMISTRY-US, V38, P11659, DOI 10.1021/bi991060o; Chen SH, 1997, BIOCHEMISTRY-US, V36, P10718, DOI 10.1021/bi9711893; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; DEUTSCHE.MP, 1968, J BIOL CHEM, V243, P4653; EMTAGE MH, 1988, ACS SYM SER, V372, P343; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; Fields CJ, 2007, J BACTERIOL, V189, P6236, DOI 10.1128/JB.00803-07; FREY PA, 1966, J BIOL CHEM, V241, P2732; Gerth U, 2008, J BACTERIOL, V190, P321, DOI 10.1128/JB.01233-07; GHIM SY, 1994, J BACTERIOL, V176, P3698, DOI 10.1128/JB.176.12.3698-3707.1994; GIBSON KJ, 1982, J BIOL CHEM, V257, P2391; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; GRANDONI JA, 1989, J BIOL CHEM, V264, P6058; GRANDONI JA, 1990, INT J PURINE PYRIMID, V1, P13; GRAVES LM, 1990, J BIOL CHEM, V265, P14947; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; HOVEJENSEN B, 1983, J BACTERIOL, V154, P177, DOI 10.1128/JB.154.1.177-184.1983; HU P, 1995, ARCH BIOCHEM BIOPHYS, V316, P260, DOI 10.1006/abbi.1995.1036; Kadziola A, 2005, J MOL BIOL, V354, P815, DOI 10.1016/j.jmb.2005.10.001; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; KHORANA HG, 1958, J BIOL CHEM, V230, P941; KITA K, 1994, J BIOL CHEM, V269, P8334; KORNBERG A, 1955, J BIOL CHEM, V215, P389; Krahn JM, 1997, BIOCHEMISTRY-US, V36, P11061, DOI 10.1021/bi9714114; Krath BN, 1999, PLANT PHYSIOL, V119, P497, DOI 10.1104/pp.119.2.497; LERNER CG, 1987, J BACTERIOL, V169, P2202, DOI 10.1128/jb.169.5.2202-2206.1987; LERNER CG, 1986, J BIOL CHEM, V261, P1156; MAKAROFF CA, 1983, J BIOL CHEM, V258, P586; MARSHALL E, 1995, SCIENCE, V268, P1713; MAURIZI MR, 1978, J BIOL CHEM, V253, P5585; Maurizi MR, 2004, STRUCTURE, V12, P175, DOI 10.1016/j.str.2004.01.021; MEYER E, 1979, J BIOL CHEM, V254, P5397; NEWAY JO, 1983, J BACTERIOL, V155, P522, DOI 10.1128/JB.155.2.522-530.1983; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; Nygaard F. B, 2001, THESIS U COPENHAGEN; PAULUS TJ, 1982, J BACTERIOL, V149, P775, DOI 10.1128/JB.149.2.775-778.1982; PAULUS TJ, 1979, J BACTERIOL, V140, P769, DOI 10.1128/JB.140.3.769-773.1979; PAULUS TJ, 1979, J BACTERIOL, V137, P82, DOI 10.1128/JB.137.1.82-91.1979; POTVIN BW, 1975, J BACTERIOL, V123, P604, DOI 10.1128/JB.123.2.604-615.1975; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; QUINN CL, 1991, J BIOL CHEM, V266, P9113; ROWE PB, 1968, J BIOL CHEM, V243, P6373; RUPPEN ME, 1983, J BIOL CHEM, V258, P2843; SETLOW P, 1975, SPORES, V6, P443; SMITH JL, 1994, SCIENCE, V264, P1427, DOI 10.1126/science.8197456; SONADA T, 1997, BIOCHIM BIOPHYS ACTA, V1350, P6; Stadtman E R, 1968, Adv Enzyme Regul, V6, P257, DOI 10.1016/0065-2571(68)90017-4; SWITZER RL, 1967, J BIOL CHEM, V242, P2658; SWITZER RL, 1973, J BIOL CHEM, V248, P1063; SWITZER RL, 1969, J BIOL CHEM, V244, P5263; TAIRA M, 1987, J BIOL CHEM, V262, P14867; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; TURNBOUGH CL, 1975, J BACTERIOL, V121, P108, DOI 10.1128/JB.121.1.108-114.1975; TURNBOUGH CL, 1975, J BACTERIOL, V121, P115, DOI 10.1128/JB.121.1.115-120.1975; TURNER RJ, 1994, J BACTERIOL, V176, P3708, DOI 10.1128/JB.176.12.3708-3722.1994; VOLLMER SJ, 1983, J BIOL CHEM, V258, P4284; WAINDLE LM, 1973, J BACTERIOL, V114, P517, DOI 10.1128/JB.114.2.517-527.1973; Weissbach H, 2008, J BIOL CHEM, V283, P23497, DOI 10.1074/jbc.X800006200; WONG JY, 1977, J BIOL CHEM, V252, P7424	69	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6585	6594		10.1074/jbc.X800012200	http://dx.doi.org/10.1074/jbc.X800012200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	18948259	Green Published, hybrid			2022-12-27	WOS:000263919000001
J	Mishra, P; Bhakuni, V				Mishra, Parul; Bhakuni, Vinod			Self-assembly of Bacteriophage-associated Hyaluronate Lyase (HYLP2) into an Enzymatically Active Fibrillar Film	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRILS; ELECTRON-MICROSCOPY; THIOFLAVINE-T; PROTEIN; AGGREGATION; CONFORMATIONS; MECHANISM; FILAMENTS; PATHWAYS; FEATURES	The in vitro assembly of a soluble protein into its mature fibrillar form is usually accompanied by loss of its functional activity. Our study is the first demonstration of a natural enzyme (Hy1P2) retaining its enzymatic activity on conversion from pre-fibril to mature fibril and supports the contention that minor conformational changes in the native folded form of a protein can lead to the formation of a functional fibril. Hyaluronate lyase (Hy1P2) is a natural enzyme of bacteriophage 10403 of Streptococcus pyogenes. AtpH5.0, the enzyme undergoes partial unfolding localized in its N-terminal domain while the C-terminal domain maintains its folded trimeric conformation. This structural variant of Hy1P2 retains about 70% enzymatic activity with hyaluronan. It further self-assembles into a fibrillar film in vitro through solvent-exposed nonpolar surfaces and intermolecular beta-sheet formation by the beta-strands in the protein. Interestingly, the mature fibrillar film of Hy1P2 also retains about 60 and 20% enzymatic activity for hyaluronic acid and chondroitin sulfate, respectively. The possession of broad substrate specificity by the fibrillar form of Hy1P2 indicates that fluctuations in pH, which do not lead to loss of functionality of Hy1P2, might assist in bacterial pathogenesis. The formation of fibrillar film-like structure has been observed for the first time among the hyaluronidase enzymes. After acquiring this film-like structure in bacteriophage, Hy1P2 still retains its enzymatic activity, which establishes that these fibrils are a genuinely acquired protein fold/structure.	[Mishra, Parul; Bhakuni, Vinod] Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Bhakuni, V (corresponding author), Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India.	bhakuniv@rediffmail.com	Mishra, Parul/AAY-2911-2020	Mishra, Parul/0000-0002-2989-7371	Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Supported by the Council of Scientific and Industrial Research, New Delhi, India.	Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; de Laureto PP, 2005, FEBS J, V272, P2176, DOI 10.1111/j.1742-4658.2005.04638.x; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; FINK AL, 1999, PROTEIN STRUCTURES M, P140; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; GLENNER GG, 1972, J HISTOCHEM CYTOCHEM, V20, P821, DOI 10.1177/20.10.821; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Inouye H, 2000, J STRUCT BIOL, V130, P123, DOI 10.1006/jsbi.2000.4258; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jimenez JL, 2001, J MOL BIOL, V311, P241, DOI 10.1006/jmbi.2001.4863; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; KRAMER MR, 2006, NATURE, V6, P533; Lackowicz J.R., 2006, PRINCIPLES FLUORESCE, DOI 10.1007/978-0-387-46312-4; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Marris E, 2006, NATURE, V444, P985, DOI 10.1038/444985a; MAXTED WR, 1952, NATURE, V170, P1020, DOI 10.1038/1701020b0; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Mishra P, 2006, J BIOL CHEM, V281, P7143, DOI 10.1074/jbc.M510991200; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; POLVERINO D, 2003, J MOL BIOL, V334, P129; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; TAN YJ, 1995, J MOL BIOL, V254, P980, DOI 10.1006/jmbi.1995.0670; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wetzel R, 1996, CELL, V86, P699, DOI 10.1016/S0092-8674(00)80143-9; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	44	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5240	5249		10.1074/jbc.M806730200	http://dx.doi.org/10.1074/jbc.M806730200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	18849564	hybrid			2022-12-27	WOS:000263416600054
J	Denison, FC; Hiscock, NJ; Carling, D; Woods, A				Denison, Fiona C.; Hiscock, Natalie J.; Carling, David; Woods, Angela			Characterization of an Alternative Splice Variant of LKB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; JEGHERS CANCER SYNDROME; TUMOR-SUPPRESSOR; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; UPSTREAM KINASE; IN-VITRO; C-ZETA; PHOSPHORYLATION; COMPLEX	LKB1 is an upstream activating kinase for the AMP-activated protein kinase (AMPK) and at least 12 other AMPK-related kinases. LKB1 therefore acts as a master kinase regulating the activity of a wide range of downstream kinases, which themselves have diverse physiological roles. Here we identify a second form of LKB1 generated by alternative splicing of the LKB1 gene. The two LKB1 proteins have different C-terminal sequences generating a 50-kDa form (termed LKB1(L)) and a 48-kDa form (LKB1(S)). LKB1(L) is widely expressed in mouse tissues, whereas LKB1S has a restricted tissue distribution with predominant expression in the testis. LKB1(S), like LKB1(L), forms a complex with MO25 and STRAD, and phosphorylates and activates AMPK both in vitro and in intact cells. A phosphorylation site (serine 431 in mouse) and a farnesylation site (cysteine 433 in mouse) within LKB1(L) are not conserved in LKB1(S) raising the possibility that these sites might be involved in differential regulation and/or localization of the two forms of LKB1. However, we show that phosphorylation of serine 431 has no effect on LKB1(L) activity and that both LKB1(L) and LKB1(S) have similar patterns of subcellular localization. These results indicate that the physiological significance of the different forms of LKB1 is not related directly to differences in the C-terminal sequences but may be due to their differential patterns of tissue distribution.	[Denison, Fiona C.; Carling, David; Woods, Angela] Ctr Clin Sci, MRC, Cellular Stress Grp, London W12 0NN, England; [Hiscock, Natalie J.] Personalised Vital Platform, Unilever Discover, Sharnbrook MK44 1LQ, Beds, England	Unilever	Carling, D (corresponding author), Ctr Clin Sci, MRC, Cellular Stress Grp, Du Cane Rd, London W12 0NN, England.	dcarling@imperial.ac.uk; angela.woods@imperial.ac.uk	Carling, David/F-1943-2014	Carling, David/0000-0002-2316-1830	Medical Research Council; European Commission [LSHM-CT-2004-005272, LSH-CT-2005-518181]; Medical Research Council [MC_U120027537] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and European Commission Grants LSHM-CT-2004-005272 and LSH-CT-2005-518181 (to D. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490	35	26	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					67	76		10.1074/jbc.M806153200	http://dx.doi.org/10.1074/jbc.M806153200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18854309	hybrid			2022-12-27	WOS:000261974800008
J	Kraft, CA; Garrido, JL; Fluharty, E; Leiva-Vega, L; Romero, G				Kraft, Catherine A.; Garrido, Jose Luis; Fluharty, Eric; Leiva-Vega, Luis; Romero, Guillermo			Role of Phosphatidic Acid in the Coupling of the ERK Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPASE-D; SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; BINDING DOMAIN; RAF-1 KINASE; B-RAF; PATHWAY; FLUORESCENCE	The production of phosphatidic acid plays a crucial role in the activation of the ERK cascade. This role was linked to the binding of phosphatidate to a specific polybasic site within the kinase domain of Raf-1. Here we show that phosphatidate promotes ERK phosphorylation in intact cells but does not activate Raf in vitro. The kinase suppressor of Ras (KSR) contains a sequence homologous to the phosphatidate binding site of Raf-1. Direct binding of phosphatidate to synthetic peptides derived from the sequences of the binding domains of Raf-1 and KSR was demonstrated by spectroscopic techniques. The specificity of these interactions was confirmed using synthetic lipids and mutated peptides in which the core of the phosphatidic acid binding domain was disrupted. Insulin and exogenous dioleoyl phosphatidate induced a rapid translocation of a mouse KSR1-EGFP construct to the plasma membrane of HIRcB cells. Mutation of two arginines located in the core of the putative phosphatidate binding site abolished dioleoyl phosphatidate and insulin-induced translocation of KSR1. Overexpression of the mutant KSR1 in HIRcB cells inhibited insulin-dependent MEK and ERK phosphorylation. The addition of dioleoyl phosphatidate or insulin increased the co-localization of KSR1 and H-Ras and promoted the formation of plasma membrane patches enriched in both proteins and phosphatidic acid. These results, in conjunction with our previous work, suggest the formation of phosphatidate-enriched membrane microdomains that contain all components of the ERK cascade. We propose that these domains act as molecular scaffolds in the coupling of signaling events.	[Kraft, Catherine A.; Garrido, Jose Luis; Fluharty, Eric; Leiva-Vega, Luis; Romero, Guillermo] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Romero, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	ggr@pitt.edu			National Institutes of Health [R01-DK-54782, T32-GM-54813]; Office of the Senior Vice Chancellor for the Health Sciences of the University of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Senior Vice Chancellor for the Health Sciences of the University of Pittsburgh(University of Pittsburgh); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK-54782 and T32-GM-54813. This work was also supported by an internal grant from the Office of the Senior Vice Chancellor for the Health Sciences of the University of Pittsburgh. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALMOG S, 1986, BIOCHEMISTRY-US, V25, P2597, DOI 10.1021/bi00357a048; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Chattopadhyay A, 1996, FEBS LETT, V391, P199, DOI 10.1016/0014-5793(96)00733-8; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Faraudo J, 2007, BIOPHYS J, V92, P2806, DOI 10.1529/biophysj.106.092015; Frank C, 1999, BIOCHEMISTRY-US, V38, P11993, DOI 10.1021/bi982586w; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Grange M, 2000, J BIOL CHEM, V275, P33379, DOI 10.1074/jbc.M006329200; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; INOUYE K, 1985, BIOCHEM BIOPH RES CO, V128, P676, DOI 10.1016/0006-291X(85)90099-3; Koch T, 2003, J BIOL CHEM, V278, P9979, DOI 10.1074/jbc.M206709200; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Lemmon MA, 2005, CELL, V120, P574, DOI 10.1016/j.cell.2005.02.023; McPhail LC, 1999, BBA-MOL CELL BIOL L, V1439, P277, DOI 10.1016/S1388-1981(99)00100-6; Panicker L, 2007, J COLLOID INTERF SCI, V311, P407, DOI 10.1016/j.jcis.2007.03.052; Pathre P, 2003, EMBO J, V22, P4059, DOI 10.1093/emboj/cdg390; PERMYAKOV EA, 1983, BIOPHYS CHEM, V18, P145, DOI 10.1016/0301-4622(83)85009-1; Piret J, 2005, CHEM PHYS LIPIDS, V133, P1, DOI 10.1016/j.chemphyslip.2004.08.002; Poveda JA, 2002, BIOCHEMISTRY-US, V41, P12253, DOI 10.1021/bi0200099; RAABE T, 2002, SCI STKE, pPE28; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 2001, J BIOL CHEM, V276, P34928, DOI 10.1074/jbc.M105918200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Sciorra VA, 1999, MOL BIOL CELL, V10, P3863, DOI 10.1091/mbc.10.11.3863; SILVIUS JR, 1990, BIOCHEMISTRY-US, V29, P2930, DOI 10.1021/bi00464a007; Stewart S, 1999, MOL CELL BIOL, V19, P5523; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; TAKAHASHI H, 1991, BIOCHIM BIOPHYS ACTA, V1069, P229, DOI 10.1016/0005-2736(91)90129-V; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; UEMURA A, 1983, BIOCHIM BIOPHYS ACTA, V729, P28, DOI 10.1016/0005-2736(83)90452-2; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; WEINBERG RB, 1985, J BIOL CHEM, V260, P4914; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhou M, 2002, J MOL BIOL, V315, P435, DOI 10.1006/jmbi.2001.5263	45	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36636	36645		10.1074/jbc.M804633200	http://dx.doi.org/10.1074/jbc.M804633200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18952605	Green Published, hybrid			2022-12-27	WOS:000261840500062
J	Nurnberg, A; Brauer, AU; Wettschureck, N; Offermanns, S				Nuernberg, Alexander; Braeuer, Anja U.; Wettschureck, Nina; Offermanns, Stefan			Antagonistic Regulation of Neurite Morphology through G(q)/G(11) and G(12)/G(13)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PROTEASE-ACTIVATED RECEPTORS; RHO-FAMILY GTPASES; LYSOPHOSPHATIDIC ACID; GROWTH CONE; NERVOUS-SYSTEM; G(12) FAMILY; RETRACTION; THROMBIN; CELLS	The induction of neurite retraction and growth cone collapse via G-protein-coupled receptors is involved in developmental as well as regenerative processes. The role of individual G-protein-mediated signaling processes in the regulation of neurite morphology is still incompletely understood. Using primary neurons from brains lacking G alpha(q)/G alpha(11) or G alpha(12)/G alpha(13), we show here that G(12)/G(13)-mediated signaling is absolutely required for neurite retraction and growth cone collapse induced by the blood-borne factors lysophosphatidic acid and thrombin. Interestingly, the effects of lysophosphatidic acid were mediated mainly by G(13), whereas thrombin effects required G(12). Surprisingly, lack of G alpha(q)/G alpha(11) resulted in overshooting responses to both stimuli, indicating that G(q)/G(11)-mediated signaling most likely via activation of Rac antagonizes the effects of G(12)/G(13).	[Nuernberg, Alexander; Wettschureck, Nina; Offermanns, Stefan] Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany; [Braeuer, Anja U.] Charite Univ Med Berlin, Ctr Anat, Inst Cell Biol & Neurobiol, D-10115 Berlin, Germany; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany	Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Offermanns, S (corresponding author), Univ Heidelberg, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	stefan.offermanns@pharma.uni-heidelberg.de	Wettschureck, Nina/L-3651-2017; Bräuer, Anja/N-3692-2019; Braeuer, Anja/K-8339-2013; Offermanns, Stefan/L-3313-2017	Wettschureck, Nina/0000-0001-6858-1460; Offermanns, Stefan/0000-0001-8676-6805	German Research Foundation [SFB 488]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the Collaborative Research Center 488 of the German Research Foundation (SFB 488). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Chun J, 2000, ANN NY ACAD SCI, V905, P110; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Couvillon AD, 2006, CELL SIGNAL, V18, P715, DOI 10.1016/j.cellsig.2005.06.012; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fritsche J, 1999, MOL CELL NEUROSCI, V14, P398, DOI 10.1006/mcne.1999.0777; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukushima N, 2004, J CELL BIOCHEM, V92, P993, DOI 10.1002/jcb.20093; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gratacap MP, 2001, J BIOL CHEM, V276, P47906, DOI 10.1074/jbc.M104442200; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Katoh H, 1996, J BIOL CHEM, V271, P29780, DOI 10.1074/jbc.271.47.29780; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Moers A, 2008, MOL CELL BIOL, V28, P1480, DOI 10.1128/MCB.00651-07; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Noorbakhsh F, 2003, NAT REV NEUROSCI, V4, P981, DOI 10.1038/nrn1255; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Postma FR, 1996, EMBO J, V15, P2388, DOI 10.1002/j.1460-2075.1996.tb00595.x; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Rasband W., 2006, IMAGEJ; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rosenfeldt Hans, 2006, J Mol Signal, V1, P8, DOI 10.1186/1750-2187-1-8; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Tigyi G, 1996, J NEUROCHEM, V66, P537; van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Wettschureck N, 2005, MOL CELL BIOL, V25, P1942, DOI 10.1128/MCB.25.5.1942-1948.2005; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; Yamaguchi Y, 2003, J BIOL CHEM, V278, P14936, DOI 10.1074/jbc.M301409200; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Yang SA, 2004, J BIOL CHEM, V279, P42331, DOI 10.1074/jbc.M404335200; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	50	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35526	35531		10.1074/jbc.M804972200	http://dx.doi.org/10.1074/jbc.M804972200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18854320	hybrid			2022-12-27	WOS:000261687900024
J	Lad, Y; Jiang, P; Ruskamo, S; Harburger, DS; Ylanne, J; Campbell, ID; Calderwood, DA				Lad, Yatish; Jiang, Pengju; Ruskamo, Salla; Harburger, David S.; Ylanne, Jari; Campbell, Iain D.; Calderwood, David A.			Structural Basis of the Migfilin-Filamin Interaction and Competition with Integrin beta Tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKBONE DYNAMICS; BINDING; ADHESIONS	A link between sites of cell adhesion and the cytoskeleton is essential for regulation of cell shape, motility, and signaling. Migfilin is a recently identified adaptor protein that localizes at cell-cell and cell-extracellular matrix adhesion sites, where it is thought to provide a link to the cytoskeleton by interacting with the actin cross-linking protein filamin. Here we have used x-ray crystallography, NMR spectroscopy, and protein-protein interaction studies to investigate the molecular basis of migfilin binding to filamin. We report that the N-terminal portion of migfilin can bind all three human filamins (FLNa, -b, or -c) and that there are multiple migfilin-binding sites in FLNa. Human filamins are composed of an N-terminal actin-binding domain followed by 24 immunoglobulin-like (IgFLN) domains and we find that migfilin binds preferentially to IgFLNa21 and more weakly to IgFLNa19 and -22. The filamin-binding site in migfilin is localized between Pro5 and Pro19 and binds to the CD face of the IgFLNa21 beta-sandwich. This interaction is similar to the previously characterized beta 7 integrin-IgFLNa21 interaction and migfilin and integrin beta tails can compete with one another for binding to IgFLNa21. This suggests that competition between filamin ligands for common binding sites on IgFLN domains may provide a general means of modulating filamin interactions and signaling. In this specific case, displacement of integrin tails from filamin by migfilin may provide a mechanism for switching between different integrin-cytoskeleton linkages.	[Lad, Yatish; Harburger, David S.; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Lad, Yatish; Harburger, David S.; Calderwood, David A.] Yale Univ, Sch Med, Interdepartmental Program Vasc Biol & Transplanta, New Haven, CT 06520 USA; [Jiang, Pengju; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, FIN-40014 Jyvaskyla, Finland	Yale University; Yale University; University of Oxford; University of Jyvaskyla	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142; Ruskamo, Salla/0000-0002-9740-9077; Ylanne, Jari/0000-0003-4627-021X	National Institutes of Health [GM068600]; Academy of Finland [114713]; BBSRC [BB/F006845/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F006845/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068600 (to D.A.C.). This work was also supported by Academy of Finland Grant 114713 (to J.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Papachristou DJ, 2007, HISTOPATHOLOGY, V51, P499, DOI 10.1111/j.1365-2559.2007.02791.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Stossel TP, 2003, DEV CELL, V4, P444, DOI 10.1016/S1534-5807(03)00098-4; Takafuta T, 2003, J BIOL CHEM, V278, P12175, DOI 10.1074/jbc.M209339200; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200	37	89	93	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35154	35163		10.1074/jbc.M802592200	http://dx.doi.org/10.1074/jbc.M802592200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18829455	Green Published, hybrid			2022-12-27	WOS:000261469100072
J	Levin-Salomon, V; Kogan, K; Ahn, NG; Livnah, O; Engelberg, D				Levin-Salomon, Vered; Kogan, Konstantin; Ahn, Natalie G.; Livnah, Oded; Engelberg, David			Isolation of Intrinsically Active (MEK-independent) Variants of the ERK Family of Mitogen-activated Protein (MAP) Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; OF-FUNCTION MUTATION; N-TERMINAL KINASE; STRESS-RESPONSE; YEAST; PATHWAY; CANCER; CELLS; PHOSPHORYLATION; TRANSDUCTION	MAPKs are key components of cell signaling pathways with a unique activation mechanism: i.e. dual phosphorylation of neighboring threonine and tyrosine residues. The ERK enzymes form a subfamily of MAPKs involved in proliferation, differentiation, development, learning, and memory. The exact role of each Erk molecule in these processes is not clear. An efficient strategy for addressing this question is to activate individually each molecule, for example, by expressing intrinsically active variants of them. However, such molecules were not produced so far. Here, we report on the isolation, via a specifically designed genetic screen, of six variants ( each carries a point mutation) of the yeast MAPK Mpk1/Erk that are active, independent of upstream phosphorylation. One of the activating mutations, R68S, occurred in a residue conserved in the mammalian Erk1 (Arg-84) and Erk2 (Arg-65) and in the Drosophila ERK Rolled (Arg-80). Replacing this conserved Arg with Ser rendered these MAPKs intrinsically active to very high levels when tested in vitro as recombinant proteins. Combination of the Arg to Ser mutation with the sevenmaker mutation ( producing Erk2(R65S+D319N) and Rolled(R80S+D334N)) resulted in even higher activity ( 45 and 70%, respectively, in reference to fully active dually phosphorylated Erk2 or Rolled). Erk2(R65S) and Erk2(R65S+D319N) were found to be spontaneously active also when expressed in human HEK293 cells. We further revealed the mechanism of action of the mutants and show that it involves acquisition of autophosphorylation activity. Thus, a first generation of Erk molecules that are spontaneously active in vitro and in vivo has been obtained.	[Levin-Salomon, Vered; Kogan, Konstantin; Livnah, Oded; Engelberg, David] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel; [Ahn, Natalie G.] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Engelberg, D (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	engelber@cc.huji.ac.il			U.S-Israel Binational Science Foundation [2005002]; Israel Science Foundation [656/06]	U.S-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This study was supported by U.S-Israel Binational Science Foundation Grant 2005002 and by the Israel Science Foundation Grant 656/06. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aebersold DM, 2004, MOL CELL BIOL, V24, P10000, DOI 10.1128/MCB.24.22.10000-10015.2004; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Askari N, 2006, MOL CELL ENDOCRINOL, V252, P231, DOI 10.1016/j.mce.2006.03.015; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; Bell M, 2003, J BIOL CHEM, V278, P14603, DOI 10.1074/jbc.C300006200; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162, DOI 10.1128/MCB.12.3.1162; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cripe LD, 2002, LEUKEMIA, V16, P799, DOI 10.1038/sj.leu.2402457; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; Emrick MA, 2001, J BIOL CHEM, V276, P46469, DOI 10.1074/jbc.M107708200; Engelberg D, 2006, METHODS, V40, P255, DOI 10.1016/j.ymeth.2006.06.014; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Ferrer I, 2001, BRAIN PATHOL, V11, P144; Garcia M, 2002, J NEUROSCI, V22, P2174, DOI 10.1523/JNEUROSCI.22-06-02174.2002; Gioeli D, 1999, CANCER RES, V59, P279; GOLDSMITH EJ, 1994, CURR OPIN STRUC BIOL, V4, P833, DOI 10.1016/0959-440X(94)90264-X; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hall JP, 1996, MOL CELL BIOL, V16, P6715; Hou XS, 1997, GENE DEV, V11, P1728, DOI 10.1101/gad.11.13.1728; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuperstein F, 2002, EUR J NEUROSCI, V16, P44, DOI 10.1046/j.1460-9568.2002.02056.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; LEVINSALOMON V, 2008, BIOCH J IN PRESS; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lin SY, 2002, MOL CARCINOGEN, V35, P21, DOI 10.1002/mc.10070; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin H, 1996, CURR GENET, V29, P516; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pei JJ, 2001, J ALZHEIMERS DIS, V3, P41, DOI 10.3233/JAD-2001-3107; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Price DT, 1999, J UROLOGY, V162, P1537, DOI 10.1016/S0022-5347(05)68354-1; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; SANGHERA JS, 1992, MOL BIOL CELL, V3, P775, DOI 10.1091/mbc.3.7.775; Sato N, 1997, BIOCHEM BIOPH RES CO, V232, P637, DOI 10.1006/bbrc.1997.6341; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; SILHAVY TJ, 1984, EXPT GENE FUSION, P75; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; van Montfrans C, 2002, BIOCHEM PHARMACOL, V64, P789, DOI 10.1016/S0006-2952(02)01140-1; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yung Y, 2001, J BIOL CHEM, V276, P35280, DOI 10.1074/jbc.M105995200; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0	68	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34500	34510		10.1074/jbc.M806443200	http://dx.doi.org/10.1074/jbc.M806443200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18829462	Green Published, hybrid			2022-12-27	WOS:000261469100004
J	Dehring, DAK; Adler, AS; Hosseini, A; Hicke, L				Dehring, Deborah A. Klos; Adler, Adam S.; Hosseini, Ava; Hicke, Linda			A C-terminal Sequence in the Guanine Nucleotide Exchange Factor Sec7 Mediates Golgi Association and Interaction with the Rsp5 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR-1; MEMBRANE-PROTEINS; FUNCTIONAL DIVERSITY; DIRECT BINDING; NEDD4 FAMILY; YEAST; DOMAIN; TRANSPORT; ARF; RECEPTOR	Arf GTPases control vesicle formation from different intracellular membranes and are regulated by Arf guanine nucleotide exchange factors (GEFs). Outside of their conserved catalytic domains, known as Sec7 domains, little is known about Arf GEFs. Rsp5 is a yeast ubiquitin ligase that regulates numerous membrane trafficking events and carries a C2 domain that is specifically required for trans-Golgi network to vacuole transport. In a screen for proteins that interact with the Rsp5 C2 domain we identified Sec7, the GEF that acts on Golgi-associated Arfs. The Rsp5-Sec7 interaction is direct, occurs in vivo, and is conserved among mammalian Rsp5 and Sec7 homologues. A 50-amino acid region near the Sec7 C terminus is required for Rsp5 binding and for normal Sec7 localization. Binding of Sec7 to Rsp5 is dependent on the presence of the phosphoinositide 3-kinase Vps34, suggesting that phosphatidylinositol 3-phosphate (PI(3) P) plays a role in regulating this interaction. Overexpression of Sec7 significantly suppresses the growth and sorting defects of an rsp5 C2 domain point mutant. These observations identify a new functional region within the Sec7/BIG family of Arf GEFs that is required for trans-Golgi network localization.	[Dehring, Deborah A. Klos; Adler, Adam S.; Hosseini, Ava; Hicke, Linda] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Hicke, L (corresponding author), Hogan Hall 2-100,2205 Tech Dr, Evanston, IL 60208 USA.	l-hicke@northwestern.edu		Adler, Adam/0000-0001-9301-0037	National Institutes of Health [DK53257, DK61299]; Training Grant [T32GM08061]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061299, R01DK053257, R56DK061299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53257 and DK61299 ( to L. H.) and Training Grant T32GM08061 ( to D. A. K. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Deitz SB, 2000, TRAFFIC, V1, P172, DOI 10.1034/j.1600-0854.2000.010209.x; Demmel L, 2008, MOL BIOL CELL, V19, P1991, DOI 10.1091/mbc.E06-10-0937; Donaldson JG, 2005, BIOCHEM SOC T, V33, P1276, DOI 10.1042/BST0331276; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; FRANZUSOFF A, 1992, NATURE, V355, P173, DOI 10.1038/355173a0; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; James P, 1996, GENETICS, V144, P1425; Jones S, 1999, GENETICS, V152, P1543; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Seron K, 1998, MOL BIOL CELL, V9, P2873, DOI 10.1091/mbc.9.10.2873; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Stack JH, 1993, CURR OPIN CELL BIOL, V5, P641, DOI 10.1016/0955-0674(93)90134-C; STACK JH, 1994, J BIOL CHEM, V269, P31552; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Watson H, 2007, MOL BIOL CELL, V18, P1781, DOI 10.1091/mbc.E06-10-0887; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wolf JR, 1996, BIOCHEM BIOPH RES CO, V224, P126, DOI 10.1006/bbrc.1996.0995; Xu KF, 2005, P NATL ACAD SCI USA, V102, P2784, DOI 10.1073/pnas.0409871102; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	80	10	10	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34188	34196		10.1074/jbc.M806023200	http://dx.doi.org/10.1074/jbc.M806023200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18832381	Green Published, hybrid			2022-12-27	WOS:000261277700047
J	Moon, SH; Jenkins, CM; Mancuso, DJ; Turk, J; Gross, RW				Moon, Sung Ho; Jenkins, Christopher M.; Mancuso, David J.; Turk, John; Gross, Richard W.			Smooth Muscle Cell Arachidonic Acid Release, Migration, and Proliferation Are Markedly Attenuated in Mice Null for Calcium-independent Phospholipase A(2)beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED DISCRIMINATION; PROTEIN-COUPLED RECEPTORS; CYTOSOLIC PHOSPHOLIPASE; NITRIC-OXIDE; SUICIDE INHIBITION; ALPHA-CHYMOTRYPSIN; HALOENOL LACTONES; EXPRESS GROUP; IDENTIFICATION; ACTIVATION	Pharmacologic evidence suggests that the lipid products generated by one or more calcium-independent phospholipases A(2) (iPLA(2)s) participate in the regulation of vascular tone through smooth muscle cell (SMC) Ca2+ signaling and the release of arachidonic acid. However, the recent identification of new members of the iPLA(2) family, each inhibitable by (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one, has rendered definitive identification of the specific enzyme(s) mediating these processes difficult. Accordingly, we used iPLA(2)beta(-/-) mice to demonstrate that iPLA(2)beta is responsible for the majority of thapsigargin and ionophore (A23187)-induced arachidonic acid release from SMCs. Both thapsigargin and A23187 stimulated robust [H-3] arachidonate (AA) release from wild-type aortic SMCs that was dramatically attenuated in iPLA(2)beta(-/-) mice (>80% reduction at 5 min; p < 0.01). Moreover, iPLA(2)beta(-/-) mice displayed defects in SMC Ca2+ homeostasis and decreased SMC migration and proliferation in a model of vascular injury. Ca2+-store depletion resulted in the rapid entry of external Ca2+ into wild-type aortic SMCs that was significantly slower in iPLA(2)beta-null cells (p < 0.01). Furthermore, SMCs from iPLA(2)beta-null mesenteric arterial explants demonstrated decreased proliferation and migration. The defects in migration and proliferation in iPLA(2)beta-null SMCs were restored by 2 mu M AA. Remarkably, the cyclooxygenase-2-specific inhibitor, NS-398, prevented AA-induced rescue of SMC migration and proliferation in iPLA(2)beta-/- mice. Moreover, PGE(2) alone rescued proliferation and migration in iPLA(2)beta-/- mice. We conclude that iPLA(2)beta is an important mediator of AA release and prostaglandin E-2 production in SMCs, modulating vascular tone, cellular signaling, proliferation, and migration.	[Moon, Sung Ho; Jenkins, Christopher M.; Mancuso, David J.; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Turk, John] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Moon, Sung Ho; Jenkins, Christopher M.; Mancuso, David J.; Turk, John; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278-10, 2RO1HL41250-13]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041250, P01HL057278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278-10 and 2RO1HL41250-13. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALONSO F, 1986, BIOCHIM BIOPHYS ACTA, V878, P273, DOI 10.1016/0005-2760(86)90156-6; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Benimetskaya L, 1997, NAT MED, V3, P414, DOI 10.1038/nm0497-414; CHAKRAVARTY PK, 1982, J BIOL CHEM, V257, P610; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; DUBEY RK, 1994, CELL TISSUE RES, V275, P133, DOI 10.1007/BF00305381; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; FINK KL, 1984, CIRC RES, V55, P585, DOI 10.1161/01.RES.55.5.585; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HAZEN SL, 1991, J BIOL CHEM, V266, P14526; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Herbert SP, 2006, J BIOL CHEM, V281, P35709, DOI 10.1074/jbc.M600699200; HETNER Y, 2000, J BIOL CHEM, V275, P37542; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Hu ZW, 2002, J PHARMACOL EXP THER, V303, P563, DOI 10.1124/jpet.102.037705; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jenkins CM, 2006, J BIOL CHEM, V281, P15615, DOI 10.1074/jbc.M511623200; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kaneyuki U, 2007, VASC PHARMACOL, V46, P286, DOI 10.1016/j.vph.2006.11.002; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Kim J, 2006, CELL SIGNAL, V18, P1695, DOI 10.1016/j.cellsig.2006.01.009; Kita Y, 2006, BBA-MOL CELL BIOL L, V1761, P1317, DOI 10.1016/j.bbalip.2006.08.001; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; LEPPERT D, 1995, FASEB J, V9, P1473, DOI 10.1096/fasebj.9.14.7589989; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; LOEB LA, 1986, J BIOL CHEM, V261, P467; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Nieves D, 2007, APOPTOSIS, V12, P1979, DOI 10.1007/s10495-007-0123-3; PETERSGOLDEN M, 1993, BIOCHEM BIOPH RES CO, V196, P147, DOI 10.1006/bbrc.1993.2227; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schneider G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-164; Seegers HC, 2002, J PHARMACOL EXP THER, V302, P918, DOI 10.1124/jpet.302.3.918; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; STEIN CA, 1995, NAT MED, V1, P1119, DOI 10.1038/nm1195-1119; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thompson MD, 2006, MOL DIAGN THER, V10, P353, DOI 10.1007/BF03256212; Tomura H, 2005, CELL SIGNAL, V17, P1466, DOI 10.1016/j.cellsig.2005.06.002; Ulven T, 2006, CURR TOP MED CHEM, V6, P1427, DOI 10.2174/15680266106061427; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Wolf MJ, 1996, J BIOL CHEM, V271, P20989, DOI 10.1074/jbc.271.35.20989; Wolf MJ, 1996, J BIOL CHEM, V271, P30879, DOI 10.1074/jbc.271.48.30879; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; WOLF RA, 1985, J BIOL CHEM, V260, P7295; Wu WT, 2005, ENDOCRINOLOGY, V146, P3387, DOI 10.1210/en.2004-1654; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yedgar S, 2006, BBA-MOL CELL BIOL L, V1761, P1373, DOI 10.1016/j.bbalip.2006.08.003; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Young W, 2000, CIRC RES, V86, P906, DOI 10.1161/01.RES.86.8.906; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	70	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33975	33987		10.1074/jbc.M805817200	http://dx.doi.org/10.1074/jbc.M805817200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18927078	Green Published, hybrid			2022-12-27	WOS:000261277700024
J	Perez-Monjaras, A; Cervantes-Roldan, R; Meneses-Morales, I; Gravel, RA; Reyes-Carmona, S; Solorzano-Vargas, S; Gonzalez-Noriega, A; Leon-Del-Rio, A				Perez-Monjaras, Anylu; Cervantes-Roldan, Rafael; Meneses-Morales, Ivan; Gravel, Roy A.; Reyes-Carmona, Sandra; Solorzano-Vargas, Sergio; Gonzalez-Noriega, Alfonso; Leon-Del-Rio, Alfonso			Impaired Biotinidase Activity Disrupts Holocarboxylase Synthetase Expression in Late Onset Multiple Carboxylase Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPIONYL-COA CARBOXYLASE; BASAL GANGLIA DISEASE; MESSENGER-RNA; RAT-LIVER; PYRUVATE-CARBOXYLASE; ESCHERICHIA-COLI; BRAIN; BIOTINYLATION; CELLS; METABOLISM	Biotinidase catalyzes the hydrolysis of the vitamin biotin from proteolytically degraded biotin-dependent carboxylases. This key reaction makes the biotin available for reutilization in the biotinylation of newly synthesized apocarboxylases. This latter reaction is catalyzed by holocarboxylase synthetase (HCS) via synthesis of 5'-biotinyl-AMP (B-AMP) from biotin and ATP, followed by transfer of the biotin to a specific lysine residue of the apocarboxylase substrate. In addition to carboxylase activation, B-AMP is also a key regulatory molecule in the transcription of genes encoding apocarboxylases and HCS itself. In humans, genetic deficiency of HCS or biotinidase results in the life-threatening disorder biotin-responsive multiple carboxylase deficiency, characterized by a reduction in the activities of all biotin-dependent carboxylases. Although the clinical manifestations of both disorders are similar, they differ in some unique neurological characteristics whose origin is not fully understood. In this study, we show that biotinidase deficiency not only reduces net carboxylase biotinylation, but it also impairs the expression of carboxylases and HCS by interfering with the B-AMP-dependent mechanism of transcription control. We propose that biotinidase-deficient patients may develop a secondary HCS deficiency disrupting the altruistic tissue-specific biotin allocation mechanism that protects brain metabolism during biotin starvation.	[Perez-Monjaras, Anylu; Cervantes-Roldan, Rafael; Meneses-Morales, Ivan; Reyes-Carmona, Sandra; Solorzano-Vargas, Sergio; Leon-Del-Rio, Alfonso] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico; [Perez-Monjaras, Anylu; Cervantes-Roldan, Rafael; Meneses-Morales, Ivan; Reyes-Carmona, Sandra; Solorzano-Vargas, Sergio; Leon-Del-Rio, Alfonso] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Mol Biol & Biotecnol, Mexico City 04510, DF, Mexico; [Gravel, Roy A.; Gonzalez-Noriega, Alfonso] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Calgary	Leon-Del-Rio, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Ciudad Univ, Mexico City 04510, DF, Mexico.	leon@biomedicas.unam.mx	Solorzano-Vargas, R Sergio/D-4869-2016; Leon-Del-Rio, Alfonso/L-5932-2019; Meneses-Morales, Ivan/F-6765-2018	Meneses-Morales, Ivan/0000-0002-3146-1374; Leon-Del-Rio, Alfonso/0000-0001-7683-5109; Reyes, Sandra/0000-0002-1015-5079; Perez Monjaras, Anylu del Carmen/0000-0002-4955-9652	Consejo Nacional de Ciencia y Tecnologia [48862]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN220206-3]; Universidad Nacional Autonoma de Mexico	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by Consejo Nacional de Ciencia y Tecnologia Grant 48862 and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Grant IN220206-3 and funds from the Universidad Nacional Autonoma de Mexico. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhisivam B, 2007, INDIAN PEDIATR, V44, P228; BAUMGARTNER ER, 1989, PEDIATR RES, V26, P260, DOI 10.1203/00006450-198909000-00021; BHAGAVAN HN, 1970, J NEUROCHEM, V17, P289, DOI 10.1111/j.1471-4159.1970.tb02213.x; Borboni P, 1996, ACTA DIABETOL, V33, P154; BURRI BJ, 1985, AM J HUM GENET, V37, P326; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; CHAUHAN J, 1991, J BIOL CHEM, V266, P10035; CHIANG GS, 1974, P SOC EXP BIOL MED, V146, P21, DOI 10.3181/00379727-146-38035; COLE H, 1994, J BIOL CHEM, V269, P6566; COLLINS JC, 1988, J BIOL CHEM, V263, P11280; DAKSHINAMURTI K, 1970, CAN J BIOCHEM CELL B, V48, P493, DOI 10.1139/o70-079; De la Vega LA, 2000, AM J PHYSIOL-CELL PH, V279, pC2037, DOI 10.1152/ajpcell.2000.279.6.C2037; DEODHAR AD, 1970, LIFE SCI 2-BIOCH GEN, V9, P581, DOI 10.1016/0024-3205(70)90166-9; Dupuis L, 1996, HUM MOL GENET, V5, P1011, DOI 10.1093/hmg/5.7.1011; Dupuis L, 1999, MOL GENET METAB, V66, P80, DOI 10.1006/mgme.1998.2785; Hassel B, 2000, MOL NEUROBIOL, V22, P21, DOI 10.1385/MN:22:1-3:021; Heller AJ, 2002, HEARING RES, V173, P62, DOI 10.1016/S0378-5955(02)00609-3; HERON B, 1993, ARCH FR PEDIATR, V50, P875; Knight HC, 1998, MAMM GENOME, V9, P327, DOI 10.1007/s003359900760; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; LO W, 1991, J NUTR SCI VITAMINOL, V37, P567, DOI 10.3177/jnsv.37.567; Maeda Y, 1996, J NUTR, V126, P61, DOI 10.1093/jn/126.1.61; Narang MA, 2004, HUM MOL GENET, V13, P15, DOI 10.1093/hmg/ddh006; Norrgard K J, 1998, Hum Mutat, V11, P410, DOI 10.1002/(SICI)1098-1004(1998)11:5<410::AID-HUMU10>3.3.CO;2-#; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; Pacheco-Alvarez D, 2005, MOL GENET METAB, V85, P301, DOI 10.1016/j.ymgme.2005.04.001; Pacheco-Alvarez D, 2004, J BIOL CHEM, V279, P52312, DOI 10.1074/jbc.M407056200; Pacheco-Alvarez D, 2002, ARCH MED RES, V33, P439, DOI 10.1016/S0188-4409(02)00399-5; PISPA J, 1965, ANN MED EXP BIOL F S, V43, P1; Rodriguez-Melendez R, 2001, J NUTR, V131, P1909, DOI 10.1093/jn/131.7.1909; Rodriguez-Melendez R, 1999, MOL GENET METAB, V66, P16, DOI 10.1006/mgme.1998.2777; SANDER JE, 1982, NEUROLOGY, V32, P878, DOI 10.1212/WNL.32.8.878; SCHULZ PE, 1988, NEUROLOGY, V38, P1326, DOI 10.1212/WNL.38.8.1326; Solorzano-Vargas RS, 2002, P NATL ACAD SCI USA, V99, P5325, DOI 10.1073/pnas.082097699; Straussberg R, 2002, NEUROLOGY, V59, P983, DOI 10.1212/WNL.59.7.983; Subramanian VS, 2006, AM J PHYSIOL-CELL PH, V291, pC851, DOI 10.1152/ajpcell.00105.2006; SUCHY SF, 1985, NEUROLOGY, V35, P1510, DOI 10.1212/WNL.35.10.1510; WEINER D, 1991, BIOCHEM MED METAB B, V46, P344, DOI 10.1016/0885-4505(91)90083-W; WOLF B, 1985, J INHERIT METAB DIS, V8, P53, DOI 10.1007/BF01800660; Wolf B., 2001, METABOLIC MOL BASES, V3935, P3962, DOI DOI 10.1097/MAO.0000000000002044; Wolf Barry, 2005, Hum Mutat, V25, P413, DOI 10.1002/humu.9329	42	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34150	34158		10.1074/jbc.M806985200	http://dx.doi.org/10.1074/jbc.M806985200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845537	hybrid, Green Published			2022-12-27	WOS:000261277700043
J	Tagliabracci, VS; Girard, JM; Segvich, D; Meyer, C; Turnbull, J; Zhao, XC; Minassian, BA; DePaoli-Roach, AA; Roach, PJ				Tagliabracci, Vincent S.; Girard, Jean Marie; Segvich, Dyann; Meyer, Catalina; Turnbull, Julie; Zhao, Xiaochu; Minassian, Berge A.; DePaoli-Roach, Anna A.; Roach, Peter J.			Abnormal Metabolism of Glycogen Phosphate as a Cause for Lafora Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; DUAL-SPECIFICITY PHOSPHATASE; PROTEIN PHOSPHATASE-1; CORPORA-AMYLACEA; MUSCLE GLYCOGEN; PHOSPHORYLATION; SYNTHASE; ACCUMULATION; STARCH; MALIN	Lafora disease is a progressive myoclonus epilepsy with onset in the teenage years followed by neurodegeneration and death within 10 years. A characteristic is the widespread formation of poorly branched, insoluble glycogen-like polymers (polyglucosan) known as Lafora bodies, which accumulate in neurons, muscle, liver, and other tissues. Approximately half of the cases of Lafora disease result from mutations in the EPM2A gene, which encodes laforin, a member of the dual specificity protein phosphatase family that is able to release the small amount of covalent phosphate normally present in glycogen. In studies of Epm2a(-/-) mice that lack laforin, we observed a progressive change in the properties and structure of glycogen that paralleled the formation of Lafora bodies. At three months, glycogen metabolism remained essentially normal, even though the phosphorylation of glycogen has increased 4-fold and causes altered physical properties of the polysaccharide. By 9 months, the glycogen has overaccumulated by 3-fold, has become somewhat more phosphorylated, but, more notably, is now poorly branched, is insoluble in water, and has acquired an abnormal morphology visible by electron microscopy. These glycogen molecules have a tendency to aggregate and can be recovered in the pellet after low speed centrifugation of tissue extracts. The aggregation requires the phosphorylation of glycogen. The aggregrated glycogen sequesters glycogen synthase but not other glycogen metabolizing enzymes. We propose that laforin functions to suppress excessive glycogen phosphorylation and is an essential component of the metabolism of normally structured glycogen.	[Tagliabracci, Vincent S.; Segvich, Dyann; Meyer, Catalina; DePaoli-Roach, Anna A.; Roach, Peter J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Girard, Jean Marie; Turnbull, Julie; Zhao, Xiaochu; Minassian, Berge A.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Indiana University System; Indiana University-Purdue University Indianapolis; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Roach, PJ (corresponding author), 635 Barnhill Dr,MS405A, Indianapolis, IN 46202 USA.	proach@iupui.edu			National Institutes of Health [DK27221]; Canadian Institutes for Health Research; Canada Research Chair in Pediatric Neurogenetics; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027221, R01DK027221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Pediatric Neurogenetics(Canada Research Chairs); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK27221 (to P. J. R.). This work was also supported by funds from the Canadian Institutes for Health Research (to J. M. G. and B. A. M.), a Canada Research Chair in Pediatric Neurogenetics (to B. A. M.), and an American Heart Association Predoctoral fellowship (to V. S. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aschenbach WG, 2001, J BIOL CHEM, V276, P39959, DOI 10.1074/jbc.M105518200; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Bergmeyer H. V., 1974, METHOD ENZYMAT AN, V2, P1196; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Chan Elayne M, 2005, Adv Neurol, V95, P47; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103; DROCHMANS P, 1962, J ULTRA MOL STRUCT R, V6, P141, DOI 10.1016/S0022-5320(62)90050-3; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; FONTANA JD, 1980, FEBS LETT, V109, P85, DOI 10.1016/0014-5793(80)81317-2; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; GUNJASMITH Z, 1970, FEBS LETT, V12, P101, DOI 10.1016/0014-5793(70)80573-7; Ianzano Leonarda, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9376; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; LIU R, 2008, MOL CELL BI IN PRESS; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; LOMAKO J, 1994, BIOFACTORS, V4, P167; Lomako J, 2004, BBA-GEN SUBJECTS, V1673, P45, DOI 10.1016/j.bbagen.2004.03.017; LOMAKO J, 1993, FEBS LETT, V329, P263, DOI 10.1016/0014-5793(93)80234-L; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Nakajima Hiromu, 2002, Current Molecular Medicine (Hilversum), V2, P197, DOI 10.2174/1566524024605734; Pederson BA, 2003, BIOCHEM BIOPH RES CO, V305, P826, DOI 10.1016/S0006-291X(03)00862-3; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; ROACH PJ, 1977, MOL CELL BIOCHEM, V15, P179, DOI 10.1007/BF01734108; Roach PJ, 1997, PROG NUCLEIC ACID RE, V57, P289, DOI 10.1016/S0079-6603(08)60284-6; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; SKURAT AV, 1993, J BIOL CHEM, V268, P14701; SMYTHE C, 1991, EUR J BIOCHEM, V200, P625, DOI 10.1111/j.1432-1033.1991.tb16225.x; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002	51	129	130	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33816	33825		10.1074/jbc.M807428200	http://dx.doi.org/10.1074/jbc.M807428200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18852261	hybrid, Green Published			2022-12-27	WOS:000261277700005
J	Becerra, SP; Perez-Mediavilla, LA; Weldon, JE; Locatelli-Hoops, S; Senanayake, P; Notari, L; Notario, V; Hollyfield, JG				Becerra, S. Patricia; Perez-Mediavilla, L. Alberto; Weldon, John E.; Locatelli-Hoops, Silvia; Senanayake, Preenie; Notari, Luigi; Notario, Vicente; Hollyfield, Joe G.			Pigment Epithelium-derived Factor Binds to Hyaluronan MAPPING OF A HYALURONAN BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERPHOTORECEPTOR MATRIX; FACTOR PEDF; TUMOR-GROWTH; RETINOBLASTOMA CELLS; EXTRACELLULAR-MATRIX; CHONDROITIN SULFATE; GENE; ANGIOGENESIS; GLYCOSAMINOGLYCANS; DIFFERENTIATION	Pigment epithelium-derived factor (PEDF) is a multifunctional serpin with antitumorigenic, antimetastatic, and differentiating activities. PEDF is found within tissues rich in the glycosaminoglycan hyaluronan (HA), and its amino acid sequence contains putative HA-binding motifs. We show that PEDF coprecipitation with glycosaminoglycans in media conditioned by human retinoblastoma Y-79 cells decreased after pretreatments with hyaluronidase, implying an association between HA and PEDF. Direct binding of human recombinant PEDF to highly purified HA was demonstrated by coprecipitation in the presence of cetylpyridinium chloride. Binding of PEDF to HA was concentration-dependent and saturable. The PEDF-HA interactions were sensitive to increasing NaCl concentrations, indicating an ionic nature of these interactions and having affinity higher than PEDF-heparin. Competition assays showed that PEDF can bind heparin and HA simultaneously. PEDF chemically modified with fluorescein retained the capacity for interacting with HA but lacked heparin affinity, suggesting one or more distinct HA-binding regions on PEDF. The HA-binding region was examined by site-directed mutagenesis. Single-point and cumulative alterations at basic residues within the putative HA-binding motif K189A/K191A/R194A/K197A drastically reduced the HA-binding activity without affecting heparin-or collagen I binding of PEDF. Cumulative alterations at sites critical for heparin binding (K146A/K147A/R149A) decreased HA affinity but not collagen I binding. Thus these clusters of basic residues (BXBXXBXXB and BX(3)AB(2)XB motifs) in PEDF are functional regions for binding HA. In the spatial PEDF structure they are located in distinct areas away from the collagen-binding site. The HA-binding activity of PEDF may contribute to deposition in the extracellular matrix and to its reported antitumor/antimetastatic effects.	[Becerra, S. Patricia; Perez-Mediavilla, L. Alberto; Weldon, John E.; Locatelli-Hoops, Silvia; Notari, Luigi] NEI, NIH, Bethesda, MD 20892 USA; [Perez-Mediavilla, L. Alberto] Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Senanayake, Preenie; Hollyfield, Joe G.] Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44195 USA; [Notario, Vicente] Georgetown Univ, Med Ctr, Dept Radiat Med, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Navarra; Case Western Reserve University; Cleveland Clinic Foundation; Georgetown University	Becerra, SP (corresponding author), NEI, NIH, Bldg 7,Rm 304,7 Mem Dr, Bethesda, MD 20892 USA.	becerrap@nei.nih.gov	/AFP-0764-2022; /AAB-6461-2022; Perez-Mediavilla, Alberto/A-5246-2011	Perez-Mediavilla, Alberto/0000-0003-1926-0972; Weldon, John/0000-0002-6516-9064	National Institutes of Health NEI Intramural Research Program; Educational and Cultural Department of the "Gobierno de Navarra," Spain; Foundation for Fighting Blindness; Research to Prevent Blindness to the Department of Ophthalmology; Cleveland Clinic Lerner College of Medicine;  [EY14240-1];  [EY 15638];  [RO1 CA64472]; NATIONAL CANCER INSTITUTE [R01CA064472] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000306, R24EY015638, R01EY014240, R56EY014240] Funding Source: NIH RePORTER	National Institutes of Health NEI Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Educational and Cultural Department of the "Gobierno de Navarra," Spain; Foundation for Fighting Blindness; Research to Prevent Blindness to the Department of Ophthalmology(Research to Prevent Blindness (RPB)); Cleveland Clinic Lerner College of Medicine; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health NEI Intramural Research Program. This work was also supported by the Educational and Cultural Department of the "Gobierno de Navarra," Spain (to A. P.-M.); by Grants EY14240-1 and EY 15638, Foundation for Fighting Blindness, and a Challenge Grant from Research to Prevent Blindness to the Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine (to J. G. H.); and by Grant RO1 CA64472 (to V. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acharya S, 1998, J BIOL CHEM, V273, P31599, DOI 10.1074/jbc.273.47.31599; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Alberdi Elena M, 2003, BMC Biochem, V4, P1, DOI 10.1186/1471-2091-4-1; Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Chen QY, 2004, J BIOL CHEM, V279, P23142, DOI 10.1074/jbc.M401584200; Crawford SE, 2001, J CELL SCI, V114, P4421; des Senanayake P, 2001, J CELL SCI, V114, P199; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Fernandez-Garcia NI, 2007, J MOL MED-JMM, V85, P15, DOI 10.1007/s00109-006-0111; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Goodstone NJ, 1998, ARCH BIOCHEM BIOPHYS, V350, P26, DOI 10.1006/abbi.1997.0472; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; GUO YJ, 1994, CANCER RES, V54, P422; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Hollyfield JG, 1997, EXP EYE RES, V65, P603, DOI 10.1006/exer.1997.0369; Hollyfield JG, 1998, EXP EYE RES, V66, P241, DOI 10.1006/exer.1997.0422; Hosomichi J, 2005, BIOCHEM BIOPH RES CO, V335, P756, DOI 10.1016/j.bbrc.2005.07.140; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Knudson W, 1996, AM J PATHOL, V148, P1721; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; McDonald J, 2002, J BIOL CHEM, V277, P4575, DOI 10.1074/jbc.R100064200; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Mohapatra S, 1996, J EXP MED, V183, P1663, DOI 10.1084/jem.183.4.1663; Normand G, 1998, GLYCOBIOLOGY, V8, P1227, DOI 10.1093/glycob/8.12.1227; Ortego J, 1996, INVEST OPHTH VIS SCI, V37, P2759; Perez-Mediavilla LA, 1998, BBA-GENE STRUCT EXPR, V1398, P203, DOI 10.1016/S0167-4781(98)00055-4; SEIGEL GM, 1994, GROWTH FACTORS, V10, P289, DOI 10.3109/08977199409010995; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stratikos E, 1996, PROTEIN SCI, V5, P2575, DOI 10.1002/pro.5560051220; Streck CJ, 2005, J PEDIATR SURG, V40, P236, DOI 10.1016/j.jpedsurg.2004.09.049; SY MS, 1992, J EXP MED, V176, P623, DOI 10.1084/jem.176.2.623; Tombran-Tink J, 2003, NAT REV NEUROSCI, V4, P628, DOI 10.1038/nrn1176; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Valnickova Z, 2007, J BIOL CHEM, V282, P6661, DOI 10.1074/jbc.M610471200; Wang L, 2003, MOL THER, V8, P72, DOI 10.1016/S1525-0016(03)00128-X; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Wu YQ, 1996, INVEST OPHTH VIS SCI, V37, P1984; WU YQ, 1995, PROTEIN EXPRES PURIF, V6, P447, DOI 10.1006/prep.1995.1060; Xu XM, 2003, CANCER RES, V63, P5685; Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558	50	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33310	33320		10.1074/jbc.M801287200	http://dx.doi.org/10.1074/jbc.M801287200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18805795	hybrid, Green Published			2022-12-27	WOS:000261183700035
J	O'Brien, K; Matlin, AJ; Lowell, AM; Moore, MJ				O'Brien, Kristine; Matlin, Arianne J.; Lowell, April M.; Moore, Melissa J.			The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL INTERACTION; REPORTER ASSAY; TRI-SNRNP; SPLICEOSOME; COMPLEX; EXPRESSION; PROTEIN; TARGET	Membrane-permeable compounds that reversibly inhibit a particular step in gene expression are highly useful tools for cell biological and biochemical/structural studies. In comparison with other gene expression steps where multiple small molecule effectors are available, very few compounds have been described that act as general inhibitors of pre-mRNA splicing. Here we report construction and validation of a set of mammalian cell lines suitable for the identification of small molecule inhibitors of pre-mRNA splicing. Using these cell lines, we identified the natural product isoginkgetin as a general inhibitor of both the major and minor spliceosomes. Isoginkgetin inhibits splicing both in vivo and in vitro at similar micromolar concentrations. It appears to do so by preventing stable recruitment of the U4/U5/U6 tri-small nuclear ribonucleoprotein, resulting in accumulation of the prespliceosomal A complex. Like two other recently reported general pre-mRNA splicing inhibitors, isoginkgetin has been previously described as an anti-tumor agent. Our results suggest that splicing inhibition is the mechanistic basis of the anti-tumor activity of isoginkgetin. Thus, pre-mRNA splicing inhibitors may represent a novel avenue for development of new anti-cancer agents.	[O'Brien, Kristine; Matlin, Arianne J.; Moore, Melissa J.] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; [O'Brien, Kristine; Matlin, Arianne J.; Lowell, April M.; Moore, Melissa J.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [O'Brien, Kristine; Moore, Melissa J.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01655 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; University of Massachusetts System; University of Massachusetts Worcester	Moore, MJ (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, HHMI, LRB 825,364 Plantat St, Worcester, MA 01605 USA.	Melissa.Moore@umassmed.edu			National Institutes of Health [R01-GM35007]; NCI [N01-CO-12400]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM35007 (to M.J.M.) and the National Institutes of Health, NCI, Initiative for Chemical Genetics, under Contract N01-CO-12400. This work was performed with the assistance of the Chemical Biology Platform of the Broad Institute of Harvard and MIT. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABMAYR SM, 1988, GENE DEV, V2, P542, DOI 10.1101/gad.2.5.542; Albert BJ, 2007, J AM CHEM SOC, V129, P2648, DOI 10.1021/ja067870m; Bakkour N, 2007, PLOS PATHOG, V3, P1530, DOI 10.1371/journal.ppat.0030159; BRODY E, 1985, SCIENCE, V228, P963, DOI 10.1126/science.3890181; Burns CG, 2002, MOL CELL BIOL, V22, P801, DOI 10.1128/MCB.22.3.801-815.2002; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; Jurica MS, 2008, NAT CHEM BIOL, V4, P3, DOI 10.1038/nchembio0108-3; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kang SS, 2005, BIOORG MED CHEM LETT, V15, P3588, DOI 10.1016/j.bmcl.2005.05.078; Kim HP, 2008, ARCH PHARM RES, V31, P265, DOI 10.1007/s12272-001-1151-3; Kim SJ, 1997, SKIN PHARMACOL, V10, P200, DOI 10.1159/000211505; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; LEE SJ, 1995, LIFE SCI, V57, P551, DOI 10.1016/0024-3205(95)00305-P; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; LESSER CF, 1993, GENETICS, V133, P851; Levinson N, 2006, RNA, V12, P925, DOI 10.1261/rna.8306; Mathew R, 2008, NAT STRUCT MOL BIOL, V15, P435, DOI 10.1038/nsmb.1415; Matlin AJ, 2007, ADV EXP MED BIOL, V623, P14, DOI 10.1007/978-0-387-77374-2_2; Nakajima H, 1996, J ANTIBIOT, V49, P1204; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Reichert V, 2000, NUCLEIC ACIDS RES, V28, P416, DOI 10.1093/nar/28.2.416; Roberts GC, 1996, EMBO J, V15, P6301, DOI 10.1002/j.1460-2075.1996.tb01020.x; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; STUTZ F, 1994, EMBO J, V13, P4096, DOI 10.1002/j.1460-2075.1994.tb06727.x; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Wang Q, 2005, MOL CELL BIOL, V25, P10745, DOI 10.1128/MCB.25.24.10745-10754.2005; Yoon SO, 2006, MOL CANCER THER, V5, P2666, DOI 10.1158/1535-7163.MCT-06-0321	38	130	132	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33147	33154		10.1074/jbc.M805556200	http://dx.doi.org/10.1074/jbc.M805556200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18826947	Green Published, hybrid			2022-12-27	WOS:000261183700016
J	Vaillant, DC; Copeland, SJ; Davis, C; Thurston, SF; Abdennur, N; Copeland, JW				Vaillant, Dominique C.; Copeland, Sarah J.; Davis, Chris; Thurston, Susan F.; Abdennur, Nezar; Copeland, John W.			Interaction of the N- and C-terminal Autoregulatory Domains of FRL2 Does Not Inhibit FRL2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; FORMIN HOMOLOGY PROTEIN; ACTIN DYNAMICS; FISSION YEAST; CELL-DIVISION; SRF ACTIVITY; FH2 DOMAIN; PROFILIN; POLYMERIZATION; MDIA1	Formin homology proteins are a highly conserved family of cytoskeletal remodeling proteins best known for their ability to induce the formation of long unbranched actin filaments. They accomplish this by nucleating the de novo polymerization of F-actin and also by acting as F-actin barbed end "leaky cappers" that allow filament elongation while antagonizing the function of capping proteins. More recently, it has been reported that the FH2 domains of FRL1 and mDia2 and the plant formin AFH1 are able to bind and bundle actin filaments via distinct mechanisms. We find that like FRL1, FRL2 and FRL3 are also able to bind and bundle actin filaments. In the case of FRL3, this activity is dependent upon a proximal DAD/WH2-like domain that is found C-terminal to the FH2 domain. In addition, we show that, like other Diaphanous-related formins, FRL3 activity is subject to autoregulation mediated by the interaction between its N-terminal DID and C-terminal DAD. In contrast, the DID and DAD of FRL2 also interact in vivo and in vitro but without inhibiting FRL2 activity. These data suggest that current models describing DID/DAD autoregulation via steric hindrance of FH2 activity must be revised. Finally, unlike other formins, we find that the FH2 and N-terminal dimerization domains of FRL2 and FRL3 are able to form hetero-oligomers.	[Vaillant, Dominique C.; Copeland, Sarah J.; Davis, Chris; Thurston, Susan F.; Abdennur, Nezar; Copeland, John W.] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Copeland, JW (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Fac Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	john.copeland@uottawa.ca		Abdennur, Nezar/0000-0001-5814-0864	Heart and Stroke Foundation of Ontario [NA 5762]; Canadian Institutes of Health [68816]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	Supported by Heart and Stroke Foundation of Ontario Grant NA 5762 and Canadian Institutes of Health Research Grant 68816.	Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Katoh M, 2003, INT J ONCOL, V22, P1161; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Loomis PA, 2006, J CELL SCI, V119, P1655, DOI 10.1242/jcs.02869; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3	35	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33750	33762		10.1074/jbc.M803156200	http://dx.doi.org/10.1074/jbc.M803156200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18835814	Green Published, hybrid			2022-12-27	WOS:000261183700081
J	Bravo, R; Arimon, M; Valle-Delgado, JJ; Garcia, R; Durany, N; Castel, S; Cruz, M; Ventura, S; Fernandez-Busquets, X				Bravo, Ramona; Arimon, Muriel; Valle-Delgado, Juan Jose; Garcia, Raquel; Durany, Nuria; Castel, Susanna; Cruz, Montserrat; Ventura, Salvador; Fernandez-Busquets, Xavier			Sulfated Polysaccharides Promote the Assembly of Amyloid beta(1-42) Peptide into Stable Fibrils of Reduced Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; CHONDROITIN SULFATE; ALZHEIMERS-DISEASE; HEPARAN-SULFATE; LIPID-BILAYERS; BETA PEPTIDES; PROTEIN-TAU; CALCIUM; GLYCOSAMINOGLYCANS; PROTEOGLYCANS	The histopathological hallmarks of Alzheimer disease are the self-aggregation of the amyloid beta peptide (A beta) in extracellular amyloid fibrils and the formation of intraneuronal Tau filaments, but a convincing mechanism connecting both processes has yet to be provided. Here we show that the endogenous polysaccharide chondroitin sulfate B (CSB) promotes the formation of fibrillar structures of the 42-residue fragment, A beta(1-42). Atomic force microscopy visualization, thioflavin T fluorescence, CD measurements, and cell viability assays indicate that CSB-induced fibrils are highly stable entities with abundant beta-sheet structure that have little toxicity for neuroblastoma cells. We propose a wedged cylinder model for A beta(1-42) fibrils that is consistent with the majority of available data, it is an energetically favorable assembly that minimizes the exposure of hydrophobic areas, and it explains why fibrils do not grow in thickness. Fluorescence measurements of the effect of different A beta(1-42) species on Ca2+ homeostasis show that weakly structured nodular fibrils, but not CSB-induced smooth fibrils, trigger a rise in cytosolic Ca2+ that depends on the presence of both extracellular and intracellular stocks. In vitro assays indicate that such transient, local Ca2+ increases can have a direct effect in promoting the formation of Tau filaments similar to those isolated from Alzheimer disease brains.	[Fernandez-Busquets, Xavier] Univ Barcelona, Nanobioengn Grp, Biomol Interact Team, Inst Bioengn Catalonia, E-08028 Barcelona, Spain; Univ Barcelona, Nanosci & Nanotechnol Inst, E-08028 Barcelona, Spain; [Garcia, Raquel; Castel, Susanna; Cruz, Montserrat] Univ Barcelona, Scientif & Tech Serv, E-08028 Barcelona, Spain; [Durany, Nuria] Univ Int Catalunya, Fac Ciencies Salut, E-08195 Sant Cugat Del Valles, Spain; [Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; University of Barcelona; Universitat Internacional de Catalunya (UIC); Autonomous University of Barcelona; Autonomous University of Barcelona	Fernandez-Busquets, X (corresponding author), Univ Barcelona, Nanobioengn Grp, Biomol Interact Team, Inst Bioengn Catalonia, Barcelona Sci Pk,Baldiri Reixac 10, E-08028 Barcelona, Spain.	xfernandez_busquets@ub.edu	Ventura, Salvador/C-7021-2008; Fernàndez-Busquets, Xavier/K-1323-2014; Arimon, Muriel/I-4054-2015; Ventura, Salvador/AAY-3170-2021; Castel, Susana/D-4642-2014; Valle-Delgado, Juan Jose/H-8857-2013	Ventura, Salvador/0000-0002-9652-6351; Fernàndez-Busquets, Xavier/0000-0002-4622-9631; Arimon, Muriel/0000-0002-0894-3324; Ventura, Salvador/0000-0002-9652-6351; Castel, Susana/0000-0002-4551-8204; Valle-Delgado, Juan Jose/0000-0002-4808-1730	Generalitat de Catalunya, Spain [2005-SGR00037]; Ministerio de Ciencia e Innovacion (MCI), Spain [BIO2002-00128, BIO2005-01591, CSD2006-00012]; Juan de la Cierva Programme	Generalitat de Catalunya, Spain(Generalitat de Catalunya); Ministerio de Ciencia e Innovacion (MCI), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva Programme	This work was supported in part by the Generalitat de Catalunya, Spain (Grant 2005-SGR00037) and the Ministerio de Ciencia e Innovacion (MCI), Spain (Grants BIO2002-00128, BIO2005-01591, and CSD2006-00012), which included Fondo Europeo de Desarrollo Regional funds. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Juan de la Cierva Programme (MCI).	Adamec E, 2002, ACTA NEUROPATHOL, V104, P92, DOI 10.1007/s00401-002-0528-6; Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Cecchi C, 2005, J CELL SCI, V118, P3459, DOI 10.1242/jcs.02473; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Christensen RA, 2004, J BIOL CHEM, V279, P53524, DOI 10.1074/jbc.M408473200; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DeGroot J, 2004, CURR OPIN PHARMACOL, V4, P301, DOI 10.1016/j.coph.2004.01.007; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Garcia-Manyes S, 2005, BIOPHYS J, V89, P1812, DOI 10.1529/biophysj.105.064030; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Green JD, 2004, J MOL BIOL, V342, P877, DOI 10.1016/j.jmb.2004.07.052; GRUETTER R, 1992, P NATL ACAD SCI USA, V89, P1109, DOI 10.1073/pnas.89.3.1109; GUPTABANSAL R, 1995, J BIOL CHEM, V270, P18666, DOI 10.1074/jbc.270.31.18666; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Hirschfield GM, 2003, INT J BIOCHEM CELL B, V35, P1608, DOI 10.1016/S1357-2725(03)00169-9; Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8; Kawahara M, 2000, BRAIN RES BULL, V53, P389, DOI 10.1016/S0361-9230(00)00370-1; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin MCA, 2002, PEPTIDES, V23, P1215, DOI 10.1016/S0196-9781(02)00057-8; Losic D, 2006, BIOPOLYMERS, V84, P519, DOI 10.1002/bip.20549; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Malinchik SB, 1998, BIOPHYS J, V74, P537, DOI 10.1016/S0006-3495(98)77812-9; Mandavilli A, 2006, NAT MED, V12, P747, DOI 10.1038/nm0706-747; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; McLaurin J, 2000, EUR J BIOCHEM, V267, P6353, DOI 10.1046/j.1432-1327.2000.01725.x; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; MEYERPUTTLITZ B, 1995, J NEUROCHEM, V65, P2327; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Naito A, 2007, BBA-BIOMEMBRANES, V1768, P1900, DOI 10.1016/j.bbamem.2007.03.025; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Roher AE, 2000, BBA-MOL BASIS DIS, V1502, P31, DOI 10.1016/S0925-4439(00)00030-2; Ruben GC, 2005, MICROSC RES TECHNIQ, V67, P175, DOI 10.1002/jemt.20197; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; SERPELL LC, 1995, J MOL BIOL, V254, P113, DOI 10.1006/jmbi.1995.0604; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Widenbrant MJO, 2006, BIOPHYS J, V91, P4071, DOI 10.1529/biophysj.106.085944; Wolfe MS, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0506-72; WOODS AG, 1995, BRAIN RES, V697, P53, DOI 10.1016/0006-8993(95)00775-L; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yang LS, 1999, J NEUROSCI RES, V55, P36, DOI 10.1002/(SICI)1097-4547(19990101)55:1<36::AID-JNR5>3.3.CO;2-5; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	81	67	74	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32471	32483		10.1074/jbc.M709870200	http://dx.doi.org/10.1074/jbc.M709870200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819917	hybrid			2022-12-27	WOS:000260893700035
J	Cassera, MB; Hazleton, KZ; Riegelhaupt, PM; Merino, EF; Luo, MK; Akabas, MH; Schramm, VL				Cassera, Maria B.; Hazleton, Keith Z.; Riegelhaupt, Paul M.; Merino, Emilio F.; Luo, Minkui; Akabas, Myles H.; Schramm, Vern L.			Erythrocytic Adenosine Monophosphate as an Alternative Purine Source in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PFNT1 NUCLEOSIDE TRANSPORTER; PARASITE PLASMA-MEMBRANE; TRANSITION-STATE ANALOG; DRUG-RESISTANT MALARIA; XENOPUS-LAEVIS OOCYTES; PYRIMIDINE METABOLISM; ADENYLATE KINASE; IN-VITRO; INHIBITORS; PHOSPHORYLASE	Plasmodium falciparum is a purine auxotroph, salvaging purines from erythrocytes for synthesis of RNA and DNA. Hypoxanthine is the key precursor for purine metabolism in Plasmodium. Inhibition of hypoxanthine-forming reactions in both erythrocytes and parasites is lethal to cultured P. falciparum. We observed that high concentrations of adenosine can rescue cultured parasites from purine nucleoside phosphorylase and adenosine deaminase blockade but not when erythrocyte adenosine kinase is also inhibited. P. falciparum lacks adenosine kinase but can salvage AMP synthesized in the erythrocyte cytoplasm to provide purines when both human and Plasmodium purine nucleoside phosphorylases and adenosine deaminases are inhibited. Transport studies in Xenopus laevis oocytes expressing the P. falciparum nucleoside transporter PfNT1 established that this transporter does not transport AMP. These metabolic patterns establish the existence of a novel nucleoside monophosphate transport pathway in P. falciparum.	[Cassera, Maria B.; Hazleton, Keith Z.; Luo, Minkui; Schramm, Vern L.] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Riegelhaupt, Paul M.; Akabas, Myles H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Merino, Emilio F.] New York Univ, Langone Med Ctr, Dept Med Parasitol, New York, NY 10010 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York University; NYU Langone Medical Center	Schramm, VL (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	vern@aecom.yu.edu	Cassera, Maria/L-1572-2013; Hazleton, Keith Z./AAD-3979-2019	Hazleton, Keith Z./0000-0003-4098-3411; Akabas, Myles/0000-0001-8781-7846	National Institutes of Health [AI49512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant Al49512. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; BERMAN PA, 1991, J CLIN INVEST, V88, P1848, DOI 10.1172/JCI115506; BEUTLER E, 1983, J CLIN INVEST, V72, P648, DOI 10.1172/JCI111014; Boison D, 2008, PROG NEUROBIOL, V84, P249, DOI 10.1016/j.pneurobio.2007.12.002; Boison D, 2008, CURR OPIN PHARMACOL, V8, P2, DOI 10.1016/j.coph.2007.09.002; BRUNS RF, 1980, N-S ARCH PHARMACOL, V315, P5, DOI 10.1007/BF00504224; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; CHOI I, 1990, EXP PARASITOL, V71, P452, DOI 10.1016/0014-4894(90)90071-J; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hyde JE, 2005, TRENDS PARASITOL, V21, P494, DOI 10.1016/j.pt.2005.08.020; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; KANAANI J, 1989, J BIOL CHEM, V264, P3194; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Kimura EA, 1996, J BIOL CHEM, V271, P14452, DOI 10.1074/jbc.271.24.14452; Komarova SV, 1999, BLOOD CELL MOL DIS, V25, P171, DOI 10.1006/bcmd.1999.0243; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Luo M, 2008, J AM CHEM SOC, V130, P2649, DOI 10.1021/ja078008x; Luo MK, 2007, J AM CHEM SOC, V129, P8008, DOI 10.1021/ja072122y; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Matsuoka I, 2002, MOL PHARMACOL, V61, P606, DOI 10.1124/mol.61.3.606; McGaraughty S, 2005, CURR TOP MED CHEM, V5, P43, DOI 10.2174/1568026053386845; MOHRENWEISER HW, 1981, AM J HEMATOL, V11, P125, DOI 10.1002/ajh.2830110203; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Quashie NB, 2008, BIOCHEM J, V411, P287, DOI 10.1042/BJ20071460; Quashie NB, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-95; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Razakantoanina V, 2008, EXP PARASITOL, V118, P181, DOI 10.1016/j.exppara.2007.07.015; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Saliba KJ, 2006, NATURE, V443, P582, DOI 10.1038/nature05149; SANCHEZ G, 1976, COMP BIOCHEM PHYS B, V53, P419, DOI 10.1016/0305-0491(76)90351-5; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; SIMMONDS HA, 1989, BIOSCIENCE REP, V9, P75, DOI 10.1007/BF01117513; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stein A, 2003, J BIOL CHEM, V278, P35127, DOI 10.1074/jbc.M306188200; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tyler PC, 2007, J AM CHEM SOC, V129, P6872, DOI 10.1021/ja0708363; Webster H K, 1984, Adv Exp Med Biol, V165 Pt A, P225; ZIGANSHIN AU, 1995, PFLUG ARCH EUR J PHY, V429, P412, DOI 10.1007/BF00374157	49	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32889	32899		10.1074/jbc.M804497200	http://dx.doi.org/10.1074/jbc.M804497200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18799466	Green Published, hybrid			2022-12-27	WOS:000260893700078
J	Gao, XD; Moriyama, S; Miura, N; Dean, N; Nishimura, SI				Gao, Xiao-Dong; Moriyama, Satoru; Miura, Nobuaki; Dean, Neta; Nishimura, Shin-Ichiro			Interaction between the C Termini of Alg13 and Alg14 Mediates Formation of the Active UDP-N-acetylglucosamine Transferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN GLYCOSYLATION; TRANSCRIPT HETEROGENEITY; CRYSTAL-STRUCTURE; YEAST; MURG; GLYCOSYLTRANSFERASE; GENE; BIOSYNTHESIS	The second step of eukaryotic N-linked glycosylation in endoplasmic reticulum is catalyzed by an UDP-N-acetylglucosamine transferase that is comprised of two subunits, Alg13 and Alg14. The interaction between Alg13 and 14 is crucial for UDP-Glc-NAc transferase activity, so formation of the Alg13/14 complex is likely to play a key role in the regulation of N-glycosylation. Using a combination of bioinformatics and molecular biological methods, we have undertaken a functional analysis of yeast Alg13 and Alg14 proteins to elucidate the mechanism of their interaction. Our mutational studies demonstrated that a short C-terminal alpha-helix of Alg13 is required for interaction with Alg14 and for enzyme activity. Electrostatic surface views of the modeled Alg13/14 complex suggest the presence of a hydrophobic cleft in Alg14 that provides a pocket for the Alg13 C-terminal alpha-helix. Co-immunoprecipitation assays confirmed the C-terminal three amino acids of Alg14 are required for maintaining the integrity of Alg13/Alg14 complex, and this depends on their hydrophobicity. Modeling studies place these three Alg14 residues at the entrance of the hydrophobic-binding pocket, suggesting their role in the stabilization of the interaction between the C termini of Alg13 and Alg14. Together, these results demonstrate that formation of this hetero-oligomeric complex is mediated by a short C-terminal alpha-helix of Alg13 in cooperation with the last three amino acids of Alg14. In addition, deletion of the N-terminal beta-strand of Alg13 caused the destruction of protein, indicating the structural importance of this region in protein stability.	[Gao, Xiao-Dong; Moriyama, Satoru; Miura, Nobuaki; Nishimura, Shin-Ichiro] Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Dean, Neta; Nishimura, Shin-Ichiro] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Hokkaido University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Nishimura, SI (corresponding author), Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Adv Life Sci, Kita Ku, N21,W11, Sapporo, Hokkaido 0010021, Japan.	shin@glyco.sci.hokudai.ac.jp			Ministry of Education, Culture, Science, Sports and Technology of Japan; National Institutes of Health [R01-GM048467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048467] Funding Source: NIH RePORTER	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was mainly supported by funding from the Ministry of Education, Culture, Science, Sports and Technology of Japan for "Innovation COE Program for Future Drug Discovery and Medical Care." This work was also supported, in part, by National Institutes of Health Grant R01-GM048467 (to N.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBRIGHT CF, 1990, J BIOL CHEM, V265, P7042; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Averbeck N, 2008, MOL BIOL CELL, V19, P2169, DOI 10.1091/mbc.E07-10-1077; Bickel T, 2005, J BIOL CHEM, V280, P34500, DOI 10.1074/jbc.M506358200; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Chantret I, 2005, J BIOL CHEM, V280, P9236, DOI 10.1074/jbc.M413941200; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gao XD, 2005, J BIOL CHEM, V280, P36254, DOI 10.1074/jbc.M507569200; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Grizot S, 2006, J MOL BIOL, V363, P383, DOI 10.1016/j.jmb.2006.07.057; Guharoy M, 2005, P NATL ACAD SCI USA, V102, P15447, DOI 10.1073/pnas.0505425102; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; Ha S., 2001, Current Drug Targets - Infectious Disorders, V1, P201, DOI 10.2174/1568005014606116; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KUKURUZINSKA MA, 1987, P NATL ACAD SCI USA, V84, P2145, DOI 10.1073/pnas.84.8.2145; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; SIKORSKI RS, 1989, GENETICS, V122, P19; Wang X, 2008, STRUCTURE, V16, P965, DOI 10.1016/j.str.2008.03.010; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Zawadzke LE, 2003, ANAL BIOCHEM, V314, P243, DOI 10.1016/S0003-2697(02)00622-X	27	32	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32534	32541		10.1074/jbc.M804060200	http://dx.doi.org/10.1074/jbc.M804060200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809682	Green Published, hybrid			2022-12-27	WOS:000260893700042
J	Langel, FD; Jain, NA; Rossman, JS; Kingeter, LM; Kashyap, AK; Schaefer, BC				Langel, Felicia D.; Jain, Nidhi A.; Rossman, Jeremy S.; Kingeter, Lara M.; Kashyap, Anuj K.; Schaefer, Brian C.			Multiple Protein Domains Mediate Interaction between Bcl10 and MALT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELL-ACTIVATION; ANTIGEN-RECEPTOR; FLUORESCENT PROTEIN; LYMPHOCYTE-ACTIVATION; CYTOKINE PRODUCTION; SIGNALING PATHWAY; CARMA1; REQUIREMENT; PARACASPASE	Bcl10 and MALT1 are essential mediators of NF-kappa B activation in response to the triggering of a diverse array of transmembrane receptors, including antigen receptors. Additionally, both proteins are translocation targets in MALT lymphoma. Thus, a detailed understanding of the interaction between these mediators is of considerable biological importance. Previous studies have indicated that a 13-amino acid region downstream of the Bcl10 caspase recruitment domain ( CARD) is responsible for interacting with the immunoglobulin-like domains of MALT1. We now provide evidence that the death domain of MALT1 and the CARD of Bcl10 also contribute to Bcl10-MALT1 interactions. Although a direct interaction between the MALT1 death domain and Bcl10 cannot be detected via immunoprecipitation, FRET data strongly suggest that the death domain of MALT1 contributes significantly to the association between Bcl10 and MALT1 in T cells in vivo. Furthermore, analysis of point mutants of conserved residues of Bcl10 shows that the Bcl10 CARD is essential for interaction with the MALT1 N terminus. Mutations that disrupt proper folding of the Bcl10 CARD strongly impair Bcl10-MALT1 interactions. Molecular modeling and functional analyses of Bcl10 point mutants suggest that residues Asp(80) and Glu(84) of helix 5 of the Bcl10 CARD directly contact MALT1. Together, these data demonstrate that the association between Bcl10 and MALT1 involves a complex interaction between multiple protein domains. Moreover, the Bcl10-MALT1 interaction is the second reported example of interactions between a CARD and a non-CARD protein region, which suggests that many signaling cascades may utilize CARD interactions with non-CARD domains.	[Langel, Felicia D.; Jain, Nidhi A.; Rossman, Jeremy S.; Kingeter, Lara M.; Kashyap, Anuj K.; Schaefer, Brian C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Schaefer, BC (corresponding author), 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	bschaefer@usuhs.mil		Schaefer, Brian C/0000-0001-8877-3507; Rossman, Jeremy/0000-0001-6124-4103	National Institutes of Health [AI057481]; Sidney Kimmel Society for Cancer Research; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Society for Cancer Research; Dana Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI057481 (to B. C. S.). This work was also supported by a Kimmel Scholar Award from the Sidney Kimmel Society for Cancer Research (to B. C. S.) and a grant from the Dana Foundation Program in Brain and Immunoimaging (to B. C. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guiet C, 2000, J CELL BIOL, V148, P1131, DOI 10.1083/jcb.148.6.1131; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li T, 2000, J VIROL, V74, P7646, DOI 10.1128/JVI.74.16.7646-7650.2000; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Malarkannan S, 2007, J IMMUNOL, V179, P3752, DOI 10.4049/jimmunol.179.6.3752; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rossman JS, 2006, MOL BIOL CELL, V17, P2166, DOI 10.1091/mbc.E05-10-0985; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez R, 2000, METH MOL B, V143, P97; Schaefer BC, 2004, P NATL ACAD SCI USA, V101, P1004, DOI 10.1073/pnas.0307858100; Schaefer BC, 2001, ANAL BIOCHEM, V297, P86, DOI 10.1006/abio.2001.5327; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; SIEGEL RM, 2000, SCI STKE, pPL1; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; WEGENER E, 2007, SCI STKE, pPE21; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	53	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32419	32431		10.1074/jbc.M800670200	http://dx.doi.org/10.1074/jbc.M800670200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806265	hybrid, Green Published			2022-12-27	WOS:000260893700030
J	Burd, CJ; Kinyamu, HK; Miller, FW; Archer, TK				Burd, Craig J.; Kinyamu, H. Karimi; Miller, Frederick W.; Archer, Trevor K.			UV Radiation Regulates Mi-2 through Protein Translation and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; REMODELING COMPLEX; P53 TRANSLATION; MUSCLE DISEASE; BREAST-CANCER; CHROMATIN; DERMATOMYOSITIS; AUTOANTIBODIES; EXPRESSION; MYOSITIS	Dermatomyositis (DM) is an autoimmune disease, which is often accompanied by the development of disease-specific autoantibodies directed against the SNF2-superfamily helicase, Mi-2. Recent evidence suggests that ultraviolet radiation exposure may be an important risk factor for the development of not only the disease but also specific autoimmunity against Mi-2. Consequently, we investigated the effects of ultraviolet radiation on Mi-2 protein expression. We observed an increase in protein levels upon ultraviolet radiation exposure in cell culture systems. These changes in expression occur quite rapidly, are maximized just 1 h following exposure, and are unique to Mi-2 when compared with other members of the NuRD complex. Changes in protein levels are not mediated through transcriptional mechanisms. Treatment results in a more efficiently translated message through regulatory elements in the 5'-UTR region of the transcript. Investigation into protein half-life further demonstrated increased stability of Mi-2 following UV exposure. Taken together, we describe a system by which Mi-2 protein expression can be quickly increased following UV exposure and then maintained up to 16 h later. These data provide a novel regulation of an important transcriptional regulator and provide insight into the possible mechanisms of the development of DM and associated autoantibodies.	[Burd, Craig J.; Kinyamu, H. Karimi; Archer, Trevor K.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Miller, Frederick W.] NIEHS, Environm Autoimmunity Grp, Off Clin Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, MD D4-01,POB 12233, Res Triangle Pk, NC 27709 USA.	archer1@niehs.nih.gov	Archer, Trevor K/E-5191-2019; kinyamu, Harriet/AAG-9069-2019; Miller, Frederick/D-2431-2019	kinyamu, Harriet/0000-0002-2377-7408; Miller, Frederick/0000-0003-2831-9593; Archer, Trevor K/0000-0001-7651-3644; Burd, Craig/0000-0002-6899-6751	Intramural Research Program of the NIEHS [Z01 ES071006-09]; National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES071006, ZIAES101074, Z01ES102445, ZICES102445, Z01ES071006, Z01ES101074] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Program Grant Z01 ES071006-09 in the Intramural Research Program of the NIEHS, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; Callen JP, 2006, CLIN DERMATOL, V24, P363, DOI 10.1016/j.clindermatol.2006.07.001; Casciola-Rosen L, 2005, J EXP MED, V201, P591, DOI 10.1084/jem.20041367; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Devereux TR, 1999, CANCER RES, V59, P6087; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Fryer CJ, 2000, J BIOL CHEM, V275, P17771, DOI 10.1074/jbc.M908729199; Fujita N, 2004, MOL ENDOCRINOL, V18, P2937, DOI 10.1210/me.2004-0258; Ghirardello A, 2005, AUTOIMMUNITY, V38, P79, DOI 10.1080/08916930400022681; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Levine SM, 2006, CURR OPIN RHEUMATOL, V18, P620, DOI 10.1097/01.bor.0000245721.02512.77; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Okada S, 2003, ARTHRITIS RHEUM-US, V48, P2285, DOI 10.1002/art.11090; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Roux S, 1998, J RHEUMATOL, V25, P395; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Schnabel Armin, 2005, Curr Rheumatol Rep, V7, P99, DOI 10.1007/s11926-005-0061-4; Sillibourne JE, 2007, MOL BIOL CELL, V18, P3667, DOI 10.1091/mbc.E06-07-0604; Sordet C, 2006, JOINT BONE SPINE, V73, P646, DOI 10.1016/j.jbspin.2006.04.005; Stevens AM, 2003, RHEUMATOLOGY, V42, P34, DOI 10.1093/rheumatology/keg025; Suber TL, 2008, NAT CLIN PRACT RHEUM, V4, P201, DOI 10.1038/ncprheum0760; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; TARGOFF IN, 1985, ARTHRITIS RHEUM, V28, P796, DOI 10.1002/art.1780280711; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	33	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34976	34982		10.1074/jbc.M805383200	http://dx.doi.org/10.1074/jbc.M805383200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922793	Green Published, hybrid			2022-12-27	WOS:000261469100054
J	Finger, EC; Lee, NY; You, HJ; Blobe, GC				Finger, Elizabeth C.; Lee, Nam Y.; You, Hye-jin; Blobe, Gerard C.			Endocytosis of the Type III Transforming Growth Factor-beta (TGF-beta) Receptor through the Clathrin-independent/Lipid Raft Pathway Regulates TGF-beta Signaling and Receptor Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-DEPENDENT ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; LIGAND-BINDING; EMERGING ROLES; INTERNALIZATION; EXPRESSION; CAVEOLAE; PROTEIN; CANCER; BETAGLYCAN	Transforming growth factor-beta(TGF-beta) signals through three highly conserved cell surface receptors, the type III TGF-beta receptor (T beta RIII), the type II TGF-beta receptor (T beta RII), and the type I TGF-beta receptor (T beta RI) to regulate diverse cellular processes including cell proliferation, differentiation, migration, and apoptosis. Although T beta RI and T beta RII undergo ligand-independent endocytosis by both clathrin-mediated endocytosis, resulting in enhanced signaling, and clathrin-independent endocytosis, resulting in receptor degradation, the mechanism and function of T beta RIII endocytosis is poorly understood. T beta RIII is a heparan sulfate proteoglycan with a short cytoplasmic tail that functions as a TGF-beta superfamily co-receptor, contributing to TGF-beta signaling through mechanisms yet to be fully defined. We have reported previously that T beta RIII endocytosis, mediated by a novel interaction with beta arrestin-2, results in decreased TGF-beta signaling. Here we demonstrate that T beta RIII undergoes endocytosis in a ligand and glycosaminoglycan modification-independent and cytoplasmic domain-dependent manner, with the interaction of Thr-841 in the cytoplasmic domain of T beta RIII with beta-arrestin2 enhancing T beta RIII endocytosis. T beta RIII undergoes both clathrin-mediated and clathrin-independent endocytosis. Importantly, inhibition of the clathrin-independent, lipid raft pathway, but not of the clathrin-dependent pathway, results in decreased TGF-beta 1 induced Smad2 and p38 phosphorylation, supporting a specific role for clathrin-independent endocytosis of T beta RIII in regulating both Smad-dependent and Smad-independent TGF-beta signaling.	[Finger, Elizabeth C.; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Lee, Nam Y.; You, Hye-jin; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27708 USA	Duke University; Duke University	Blobe, GC (corresponding author), B354 LSRC,Box 91004 DUMC, Durham, NC 27708 USA.	blobe001@mc.duke.edu	You, Hye Jin/AAF-7666-2019; Lee, Nam/H-3073-2016; Blobe, Gerard/AAJ-5945-2020; YOU, HYEJIN/K-8951-2019	You, Hye Jin/0000-0001-5566-5171; Blobe, Gerard/0000-0002-4274-8901; 	National Institutes of Health [R01-CA106307]; NATIONAL CANCER INSTITUTE [R01CA106307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA106307 (NCI; to G. C. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anders RA, 1997, MOL BIOL CELL, V8, P2133, DOI 10.1091/mbc.8.11.2133; ANDRES JL, 1992, J BIOL CHEM, V267, P5927; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Buchanan FG, 2006, CELL CYCLE, V5, P2060, DOI 10.4161/cc.5.18.3212; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; CHEIFETZ S, 1989, J BIOL CHEM, V264, P12025; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Deng XB, 1999, CELL GROWTH DIFFER, V10, P11; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Dore JJE, 2001, MOL BIOL CELL, V12, P675, DOI 10.1091/mbc.12.3.675; Ehrlich M, 2001, J CELL SCI, V114, P1777; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gordon KJ, 2008, CARCINOGENESIS, V29, P252, DOI 10.1093/carcin/bgm249; Hempel N, 2007, CANCER RES, V67, P5231, DOI 10.1158/0008-5472.CAN-07-0035; Kirkbride KC, 2005, TRENDS BIOCHEM SCI, V30, P611, DOI 10.1016/j.tibs.2005.09.003; Kirkbride KC, 2003, EXPERT OPIN BIOL TH, V3, P251; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Leof EB, 2000, TRENDS CELL BIOL, V10, P343, DOI 10.1016/S0962-8924(00)01795-5; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Luttrell LM, 2002, J CELL SCI, V115, P455; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McDonald PH, 2001, CELL SIGNAL, V13, P683, DOI 10.1016/S0898-6568(01)00203-0; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; OKA Y, 1986, J BIOL CHEM, V261, P9090; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; You HJ, 2007, CARCINOGENESIS, V28, P2491, DOI 10.1093/carcin/bgm195	55	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34808	34818		10.1074/jbc.M804741200	http://dx.doi.org/10.1074/jbc.M804741200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845534	hybrid, Green Published			2022-12-27	WOS:000261469100037
J	Patel, V; Booker, M; Kramer, M; Ross, L; Celatka, CA; Kennedy, LM; Dvorin, JD; Duraisingh, MT; Sliz, P; Wirth, DF; Clardy, J				Patel, Vishal; Booker, Michael; Kramer, Martin; Ross, Leila; Celatka, Cassandra A.; Kennedy, Leah M.; Dvorin, Jeffrey D.; Duraisingh, Manoj T.; Sliz, Piotr; Wirth, Dyann F.; Clardy, Jon			Identification and Characterization of Small Molecule Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MALARIA; PYRIMIDINE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; CHLOROQUINE; RESISTANCE; ENZYMES; BINDING; DRUG; LEFLUNOMIDE	Plasmodium falciparum causes the most deadly form of malaria and accounts for over one million deaths annually. The malaria parasite is unable to salvage pyrimidines and relies on de novo biosynthesis for survival. Dihydroorotate dehydrogenase (DHOD), a mitochondrially localized flavoenzyme, catalyzes the rate-limiting step of this pathway and is therefore an attractive antimalarial chemotherapeutic target. Using a target-based high throughput screen, we have identified a series of potent, species-specific inhibitors of P. falciparum DHOD (pfDHOD) that are also efficacious against three cultured strains (3D7, HB3, and Dd2) of P. falciparum. The primary antimalarial mechanism of action of these compounds was confirmed to be inhibition of pfDHOD through a secondary assay with transgenic malaria parasites, and the structural basis for enzyme inhibition was explored through in silico structure-based docking and site-directed mutagenesis. Compound-mediated cytotoxicity was not observed with human dermal fibroblasts or renal epithelial cells. These data validate pfDHOD as an antimalarial drug target and provide chemical scaffolds with which to begin medicinal chemistry efforts.	[Patel, Vishal; Ross, Leila; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Patel, Vishal; Dvorin, Jeffrey D.; Duraisingh, Manoj T.; Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Booker, Michael; Kramer, Martin; Celatka, Cassandra A.; Kennedy, Leah M.] Genzyme Corp, Drug & Biomat Res & Dev, Waltham, MA 02451 USA; [Dvorin, Jeffrey D.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Sliz, Piotr] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Sanofi-Aventis; Genzyme Corporation; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Clardy, J (corresponding author), 240 Longwood Ave,C-643, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu		Ross, Leila/0000-0003-4360-5213; Sliz, Piotr/0000-0002-6522-0835; Dvorin, Jeffrey/0000-0002-5883-7271	National Institutes of Health [NIH R21NS053660, R21NS059404, K12-HD000850]; National Science Foundation Graduate Research Fellowship Program; Medicines for Malaria Venture, Harvard Malaria Initiative; Broad Institute of Harvard and Massachusetts Institute of Technology [2737380]; Humanitarian Assistance for Neglected Diseases Initiate of Genzyme Corp; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059404, R21NS053660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Medicines for Malaria Venture, Harvard Malaria Initiative; Broad Institute of Harvard and Massachusetts Institute of Technology; Humanitarian Assistance for Neglected Diseases Initiate of Genzyme Corp(Sanofi-AventisGenzyme Corporation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH R21NS053660 (USPHS to J.C.), R21NS059404 (to J.C.), and K12-HD000850 (NICHD to J.D.D.). This work was also supported by National Science Foundation Graduate Research Fellowship Program (to V.P.), Medicines for Malaria Venture, Harvard Malaria Initiative (to D.F.W.), SPARC Grant 2737380 from the Broad Institute of Harvard and Massachusetts Institute of Technology, and the Humanitarian Assistance for Neglected Diseases Initiate of Genzyme Corp. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALEMAN V, 1967, J BIOL CHEM, V242, P4087; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Baldwin J, 2002, J BIOL CHEM, V277, P41827, DOI 10.1074/jbc.M206854200; BANYAL HS, 1982, LIFE SCI, V31, P1141, DOI 10.1016/0024-3205(82)90088-1; Bjornberg O, 2001, ARCH BIOCHEM BIOPHYS, V391, P286, DOI 10.1006/abbi.2001.2409; CADIGAN FC, 1968, T ROY SOC TROP MED H, V62, P562, DOI 10.1016/0035-9203(68)90145-4; CAROLINE DF, 1969, J BACTERIOL, V100, P1371, DOI 10.1128/JB.100.3.1371-1377.1969; CHARLES LJ, 1962, B WORLD HEALTH ORGAN, V26, P103; CHEN GX, 1987, MOL PHARMACOL, V31, P430; CHEN JJ, 1976, ARCH BIOCHEM BIOPHYS, V176, P82, DOI 10.1016/0003-9861(76)90143-0; CHULAY JD, 1983, EXP PARASITOL, V55, P138, DOI 10.1016/0014-4894(83)90007-3; CLYDE DF, 1954, T ROY SOC TROP MED H, V48, P495, DOI 10.1016/0035-9203(54)90085-1; Copeland RA, 2000, J BIOL CHEM, V275, P33373, DOI 10.1074/jbc.M004451200; DENISDUPHIL M, 1989, BIOCHEM CELL BIOL, V67, P612, DOI 10.1139/o89-094; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; EAKIN RT, 1969, ARCH BIOCHEM BIOPHYS, V134, P160, DOI 10.1016/0003-9861(69)90262-8; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; GEARY TG, 1983, J PARASITOL, V69, P577, DOI 10.2307/3281373; GERO AM, 1981, AUST J EXP BIOL MED, V59, P477, DOI 10.1038/icb.1981.41; GERO AM, 1985, BIOCHEM MED METAB B, V34, P70, DOI 10.1016/0006-2944(85)90063-8; Goldenberg MM, 1999, CLIN THER, V21, P1837, DOI 10.1016/S0149-2918(00)86732-6; GREENE S, 1995, BIOCHEM PHARMACOL, V50, P861, DOI 10.1016/0006-2952(95)00255-X; GUTTERIDGE WE, 1979, BIOCHIM BIOPHYS ACTA, V582, P390, DOI 10.1016/0304-4165(79)90131-4; Hansen M, 2004, PROTEIN SCI, V13, P1031, DOI 10.1110/ps.03533004; Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0; HESS U, 1983, AM J TROP MED HYG, V32, P217, DOI 10.4269/ajtmh.1983.32.217; HILL B, 1981, INT J BIOCHEM, V13, P303, DOI 10.1016/0020-711X(81)90082-3; HINES V, 1989, BIOCHEMISTRY-US, V28, P1222, DOI 10.1021/bi00429a040; Hurt DE, 2006, BIOORG MED CHEM LETT, V16, P1610, DOI 10.1016/j.bmcl.2005.12.029; Hurt DE, 2006, ACTA CRYSTALLOGR D, V62, P312, DOI 10.1107/S0907444905042642; JEARNPIPATKUL A, 1980, EXPERIENTIA, V36, P1063, DOI 10.1007/BF01965970; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Jordan DB, 2000, ARCH BIOCHEM BIOPHYS, V378, P84, DOI 10.1006/abbi.2000.1823; KENNEDY J, 1973, ARCH BIOCHEM BIOPHYS, V157, P369, DOI 10.1016/0003-9861(73)90651-6; Knecht W, 1997, PROTEIN EXPRES PURIF, V10, P89, DOI 10.1006/prep.1996.0714; Knecht W, 1996, EUR J BIOCHEM, V240, P292, DOI 10.1111/j.1432-1033.1996.0292h.x; KRUNGKRAI J, 1993, EXP PARASITOL, V77, P136, DOI 10.1006/expr.1993.1070; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; MAHONEY LE, 1968, LANCET, V2, P1139; Malmquist NA, 2008, BIOCHEMISTRY-US, V47, P2466, DOI 10.1021/bi702218c; Marcinkeviciene J, 2000, BIOCHEM PHARMACOL, V60, P339, DOI 10.1016/S0006-2952(00)00348-8; Marcinkeviciene J, 2000, ARCH BIOCHEM BIOPHYS, V377, P178, DOI 10.1006/abbi.2000.1769; McLean JE, 2001, BIOCHEMISTRY-US, V40, P2194, DOI 10.1021/bi001810q; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; MILLER RW, 1969, CAN J BIOCHEM CELL B, V47, P725, DOI 10.1139/o69-110; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Nara T, 2000, GENE, V257, P209, DOI 10.1016/S0378-1119(00)00411-X; Neidhardt Edie A., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P183; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; PETERS W, 1969, LANCET, V2, P54; PHIFER KO, 1966, EXP PARASITOL, V19, P102, DOI 10.1016/0014-4894(66)90058-0; POWELL G, 1969, J BIOL CHEM, V244, P4793; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Rowland P, 1997, STRUCTURE, V5, P239, DOI 10.1016/S0969-2126(97)00182-2; RUMANS LW, 1979, LANCET, V2, P580; SCHUELER FW, 1964, J PHARMACOL EXP THER, V143, P278; Skophammer RG, 2007, MOL BIOL EVOL, V24, P1761, DOI 10.1093/molbev/msm096; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Subbayya INS, 1997, INDIAN J MED RES, V106, P79; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; TAYLOR ML, 1971, J BACTERIOL, V105, P1015, DOI 10.1128/JB.105.3.1015-1027.1971; TAYLOR WH, 1964, J BACTERIOL, V88, P105, DOI 10.1128/JB.88.1.105-110.1964; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VANDERPLAS J, 1983, J BACTERIOL, V153, P1027, DOI 10.1128/JB.153.2.1027-1037.1983; VLEUGELS MPH, 1982, TROP GEOGR MED, V34, P263; Wang P, 1997, MOL MICROBIOL, V23, P979, DOI 10.1046/j.1365-2958.1997.2821646.x; WILLIAMS JC, 1973, J BACTERIOL, V115, P1071, DOI 10.1128/JB.115.3.1071-1076.1973; YOUNG MD, 1963, AM J TROP MED HYG, V12, P305, DOI 10.4269/ajtmh.1963.12.305; YOUNG MD, 1961, AM J TROP MED HYG, V10, P317, DOI 10.4269/ajtmh.1961.10.317; Zameitat E, 2004, FEBS LETT, V568, P129, DOI 10.1016/j.febslet.2004.05.017; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	74	75	79	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35078	35085		10.1074/jbc.M804990200	http://dx.doi.org/10.1074/jbc.M804990200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842591	Green Published, hybrid			2022-12-27	WOS:000261469100065
J	Vukcevic, M; Spagnoli, GC; Iezzi, G; Zorzato, F; Treves, S				Vukcevic, Mirko; Spagnoli, Giulio C.; Iezzi, Giandomenica; Zorzato, Francesco; Treves, Susan			Ryanodine Receptor Activation by Ca(v)1.2 Is Involved in Dendritic Cell Major Histocompatibility Complex Class II Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE DIHYDROPYRIDINE RECEPTOR; CA2+ RELEASE CHANNELS; CALCIUM-CHANNELS; MATURATION; IDENTIFICATION; MECHANISMS; MUTATIONS; DIFFERENTIATION; HOMEOSTASIS; INHIBITION	Dendritic cells express the skeletal muscle ryanodine receptor (RyR1), yet little is known concerning its physiological role and activation mechanism. Here we show that dendritic cells also express the Ca(v)1.2 subunit of the L-type Ca2+ channel and that release of intracellular Ca2+ via RyR1 depends on the presence of extracellular Ca2+ and is sensitive to ryanodine and nifedipine. Interestingly, RyR1 activation causes a very rapid increase in expression of major histocompatibility complex II molecules on the surface of dendritic cells, an effect that is also observed upon incubation of mouse BM12 dendritic cells with transgenic T cells whose T cell receptor is specific for the I-A(bm12) protein. Based on the present results, we suggest that activation of the RyR1 signaling cascade may be important in the early stages of infection, providing the immune system with a rapid mechanism to initiate an early response, facilitating the presentation of antigens to T cells by dendritic cells before their full maturation.	[Vukcevic, Mirko; Treves, Susan] Univ Basel Hosp, Dept Anaesthesia, CH-4031 Basel, Switzerland; [Vukcevic, Mirko; Treves, Susan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Spagnoli, Giulio C.; Iezzi, Giandomenica] Univ Basel Hosp, Inst Surg Res, CH-4031 Basel, Switzerland; [Zorzato, Francesco] Univ Ferrara, Gen Pathol sect, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy	University of Basel; University of Basel; University of Basel; University of Ferrara	Treves, S (corresponding author), Univ Basel Hosp, Dept Anaesthesia, Hebelstr 20, CH-4031 Basel, Switzerland.	susan.treves@unibas.ch		Treves, Susan/0000-0002-0007-9631; Iezzi, Giandomenica/0000-0001-5841-495X	Swiss National Science Foundation [3200B0-114597, 31600-117383, 3200B0-104060]; Swiss Muscle Foundation; Association Francaise Contre les Myopathies	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Muscle Foundation; Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by Swiss National Science Foundation Grants 3200B0-114597, 31600-117383 and 3200B0-104060 and by Swiss Muscle Foundation and Association Francaise Contre les Myopathies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; Bracci L, 2007, J CELL SCI, V120, P2232, DOI 10.1242/jcs.007203; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Dauer M, 2003, J IMMUNOL, V170, P4069, DOI 10.4049/jimmunol.170.8.4069; Ducreux S, 2006, BIOCHEM J, V395, P259, DOI 10.1042/BJ20051282; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Goth SR, 2006, ENVIRON HEALTH PERSP, V114, P1083, DOI 10.1289/ehp.8881; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Hosoi E, 2001, J IMMUNOL, V167, P4887, DOI 10.4049/jimmunol.167.9.4887; KWAN CY, 1990, AM J PHYSIOL, V258, pC1006, DOI 10.1152/ajpcell.1990.258.6.C1006; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; O'Connell PJ, 2002, FEBS LETT, V512, P67, DOI 10.1016/S0014-5793(01)03321-X; Panyi G, 2004, IMMUNOL LETT, V92, P55, DOI 10.1016/j.imlet.2003.11.020; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; Ralevic V, 1998, PHARMACOL REV, V50, P413; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schuhmeier RP, 2005, BIOPHYS J, V88, P1765, DOI 10.1529/biophysj.104.051318; Sedej S, 2004, J PHYSIOL-LONDON, V555, P769, DOI 10.1113/jphysiol.2003.058271; Sei Y, 1999, J BIOL CHEM, V274, P5995, DOI 10.1074/jbc.274.9.5995; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Tarroni P, 1997, J BIOL CHEM, V272, P19808, DOI 10.1074/jbc.272.32.19808; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Uemura Y, 2007, BIOCHEM BIOPH RES CO, V362, P510, DOI 10.1016/j.bbrc.2007.08.024; Vignali S, 2006, J PHYSIOL-LONDON, V572, P691, DOI 10.1113/jphysiol.2005.102368; Wehrens XHT, 2003, TRENDS BIOCHEM SCI, V28, P671, DOI 10.1016/j.tibs.2003.10.003; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; ZIMANYI I, 1992, MOL PHARMACOL, V42, P1049	51	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34913	34922		10.1074/jbc.M804472200	http://dx.doi.org/10.1074/jbc.M804472200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18927079	Green Published, hybrid			2022-12-27	WOS:000261469100048
J	Yu, Z; Koningstein, G; Pop, A; Luirink, J				Yu, Zhong; Koningstein, Gregory; Pop, Ana; Luirink, Joen			The Conserved Third Transmembrane Segment of YidC Contacts Nascent Escherichia coli Inner Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; SYNTHASE SUBUNIT-C; INSERTION; BIOGENESIS; SECY; ATP; REQUIREMENTS; TRANSLOCATION; SUBSTRATE; TRANSPORT	Escherichia coli YidC is a polytopic inner membrane protein that plays an essential and versatile role in the biogenesis of inner membrane proteins. YidC functions in Sec-dependent membrane insertion but acts also independently as a separate insertase for certain small membrane proteins. We have used a site-specific cross-linking approach to show that the conserved third transmembrane segment of YidC contacts the transmembrane domains of both nascent Sec-dependent and -independent substrates, indicating a generic recognition of insertion intermediates by YidC. Our data suggest that specific residues of the third YidC transmembrane segment alpha-helix is oriented toward the transmembrane domains of nascent inner membrane proteins that, in contrast, appear quite flexibly positioned at this stage in biogenesis.	[Yu, Zhong; Koningstein, Gregory; Pop, Ana; Luirink, Joen] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Luirink, J (corresponding author), Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	joen.luirink@falw.vu.nl	Luirink, Joen/AAB-8658-2021	Luirink, J./0000-0001-8431-0804				Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; DEVRIJE T, 1987, BIOCHIM BIOPHYS ACTA, V900, P63, DOI 10.1016/0005-2736(87)90278-1; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Houben ENG, 2004, EMBO REP, V5, P970, DOI 10.1038/sj.embor.7400261; Houben ENG, 2002, J BIOL CHEM, V277, P35880, DOI 10.1074/jbc.M205556200; Houben ENG, 2000, FEBS LETT, V476, P229, DOI 10.1016/S0014-5793(00)01735-X; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kiefer D, 2007, INT REV CYTOL, V259, P113, DOI 10.1016/S0074-7969(06)59003-5; LERNER CG, 1990, NUCLEIC ACIDS RES, V18, P4631, DOI 10.1093/nar/18.15.4631; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Sauri A, 2007, J MOL BIOL, V366, P366, DOI 10.1016/j.jmb.2006.11.052; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Urbanus ML, 2002, J BIOL CHEM, V277, P12718, DOI 10.1074/jbc.M200311200; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2005, CURR OPIN MICROBIOL, V8, P182, DOI 10.1016/j.mib.2005.02.004; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Yuan J, 2007, J BACTERIOL, V189, P8961, DOI 10.1128/JB.01365-07	41	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34635	34642		10.1074/jbc.M804344200	http://dx.doi.org/10.1074/jbc.M804344200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18840604	Green Published, hybrid			2022-12-27	WOS:000261469100018
J	Chen, JL; Lin, HH; Kim, KJ; Lin, AN; Forman, HJ; Ann, DK				Chen, Jo-Lin; Lin, Her H.; Kim, Kwang-Jin; Lin, Anning; Forman, Henry J.; Ann, David K.			Novel Roles for Protein Kinase C delta-dependent Signaling Pathways in Acute Hypoxic Stress-induced Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; PKC-DELTA; APOPTOSIS; MACROAUTOPHAGY; ACTIVATION; PHOSPHORYLATION; INDUCTION; CANCER; DEATH; LC3	Macroautophagy, a tightly orchestrated intracellular process for bulk degradation of cytoplasmic proteins or organelles, is believed to be essential for cell survival or death in response to stress conditions. Recent observations indicate that autophagy is an adaptive response in cells subjected to prolonged hypoxia. However, the signaling mechanisms that activate autophagy under acute hypoxic stress are not clearly understood. In this study, we show that acute hypoxic stress by treatment with 1% O-2 or desferroxamine, a hypoxia-mimetic agent, of cells renders a rapid induction of LC3-II level changes and green fluorescent protein-LC3 puncta accumulation, hallmarks of autophagic processing, and that this process involves protein kinase C delta (PKC delta), and occurs prior to the induction of BNIP3 (Bcl-2/adenovirus E1B 19-kDa interacting protein 3). Interestingly, hypoxic stress leads to a rapid and transient activation of JNK in Pa-4 or mouse embryo fibroblast cells. Acute hypoxic stress-induced changes in LC3-II level and JNK activation are attenuated in Pa-4 cells by dominant negative PKC delta KD or in mouse embryo fibroblast/PKC delta-null cells. Intriguingly, the requirement of PKC delta is not apparent for starvation-induced autophagy. The importance of PKC delta in hypoxic stress-induced adaptive responses is further supported by our findings that inhibition of PKC delta-facilitated autophagy by 3-methyladenine or Atg5 knock-out renders a greater prevalence of cell death following prolonged desferroxamine treatment, whereas PKC delta- or JNK1-deficient cells exhibit resistance to extended hypoxic exposure. These results uncover dual roles of PKC delta-dependent signaling in the cell fate determination upon hypoxic exposure.	[Chen, Jo-Lin; Lin, Her H.; Ann, David K.] City Hope Natl Med Ctr, Dept Clin & Mol Pharmacol, Duarte, CA 91010 USA; [Chen, Jo-Lin; Kim, Kwang-Jin; Ann, David K.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90033 USA; [Kim, Kwang-Jin; Ann, David K.] Univ So Calif, Dept Med, Los Angeles, CA 90033 USA; [Kim, Kwang-Jin] Univ So Calif, Will Rogers Inst, Pulm Res Ctr, Los Angeles, CA 90033 USA; [Lin, Anning] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; [Forman, Henry J.] Univ Calif, Sch Nat Sci, Merced, CA 95344 USA	City of Hope; University of Southern California; University of Southern California; University of Southern California; University of Chicago; University of California System; University of California Merced	Ann, DK (corresponding author), City Hope Natl Med Ctr, Dept Clin & Mol Pharmacol, KCRB Rm 1028,1500 E Duarte Rd, Duarte, CA 91010 USA.	dann@coh.org		Forman, Henry Jay/0000-0001-5838-2791	National Institutes of Health [DE 10742, DE 14183, HL 38658, HL 64365]; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038658, R01HL064365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE 10742 and DE 14183 (to D. K. A.) and HL 38658 and HL 64365 (to K. J. K.). This work was also supported in part by the Hastings Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Borger DR, 2008, BIOCHEM BIOPH RES CO, V370, P230, DOI 10.1016/j.bbrc.2008.03.056; Clavijo C, 2007, AM J PHYSIOL-CELL PH, V292, pC2150, DOI 10.1152/ajpcell.00425.2006; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Egami Y, 2008, EXP CELL RES, V314, P729, DOI 10.1016/j.yexcr.2007.11.018; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Leitges M, 2001, J CLIN INVEST, V108, P1505; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nguyen HV, 2006, AM J PATHOL, V168, P1452, DOI 10.2353/ajpath.2006.050782; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Papandreou I, 2008, CELL DEATH DIFFER, V15, P1572, DOI 10.1038/cdd.2008.84; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Qi X, 2007, J MOL CELL CARDIOL, V43, P420, DOI 10.1016/j.yjmcc.2007.07.061; Rami A, 2008, AUTOPHAGY, V4, P227, DOI 10.4161/auto.5339; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Song KS, 2008, AUTOPHAGY, V4, P650, DOI 10.4161/auto.6057; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang H, 2008, AM J RESP CELL MOL, V38, P483, DOI 10.1165/rcmb.2007-0260OC; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	58	43	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34432	34444		10.1074/jbc.M804239200	http://dx.doi.org/10.1074/jbc.M804239200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18836180	Green Published, hybrid			2022-12-27	WOS:000261277700071
J	Kan, JS; Zou, L; Zhang, JJ; Wu, RT; Wang, ZY; Liang, C				Kan, Junsuo; Zou, Lan; Zhang, Jingjing; Wu, Rentian; Wang, Ziyi; Liang, Chun			Origin Recognition Complex (ORC) Mediates Histone 3 Lysine 4 Methylation through Cooperation with Spp1 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; H3 LYSINE-4; MCM PROTEINS; SET1 COMPLEX; COMPASS; ASSOCIATION; INITIATION; HETEROCHROMATIN; ACTIVATION; CHECKPOINT	The heterohexameric origin recognition complex (ORC) has been implicated in many cellular activities, including DNA replication, transcriptional control, heterochromatin assembly, centromere and telomere function, and so on. Here, we report a new function for ORC in mediating histone methylation. Using the yeast two-hybrid system, we identify a physical interaction between Orc2p and Spp1p, a member of the Set1 complex, and we demonstrate the interaction between the endogenous ORC and Spp1p by co-immunoprecipitation from yeast extracts. Furthermore, we find that Orc2p physically interacts with trimethylated histone 3 lysine 4 (H3K4) on chromatin by co-immunoprecipitation. Finally, we show that the trimethylation of H3K4 is decreased in orc2-1 cells and abolished in orc2-1, spp1 Delta double mutants. Our data reveal a novel facet of ORC in mediating histone methylation in collaboration with Spp1p and demonstrate a connection between ORC and chromatin structure via the Set1 complex.	[Liang, Chun] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Canc Res, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Liang, C (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	bccliang@ust.hk	Wu, Rentian/Q-7413-2017	Wu, Rentian/0000-0003-3862-6394	Hong Kong Research Grants Council [HKUST6114/04M]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by a grant from the Hong Kong Research Grants Council (Grant HKUST6114/04M). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Hou ZG, 2005, P NATL ACAD SCI USA, V102, P8489, DOI 10.1073/pnas.0503525102; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schramke V, 2001, GENE DEV, V15, P1845, DOI 10.1101/gad.193901; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Shore D, 2001, CURR BIOL, V11, pR816, DOI 10.1016/S0960-9822(01)00493-6; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Wood A, 2005, NAT STRUCT MOL BIOL, V12, P839, DOI 10.1038/nsmb1005-839; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276; Zhang YX, 2002, CELL, V109, P849, DOI 10.1016/S0092-8674(02)00805-X	39	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33803	33807		10.1074/jbc.C800182200	http://dx.doi.org/10.1074/jbc.C800182200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845545	Green Published, hybrid			2022-12-27	WOS:000261277700003
J	Goytain, A; Hines, RM; Quamme, GA				Goytain, Angela; Hines, Rochelle M.; Quamme, Gary A.			Huntingtin-interacting Proteins, HIP14 and HIP14L, Mediate Dual Functions, Palmitoyl Acyltransferase and Mg2+ Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTORS; WILD-TYPE; CHANNEL; TRAFFICKING; SUBUNIT; DISEASE; IRON; IDENTIFICATION; FERRITIN; KINASE	Polyglutamine expansions of huntingtin protein are responsible for the Huntington neurological disorder. HIP14 protein has been shown to interact with huntingtin. HIP14 and a HIP14-like protein, HIP14L, with a 69% similarity reside in the Golgi and possess palmitoyl acyltransferase activity through innate cysteine-rich domains, DHHC. Here, we used microarray analysis to show that reduced extracellular magnesium concentration increases HIP14L mRNA suggesting a role in cellular magnesium metabolism. Because HIP14 was not on the microarray platform, we used real-time reverse transcriptase-PCR to show that HIP14 and HIP14L transcripts were up-regulated 3-fold with low magnesium. Western analysis with a specific HIP14 antibody also showed that endogenous HIP14 protein increased with diminished magnesium. Furthermore, we demonstrate that when expressed in Xenopus oocytes, HIP14 and HIP14L mediate Mg2+ uptake that is electrogenic, voltage-dependent, and saturable with Michaelis constants of 0.87 +/- 0.02 and 0.74 +/- 0.07 mM, respectively. Diminished magnesium leads to an apparent increase in HIP14-green fluorescent protein and HIP14L-green fluorescent fusion proteins in the Golgi complex and subplasma membrane post-Golgi vesicles of transfected epithelial cells. We also show that inhibition of palmitoylation with 2-bromopalmitate, or deletion of the DHHC motif HIP14 Delta DHHC, diminishes HIP14-mediated Mg2+ transport by about 50%. Coexpression of an independent protein acyltransferase, GODZ, with the deleted HIP14 Delta DHHC mutant restored Mg2+ transport to values observed with wild-type HIP14. Although we did not directly measure palmitoylation of HIP14 in these studies, the data are consistent with a regulatory role of autopalmitoylation in HIP14-mediated Mg2+ transport. We conclude that the huntingtin interacting protein genes, HIP14 and HIP14L, encode Mg2+ transport proteins that are regulated by their innate palmitoyl acyltransferases thus fulfilling the characteristics of "chanzymes."	[Goytain, Angela; Quamme, Gary A.] Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada; [Hines, Rochelle M.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Quamme, GA (corresponding author), Vancouver Hosp, Koerner Pavil,2211 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	quamme@interchange.ubc.ca	Hines, Rochelle/AAE-3784-2020	Hines, Rochelle/0000-0002-0459-7911	Canadian Institutes of Health Research (CIHR) [MOP-53288]; CIHR; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by Canadian Institutes of Health Research (CIHR) Grant MOP-53288 (to G. A. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by studentships from CIHR and the Michael Smith Foundation for Health Research. To whom correspondence should be addressed: Vancouver Hospital, Koerner Pavilion, 2211 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada. Tel.: 604-822-7156; Fax: 604-822-7897; E-mail: quamme@interchange.ubc.ca.	Bartzokis G, 2000, CELL MOL BIOL, V46, P821; BONILLA E, 1991, NEUROSCI LETT, V129, P22, DOI 10.1016/0304-3940(91)90711-2; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; CHEN JC, 1993, AM J NEURORADIOL, V14, P275; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Draper JM, 2007, J LIPID RES, V48, P1873, DOI 10.1194/jlr.M700179-JLR200; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; Goytain A, 2007, J BIOL CHEM, V282, P8060, DOI 10.1074/jbc.M610314200; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Hoffner G, 2002, J CELL SCI, V115, P941; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lumsden AL, 2007, HUM MOL GENET, V16, P1905, DOI 10.1093/hmg/ddm138; Metzler M, 2000, HUM MOL GENET, V9, P387, DOI 10.1093/hmg/9.3.387; Mies F, 2007, J BIOL CHEM, V282, P18339, DOI 10.1074/jbc.M611160200; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Truant R, 2006, BIOCHEM CELL BIOL, V84, P912, DOI 10.1139/O06-181; Uemura T, 2002, BIOCHEM BIOPH RES CO, V296, P492, DOI 10.1016/S0006-291X(02)00900-2; Varner AS, 2003, BIOCHEM J, V373, P91, DOI 10.1042/BJ20021598; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	49	63	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33365	33374		10.1074/jbc.M801469200	http://dx.doi.org/10.1074/jbc.M801469200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18794299	hybrid, Green Published			2022-12-27	WOS:000261183700041
J	Nicolaou, P; Knoll, R; Haghighi, K; Fan, GC; Dorn, GW; Hasenfuss, G; Kranias, EG				Nicolaou, Persoulla; Knoell, Ralph; Haghighi, Kobra; Fan, Guo-Chang; Dorn, Gerald W., II; Hasenfuss, Gerd; Kranias, Evangelia G.			Human Mutation in the Anti-apoptotic Heat Shock Protein 20 Abrogates Its Cardioprotective Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAILING HUMAN HEART; RAT-HEART; ISCHEMIA/REPERFUSION-INJURY; ALPHA-CRYSTALLIN; ISCHEMIA-REPERFUSION; HSP20; HEAT-SHOCK-PROTEIN-20; FAILURE; CARDIOMYOCYTES; IDENTIFICATION	The small heat shock protein Hsp20 protects cardiomyocytes against apoptosis, and phosphorylation at its Ser(16) site enhances its cardioprotection. To determine whether genetic variants exist in human Hsp20, which may modify these beneficial effects, we sequenced the coding region of the Hsp20 gene in 1347 patients suffering from dilated cardiomyopathy and 744 subjects with no heart disease. We identified a C59T substitution in the human Hsp20 gene in one patient and three individuals without heart disease. All subjects were heterozygous for this mutation, which changes a fully conserved proline residue into leucine at position 20 (P20L), resulting in secondary structural alterations. To examine the potential functional significance of the P20L-Hsp20 human variant, adult rat cardiomyocytes were infected with Ad. GFP (where Ad is adenovirus and GFP is green fluorescent protein), Ad. WT-Hsp20 (where WT is wild-type), and Ad.P20L-Hsp20 and subjected to simulated ischemia/reperfusion injury. Expression of WT-Hsp20 resulted in significant attenuation of apoptosis compared with the GFP control. However, the P20L-Hsp20 mutant showed no protection against apoptosis, assessed by Hoechst staining and DNA fragmentation. The loss of cardioprotection by the mutant Hsp20 was associated with its diminished phosphorylation at Ser16 compared with WT-Hsp20. Furthermore, maximal stimulation of cardiomyocytes with isoproterenol or protein kinase A-mediated phosphorylation in vitro confirmed the impaired ability of the mutant Hsp20 to become phosphorylated at Ser16. In conclusion, we have identified a P20L substitution in human Hsp20, which is associated with diminished phosphorylation at Ser16 and complete abrogation of the Hsp20 cardioprotective effects which may adversely affect the ability of human carriers to cope with cellular stress.	[Nicolaou, Persoulla; Haghighi, Kobra; Fan, Guo-Chang; Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Knoell, Ralph; Hasenfuss, Gerd] Univ Gottingen, Univ Hosp, Dept Cardiol & Pneumol, D-37099 Gottingen, Germany; [Dorn, Gerald W., II] Univ Cincinnati, Coll Med, Ctr Mol Cardiovasc Res, Cincinnati, OH 45267 USA; [Kranias, Evangelia G.] Acad Athens, Fdn Biomed Res, Athens 11527, Greece	University System of Ohio; University of Cincinnati; University of Gottingen; University System of Ohio; University of Cincinnati; Academy of Athens	Kranias, EG (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	Litsa.Kranias@uc.edu	Knöll, Ralph/GOH-3587-2022; Fan, Guo-Chang/E-1153-2012; Ralph, Knoell/AAE-5990-2020	Fan, Guo-Chang/0000-0002-0439-8277; Ralph, Knoell/0000-0001-8871-112X	National Institutes of Health [HL-26507, HL-64018, HL-77101, HL-087861]; Leducq Foundation; American Heart Association [0715500B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077101, R01HL087861, R01HL064018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or part, by National Institutes of Health Grants HL-26507, HL-64018, HL-77101 (to E. G. K.), and HL-087861 (to G.- C. F.). This work was also supported by the Leducq Foundation (to E. G. K.) and American Heart Association Predoctoral Fellowship 0715500B (to P. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Boluyt MO, 2006, PROTEOMICS, V6, P3154, DOI 10.1002/pmic.200401356; Chu GX, 2004, CIRC RES, V94, P184, DOI 10.1161/01.RES.0000107198.90218.21; CURRIE RW, 1987, J MOL CELL CARDIOL, V19, P795; De Celle T, 2005, EXP PHYSIOL, V90, P593, DOI 10.1113/expphysiol.2005.030296; DILLMANN WH, 1986, CIRC RES, V59, P110, DOI 10.1161/01.RES.59.1.110; Dohke T, 2006, J CARD FAIL, V12, P77, DOI 10.1016/j.cardfail.2005.07.006; DONNELLY TJ, 1992, CIRCULATION, V85, P769, DOI 10.1161/01.CIR.85.2.769; Fan GC, 2005, CIRCULATION, V111, P1792, DOI 10.1161/01.CIR.0000160851.41872.C6; Fan GC, 2004, CIRC RES, V94, P1474, DOI 10.1161/01.RES.0000129179.66631.00; Fan GC, 2006, CIRC RES, V99, P1233, DOI 10.1161/01.RES.0000251074.19348.af; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Guerra S, 1999, CIRC RES, V85, P856, DOI 10.1161/01.RES.85.9.856; Islamovic E, 2007, J MOL CELL CARDIOL, V42, P862, DOI 10.1016/j.yjmcc.2007.01.002; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; KATO K, 1994, J BIOL CHEM, V269, P15302; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; Li ZH, 1997, AM J PHYSIOL-HEART C, V272, pH2313, DOI 10.1152/ajpheart.1997.272.5.H2313; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Pipkin W, 2003, CIRCULATION, V107, P469, DOI 10.1161/01.CIR.0000044386.27444.5A; Qin YM, 2004, AM J PHYSIOL-HEART C, V286, pH2280, DOI 10.1152/ajpheart.01063.2003; Rodriguez P, 2006, J BIOL CHEM, V281, P38599, DOI 10.1074/jbc.M604139200; Sharov VG, 1996, AM J PATHOL, V148, P141; Teiger E, 1996, J CLIN INVEST, V97, P2891, DOI 10.1172/JCI118747; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; van de Klundert FAJM, 1998, EUR J BIOCHEM, V258, P1014, DOI 10.1046/j.1432-1327.1998.2581014.x; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; WHITE FP, 1986, CARDIOVASC RES, V20, P512, DOI 10.1093/cvr/20.7.512; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhu YH, 2005, ACTA PHARMACOL SIN, V26, P1193, DOI 10.1111/j.1745-7254.2005.00139.x; Zhu YH, 2005, ACTA PHARMACOL SIN, V26, P1076, DOI 10.1111/j.1745-7254.2005.00137.x	34	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33465	33471		10.1074/jbc.M802307200	http://dx.doi.org/10.1074/jbc.M802307200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18790732	Green Published, hybrid			2022-12-27	WOS:000261183700051
J	Trowitzsch, S; Weber, G; Luhrmann, R; Wahl, MC				Trowitzsch, Simon; Weber, Gert; Luehrmann, Reinhard; Wahl, Markus C.			An Unusual RNA Recognition Motif Acts as a Scaffold for Multiple Proteins in the Pre-mRNA Retention and Splicing Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U2 SNRNP PROTEIN; NUCLEAR RETENTION; GENE-EXPRESSION; CATALYTIC STEP; SPLICEOSOME; CORE; ACTIVATION; COMPONENTS; U2AF(65); SEQUENCE	The yeast pre-mRNA retention and splicing complex counteracts the escape of unspliced pre-mRNAs from the nucleus and activates splicing of a subset of Mer1p-dependent genes. A homologous complex is present in activated human spliceosomes. In many components of the spliceosome, RNA recognition motifs (RRMs) serve as versatile protein-RNA or protein-protein interaction platforms. Here, we show that in the retention and splicing complex, an atypical RRM of the Snu17p (small nuclear ribonucleoprotein-associated protein 17) subunit acts as a scaffold that organizes the other two constituents, Bud13p (bud site selection 13) and Pml1p (pre-mRNA leakage 1). GST pull-down experiments and size exclusion chromatography revealed that Snu17p constitutes the central platform of the complex, whereas Bud13p and Pml1p do not interact with each other. Fluorimetric structure probing showed the entire Bud13p and the N-terminal third of Pml1p to be natively disordered in isolation. Mutational analysis and tryptophan fluorescence confirmed that a conserved tryptophan-containing motif in the C terminus of Bud13p binds to the core RRM of Snu17p, whereas a different interaction surface encompassing a C-terminal extension of the Snu17p RRM is required to bind an N-terminal peptide of Pml1p. Isothermal titration calorimetry revealed 1: 1 interaction stoichiometries, large negative binding entropies, and dissociation constants in the low nanomolar and micromolar ranges for the Snu17p-Bud13p and the Snu17p-Pml1p interactions, respectively. Our results demonstrate that the noncanonical Snu17p RRM concomitantly binds multiple ligand proteins via short, intrinsically unstructured peptide epitopes and thereby acts as a platform that displays functional modules of the ligands, such as a forkhead-associated domain of Pml1p and a conserved polylysine motif of Bud13p.	[Trowitzsch, Simon; Weber, Gert; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Wahl, Markus C.] Univ Gottingen, Univ Med, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen	Wahl, MC (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	mwahl@gwdg.de	Trowitzsch, Simon/O-4957-2016; Wahl, Markus C./D-6365-2017; Weber, Gert/I-1800-2013	Trowitzsch, Simon/0000-0001-9143-766X; Wahl, Markus C./0000-0002-2811-5307; Weber, Gert/0000-0003-3624-1060	Max-Planck-Society	Max-Planck-Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max-Planck-Society (to R. L. and M. C. W.). The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Gottschalk A, 2001, MOL CELL BIOL, V21, P3037, DOI 10.1128/MCB.21.9.3037-3046.2001; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; Schellenberg MJ, 2006, P NATL ACAD SCI USA, V103, P1266, DOI 10.1073/pnas.0508048103; Scherrer FW, 2006, RNA, V12, P1361, DOI 10.1261/rna.2276806; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sommer P, 2005, CURR OPIN CELL BIOL, V17, P294, DOI 10.1016/j.ceb.2005.04.007; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Taniguchi I, 2007, P NATL ACAD SCI USA, V104, P13684, DOI 10.1073/pnas.0704922104; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vincent K, 2003, GENETICS, V164, P895; Wang Q, 2005, MOL CELL BIOL, V25, P10745, DOI 10.1128/MCB.25.24.10745-10754.2005; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; WILL CL, 2006, RNA WORLD, V3, P369	41	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32317	32327		10.1074/jbc.M804977200	http://dx.doi.org/10.1074/jbc.M804977200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809678	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000260893700018
J	Urbach, C; Fastrez, J; Soumillion, P				Urbach, Carole; Fastrez, Jacques; Soumillion, Patrice			A New Family of Cyanobacterial Penicillin-binding Proteins A MISSING LINK IN THE EVOLUTION OF CLASS A beta-LACTAMASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; COMPLETE GENOME STRUCTURE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; BACTERIAL-RESISTANCE; STREPTOMYCES R61; ACYL-ENZYME; OMEGA-LOOP; SUBSTRATE-SPECIFICITY	It is largely accepted that serine beta-lactamases evolved from some ancestral DD-peptidases involved in the biosynthesis and maintenance of the bacterial peptidoglycan. DD-peptidases are also called penicillin-binding proteins (PBPs), since they form stable acyl-enzymes with beta-lactam antibiotics, such as penicillins. On the other hand, beta-lactamases react similarly with these antibiotics, but the acyl-enzymes are unstable and rapidly hydrolyzed. Besides, all known PBPs and beta-lactamases share very low sequence similarities, thus rendering it difficult to understand how a PBP could evolve into a beta-lactamase. In this study, we identified a new family of cyanobacterial PBPs featuring the highest sequence similarity with the most widespread class A beta-lactamases. Interestingly, the Omega-loop, which, in the beta-lactamases, carries an essential glutamate involved in the deacylation process, is six amino acids shorter and does not contain any glutamate residue. From this new family of proteins, we characterized PBP-A from Thermosynechococcus elongatus and discovered hydrolytic activity with synthetic thiolesters that are usually good substrates of DD-peptidases. Penicillin degradation pathways as well as acylation and deacylation rates are characteristic of PBPs. In a first attempt to generate beta-lactamase activity, a 90-fold increase in deacylation rate was obtained by introducing a glutamate in the shorter Omega-loop.	[Urbach, Carole; Fastrez, Jacques; Soumillion, Patrice] Catholic Univ Louvain, Inst Sci Vie, Lab Ingn Prot & Peptides, B-1348 Louvain, Belgium	Universite Catholique Louvain	Soumillion, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Lab Ingn Prot & Peptides, Pl Croix Sud 4-5,Bte3, B-1348 Louvain, Belgium.	patrice.soumillion@uclouvain.be			Belgian Program on Interuniversity Poles of Attraction [PAI 5/33]; Fonds National de la Recherche Scientifique of Belgium	Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Fonds National de la Recherche Scientifique of Belgium(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by Belgian Program on Interuniversity Poles of Attraction Grant PAI 5/33 and the Fonds National de la Recherche Scientifique of Belgium. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADACHI H, 1991, J BIOL CHEM, V266, P3186; ADAM M, 1990, BIOCHEM J, V270, P525, DOI 10.1042/bj2700525; AMANUMA H, 1984, J BACTERIOL, V160, P822, DOI 10.1128/JB.160.2.822-823.1984; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Arpin C, 2001, ANTIMICROB AGENTS CH, V45, P2480, DOI 10.1128/AAC.45.9.2480-2485.2001; ASANO Y, 1989, J BIOL CHEM, V264, P14233; Banerjee S, 1998, BIOCHEMISTRY-US, V37, P3286, DOI 10.1021/bi972127f; Chesnel L, 2002, EUR J BIOCHEM, V269, P1678, DOI 10.1046/j.1432-1327.2002.02815.x; DAMBLON C, 1995, BIOCHEM J, V309, P431, DOI 10.1042/bj3090431; Davies C, 2001, J BIOL CHEM, V276, P616, DOI 10.1074/jbc.M004471200; Deghorain M, 2007, J BACTERIOL, V189, P4332, DOI 10.1128/JB.01829-06; Domanski TL, 1995, GENE, V167, P111, DOI 10.1016/0378-1119(96)82965-9; DUBOIS SK, 1995, J ANTIMICROB CHEMOTH, V35, P7; DUBUS A, 1994, BIOCHEM J, V301, P485, DOI 10.1042/bj3010485; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; Ferain T, 1996, J BACTERIOL, V178, P5431, DOI 10.1128/JB.178.18.5431-5437.1996; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Frere J M, 1976, Methods Enzymol, V45, P610; FRERE JM, 1975, NATURE, V258, P168, DOI 10.1038/258168a0; FRERE JM, 1976, NATURE, V260, P451, DOI 10.1038/260451a0; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; FRERE JM, 1992, CHEM BETA LACTAMS, P149; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Ghuysen JM, 1997, INT J ANTIMICROB AG, V8, P45, DOI 10.1016/S0924-8579(96)00358-5; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; GOODELL EW, 1985, J BACTERIOL, V163, P305, DOI 10.1128/JB.163.1.305-310.1985; Guillaume G, 1997, J BIOL CHEM, V272, P5438, DOI 10.1074/jbc.272.9.5438; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; HAMMARSTROM S, 1975, P NATL ACAD SCI USA, V72, P3463, DOI 10.1073/pnas.72.9.3463; Harris F, 2002, EUR J BIOCHEM, V269, P5821, DOI 10.1046/j.1432-1033.2002.03295.x; Hayes F, 1997, J BIOL CHEM, V272, P28833, DOI 10.1074/jbc.272.46.28833; Hoiczyk E, 2000, J BACTERIOL, V182, P1191, DOI 10.1128/JB.182.5.1191-1199.2000; JAMIN M, 1991, BIOCHEM J, V280, P499, DOI 10.1042/bj2800499; JAMIN M, 1995, ESSAYS BIOCHEM, V29, P1; JORIS B, 1988, BIOCHEM J, V250, P313, DOI 10.1042/bj2500313; KELLY JA, 1986, SCIENCE, V231, P1429, DOI 10.1126/science.3082007; Leganes F, 2005, ARCH MICROBIOL, V184, P234, DOI 10.1007/s00203-005-0046-8; Lewis ER, 1997, P NATL ACAD SCI USA, V94, P443, DOI 10.1073/pnas.94.2.443; LOBKOVSKY E, 1994, BIOCHEMISTRY-US, V33, P6762, DOI 10.1021/bi00188a004; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; MATAGNE A, 1995, BBA-PROTEIN STRUCT M, V1246, P109, DOI 10.1016/0167-4838(94)00177-I; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Morlot C, 2005, J BIOL CHEM, V280, P15984, DOI 10.1074/jbc.M408446200; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Nakamura Y, 2002, DNA RES, V9, P135, DOI 10.1093/dnares/9.4.135; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; NICHOLAS RA, 1988, J BIOL CHEM, V263, P2034; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; Osuna J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh135; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; PRATT RF, 2002, J CHEM SOC P2, V5, P851; Rhazi N, 2003, BIOCHEMISTRY-US, V42, P2895, DOI 10.1021/bi027256x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schrader-Fischer G, 2001, ANTIMICROB AGENTS CH, V45, P407, DOI 10.1128/AAC.45.2.407-412.2001; SHIBATA KI, 1987, J BACTERIOL, V169, P3409, DOI 10.1128/jb.169.8.3409-3413.1987; SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0; VANDERLINDEN MPG, 1992, J BACTERIOL, V174, P7572, DOI 10.1128/JB.174.23.7572-7578.1992; Vanwetswinkel S, 2000, J MOL BIOL, V295, P527, DOI 10.1006/jmbi.1999.3376; WAXMAN DJ, 1979, J BIOL CHEM, V254, P2056; WILKIN JM, 1993, BIOCHEM J, V293, P195, DOI 10.1042/bj2930195; ZHU YF, 1990, J BACTERIOL, V172, P1137, DOI 10.1128/jb.172.2.1137-1141.1990	67	17	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32516	32526		10.1074/jbc.M805375200	http://dx.doi.org/10.1074/jbc.M805375200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801739	hybrid			2022-12-27	WOS:000260893700040
J	Banerjee, S; Bond, JS				Banerjee, Sanjita; Bond, Judith S.			Prointerleukin-18 Is Activated by Meprin beta in Vitro and in Vivo in Intestinal Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BOND SPECIFICITY; ALPHA-SUBUNIT; CONVERTING-ENZYME; EPITHELIAL-CELLS; EXPRESSION; SUBSTRATE; MATRIX; INTERLEUKIN-1-BETA; METALLOPROTEASES; SECRETION	Interleukin-18 (IL-18), a pro-inflammatory cytokine, is a key factor in inflammatory bowel disease (IBD). Caspase-1 activates this cytokine, but other proteases are likely involved in maturation. Because meprin metalloproteinases have been implicated in IBD, the interaction of these proteases with proIL-18 was studied. The results demonstrate that the meprin beta subunit of meprins A and B cleaves proIL-18 into a smaller 17-kDa product. The cleavage is at the Asn(51)-Asp(52) bond, a site C-terminal to caspase-1 cleavage. The cleavage occurred in vitro with a K-m of 1.3 mu M and in Madin-Darby canine kidney cells transfected with meprin beta when proIL-18 was added to the culture medium. The product of meprin B cleavage of proIL-18 activated NF-kappa B in EL-4 cells, indicating that it was biologically active. To determine the physiological significance of the interactions of meprins with proIL-18, an experimental model of IBD was produced by administering dextran sulfate sodium (DSS) to wildtype and meprin beta knock-out (beta KO) mice, and the serum levels of active IL-18 were determined. DSS-treated meprin beta KO mice had lower levels of the active cytokine in the serum compared with wild-type mice. Furthermore, in meprin alpha KO mice, which express meprin beta but not alpha, active IL-18 was elevated in the serum of DSS-treated mice compared with wild-type mice, indicating that the meprin isoforms have opposing effects on the IL-18 levels in vivo. This study identifies proIL-18 as a biologically important substrate for meprin beta and implicates meprins in the modulation of inflammation.	[Banerjee, Sanjita; Bond, Judith S.] Penn State Univ Hosp, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bond, JS (corresponding author), Penn State Univ Hosp, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr,H171, Hershey, PA 17033 USA.	jbond@psu.edu			National Institutes of Health [DK19691]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK019691, R01DK019691, R37DK019691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK19691 (to J. S. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambort D, 2008, FEBS J, V275, P4490, DOI 10.1111/j.1742-4658.2008.06592.x; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Bankus JM, 1996, ARCH BIOCHEM BIOPHYS, V331, P87, DOI 10.1006/abbi.1996.0286; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2002, BIOL CHEM, V383, P1175, DOI 10.1515/BC.2002.129; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; DUMERMUTH E, 1993, FEBS LETT, V335, P367, DOI 10.1016/0014-5793(93)80421-P; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Garrigue-Antar L, 2001, J BIOL CHEM, V276, P26237, DOI 10.1074/jbc.M010814200; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hengst JA, 2004, J BIOL CHEM, V279, P34856, DOI 10.1074/jbc.M405774200; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Ishmael FT, 2005, J BIOL CHEM, V280, P13895, DOI 10.1074/jbc.M414218200; Johnson DE, 2000, LEUKEMIA, V14, P1695, DOI 10.1038/sj.leu.2401879; Kanai T, 2001, GASTROENTEROLOGY, V121, P875, DOI 10.1053/gast.2001.28021; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Mohan MJ, 2002, BIOCHEMISTRY-US, V41, P9462, DOI 10.1021/bi0260132; Monteleone G, 1999, J IMMUNOL, V163, P143; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Reuter BK, 2004, EUR J IMMUNOL, V34, P2347, DOI 10.1002/eji.200425351; Sivakumar PV, 2002, GUT, V50, P812, DOI 10.1136/gut.50.6.812; Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568; Villa JP, 2003, J BIOL CHEM, V278, P42545, DOI 10.1074/jbc.M303718200; Wiercinska-Drapalo A, 2005, WORLD J GASTROENTERO, V11, P605, DOI 10.3748/wjg.v11.i4.605	34	79	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31371	31377		10.1074/jbc.M802814200	http://dx.doi.org/10.1074/jbc.M802814200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786924	Green Published, hybrid			2022-12-27	WOS:000260760800015
J	Montoya-Durango, DE; Velu, CS; Kazanjian, A; Rojas, MEB; Jay, CM; Longmore, GD; Grimes, HL				Montoya-Durango, Diego E.; Velu, Chinavenmeni S.; Kazanjian, Avedis; Rojas, Meghan E. B.; Jay, Chris M.; Longmore, Gregory D.; Grimes, H. Leighton			Ajuba Functions as a Histone Deacetylase-dependent Co-repressor for Autoregulation of the Growth Factor-independent-1 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIM PROTEIN AJUBA; SEVERE CONGENITAL NEUTROPENIA; ZINC-FINGER PROTEIN; FACTOR INDEPENDENCE-1; DOMAIN PROTEIN; ONLY PROTEIN; COMPLEX; GFI-1; DNA; COREPRESSOR	Growth factor independent-1 (Gfi1) is a zinc finger protein with a SNAG-transcriptional repressor domain. Ajuba is a LIM domain protein that shuttles between the cytoplasm and the nucleus. Ajuba functions as a co-repressor for synthetic Gfi1 SNAG-repressor domain-containing constructs, but a role for Ajuba co-repression of the cognate DNA bound Gfi1 protein has not been defined. Co-immunoprecipitation of synthetic and endogenous proteins and co-elution with gel filtration suggest that an endogenous Ajuba.Gfi1.HDAC multiprotein complex is possible. Active histone deacetylase activity co-immunoprecipitates with Ajuba or Gfi1, and both proteins depend upon histone deacetylases for full transcriptional repression activity. Ajuba LIM domains directly bind to Gfi1, but the association is not SNAG domain-dependent. ChIP analysis and reciprocal knockdown experiments suggest that Ajuba selectively functions as a co-repressor for Gfi1 autoregulation. The data suggest that Ajuba is utilized as a corepressor selectively on Gfi1 target genes.	[Montoya-Durango, Diego E.; Kazanjian, Avedis; Jay, Chris M.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Velu, Chinavenmeni S.; Rojas, Meghan E. B.; Grimes, H. Leighton] Cincinnati Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Longmore, Gregory D.] Washington Univ, Dept Med, St Louis, MO 63130 USA	University of Louisville; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Washington University (WUSTL)	Grimes, HL (corresponding author), 3333 Burnet Ave,MLC 7038, Cincinnati, OH 45229 USA.	lee.grimes@cchmc.org		Grimes, H. Leighton/0000-0001-8162-6758	National Institutes of Health [R01 HL079574, CA105152]; Leukemia Lymphoma Society Scholar; NATIONAL CANCER INSTITUTE [R01CA105152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Lymphoma Society Scholar(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079574 and CA105152 (to H. L. G.). This work was also supported by a Leukemia Lymphoma Society Scholar award (to H. L. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doan LL, 2004, NUCLEIC ACIDS RES, V32, P2508, DOI 10.1093/nar/gkh570; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Feng YF, 2007, J BIOL CHEM, V282, P39, DOI 10.1074/jbc.M607399200; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; GILKS C, 1993, MOL CELL BIOL, V113, P1759; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Howard PW, 2001, J BIOL CHEM, V276, P19020, DOI 10.1074/jbc.M101782200; Kanungo J, 2000, MOL BIOL CELL, V11, P3299, DOI 10.1091/mbc.11.10.3299; Kazanjian A, 2004, CANCER RES, V64, P6874, DOI 10.1158/0008-5472.CAN-04-0633; Kazanjian A, 2006, CRIT REV ONCOL HEMAT, V59, P85, DOI 10.1016/j.critrevonc.2006.02.002; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; McLoughlin P, 2002, J BIOL CHEM, V277, P37045, DOI 10.1074/jbc.M203336200; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Retaux S, 2002, MOL NEUROBIOL, V26, P269, DOI 10.1385/MN:26:2-3:269; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang Y, 2001, BBA-MOL CELL RES, V1538, P260, DOI 10.1016/S0167-4889(01)00077-5; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zarebski A, 2008, IMMUNITY, V28, P370, DOI 10.1016/j.immuni.2007.12.020; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	42	48	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32056	32065		10.1074/jbc.M802320200	http://dx.doi.org/10.1074/jbc.M802320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18805794	Green Published, hybrid			2022-12-27	WOS:000260760800087
J	Roychaudhuri, R; Yang, M; Hoshi, MM; Teplow, DB				Roychaudhuri, Robin; Yang, Mingfeng; Hoshi, Minako M.; Teplow, David B.			Amyloid beta-Protein Assembly and Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; PEPTIDE; NEURODEGENERATION; AGGREGATION; NEUROTOXICITY; MECHANISMS; MEMBRANE; DISTINCT; FIBRILS		[Roychaudhuri, Robin; Yang, Mingfeng; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Hoshi, Minako M.] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Teplow, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	dteplow@ucla.edu		Roychaudhuri, Robin/0000-0003-3851-4181	National Institutes of Heath [NS038328, AG027818]; Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers at UCLA; State of California Alzheimer's Disease Research Fund [07-65806]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027818] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers at UCLA; State of California Alzheimer's Disease Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Heath Grants NS038328 and AG027818. This work was also supported by the Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarkers at UCLA and State of California Alzheimer's Disease Research Fund Grant 07-65806. This is the seventh article of eleven in the Thematic Minireview Series on the Molecular Basis of Alzheimer Disease. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Butterfield DA, 2003, CURR MED CHEM, V10, P2651, DOI 10.2174/0929867033456422; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen JX, 2007, J ALZHEIMERS DIS, V12, P177; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Crouch PJ, 2007, REJUV RES, V10, P349, DOI 10.1089/rej.2007.0592; Crouch PJ, 2008, INT J BIOCHEM CELL B, V40, P181, DOI 10.1016/j.biocel.2007.07.013; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Green JD, 2004, J MOL BIOL, V342, P877, DOI 10.1016/j.jmb.2004.07.052; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 1996, ANN MED, V28, P255, DOI 10.3109/07853899609033127; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Jun S, 2007, ANGEW CHEM INT EDIT, V46, P5263, DOI 10.1002/anie.200790133; Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Malaplate-Armand C, 2006, NEUROBIOL DIS, V23, P178, DOI 10.1016/j.nbd.2006.02.010; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Murakami K, 2005, J AM CHEM SOC, V127, P15168, DOI 10.1021/ja054041c; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sipe JD, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P1, DOI 10.1002/9783527619344; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Tashima Y, 2004, J BIOL CHEM, V279, P17587, DOI 10.1074/jbc.M308622200; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Tycko R, 2006, METHOD ENZYMOL, V413, P103, DOI 10.1016/S0076-6879(06)13006-2; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Westlind-Danielsson A, 2001, BIOCHEMISTRY-US, V40, P14736, DOI 10.1021/bi010375c; Yamin G, 2008, CURR PHARM DESIGN, V14, P3231, DOI 10.2174/138161208786404137; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200	50	508	520	1	92	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4749	4753		10.1074/jbc.R800036200	http://dx.doi.org/10.1074/jbc.R800036200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	18845536	Green Published, hybrid			2022-12-27	WOS:000263416600001
J	Wang, JH; Palzkill, T; Chow, DC				Wang, Jihong; Palzkill, Timothy; Chow, Dar-Chone			Structural Insight into the Kinetics and Delta Cp of Interactions between TEM-1 beta-Lactamase and beta-Lactamase Inhibitory Protein (BLIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIMETRIC ENTHALPIES; CONTACT RESIDUES; GROWTH-HORMONE; PHAGE DISPLAY; VANT-HOFF; HOT-SPOT; BINDING; INTERFACE; THERMODYNAMICS; RECOGNITION	In a previous study, we examined thermodynamic parameters for 20 alanine mutants in beta-lactamase inhibitory protein( BLIP) for binding to TEM-1 beta-lactamase. Here we have determined the structures of two thermodynamically distinctive complexes of BLIP mutants with TEM-1 beta-lactamase. The complex BLIP Y51A-TEM-1 is a tight binding complex with the most negative binding heat capacity change ( Delta G = similar to-13 kcal mol(-1) and Delta Cp = similar to-0.8 kcal mol(-1) K-1) among all of the mutants, whereas BLIP W150A-TEM-1 is a weak complex with one of the least negative binding heat capacity changes (Delta G = similar to-8.5 kcal mol(-1) and Delta Cp = similar to-0.27 kcal mol(-1) K-1). We previously determined that BLIP Tyr(51) is a canonical and Trp(150) an anti-canonical TEM-1-contact residue, where canonical refers to the alanine substitution resulting in a matched change in the hydrophobicity of binding free energy. Structure determination indicates a rearrangement of the interactions between Asp(49) of the W150A BLIP mutant and the catalytic pocket of TEM-1. The Asp(49) of W150A moves more than 4 angstrom to form two new hydrogen bonds while losing four original hydrogen bonds. This explains the anti-canonical nature of the Trp(150) to alanine substitution, and also reveals a strong long distance coupling between Trp(150) and Asp(49) of BLIP, because these two residues are more than 25 angstrom apart. Kinetic measurements indicate that the mutations influence the dissociation rate but not the association rate. Further analysis of the structures indicates that an increased number of interface-trapped water molecules correlate with poor interface packing in a mutant. It appears that the increase of interface-trapped water molecules is inversely correlated with negative binding heat capacity changes.	[Wang, Jihong; Chow, Dar-Chone] Univ Houston, Dept Chem, Houston, TX 77204 USA; [Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine	Chow, DC (corresponding author), Univ Houston, Dept Chem, Univ Pk, Houston, TX 77204 USA.	dchow@mail.uh.edu			American Heart Association [0435186N]; University of Houston; Institute for Molecular Design; National Institutes of Health [AI32956]; National Science Foundation [DBI-9871464]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032956, R37AI032956] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Houston; Institute for Molecular Design; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Scientist Development Grant 0435186N from the American Heart Association and startup funding from University of Houston and the Institute for Molecular Design ( to D. C.). This work was also supported in part by National Institutes of Health Grant AI32956 ( to T. P.). Data used in this publication were collected at the Gulf Coast Protein Crystallography Beamline at the Center for Advanced Microstructures and Devices. This beamline is supported by the National Science Foundation Grant DBI-9871464 with co-funding from the National Institutes of Health ( NIGMS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albeck S, 1999, BIOCHEMISTRY-US, V38, P11, DOI 10.1021/bi981772z; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Cantu C, 1997, J BIOL CHEM, V272, P29144, DOI 10.1074/jbc.272.46.29144; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Dauter Z, 2003, METHOD ENZYMOL, V368, P288, DOI 10.1016/S0076-6879(03)68016-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fletcher S, 2007, CURR TOP MED CHEM, V7, P922, DOI 10.2174/156802607780906735; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; GOMEZ J, 1995, J MOL BIOL, V252, P337, DOI 10.1006/jmbi.1995.0501; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HIBBITS KA, 1994, BIOCHEMISTRY-US, V33, P3584, DOI 10.1021/bi00178a015; Horn JR, 2001, BIOCHEMISTRY-US, V40, P1774, DOI 10.1021/bi002408e; Horn JR, 2002, BIOCHEMISTRY-US, V41, P7501, DOI 10.1021/bi025626b; Huang WZ, 2000, J BIOL CHEM, V275, P14964, DOI 10.1074/jbc.M001285200; Huang WZ, 2003, PROTEIN ENG, V16, P853, DOI 10.1093/protein/gzg108; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikura T, 2004, CHEM PHYS, V307, P111, DOI 10.1016/j.chemphys.2004.05.010; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Janin J, 2008, SCIENCE, V319, P165, DOI 10.1126/science.1152930; Janin J, 2007, ACTA CRYSTALLOGR D, V63, P1, DOI 10.1107/S090744490603575X; Kouadio JLK, 2005, J BIOL CHEM, V280, P25524, DOI 10.1074/jbc.M502167200; Ladbury JE, 2004, CURR OPIN STRUC BIOL, V14, P562, DOI 10.1016/j.sbi.2004.08.001; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Majiduddin FK, 2002, INT J MED MICROBIOL, V292, P127, DOI 10.1078/1438-4221-00198; MURPHY KP, 1993, PROTEINS, V15, P113, DOI 10.1002/prot.340150203; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearce KH, 1996, BIOCHEMISTRY-US, V35, P10300, DOI 10.1021/bi960513b; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Reichmann D, 2008, BIOCHEMISTRY-US, V47, P1051, DOI 10.1021/bi7019639; Reynolds KA, 2006, J BIOL CHEM, V281, P26745, DOI 10.1074/jbc.M603878200; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Rudgers GW, 2001, PROTEIN ENG, V14, P487, DOI 10.1093/protein/14.7.487; Rudgers GW, 2001, ANTIMICROB AGENTS CH, V45, P3279, DOI 10.1128/AAC.45.12.3279-3286.2001; SCHWARZ FP, 1995, EUR J BIOCHEM, V228, P388; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Sundberg EJ, 2000, BIOCHEMISTRY-US, V39, P15375, DOI 10.1021/bi000704l; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; TSUMOTO K, 1994, J BIOL CHEM, V269, P28777; Wang JH, 2007, J BIOL CHEM, V282, P17676, DOI 10.1074/jbc.M611548200; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Whitty A, 2006, NAT CHEM BIOL, V2, P112, DOI 10.1038/nchembio0306-112; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Zhang Z, 2004, J BIOL CHEM, V279, P42860, DOI 10.1074/jbc.M406157200; Zhang Z, 2003, J BIOL CHEM, V278, P45706, DOI 10.1074/jbc.M308572200	60	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					595	609		10.1074/jbc.M804089200	http://dx.doi.org/10.1074/jbc.M804089200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18840610	hybrid, Green Published			2022-12-27	WOS:000261974800065
J	Blokzijl, H; Van Steenpaal, A; Borght, SV; Bok, LIH; Libbrecht, L; Tamminga, M; Geuken, M; Roskams, TAD; Dijkstra, G; Moshage, H; Jansen, PLM; Faber, KN				Blokzijl, Hans; Van Steenpaal, Axel; Borght, Sara Vander; Bok, Lisette I. H.; Libbrecht, Louis; Tamminga, Marieke; Geuken, Mariska; Roskams, Tania A. D.; Dijkstra, Gerard; Moshage, Han; Jansen, Peter L. M.; Faber, Klaas Nico			Up-regulation and Cytoprotective Role of Epithelial Multidrug Resistance-associated Protein 1 in Inflammatory Bowel Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; P-GLYCOPROTEIN; ULCERATIVE-COLITIS; INDUCED APOPTOSIS; DRUG-RESISTANCE; EXPRESSION; GENE; GLUTATHIONE; TRANSPORT; MDR1	MRP1 (multidrug resistance-associated protein 1) is well known for its role in providing multidrug resistance to cancer cells. In addition, MRP1 has been associated with both pro- and anti-inflammatory functions in nonmalignant cells. The pro- inflammatory function is evident from the fact that MRP1 is a high affinity transporter for cysteinyl-leukotriene C-4 (LTC4), a lipid mediator of inflammation. It remains unexplained, however, why the absence of Mrp1 leads to increased intestinal epithelial damage in mice treated with dextran-sodium sulfate, a model for inflammatory bowel disease (IBD). We found that MRP1 expression is induced in the inflamed intestine of IBD patients, e. g. Crohn disease and ulcerative colitis. Increased MRP1 expression was detected at the basolateral membrane of intestinal epithelial cells. To study a putative role for MRP1 in protecting epithelial cells against inflammatory cues, we manipulated MRP1 levels in human epithelial DLD-1 cells and exposed these cells to cytokines and anti-Fas. Inhibition of MRP1 (by MK571 or RNA interference) resulted in increased cytokine- and anti-Fas-induced apoptosis of DLD-1 cells. Opposite effects, e. g. protection of DLD-1 cells against cytokine- and anti-Fas-induced apoptosis, were observed after recombinant MRP1 overexpression. Inhibition of LTC4 synthesis reduced anti-Fas-induced apoptosis when MRP1 function was blocked, suggesting that LTC4 is the pro- apoptotic compound exported by epithelial MRP1 during inflammation. These data show that MRP1 protects intestinal epithelial cells against inflammation-induced apoptotic cell death and provides a functional role for MRP1 in the inflamed intestinal epithelium of IBD patients.	[Blokzijl, Hans; Van Steenpaal, Axel; Bok, Lisette I. H.; Tamminga, Marieke; Geuken, Mariska; Dijkstra, Gerard; Moshage, Han; Faber, Klaas Nico] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands; [Borght, Sara Vander; Libbrecht, Louis; Roskams, Tania A. D.] Univ Leuven, Dept Pathol, B-3000 Louvain, Belgium; [Jansen, Peter L. M.] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; KU Leuven; University of Amsterdam; Academic Medical Center Amsterdam	Faber, KN (corresponding author), POB 30-001, NL-9700 RB Groningen, Netherlands.	k.n.faber@med.umcg.nl	Jansen, Peter LM/I-4509-2013	/0000-0003-4563-7462; Moshage, Han/0000-0002-4764-0246; Roskams, Tania/0000-0002-2816-1530				Albermann N, 2005, BIOCHEM PHARMACOL, V70, P949, DOI 10.1016/j.bcp.2005.06.018; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Blokzijl H, 2007, INFLAMM BOWEL DIS, V13, P710, DOI 10.1002/ibd.20088; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4; Brant SR, 2003, AM J HUM GENET, V73, P1282, DOI 10.1086/379927; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Dijkstra G, 2004, J PATHOL, V204, P296, DOI 10.1002/path.1656; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Flens MJ, 1996, AM J PATHOL, V148, P1237; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hammond CL, 2001, J HEPATOL, V34, P946, DOI 10.1016/S0168-8278(01)00037-X; Han SY, 2000, BIOL PHARM BULL, V23, P420; Hayashi H, 1998, APOPTOSIS, V3, P431, DOI 10.1023/A:1009662619907; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Kwak JY, 2000, CELL IMMUNOL, V203, P84, DOI 10.1006/cimm.2000.1682; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Luo M, 2003, HISTOL HISTOPATHOL, V18, P587, DOI 10.14670/HH-18.587; Michalsky MP, 2001, J PEDIATR SURG, V36, P1130, DOI 10.1053/jpsu.2001.25730; Nies AT, 2008, EXPERT OPIN DRUG MET, V4, P545, DOI [10.1517/17425255.4.5.545, 10.1517/17425255.4.5.545 ]; NISHIKAWA M, 1995, J GASTROENTEROL, V30, P34, DOI 10.1007/BF01211372; Panwala CM, 1998, J IMMUNOL, V161, P5733; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Plass JRM, 2002, HEPATOLOGY, V35, P589, DOI 10.1053/jhep.2002.31724; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; Ros JE, 2003, J PATHOL, V200, P553, DOI 10.1002/path.1379; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Scheffer GL, 2000, CANCER RES, V60, P5269; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Sharma J. N., 2006, Inflammopharmacology, V14, P10, DOI 10.1007/s10787-006-1496-6; Strater J, 1997, GASTROENTEROLOGY, V113, P160, DOI 10.1016/S0016-5085(97)70091-X; Strater J, 2000, ANN NY ACAD SCI, V915, P162; Taketo MM, 2002, BBA-MOL CELL BIOL L, V1585, P72, DOI 10.1016/S1388-1981(02)00326-8; Ten Hove T, 2002, DIGEST DIS SCI, V47, P2056, DOI 10.1023/A:1019629013945; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Van Limbergen J, 2007, AM J GASTROENTEROL, V102, P2820, DOI 10.1111/j.1572-0241.2007.01527.x; vandenDobbelsteen DJ, 1996, J BIOL CHEM, V271, P15420, DOI 10.1074/jbc.271.26.15420; Vander Borght S, 2005, J PATHOL, V207, P471, DOI 10.1002/path.1852; VANDULLEMEN H, 1997, SCAND J GASTROENTERO, V223, pS92; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Yukawa M, 2002, INT J COLORECTAL DIS, V17, P70, DOI 10.1007/s003840100340; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	51	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35630	35637		10.1074/jbc.M804374200	http://dx.doi.org/10.1074/jbc.M804374200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18838379	hybrid			2022-12-27	WOS:000261687900036
J	Clifford, RL; Deacon, K; Knox, AJ				Clifford, Rachel L.; Deacon, Karl; Knox, Alan J.			Novel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor beta(1) REQUIREMENT FOR Smads, beta-CATENIN, AND GSK3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR; FACTOR GENE; SIGNALING ACTIVITY; FACTOR EXPRESSION; COLON-CANCER; ANGIOGENESIS; DISEASE; MECHANISMS; HYPOXIA	Vascular endothelial growth factor ( VEGF) is a vital angiogenic effector, regulating key angiogenic processes. Vascular development relies on numerous signaling pathways, of which those induced by transforming growth factor-beta(TGF beta) are critical. The Wnt/beta-catenin signaling pathway is emerging as necessary for vascular development. Although VEGF, TGF beta, and Wnt signal transductions are well studied individually, it has not been demonstrated previously that all three can interact or be dependent on each other. We show that regulation of VEGF by TGF beta(1), in human pulmonary artery smooth muscle cells (PASMCs), depends on a direct interaction between TGF beta signaling proteins, Smads, and members of the Wnt/beta- catenin signaling family. VEGF promoter reporter constructs identified a region of the VEGF promoter containing two T cell factor (TCF)-binding sites as necessary for TGF beta(1)-induced VEGF transcription. Mutation of TCF sites and expression of dominant negative TCF4 abolished TGF beta(1)-induced VEGF promoter activity. Studies in Smad2 and Smad3 knock-out mouse embryonic fibroblasts demonstrated that one or both are required for VEGF regulation by TGF beta(1), with transfection of dominant negative Smad2 or Smad3 into PASMCs confirming this. Chromatin immunoprecipitation assays showed in cell interactions of Smad2 and Smad3 with TCF4 and beta-catenin at the VEGF promoter, whereas co-immunoprecipitation showed a direct physical interaction between Smad2 and beta-catenin in the nucleus of PASMCs. Finally, we demonstrate that TGF beta 1 regulates TCF by modifying beta-catenin phosphorylation via regulation of glycogen synthase kinase 3 beta. These results provide new insight into the molecular regulation of VEGF by two interacting pathways necessary for vascular development, maintenance, and disease.	[Clifford, Rachel L.; Deacon, Karl; Knox, Alan J.] Univ Nottingham, Ctr Resp Res, Nottingham NG5 1PB, England	University of Nottingham	Knox, AJ (corresponding author), City Hosp, Ctr Resp Res, Hucknall Rd, Nottingham NG5 1PB, England.	alan.knox@nottingham.ac.uk		Knox, Alan/0000-0002-5906-4143; Clifford, Rachel/0000-0002-8677-452X	British Heart Foundation; Wellcome Trust	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the British Heart Foundation and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ballara SC, 1999, INT J EXP PATHOL, V80, P235, DOI 10.1046/j.1365-2613.1999.00129.x; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Beck PL, 1999, INFLAMM BOWEL DIS, V5, P44, DOI 10.1097/00054725-199902000-00007; Benckert C, 2003, CANCER RES, V63, P1083; Biggs JR, 1996, J BIOL CHEM, V271, P901, DOI 10.1074/jbc.271.2.901; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Bradbury D, 2005, J BIOL CHEM, V280, P29993, DOI 10.1074/jbc.M414530200; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen H, 2007, J CELL BIOCHEM, V102, P1281, DOI 10.1002/jcb.21358; Clavel G, 2003, JOINT BONE SPINE, V70, P321, DOI 10.1016/S1297-319X(03)00088-5; Dunn NR, 2005, GENE DEV, V19, P152, DOI 10.1101/gad.1243205; FINKENZELLER G, 1995, BIOCHEM BIOPH RES CO, V208, P432, DOI 10.1006/bbrc.1995.1356; Gille J, 1997, EMBO J, V16, P750, DOI 10.1093/emboj/16.4.750; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Hagen T, 2004, BIOCHEM J, V379, P471, DOI 10.1042/BJ20031749; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kanazawa H, 2003, AM J MED, V114, P354, DOI 10.1016/S0002-9343(02)01562-0; Kanazawa H, 2002, THORAX, V57, P885, DOI 10.1136/thorax.57.10.885; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Knox AJ, 2001, FASEB J, V15, P2480, DOI 10.1096/fj.01-0256com; Leung KW, 2006, J BIOL CHEM, V281, P36280, DOI 10.1074/jbc.M606698200; Li JN, 2005, GASTROENTEROLOGY, V128, P1907, DOI 10.1053/j.gastro.2005.02.067; Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010; Masckauchan THN, 2006, PHYSIOLOGY, V21, P181, DOI 10.1152/physiol.00058.2005; McColl BK, 2004, APMIS, V112, P463, DOI 10.1111/j.1600-0463.2004.apm11207-0807.x; Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104; Nik SA, 2007, EXP CELL RES, V313, P2887, DOI 10.1016/j.yexcr.2007.05.024; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Ray BK, 2007, J IMMUNOL, V178, P1774, DOI 10.4049/jimmunol.178.3.1774; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Takahashi-Yanaga Fumi, 2007, Fukuoka Acta Medica, V98, P93; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; van Gijn ME, 2002, CARDIOVASC RES, V55, P16, DOI 10.1016/S0008-6363(02)00221-3; Xie WF, 1998, J BIOL CHEM, V273, P5026, DOI 10.1074/jbc.273.9.5026; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	45	81	86	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35337	35353		10.1074/jbc.M803342200	http://dx.doi.org/10.1074/jbc.M803342200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952601	hybrid			2022-12-27	WOS:000261687900005
J	Nafisi, H; Banihashemi, B; Daigle, M; Albert, PR				Nafisi, Houman; Banihashemi, Behzad; Daigle, Mireille; Albert, Paul R.			GAP1(IP4BP)/RASA3 Mediates G alpha(i)-induced Inhibition of Mitogen-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN-RELEASING-HORMONE; LACTOTROPH HYPERPLASIA; PITUITARY-CELLS; D2 RECEPTORS; GAP1 FAMILY; DOPAMINE; PROLACTIN; RAS; IDENTIFICATION; SPECIFICITY	The dopamine D2S receptor (short isoform) couples to inhibitory G alpha(i/o) proteins to inhibit thyrotropin-releasing hormone (TRH)-stimulated p42/p44 mitogen-activated protein kinase (ERK1/2) phosphorylation in GH4ZR7 rat pituitary cells, consistent with its actions to inhibit prolactin gene transcription and cell proliferation. However, the underlying mechanism is unclear. To identify novel G alpha(i) effectors, yeast two-hybrid screening of a GH4ZR7 cDNA library was done using constitutively active G alpha(i3)-Q204L, and multiple clone of the RasGAP cDNA GAP1(IP4BP)/RASA3 were identified. In yeast mating assay, RASA3 preferentially interacted with activated forms of G alpha(i/o/z) proteins, but not with G alpha(s). A direct interaction was indicated by in vitro pull-down assay, in which S-His-RASA3 preferentially bound guanosine 5'-O-(gamma-thio)triphosphate-activated G alpha(i3) and G alpha(i2) compared with guanosine 5'-O-(beta-thio) diphosphate-inactivated proteins. Similarly, in co-immunoprecipitation studies in HEK-293 cells, FLAG-tagged RASA3 preferentially interacted with activated mutants of G alpha(i3) and G alpha(i2) compared with wild type proteins. In GH4ZR7 cells, co-immunoprecipitation studies of endogenous proteins demonstrated a G alpha(i3)-RASA3 complex that was induced upon TRH/D2S receptor co-activation. To address RASA3 function in dopamine D2S receptor-induced inhibition of ERK1/2 activity, endogenous RASA3 protein expression was suppressed (70% knockdown) in GH4ZR7 cells stably transfected with full-length antisense cDNA of RASA3. The selected antisense clones had similar levels of dopamine D2S receptor binding and D2S-induced inhibition of cAMP formation compared with parental GH4ZR7 cells. In these clones, D2S-mediated inhibition of TRH-induced phospho-ERK1/2 was reversed by 70-80% compared with parental GH4ZR7 cells. Our results provide a novel mechanism for dopamine D2S-induced inhibition of ERK1/2 and indicate that RASA3 links G alpha(i) proteins to inhibit G(q)-induced Ras/ ERK1/2 activation.	[Nafisi, Houman; Banihashemi, Behzad; Daigle, Mireille; Albert, Paul R.] Univ Ottawa, Ottawa Hlth Res Inst Neurosci, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute		palbert@uottawa.ca	Albert, Paul/E-4804-2010	Albert, Paul/0000-0002-1809-3554	Canadian Institutes of Health; Ontario Mental Health Research	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Research	This work was supported by grants from the Canadian Institutes of Health and the Ontario Mental Health Research (to P.R.A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBERT PR, 1994, TRENDS PHARMACOL SCI, V15, P250, DOI 10.1016/0165-6147(94)90320-4; Albert PR, 2002, MOL ENDOCRINOL, V16, P1903, DOI 10.1210/me.2001-0329; ALBERT PR, 1997, DOPAMINE RECEPTORS, P359; Asa SL, 1999, ENDOCRINOLOGY, V140, P5348, DOI 10.1210/en.140.11.5348; Banihashemi B, 2002, MOL ENDOCRINOL, V16, P2393, DOI 10.1210/me.2001-0220; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; CIVELLI O, 1993, ANNU REV PHARMACOL, V33, P281, DOI 10.1146/annurev.pa.33.040193.001433; Colao A, 2000, HORM RES, V53, P76, DOI 10.1159/000023539; Cozier GE, 2000, J BIOL CHEM, V275, P28261; Cozier GE, 2003, J BIOL CHEM, V278, P39489, DOI 10.1074/jbc.M307785200; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Hnasko TS, 2007, NEUROENDOCRINOLOGY, V86, P48, DOI 10.1159/000105242; Iaccarino C, 2002, P NATL ACAD SCI USA, V99, P14530, DOI 10.1073/pnas.222319599; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Kupzig S, 2006, METHOD ENZYMOL, V407, P64, DOI 10.1016/S0076-6879(05)07007-2; Liu JC, 2005, MOL ENDOCRINOL, V19, P1904, DOI 10.1210/me.2004-0111; Liu JC, 2002, J BIOL CHEM, V277, P35819, DOI 10.1074/jbc.M202920200; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Liu YF, 1999, J BIOL CHEM, V274, P16444, DOI 10.1074/jbc.274.23.16444; LIU YF, 1994, J BIOL CHEM, V269, P13880; Lockyer PJ, 1997, CURR BIOL, V7, P1007, DOI 10.1016/S0960-9822(06)00423-4; Lockyer PJ, 1999, BIOCHEM BIOPH RES CO, V255, P421, DOI 10.1006/bbrc.1999.0217; Lockyer PJ, 1999, CURR BIOL, V9, P265, DOI 10.1016/S0960-9822(99)80116-X; McNulty TJ, 2001, CELL SIGNAL, V13, P877, DOI 10.1016/S0898-6568(01)00197-8; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Pinzone JJ, 2000, J CLIN ENDOCR METAB, V85, P3053, DOI 10.1210/jc.85.9.3053; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Signore AP, 1999, J NEUROSCI RES, V55, P321, DOI 10.1002/(SICI)1097-4547(19990201)55:3<321::AID-JNR7>3.0.CO;2-A; Smith J, 2001, MOL ENDOCRINOL, V15, P1539, DOI 10.1210/me.15.9.1539; Trouillas J, 1999, ENDOCRINOLOGY, V140, P13, DOI 10.1210/en.140.1.13; Van-Ham II, 2007, J NEUROCHEM, V102, P1796, DOI 10.1111/j.1471-4159.2007.04650.x; Wang YH, 1999, MOL ENDOCRINOL, V13, P1094, DOI 10.1210/me.13.7.1094; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846; [No title captured]	41	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35908	35917		10.1074/jbc.M803622200	http://dx.doi.org/10.1074/jbc.M803622200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952607	hybrid			2022-12-27	WOS:000261687900066
J	Okada, S; Yamada, E; Saito, T; Ohshima, K; Hashimoto, K; Yamada, M; Uehara, Y; Tsuchiya, T; Shimizu, H; Tatei, K; Izumi, T; Yamauchi, K; Hisanaga, S; Pessin, JE; Mori, M				Okada, Shuichi; Yamada, Eijiro; Saito, Tsugumichi; Ohshima, Kihachi; Hashimoto, Koshi; Yamada, Masanobu; Uehara, Yutaka; Tsuchiya, Takafumi; Shimizu, Hiroyuki; Tatei, Kazuaki; Izumi, Takashi; Yamauchi, Keishi; Hisanaga, Shin-ichi; Pessin, Jeffrey E.; Mori, Masatomo			CDK5-dependent Phosphorylation of the Rho Family GTPase TC10 alpha Regulates Insulin-stimulated GLUT4 Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; PROTEIN INTERACTIONS; FILAMENTOUS ACTIN; PLASMA-MEMBRANE; CORTICAL ACTIN; CDK5 ACTIVATOR; ADIPOCYTES; TC10; P35; ENDOCYTOSIS	Insulin stimulation results in the activation of cyclin-dependent kinase-5 (CDK5) in lipid raft domains via a Fyn-dependent phosphorylation on tyrosine residue 15. In turn, activated CDK5 phosphorylates the Rho family GTP-binding protein TC10 alpha on threonine 197 that is sensitive to the CDK5 inhibitor olomoucine and blocked by small interfering RNA-mediated knockdown of CDK5. The phosphorylation deficient mutant T197A-TC10 alpha was not phosphorylated and excluded from the lipid raft domain, whereas the phosphorylation mimetic mutant (T197D-TC10 alpha) was lipid raft localized. Insulin resulted in the GTP loading of T197D-TC10 alpha but not T197A-TC10 alpha and in parallel, T197D-TC10 alpha but not T197A-TC10 alpha depolymerized cortical actin and inhibited insulin-stimulated GLUT4 translocation. These data demonstrate that CDK5-dependent phosphorylation maintains TC10 alpha in lipid raft compartments thereby disrupting cortical actin, whereas subsequent dephosphorylation of TC10 alpha through inactivation of CDK5 allows for the re-assembly of F-actin. Because cortical actin reorganization is required for insulin-stimulated GLUT4 translocation, these data are consistent with a CDK5-dependent TC10 alpha cycling between lipid raft and non-lipid raft compartments.	[Okada, Shuichi; Yamada, Eijiro; Saito, Tsugumichi; Hashimoto, Koshi; Yamada, Masanobu; Uehara, Yutaka; Tsuchiya, Takafumi; Shimizu, Hiroyuki; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma 3710034, Japan; [Tatei, Kazuaki; Izumi, Takashi] Gunma Univ, Grad Sch Med, Dept Mol Biochem, Gunma 3710034, Japan; [Ohshima, Kihachi] Gunma Univ, Hlth & Med Ctr, Gunma 3718511, Japan; [Yamauchi, Keishi] Nagano Red Cross Hosp, Dept Endocrinol & Diabet, Nagano 3808582, Japan; [Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Gunma University; Gunma University; Gunma University; Nagano Red Cross Hospital; Tokyo Metropolitan University; Yeshiva University; Albert Einstein College of Medicine	Okada, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, 3-39-15 Showa Machi, Gunma 3710034, Japan.	okadash@showa.gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X				Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Chiang SH, 2002, J BIOL CHEM, V277, P13067, DOI 10.1074/jbc.M109471200; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Fielding CJ, 2003, BBA-BIOMEMBRANES, V1610, P219, DOI 10.1016/S0005-2736(03)00020-8; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Hou JCQ, 2003, MOL BIOL CELL, V14, P3578, DOI 10.1091/mbc.E03-02-0012; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kanzaki M, 2002, J BIOL CHEM, V277, P25867, DOI 10.1074/jbc.C200292200; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Lim ACB, 2003, NEUROSIGNALS, V12, P230, DOI 10.1159/000074625; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Okada Shuichi, 2003, Methods Mol Med, V83, P93; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	30	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35455	35463		10.1074/jbc.M806531200	http://dx.doi.org/10.1074/jbc.M806531200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948252	hybrid			2022-12-27	WOS:000261687900017
J	Ransom, JF; King, IN; Garg, V; Srivastava, D				Ransom, Joshua F.; King, Isabelle N.; Garg, Vidu; Srivastava, Deepak			A Rare Human Sequence Variant Reveals Myocardin Autoinhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; MUSCLE GENE-EXPRESSION; TRANSCRIPTION FACTOR-B; CARDIOVASCULAR DEVELOPMENT; DIFFERENTIATION; HEART; COACTIVATORS; HYPERTROPHY; REQUIREMENT; MODULATION	Myocardin (MYOCD) is a transcriptional co-activator that promotes cardiac or smooth muscle gene programs through its interaction with myocyte-enhancing factor (MEF2) or serumresponse factor (SRF). Isoforms of MYOCD with a truncated amino terminus show increased activity when compared with those with the full-length amino terminus, but how this is achieved remains unknown. We identified a rare human sequence variation in MYOCD in a patient with congenital heart disease that resulted in a missense mutation at codon 259 (K259R). This variation created a hypomorphic cardiac isoform with impaired SRF binding and transactivation capacity but did not impair the smooth muscle isoform of MYOCD, which lacks the amino terminus. Consistent with differential effects of the amino terminus on the K259R mutation, we found that the cardiac-specific amino terminus acted in an autoinhibitory fashion to bind MYOCD via specific negatively charged residues and thereby repressed SRF-dependent MYOCD activity. This effect was exaggerated in the MYOCD-K259R mutant. The amino terminus was sufficient to impair MYOCD-dependent fibroblast conversion into smooth muscle cells as well as cardiomyocyte hypertrophy. These findings identify a novel mechanism that regulates levels of MYOCD-dependent activation of the SRF genetic program differentially in cardiac and smooth muscle.	[Ransom, Joshua F.; King, Isabelle N.; Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ransom, Joshua F.; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Ransom, Joshua F.; King, Isabelle N.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Garg, Vidu] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Garg, Vidu] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	Garg, Vidu/E-3101-2011; Garg, Vidu/D-8240-2012	Garg, Vidu/0000-0002-3778-5927; Ransom, Joshua/0000-0002-3591-0288	National Institutes of Health [R01 HL080592]; University of Texas Southwestern Cardiovascular Training [5-T32-HL007360]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079260, T32HL007360, R01HL080592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Cardiovascular Training; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL080592 and by University of Texas Southwestern Cardiovascular Training Grant NIH 5-T32-HL007360. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Li J, 2005, P NATL ACAD SCI USA, V102, P8916, DOI 10.1073/pnas.0503741102; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Oh J, 2004, MOL CELL BIOL, V24, P8519, DOI 10.1128/MCB.24.19.8519-8528.2004; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Peterson JR, 2004, J CELL BIOCHEM, V93, P68, DOI 10.1002/jcb.20184; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	28	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35845	35852		10.1074/jbc.M805909200	http://dx.doi.org/10.1074/jbc.M805909200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18852265	hybrid, Green Published			2022-12-27	WOS:000261687900059
J	Tanuma, N; Kim, SE; Beullens, M; Tsubaki, Y; Mitsuhashi, S; Nomura, M; Kawamura, T; Isono, K; Koseki, H; Sato, M; Bollen, M; Kikuchi, K; Shima, H				Tanuma, Nobuhiro; Kim, Sei-Eun; Beullens, Monique; Tsubaki, Yao; Mitsuhashi, Shinya; Nomura, Miyuki; Kawamura, Takeshi; Isono, Kyoichi; Koseki, Haruhiko; Sato, Masami; Bollen, Mathieu; Kikuchi, Kunimi; Shima, Hiroshi			Nuclear Inhibitor of Protein Phosphatase-1 (NIPP1) Directs Protein Phosphatase-1 (PP1) to Dephosphorylate the U2 Small Nuclear Ribonucleoprotein Particle (snRNP) Component, Spliceosome-associated Protein 155 (Sap155)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; C-TERMINUS; IN-VIVO; PHOSPHORYLATION; KINASE; REGULATOR; INACTIVATION; EXPRESSION; COMPLEX; BINDS	Pre-mRNA splicing entails reversible phosphorylation of spliceosomal proteins. Recent work has revealed essential roles for Ser/Thr phosphatases, such as protein phosphatase-1 (PP1), in splicing, but how these phosphatases are regulated is largely unknown. We show that nuclear inhibitor of PP1 (NIPP1), a major PP1 interactor in the vertebrate nucleus, recruits PP1 to Sap155 (spliceosome-associated protein 155), an essential component of U2 small nuclear ribonucleoprotein particles, and promotes Sap155 dephosphorylation. C-terminally truncated NIPP1 (NIPP1-Delta C) formed a hyper-active holoenzyme with PP1, rendering PP1 minimally phosphorylated on an inhibitory site. Forced expression of NIPP1-WT and -Delta C resulted in slight and severe decreases in Sap155 hyperphosphorylation, respectively, and the latter was accompanied with inhibition of splicing. PP1 overexpression produced similar effects, whereas small interfering RNA-mediated NIPP1 knockdown enhanced Sap155 hyperphosphorylation upon okadaic acid treatment. NIPP1 did not inhibit but rather stimulated Sap155 dephosphorylation by PP1 in vitro through facilitating Sap155/PP1 interaction. Further analysis revealed that NIPP1 specifically recognizes hyperphosphorylated Sap155 thorough its Forkhead-associated domain and dissociates from Sap155 after dephosphorylation by associated PP1. Thus NIPP1 works as a molecular sensor for PP1 to recognize phosphorylated Sap155.	[Tanuma, Nobuhiro; Nomura, Miyuki; Sato, Masami; Shima, Hiroshi] Miyagi Canc Ctr, Res Inst, Div Canc Chemotherapy, Natori, Miyagi 9811293, Japan; [Tanuma, Nobuhiro; Kim, Sei-Eun; Tsubaki, Yao; Mitsuhashi, Shinya; Kikuchi, Kunimi] Hokkaido Univ, Inst Med Genet, Div Biochem Oncol & Immunol, Sapporo, Hokkaido 0600815, Japan; [Mitsuhashi, Shinya] Hokkaido Univ, Res Fac Agr, Div Appl Biosci, Sapporo, Hokkaido 0600815, Japan; [Beullens, Monique; Bollen, Mathieu] Katholieke Univ Leuven, Fac Med, Lab Biosignaling & Therapeut, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Kawamura, Takeshi] Univ Tokyo, RCAST, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Isono, Kyoichi; Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan	Miyagi Cancer Center; Hokkaido University; Hokkaido University; KU Leuven; University of Tokyo; RIKEN	Tanuma, N (corresponding author), Miyagi Canc Ctr, Res Inst, Div Canc Chemotherapy, Natori, Miyagi 9811293, Japan.	tanuma-no872@pref.miyagi.jp; shima-hi632@pref.miyagi.jp	Koseki, Haruhiko/I-3825-2014; Mitsuhashi, Shinya/A-4337-2012	Koseki, Haruhiko/0000-0001-8424-5854; Isono, Kyoichi/0000-0002-4609-8985	Japan Society for the Promotion of Science of Japan	Japan Society for the Promotion of Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research (B and C) provided by the Japan Society for the Promotion of Science of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Banerjee H, 2004, RNA, V10, P240, DOI 10.1261/rna.5153204; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; BEULLENS M, 1993, J BIOL CHEM, V268, P13172; Beullens M, 2002, J BIOL CHEM, V277, P19855, DOI 10.1074/jbc.M200847200; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Boudrez A, 2002, J BIOL CHEM, V277, P31834, DOI 10.1074/jbc.M204427200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; Friend K, 2007, MOL CELL, V28, P240, DOI 10.1016/j.molcel.2007.09.026; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Johnson D, 1997, EUR J BIOCHEM, V244, P931, DOI 10.1111/j.1432-1033.1997.00931.x; Kim SE, 2000, INT J ONCOL, V16, P751; Kumeta H, 2008, J BIOMOL NMR, V40, P219, DOI 10.1007/s10858-008-9222-x; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Misteli T, 1999, CURR BIOL, V9, pR198, DOI 10.1016/S0960-9822(99)80128-6; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; TAKIZAWA N, 1994, J BIOCHEM-TOKYO, V116, P411, DOI 10.1093/oxfordjournals.jbchem.a124540; Tran HT, 2004, MOL CELL PROTEOMICS, V3, P257, DOI 10.1074/mcp.M300115-MCP200; Trinkle-Mulcahy L, 1999, J CELL SCI, V112, P157; Van Eynde A, 2004, MOL CELL BIOL, V24, P5863, DOI 10.1128/MCB.24.13.5863-5874.2004; VAN EYNDE A, 1994, BIOCHEM J, V297, P447, DOI 10.1042/bj2970447; Vulsteke V, 2004, J BIOL CHEM, V279, P8642, DOI 10.1074/jbc.M311466200; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Weiser DC, 2004, J BIOL CHEM, V279, P48904, DOI 10.1074/jbc.M404416200; YAMANO H, 1994, EMBO J, V13, P5310, DOI 10.1002/j.1460-2075.1994.tb06865.x; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	41	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35805	35814		10.1074/jbc.M805468200	http://dx.doi.org/10.1074/jbc.M805468200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18842582	hybrid			2022-12-27	WOS:000261687900055
J	Brown, MD; Bry, L; Li, ZG; Sacks, DB				Brown, Matthew D.; Bry, Lynn; Li, Zhigang; Sacks, David B.			Actin Pedestal Formation by Enteropathogenic Escherichia coli Is Regulated by IQGAP1, Calcium, and Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATED INTIMIN RECEPTOR; EPITHELIAL-CELLS; INTEGRATES CA2+/CALMODULIN; TYROSINE PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVITY; SIGNAL-TRANSDUCTION; EFFACING LESIONS; ALPHA-ACTININ; HOST-CELLS; B-RAF	During infection, enteropathogenic Escherichia coli (EPEC) injects effector proteins into the host cell to manipulate the actin cytoskeleton and promote formation of actin pedestals. IQGAP1 is a multidomain protein that participates in numerous cellular functions, including Rac1/Cdc42 and Ca2+/calmodulin signaling and actin polymerization. Here we report that IQGAP1, Ca2+, and calmodulin modulate actin pedestal formation by EPEC. Infection with EPEC promotes both the interaction of IQGAP1 with calmodulin and the localization of IQGAP1 and calmodulin to actin pedestals while reducing the interaction of IQGAP1 with Rac1 and Cdc42. IQGAP1-null fibroblasts display a reduced polymerization of actin in response to EPEC. In addition, antagonism of calmodulin or chelation of intracellular Ca2+ reduces EPEC-dependent actin polymerization. Furthermore, IQGAP1 specifically interacts with Tir in vitro and in cells. Together these data identify IQGAP1, Ca2+, and calmodulin as a novel signaling complex regulating actin pedestal formation by EPEC.	[Sacks, David B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sacks, DB (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Thorn 530,75 Francis St, Boston, MA 02115 USA.	dsacks@rics.bwh.harvard.edu		Bry, Lynn/0000-0002-8792-8527; Sacks, David/0000-0003-3100-0735	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health grants (to D. B. S. and L. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Bain C, 1998, INFECT IMMUN, V66, P3900, DOI 10.1128/IAI.66.8.3900-3908.1998; BALDWIN TJ, 1991, INFECT IMMUN, V59, P1599, DOI 10.1128/IAI.59.5.1599-1604.1991; Ben-Ami G, 1998, INFECT IMMUN, V66, P1755, DOI 10.1128/IAI.66.4.1755-1758.1998; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DYTOC M, 1994, GASTROENTEROLOGY, V106, P1150, DOI 10.1016/0016-5085(94)90004-3; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; FOUBISTER V, 1994, J EXP MED, V179, P993, DOI 10.1084/jem.179.3.993; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; GIULIANO KA, 1995, CURR OPIN CELL BIOL, V7, P4, DOI 10.1016/0955-0674(95)80038-7; Goosney DL, 2000, CURR BIOL, V10, P735, DOI 10.1016/S0960-9822(00)00543-1; Goosney DL, 2000, ANNU REV CELL DEV BI, V16, P173, DOI 10.1146/annurev.cellbio.16.1.173; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Hardwidge PR, 2004, J BIOL CHEM, V279, P20127, DOI 10.1074/jbc.M401228200; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Ide T, 2003, INFECT IMMUN, V71, P1725, DOI 10.1128/IAI.71.4.1725-1732.2003; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; KennedyKalafatis S, 1996, J GEOGR HIGHER EDUC, V20, P323, DOI 10.1080/03098269608709376; Kenny B, 1997, INFECT IMMUN, V65, P2528, DOI 10.1128/IAI.65.7.2528-2536.1997; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Lommel S, 2004, CELL MICROBIOL, V6, P243, DOI 10.1111/j.1462-5822.2004.00364.x; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; Michgehl S, 2006, CELL MICROBIOL, V8, P625, DOI 10.1111/j.1462-5822.2005.00655.x; NORMAN JA, 1987, MOL PHARMACOL, V31, P535; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; Patel A, 2006, CELL MICROBIOL, V8, P55, DOI 10.1111/j.1462-5822.2005.00600.x; Phillips N, 2004, NAT CELL BIOL, V6, P618, DOI 10.1038/ncb1148; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; ROSENSHINE I, 1992, EMBO J, V11, P3551, DOI 10.1002/j.1460-2075.1992.tb05438.x; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; SHELANSKI ML, 1989, ANN NY ACAD SCI, V568, P121; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Unsworth KE, 2007, CELL MICROBIOL, V9, P438, DOI 10.1111/j.1462-5822.2006.00801.x; Zhang HZ, 1996, MOL MICROBIOL, V21, P787, DOI 10.1046/j.1365-2958.1996.431403.x	65	36	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35212	35222		10.1074/jbc.M803477200	http://dx.doi.org/10.1074/jbc.M803477200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18809683	hybrid, Green Published			2022-12-27	WOS:000261469100077
J	Lei, XY; Zhang, S; Bohrer, A; Ramanadham, S				Lei, Xiaoyong; Zhang, Sheng; Bohrer, Alan; Ramanadham, Sasanka			Calcium-independent Phospholipase A(2) (iPLA(2)beta)-mediated Ceramide Generation Plays a Key Role in the Cross-talk between the Endoplasmic Reticulum (ER) and Mitochondria during ER Stress-induced Insulin-secreting Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; CYTOCHROME-C RELEASE; TYPE-2 DIABETES-MELLITUS; TANDEM MASS-SPECTROMETRY; SARCOENDOPLASMIC RETICULUM; CASPASE-12 ACTIVATION; ARACHIDONIC-ACID; OXIDATIVE STRESS; PATHWAY; ISLETS	Endoplasmic reticulum ( ER) stress induces INS-1 cell apoptosis by a pathway involving Ca2+-independent phospholipase A(2) (iPLA(2)beta)-mediated ceramide generation, but the mechanism by which iPLA(2)beta and ceramides contribute to apoptosis is not well understood. We report here that both caspase-12 and caspase-3 are activated in INS-1 cells following induction of ER stress with thapsigargin, but only caspase-3 cleavage is amplified in iPLA(2)beta overexpressing INS-1 cells (OE), relative to empty vector-transfected cells, and is suppressed by iPLA(2)beta inhibition. ER stress also led to the release of cytochrome c and Smac and, unexpectedly, their accumulation in the cytosol is amplified in OE cells. These findings raise the likelihood that iPLA(2)beta participates in ER stress-induced apoptosis by activating the intrinsic apoptotic pathway. Consistent with this possibility, we find that ER stress promotes iPLA(2)beta accumulation in the mitochondria, opening of mitochondrial permeability transition pore, and loss in mitochondrial membrane potential (Delta Psi) in INS-1 cells and that these changes are amplified in OE cells. ER stress also led to greater ceramide generation in ER and mitochondria fractions of OE cells. Exposure to ceramide alone induces loss in Delta Psi and apoptosis and these are suppressed by forskolin. ER stress-induced mitochondrial dysfunction and apoptosis are also inhibited by forskolin, as well as by inactivation of iPLA(2)beta or NSMase, suggesting that iPLA(2)beta-mediated generation of ceramides via sphingomyelin hydrolysis during ER stress affect the mitochondria. In support, inhibition of iPLA(2)beta or NSMase prevents cytochrome c release. Collectively, our findings indicate that the iPLA(2)beta-ceramide axis plays a critical role in activating the mitochondrial apoptotic pathway in insulin-secreting cells during ER stress.	[Lei, Xiaoyong; Zhang, Sheng; Bohrer, Alan; Ramanadham, Sasanka] Washington Univ, Sch Med, Dept Med, Mass Spectrometry Resource & Div Endocrinol Metab, St Louis, MO 63110 USA	Washington University (WUSTL)	Ramanadham, S (corresponding author), Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	sramanad@dom.wustl.edu			National Institutes of Health [R01-DK69455, R37-DK34388, P41-RR00954, P60-DK20579, P30DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, R01DK069455, P60DK020579, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK69455, R37-DK34388, P41-RR00954, P60-DK20579, and P30DK56341. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; CORBETT JA, 1992, DIABETES, V41, P897, DOI 10.2337/diabetes.41.8.897; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; Darios F, 2003, J NEUROCHEM, V84, P643, DOI 10.1046/j.1471-4159.2003.01590.x; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Di Sano F, 2006, J BIOL CHEM, V281, P2693, DOI 10.1074/jbc.M509110200; Diaz-Horta O, 2002, DIABETES, V51, P1815, DOI 10.2337/diabetes.51.6.1815; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Falluel-Morel A, 2004, J NEUROCHEM, V91, P1231, DOI 10.1111/j.1471-4159.2004.02810.x; Fensome AC, 2002, BIOCHEM J, V365, P69, DOI 10.1042/BJ20020120; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gijon MA, 1997, SEMIN CELL DEV BIOL, V8, P297, DOI 10.1006/scdb.1997.0151; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Hajnoczky G, 2000, J PHYSIOL-LONDON, V529, P69, DOI 10.1111/j.1469-7793.2000.00069.x; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hasenjager A, 2004, ONCOGENE, V23, P4523, DOI 10.1038/sj.onc.1207594; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P437, DOI 10.1016/S1044-0305(99)00150-6; Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kong JY, 2005, MOL CELL BIOCHEM, V278, P39, DOI 10.1007/s11010-005-1979-6; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; KRONCKE KD, 1993, BIOCHIM BIOPHYS ACTA, V1182, P221, DOI 10.1016/0925-4439(93)90144-P; Kudva Yogish C., 1997, P119; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ma ZM, 1997, J BIOL CHEM, V272, P11118; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Morales MC, 2007, FREE RADICAL RES, V41, P591, DOI 10.1080/10715760701218558; Muranaka S, 2004, FREE RADICAL RES, V38, P613, DOI 10.1080/10715760410001694035; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Predescu SA, 2007, J BIOL CHEM, V282, P17166, DOI 10.1074/jbc.M608996200; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Rath GM, 2006, INT J BIOCHEM CELL B, V38, P2219, DOI 10.1016/j.biocel.2006.07.004; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shiraishi H, 2006, J CELL SCI, V119, P3958, DOI 10.1242/jcs.03160; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Socha L, 2003, ANN NY ACAD SCI, V1005, P178, DOI 10.1196/annals.1288.022; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; TAMIYAKOIZUMI K, 1989, J BIOCHEM, V106, P593, DOI 10.1093/oxfordjournals.jbchem.a122901; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Turk J, 2004, CAN J PHYSIOL PHARM, V82, P824, DOI 10.1139/Y04-064; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Wilkins WP, 2008, CURR DRUG TARGETS, V9, P683, DOI 10.2174/138945008785132385; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	83	76	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34819	34832		10.1074/jbc.M807409200	http://dx.doi.org/10.1074/jbc.M807409200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936091	Green Published, hybrid			2022-12-27	WOS:000261469100038
J	Horike, N; Sakoda, H; Kushiyama, A; Ono, H; Fujishiro, M; Kamata, H; Nishiyama, K; Uchijima, Y; Kurihara, Y; Kurihara, H; Asano, T				Horike, Nanao; Sakoda, Hideyuki; Kushiyama, Akifumi; Ono, Hiraku; Fujishiro, Midori; Kamata, Hideaki; Nishiyama, Koichi; Uchijima, Yasunobu; Kurihara, Yukiko; Kurihara, Hiroki; Asano, Tomoichiro			AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3 beta and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; PROMOTER-REGULATORY REGION; ACETYL-COA CARBOXYLASE; LEUCINE-ZIPPER DOMAIN; GTP GENE; GLUCOSE-METABOLISM; HEPATIC GLUCONEOGENESIS; COACTIVATOR TORC2; INSULIN; IDENTIFICATION	AMP-activated protein kinase (AMPK) activation reportedly suppresses transcriptional activity of the cAMP-responsive element (CRE) in the phosphoenolpyruvate carboxykinase C (PEPCK-C) promoter and reduces hepatic PEPCK-C expression. Although a previous study found TORC2 phosphorylation to be involved in the suppression of AMPK-mediated CRE transcriptional activity, we herein present evidence that glycogen synthase kinase 3 beta (GSK3 beta) phosphorylation induced by AMPK also plays an important role. We initially found that injecting fasted mice with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) markedly increased Ser-9 phosphorylation of hepatic GSK3 beta within 15 min. Stimulation with AICAR or the GSK3 beta inhibitor SB-415286 strongly inhibited CRE-containing promoter activity in HepG2 cells. Using the Gal4-based transactivation assay system, the transcriptional activity of cAMP-response element-binding protein (CREB) was suppressed by both AICAR and SB415286, whereas that of TORC2 was repressed significantly by AICAR but very slightly by SB415286. These results show inactivation of GSK3 beta to directly inhibit CREB but not TORC2. Importantly, the AICAR-induced suppression of PEPCK-C expression was shown to be blunted by overexpression of GSK3 beta(S9G) but not wild-type GSK3 beta. In addition, AICAR stimulation decreased, whereas Compound C (AMPK inhibitor) increased CREB phosphorylation (Ser-129) in HepG2 cells. The time-courses of decreased CREB phosphorylation (Ser-129) and increased GSK3 beta phosphorylation were very similar. Furthermore, AMPK-mediated GSK3 beta phosphorylation was inhibited by an Akt-specific inhibitor in HepG2 cells, suggesting involvement of the Akt pathway. In summary, phosphorylation (Ser-9) of GSK3 beta is very likely to be critical for AMPK-mediated PEPCK-C gene suppression. Reduced CREB phosphorylation (Ser- 129) associated with inactivation of GSK3 beta by Ser- 9 phosphorylation may be the major mechanism underlying PEPCK-C gene suppression by AMPK-activating agents such as biguanide.	[Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Horike, Nanao; Nishiyama, Koichi; Uchijima, Yasunobu; Kurihara, Yukiko; Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo, Japan; [Sakoda, Hideyuki; Ono, Hiraku; Fujishiro, Midori] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan	Hiroshima University; University of Tokyo; University of Tokyo; Asahi Life Foundation	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asano-tky@umin.ac.jp	Kushiyama, Akifumi/A-6386-2011; Kamata, Hideaki/N-3907-2017; Nishiyama, Koichi/H-4275-2014; Kushiyama, Akifumi/W-5988-2019	Kushiyama, Akifumi/0000-0003-1385-7487; Nishiyama, Koichi/0000-0003-0529-4207; Kushiyama, Akifumi/0000-0003-1385-7487; Kurihara, Hiroki/0000-0002-6476-5593				Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Boer U, 2007, BIOCHEM J, V408, P69, DOI 10.1042/BJ20070796; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Croniger C, 1998, J BIOL CHEM, V273, P31629, DOI 10.1074/jbc.273.48.31629; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; IZATOS A, 2006, MOL CELL BIOL, V26, P63; Kaidanovich-Beilin O, 2006, J PHARMACOL EXP THER, V316, P17, DOI 10.1124/jpet.105.090266; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; KLEMM DJ, 1990, MOL CELL BIOL, V10, P480, DOI 10.1128/MCB.10.2.480; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Leahy P, 1999, J BIOL CHEM, V274, P8813, DOI 10.1074/jbc.274.13.8813; Lipina C, 2005, BIOCHEM J, V392, P633, DOI 10.1042/BJ20051046; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Lochhead PA, 2001, DIABETES, V50, P937, DOI 10.2337/diabetes.50.5.937; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; Parker D, 1996, MOL CELL BIOL, V16, P694; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SASAKI K, 1984, J BIOL CHEM, V259, P5242; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; SHORT JM, 1986, J BIOL CHEM, V261, P9721; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tyson DR, 2002, ENDOCRINOLOGY, V143, P674, DOI 10.1210/en.143.2.674; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yeagley D, 1998, J BIOL CHEM, V273, P18743, DOI 10.1074/jbc.273.30.18743; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050	51	149	153	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33902	33910		10.1074/jbc.M802537200	http://dx.doi.org/10.1074/jbc.M802537200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18801732	Green Published, hybrid			2022-12-27	WOS:000261277700016
J	Wang, KP; Wang, CH; Xiao, F; Wang, HX; Wu, ZG				Wang, Kepeng; Wang, Chihao; Xiao, Fang; Wang, Haixia; Wu, Zhenguo			JAK2/STAT2/STAT3 Are Required for Myogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; SATELLITE CELL-PROLIFERATION; EMBRYONIC STEM-CELLS; GROWTH-FACTOR-II; SIGNALING PATHWAYS; ADULT MYOGENESIS; TYROSINE KINASE; GENE-EXPRESSION; MEF2 PROTEINS; STAT3	Skeletal muscle satellite cell-derived myoblasts are mainly responsible for postnatal muscle growth and injury-induced regeneration. However, the cellular signaling pathways that control proliferation and differentiation of myoblasts remain poorly defined. Recently, we found that JAK1/STAT1/STAT3 not only participate in myoblast proliferation but also actively prevent them from premature differentiation. Unexpectedly, we found that a related pathway consisting of JAK2, STAT2, and STAT3 is required for early myogenic differentiation. Interference of this pathway by either a small molecule inhibitor or small interfering RNA inhibits myogenic differentiation. Consistently, all three molecules are activated upon differentiation. The pro-differentiation effect of JAK2/STAT2/STAT3 is partially mediated by MyoD and MEF2. Interestingly, the expression of the IGF2 gene and the HGF gene is also regulated by JAK2/STAT2/STAT3, suggesting that this pathway could also promote differentiation by regulating signaling molecules known to be involved in myogenic differentiation. In summary, our current study reveals a novel role for the JAK2/STAT2/STAT3 pathway in myogenic differentiation.	[Wang, Kepeng; Wang, Chihao; Xiao, Fang; Wang, Haixia; Wu, Zhenguo] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Wu, ZG (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China.	bczgwu@ust.hk	Wang, Kepeng/F-8363-2014	Wang, Kepeng/0000-0001-6428-4709; Wu, Zhenguo/0000-0003-3049-8324	Hong Kong Research Grant Council [663007, CA06/07.SC02]; Hong Kong University Grant Committee [AoE/B-15/01]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); Hong Kong University Grant Committee	This work was supported by Hong Kong Research Grant Council Grants 663007 and CA06/07.SC02 (to Z.W.) and Area of Excellence Scheme AoE/B-15/01 from the Hong Kong University Grant Committee. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; CHENG TC, 1992, J CELL BIOL, V119, P1649, DOI 10.1083/jcb.119.6.1649; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; FLIER JS, 1989, NEW ENGL J MED, V321, P1383, DOI 10.1056/NEJM198911163212007; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9; Garcia R, 1998, J BIOMED SCI, V5, P79, DOI 10.1159/000025316; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kataoka Y, 2003, J BIOL CHEM, V278, P44178, DOI 10.1074/jbc.M304884200; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Stewart CEH, 1996, J CELL PHYSIOL, V169, P23, DOI 10.1002/(SICI)1097-4652(199610)169:1<23::AID-JCP3>3.0.CO;2-G; Stewart CEH, 1996, J BIOL CHEM, V271, P11330, DOI 10.1074/jbc.271.19.11330; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tamir Y, 2000, J BIOL CHEM, V275, P34424, DOI 10.1074/jbc.M005815200; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zong CS, 1998, J BIOL CHEM, V273, P28065, DOI 10.1074/jbc.273.43.28065	57	96	100	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34029	34036		10.1074/jbc.M803012200	http://dx.doi.org/10.1074/jbc.M803012200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18835816	Green Published, hybrid			2022-12-27	WOS:000261277700030
J	Zhang, F; Wang, W; Tsuji, Y; Torti, SV; Torti, FM				Zhang, Fan; Wang, Wei; Tsuji, Yoshiaki; Torti, Suzy V.; Torti, Frank M.			Post-transcriptional Modulation of Iron Homeostasis during p53-dependent Growth Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; H-FERRITIN; TUMOR-SUPPRESSOR; MESSENGER-RNA; CANCER CELLS; IN-VITRO; P53; PROTEIN; EXPRESSION; REPRESSION	Iron plays an essential role in cell proliferation and is a required cofactor for a number of critical cellular enzymes. In this report we investigate changes in proteins of iron metabolism during p53-mediated replicative arrest. Following the induction of p53 in H1299 lung cancer cells containing a doxycycline-inducible p53, an increase in both H and L subunits of ferritin protein was observed. To determine the mechanism of this effect, we investigated the ability of p53 to regulate ferritin. Real time reverse transcription-PCR demonstrated no difference in levels of ferritin H mRNA in the presence and absence of p53. Because these results suggested that transcriptional mechanisms were not responsible for the p53-dependent increase in ferritin, we tested whether a post-transcriptional mechanism was involved. RNA bandshift assays revealed that induction of p53 decreased iron regulatory protein binding. Consistent with this observation, Western blot analysis revealed a decline in transferrin receptor 1 protein levels following induction of p53. Collectively, these results suggest that p53 may induce cell cycle arrest not only by well described mechanisms involving the induction of cyclin-dependent kinase inhibitors but also by the recruitment of pathways that reduce the availability of intracellular iron.	[Zhang, Fan; Wang, Wei; Tsuji, Yoshiaki; Torti, Frank M.] Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Torti, Suzy V.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Tsuji, Yoshiaki; Torti, Frank M.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Torti, SV (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	storti@wfubmc.edu			National Institutes of Health [DK42412]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042412, R01DK042412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK42412 (to F. M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bevilacqua MA, 1998, BIOCHEM J, V335, P521, DOI 10.1042/bj3350521; Blish KR, 2008, MOL BIOL CELL, V19, P457, DOI 10.1091/mbc.E07-05-0433; Brown L, 2007, CRIT REV EUKAR GENE, V17, P73, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.50; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Buss JL, 2004, CURR TOP MED CHEM, V4, P1623, DOI 10.2174/1568026043387269; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Chang HC, 1999, CANCER LETT, V145, P1, DOI 10.1016/S0304-3835(99)00209-8; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Epsztejn S, 1999, BLOOD, V94, P3593, DOI 10.1182/blood.V94.10.3593.422k26_3593_3603; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; Faniello MC, 2008, INT J BIOCHEM CELL B, V40, P2110, DOI 10.1016/j.biocel.2008.02.010; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Greene BT, 2002, J BIOL CHEM, V277, P25568, DOI 10.1074/jbc.M110345200; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kakhlon O, 2002, BIOCHEM SOC T, V30, P777, DOI 10.1042/bst0300777; Kakhlon O, 2001, BIOCHEM J, V356, P311, DOI 10.1042/0264-6021:3560311; Kim SW, 2002, P NATL ACAD SCI USA, V99, P12214, DOI 10.1073/pnas.192316099; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Kulp KS, 1996, EXP CELL RES, V229, P60, DOI 10.1006/excr.1996.0343; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Minotti G, 1998, FASEB J, V12, P541, DOI 10.1096/fasebj.12.7.541; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Pahl PMB, 2000, J BIOL CHEM, V275, P17821, DOI 10.1074/jbc.M909918199; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Theil EC, 2006, J INORG BIOCHEM, V100, P2074, DOI 10.1016/j.jinorgbio.2006.09.011; Thornborrow EC, 1999, J BIOL CHEM, V274, P33747, DOI 10.1074/jbc.274.47.33747; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; TSUJI Y, 1995, MOL CELL BIOL, V15, P5152; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2000, NAT CELL BIOL, V2, pE178, DOI 10.1038/35036427; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Weizer-Stern O, 2007, BRIT J HAEMATOL, V138, P253, DOI 10.1111/j.1365-2141.2007.06638.x; Wilkinson J, 2003, ADV ENZYME REGUL, V43, P135, DOI 10.1016/S0065-2571(02)00037-7; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	46	62	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33911	33918		10.1074/jbc.M806432200	http://dx.doi.org/10.1074/jbc.M806432200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819919	hybrid, Green Published			2022-12-27	WOS:000261277700017
J	Kalantari, P; Narayan, V; Natarajan, SK; Muralidhar, K; Gandhi, UH; Vunta, H; Henderson, AJ; Prabhu, KS				Kalantari, Parisa; Narayan, Vivek; Natarajan, Sathish K.; Muralidhar, Kambadur; Gandhi, Ujjawal H.; Vunta, Hema; Henderson, Andrew J.; Prabhu, K. Sandeep			Thioredoxin Reductase-1 Negatively Regulates HIV-1 Transactivating Protein Tat-dependent Transcription in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; REDOX REGULATION; CONTROLLED-TRIAL; T-CELLS; TYPE-1; SUPPLEMENTATION; MORTALITY; MECHANISM; WOMEN	Epidemiological studies suggest a correlation between severity of acquired immunodeficiency syndrome (AIDS) and selenium deficiency, indicating a protective role for this anti-oxidant during HIV infection. Here we demonstrate that thioredoxin reductase-1 (TR1), a selenium-containing pyridine nucleotide-disulfide oxidoreductase that reduces protein disulfides to free thiols, negatively regulates the activity of the HIV-1 encoded transcriptional activator, Tat, in human macrophages. We used a small interfering RNA approach as well as a high affinity substrate of TR1, ebselen, to demonstrate that Tat-dependent transcription and HIV-1 replication were significantly increased in human macrophages when TR1 activity was reduced. The increase in HIV-1 replication in TR1 small interfering RNA-treated cells was independent of the redox-sensitive transcription factor, NF-kappa B. These studies indicate that TR-1 acts as a negative regulator of Tat-dependent transcription. Furthermore, in vitro biochemical assays with recombinant Tat protein confirmed that TR1 targets two disulfide bonds within the Cys-rich motif required for efficient HIV-1 transactivation. Increasing TR1 expression along with other selenoproteins by supplementing with selenium suggests a potential inexpensive adjuvant therapy for HIV/AIDS patients.	[Henderson, Andrew J.] Boston Univ, Sch Med, Dept Med, Ctr HIV AIDS Care & Res, Boston, MA 02118 USA; [Kalantari, Parisa; Narayan, Vivek; Muralidhar, Kambadur; Gandhi, Ujjawal H.; Vunta, Hema; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Kalantari, Parisa; Narayan, Vivek; Muralidhar, Kambadur; Gandhi, Ujjawal H.; Vunta, Hema; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Natarajan, Sathish K.] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA	Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Nebraska System; University of Nebraska Lincoln	Henderson, AJ (corresponding author), Boston Univ, Sch Med, Dept Med, Ctr HIV AIDS Care & Res, Boston, MA 02118 USA.	andrew.henderson@bmc.org; ksp4@psu.edu		Henderson, Andrew/0000-0002-9299-5302; Narayan, Vivek/0000-0002-3232-7898	National Institutes of Health [R01 AI062467, R01 DK077152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI062467 (to A.J.H.) and R01 DK077152 (to K.S.P.) from the Public Health Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Baum MK, 1998, NUTR REV, V56, pS135; Baum MK, 1997, J ACQ IMMUN DEF SYND, V15, P370, DOI 10.1097/00042560-199708150-00007; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Bourgeois CF, 2002, MOL CELL BIOL, V22, P1079, DOI 10.1128/MCB.22.4.1079-1093.2002; Burbano Ximena, 2002, HIV Clin Trials, V3, P483; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gladyshev VN, 1999, P NATL ACAD SCI USA, V96, P835, DOI 10.1073/pnas.96.3.835; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; Kaiser JD, 2006, JAIDS-J ACQ IMM DEF, V42, P523, DOI 10.1097/01.qai.0000230529.25083.42; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kirsch T, 1996, PROTEIN EXPRES PURIF, V8, P75, DOI 10.1006/prep.1996.0076; KOKEN SEC, 1994, J BIOL CHEM, V269, P8366; Kupka R, 2005, EUR J CLIN NUTR, V59, P1250, DOI 10.1038/sj.ejcn.1602236; Kupka R, 2004, J NUTR, V134, P2556, DOI 10.1093/jn/134.10.2556; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; McClelland RS, 2004, JAIDS-J ACQ IMM DEF, V37, P1657, DOI 10.1097/00126334-200412150-00021; McDermid JM, 2002, J ACQ IMMUN DEF SYND, V29, P158, DOI 10.1097/00042560-200202010-00008; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; NEWMAN GW, 1994, J EXP MED, V180, P359, DOI 10.1084/jem.180.1.359; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Ogunro P S, 2006, Niger Postgrad Med J, V13, P1; Patki AH, 1996, CELL IMMUNOL, V169, P40, DOI 10.1006/cimm.1996.0088; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Shor-Posner G, 2003, INT J PSYCHIAT MED, V33, P55, DOI 10.2190/PFFD-D920-V041-N5KD; STADTMAN TC, 1990, ANNU REV BIOCHEM, V59, P111, DOI 10.1146/annurev.bi.59.070190.000551; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	43	56	57	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33183	33190		10.1074/jbc.M807403200	http://dx.doi.org/10.1074/jbc.M807403200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18835810	Green Published, hybrid			2022-12-27	WOS:000261183700021
J	Tachado, SD; Li, X; Swan, K; Patel, N; Koziel, H				Tachado, Souvenir D.; Li, Xin; Swan, Katharine; Patel, Naimish; Koziel, Henry			Constitutive Activation of Phosphatidylinositol 3-Kinase Signaling Pathway Down-regulates TLR4-mediated Tumor Necrosis Factor-alpha Release in Alveolar Macrophages from Asymptomatic HIV-positive Persons in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	103rd International Conference of the American-Thoracic-Society	MAY 18-23, 2007	San Francisco, CA	Amer Thorac Soc			HUMAN-IMMUNODEFICIENCY-VIRUS; NEF PROTEIN; CYTOKINE PRODUCTION; MANNOSE RECEPTOR; INTERLEUKIN-10; AKT; KINASE; INFECTION; BINDING; IL-12	Alveolar macrophages represent critical effector cells of innate immunity to infectious challenge in the lungs and recognize bacterial pathogens through pattern recognition receptors such as Toll-like receptors (TLRs). Phosphatidylinositol 3-kinse (PI3K) regulates TLR-mediated cytokine release, but whether HIV infection influences PI3K signaling pathway and alters TLR4-mediated macrophage response has not been investigated. In the current study, surface TLR4 expression were similar but TLR4 activation (lipid A, 10 mu g/ml) resulted in lower TNF-alpha release by HIV+ human macrophages compared with healthy cells. Pharmacological inhibition of PI3K (LY294002) normalized TNF-alpha release in HIV+ macrophages and augments ERK1/2 mitogen-activated protein kinase phosphorylation in response to lipid A. Importantly, HIV+ macrophages demonstrated increased constitutive phosphatidylinositol 3,4,5-trisphosphate formation, increased phosphorylation of downstream signaling molecules Akt and glycogen synthase kinase-3 beta(GSK-3 beta) at Ser(9), and reduced PTEN protein expression. As a functional assessment of GSK-3 beta phosphorylation, TLR4-mediated interleukin-10 release was significantly higher in HIV+ human macrophages compared with healthy cells. Incubation of human macrophages with exogenous HIV Nef protein induced phosphorylation of Akt and GSK-3 beta(whereas phosphorylation was reduced by PI3K inhibition) and promoted interleukin-10 release. Taken together, these data demonstrate increased constitutive activation of the PI3K signaling pathway in HIV+ macrophages and support the concept that PI3K activation (by HIV proteins such as Nef) may contribute to reduced TLR4-mediated TNF-alpha release in HIV+ human macrophages and impair host cell response to infectious challenge.	[Tachado, Souvenir D.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Tachado, SD (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Dept Med, 330 Brookline Ave,Kirstein Bldg,Rm KSB-023, Boston, MA 02215 USA.	stachado@bidmc.harvard.edu		Tachado, Souvenir/0000-0002-8368-6102	NHLBI NIH HHS [R01-HL063655] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063655] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AMEISEN JC, 1989, AIDS RES HUM RETROV, V5, P279, DOI 10.1089/aid.1989.5.279; Benito N, 2001, J ACQ IMMUN DEF SYND, V27, P35, DOI 10.1097/00126334-200105010-00006; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Brightbill HD, 2000, IMMUNOLOGY, V101, P1, DOI 10.1046/j.1365-2567.2000.00093.x; Brigino E, 1997, P NATL ACAD SCI USA, V94, P3178, DOI 10.1073/pnas.94.7.3178; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao XH, 2004, J IMMUNOL, V172, P4851, DOI 10.4049/jimmunol.172.8.4851; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Feikin DR, 2004, LANCET INFECT DIS, V4, P445, DOI 10.1016/S1473-3099(04)01060-6; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FOLKS TM, 1988, J IMMUNOL, V140, P1117; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Fujii Y, 1996, FEBS LETT, V393, P105, DOI 10.1016/0014-5793(96)00862-9; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Graziani A, 1996, J BIOL CHEM, V271, P6590, DOI 10.1074/jbc.271.12.6590; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Klber MA, 2008, CLIN IMMUNOL, V126, P315, DOI 10.1016/j.clim.2007.10.002; Koziel H, 1998, J CLIN INVEST, V102, P1332, DOI 10.1172/JCI560; Lalani I, 1997, ANN ALLERG ASTHMA IM, V79, P469, DOI 10.1016/S1081-1206(10)63052-9; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Maris NA, 2006, EUR RESPIR J, V28, P622, DOI 10.1183/09031936.06.00010806; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Park IW, 1999, AM J RESP CELL MOL, V20, P864, DOI 10.1165/ajrcmb.20.5.3547; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; ROGY MA, 1995, J EXP MED, V181, P2289, DOI 10.1084/jem.181.6.2289; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Tachado SD, 2005, AM J RESP CELL MOL, V33, P610, DOI 10.1165/rcmb.2004-0341OC; Tachado SD, 2007, J LEUKOCYTE BIOL, V81, P205, DOI 10.1189/jlb.1005580; Wallace JM, 1997, AM J RESP CRIT CARE, V155, P72, DOI 10.1164/ajrccm.155.1.9001292; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Zhang JM, 2004, INFECT IMMUN, V72, P3147, DOI 10.1128/IAI.72.6.3147-3160.2004	41	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33191	33198		10.1074/jbc.M805067200	http://dx.doi.org/10.1074/jbc.M805067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	376KY	18826950	Green Published, hybrid			2022-12-27	WOS:000261183700022
J	Thuault, S; Tan, EJ; Peinado, H; Cano, A; Heldin, CH; Moustakas, A				Thuault, Sylvie; Tan, E-Jean; Peinado, Hector; Cano, Amparo; Heldin, Carl-Henrik; Moustakas, Aristidis			HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; PROGRESSION	Epithelial-mesenchymal transition (EMT) is important during embryonic cell layer movement and tumor cell invasiveness. EMT converts adherent epithelial cells to motile mesenchymal cells, favoring metastasis in the context of cancer progression. Transforming growth factor-beta (TGF-beta) triggers EMT via intracellular Smad transducers and other signaling proteins. We previously reported that the high mobility group A2 (HMGA2) gene is required for TGF-beta to elicit EMT in mammary epithelial cells. In the present study we investigated the molecular mechanisms by which HMGA2 induces EMT. We found that HMGA2 regulates expression of many important repressors of E-cadherin. Among these, we analyzed in detail the zinc-finger transcription factor SNAIL1, which plays key roles in tumor progression and EMT. We demonstrate that HMGA2 directly binds to the SNAIL1 promoter and acts as a transcriptional regulator of SNAIL1 expression. Furthermore, we observed that HMGA2 cooperates with the TGF-beta/Smad pathway in regulating SNAIL1 gene expression. The mechanism behind this cooperation involves physical interaction between these factors, leading to an increased binding of Smads to the SNAIL1 promoter. SNAIL1 seems to play the role of a master effector downstream of HMGA2 for induction of EMT, as SNAIL1 knock-down partially reverts HMGA2-induced loss of epithelial differentiation. The data propose that HMGA2 acts in a gene-specific manner to orchestrate the transcriptional network necessary for the EMT program.	[Thuault, Sylvie; Tan, E-Jean; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Peinado, Hector; Cano, Amparo] Univ Autonoma Madrid, Fac Med, CSIC, Dept Bioquim,Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain	Ludwig Institute for Cancer Research; Uppsala University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Moustakas, A (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, Box 595, SE-75124 Uppsala, Sweden.	aris.moustakas@licr.uu.se	Tan, E-Jean/J-3425-2019; Peinado, Hector/A-6417-2013	Tan, E-Jean/0000-0002-4631-174X; Peinado, Hector/0000-0002-4256-3413; THUAULT, Sylvie/0000-0003-0133-3803	Ludwig Institute for Cancer Research; Swedish Cancer Society [4855-B03-01XAC, CAN 2006/1078]; Spanish Ministry of Education and Science [SAF2007-63051]; Consolider-Ingenio [2010-26102]; Marie Curie Research Training Network [MRTN-2005-005428]	Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Spanish Ministry of Education and Science(Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie Curie Research Training Network(European Commission)	This work was supported by Ludwig Institute for Cancer Research and the Swedish Cancer Society Projects 4855-B03-01XAC and CAN 2006/1078 (to A. M.) and Spanish Ministry of Education and Science Grants SAF2007-63051 and Consolider-Ingenio 2010-26102 (to A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program project MRTN-2005-005428.	Cattaruzzi G, 2007, NUCLEIC ACIDS RES, V35, P1751, DOI 10.1093/nar/gkl1106; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Noro B, 2003, BIOCHEMISTRY-US, V42, P4569, DOI 10.1021/bi026605k; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	22	283	301	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33437	33446		10.1074/jbc.M802016200	http://dx.doi.org/10.1074/jbc.M802016200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18832382	Green Published, hybrid			2022-12-27	WOS:000261183700048
J	Gandhi, R; Manzoor, M; Hudak, KA				Gandhi, Rikesh; Manzoor, Mahira; Hudak, Katalin A.			Depurination of Brome Mosaic Virus RNA3 in Vivo Results in Translation-dependent Accelerated Degradation of the Viral RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POKEWEED ANTIVIRAL PROTEIN; RIBOSOME-INACTIVATING PROTEINS; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TERMINATION CODONS; QUALITY-CONTROL; FACTOR ERF1; INHIBITION; CELLS; REPLICATION	Pokeweed antiviral protein (PAP) is a ribosome-inactivating protein isolated from the pokeweed plant (Phytolacca americana) that exhibits antiviral activity against several plant and animal viruses. We have shown previously that PAP depurinates Brome mosaic virus (BMV) RNAs in vitro and that prior incubation of these RNAs with PAP reduced their synthesis in barley protoplasts. To investigate the post-transcriptional effect of PAP on viral RNA in vivo, we transcribed BMV RNA3 and expressed PAP in the yeast, Saccharomyces cerevisiae, which is a surrogate host for BMV. With an inducible transcription system, we show that the half-life of RNA3 in PAP-expressing cells was significantly less than in cells expressing PAPx, its enzymatically inactive form. PAP bound to RNA3 and depurinated the RNA within open reading frames 3 and 4 and within untranslated regions of the RNA. The depurinated RNA was associated with polysomes, caused ribosomes to stall at the point of depurination, and was targeted for accelerated degradation by components of the No-go decay pathway. As a consequence of translation elongation arrest and increased RNA degradation, expression of PAP in yeast also decreased the level of protein 3a, encoded by the 5'-proximal open reading frame 3 of BMV RNA3. These data provide the first evidence of viral RNA depurination in vivo by any ribosome-inactivating protein and support our hypothesis that depurination contributes to the antiviral activity of PAP, by enhancing viral RNA degradation and reducing translation of viral protein product.	[Gandhi, Rikesh; Manzoor, Mahira; Hudak, Katalin A.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	York University - Canada	Hudak, KA (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	hudak@yorku.ca			Natural Sciences and Engineering Research Council of Canada and a Premier's Research Excellence Award	Natural Sciences and Engineering Research Council of Canada and a Premier's Research Excellence Award(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada and a Premier's Research Excellence Award ( to K. A. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AHLQUIST P, 1981, CELL, V23, P183, DOI 10.1016/0092-8674(81)90283-X; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Ahola T, 2000, J VIROL, V74, P8803, DOI 10.1128/JVI.74.19.8803-8811.2000; ALLISON R, 1990, P NATL ACAD SCI USA, V87, P1820, DOI 10.1073/pnas.87.5.1820; ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; ARON GM, 1980, ANTIMICROB AGENTS CH, V17, P1032, DOI 10.1128/AAC.17.6.1032; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Culbertson MR, 2005, RNA, V11, P1333, DOI 10.1261/rna.2113605; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; ENDO Y, 1988, BIOCHEM BIOPH RES CO, V150, P1032, DOI 10.1016/0006-291X(88)90733-4; FELDEN B, 1994, J MOL BIOL, V235, P508, DOI 10.1006/jmbi.1994.1010; FOATOMASI L, 1982, ARCH VIROL, V71, P323, DOI 10.1007/BF01315062; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GESSNER SL, 1980, J BIOL CHEM, V255, P3251; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; HARTLEY MR, 1991, FEBS LETT, V290, P65, DOI 10.1016/0014-5793(91)81227-Y; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Hudak KA, 2000, RNA, V6, P369, DOI 10.1017/S1355838200991337; HUR Y, 1995, P NATL ACAD SCI USA, V92, P8448, DOI 10.1073/pnas.92.18.8448; Inagaki Y, 2000, MOL BIOL EVOL, V17, P882, DOI 10.1093/oxfordjournals.molbev.a026368; IRVIN JD, 1975, ARCH BIOCHEM BIOPHYS, V169, P522, DOI 10.1016/0003-9861(75)90195-2; IRVIN JD, 1992, PHARMACOL THERAPEUT, V55, P279, DOI 10.1016/0163-7258(92)90053-3; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JANDA M, 1993, CELL, V72, P961, DOI 10.1016/0092-8674(93)90584-D; Kao CC, 2000, MOL PLANT PATHOL, V1, P91, DOI 10.1046/j.1364-3703.2000.00017.x; Kong F, 1999, VIROLOGY, V259, P200, DOI 10.1006/viro.1999.9763; Krol MA, 1999, P NATL ACAD SCI USA, V96, P13650, DOI 10.1073/pnas.96.24.13650; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; LODGE JK, 1993, P NATL ACAD SCI USA, V90, P7089, DOI 10.1073/pnas.90.15.7089; MILLER WA, 1985, NATURE, V313, P68, DOI 10.1038/313068a0; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Noueiry AO, 2003, ANNU REV PHYTOPATHOL, V41, P77, DOI 10.1146/annurev.phyto.41.052002.095717; Parikh BA, 2002, J BIOL CHEM, V277, P41428, DOI 10.1074/jbc.M205463200; Picard D, 2005, J BIOL CHEM, V280, P20069, DOI 10.1074/jbc.M413452200; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V263, P419, DOI 10.1006/bbrc.1999.1335; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; TAYLOR S, 1994, PLANT J, V5, P827, DOI 10.1046/j.1365-313X.1994.5060827.x; Tumer NE, 1997, P NATL ACAD SCI USA, V94, P3866, DOI 10.1073/pnas.94.8.3866; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wagner E, 2002, J CELL SCI, V115, P3033; Wallrapp C, 1998, FEBS LETT, V440, P387, DOI 10.1016/S0014-5793(98)01492-6; ZARLING JM, 1990, NATURE, V347, P92, DOI 10.1038/347092a0; Zoubenko O, 2000, PLANT MOL BIOL, V44, P219, DOI 10.1023/A:1006443626864	50	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32218	32228		10.1074/jbc.M803785200	http://dx.doi.org/10.1074/jbc.M803785200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815133	hybrid			2022-12-27	WOS:000260893700008
J	Guyot, N; Butler, MW; Mcnally, P; Weldon, S; Greene, CM; Levine, RL; O'Neill, SJ; Taggart, CC; McElvaney, NG				Guyot, Nicolas; Butler, Marcus W.; McNally, Paul; Weldon, Sinead; Greene, Catherine M.; Levine, Rodney L.; O'Neill, Shane J.; Taggart, Clifford C.; McElvaney, Noel G.			Elafin, an Elastase-specific Inhibitor, Is Cleaved by Its Cognate Enzyme Neutrophil Elastase in Sputum from Individuals with Cystic Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE PROTEINASE-INHIBITOR; PRE-ELAFIN; HUMAN KERATINOCYTES; EPITHELIAL-CELLS; GENE-EXPRESSION; LIPOPOLYSACCHARIDE; SKALP/ELAFIN; SEQUENCE; INACTIVATION; INFLAMMATION	Elafin is a neutrophil serine protease inhibitor expressed in lung and displaying anti-inflammatory and anti-bacterial properties. Previous studies demonstrated that some innate host defense molecules of the cystic fibrosis (CF) and chronic obstructive pulmonary disease airways are impaired due to increased proteolytic degradation observed during lung inflammation. In light of these findings, we thus focused on the status of elafin in CF lung. We showed in the present study that elafin is cleaved in sputum from individuals with CF. Pseudomonas aeruginosa-positive CF sputum, which was found to contain lower elafin levels and higher neutrophil elastase (NE) activity compared with P. aeruginosa-negative samples, was particularly effective in cleaving recombinant elafin. NE plays a pivotal role in the process as only NE inhibitors are able to inhibit elafin degradation. Further in vitro studies demonstrated that incubation of recombinant elafin with excess of NE leads to the rapid cleavage of the inhibitor. Two cleavage sites were identified at the N-terminal extremity of elafin (Val-5-Lys-6 and Val-9-Ser-10). Interestingly, purified fragments of the inhibitor (Lys-6-Gln-57 and Ser-10-Gln-57) were shown to still be active for inhibiting NE. However, NE in excess was shown to strongly diminish the ability of elafin to bind lipopolysaccharide(LPS) and its capacity to be immobilized by transglutamination. In conclusion, this study provides evidence that elafin is cleaved by its cognate enzyme NE present at excessive concentration in CF sputum and that P. aeruginosa infection promotes this effect. Such cleavage may have repercussions on the innate immune function of elafin.	[Guyot, Nicolas; Butler, Marcus W.; McNally, Paul; Weldon, Sinead; Greene, Catherine M.; O'Neill, Shane J.; Taggart, Clifford C.; McElvaney, Noel G.] Beaumont Hosp, Royal Coll Surg Ireland, Pulm Res Div, Dept Med, Dublin 9, Ireland; [Levine, Rodney L.] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Royal College of Surgeons - Ireland; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Taggart, CC (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Pulm Res Div, Dept Med, Dublin 9, Ireland.	c.taggart@qub.ac.uk	Weldon, Sinead/J-5451-2014; McNally, Paul/I-3151-2013; Taggart, Clifford C/G-4492-2014; McElvaney, Noel/A-6809-2010; Levine, Rodney L/D-9885-2011; Greene, Catherine M/D-3513-2012; McNally, Paul/AAL-4407-2021	Weldon, Sinead/0000-0001-5628-6624; McNally, Paul/0000-0001-7102-1712; Greene, Catherine M/0000-0003-2549-2569; McNally, Paul/0000-0001-7102-1712; mcelvaney, Noel/0000-0002-0152-4370; Butler, Marcus/0000-0003-2026-7709; Taggart, Clifford/0000-0002-9930-2978	Health Research Board; Alpha One Foundation; rogram for Research in Third Levels Institutes administered by Higher Education Authority, Science Foundation Ireland; Cystic Fibrosis Hope Source; Cystic Fibrosis Research Trust; Cystic Fibrosis Association of Ireland; Royal College of Surgeons in Ireland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000225, Z01HL000225] Funding Source: NIH RePORTER	Health Research Board; Alpha One Foundation; rogram for Research in Third Levels Institutes administered by Higher Education Authority, Science Foundation Ireland(Science Foundation Ireland); Cystic Fibrosis Hope Source; Cystic Fibrosis Research Trust; Cystic Fibrosis Association of Ireland; Royal College of Surgeons in Ireland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was also supported by the Health Research Board, The Alpha One Foundation, The Program for Research in Third Levels Institutes administered by Higher Education Authority, Science Foundation Ireland, Cystic Fibrosis Hope Source, Cystic Fibrosis Research Trust, Cystic Fibrosis Association of Ireland (to C. T.), and the Royal College of Surgeons in Ireland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALKEMADE JAC, 1994, J CELL SCI, V107, P2335; Bingle L, 2001, AM J RESP CELL MOL, V25, P84, DOI 10.1165/ajrcmb.25.1.4341; BLOW AMJ, 1977, BIOCHEM J, V161, P13, DOI 10.1042/bj1610013; Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; BRITIGAN BE, 1993, INFECT IMMUN, V61, P5049, DOI 10.1128/IAI.61.12.5049-5055.1993; Butler MW, 2006, J BIOL CHEM, V281, P34730, DOI 10.1074/jbc.M604844200; Carroll TP, 2005, CURR RESPIR MED REV, V1, P43, DOI 10.2174/1573398052953640; Chaby R, 2004, CELL MOL LIFE SCI, V61, P1697, DOI 10.1007/s00018-004-4020-4; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; Francart C, 1997, J MOL BIOL, V268, P666, DOI 10.1006/jmbi.1997.0983; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; JOHNSON DA, 1982, AM REV RESPIR DIS, V126, P1070; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Laskowski Jr. M., 2000, PROTEIN PROTEIN RECO, P228; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; McMichael JW, 2005, AM J RESP CELL MOL, V32, P443, DOI 10.1165/rcmb.2004-0250OC; Meyer-Hoffert U, 2003, EXP DERMATOL, V12, P418, DOI 10.1034/j.1600-0625.2002.120409.x; Mihaila A, 2001, Z NATURFORSCH C, V56, P291; MOLHUIZEN HOF, 1993, J BIOL CHEM, V268, P12028; Muto J, 2007, J INVEST DERMATOL, V127, P1358, DOI 10.1038/sj.jid.5700647; NARA K, 1994, J BIOCHEM, V115, P441, DOI 10.1093/oxfordjournals.jbchem.a124357; NONOMURA K, 1994, J INVEST DERMATOL, V103, P88, DOI 10.1111/1523-1747.ep12391802; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; Pfundt R, 2000, ARCH DERMATOL RES, V292, P180, DOI 10.1007/s004030050475; Pfundt R, 1996, J CLIN INVEST, V98, P1389, DOI 10.1172/JCI118926; Reid PT, 1999, FEBS LETT, V457, P33, DOI 10.1016/S0014-5793(99)01004-2; Rogan MP, 2004, J INFECT DIS, V190, P1245, DOI 10.1086/423821; SALLENAVE JM, 1994, AM J RESP CELL MOL, V11, P733, DOI 10.1165/ajrcmb.11.6.7946401; SALLENAVE JM, 1992, BIOL CHEM H-S, V373, P27, DOI 10.1515/bchm3.1992.373.1.27; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Simpson AJ, 2001, HUM GENE THER, V12, P1395, DOI 10.1089/104303401750298553; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; STREIT V, 1995, J INVEST DERMATOL, V105, P562, DOI 10.1111/1523-1747.ep12323460; Taggart C, 2000, AM J PHYSIOL-LUNG C, V278, pL33, DOI 10.1152/ajplung.2000.278.1.L33; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Tate S, 2002, THORAX, V57, P926, DOI 10.1136/thorax.57.11.926; TSUNEMI M, 1992, BIOCHEM BIOPH RES CO, V185, P967, DOI 10.1016/0006-291X(92)91721-2; Tsunemi M, 1996, BIOCHEMISTRY-US, V35, P11570, DOI 10.1021/bi960900l; Vachon E, 2002, BIOL CHEM, V383, P1249, DOI 10.1515/BC.2002.138; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51, DOI 10.1152/ajplung.2000.278.1.L51; YING QL, 1993, BIOCHEMISTRY-US, V32, P1866, DOI 10.1021/bi00058a021; Zani ML, 2004, EUR J BIOCHEM, V271, P2370, DOI 10.1111/j.1432-1033.2004.04156.x	49	63	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32377	32385		10.1074/jbc.M803707200	http://dx.doi.org/10.1074/jbc.M803707200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18799464	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000260893700025
J	Pineau, B; Layoune, O; Danon, A; De Paepe, R				Pineau, Bernard; Layoune, Ouardia; Danon, Antoine; De Paepe, Rosine			L-Galactono-1,4-lactone Dehydrogenase Is Required for the Accumulation of Plant Respiratory Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; NUCLEAR-ENCODED SUBUNITS; NICOTIANA-SYLVESTRIS; ARABIDOPSIS-THALIANA; SUPRAMOLECULAR ORGANIZATION; ASCORBATE BIOSYNTHESIS; POLYACRYLAMIDE GELS; ELECTRON-TRANSPORT; PROTEOMIC APPROACH; LEAF MITOCHONDRIA	Mitochondrial NADH-ubiquinone oxidoreductase (complex I) is the largest enzyme of the oxidative phosphorylation system, with subunits located at the matrix and membrane domains. In plants, holocomplex I is composed of more than 40 subunits, 9 of which are encoded by the mitochondrial genome (NAD subunits). In Nicotiana sylvestris, a minor 800-kDa subcomplex containing subunits of both domains and displaying NADH dehydrogenase activity is detectable. The NMS1 mutant lacking the membrane arm NAD4 subunit and the CMSII mutant lacking the peripheral NAD7 subunit are both devoid of the holoenzyme. In contrast to CMSII, the 800-kDa subcomplex is present in NMS1 mitochondria, indicating that it could represent an assembly intermediate lacking the distal part of the membrane arm. L-galactono-1,4-lactone dehydrogenase (GLDH), the last enzyme in the plant ascorbate biosynthesis pathway, is associated with the 800-kDa subcomplex but not with the holocomplex. To investigate possible relationships between GLDH and complex I assembly, we characterized an Arabidopsis thaliana gldh insertion mutant. Homozygous gldh mutant plants were not viable in the absence of ascorbate supplementation. Analysis of crude membrane extracts by blue native and two-dimensional SDS-PAGE showed that complex I accumulation was strongly prevented in leaves and roots of Atgldh plants, whereas other respiratory complexes were found in normal amounts. Our results demonstrate the role of plant GLDH in both ascorbate biosynthesis and complex I accumulation.	[Pineau, Bernard; Layoune, Ouardia; Danon, Antoine; De Paepe, Rosine] Univ Paris 11, CNRS, Inst Biotechnol Plantes, UMR 8618, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pineau, B (corresponding author), Univ Paris 11, CNRS, Inst Biotechnol Plantes, UMR 8618, F-91405 Orsay, France.	bernard.pineau@u-psud.fr	Danon, Antoine/A-6058-2009; Danon, Antoine/F-7790-2018	Danon, Antoine/0000-0001-6311-6076	CNRS; Universite Paris-Sud 11	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Sud 11	This work was supported by the CNRS and the Universite Paris-Sud 11. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Bartoli CG, 2005, J EXP BOT, V56, P1269, DOI 10.1093/jxb/eri111; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brangeon J, 2000, PLANT J, V21, P269, DOI 10.1046/j.1365-313x.2000.00679.x; Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2; Cardol P, 2008, BBA-BIOENERGETICS, V1777, P388, DOI 10.1016/j.bbabio.2008.01.001; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; Gutierres S, 1997, P NATL ACAD SCI USA, V94, P3436, DOI 10.1073/pnas.94.7.3436; Heazlewood JL, 2003, BBA-BIOENERGETICS, V1604, P159, DOI 10.1016/S0005-2728(03)00045-8; Heinemeyer J, 2004, PHYTOCHEMISTRY, V65, P1683, DOI 10.1016/j.phytochem.2004.04.022; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Karpova OV, 1999, PLANT J, V17, P511, DOI 10.1046/j.1365-313X.1999.00401.x; Krause F, 2004, J BIOL CHEM, V279, P48369, DOI 10.1074/jbc.M406085200; Kuffner R, 1998, J MOL BIOL, V283, P409, DOI 10.1006/jmbi.1998.2114; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Marques I, 2007, EUKARYOT CELL, V6, P2391, DOI 10.1128/EC.00149-07; Millar AH, 2003, PLANT PHYSIOL, V133, P443, DOI 10.1104/pp.103.028399; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Pineau B, 2005, J BIOL CHEM, V280, P25994, DOI 10.1074/jbc.M500508200; PLA M, 1995, MOL GEN GENET, V248, P79, DOI 10.1007/BF02456616; Sabar M, 2000, PLANT PHYSIOL, V124, P1239, DOI 10.1104/pp.124.3.1239; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	51	108	115	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32500	32505		10.1074/jbc.M805320200	http://dx.doi.org/10.1074/jbc.M805320200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18799460	hybrid, Green Published			2022-12-27	WOS:000260893700038
J	Zhong, N; Weisgraber, KH				Zhong, Ning; Weisgraber, Karl H.			Understanding the Association of Apolipoprotein E4 with Alzheimer Disease: Clues from Its Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMINO-TERMINAL DOMAIN; NEURONAL CELLS; THERAPEUTIC TARGET; AQUEOUS-SOLUTION; TRANSGENIC MICE; MOLTEN GLOBULE; E GENOTYPE; IN-VITRO; PROTEIN; PEPTIDE	Despite intense interest, the molecular mechanisms underlying the association of apoE4 with Alzheimer disease are not clear. Because the function (or dysfunction) of a protein is based on its structure, this review focuses on the effects of the structural differences among the isoforms on neurodegeneration. Understanding how apoE4 structure impacts neurodegeneration is likely to provide mechanistic insight as well as potential therapeutic approaches to blunt or reduce its effects.	[Zhong, Ning; Weisgraber, Karl H.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Weisgraber, Karl H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weisgraber, KH (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	kweisgraber@gladstone.ucsf.edu		Zhong, Ning/0000-0002-3696-5301	National Institutes of Health [PO1 AG022074]; National Center for Research Resources [CO6 RR0118928]; American Health Assistance Foundation Pilot [A2006-231]; Alzheimer's Association Zenith Award; Gladstone Institutes; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Health Assistance Foundation Pilot; Alzheimer's Association Zenith Award(Alzheimer's Association); Gladstone Institutes(University of California System); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AG022074 (Project 2, to K. H. W.) and Grant CO6 RR0118928 from the National Center for Research Resources. This work was also supported by American Health Assistance Foundation Pilot Grant for Alzheimer's Disease Research A2006-231 (to N.Z.), the Alzheimer's Association Zenith Award (to K. H. W.), and the Gladstone Institutes.	AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hatters DM, 2006, J MOL BIOL, V361, P932, DOI 10.1016/j.jmb.2006.06.080; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Montine KS, 1998, J LIPID RES, V39, P2443; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Ramaswamy G, 2005, J NEUROSCI, V25, P10658, DOI 10.1523/JNEUROSCI.1922-05.2005; RAMASWAMY G, 2007, SOC NEUROSCIENCE NEU; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Walton HS, 2007, NEUROCHEM INT, V50, P1052, DOI 10.1016/j.neuint.2006.10.007; WEISGRABER KH, 1991, J BIOL CHEM, V266, P12029; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WISNIEWSKI T, 1995, LANCET, V345, P956, DOI 10.1016/S0140-6736(95)90701-7; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Zhong N, 2008, ALZHEIMERS DEMENT, V4, P179, DOI 10.1016/j.jalz.2008.01.006	43	107	109	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6027	6031		10.1074/jbc.R800009200	http://dx.doi.org/10.1074/jbc.R800009200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	18948255	Green Published, hybrid			2022-12-27	WOS:000263742700002
J	Chen, Q; Chen, HY; Zheng, DW; Kuang, CZ; Fang, H; Zou, BY; Zhu, WQ; Bu, GX; Jin, T; Wang, ZZ; Zhang, X; Chen, J; Field, LJ; Rubart, M; Shou, WN; Chen, Y				Chen, Qian; Chen, Hanying; Zheng, Dawei; Kuang, Chenzhong; Fang, Hong; Zou, Bingyu; Zhu, Wuqiang; Bu, Guixue; Jin, Ting; Wang, Zhenzhen; Zhang, Xin; Chen, Ju; Field, Loren J.; Rubart, Michael; Shou, Weinian; Chen, Yan			Smad7 Is Required for the Development and Function of the Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY MOUSE EMBRYO; TGF-BETA; CARDIAC DEVELOPMENT; ENDOCARDIAL CUSHION; NEUREGULIN RECEPTOR; MESODERM INDUCTION; COLORECTAL-CANCER; CELL-MEMBRANE; MICE LACKING; EXPRESSION	Transforming growth factor-beta (TGF-beta) family members, including TGF-beta s, activins, and bone morphogenetic proteins, exert diverse biological activities in cell proliferation, differentiation, apoptosis, embryonic development, and many other processes. These effects are largely mediated by Smad proteins. Smad7 is a negative regulator for the signaling of TGF-beta family members. Dysregulation of Smad7 is associated with pathogenesis of a variety of human diseases. However, the in vivo physiological roles of Smad7 have not been elucidated due to the lack of a mouse model with significant loss of Smad7 function. Here we report generation and initial characterization of Smad7 mutant mice with targeted deletion of the indispensable MH2 domain. The majority of Smad7 mutant mice died in utero due to multiple defects in cardiovascular development, including ventricular septal defect and non-compaction, as well as outflow tract malformation. The surviving adult Smad7 mutant mice had impaired cardiac functions and severe arrhythmia. Further analyses suggest that Smad2/3 phosphorylation was elevated in atrioventricular cushion in the heart of Smad7 mutant mice, accompanied by increased apoptosis in this region. Taken together, these observations pinpoint an important role of Smad7 in the development and function of the mouse heart in vivo.	[Chen, Qian; Kuang, Chenzhong; Zou, Bingyu; Zhang, Xin; Shou, Weinian] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Chen, Qian; Chen, Hanying; Zhu, Wuqiang; Bu, Guixue; Field, Loren J.; Rubart, Michael; Shou, Weinian] Indiana Univ, Sch Med, Riley Heart Res Ctr, Herman B Wells Ctr Pediatr Res,Div Pediat Cardiol, Indianapolis, IN 46202 USA; [Fang, Hong; Shou, Weinian] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; Walther Canc Inst, Indianapolis, IN 46202 USA; [Zheng, Dawei; Jin, Ting; Wang, Zhenzhen; Chen, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California San Diego	Shou, WN (corresponding author), Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	wshou@iupui.edu; ychen3@sibs.ac.cn	Chen, Ju/E-5579-2011; Chen, Qian/F-3590-2012; Bu, Guixue/E-8291-2010; Bu, Guixue/B-1957-2010		National Institutes of Health [R21-CA122764, 03-HD049556, R01-HL81092, R01-HL70259, P01-HL85098]; Indiana Genomics Initiative (INGEN); National Natural Science Foundation of China [30588002]; Ministry of Science and Technology of China [2006CB943902, 2007CB947100]; Science & Technology Commission of Shanghai Municipality [07DJ14005]; Riley Children Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD049556] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA122764] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075165, P01HL085098, R01HL070259, R01HL081092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Genomics Initiative (INGEN); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Riley Children Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-CA122764 and R03-HD049556, by NIH Grants R01-HL81092 and R01-HL70259 (to W. S.), and by NIH Grant P01-HL85098 (to L.J.F. and W.S.). This work was also supported by the Indiana Genomics Initiative (INGEN), the National Natural Science Foundation of China (Grant 30588002), the Ministry of Science and Technology of China (Grants 2006CB943902 and 2007CB947100), the Science & Technology Commission of Shanghai Municipality (Grant 07DJ14005) (to Y.C.), and the Riley Children Foundation (to W. S. and L.J.F.).	Arnold NB, 2004, CANCER RES, V64, P3599, DOI 10.1158/0008-5472.CAN-03-2999; Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Bartram U, 2001, CIRCULATION, V103, P2745; Boulay JL, 2003, INT J CANCER, V104, P446, DOI 10.1002/ijc.10908; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629; Keyes WM, 2002, AM J PHYSIOL-CELL PH, V282, pC1348, DOI 10.1152/ajpcell.00509.2001; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Liang XQ, 2007, CIRC RES, V100, P527, DOI 10.1161/01.RES.0000259041.37059.8c; Liu XB, 2007, BBA-GENE STRUCT EXPR, V1769, P149, DOI 10.1016/j.bbaexp.2007.01.001; Lopes SMCD, 2003, GENE EXPR PATTERNS, V3, P355, DOI 10.1016/S1567-133X(03)00029-2; Luukko K, 2001, MECH DEVELOP, V101, P209, DOI 10.1016/S0925-4773(00)00556-6; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mo FE, 2006, CIRC RES, V99, P961, DOI 10.1161/01.RES.0000248426.35019.89; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stockwell BR, 1998, CHEM BIOL, V5, P385, DOI 10.1016/S1074-5521(98)90072-2; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Yamaguchi T, 2006, J MOL ENDOCRINOL, V36, P569, DOI 10.1677/jme.1.01966; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Zwijsen A, 2000, DEV DYNAM, V218, P663, DOI 10.1002/1097-0177(200008)218:4<663::AID-DVDY1020>3.0.CO;2-7	46	84	85	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					292	300		10.1074/jbc.M807233200	http://dx.doi.org/10.1074/jbc.M807233200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18952608	hybrid, Green Published			2022-12-27	WOS:000261974800033
J	Budzik, JM; Oh, SY; Schneewind, O				Budzik, Jonathan M.; Oh, So-Young; Schneewind, Olaf			Cell Wall Anchor Structure of BcpA Pili in Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL SURFACE-PROTEINS; AUREUS SORTASE; LPXTG MOTIF; HEME-IRON; PEPTIDOGLYCAN; STREPTOCOCCI; PURIFICATION; SUBSTRATE; ENVELOPE; PEPTIDE	Assembly of pili in Gram-positive bacteria and their attachment to the cell wall envelope are mediated by sortases. In Bacillus cereus and its close relative Bacillus anthracis, the major pilin protein BcpA is cleaved between the threonine and the glycine of its C-terminal LPXTG motif sorting signal by the pilin-specific sortase D. The resulting acyl enzyme intermediate is relieved by the nucleophilic attack of the side-chain amino group of lysine within the YPKN motif of another BcpA subunit. Cell wall anchoring of assembled BcpA pili requires sortase A, which also cleaves the LPXTG sorting signal of BcpA between its threonine and glycine residues. We show here that sortases A and D require only the C-terminal sorting signal of BcpA for substrate cleavage. Unlike sortase D, which accepts the YPKN motif as a nucleophile, sortase A forms an amide bond between the BcpA C-terminal carboxyl group of threonine and the side-chain amino group of diaminopimelic acid within the cell wall peptidoglycan of bacilli. These results represent the first demonstration of a cell wall anchor structure for pili, which are deposited by sortase A into the envelope of many different microbes.	[Budzik, Jonathan M.; Oh, So-Young; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			National Institutes of Health; United States Public Health Service [AI38897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI038897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, United States Public Health Service Grant AI38897 (to O.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 A trainee of National Institutes of Health Medical Scientist Training Program Grant GM07281 at The University of Chicago. 2 A member of and supported by the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (NIAID, NIH Award 1-U54-AI-057153).	Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; CALANDRA GB, 1980, INFECT IMMUN, V28, P1033; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; GHUYSEN J. M., 1965, BIOCHEMISTRY, V4, P2245, DOI 10.1021/bi00886a043; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HIGASHI Y, 1967, P NATL ACAD SCI USA, V57, P1878, DOI 10.1073/pnas.57.6.1878; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Maresso AW, 2007, J BIOL CHEM, V282, P23129, DOI 10.1074/jbc.M701857200; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; Severin A, 2004, MICROB DRUG RESIST, V10, P77, DOI 10.1089/1076629041310082; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; TonThat H, 1997, J BIOL CHEM, V272, P22285, DOI 10.1074/jbc.272.35.22285; TONTHAT H, 2004, MOL MICROBIOL, V53, P1147, DOI DOI 10.1111/J.1365-2958.2004.04193.X; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156	48	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36676	36686		10.1074/jbc.M806796200	http://dx.doi.org/10.1074/jbc.M806796200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940793	Green Published, hybrid			2022-12-27	WOS:000261840500066
J	Li, J; Taylor, IA; Lloyd, J; Clapperton, JA; Howell, S; MacMillan, D; Smerdon, SJ				Li, Jiejin; Taylor, Ian A.; Lloyd, Janette; Clapperton, Julie A.; Howell, Steven; MacMillan, Derek; Smerdon, Stephen J.			Chk2 Oligomerization Studied by Phosphopeptide Ligation IMPLICATIONS FOR REGULATION AND PHOSPHODEPENDENT INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; TUMOR-SUPPRESSOR KINASE; POLO-BOX DOMAIN; PROTEIN-KINASE; IN-VITRO; FHA DOMAIN; THREONINE-68 PHOSPHORYLATION; IONIZING-RADIATION; WIP1 PHOSPHATASE; MOLECULAR-BASIS	Chk2/CHEK2/hCds1 is a modular serine-threonine kinase involved in transducing DNA damage signals. Phosphorylation by ataxia telangiectasia-mutated kinase (ATM) promotes Chk2 self-association, autophosphorylation, and activation. Here we use expressed protein ligation to generate a Chk2 N-terminal regulatory region encompassing a fork-head-associated (FHA) domain, a stoichiometrically phosphorylated Thr-68 motif and intervening linker. Hydrodynamic analysis reveals that Thr-68 phosphorylation stabilizes weak FHA-FHA interactions that occur in the unphosphorylated species to form a high affinity dimer. Although clearly a prerequisite for Chk2 activation in vivo, we show that dimerization modulates potential phosphodependent interactions with effector proteins and substrates through either the pThr-68 site, or the canonical FHA phosphobinding surface with which it is tightly associated. We further show that the dimer-occluded pThr-68 motif is released by intra-dimer autophosphorylation of the FHA domain at the highly conserved Ser-140 position, a major pThr contact in all FHA-phosphopeptide complex structures, revealing a mechanism of Chk2 dimer dissociation following kinase domain activation.	[MacMillan, Derek] UCL, Dept Chem, London WC1H 0AJ, England; [Li, Jiejin; Taylor, Ian A.; Lloyd, Janette; Clapperton, Julie A.; Howell, Steven; Smerdon, Stephen J.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England	University of London; University College London; MRC National Institute for Medical Research	MacMillan, D (corresponding author), UCL, Dept Chem, London WC1H 0AJ, England.	d.macmillan@ucl.ac.uk; stephen.smerdon@nimr.mrc.ac.uk	Li, Jiejin/G-4980-2010	Li, Jiejin/0000-0003-1525-7768; Smerdon, Stephen/0000-0001-5688-8465	Royal Society; Medical Research Council, UK; Association for International Cancer Research; MRC [MC_U117584228, MC_U117565647] Funding Source: UKRI; Medical Research Council [MC_U117565647, MC_U117584228] Funding Source: researchfish	Royal Society(Royal Society of London); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association for International Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the laboratory for useful discussions. We also thank Graeme Smith for preliminary characterization of the pSer-140 antibody and Steve Martin for advice and discussions. DM acknowledges the Royal Society for financial support.; This work was supported by the Medical Research Council, UK and the Association for International Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Flavell RR, 2002, ORG LETT, V4, P165, DOI 10.1021/ol016859i; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gabant G, 2008, J MOL BIOL, V380, P489, DOI 10.1016/j.jmb.2008.04.053; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Kass EM, 2007, J BIOL CHEM, V282, P30311, DOI 10.1074/jbc.M704642200; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Ma NJL, 2008, CELL CYCLE, V7, P808, DOI 10.4161/cc.7.6.5595; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Qin DY, 2003, BIOCHEM BIOPH RES CO, V311, P803, DOI 10.1016/j.bbrc.2003.10.076; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Shieh SY, 2000, GENE DEV, V14, P289; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Tominaga K, 1999, J BIOL CHEM, V274, P31463, DOI 10.1074/jbc.274.44.31463; Tosti E, 2004, J BIOL CHEM, V279, P47652, DOI 10.1074/jbc.M409961200; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Tsvetkov LM, 2005, CELL CYCLE, V4, P609; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Wei JH, 2005, J BIOL CHEM, V280, P7748, DOI 10.1074/jbc.M410152200; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Yoda A, 2006, J BIOL CHEM, V281, P24847, DOI 10.1074/jbc.M600403200	50	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36019	36030		10.1074/jbc.M804075200	http://dx.doi.org/10.1074/jbc.M804075200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948271	hybrid			2022-12-27	WOS:000261687900076
J	Yogalingam, G; Pendergast, AM				Yogalingam, Gouri; Pendergast, Ann Marie			Abl Kinases Regulate Autophagy by Promoting the Trafficking and Function of Lysosomal Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TYROSINE KINASE; FAMILY KINASES; C-ABL; MONITORING AUTOPHAGY; IMATINIB; GROWTH; MTOR; ORGANIZATION; INHIBITION	Autophagy is a lysosome-dependent degradative pathway that regulates the turnover of intracellular organelles, parasites, and long-lived proteins. Deregulation of autophagy results in a variety of pathological conditions, but little is known regarding the mechanisms that link normal cellular and pathological signals to the regulation of distinct stages in the autophagy pathway. Here we uncover a novel role for the Abl family kinases in the regulation of the late stages of autophagy. Inhibition, depletion, or knockout of of the Abl family kinases, Abl and Arg, resulted in a dramatic reduction in the intracellular activities of the lysosomal glycosidases alpha-galactosidase, alpha-mannosidase and neuraminidase. Inhibition of Abl kinases also reduced the processing of the precursor forms of cathepsin D and cathepsin L to their mature, lysosomal forms, which coincided with the impaired turnover of long- lived cytosolic proteins and accumulation of autophagosomes. Furthermore, defective lysosomal degradation of long-lived proteins in the absence of Abl kinase signaling was accompanied by a perinuclear redistribution of lysosomes and increased glycosylation and stability of lysosome-associated membrane proteins, which are known to be substrates for lysosomal enzymes and play a role in regulating lysosome mobility. Our findings reveal a role for Abl kinases in the regulation of late-stage autophagy and have important implications for therapies that employ pharmacological inhibitors of the Abl kinases.	[Yogalingam, Gouri; Pendergast, Ann Marie] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Pendergast, AM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	pende014@mc.duke.edu		Pendergast, Ann Marie/0000-0002-1250-6880	National Institutes of Health [CA70940]; NATIONAL CANCER INSTITUTE [R01CA070940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA70940 (to A.M.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Appel S, 2005, CLIN CANCER RES, V11, P1928, DOI 10.1158/1078-0432.CCR-04-1713; Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; KOMINAMI E, 1988, FEBS LETT, V231, P225, DOI 10.1016/0014-5793(88)80736-1; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martin M, 2005, MOL BIOL CELL, V16, P4225, DOI 10.1091/mbc.E05-02-0116; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Van Glabbeke M, 2006, EUR J CANCER, V42, P2277, DOI 10.1016/j.ejca.2006.03.029; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhang Peilin, 2003, Mol Cancer, V2, P1	48	82	84	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35941	35953		10.1074/jbc.M804543200	http://dx.doi.org/10.1074/jbc.M804543200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945674	hybrid, Green Published			2022-12-27	WOS:000261687900069
J	Donovan, J; Caban, K; Ranaweera, R; Gonzalez-Flores, JN; Copeland, PR				Donovan, Jesse; Caban, Kelvin; Ranaweera, Ruchira; Gonzalez-Flores, Jonathan N.; Copeland, Paul R.			A Novel Protein Domain Induces High Affinity Selenocysteine Insertion Sequence Binding and Elongation Factor Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING; INCORPORATION MACHINERY; DECODING APPARATUS; CROSS-LINKING; SECIS RNA; IN-VIVO; BINDING-PROTEIN-2; RIBOSOME; SBP2; FORMALDEHYDE	Selenocysteine (Sec) is incorporated at UGA codons in mRNAs possessing a Sec insertion sequence (SECIS) element in their 3'-untranslated region. At least three additional factors are necessary for Sec incorporation: SECIS-binding protein 2 (SBP2), Sec-tRNA(Sec), and a Sec-specific translation elongation factor (eEFSec). The C-terminal half of SBP2 is sufficient to promote Sec incorporation in vitro, which is carried out by the concerted action of a novel Sec incorporation domain and an L7Ae RNA-binding domain. Using alanine scanning mutagenesis, we show that two distinct regions of the Sec incorporation domain are required for Sec incorporation. Physical separation of the Sec incorporation and RNA-binding domains revealed that they are able to function in trans and established a novel role of the Sec incorporation domain in promoting SECIS and eEFSec binding to the SBP2 RNA-binding domain. We propose a model in which SECIS binding induces a conformational change in SBP2 that recruits eEFSec, which in concert with the Sec incorporation domain gains access to the ribosomal A site.	[Donovan, Jesse; Caban, Kelvin; Ranaweera, Ruchira; Gonzalez-Flores, Jonathan N.; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), 675 Hoes Ln, Piscataway, NJ 08854 USA.	copeland@umdnj.edu		Ranaweera, Ruchira/0000-0002-0671-2936; Copeland, Paul/0000-0003-3343-0587	Public Health Service [GM068077, GM077073, F31GM081920]; Virus Host Interactions Training [T32AI007403]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073, R01GM068077, F31GM081920] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Virus Host Interactions Training; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service Grants GM068077 and GM077073 (to P.R.C.) and F31GM081920 (to K.C.) and Virus Host Interactions Training Grant T32AI007403 (to J.D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Allmang C, 2002, RNA, V8, P1308, DOI 10.1017/S1355838202020034; Bubenik JL, 2007, J BIOL CHEM, V282, P34653, DOI 10.1074/jbc.M707059200; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Clery A, 2007, NUCLEIC ACIDS RES, V35, P1868, DOI 10.1093/nar/gkm066; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; DIAMOND A, 1981, CELL, V25, P497, DOI 10.1016/0092-8674(81)90068-4; Fagegaltier D, 2000, BIOCHIMIE, V82, P117, DOI 10.1016/S0300-9084(00)00192-9; Fletcher JE, 2001, RNA, V7, P1442; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; Lescure A, 2002, CURR PROTEIN PEPT SC, V3, P143, DOI 10.2174/1389203023380783; LUCASLEN.J, 1966, P NATL ACAD SCI USA, V55, P1562, DOI 10.1073/pnas.55.6.1562; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; MOLLER K, 1977, EUR J BIOCHEM, V76, P175, DOI 10.1111/j.1432-1033.1977.tb11583.x; Ozturk SB, 2008, J BIOL CHEM, V283, P23244, DOI 10.1074/jbc.M801095200; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; Zavacki AM, 2003, MOL CELL, V11, P773, DOI 10.1016/S1097-2765(03)00064-9	21	48	52	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35129	35139		10.1074/jbc.M806008200	http://dx.doi.org/10.1074/jbc.M806008200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18948268	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000261469100070
J	Kang, JS; Colon, S; Hellmark, T; Sado, Y; Hudson, BG; Borza, DB				Kang, Jeong Suk; Colon, Selene; Hellmark, Thomas; Sado, Yoshikazu; Hudson, Billy G.; Borza, Dorin-Bogdan			Identification of Noncollagenous Sites Encoding Specific Interactions and Quaternary Assembly of alpha 3 alpha 4 alpha 5(IV) Collagen IMPLICATIONS FOR ALPORT GENE THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; IV COLLAGEN; NC1 DOMAINS; GOODPASTURE AUTOANTIBODIES; RENAL-TRANSPLANTATION; CRYSTAL-STRUCTURE; IMMUNE-RESPONSES; STRUCTURAL BASIS; HEMOPHILIA-A; CROSS-LINKS	Defective assembly of alpha 3 alpha 4 alpha 5(IV) collagen in the glomerular basement membrane causes Alport syndrome, a hereditary glomerulonephritis progressing to end-stage kidney failure. Assembly of collagen IV chains into heterotrimeric molecules and networks is driven by their noncollagenous (NC1) domains, but the sites encoding the specificity of these interactions are not known. To identify the sites directing quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen, correctly folded NC1 chimeras were produced, and their interactions with other NC1 monomers were evaluated. All alpha 1/alpha 5 chimeras containing alpha 5NC1 residues 188-227 replicated the ability of alpha 5NC1 to bind to alpha 3NC1 and co-assemble into NC1 hexamers. Conversely, substitution of alpha 5NC1 residues 188-227 by alpha 1NC1 abolished these quaternary interactions. The amino-terminal 58 residues of alpha 3NC1 encoded binding to alpha 5NC1, but this interaction was not sufficient for hexamer co-assembly. Because alpha 5NC1 residues 188-227 are necessary and sufficient for assembly into alpha 3 alpha 4 alpha 5NC1 hexamers, whereas the immunodominant alloantigenic sites of alpha 5NC1 do not encode specific quaternary interactions, the findings provide a basis for the rational design of less immunogenic alpha 5(IV) collagen constructs for the gene therapy of X-linked Alport patients.	[Borza, Dorin-Bogdan] Vanderbilt Univ, Div Nephrol, Dept Med, Med Ctr, Nashville, TN 37232 USA; [Hudson, Billy G.; Borza, Dorin-Bogdan] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.; Borza, Dorin-Bogdan] Vanderbilt Univ, Ctr Matrix Biol, Nashville, TN 37232 USA; [Hellmark, Thomas] Lund Univ, Kidney Res Lab, SE-22184 Lund, Sweden; [Sado, Yoshikazu] Shigei Med Res Inst, Okayama 701, Japan	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Lund University	Borza, DB (corresponding author), Vanderbilt Univ, Div Nephrol, Dept Med, Med Ctr, S-3223 Med Ctr N, Nashville, TN 37232 USA.	Dorin-Bogdan.Borza@vanderbilt.edu	Borza, Dorin-Bogdan/AAF-2156-2020; Hellmark, Thomas/U-6289-2017	Borza, Dorin-Bogdan/0000-0003-4568-279X; Hellmark, Thomas/0000-0002-2952-1155; Hudson, Billy/0000-0002-5420-4100	National Institutes of Health [R01 DK080799, P01 DK065123, R21 AI069874]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018381, R01DK080799, P01DK065123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK080799, P01 DK065123, and R21 AI069874 (to D.-B.B.) and R37 DK18381 (to B.G.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; Borza DB, 2002, J BIOL CHEM, V277, P40075, DOI 10.1074/jbc.M207769200; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Borza DB, 2007, NEPHRON EXP NEPHROL, V106, pE37, DOI 10.1159/000101791; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Brainwood D, 1998, KIDNEY INT, V53, P762, DOI 10.1046/j.1523-1755.1998.00794.x; Ferrer A, 2000, GENE THER, V7, P1439, DOI 10.1038/sj.gt.3301259; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gunnarsson A, 2000, J BIOL CHEM, V275, P30844, DOI 10.1074/jbc.M004717200; Harvey SJ, 2003, AM J PATHOL, V162, P873, DOI 10.1016/S0002-9440(10)63883-7; Heidet L, 2003, AM J PATHOL, V163, P1633, DOI 10.1016/S0002-9440(10)63520-1; Heikkila P, 2001, GENE THER, V8, P882, DOI 10.1038/sj.gt.3301342; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; Hellmark T, 1999, KIDNEY INT, V55, P936, DOI 10.1046/j.1523-1755.1999.055003936.x; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kalluri R, 2000, TRANSPLANTATION, V69, P679, DOI 10.1097/00007890-200002270-00038; Kang JS, 2007, J BIOL CHEM, V282, P10670, DOI 10.1074/jbc.M611892200; Kashtan CE, 2006, PEDIATR TRANSPLANT, V10, P651, DOI 10.1111/j.1399-3046.2006.00528.x; Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Parker ET, 2004, BLOOD, V104, P704, DOI 10.1182/blood-2003-11-3891; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; SADO Y, 1995, HISTOCHEM CELL BIOL, V104, P267, DOI 10.1007/BF01464322; Sarkar R, 2000, HUM GENE THER, V11, P881, DOI 10.1089/10430340050015491; Shull R, 1996, BLOOD, V88, P377; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Tryggvason K, 1997, KIDNEY INT, V51, P1493, DOI 10.1038/ki.1997.205; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; Wang XP, 2005, J AM SOC NEPHROL, V16, P3563, DOI 10.1681/ASN.2005060670; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359	35	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35070	35077		10.1074/jbc.M806396200	http://dx.doi.org/10.1074/jbc.M806396200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930919	Green Published, hybrid			2022-12-27	WOS:000261469100064
J	Li, YK; Zhang, Y; Dorweiler, B; Cui, DY; Wang, T; Woo, CW; Brunkan, CS; Wolberger, C; Imai, SI; Tabas, I				Li, Yankun; Zhang, Yuan; Dorweiler, Bernhard; Cui, Dongying; Wang, Tao; Woo, Connie W.; Brunkan, Cynthia S.; Wolberger, Cynthia; Imai, Shin-ichiro; Tabas, Ira			Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-ENHANCING FACTOR; ENDOPLASMIC-RETICULUM STRESS; TYPE-2 DIABETES-MELLITUS; CHOLESTEROL-LOADED MACROPHAGES; TUMOR-ASSOCIATED MACROPHAGES; UNFOLDED PROTEIN RESPONSE; LOW-DENSITY-LIPOPROTEIN; ER STRESS; MOLECULAR-MECHANISMS; BIOSYNTHETIC ENZYME	Macrophages play key roles in obesity-associated pathophysiology, including inflammation, atherosclerosis, and cancer, and processes that affect the survival-death balance of macrophages may have an important impact on obesity-related diseases. Adipocytes and other cells secrete a protein called extracellular nicotinamide phosphoribosyltransferase (eNampt; also known as pre-B cell colony enhancing factor or visfatin), and plasma levels of eNampt increase in obesity. Herein we tested the hypothesis that eNampt could promote cell survival in macrophages subjected to endoplasmic reticulum ( ER) stress, a process associated with obesity and obesity-associated diseases. We show that eNampt potently blocks macrophage apoptosis induced by a number of ER stressors. The mechanism involves a two-step sequential process: rapid induction of interleukin 6 (IL-6) secretion, followed by IL-6-mediated autocrine/paracrine activation of the prosurvival signal transducer STAT3. The ability of eNampt to trigger this IL-6/STAT3 cell survival pathway did not depend on the presence of the Nampt enzymatic substrate nicotinamide in the medium, could not be mimicked by the Nampt enzymatic product nicotinamide mononucleotide (NMN), was not blocked by the Nampt enzyme inhibitor FK866, and showed no correlation with enzyme activity in a series of site-directed mutant Nampt proteins. Thus, eNampt protects macrophages from ER stress-induced apoptosis by activating an IL-6/STAT3 signaling pathway via a nonenzymatic mechanism. These data suggest a novel action and mechanism of eNampt that could affect the balance of macrophage survival and death in the setting of obesity, which in turn could play important roles in obesity-associated diseases.	[Li, Yankun; Zhang, Yuan; Dorweiler, Bernhard; Cui, Dongying; Woo, Connie W.; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Univ Hosp, Dept Cardiothorac & Vasc Surg, Mainz, Germany; [Wang, Tao; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Wang, Tao; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Brunkan, Cynthia S.; Imai, Shin-ichiro] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Columbia University; Columbia University; Columbia University; Johannes Gutenberg University of Mainz; University Hospital Mainz; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Washington University (WUSTL)	Tabas, I (corresponding author), Columbia Univ, Dept Med, 630 W 168th St, New York, NY 10032 USA.	iat1@columbia.edu	Woo, Connie/AAX-2588-2020	Wolberger, Cynthia/0000-0001-8578-2969	National Institutes of Health [R01 HL075662, P01 HL087123, AG024150]; United States Army Medical Research and Materiel Command (USAMRMC) [W81XWH-06-1-0212]; Glenn Foundation; Ellison Medical Foundation; American Diabetes Association; Juvenile Diabetes Research Foundation; Deutsche Forschungsgemeinschaft [DO1289/2-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Glenn Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL075662 and P01 HL087123 ( to I. T.) and National Institutes of Health, NIA, Grant AG024150. This work was also supported by United States Army Medical Research and Materiel Command (USAMRMC) Grant W81XWH-06-1-0212 ( to I. T.); grants from the Glenn Foundation, Ellison Medical Foundation, American Diabetes Association, and Juvenile Diabetes Research Foundation ( to S. I.); and Deutsche Forschungsgemeinschaft Grant DO1289/2-1 ( to B. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Cook AD, 2003, J IMMUNOL, V171, P4816, DOI 10.4049/jimmunol.171.9.4816; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Haider DG, 2006, J PEDIATR GASTR NUTR, V43, P548, DOI 10.1097/01.mpg.0000235749.50820.b3; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Irigaray P, 2007, BIOMED PHARMACOTHER, V61, P665, DOI 10.1016/j.biopha.2007.10.008; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Knorre A, 2002, BIOL CHEM, V383, P271, DOI 10.1515/BC.2002.029; Lang R, 2005, IMMUNOBIOLOGY, V210, P63, DOI 10.1016/j.imbio.2005.05.001; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Libby Peter, 1993, Current Opinion in Lipidology, V4, P355, DOI 10.1097/00041433-199310000-00003; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Marriott HM, 2006, J IMMUNOL, V177, P6480, DOI 10.4049/jimmunol.177.9.6480; Matarese G, 2007, CURR PHARM DESIGN, V13, P3676, DOI 10.2174/138161207783018635; Miselis NR, 2008, MOL CANCER THER, V7, P788, DOI 10.1158/1535-7163.MCT-07-0579; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Nielsen M, 1997, P NATL ACAD SCI USA, V94, P6764, DOI 10.1073/pnas.94.13.6764; Nowell MA, 2006, ARTHRITIS RHEUM-US, V54, P2084, DOI 10.1002/art.21942; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Porta C, 2007, ADV EXP MED BIOL, V604, P67, DOI 10.1007/978-0-387-69116-9_5; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sandeep S, 2007, METABOLISM, V56, P565, DOI 10.1016/j.metabol.2006.12.005; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196; Tsutsumi S, 2003, FEBS LETT, V534, P49, DOI 10.1016/S0014-6793(02)03773-0; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	61	161	173	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34833	34843		10.1074/jbc.M805866200	http://dx.doi.org/10.1074/jbc.M805866200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945671	hybrid, Green Published			2022-12-27	WOS:000261469100039
J	Nomura, T; Quesada, AL; Kutchan, TM				Nomura, Taiji; Quesada, Alfonso Lara; Kutchan, Toni M.			The New beta-D-Glucosidase in Terpenoid-Isoquinoline Alkaloid Biosynthesis in Psychotria ipecacuanha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION CULTURES; MONOTERPENOID INDOLE ALKALOIDS; ALANGIUM-LAMARCKII THW; STRICTOSIDINE SYNTHASE; CATHARANTHUS-ROSEUS; KEY INTERMEDIATE; SUBCELLULAR-LOCALIZATION; RAUVOLFIA-SERPENTINA; MOLECULAR-CLONING; FREE-EXTRACTS	Ipecac alkaloids produced in the medicinal plant Psychotria ipecacuanha such as emetine and cephaeline possess a monoterpenoid-tetrahydroisoquinoline skeleton, which is formed by condensation of dopamine and secologanin. Deglucosylation of one of the condensed products N-deacetylisoipecoside(1 alpha(S)-epimer) is considered to be a part of the reactions for emetine biosynthesis, whereas its 1 beta(R)-epimer N-deacetylipecoside is converted to ipecoside in P. ipecacuanha. Here, we isolated a cDNA clone Ipeglu1 encoding Ipecac alkaloid beta-D-glucosidase from P. ipecacuanha. The deduced protein showed 54 and 48% identities to raucaffricine beta-glucosidase and strictosidine beta-glucosidase, respectively. Recombinant IpeGlu1 enzyme preferentially hydrolyzed glucosidic Ipecac alkaloids except for their lactams, but showed poor or no activity toward other substrates, including terpenoid-indole alkaloid glucosides. Liquid chromatography-tandem mass spectrometry analysis of deglucosylated products of N-deacetylisoipecoside revealed spontaneous transitions of the highly reactive aglycons, one of which was supposed to be the intermediate for emetine biosynthesis. IpeGlu1 activity was extremely poor toward 7-O-methyl and 6,7-O,O-dimethyl derivatives. However, 6-O-methyl derivatives were hydrolyzed as efficiently as non-methylated substrates, suggesting the possibility of 6-O-methylation prior to deglucosylation by IpeGlu1. In contrast to the strictosidine beta-glucosidase that stereospecifically hydrolyzes 3 alpha(S)-epimer in terpenoid-indole alkaloid biosynthesis, IpeGlu1 lacked stereospecificity for its substrates where 1 beta(R)-epimers were preferred to 1 alpha(S)-epimers, although ipecoside (1 beta(R)) is a major alkaloidal glucoside in P. ipecacuanha, suggesting the compartmentalization of IpeGlu1 from ipecoside. These facts have significant implications for distinct physiological roles of 1 alpha(S)- and 1 beta(R)-epimers and for the involvement of IpeGlu1 in the metabolic fate of both of them.	[Nomura, Taiji; Kutchan, Toni M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Quesada, Alfonso Lara; Kutchan, Toni M.] Leibniz Inst Pflanzenbiochem, D-06120 Halle, Germany	Donald Danforth Plant Science Center; Leibniz Institut fur Pflanzenbiochemie	Nomura, T (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tnomura@danforthcenter.org	Kutchan, Toni/L-4625-2013	Nomura, Taiji/0000-0003-4876-9866				Barleben L, 2007, PLANT CELL, V19, P2886, DOI 10.1105/tpc.106.045682; BATTERSB.AR, 1969, J CHEM SOC C, P1193, DOI 10.1039/j39690001193; Battersby A. R., 1971, CHEM COMMUN, P901; BATTERSBY AR, 1969, J CHEM SOC C, P1187, DOI 10.1039/j39690001187; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BHAKUNI DS, 1983, J CHEM SOC PERK T 1, P1949, DOI 10.1039/p19830001949; BRACHER D, 1992, ARCH BIOCHEM BIOPHYS, V294, P717, DOI 10.1016/0003-9861(92)90746-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; De-Eknamkul W, 2000, PHYTOCHEMISTRY, V55, P177, DOI 10.1016/S0031-9422(00)00260-0; DeEknamkul W, 1997, PHYTOCHEMISTRY, V45, P477, DOI 10.1016/S0031-9422(96)00828-X; DEWAAL A, 1995, BIOCHEM J, V306, P571, DOI 10.1042/bj3060571; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fujii T, 1998, ALKALOIDS CHEM BIOL, V51, P271; Geerlings A, 2000, J BIOL CHEM, V275, P3051, DOI 10.1074/jbc.275.5.3051; Gerasimenko I, 2002, EUR J BIOCHEM, V269, P2204, DOI 10.1046/j.1432-1033.2002.02878.x; HAMPP N, 1988, PHYTOCHEMISTRY, V27, P3811, DOI 10.1016/0031-9422(88)83023-1; ITOH A, 1995, J NAT PRODUCTS, V58, P1228, DOI 10.1021/np50122a011; Jain S, 2002, PHYTOCHEMISTRY, V60, P853, DOI 10.1016/S0031-9422(02)00057-2; JANOT MM, 1953, ALKALOIDS-CHEM BIOL, V3, P363; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Luijendijk TJC, 1996, J CHEM ECOL, V22, P1355, DOI 10.1007/BF02027718; Luijendijk TJC, 1998, PLANT PHYSIOL BIOCH, V36, P419, DOI 10.1016/S0981-9428(98)80205-2; MCKNIGHT TD, 1991, PLANTA, V185, P148, DOI 10.1007/BF00194055; NAGAKURA N, 1978, PLANTA MED, V34, P381, DOI 10.1055/s-0028-1097467; NAGAKURA N, 1978, J CHEM SOC CHEM COMM, P896, DOI 10.1039/c39780000896; NIEMEYER HM, 1988, PHYTOCHEMISTRY, V27, P3349, DOI 10.1016/0031-9422(88)80731-3; Ounaroon A, 2003, PLANT J, V36, P808, DOI 10.1046/j.1365-313X.2003.01928.x; PFITZNER U, 1989, PLANTA MED, P525, DOI 10.1055/s-2006-962086; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; RUEFFER M, 1978, TETRAHEDRON LETT, P1593; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHOEB A, 1975, J CHEM SOC PERK T 1, P1245, DOI 10.1039/p19750001245; STEVENS LH, 1993, PLANT CELL REP, V12, P573, DOI 10.1007/BF00233063; STEVENS LH, 1993, PHYTOCHEMISTRY, V33, P99, DOI 10.1016/0031-9422(93)85403-E; STOCKIGT J, 1977, J CHEM SOC CHEM COMM, P646, DOI 10.1039/c39770000646; STOCKIGT J, 1977, J CHEM SOC CHEM COMM, P164, DOI 10.1039/c39770000164; STOCKIGT J, 1977, FEBS LETT, V79, P233, DOI 10.1016/0014-5793(77)80794-1; STOCKIGT J, 1976, FEBS LETT, V70, P267, DOI 10.1016/0014-5793(76)80772-7; TREIMER JF, 1979, EUR J BIOCHEM, V101, P225, DOI 10.1111/j.1432-1033.1979.tb04235.x; Warzecha H, 2000, PHYTOCHEMISTRY, V54, P657, DOI 10.1016/S0031-9422(00)00175-8; Yamazaki Y, 2003, PLANT CELL PHYSIOL, V44, P395, DOI 10.1093/pcp/pcg051	41	38	39	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34650	34659		10.1074/jbc.M806953200	http://dx.doi.org/10.1074/jbc.M806953200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18927081	Green Published, hybrid			2022-12-27	WOS:000261469100020
J	Parkash, V; Leppanen, VM; Virtanen, H; Jurvansuu, JM; Bespalov, MM; Sidorova, YA; Runeberg-Roos, P; Saarma, M; Goldman, A				Parkash, Vimal; Leppanen, Veli-Matti; Virtanen, Heidi; Jurvansuu, Jaana M.; Bespalov, Maxim M.; Sidorova, Yulia A.; Runeberg-Roos, Pia; Saarma, Mart; Goldman, Adrian			The Structure of the Glial Cell Line-derived Neurotrophic Factor-Coreceptor Complex INSIGHTS INTO RET SIGNALING AND HEPARIN BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDNF FAMILY LIGANDS; TYROSINE KINASE; RECEPTOR COMPLEX; GROWTH-FACTOR; GFR-ALPHA-1; ACTIVATION; SULFATE; DOMAIN; NEURTURIN; ARTEMIN	Glial cell line-derived neurotrophic factor (GDNF), a neuronal survival factor, binds its co-receptor GDNF family receptor alpha 1 (GFR alpha 1) in a 2: 2 ratio and signals through the receptor tyrosine kinase RET. We have solved the GDNF(2).GFR alpha 1(2) complex structure at 2.35 angstrom resolution in the presence of a heparin mimic, sucrose octasulfate. The structure of our GDNF(2).GFR alpha 1(2) complex and the previously published artemin(2).GFR alpha 3(2) complex are unlike in three ways. First, we have experimentally identified residues that differ in the ligand-GFR alpha interface between the two structures, in particular ones that buttress the key conserved Arg(GFR alpha)-Glu(ligand)-Arg(GFR alpha) interaction. Second, the flexible GDNF ligand "finger" loops fit differently into the GFR alpha s, which are rigid. Third, and we believe most importantly, the quaternary structure of the two tetramers is dissimilar, because the angle between the two GDNF monomers is different. This suggests that the RET-RET interaction differs in different ligand(2)-co-receptor(2)-RET2 heterohexamer complexes. Consistent with this, we showed that GDNF(2).GFR alpha 1(2) and artemin(2).GFR alpha 3(2) signal differently in a mitogen-activated protein kinase assay. Furthermore, we have shown by mutagenesis and enzyme-linked immunosorbent assays of RET phosphorylation that RET probably interacts with GFR alpha 1 residues Arg-190, Lys-194, Arg-197, Gln-198, Lys-202, Arg-257, Arg-259, Glu-323, and Asp-324 upon both domains 2 and 3. Interestingly, in our structure, sucrose octasulfate also binds to the Arg(190)-Lys(202) region in GFR alpha 1 domain 2. This may explain how GDNF.GFR alpha 1 can mediate cell adhesion and how heparin might inhibit GDNF signaling through RET.	[Goldman, Adrian] Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, Bioctr 3, FIN-00014 Helsinki, Finland; [Goldman, Adrian] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Goldman, A (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Struct Biol & Biophys, Bioctr 3, Viikinkaari 1, FIN-00014 Helsinki, Finland.	adrian.goldman@helsinki.fi	Bespalov, Maxim/O-2817-2016; Jurvansuu, Jaana/H-1599-2012; Jurvansuu, Jaana/AAZ-8835-2020; Sidorova, Yulia/L-5340-2019	Bespalov, Maxim/0000-0002-8754-5753; Jurvansuu, Jaana/0000-0002-7801-3237; Goldman, Adrian/0000-0001-8032-9700; Sidorova, Yulia/0000-0001-8230-0530; Leppanen, Veli-Matti/0000-0001-7100-965X	Academy of Finland [1111771, 1114752, 70891, 1105237, 1109071]; Sigrid Juselius Foundation; Biocentrum Helsinki; Neuroscience Centre	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Neuroscience Centre	This work was supported by Academy of Finland Grants 1111771 and 1114752 (to A.G.), 70891 (to V.-M.L.), and 1105237 and 1109071 (to M.S.) and by grants from the Sigrid Juselius Foundation (to A.G. and M.S.), Biocentrum Helsinki (to A.G. and M.S.), and the Neuroscience Centre (to A.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alfano I, 2007, BIOCHEM J, V404, P131, DOI 10.1042/BJ20061747; Amoresano A, 2005, CELL SIGNAL, V17, P717, DOI 10.1016/j.cellsig.2004.10.012; Arighi E, 2005, CYTOKINE GROWTH F R, V16, P441, DOI 10.1016/j.cytogfr.2005.05.010; Baloh RH, 2000, J BIOL CHEM, V275, P3412, DOI 10.1074/jbc.275.5.3412; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Cabrera JR, 2006, J BIOL CHEM, V281, P14330, DOI 10.1074/jbc.M509572200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Coulpier M, 2002, J BIOL CHEM, V277, P1991, DOI 10.1074/jbc.M107992200; Davies JA, 2003, GROWTH FACTORS, V21, P109, DOI 10.1080/08977190310001621005; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kjaer S, 2003, J BIOL CHEM, V278, P47898, DOI 10.1074/jbc.M309772200; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Lakhani VT, 2007, ANNU REV MED, V58, P253, DOI 10.1146/annurev.med.58.100305.115303; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Lee RHK, 2006, J NEUROSCI RES, V83, P80, DOI 10.1002/jnr.20701; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Lindahl M, 2001, J BIOL CHEM, V276, P9344, DOI 10.1074/jbc.M008279200; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Plaza-Menacho I, 2006, TRENDS GENET, V22, P627, DOI 10.1016/j.tig.2006.09.005; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rickard SM, 2003, GLYCOBIOLOGY, V13, P419, DOI 10.1093/glycob/cwg046; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Shults CW, 1996, NEUROREPORT, V7, P627, DOI 10.1097/00001756-199601310-00060; Silvian L, 2006, BIOCHEMISTRY-US, V45, P6801, DOI 10.1021/bi060035x; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; Virtanen H, 2005, BIOCHEM J, V387, P817, DOI 10.1042/BJ20041257; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Yasuhara T, 2007, ACTA MED OKAYAMA, V61, P51	48	62	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35164	35172		10.1074/jbc.M802543200	http://dx.doi.org/10.1074/jbc.M802543200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18845535	hybrid, Green Published			2022-12-27	WOS:000261469100073
J	Sanada, T; Takaesu, G; Mashima, R; Yoshida, R; Kobayashi, T; Yoshimura, A				Sanada, Takahito; Takaesu, Giichi; Mashima, Ryuichi; Yoshida, Ryoko; Kobayashi, Takashi; Yoshimura, Akihiko			FLN29 Deficiency Reveals Its Negative Regulatory Role in the Toll-like Receptor (TLR) and Retinoic Acid-inducible Gene I (RIG-I)-like Helicase Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR CYLD; RIG-I; ADAPTER PROTEIN; ANTIVIRAL RESPONSES; KAPPA-B; INTERFERON; VIRUS; A20; INDUCTION	FLN29 was identified as an interferon (IFN)-inducible gene, and it has been shown to suppress Toll-like receptor 4-mediated NF-kappa B activation by binding to TRAF6. To elucidate the physiological roles of FLN29, we generated FLN29-deficient mice. FLN29 deficiency resulted in hyper-response to LPS both in vivo and in vitro, demonstrating the negative regulatory role of FLN29 in TLR4 signaling. Furthermore, we found that FLN29(-/-) mice exhibited increased susceptibility to poly(I:C)induced septic shock compared with WT mice. FLN29(-/-) fibroblasts were highly resistant to vesicular stomatitis virus infection, and these cells produced more IFN-beta than WT cells did in response to not only intracellular poly(I:C) but also overexpression of IPS-1. Forced expression of FLN29 inhibited the IPS-1-dependent activation of both NF-kappa B and IRF3. We also found that FLN29 could interact with TRIF, IPS-1, TRAF3, and TRAF6. Together, these results suggest that FLN29, in addition to playing a negative regulatory role in the TLR4 signaling pathway, negatively regulates the RIG-I-like helicase signaling pathway at the level of IPS-1/TRAF6 and IPS-1/TRAF3 complexes.	[Sanada, Takahito; Takaesu, Giichi; Yoshida, Ryoko; Kobayashi, Takashi; Yoshimura, Akihiko] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan; [Mashima, Ryuichi] Univ Tokyo, Inst Med Sci, Div Genet, Tokyo 1088639, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 332001, Japan	Kyushu University; University of Tokyo; Keio University; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013	Takaesu, Giichi/0000-0002-1581-1055	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); Nakatomi Foundation; Takeda Science Foundation; Kato Memorial Trust Foundation for Nanbyo Research; Suzuken Memorial Foundation; Japan Intractable Disease Research Foundation; Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Trust Foundation for Nanbyo Research; Suzuken Memorial Foundation; Japan Intractable Disease Research Foundation; Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research Fund	This work was supported in part by special Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the Nakatomi Foundation, the Takeda Science Foundation, The Kato Memorial Trust Foundation for Nanbyo Research, the Suzuken Memorial Foundation, the Japan Intractable Disease Research Foundation, the Mitsubishi Pharma Research Foundation, the Uehara Memorial Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Yakult Bioscience Research Foundation, and the Princess Takamatsu Cancer Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Mashima R, 2005, J BIOL CHEM, V280, P41289, DOI 10.1074/jbc.M508221200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200	26	42	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33858	33864		10.1074/jbc.M806923200	http://dx.doi.org/10.1074/jbc.M806923200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18849341	Green Published, hybrid			2022-12-27	WOS:000261277700010
J	Sanggaard, KW; Sonne-Schmidt, CS; Krogager, TP; Kristensen, T; Wisniewski, HG; Thogersen, IB; Enghild, JJ				Sanggaard, Kristian W.; Sonne-Schmidt, Carsten S.; Krogager, Toke P.; Kristensen, Torsten; Wisniewski, Hans-Georg; Thogersen, Ida B.; Enghild, Jan J.			TSG-6 Transfers Proteins between Glycosaminoglycans via a Ser(28)-mediated Covalent Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TRYPSIN INHIBITOR; HEAVY-CHAIN TRANSFER; ACYL-ENZYME COMPLEX; STIMULATED GENE-6; LINK MODULE; INDUCED ARTHRITIS; CROSS-LINKS; HYALURONAN; BINDING; SHAP	Studies of the interaction between Bikunin proteins, tumor necrosis factor-stimulated gene-6 protein (TSG-6), and glycos-aminoglycans have revealed a unique catalytic activity where TSG-6/heavy chain 2 transfer heavy chain subunits between glycosaminoglycan chains. The activity is mediated by TSG-6/heavy chain 2 and involves a transient SDS stable interaction between TSG-6 and the heavy chain to be transferred. The focus of this study was to characterize the molecular structure of this cross-link to gain further insight into the catalytic mechanism. The result showed that the C-terminal Asp residue of the heavy chains forms an ester bond to Ser(28) carbon of TSG-6 suggesting that this residue plays a role during catalysis.	[Sanggaard, Kristian W.; Sonne-Schmidt, Carsten S.; Krogager, Toke P.; Kristensen, Torsten; Thogersen, Ida B.; Enghild, Jan J.] Univ Aarhus, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus C, Denmark; [Sanggaard, Kristian W.; Sonne-Schmidt, Carsten S.; Krogager, Toke P.; Kristensen, Torsten; Thogersen, Ida B.; Enghild, Jan J.] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Wisniewski, Hans-Georg] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Aarhus University; Aarhus University; New York University	Enghild, JJ (corresponding author), Gustav Wiedsvej 10C, DK-8000 Aarhus C, Denmark.	jje@inano.dk	; Scavenius, Carsten/Q-5941-2017	Enghild, Jan Johannes/0000-0001-9292-9172; Scavenius, Carsten/0000-0002-4304-0681	Danish National Science Foundation; Carlsberg Foundation	Danish National Science Foundation(Danmarks Grundforskningsfond); Carlsberg Foundation(Carlsberg Foundation)	This work was supported by grants from the Danish National Science Foundation (to J. J. E.) and the Carlsberg Foundation (to K. W. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; HUANG L, 1993, J BIOL CHEM, V268, P26725; Katona G, 2002, J BIOL CHEM, V277, P21962, DOI 10.1074/jbc.M200676200; Keough T, 2002, RAPID COMMUN MASS SP, V16, P1003, DOI 10.1002/rcm.670; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; SANDSON J, 1964, SCIENCE, V146, P70, DOI 10.1126/science.146.3640.70; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; YONEDA M, 1990, J BIOL CHEM, V265, P5247; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	45	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33919	33926		10.1074/jbc.M804240200	http://dx.doi.org/10.1074/jbc.M804240200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18820257	hybrid, Green Published			2022-12-27	WOS:000261277700018
J	Fletcher, JM; Morton, CJ; Zwar, RA; Murray, SS; O'Leary, PD; Hughes, RA				Fletcher, Jordan M.; Morton, Craig J.; Zwar, Richard A.; Murray, Simon S.; O'Leary, Paul D.; Hughes, Richard A.			Design of a Conformationally Defined and Proteolytically Stable Circular Mimetic of Brain-derived Neurotrophic Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NF-KAPPA-B; CRYSTAL-STRUCTURE; SENSORY NEURONS; TRK RECEPTORS; BINDING; P75; NGF; SURVIVAL; BDNF	Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of neurotrophic factors. BDNF has long been recognized to have potential for the treatment of a variety of human neurodegenerative diseases. However, clinical trials with recombinant BDNF have yet to yield success, leading to the suggestion that alternative means of harnessing BDNF actions for therapeutic use may be required. Here we describe an approach to create low molecular weight peptides that, like BDNF, promote neuronal survival. The peptides were designed to mimic a cationic tripeptide sequence in loop 4 of BDNF shown in previous studies to contribute to the binding of BDNF to the common neurotrophin receptor p75(NTR). The best of these peptides, the cyclic pentapeptide 2 (cyclo(-D-Pro-Ala-Lys-Arg-)), despite being of low molecular weight (M-r 580), was found to be an effective promoter of the survival of embryonic chick dorsal root ganglion sensory neurons in vitro (maximal survival, 68 +/- 3% of neurons supported by BDNF). Pentapeptide 2 did not affect the phosphorylation of either TrkB (the receptor tyrosine kinase for BDNF) or the downstream signaling molecule MAPK, indicating that its mechanism of neuronal survival action is independent of TrkB. NMR studies reveal that pentapeptide 2 adopts a well defined backbone conformation in solution. Furthermore, pentapeptide 2 was found to be effectively resistant to proteolysis when incubated in a solution of rat plasma in vitro. These properties of pentapeptide 2 (low molecular weight, appropriate pharmacological actions, a well defined solution conformation, and proteolytic stability) render it worthy of further investigation, either as a template for the further design of neuronal survival promoting agents or as a lead compound with therapeutic potential in its own right.	[Fletcher, Jordan M.; Zwar, Richard A.; O'Leary, Paul D.; Hughes, Richard A.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Morton, Craig J.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Murray, Simon S.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Hughes, RA (corresponding author), Univ Melbourne, Dept Pharmacol, Grattan St, Melbourne, Vic 3010, Australia.	rahughes@unimelb.edu.au	Morton, Craig/GON-8638-2022	Morton, Craig/0000-0001-5452-5193; Murray, Simon/0000-0001-6671-192X; Fletcher, Jordan/0000-0003-3203-4355; O'Leary, Paul/0000-0003-2717-0790	National Health and Medical Research Council of Australia; Motor Neurone Disease Association of Australia; Calibre Biotechnology Pty. Ltd.; University of Melbourne; Melbourne Research Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Motor Neurone Disease Association of Australia; Calibre Biotechnology Pty. Ltd.; University of Melbourne(University of Melbourne); Melbourne Research Scholarship	This work was supported in part by the National Health and Medical Research Council of Australia, the Motor Neurone Disease Association of Australia, Calibre Biotechnology Pty. Ltd., and a publication grant from the University of Melbourne. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a Melbourne Research Scholarship.	Alberch J, 2004, PROG BRAIN RES, V146, P195, DOI 10.1016/S0079-6123(03)46014-7; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; ASKANAS V, 1995, ADV NEUROL, V68, P241; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; BERGER H, 1979, BIOCHEM PHARMACOL, V28, P3173, DOI 10.1016/0006-2952(79)90058-3; Bhakar AL, 1999, J BIOL CHEM, V274, P21443, DOI 10.1074/jbc.274.30.21443; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Butte MJ, 1998, BIOCHEMISTRY-US, V37, P16846, DOI 10.1021/bi981254o; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chan WC, 2000, PRACT APPROACH SER, V222, P41; Erickson JT, 2001, J NEUROSCI, V21, P581, DOI 10.1523/JNEUROSCI.21-02-00581.2001; Fletcher JM, 2006, J PEPT SCI, V12, P515, DOI 10.1002/psc.760; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hallbook F, 1999, CURR OPIN NEUROBIOL, V9, P616, DOI 10.1016/S0959-4388(99)00011-2; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; Heller M, 2006, J AM CHEM SOC, V128, P13806, DOI 10.1021/ja063174a; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Maliartchouk S, 2000, J BIOL CHEM, V275, P9946, DOI 10.1074/jbc.275.14.9946; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; O'Leary PD, 1998, J NEUROCHEM, V70, P1712; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Raguse JD, 2004, ORAL ONCOL, V40, P228, DOI 10.1016/j.oraloncology.2003.08.003; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Robinson RC, 1999, PROTEIN SCI, V8, P2589; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RYDEN M, 1995, EMBO J, V14, P1979, DOI 10.1002/j.1460-2075.1995.tb07190.x; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang XM, 2007, J MED CHEM, V50, P2921, DOI 10.1021/jm070084n	44	40	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33375	33383		10.1074/jbc.M802789200	http://dx.doi.org/10.1074/jbc.M802789200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18809686	Green Published, hybrid			2022-12-27	WOS:000261183700042
J	Lu, P; Rha, GB; Melikishvili, M; Wu, GT; Adkins, BC; Fried, MG; Chi, YI				Lu, Peng; Rha, Geun Bae; Melikishvili, Manana; Wu, Guangteng; Adkins, Brandon C.; Fried, Michael G.; Chi, Young-In			Structural Basis of Natural Promoter Recognition by a Unique Nuclear Receptor, HNF4 alpha DIABETES GENE PRODUCT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; CIRCULAR-DICHROISM SPECTRA; RETINOID-X-RECEPTOR; FACTOR 4-ALPHA; RESPONSE ELEMENTS; TRANSCRIPTIONAL ACTIVITY; LIGAND SPECIFICITY; INSULIN-SECRETION; VISCERAL ENDODERM; CENTRAL REGULATOR	HNF4 alpha ( hepatocyte nuclear factor 4 alpha) plays an essential role in the development and function of vertebrate organs, including hepatocytes and pancreatic beta-cells by regulating expression of multiple genes involved in organ development, nutrient transport, and diverse metabolic pathways. As such, HNF4 alpha is a culprit gene product for a monogenic and dominantly inherited form of diabetes, known as maturity onset diabetes of the young (MODY). As a unique member of the nuclear receptor superfamily, HNF4 alpha recognizes target genes containing two hexanucleotide direct repeat DNA-response elements separated by one base pair (DR1) by exclusively forming a cooperative homodimer. We describe here the 2.0 angstrom crystal structure of human HNF4 alpha DNA binding domain in complex with a high affinity promoter element of another MODY gene, HNF1 alpha, which reveals the molecular basis of unique target gene selection/recognition, DNA binding cooperativity, and dysfunction caused by diabetes-causing mutations. The predicted effects of MODY mutations have been tested by a set of biochemical and functional studies, which show that, in contrast to other MODY gene products, the subtle disruption of HNF4 alpha molecular function can cause significant effects in afflicted MODY patients.	[Chi, Young-In] Univ Kentucky, Struct Biol Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Chi, YI (corresponding author), Univ Kentucky, Struct Biol Ctr, Dept Mol & Cellular Biochem, 741 S Limestone Ave, Lexington, KY 40536 USA.	ychi@uky.edu			National Institutes of Health [P20RR20171, GM070662]; Juvenile Diabetes Research Foundation [1-2004-506]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR20171 from the COBRE program of the National Center for Research Resources ( to Y. I. C.) and National Institutes of Health Grant GM070662 ( to M. G. F.). This work was also supported by Juvenile Diabetes Research Foundation Grant 1-2004-506 ( to Y. I. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggelidou E, 2006, FEBS J, V273, P1948, DOI 10.1111/j.1742-4658.2006.05208.x; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P156, DOI 10.1016/j.abb.2006.05.008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chi YI, 2002, MOL CELL, V10, P1129, DOI 10.1016/S1097-2765(02)00704-9; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Duncan SA, 1997, DEVELOPMENT, V124, P279; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Gragnoli C, 1997, DIABETES, V46, P1648, DOI 10.2337/diabetes.46.10.1648; Guo HT, 2006, BIOCHEM J, V394, P379, DOI 10.1042/BJ20051730; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hertz R, 2005, J BIOL CHEM, V280, P24451, DOI 10.1074/jbc.M500732200; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Holmbeck SMA, 1998, J MOL BIOL, V284, P533, DOI 10.1006/jmbi.1998.2207; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Jakob M, 2007, NUCLEIC ACIDS RES, V35, P2705, DOI 10.1093/nar/gkm162; Jiang GQ, 1997, J BIOL CHEM, V272, P1218, DOI 10.1074/jbc.272.2.1218; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Kritis AA, 1996, GENE, V173, P275, DOI 10.1016/0378-1119(96)00183-7; Kulkarni RN, 2004, SCIENCE, V303, P1311, DOI 10.1126/science.1095486; Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lu P, 2008, ACTA CRYSTALLOGR F, V64, P313, DOI 10.1107/S1744309108007136; Lu P, 2007, BIOCHEMISTRY-US, V46, P12071, DOI 10.1021/bi7010527; Malecki MT, 1999, DIABETIC MED, V16, P193, DOI 10.1046/j.1464-5491.1999.00073.x; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIURA N, 1993, NUCLEIC ACIDS RES, V21, P3731, DOI 10.1093/nar/21.16.3731; Monney CT, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9050; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oxombre B, 2004, BIOCHEM J, V383, P573, DOI 10.1042/BJ20040473; Oxombre W, 2002, J MOL MED-JMM, V80, P423, DOI 10.1007/s00109-002-0340-8; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pearson ER, 2005, DIABETOLOGIA, V48, P878, DOI 10.1007/s00125-005-1738-y; Petrescu AD, 2005, J BIOL CHEM, V280, P16714, DOI 10.1074/jbc.M405906200; Petrescu AD, 2002, J BIOL CHEM, V277, P23988, DOI 10.1074/jbc.M201241200; Pruhova S, 2003, DIABETOLOGIA, V46, P291, DOI 10.1007/s00125-002-1010-7; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Schroeder F, 2005, LIPIDS, V40, P559, DOI 10.1007/s11745-005-1416-y; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Sladek FM, 1998, DIABETES, V47, P985, DOI 10.2337/diabetes.47.6.985; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Tsodikov OV, 2001, BIOPHYS J, V81, P1960, DOI 10.1016/S0006-3495(01)75847-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Vaxillaire M, 2006, ENDOCRIN METAB CLIN, V35, P371, DOI 10.1016/j.ecl.2006.02.009; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhao Q, 2000, J MOL BIOL, V296, P509, DOI 10.1006/jmbi.1999.3457	80	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33685	33697		10.1074/jbc.M806213200	http://dx.doi.org/10.1074/jbc.M806213200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829458	Green Published, hybrid			2022-12-27	WOS:000261183700075
J	Tian, G; Kober, FX; Lewandrowski, U; Sickmann, A; Lennarz, WJ; Schindelin, H				Tian, Geng; Kober, Franz-Xaver; Lewandrowski, Urs; Sickmann, Albert; Lennarz, William J.; Schindelin, Hermann			The Catalytic Activity of Protein-disulfide Isomerase Requires a Conformationally Flexible Moleculele	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; FUNCTIONAL-PROPERTIES; CRYSTAL-STRUCTURE; FOLDING CATALYST; PEPTIDE-BINDING; YEAST; SITE; DOMAIN	Protein-disulfide isomerase (PDI) catalyzes the formation of the correct pattern of disulfide bonds in secretory proteins. A low resolution crystal structure of yeast PDI described here reveals large scale conformational changes compared with the initially reported structure, indicating that PDI is a highly flexible molecule with its catalytic domains, a and a', representing two mobile arms connected to a more rigid core composed of the b and b' domains. Limited proteolysis revealed that the linker between the a domain and the core is more susceptible to degradation than that connecting the a' domain to the core. By restricting the two arms with inter-domain disulfide bonds, the molecular flexibility of PDI, especially that of its a domain, was demonstrated to be essential for the enzymatic activity in vitro and in vivo. The crystal structure also featured a PDI dimer, and a propensity to dimerize in solution and in the ER was confirmed by cross-linking experiments and the split green fluorescent protein system. Although sedimentation studies suggested that the self-association of PDI is weak, we hypothesize that PDI exists as an interconvertible mixture of monomers and dimers in the endoplasmic reticulum due to its high abundance in this compartment.	[Tian, Geng; Lennarz, William J.; Schindelin, Hermann] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Kober, Franz-Xaver; Lewandrowski, Urs; Sickmann, Albert; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97078 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Schindelin, H (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	hermann.schindelin@virchow.uni-wuerzburg.de	Tian, Geng/G-7374-2011; Schindelin, Hermann/Q-2697-2019; Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265	National Institutes of Health [GM33184, DK54835]; Deutsche Forschungsgemeinschaft [FZ82]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33184 (to W. J. L.) and DK54835 ( to H. S.). This work was also supported by Deutsche Forschungsgemeinschaft Grant FZ82 ( to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brachmann CB, 1998, YEAST, V14, P115; CAI H, 1994, J BIOL CHEM, V269, P24550; DeLano W.L, PYMOL MOL GRAPHICS S; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; GALLAGHER SR, 1999, CURRENT PROTOCOLS MO, V2, DOI DOI 10.12B.11-10.12B.15; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Grillo C, 2007, J BIOL CHEM, V282, P10299, DOI 10.1074/jbc.M700966200; Holst B, 1997, J CELL BIOL, V138, P1229, DOI 10.1083/jcb.138.6.1229; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KELLEHER DJ, 1994, J BIOL CHEM, V269, P12908; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LAMANTIA M, 1991, P NATL ACAD SCI USA, V88, P4453, DOI 10.1073/pnas.88.10.4453; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; LAMBERT N, 1983, BIOCHEM J, V213, P225, DOI 10.1042/bj2130225; LEBECHE D, 1994, BIOCHEM BIOPH RES CO, V202, P556, DOI 10.1006/bbrc.1994.1964; LI SJ, 2005, J BIOL CHEM; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Solovyov A, 2004, J BIOL CHEM, V279, P34095, DOI 10.1074/jbc.M405640200; Solovyov A, 2004, PROTEIN SCI, V13, P1902, DOI 10.1110/ps.04716104; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun XX, 2000, J BIOL CHEM, V275, P22743, DOI 10.1074/jbc.M002406200; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Westphal V, 1999, J MOL BIOL, V286, P1229, DOI 10.1006/jmbi.1999.2560; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Yan AX, 2003, J BIOL CHEM, V278, P33078, DOI 10.1074/jbc.M305337200; ZAPUN A, 1992, PROTEINS, V14, P10, DOI 10.1002/prot.340140104	48	64	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33630	33640		10.1074/jbc.M806026200	http://dx.doi.org/10.1074/jbc.M806026200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18815132	hybrid, Green Published			2022-12-27	WOS:000261183700069
J	Yoon, WJ; Cho, YD; Cho, KH; Woo, KM; Baek, JH; Cho, JY; Kim, GS; Ryoo, HM				Yoon, Won-Joon; Cho, Young-Dan; Cho, Kwang-Hwi; Woo, Kyung-Mi; Baek, Jeong-Hwa; Cho, Je-Yoel; Kim, Gwan-Shik; Ryoo, Hyun-Mo			The Boston-type Craniosynostosis Mutation MSX2 (P148H) Results in Enhanced Susceptibility of MSX2 to Ubiquitin-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL SUTURE MORPHOGENESIS; CALVARIAL BONE-DEVELOPMENT; APICAL ECTODERMAL RIDGE; HOMEOBOX GENE; OSTEOBLAST DIFFERENTIATION; HOMEODOMAIN PROTEINS; RETINOBLASTOMA GENE; DEVELOPING LIMB; EXTRA COPY; EXPRESSION	Boston-type craniosynostosis is caused by a single amino acid substitution, P148H, in the transcription factor MSX2. The increased binding affinity of MSX2 (P148H) to the response element has led many to hypothesize that the substitution is a gain-of-function mutation. However, there have been conflicting reports on the function of MSX2, and by extension, the nature of the P148H mutation remains unclear. In this study, we have examined the molecular mechanism of MSX2 function and the nature of the P148H mutation. During cranial suture closure of rodent, Msx2 expression was detected in the suture space. Overexpression of wild type MSX2 in mesenchymal cells stimulated cell proliferation and cyclin D1 expression, whereas P148H mutant did not. These results indicated that MSX2 is involved in maintaining the suture space by stimulating suture mesenchymal cell proliferation and that P148H is defective in this process. The protein levels of P148H were lower than wild type Msx2 (Msx2-WT), and pulse-chase experiments indicated that the mutant protein has a shorter half-life than the Msx2-WT protein. The ubiquitylation level of P148H was greater than that of Msx2-WT. The degradation of Msx2 was mediated by Praja1, and the P148H mutant was degraded more effectively than WT. The ubiquitylation of Msx2-WT was higher in the presence of Msx2 (P148H), which indicated that P148H functions as a dominant-negative mutant. Collectively, the primary function of MSX2 in suture closure is the induction of cell proliferation and suture maintenance, and the mutation results in an increased susceptibility of both wild type and mutant MSX2 to proteasomal degradation.	[Yoon, Won-Joon; Cho, Young-Dan; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Ryoo, Hyun-Mo] Seoul Natl Univ, Dept Cell & Dev Biol, Sch Dent, Seoul 110749, South Korea; [Yoon, Won-Joon; Cho, Young-Dan; Woo, Kyung-Mi; Baek, Jeong-Hwa; Kim, Gwan-Shik; Ryoo, Hyun-Mo] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea; [Cho, Kwang-Hwi] Soongsil Univ, Dept Bioinformat & Life Sci, Seoul 156743, South Korea; [Cho, Je-Yoel] Kyungpook Natl Univ, Dept Biochem, Sch Dent, Taegu 700422, South Korea; [Cho, Je-Yoel] Kyungpook Natl Univ, Dept Biochem, Skeletal Dis Genome Res Ctr, Taegu 700422, South Korea	Seoul National University (SNU); Seoul National University (SNU); Soongsil University; Kyungpook National University; Kyungpook National University	Ryoo, HM (corresponding author), 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Baek, Jeong-Hwa/A-8628-2012; Woo, Kyung Mi/A-2793-2009; Cho, Young-Dan/AAR-4573-2021; Ryoo, Hyun-Mo/D-5839-2012	Woo, Kyung Mi/0000-0002-2782-1189; Ryoo, Hyun-Mo/0000-0001-6769-8341	Basic Research Program of the Korea Science & Engineering Foundation [R01-2005-000-106650]; Korea Health 21 R D Project; Ministry of Health and Welfare Project [A010252]	Basic Research Program of the Korea Science & Engineering Foundation(Korea Science and Engineering Foundation); Korea Health 21 R D Project; Ministry of Health and Welfare Project	This work was supported by Basic Research Program of the Korea Science & Engineering Foundation Grant R01-2005-000-106650 and by Korea Health 21 R & D Project, Ministry of Health and Welfare Project A010252.	Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Dodig M, 1999, DEV BIOL, V209, P298, DOI 10.1006/dbio.1999.9258; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Kim HJ, 1998, DEVELOPMENT, V125, P1241; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Koshiba K, 1998, J EXP ZOOL, V282, P703, DOI 10.1002/(SICI)1097-010X(19981215)282:6<703::AID-JEZ6>3.0.CO;2-P; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; LIU YH, 1994, MECH DEVELOP, V48, P187, DOI 10.1016/0925-4773(94)90059-0; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; LIU YH, 1995, P NATL ACAD SCI USA, V92, P6137, DOI 10.1073/pnas.92.13.6137; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Montanaro L, 2007, CELL PROLIFERAT, V40, P532, DOI 10.1111/j.1365-2184.2007.00448.x; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Newberry EP, 1997, J BIOL CHEM, V272, P29607, DOI 10.1074/jbc.272.47.29607; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; NISHIKAWA K, 1994, BIOCHEM MOL BIOL INT, V32, P763; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; Rice R, 2003, DEV BIOL, V262, P75, DOI 10.1016/S0012-1606(03)00355-5; ROMANO JW, 1989, ONCOGENE, V4, P1483; ROS MA, 1994, DEV BIOL, V166, P59, DOI 10.1006/dbio.1994.1296; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; Shiihara T, 2004, AM J MED GENET A, V128A, P214, DOI 10.1002/ajmg.a.20552; SUMOY L, 1995, DEV BIOL, V170, P230, DOI 10.1006/dbio.1995.1210; Towler DA, 2006, ANN NY ACAD SCI, V1068, P327, DOI 10.1196/annals.1346.036; Wang JC, 2007, AM J MED GENET A, V143A, P2931, DOI 10.1002/ajmg.a.31946; Wang WP, 1999, J INVEST DERM SYMP P, V4, P278, DOI 10.1038/sj.jidsp.5640229; WARMAN ML, 1993, AM J MED GENET, V46, P444, DOI 10.1002/ajmg.1320460420; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Yoshizawa T, 2004, MOL CELL BIOL, V24, P3460, DOI 10.1128/MCB.24.8.3460-3472.2004; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	37	24	24	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32751	32761		10.1074/jbc.M803183200	http://dx.doi.org/10.1074/jbc.M803183200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18786927	hybrid			2022-12-27	WOS:000260893700064
J	Cao, XQ; Tanis, KQ; Koleske, AJ; Colicelli, J				Cao, Xiaoqing; Tanis, Keith Q.; Koleske, Anthony J.; Colicelli, John			Enhancement of ABL Kinase Catalytic Efficiency by a Direct Binding Regulator Is Independent of Other Regulatory Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; C-ABL; BCR-ABL; FAMILY KINASES; CELL-MIGRATION; DOCKING SITE; MAP KINASE; PHOSPHORYLATION; DOMAIN; ACTIVATION	ABL family tyrosine kinases are tightly regulated by autoinhibition and phosphorylation mechanisms. These kinases maintain an inactive conformation through intramolecular interactions involving SH3 and SH2 domains. RIN1, a downstream effector of RAS, binds to the ABL SH3 and SH2 domains and stimulates ABL tyrosine kinase activity. RIN1 binding to the ABL2 kinase resulted in a large decrease in K-m and a small increase in V-max toward an ABL consensus substrate peptide. The enzyme efficiency (k(cat)/K-m) was increased more than 5-fold by RIN1. In addition, RIN1 strongly enhanced ABL-mediated phosphorylation of CRK, PSTPIP1, and DOK1, all established ABL substrates but with unique protein structures and distinct target sequences. Importantly RIN1-mediated stimulation of ABL kinase activity was independent of activation by SRC-mediated phosphorylation. RIN1 increased the kinase activity of both ABL1 and ABL2, and this occurred in the presence or absence of ABL regulatory domains outside the SH3-SH2-tyrosine kinase domain core. We further demonstrate that a catalytic site mutation associated with broad drug resistance, ABL1(T315I), remains responsive to stimulation by RIN1. These findings are consistent with an allosteric kinase activation mechanism by which RIN1 binding promotes a more accessible ABL catalytic site through relief of autoinhibition. Direct disruption of RIN1 binding may therefore be a useful strategy to suppress the activity of normal and oncogenic ABL, including inhibitor-resistant mutants that confound current therapeutic strategies. Stimulation through derepression may be applicable to many other tyrosine kinases autoinhibited by coupled SH3 and SH2 domains.	[Cao, Xiaoqing; Colicelli, John] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Inst Mol Biol, Los Angeles, CA 90095 USA; [Cao, Xiaoqing; Colicelli, John] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Canc Ctr, Los Angeles, CA 90095 USA; [Tanis, Keith Q.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University	Colicelli, J (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, 615 Charles E Young Dr,34609 BSRB, Los Angeles, CA 90095 USA.	colicelli@mednet.ucla.edu		Tanis, Keith/0000-0001-6744-1183	National Institutes of Health [RO1 NS046787, NS39475, MH77306]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH077306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046787, R01NS039475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 NS046787 (to J. C.) and NS39475 and MH77306 (to A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afar DEH, 1997, IMMUNITY, V6, P773, DOI 10.1016/S1074-7613(00)80452-5; Amoui M, 2000, CELL SIGNAL, V12, P637, DOI 10.1016/S0898-6568(00)00107-8; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cujec TP, 2002, CHEM BIOL, V9, P253, DOI 10.1016/S1074-5521(02)00098-4; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Finn AJ, 2003, NAT NEUROSCI, V6, P717, DOI 10.1038/nn1071; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Goss VL, 2006, BLOOD, V107, P4888, DOI 10.1182/blood-2005-08-3399; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Hu HL, 2008, MOL CELL BIOL, V28, P1573, DOI 10.1128/MCB.01087-07; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Huang YP, 2008, BLOOD, V112, P111, DOI 10.1182/blood-2007-10-118232; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jung JH, 2008, BIOCHEMISTRY-US, V47, P1094, DOI 10.1021/bi701533j; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Milstein M, 2007, CANCER RES, V67, P11510, DOI 10.1158/0008-5472.CAN-07-1147; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Skaggs BJ, 2006, P NATL ACAD SCI USA, V103, P19466, DOI 10.1073/pnas.0609239103; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Wang JYJ, 2005, CELL RES, V15, P43, DOI 10.1038/sj.cr.7290263; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Xiong XL, 2008, BBA-MOL CELL RES, V1783, P737, DOI 10.1016/j.bbamcr.2008.01.028	46	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31401	31407		10.1074/jbc.M804002200	http://dx.doi.org/10.1074/jbc.M804002200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18796434	hybrid, Green Published			2022-12-27	WOS:000260760800019
J	Emami, K; Topakas, E; Nagy, T; Henshaw, J; Jackson, KA; Nelson, KE; Mongodin, EF; Murray, JW; Lewis, RJ; Gilbert, HJ				Emami, Kaveh; Topakas, Evangelos; Nagy, Tibor; Henshaw, Joanna; Jackson, Kelly A.; Nelson, Karen E.; Mongodin, Emmanuel F.; Murray, James W.; Lewis, Richard J.; Gilbert, Harry J.			Regulation of the Xylan-degrading Apparatus of Cellvibrio japonicus by a Novel Two-component System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENS SUBSP CELLULOSA; HYDROLASE FAMILY-51 ARABINOFURANOSIDASE; CARBOHYDRATE-BINDING MODULES; CELL WALL HYDROLASES; PHOQ SENSOR DOMAIN; PSEUDOMONAS-FLUORESCENS; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; LIGAND-BINDING	The microbial degradation of lignocellulose biomass is not only an important biological process but is of increasing industrial significance in the bioenergy sector. The mechanism by which the plant cell wall, an insoluble composite structure, activates the extensive repertoire of microbial hydrolytic enzymes required to catalyze its degradation is poorly understood. Here we have used a transposon mutagenesis strategy to identify a genetic locus, consisting of two genes that modulate the expression of xylan side chain-degrading enzymes in the saprophytic bacterium Cellvibrio japonicus. Significantly, the locus encodes a two-component signaling system, designated AbfS (sensor histidine kinase) and AbfR (response regulator). The AbfR/S two-component system is required to activate the expression of the suite of enzymes that remove the numerous side chains from xylan, but not the xylanases that hydrolyze the beta 1,4-linked xylose polymeric backbone of this polysaccharide. Studies on the recombinant sensor domain of AbfS (AbfS(SD)) showed that it bound to decorated xylans and arabinoxylo-oligosaccharides, but not to undecorated xylo-oligosaccharides or other plant structural polysaccharides/oligosaccharides. The crystal structure of AbfS(SD) was determined to a resolution of 2.6 angstrom. The overall fold of AbfS(SD) is that of a classical Per Arndt Sim domain with a central antiparallel four-stranded beta-sheet flanked by alpha-helices. Our data expand the number of molecules known to bind to the sensor domain of two-component histidine kinases to include complex carbohydrates. The biological rationale for a regulatory system that induces enzymes that remove the side chains of xylan, but not the hydrolases that cleave the backbone of the polysaccharide, is discussed.	[Emami, Kaveh; Topakas, Evangelos; Nagy, Tibor; Henshaw, Joanna; Jackson, Kelly A.; Murray, James W.; Lewis, Richard J.; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Nelson, Karen E.; Mongodin, Emmanuel F.] Inst Genom Res, Rockville, MD 20850 USA	Newcastle University - UK; J. Craig Venter Institute	Lewis, RJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	r.lewis@ncl.ac.uk; h.j.gilbert@ncl.ac.uk	Topakas, Evangelos/C-6528-2012; Topakas, Evangelos/J-7554-2019; Mongodin, Emmanuel/AAF-1850-2020	Topakas, Evangelos/0000-0003-0078-5904; Mongodin, Emmanuel/0000-0003-3833-7437; Emami, Kaveh/0000-0003-0182-0070; Murray, James/0000-0002-8897-0161; Jackson, Kelly/0000-0001-9116-3769; lewis, richard/0000-0003-2641-8643	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D000475/1] Funding Source: researchfish; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aro N, 2001, J BIOL CHEM, V276, P24309, DOI 10.1074/jbc.M003624200; Bartolome B, 1997, APPL ENVIRON MICROB, V63, P208; Beylot MH, 2001, BIOCHEM J, V358, P599, DOI 10.1042/0264-6021:3580599; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BORGSTAHL GEO, 1995, BIOCHEMISTRY-US, V34, P6278, DOI 10.1021/bi00019a004; Brett CT, 1996, PHYSL BIOCH PLANT CE; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cowtan K, 2001, ACTA CRYSTALLOGR D, V57, P1435, DOI 10.1107/S0907444901010812; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Emami K, 2002, J BACTERIOL, V184, P4124, DOI 10.1128/JB.184.15.4124-4133.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS P, 1993, CCP4 DARESBURY STUDY; Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999; FERREIRA LMA, 1993, BIOCHEM J, V294, P349, DOI 10.1042/bj2940349; Firbank SJ, 2008, J MOL BIOL, V381, P529, DOI 10.1016/j.jmb.2008.06.004; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; Golby P, 1999, J BACTERIOL, V181, P1238, DOI 10.1128/JB.181.4.1238-1248.1999; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; HARRIS GW, 1994, STRUCTURE, V2, P1107, DOI 10.1016/S0969-2126(94)00112-X; Hasper AA, 2000, MOL MICROBIOL, V36, P193, DOI 10.1046/j.1365-2958.2000.01843.x; Hazlewood GP, 1998, PROG NUCLEIC ACID RE, V61, P211, DOI 10.1016/S0079-6603(08)60828-4; Hazlewood GP, 1998, BIOCHEM SOC T, V26, P185, DOI 10.1042/bst0260185; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaspar S, 1999, MOL MICROBIOL, V33, P858, DOI 10.1046/j.1365-2958.1999.01536.x; Kaspar S, 2002, ARCH MICROBIOL, V177, P313, DOI 10.1007/s00203-001-0393-z; KELLETT LE, 1990, BIOCHEM J, V272, P369, DOI 10.1042/bj2720369; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; LESLIE AGW, 1992, JOINT CCCP4 ESF EAMC, V26; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Miyazaki K, 2003, J BACTERIOL, V185, P2219, DOI 10.1128/JB.185.7.2219-2226.2003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy T, 2002, J BACTERIOL, V184, P4925, DOI 10.1128/JB.184.17.4925-4929.2002; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sticklen M, 2006, CURR OPIN BIOTECH, V17, P315, DOI 10.1016/j.copbio.2006.05.003; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tomme P, 1996, BIOCHEMISTRY-US, V35, P13885, DOI 10.1021/bi961185i; WANG P, 1997, XYLANASES STREPTOMYC, P25; Zientz E, 1998, J BACTERIOL, V180, P5421, DOI 10.1128/JB.180.20.5421-5425.1998	68	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1086	1096		10.1074/jbc.M805100200	http://dx.doi.org/10.1074/jbc.M805100200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18922794	hybrid			2022-12-27	WOS:000262122900045
J	Wang, Y; Branicky, R; Stepanyan, Z; Carroll, M; Guimond, MP; Hihi, A; Hayes, S; McBride, K; Hekimi, S				Wang, Ying; Branicky, Robyn; Stepanyan, Zaruhi; Carroll, Melissa; Guimond, Marie-Pierre; Hihi, Abdelmadjid; Hayes, Steve; McBride, Kevin; Hekimi, Siegfried			The Anti-neurodegeneration Drug Clioquinol Inhibits the Aging-associated Protein CLK-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; AMYLOID BETA-PEPTIDE; LACKING COENZYME-Q; CAENORHABDITIS-ELEGANS; LIFE-SPAN; ALZHEIMERS-DISEASE; UBIQUINONE BIOSYNTHESIS; ESCHERICHIA-COLI; OXIDATIVE DAMAGE; TRANSGENIC MICE	The development of neurodegenerative diseases such as Alzheimer, Parkinson, and Huntington disease is strongly age-dependent. Discovering drugs that act on the high rate of aging in older individuals could be a means of combating these diseases. Reduction of the activity of the mitochondrial enzyme CLK-1 (also known as COQ7) slows down aging in Caenorhabditis elegans and in mice. Clioquinol is a metal chelator that has beneficial effects in several cellular and animal models of neurodegenerative diseases as well as on Alzheimer disease patients. Here we show that clioquinol inhibits the activity of mammalian CLK-1 in cultured cells, an inhibition that can be blocked by iron or cobalt cations, suggesting that chelation is involved in the mechanism of action of clioquinol on CLK-1. We also show that treatment of nematodes and mice with clioquinol mimics a variety of phenotypes produced by mutational reduction of CLK-1 activity in these organisms. These results suggest that the surprising action of clioquinol on several age-dependent neurodegenerative diseases with distinct etiologies might result from a slowing down of the aging process through action of the drug on CLK-1. Our findings support the hypothesis that pharmacologically targeting aging-associated proteins could help relieve age-dependent diseases.	[Carroll, Melissa; Guimond, Marie-Pierre; Hihi, Abdelmadjid; Hayes, Steve; McBride, Kevin] Chronogen Inc, Montreal, PQ H1W 4A4, Canada; [Wang, Ying; Branicky, Robyn; Stepanyan, Zaruhi; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	McBride, K (corresponding author), Chronogen Inc, Montreal, PQ H1W 4A4, Canada.	kevinmcbride@sympatico.ca; Siegfried.Hekimi@McGill.Ca			National Science and Engineering Research Council of Canada; National Cancer Institute of Canada, McGill University; Chronogen Inc	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Cancer Institute of Canada, McGill University; Chronogen Inc	This work was supported in part by grants from the National Science and Engineering Research Council of Canada, the National Cancer Institute of Canada, McGill University, and a research contract from Chronogen Inc. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Branicky R, 2006, MOL CELL BIOL, V26, P3976, DOI 10.1128/MCB.26.10.3976-3985.2006; Caragounis A, 2007, BIOCHEM J, V407, P435, DOI 10.1042/BJ20070579; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; CHRONOGEN INC, 2008, Patent No. 2008014602; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Du T, 2008, J PHARMACOL EXP THER, V324, P360, DOI 10.1124/jpet.107.130377; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881; Hihi AK, 2003, J BIOL CHEM, V278, P41013, DOI 10.1074/jbc.M305034200; Ibach B, 2005, PHARMACOPSYCHIATRY, V38, P178, DOI 10.1055/s-2005-871241; Jiang N, 2001, J BIOL CHEM, V276, P29218, DOI 10.1074/jbc.M103686200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kwon O, 2000, FEMS MICROBIOL LETT, V186, P157, DOI 10.1016/S0378-1097(00)00134-8; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Regland B, 2001, DEMENT GERIATR COGN, V12, P408, DOI 10.1159/000051288; Ritchie CW, 2004, EXPERT OPIN INV DRUG, V13, P1585, DOI 10.1517/13543784.13.12.1585; Saiki R, 2008, AGING CELL, V7, P291, DOI 10.1111/j.1474-9726.2008.00378.x; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; TSUBAKI T, 1971, LANCET, V1, P696, DOI 10.1016/S0140-6736(71)92699-7; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; WONG A, 1995, GENETICS, V139, P1247; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788	40	41	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					314	323		10.1074/jbc.M807579200	http://dx.doi.org/10.1074/jbc.M807579200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18927074	hybrid			2022-12-27	WOS:000261974800036
J	Del Re, DP; Miyamoto, S; Brown, JH				Del Re, Dominic P.; Miyamoto, Shigeki; Brown, Joan Heller			Focal Adhesion Kinase as a RhoA-activable Signaling Scaffold Mediating Akt Activation and Cardiomyocyte Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; CELL-SURVIVAL; SH2 DOMAINS; MAP-KINASE; IN-VITRO; PROTEIN; INHIBITION; APOPTOSIS	RhoA a small G-protein that has an established role in cell growth and in regulation of the actin cytoskeleton. Far less is known about whether RhoA can modulate cell fate. We previously reported that sustained RhoA activation induces cardiomyocyte apoptosis (Del Re, D. P., Miyamoto, S., and Brown, J. H. (2007) J. Biol. Chem. 282, 8069-8078). Here we demonstrate that less chronic RhoA activation affords a survival advantage, protecting cardiomyocytes from apoptotic insult induced by either hydrogen peroxide treatment or glucose deprivation. Under conditions where RhoA is protective, we observe Rho kinase-dependent cytoskeletal rearrangement and activation of focal adhesion kinase (FAK). Activation of endogenous cardiomyocyte FAK leads to its increased association with the p85 regulatory subunit of phosphatidylinositol-3-kinase (PI3K) and to concomitant activation of Akt. Treatment of isolated perfused hearts with sphingosine 1-phosphate recapitulates this response. The pathway by which RhoA mediates cardiomyocyte Akt activation is demonstrated to require Rho kinase, FAK and PI3K, but not Src, based on studies with pharmacological inhibitors (Y-27632, LY294002, PF271 and PP2) and inhibitory protein expression (FAK-related nonkinase). Inhibition of RhoA-mediated Akt activation at any of these steps, including inhibition of FAK, prevents RhoA from protecting cardiomyocytes against apoptotic insult. We further demonstrate that stretch of cardiomyocytes, which activates endogenous RhoA, induces the aforementioned signaling pathway, providing a physiologic context in which RhoA-mediated FAK phosphorylation can activate PI3K and Akt. We suggest that RhoA-mediated effects on the cardiomyocyte cytoskeleton provide a novel mechanism for protection from apoptosis.	[Del Re, Dominic P.; Miyamoto, Shigeki; Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Del Re, Dominic P.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Brown, JH (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu	Miyamoto, Shigeki/L-4004-2019	Del Re, Dominic/0000-0002-5504-9114	National Institutes of Health [HL28143]; American Heart Association [AHA55243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028143, R37HL028143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL28143 (to J.H.B.). This work was also supported by American Heart Association Grant AHA55243 (to S.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JW, 1998, CIRC RES, V83, P167, DOI 10.1161/01.RES.83.2.167; Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; Bachelot C, 1996, BBA-MOL CELL RES, V1311, P45, DOI 10.1016/0167-4889(95)00176-X; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Berestetskaya YV, 1998, J BIOL CHEM, V273, P27816, DOI 10.1074/jbc.273.43.27816; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; De Sarno L, 2005, BRAIN RES, V1041, P112, DOI 10.1016/j.brainres.2005.01.081; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; DiMichele LA, 2006, CIRC RES, V99, P636, DOI 10.1161/01.RES.0000240498.44752.d6; Eble DM, 2000, AM J PHYSIOL-HEART C, V278, pH1695, DOI 10.1152/ajpheart.2000.278.5.H1695; Esteve P, 1998, ONCOGENE, V17, P1855, DOI 10.1038/sj.onc.1202082; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Franchini KG, 2000, CIRC RES, V87, P558, DOI 10.1161/01.RES.87.7.558; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Heidkamp MC, 2003, AM J PHYSIOL-HEART C, V285, pH1684, DOI 10.1152/ajpheart.00016.2003; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; KUMAGAI N, 1993, FEBS LETT, V329, P273, DOI 10.1016/0014-5793(93)80236-N; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Matsui T, 2001, CIRCULATION, V104, P330; Means CK, 2007, AM J PHYSIOL-HEART C, V292, pH2944, DOI 10.1152/ajpheart.01331.2006; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moorman JP, 1999, ONCOGENE, V18, P47, DOI 10.1038/sj.onc.1202262; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Peng X, 2006, J CLIN INVEST, V116, P217, DOI 10.1172/JCI24497; RANKIN S, 1994, FEBS LETT, V354, P315, DOI 10.1016/0014-5793(94)01148-6; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Shi JJ, 2008, J MOL CELL CARDIOL, V44, P551, DOI 10.1016/j.yjmcc.2007.11.018; Sinnett-Smith J, 2001, EXP CELL RES, V266, P292, DOI 10.1006/excr.2001.5219; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Taylor JM, 2000, J BIOL CHEM, V275, P19250, DOI 10.1074/jbc.M909099199; Thorburn J, 1997, EMBO J, V16, P1888, DOI 10.1093/emboj/16.8.1888; Torsoni AS, 2005, AM J PHYSIOL-HEART C, V289, pH1488, DOI 10.1152/ajpheart.00692.2004; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Xu LH, 1998, CELL GROWTH DIFFER, V9, P999; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	66	87	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35622	35629		10.1074/jbc.M804036200	http://dx.doi.org/10.1074/jbc.M804036200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18854312	Green Published, hybrid			2022-12-27	WOS:000261687900035
J	Kirby, K; Jensen, LT; Binnington, J; Hilliker, AJ; Ulloa, J; Culotta, VC; Phillips, JP				Kirby, Kim; Jensen, Laran T.; Binnington, Janet; Hilliker, Arthur J.; Ulloa, Janella; Culotta, Valeria C.; Phillips, John P.			Instability of Superoxide Dismutase 1 of Drosophila in Mutants Deficient for Its Cognate Copper Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; SOD1; METAL; CCS; CLUSTER; CU; MELANOGASTER; MECHANISMS; PROTECTION; CONTRIBUTE	Copper, zinc superoxide dismutase (SOD1) in mammals is activated principally via a copper chaperone (CCS) and to a lesser degree by a CCS-independent pathway of unknown nature. In this study, we have characterized the requirement for CCS in activating SOD1 from Drosophila. A CCS-null mutant (Ccs(n29E)) of Drosophila was created and found to phenotypically resemble Drosophila SOD1-null mutants in terms of reduced adult life span, hypersensitivity to oxidative stress, and loss of cytosolic aconitase activity. However, the phenotypes of CCS-null flies were less severe, consistent with some CCS-independent activation of Drosophila SOD1 (dSOD1). Yet SOD1 activity was not detectable in Ccsn29E flies, due largely to a striking loss of SOD1 protein. In contrast, human SOD1 expressed in CCS-null flies is robustly active and rescues the deficits in adult life span and sensitivity to oxidative stress. The dependence of dSOD1 on CCS was also observed in a yeast expression system where the dSOD1 polypeptide exhibited unusual instability in CCS-null (ccs1 Delta) yeast. The residual dSOD1 polypeptide in ccs1 Delta yeast was nevertheless active, consistent with CCS-independent activation. Stability of dSOD1 in ccs1 Delta cells was readily restored by expression of either yeast or Drosophila CCS, and this required copper insertion into the enzyme. The yeast expression system also revealed some species specificity for CCS. Yeast SOD1 exhibits preference for yeast CCS over Drosophila CCS, whereas dSOD1 is fully activated with either CCS molecule. Such variation in mechanisms of copper activation of SOD1 could reflect evolutionary responses to unique oxygen and/or copper environments faced by divergent species.	[Kirby, Kim; Binnington, Janet; Phillips, John P.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Jensen, Laran T.; Ulloa, Janella; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; [Hilliker, Arthur J.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada	University of Guelph; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; York University - Canada	Phillips, JP (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	jphillip@uoguelph.ca		Jensen, Laran/0000-0003-3199-1743	National Institutes of Health [GM50016]; NIEHS; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050016, R37GM050016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM50016 ( to V. C. C.) and NIEHS ( Johns Hopkins University). This work was also supported by Natural Sciences and Engineering Research Council of Canada ( to J. P. P.) and the Canadian Institutes of Health Research ( to J. P. P. and A. J. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; BOYNTON S, 1992, GENETICS, V131, P655; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Eisses JF, 2000, BIOCHEMISTRY-US, V39, P7337, DOI 10.1021/bi000690j; Field LS, 2002, J BIOENERG BIOMEMBR, V34, P373, DOI 10.1023/A:1021202119942; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0; HU J, 2004, THESIS U GUELPH GUEL; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; LIU XF, 1992, J BIOL CHEM, V267, P18298; Missirlis F, 2003, J BIOL CHEM, V278, P47365, DOI 10.1074/jbc.M307700200; Parkes TL, 1998, GENOME, V41, P642; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; PHILLIPS JP, 1995, P NATL ACAD SCI USA, V92, P8574, DOI 10.1073/pnas.92.19.8574; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rogina B, 2000, BIOGERONTOLOGY, V1, P163, DOI 10.1023/A:1010039813107; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Sherman F., 1978, METHODS YEAST GENETI; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Stasser JP, 2007, BIOCHEMISTRY-US, V46, P11845, DOI 10.1021/bi700566h; Stasser JP, 2005, BIOCHEMISTRY-US, V44, P3143, DOI 10.1021/bi0478392; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Woodruff RC, 2004, GENOME, V47, P1029, DOI 10.1139/G04-083; Zhu HN, 2000, BIOCHEMISTRY-US, V39, P5413, DOI 10.1021/bi992727+	37	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35393	35401		10.1074/jbc.M807131200	http://dx.doi.org/10.1074/jbc.M807131200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18948262	hybrid, Green Published			2022-12-27	WOS:000261687900010
J	Wagner, MC; Rhodes, G; Wang, E; Pruthi, V; Arif, E; Saleem, MA; Wean, SE; Garg, P; Verma, R; Holzman, LB; Gattone, V; Molitoris, BA; Nihalani, D				Wagner, Mark C.; Rhodes, George; Wang, Exing; Pruthi, Vikas; Arif, Ehtesham; Saleem, Moin A.; Wean, Sarah E.; Garg, Puneet; Verma, Rakesh; Holzman, Lawrence B.; Gattone, Vince; Molitoris, Bruce A.; Nihalani, Deepak			Ischemic Injury to Kidney Induces Glomerular Podocyte Effacement and Dissociation of Slit Diaphragm Proteins Neph1 and ZO-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-RENAL-FAILURE; TIGHT JUNCTION; ACTIN CYTOSKELETON; ATP DEPLETION; TYROSINE PHOSPHORYLATION; DIABETIC-NEPHROPATHY; EPITHELIAL TISSUES; ZONULA OCCLUDENS-1; E-CADHERIN; POLYMERIZATION	Glomerular injury is often characterized by the effacement of podocytes, loss of slit diaphragms, and proteinuria. Renal ischemia or the loss of blood flow to the kidneys has been widely associated with tubular and endothelial injury but rarely has been shown to induce podocyte damage and disruption of the slit diaphragm. In this study, we have used an in vivo rat ischemic model to demonstrate that renal ischemia induces podocyte effacement with loss of slit diaphragm and proteinuria. Biochemical analysis of the ischemic glomerulus shows that ischemia induces rapid loss of interaction between slit diaphragm junctional proteins Neph1 and ZO-1. To further understand the effect of ischemia on molecular interactions between slit diaphragm proteins, a cell culture model was employed to study the binding between Neph1 and ZO-1. Under physiologic conditions, Neph1 co-localized with ZO-1 at cell-cell contacts in cultured human podocytes. Induction of injury by ATP depletion resulted in rapid loss of Neph1 and ZO-1 binding and redistribution of Neph1 and ZO-1 proteins from cell membrane to the cytoplasm. Recovery resulted in increased Neph1 tyrosine phosphorylation, restoring Neph1 and ZO-1 binding and their localization at the cell membrane. We further demonstrate that tyrosine phosphorylation of Neph1 mediated by Fyn results in significantly increased Neph1 and ZO-1 binding, suggesting a critical role for Neph1 tyrosine phosphorylation in reorganizing the Neph1-ZO-1 complex. This study documents that renal ischemia induces dynamic changes in the molecular interactions between slit diaphragm proteins, leading to podocyte damage and proteinuria.	[Wagner, Mark C.; Rhodes, George; Wang, Exing; Pruthi, Vikas; Arif, Ehtesham; Wean, Sarah E.; Gattone, Vince; Molitoris, Bruce A.; Nihalani, Deepak] Indiana Univ, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA; [Saleem, Moin A.] Univ Bristol, Bristol Royal Hosp Children, Childrens Renal Unit, Bristol BS2 8BJ, Avon, England; [Garg, Puneet; Verma, Rakesh; Holzman, Lawrence B.] Univ Michigan, Sch Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Saleem, Moin A.] Dept Vet Affairs, Ann Arbor, MI 48105 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Bristol Royal Hospital For Children; University of Bristol; University of Michigan System; University of Michigan	Nihalani, D (corresponding author), Indiana Univ, Dept Med, Div Nephrol, 950 W Walnut St,R2-254, Indianapolis, IN 46202 USA.	dnihalan@iupui.edu	Arif, Ehtesham/AAV-8272-2020; nihalani, deepak/AAK-9453-2020	Pruthi, Vikas/0000-0002-3666-5552; Holzman, Lawrence/0000-0002-8961-234X; Saleem, Moin/0000-0002-9808-4518; Arif, Ehtesham/0000-0001-9638-3189; Garg, Puneet/0000-0001-7439-459X	National Institutes of Health, NIDDK [K01 DK072047-03, RO1 DK069408, P-50 DK061594]; Indiana University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069408, P50DK061594, K01DK072047, K08DK081403] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Indiana University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant K01 DK072047-03 (to D.N.) and Grants RO1 (DK069408) and P-50 (DK061594) (to B.M.). This work was also supported by a Research Support Funds Grant from Indiana University (to D.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ANDREWS P, 1988, J ELECTRON MICR TECH, V9, P115, DOI 10.1002/jemt.1060090203; Ashworth SL, 2004, AM J PHYSIOL-RENAL, V286, pF988, DOI 10.1152/ajprenal.00168.2003; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; BACALLAO R, 1994, J CELL SCI, V107, P3301; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; BARNES JL, 1981, LAB INVEST, V45, P378; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Kelly KJ, 2000, SEMIN NEPHROL, V20, P4; KURIHARA H, 1992, AM J PATHOL, V141, P805; KURIHARA H, 1992, P NATL ACAD SCI USA, V89, P7075, DOI 10.1073/pnas.89.15.7075; Kwon O, 2002, AM J PHYSIOL-RENAL, V282, pF1012, DOI 10.1152/ajprenal.00294.2001; Lee DBN, 2006, AM J PHYSIOL-RENAL, V290, pF20, DOI 10.1152/ajprenal.00052.2005; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x; Lowenborg EKM, 2000, NEPHROL DIAL TRANSPL, V15, P1547, DOI 10.1093/ndt/15.10.1547; MANDEL LJ, 1994, J CELL SCI, V107, P3315; Molitoris BA, 2004, KIDNEY INT, V66, P496, DOI 10.1111/j.1523-1755.2004.761_5.x; Molitoris BA, 2003, J AM SOC NEPHROL, V14, P265, DOI 10.1097/01.ASN.0000048852.53881.D9; Molitoris BA, 2008, NAT CLIN PRACT NEPHR, V4, P154, DOI 10.1038/ncpneph0723; National Institutes of Health, 1996, GUID CAR US LAB AN; NIHALANI D, 2007, MOL CELL BIOL; Obeidova H, 2006, Prague Med Rep, V107, P5; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Parikh CR, 2007, J INVEST MED, V55, P333, DOI 10.2310/6650.2007.00015; Patari-Sampo A, 2006, ANN MED, V38, P483, DOI 10.1080/07853890600978149; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Rincon-Choles H, 2006, DIABETES, V55, P894, DOI 10.2337/diabetes.55.04.06.db05-0355; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sutton TA, 1998, SEMIN NEPHROL, V18, P490; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tsukamoto T, 1999, AM J PHYSIOL-RENAL, V276, pF737, DOI 10.1152/ajprenal.1999.276.5.F737; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wang LM, 2005, J AM SOC NEPHROL, V16, P3611, DOI 10.1681/ASN.2005020167; Wolf G, 2007, NEPHRON PHYSIOL, V106, P26, DOI 10.1159/000101797; Ye JM, 1999, AM J PHYSIOL-RENAL, V277, pF524, DOI 10.1152/ajprenal.1999.277.4.F524; Yin M, 2002, RENAL FAILURE, V24, P147, DOI 10.1081/JDI-120004092	57	61	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35579	35589		10.1074/jbc.M805507200	http://dx.doi.org/10.1074/jbc.M805507200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18922801	hybrid, Green Published			2022-12-27	WOS:000261687900030
J	Dieteren, CEJ; Willems, PHGM; Vogel, RO; Swarts, HG; Fransen, J; Roepman, R; Crienen, G; Smeitink, JAM; Nijtmans, LGJ; Koopman, WJH				Dieteren, Cindy E. J.; Willems, Peter H. G. M.; Vogel, Rutger O.; Swarts, Herman G.; Fransen, Jack; Roepman, Ronald; Crienen, Gijs; Smeitink, Jan A. M.; Nijtmans, Leo G. J.; Koopman, Werner J. H.			Subunits of Mitochondrial Complex I Exist as Part of Matrix- and Membrane-associated Subcomplexes in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATERAL DIFFUSION; INNER MEMBRANE; DYNAMICS; IDENTIFICATION; TRAFFICKING; COMPONENTS; MOTILITY; MOBILITY; RAS	Mitochondrial complex I (CI) is a large assembly of 45 different subunits, and defects in its biogenesis are the most frequent cause of mitochondrial disorders. In vitro evidence suggests a stepwise assembly process involving pre-assembled modules. However, whether these modules also exist in vivo is as yet unresolved. To answer this question, we here applied submitochondrial fluorescence recovery after photobleaching to HEK293 cells expressing 6 GFP-tagged subunits selected on the basis of current CI assembly models. We established that each subunit was partially present in a virtually immobile fraction, possibly representing the holo-enzyme. Four subunits (NDUFV1, NDUFV2, NDUFA2, and NDUFA12) were also present as highly mobile matrix-soluble monomers, whereas, in sharp contrast, the other two subunits (NDUFB6 and NDUFS3) were additionally present in a slowly mobile fraction. In the case of the integral membrane protein NDUFB6, this fraction most likely represented one or more membrane-bound subassemblies, whereas biochemical evidence suggested that for the NDUFS3 protein this fraction most probably corresponded to a matrix-soluble subassembly. Our results provide first time evidence for the existence of CI subassemblies in mitochondria of living cells.	[Dieteren, Cindy E. J.; Vogel, Rutger O.; Smeitink, Jan A. M.; Nijtmans, Leo G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, NL-6500 HB Nijmegen, Netherlands; [Dieteren, Cindy E. J.; Willems, Peter H. G. M.; Swarts, Herman G.; Crienen, Gijs; Koopman, Werner J. H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Fransen, Jack] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6500 HB Nijmegen, Netherlands; [Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Willems, Peter H. G. M.; Fransen, Jack; Koopman, Werner J. H.] Radboud Univ Nijmegen, Med Ctr, Microscop Imaging Ctr Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Nijtmans, LGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, Geert Grootepl 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.	l.nijtmans@cukz.umcn.nl	Smeitink, Jan A.M./D-6064-2011; Koopman, Werner J.H./AAC-9668-2020; Smeitink, Jan/C-1351-2013; Nijtmans, L.G.J./L-4549-2015; Koopman, Werner J.H./D-3592-2009; Dieteren, Cindy E.J./D-6042-2011; Roepman, Ronald/B-1339-2014; Fransen, Jack/E-8924-2010; Willems, P.H.G.M./L-4759-2015	Koopman, Werner J.H./0000-0002-5340-6747; Koopman, Werner J.H./0000-0002-5340-6747; Roepman, Ronald/0000-0002-5178-8163; Fransen, Jack/0000-0002-0571-7639; Willems, P.H.G.M./0000-0002-0915-1599	Radboud University Nijmegen Medical Centre; Netherlands Organization for Health Research and Development [903-46-176]; NWO ( Netherlands Organization for Scientific [911-02-008]	Radboud University Nijmegen Medical Centre; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); NWO ( Netherlands Organization for Scientific(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Radboud University Nijmegen Medical Centre ( RUNMC, to W. J. H. K. and L. G. J. N.) and equipment grants of ZON ( Netherlands Organization for Health Research and Development, 903-46-176) and NWO ( Netherlands Organization for Scientific Research, No: 911-02-008). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292; Cardol P, 2008, BBA-BIOENERGETICS, V1777, P388, DOI 10.1016/j.bbabio.2008.01.001; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CHAZOTTE B, 1991, J BIOL CHEM, V266, P5973; Chen Y, 2006, METHODS, V39, P147, DOI 10.1016/j.ymeth.2006.05.008; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; GUPTE SS, 1991, BIOCHIM BIOPHYS ACTA, V1069, P131, DOI 10.1016/0005-2736(91)90114-N; Haggie PM, 2002, J BIOL CHEM, V277, P40782, DOI 10.1074/jbc.M207456200; HOETS SJ, 2008, AM J HUM GENET, V82, P1306; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Koopman WJH, 2007, BBA-BIOENERGETICS, V1767, P940, DOI 10.1016/j.bbabio.2007.03.013; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LAZAROU M, 2008, BIOCH BIOPH IN PRESS; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Lenaz G, 2007, AM J PHYSIOL-CELL PH, V292, pC1221, DOI 10.1152/ajpcell.00263.2006; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Olveczky BP, 1998, BIOPHYS J, V74, P2722, DOI 10.1016/S0006-3495(98)77978-0; Picard D, 2006, EXP CELL RES, V312, P3949, DOI 10.1016/j.yexcr.2006.08.026; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Vogel RO, 2007, MOL GENET METAB, V91, P176, DOI 10.1016/j.ymgme.2007.02.007; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Zuo DM, 2007, NUCLEIC ACIDS RES, V35, pD680, DOI 10.1093/nar/gkl898	34	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34753	34761		10.1074/jbc.M807323200	http://dx.doi.org/10.1074/jbc.M807323200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18826940	Green Published, hybrid			2022-12-27	WOS:000261469100032
J	Majtan, T; Singh, LR; Wang, LQ; Kruger, WD; Kraus, JP				Majtan, Tomas; Singh, Laishram R.; Wang, Liqun; Kruger, Warren D.; Kraus, Jan P.			Active Cystathionine beta-Synthase Can Be Expressed in Heme-free Systems in the Presence of Metal-substituted Porphyrins or a Chemical Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; ADENOSYL-L-METHIONINE; ALZHEIMERS-DISEASE; LIGAND SWITCH; MUTATIONS; PROTEIN; YEAST; TRANSSULFURATION; BINDING; ENZYME	Cystathionine beta-synthase (CBS), a key enzyme in the metabolism of homocysteine, has previously been shown to require a heme co-factor for maximal activity. However, the biochemical function of the CBS heme is not well defined. Here, we show that expression of human CBS in heme-deficient strains of Saccharomyces cerevisiae and Escherichia coli results in production of an enzyme that is misfolded and degraded. Addition of exogenous heme, porphyrins with non-iron metal, or porphyrin lacking metal entirely produced stable and active CBS enzyme. Purification of recombinant CBS enzyme expressed in the presence of various metalloporphyrins confirmed that Mn(III) and Co (III) had 30-60% of the specific activity of Fe(III)-CBS, and still responded to allosteric activation by S-adenosyl-L-methionine. Treatment of S. cerevisiae with the chemical chaperone trimethylamine-N-oxide resulted in near complete restoration of function to human CBS produced in a heme-deficient strain. Taken together, these results suggest that porphyrin moiety of the heme plays a critical role in proper CBS folding and assembly, but that the metal ion is not essential for this function or for allosteric regulation by S-adenosyl-L-methionine.	[Majtan, Tomas; Kraus, Jan P.] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA; [Majtan, Tomas] Slovak Acad Sci, Inst Mol Biol, Dept Genom & Biotechnol, Bratislava 84551, Slovakia; [Singh, Laishram R.; Wang, Liqun; Kruger, Warren D.] Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Slovak Academy of Sciences; Fox Chase Cancer Center	Kraus, JP (corresponding author), Univ Colorado, Dept Pediat, Aurora, CO 80045 USA.	jan.kraus@ucdenver.edu	Kruger, Warren/Y-2541-2018; kruger, warren/A-6407-2008; Majtan, Tomas/AAE-8426-2021	kruger, warren/0000-0002-4990-3695; Majtan, Tomas/0000-0002-2751-2124	National Institutes of Health [HL065217-06A2]; American Heart Association [AHA 2-5-80663]; Jerome Lejeune Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Jerome Lejeune Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL065217-06A2. This work was also supported by American Heart Association Grant AHA 2-5-80663, the Jerome Lejeune Foundation (to J. P. K.), and a generous gift from Margie McGlynn. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bender AT, 2002, J INORG BIOCHEM, V91, P625, DOI 10.1016/S0162-0134(02)00430-0; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bruno S, 2001, J BIOL CHEM, V276, P16, DOI 10.1074/jbc.C000588200; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Evande R, 2004, ARCH BIOCHEM BIOPHYS, V427, P188, DOI 10.1016/j.abb.2004.04.027; FABRY TL, 1968, BIOCHIM BIOPHYS ACTA, V160, P118, DOI 10.1016/0005-2795(68)90072-X; Frank N, 2008, ARCH BIOCHEM BIOPHYS, V470, P64, DOI 10.1016/j.abb.2007.11.006; Frank N, 2006, BIOCHEMISTRY-US, V45, P11021, DOI 10.1021/bi060737m; Gupta K, 2006, ACTA CRYSTALLOGR D, V62, P151, DOI 10.1107/S0907444905036309; Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jhee KH, 2000, J BIOL CHEM, V275, P11541, DOI 10.1074/jbc.C000056200; KERY V, 1995, ARCH BIOCHEM BIOPHYS, V316, P24, DOI 10.1006/abbi.1995.1005; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; KERY V, 1994, J BIOL CHEM, V269, P25283; KIM IC, 1976, BIOCHEMISTRY-US, V15, P4925, DOI 10.1021/bi00667a027; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JM, 1988, J BACTERIOL, V170, P1021, DOI 10.1128/jb.170.2.1021-1025.1988; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maclean KN, 2000, J INORG BIOCHEM, V81, P161, DOI 10.1016/S0162-0134(00)00100-8; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; MILLS JL, 1996, J NUTR, V126, P756; Mudd S., 2001, METABOLIC MOL BASES, P2007; Nozaki T, 2001, J BIOL CHEM, V276, P6516, DOI 10.1074/jbc.M009774200; Oliveriusova J, 2002, J BIOL CHEM, V277, P48386, DOI 10.1074/jbc.M207087200; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Stojiljkovic I, 2001, EXPERT OPIN INV DRUG, V10, P309, DOI 10.1517/13543784.10.2.309; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; UMANOFF H, 1988, J BACTERIOL, V170, P4969, DOI 10.1128/jb.170.10.4969-4971.1988; Vadon-Le Goff S, 2001, BIOCHEM BIOPH RES CO, V283, P487, DOI 10.1006/bbrc.2001.4807; Woodward JJ, 2007, NAT METHODS, V4, P43, DOI 10.1038/NMETH984	45	44	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34588	34595		10.1074/jbc.M805928200	http://dx.doi.org/10.1074/jbc.M805928200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18849566	hybrid, Green Published			2022-12-27	WOS:000261469100013
J	Liu, X; Zhao, DZ; Qin, LL; Li, J; Zeng, HY				Liu, Xin; Zhao, Dezheng; Qin, Liuliang; Li, Jian; Zeng, Huiyan			Transcription Enhancer Factor 3 (TEF3) Mediates the Expression of Down Syndrome Candidate Region 1 Isoform 1 (DSCR1-1L) in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; INHIBITS CALCINEURIN; GENE-EXPRESSION; MULTIGENE FAMILY; OXIDATIVE STRESS; SKELETAL-MUSCLE; MESSENGER-RNA; TEA DOMAIN; PROTEIN; ANGIOGENESIS	The Down syndrome candidate region 1 gene (DSCR1) can be expressed as four isoforms, one of which is the well-studied isoform 4 (DSCR1-4) that is induced by VEGF-A(165) to provide a negative feedback loop in the VEGF-A(165)-induced angiogenesis. We reported previously that another DSCR1 isoform, DSCR1-1L, was also up-regulated by VEGF-A(165) in cultured endothelial cells and in several in vivo models of pathological angiogenesis and that different from DSCR1-4, DSCR1-1L overexpression alone induced cultured endothelial cell proliferation and promoted angiogenesis in Matrigel assays. It was reported recently that tumor growth was greatly repressed in DSCR1 knock-out mice. Although DSCR1-4 transcription was primarily regulated by NFAT, the mechanism regulating DSCR1-1L expression was still unknown. We developed human DSCR1-1L promoter-driven luciferase system and found that deletion of a putative conserved M-CAT site located 1426-bp upstream of the translation start site blunted promoter activity. We further showed that knockdown of TEF3, not other members of TEF family inhibited VEGF-A(165)-induced DSCR1-1L expression. We also demonstrated that TEF3 directly interacted with the putative M-CAT site in the DSCR1-1L promoter in vitro and in vivo. Finally, overexpression of TEF3 isoform 1, not isoform 3, in HUVEC was sufficient to induce DSCR1-1L expression even in the absence of VEGF-A(165) stimulation. Taken together, we elucidated a novel function of transcriptional factor TEF3. TEF3 was required for DSCR1-1L expression through binding to the M-CAT site in its promoter and could be an attractive target for anti-angiogenesis therapy.	[Zeng, Huiyan] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Zhao, Dezheng] Beth Israel Deaconess Med Ctr, Dept Gastroenterol, Boston, MA 02215 USA; [Li, Jian] Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA 02215 USA; [Liu, Xin; Zhao, Dezheng; Zeng, Huiyan] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Zeng, HY (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, 99 Brookline Ave RN 270F, Boston, MA 02215 USA.	hzeng@caregroup.harvard.edu			ACS [RSG-05-118-01-CSM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082837] Funding Source: NIH RePORTER	ACS(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by ACS Grant RSG-05-118-01-CSM. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Appukuttan B, 2007, INVEST OPHTH VIS SCI, V48, P3775, DOI 10.1167/iovs.06-1172; Azakie A, 2005, AM J PHYSIOL-CELL PH, V289, pC1522, DOI 10.1152/ajpcell.00126.2005; Azakie A, 1996, J BIOL CHEM, V271, P8260, DOI 10.1074/jbc.271.14.8260; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Chen JX, 2004, J APPL PHYSIOL, V96, P612, DOI 10.1152/japplphysiol.00728.2003; Cho YJ, 2005, ARCH BIOCHEM BIOPHYS, V439, P121, DOI 10.1016/j.abb.2005.05.002; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; Faruqi SA, 2002, CANCER GENET CYTOGEN, V138, P165, DOI 10.1016/S0165-4608(02)00596-4; FRIGERIO JM, 1995, HUM MOL GENET, V4, P37, DOI 10.1093/hmg/4.1.37; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hsu DKW, 1996, J BIOL CHEM, V271, P13786, DOI 10.1074/jbc.271.23.13786; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; Ilan N, 2003, LAB INVEST, V83, P1105, DOI 10.1097/01.LAB.0000083531.84403.8B; Jacquemin P, 1996, J BIOL CHEM, V271, P21775, DOI 10.1074/jbc.271.36.21775; Jiang SW, 1999, MOL ENDOCRINOL, V13, P879, DOI 10.1210/me.13.6.879; Kaneko KJ, 1998, DEV GENET, V22, P43, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;43::AID-DVG5&gt;3.0.CO;2-7; Leahy KP, 1999, ARCH BIOCHEM BIOPHYS, V368, P67, DOI 10.1006/abbi.1998.1059; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Mann KM, 2004, J CELL BIOL, V165, P483, DOI 10.1083/jcb.200402105; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Qin LL, 2006, MOL CANCER RES, V4, P811, DOI 10.1158/1541-7786.MCR-06-0126; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Semsarian C, 1999, NATURE, V400, P576, DOI 10.1038/23054; Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200; Smucker JD, 1999, GYNECOL ONCOL, V74, P512, DOI 10.1006/gyno.1999.5453; Stewart AFR, 1996, GENOMICS, V37, P68, DOI 10.1006/geno.1996.0522; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; VERHEST A, 1991, 4 INT WORKSH CHROM S; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Yasunami M, 1996, BIOCHEM BIOPH RES CO, V228, P365, DOI 10.1006/bbrc.1996.1667; Yockey CE, 1996, J BIOL CHEM, V271, P3727, DOI 10.1074/jbc.271.7.3727; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200	50	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34159	34167		10.1074/jbc.M806338200	http://dx.doi.org/10.1074/jbc.M806338200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840614	Green Published, hybrid			2022-12-27	WOS:000261277700044
J	Milstein, O; Tseng, SY; Starr, T; Llodra, J; Nans, A; Liu, ML; Wild, MK; van der Merwe, PA; Stokes, DL; Reisner, Y; Dustin, ML				Milstein, Oren; Tseng, Su-Yi; Starr, Toby; Llodra, Jaime; Nans, Andrea; Liu, Mengling; Wild, Martin K.; van der Merwe, P. Anton; Stokes, David L.; Reisner, Yair; Dustin, Michael L.			Nanoscale Increases in CD2-CD48-mediated Intermembrane Spacing Decrease Adhesion and Reorganize the Immunological Synapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-RECEPTOR MICROCLUSTERS; ANTIGEN RECOGNITION; ACTIVATION; CD2; COMPLEX; DIMENSIONS; MOLECULES; SURFACE; DOMAIN; ICAM-1	The relationship between intermembrane spacing, adhesion efficiency, and lateral organization of adhesion receptors has not been established for any adhesion system. We have utilized the CD2 ligand CD48 with two (wild type CD48 (CD48-WT)), four (CD48-CD2), or five (CD48-CD22) Ig-like domains. CD48-WT was 10-fold more efficient in mediating adhesion than CD48-CD2 or CD48-CD22. Electron tomography of contact areas with planar bilayers demonstrated average intermembrane spacing of 12.8 nm with CD48-WT, 14.7 nm with CD48-CD2, and 15.6 nm with CD48-CD22. Both CD48-CD2 and CD48-CD22 chimeras segregated completely from CD48-WT in mixed contact areas. In contrast, CD48-CD2 and CD48-CD22 co-localized when mixed contacts were formed. Confocal imaging of immunological synapses formed between primary T lymphocytes and Chinese hamster ovary cells presenting major histocompatibility complex-peptide complexes, and different forms of CD48 demonstrated that CD48-CD2 and CD48-CD22 induce an eccentric CD2/T cell antigen receptor cluster. We propose that this reorganization of the immunological synapse sequesters the T cell antigen receptor in a location where it cannot interact with its ligand and dramatically reduces T cell sensitivity.	[Milstein, Oren; Tseng, Su-Yi; Starr, Toby; Dustin, Michael L.] NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA; [Llodra, Jaime; Nans, Andrea; Stokes, David L.] NYU, Sch Med, Program Struct Biol, Helen & Martin Kimmel Ctr Biol & Med,Skirball Ins, New York, NY 10016 USA; [Liu, Mengling] NYU, Inst Canc, Div Biostat, New York, NY 10016 USA; [Milstein, Oren; Reisner, Yair] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Wild, Martin K.] Max Planck Inst Mol Med, D-48149 Munster, Germany; [van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	New York University; New York University; New York University; Weizmann Institute of Science; Max Planck Society; University of Oxford	Dustin, ML (corresponding author), NYU, Sch Med, Program Mol Pathogenesis, 540 1st Ave, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020; van der Merwe, P. Anton/F-8539-2011; Reisner, Yair/AAA-4772-2019	Liu, Mengling/0000-0001-9758-8522; Dustin, Michael/0000-0003-4983-6389; Reisner, Yair/0000-0002-3354-6945	National Institutes of Health [AI43542, GM071044, P30 CA016087]; European Molecular Biology Organization Fellowship [ASTF.49.00-05]; Leukemia and Lymphoma Society Fellowship [5456-04]; MRC [G9722488] Funding Source: UKRI; Medical Research Council [G9722488] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043542, R37AI043542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071044] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0741914] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization Fellowship(European Molecular Biology Organization (EMBO)); Leukemia and Lymphoma Society Fellowship(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants AI43542 (to M. L. D.), GM071044 (to D. L. S.), and P30 CA016087 (to M. L.). This work was also supported by European Molecular Biology Organization Fellowship ASTF.49.00-05 (to O. M.) and Leukemia and Lymphoma Society Fellowship 5456-04 (to S. Y. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994; BOCKENSTEDT LK, 1988, J IMMUNOL, V141, P1904; BROWN MH, 1989, NATURE, V339, P551, DOI 10.1038/339551a0; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; CARPEN O, 1991, J CELL BIOL, V115, P861, DOI 10.1083/jcb.115.3.861; CHAN PY, 1992, MOL BIOL CELL, V3, P157, DOI 10.1091/mbc.3.2.157; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin M. L., 2007, CURRENT PROTOCOLS IM; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Gaglia JL, 2001, CELL IMMUNOL, V213, P83, DOI 10.1006/cimm.2001.1867; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tseng SY, 2005, J IMMUNOL, V175, P7829, DOI 10.4049/jimmunol.175.12.7829; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	39	52	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34414	34422		10.1074/jbc.M804756200	http://dx.doi.org/10.1074/jbc.M804756200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18826951	hybrid, Green Published			2022-12-27	WOS:000261277700069
J	Nasser, MW; Datta, J; Nuovo, G; Kutay, H; Motiwala, T; Majumder, S; Wang, B; Suster, S; Jacob, ST; Ghoshal, K				Nasser, Mohd W.; Datta, Jharna; Nuovo, Gerard; Kutay, Huban; Motiwala, Tasneem; Majumder, Sarmila; Wang, Bo; Suster, Saul; Jacob, Samson T.; Ghoshal, Kalpana			RETRACTED: Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer SUPPRESSION OF TUMORIGENIC PROPERTY OF LUNG CANCER CELLS AND THEIR SENSITIZATION TO DOXORUBICIN-INDUCED APOPTOSIS BY miR-1 (Retracted article. See vol. 293, pg. 12945, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							TUMOR-SUPPRESSOR; C/EBP-ALPHA; MICRORNA; EXPRESSION; DEGRADATION; SURVIVAL; PATHWAY; GROWTH; MCL-1; FOXP1	Micro-RNAs are similar to 21-25-nucleotide-long noncoding RNAs that regulate gene expression primarily at the post-transcriptional level in animals. Here, we report that micro-RNA-1 (miR-1), abundant in the cardiac and smooth muscles, is expressed in the lung and is down-regulated in human primary lung cancer tissues and cell lines. In situ hybridization demonstrated localization of miR-1 in bronchial epithelial cells. The tumor suppressor C/EBP alpha, frequently suppressed in lung cancer, reactivated miR-1 expression in the lung cancer cells. Repressed miR-1 was also activated in lung cancer cells upon treatment with a histone deacetylase inhibitor. These observations led us to examine the antitumorigenic potential of miR-1 in lung cancer cells. Expression of miR-1 in nonexpressing A549 and H1299 cells reversed their tumorigenic properties, such as growth, replication potential, motility/migration, clonogenic survival, and tumor formation in nude mice. Exogenous miR-1 significantly reduced expression of oncogenic targets, such as MET, a receptor tyrosine kinase, and Pim-1, a Ser/Thr kinase, frequently upregulated in lung cancer. Similarly, the levels of two additional targets, FoxP1, a transcription factor with oncogeneic property, and HDAC4 that represses differentiation-promoting genes, were reduced in miR-1-expressing cells. Conversely, depletion of miR-1 facilitated N417 cell growth with concomitant elevation of these targets. Further, ectopic miR-1 induced apoptosis in A549 cells in response to the potent anticancer drug doxorubicin. Enhanced activation of caspases 3 and 7, cleavage of their substrate PARP-1, and depletion of anti-apoptotic Mcl-1 contributed to the sensitivity of miR-1-expressing cells to doxorubicin. Thus, miR-1 has potential therapeutic application against lung cancers.	[Nasser, Mohd W.; Datta, Jharna; Kutay, Huban; Motiwala, Tasneem; Majumder, Sarmila; Wang, Bo; Jacob, Samson T.; Ghoshal, Kalpana] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Nuovo, Gerard; Suster, Saul] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Majumder, Sarmila; Jacob, Samson T.; Ghoshal, Kalpana] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Jacob, ST (corresponding author), 420 W 12th Ave, Columbus, OH 43210 USA.	Samson.Jacob@osumc.edu; Kalpana.Ghoshal@osumc.edu	Wang, Bo/F-6519-2011; Motiwala, Tasneem/AAB-9067-2021; Jacob, Samson/H-3135-2011		National Institutes of Health [CA122695, PO1CA101956]; NATIONAL CANCER INSTITUTE [P01CA101956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122695 and PO1CA101956. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Bai S, 2007, J BIOL CHEM, V282, P27171, DOI 10.1074/jbc.M700691200; Banham AH, 2005, CLIN CANCER RES, V11, P1065; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Costa DB, 2006, LUNG CANCER, V53, P253, DOI 10.1016/j.lungcan.2006.04.011; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Fulda S, 2004, CURR CANCER DRUG TAR, V4, P569, DOI 10.2174/1568009043332763; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hogan C, 2008, J BIOL CHEM, V283, P18012, DOI 10.1074/jbc.M709695200; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Laskin JJ, 2005, CANCER INVEST, V23, P427, DOI 10.1081/CNV-200067172; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Ramalingam SS, 2007, CLIN CANCER RES, V13, P3605, DOI 10.1158/1078-0432.CCR-07-0162; SCHUG J, 2008, CURRENT PROTOCOLS BI, P21; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takimoto CH, 2008, CANCER CHEMOTH PHARM, V61, P535, DOI 10.1007/s00280-007-0639-9; Van Rooij E, 2007, PHYSIOL GENOMICS, V31, P365, DOI 10.1152/physiolgenomics.00206.2007; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	66	305	328	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33394	33405		10.1074/jbc.M804788200	http://dx.doi.org/10.1074/jbc.M804788200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18818206	hybrid, Green Published			2022-12-27	WOS:000261183700044
J	Trajkovski, M; Mziaut, H; Schubert, S; Kalaidzidis, Y; Altkruerger, A; Solimena, M				Trajkovski, Mirko; Mziaut, Hassan; Schubert, Sandra; Kalaidzidis, Yannis; Altkruerger, Anke; Solimena, Michele			Regulation of Insulin Granule Turnover in Pancreatic beta-Cells by Cleaved ICA512	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; AUTOANTIGENS IA-2; IN-VIVO; GLUCOSE; EXOCYTOSIS; SECRETION; DYNAMICS; MEMBRANE; BINDING; PHOGRIN	Insulin maintains homeostasis of glucose by promoting its uptake into cells from the blood. Hyperglycemia triggers secretion of insulin from pancreatic beta-cells. This process is mediated by secretory granule exocytosis. However, how beta-cells keep granule stores relatively constant is still unknown. ICA512 is an intrinsic granule membrane protein, whose cytosolic domain binds beta 2-syntrophin, an F-actin-associated protein, and is cleaved upon granule exocytosis. The resulting cleaved cytosolic fragment, ICA512-CCF, reaches the nucleus and up-regulates the transcription of granule genes, including insulin and ICA512. Here, we show that ICA512-CCF also dimerizes with intact ICA512 on granules, thereby displacing it from beta 2-syntrophin. This leads to increased granule mobility and insulin release. Based on these findings, we propose a model whereby the generation of ICA512-CCF first amplifies insulin secretion. The ensuing reduction of granule stores would then increase the probability of newly generated ICA512-CCF to reach the nucleus and enhance granule biogenesis, thus allowing beta-cells to constantly adjust production of granules to their storage size and consumption. Pharmacological modulation of these feedback loops may alleviate deficient insulin release in diabetes.	[Trajkovski, Mirko; Mziaut, Hassan; Schubert, Sandra; Altkruerger, Anke; Solimena, Michele] Tech Univ Dresden, Lab Expt Diabetol, Sch Med, D-01307 Dresden, Germany; [Solimena, Michele] Tech Univ Dresden, Dept Med 3, Sch Med, D-01307 Dresden, Germany; [Solimena, Michele] Tech Univ Dresden, Ctr Regenerat Therapy Dresden, Sch Med, D-01307 Dresden, Germany; [Kalaidzidis, Yannis; Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society; Lomonosov Moscow State University	Solimena, M (corresponding author), Fetscherstr 74, D-01307 Dresden, Germany.	michele.solimena@tu-dresden.de	Solimena, Michele/E-1275-2011; Solimena, Michele/GVS-5990-2022; Kalaidzidis, Yannis/H-3094-2016	Kalaidzidis, Yannis/0000-0002-6137-1193; Trajkovski, Mirko/0000-0002-3152-9551	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung [NBL3]; European Foundation for the Study of Diabetes; Juvenile Diabetes Research Foundation; Max Planck Society; TU Dresden	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Foundation for the Study of Diabetes; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Max Planck Society(Max Planck SocietyFoundation CELLEX); TU Dresden(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft SFB655 (Sonderforschungsbereich), Bundesministerium fur Bildung und Forschung Grant NBL3, the European Foundation for the Study of Diabetes, the Juvenile Diabetes Research Foundation, and the Max Planck Society (to M. S.) and a MeDDrive Grant from TU Dresden (to M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Bruun TZ, 2000, EUR J PHARMACOL, V403, P221, DOI 10.1016/S0014-2999(00)00602-6; Cai T, 2004, J NEUROSCI, V24, P3115, DOI 10.1523/JNEUROSCI.0101-04.2004; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cheviet S, 2004, TRENDS CELL BIOL, V14, P525, DOI 10.1016/j.tcb.2004.08.001; Chin CN, 2005, FEBS LETT, V579, P3855, DOI 10.1016/j.febslet.2005.05.071; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Drake PG, 2003, BIOCHEM J, V373, P393, DOI 10.1042/BJ20021851; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Harashima S, 2005, P NATL ACAD SCI USA, V102, P8704, DOI 10.1073/pnas.0408887102; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hermel JM, 1999, EUR J NEUROSCI, V11, P2609, DOI 10.1046/j.1460-9568.1999.00677.x; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kim SJ, 2007, DIABETES, V56, P41, DOI 10.2337/db06-0237; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Magistrelli G, 1996, BIOCHEM BIOPH RES CO, V227, P581, DOI 10.1006/bbrc.1996.1549; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Ort T, 2000, EUR J CELL BIOL, V79, P621, DOI 10.1078/0171-9335-00095; Pouli AE, 1998, BIOCHEM J, V333, P193, DOI 10.1042/bj3330193; RABIN DU, 1994, J IMMUNOL, V152, P3183; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Shibasaki T, 2005, METHOD ENZYMOL, V403, P408, DOI 10.1016/S0076-6879(05)03036-3; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Solimena M, 2003, TRENDS CELL BIOL, V13, P399, DOI 10.1016/S0962-8924(03)00150-8; STEINER DF, 2001, HDB PHYSL ENDOCRINE, V2, P49; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Varadi A, 2002, J CELL SCI, V115, P4177, DOI 10.1242/jcs.00083; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Zahn TR, 2001, J COMP NEUROL, V429, P127, DOI 10.1002/1096-9861(20000101)429:1&lt;127::AID-CNE10&gt;3.0.CO;2-H; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	56	29	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33719	33729		10.1074/jbc.M804928200	http://dx.doi.org/10.1074/jbc.M804928200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824546	Green Published, hybrid			2022-12-27	WOS:000261183700078
J	Purushothaman, A; Chen, LG; Yang, Y; Sanderson, RD				Purushothaman, Anurag; Chen, Ligong; Yang, Yang; Sanderson, Ralph D.			Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE PLASMINOGEN-ACTIVATOR; HEPATOCYTE GROWTH-FACTOR; BREAST-CANCER CELLS; MULTIPLE SIGNALING PATHWAYS; MARROW ENDOTHELIAL-CELLS; UP-REGULATION; MATRIX METALLOPROTEINASES; MAMMALIAN HEPARANASE; MATRIX-METALLOPROTEINASE-9 MMP-9; SULFATE PROTEOGLYCANS	High levels of heparanase are an indicator of poor prognosis in myeloma patients, and up-regulation of the enzyme enhances tumor growth, angiogenesis, and metastasis in animal models. At least part of the impact of heparanase in driving the aggressive tumor phenotype is due to its effect on increasing the expression and shedding of the heparan sulfate proteoglycan syndecan-1, a molecule known to promote myeloma progression. The present work demonstrated that elevation in heparanase expression in myeloma cells stimulates sustained ERK phosphorylation that in turn drives MMP-9 expression. In addition, urokinase-type plasminogen activator (uPA) and uPA receptor expression levels increased, and blocking the proteolytic activation of either MMP-9 or uPA inhibited the heparanase-induced increase in syndecan-1 shedding. Together these data provide a mechanism for heparanase-induced syndecan-1 shedding and, more importantly, demonstrate that heparanase activity in myeloma cells can lead to increased levels of proteases that are known to play important roles in the aggressive behavior of myeloma tumors. This in addition to its other known biological roles, indicates that heparanase acts as a master regulator of the aggressive tumor phenotype by up-regulating protease expression and activity within the tumor microenvironment.	[Purushothaman, Anurag; Chen, Ligong; Yang, Yang; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Ctr Metab Bone Dis, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Chen, Ligong; Yang, Yang; Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Sanderson, Ralph D.] Vet Adm Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, Ctr Metab Bone Dis, 814 SHEL,1530 3rd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu			National Institutes of Health [CA103054, CA055819, CA013148]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P01CA055819, P30CA013148, R01CA103054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103054, CA055819, and CA013148 ( to R. D. S.). This work was also supported by a VISN7 Research Career Development Award from the Department of Veterans Affairs ( to R. D. S.).	Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Barlogie B, 2006, WILLIAMS HEMATOLOGY, P1501; Bartlett AH, 2007, MOL CELLS, V24, P153; Bendre MS, 2002, CANCER RES, V62, P5571; Borset M, 2000, BLOOD, V96, P2528; Breitkreutz I, 2007, BRIT J HAEMATOL, V139, P55, DOI 10.1111/j.1365-2141.2007.06747.x; Broek IV, 2004, LEUKEMIA, V18, P976, DOI 10.1038/sj.leu.2403331; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Cortes-Reynosa P, 2008, MATRIX BIOL, V27, P220, DOI 10.1016/j.matbio.2007.11.003; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Dhodapkar MV, 1997, BRIT J HAEMATOL, V99, P368, DOI 10.1046/j.1365-2141.1997.3893203.x; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Hecht M, 2008, EXP CELL RES, V314, P1082, DOI 10.1016/j.yexcr.2007.10.021; Hecht M, 2007, BRIT J HAEMATOL, V138, P446, DOI 10.1111/j.1365-2141.2007.06665.x; Hideshima T, 2003, BLOOD, V101, P703, DOI 10.1182/blood-2002-06-1874; Hjertner O, 2000, BRIT J HAEMATOL, V109, P815, DOI 10.1046/j.1365-2141.2000.02089.x; Holt RU, 2008, HAEMATOLOGICA, V93, P619, DOI 10.3324/haematol.11867; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Joyce JA, 2005, ONCOGENE, V24, P4037, DOI 10.1038/sj.onc.1208602; Kelly T, 2003, CANCER RES, V63, P8749; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Koliopanos A, 2001, CANCER RES, V61, P4655; Kunigal S, 2007, INT J CANCER, V121, P2307, DOI 10.1002/ijc.22962; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Menu E, 2004, BLOOD CELL MOL DIS, V33, P111, DOI 10.1016/j.bcmd.2004.04.012; Miao HQ, 2002, PROTEIN EXPRES PURIF, V26, P425, DOI 10.1016/S1046-5928(02)00558-2; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Parmo-Cabanas M, 2006, J PATHOL, V208, P108, DOI 10.1002/path.1876; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Rao JS, 2005, MOL CANCER THER, V4, P1399, DOI 10.1158/1535-7163.MCT-05-0082; Reiland J, 2006, NEOPLASIA, V8, P596, DOI 10.1593/neo.06244; RIDLEY RC, 1993, BLOOD, V81, P767; Rigolin GM, 2003, BRIT J HAEMATOL, V120, P953, DOI 10.1046/j.1365-2141.2003.04176.x; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Seidel C, 2000, BLOOD, V95, P388, DOI 10.1182/blood.V95.2.388; Sfiridaki A, 2005, CLIN CHEM LAB MED, V43, P934, DOI 10.1515/CCLM.2005.160; Uno F, 2001, CANCER RES, V61, P7855; Van Valckenborgh E, 2004, AM J PATHOL, V165, P869, DOI 10.1016/S0002-9440(10)63349-4; Van Valckenborgh E, 2002, INT J CANCER, V101, P512, DOI 10.1002/ijc.10642; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yao J, 2001, ONCOGENE, V20, P8066, DOI 10.1038/sj.onc.1204944; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811	65	160	166	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32628	32636		10.1074/jbc.M806266200	http://dx.doi.org/10.1074/jbc.M806266200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18812315	hybrid, Green Published			2022-12-27	WOS:000260893700052
J	Putz, U; Howitt, J; Lackovic, J; Foot, N; Kumar, S; Silke, J; Tan, SS				Putz, Ulrich; Howitt, Jason; Lackovic, Jenny; Foot, Natalie; Kumar, Sharad; Silke, John; Tan, Seong-Seng			Nedd4 Family-interacting Protein 1 (Ndfip1) Is Required for the Exosomal Secretion of Nedd4 Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL DIVERSITY; MULTIVESICULAR BODY; UBIQUITIN LIGASES; MEMBRANE-PROTEIN; WW DOMAINS; IDENTIFICATION; VESICLE; TRAFFICKING; SURVIVAL; CHANNELS	The ability to remove unwanted proteins is an important cellular feature. Classically, this involves the enzymatic addition of ubiquitin moieties followed by degradation in the proteasome. Nedd4 proteins are ubiquitin ligases important not only for protein degradation, but also for protein trafficking. Nedd4 proteins can bind to target proteins either by themselves or through adaptor protein Ndfip1 (Nedd4 family-interacting protein 1). An alternative mechanism for protein removal and trafficking is provided by exosomes, which are small vesicles (50-90-nm diameter) originating from late endosomes and multivesicular bodies (MVBs). Exosomes provide a rapid means of shedding obsolete proteins and also for cell to cell communication. In the present work, we show that Ndfip1 is detectable in exosomes secreted from transfected cells and also from primary neurons. Compared with control, Ndfip1 increases exosome secretion from transfected cells. Furthermore, while Nedd4, Nedd4-2, and Itch are normally absent from exosomes, expression of Ndfip1 results in recruitment of all three Nedd4 proteins into exosomes. Together, these results suggest that Ndfip1 is important for protein trafficking via exosomes, and provides a mechanism for cargoing passenger proteins such as Nedd4 family proteins. Given the positive roles of Ndfip1/Nedd4 in improving neuronal survival during brain injury, it is possible that exosome secretion provides a novel route for rapid sequestration and removal of proteins during stress.	[Putz, Ulrich; Howitt, Jason; Lackovic, Jenny; Tan, Seong-Seng] Univ Melbourne, Howard Florey Inst, Brain Dev Lab, Parkville, Vic 3010, Australia; [Putz, Ulrich; Howitt, Jason; Lackovic, Jenny; Tan, Seong-Seng] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Foot, Natalie; Kumar, Sharad] IMVS, Hanson Ctr, Mol Regulat Lab, Adelaide, SA 5000, Australia; [Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Institute Medical & Veterinary Science Australia; La Trobe University	Tan, SS (corresponding author), Univ Melbourne, Howard Florey Inst, Brain Dev Lab, Parkville, Vic 3010, Australia.	stan@florey.edu.au	Kumar, Sharad/AAX-7787-2020; Foot, Natalie/AAC-4238-2022; Silke, John/B-7622-2008; Foot, Natalie/AAK-8965-2020	Kumar, Sharad/0000-0001-7126-9814; Silke, John/0000-0002-7611-5774; Foot, Natalie/0000-0002-6567-9283; Howitt, Jason/0000-0001-9922-7931	Victorian Neurotrauma Initiative of the TAC; National Health and Medical Research Council (NH and MRC)	Victorian Neurotrauma Initiative of the TAC; National Health and Medical Research Council (NH and MRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants under the Victorian Neurotrauma Initiative of the TAC and the National Health and Medical Research Council (NH and MRC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Buschow SI, 2005, BLOOD CELL MOL DIS, V35, P398, DOI 10.1016/j.bcmd.2005.08.005; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; Denzer K, 2000, J CELL SCI, V113, P3365; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ikeda M, 2007, VIROLOGY, V360, P461, DOI 10.1016/j.virol.2006.10.046; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Putz U, 2005, NAT NEUROSCI, V8, P322, DOI 10.1038/nn1407; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Shearwin-Whyatt LM, 2004, J CELL SCI, V117, P3679, DOI 10.1242/jcs.01212; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x	36	111	120	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32621	32627		10.1074/jbc.M804120200	http://dx.doi.org/10.1074/jbc.M804120200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819914	hybrid			2022-12-27	WOS:000260893700051
J	Valdramidou, D; Humphries, MJ; Mould, AP				Valdramidou, Dimitra; Humphries, Martin J.; Mould, A. Paul			Distinct Roles of beta 1 Metal Ion-dependent Adhesion Site (MIDAS), Adjacent to MIDAS (ADMIDAS), and Ligand-associated Metal-binding Site (LIMBS) Cation-binding Sites in Ligand Recognition by Integrin alpha 2 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL REGION; I-LIKE DOMAIN; A-DOMAIN; STRUCTURAL BASIS; EXTRACELLULAR SEGMENT; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; PROPELLER DOMAIN; HYBRID DOMAIN; OUTSIDE-IN	Integrin-ligand interactions are regulated in a complex manner by divalent cations, and previous studies have identified ligand-competent, stimulatory, and inhibitory cation-binding sites. In collagen-binding integrins, such as alpha 2 beta 1, ligand recognition takes place exclusively at the alpha subunit I domain. However, activation of the alpha I domain depends on its interaction with a structurally similar domain in the beta subunit known as the I-like or beta I domain. The top face of the beta I domain contains three cation-binding sites: the metal-ion dependent adhesion site (MIDAS), the ADMIDAS (adjacent to MIDAS), and LIMBS (ligand-associated metal-binding site). The role of these sites in controlling ligand binding to the alpha I domain has yet to be elucidated. Mutation of the MIDAS or LIMBS completely blocked collagen binding to alpha 2 beta 1; in contrast mutation of the ADMIDAS reduced ligand recognition but this effect could be overcome by the activating monoclonal antibody TS2/16. Hence, the MIDAS and LIMBS appear to be essential for the interaction between alpha I and beta I, whereas occupancy of the ADMIDAS has an allosteric effect on the conformation of beta I. An activating mutation in the alpha 2 I domain partially restored ligand binding to the MIDAS and LIMBS mutants. Analysis of the effects of Ca2+, Mg2+, and Mn2+ on ligand binding to these mutants showed that the MIDAS is a ligand-competent site through which Mn2+ stimulates ligand binding, whereas the LIMBS is a stimulatory Ca2+-binding site, occupancy of which increases the affinity of Mg2+ for the MIDAS.	[Valdramidou, Dimitra; Humphries, Martin J.; Mould, A. Paul] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Mould, AP (corresponding author), Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	paul.mould@manchester.ac.uk		Humphries, Martin/0000-0002-4331-6967; Mould, Paul/0000-0003-0076-6228	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Wellcome Trust (to M.J.H.).	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Baker EK, 1997, P NATL ACAD SCI USA, V94, P1973, DOI 10.1073/pnas.94.5.1973; Barton SJ, 2004, BIOCHEM J, V380, P401, DOI 10.1042/BJ20031973; Burrows L, 1999, BIOCHEM J, V344, P527, DOI 10.1042/0264-6021:3440527; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Choi S, 2007, J MED CHEM, V50, P5457, DOI 10.1021/jm070252b; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Goodman TG, 1996, J BIOL CHEM, V271, P23729, DOI 10.1074/jbc.271.39.23729; GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644; GRZESIAK JJ, 1992, J CELL BIOL, V117, P1109, DOI 10.1083/jcb.117.5.1109; Grzesiak JJ, 2008, INT J CANCER, V122, P2199, DOI 10.1002/ijc.23368; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kapyla J, 2007, J MED CHEM, V50, P2742, DOI 10.1021/jm070063t; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lu CF, 1998, J BIOL CHEM, V273, P15138, DOI 10.1074/jbc.273.24.15138; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 2003, J BIOL CHEM, V278, P51622, DOI 10.1074/jbc.M306655200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Murcia M, 2008, PROTEINS, V71, P1779, DOI 10.1002/prot.21859; Oxvig C, 1998, P NATL ACAD SCI USA, V95, P4870, DOI 10.1073/pnas.95.9.4870; Park EJ, 2007, J CLIN INVEST, V117, P2526, DOI 10.1172/JCI31570; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Tuckwell DS, 2000, BIOCHEM J, V350, P485, DOI 10.1042/0264-6021:3500485; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamanouchi J, 2002, THROMB HAEMOSTASIS, V87, P756, DOI 10.1055/s-0037-1613076; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101	48	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32704	32714		10.1074/jbc.M802066200	http://dx.doi.org/10.1074/jbc.M802066200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18820259	Green Accepted, hybrid			2022-12-27	WOS:000260893700060
J	Sela, D; Yaffe, N; Shlomai, J				Sela, Dotan; Yaffe, Nurit; Shlomai, Joseph			Enzymatic Mechanism Controls Redox-mediated Protein-DNA Interactions at the Replication Origin of Kinetoplast DNA Minicircles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; OF-CELLULAR-FUNCTIONS; ZINC-FINGER PROTEIN; UNIVERSAL MINICIRCLE; CRITHIDIA-FASCICULATA; OXIDATIVE STRESS; HYDROPEROXIDE METABOLISM; GLUTATHIONE-REDUCTASE; MITOCHONDRIAL GENOME; TRYPANOSOMA-BRUCEI	Kinetoplast DNA (kDNA) is the mitochondrial DNA of trypanosomatids. Its major components are several thousand topologically interlocked DNA minicircles. Their replication origins are recognized by universal minicircle sequence-binding protein (UMSBP), a CCHC-type zinc finger protein, which has been implicated with minicircle replication initiation and kDNA segregation. Interactions of UMSBP with origin sequences in vitro have been found to be affected by the protein's redox state. Reduction of UMSBP activates its binding to the origin, whereas UMSBP oxidation impairs this activity. The role of redox in the regulation of UMSBP in vivo was studied here in synchronized cell cultures, monitoring both UMSBP origin binding activity and its redox state, throughout the trypanosomatid cell cycle. These studies indicated that UMSBP activity is regulated in vivo through the cell cycle dependent control of the protein's redox state. The hypothesis that UMSBP's redox state is controlled by an enzymatic mechanism, which mediates its direct reduction and oxidation, was challenged in a multienzyme reaction, reconstituted with pure enzymes of the trypanosomal major redox-regulating pathway. Coupling in vitro of this reaction with a UMSBP origin-binding reaction revealed the regulation of UMSBP activity through the opposing effects of tryparedoxin and tryparedoxin peroxidase. In the course of this reaction, tryparedoxin peroxidase directly oxidizes UMSBP, revealing a novel regulatory mechanism for the activation of an origin-binding protein, based on enzyme-mediated reversible modulation of the protein's redox state. This mode of regulation may represent a regulatory mechanism, functioning as an enzyme-mediated, redox-based biological switch.	[Sela, Dotan; Yaffe, Nurit; Shlomai, Joseph] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Parasitol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Shlomai, J (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Parasitol, IL-91120 Jerusalem, Israel.	josephs@ekmd.huji.ac.il			United States-Israel Binational Science Foundation (Jerusalem, Israel) [2005023]; Israel Science Foundation [54/06]	United States-Israel Binational Science Foundation (Jerusalem, Israel)(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This study was supported, in part, by United States-Israel Binational Science Foundation (Jerusalem, Israel) Grant 2005023 and by Israel Science Foundation Grant 54/06. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABELIOVICH H, 1993, MOL CELL BIOL, V13, P7766, DOI 10.1128/MCB.13.12.7766; Abu-Elneel K, 1999, J BIOL CHEM, V274, P13419, DOI 10.1074/jbc.274.19.13419; Abu-Elneel K, 2001, J CELL BIOL, V153, P725, DOI 10.1083/jcb.153.4.725; Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; AVRAHAMI D, 1995, P NATL ACAD SCI USA, V92, P10511, DOI 10.1073/pnas.92.23.10511; Baldwin MA, 2002, METHOD ENZYMOL, V353, P54; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Budde H, 2003, BIOFACTORS, V17, P83, DOI 10.1002/biof.5520170109; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; Castro H, 2002, FREE RADICAL BIO MED, V33, P1552, DOI 10.1016/S0891-5849(02)01089-4; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; FAIRLAMB AH, 1985, MOL BIOCHEM PARASIT, V14, P187, DOI 10.1016/0166-6851(85)90037-4; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Hainaut P, 2001, ANTIOXID REDOX SIGN, V3, P611, DOI 10.1089/15230860152542961; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lunec J, 2003, BIOFACTORS, V17, P315, DOI 10.1002/biof.5520170131; Makmura L, 2001, ANTIOXID REDOX SIGN, V3, P1105, DOI 10.1089/152308601317203611; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Milman N, 2007, P NATL ACAD SCI USA, V104, P19250, DOI 10.1073/pnas.0706858104; Motyka SA, 2006, J BIOL CHEM, V281, P18499, DOI 10.1074/jbc.M602880200; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nishinaka Y, 2001, REDOX REP, V6, P289, DOI 10.1179/135100001101536427; Onn I, 2004, EUKARYOT CELL, V3, P277, DOI 10.1128/EC.3.2.277-287.2004; Onn I, 2006, J BIOL CHEM, V281, P37468, DOI 10.1074/jbc.M606374200; Park JS, 1999, J BIOL CHEM, V274, P29075, DOI 10.1074/jbc.274.41.29075; PASION SG, 1994, J CELL SCI, V107, P3515; Roy J, 2007, PROTIST, V158, P385, DOI 10.1016/j.protis.2007.03.002; Sanders CM, 2007, NUCLEIC ACIDS RES, V35, P3504, DOI 10.1093/nar/gkm166; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; SHLOMAI J, 1986, J BIOL CHEM, V261, P6219; Tanaka T, 2000, FREE RADICAL RES, V33, P851, DOI 10.1080/10715760000301361; Tetaud E, 1998, MOL BIOCHEM PARASIT, V96, P111, DOI 10.1016/S0166-6851(98)00120-0; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; TZFATI Y, 1992, P NATL ACAD SCI USA, V89, P6891, DOI 10.1073/pnas.89.15.6891; TZFATI Y, 1995, J BIOL CHEM, V270, P21339, DOI 10.1074/jbc.270.36.21339; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Wang M, 2001, ANTIOXID REDOX SIGN, V3, P657, DOI 10.1089/15230860152543005; Webster KA, 2001, ANTIOXID REDOX SIGN, V3, P535, DOI 10.1089/15230860152542916; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017	51	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32034	32044		10.1074/jbc.M804417200	http://dx.doi.org/10.1074/jbc.M804417200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799461	hybrid			2022-12-27	WOS:000260760800085
J	Stewart, JA; Miller, AS; Campbell, JL; Bambara, RA				Stewart, Jason A.; Miller, Adam S.; Campbell, Judith L.; Bambara, Robert A.			Dynamic Removal of Replication Protein A by Dna2 Facilitates Primer Cleavage during Okazaki Fragment Processing in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; FLAP ENDONUCLEASE-1; IN-VIVO; YEAST; RPA; MATURATION; HELICASE/NUCLEASE; POLYMERASE; PREDICTION; MECHANISM	Eukaryotic Okazaki fragments are initiated by a RNA/DNA primer, which is removed before the fragments are joined. Polymerase delta displaces the primer into a flap for processing. Dna2 nuclease/helicase and flap endonuclease 1 (FEN1) are proposed to cleave the flap. The single-stranded DNA-binding protein, replication protein A (RPA), governs cleavage activity. Flap-bound RPA inhibits FEN1. This necessitates cleavage by Dna2, which is stimulated by RPA. FEN1 then cuts the remaining RPA-free flap to create a nick for ligation. Cleavage by Dna2 requires that it enter the 5'-end and track down the flap. Because Dna2 cleaves the RPA-bound flap, we investigated the mechanism by which Dna2 accesses the protein-coated flap for cleavage. Using a nuclease-defective Dna2 mutant, we showed that just binding of Dna2 dissociates the flap-bound RPA. Facile dissociation is specific to substrates with a genuine flap, and will not occur with an RPA-coated single strand. We also compared the cleavage patterns of Dna2 with and without RPA to better define RPA stimulation of Dna2. Stimulation derived from removal of DNA folding in the flap. Apparently, coordinated with its dissociation, RPA relinquishes the flap to Dna2 for tracking in a way that does not allow flap structure to reform. We also found that RPA strand melting activity promotes excessive flap elongation, but it is suppressed by Dna2-promoted RPA dissociation. Overall, results indicate that Dna2 and RPA coordinate their functions for efficient flap cleavage and preparation for FEN1.	[Stewart, Jason A.; Miller, Adam S.; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_Bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM024441 (to R. A. B.), with additional support from Grant GM087666 (to J. L. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; GEORGAKI A, 1992, FEBS LETT, V308, P240, DOI 10.1016/0014-5793(92)81283-R; GEORGAKI A, 1993, NUCLEIC ACIDS RES, V21, P3659, DOI 10.1093/nar/21.16.3659; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HEYER WD, 1990, EMBO J, V9, P2321, DOI 10.1002/j.1460-2075.1990.tb07404.x; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kim DH, 2005, NUCLEIC ACIDS RES, V33, P1372, DOI 10.1093/nar/gki255; KORNBERG A, 1992, DNA REPLICATION, P140; KUO CL, 1983, P NATL ACAD SCI-BIOL, V80, P6465, DOI 10.1073/pnas.80.21.6465; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Maga G, 2001, J BIOL CHEM, V276, P18235, DOI 10.1074/jbc.M009599200; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2006, J BIOL CHEM, V281, P38555, DOI 10.1074/jbc.M604925200; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P8869, DOI 10.1021/bi00027a039; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Smith J, 2000, BIOCHIMIE, V82, P71, DOI 10.1016/S0300-9084(00)00183-8; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	37	37	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31356	31365		10.1074/jbc.M805965200	http://dx.doi.org/10.1074/jbc.M805965200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799459	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000260760800013
J	Surgucheva, I; Shestopalov, VI; Surguchov, A				Surgucheva, Irina; Shestopalov, Valery I.; Surguchov, Andrei			Effect of gamma-Synuclein Silencing on Apoptotic Pathways in Retinal Ganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEVATED INTRAOCULAR-PRESSURE; OPTIC-NERVE HEAD; GENE-EXPRESSION; ALPHA-SYNUCLEIN; EXPERIMENTAL GLAUCOMA; TRABECULAR MESHWORK; BAD PHOSPHORYLATION; SURVIVAL SIGNALS; DEATH; ACTIVATION	gamma-Synuclein (Syn G) is highly expressed in retinal ganglion cells and the loss of these cells in glaucoma is associated with significant reduction of the intracellular Syn G level. However, a causative relationship between these two events has not been established. Here we show that the knockdown of Syn G results in a decreased viability of the immortalized retinal ganglion cells (RGC-5). The Syn G silencing reduces phosphorylation of serine 112 (Ser(112)) in Bad protein, a member of the Bcl-2 family that plays a critical role in apoptotic cell death signaling. Our gene expression analysis data suggests that changes in Bad phosphorylation status may be caused by a coordinated shift in activities of kinases controlling Bad phosphorylation and phosphatases catalyzing its dephosphorylation. Moreover, increased phosphorylation of Bad-sequestering protein 14-3-3 detected in these cells is also pro-apoptotic. These results suggest that the homeostatic level of Syn G in RGC-5 cells is required for transcriptional regulation of protein kinases and phosphatases, controlling phosphorylation of Bad and 14-3-3. Lowering Syn G causes Bad dephosphorylation, dissociation from phosphorylated 14-3-3, and translocation to mitochondria where it initiates apoptotic death cascade.	[Surgucheva, Irina; Surguchov, Andrei] Vet Adm Med Ctr, Lab Retinal Biol, Kansas City, MO 64128 USA; [Surgucheva, Irina; Surguchov, Andrei] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; [Shestopalov, Valery I.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Shestopalov, Valery I.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Miami; Bascom Palmer Eye Institute; University of Miami	Surguchov, A (corresponding author), Vet Adm Med Ctr, Lab Retinal Biol, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	asurguchov@kumc.edu	Shestopalov, Valery/AAE-9838-2020	Shestopalov, Valery/0000-0002-1568-6637	National Institutes of Health [EY02687, EY017991, P30 EY014801]; Veterans Affairs Merit Review; Glaucoma Foundation; Midwest Biomedical Research Foundation (MBRF); University of Miami Department of Ophthalmology from Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY017991, P30EY002687, P30EY014801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Glaucoma Foundation; Midwest Biomedical Research Foundation (MBRF); University of Miami Department of Ophthalmology from Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY02687, EY017991, and Center Grant P30 EY014801. This work was also supported by a Veterans Affairs Merit Review grant, The Glaucoma Foundation, Midwest Biomedical Research Foundation (MBRF), and an unrestricted grant to the University of Miami Department of Ophthalmology from Research to Prevent Blindness. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Charles I, 2005, INVEST OPHTH VIS SCI, V46, P1330, DOI 10.1167/iovs.04-0363; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Diskin S, 2006, INVEST OPHTH VIS SCI, V47, P1491, DOI 10.1167/iovs.05-0736; Farkas RH, 2004, INVEST OPHTH VIS SCI, V45, P2503, DOI 10.1167/iovs.03-1391; Fortune B, 2004, INVEST OPHTH VIS SCI, V45, P1854, DOI 10.1167/iovs.03-1411; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Golubnitschaja-Labudova O, 2000, CURR EYE RES, V21, P867, DOI 10.1076/ceyr.21.5.867.5534; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Han JY, 2008, J NEUROSCI RES, V86, P3221, DOI 10.1002/jnr.21759; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hu XF, 2007, BRIT J CANCER, V96, P918, DOI 10.1038/sj.bjc.6603641; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; Hui L, 2005, J BIOL CHEM, V280, P35829, DOI 10.1074/jbc.M504192200; Ivanov D, 2006, FEBS LETT, V580, P331, DOI 10.1016/j.febslet.2005.12.017; Jia TL, 1999, CANCER RES, V59, P742; Jiang YF, 2004, CANCER RES, V64, P4539, DOI 10.1158/0008-5472.CAN-03-3650; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kamada H, 2007, J CEREBR BLOOD F MET, V27, P521, DOI 10.1038/sj.jcbfm.9600367; Khalyfa A, 2007, MOL VIS, V13, P293; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kim HS, 2005, BRAIN RES, V1057, P17, DOI 10.1016/j.brainres.2005.07.005; Klumpp S, 2003, NEUROCHEM INT, V42, P555, DOI 10.1016/S0197-0186(02)00174-2; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kuhn M, 2007, NEUROGENETICS, V8, P71, DOI 10.1007/s10048-007-0079-z; Lee SW, 2007, J ETHNOPHARMACOL, V111, P213, DOI 10.1016/j.jep.2006.11.012; Levin Leonard A, 2008, Am J Manag Care, V14, pS11; Li YY, 2006, CANCER RES, V66, P6741, DOI 10.1158/0008-5472.CAN-05-4272; Liton P, 2006, MOL VIS, V12, P774; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Morgan JE, 2000, BRIT J OPHTHALMOL, V84, P303, DOI 10.1136/bjo.84.3.303; Nickells RW, 2007, CAN J OPHTHALMOL, V42, P278, DOI 10.3129/canjophthalmol.i07-036; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ohi N, 2006, AM J PATHOL, V168, P1097, DOI 10.2353/ajpath.2006.050462; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Piri N, 2006, MOL VIS, V12, P1660; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Springer JE, 2000, J NEUROSCI, V20, P7246; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Surgucheva IG, 2003, ARCH BIOCHEM BIOPHYS, V410, P167, DOI 10.1016/S0003-9861(02)00664-1; Surgucheva I, 2008, MOL VIS, V14, P1540; Surguchov A, 2001, J NEUROSCI RES, V65, P68, DOI 10.1002/jnr.1129; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Tezel G, 2005, EXP EYE RES, V81, P207, DOI 10.1016/j.exer.2005.01.022; Tezel G., 2007, GLAUCOMA CHEM IMMUNO, V92, P221; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wan X, 2002, CELL DEATH DIFFER, V9, P414, DOI 10.1038/sj.cdd.4400982; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang XJ, 2008, INVEST OPHTH VIS SCI, V49, P2483, DOI 10.1167/iovs.07-1344; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	74	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36377	36385		10.1074/jbc.M806660200	http://dx.doi.org/10.1074/jbc.M806660200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18936092	Green Published, hybrid			2022-12-27	WOS:000261840500035
J	Araie, H; Suzuki, I; Shiraiwa, Y				Araie, Hiroya; Suzuki, Iwane; Shiraiwa, Yoshihiro			Identification and Characterization of a Selenoprotein, Thioredoxin Reductase, in a Unicellular Marine Haptophyte Alga, Emiliania huxleyi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN; SELENIUM; SELENOCYSTEINE; NADPH; CLASSIFICATION; CHLOROPLAST; PREDICTION; PROTEINS; DYNAMICS; SEQUENCE	We found six selenoproteins (EhSEP1-6) in the coccolithophorid Emiliania huxleyi (Haptophyceae) using the Se-75 radiotracer technique. Previously, the most abundant selenoprotein, EhSEP2, was identified as a novel selenoprotein, a protein disulfide isomerase-like protein (Obata, T., and Shiraiwa, Y. ( 2005) J. Biol. Chem. 280, 18462-18468). The present study focused on the second abundant selenoprotein, EhSEP1, in the same cells and analyzed its molecular properties and regulation of gene expression by selenium. The cDNA sequence of EhSEP1 consists of 1950 base pairs encoding a putative product of 495 amino acids with a calculated molecular mass of 52.2 kDa. The nucleotide and amino acid sequences of EhSEP1 showed strong similarities to those of the enzyme thioredoxin reductase (TR) 1 in the public databases. The EhSEP1 protein contains redox-active cysteine residues in the putative FAD binding domain of the pyridine nucleotide-disulfide oxidoreductase class-1 domain, a dimerization domain, and a C-terminal Gly-Cys-Sec (selenocysteine)-Gly sequence that is known to function as an additional redox center. In the 3'-untranslated region of EhSEP1 cDNA, we found a selenocysteine insertion sequence ( SECIS) that is similar to the SECIS found previously in animals. The expression of EhSEP1 showed almost the same pattern under both selenium-sufficient and selenium-deficient conditions. Conversely, TR activity gradually increased 4-fold within ca. 70 h when cells were transferred to the medium containing 10 nM selenite. These data show that selenium is essential for the induction of TR activity at the translational level but not at the transcriptional level in this alga.	[Araie, Hiroya; Suzuki, Iwane; Shiraiwa, Yoshihiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Shiraiwa, Y (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058572, Japan.	emilhux@biol.tsukuba.ac.jp	Shiraiwa, Yoshihiro/AAD-2501-2022		Ministry of Education, Culture, Sports, Science, and Technology [15657026]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant-in-aid for Scientific Research in an exploratory research area (15657026) from the Ministry of Education, Culture, Sports, Science, and Technology (to Y.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agorio A, 2003, J BIOL CHEM, V278, P12920, DOI 10.1074/jbc.M209266200; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brown K M, 2001, Public Health Nutr, V4, P593; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Danbara A, 1999, PLANT CELL PHYSIOL, V40, P762, DOI 10.1093/oxfordjournals.pcp.a029603; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Grundner-Culemann E, 1999, RNA, V5, P625, DOI 10.1017/S1355838299981542; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; Hanawa Y., 2004, JPN J PHYCOL S, V52, P95; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; Hishiya S, 2008, PLANT CELL PHYSIOL, V49, P11, DOI 10.1093/pcp/pcm158; Jacquot JP, 1997, NEW PHYTOL, V136, P543, DOI 10.1046/j.1469-8137.1997.00784.x; Kim HY, 2006, BIOCHEMISTRY-US, V45, P13697, DOI 10.1021/bi0611614; Krol A, 2002, BIOCHIMIE, V84, P765, DOI 10.1016/S0300-9084(02)01405-0; Kryukov GV, 2004, EMBO REP, V5, P538, DOI 10.1038/sj.embor.7400126; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Martinez JM, 2007, APPL ENVIRON MICROB, V73, P554, DOI 10.1128/AEM.00864-06; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Novoselov SV, 2002, EMBO J, V21, P3681, DOI 10.1093/emboj/cdf372; Obata T, 2005, J BIOL CHEM, V280, P18462, DOI 10.1074/jbc.M501517200; Obata T, 2004, PLANT CELL PHYSIOL, V45, P1434, DOI 10.1093/pcp/pch164; PRICE NM, 1988, PLANT PHYSIOL, V86, P192, DOI 10.1104/pp.86.1.192; RUSSEL M, 1988, J BIOL CHEM, V263, P9015; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; Spinola MC, 2008, PHYSIOL PLANTARUM, V133, P516, DOI 10.1111/j.1399-3054.2008.01088.x; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; VENDELAND SC, 1995, P NATL ACAD SCI USA, V92, P8749, DOI 10.1073/pnas.92.19.8749	36	22	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35329	35336		10.1074/jbc.M805472200	http://dx.doi.org/10.1074/jbc.M805472200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18945673	Green Submitted, hybrid			2022-12-27	WOS:000261687900004
J	Liu, M; Aneja, R; Sun, XD; Xie, SB; Wang, HX; Wu, XJ; Dong, T; Li, MG; Joshi, HC; Zhou, J				Liu, Min; Aneja, Ritu; Sun, Xiaodong; Xie, Songbo; Wang, Hongxia; Wu, Xiaojing; Dong, Tang; Li, Minggang; Joshi, Harish C.; Zhou, Jun			Parkin Regulates Eg5 Expression by Hsp70 Ubiquitination-dependent Inactivation of c-Jun NH2-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LIGASE; MICROTUBULES; DEGRADATION; ACTIVATION; MECHANISMS; PROMOTES; SPINDLE	Eg5 is a motor protein of the kinesin family that is critical for spindle assembly during mitosis and has recently been implicated in tumorigenesis. It is largely unknown how Eg5 expression is regulated in cells. In this study, we present the first evidence that the cellular Eg5 level is down-regulated by Parkin, an E3 ubiquitin ligase well known for its role in the development of Parkinson disease. Our data show that Parkin does not trigger Eg5 protein degradation through the ubiquitin-proteasome pathway. Instead, Parkin represses Eg5 gene transcription by blocking c-Jun binding to the activator protein 1 site present in the Eg5 promoter. Our data further show that Parkin inactivates c-Jun NH2-terminal kinase (JNK), resulting in decreased phosphorylation of c-Jun. The inactivation of JNK is further mediated by multiple monoubiquitination of Hsp70. Importantly, both the ubiquitination of Hsp70 and the subsequent inactivation of the JNK-c-Jun pathway are crucial for Parkin to down-regulate Eg5 expression. These results thus uncover a novel function for Parkin in modulating the expression of Eg5 through the Hsp70-JNK-c-Jun signaling pathway.	[Liu, Min; Sun, Xiaodong; Xie, Songbo; Wang, Hongxia; Wu, Xiaojing; Dong, Tang; Li, Minggang; Zhou, Jun] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Joshi, Harish C.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Nankai University; University System of Georgia; Georgia State University; Emory University	Zhou, J (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn	Xie, Songbo/AAD-9850-2020; Zhou, Jun/D-4654-2017; Wang, Hongxia/D-8812-2014	Zhou, Jun/0000-0001-7858-8260; Dong, Jin-Tang/0000-0003-2349-5782	Ministry of Education [107025]; Scientific Research Foundation; Ministry of Education, Tianjin Natural Science Foundation [07JCZDJC03000]; National Key Scientific Program of China [2007CB914802, 2007CB914503]	Ministry of Education; Scientific Research Foundation; Ministry of Education, Tianjin Natural Science Foundation; National Key Scientific Program of China	This work was supported by the Key Project of the Ministry of Education Grant 107025, the Scientific Research Foundation for the Returned Overseas Chinese Scholars of the Ministry of Education, Tianjin Natural Science Foundation Grant 07JCZDJC03000, and National Key Scientific Program of China Grants 2007CB914802 and 2007CB914503. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Castillo A, 2007, CANCER RES, V67, P10138, DOI 10.1158/0008-5472.CAN-07-0326; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Duhl DM, 2005, CURR OPIN DRUG DISC, V8, P431; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Hansen GM, 1999, ONCOGENE, V18, P6531, DOI 10.1038/sj.onc.1203023; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jankowski Marek, 2007, Postepy Biochem, V53, P297; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kashina AS, 1997, BBA-MOL CELL RES, V1357, P257, DOI 10.1016/S0167-4889(97)00037-2; Koushika SP, 2008, BIOESSAYS, V30, P10, DOI 10.1002/bies.20695; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Liu M, 2007, J BIOL CHEM, V282, P17581, DOI 10.1074/jbc.M702206200; Liu M, 2006, J BIOL CHEM, V281, P18090, DOI 10.1074/jbc.M601324200; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Nowicki MO, 2003, ONCOGENE, V22, P3952, DOI 10.1038/sj.onc.1206620; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	28	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35783	35788		10.1074/jbc.M806860200	http://dx.doi.org/10.1074/jbc.M806860200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18845538	hybrid			2022-12-27	WOS:000261687900052
J	Creacy, SD; Routh, ED; Iwamoto, F; Nagamine, Y; Akman, SA; Vaughn, JP				Creacy, Steven D.; Routh, Eric D.; Iwamoto, Fumiko; Nagamine, Yoshikuni; Akman, Steven A.; Vaughn, James P.			G4 Resolvase 1 Binds Both DNA and RNA Tetramolecular Quadruplex with High Affinity and Is the Major Source of Tetramolecular Quadruplex G4-DNA and G4-RNA Resolving Activity in HeLa Cell Lysates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GENOME; PROMOTER REGION; C-MYC; PROTEIN; TRANSCRIPTION; GENE; RECOMBINATION; NUCLEOLIN; STABILITY; MOLECULE	Quadruplex structures that result from stacking of guanine quartets in nucleic acids possess such thermodynamic stability that their resolution in vivo is likely to require specific recognition by specialized enzymes. We previously identified the major tetramolecular quadruplex DNA resolving activity in HeLa cell lysates as the gene product of DHX36 (Vaughn, J. P., Creacy, S. D., Routh, E. D., Joyner-Butt, C., Jenkins, G. S., Pauli, S., Nagamine, Y., and Akman, S. A. (2005) J. Biol Chem. 280, 38117 38120), naming the enzyme G4 Resolvase 1 (G4R1). G4R1 is also known as RHAU, an RNA helicase associated with the AU-rich sequence of mRNAs. We now show that G4R1/RHAU binds to and resolves tetramolecular RNA quadruplex as well as tetramolecular DNA quadruplex structures. The apparent K-d values of G4R1/RHAU for tetramolecular RNA quadruplex and tetramolecular DNA quadruplex were exceptionally low: 39 +/- 6 and 77 +/- 6 pM, respectively, as measured by gel mobility shift assay. In competition studies tetramolecular RNA quadruplex structures inhibited tetramolecular DNA quadruplex structure resolution by G4R1/RHAU more efficiently than tetramolecular DNA quadruplex structures inhibited tetramolecular RNA quadruplex structure resolution. Down-regulation of G4R1/RHAU in HeLa T-REx cells by doxycycline-inducible short hairpin RNA caused an 8-fold loss of RNA and DNA tetramolecular quadruplex resolution, consistent with G4R1/RHAU representing the major tetramolecular quadruplex helicase activity for both RNA and DNA structures in HeLa cells. This study demonstrates for the first time the RNA quadruplex resolving enzymatic activity associated with G4R1/RHAU and its exceptional binding affinity, suggesting a potential novel role for G4R1/RHAU in targeting in vivo RNA quadruplex structures.	[Creacy, Steven D.; Routh, Eric D.; Akman, Steven A.; Vaughn, James P.] Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Creacy, Steven D.; Routh, Eric D.; Akman, Steven A.; Vaughn, James P.] Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; [Iwamoto, Fumiko; Nagamine, Yoshikuni] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Wake Forest University; Wake Forest University; Friedrich Miescher Institute for Biomedical Research; Novartis	Akman, SA (corresponding author), Med Ctr Blvd, Winston Salem, NC 27157 USA.	sakman@wfubmc.edu; jvaughn@wfubmc.edu		Routh, Eric/0000-0002-7371-1802	National Institutes of Health [P30-CA12197]; Wake Forest Comprehensive Cancer Center; Ware Foundation; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest Comprehensive Cancer Center; Ware Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant P30-CA12197. This work was also supported by a grant to the Wake Forest Comprehensive Cancer Center and a gift from the Ware Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arhin GK, 2002, NUCLEIC ACIDS RES, V30, P1842, DOI 10.1093/nar/30.8.1842; Arthanari H, 2001, CHEM BIOL, V8, P221, DOI 10.1016/S1074-5521(01)00007-2; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Boan F, 2004, FEBS LETT, V571, P112, DOI 10.1016/j.febslet.2004.06.062; Chang CC, 2006, ANAL CHEM, V78, P2810, DOI 10.1021/ac052218f; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Connor AC, 2006, J AM CHEM SOC, V128, P4986, DOI 10.1021/ja056097c; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Guo K, 2007, J AM CHEM SOC, V129, P10220, DOI 10.1021/ja072185g; GUSCHLBAUER W, 1990, J BIOMOL STRUCT DYN, V8, P491, DOI 10.1080/07391102.1990.10507825; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Harrington C, 1997, J BIOL CHEM, V272, P24631, DOI 10.1074/jbc.272.39.24631; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Kostadinov R, 2006, NUCLEIC ACIDS RES, V34, pD119, DOI 10.1093/nar/gkj073; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lew A, 2000, P NATL ACAD SCI USA, V97, P12508, DOI 10.1073/pnas.97.23.12508; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Zhang SS, 2004, ACTA BIOCH BIOPH SIN, V36, P177, DOI 10.1093/abbs/36.3.177	40	131	143	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34626	34634		10.1074/jbc.M806277200	http://dx.doi.org/10.1074/jbc.M806277200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842585	Green Published, hybrid			2022-12-27	WOS:000261469100017
J	Kachirskaia, I; Shi, XB; Yamaguchi, H; Tanoue, K; Wen, H; Wang, EW; Appella, E; Gozani, O				Kachirskaia, Ioulia; Shi, Xiaobing; Yamaguchi, Hiroshi; Tanoue, Kan; Wen, Hong; Wang, Evelyn W.; Appella, Ettore; Gozani, Or			Role for 53BP1 Tudor Domain Recognition of p53 Dimethylated at Lysine 382 in DNA Damage Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H4; METHYLATION; METHYLTRANSFERASE; REPRESSION; PR-SET7; BREAKS; SET8	Modification of histone proteins by lysine methylation is a principal chromatin regulatory mechanism (Shi, Y., and Whet-stine, J. R. (2007) Mol. Cell 25, 1-14). Recently, lysine methylation has been shown also to play a role in regulating non-histone proteins, including the tumor suppressor protein p53 (Huang, J., and Berger, S. L. (2008) Curr. Opin. Genet. Dev. 18, 152-158). Here, we identify a novel p53 species that is dimethylated at lysine 382 (p53K382me2) and show that the tandem Tudor domain of the DNA damage response mediator 53BP1 acts as an "effector" for this mark. We demonstrate that the 53BP1 tandem Tudor domain recognizes p53K382me2 with a selectivity relative to several other protein lysine methylation sites and saturation states. p53K382me2 levels increase with DNA damage, and recognition of this modification by 53BP1 facilitates an interaction between p53 and 53BP1. The generation of p53K382me2 promotes the accumulation of p53 protein that occurs upon DNA damage, and this increase in p53 levels requires 53BP1. Taken together, our study identifies a novel p53 modification, demonstrates a new effector function for the 53BP1 tandem Tudor domain, and provides insight into how DNA damage signals are transduced to stabilize p53.	[Kachirskaia, Ioulia; Shi, Xiaobing; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Yamaguchi, Hiroshi; Tanoue, Kan; Appella, Ettore] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Wen, Hong; Wang, Evelyn W.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University	Gozani, O (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ogozani@stanford.edu	Gozani, Or P/I-6157-2013	Wen, Hong/0000-0001-8739-4572; Shi, Xiaobing/0000-0001-5242-8189; Gozani, Or/0000-0002-1365-4463	National Institutes of Health [GM079641]; NATIONAL CANCER INSTITUTE [ZIABC005599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM079641 (to O.G.) and the Intramural Research Program of the National Institutes of Health (to E. A. and H. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Al Rashid ST, 2005, CANCER RES, V65, P10810, DOI 10.1158/0008-5472.CAN-05-0729; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Gottifredi V, 2000, COLD SPRING HARB SYM, V65, P483, DOI 10.1101/sqb.2000.65.483; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang TTK, 2008, J PEDIATR-US, V152, P158, DOI 10.1016/j.jpeds.2007.09.032; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182	20	67	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34660	34666		10.1074/jbc.M806020200	http://dx.doi.org/10.1074/jbc.M806020200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18840612	hybrid, Green Published			2022-12-27	WOS:000261469100021
J	Wolthers, KR; Rigby, SEJ; Scrutton, NS				Wolthers, Kirsten R.; Rigby, Stephen E. J.; Scrutton, Nigel S.			Mechanism of Radical-based Catalysis in the Reaction Catalyzed by Adenosylcobalamin-dependent Ornithine 4,5-Aminomutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHANOLAMINE AMMONIA-LYASE; METHYLMALONYL-COA MUTASE; PARTIAL-PROTON-TRANSFER; HYDROGEN-ATOM ABSTRACTION; CARBON BOND HOMOLYSIS; GLUTAMATE MUTASE; CLOSTRIDIUM-STICKLANDII; LYSINE 5,6-AMINOMUTASE; 2-METHYLENEGLUTARATE MUTASE; SUICIDE INACTIVATION	We report an analysis of the reaction mechanism of ornithine 4,5-aminomutase, an adenosylcobalamin (AdoCbl)- and pyridoxal L-phosphate (PLP)-dependent enzyme that catalyzes the 1,2-rearrangement of the terminal amino group of D-ornithine to generate (2R,4S)-2,4-diaminopentanoic acid. We show by stopped-flow absorbance studies that binding of the substrate D-ornithine or the substrate analogue D-2,4-diaminobutryic acid (DAB) induces rapid homolysis of the AdoCbl Co-C bond (781 s(-1), D-ornithine; 513 s(-1), DAB). However, only DAB results in the stable formation of a cob(II) alamin species. EPR spectra of DAB and [2,4,4-2H3] DAB bound to holo-ornithine 4,5-aminomutase suggests strong electronic coupling between cob(II) alamin and a radical form of the substrate analog. Loading of substrate/analogue onto PLP (i.e. formation of an external aldimine) is also rapid (532 s(-1), D-ornithine; 488 s(-1), DAB). In AdoCbl-depleted enzyme, formation of the external aldimine occurs over long time scales (similar to 50 s) and occurs in three resolvable kinetic phases, identifying four distinct spectral intermediates (termed A-D). We infer that these represent the internal aldimine (lambda(max) 416 nm; A), two different unliganded PLP states of the enzyme (lambda(max) at 409 nm; B and C), and the external aldimine (lambda(max) 426 nm; D). An imine linkage with D-ornithine and DAB generates both tautomeric forms of the external aldimine, but with D-ornithine the equilibrium is shifted toward the ketoimine state. The influence of this equilibrium distribution of prototropic isomers in driving homolysis and stabilizing radical intermediate states is discussed. Our work provides the first detailed analysis of radical-based catalysis in this Class III AdoCbl-dependent enzyme.	[Wolthers, Kirsten R.; Rigby, Stephen E. J.; Scrutton, Nigel S.] Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of Manchester	Wolthers, KR (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, 131 Princess St, Manchester M1 7DN, Lancs, England.	kirsten.wolthers@manchester.ac.uk	Wolthers, Kirsten/M-6833-2019		United Kingdom Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: researchfish; BBSRC [BB/D01963X/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the United Kingdom Biotechnology and Biological Sciences Research Council (to N. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abend A, 2000, BIOCHEMISTRY-US, V39, P6250, DOI 10.1021/bi992963k; Bach RD, 1999, J AM CHEM SOC, V121, P6542, DOI 10.1021/ja9907616; BAKER JJ, 1973, BIOCHEMISTRY-US, V12, P1054, DOI 10.1021/bi00730a006; Bandarian V, 2000, BIOCHEMISTRY-US, V39, P12069, DOI 10.1021/bi001014k; Bandarian V, 2002, BIOCHEMISTRY-US, V41, P8580, DOI 10.1021/bi0201217; Bandarian V, 1999, BIOCHEMISTRY-US, V38, P12394, DOI 10.1021/bi990620g; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; BARKER JJ, 1984, B 12, V2, P203; Berkovitch F, 2004, P NATL ACAD SCI USA, V101, P15870, DOI 10.1073/pnas.0407074101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Chen HP, 2004, EUR J BIOCHEM, V271, P4293, DOI 10.1111/j.1432-1033.2004.04369.x; Chen HP, 2001, J BIOL CHEM, V276, P44744, DOI 10.1074/jbc.M108365200; Cheng MC, 2007, BIOCHEMISTRY-US, V46, P883, DOI 10.1021/bi0616908; FINKE RG, 1984, INORG CHEM, V23, P3041, DOI 10.1021/ic00188a002; Jones AR, 2007, J AM CHEM SOC, V129, P15718, DOI 10.1021/ja077124x; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Mansoorabadi SO, 2005, BIOCHEMISTRY-US, V44, P3153, DOI 10.1021/bi0482102; Marsh ENG, 2001, CURR OPIN CHEM BIOL, V5, P499, DOI 10.1016/S1367-5931(00)00238-6; Marsh ENG, 1998, BIOCHEMISTRY-US, V37, P11864, DOI 10.1021/bi980512e; MICHEL C, 1992, EUR J BIOCHEM, V205, P767, DOI 10.1111/j.1432-1033.1992.tb16841.x; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; PADMAKUMAR R, 1995, J BIOL CHEM, V270, P9295, DOI 10.1074/jbc.270.16.9295; Padmakumar R, 1997, BIOCHEMISTRY-US, V36, P3713, DOI 10.1021/bi962503g; Reed GH, 2003, CURR OPIN STRUC BIOL, V13, P716, DOI 10.1016/j.sbi.2003.10.011; Roymoulik I, 1999, J BIOL CHEM, V274, P11619, DOI 10.1074/jbc.274.17.11619; Smith DM, 1999, J AM CHEM SOC, V121, P5700, DOI 10.1021/ja990209g; Smith DM, 1999, J AM CHEM SOC, V121, P1037, DOI 10.1021/ja9827245; Smith DM, 1999, J AM CHEM SOC, V121, P1383, DOI 10.1021/ja983512a; Smith DM, 1999, J AM CHEM SOC, V121, P9388, DOI 10.1021/ja991649a; Tang KH, 2003, ARCH BIOCHEM BIOPHYS, V418, P49, DOI 10.1016/S0003-9861(03)00346-1; Tang KH, 2001, BIOCHEMISTRY-US, V40, P5190, DOI 10.1021/bi010157j; Toney MD, 2001, BIOCHEMISTRY-US, V40, P1378, DOI 10.1021/bi0012383; Toraya T, 2003, CHEM REV, V103, P2095, DOI 10.1021/cr020428b; Tseng CH, 2007, FEMS MICROBIOL LETT, V274, P148, DOI 10.1111/j.1574-6968.2007.00820.x; Wetmore SD, 2000, J AM CHEM SOC, V122, P10208, DOI 10.1021/ja001651y; Wetmore SD, 2001, J AM CHEM SOC, V123, P8678, DOI 10.1021/ja010211j; Wetmore SD, 2001, J AM CHEM SOC, V123, P7963, DOI 10.1021/ja004246f; ZELDER O, 1994, EUR J BIOCHEM, V226, P577, DOI 10.1111/j.1432-1033.1994.tb20083.x	39	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34615	34625		10.1074/jbc.M807911200	http://dx.doi.org/10.1074/jbc.M807911200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18948256	hybrid, Green Published			2022-12-27	WOS:000261469100016
J	Kintses, B; Yang, ZH; Malnasi-Csizmadia, A				Kintses, Balint; Yang, Zhenhui; Malnasi-Csizmadia, Andras			Experimental Investigation of the Seesaw Mechanism of the Relay Region That Moves the Myosin Lever Arm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; RECOVERY STROKE; MOTOR DOMAIN; MUSCLE-CONTRACTION; II MOTOR; NUCLEOTIDE; STATES; ACTIVATION; TRANSITION; RESOLUTION	A seesaw-like movement of the relay region upon the recovery step of myosin was recently simulated in silico. In this model the relay helix tilts around its pivoting point formed by a phenylalanine cluster (Phe(481), Phe(482), and Phe(652)), which moves the lever arm of myosin. To study the effect of the elimination of the proposed pivoting point, these phenylalanines were mutated to alanines in two Dictyostelium myosin II motor domain constructs (M-F481A,M- F482A and M-F652A). The relay movement was followed by the fluorescence change of Trp(501) located in the relay region. The steady-state and transient kinetic fluorescence experiments showed that the lack of the phenylalanine fulcrum perturbs the formation of the "up" lever arm state, and only moderate effects were found in the nucleotide binding, the formation of the "down" lever arm position, and the ATP hydrolysis steps. We conclude that the lack of the fulcrum decouples the distal part of the relay from the nucleotide binding site upon the recovery step. Our molecular dynamics simulations also showed that the conformation of the motor is not perturbed by the mutation in the down lever arm state, however, the lack of the pivoting point rearranges the dynamic pattern of the kink region of the relay helix.	[Kintses, Balint; Yang, Zhenhui; Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	Eotvos Lorand University	Malnasi-Csizmadia, A (corresponding author), Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary.	malna@.elte.hu	Csizmadia, András Málnási/K-7632-2018	Csizmadia, András Málnási/0000-0002-2430-8398; Kintses, Balint/0000-0003-0844-0310	The European Research Council [208319]	The European Research Council(European Research Council (ERC))	This work was supported by The European Research Council under the European Community's Seventh Framework Program FP7/2007-2013/ERC Grant 208319. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bauer CB, 2000, J BIOL CHEM, V275, P38494, DOI 10.1074/jbc.M005585200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Conibear PB, 2003, NAT STRUCT BIOL, V10, P831, DOI 10.1038/nsb986; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gyimesi M, 2008, J BIOL CHEM, V283, P8153, DOI 10.1074/jbc.M708863200; Gyimesi M, 2008, BIOCHEMISTRY-US, V47, P283, DOI 10.1021/bi701554a; HARRIS MJ, 2008, EUR BIOPHYS IN PRESS; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; Ho BK, 2003, PROTEIN SCI, V12, P2508, DOI 10.1110/ps.03235203; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; Koppole S, 2007, STRUCTURE, V15, P825, DOI 10.1016/j.str.2007.06.008; Liang WC, 1998, P NATL ACAD SCI USA, V95, P12844, DOI 10.1073/pnas.95.22.12844; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Mesentean S, 2007, J MOL BIOL, V367, P591, DOI 10.1016/j.jmb.2006.12.058; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Urbanke C, 2001, BIOCHEM J, V358, P165, DOI 10.1042/0264-6021:3580165; Yu HB, 2007, PLOS COMPUT BIOL, V3, P199, DOI 10.1371/journal.pcbi.0030021; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023	26	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34121	34128		10.1074/jbc.M805848200	http://dx.doi.org/10.1074/jbc.M805848200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854311	hybrid, Green Published			2022-12-27	WOS:000261277700040
J	Umemori, H; Sanes, JR				Umemori, Hisashi; Sanes, Joshua R.			Signal Regulatory Proteins (SIRPS) Are Secreted Presynaptic Organizing Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-ASSOCIATED PROTEIN; CEREBRAL CORTICAL-NEURONS; NEURAL ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR FAMILY; SYNAPTIC DIFFERENTIATION; RECEPTOR SPECIFICITY; NEGATIVE REGULATION; NEURITE OUTGROWTH; CELL-MIGRATION	Formation of chemical synapses requires exchange of organizing signals between the synaptic partners. Using synaptic vesicle aggregation in cultured neurons as a marker of presynaptic differentiation, we purified candidate presynaptic organizers from mouse brain. A major bioactive species was the extracellular domain of signal regulatory protein alpha(SIRP-alpha), a transmembrane immunoglobulin superfamily member concentrated at synapses. Theextracellular domain of SIRP-alpha is cleaved and shed in a developmentally regulated manner. The presynaptic organizing activity of SIRP-alpha is mediated in part by CD47. SIRP-alpha homologues, SIRP-beta and -gamma also have synaptic vesicle clustering activity. The effects of SIRP-alpha are distinct from those of another presynaptic organizer, FGF22: the two proteins induced vesicle clusters of different sizes, differed in their ability to promote neurite branching, and acted through different receptors and signaling pathways. SIRP family proteins may act together with other organizing molecules to pattern synapses.	[Umemori, Hisashi] Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Umemori, Hisashi] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Umemori, Hisashi; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Umemori, Hisashi; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard University	Umemori, H (corresponding author), Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Rm 5065,BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	umemoh@umich.edu		Umemori, Hisashi/0000-0001-7198-2062				AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Araki T, 2000, J NEUROCHEM, V75, P1502, DOI 10.1046/j.1471-4159.2000.0751502.x; Babic I, 2000, J IMMUNOL, V164, P3652, DOI 10.4049/jimmunol.164.7.3652; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; CHUANG W, 1990, DEV BIOL, V137, P219, DOI 10.1016/0012-1606(90)90249-I; Comu S, 1997, J NEUROSCI, V17, P8702; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kato H, 2005, J THROMB HAEMOST, V3, P763, DOI 10.1111/j.1538-7836.2005.01235.x; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kontaridis MI, 2001, J CELL SCI, V114, P2187; Koshimizu H, 2002, J NEUROCHEM, V82, P249, DOI 10.1046/j.1471-4159.2002.00965.x; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Mi ZP, 2000, J COMP NEUROL, V416, P335; Mitsuhashi H, 2005, J BIOCHEM, V137, P495, DOI 10.1093/jb/mvi058; Mitsuhashi H, 2008, J NEUROCHEM, V105, P101, DOI 10.1111/j.1471-4159.2007.05121.x; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Numakawa T, 2004, J BIOL CHEM, V279, P43245, DOI 10.1074/jbc.M406733200; Ohnishi H, 2005, J NEUROSCI, V25, P2702, DOI 10.1523/JNEUROSCI.5173-04.2005; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; RENSDOMIANO S, 1995, FASEB J, V9, P1059, DOI 10.1096/fasebj.9.11.7649405; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Seiffert M, 2001, BLOOD, V97, P2741, DOI 10.1182/blood.V97.9.2741; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; van Beek EM, 2005, J IMMUNOL, V175, P7781, DOI 10.4049/jimmunol.175.12.7781; van den Berg TK, 2005, J IMMUNOL, V175, P7788, DOI 10.4049/jimmunol.175.12.7788; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang XXX, 2006, J CELL SCI, V119, P172, DOI 10.1242/jcs.02710; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	56	36	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34053	34061		10.1074/jbc.M805729200	http://dx.doi.org/10.1074/jbc.M805729200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18819922	Green Published, hybrid			2022-12-27	WOS:000261277700033
J	Chang, A; Lim, MH; Lee, SW; Robb, EJ; Nazar, RN				Chang, Ancheol; Lim, Myung-Ho; Lee, Shin-Woo; Robb, E. Jane; Nazar, Ross N.			Tomato Phenylalanine Ammonia-Lyase Gene Family, Highly Redundant but Strongly Underutilized	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGROBACTERIUM-TUMEFACIENS; DNA METHYLATION; DUPLICATE GENES; EXPRESSION; EVOLUTION; IDENTIFICATION; CONSEQUENCES; ORGANIZATION; SEQUENCE; VECTOR	Phenylalanine ammonia-lyase ( PAL) is an important enzyme in both plant development and pathogen defense. In all plants it is encoded by a multi-gene family, ranging in copy number from four in Arabidopsis to a dozen or more copies in some higher plants. Many studies indicate that alternate genes are differentially regulated in response to environmental stimuli. In this study, Southern blot and dot blot analyses in tomato indicate a surprisingly large family of related sequences with similar to 26 copies in the diploid genome, some easily distinguished by restriction enzyme digestion. Analyses of a BAC genome library suggest that the genes are generally not clustered. A more detailed comparison of the gene sequences using PCR to isolate the individual copies and reverse transcription-PCR to study the transcripts that they encode indicates a significant diversity in the gene sequences themselves, but surprisingly only one mRNA transcript can be detected even when additional expression is induced by pathogen growth or wounding. Consistent with previous reports in other plants, a parallel study with a closely related plant, the potato, indicates a much broader utilization of the PAL genes, highlighting the unusual nature of this family in tomato and of the mechanism(s) that silences so many members. Plant transformation analyses further demonstrate the presence of very active silencing, suggesting aggressive competition between PAL gene duplication and copy inactivation during PAL gene evolution.	[Chang, Ancheol; Lim, Myung-Ho; Lee, Shin-Woo; Robb, E. Jane; Nazar, Ross N.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Nazar, RN (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rnnazar@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; BERNARDS MA, 1991, PLANT PHYSIOL, V97, P1494, DOI 10.1104/pp.97.4.1494; Budiman MA, 2000, GENOME RES, V10, P129; CRAMER CL, 1989, PLANT MOL BIOL, V12, P367, DOI 10.1007/BF00017577; Cushman JC, 1995, METHOD CELL BIOL, V50, P113, DOI 10.1016/S0091-679X(08)61026-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GERARD GF, 1987, FOCUS, V9, P5; Heinz R, 1998, PHYSIOL MOL PLANT P, V52, P385, DOI 10.1006/pmpp.1998.0163; HOAGLUND DR, 1950, CIRCULAR CALIFORNIA, V347; HOEKEMA A, 1983, NATURE, V303, P179, DOI 10.1038/303179a0; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Jacobsen SE, 1999, CURR BIOL, V9, pR617, DOI 10.1016/S0960-9822(99)80388-1; JOOS HJ, 1992, EUR J BIOCHEM, V204, P621, DOI 10.1111/j.1432-1033.1992.tb16675.x; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Kumar A, 2001, PLANT PHYSIOL, V127, P230, DOI 10.1104/pp.127.1.230; LEE SW, 1992, J BIOL CHEM, V267, P11824; LEE SW, 1994, EUR J BIOCHEM, V226, P109, DOI 10.1111/j.1432-1033.1994.tb20031.x; LEE SW, 1992, PLANT MOL BIOL, V18, P345, DOI 10.1007/BF00034961; LIANG X, 1989, P NATL ACAD SCI USA, V86, P9284, DOI 10.1073/pnas.86.23.9284; LIANG XW, 1989, J BIOL CHEM, V264, P14486; LIAO Y, 1996, PLANT GENE REGISTER; LOIS R, 1989, EMBO J, V8, P1641, DOI 10.1002/j.1460-2075.1989.tb03554.x; LOIS R, 1989, BIOSCI Z NATURFORSCH, V47, P90; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Morris K, 2005, CELL MOL LIFE SCI, V62, P3057, DOI 10.1007/s00018-005-5182-4; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; STACHEL SE, 1985, NATURE, V318, P624, DOI 10.1038/318624a0; THOMPSON GA, 1990, PLANT MOL BIOL, V15, P755, DOI 10.1007/BF00016125; Van der Hoeven R, 2002, PLANT CELL, V14, P1441, DOI 10.1105/tpc.010478; WANNER LA, 1995, PLANT MOL BIOL, V27, P327, DOI 10.1007/BF00020187; Yu H, 2003, PLANT CELL REP, V22, P167, DOI 10.1007/s00299-003-0699-1	38	75	88	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33591	33601		10.1074/jbc.M804428200	http://dx.doi.org/10.1074/jbc.M804428200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838378	Green Published, hybrid			2022-12-27	WOS:000261183700065
J	Chung, YM; Lee, SB; Kim, HJ; Park, SH; Kim, JJ; Chung, JS; Do Yoo, Y				Chung, Young Min; Lee, Seung Baek; Kim, Hyung Jung; Park, Seon Ho; Kim, Jung Jin; Chung, Jin Sil; Do Yoo, Young			Replicative Senescence Induced by Romo1-derived Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; MITOCHONDRIAL-DNA; LIFE-SPAN; CELL-PROLIFERATION; SIGNALING PATHWAYS; FREE-RADICALS; HUMAN BRAIN; AGING MICE; ROS	Persistent accumulation of DNA damage induced by reactive oxygen species (ROS) is proposed to be a major contributor toward the aging process. Furthermore, an increase in age-associated ROS is strongly correlated with aging in various species, including humans. Here we showed that the enforced expression of the ROS modulator 1 (Romo1) triggered premature senescence by ROS production, and this also contributed toward induction of DNA damage. Romo1-derived ROS was found to originate in the mitochondrial electron transport chain. Romo1 expression gradually increased in proportion to population doublings of IMR-90 human fibroblasts. An increase in ROS production in these cells with high population doubling was blocked by the Romo1 knockdown using Romo1 small interfering RNA. Romo1 knockdown also inhibited the progression of replicative senescence. Based on these results, we suggest that age-related ROS levels increase, and this contributes to replicative senescence, which is directly associated with Romo1 expression.	[Chung, Young Min; Lee, Seung Baek; Park, Seon Ho; Kim, Jung Jin; Chung, Jin Sil; Do Yoo, Young] Korea Univ, Coll Med, Grad Sch Med, Brain Korea Program Biomed Sci 21, Seoul 136705, South Korea; [Kim, Hyung Jung] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 135270, South Korea	Korea University; Korea University Medicine (KU Medicine); Yonsei University; Yonsei University Health System	Do Yoo, Y (corresponding author), Korea Univ, Coll Med, Anam Hosp, 126-1,5Ka, Seoul 136705, South Korea.	ydy1130@korea.ac.kr	Chung, Young Min/AAV-7656-2020		Korea Government (MEST) [FG06-2-20]; Basic Research Program of the Korea Science and Engineering Foundation [R01-2006-000-10113-0]; Research Center for Woman's Diseases of the Korea Science and Engineering Foundation [R11-2005017-01001-0]	Korea Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Research Program of the Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Research Center for Woman's Diseases of the Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Grant FG06-2-20 from the 21st Century Frontier Functional Human Genome Project funded by the Korea Government (MEST), by Grant R01-2006-000-10113-0 from the Basic Research Program of the Korea Science and Engineering Foundation, and by Grant R11-2005017-01001-0 from the Research Center for Woman's Diseases of the Korea Science and Engineering Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arora-Kuruganti P, 1999, J NEURO-ONCOL, V44, P213, DOI 10.1023/A:1006315332098; ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Caporossi D, 2003, FREE RADICAL BIO MED, V35, P1355, DOI 10.1016/j.freeradbiomed.2003.08.008; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chung YM, 2006, BIOCHEM BIOPH RES CO, V347, P649, DOI 10.1016/j.bbrc.2006.06.140; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hwang IT, 2007, BIOCHEM BIOPH RES CO, V359, P304, DOI 10.1016/j.bbrc.2007.05.088; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Ishii N, 2007, CORNEA, V26, pS3, DOI 10.1097/ICO.0b013e31812f6745; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Laurent A, 2005, CANCER RES, V65, P948; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Liu SL, 2002, ARCH BIOCHEM BIOPHYS, V406, P173, DOI 10.1016/S0003-9861(02)00430-7; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Martin V, 2007, FREE RADICAL BIO MED, V42, P1715, DOI 10.1016/j.freeradbiomed.2007.02.028; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miwa S, 2004, ANN NY ACAD SCI, V1019, P388, DOI 10.1196/annals.1297.069; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Na AR, 2008, BIOCHEM BIOPH RES CO, V369, P672, DOI 10.1016/j.bbrc.2008.02.098; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sekharam M, 1998, TOXICOL APPL PHARM, V149, P210, DOI 10.1006/taap.1997.8361; Shawi M, 2008, MECH AGEING DEV, V129, P3, DOI 10.1016/j.mad.2007.11.007; Sigaud S, 2005, ANTIOXID REDOX SIGN, V7, P6, DOI 10.1089/ars.2005.7.6; Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Yoo YA, 2005, MOL CELL BIOL, V25, P6603, DOI 10.1128/MCB.25.15.6603-6616.2005; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	46	54	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33763	33771		10.1074/jbc.M805334200	http://dx.doi.org/10.1074/jbc.M805334200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18836179	hybrid, Green Published			2022-12-27	WOS:000261183700082
J	Bao, XM; Cai, WL; Deng, H; Zhang, WG; Krencik, R; Girton, J; Johansen, J; Johansen, KM				Bao, Xiaomin; Cai, Weili; Deng, Huai; Zhang, Weiguo; Krencik, Robert; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.			The COOH-terminal Domain of the JIL-1 Histone H3S10 Kinase Interacts with Histone H3 and Is Required for Correct Targeting to Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA POLYTENE CHROMOSOMES; DOSAGE COMPENSATION COMPLEX; POSITION-EFFECT VARIEGATION; CHROMODOMAIN PROTEIN; PHOSPHORYLATION; GENES; HETEROCHROMATIN; ALLELES	The JIL-1 histone H3S10 kinase in Drosophila localizes specifically to euchromatic interband regions of polytene chromosomes and is enriched 2-fold on the male X chromosome. JIL-1 can be divided into four main domains including an NH2-terminal domain, two separate kinase domains, and a COOH-terminal domain. Our results demonstrate that the COOH-terminal domain of JIL-1 is necessary and sufficient for correct chromosome targeting to autosomes but that both COOH-and NH2-terminal sequences are necessary for enrichment on the male X chromosome. We furthermore show that a small 53-amino acid region within the COOH-terminal domain can interact with the tail region of histone H3, suggesting that this interaction is necessary for the correct chromatin targeting of the JIL-1 kinase. Interestingly, our data indicate that the COOH-terminal domain alone is sufficient to rescue JIL-1 null mutant polytene chromosome defects including those of the male X chromosome. Nonetheless, we also found that a truncated JIL-1 protein which was without the COOH-terminal domain but retained histone H3S10 kinase activity was able to rescue autosome as well as partially rescue male X polytene chromosome morphology. Taken together these findings indicate that JIL-1 may participate in regulating chromatin structure by multiple and partially redundant mechanisms.	[Bao, Xiaomin; Cai, Weili; Deng, Huai; Zhang, Weiguo; Krencik, Robert; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Johansen, KM (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 3154 Mol Biol Bldg, Ames, IA 50011 USA.	kristen@iastate.edu	Cai, Weili/B-7691-2013	Zhang, Weiguo/0000-0002-3045-0569; Bao, Xiaomin/0000-0002-8845-5012; Cai, Weili/0000-0002-6781-5322; Krencik, Robert/0000-0002-2968-3162	National Institutes of Health [GM62916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62916 (to K.M.J.).	Bao XM, 2007, GENETICS, V176, P1355, DOI 10.1534/genetics.107.073676; Bao XM, 2005, J CELL SCI, V118, P5079, DOI 10.1242/jcs.02611; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Cai WL, 2008, DEVELOPMENT, V135, P2917, DOI 10.1242/dev.024927; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; DIMARIO P, 2006, DROS INF SERV, V89, P115; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; GORMAN M, 1995, DEVELOPMENT, V121, P463; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; LINDSLEY DL, 1992, GENOME DROSOPHILA ME, P1071; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Rath U, 2006, J CELL SCI, V119, P2332, DOI 10.1242/jcs.02960; Roberts D.B., 1998, DROSOPHILA PRACTICAL, P1; Sambrook J., 2001, MOL CLONING LAB MANU; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhang WG, 2003, GENETICS, V165, P1341; Zhang WG, 2003, J BIOL CHEM, V278, P11696, DOI 10.1074/jbc.M213269200	26	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32741	32750		10.1074/jbc.M806227200	http://dx.doi.org/10.1074/jbc.M806227200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819909	Green Published, hybrid			2022-12-27	WOS:000260893700063
J	Yamazaki, S; Matsuo, S; Muta, T; Yamamoto, M; Akira, S; Takeshige, K				Yamazaki, Soh; Matsuo, Susumu; Muta, Tatsushi; Yamamoto, Masahiro; Akira, Shizuo; Takeshige, Koichiro			Gene-specific Requirement of a Nuclear Protein, I kappa B-zeta, for Promoter Association of Inflammatory Transcription Regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILIZATION; EPITHELIAL-CELLS; INDUCTION; EXPRESSION; RECEPTOR; MACROPHAGES; ROLES; SITES; MICE; LAP	Expression of many inflammatory genes is induced through activation of the transcription factor NF-kappa B. In contrast to the advanced understanding of cytoplasmic control of NF-kappa B activation, its regulation in the nucleus has not been fully understood despite its importance in selective gene expression. We previously identified an inducible nuclear protein, I kappa B-zeta, and demonstrated that this molecule is indispensable for the expression of a group of NF-kappa B-regulated genes. In this study, we established a unique gene induction system, in which I kappa B-zeta is expressed independently of inflammatory stimuli, to specifically investigate the molecular basis underlying I kappa B-zeta-mediated gene activation. We show that in the presence of I kappa B-zeta other primary response genes are dispensable for the expression of the target secondary response genes. ChIP analyses revealed that I kappa B-zeta is required for stimulus-induced recruitment of NF-kappa B onto the target promoter in a gene-specific manner. Surprisingly, I kappa B-zeta is also necessary for the gene-selective promoter recruitment of another inflammatory transcription factor, C/EBP beta, and the chromatin remodeling factor Brg1. We propose a new gene regulatory mechanism underlying the selective expression of inflammatory genes.	[Yamazaki, Soh] Kyushu Univ, Grad Sch Med Sci, Dept Mol & Cellular Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Muta, Tatsushi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan; [Yamamoto, Masahiro; Akira, Shizuo] Osaka Univ, Japan Sci & Technol Agcy, ERATO,Dept Host Def, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Kyushu University; Tohoku University; Japan Science & Technology Agency (JST); Osaka University	Yamazaki, S (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol & Cellular Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	syamaz@mailserver.med.kyushu-u.ac.jp	Akira, Shizuo/C-3134-2009	Yamazaki, Soh/0000-0001-5038-1567	Ministry of Education, Culture, Sports, Science and Technology in Japan; Sankyo Foundation of Life Science	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (to S. Y. and K. T.) and a grant from Sankyo Foundation of Life Science (to S. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Natoli G, 2006, FEBS LETT, V580, P2843, DOI 10.1016/j.febslet.2006.02.072; PETERSON MG, 1986, EUR J BIOCHEM, V160, P579, DOI 10.1111/j.1432-1033.1986.tb10077.x; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; SHANAHAN CM, 1989, MOL CELL BIOL, V9, P5473, DOI 10.1128/MCB.9.12.5473; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yamazaki S, 2008, BBA-GENE REGUL MECH, V1779, P108, DOI 10.1016/j.bbagmi.2007.11.001; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	32	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32404	32411		10.1074/jbc.M802148200	http://dx.doi.org/10.1074/jbc.M802148200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18824552	hybrid			2022-12-27	WOS:000260893700028
J	Zhao, Q; Barakat, BM; Qin, S; Ray, A; El-Mahdy, MA; Wani, G; Arafa, ES; Mir, SN; Wang, QE; Wani, AA				Zhao, Qun; Barakat, Bassant M.; Qin, Song; Ray, Alo; El-Mahdy, Mohamed A.; Wani, Gulzar; Arafa, El-Shaimaa; Mir, Safita N.; Wang, Qi-En; Wani, Altaf A.			The p38 Mitogen-activated Protein Kinase Augments Nucleotide Excision Repair by Mediating DDB2 Degradation and Chromatin Relaxation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGED-DNA-BINDING; GROUP-E CELLS; CYCLOBUTANE PYRIMIDINE DIMERS; GLOBAL GENOMIC REPAIR; UV-IRRADIATION; HISTONE H3; IN-VITRO; C-FOS; DEPENDENT DEGRADATION; MOLECULAR-MECHANISM	The p38 MAPK is a family of serine/threonine protein kinases that play important roles in cellular responses to external stress signals, e. g. UV irradiation. To assess the role of p38 MAPK pathway in nucleotide excision repair (NER), the most versatile DNA repair pathway, we determined the efficiency of NER in cells treated with p38 MAPK inhibitor SB203580 and found that p38 MAPK is required for the prompt repair of UV-induced DNA damage CPD. We further investigated the possible mechanism through which p38 MAPK regulates NER and found that p38 MAPK mediates UV-induced histone H3 acetylation and chromatin relaxation. Moreover, p38 MAPK also regulates UV-induced DDB2 ubiquitylation and degradation via phosphorylation of the target protein. Finally, our results showed that p38 MAPK is required for the recruitment of NER factors XPC and TFIIH to UV-induced DNA damage sites. We conclude that p38 MAPK regulates chromatin remodeling as well as DDB2 degradation for facilitating NER factor assembly.	[Zhao, Qun; Barakat, Bassant M.; Qin, Song; Ray, Alo; El-Mahdy, Mohamed A.; Wani, Gulzar; Arafa, El-Shaimaa; Mir, Safita N.; Wang, Qi-En; Wani, Altaf A.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Wang, QE (corresponding author), Ohio State Univ, Dept Radiol, 460 W 12th Ave, Columbus, OH 43210 USA.	wang.771@osu.edu; wani.2@osu.edu	Arafa, Elshaimaa/Q-1316-2019; Arafa, El-Shaimaa A/C-4777-2013	Arafa, Elshaimaa/0000-0002-9034-6624; Arafa, El-Shaimaa A/0000-0002-9034-6624; Barakat, Bassant/0000-0003-1800-5814	National Institutes of Health [ES2388, ES12991, CA93413]; NATIONAL CANCER INSTITUTE [R01CA093413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002388, R01ES012991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES2388, ES12991, and CA93413. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Andrieux LO, 2007, CANCER RES, V67, P2114, DOI 10.1158/0008-5472.CAN-06-3821; Araujo SJ, 2000, GENE DEV, V14, P349; Bessho T, 1997, J BIOL CHEM, V272, P3833, DOI 10.1074/jbc.272.6.3833; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Cheung KJ, 2001, CANCER RES, V61, P4974; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Christmann M, 2007, CARCINOGENESIS, V28, P183, DOI 10.1093/carcin/bgl119; Christmann M, 2006, NUCLEIC ACIDS RES, V34, P6530, DOI 10.1093/nar/gkl895; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; HANAWALT P, 1993, CURR BIOL, V3, P67, DOI 10.1016/0960-9822(93)90156-I; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kulaksiz G, 2005, MOL CELL BIOL, V25, P9784, DOI 10.1128/MCB.25.22.9784-9792.2005; Kuo WHW, 2007, EXP CELL RES, V313, P1628, DOI 10.1016/j.yexcr.2007.02.010; Kusumoto R, 2001, MUTAT RES-DNA REPAIR, V485, P219, DOI 10.1016/S0921-8777(00)00082-3; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Li JP, 2007, J CELL PHYSIOL, V212, P481, DOI 10.1002/jcp.21042; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; RAMANATHAN B, 1989, J BIOL CHEM, V264, P11026; RAMANATHAN B, 1986, CARCINOGENESIS, V7, P1087, DOI 10.1093/carcin/7.7.1087; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rouget R, 2008, J BIOL CHEM, V283, P5533, DOI 10.1074/jbc.M706257200; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; SMERDON MJ, 1990, CELL, V61, P675, DOI 10.1016/0092-8674(90)90479-X; SMERDON MJ, 1982, J BIOL CHEM, V257, P13441; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004; Venkatachalam S, 1997, ONCOGENE, V14, P801, DOI 10.1038/sj.onc.1200890; Wakasugi M, 2001, J BIOL CHEM, V276, P15434, DOI 10.1074/jbc.M011177200; Wang D, 2004, J BIOL CHEM, V279, P20622, DOI 10.1074/jbc.M402547200; Wang J, 2006, CANCER RES, V66, P1906, DOI 10.1158/0008-5472.CAN-05-3444; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wang QE, 2003, DNA REPAIR, V2, P483, DOI 10.1016/S1568-7864(03)00002-8; WANG Z, 1991, J BIOL CHEM, V269, P19034; Wang ZG, 1997, J BIOL CHEM, V272, P24064, DOI 10.1074/jbc.272.38.24064; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199	70	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32553	32561		10.1074/jbc.M803963200	http://dx.doi.org/10.1074/jbc.M803963200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806262	hybrid, Green Published			2022-12-27	WOS:000260893700044
J	Bowling, KM; Huang, ZN; Xu, D; Ferdousy, F; Funderburk, CD; Karnik, N; Neckameyer, W; O'Donnell, JM				Bowling, Kevin M.; Huang, Zhinong; Xu, Dong; Ferdousy, Faiza; Funderburk, Christopher D.; Karnik, Nirmala; Neckameyer, Wendi; O'Donnell, Janis M.			Direct Binding of GTP Cyclohydrolase and Tyrosine Hydroxylase REGULATORY INTERACTIONS BETWEEN KEY ENZYMES IN DOPAMINE BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; AMINO-ACID HYDROXYLASES; DROSOPHILA-MELANOGASTER; TETRAHYDROBIOPTERIN BIOSYNTHESIS; PUNCH LOCUS; RAT-BRAIN; PHOSPHORYLATION; GENE; ISOFORMS; PHENYLKETONURIA	The signaling functions of dopamine require a finely tuned regulatory network for rapid induction and suppression of output. A key target of regulation is the enzyme tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, which is activated by phosphorylation and modulated by the availability of its cofactor, tetrahydrobiopterin. The first enzyme in the cofactor synthesis pathway, GTP cyclohydrolase I, is activated by phosphorylation and inhibited by tetrahydrobiopterin. We previously reported that deficits in GTP cyclohydrolase activity in Drosophila heterozygous for mutant alleles of the gene encoding this enzyme led to tightly corresponding diminution of in vivo tyrosine hydroxylase activity that could not be rescued by exogenous cofactor. We also found that the two enzymes could be coimmunoprecipitated from tissue extracts and proposed functional interactions between the enzymes that extended beyond provision of cofactor by one pathway for another. Here, we confirm the physical association of these enzymes, identifying interacting regions in both, and we demonstrate that their association can be regulated by phosphorylation. The functional consequences of the interaction include an increase in GTP cyclohydrolase activity, with concomitant protection from end-product feedback inhibition. In vivo, this effect would in turn provide sufficient cofactor when demand for catecholamine synthesis is greatest. The activity of tyrosine hydroxylase is also increased by this interaction, in excess of the stimulation resulting from phosphorylation alone. V-max is elevated, with no change in K-m. These results demonstrate that these enzymes engage in mutual positive regulation.	[Bowling, Kevin M.; Huang, Zhinong; Xu, Dong; Ferdousy, Faiza; Funderburk, Christopher D.; Karnik, Nirmala; O'Donnell, Janis M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Neckameyer, Wendi] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Alabama System; University of Alabama Tuscaloosa; Saint Louis University	O'Donnell, JM (corresponding author), Univ Alabama, Dept Biol Sci, Box 870344,411 Hackberry Lane, Tuscaloosa, AL 35487 USA.	jodonnel@bama.ua.edu	Funderburk, Christopher D./R-4092-2019; Funderburk, Christopher D./X-5473-2019	Funderburk, Christopher D./0000-0001-5502-1456	National Institutes of Health [GM62879]; University of Alabama; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62879 (to J. M. O.). This work was also supported by the University of Alabama. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P7713, DOI 10.1073/pnas.81.24.7713; Bencsics C, 1996, J NEUROSCI, V16, P4449; BIRMAN S, 1994, J BIOL CHEM, V269, P26559; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen R, 2003, J BIOMED SCI, V10, P774, DOI 10.1159/000073965; CHEN XY, 1994, J CELL SCI, V107, P3501; DANKS DM, 1975, LANCET, V2, P1043; Dassesse D, 1997, BRAIN RES, V777, P187, DOI 10.1016/S0006-8993(97)01111-6; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; FUNAKOSHI H, 1991, J BIOL CHEM, V266, P15614; Funderburk CD, 2006, J BIOL CHEM, V281, P33302, DOI 10.1074/jbc.M602196200; Furukawa Y, 1996, ANN NEUROL, V39, P609, DOI 10.1002/ana.410390510; GOLDSTEIN F, 1961, J BIOL CHEM, V236, P2656; GOLEMIS E, 2002, PROTEIN PROTEIN INTE, P37; HARADA T, 1993, SCIENCE, V260, P1507, DOI 10.1126/science.8502995; HARLOW E, 1999, USING ANTIBODIES LAB, P323; Hesslinger C, 1998, J BIOL CHEM, V273, P21616, DOI 10.1074/jbc.273.34.21616; Hirayama K, 1998, J NEUROCHEM, V70, P164; Hsouna A, 2007, DEV BIOL, V308, P30, DOI 10.1016/j.ydbio.2007.04.047; HUFTON SE, 1995, BIOCHEM J, V311, P353, DOI 10.1042/bj3110353; Kapatos G, 1999, J NEUROCHEM, V72, P669, DOI 10.1046/j.1471-4159.1999.0720669.x; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kolinsky MA, 2004, J BIOL CHEM, V279, P40677, DOI 10.1074/jbc.M405370200; Krishnakumar S, 2000, J NEUROGENET, V14, P1, DOI 10.3109/01677060009083474; KUCZENSKI RT, 1972, J BIOL CHEM, V247, P3114; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lapize C, 1998, BIOCHEM BIOPH RES CO, V251, P802, DOI 10.1006/bbrc.1998.9552; LEBOURDELLES B, 1991, J BIOL CHEM, V266, P17124; MACKAY WJ, 1983, GENETICS, V105, P35; MAIER J, 1995, BIOCHEM BIOPH RES CO, V212, P705, DOI 10.1006/bbrc.1995.2026; Maita N, 2001, ACTA CRYSTALLOGR D, V57, P1153, DOI 10.1107/S0907444901005558; Mandel RJ, 1998, J NEUROSCI, V18, P4271; MCLEAN JR, 1993, J BIOL CHEM, V268, P27191; Milstien S, 1996, J BIOL CHEM, V271, P19743, DOI 10.1074/jbc.271.33.19743; Nagatsu I, 1997, NEUROSCI LETT, V224, P185, DOI 10.1016/S0304-3940(97)00159-6; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Neckameyer W, 2001, J NEUROBIOL, V47, P280, DOI 10.1002/neu.1035; Neckameyer WS, 2005, BIOCHEM GENET, V43, P425, DOI 10.1007/s10528-005-6781-3; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; Neckameyer WS, 2000, NEUROBIOL AGING, V21, P145, DOI 10.1016/S0197-4580(99)00109-8; REYNOLDS ER, 1987, DEV BIOL, V123, P430, DOI 10.1016/0012-1606(87)90401-5; Segawa M, 1976, Adv Neurol, V14, P215; Swick L, 2006, J NEUROCHEM, V97, P1447, DOI 10.1111/j.1471-4159.2006.03836.x; Szczypka MS, 1999, NEURON, V22, P167, DOI 10.1016/S0896-6273(00)80688-1; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Vie A, 1999, J BIOL CHEM, V274, P16788, DOI 10.1074/jbc.274.24.16788; Widder JD, 2007, CIRC RES, V101, P830, DOI 10.1161/CIRCRESAHA.107.153809; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	51	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31449	31459		10.1074/jbc.M802552200	http://dx.doi.org/10.1074/jbc.M802552200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801743	Green Published, hybrid			2022-12-27	WOS:000260760800024
J	Cobb, NJ; Apetri, AC; Surewicz, WK				Cobb, Nathan J.; Apetri, Adrian C.; Surewicz, Witold K.			Prion Protein Amyloid Formation under Native-like Conditions Involves Refolding of the C-terminal alpha-Helical Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; IN-VITRO; NMR STRUCTURE; SCRAPIE; CONVERSION; FIBRILS; PRPSC; SITE; CONFORMATION; PATHWAY	Transmissible spongiform encephalopathies are associated with conformational conversion of the cellular prion protein, PrPC, into a proteinase K-resistant, amyloid-like aggregate, PrPSc. Although the structure of PrPSc remains enigmatic, recent studies have afforded increasingly detailed characterization of recombinant PrP amyloid. However, all previous studies were performed using amyloid fibrils formed in the presence of denaturing agents that significantly alter the folding state(s) of the precursor monomer. Here we report that PrP amyloid can also be generated under physiologically relevant conditions, where the monomeric protein is natively folded. Remarkably, site-directed spin labeling studies reveal that these fibrils possess a beta-core structure nearly indistinguishable from that of amyloid grown under denaturing conditions, where the C-terminal alpha-helical domain of the PrP monomer undergoes major refolding to a parallel and in-register beta-structure upon conversion. The structural similarity of fibrils formed under drastically different conditions strongly suggests that the common beta-sheet architecture within the similar to 160-220 core region represents a distinct global minimum in the PrP conversion free energy landscape. We also show that the N-terminal region of fibrillar PrP displays conformational plasticity, undergoing a reversible structural transition with an apparent pK(a) of similar to 5.3. The C-terminal region, on the other hand, retains its beta-structure over the pH range 1-11, whereas more alkaline buffer conditions denature the fibrils into constituent PrP monomers. This profile of pH-dependent stability is reminiscent of the behavior of brain-derived PrPSc, suggesting a substantial degree of structural similarity within the beta-core region of these PrP aggregates.	[Cobb, Nathan J.; Apetri, Adrian C.; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	witold.surewicz@case.edu			National Institutes of Health [NS 38604, AG 14359]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 38604 and AG 14359.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Apetri AC, 2005, BIOCHEMISTRY-US, V44, P15880, DOI 10.1021/bi051455+; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; BROWN P, 1986, J INFECT DIS, V153, P1145, DOI 10.1093/infdis/153.6.1145; Calzolai L, 2003, J BIOL CHEM, V278, P35592, DOI 10.1074/jbc.M303005200; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; Caughey B, 2001, ADV VIRUS RES, V56, P277, DOI 10.1016/S0065-3527(01)56031-5; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kasermann F, 2003, J GEN VIROL, V84, P3173, DOI 10.1099/vir.0.19355-0; Korth C, 2000, J GEN VIROL, V81, P2555, DOI 10.1099/0022-1317-81-10-2555; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1981, P NATL ACAD SCI-BIOL, V78, P4606, DOI 10.1073/pnas.78.7.4606; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Surewicz WK, 2006, ACCOUNTS CHEM RES, V39, P654, DOI 10.1021/ar050226c; Suzuki SY, 2008, J VET MED SCI, V70, P159, DOI 10.1292/jvms.70.159; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Weissmann C, 2005, CELL, V122, P165, DOI 10.1016/j.cell.2005.07.001; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	50	46	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34704	34711		10.1074/jbc.M806701200	http://dx.doi.org/10.1074/jbc.M806701200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930924	hybrid, Green Published			2022-12-27	WOS:000261469100026
J	De Pascale, G; Lloyd, AJ; Schouten, JA; Gilbey, AM; Roper, DI; Dowson, CG; Bugg, TDH				De Pascale, Gianfranco; Lloyd, Adrian J.; Schouten, James A.; Gilbey, Andrea M.; Roper, David I.; Dowson, Christopher G.; Bugg, Timothy D. H.			Kinetic Characterization of Lipid II-Ala:Alanyl-tRNA Ligase (MurN) from Streptococcus pneumoniae using Semisynthetic Aminoacyl-lipid II Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CELL-WALLS; HIGH-LEVEL PENICILLIN; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; ANTIBIOTIC TOLERANCE; INTERPEPTIDE BRIDGES; VIRIDESCENS FEMX; PEPTIDOGLYCAN; RESISTANCE; PENTAPEPTIDE	MurM and MurN are tRNA-dependent ligases that catalyze the addition of the first (L-Ala/L-Ser) and second (L-Ala) amino acid onto lipid II substrates in the biosynthesis of the peptidoglycan layer of Streptococcus pneumoniae. We have previously characterized the first ligase, MurM (Lloyd, A. J., Gilbey, A. M., Blewett, A. M., De Pascale, G., El Zoeiby, A., Levesque, R. C., Catherwood, A. C., Tomasz, A., Bugg, T. D., Roper, D. I., and Dowson, C. G. (2008) J. Biol. Chem. 283, 6402-6417). In order to characterize the second ligase MurN, we have developed a chemoenzymatic route to prepare the lipid II-Ala and lipid II-Ser substrates. Recombinant MurN enzymes from penicillin-resistant (159) and - sensitive (Pn16) S. pneumoniae were expressed and purified as MBP fusion proteins and reconstituted using a radiochemical assay. MurN ligases from strains 159 and Pn16 both showed a 20-fold higher catalytic efficiency for lipid II-L-Ala over lipid II-L-Ser, with no activity against unmodified lipid II, and similar kinetic parameters were measured for MurN from penicillin-resistant and penicillin-sensitive strains. These results concur with the peptidoglycan analysis of S. pneumoniae, in which the major cross-link observed is L-Ala-L-Ala. The combined action of ligases Mur M and MurN is therefore required in order to rationalize the high level of dipeptide cross-links in penicillin-resistant S. pneumoniae, with ligase MurM showing the major difference between penicillin-resistant and penicillin-sensitive strains.	[De Pascale, Gianfranco; Schouten, James A.; Bugg, Timothy D. H.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [De Pascale, Gianfranco; Lloyd, Adrian J.; Gilbey, Andrea M.; Roper, David I.; Dowson, Christopher G.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Bugg, TDH (corresponding author), Univ Warwick, Dept Chem, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	T.D.Bugg@warwick.ac.uk	Dowson, Chris/N-6195-2014; Roper, David I/A-2323-2011; Dowson, Christopher/ABG-5083-2021	Dowson, Chris/0000-0002-8294-8836; Roper, David I/0000-0003-0009-621X; Dowson, Christopher/0000-0002-8294-8836; Lloyd, Adrian/0000-0002-4638-4586	Medical Research Council [G0400848]; Wellcome Trust [066443]; Biotechnology and Biological Sciences Research Council; Medical Research Fund (University of Warwick); European Community Framework 6 COBRA; Medical Research Council [G0701400] Funding Source: researchfish; MRC [G0400848, G0701400] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Fund (University of Warwick); European Community Framework 6 COBRA(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0400848, Wellcome Trust Grant 066443, a Biotechnology and Biological Sciences Research Council studentship, the Medical Research Fund (University of Warwick), and the European Community Framework 6 COBRA network. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARCUS VA, 1995, FEMS MICROBIOL LETT, V126, P299, DOI 10.1016/0378-1097(95)00026-2; BERGERBACHI B, 1989, MOL GEN GENET, V219, P263; Biarrotte-Sorin S, 2004, STRUCTURE, V12, P257, DOI 10.1016/j.str.2004.01.006; Bouhss A, 2001, J BACTERIOL, V183, P5122, DOI 10.1128/JB.183.17.5122-5127.2001; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; BUGG T, 1999, COMPREHENSIVE NATURA, P241; El Zoeiby A, 2001, FEMS MICROBIOL LETT, V201, P229, DOI 10.1016/S0378-1097(01)00268-3; Filipe SR, 2000, J BIOL CHEM, V275, P27768; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Filipe SR, 2001, MICROB DRUG RESIST, V7, P303, DOI 10.1089/10766290152773310; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; Filipe SR, 2001, J BIOL CHEM, V276, P39618, DOI 10.1074/jbc.M106425200; Filipe SR, 2000, J BACTERIOL, V182, P6798, DOI 10.1128/JB.182.23.6798-6805.2000; GHUYSEN JM, 1968, BIOCHEMISTRY-US, V7, P1450, DOI 10.1021/bi00844a030; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Hegde SS, 2001, J BIOL CHEM, V276, P6998, DOI 10.1074/jbc.M008591200; Hegde SS, 2003, J BIOL CHEM, V278, P22861, DOI 10.1074/jbc.M301565200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Lee SK, 2005, APPL ENVIRON MICROB, V71, P6856, DOI 10.1128/AEM.71.11.6856-6862.2005; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Maillard AP, 2005, J BACTERIOL, V187, P3833, DOI 10.1128/JB.187.11.3833-3838.2005; MATSUHASHI M, 1965, P NATL ACAD SCI USA, V54, P587, DOI 10.1073/pnas.54.2.587; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000; PETIT JF, 1968, J BIOL CHEM, V243, P757; PLAPP R, 1970, J BIOL CHEM, V245, P3667; PROMEGA, 1996, PROTOCOLS APPL GUIDE; Reddy SG, 1999, J AM CHEM SOC, V121, P1175, DOI 10.1021/ja983850b; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Rohrer S, 2003, ANTIMICROB AGENTS CH, V47, P837, DOI 10.1128/AAC.47.3.837-846.2003; Sambrook J., 1989, MOL CLONING LAB MANU; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Smith AM, 2001, ANTIMICROB AGENTS CH, V45, P2393, DOI 10.1128/AAC.45.8.2393-2396.2001; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tschierske M, 1999, FEMS MICROBIOL LETT, V171, P97, DOI 10.1016/S0378-1097(98)00586-2; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999	41	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34571	34579		10.1074/jbc.M805807200	http://dx.doi.org/10.1074/jbc.M805807200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842590	Green Published, hybrid			2022-12-27	WOS:000261469100011
J	Dekker, J				Dekker, Job			Mapping in Vivo Chromatin Interactions in Yeast Suggests an Extended Chromatin Fiber with Regional Variation in Compaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER-ORDER STRUCTURE; CEREVISIAE LINKER HISTONE; LINKING NUMBER CHANGE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME CONFORMATION; NUCLEOSOMAL ARRAYS; H4-K16 ACETYLATION; MODEL; DNA; ARCHITECTURE	The higher order arrangement of nucleosomes and the level of compaction of the chromatin fiber play important roles in the control of gene expression and other genomic activities. Analysis of chromatin in vitro has suggested that under near physiological conditions chromatin fibers can become highly compact and that the level of compaction can be modulated by histone modifications. However, less is known about the organization of chromatin fibers in living cells. Here, we combine chromosome conformation capture (3C) data with distance measurements and polymer modeling to determine the in vivo mass density of a transcriptionally active 95-kb GC-rich domain on chromosome III of the yeast Saccharomyces cerevisiae. In contrast to previous reports, we find that yeast does not form a compact fiber but that chromatin is extended with a mass per unit length that is consistent with a rather loose arrangement of nucleosomes. Analysis of 3C data from a neighboring AT-rich chromosomal domain indicates that chromatin in this domain is more compact, but that mass density is still well below that of a canonical 30 nm fiber. Our approach should be widely applicable to scale 3C data to real spatial dimensions, which will facilitate the quantification of the effects of chromatin modifications and transcription on chromatin fiber organization.	[Dekker, Job] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Lazare Res Bldg,Rm 519,364 Plantat St, Worcester, MA 01605 USA.	Job.Dekker@umassmed.edu			National Institutes of Health [HG003143]; Keck Foundation; Cystic Fibrosis Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grant HG003143. This work was also supported by the Keck Foundation and the Cystic Fibrosis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ATHEY BD, 1990, J CELL BIOL, V111, P795, DOI 10.1083/jcb.111.3.795; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Belmont AS, 1999, CURR OPIN CELL BIOL, V11, P307, DOI 10.1016/S0955-0674(99)80041-6; Ben-Aroya S, 2004, MOL CELL, V15, P221, DOI 10.1016/j.molcel.2004.06.002; Bressan DA, 2004, J CELL BIOL, V164, P361, DOI 10.1083/jcb.200311063; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r116; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; Freidkin I, 2001, NUCLEIC ACIDS RES, V29, P4043, DOI 10.1093/nar/29.19.4043; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gheldof N, 2006, P NATL ACAD SCI USA, V103, P12463, DOI 10.1073/pnas.0605343103; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Kepper N, 2008, BIOPHYS J, V95, P3692, DOI 10.1529/biophysj.107.121079; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Marin A, 2003, YEAST, V20, P703, DOI 10.1002/yea.992; McBryant SJ, 2008, MOL CELL BIOL, V28, P3563, DOI 10.1128/MCB.01389-07; MIELE A, 2006, CURRENT PROTOCOLS MO, V74; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; NORTON VG, 1990, J BIOL CHEM, V265, P19848; OSTASHEVSKY JY, 1994, J BIOMOL STRUCT DYN, V11, P813, DOI 10.1080/07391102.1994.10508034; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Rydberg B, 1998, J MOL BIOL, V284, P71, DOI 10.1006/jmbi.1998.2150; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon P, 2002, EMBO J, V21, P2282, DOI 10.1093/emboj/21.9.2282; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; van Holde KE., 1989, SPRINGER SERIES MOL; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; VANHOLDE K, 1995, J BIOL CHEM, V270, P8373, DOI 10.1074/jbc.270.15.8373; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Wedemann G, 2002, BIOPHYS J, V82, P2847, DOI 10.1016/S0006-3495(02)75627-0; WIDOM J, 1989, ANNU REV BIOPHYS BIO, V18, P365, DOI 10.1146/annurev.biophys.18.1.365; Wolffe A., 1998, CHROMATIN STRUCTURE; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; WOODCOCK CL, 1995, TRENDS CELL BIOL, V5, P272, DOI 10.1016/S0962-8924(00)89038-8; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; Wu CY, 2007, EMBO REP, V8, P1129, DOI 10.1038/sj.embor.7401115; Yokota H, 1997, CHROMOSOME RES, V5, P157, DOI 10.1023/A:1018438729203	62	108	109	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34532	34540		10.1074/jbc.M806479200	http://dx.doi.org/10.1074/jbc.M806479200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18930918	hybrid, Green Published			2022-12-27	WOS:000261469100007
J	Yamada, K; Hashimoto, T; Yabuki, C; Nagae, Y; Tachikawa, M; Strickland, DK; Liu, Q; Bu, G; Basak, JM; Holtzman, DM; Ohtsuki, S; Terasaki, T; Iwatsubo, T				Yamada, Kaoru; Hashimoto, Tadafumi; Yabuki, Chiori; Nagae, Yusuke; Tachikawa, Masanori; Strickland, Dudley K.; Liu, Qiang; Bu, Guojun; Basak, Jacob M.; Holtzman, David M.; Ohtsuki, Sumio; Terasaki, Tetsuya; Iwatsubo, Takeshi			The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid beta Peptides in an in Vitro Model of the Blood-Brain Barrier Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; ALPHA-2-MACROGLOBULIN RECEPTOR; PRECURSOR PROTEIN; PLASMINOGEN-ACTIVATOR; LIGAND-BINDING; CLEARANCE; ALPHA(2)-MACROGLOBULIN; DEGRADATION; TRANSPORT	The metabolism of amyloid beta peptide (A beta) in the brain is crucial to the pathogenesis of Alzheimer disease. A body of evidence suggests that A beta is actively transported from brain parenchyma to blood across the blood-brain barrier (BBB), although the precise mechanism remains unclear. To unravel the cellular and molecular mechanism of A beta transport across the BBB, we established a new in vitro model of the initial internalization step of A beta transport using TR-BBB cells, a conditionally immortalized endothelial cell line from rat brain. We show that TR-BBB cells rapidly internalize A beta through a receptor-mediated mechanism. We also provide evidence that A beta internalization is mediated by LRP1 (low density lipoprotein receptor-related protein 1), since administration of LRP1 antagonist, receptor-associated protein, neutralizing antibody, or small interference RNAs all reduced A beta uptake. Despite the requirement of LRP1-dependent internalization, A beta does not directly bind to LRP1 in an in vitro binding assay. Unlike TR-BBB cells, mouse embryonic fibroblasts endogenously expressing functional LRP1 and exhibiting the authentic LRP1-mediated endocytosis (e.g. of tissue plasminogen activator) did not show rapid A beta uptake. Based on these data, we propose that the rapid LRP1-dependent internalization of A beta occurs under the BBB-specific cellular context and that TR-BBB is a useful tool for analyzing the molecular mechanism of the rapid transport of A beta across BBB.	[Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, Tokyo 1130033, Japan; [Yamada, Kaoru; Hashimoto, Tadafumi; Yabuki, Chiori; Nagae, Yusuke; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neurosci, Tokyo 1130033, Japan; [Hashimoto, Tadafumi; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan; [Tachikawa, Masanori; Ohtsuki, Sumio; Terasaki, Tetsuya] Tohoku Univ, Dept Mol Biopharm & Genet, Sendai, Miyagi 980, Japan; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Liu, Qiang; Bu, Guojun] Washington Univ, Sch Med, Dept Pediat Cell Biol & Physiol, St Louis, MO 63110 USA; [Basak, Jacob M.; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University of Tokyo; University of Tokyo; University of Tokyo; Tohoku University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL); Washington University (WUSTL)	Iwatsubo, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iwatsubo@mol.f.u-tokyo.ac.jp	Ohtsuki, Sumio/S-4360-2016; Yamada, Kaoru/GSD-3923-2022; Terasaki, Tetsuya/K-6730-2012; Liu, Qiang/E-9245-2011; Hashimoto, Tadafumi/A-7723-2013	Ohtsuki, Sumio/0000-0003-4634-7133; Yamada, Kaoru/0000-0003-3696-0604; Terasaki, Tetsuya/0000-0002-6332-7575; Hashimoto, Tadafumi/0000-0001-5442-4800	National Institutes of Health [R01 AG027924, AG13956]; Core Research for Evolutional Science and Technology of Japan Science and Technology agency; National Institute of Biomedical Innovation; Japan Society for the Promotion of Science; Takeda Science Foundation; NATIONAL INSTITUTE ON AGING [R01AG013956, R01AG027924, R37AG013956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Research for Evolutional Science and Technology of Japan Science and Technology agency(Core Research for Evolutional Science and Technology (CREST)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG027924 (to G. B.) and AG13956 (to D. H.). This work was also supported by Core Research for Evolutional Science and Technology of Japan Science and Technology agency, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by grants-in-aid from the Japan Society for the Promotion of Science (to T. H. and K. Y.) and from the Takeda Science Foundation (to K. Y.), Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; BU GJ, 1993, J BIOL CHEM, V268, P13002; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; Hosoya K, 2000, J DRUG TARGET, V8, P357, DOI 10.3109/10611860008997912; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kinoshita A, 2003, J BIOL CHEM, V278, P41182, DOI 10.1074/jbc.M306403200; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Lee SH, 2006, J BIOCHEM, V139, P391, DOI 10.1093/jb/mvj039; LEVEUGLE B, 1994, NEUROREPORT, V5, P1389, DOI 10.1097/00001756-199406000-00025; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Narita M, 1997, J NEUROCHEM, V69, P1904; NAZER B, 2008, J NEUROBIOL, V30, P94; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Sarafanov AG, 2001, J BIOL CHEM, V276, P11970, DOI 10.1074/jbc.M008046200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shiiki T, 2004, J NEUROSCI, V24, P9632, DOI 10.1523/JNEUROSCI.2236-04.2004; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tanabe S, 1999, J PHARMACOL EXP THER, V290, P561; Terasaki T, 2001, BIOL PHARM BULL, V24, P111, DOI 10.1248/bpb.24.111; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WILLNOW TE, 1994, J CELL SCI, V107, P719; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yazawa H, 2001, FASEB J, V15, P2454, DOI 10.1096/fj.01-0251com; Ziere GJ, 1996, EUR J BIOCHEM, V242, P703, DOI 10.1111/j.1432-1033.1996.0703r.x; ZLOKOVIC BV, 1995, PHARM RES-DORDR, V12, P1395, DOI 10.1023/A:1016254514167	55	87	90	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34554	34562		10.1074/jbc.M801487200	http://dx.doi.org/10.1074/jbc.M801487200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940800	Green Published, hybrid			2022-12-27	WOS:000261469100009
J	Wang, N; Glidden, EJ; Murphy, SR; Pearse, BR; Hebert, DN				Wang, Ning; Glidden, Emily J.; Murphy, Stephanie R.; Pearse, Bradley R.; Hebert, Daniel N.			The Cotranslational Maturation Program for the Type II Membrane Glycoprotein Influenza Neuraminidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; SECRETORY PATHWAY; UDP-GLC; VIRUS HEMAGGLUTININ; PROTEIN MATURATION; LIVING CELLS; CALNEXIN; GLUCOSYLTRANSFERASE	The earliest steps in nascent protein maturation greatly affect its overall efficiency. Constraints placed on maturing proteins at these early stages limit available conformations and help to direct the native maturation process. For type II membrane proteins, these cotranslational constraints include N- and C- terminal membrane tethering, chaperone binding, and disulfide bond formation. The cotranslational maturation process for the type II membrane glycoprotein influenza neuraminidase (NA) was investigated to provide a deeper understanding of these initial endoplasmic reticulum events. The type II orientation provides experimental advantages to monitor the first maturation steps. Calnexin was shown to cotranslationally interact with NA prior to calreticulin. These interactions were required for the efficient maturation of NA as it prematurely formed intramolecular disulfides and aggregated when calnexin and calreticulin interactions were abolished. Lectin chaperone binding slowed the NA maturation process, increasing its fidelity. Carbohydrates were required for NA maturation in a regio-specific manner. A subset of NA formed intermolecular disulfides and oligomerized cotranslationally. This fraction increased in the absence of calnexin and calreticulin binding. NA dimerization also occurred for an NA mutant lacking the critical large loop disulfide bond, indicating that dimerization did not require proper NA oxidation. The strict evaluation of proper maturation carried out by the quality control machinery was instilled at the tetramerization step. This study illustrates the type II membrane protein maturation process and shows how important cotranslational events contribute to the proper cellular maturation of glycoproteins.	[Wang, Ning; Glidden, Emily J.; Murphy, Stephanie R.; Pearse, Bradley R.; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Wang, Ning; Pearse, Bradley R.; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hebert, DN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	dhebert@biochem.umass.edu			National Institutes of Health Chemistry-Biology Interface [T32GM00815]; U. S. Public Health Service [CA79864]; NATIONAL CANCER INSTITUTE [R01CA079864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515] Funding Source: NIH RePORTER	National Institutes of Health Chemistry-Biology Interface(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Chemistry-Biology Interface Training Grant T32GM00815 (to B. R. P.). This work was also supported by U. S. Public Health Service Grant CA79864 (to D. N. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Braakman I, 2000, TRAFFIC, V1, P533, DOI 10.1034/j.1600-0854.2000.010702.x; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; Chen W, 2000, MOL BIOL CELL, V11, P765, DOI 10.1091/mbc.11.2.765; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; COLMAN PM, 1985, CURR TOP MICROBIOL I, V114, P178; COLMAN PM, 1989, INFLUENZA VIRUSES, P175; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gilmore R, 1996, EMBO J, V15, P2651, DOI 10.1002/j.1460-2075.1996.tb00625.x; GILMORE R, 1991, METHOD CELL BIOL, V34, P223; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; KUNDU A, 1991, MOL CELL BIOL, V11, P2675, DOI 10.1128/MCB.11.5.2675; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MUNK K, 1992, GLYCOBIOLOGY, V2, P233, DOI 10.1093/glycob/2.3.233; NILSSON I, 1993, J BIOL CHEM, V268, P5798; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pearse BR, 2008, J CELL BIOL, V181, P309, DOI 10.1083/jcb.200712068; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Taylor SC, 2003, EMBO REP, V4, P405, DOI 10.1038/sj.embor.embor797; TULIP WR, 1991, J MOL BIOL, V221, P487, DOI 10.1016/0022-2836(91)80069-7; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2	55	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33826	33837		10.1074/jbc.M806897200	http://dx.doi.org/10.1074/jbc.M806897200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18849342	Green Published, hybrid			2022-12-27	WOS:000261277700006
J	Gao, MH; Tang, T; Guo, T; Miyanohara, A; Yajima, T; Pestonjamasp, K; Feramisco, JR; Hammond, HK				Gao, Mei Hua; Tang, Tong; Guo, Tracy; Miyanohara, Atsushi; Yajima, Toshitaka; Pestonjamasp, Kersi; Feramisco, James R.; Hammond, H. Kirk			Adenylyl Cyclase Type VI Increases Akt Activity and Phospholamban Phosphorylation in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; ENHANCED MYOCARDIAL-CONTRACTILITY; FORKHEAD TRANSCRIPTION FACTORS; ISCHEMIA-REPERFUSION INJURY; RAT VENTRICULAR MYOCYTES; II INHIBITION PROTECTS; SARCOPLASMIC-RETICULUM; TRANSGENIC MICE; HEART-FAILURE; BETA(1)-ADRENERGIC RECEPTOR	Increased expression of adenylyl cyclase VI has beneficial effects on the heart, but strategies that increase cAMP production in cardiac myocytes usually are harmful. Might adenylyl cyclase VI have beneficial effects unrelated to increased beta-adrenergic receptor-mediated signaling? We previously reported that adenylyl cyclase VI reduces cardiac phospholamban expression. Our focus in the current studies is how adenylyl cyclase VI influences phospholamban phosphorylation. In cultured cardiac myocytes, increased expression of adenylyl cyclase VI activates Akt by phosphorylation at serine 473 and threonine 308 and is associated with increased nuclear phospho-Akt. Activated Akt phosphorylates phospholamban, a process that does not require beta-adrenergic receptor stimulation or protein kinase A activation. These previously unrecognized signaling events would be predicted to promote calcium handling and increase contractile function of the intact heart independently of beta-adrenergic receptor activation. We speculate that phospholamban phosphorylation, through activation of Akt, may be an important mechanism by which adenylyl cyclase VI increases the function of the failing heart.	[Gao, Mei Hua; Tang, Tong; Hammond, H. Kirk] Vet Adm San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Gao, Mei Hua; Tang, Tong; Guo, Tracy; Miyanohara, Atsushi; Yajima, Toshitaka; Pestonjamasp, Kersi; Feramisco, James R.; Hammond, H. Kirk] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Miyanohara, Atsushi; Pestonjamasp, Kersi; Feramisco, James R.] Univ Calif San Diego, Canc Ctr Microscopy Shared Resource, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hammond, HK (corresponding author), VASDHS III A, 3-A,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	khammond@ucsd.edu		Pestonjamasp, Kersi/0000-0001-8586-303X	National Institutes of Health [5P01HL066941, HL081741, HL088426-01]; American Heart Association [0865147F]; Department of Veterans Affairs;  [0765064Y]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081741, R01HL088426, P01HL066941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P01HL066941, HL081741, and HL088426-01 ( to H. K. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1 Supported by Grant-In-Aid 0765064Y.; 2 Supported by Grant-In-Aid 0865147F from the Western States Affiliate of the American Heart Association.; 3 Supported by a Merit grant from the Department of Veterans Affairs.	Ahmet I, 2004, CIRCULATION, V110, P1083, DOI 10.1161/01.CIR.0000139844.15045.F9; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Allen BG, 1996, MOL CELL BIOCHEM, V155, P91; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Babu CVS, 2005, ELECTROPHORESIS, V26, P3765, DOI [10.1002/elps.20050007, 10.1002/elps.200500007]; Bartel S, 2000, J MOL CELL CARDIOL, V32, P2173, DOI 10.1006/jmcc.2000.1243; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Breitenlechner CB, 2005, J MED CHEM, V48, P163, DOI 10.1021/jm049701n; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Engelhardt S, 2001, MOL PHARMACOL, V60, P712; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; FUJII J, 1989, J BIOL CHEM, V264, P12950; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Fukunaga K, 2005, J PHARMACOL SCI, V98, P205, DOI 10.1254/jphs.FMJ05001X3; Gao MH, 2004, J BIOL CHEM, V279, P38797, DOI 10.1074/jbc.M405701200; Gao MH, 1998, P NATL ACAD SCI USA, V95, P1038, DOI 10.1073/pnas.95.3.1038; Gao MH, 1999, CIRCULATION, V99, P1618, DOI 10.1161/01.CIR.99.12.1618; Gao MH, 2002, CARDIOVASC RES, V56, P197, DOI 10.1016/S0008-6363(02)00539-4; Gao YS, 2002, EUR J PHARMACOL, V436, P227, DOI 10.1016/S0014-2999(02)01261-X; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Ibrahimi A, 1999, AM J PHYSIOL-CELL PH, V276, pC487, DOI 10.1152/ajpcell.1999.276.2.C487; Ishikawa Y, 1997, CIRC RES, V80, P297, DOI 10.1161/01.RES.80.3.297; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kaliman P, 2005, J BIOL CHEM, V280, P8016, DOI 10.1074/jbc.M412845200; Kim D, 2002, J BIOCHEM MOL BIOL, V35, P106; Kudlacek O, 2001, J BIOL CHEM, V276, P3010, DOI 10.1074/jbc.M007910200; LAI NC, 2005, CIRCULATION S, V112, P64; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Ogata Y, 2003, DRUG NEWS PERSPECT, V16, P446, DOI 10.1358/dnp.2003.16.7.829356; Onda T, 2001, J BIOL CHEM, V276, P47785, DOI 10.1074/jbc.M107233200; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; RAEYMAEKERS L, 1988, BIOCHEM J, V252, P269, DOI 10.1042/bj2520269; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Roth DM, 2002, CIRCULATION, V105, P1989, DOI 10.1161/01.CIR.0000014968.54967.D3; Roth DM, 1999, CIRCULATION, V99, P3099, DOI 10.1161/01.CIR.99.24.3099; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; SIBLEY DR, 1987, MOL NEUROBIOL, V1, P121, DOI 10.1007/BF02935266; TADA M, 1979, J BIOL CHEM, V254, P319; TADA M, 1980, J BIOL CHEM, V255, P1985; Tang T, 2004, AM J PHYSIOL-HEART C, V287, pH1906, DOI 10.1152/ajpheart.00356.2004; Tsujita Y, 2006, P NATL ACAD SCI USA, V103, P11946, DOI 10.1073/pnas.0510138103; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Vittone L, 2008, FRONT BIOSCI-LANDMRK, V13, P5988, DOI 10.2741/3131; Woods YL, 2002, BIOCHEM SOC T, V30, P391, DOI 10.1042/bst0300391; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang QH, 2005, CELL CALCIUM, V37, P259, DOI 10.1016/j.ceca.2004.10.007; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005	61	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33527	33535		10.1074/jbc.M805825200	http://dx.doi.org/10.1074/jbc.M805825200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838385	hybrid, Green Published			2022-12-27	WOS:000261183700057
J	Li, YH; Werner, H; Puschel, AW				Li, Ying-Hua; Werner, Hendrikje; Pueschel, Andreas W.			Rheb and mTOR Regulate Neuronal Polarity through Rap1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LOCALIZATION; CAP-DEPENDENT TRANSLATION; UBIQUITIN LIGASE SMURF2; CELL-GROWTH; ACTIN CYTOSKELETON; AXON PROJECTIONS; TOR COMPLEX-2; DIRECT TARGET; ESTABLISHMENT; PROTEIN	The development of polarized hippocampal neurons with a single axon and multiple dendrites depends on the activity of phosphoinositide 3-kinase (PI3K) and the GTPase Rap1B. Here we show that PI3K regulates axon specification and elongation through the GTPase Rheb and its target mammalian target of rapamycin (mTOR). Overexpression of Rheb induces the formation of multiple axons, whereas its suppression by RNA interference blocks axon specification. mTOR is a central regulator of translation that phosphorylates eIF4E-binding proteins like 4E-BP1. Axon formation was suppressed by inhibition of mTOR and expression of mTOR-insensitive 4E-BP1 mutants. Inhibition of PI3K or mTOR reduced the level of Rap1B, which acts downstream of Rheb and mTOR. The ubiquitin E3 ligase Smurf2 mediates the restriction of Rap1B by initiating its degradation. Suppression of Smruf2 by RNA interference is able to compensate the loss of Rheb. These results indicate that the mTOR pathway is required to counteract the Smurf2-initiated degradation of Rap1B during the establishment of neuronal polarity.	[Li, Ying-Hua; Werner, Hendrikje; Pueschel, Andreas W.] Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, D-48149 Munster, Germany	University of Munster	Puschel, AW (corresponding author), Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, Schlosspl 5, D-48149 Munster, Germany.	apuschel@uni-muenster.de			Deutsche Forschungsgemeinschaft [SPP1111, SFB 629]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SPP1111 and SFB 629 (to A.W.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Blackshear PJ, 1997, J BIOL CHEM, V272, P31510, DOI 10.1074/jbc.272.50.31510; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Catalano SM, 1998, MOL CELL NEUROSCI, V11, P173, DOI 10.1006/mcne.1998.0687; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gartner A, 2006, J CELL SCI, V119, P3927, DOI 10.1242/jcs.03159; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Huang YS, 2004, CURR OPIN CELL BIOL, V16, P308, DOI 10.1016/j.ceb.2004.03.002; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oinuma I, 2007, J BIOL CHEM, V282, P303, DOI 10.1074/jbc.M607979200; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Tabata H, 2003, J NEUROSCI, V23, P9996; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, MOL CELL BIOL, V22, P1674, DOI 10.1128/MCB.22.6.1674-1683.2002; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; White FA, 2000, DEV BIOL, V225, P79, DOI 10.1006/dbio.2000.9822; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	70	56	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33784	33792		10.1074/jbc.M802431200	http://dx.doi.org/10.1074/jbc.M802431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18842593	Green Published, hybrid			2022-12-27	WOS:000261183700084
J	Prouzet-Mauleon, V; Lefebvre, F; Thoraval, D; Crouzet, M; Doignon, F				Prouzet-Mauleon, Valerie; Lefebvre, Fabien; Thoraval, Didier; Crouzet, Marc; Doignon, Francois			Phosphoinositides Affect both the Cellular Distribution and Activity of the F-BAR-containing RhoGAP Rgd1p in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; RAS SUPERFAMILY GENES; FAMILY SMALL GTPASES; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; MEMBRANE INVAGINATION; DOMAIN PROTEINS; PLASMA-MEMBRANE; BUD FORMATION; LOW-PH	Cell polarity is a key element of development in most eukaryotes. The Rho GTPase-activating protein Rgd1p positively regulates the GTPase activity of Rho3p and Rho4p, which are involved in bud growth and cytokinesis, respectively, in the budding yeast Saccharomyces cerevisiae. Rgd1p contains an F-BAR domain at its N-terminal end in addition to its RhoGAP domain at its C-terminal end. We demonstrate here that phospholipids discriminate between the GTPase activities of Rho3p and Rho4p through Rgd1p and specifically stimulate the RhoGAP activity on Rho4p. The central region of the protein contiguous to the F-BAR domain is required for this stimulation. The F-BAR region binds to phosphoinositides in vitro and also plays a key role in the localization of Rgd1p to the bud tip and neck during the cell cycle. Studies of heat-sensitive mutants lacking phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-biphosphate suggested that Rgd1p initially binds to Golgi membranes via phosphatidylinositol 4-phosphate and is then transported to the plasma membrane, where it binds phosphatidylinositol 4,5-biphosphate. We demonstrate here the dual effects of phosphoinositides on a RhoGTPase-activating protein. Phosphoinositides both regulate the recruitment and trafficking of Rgd1p to membranes via the F-BAR domain and specifically stimulate GTPase-activating protein activity, consistent with functional interplay between lipids, RhoGAP, and its related GTPases in yeast growth.	Univ Bordeaux, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France; CNRS, UMR 5095, F-33076 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Doignon, F (corresponding author), Univ Bordeaux 2, Box 64,146 Rue Leo Saignat, F-33076 Bordeaux, France.	doignon@u-bordeaux2.fr	DOIGNON, François/AAX-8788-2020	DOIGNON, François/0000-0002-9007-2408; Prouzet-Mauleon, Valerie/0000-0001-5432-6231	CNRS; UB2; Vytas Bankaitis (University of North Carolina, Chapel Hill); Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union [2003227]	CNRS(Centre National de la Recherche Scientifique (CNRS)); UB2; Vytas Bankaitis (University of North Carolina, Chapel Hill); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union(European Commission)	This work was supported by CNRS and UB2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; We thank Marco Geymonat and Steve Sedgwick (National Institute for Medical Research, London) for providing the plasmid and the yeast strain for optimized protein production in yeast. We thank Isabelle Sagot for providing the pRS305-3xGFP and for assistance with microscopy. The heat-sensitive strains AAY104, SEY6210, and AAY202 were generously provided by Chris Stefan (University of California, San Diego), and strain CTY1568 was obtained from Vytas Bankaitis (University of North Carolina, Chapel Hill). We thank Erzsebet Ligeti (Semmelweis University, Budapest) for receiving VPM in her laboratory and Magdolna Levay for kind help. DNA sequencing was performed at the Genotyping and Sequencing Facility of the University of Bordeaux (supported by Conseil Regional d'Aquitaine Grants 20030304002FA and 20040305003FA and European Union Grant FEDER 2003227).	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; AHMED S, 1995, METHOD ENZYMOL, V256, P114; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; de Bettignies G, 2001, GENETICS, V159, P1435; De Bettignies G, 1999, YEAST, V15, P1719, DOI 10.1002/(SICI)1097-0061(199912)15:16<1719::AID-YEA499>3.0.CO;2-F; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doignon F, 1999, FEBS LETT, V459, P458, DOI 10.1016/S0014-5793(99)01293-4; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Fernandes H, 2006, MICROBIOL-SGM, V152, P695, DOI 10.1099/mic.0.28231-0; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gatti X, 2005, GENE, V351, P159, DOI 10.1016/j.gene.2005.03.034; Geymonat M, 2007, GENE, V399, P120, DOI 10.1016/j.gene.2007.05.001; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Heath RJW, 2008, J CELL SCI, V121, P1054, DOI 10.1242/jcs.021113; Imai J, 1996, GENETICS, V142, P359; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Ligeti E, 2006, METHOD ENZYMOL, V406, P104, DOI 10.1016/S0076-6879(06)06009-5; Ligeti E, 2004, J BIOL CHEM, V279, P5055, DOI 10.1074/jbc.C300547200; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; MATSUI Y, 1992, GENE, V114, P43, DOI 10.1016/0378-1119(92)90705-T; MATSUI Y, 1992, MOL CELL BIOL, V12, P5690, DOI 10.1128/MCB.12.12.5690; Molnar G, 2001, BIOCHEMISTRY-US, V40, P10542, DOI 10.1021/bi011158e; Moskwa P, 2005, J BIOL CHEM, V280, P6716, DOI 10.1074/jbc.M412563200; Motizuki M, 2008, BBA-GEN SUBJECTS, V1780, P179, DOI 10.1016/j.bbagen.2007.10.003; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Rose MD., 1990, METHODS YEAST GENETI; Roumanie O, 2000, MOL MICROBIOL, V36, P1403, DOI 10.1046/j.1365-2958.2000.01958.x; Roumanie O, 2005, J CELL BIOL, V170, P583, DOI 10.1083/jcb.200504108; Roumanie O, 2002, CURR GENET, V40, P317, DOI 10.1007/s00294-001-0268-5; Roumanie O, 2001, FEBS LETT, V506, P149, DOI 10.1016/S0014-5793(01)02906-4; Routt SM, 2005, TRAFFIC, V6, P1157, DOI 10.1111/j.1600-0854.2005.00350.x; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; VAN AL, 1997, GENE DEV, V11, P2295; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	56	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33249	33257		10.1074/jbc.M805161200	http://dx.doi.org/10.1074/jbc.M805161200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18845541	Green Published, hybrid			2022-12-27	WOS:000261183700028
J	Sato, T; Ananda, K; Cheng, CI; Suh, EJ; Narayanan, S; Wolfe, MS				Sato, Toru; Ananda, Kuppanna; Cheng, Cathy I.; Suh, Eric J.; Narayanan, Saravanakumar; Wolfe, Michael S.			Distinct Pharmacological Effects of Inhibitors of Signal Peptide Peptidase and gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTRAMEMBRANE PROTEOLYSIS; ASPARTIC PROTEASE; ACTIVE-SITE; ALZHEIMERS-DISEASE; BINDING SITE; PRESENILIN; SUBSTRATE; COMPLEX; ENDOPROTEOLYSIS	Signal peptide peptidase (SPP) and gamma-secretase are intramembrane aspartyl proteases that bear similar active site motifs but with opposite membrane topologies. Both proteases are inhibited by the same aspartyl protease transition-state analogue inhibitors, further evidence that these two enzymes have the same basic cleavage mechanism. Here we report that helical peptide inhibitors designed to mimic SPP substrates and interact with the SPP initial substrate-binding site (the "docking site") inhibit both SPP and gamma-secretase, but with submicromolar potency for SPP. SPP was labeled by helical peptide and transition-state analogue affinity probes but at distinct sites. Nonsteroidal anti-inflammatory drugs, which shift the site of proteolysis by SPP and gamma-secretase, did not affect the labeling of SPP or gamma-secretase by the helical peptide or transition-state analogue probes. On the other hand, another class of previously reported gamma-secretase modulators, naphthyl ketones, inhibited SPP activity as well as selective proteolysis by gamma-secretase. These naphthyl ketones significantly disrupted labeling of SPP by the helical peptide probe but did not block labeling of SPP by the transition-state analogue probe. With respect to gamma-secretase, the naphthyl ketone modulators allowed labeling by the transition-state analogue probe but not the helical peptide probe. Thus, the naphthyl ketones appear to alter the docking sites of both SPP and gamma-secretase. These results indicate that pharmacological effects of the four different classes of inhibitors (transition-state analogues, helical peptides, nonsteroidal anti-inflammatory drugs, and naphthyl ketones) are distinct from each other, and they reveal similarities and differences with how they affect SPP and gamma-secretase.	[Wolfe, Michael S.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wolfe, MS (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	mwolfe@rics.bwh.harvard.edu			National Institutes of Health [GM79555, NS41355, AG17574]; Uehara Memorial Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM79555, NS41355, and AG17574 ( to M. S. W.). This work was also supported by a research fellowship from the Uehara Memorial Foundation ( to T. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Bihel F, 2004, J MED CHEM, V47, P3931, DOI 10.1021/jm049788c; Brown GR, 2000, BIOORG MED CHEM LETT, V10, P575, DOI 10.1016/S0960-894X(00)00051-2; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; KARLE IL, 1990, BIOCHEMISTRY-US, V29, P6747, DOI 10.1021/bi00481a001; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TOMITA T, 2007, ARCH PHARM, V377, P295; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	38	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33287	33295		10.1074/jbc.M805670200	http://dx.doi.org/10.1074/jbc.M805670200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829463	Green Published, hybrid			2022-12-27	WOS:000261183700032
J	Kanki, T; Klionsky, DJ				Kanki, Tomotake; Klionsky, Daniel J.			Mitophagy in Yeast Occurs through a Selective Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-AUTOPHAGOSOMAL STRUCTURE; VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; MONITORING AUTOPHAGY; ENDOPLASMIC-RETICULUM; CYTOPLASM; MITOCHONDRIA; DEGRADATION; MACHINERY; PROTEINS	The regulation of mitochondrial degradation through autophagy is expected to be a tightly controlled process, considering the significant role of this organelle in many processes ranging from energy production to cell death. However, very little is known about the specific nature of the degradation process. We developed a new method to detect mitochondrial autophagy (mitophagy) by fusing the green fluorescent protein at the C terminus of two endogenous mitochondrial proteins and monitored vacuolar release of green fluorescent protein. Using this method, we screened several atg mutants and found that ATG11, a gene that is essential only for selective autophagy, is also essential for mitophagy. In addition, we found that mitophagy is blocked even under severe starvation conditions, if the carbon source makes mitochondria essential for metabolism. These findings suggest that the degradation of mitochondria is a tightly regulated process and that these organelles are largely protected from nonspecific autophagic degradation.	[Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	klionsky@umich.edu	Kanki, Tomotake/H-7250-2012	Kanki, Tomotake/0000-0001-9646-5379	National Institutes of Health [GM53396]; Japan Society for the Promotion of Science Postdoctoral Fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science Postdoctoral Fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53396 (to D.J.K.). This work was also supported by Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (to T.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; Abeliovich H, 2007, AUTOPHAGY, V3, P275, DOI 10.4161/auto.3915; Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Bogenhagen DF, 1999, AM J HUM GENET, V64, P1276, DOI 10.1086/302392; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; DAMSKY CH, 1976, J CELL BIOL, V71, P123, DOI 10.1083/jcb.71.1.123; Dunn WA, 2005, AUTOPHAGY, V1, P75; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Hutchins MU, 1999, J CELL SCI, V112, P4079; IBRAHIM NG, 1973, EUR J BIOCHEM, V36, P519, DOI 10.1111/j.1432-1033.1973.tb02938.x; Kabeya Y, 2007, BIOCHEM BIOPH RES CO, V356, P405, DOI 10.1016/j.bbrc.2007.02.150; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Keeble JA, 2007, CELL RES, V17, P976, DOI 10.1038/cr.2007.101; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Klionsky Daniel J., 2007, V390, P363; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Reggiori F, 2005, MOL BIOL CELL, V16, P5843, DOI 10.1091/mbc.E05-07-0629; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; Rep M, 1996, CURR GENET, V30, P367, DOI 10.1007/s002940050145; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tucker KA, 2003, J BIOL CHEM, V278, P48445, DOI 10.1074/jbc.M309238200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VISSER W, 1995, ANTON LEEUW INT J G, V67, P243, DOI 10.1007/BF00873688; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	57	260	270	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32386	32393		10.1074/jbc.M802403200	http://dx.doi.org/10.1074/jbc.M802403200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18818209	hybrid, Green Published			2022-12-27	WOS:000260893700026
J	Linderman, JJ				Linderman, Jennifer J.			Modeling of G-protein-coupled Receptor Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MEDIATED ACTIVATION; ADENYLATE-CYCLASE; BETA-ARRESTINS; DIFFUSION; KINETICS; BINDING; CELL; COMPARTMENTATION; DESENSITIZATION; DIMERIZATION		[Linderman, Jennifer J.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Linderman, Jennifer J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Linderman, Jennifer J.] Univ Michigan, Program Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Linderman, JJ (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	linderma@umich.edu			NHLBI NIH HHS [R33 HL092844, R33 HL092844-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM062930, R01 GM062930-03] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL092844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062930] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Batada NN, 2006, PLOS COMPUT BIOL, V2, P343, DOI 10.1371/journal.pcbi.0020044; Bhalla US, 2004, BIOPHYS J, V87, P733, DOI 10.1529/biophysj.104.040469; Bisegna P, 2008, BIOPHYS J, V94, P3363, DOI 10.1529/biophysj.107.114058; Bornheimer SJ, 2004, P NATL ACAD SCI USA, V101, P15899, DOI 10.1073/pnas.0407009101; Christopoulos A, 2001, PHARM TOXIC, P195; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Fall CP., 2002, COMPUTATIONAL CELL B; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; GRAESER D, 1993, MOL PHARMACOL, V43, P434; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Howard AD, 2001, TRENDS PHARMACOL SCI, V22, P132, DOI 10.1016/S0165-6147(00)01636-9; Iancu RV, 2007, BIOPHYS J, V92, P3317, DOI 10.1529/biophysj.106.095356; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kinzer-Ursem TL, 2007, PLOS COMPUT BIOL, V3, P84, DOI 10.1371/journal.pcbi.0030006; Kinzer-Ursem TL, 2006, CELL SIGNAL, V18, P1732, DOI 10.1016/j.cellsig.2006.01.014; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Levine H, 2006, P NATL ACAD SCI USA, V103, P9761, DOI 10.1073/pnas.0601302103; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; MAHAMA PA, 1994, BIOPHYS J, V67, P1345, DOI 10.1016/S0006-3495(94)80606-X; Maurya MR, 2007, BIOPHYS J, V93, P729, DOI 10.1529/biophysj.106.097501; Maurya MR, 2005, IEE P SYST BIOL, V152, P229, DOI 10.1049/ip-syb:20050014; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; MEHTA G, 2008, BIOL APPL MICROFLUID, P83; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Mishra J, 2002, BIOPHYS J, V83, P1298, DOI 10.1016/S0006-3495(02)73901-5; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Narang A, 2006, J THEOR BIOL, V240, P538, DOI 10.1016/j.jtbi.2005.10.022; Neves SR, 2002, BIOESSAYS, V24, P1110, DOI 10.1002/bies.1154; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Shea LD, 1997, BIOPHYS J, V73, P2949, DOI 10.1016/S0006-3495(97)78323-1; Shea LD, 2000, LIFE SCI, V68, P647, DOI 10.1016/S0024-3205(00)00977-2; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; STICKLE D, 1993, MOL PHARMACOL, V43, P397; THOMSEN WJ, 1989, BIOCHEMISTRY-US, V28, P8778, DOI 10.1021/bi00448a015; TOLKOVSKY AM, 1981, J CYCLIC NUCL PROT, V7, P139; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Woolf PJ, 2003, BIOPHYS CHEM, V104, P217, DOI 10.1016/S0301-4622(02)00369-1; Woolf PJ, 2003, BIOPHYS J, V84, P3, DOI 10.1016/S0006-3495(03)74828-0; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837	59	36	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5427	5431		10.1074/jbc.R800028200	http://dx.doi.org/10.1074/jbc.R800028200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	18940812	hybrid			2022-12-27	WOS:000263560600002
J	Ma'ayan, A				Ma'ayan, Avi			Insights into the Organization of Biochemical Regulatory Networks Using Graph Theory Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSCRIPTIONAL REGULATION; SIGNAL PROPAGATION; PROTEIN NETWORKS; MOTIFS; MODULARITY	Graph theory has been a valuable mathematical modeling tool to gain insights into the topological organization of biochemical networks. There are two types of insights that may be obtained by graph theory analyses. The first provides an overview of the global organization of biochemical networks; the second uses prior knowledge to place results from multivariate experiments, such as microarray data sets, in the context of known pathways and networks to infer regulation. Using graph analyses, biochemical networks are found to be scale-free and small-world, indicating that these networks contain hubs, which are proteins that interact with many other molecules. These hubs may interact with many different types of proteins at the same time and location or at different times and locations, resulting in diverse biological responses. Groups of components in networks are organized in recurring patterns termed network motifs such as feedback and feed-forward loops. Graph analysis revealed that negative feedback loops are less common and are present mostly in proximity to the membrane, whereas positive feedback loops are highly nested in an architecture that promotes dynamical stability. Cell signaling networks have multiple pathways from some input receptors and few from others. Such topology is reminiscent of a classification system. Signaling networks display a bow-tie structure indicative of funneling information from extracellular signals and then dispatching information from a few specific central intracellular signaling nexuses. These insights show that graph theory is a valuable tool for gaining an understanding of global regulatory features of biochemical networks.	Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Ma'ayan, A (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	avi.maayan@mssm.edu	Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017	National Institutes of Health [1P50GM071558-01A27398]; Mount Sinai School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Sinai School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P50GM071558-01A27398. This work was also supported by a startup fund from the Mount Sinai School of Medicine (to A. M.).	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Chin G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S6; Chris Anderson, 2008, END THEORY DATA DELU; DIJKSTRA EW, 1959, NUMER MATH, V1, pS269; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Euler L., 1736, COMMENTARII ACAD SCI, V8, P128; Eungdamrong NJ, 2004, TRENDS CELL BIOL, V14, P661, DOI 10.1016/j.tcb.2004.10.007; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hardy S, 2008, BIOINFORMATICS, V24, P209, DOI 10.1093/bioinformatics/btm560; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayot F, 2005, J THEOR BIOL, V234, P133, DOI 10.1016/j.jtbi.2004.11.010; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; KWON YK, 2008, BIOINFORMATICS; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Lipshtat A, 2008, BIOPHYS J, V94, P2566, DOI 10.1529/biophysj.107.116673; Ma'ayan A, 2008, IET SYST BIOL, V2, P103, DOI 10.1049/iet-syb:20070036; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Ma'ayan A, 2005, ANNU REV BIOPH BIOM, V34, P319, DOI 10.1146/annurev.biophys.34.040204.144415; Ma'ayan A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061912; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; ODA K, 2006, MOL SYST BIOL, V2, pNI137; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stryer L, 1981, BIOCHEMISTRY; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE AG, 2007, P 41 AS C SIGN SYST; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu HY, 2006, BIOINFORMATICS, V22, P823, DOI 10.1093/bioinformatics/btl014	49	45	46	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5451	5455		10.1074/jbc.R800056200	http://dx.doi.org/10.1074/jbc.R800056200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	18940806	Green Published, hybrid			2022-12-27	WOS:000263560600006
J	Crosetto, N; Bienko, M; Hibbert, RG; Perica, T; Ambrogio, C; Kensche, T; Hofmann, K; Sixma, TK; Dikic, I				Crosetto, Nicola; Bienko, Marzena; Hibbert, Richard G.; Perica, Tina; Ambrogio, Chiara; Kensche, Tobias; Hofmann, Kay; Sixma, Titia K.; Dikic, Ivan			Human Wrnip1 Is Localized in Replication Factories in a Ubiquitin-binding Zinc Finger-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS48-LINKED POLYUBIQUITIN CHAIN; DNA-DAMAGE TOLERANCE; WERNER HELICASE; PHYSICAL INTERACTION; GENOME STABILITY; POLYMERASE-ETA; TARGETS BRCA1; UBA DOMAIN; IN-VITRO; PROTEIN	Wrnip1 (Werner helicase-interacting protein 1) has been implicated in the bypass of stalled replication forks in bakers' yeast. However, the function(s) of human Wrnip1 has remained elusive so far. Here we report that Wrnip1 is distributed inside heterogeneous structures detectable in nondamaged cells throughout the cell cycle. In an attempt to characterize these structures, we found that Wrnip1 resides in DNA replication factories. Upon treatments that stall replication forks, such as UVC light, the amount of chromatin-bound Wrnip1 and the number of foci significantly increase, further implicating Wrnip1 in DNA replication. Interestingly, the nuclear pattern of Wrnip1 appears to extend to a broader landscape, as it can be detected in promyelocytic leukemia nuclear bodies. The presence of Wrnip1 into these heterogeneous subnuclear structures requires its ubiquitin-binding zinc finger (UBZ) domain, which is able to interact with different ubiquitin (Ub) signals, including mono-Ub and chains linked via lysine 48 and 63. Moreover, the oligomerization of Wrnip1 mediated by its C terminus is also important for proper subnuclear localization. Our study is the first to reveal the composite and regulated topography of Wrnip1 in the human nucleus, highlighting its potential role in replication and other nuclear transactions.	[Crosetto, Nicola; Bienko, Marzena; Perica, Tina; Kensche, Tobias; Dikic, Ivan] Goethe Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany; [Crosetto, Nicola; Bienko, Marzena; Perica, Tina; Kensche, Tobias; Dikic, Ivan] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60590 Frankfurt, Germany; [Hibbert, Richard G.; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Ambrogio, Chiara] Univ Turin, Ctr Expt Res & Med Studies, I-10126 Turin, Italy; [Ambrogio, Chiara] Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy; [Hofmann, Kay] Miltenyi Biotec GmbH, MACS Mol Business Unit, Bioinformat Grp, D-50829 Cologne, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Netherlands Cancer Institute; University of Turin; University of Turin; Miltenyi Biotec	Dikic, I (corresponding author), Goethe Univ Frankfurt, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Bienko, Magda/AAM-8867-2020; Hofmann, Kay/D-6714-2011; Dikic, Ivan/O-4650-2015	Bienko, Magda/0000-0002-6499-9082; Hofmann, Kay/0000-0002-2289-9083; Dikic, Ivan/0000-0001-8156-9511; Perica, Tina/0000-0003-3152-8425; Ambrogio, Chiara/0000-0003-4122-701X; Sixma, Titia K/0000-0001-6180-0632	Deutsche Forschungsgemeineschaft [DI 931/3-1]; Cluster of Excellence "Macromolecular Complexes" of the Frankfurt "J.W. Goethe" University; NWO-CW	Deutsche Forschungsgemeineschaft(German Research Foundation (DFG)); Cluster of Excellence "Macromolecular Complexes" of the Frankfurt "J.W. Goethe" University; NWO-CW(Netherlands Organization for Scientific Research (NWO))	This work was supported by Deutsche Forschungsgemeineschaft Grant DI 931/3-1 and grants from the Cluster of Excellence "Macromolecular Complexes" of the Frankfurt "J.W. Goethe" University (to I.D.) and NWO-CW (to T.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bish RA, 2007, J BIOL CHEM, V282, P23184, DOI 10.1074/jbc.M701042200; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Hayashi T, 2008, GENES GENET SYST, V83, P95, DOI 10.1266/ggs.83.95; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hishida T, 2002, EMBO J, V21, P2019, DOI 10.1093/emboj/21.8.2019; Hishida T, 2001, P NATL ACAD SCI USA, V98, P8283, DOI 10.1073/pnas.121009098; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kawabe Y, 2001, J BIOL CHEM, V276, P20364, DOI 10.1074/jbc.C100035200; Kawabe YI, 2006, DNA REPAIR, V5, P816, DOI 10.1016/j.dnarep.2006.04.006; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Pageau GJ, 2006, J CELL BIOL, V175, P693, DOI 10.1083/jcb.200602055; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Suzuki T, 2001, ONCOGENE, V20, P2551, DOI 10.1038/sj.onc.1204344; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Tsurimoto T, 2005, GENES CELLS, V10, P13, DOI 10.1111/j.1365-2443.2004.00812.x; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; von Kobbe C, 2002, J CELL SCI, V115, P3901, DOI 10.1242/jcs.00076; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yoshimura A, 2006, BIOL PHARM BULL, V29, P2192, DOI 10.1248/bpb.29.2192; Yuasa MS, 2006, GENES CELLS, V11, P731, DOI 10.1111/j.1365-2443.2006.00974.x	49	56	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35173	35185		10.1074/jbc.M803219200	http://dx.doi.org/10.1074/jbc.M803219200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842586	Green Published, hybrid			2022-12-27	WOS:000261469100074
J	Fang, S; Tsang, S; Jones, R; Ponugoti, B; Yoon, H; Wu, SY; Chiang, CM; Willson, TM; Kemper, JK				Fang, Sungsoon; Tsang, Stephanie; Jones, Ryan; Ponugoti, Bhaskar; Yoon, Hyeryoung; Wu, Shwu-Yuan; Chiang, Cheng-Ming; Willson, Timothy M.; Kemper, Jongsook Kim			The p300 Acetylase Is Critical for Ligand-activated Farnesoid X Receptor (FXR) Induction of SHP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE FEEDBACK-REGULATION; NUCLEAR-RECEPTOR; BILE-ACID; DNA-BINDING; REGULATES TRANSCRIPTION; SMALL-INTESTINE; CHOLESTEROL; COACTIVATOR; METABOLISM; MECHANISMS	The primary bile acid receptor farnesoid X receptor (FXR) maintains lipid and glucose homeostasis by regulating expression of numerous bile acid-responsive genes, including an orphan nuclear receptor and metabolic regulator SHP. Using SHP as a model gene, we studied how FXR activity is regulated by p300 acetylase. FXR interaction with p300 and their recruitment to the SHP promoter and acetylated histone levels at the promoter were increased by FXR agonists in mouse liver and HepG2 cells. In contrast, p300 recruitment and acetylated histones at the promoter were not detected in FXR-null mice. p300 directly interacted with and acetylated FXR in vitro. Overexpression of p300 wild type increased, whereas a catalytically inactive p300 mutant decreased, acetylated FXR levels and FXR transactivation in cells. While similar results were observed with a related acetylase, CBP, GCN5 did not enhance FXR transactivation, and its recruitment to the promoter was not increased by FXR agonists, suggesting functional specificity of acetylases in FXR signaling. Down-regulation of p300 by siRNA decreased acetylated FXR and acetylated histone levels, and occupancy of FXR at the promoter, resulting in substantial inhibition of SHP expression. These results indicate that p300 acts as a critical coactivator of FXR induction of SHP by acetylating histones at the promoter and FXR itself. Surprisingly, p300 down-regulation altered expression of other metabolic FXR target genes involved in lipoprotein and glucose metabolism, such that beneficial lipid and glucose profiles would be expected. These unexpected findings suggest that inhibition of hepatic p300 activity may be beneficial for treating metabolic diseases.	[Fang, Sungsoon; Tsang, Stephanie; Jones, Ryan; Ponugoti, Bhaskar; Yoon, Hyeryoung; Kemper, Jongsook Kim] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Willson, Timothy M.] GlaxoSmithKline, Discovery Med Chem, Res Triangle Pk, NC 27709 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; GlaxoSmithKline	Kemper, JK (corresponding author), 407 S Goodwin Ave, Urbana, IL 61801 USA.	jongsook@uiuc.edu	PONUGOTI, BHASKAR/H-2230-2011; feinstein, doug/M-9414-2019		National Institutes of Health [CA103867, CA124760, DK062777, AHA 0756028Z]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062777, R01DK080032, R01DK062777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103867 and CA124760 (to C.M.C.) and DK062777 and AHA 0756028Z (to J.K.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ananthanarayanan M, 2004, J BIOL CHEM, V279, P54348, DOI 10.1074/jbc.M410021200; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kraus WL, 2002, EUR J BIOCHEM, V269, P2275, DOI 10.1046/j.1432-1033.2002.02889.x; Kuninger D, 2004, HUM GENE THER, V15, P1287, DOI 10.1089/hum.2004.15.1287; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LAZAR MA, 2003, NUCL RECEPT SIGNAL, V1, P2001; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lee YK, 2002, J BIOL CHEM, V277, P2463, DOI 10.1074/jbc.M105161200; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Muraoka M, 1996, ONCOGENE, V12, P1565; Nakahara M, 2005, J BIOL CHEM, V280, P42283, DOI 10.1074/jbc.M507454200; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Rizzo G, 2005, MOL PHARMACOL, V68, P551, DOI 10.1124/mol.105.012104; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Torra IP, 2004, J BIOL CHEM, V279, P36184, DOI 10.1074/jbc.M405126200; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang L, 2006, MOL ENDOCRINOL, V20, P2671, DOI 10.1210/me.2006-0224; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Willson TM, 2001, MED RES REV, V21, P513, DOI 10.1002/med.1023; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	56	51	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35086	35095		10.1074/jbc.M803531200	http://dx.doi.org/10.1074/jbc.M803531200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842595	hybrid, Green Published			2022-12-27	WOS:000261469100066
J	Kanzaki, T; Iizuka, R; Takahashi, K; Maki, K; Masuda, R; Sahlan, M; Yebenes, H; Valpuesta, JM; Oka, T; Furutani, M; Ishii, N; Kuwajima, K; Yohda, M				Kanzaki, Taro; Iizuka, Ryo; Takahashi, Kazunobu; Maki, Kosuke; Masuda, Rie; Sahlan, Muhamad; Yebenes, Hugo; Valpuesta, Jose M.; Oka, Toshihiko; Furutani, Masahiro; Ishii, Noriyuki; Kuwajima, Kunihiro; Yohda, Masafumi			Sequential Action of ATP-dependent Subunit Conformational Change and Interaction between Helical Protrusions in the Closure of the Built-in Lid of Group II Chaperonins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ALLOSTERIC TRANSITIONS; TRANSIENT KINETIC-ANALYSIS; THERMOCOCCUS STRAIN KS-1; EUKARYOTIC CHAPERONIN; CYTOPLASMIC CHAPERONIN; CIS-CAVITY; PROTEIN; GROEL; THERMOSOME; SUBSTRATE	ATP drives the conformational change of the group II chaperonin from the open lid substrate-binding conformation to the closed lid conformation to encapsulate an unfolded protein in the central cavity. The detailed mechanism of this conformational change remains unknown. To elucidate the intra-ring cooperative action of subunits for the conformational change, we constructed Thermococcus chaperonin complexes containing mutant subunits in an ordered manner and examined their folding and conformational change abilities. Chaperonin complexes containing wild-type subunits and mutant subunits with impaired ATP-dependent conformational change ability or ATP hydrolysis activity, one by one, exhibited high protein refolding ability. The effects of the mutant subunits correlate with the number and order in the ring. In contrast, the use of a mutant lacking helical protrusion severely affected the function. Interestingly, these mutant chaperonin complexes also exhibited ATP-dependent conformational changes as demonstrated by small angle x-ray scattering, protease digestion, and changes in fluorescence of the fluorophore attached to the tip of the helical protrusion. However, their conformational change is likely to be transient. They captured denatured proteins even in the presence of ATP, whereas addition of ATP impaired the ability of the wild-type chaperonin to protect citrate synthase from thermal aggregation. These results suggest that ATP binding/hydrolysis causes the independent conformational change of the subunit, and further conformational change for the complete closure of the lid is induced and stabilized by the interaction between helical protrusions.	[Kanzaki, Taro; Iizuka, Ryo; Masuda, Rie; Sahlan, Muhamad; Yohda, Masafumi] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Iizuka, Ryo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Takahashi, Kazunobu; Kuwajima, Kunihiro] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Takahashi, Kazunobu] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Maki, Kosuke] Nagoya Univ, Grad Sch Sci, Dept Phys, Aichi 4648602, Japan; [Yebenes, Hugo; Valpuesta, Jose M.] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Oka, Toshihiko] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Kanagawa 2238522, Japan; [Furutani, Masahiro] Sekisui Chem Co Ltd, Minase Res Inst, Osaka 6188589, Japan; [Ishii, Noriyuki] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba, Ibaraki 3058566, Japan; [Kuwajima, Kunihiro] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Dept Funct Mol Sci, Okazaki, Aichi 4448787, Japan	Tokyo University of Agriculture & Technology; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); University of Tokyo; Nagoya University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Keio University; Sekisui Chemical Co Ltd; National Institute of Advanced Industrial Science & Technology (AIST); Graduate University for Advanced Studies - Japan	Yohda, M (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	yohda@cc.tuat.ac.jp	Oka, Toshihiko/C-3757-2015; Valpuesta, José M/T-1977-2017; Valpuesta, Jose M/AAA-6002-2019; Yohda, Masafumi/A-5149-2013; Ishii, Noriyuki/E-5661-2011	Oka, Toshihiko/0000-0002-1676-9231; Valpuesta, José M/0000-0001-7468-8053; Yohda, Masafumi/0000-0001-8307-9671; Ishii, Noriyuki/0000-0002-4120-6203; Yebenes, Hugo/0000-0002-0448-217X; Iizuka, Ryo/0000-0002-9328-5628; Sahlan, Muhamad/0000-0001-6360-3691	Ministry of Education, Science, Sports, Culture, and Technology; Tokyo University of Agriculture and Technology [17028013, 19370038, 20059013]; National Project on Protein Structural and Functional Analyses; Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, Culture, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo University of Agriculture and Technology; National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is a part of the 21st Century Center of Excellence Program of the "Future Nano-Materials" Research and Education Project supported by the Ministry of Education, Science, Sports, Culture, and Technology through Tokyo University of Agriculture and Technology and supported in part by Grants-in-aids for Scientific Research 17028013, 19370038, and 20059013 and a grant from the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Science, Sports, and Culture of Japan ( to M.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai M, 2003, J MOL BIOL, V329, P779, DOI 10.1016/S0022-2836(03)00511-4; Arai M, 2002, J MOL BIOL, V321, P121, DOI 10.1016/S0022-2836(02)00566-1; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Bigotti MG, 2005, J MOL BIOL, V348, P13, DOI 10.1016/j.jmb.2005.01.066; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Furutani M, 2005, PROTEIN SCI, V14, P341, DOI 10.1110/ps.041043905; Furutani M, 1998, J BIOL CHEM, V273, P28399, DOI 10.1074/jbc.273.43.28399; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Gutsche I, 2001, J STRUCT BIOL, V135, P139, DOI 10.1006/jsbi.2001.4373; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Iizuka R, 2005, J BIOL CHEM, V280, P40375, DOI 10.1074/jbc.M506785200; Iizuka R, 2004, J BIOL CHEM, V279, P18834, DOI 10.1074/jbc.M400839200; Iizuka R, 2003, J BIOL CHEM, V278, P44959, DOI 10.1074/jbc.M305484200; Iizuka R, 2001, BIOCHEM BIOPH RES CO, V289, P1118, DOI 10.1006/bbrc.2001.6139; Kafri G, 2003, J MOL BIOL, V326, P981, DOI 10.1016/S0022-2836(03)00046-9; Kafri G, 2001, PROTEIN SCI, V10, P445, DOI 10.1110/ps.44401; KAGAWA HK, 1995, J MOL BIOL, V253, P712, DOI 10.1006/jmbi.1995.0585; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; Klunker D, 2003, J BIOL CHEM, V278, P33256, DOI 10.1074/jbc.M302018200; Kurimoto E, 2008, PROTEINS, V70, P1257, DOI 10.1002/prot.21606; Lin P, 1997, P NATL ACAD SCI USA, V94, P10780, DOI 10.1073/pnas.94.20.10780; Llorca O, 1999, NAT STRUCT BIOL, V6, P639; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Rivenzon-Segal D, 2005, NAT STRUCT MOL BIOL, V12, P233, DOI 10.1038/nsmb901; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; Yoshida T, 2002, J MOL BIOL, V315, P73, DOI 10.1006/jmbi.2001.5220; Yoshida T, 1997, J MOL BIOL, V273, P635, DOI 10.1006/jmbi.1997.1337	39	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34773	34784		10.1074/jbc.M805303200	http://dx.doi.org/10.1074/jbc.M805303200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18854314	Green Published, hybrid			2022-12-27	WOS:000261469100034
J	Rylski, M; Amborska, R; Zybura, K; Mioduszewska, B; Michaluk, P; Jaworski, J; Kaczmarek, L				Rylski, Marcin; Amborska, Renata; Zybura, Katarzyna; Mioduszewska, Barbara; Michaluk, Piotr; Jaworski, Jacek; Kaczmarek, Leszek			Yin Yang 1 Is a Critical Repressor of Matrix Metalloproteinase-9 Expression in Brain Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR YIN-YANG-1; ELEMENT-BINDING PROTEIN; HISTONE MODIFICATIONS; NEUROTROPHIC-FACTOR; PROXIMAL REGION; GELATINASE-B; IN-VIVO; YY1; RECRUITMENT; PROMOTER	Membrane depolarization controls long lasting adaptive neuronal changes in brain physiology and pathology. Such responses are believed to be gene expression-dependent. Notably, however, only a couple of gene repressors active in nondepolarized neurons have been described. In this study, we show that in the unstimulated rat hippocampus in vivo, as well as in the nondepolarized brain neurons in primary culture, the transcriptional regulator Yin Yang 1 (YY1) is bound to the proximal Mmp-9 promoter and strongly represses Mmp-9 transcription. Furthermore, we demonstrate that monoubiquitinated and CtBP1 (C-terminal binding protein 1)-bound YY1 regulates Mmp-9 mRNA synthesis in rat brain neurons controlling its transcription apparently via HDAC3-dependent histone deacetylation. In conclusion, our data suggest that YY1 exerts, via epigenetic mechanisms, a control over neuronal expression of MMP-9. Because MMP-9 has recently been shown to play a pivotal role in physiological and pathological neuronal plasticity, YY1 may be implicated in these phenomena as well.	[Rylski, Marcin; Amborska, Renata; Zybura, Katarzyna; Mioduszewska, Barbara; Michaluk, Piotr; Kaczmarek, Leszek] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Michaluk, Piotr] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Michaluk, Piotr] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; [Jaworski, Jacek] Int Inst Mol & Cell Biol, Mol & Cellular Neurobiol Lab, PL-02109 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Rylski, M (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, Pasteura 3, PL-02093 Warsaw, Poland.	m.rylski@gmail.com; l.kaczmarek@nencki.gov.pl	Rylski, Marcin/AAB-9277-2021; Michaluk, Piotr/AAR-5238-2021; Kaczmarek, Leszek/AHA-0076-2022; Kaczmarek, Leszek/B-6171-2008	Michaluk, Piotr/0000-0003-2306-3314; Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; Rylski, Marcin/0000-0002-9892-8979; Zybura-Broda, Katarzyna/0000-0002-4117-2613; Jaworski, Jacek/0000-0001-8760-7865	Polish Ministry of Science and Higher Education [2 P04A 081 29]; 7 FP European Union	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); 7 FP European Union(European Commission)	This work was supported by the Polish Ministry of Science and Higher Education Grant 2 P04A 081 29 and 7 FP European Union Grant MemStick. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Antoniv TT, 2005, J BIOL CHEM, V280, P35417, DOI 10.1074/jbc.M502681200; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; Barath P, 2004, EUR J BIOCHEM, V271, P1781, DOI 10.1111/j.1432-1033.2004.04090.x; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Dubberke R, 1998, PFLUG ARCH EUR J PHY, V437, P79, DOI 10.1007/s004240050750; Dzwonek J, 2004, FEBS LETT, V567, P129, DOI 10.1016/j.febslet.2004.03.070; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; GUO B, 1995, P NATL ACAD SCI USA, V92, P10526, DOI 10.1073/pnas.92.23.10526; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Hering H, 2003, J NEUROSCI, V23, P11759; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Huang YF, 2002, J NEUROSCI, V22, P8422; INOUYE CJ, 1994, J BIOL CHEM, V269, P6506; Jaworski J, 2003, J NEUROSCI, V23, P4519; Jia YH, 2006, NEUROSCI LETT, V403, P103, DOI 10.1016/j.neulet.2006.04.027; KACZMAREK L, 2002, IMMEDIATE EARLY GENE; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; Konopacki FA, 2007, NEUROSCIENCE, V150, P31, DOI 10.1016/j.neuroscience.2007.08.026; LEE TC, 1992, P NATL ACAD SCI USA, V89, P9814, DOI 10.1073/pnas.89.20.9814; Luke MPS, 2006, J BIOL CHEM, V281, P33226, DOI 10.1074/jbc.M606584200; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Masson V, 2004, FASEB J, V18, P234, DOI 10.1096/fj.04-2140fje; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Meldrum B, 2002, EPILEPSY RES, V50, P33, DOI 10.1016/S0920-1211(02)00066-9; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; Mohan R, 1998, J BIOL CHEM, V273, P25903, DOI 10.1074/jbc.273.40.25903; Mokrani H, 2006, MOL CELL BIOL, V26, P8551, DOI 10.1128/MCB.00420-06; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nowak K, 2006, J NEUROCHEM, V96, P1696, DOI 10.1111/j.1471-4159.2006.03692.x; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; SCHORMAIR C, 1993, BRAIN RES BULL, V32, P329, DOI 10.1016/0361-9230(93)90196-I; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Sucharov CC, 2006, AM J PHYSIOL-CELL PH, V291, pC1029, DOI 10.1152/ajpcell.00059.2006; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Taniura H, 2006, HISTOL HISTOPATHOL, V21, P785, DOI 10.14670/HH-21.785; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; WALDEN J, 1988, BRAIN RES, V473, P294, DOI 10.1016/0006-8993(88)90858-X; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wright JW, 2003, BRAIN RES, V963, P252, DOI 10.1016/S0006-8993(02)04036-2; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zhao T., 2008, Experimental Oncology, V30, P60	57	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35140	35153		10.1074/jbc.M804540200	http://dx.doi.org/10.1074/jbc.M804540200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940814	Green Published, hybrid			2022-12-27	WOS:000261469100071
J	Cha, SS; Il Jung, H; Jeon, H; An, YJ; Kim, IK; Yun, S; Ahn, HJ; Chung, KC; Lee, SH; Suh, PG; Kang, SO				Cha, Sun-Shin; Il Jung, Ha; Jeon, Hyesung; An, Young Jun; Kim, In-Kwon; Yun, Sanguk; Ahn, Hyun Jin; Chung, Kwang Chul; Lee, Sang Hee; Suh, Pann-Ghill; Kang, Sa-Ouk			Crystal Structure of Filamentous Aggregates of Human DJ-1 Formed in an Inorganic Phosphate-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; MULTIPLE SYSTEM ATROPHY; OXIDATIVE STRESS; DROSOPHILA DJ-1; ALPHA-SYNUCLEIN; PROTEIN DJ-1; CELL-DEATH; FERTILITY; L166P; INACTIVATION	Mutations in the DJ-1 gene have been implicated in the autosomal recessive early onset parkinsonism. DJ-1 is a soluble dimeric protein with critical roles in response to oxidative stress and in neuronal maintenance. However, several lines of evidence suggest the existence of a nonfunctional aggregated form of DJ-1 in the brain of patients with some neurodegenerative diseases. Here, we show that inorganic phosphate, an important anion that exhibits elevated levels in patients with Parkinson disease, transforms DJ-1 into filamentous aggregates. According to the 2.4-angstrom crystal structure, DJ-1 dimers are linearly stacked through P-i-mediated interactions to form protofilaments, which are then bundled into a filamentous assembly.	[Cha, Sun-Shin; Il Jung, Ha; An, Young Jun] Korea Ocean Res & Dev Inst, Marine & Extreme Genome Res Ctr, Ansan 426744, South Korea; [Jeon, Hyesung] Korea Inst Sci & Technol, Seoul 130650, South Korea; [Kim, In-Kwon; Kang, Sa-Ouk] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Yun, Sanguk; Suh, Pann-Ghill] POSTECH, Dept Life Sci, Pohang 790784, South Korea; [Il Jung, Ha; An, Young Jun; Lee, Sang Hee] Myongji Univ, Dept Biol Sci, Yongin 449728, South Korea; [Ahn, Hyun Jin; Chung, Kwang Chul] Yonsei Univ, Dept Biol, Seoul 120749, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Myongji University; Yonsei University	Cha, SS (corresponding author), Korea Ocean Res & Dev Inst, Marine & Extreme Genome Res Ctr, Ansan 426744, South Korea.	chajung@kordi.re.kr; kangsaou@snu.ac.kr	Cha, Sun Shin/B-7370-2009; Suh, Pann-Ghill/F-3610-2010; Lee, Sang Hee/A-3200-2012	Lee, Sang Hee/0000-0002-5660-7122; Cha, Sun-Shin/0000-0002-0913-8706	Functional Proteomics Center Program; Korea Ministry of Science and Technology; Marine & Extreme Genome Research Center Program; Ministry of Land, Transport, and Maritime Affairs, Republic of Korea; BK21 Project, Republic of Korea	Functional Proteomics Center Program; Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Marine & Extreme Genome Research Center Program; Ministry of Land, Transport, and Maritime Affairs, Republic of Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); BK21 Project, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Functional Proteomics Center Program, Korea Ministry of Science and Technology and by the Marine & Extreme Genome Research Center Program, Ministry of Land, Transport, and Maritime Affairs, Republic of Korea. This work was also supported by Korea Institute of Science and Technology institutional grants and a Research Fellowship of the BK21 Project, Republic of Korea (to I. K. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340; Barbiroli B, 1999, MOVEMENT DISORD, V14, P430, DOI 10.1002/1531-8257(199905)14:3<430::AID-MDS1007>3.0.CO;2-S; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; BROWN GG, 1989, NEUROLOGY, V39, P1423, DOI 10.1212/WNL.39.11.1423; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.3.CO;2-8; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Huai Q, 2003, FEBS LETT, V549, P171, DOI 10.1016/S0014-5793(03)00764-6; Jin JH, 2005, MOL BRAIN RES, V134, P119, DOI 10.1016/j.molbrainres.2004.10.003; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Klinefelter GR, 1997, J ANDROL, V18, P139; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; LIU F, 2008, J NEUROCHEM; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Rizzu P, 2004, ANN NEUROL, V55, P113, DOI 10.1002/ana.10782; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Wagenfeld A, 1998, BIOL REPROD, V58, P1257, DOI 10.1095/biolreprod58.5.1257; Welch JE, 1998, J ANDROL, V19, P385; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Yanagisawa D, 2008, J CEREBR BLOOD F MET, V28, P563, DOI 10.1038/sj.jcbfm.9600553; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102	44	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34069	34075		10.1074/jbc.M804243200	http://dx.doi.org/10.1074/jbc.M804243200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18922803	Green Published, hybrid			2022-12-27	WOS:000261277700035
J	Fischer, M; Kaldenhoff, R				Fischer, Matthias; Kaldenhoff, Ralf			On the pH Regulation of Plant Aquaporins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; WATER TRANSPORT; VESICLES; WHEAT; CELLS	The majority of plants are unable to evade unfavorable conditions such as flooding, salinity, or drought. Therefore, a fine-tuned water homeostasis appears to be of crucial importance for plant survival, and it was assumed that aquaporins play a significant role in these processes. Regulation of plant aquaporin conductivity was suggested to be achieved by a gating mechanism that involves protein phosphorylation under drought stress conditions and protonation after cytosolic acidification during flooding. The effect of protein phosphorylation or protonation of aquaporins was studied on two plasma membrane intrinsic proteins, NtPIP2;1 and NtAQP1 from tobacco, which were heterologously expressed in yeast. Our results on mutated aquaporins with serine-to-alanine exchange indicate that phosphorylation of the two key serine residues did not affect the pH-dependent modification of water permeability. Protonation on a conserved histidine residue decreased water conductivity of NtPIP2;1. Although cells expressing NtPIP2; 1 with a replacement of the histidine by an alanine were found to be pH-insensitive with regard to water permeability, these maintain high water transport rates, similar to those obtained under acidic conditions. The data clearly support the role of histidine at 196 as a component of pH dependent modification of aquaporin-facilitated water transport. The predictions of combined effects from phosphorylation at conserved serines and histidine protonation were not supported by the results of functional analysis. The obtained results challenge the gating model as a general regulation mechanism for plant plasma membrane aquaporins.	[Fischer, Matthias; Kaldenhoff, Ralf] Tech Univ Darmstadt, D-64287 Darmstadt, Germany	Technical University of Darmstadt	Kaldenhoff, R (corresponding author), Tech Univ Darmstadt, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	kaldenhoff@bio.tu-darmstadt.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a grant from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Gerbeau P, 2002, PLANT J, V30, P71, DOI 10.1046/j.1365-313X.2002.01268.x; Kamaluddin M, 2004, TREE PHYSIOL, V24, P1173, DOI 10.1093/treephys/24.10.1173; NAKAMOTO RK, 1991, J BIOL CHEM, V266, P7940; SANFORD JC, 1993, METHOD ENZYMOL, V217, P483; SLAVIK J, 1982, FEBS LETT, V140, P22, DOI 10.1016/0014-5793(82)80512-7; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; Zhang WH, 1999, PLANT PHYSIOL, V120, P849, DOI 10.1104/pp.120.3.849	11	57	58	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33889	33892		10.1074/jbc.M803865200	http://dx.doi.org/10.1074/jbc.M803865200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818207	hybrid, Green Published			2022-12-27	WOS:000261277700014
J	Smadja-Lamere, N; Boulanger, MC; Champagne, C; Branton, PE; Lavoie, JN				Smadja-Lamere, Nicolas; Boulanger, Marie-Chloe; Champagne, Claudia; Branton, Philip E.; Lavoie, Josee N.			JNK-mediated Phosphorylation of Paxillin in Adhesion Assembly and Tension-induced Cell Death by the Adenovirus Death Factor E4orf4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; C-JUN; TRANSFORMED-CELLS; MATRIX ADHESIONS; P53-INDEPENDENT APOPTOSIS; ALPHA-1-FETOPROTEIN GENE; ACTIN POLYMERIZATION; MYOSIN-II; KINASE; ACTIVATION	The adenovirus type 2 Early Region 4 ORF4 (E4orf4) protein induces a caspase-independent death program in tumor cells involving changes in actin dynamics that are functionally linked to cell killing. Because an increase in myosin II-based contractility is needed for the death of E4orf4-expressing cells, we have proposed that alteration of cytoskeletal tension is part of the signals engaging the death pathway. Yet the mechanisms involved are poorly defined. Herein, we show that the Jun N-terminal kinase JNK is activated in part through a pathway involving Src, Rho, and ROCK (Rho kinase) and contributes to dysregulate adhesion dynamics and to kill cells in response to E4orf4. JNK supports the formation of atypically robust focal adhesions, which are bound to the assembly of the peculiar actomyosin network typifying E4orf4-induced cell death and which are required for driving nuclear condensation. Remarkably, the dramatic enlargement of focal adhesions, actin remodeling, and cell death all rely on paxillin phosphorylation at Ser-178, which is induced by E4orf4 in a JNK-dependent way. Furthermore, we found that Ser-178-paxillin phosphorylation is necessary to decrease adhesion turnover and to enhance the time residency of paxillin at focal adhesions, promoting its recruitment from an internal pool. Our results indicate that perturbation of tensional homeostasis by E4orf4 involves JNK-regulated changes in paxillin adhesion dynamics that are required to engage the death pathway. Moreover, our findings support a role for JNK-mediated paxillin phosphorylation in adhesion growth and stabilization during tension signaling.	[Smadja-Lamere, Nicolas; Boulanger, Marie-Chloe; Champagne, Claudia; Lavoie, Josee N.] Univ Laval, Hotel Dieu, Ctr Rech Cancerol, CRCHUQ, Quebec City, PQ G1R 2J6, Canada; [Branton, Philip E.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Branton, Philip E.] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	Laval University; McGill University; McGill University	Lavoie, JN (corresponding author), Univ Laval, Hotel Dieu, Ctr Rech Cancerol, CRCHUQ, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	josee.lavoie@crhdq.ulaval.ca		Lavoie, Josee N/0000-0001-6912-1132	Canadian Institutes of Health Research Operating [MOP-49450]; National Cancer Institute of Canada	Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported by the Canadian Institutes of Health Research Operating Grant MOP-49450 (to J. N. L.), a maintenance Grant for the Cell imaging core facility (to J. N. L.), and by the National Cancer Institute of Canada (to P. E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amagasaki K, 2006, J BIOL CHEM, V281, P22173, DOI 10.1074/jbc.M513307200; BERNIER D, 1993, MOL CELL BIOL, V13, P1619, DOI 10.1128/MCB.13.3.1619; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Branton PE, 2001, ONCOGENE, V20, P7855, DOI 10.1038/sj.onc.1204862; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; BROWN PH, 1993, ONCOGENE, V8, P877; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Champagne C, 2004, J BIOL CHEM, V279, P25905, DOI 10.1074/jbc.M400933200; Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Gingras MC, 2002, MOL CELL BIOL, V22, P41, DOI 10.1128/MCB.22.1.41-56.2002; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GUERTIN M, 1988, MOL CELL BIOL, V8, P1398, DOI 10.1128/MCB.8.4.1398; Gupta P, 2006, PHARMACOL THERAPEUT, V111, P596, DOI 10.1016/j.pharmthera.2005.11.005; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; Hinz B, 2006, EUR J CELL BIOL, V85, P175, DOI 10.1016/j.ejcb.2005.09.004; Hsieh MH, 2005, INT REV CYTOL, V245, P45, DOI 10.1016/S0074-7696(05)45003-2; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P125, DOI 10.1167/iovs.07-0725; Kleinberger T, 2004, PROG MOL SUBCELL BIO, V36, P245; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Landry MC, 2006, B CANCER, V93, P921; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Lavoie JN, 2000, J CELL BIOL, V150, P1037, DOI 10.1083/jcb.150.5.1037; Lele TP, 2006, J CELL BIOCHEM, V97, P1175, DOI 10.1002/jcb.20761; LI S, 2008, ONCOGENE IN PRESS; Livne A, 2001, J VIROL, V75, P789, DOI 10.1128/JVI.75.2.789-798.2001; Llense F, 2008, CURR BIOL, V18, P538, DOI 10.1016/j.cub.2008.03.029; LUFTIG RB, 1977, J HISTOCHEM CYTOCHEM, V25, P175, DOI 10.1177/25.3.402414; Ma Z, 2007, J CELL BIOL, V179, P23, DOI 10.1083/jcb.200706097; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Marinissen MJ, 2005, TRENDS BIOCHEM SCI, V30, P423, DOI 10.1016/j.tibs.2005.06.006; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Melani M, 2008, CURR BIOL, V18, P532, DOI 10.1016/j.cub.2008.03.024; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Noteborn MHM, 2005, CELL MOL BIOL, V51, P49, DOI 10.1170/T597; Pelish HE, 2006, NAT CHEM BIOL, V2, P221, DOI 10.1038/nchembio0406-221b; Robert A, 2002, J CELL BIOL, V158, P519, DOI 10.1083/jcb.200201106; Robert A, 2006, MOL BIOL CELL, V17, P3329, DOI 10.1091/mbc.E05-12-1146; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xu B, 2006, ORG BIOMOL CHEM, V4, P4149, DOI 10.1039/b609143a; Zaidel-Bar R, 2005, J CELL SCI, V118, P3997, DOI 10.1242/jcs.02523; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 1999, J CELL SCI, V112, P1655	73	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34352	34364		10.1074/jbc.M803364200	http://dx.doi.org/10.1074/jbc.M803364200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18818208	hybrid, Green Published			2022-12-27	WOS:000261277700063
J	Volk, APD; Heise, CK; Hougen, JL; Artman, CM; Volk, KA; Wessels, D; Soll, DR; Nauseef, WM; Lamb, FS; Moreland, JG				Volk, A. Paige Davis; Heise, Christine K.; Hougen, Jami L.; Artman, Christopher M.; Volk, Kenneth A.; Wessels, Deborah; Soll, David R.; Nauseef, William M.; Lamb, Fred S.; Moreland, Jessica G.			ClC-3 and IClswell are Required for Normal Neutrophil Chemotaxis and Shape Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-VOLUME REGULATION; CHLORIDE CHANNEL; NADPH-OXIDASE; POLYMORPHONUCLEAR LEUKOCYTES; MURINE NEUTROPHILS; PH REGULATION; ION CHANNELS; CL-CHANNELS; ACTIVATION; MIGRATION	Polymorphonuclear leukocytes undergo directed movement to sites of infection, a complex process known as chemotaxis. Extension of the polymorphonuclear leukocyte (PMN) leading edge toward a chemoattractant in association with uropod retraction must involve a coordinated increase/decrease in membrane, redistribution of cell volume, or both. Deficits in PMN phagocytosis and trans-endothelial migration, both highly motile PMN functions, suggested that the anion transporters, ClC-3 and IClswell, are involved in cell motility and shape change (Moreland, J. G., Davis, A. P., Bailey, G., Nauseef, W. M., and Lamb, F. S. (2006) J. Biol. Chem. 281, 12277-12288). We hypothesized that ClC-3 and IClswell are required for normal PMN chemotaxis through regulation of cell volume and shape change. Using complementary chemotaxis assays, EZ-TAXIScan (TM) and dynamic imaging analysis software, we analyzed the directed cell movement and morphology of PMNs lacking normal anion transporter function. Murine Clcn3(-/-) PMNs and human PMNs treated with anion transporter inhibitors demonstrated impaired chemotaxis in response to formyl peptide. This included decreased cell velocity and failure to undergo normal cycles of elongation and retraction. Impaired chemotaxis was not due to a diminished number of formyl peptide receptors in either murine or human PMNs, as measured by flow cytometry. Murine Clcn3(-/-) and Clcn3(-/-) PMNs demonstrated a similar regulatory volume decrease, indicating that the IClswell response to hypotonic challenge was intact in these cells. We further demonstrated that IClswell is essential for shape change during human PMN chemotaxis. We speculate that ClC-3 and IClswell have unique roles in regulation of PMN chemotaxis; IClswell through direct effects on PMN volume and ClC-3 through regulation of IClswell.	[Volk, A. Paige Davis; Heise, Christine K.; Hougen, Jami L.; Artman, Christopher M.; Volk, Kenneth A.; Lamb, Fred S.; Moreland, Jessica G.] Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [Wessels, Deborah; Soll, David R.] Univ Iowa, Coll Med, Dept Biol Sci, WM Keck Dynam Image Anal Facil, Iowa City, IA 52242 USA; [Nauseef, William M.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Volk, A. Paige Davis; Heise, Christine K.; Hougen, Jami L.; Artman, Christopher M.; Nauseef, William M.; Moreland, Jessica G.] Univ Iowa, Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Volk, A. Paige Davis; Heise, Christine K.; Hougen, Jami L.; Artman, Christopher M.; Nauseef, William M.; Moreland, Jessica G.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Volk, APD (corresponding author), 7770-C JPP UIHC,200 Hawkins Dr, Iowa City, IA 52242 USA.	paige-volk@uiowa.edu		Nauseef, William/0000-0003-4032-757X; Lamb, Fred/0000-0003-2955-5133	National Institutes of Health [HD-041922, HD-047349, HD-18577, AI-34879, HL-62483, AI-067533, AI-073872]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018577, T32HD041922] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL062483, R01HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073872, R01AI034879, R56AI034879, R21AI067533] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HD-041922 and HD-047349 (to A. P. D. V.), HD-18577 (to D. R. S.), AI-34879 (to W. M. N.), HL-62483 (to F. S. L.), and AI-067533 and AI-073872 (to J. G. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BORREGAARD N, 1993, EUR J HAEMATOL, V51, P187; Browe DM, 2004, J GEN PHYSIOL, V124, P273, DOI 10.1085/jgp.200409040; CALA A, 1990, CHLORIDE CHANNELS CA; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; Demaurex N, 1996, J CELL BIOL, V133, P1391, DOI 10.1083/jcb.133.6.1391; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; DOWNEY GP, 1995, J CELL PHYSIOL, V163, P96, DOI 10.1002/jcp.1041630111; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Garcia-Duran M, 1999, CIRC RES, V85, P1020; Geiger J, 2003, CELL MOTIL CYTOSKEL, V56, P27, DOI 10.1002/cm.10133; Greenwood IA, 1998, AM J PHYSIOL-HEART C, V275, pH1524, DOI 10.1152/ajpheart.1998.275.5.H1524; Hayashi H, 2008, AM J PHYSIOL-CELL PH, V294, pC526, DOI 10.1152/ajpcell.00219.2007; Hermoso M, 2002, J BIOL CHEM, V277, P40066, DOI 10.1074/jbc.M205132200; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; KELLY MEM, 1994, J PHYSIOL-LONDON, V475, P377, DOI 10.1113/jphysiol.1994.sp020079; Kim MJ, 2004, CLIN EXP IMMUNOL, V138, P453, DOI 10.1111/j.1365-2249.2004.02635.x; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; KRAUSE KH, 1990, J CLIN INVEST, V85, P491, DOI 10.1172/JCI114464; Lala A, 1997, BIOCHEM PHARMACOL, V54, P381, DOI 10.1016/S0006-2952(97)00191-3; Lang F, 1998, CELL PHYSIOL BIOCHEM, V8, P1, DOI 10.1159/000016269; Lavigne MC, 2002, CELL IMMUNOL, V218, P7, DOI 10.1016/S0008-8749(02)00564-6; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Liu L, 1998, J IMMUNOL, V160, P2463; Mao JW, 2007, CELL PHYSIOL BIOCHEM, V19, P249, DOI 10.1159/000100644; Matsuda JJ, 2008, AM J PHYSIOL-CELL PH, V294, pC251, DOI 10.1152/ajpcell.00338.2007; MATSUDA JJ, 2008, FASEB J, V22; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; MORELAND JG, 2007, J BIOL CHEM; Nobles M, 2004, AM J PHYSIOL-CELL PH, V287, pC1426, DOI 10.1152/ajpcell.00549.2002; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; ROSENGREN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1623, DOI 10.1152/ajpcell.1994.267.6.C1623; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; SENGELOV H, 1993, J IMMUNOL, V150, P1535; SHIMIZU Y, 1993, BIOCHEM PHARMACOL, V45, P1743; SIMCHOWITZ L, 1991, AM J PHYSIOL, V261, pC906, DOI 10.1152/ajpcell.1991.261.5.C906; SIMCHOWITZ L, 1986, J GEN PHYSIOL, V88, P167, DOI 10.1085/jgp.88.2.167; SIMCHOWITZ L, 1993, AM J PHYSIOL, V265, pC143, DOI 10.1152/ajpcell.1993.265.1.C143; SOLL DR, 1988, J CELL BIOCHEM, V37, P177, DOI 10.1002/jcb.240370205; Soll DR, 1995, INT REV CYTOL, V163, P43; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Stepanovic V, 2004, CELL MOTIL CYTOSKEL, V57, P158, DOI 10.1002/cm.10164; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; STODDARD JS, 1993, AM J PHYSIOL, V265, pC156, DOI 10.1152/ajpcell.1993.265.1.C156; SUGAWARA T, 1995, J PHARMACOL TOXICOL, V33, P91, DOI 10.1016/1056-8719(94)00062-9; VALVERDE MA, 1993, PFLUG ARCH EUR J PHY, V425, P552, DOI 10.1007/BF00374885; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; VARNUM B, 1984, J CELL BIOL, V99, P1151, DOI 10.1083/jcb.99.3.1151; Wang J, 2005, JPN J PHYSIOL, V55, P379, DOI 10.2170/jjphysiol.S655; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; Weylandt KH, 2001, J BIOL CHEM, V276, P17461, DOI 10.1074/jbc.M011667200; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	58	43	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34315	34326		10.1074/jbc.M803141200	http://dx.doi.org/10.1074/jbc.M803141200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840613	hybrid, Green Published			2022-12-27	WOS:000261277700059
J	Dixit, R; Levy, JR; Tokito, M; Ligon, LA; Holzbaur, ELF				Dixit, Ram; Levy, Jennifer R.; Tokito, Mariko; Ligon, Lee A.; Holzbaur, Erika L. F.			Regulation of Dynactin through the Differential Expression of p150(Glued) Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DISEASE; CYTOPLASMIC DYNEIN; MICROTUBULE-BINDING; G59S MUTATION; DCTN1 GENE; IN-VITRO; TRANSPORT; ENDS; DEGENERATION; PROCESSIVITY	Cytoplasmic dynein and dynactin interact to drive microtubule-based transport in the cell. The p150(Glued) subunit of dynactin binds to dynein, and directly to microtubules. We have identified alternatively spliced isoforms of p150(Glued) that are expressed in a tissue-specific manner and which differ significantly in their affinity for microtubules. Live cell assays indicate that these alternatively spliced isoforms also differ significantly in their microtubule plus end-tracking activity, suggesting a mechanism by which the cell may regulate the dynamic localization of dynactin. To test the function of the microtubule-binding domain of p150(Glued), we used RNAi to deplete the endogenous polypeptide from HeLa cells, followed by rescue with constructs encoding either the full-length polypeptide or an isoform lacking the microtubule-binding domain. Both constructs fully rescued defects in Golgi morphology induced by depletion of p150(Glued), indicating that an independent microtubule-binding site in dynactin may not be required for dynactin-mediated trafficking in some mammalian cell types. In neurons, however, a mutation within the microtubule-binding domain of p150(Glued) results in motor neuron disease; here we investigate the effects of four other mutations in highly conserved domains of the polypeptide (M571T, R785W, R1101K, and T1249I) associated in genetic studies with Amyotrophic Lateral Sclerosis. Both biochemical and cellular assays reveal that these amino acid substitutions do not result in functional differences, suggesting that these sequence changes are either allelic variants or contributory risk factors rather than causative for motor neuron disease. Together, these studies provide further insight into the regulation of dynein-dynactin function in the cell.	[Dixit, Ram; Levy, Jennifer R.; Tokito, Mariko; Ligon, Lee A.; Holzbaur, Erika L. F.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Holzbaur, ELF (corresponding author), Univ Penn, Sch Med, Dept Physiol, D400 Richards Bldg,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu		Ligon, Lee/0000-0002-5735-3654	National Institutes of Health [GM068591, GM48661]; ALS Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068591, R01GM048661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by Grants GM068591 and GM48661 from the National Institutes of Health. This work was also supported by the ALS Association (to E. L. F. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Chevalier-Larsen ES, 2008, HUM MOL GENET, V17, P1946, DOI 10.1093/hmg/ddn092; Culver-Hanlon TL, 2006, NAT CELL BIOL, V8, P264, DOI 10.1038/ncb1370; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lai C, 2007, J NEUROSCI, V27, P13982, DOI 10.1523/JNEUROSCI.4226-07.2007; Levy JR, 2006, J CELL BIOL, V172, P733, DOI 10.1083/jcb.200511068; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Tokito MK, 1998, BBA-GENE STRUCT EXPR, V1442, P432, DOI 10.1016/S0167-4781(98)00195-X; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan KT, 1999, J CELL SCI, V112, P1437; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	28	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33611	33619		10.1074/jbc.M804840200	http://dx.doi.org/10.1074/jbc.M804840200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18812314	Green Published, hybrid			2022-12-27	WOS:000261183700067
J	Inagaki, M; Omori, E; Kim, JY; Komatsu, Y; Scott, G; Ray, MK; Yamada, G; Matsumoto, K; Mishina, Y; Ninomiya-Tsuji, J				Inagaki, Maiko; Omori, Emily; Kim, Jae-Young; Komatsu, Yoshihiro; Scott, Greg; Ray, Manas K.; Yamada, Gen; Matsumoto, Kunihiro; Mishina, Yuji; Ninomiya-Tsuji, Jun			TAK1-binding Protein 1, TAB1, Mediates Osmotic Stress-induced TAK1 Activation but Is Dispensable for TAK1-mediated Cytokine Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; KINASE TAK1; TRANSDUCTION PATHWAY; IN-VIVO; IL-1; COMPLEX; MAPKKK; JNK; IKK; AUTOPHOSPHORYLATION	TAK1 kinase is an indispensable intermediate in several cytokine signaling pathways including tumor necrosis factor, interleukin-1, and transforming growth factor-beta signaling pathways. TAK1 also participates in stress-activated intracellular signaling pathways such as osmotic stress signaling pathway. TAK1-binding protein 1 (TAB1) is constitutively associated with TAK1 through its C-terminal region. Although TAB1 is known to augment TAK1 catalytic activity when it is overexpressed, the role of TAB1 under physiological conditions has not yet been identified. In this study, we determined the role of TAB1 in TAK1 signaling by analyzing TAB1-deficient mouse embryonic fibroblasts (MEFs). Tumor necrosis factor- and interleukin-1-induced activation of TAK1 was entirely normal in Tab1-deficient MEFs and could activate both mitogen-activated protein kinases and NF-kappa B. In contrast, we found that osmotic stress-induced activation of TAK1 was largely impaired in Tab1-deficient MEFs. Furthermore, we showed that the C-terminal 68 amino acids of TAB1 were sufficient to mediate osmotic stress-induced TAK1 activation. Finally, we attempted to determine the mechanism by which TAB1 activates TAK1. We found that TAK1 is spontaneously activated when the concentration is increased and that it is totally dependent on TAB1. Cell shrinkage under the osmotic stress condition increases the concentration of TAB1-TAK1 and may oligomerize and activate TAK1 in a TAB1-dependent manner. These results demonstrate that TAB1 mediates TAK1 activation only in a subset of TAK1 pathways that are mediated through spontaneous oligomerization of TAB1-TAK1.	[Inagaki, Maiko; Omori, Emily; Kim, Jae-Young; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Komatsu, Yoshihiro; Mishina, Yuji] NIEHS, Mol Dev Biol Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Komatsu, Yoshihiro; Yamada, Gen] Kumamoto Univ, Grad Sch Mol & Genom Pharm, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; [Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; [Matsumoto, Kunihiro] Japan Sci & Technol Agcy, Tokyo, Japan; [Mishina, Yuji] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA	University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kumamoto University; Nagoya University; Japan Science & Technology Agency (JST); University of Michigan System; University of Michigan	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu		Kim, Jae-Young/0000-0001-6700-1372; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [ES071003-10, GM068812]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIGES102425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES071003-10 (Y.M.) and GM068812 (to J.N.-T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Inagaki M, 2008, GENESIS, V46, P431, DOI 10.1002/dvg.20418; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kitamura T, 1998, INT J HEMATOL, V67, P351; Komatsu Y, 2002, MECH DEVELOP, V119, P239, DOI 10.1016/S0925-4773(02)00391-X; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Roger F, 1999, J BIOL CHEM, V274, P34103, DOI 10.1074/jbc.274.48.34103; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179	40	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33080	33086		10.1074/jbc.M807574200	http://dx.doi.org/10.1074/jbc.M807574200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829460	Green Published, hybrid			2022-12-27	WOS:000261183700008
J	Porubsky, PR; Meneely, KM; Scott, EE				Porubsky, Patrick R.; Meneely, Kathleen M.; Scott, Emily E.			Structures of Human Cytochrome P-450 2E1 INSIGHTS INTO THE BINDING OF INHIBITORS AND BOTH SMALL MOLECULAR WEIGHT AND FATTY ACID SUBSTRATES.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P450 2E1; ACETAMINOPHEN ACTIVATION; BACULOVIRUS EXPRESSION; LIVER-MICROSOMES; ACTIVE-SITE; ETHANOL; OXIDATION; CYP2E1; B(5); RAT	Human microsomal cytochrome P-450 2E1 (CYP2E1) monooxygenates > 70 low molecular weight xenobiotic compounds, as well as much larger endogenous fatty acid signaling molecules such as arachidonic acid. In the process, CYP2E1 can generate toxic or carcinogenic compounds, as occurs with acetaminophen overdose, nitrosamines in cigarette smoke, and reactive oxygen species from uncoupled catalysis. Thus, the diverse roles that CYP2E1 has in normal physiology, toxicity, and drug metabolism are related to its ability to metabolize diverse classes of ligands, but the structural basis for this was previously unknown. Structures of human CYP2E1 have been solved to 2.2 A for an indazole complex and 2.6 angstrom for a 4-methylpyrazole complex. Both inhibitors bind to the heme iron and hydrogen bond to Thr(303) within the active site. Complementing its small molecular weight substrates, the hydrophobic CYP2E1 active site is the smallest yet observed for a human cytochrome P-450. The CYP2E1 active site also has two adjacent voids: one enclosed above the I helix and the other forming a channel to the protein surface. Minor repositioning of the Phe(478) aromatic ring that separates the active site and access channel would allow the carboxylate of fatty acid substrates to interact with conserved (216)QXXNN(220) residues in the access channel while positioning the hydrocarbon terminus in the active site, consistent with experimentally observed omega-1 hydroxylation of saturated fatty acids. Thus, these structures provide insights into the ability of CYP2E1 to effectively bind and metabolize both small molecule substrates and fatty acids.	[Porubsky, Patrick R.; Meneely, Kathleen M.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of Kansas	Scott, EE (corresponding author), 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu			National Institutes of Health [RR016475, RR017708, GM076343]; University of Kansas New Faculty General Research Grant Program; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343, R01GM076343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas New Faculty General Research Grant Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RR016475 (to P.R.P.) and RR017708 and GM076343 (to E.E.S.). This work was also supported by the University of Kansas New Faculty General Research Grant Program (to E.E.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adas F, 1999, J LIPID RES, V40, P1990; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARNETT CR, 1993, BIOCHEM PHARMACOL, V45, P313, DOI 10.1016/0006-2952(93)90066-6; Bell LC, 1997, J BIOL CHEM, V272, P29643, DOI 10.1074/jbc.272.47.29643; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; Bieche I, 2007, PHARMACOGENET GENOM, V17, P731, DOI 10.1097/FPC.0b013e32810f2e58; Blobaum AL, 2004, J PHARMACOL EXP THER, V310, P281, DOI 10.1124/jpet.104.065508; Bronstein AC, 2007, CLIN TOXICOL, V45, P815, DOI 10.1080/15563650701754763; Chen WQ, 1996, ARCH BIOCHEM BIOPHYS, V335, P123, DOI 10.1006/abbi.1996.0489; Chen WQ, 1998, CHEM RES TOXICOL, V11, P295, DOI 10.1021/tx9701687; Collom SL, 2008, J BIOL CHEM, V283, P3487, DOI 10.1074/jbc.M707630200; Das A, 2007, J AM CHEM SOC, V129, P13778, DOI 10.1021/ja074864x; DeLano WL, 2002, PYMOL USERS MANUAL; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Dostalek M, 2008, J BIOL CHEM, V283, P17147, DOI 10.1074/jbc.M802447200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fairbrother KS, 1998, PHARMACOGENETICS, V8, P543, DOI 10.1097/00008571-199812000-00011; FUKUDA T, 1994, J BIOCHEM-TOKYO, V115, P338, DOI 10.1093/oxfordjournals.jbchem.a124339; FUKUDA T, 1993, J BIOCHEM-TOKYO, V113, P7, DOI 10.1093/oxfordjournals.jbchem.a124006; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; GILLAM EMJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P59, DOI 10.1006/abbi.1994.1280; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hu Y, 1997, MOL PHARMACOL, V51, P370; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; Ioannides C, 2004, CURR TOP MED CHEM, V4, P1767, DOI 10.2174/1568026043387188; JOHANSSON I, 1988, BIOCHEMISTRY-US, V27, P1925, DOI 10.1021/bi00406a019; Kharasch ED, 1996, LANCET, V347, P1367, DOI 10.1016/S0140-6736(96)91011-9; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KOOP DR, 1986, MOL PHARMACOL, V29, P399; KOOP DR, 1986, ALCOHOL CLIN EXP RES, V10, pS44, DOI 10.1111/j.1530-0277.1986.tb05179.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; LASKER JM, 1987, BIOCHEM BIOPH RES CO, V148, P232, DOI 10.1016/0006-291X(87)91100-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Mackman R, 1996, CHEM RES TOXICOL, V9, P223, DOI 10.1021/tx950130z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moran JH, 2000, TOXICOL APPL PHARM, V168, P268, DOI 10.1006/taap.2000.9053; Moreno RL, 2001, ARCH BIOCHEM BIOPHYS, V391, P99, DOI 10.1006/abbi.2001.2390; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; PATTEN CJ, 1995, ARCH BIOCHEM BIOPHYS, V317, P504, DOI 10.1006/abbi.1995.1194; PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019; PETER R, 1990, CHEM RES TOXICOL, V3, P566, DOI 10.1021/tx00018a012; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; RAUCY JL, 1991, MOL PHARMACOL, V39, P275; RAY DC, 1991, BRIT J ANAESTH, V67, P84, DOI 10.1093/bja/67.1.84; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Roy U, 2005, BIOCHEM J, V390, P719, DOI 10.1042/BJ20050681; SALAZAR DE, 1988, BIOCHEM BIOPH RES CO, V157, P315, DOI 10.1016/S0006-291X(88)80049-4; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Smith SV, 2000, BIOCHEMISTRY-US, V39, P5731, DOI 10.1021/bi000129l; SONG BJ, 1987, MOL ENDOCRINOL, V1, P542, DOI 10.1210/mend-1-8-542; Spatzenegger M, 2003, J PHARMACOL EXP THER, V304, P477, DOI 10.1124/jpet.102.043323; SWANSON BA, 1991, J BIOL CHEM, V266, P19258; TASSANEEYAKUL W, 1994, BIOCHEM PHARMACOL, V47, P1767, DOI 10.1016/0006-2952(94)90304-2; Vaz ADN, 1998, P NATL ACAD SCI USA, V95, P3555, DOI 10.1073/pnas.95.7.3555; Vaz ADN, 1996, P NATL ACAD SCI USA, V93, P4644, DOI 10.1073/pnas.93.10.4644; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; WRIGHTON SA, 1986, BIOCHEMISTRY-US, V25, P6731, DOI 10.1021/bi00370a001; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	71	174	182	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33698	33707		10.1074/jbc.M805999200	http://dx.doi.org/10.1074/jbc.M805999200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18818195	hybrid, Green Published			2022-12-27	WOS:000261183700076
J	Sakakura, M; Oo-Puthinan, S; Moriyama, C; Kimura, T; Moriya, J; Irimura, T; Shimada, I				Sakakura, Masayoshi; Oo-Puthinan, Sarawut; Moriyama, Chifumi; Kimura, Tomomi; Moriya, Jun; Irimura, Tatsuro; Shimada, Ichio			Carbohydrate Binding Mechanism of the Macrophage Galactose-type C-type Lectin 1 Revealed by Saturation Transfer Experiments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGALACTOSAMINE BINDING; IMMATURE DENDRITIC CELLS; MOLECULAR-CLONING; ASIALOGLYCOPROTEIN RECEPTOR; IMPROVED SENSITIVITY; RECOGNITION DOMAIN; STRUCTURAL BASIS; NMR EXPERIMENTS; MOUSE EMBRYOS; PROTEIN	Macrophage galactose-type C-type lectins 1 and 2 (MGL1/2) are expressed on the surfaces of macrophages and immature dendritic cells. Despite the high similarity between the primary sequences of MGL1 and MGL2, they display different ligand specificities. MGL1 shows high affinity for the Lewis(X) trisaccharide, whereas MGL2 shows affinity for N-acetylgalactosamine. To elucidate the structural basis for the ligand specificities of the MGLs, we performed NMR analyses of the MGL1-Lewis(X) complex. To identify the Lewis(X) binding site on MGL1, a saturation transfer experiment for the MGL1-Lewis(X) complex where sugar-CH/CH2-selective saturation was applied was carried out. To obtain sugar moiety-specific information on the interface between MGL1 and the Lewis(X) trisaccharide, saturation transfer experiments where each of galactose-H5-, fucose-CH3-, and N-acetylglucosamine-CH3-selective saturations was applied to the MGL1-Lewis(X) complex were performed. Based on these results, we present a Lewis(X) binding mode on MGL1 where the galactose moiety is bound to the primary sugar binding site, including Asp-94, Trp-96, and Asp-118, and the fucose moiety interacts with the secondary sugar binding site, including Ala-89 and Thr-111. Ala-89 and Thr-111 in MGL1 are replaced with arginine and serine in MGL2, respectively. The hydrophobic environment formed by a small side chain of Ala-89 and a methyl group of Thr-111 is a requisite for the accommodation of the fucose moiety of the Lewis(X) trisaccharide within the sugar binding site of MGL1.	[Sakakura, Masayoshi; Moriyama, Chifumi; Kimura, Tomomi; Moriya, Jun; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Phys Chem Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Oo-Puthinan, Sarawut; Irimura, Tatsuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Bunkyo Ku, Tokyo 1130033, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, BIRC, Koto Ku, Tokyo 1350064, Japan	University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Phys Chem Lab, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [17035020]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research on Priority Areas 17035020 from The Ministry of Education, Culture, Sports, Science and Technology (MEXT). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Coombs PJ, 2006, GLYCOBIOLOGY, V16, p1C, DOI 10.1093/glycob/cwj126; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; Denda-Nagai K, 2002, GLYCOBIOLOGY, V12, P443, DOI 10.1093/glycob/cwf061; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; EDISON AS, 1994, METHOD ENZYMOL, V239, P3; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Higashi N, 2002, J BIOL CHEM, V277, P20686, DOI 10.1074/jbc.M202104200; Ichii S, 1997, J LEUKOCYTE BIOL, V62, P761, DOI 10.1002/jlb.62.6.761; Ichii S, 2000, CANCER IMMUNOL IMMUN, V49, P1, DOI 10.1007/s002620050021; Karlsson Robert, 1994, Methods (Orlando), V6, P99, DOI 10.1006/meth.1994.1013; KAWAKAMI K, 1994, JPN J CANCER RES, V85, P744, DOI 10.1111/j.1349-7006.1994.tb02423.x; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kise KJ, 2001, BIOORGAN MED CHEM, V9, P2485, DOI 10.1016/S0968-0896(01)00216-4; Kogelberg H, 2001, CURR OPIN STRUC BIOL, V11, P635, DOI 10.1016/S0959-440X(00)00259-1; Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679; Kolatkar AR, 1998, J BIOL CHEM, V273, P19502, DOI 10.1074/jbc.273.31.19502; Linehan SA, 2000, MICROBES INFECT, V2, P279, DOI 10.1016/S1286-4579(00)00300-2; Mal TK, 2004, J MOL BIOL, V339, P681, DOI 10.1016/j.jmb.2004.04.020; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Mizuochi S, 1998, GLYCOCONJUGATE J, V15, P397, DOI 10.1023/A:1006930019886; Mizuochi S, 1997, GLYCOBIOLOGY, V7, P137, DOI 10.1093/glycob/7.1.137; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Oo-Puthinan S, 2008, BBA-GEN SUBJECTS, V1780, P89, DOI 10.1016/j.bbagen.2007.10.017; SATO M, 1992, J BIOCHEM-TOKYO, V111, P331, DOI 10.1093/oxfordjournals.jbchem.a123758; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Suzuki N, 1996, J IMMUNOL, V156, P128; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuita H, 2005, GLYCOBIOLOGY, V15, P1368, DOI 10.1093/glycob/cwj028	42	20	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33665	33673		10.1074/jbc.M804067200	http://dx.doi.org/10.1074/jbc.M804067200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18790731	hybrid, Green Published			2022-12-27	WOS:000261183700073
J	Dam, TK; Torres, M; Brewer, CF; Casadevall, A				Dam, Tarun K.; Torres, Marcela; Brewer, C. Fred; Casadevall, Arturo			Isothermal Titration Calorimetry Reveals Differential Binding Thermodynamics of Variable Region-identical Antibodies Differing in Constant Region for a Univalent Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTOCOCCUS-NEOFORMANS; FINE SPECIFICITY; CARBOHYDRATE-BINDING; ANTIGEN RECOGNITION; CONCANAVALIN-A; COMBINING SITE; PEPTIDE; ISOTYPE; LIPOPOLYSACCHARIDE; IDENTIFICATION	The classical view of immunoglobulin molecules posits two functional domains defined by the variable (V) and constant (C) regions, which are responsible for antigen binding and antibody effector functions, respectively. These two domains are thought to function independently. However, several lines of evidence strongly suggest that C region domains can affect the specificity and affinity of an antibody for its antigen (Ag), independent of avidity-type effects. In this study, we used isothermal titration calorimetry to investigate the thermodynamic properties of the interactions of four V region-identical monoclonal antibodies with a univalent peptide antigen. Comparison of the binding of IgG1, IgG2a, IgG2b, and IgG3 with a 12-mer peptide mimetic of Cryptococcus neoformans polysaccharide revealed a stoichiometry of 1.9-2.0 with significant differences in thermodynamic binding parameters. Binding of this peptide to the antibodies was dominated by favorable entropy. The interaction of these antibodies with biotinylated peptides manifested greater enthalpy than for native peptides indicating that biotin labeling affected the types of Ag-Ab complexes formed. Our results provide unambiguous thermodynamic evidence for the notion that the C region can affect the interaction of the V region with an Ag.	[Dam, Tarun K.; Brewer, C. Fred] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Torres, Marcela; Brewer, C. Fred; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Dam, TK (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tdam@aecom.yu.edu; casadeva@aecom.yu.edu			National Institutes of Health [AI033142-15, AI033774-15, HL059842-11, AI052733-05, 5U54AI057158-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733, R01AI033142, R37AI033142, U54AI057158, R01AI033774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI033142-15, AI033774-15, HL059842-11, AI052733-05, and 5U54AI057158-05 (to A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; CYGLER M, 1993, BIOCHEM SOC T, V21, P437, DOI 10.1042/bst0210437; GREENSPAN NS, 1989, FASEB J, V3, P2203, DOI 10.1096/fasebj.3.10.2666233; Gupta D, 1996, BIOCHEMISTRY-US, V35, P15236, DOI 10.1021/bi961458+; HERRON JN, 1986, BIOCHEMISTRY-US, V25, P4602, DOI 10.1021/bi00364a022; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; LEMIEUX RU, 1989, CHEM SOC REV, V18, P347, DOI 10.1039/cs9891800347; LEMIEUX RU, 1991, CIBA F SYMP, V158, P231; MARIUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50, DOI 10.1016/0952-7915(93)90080-C; McCloskey N, 1996, IMMUNOLOGY, V88, P169, DOI 10.1111/j.1365-2567.1996.tb00001.x; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; MORELOCK MM, 1994, J BIOL CHEM, V269, P13048; MUNSKE GR, 1984, ARCH BIOCHEM BIOPHYS, V233, P582, DOI 10.1016/0003-9861(84)90482-X; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; SCHREIBER JR, 1993, J INFECT DIS, V167, P221, DOI 10.1093/infdis/167.1.221; SCHWARZ FP, 1993, J BIOL CHEM, V268, P7668; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; SPIRA G, 1992, J IMMUNOL METHODS, V148, P121, DOI 10.1016/0022-1759(92)90165-P; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001310; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Valadon P, 1996, J MOL BIOL, V261, P11, DOI 10.1006/jmbi.1996.0438; Vyas NK, 2003, P NATL ACAD SCI USA, V100, P15023, DOI 10.1073/pnas.2431286100; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387; Welfle K, 2003, J MOL RECOGNIT, V16, P54, DOI 10.1002/jmr.607; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Young ACM, 1997, J MOL BIOL, V274, P622, DOI 10.1006/jmbi.1997.1407	31	54	55	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31366	31370		10.1074/jbc.M806473200	http://dx.doi.org/10.1074/jbc.M806473200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18806257	hybrid, Green Published			2022-12-27	WOS:000260760800014
J	Pei, DQ				Pei, Duanqing			Regulation of Pluripotency and Reprogramming by Transcription Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							STEM-CELL PLURIPOTENCY; SUSTAINING FACTOR; SELF-RENEWAL; NANOG; SOX2; GENERATION; EXPRESSION; NETWORK; OCT4; DIFFERENTIATION	Living organisms, from virus to human, rely on the transcription machinery to express specific parts of their genomes to execute critical biological functions during their life cycle by responding to environmental or developmental signals. Thus, transcription constitutes a critical step in regulating biological processes, and transcription factors have been considered as master switches for cell fate determination. Stem cell biology has benefited from rapid advances in recent years, largely because of the characterization of several transcription factors as master regulators of stem cell pluripotency. The same factors, viz. Oct4, Sox2, Nanog, Klf4, and Myc, have been shown to possess the magic power to reprogram somatic cells into pluripotent ones, a remarkable achievement with both practical and theoretical implications. This minireview summarizes recent advances in pluripotency and reprogramming by focusing on key transcription factors and the likely mechanisms.	Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510663, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	zhou, xingru/G-4442-2012		National Natural Science Foundation of China [30725012, 30630039]; Chinese Academy of Sciences [KSCX2-YW-R-48]; Guangzhou Science and Technology [2006A50104002]; Ministry of Science and Technology 973 Grants [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Guangzhou Science and Technology; Ministry of Science and Technology 973 Grants(National Basic Research Program of China)	This work was supported in part by National Natural Science Foundation of China Grants 30725012 and 30630039; Chinese Academy of Sciences Grant KSCX2-YW-R-48; Guangzhou Science and Technology Grant 2006A50104002; and Ministry of Science and Technology 973 Grants 2006CB701504, 2006CB943600, 2007CB948002, and 2007CB947804. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Li J, 2007, J BIOL CHEM, V282, P19481, DOI 10.1074/jbc.M702056200; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pei DQ, 2008, CELL RES, V18, P221, DOI 10.1038/cr.2008.21; Qin DJ, 2007, CELL RES, V17, P959, DOI 10.1038/cr.2007.92; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang JL, 2008, CELLS TISSUES ORGANS, V188, P23, DOI 10.1159/000113532; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	41	78	91	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3365	3369		10.1074/jbc.R800063200	http://dx.doi.org/10.1074/jbc.R800063200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	18819918	hybrid			2022-12-27	WOS:000262872500001
J	Hashimoto, K; Suzuki, H; Taniguchi, K; Noguchi, T; Yohda, M; Odaka, M				Hashimoto, Koichi; Suzuki, Hiroyuki; Taniguchi, Kayoko; Noguchi, Takumi; Yohda, Masafumi; Odaka, Masafumi			Catalytic Mechanism of Nitrile Hydratase Proposed by Time-resolved X-ray Crystallography Using a Novel Substrate, tert-Butylisonitrile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONHEME IRON CENTER; CRYSTAL-STRUCTURE; CO(III) COMPLEXES; ACTIVE-SITE; PROTEIN; OXIDE	Nitrile hydratases (NHases) have an unusual iron or cobalt catalytic center with two oxidized cysteine ligands, cysteinesulfinic acid and cysteine-sulfenic acid, catalyzing the hydration of nitriles to amides. Recently, we found that the NHase of Rhodococcus erythropolis N771 exhibited an additional catalytic activity, converting tert-butylisonitrile (tBuNC) to tert-butylamine. Taking advantage of the slow reactivity of tBuNC and the photoreactivity of nitrosylated NHase, we present the first structural evidence for the catalytic mechanism of NHase with time-resolved x-ray crystallography. By monitoring the reaction with attenuated total reflectance Fourier transform infrared spectroscopy, the product from the isonitrile carbon was identified as a CO molecule. Crystals of nitrosylated inactive NHase were soaked with tBuNC. The catalytic reaction was initiated by photo-induced denitrosylation and stopped by flash cooling. tBuNC was first trapped at the hydrophobic pocket above the iron center and then coordinated to the iron ion at 120 min. At 440 min, the electron density of tBuNC was significantly altered, and a new electron density was observed near the isonitrile carbon as well as the sulfenate oxygen of alpha Cys(114). These results demonstrate that the substrate was coordinated to the iron and then attacked by a solvent molecule activated by alpha Cys(114)-SOH.	[Hashimoto, Koichi; Yohda, Masafumi] Tokyo Univ Agr & Technol, Grad Sch Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Suzuki, Hiroyuki; Noguchi, Takumi; Odaka, Masafumi] Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan; [Taniguchi, Kayoko] RIKEN, Ecosoft Mat Res Units, Wako, Saitama 3510198, Japan	Tokyo University of Agriculture & Technology; University of Tsukuba; RIKEN	Odaka, M (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	modaka@cc.tuat.ac.jp	Odaka, Masafumi/C-2378-2013; Noguchi, Takumi/I-7105-2014; Yohda, Masafumi/A-5149-2013	Yohda, Masafumi/0000-0001-8307-9671	21st Century Center of Excellence" Project [19350080]; Creative Scientific Research [17GS0314]; Japanese Society for the Promotion of Science Fellows [19252]; Ministry of Education, Science, Sports and Culture of Japan	21st Century Center of Excellence" Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creative Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society for the Promotion of Science Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-aid for scientific research from the "Future nano materials" section of the "21st Century Center of Excellence" Project, Grant-in-Aid for Scientific Research (B) KAKENHI 19350080 (to M.O.), Grant-in-Aid for Creative Scientific Research 17GS0314 (to T.N.), Grant-in-Aid from the Japanese Society for the Promotion of Science Fellows 19252 ( to H. S.), and a grant from the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Science, Sports and Culture of Japan (to M.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arakawa T, 2007, J MOL BIOL, V366, P1497, DOI 10.1016/j.jmb.2006.12.011; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonnet D, 1997, FEBS LETT, V409, P216, DOI 10.1016/S0014-5793(97)00511-5; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo I, 2001, J INORG BIOCHEM, V83, P247, DOI 10.1016/S0162-0134(00)00171-9; Heinrich L, 2001, EUR J INORG CHEM, P2203; Hopmann KH, 2008, EUR J INORG CHEM, P1406, DOI 10.1002/ejic.200701137; Hopmann KH, 2007, INORG CHEM, V46, P4850, DOI 10.1021/ic061894c; Hourai S, 2003, BIOCHEM BIOPH RES CO, V312, P340, DOI 10.1016/j.bbrc.2003.10.124; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; Kubiak K, 2008, BIOPHYS J, V94, P3824, DOI 10.1529/biophysj.107.116665; Lugo-Mas P, 2006, J AM CHEM SOC, V128, P11211, DOI 10.1021/ja062706k; Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P11642, DOI 10.1021/bi035260i; Noguchi T, 1996, BIOCHEMISTRY-US, V35, P16777, DOI 10.1021/bi961562r; Noveron JC, 1999, J AM CHEM SOC, V121, P3553, DOI 10.1021/ja9833523; Odaka M, 1997, J AM CHEM SOC, V119, P3785, DOI 10.1021/ja962179c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shearer J, 2001, J AM CHEM SOC, V123, P463, DOI 10.1021/ja002642s; SUGIURA Y, 1987, J AM CHEM SOC, V109, P5848, DOI 10.1021/ja00253a046; Takarada H, 2006, BIOSCI BIOTECH BIOCH, V70, P881, DOI 10.1271/bbb.70.881; Taniguchi K, 2008, J BIOSCI BIOENG, V106, P174, DOI 10.1263/jbb.106.174; Tsujimura M, 2003, J AM CHEM SOC, V125, P11532, DOI 10.1021/ja035018z; Tsujimura M, 1996, J BIOCHEM-TOKYO, V119, P407; Tyler LA, 2003, INORG CHEM, V42, P5751, DOI 10.1021/ic030088s; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yano T, 2007, INORG CHEM, V46, P10345, DOI 10.1021/ic701107x	34	45	46	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36617	36623		10.1074/jbc.M806577200	http://dx.doi.org/10.1074/jbc.M806577200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18948265	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000261840500060
J	Vasudevan, S; Yuan, J; Osapay, G; Tran, P; Tai, K; Liang, W; Kumar, V; Selsted, ME; Cocco, MJ				Vasudevan, Sheeja; Yuan, Jun; Oesapay, George; Tran, Patti; Tai, Kenneth; Liang, Warren; Kumar, Vasanth; Selsted, Michael E.; Cocco, Melanie J.			Synthesis, Structure, and Activities of an Oral Mucosal alpha-Defensin from Rhesus Macaque	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; SALT BRIDGE; CRYPTDIN-4; SYSTEM; NP-2	The oral cavity is an environment challenged by a large variety of pathogens. Consequently, the antimicrobial peptides expressed in that environment are interesting as they evolved to defend against a broad spectrum of bacteria and fungi. Here we report the discovery of new alpha-defensins from rhesus macaque oral mucosa and determine the first alpha-defensin structure from that species. The new peptides were identified by sequencing of reverse transcriptase-PCR products obtained from oral mucosal tissues, disclosing three mucosal alpha-defensins, termed rhesus macaque oral alpha-defensins (ROADs). The peptide corresponding to fully processed ROAD-1 was synthesized, subjected to folding/ oxidation conditions, and purified. ROAD-1 was active against Staphylococcus aureus, Escherichia coli, and Candida albicans in a concentration-dependent manner. Wedetermined the structure of ROAD-1 using NMR spectroscopy and find that the synthetic peptide adopts the canonical disulfide pairing and alpha-defensin fold. The antimicrobial mechanism of defensins has been correlated with their ability to disrupt and permeabilize the cell envelope, activities that depend on the surface features of the folded peptide. Although ROAD-1 maintains the defensin fold, the oral defensin displays distinct surface features when compared with other alpha-defensin structures.	[Vasudevan, Sheeja; Tai, Kenneth; Cocco, Melanie J.] Univ Calif Irvine, Sch Med, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Yuan, Jun; Oesapay, George; Tran, Patti; Liang, Warren; Kumar, Vasanth; Selsted, Michael E.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Selsted, ME (corresponding author), Univ Calif Irvine, Sch Med, Dept Mol Biol & Biochem, D440 Med Sci 1, Irvine, CA 92697 USA.	michael.selsted@uci.edu; mcocco@uci.edu	Cocco, Melanie J/B-7929-2010	Cocco, Melanie J/0000-0003-4039-5863	National Institutes of Health [DE15517, AI229331, AI58129]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE15517, AI229331, and AI58129 ( to M. E. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Dale BA, 2005, CURR ISSUES MOL BIOL, V7, P119; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hristova K, 1997, J BIOL CHEM, V272, P24224, DOI 10.1074/jbc.272.39.24224; Jing WG, 2004, BIOCHEMISTRY-US, V43, P15759, DOI 10.1021/bi048645p; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar S, 2001, IBM J RES DEV, V45, P499, DOI 10.1147/rd.453.0499; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; McManus AM, 2000, BIOCHEMISTRY-US, V39, P15757, DOI 10.1021/bi000457l; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Ouellette AJ, 1999, INFECT IMMUN, V67, P6643; PARDI A, 1992, BIOCHEMISTRY-US, V31, P11357, DOI 10.1021/bi00161a013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, INFECT IMMUN, V72, P1470, DOI 10.1128/IAI.72.3.1470-1478.2004; Tang YQ, 1999, INFECT IMMUN, V67, P6139, DOI 10.1128/IAI.67.11.6139-6144.1999; Thennarasu S, 1999, BIOCHEM BIOPH RES CO, V254, P281, DOI 10.1006/bbrc.1998.9933; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wong JH, 2007, CURR PROTEIN PEPT SC, V8, P446, DOI 10.2174/138920307782411446; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wuthrich K, 1986, NMR PROTEINS NUCL AC	34	6	6	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35869	35877		10.1074/jbc.M806915200	http://dx.doi.org/10.1074/jbc.M806915200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18930922	Green Published, hybrid			2022-12-27	WOS:000261687900062
J	Berniakovich, I; Trinei, M; Stendardo, M; Migliaccio, E; Minucci, S; Bernardi, P; Pelicci, PG; Giorgio, M				Berniakovich, Ina; Trinei, Mirella; Stendardo, Massimo; Migliaccio, Enrica; Minucci, Saverio; Bernardi, Paolo; Pelicci, Pier Giuseppe; Giorgio, Marco			p66(Shc)-generated Oxidative Signal Promotes Fat Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; HYDROGEN-PEROXIDE; INSULIN-RECEPTOR; ADIPOCYTE DIFFERENTIATION; UNCOUPLING PROTEINS; 3T3-L1 ADIPOCYTES; REDOX REGULATION; ADAPTER PROTEIN; ADIPOSE-TISSUE; GENE PROTECTS	Reactive oxygen species (ROS) and insulin signaling in the adipose tissue are critical determinants of aging and age-associated diseases. It is not clear, however, if they represent independent factors or they are mechanistically linked. We investigated the effects of ROS on insulin signaling using as model system the p66(Shc)-null mice. p66(Shc) is a redox enzyme that generates mitochondrial ROS and promotes aging in mammals. We report that insulin activates the redox enzyme activity of p66(Shc) specifically in adipocytes and that p66(Shc)-generated ROS regulate insulin signaling through multiple mechanisms, including AKT phosphorylation, Foxo localization, and regulation of selected insulin target genes. Deletion of p66(Shc) resulted in increased mitochondrial uncoupling and reduced triglyceride accumulation in adipocytes and in vivo increased metabolic rate and decreased fat mass and resistance to diet-induced obesity. In addition, p66(Shc-/-) mice showed impaired thermo-insulation. These findings demonstrate that p66(Shc)-generated ROS regulate the effect of insulin on the energetic metabolism in mice and suggest that intracellular oxidative stress might accelerate aging by favoring fat deposition and fat-related disorders.	[Berniakovich, Ina; Stendardo, Massimo; Migliaccio, Enrica; Minucci, Saverio; Pelicci, Pier Giuseppe; Giorgio, Marco] European Inst Oncol, I-20141 Milan, Italy; [Berniakovich, Ina; Stendardo, Massimo; Migliaccio, Enrica; Pelicci, Pier Giuseppe; Giorgio, Marco] Firc Inst Mol Oncol, I-20139 Milan, Italy; [Trinei, Mirella; Minucci, Saverio] Genextra SpA, I-20139 Milan, Italy; [Bernardi, Paolo] Univ Padua, Dipartimento Sci Biochim, I-35128 Padua, Italy; [Pelicci, Pier Giuseppe] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20142 Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Padua; University of Milan	Giorgio, M (corresponding author), Ist Europeo Oncol, Via Ripamonti 435, I-20139 Milan, Italy.	marco.giorgio@ifom-ieo-campus.it	Migliaccio, Enrica/AAQ-8880-2020; Giorgio, Marco/I-9425-2012; Minucci, Saverio/J-9669-2012; Bernardi, Paolo/C-3656-2008; Pelicci, Pier Giuseppe/AAL-6572-2020	Giorgio, Marco/0000-0002-5842-6042; Bernardi, Paolo/0000-0001-9187-3736; 	National Institutes of Health [1P01AG025532-01A1]; Associazione Italiana per la Ricerca sul Cancro; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01AG025532-01A1. This work was also supported by grants from Associazione Italiana per la Ricerca sul Cancro. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bevan P, 2001, J CELL SCI, V114, P1429; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; CHAMPIGNY O, 1992, MOL CELL ENDOCRINOL, V86, P73, DOI 10.1016/0303-7207(92)90177-8; Cho KJ, 2003, J BIOL CHEM, V278, P34823, DOI 10.1074/jbc.M210747200; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Harman D, 1998, ANN NY ACAD SCI, V854, P1, DOI 10.1111/j.1749-6632.1998.tb09886.x; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Kao AW, 1997, ENDOCRINOLOGY, V138, P2474, DOI 10.1210/en.138.6.2474; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; Kim JR, 2006, EXP MOL MED, V38, P162, DOI 10.1038/emm.2006.20; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; MAY JM, 1979, J BIOL CHEM, V254, P9017; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Sjogren K, 2001, J NUTR, V131, P2963, DOI 10.1093/jn/131.11.2963; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Weindruch R., 1988, RETARDATION AGING DI; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F	41	128	130	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34283	34293		10.1074/jbc.M804362200	http://dx.doi.org/10.1074/jbc.M804362200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18838380	hybrid, Green Published			2022-12-27	WOS:000261277700056
J	Cheung, WD; Sakabe, K; Housley, MP; Dias, WB; Hart, GW				Cheung, Win D.; Sakabe, Kaoru; Housley, Michael P.; Dias, Wagner B.; Hart, Gerald W.			O-Linked beta-N-Acetylglucosaminyltransferase Substrate Specificity Is Regulated by Myosin Phosphatase Targeting and Other Interacting Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLE; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; TETRATRICOPEPTIDE REPEATS; IN-VIVO; PHOSPHORYLATION; NUCLEAR; GLCNACYLATION; ROLES; GLYCOSYLATION	O-GlcNAc-transferase (OGT) substrate specificity is regulated by transiently interacting proteins. To further examine the regulation of OGT, we have identified 27 putative OGT-interacting proteins through a yeast two-hybrid screen. Two of these proteins, Trak1 (OIP106) and O-GlcNA case, have been shown previously to interact with and regulate OGT. We demonstrate here that MYPT1 and CARM1 also interact with and target OGT. MYPT1 and CARM1 are substrates of OGT in vitro and in vivo. MYPT1 and CARM1 also function to alter OGT substrate specificity in vitro. Furthermore depletion of MYPT1 in Neuro-2a neuroblastoma cells alters GlcNA cylation of several proteins under basal conditions, suggesting that MYPT1 regulates OGT substrate specificity in vivo.	[Cheung, Win D.; Sakabe, Kaoru; Housley, Michael P.; Dias, Wagner B.; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Dias, Wagner/B-1401-2016	Dias, Wagner/0000-0002-8378-8846; Hart, Gerald/0000-0001-7812-4351	National Institutes of Health [R01 HD13563, R01 CA42486]; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD13563 and R01 CA42486 (to G. W. H.). This work was also supported by a National Science Foundation graduate research fellowship (to W. D. C.). Under a licensing agreement between The Johns Hopkins University, Covance Research Products, Sigma-Aldrich, and Santa Cruz Biotechnology, G. W. H. receives royalties from the sale of the CTD110.6 O-GlcNAc antibody. The terms of this agreement are managed by The Johns Hopkins University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cieniewski-Bernard C, 2004, MOL CELL PROTEOMICS, V3, P577, DOI 10.1074/mcp.M400024-MCP200; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hedou J, 2007, J BIOL CHEM, V282, P10360, DOI 10.1074/jbc.M606787200; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Marz P, 2006, J BIOL CHEM, V281, P20263, DOI 10.1074/jbc.M601563200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; Nolte D, 2002, MAMM GENOME, V13, P62, DOI 10.1007/s00335-001-2108-9; Okamoto R, 2005, TRANSGENIC RES, V14, P337, DOI 10.1007/s11248-005-3453-3; Riu IH, 2008, BIOCHEM BIOPH RES CO, V372, P203, DOI 10.1016/j.bbrc.2008.05.034; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Xia DL, 2005, EXP CELL RES, V304, P506, DOI 10.1016/j.yexcr.2004.11.025; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	37	119	120	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33935	33941		10.1074/jbc.M806199200	http://dx.doi.org/10.1074/jbc.M806199200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840611	Green Published, hybrid			2022-12-27	WOS:000261277700020
J	Hao, N; Zeng, YX; Elston, TC; Dohlman, HG				Hao, Nan; Zeng, Yaxue; Elston, Timothy C.; Dohlman, Henrik G.			Control of MAPK Specificity by Feedback Phosphorylation of Shared Adaptor Protein Ste50	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; SIGNAL-TRANSDUCTION; RESPONSE PATHWAY; OSMOTIC-STRESS; INVASIVE GROWTH; PLASMA-MEMBRANE; KINASE CASCADE; STE11P MAPKKK; SAM DOMAIN	Many different signaling pathways share common components but nevertheless invoke distinct physiological responses. In yeast, the adaptor protein Ste50 functions in multiple mitogen-activated protein (MAP) kinase pathways, each with unique dynamical and developmental properties. Although Kss1 activity is sustained and promotes invasive growth, Hog1 activity is transient and promotes cell adaptation to osmotic stress. Here we show that osmotic stress activates Kss1 as well as Hog1. We show further that Hog1 phosphorylates Ste50 and that phosphorylation of Ste50 limits the duration of Kss1 activation and prevents invasive growth under high osmolarity growth conditions. Thus feedback regulation of a shared component can restrict the activity of a competing MAP kinase to ensure signal fidelity.	[Zeng, Yaxue; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Hao, Nan; Elston, Timothy C.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu	Hao, Nan/O-3462-2016	Hao, Nan/0000-0003-2857-4789; Dohlman, Henrik/0000-0003-2443-0729				Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Bhattacharjya S, 2004, J MOL BIOL, V344, P1071, DOI 10.1016/j.jmb.2004.09.018; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Davenport KD, 1999, GENETICS, V153, P1091; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Erdman S, 2001, GENETICS, V159, P919; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grimshaw SJ, 2004, J BIOL CHEM, V279, P2192, DOI 10.1074/jbc.M305605200; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Jansen G, 2001, MOL GENET GENOMICS, V265, P102, DOI 10.1007/s004380000394; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1998, MOL CELL BIOL, V18, P5788, DOI 10.1128/MCB.18.10.5788; RAD MR, 1992, MOL GEN GENET, V236, P145; Rad MR, 1998, MOL GEN GENET, V259, P29, DOI 10.1007/s004380050785; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Truckses DM, 2006, MOL CELL BIOL, V26, P912, DOI 10.1128/MCB.26.3.912-928.2006; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Wu CL, 1999, MOL BIOL CELL, V10, P2425, DOI 10.1091/mbc.10.7.2425; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706; Wu CL, 2003, EUKARYOT CELL, V2, P949, DOI 10.1128/EC.2.5.949-961.2003; Xu G, 1996, MOL MICROBIOL, V20, P773, DOI 10.1111/j.1365-2958.1996.tb02516.x; Zaragoza O, 2000, ANTON LEEUW INT J G, V78, P187, DOI 10.1023/A:1026594407609	45	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33798	33802		10.1074/jbc.C800179200	http://dx.doi.org/10.1074/jbc.C800179200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854322	Green Published, hybrid			2022-12-27	WOS:000261277700002
J	Ogawa, E; Okuyama, R; Egawa, T; Nagoshi, H; Obinata, M; Tagami, H; Ikawa, S; Aiba, S				Ogawa, Eisaku; Okuyama, Ryuhei; Egawa, Teie; Nagoshi, Hirokazu; Obinata, Masuo; Tagami, Hachiro; Ikawa, Shuntaro; Aiba, Setsuya			p63/p51-induced Onset of Keratinocyte Differentiation via the c-Jun N-terminal Kinase Pathway Is Counteracted by Keratinocyte Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 HOMOLOG; STEM-CELLS; P63; SKIN; EXPRESSION; COMMITMENT; PROTEIN; PROLIFERATION; PSORIASIS; EPIDERMIS	p63/p51, a homolog of the tumor suppressor protein p53, is chiefly expressed in epithelial tissues, including the epidermis. p63 affects cell death similar to p53, and also plays important roles in the development of epithelial tissues and the maintenance of epithelial stem cells. Because it remains unclear how p63 regulates epithelial cell differentiation, we examined the function(s) of p63 in keratinocyte differentiation through the use of a keratinocyte culture system. Delta Np63 alpha(Delta Np51B), a p63 isoform specifically expressed in basal keratinocytes, suppressed the differentiation of specific late-stage proteins, such as filaggrin and loricrin. In contrast, Delta Np63 alpha induced keratin 1 (K1), which is expressed at the start of differentiation, via c-Jun N-terminal kinase (JNK)/AP-1 activation. However, p63 did not induce K1 expression in the basal layer in vivo, although basal keratinocytes had high levels of p63. This discrepancy was explained by the suppression of K1 expression by dermis-secreted keratinocyte growth factor. This suppression occurred via extracellular signal-related kinase (ERK) signaling, and counteracted the p63-mediated induction of K1. Thus, a precise balance between p63 and keratinocyte growth factor mediates the onset of epithelial cell differentiation, through JNK and ERK signaling. These data may provide mechanistic explanations for the pathological features of skin diseases, including psoriasis.	[Ogawa, Eisaku; Okuyama, Ryuhei; Egawa, Teie; Tagami, Hachiro; Aiba, Setsuya] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi 9808574, Japan; [Nagoshi, Hirokazu; Obinata, Masuo; Ikawa, Shuntaro] Tohoku Univ, Dept Cell Biol, Inst Dev Aging & Canc, Sendai, Miyagi 9808574, Japan; [Nagoshi, Hirokazu; Ikawa, Shuntaro] Tohoku Univ, Interdisciplinary Res Ctr, Ikawa Grp, Sendai, Miyagi 9808574, Japan	Tohoku University; Tohoku University; Tohoku University	Okuyama, R (corresponding author), 1-1 Seriyo Machi,Aoba Ku, Sendai, Miyagi 9808574, Japan.	rokuyama@mail.tains.tohoku.ac.jp	井川, 俊太郎/L-5911-2015		Ministry of Education, Culture, Sports, Science, and Technology of the Japanese	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese government. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreadis ST, 2001, FASEB J, V15, P898, DOI 10.1096/fj.00-0324com; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Finch PW, 1997, AM J PATHOL, V151, P1619; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Fomenkov A, 2003, J BIOL CHEM, V278, P23906, DOI 10.1074/jbc.M300746200; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Glickman JN, 2001, HUM PATHOL, V32, P1157, DOI 10.1053/hupa.2001.28951; Haase I, 2001, J CLIN INVEST, V108, P527, DOI 10.1172/JCI200112153; Honeycutt KA, 2004, J INVEST DERM SYMP P, V9, P261, DOI 10.1111/j.1087-0024.2004.09312.x; Hu H, 2002, INT J CANCER, V102, P580, DOI 10.1002/ijc.10739; HUFF CA, 1993, J BIOL CHEM, V268, P377; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Koster MI, 2005, J INVEST DERM SYMP P, V10, P118, DOI 10.1111/j.1087-0024.2005.200416.x; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; LU B, 1994, J BIOL CHEM, V269, P7443; Massion PP, 2003, CANCER RES, V63, P7113; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mills AA, 2006, CURR OPIN GENET DEV, V16, P38, DOI 10.1016/j.gde.2005.12.001; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Ogawa E, 2008, ONCOGENE, V27, P848, DOI 10.1038/sj.onc.1210682; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Ridky TW, 2004, CELL CYCLE, V3, P621; SCHRODER JM, 1995, J INVEST DERMATOL, V105, P20; Shen CS, 2005, J DERMATOL, V32, P236, DOI 10.1111/j.1346-8138.2005.tb00755.x; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Takahashi H, 2002, J DERMATOL SCI, V30, P94, DOI 10.1016/S0923-1811(02)00064-6; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8	41	33	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34241	34249		10.1074/jbc.M804101200	http://dx.doi.org/10.1074/jbc.M804101200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18849344	Green Published, hybrid			2022-12-27	WOS:000261277700052
J	Racek, T; Buhlmann, S; Rust, F; Knoll, S; Alla, V; Putzer, BM				Racek, Tomas; Buhlmann, Sven; Ruest, Franziska; Knoll, Susanne; Alla, Vijay; Puetzer, Brigitte M.			Transcriptional Repression of the Prosurvival Endoplasmic Reticulum Chaperone GRP78/BIP by E2F1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CARCINOMA-CELL-LINES; NF-Y CBF; STRESS-RESPONSE; GENE-EXPRESSION; BREAST-CANCER; TFII-I; E2F1-INDUCED APOPTOSIS; DRUG-RESISTANCE; BINDING-SITE	The endoplasmic reticulum chaperone GRP78/BIP plays a central role in the prosurvival machinery, and its enhanced expression has been implicated in drug resistance, carcinogenesis, and metastasis. E2F1, as part of an antitumor safeguard mechanism, promotes apoptosis regardless of functional p53. Using cells that are defective in p53, we show that E2F1 represses GRP78/BIP at the transcriptional level, and this requires its DNA binding domain. Analysis of human GRP78/BIP promoter reporter constructs revealed that the region between -371 and -109 of the proximal promoter contains major E2F1-responsive elements. Toward understanding the underlying mechanism of this regulation, we performed chromatin immunoprecipitation and gel shift assays, demonstrating that E2F1 directly binds to GC-rich regions in the distal GC-box and endoplasmic reticulum stress response element -126 by interfering with the binding of positive regulatory proteins Sp1 and TFII-I of the ER stress response element-binding factor complex. We further show that TFII-I, which is required for optimal stress induction of GRP78/BIP, is suppressed by E2F1 on the protein level. Finally, our studies suggest a molecular link between the inhibition of GRP78/BIP and E2F1-mediated chemosensitization of tumor cells, underscoring its relevance for cancer treatment. Together, the data provide a new mechanism for the incompletely understood tumor suppressor function of E2F1.	[Racek, Tomas; Buhlmann, Sven; Ruest, Franziska; Knoll, Susanne; Alla, Vijay; Puetzer, Brigitte M.] Univ Rostock, Biomed Res Ctr, Dept Vectorol & Expt Gene Therapy, D-18055 Rostock, Germany	University of Rostock	Putzer, BM (corresponding author), Schillingallee 69, D-18055 Rostock, Germany.	brigitte.puetzer@med.uni-rostock.de			Forschungsforderung der Medizinischen Fakultat der Rostocker Universitat [889007]	Forschungsforderung der Medizinischen Fakultat der Rostocker Universitat	This work was supported by Forschungsforderung der Medizinischen Fakultat der Rostocker Universitat Grant 889007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdelrahim M, 2005, J BIOL CHEM, V280, P16508, DOI 10.1074/jbc.C500030200; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blais A, 2002, J BIOL CHEM, V277, P31679, DOI 10.1074/jbc.M204554200; Brown JM, 1998, CANCER RES, V58, P1408; Chen M, 2002, CIRCULATION, V106, P2707, DOI 10.1161/01.CIR.0000038706.30661.86; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Desgranges ZP, 2005, MOL CELL BIOL, V25, P10940, DOI 10.1128/MCB.25.24.10940-10952.2005; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Dong DZ, 2004, HUM GENE THER, V15, P553, DOI 10.1089/104303404323142006; Dong YB, 2002, CANCER RES, V62, P1776; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Eischen CM, 2001, ONCOGENE, V20, P6983, DOI 10.1038/sj.onc.1204892; Elliott MJ, 2002, TUMOR BIOL, V23, P76, DOI 10.1159/000059708; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Fueyo J, 1998, NAT MED, V4, P685, DOI 10.1038/nm0698-685; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Hunt KK, 1997, CANCER RES, V57, P4722; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Joshi B, 2007, BIOCHEM J, V401, P155, DOI 10.1042/BJ20060364; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Li WW, 1997, MOL CELL BIOL, V17, P54, DOI 10.1128/MCB.17.1.54; Li ZP, 2006, PROTEOMICS, V6, P5735, DOI 10.1002/pmic.200600290; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Liu TJ, 1999, CANCER GENE THER, V6, P163, DOI 10.1038/sj.cgt.7700007; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Meng RD, 1999, INT J ONCOL, V14, P5; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rodicker F, 2001, CANCER RES, V61, P7052; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Shin EK, 1996, J BIOL CHEM, V271, P12261, DOI 10.1074/jbc.271.21.12261; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Stanelle J, 2003, CARDIOVASC RES, V59, P512, DOI 10.1016/S0008-6363(03)00392-4; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; SUGAWARA S, 1993, CANCER RES, V53, P6001; vanGinkel PR, 1997, J BIOL CHEM, V272, P18367, DOI 10.1074/jbc.272.29.18367; Wang Y, 2000, J BIOL CHEM, V275, P27013; Watanabe G, 1998, MOL CELL BIOL, V18, P3212, DOI 10.1128/MCB.18.6.3212; Won JJ, 2002, FASEB J, V16, P1943, DOI 10.1096/fj.02-0311fje; Wu S, 2008, BIOCHEM BIOPH RES CO, V365, P75, DOI 10.1016/j.bbrc.2007.10.145; Yang HL, 1999, CLIN CANCER RES, V5, P2242; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Zhang Ping-an, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P410	67	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34305	34314		10.1074/jbc.M803925200	http://dx.doi.org/10.1074/jbc.M803925200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18840615	Green Published, hybrid			2022-12-27	WOS:000261277700058
J	Subbaramaiah, K; Benezra, R; Hudis, C; Dannenberg, AJ				Subbaramaiah, Kotha; Benezra, Robert; Hudis, Clifford; Dannenberg, Andrew J.			RETRACTED: Cyclooxygenase-2-derived Prostaglandin E-2 Stimulates Id-1 Transcription (Retracted article. See vol. 295, pg. 296, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							COLON-CANCER CELLS; BREAST-CANCER; REGULATES ANGIOGENESIS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; PHORBOL ESTER; GROWTH; EXPRESSION; MAMMARY; CELECOXIB	Cyclooxygenase-2 (COX-2) and Id-1 are overexpressed in a variety of human malignancies. Recently, each of these genes was found to play a role in mediating breast cancer metastasis to the lungs, but their potential interdependence was not evaluated. Hence, the main objective of the current study was to determine whether COX-2-derived prostaglandin (PGE(2)) activated Id-1 transcription, leading in turn to increased invasiveness of mammary epithelial cells. In MDA-MB-231 cells, treatment with PGE(2) induced Id-1, an effect that was mimicked by an EP4 agonist. PGE2 via EP4 activated the epidermal growth factor receptor (EGFR) -> ERK1/2 pathway, which led to increased expression of Egr-1. PGE(2) stimulated EGFR signaling by inducing the release of amphiregulin, an EGFR ligand. The ability of PGE(2) to activate Id-1 transcription was mediated by enhanced binding of Egr-1 to the Id-1 promoter. Silencing of COX-2 or pharmacological inhibition of COX-2 led to reduced PGE(2) production, decreased Id-1 expression, and reduced migration of cells through extracellular matrix. A similar decrease in cell migration was found when Id-1 was silenced. The interrelationship between COX-2, PGE(2), Id-1, and cell invasiveness was also compared in nontumorigenic SCp2 and tumorigenic SCg6 mammary epithelial cells. Consistent with the findings in MDA-MB-231 cells, COX-2-derived PGE(2) induced Id-1, leading in turn to increased cell invasiveness. Taken together, these results suggest that PGE(2) via EP4 activated the EGFR -> ERK1/2 3 Egr-1 pathway, leading to increased Id-1 transcription and cell invasion. These findings provide new insights into the relationship between COX- 2 and Id-1 and their potential role in metastasis.	[Subbaramaiah, Kotha; Dannenberg, Andrew J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Subbaramaiah, Kotha; Dannenberg, Andrew J.] Weill Cornell Med Coll, Weill Cornell Canc Ctr, New York, NY 10065 USA; [Benezra, Robert] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Hudis, Clifford] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Subbaramaiah, K (corresponding author), Weill Cornell Med Coll, Dept Med, 525 E 68th St,Rm F-203A, New York, NY 10065 USA.	ksubba@med.cornell.edu	Hudis, Clifford/AAW-9482-2021	Hudis, Clifford/0000-0001-7144-8791	Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; Center for Cancer Prevention Research	Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; Center for Cancer Prevention Research	This work was supported by the Breast Cancer Research Foundation, the Botwinick-Wolfensohn Foundation, and the Center for Cancer Prevention Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BEN AVP, 1995, FEBS LETT, V372, P83; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Cherukuri DP, 2007, EXP CELL RES, V313, P2969, DOI 10.1016/j.yexcr.2007.06.004; Chulada PC, 2000, CANCER RES, V60, P4705; Dannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Desprez Pierre-Yves, 1993, Molecular and Cellular Differentiation, V1, P99; Desprez PY, 1998, MOL CELL BIOL, V18, P4577, DOI 10.1128/MCB.18.8.4577; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; DUBOIS RN, 1994, J CLIN INVEST, V93, P493, DOI 10.1172/JCI116998; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Harris RE, 2000, CANCER RES, V60, P2101; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Howe LR, 2002, CANCER RES, V62, P5405; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; JONES DA, 1993, J BIOL CHEM, V268, P9049; Kawamori T, 1998, CANCER RES, V58, P409; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Lochter A, 1997, J BIOL CHEM, V272, P5007, DOI 10.1074/jbc.272.8.5007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller-Decker K, 2006, GASTROENTEROLOGY, V130, P2165, DOI 10.1053/j.gastro.2006.03.053; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sawaoka H, 1998, AM J PHYSIOL-GASTR L, V274, pG1061, DOI 10.1152/ajpgi.1998.274.6.G1061; Shao JY, 2004, J BIOL CHEM, V279, P14287, DOI 10.1074/jbc.M313276200; Shao JY, 2003, CANCER RES, V63, P5218; Sheng HM, 1998, CANCER RES, V58, P362; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; SMITH WL, 1995, SEMIN NEPHROL, V15, P179; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Subbaramaiah K, 1996, CANCER RES, V56, P4424; Subbaramaiah K, 2008, J BIOL CHEM, V283, P3433, DOI 10.1074/jbc.M705409200; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tiano HF, 2002, CANCER RES, V62, P3395; Tournay O, 1996, MOL CELL BIOL, V16, P2418; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Volpert OV, 2002, CANCER CELL, V2, P473, DOI 10.1016/S1535-6108(02)00209-X; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	59	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33955	33968		10.1074/jbc.M805490200	http://dx.doi.org/10.1074/jbc.M805490200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18842581	Green Published, hybrid			2022-12-27	WOS:000261277700022
J	Duan, Q; Chen, HB; Costa, M; Dai, W				Duan, Qing; Chen, Haobin; Costa, Max; Dai, Wei			Phosphorylation of H3S10 Blocks the Access of H3K9 by Specific Antibodies and Histone Methyltransferase IMPLICATION IN REGULATING CHROMATIN DYNAMICS AND EPIGENETIC INHERITANCE DURING MITOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME CONDENSATION; HETEROCHROMATIN; MAINTENANCE; METHYLATION; SERINE-10; ACTIVATION; CELLS	Post-translational modifications of histones play a critical role in regulating genome structures and integrity. We have focused on the regulatory relationship between covalent modifications of histone H3 lysine 9 (H3K9) and H3S10 during the cell cycle. Immunofluorescence microscopy revealed that H3S10 phosphorylation in HeLa, A549, and HCT116 cells was high during prophase, prometaphase, and metaphase, whereas H3K9 monomethylation (H3K9me1) and dimethylation (H3K9me2), but not H3K9 trimethylation (H3K9me3), were significantly suppressed. When H3S10 phosphorylation started to diminish during anaphase, H3K9me1 and H3K9me2 signals reemerged. Western blot analyses confirmed that mitotic histones, extracted in an SDS-containing buffer, had little H3K9me1 and H3K9me2 signals but abundant H3K9me3 signals. However, when mitotic histones were extracted in the same buffer without SDS, the difference in H3K9me1 and H3K9me2 signals between interphase and mitotic cells disappeared. Removal of H3S10 phosphorylation by pretreatment with lambda-phosphatase unmasked mitotic H3K9me1 and H3K9me2 signals detected by both fluorescence microscopy and Western blotting. Further, H3S10 phosphorylation completely blocked methylation of H3K9 but not demethylation of the same residue in vitro. Given that several conserved motifs consisting of a Lys residue immediately followed by a Ser residue are present in histone tails, our studies reveal a potential new mechanism by which phosphorylation not only regulates selective access of methylated lysines by cellular factors but also serves to preserve methylation patterns and epigenetic programs during cell division.	[Duan, Qing; Chen, Haobin; Costa, Max; Dai, Wei] NYU, Sch Med, Dept Environm Med & Pharmacol, Tuxedo Pk, NY 10987 USA	New York University	Dai, W (corresponding author), NYU, Sch Med, Dept Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@med.nyu.edu	costa, max/H-1754-2012	Dai, Wei/0000-0003-0169-8327	NATIONAL CANCER INSTITUTE [R01CA090658] Funding Source: NIH RePORTER; NCI NIH HHS [CA090658] Funding Source: Medline; NIEHS NIH HHS [ES005512] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BODE AM, 2005, SCI STKE, pRE4; Bui HT, 2007, REPRODUCTION, V133, P371, DOI 10.1530/REP-06-0099; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Houben A, 2007, BBA-GENE STRUCT EXPR, V1769, P308, DOI 10.1016/j.bbaexp.2007.01.002; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kaszas E, 2000, J CELL SCI, V113, P3217; Ke QD, 2008, CARCINOGENESIS, V29, P1276, DOI 10.1093/carcin/bgn084; Krouwels IM, 2005, J CELL BIOL, V170, P537, DOI 10.1083/jcb.200502154; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Van Hooser A, 1998, J CELL SCI, V111, P3497; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	22	66	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33585	33590		10.1074/jbc.M803312200	http://dx.doi.org/10.1074/jbc.M803312200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18835819	hybrid, Green Published			2022-12-27	WOS:000261183700064
J	Hartl, D; He, CH; Koller, B; Da Silva, CA; Homer, R; Lee, CG; Elias, JA				Hartl, Dominik; He, Chuan Hua; Koller, Barbara; Da Silva, Carla A.; Homer, Robert; Lee, Chun G.; Elias, Jack A.			Acidic Mammalian Chitinase Is Secreted via an ADAM17/Epidermal Growth Factor Receptor-dependent Pathway and Stimulates Chemokine Production by Pulmonary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; SIGNAL-TRANSDUCTION; MUCIN PRODUCTION; ASTHMA; ADAM17; INFLAMMATION; ALPHA; ACTIVATION; INTERNALIZATION; INTERLEUKIN-13	Acidic mammalian chitinase (AMCase) is expressed in an exaggerated fashion in epithelial cells at sites of pulmonary T helper cell type 2 inflammation and plays important roles in the pathogenesis of anti-parasite and asthma-like responses. However, the mechanisms that control epithelial cell AMCase secretion and its effector responses have not been adequately defined. To address these issues, we used in vivo and in vitro experimental systems to define the pathways of epithelial AMCase secretion and its epithelial regulatory effects. Here we demonstrate that, in murine T helper cell type 2 modeling systems, AMCase colocalizes with the epidermal growth factor receptor (EGFR) and ADAM17 (a membrane disintegrin and metallopeptidase 17) in lung epithelial cells. In vitro cotransfection experiments in A549 cells demonstrated that AMCase and EGFR physically interact with each other. Cotransfection of AMCase and EGFR also increased, whereas EGFR inhibition decreased AMCase secretion. Interestingly, AMCase secretion was not significantly altered by treatment with EGF but was significantly decreased when the upstream EGFR transactivator ADAM17 was inhibited. AMCase secretion was also decreased when the EGFR-downstream Ras was blocked. Transfected and recombinant AMCase induced epithelial cell production of CCL2, CCL17, and CXCL8. These studies demonstrate that lung epithelial cells secrete AMCase via an EGFR-dependent pathway that is activated by ADAM17 and mediates its effects via Ras. They also demonstrate that the AMCase that is secreted feeds back in an autocrine and/or paracrine fashion to stimulate pulmonary epithelial cell chemokine production.	[Elias, Jack A.] Yale Univ, Yale New Haven Hosp, Sch Med,Sect Pulm & Crit Care Med, Dept Internal Med,Beeson Serv, New Haven, CT 06520 USA	Yale University	Elias, JA (corresponding author), Yale Univ, Yale New Haven Hosp, Sch Med,Sect Pulm & Crit Care Med, Dept Internal Med,Beeson Serv, 333 Cedar St,1072 LMP,POB 208056, New Haven, CT 06520 USA.	jack.elias@yale.edu	homer, robert/P-3884-2019; Lee, Chun Geun/AAC-2838-2021	homer, robert/0000-0002-2055-5885; Lee, Chun Geun/0000-0002-9514-3658	National Institutes of Health; NHLB [R01-HL-081639, P01-HL-056389]; Deutsche Forschungsgemeinschaft [HA 5274/2-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056389, R01HL081639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLB; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLB, Grants R01-HL-081639 and P01-HL-056389 ( to J. E.). This work was also supported by Deutsche Forschungsgemeinschaft Research Scholarship HA 5274/2-1 (to D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Booth BW, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-51; Chan HW, 2006, PULM PHARMACOL THER, V19, P74, DOI 10.1016/j.pupt.2005.04.005; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Davies DE, 1999, ALLERGY, V54, P771; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Elias JA, 2003, CHEST, V123, p339S, DOI 10.1378/chest.123.3_suppl.339S-a; Elias JA, 2003, AM J RESP CELL MOL, V28, P401, DOI 10.1165/rcmb.F264; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Gao JX, 2005, ACTA BIOCH BIOPH SIN, V37, P525, DOI 10.1111/j.1745-7270.2005.00076.x; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Heijink IH, 2007, AM J RESP CELL MOL, V36, P351, DOI 10.1165/rcmb.2006-0160OC; Holbrook MR, 1999, BIOCHEMISTRY-US, V38, P9348, DOI 10.1021/bi990195r; Homer RJ, 2006, AM J PHYSIOL-LUNG C, V291, pL502, DOI 10.1152/ajplung.00364.2005; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; McKenna WG, 2003, ONCOGENE, V22, P5866, DOI 10.1038/sj.onc.1206699; Morcillo EJ, 2006, CURR OPIN PULM MED, V12, P1, DOI 10.1097/01.mcp.0000198064.27586.37; Motulsky H., 1995, INTUITIVE BIOSTATIST; Nadel JA, 2001, RESP RES, V2, P85, DOI 10.1186/rr43; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; ROCHAT TR, 1988, J LAB CLIN MED, V112, P418; SCHUTTE B, 1995, CYTOMETRY, V21, P177, DOI 10.1002/cyto.990210210; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; Shim JJ, 2001, AM J PHYSIOL-LUNG C, V280, pL134, DOI 10.1152/ajplung.2001.280.1.L134; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; Spindler KD, 1999, EXS, V87, P201; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Takeyama K, 2001, AM J RESP CRIT CARE, V163, P511, DOI 10.1164/ajrccm.163.2.2001038; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; Walcheck B, 2006, EUR J IMMUNOL, V36, P968, DOI 10.1002/eji.200535257; Watson EL, 1999, CRIT REV ORAL BIOL M, V10, P284, DOI 10.1177/10454411990100030301; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; Zhu Z, 2001, AM J RESP CRIT CARE, V164, pS67, DOI 10.1164/ajrccm.164.supplement_2.2106070	48	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33472	33482		10.1074/jbc.M805574200	http://dx.doi.org/10.1074/jbc.M805574200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824549	hybrid, Green Published			2022-12-27	WOS:000261183700052
J	Jarnaess, E; Ruppelt, A; Stokka, AJ; Lygren, B; Scott, JD; Tasken, K				Jarnaess, Elisabeth; Ruppelt, Anja; Stokka, Anne Jorunn; Lygren, Birgitte; Scott, John D.; Tasken, Kjetil			Dual Specificity A-kinase Anchoring Proteins (AKAPs) Contain an Additional Binding Region That Enhances Targeting of Protein Kinase A Type I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT RII; SECONDARY STRUCTURE; SIGNALING PATHWAY; MOLECULAR-BASIS; CAMP; ALPHA; TRIFLUOROETHANOL; IDENTIFICATION; LOCALIZATION; ASSOCIATION	A-kinase anchoring proteins (AKAPs) target protein kinase A (PKA) to a variety of subcellular locations. Conventional AKAPs contain a 14-18-amino acid sequence that forms an amphipathic helix that binds with high affinity to the regulatory (R) subunit of PKA type II. More recently, a group of dual specificity AKAPs has been classified on the basis of their ability to bind the PKA type I and the PKA type II isozymes. In this study we show that dual specificity AKAPs contain an additional PKA binding determinant called the RI Specifier Region (RISR). A variety of protein interaction assays and immunoprecipitation and immunolocalization experiments indicates that the RISR augments RI binding in vitro and inside cells. Cellular delivery of the RISR peptide uncouples RI anchoring to Ezrin leading to release of T cell inhibition by cAMP. Likewise, expression of mutant Ezrin forms where RI binding has been abrogated by substitution of the RISR sequence prevents cAMP-mediated inhibition of T cell function. Thus, we propose that the RISR acts in synergy with the amphipathic helix in dual specificity anchoring proteins to enhance anchoring of PKA type I.	[Jarnaess, Elisabeth; Ruppelt, Anja; Stokka, Anne Jorunn; Lygren, Birgitte; Tasken, Kjetil] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Jarnaess, Elisabeth; Ruppelt, Anja; Stokka, Anne Jorunn; Lygren, Birgitte; Tasken, Kjetil] Univ Oslo, Ctr Mol Med Norway, Nord EMBL Partnership, N-0317 Oslo, Norway; [Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA	University of Oslo; University of Oslo; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Tasken, K (corresponding author), Univ Oslo, Biotechnol Ctr Oslo, POB 1125, N-0317 Oslo, Norway.	kjetil.tasken@biotek.uio.no		Tasken, Kjetil/0000-0003-2841-4697	Norwegian Functional Genomics Programme; The Research Council of Norway; The Norwegian Cancer Society; Novo Nordic Foundation; European Union [037189]; thera-cAMP; National Institutes of Health [DK 54441]; Foundation Leducq; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	Norwegian Functional Genomics Programme(Research Council of Norway); The Research Council of Norway(Research Council of Norway); The Norwegian Cancer Society(Norwegian Cancer SocietyEuropean Commission); Novo Nordic Foundation(Novo Nordisk Foundation); European Union(European Commission); thera-cAMP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq(Leducq Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants ( to K. T.) from the Norwegian Functional Genomics Programme, The Research Council of Norway, The Norwegian Cancer Society, Novo Nordic Foundation, the European Union Grant 037189, thera-cAMP and Grants ( to J.D.S.) from the National Institutes of Health (DK 54441) and Foundation Leducq. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aandahl EM, 1998, FASEB J, V12, P855, DOI 10.1096/fasebj.12.10.855; Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Angelo R, 1998, J BIOL CHEM, V273, P14633, DOI 10.1074/jbc.273.23.14633; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Banky P, 2000, J BIOL CHEM, V275, P35146, DOI 10.1074/jbc.M003961200; Banky P, 1998, J BIOL CHEM, V273, P35048, DOI 10.1074/jbc.273.52.35048; Birkemo GA, 2004, BBA-PROTEINS PROTEOM, V1699, P221, DOI 10.1016/j.bbapap.2004.03.001; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; DURGERIAN S, 1989, J BIOL CHEM, V264, P9807; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gronholm M, 2003, J BIOL CHEM, V278, P41167, DOI 10.1074/jbc.M306149200; Hausken ZE, 1998, METH MOL B, V88, P47; Hausken ZE, 1996, BIOCHEM SOC T, V24, P986, DOI 10.1042/bst0240986; Hausken ZE, 1996, J BIOL CHEM, V271, P29016, DOI 10.1074/jbc.271.46.29016; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kussel-Andermann P, 2000, J BIOL CHEM, V275, P29654, DOI 10.1074/jbc.M004393200; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; Leon DA, 1997, J BIOL CHEM, V272, P28431, DOI 10.1074/jbc.272.45.28431; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li HW, 2003, P NATL ACAD SCI USA, V100, P1627, DOI 10.1073/pnas.0337678100; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; SKALHEGG BS, 1994, SCIENCE, V263, P84, DOI 10.1126/science.8272870; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Stokka AJ, 2006, BIOCHEM J, V400, P493, DOI 10.1042/BJ20060962; Takahashi M, 2000, J BIOL CHEM, V275, P34592, DOI 10.1074/jbc.M005285200; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	52	55	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33708	33718		10.1074/jbc.M804807200	http://dx.doi.org/10.1074/jbc.M804807200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18824551	Green Published, hybrid			2022-12-27	WOS:000261183700077
J	Krivosheya, D; Tapia, L; Levinson, JN; Huang, K; Kang, Y; Hines, R; Ting, AK; Craig, AM; Mei, L; Bamji, SX; El-Husseini, A				Krivosheya, Daria; Tapia, Lucia; Levinson, Joshua N.; Huang, Kun; Kang, Yunhee; Hines, Rochelle; Ting, Annie K.; Craig, Ann Marie; Mei, Lin; Bamji, Shernaz X.; El-Husseini, Alaa			ErbB4-Neuregulin Signaling Modulates Synapse Development and Dendritic Arborization through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVOUS-SYSTEM; ERBB RECEPTORS; INTRACELLULAR DOMAIN; INHIBITORY SYNAPSES; CONTAINING PROTEINS; NEURONAL MIGRATION; NEURAL DEVELOPMENT; NEURITE OUTGROWTH; PREFRONTAL CORTEX; TYROSINE KINASE	Perturbations in neuregulin-1 (NRG1)/ErbB4 function have been associated with schizophrenia. Affected patients exhibit altered levels of these proteins and display hypofunction of glutamatergic synapses as well as altered neuronal circuitry. However, the role of NRG1/ErbB4 in regulating synapse maturation and neuronal process formation has not been extensively examined. Here we demonstrate that ErbB4 is expressed in inhibitory interneurons at both excitatory and inhibitory postsynaptic sites. Overexpression of ErbB4 postsynaptically enhances size but not number of presynaptic inputs. Conversely, knockdown of ErbB4 using shRNA decreases the size of presynaptic inputs, demonstrating a specific role for endogenous ErbB4 in synapse maturation. Using ErbB4 mutant constructs, we demonstrate that ErbB4-mediated synapse maturation requires its extracellular domain, whereas its tyrosine kinase activity is dispensable for this process. We also demonstrate that depletion of ErbB4 decreases the number of primary neurites and that stimulation of ErbB4 using a soluble form of NRG1 results in exuberant dendritic arborization through activation of the tyrosine kinase domain of ErbB4 and the phosphoinositide 3-kinase pathway. These findings demonstrate that NRG1/ErbB4 signaling differentially regulates synapse maturation and dendritic morphology via two distinct mechanisms involving trans-synaptic signaling and tyrosine kinase activity, respectively.	[Tapia, Lucia; Levinson, Joshua N.; Bamji, Shernaz X.] Univ British Columbia, Brain Res Ctr, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Krivosheya, Daria; Levinson, Joshua N.; Huang, Kun; Kang, Yunhee; Hines, Rochelle; Craig, Ann Marie; El-Husseini, Alaa] Univ British Columbia, Brain Res Ctr, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; [Ting, Annie K.] Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA	University of British Columbia; University of British Columbia; University System of Georgia; Augusta University	Bamji, SX (corresponding author), Univ British Columbia, Brain Res Ctr, Dept Cellular & Physiol Sci, Life Sci Bldg,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	sbamji@interchange.ubc.ca	Hines, Rochelle/AAE-3784-2020; Craig, Ann Marie/M-2054-2014; Mei, Lin/G-8755-2012	Hines, Rochelle/0000-0002-0459-7911	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860, R21MH083563, R01MH083317] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from Canadian Institutes of Health Research and Michael Smith Foundation for Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anton ES, 1997, DEVELOPMENT, V124, P3501; Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; El-Hussein AE, 2000, SCIENCE, V290, P1364; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fox IJ, 2005, J NEUROSCI RES, V79, P584, DOI 10.1002/jnr.20381; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Huang YZ, 2002, INT J DEV NEUROSCI, V20, P173, DOI 10.1016/S0736-5748(02)00011-4; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Law AJ, 2004, NEUROSCIENCE, V127, P125, DOI 10.1016/j.neuroscience.2004.04.026; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Linggi B, 2006, ONCOGENE, V25, P160, DOI 10.1038/sj.onc.1209003; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Petryshen TL, 2005, MOL PSYCHIATR, V10, P366, DOI 10.1038/sj.mp.4001608; Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Rodgers EE, 2002, INT J DEV NEUROSCI, V20, P187, DOI 10.1016/S0736-5748(02)00047-3; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Vartanian T, 1999, P NATL ACAD SCI USA, V96, P731, DOI 10.1073/pnas.96.2.731; Vaskovsky A, 2000, J NEUROCHEM, V74, P979, DOI 10.1046/j.1471-4159.2000.0740979.x; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xie F, 2007, J NEUROCHEM, V100, P62, DOI 10.1111/j.1471-4159.2006.04182.x; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252	56	85	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32944	32956		10.1074/jbc.M800073200	http://dx.doi.org/10.1074/jbc.M800073200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819924	hybrid, Green Published			2022-12-27	WOS:000260893700083
J	Patel, A; Vought, VE; Dharmarajan, V; Cosgrove, MS				Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.			A Conserved Arginine-containing Motif Crucial for the Assembly and Enzymatic Activity of the Mixed Lineage Leukemia Protein-1 Core Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 LYSINE-4; H3-LYS(4) METHYLTRANSFERASE COMPLEX; SET-DOMAIN PROTEIN; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; MOLECULAR RECOGNITION; DROSOPHILA-TRITHORAX; NUCLEOSOME MOBILITY; BINDING MODULES; METHYLATION	The mixed lineage leukemia protein-1 (MLL1) belongs to the SET1 family of histone H3 lysine 4 methyltransferases. Recent studies indicate that the catalytic subunits of SET1 family members are regulated by interaction with a conserved core group of proteins that include the WD repeat protein-5 (WDR5), retinoblastoma-binding protein-5 (RbBP5), and the absent small homeotic-2-like protein (Ash2L). It has been suggested that WDR5 functions to bridge the interactions between the catalytic and regulatory subunits of SET1 family complexes. However, the molecular details of these interactions are unknown. To gain insight into the interactions among these proteins, we have determined the biophysical basis for the interaction between the human WDR5 and MLL1. Our studies reveal that WDR5 preferentially recognizes a previously unidentified and conserved arginine-containing motif, called the "Win" or WDR5 interaction motif, which is located in the N-SET region of MLL1 and other SET1 family members. Surprisingly, our structural and functional studies show that WDR5 recognizes arginine 3765 of the MLL1 Win motif using the same arginine binding pocket on WDR5 that was previously shown to bind histone H3. We demonstrate that WDR5's recognition of arginine 3765 of MLL1 is essential for the assembly and enzymatic activity of the MLL1 core complex in vitro.	[Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Cosgrove, MS (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA.	mscosgro@syr.edu			March of Dimes Birth Defects Foundation [5-FY06-585]; Syracuse University; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); Syracuse University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Research Grant 5-FY06-585 from the March of Dimes Birth Defects Foundation (to M. S. C.) and by funds from Syracuse University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cosgrove MS, 2007, EXPERT REV PROTEOMIC, V4, P465, DOI 10.1586/14789450.4.4.465; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; COUTURE J, 2006, NAT STRUCT MOL BIOL; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katsani KR, 2001, GENE DEV, V15, P2197, DOI 10.1101/gad.201901; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Rasio D, 1996, CANCER RES, V56, P1766; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Rozovskaia T, 2000, ONCOGENE, V19, P351, DOI 10.1038/sj.onc.1203307; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P26; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	61	134	140	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32162	32175		10.1074/jbc.M806317200	http://dx.doi.org/10.1074/jbc.M806317200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18829457	hybrid			2022-12-27	WOS:000260893700003
J	Sobhany, M; Kakuta, Y; Sugiura, N; Kimata, K; Negishi, M				Sobhany, Mack; Kakuta, Yoshimitsu; Sugiura, Nobuo; Kimata, Koji; Negishi, Masahiko			The Chondroitin Polymerase K4CP and the Molecular Mechanism of Selective Bindings of Donor Substrates to Two Active Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASTEURELLA-MULTOCIDA; HYALURONAN SYNTHASE; ENZYME-ACTIVITY; SULFATE; GLYCOSYLTRANSFERASES; BIOSYNTHESIS; PROTEOGLYCAN; EXPRESSION; CARTILAGE; CLONING	Bacterial chondroitin polymerase K4CP is a multifunctional enzyme with two active sites. K4CP catalyzes alternative transfers of glucoronic acid (GlcA) and N-acetylgalactosamine (GalNAc) to elongate a chain consisting of the repeated disaccharide sequence GlcA beta 1-3GalNAc beta 1-4. Unlike the polymerization reactions of DNA and RNA and polypeptide synthesis, which depend upon templates, the monosaccharide polymerization by K4CP does not. To investigate the catalytic mechanism of this reaction, we have used isothermal titration calorimetry to determine the binding of the donor substrates UDP-GlcA and UDP-GalNAc to purified K4CP protein and its mutants. Only one donor molecule bound to one molecule of K4CP at a time. UDP-GlcA bound only to the C-terminal active site at a high affinity (K-d = 6.81 mu M), thus initiating the polymerization reaction. UDP-GalNAc could bind to either the N-terminal or C-terminal active sites at a low affinity (K-d = 266-283 mu M) but not to both sites at the same time. The binding affinity of UDP-GalNAc to a K4CP N-terminal fragment (residues 58-357) was profoundly decreased, yielding the average K-d value of 23.77 mu M, closer to the previously reported K-m value for the UDP-GalNAc transfer reaction that takes place at the N-terminal active site. Thus, the first step of the reaction appears to be the binding of UDP-GlcA to the C-terminal active site, whereas the second step involves the C-terminal region of the K4CP molecule regulating the binding of UDP-GalNAc to only the N-terminal active site. Alternation of these two specific bindings advances the polymerization reaction by K4CP.	[Sobhany, Mack; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Kakuta, Yoshimitsu] Kyushu Univ, Fac Agr, Dept Biochem, Fukuoka 8128581, Japan; [Sugiura, Nobuo; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Kyushu University; Aichi Medical University	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, Z01ES080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Grant Intramural Research Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BERTON C, 2001, BIOCHIMIE, V83, P713; BOUNRNE Y, 2001, CURR OPT STRUCT BIOL, V11, P593; Breton C, 1998, J BIOCHEM, V123, P1000; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; DAVID G, 1989, J CELL BIOL, V108, P1165, DOI 10.1083/jcb.108.3.1165; Fitch MT, 1999, J NEUROSCI, V19, P8182; Gotting C, 2004, J BIOL CHEM, V279, P42566, DOI 10.1074/jbc.M401340200; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; OOHIRA A, 1994, NEUROSCI RES, V20, P195, DOI 10.1016/0168-0102(94)90088-4; OSAWA T, 2009, BIOCH BIOPH IN PRESS; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; PRESS WH, 1989, NUMERICAL RECIPES FO; Roughley P, 2006, EUR CELLS MATER, V11, P1; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; SEGEL IH, 1976, BIOCH CALCULATIONS, P145; Sobhany M, 2005, J BIOL CHEM, V280, P23441, DOI 10.1074/jbc.M413379200; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Zako M, 1997, J NEUROCHEM, V69, P2155	26	21	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32328	32333		10.1074/jbc.M804332200	http://dx.doi.org/10.1074/jbc.M804332200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806260	hybrid, Green Published			2022-12-27	WOS:000260893700019
J	Wilbur, JD; Chen, CY; Manalo, V; Hwang, PK; Fletterick, RJ; Brodsky, FM				Wilbur, Jeremy D.; Chen, Chih-Ying; Manalo, Venus; Hwang, Peter K.; Fletterick, Robert J.; Brodsky, Frances M.			Actin Binding by Hip1 (Huntingtin-interacting Protein 1) and Hip1R (Hip1-related Protein) Is Regulated by Clathrin Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CRYSTAL-STRUCTURE; F-ACTIN; ENDOCYTOSIS; MEMBRANE; YEAST; FLEXIBILITY; TROPOMYOSIN; DISRUPTION; VESICLES	The huntingtin-interacting protein family members (Hip1 and Hip1R in mammals and Sla2p in yeast) link clathrin-mediated membrane traffic to actin cytoskeleton dynamics. Genetic data in yeast have implicated the light chain subunit of clathrin in regulating this link. To test this hypothesis, the biophysical properties of mammalian Hip1 and Hip1R and their interaction with clathrin light chain and actin were analyzed. The coiled-coil domains (clathrin light chain-binding) of Hip1 and Hip1R were found to be stable homodimers with no propensity to heterodimerize in vitro. Homodimers were also predominant in vivo, accounting for cellular segregation of Hip1 and Hip1R functions. Coiled-coil domains of Hip1 and Hip1R differed in their stability and flexibility, correlating with slightly different affinities for clathrin light chain and more markedly with effects of clathrin light chain binding on Hip protein-actin interactions. Clathrin light chain binding induced a compact conformation of both Hip1 and Hip1R and significantly reduced actin binding by their THATCH domains. Thus, clathrin is a negative regulator of Hip-actin interactions. These observations necessarily change models proposed for Hip protein function.	[Chen, Chih-Ying; Manalo, Venus; Brodsky, Frances M.] Univ Calif San Francisco, George Williams Hooper Fdn, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Wilbur, Jeremy D.] Univ Calif San Francisco, Grad Program Biophys, San Francisco, CA 94143 USA; [Hwang, Peter K.; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Brodsky, FM (corresponding author), Univ Calif San Francisco, George Williams Hooper Fdn, Dept Biopharmaceut Sci, Box 0552,513 Parnassus Ave, San Francisco, CA 94143 USA.	frances.brodsky@ucsf.edu		Brodsky, Frances/0000-0002-1334-9258	National Institutes of Health [GM038093]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM038093 (to F.M.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ACTON SL, 1993, MOL BIOL CELL, V4, P647, DOI 10.1091/mbc.4.6.647; Bradley SV, 2007, HUM MOL GENET, V16, P1279, DOI 10.1093/hmg/ddm076; Brett TJ, 2006, NAT STRUCT MOL BIOL, V13, P121, DOI 10.1038/nsmb1043; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Brown JH, 1996, PROTEINS, V26, P134; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chen CY, 2005, J BIOL CHEM, V280, P6109, DOI 10.1074/jbc.M408454200; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DEMELER B, 2005, MODERN ANAL ULTRACEN; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Engqvist-Goldstein AEY, 1999, J CELL BIOL, V147, P1503, DOI 10.1083/jcb.147.7.1503; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Hackam AS, 2000, J BIOL CHEM, V275, P41299, DOI 10.1074/jbc.M008408200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Legendre-Guillemin V, 2002, J BIOL CHEM, V277, P19897, DOI 10.1074/jbc.M112310200; Legendre-Guillemin V, 2005, J BIOL CHEM, V280, P6101, DOI 10.1074/jbc.M408430200; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Metzler M, 2003, EMBO J, V22, P3254, DOI 10.1093/emboj/cdg334; Mills IG, 2005, J CELL BIOL, V170, P191, DOI 10.1083/jcb.200503106; Newpher TM, 2006, MOL BIOL CELL, V17, P4343, DOI 10.1091/mbc.E06-07-0606; Niu Q, 2008, J MOL BIOL, V375, P1197, DOI 10.1016/j.jmb.2007.11.036; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Yang S, 1999, MOL BIOL CELL, V10, P2265, DOI 10.1091/mbc.10.7.2265; Ybe JA, 2007, J MOL BIOL, V367, P8, DOI 10.1016/j.jmb.2006.12.052	36	59	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32870	32879		10.1074/jbc.M802863200	http://dx.doi.org/10.1074/jbc.M802863200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790740	Green Published, hybrid			2022-12-27	WOS:000260893700076
J	Song, QJ; Saucerman, JJ; Bossuyt, J; Bers, DM				Song, Qiujing; Saucerman, Jeffrey J.; Bossuyt, Julie; Bers, Donald M.			Differential Integration of Ca2+-Calmodulin Signal in Intact Ventricular Myocytes at Low and High Affinity Ca2+-Calmodulin Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; FREQUENCY-DEPENDENT ACCELERATION; LIGHT-CHAIN PHOSPHORYLATION; CALMODULIN-BINDING; CARDIAC MYOCYTES; SKELETAL-MUSCLE; HEART-FAILURE; LIVING CELLS; RYANODINE RECEPTOR; ACTIVITY SENSOR	Cardiac myocyte intracellular calcium varies beat-to-beat and calmodulin (CaM) transduces Ca2+ signals to regulate many cellular processes (e. g. via CaM targets such as CaM-dependent kinase and calcineurin). However, little is known about the dynamics of how CaM targets process the Ca2+ signals to generate appropriate biological responses in the heart. We hypothesized that the different affinities of CaM targets for the Ca2+-bound CaM (Ca2+-CaM) shape their actions through dynamic and tonic interactions in response to the repetitive Ca2+ signals in myocytes. To test our hypothesis, we used two fluorescence resonance energy transfer-based biosensors, BsCaM-45 (K-d = similar to 45 nM) and BsCaM-2 (K-d = similar to 2 nM), to monitor the real time Ca2+-CaM dynamics at low and high affinity CaM targets in paced adult ventricular myocytes. Compared with BsCaM-2, BsCaM-45 tracks the beat-to-beat Ca2+-CaM alterations more closely following the Ca2+ oscillations at each myocyte contraction. When pacing frequency is raised from 0.1 to 1.0 Hz, the higher affinity BsCaM-2 demonstrates significant elevation of diastolic Ca2+-CaM binding compared with the lower affinity BsCaM-45. Biochemically detailed computational models of Ca2+-CaM biosensors in beating cardiac myocytes revealed that the different Ca2+-CaM binding affinities of BsCaM-2 and BsCaM-45 are sufficient to predict their differing kinetics and diastolic integration. Thus, data from both experiments and computational modeling suggest that CaM targets with low versus high Ca2+-CaM affinities (like CaM-dependent kinase versus calcineurin) respond differentially to the same Ca2+ signal (phasic versus integrating), presumably tuned appropriately for their respective and distinct Ca2+ signaling pathways.	[Bossuyt, Julie; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Song, Qiujing; Bossuyt, Julie; Bers, Donald M.] Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA; [Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of California System; University of California Davis; Loyola University Chicago; University of Virginia	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, Genome Bldg 3513,451 E Hlth Sci Dr, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483; Saucerman, Jeffrey/0000-0001-9464-8374; Bossuyt, Julie/0000-0001-8874-4765	National Institutes of Health [HL30077, HL80101]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030077, P01HL080101, R37HL030077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL30077 and HL80101 (to D. M. B.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to Q. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; BASSANI JWM, 1995, BIOPHYS J, V68, P1453, DOI 10.1016/S0006-3495(95)80318-8; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Biermann M, 1998, J CARDIOVASC ELECTR, V9, P1348, DOI 10.1111/j.1540-8167.1998.tb00110.x; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; DAVIS BA, 1983, J BIOL CHEM, V258, P3587; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; DeSantiago J, 2002, J MOL CELL CARDIOL, V34, P975, DOI 10.1006/jmcc.2002.2034; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; HUBBARD MJ, 1987, J BIOL CHEM, V262, P15062; Huke S, 2007, J MOL CELL CARDIOL, V42, P590, DOI 10.1016/j.yjmcc.2006.12.007; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; KLEE CB, 1988, INTERACTION CALMODUL; Lakatta EG, 2004, CELL CALCIUM, V35, P629, DOI 10.1016/j.ceca.2004.01.017; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Maier LS, 2006, J MOL CELL CARDIOL, V41, P451, DOI 10.1016/j.yjmcc.2006.04.020; Mattiazzi A, 2007, CARDIOVASC RES, V73, P648, DOI 10.1016/j.cardiores.2006.12.002; McCullagh KJA, 2004, P NATL ACAD SCI USA, V101, P10590, DOI 10.1073/pnas.0308035101; Newman RH, 2008, MOL BIOSYST, V4, P496, DOI 10.1039/b720034j; Peersen OB, 1997, PROTEIN SCI, V6, P794; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Picht E, 2007, J MOL CELL CARDIOL, V42, P196, DOI 10.1016/j.yjmcc.2006.09.007; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Pitt GS, 2007, CARDIOVASC RES, V73, P641, DOI 10.1016/j.cardiores.2006.10.019; Quintana AR, 2005, BIOCHEM BIOPH RES CO, V334, P674, DOI 10.1016/j.bbrc.2005.06.152; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sanhueza M, 2007, J NEUROSCI, V27, P5190, DOI 10.1523/JNEUROSCI.5049-06.2007; SAUCERMAN JJ, 2008, BIOPHYS J IN PRESS; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Spratt DE, 2007, BIOCHEMISTRY-US, V46, P8288, DOI 10.1021/bi062130b; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Tanaka H, 1998, J PHYSIOL-LONDON, V508, P145, DOI 10.1111/j.1469-7793.1998.145br.x; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Wu X, 2007, CELL CALCIUM, V41, P353, DOI 10.1016/j.ceca.2006.07.011; Wu YJ, 2001, P NATL ACAD SCI USA, V98, P2877, DOI 10.1073/pnas.051449198; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	53	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31531	31540		10.1074/jbc.M804902200	http://dx.doi.org/10.1074/jbc.M804902200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18790737	Green Published, hybrid			2022-12-27	WOS:000260760800032
J	Bond, S; Forgac, M				Bond, Sarah; Forgac, Michael			The Ras/cAMP/Protein Kinase A Pathway Regulates Glucose-dependent Assembly of the Vacuolar (H+)-ATPase in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-SCALE ANALYSIS; H+-ATPASE; V-ATPASE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; GENE-EXPRESSION; PROTON PUMPS; SUBUNIT-G; ACTIVATION; RAS	Vacuolar (H+)-ATPases (V-ATPases) are ubiquitous, ATP-driven proton pumps that acidify organelles or the extracellular space. A rapid and effective mechanism for regulating V-ATPase activity involves reversible dissociation of the two functional domains of the pump, V-1 and V-0. This process is best characterized in yeast, where V-ATPases are reversibly disassembled in response to glucose depletion. To identify regulators that control this process in vivo, a genetic screen was performed in yeast to search for mutants that cannot disassemble their V-ATPases when grown in the absence of glucose. This screen identified IRA1 (inhibitory regulator of the Ras/cAMP pathway 1) and IRA2 as essential genes for regulating V-ATPase dissociation in vivo. IRA1 and IRA2 encode GTPase-activating proteins that negatively regulate Ras in nutrient-poor conditions. Downregulation of Ras lowers cAMP levels by reducing adenylate cyclase activity. Decreased cAMP levels in turn lead to reduced activity of protein kinase A (PKA). Our results show that targeted deletion of IRA2 results in defective disassembly of the V-ATPase in response to glucose depletion, and reexpression of the gene rescues this phenotype. Glucose-dependent dissociation is also blocked in strains expressing the dominant active RAS2(val19) allele or in strains deficient for the regulatory subunit of PKA, both of which lead to constitutively active PKA. These results reveal a role for PKA in controlling glucose-dependent V-ATPase assembly in yeast.	[Bond, Sarah; Forgac, Michael] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM 34478, T32DK007542, DK34928]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928, T32DK007542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 34478 (to M. F.) and predoctoral fellowship support from National Institutes of Health Grant T32DK007542. E. coli strains were provided by National Institutes of Health Grant DK34928. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARAI H, 1987, BIOCHEMISTRY-US, V26, P6632, DOI 10.1021/bi00395a011; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bles N, 2007, J IMMUNOL, V179, P3550, DOI 10.4049/jimmunol.179.6.3550; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; Dames P, 2006, P NATL ACAD SCI USA, V103, P3926, DOI 10.1073/pnas.0600011103; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Henry JP, 1998, NEUROCHEM INT, V32, P227, DOI 10.1016/S0197-0186(97)00092-2; HINTON A, 2007, PFLUGERS AR IN PRESS; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Howard SC, 2001, GENETICS, V159, P77; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; MORRIS RC, 1968, J CLIN INVEST, V47, P1389, DOI 10.1172/JCI105830; NANDA A, 1992, J BIOL CHEM, V267, P22740; ORCI L, 1994, J CELL BIOL, V126, P1149, DOI 10.1083/jcb.126.5.1149; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pastor-Soler NM, 2008, AM J PHYSIOL-CELL PH, V294, pC488, DOI 10.1152/ajpcell.00537.2007; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Qi J, 2007, J BIOL CHEM, V282, P24743, DOI 10.1074/jbc.M700663200; Rein J, 2008, AM J PHYSIOL-CELL PH, V294, pC56, DOI 10.1152/ajpcell.00041.2007; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; RossMacdonald P, 1997, P NATL ACAD SCI USA, V94, P190, DOI 10.1073/pnas.94.1.190; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; SCHLESINGER PH, 1994, MINER ELECTROL METAB, V20, P31; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; SIKORSKI RS, 1989, GENETICS, V122, P19; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; SUPEK F, 1994, J BIOL CHEM, V269, P24102; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TANAKA K, 1989, MOL CELL BIOL, V9, P757, DOI 10.1128/MCB.9.2.757; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; VOSS M, 2008, CELL TISSUE IN PRESS; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wilkin F, 2001, J IMMUNOL, V166, P7172, DOI 10.4049/jimmunol.166.12.7172; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200	59	64	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36513	36521		10.1074/jbc.M805232200	http://dx.doi.org/10.1074/jbc.M805232200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18936098	Green Published, hybrid			2022-12-27	WOS:000261840500049
J	Hansen, SB; Wang, HL; Taylor, P; Sine, SM				Hansen, Scott B.; Wang, Hai-Long; Taylor, Palmer; Sine, Steven M.			An Ion Selectivity Filter in the Extracellular Domain of Cys-loop Receptors Reveals Determinants for Ion Conductance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACH-BINDING PROTEIN; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CHANNEL; MECHANISMS; INTERFACES	Neurotransmitter binding to Cys-loop receptors promotes a prodigious transmembrane flux of several million ions/s, but to date, structural determinants of ion flux have been identified flanking the membrane-spanning region. Using x-ray crystallography, sequence analysis, and single-channel recording, we identified a novel determinant of ion conductance near the point of entry of permeant ions. Co-crystallization of acetylcholine-binding protein with sulfate anions revealed coordination of SO42- with a ring of lysines at a position equivalent to 24 A above the lipid membrane in homologous Cys-loop receptors. Analysis of multiple sequence alignments revealed that residues equivalent to the ring of lysines are negatively charged in cation-selective receptors but are positively charged in anion-selective receptors. Charge reversal of side chains at homologous positions in the nicotinic receptor from the motor end plate decreases unitary conductance up to 80%. Selectivity filters stemming from transmembrane alpha-helices have similar pore diameters and compositions of amino acids. These findings establish that when the channel opens under a physiological electrochemical gradient, permeant ions are initially stabilized within the extracellular vestibule of Cys-loop receptors, and this stabilization is a major determinant of ion conductance.	[Hansen, Scott B.; Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; [Wang, Hai-Long; Sine, Steven M.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA; [Sine, Steven M.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA	University of California System; University of California San Diego; Mayo Clinic; Mayo Clinic	Taylor, P (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu; sine@mayo.edu			United States Public Health Service [R37-GM18360/UO1-DA019372, R37-NS031744]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA019372] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by United States Public Health Service Grants R37-GM18360/UO1-DA019372 (to P. T.) and R37-NS031744 (to S. M. S). Beamline 8.2.2 is supported by the Howard Hughes Medical Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2004, J BIOL CHEM, V279, P24197, DOI 10.1074/jbc.M402452200; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kehoe J, 1998, J NEUROSCI, V18, P8198; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LEWIS CA, 1983, P NATL ACAD SCI-BIOL, V80, P6110, DOI 10.1073/pnas.80.19.6110; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	30	50	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36066	36070		10.1074/jbc.C800194200	http://dx.doi.org/10.1074/jbc.C800194200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18940802	Green Published, hybrid			2022-12-27	WOS:000261840500002
J	Barr, RK; Lynn, HE; Moretti, PAB; Khew-Goodall, Y; Pitson, SM				Barr, Renae K.; Lynn, Helen E.; Moretti, Paul A. B.; Khew-Goodall, Yeesim; Pitson, Stuart M.			Deactivation of Sphingosine Kinase 1 by Protein Phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CELL-TRANSFORMATION; PLASMA-MEMBRANE; DEPENDENT TRANSLOCATION; REGULATORY SUBUNIT; TUMOR-ANTIGEN; BINDING SITE; FTY720; PP2A; ACTIVATION; CANCER	Sphingosine kinase 1 (SK1) is an important regulator of cellular signaling that has been implicated in a broad range of cellular processes. Cell exposure to a wide array of growth factors, cytokines, and other cell agonists can result in a rapid and transient increase in SK activity via an activating phosphorylation. We have previously identified extracellular signal-regulated kinases 1 and 2 (ERK1/2) as the kinases responsible for the phosphorylation of human SK1 at Ser(225), but the corresponding phosphatase targeting this phosphorylation has remained undefined. Here, we provide data to support a role for protein phosphatase 2A (PP2A) in the deactivation of SK1 through dephosphorylation of phospho-Ser(225). The catalytic subunit of PP2A (PP2Ac) was found to interact with SK1 using both GST-pulldown and coimmunoprecipitation analyses. Coexpression of PP2Ac with SK1 resulted in reduced Ser(225) phosphorylation of SK1 in human embryonic kidney (HEK293) cells. In vitro phosphatase assays showed that PP2Ac dephosphorylated both recombinant SK1 and a phosphopeptide based on the phospho-Ser225 region of SK1. Finally, both basal and tumor necrosis factor-alpha-stimulated cellular SK1 activity were regulated by molecular manipulation of PP2Ac activity. Thus, PP2A appears to function as an endogenous regulator of SK1 phosphorylation.	[Barr, Renae K.; Lynn, Helen E.; Moretti, Paul A. B.; Khew-Goodall, Yeesim; Pitson, Stuart M.] Univ Adelaide, Div Human Immunol, Inst Med & Vet Sci, Hanson Inst, Adelaide, SA 5005, Australia; [Khew-Goodall, Yeesim; Pitson, Stuart M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Hanson Institute; Institute Medical & Veterinary Science Australia; University of Adelaide; University of Adelaide	Pitson, SM (corresponding author), Inst Med & Vet Sci, Div Human Immunol, Frome Rd, Adelaide, SA 5000, Australia.	stuart.pitson@imvs.sa.gov.au	Pitson, Stuart/B-9342-2009	Pitson, Stuart/0000-0002-9527-2740; Barr, Renae/0000-0003-1601-7299	Fay Fuller Foundation; Cancer Council of South Australia; National Health and Medical Research Council of Australia; Peter Doherty Postdoctoral Research Fellowship [430909]; Senior Research Fellowship [508098]; Project Grant [453512]	Fay Fuller Foundation; Cancer Council of South Australia(Cancer Council South Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Peter Doherty Postdoctoral Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Senior Research Fellowship; Project Grant(Wellcome Trust)	This work was supported by the Fay Fuller Foundation, a Senior Research Fellowship from the Cancer Council of South Australia (to Y.K.-G.), and the National Health and Medical Research Council of Australia through a Peter Doherty Postdoctoral Research Fellowship 430909 (to R.K.B.), a Senior Research Fellowship 508098 (to S.M.P.), and Project Grant 453512. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; French KJ, 2003, CANCER RES, V63, P5962; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hu MCT, 1998, J BIOL CHEM, V273, P33561, DOI 10.1074/jbc.273.50.33561; Imai A, 2006, J Obstet Gynaecol, V26, P37; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Leclercq TM, 2006, IUBMB LIFE, V58, P467, DOI 10.1080/15216540600871126; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; MAYERJAEKEL RE, 1994, J CELL SCI, V107, P2609; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Ogris E, 1999, J VIROL, V73, P7390, DOI 10.1128/JVI.73.9.7390-7398.1999; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Ricciarelli R, 1998, ARCH BIOCHEM BIOPHYS, V355, P197, DOI 10.1006/abbi.1998.0732; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; SCHONTHAL AH, 1998, FRONT BIOSCI, V3, P1262; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Sontag JM, 2006, CELL MOL LIFE SCI, V63, P2979, DOI 10.1007/s00018-006-6300-7; Spiegel S, 2002, LEUKEMIA, V16, P1596, DOI 10.1038/sj.leu.2402611; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Sugiyama M, 2003, AM J OBSTET GYNECOL, V189, P1666, DOI 10.1016/S0002-9378(03)00907-4; Sugiyama M, 2003, ONCOL REP, V10, P1885; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; TUNG HYL, 1985, EUR J BIOCHEM, V149, P305, DOI 10.1111/j.1432-1033.1985.tb08927.x; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Zhou GS, 2004, J BIOL CHEM, V279, P49551, DOI 10.1074/jbc.M410317200; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200	54	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34994	35002		10.1074/jbc.M804658200	http://dx.doi.org/10.1074/jbc.M804658200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18852266	hybrid, Green Published			2022-12-27	WOS:000261469100056
J	Laneve, P; Gioia, U; Ragno, R; Altieri, F; Di Franco, C; Santini, T; Arceci, M; Bozzoni, I; Caffarelli, E				Laneve, Pietro; Gioia, Ubaldo; Ragno, Rino; Altieri, Fabio; Di Franco, Carmen; Santini, Tiziana; Arceci, Massimo; Bozzoni, Irene; Caffarelli, Elisa			The Tumor Marker Human Placental Protein 11 Is an Endoribonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNA; DIAGNOSTIC-SIGNIFICANCE; IN-VITRO; XENDOU; PURIFICATION; CLEAVAGE; CLONING; SERVER; PP11; SP1	Human PP11 ( placental protein 11) was previously described as a serine protease specifically expressed in the syncytiotrophoblast and in numerous tumor tissues. Several PP11-like proteins were annotated in distantly related organisms, such as worms and mammals, suggesting their involvement in evolutionarily conserved processes. Based on sequence similarity, human PP11 was included in a protein family whose characterized members are XendoU, a Xenopus laevis endoribonuclease involved in small nucleolar RNA processing, and Nsp15, an endoribonuclease essential for coronavirus replication. Here we show that the bacterially expressed human PP11 displays RNA binding capability and cleaves single stranded RNA in a Mn2+-dependent manner at uridylates, to produce molecules with 2', 3'-cyclic phosphate ends. These features, together with structural and mutagenesis analyses, which identified the potential active site residues, reveal striking parallels to the amphibian XendoU and assign a ribonuclease function to PP11. This newly discovered enzymatic activity places PP11-like proteins in a completely new perspective.	[Laneve, Pietro; Arceci, Massimo; Bozzoni, Irene; Caffarelli, Elisa] Univ Roma La Sapienza, CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy; [Gioia, Ubaldo; Di Franco, Carmen; Santini, Tiziana; Bozzoni, Irene] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Ragno, Rino] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farm, I-00185 Rome, Italy; [Altieri, Fabio] Univ Roma La Sapienza, Dipartimento Biochim, I-00185 Rome, Italy; [Bozzoni, Irene] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Caffarelli, E (corresponding author), Univ Roma La Sapienza, CNR, Ist Biol & Patol Mol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	elisa.caffarelli@uniroma1.it	Ragno, Rino/I-1286-2013; Gioia, Ubaldo/GZL-7436-2022; laneve, pietro/ABD-1633-2020; Gioia, Ubaldo/O-1660-2014; Altieri, Fabio/D-2790-2009; laneve, pietro/M-3386-2014	Ragno, Rino/0000-0001-5399-975X; Gioia, Ubaldo/0000-0002-4993-5283; Gioia, Ubaldo/0000-0002-4993-5283; Altieri, Fabio/0000-0002-6546-2738; laneve, pietro/0000-0002-8865-4038; bozzoni, irene/0000-0002-3485-8537; Santini, Tiziana/0000-0002-7181-7267	6th Framework Programme of the European Commission [LSHG-CT-2006037900]; PRIN and Centro di Eccellenza BEMM; Associazione Italiana Ricerca sul Cancro ( AIRC); AIRC-Rome Oncogenomic Center	6th Framework Programme of the European Commission(European Commission); PRIN and Centro di Eccellenza BEMM; Associazione Italiana Ricerca sul Cancro ( AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC-Rome Oncogenomic Center(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by grants from the 6th Framework Programme of the European Commission ( SIROCCO Project, LSHG-CT-2006037900), the ESF project " NuRNASu", PRIN and Centro di Eccellenza BEMM, Associazione Italiana Ricerca sul Cancro ( AIRC) and AIRC-Rome Oncogenomic Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bhardwaj K, 2006, J MOL BIOL, V361, P243, DOI 10.1016/j.jmb.2006.06.021; BOHN H, 1980, ARCH GYNECOL, V229, P293, DOI 10.1007/BF02108580; BOHN H, 1981, ONCODEV BIOL MED, V2, P141; CAFFARELLI E, 1994, MOL CELL BIOL, V14, P2966, DOI 10.1128/MCB.14.5.2966; Filippini D, 2001, BIOCHEM BIOPH RES CO, V288, P16, DOI 10.1006/bbrc.2001.5720; Gioia U, 2005, J BIOL CHEM, V280, P18996, DOI 10.1074/jbc.M501160200; GRUNDMANN U, 1990, DNA CELL BIOL, V9, P243, DOI 10.1089/dna.1990.9.243; Gupta AK, 2004, CLIN CHEM, V50, P2187, DOI 10.1373/clinchem.2004.040196; Huppertz B, 1998, HISTOCHEM CELL BIOL, V110, P495, DOI 10.1007/s004180050311; INABA N, 1982, ONCODEV BIOL MED, V3, P379; INABA N, 1980, KLIN WOCHENSCHR, V58, P789, DOI 10.1007/BF01478287; INABA N, 1981, ARCH GYNECOL, V231, P87, DOI 10.1007/BF02110028; INABA N, 1980, ARCH GYNECOL, V230, P109, DOI 10.1007/BF02108266; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; KOI H, 2000, BIOONE ONLINE J, V64, P1001; KRISCH K, 1966, BIOCHIM BIOPHYS ACTA, V122, P265, DOI 10.1016/0926-6593(66)90067-1; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; PAN T, 1992, BIOCHEMISTRY-US, V31, P3887, DOI 10.1021/bi00131a001; Pinard R, 1999, BIOCHEMISTRY-US, V38, P16035, DOI 10.1021/bi992024s; Renzi F, 2006, ACTA CRYSTALLOGR F, V62, P298, DOI 10.1107/S1744309106006373; Renzi F, 2006, P NATL ACAD SCI USA, V103, P12365, DOI 10.1073/pnas.0602426103; Roberts SA, 2007, J BIOL CHEM, V282, P10605, DOI 10.1074/jbc.M611125200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	29	37	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34712	34719		10.1074/jbc.M805759200	http://dx.doi.org/10.1074/jbc.M805759200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18936097	Green Published, hybrid			2022-12-27	WOS:000261469100027
J	Cartmell, A; Topakas, E; Ducros, VMA; Suits, MDL; Davies, GJ; Gilbert, HJ				Cartmell, Alan; Topakas, Evangelos; Ducros, Valerie M-A.; Suits, Michael D. L.; Davies, Gideon J.; Gilbert, Harry J.			The Cellvibrio japonicus Mannanase CjMan26C Displays a Unique exo-Mode of Action That Is Conferred by Subtle Changes to the Distal Region of the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT CONFORMATIONAL ITINERARIES; GLYCOSIDE HYDROLASE FAMILY-5; CELL-WALL DEGRADATION; CLOSTRIDIUM-THERMOCELLUM; ALPHA-AMYLASE; PSEUDOMONAS-CELLULOSA; SUBSTRATE DISTORTION; CRYSTAL-STRUCTURE; BETA-MANNANASE; HYDROLYSIS	The microbial degradation of the plant cell wall is a pivotal biological process that is of increasing industrial significance. One of the major plant structural polysaccharides is mannan, a beta-1,4-linked D-mannose polymer, which is hydrolyzed by endo- and exo-acting mannanases. The mechanisms by which the exoacting enzymes target the chain ends of mannan and how galactose decorations influence activity are poorly understood. Here we report the crystal structure and biochemical properties of CjMan26C, a Cellvibrio japonicus GH26 mannanase. The exoacting enzyme releases the disaccharide mannobiose from the nonreducing end of mannan and mannooligosaccharides, harnessing four mannose-binding subsites extending from -2 to +2. The structure of CjMan26C is very similar to that of the endo- acting C. japonicus mannanase CjMan26A. The exo-activity displayed by CjMan26C, however, reflects a subtle change in surface topography in which a four-residue extension of surface loop creates a steric block at the distal glycone -2 subsite. endo-Activity can be introduced into enzyme variants through truncation of an aspartate side chain, a component of a surface loop, or by removing both the aspartate and its flanking residues. The structure of catalytically competent CjMan26C, in complex with a decorated manno-oligosaccharide, reveals a predominantly unhydrolyzed substrate in an approximate S-1(5) conformation. The complex structure helps to explain how the substrate "side chain" decorations greatly reduce the activity of the enzyme; the galactose side chain at the -1 subsite makes polar interactions with the aglycone mannose, possibly leading to suboptimal binding and impaired leaving group departure. This report reveals how subtle differences in the loops surrounding the active site of a glycoside hydrolase can lead to a change in the mode of action of the enzyme.	[Cartmell, Alan; Topakas, Evangelos; Gilbert, Harry J.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Ducros, Valerie M-A.; Suits, Michael D. L.; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England	Newcastle University - UK; University of York - UK	Gilbert, HJ (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	davies@ysbl.york.ac.uk	Topakas, Evangelos/J-7554-2019; Topakas, Evangelos/C-6528-2012; Davies, Gideon J/A-9042-2011	Topakas, Evangelos/0000-0003-0078-5904; Davies, Gideon J/0000-0002-7343-776X; Cartmell, Alan/0000-0002-5512-249X	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/B/05974, BB/D000475/1, BB/E000568/1] Funding Source: researchfish; BBSRC [BB/E000568/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (to H. J. G. and G. J. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRAITHWAITE KL, 1995, BIOCHEM J, V305, P1005, DOI 10.1042/bj3051005; Brett C. T., 1996, TOPICS PLANT FUNCTIO; Brumer H, 1999, BIOCHEM J, V339, P43, DOI 10.1042/0264-6021:3390043; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P9099, DOI 10.1021/bi0000317; Centeno MSJ, 2006, FEMS MICROBIOL LETT, V261, P123, DOI 10.1111/j.1574-6968.2006.00342.x; Dauter Z, 1999, BIOCHEMISTRY-US, V38, P8385, DOI 10.1021/bi990256l; Davies G., 1997, COMPREHENSIVE BIOL C; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DAVIES GJ, 2008, BIOCH J IN PRESS; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Emami K, 2002, J BACTERIOL, V184, P4124, DOI 10.1128/JB.184.15.4124-4133.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; Halstead JR, 1999, MICROBIOL-SGM, V145, P3101, DOI 10.1099/00221287-145-11-3101; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Kiyohara M, 2005, BIOCHEM J, V388, P949, DOI 10.1042/BJ20050190; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurokawa J, 2001, BIOSCI BIOTECH BIOCH, V65, P548, DOI 10.1271/bbb.65.548; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; MCCLEARY BV, 1988, METHOD ENZYMOL, V160, P523; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Money VA, 2006, ANGEW CHEM INT EDIT, V45, P5136, DOI 10.1002/anie.200600802; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nerinckx W, 2006, ARKIVOC, P90, DOI 10.3998/ark.5550190.0007.d10; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages S, 2001, J BIOL CHEM, V276, P33652, DOI 10.1074/jbc.M105770200; Pell G, 2004, J BIOL CHEM, V279, P11777, DOI 10.1074/jbc.M311947200; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Puchart V, 2004, BBA-GEN SUBJECTS, V1674, P239, DOI 10.1016/j.bbagen.2004.06.022; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; SAMSON R, 1978, J CHEM PHYS, V68, P285, DOI 10.1063/1.435494; Stoll D, 1999, APPL ENVIRON MICROB, V65, P2598; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Taylor EJ, 2005, J BIOL CHEM, V280, P32761, DOI 10.1074/jbc.M506580200; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Vincent F, 2004, CHEMBIOCHEM, V5, P1596, DOI 10.1002/cbic.200400169; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183	47	67	68	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34403	34413		10.1074/jbc.M804053200	http://dx.doi.org/10.1074/jbc.M804053200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18799462	Green Published, hybrid			2022-12-27	WOS:000261277700068
J	Li, F; ten Dam, GB; Murugan, S; Yamada, S; Hashiguchi, T; Mizumoto, S; Oguri, K; Okayama, M; van Kuppevelt, TH; Sugahara, K				Li, Fuchuan; ten Dam, Gerdy B.; Murugan, Sengottuvelan; Yamada, Shuhei; Hashiguchi, Taishi; Mizumoto, Shuji; Oguri, Kayoko; Okayama, Minoru; van Kuppevelt, Toin H.; Sugahara, Kazuyuki			Involvement of Highly Sulfated Chondroitin Sulfate in the Metastasis of the Lewis Lung Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX-VIRUS INFECTIVITY; HUMAN-MELANOMA CELLS; HEPARAN-SULFATE; P-SELECTIN; SYNDECAN-1 EXPRESSION; DERMATAN SULFATE; ANTIBODY GD3G7; FIBRIN MATRIX; CANCER CELLS; TUMOR-CELLS	The altered expression of cell surface chondroitin sulfate ( CS) and dermatan sulfate (DS) in cancer cells has been demonstrated to play a key role in malignant transformation and tumor metastasis. However, the functional highly sulfated structures in CS/DS chains and their involvement in the process have not been well documented. In the present study, a structural analysis of CS/DS from two mouse Lewis lung carcinoma (3LL)-derived cell lines with different metastatic potentials revealed a higher proportion of Delta(4,5)HexUA-GalNAc(4,6-O-disulfate) generated from E-units (GlcUA-GalNAc(4,6-O-disulfate)) in highly metastatic LM66-H11 cells than in low metastatic P29 cells, although much less CS/DS is expressed by LM66-H11 than P29 cells. This key finding prompted us to study the role of CS-E-like structures in experimental lung metastasis. The metastasis of LM66-H11 cells to lungs was effectively inhibited by enzymatic removal of tumor cell surface CS or by preadministration of CS-E rich in E-units in a dose-dependent manner. In addition, immunocytochemical analysis showed that LM66-H11 rather than P29 cells expressed more strongly the CS-E epitope, which was specifically recognized by the phage display antibody GD3G7. More importantly, this antibody and a CS-E decasaccharide fraction, the minimal structure recognized by GD3G7, strongly inhibited the metastasis of LM66-H11 cells probably by modifying the proliferative and invading behavior of the metastatic tumor cells. These results suggest that the E-unit-containing epitopes are involved in the metastatic process and a potential target for the diagnosis and treatment of malignant tumors.	[Sugahara, Kazuyuki] Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut,Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Li, Fuchuan; Yamada, Shuhei; Sugahara, Kazuyuki] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6588558, Japan; [Oguri, Kayoko] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi 4600001, Japan; [Okayama, Minoru] Kyoto Sangyo Univ, Fac Engn, Dept Biotechnol, Kyoto 6038555, Japan; [ten Dam, Gerdy B.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Hokkaido University; Kobe Pharmaceutical University; Nagoya Medical Center; Kyoto Sangyo University; Radboud University Nijmegen	Sugahara, K (corresponding author), Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut,Kita Ku, Nishi 11,Kita 21, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp	van Kuppevelt, A.H.M.S.M./L-4463-2015; Mizumoto, Shuji/F-8313-2018; Murugan, Sengottuvelan/G-9153-2012	Mizumoto, Shuji/0000-0002-4641-1505; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); New Energy and Industrial Technology Development Organization; Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Human Frontier Science Program [RGP62/2004, RGP18/2005]; Dutch Cancer Society Grant [2008-4058]; Scientific Research on Priority Areas [17046028]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Human Frontier Science Program(Human Frontier Science ProgramCore Research for Evolutional Science and Technology (CREST)); Dutch Cancer Society Grant(KWF Kankerbestrijding); Scientific Research on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid 16390026 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), funds from the New Energy and Industrial Technology Development Organization (to K. S.) and the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Human Frontier Science Program Grants RGP62/2004 (to T. H. V. K.) and RGP18/2005 (to K. S.), Dutch Cancer Society Grant 2008-4058 (to G. T. D.), the "Academic Frontier" Project for Private Universities matching funds subsidy (to M. O.), and in part by Grant-in Aid for Scientific Research on Priority Areas 17046028 (to K. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; Day RM, 1999, VIRCHOWS ARCH, V434, P121, DOI 10.1007/s004280050315; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Denholm EM, 2001, EUR J PHARMACOL, V416, P213, DOI 10.1016/S0014-2999(01)00884-6; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; FAASSEN AE, 1992, J CELL BIOL, V116, P521, DOI 10.1083/jcb.116.2.521; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gallagher JT, 1989, CURR OPIN CELL BIOL, V1, P1201, DOI 10.1016/S0955-0674(89)80072-9; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; Iida J, 1998, J BIOL CHEM, V273, P5955, DOI 10.1074/jbc.273.10.5955; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; INKI P, 1994, BRIT J CANCER, V70, P319, DOI 10.1038/bjc.1994.300; ITANO N, 1993, J BIOCHEM, V114, P862, DOI 10.1093/oxfordjournals.jbchem.a124269; Ito Y, 2007, ACTA HISTOCHEM CYTOC, V40, P53, DOI 10.1267/ahc.07004; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kumar-Singh S, 1998, J PATHOL, V186, P300, DOI 10.1002/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q; KURE S, 1987, JPN J CANCER RES, V78, P1238; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Ludwig RJ, 2004, CANCER RES, V64, P2743, DOI 10.1158/0008-5472.CAN-03-1054; Lv HZ, 2007, ONCOLOGY-BASEL, V72, P347, DOI 10.1159/000113145; LYNCH SA, 1991, CANCER METAST REV, V10, P141, DOI 10.1007/BF00049411; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Matsumoto A, 1997, INT J CANCER, V74, P482, DOI 10.1002/(SICI)1097-0215(19971021)74:5<482::AID-IJC2>3.0.CO;2-#; MOCZAR M, 1993, CLIN EXP METASTAS, V11, P462, DOI 10.1007/BF00054937; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Munesue S, 2002, BIOCHEM J, V363, P201, DOI 10.1042/0264-6021:3630201; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; Nackaerts K, 1997, INT J CANCER, V74, P335, DOI 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.3.CO;2-4; NAKANISHI H, 1992, BIOCHEM J, V288, P215, DOI 10.1042/bj2880215; Nikitovic D, 2008, INT J BIOCHEM CELL B, V40, P72, DOI 10.1016/j.biocel.2007.06.019; Pluschke G, 1996, P NATL ACAD SCI USA, V93, P9710, DOI 10.1073/pnas.93.18.9710; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; REDINI F, 1986, BIOCHIM BIOPHYS ACTA, V883, P98, DOI 10.1016/0304-4165(86)90140-6; ROBINSON J, 1984, J CELL BIOL, V98, P946, DOI 10.1083/jcb.98.3.946; Safaiyan F, 1998, EUR J BIOCHEM, V252, P576, DOI 10.1046/j.1432-1327.1998.2520576.x; SAITO H, 1968, J BIOL CHEM, V243, P1536; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; STAMATOGLOU SC, 1983, J CELL BIOL, V96, P1820, DOI 10.1083/jcb.96.6.1820; Stanley MJ, 1999, AM J CLIN PATHOL, V112, P377; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Timar J, 2002, SEMIN CANCER BIOL, V12, P173, DOI 10.1016/S1044-579X(02)00021-4; TIMAR J, 1992, AM J PATHOL, V141, P467; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Yoshitomi Y, 2004, CANCER LETT, V207, P165, DOI 10.1016/j.canlet.2003.11.037	61	85	90	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34294	34304		10.1074/jbc.M806015200	http://dx.doi.org/10.1074/jbc.M806015200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18930920	Green Published, hybrid			2022-12-27	WOS:000261277700057
J	Lin, HL; Kumanovics, A; Nelson, JM; Warner, DE; Ward, DM; Kaplan, J				Lin, Huilan; Kumanovics, Attila; Nelson, Jenifer M.; Warner, David E.; Ward, Diane McVey; Kaplan, Jerry			Single Amino Acid Change in the Yeast Vacuolar Metal Transporters Zrc1 and Cot1 Alters Their Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; COPPER DETOXIFICATION; CATION-TRANSPORT; GENE-EXPRESSION; PLASMA-MEMBRANE; ZINC STORAGE; IRON STORAGE; H+-ATPASE; METABOLISM; RESISTANCE	Iron is an essential nutrient but in excess may damage cells by generating reactive oxygen species due to Fenton reaction or by substituting for other transition metals in essential proteins. The budding yeast Saccharomyces cerevisiae detoxifies cytosolic iron by storage in the vacuole. Deletion of CCC1, which encodes the vacuolar iron importer, results in high iron sensitivity due to increased cytosolic iron. We selected mutants that permitted Delta ccc1 cells to grow under high iron conditions by UV mutagenesis. We identified a mutation (N44I) in the vacuolar zinc transporter ZRC1 that changed the substrate specificity of the transporter from zinc to iron. COT1, a vacuolar zinc and cobalt transporter, is a homologue of ZRC1 and both are members of the cation diffusion facilitator family. Mutation of the homologous amino acid (N45I) in COT1 results in an increased ability to transport iron and decreased ability to transport cobalt. These mutations are within the second hydrophobic domain of the transporters and show the essential nature of this domain in the specificity of metal transport.	[Lin, Huilan; Kumanovics, Attila; Nelson, Jenifer M.; Warner, David E.; Ward, Diane McVey; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu	Lin, Huilan/B-7671-2013		National Institutes of Health [DK30534, NCI-CCSG P30CA 42014]; NCI; NIDDK Center of Excellence [5P30KD72437]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, T32DK007115, R37DK030534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30534 ( to J. K.), support for use of the Core Facilities was provided through NCI, National Institutes of Health Grant NCI-CCSG P30CA 42014 and NIDDK Center of Excellence Award 5P30KD72437. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; CALVIN NM, 1988, J BACTERIOL, V170, P2796, DOI 10.1128/jb.170.6.2796-2801.1988; CONKLIN DS, 1994, MOL GEN GENET, V244, P303, DOI 10.1007/BF00285458; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DIX DR, 1994, J BIOL CHEM, V269, P26092; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lapinskas PJ, 1996, MOL MICROBIOL, V21, P519, DOI 10.1111/j.1365-2958.1996.tb02561.x; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lu JMY, 1998, P NATL ACAD SCI USA, V95, P9025, DOI 10.1073/pnas.95.15.9025; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; MacDiarmid CW, 2003, J BIOL CHEM, V278, P15065, DOI 10.1074/jbc.M300568200; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Moore DD, 1995, GLOB MOB SURV; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Tuttle MS, 2003, J BIOL CHEM, V278, P1273, DOI 10.1074/jbc.M209631200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x	36	22	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33865	33873		10.1074/jbc.M804377200	http://dx.doi.org/10.1074/jbc.M804377200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18930916	Green Published, hybrid			2022-12-27	WOS:000261277700011
J	Wang, YL; Faiola, F; Xu, MY; Pan, SQ; Martinez, E				Wang, Yuan-Liang; Faiola, Francesco; Xu, Muyu; Pan, Songqin; Martinez, Ernest			Human ATAC Is a GCN5/PCAF-containing Acetylase Complex with a Novel NC2-like Histone Fold Module That Interacts with the TATA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASE ACTIVITY; TRANSCRIPTION FACTOR; GCN5; DISTINCT; PCAF; SAGA; METHYLTRANSFERASE; IDENTIFICATION; ONCOPROTEIN; COACTIVATOR	Eukaryotic GCN5 acetyltransferases influence diverse biological processes by acetylating histones and non-histone proteins and regulating chromatin and gene-specific transcription as part of multiprotein complexes. In lower eukaryotes and invertebrates, these complexes include the yeast ADA complex that is still incompletely understood; the SAGA (Spt-Ada-Gcn5 acetylase) complexes from yeast to Drosophila that are mostly coactivators; and the ATAC (Ada Two-A containing) complex, only known in Drosophila and still poorly characterized. In contrast, vertebrate organisms, express two paralogous GCN5-like acetyltransferases (GCN5 and PCAF), which have been found so far only in SAGA-type complexes referred to hereafter as the STAGA (SPT3-TAF9-GCN5/PCAF acetylase) complexes. We now report the purification and characterization of vertebrate (human) ATAC-type complexes and identify novel components of STAGA. We show that human ATAC complexes incorporate in addition to GCN5 or PCAF (GCN5/PCAF), other epigenetic coregulators (ADA2-A, ADA3, STAF36, and WDR5), cofactors of chromatin assembly/remodeling and DNA replication machineries (POLE3/CHRAC17 and POLE4), the stress- and TGF beta-activated protein kinase (TAK1/MAP3K7) and MAP3-kinase regulator (MBIP), additional cofactors of unknown function, and a novel YEATS2-NC2 beta histone fold module that interacts with the TATA-binding protein (TBP) and negatively regulates transcription when recruited to a promoter. We further identify the p38 kinase-interacting protein (p38IP/FAM48A) as a novel component of STAGA with distant similarity to yeast Spt20. These results suggest that vertebrate ATAC-type and STAGA-type complexes link specific extracellular signals to modification of chromatin structure and regulation of the basal transcription machinery.	[Wang, Yuan-Liang; Faiola, Francesco; Xu, Muyu; Martinez, Ernest] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Pan, Songqin] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Pan, Songqin] Univ Calif Riverside, Inst Integrat Genome Biol, WM Keck Prote Lab, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Martinez, E (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	ernest.martinez@ucr.edu	Lv, Yuanjie/AER-0767-2022; Faiola, Francesco/Q-4218-2018; xu, muyu/R-3044-2017	Faiola, Francesco/0000-0002-3512-8253; xu, muyu/0000-0002-0921-3665	National Institutes of Health [CA100464]; National Science Foundation [MCB-0448488]; NATIONAL CANCER INSTITUTE [R01CA100464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100464. This work was also supported by Career Grant MCB-0448488 from the National Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Barlev NA, 2003, MOL CELL BIOL, V23, P6944, DOI 10.1128/MCB.23.19.6944-6957.2003; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Carre C, 2008, EMBO REP, V9, P187, DOI 10.1038/sj.embor.7401141; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Fukuyama K, 2000, J BIOL CHEM, V275, P21247, DOI 10.1074/jbc.M001488200; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Hardy S, 2002, J BIOL CHEM, V277, P32875, DOI 10.1074/jbc.M205860200; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; INOSTROZA JA, 1992, CELL, V70, P477; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Menon Suchithra, 2008, BMC Biochemistry, V9, P1, DOI 10.1186/1471-2091-9-1; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	44	152	153	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33808	33815		10.1074/jbc.M806936200	http://dx.doi.org/10.1074/jbc.M806936200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18838386	hybrid, Green Published			2022-12-27	WOS:000261277700004
J	Lee, JN; Zhang, XY; Feramisco, JD; Gong, Y; Ye, J				Lee, Joon No; Zhang, Xiangyu; Feramisco, Jamison D.; Gong, Yi; Ye, Jin			Unsaturated Fatty Acids Inhibit Proteasomal Degradation of Insig-1 at a Postubiquitination Step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL-REGULATED UBIQUITINATION; CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEIN-1C; BOUND TRANSCRIPTION FACTOR; ER-ASSOCIATED DEGRADATION; ACYL-COA SYNTHETASE; MEMBRANE-PROTEIN; CELLS; CHOLESTEROL; REDUCTASE	Proteasomes mediate the regulated degradation of Insig-1, a membrane protein of the endoplasmic reticulum (ER) that plays a crucial role in lipid metabolism. We showed previously that sterols inhibit this degradation by blocking ubiquitination of Insig-1. Here we show that unsaturated fatty acids stabilize Insig-1 without affecting its ubiquitination. Instead unsaturated fatty acids inhibit extraction of ubiquitinated Insig-1 from membranes, a process known to be mediated by valosin-containing protein and necessary for ER-associated degradation. Valosin-containing protein is recruited to Insig-1 through the action of another protein, Ubxd8. Unsaturated fatty acids block the binding between Ubxd8 and Insig-1, thereby abrogating the membrane extraction of Insig-1. Unsaturated fatty acid-mediated stabilization of Insig-1 enhances the ability of sterols to inhibit proteolytic activation of SREBP-1, which activates transcription of genes involved in fatty acid synthesis. The current study provides a molecular mechanism for regulation of proteasome-mediated ER protein degradation at a postubiquitination step.	[Lee, Joon No; Zhang, Xiangyu; Feramisco, Jamison D.; Gong, Yi; Ye, Jin] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Ye, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	jin.ye@utsouthwestern.edu	Gong, Yi/AAQ-7515-2020		National Institutes of Health [HL-20948]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-20948. This work was also supported by the Perot Family Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Dobrzyn A, 2005, PROSTAG LEUKOTR ESS, V73, P35, DOI 10.1016/j.plefa.2005.04.011; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Imai Y, 2002, BIOCHEM BIOPH RES CO, V297, P1282, DOI 10.1016/S0006-291X(02)02380-X; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee JN, 2006, P NATL ACAD SCI USA, V103, P4958, DOI 10.1073/pnas.0600422103; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Liang J, 2006, J CELL SCI, V119, P4011, DOI 10.1242/jcs.03163; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; TOMODA H, 1991, J BIOL CHEM, V266, P4214; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	51	69	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33772	33783		10.1074/jbc.M806108200	http://dx.doi.org/10.1074/jbc.M806108200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18835813	Green Published, hybrid			2022-12-27	WOS:000261183700083
J	Kurita, S; Watanabe, Y; Gunji, E; Ohashi, K; Mizuno, K				Kurita, Souichi; Watanabe, Yosuke; Gunji, Emi; Ohashi, Kazumasa; Mizuno, Kensaku			Molecular Dissection of the Mechanisms of Substrate Recognition and F-actin-mediated Activation of Cofilin-phosphatase Slingshot-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; LIM-KINASE; CATALYTIC ACTIVATION; CRYSTAL-STRUCTURE; REGULATES COFILIN; CORONIN 1B; PHOSPHORYLATION; BINDING; REORGANIZATION; SPECIFICITY	Slingshot-1 (SSH1), a member of a dual-specificity protein phosphatase family, regulates actin dynamics by dephosphorylating and reactivating cofilin, an actin-depolymerizing factor. SSH1 has the SSH family-specific, N-terminal, noncatalytic (SSH-N) domain, consisting of the A and B subdomains. SSH1 is activated by binding to actin filaments. In this study, we examined the mechanisms of SSH1 substrate recognition of phospho-cofilin (P-cofilin) and SSH1 activation by F-actin. We found that P-cofilin binds to a phosphatase-inactive mutant, SSH1(CS), in which the catalytic Cys-393 is replaced by Ser. Using a series of deletion mutants, we provided evidence that both the phosphatase (P) domain and the adjacent B domain are indispensable for P-cofilin binding of SSH1(CS) and cofilin-phosphatase activity of SSH1. In contrast, the A domain is required for the F-actin-mediated activation of SSH1, but not for P-cofilin binding or basal cofilin-phosphatase activity. The P domain alone is sufficient for the phosphatase activity toward p-nitrophenyl phosphate (pNPP), indicating that the SSH-N domain is not essential for the basal phosphatase activity of SSH1. Addition of F-actin increased the cofilin-phosphatase activity of SSH1 more than 1200-fold,but the pNPP-phosphatase activity only 2.2-fold, which suggests that F-actin principally affects the cofilin-specific phosphatase activity of SSH1. When expressed in cultured cells, SSH1, but not its mutant deleted of SSH-N, accumulated in the rear of the lamellipodium. Together, these findings suggest that the conserved SSH-N domain plays critical roles in P-cofilin recognition, F-actin-mediated activation, and subcellular localization of SSH1.	[Kurita, Souichi; Watanabe, Yosuke; Gunji, Emi; Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Mizuno, Kensaku/G-8631-2015; Ohashi, Kazumasa/U-7028-2019	Ohashi, Kazumasa/0000-0001-7617-403X	Ministry of Education, Culture, Science, Sports and Technology of Japan	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Science, Sports and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jung SK, 2007, PROTEINS, V68, P408, DOI 10.1002/prot.21399; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kolmodin K, 2001, FEBS LETT, V498, P208, DOI 10.1016/S0014-5793(01)02479-6; Kurita S, 2007, GENES CELLS, V12, P663, DOI 10.1111/j.1365-2443.2007.01078.x; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nichols A, 2000, J BIOL CHEM, V275, P24613, DOI 10.1074/jbc.M001515200; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YONEZAWA N, 1988, BIOCHEM J, V251, P121, DOI 10.1042/bj2510121; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4	35	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32542	32552		10.1074/jbc.M804627200	http://dx.doi.org/10.1074/jbc.M804627200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809681	hybrid			2022-12-27	WOS:000260893700043
J	Patel, A; Dharmarajan, V; Cosgrove, MS				Patel, Anamika; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.			Structure of WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3 LYSINE-4; METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; MOLECULAR RECOGNITION; MLL; METHYLATION; EXPRESSION; MICE	The mixed lineage leukemia protein-1 (MLL1) catalyzes histone H3 lysine 4 methylation and is regulated by interaction with WDR5 (WD-repeat protein-5), RbBP5 (retinoblastoma-binding protein-5), and the Ash2L (absent, small, homeotic discs-2-like) oncoprotein. In the accompanying investigation, we describe the identification of a conserved arginine containing motif, called the "Win" or WDR5 interaction motif, that is essential for the assembly and H3K4 dimethylation activity of the MLL1 core complex. Here we present a 1.7-angstrom crystal structure of WDR5 bound to a peptide derived from the MLL1 Win motif. Our results show that Arg-3765 of MLL1 is bound in the same arginine binding pocket on WDR5 that was previously suggested to bind histone H3. Thermodynamic binding experiments show that the MLL1 Win peptide is preferentially recognized by WDR5. These results are consistent with a model in which WDR5 recognizes Arg-3765 of MLL1, which is essential for the assembly and enzymatic activity of the MLL1 core complex.	[Patel, Anamika; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Cosgrove, MS (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA.	mscosgro@syr.edu			March of Dimes Birth Defects Foundation [5-FY06-585]; Syracuse University; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); Syracuse University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Research Grant 5-FY06-585 from the March of Dimes Birth Defects Foundation (to M. S. C.) and by funds from Syracuse University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; DeLano W.L, PYMOL MOL GRAPHICS S; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	23	121	128	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32158	32161		10.1074/jbc.C800164200	http://dx.doi.org/10.1074/jbc.C800164200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18829459	hybrid			2022-12-27	WOS:000260893700002
J	Burgers, PMJ				Burgers, Peter M. J.			Polymerase Dynamics at the Eukaryotic DNA Replication Fork	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OKAZAKI FRAGMENT MATURATION; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; FLAP ENDONUCLEASE-1; CATALYTIC DOMAINS; LIGATABLE NICK; DELTA; EPSILON; YEAST; COMPONENTS	This review discusses recent insights in the roles of DNA polymerases (Pol) delta and is an element of in eukaryotic DNA replication. A growing body of evidence specifies Pol is an element of as the leading strand DNA polymerase and Pol delta as the lagging strand polymerase during undisturbed DNA replication. New evidence supporting this model comes from the use of polymerase mutants that show an asymmetric mutator phenotype for certain mispairs, allowing an unambiguous strand assignment for these enzymes. On the lagging strand, Pol delta corrects errors made by Pol alpha during Okazaki fragment initiation. During Okazaki fragment maturation, the extent of strand displacement synthesis by Pol delta determines whether maturation proceeds by the short or long flap processing pathway. In the more common short flap pathway, Pol delta coordinates with the flap endonuclease FEN1 to degrade initiator RNA, whereas in the long flap pathway, RNA removal is initiated by the Dna2 nuclease/helicase.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PMJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM32431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32431. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Ohya T, 2002, J BIOL CHEM, V277, P28099, DOI 10.1074/jbc.M111573200; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Shcherbakova PV, 1996, GENETICS, V142, P717; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Zlotkin T, 1996, EMBO J, V15, P2298, DOI 10.1002/j.1460-2075.1996.tb00583.x	38	241	249	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4041	4045		10.1074/jbc.R800062200	http://dx.doi.org/10.1074/jbc.R800062200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	18835809	Green Published, hybrid			2022-12-27	WOS:000263134400001
J	Funkelstein, L; Toneff, T; Mosier, C; Hwang, SR; Beuschlein, F; Lichtenauer, UD; Reinheckel, T; Peters, C; Hook, V				Funkelstein, Lydiane; Toneff, Thomas; Mosier, Charles; Hwang, Shin-Rong; Beuschlein, Felix; Lichtenauer, Urs D.; Reinheckel, Thomas; Peters, Christoph; Hook, Vivian			Major Role of Cathepsin L for Producing the Peptide Hormones ACTH, beta-Endorphin, and alpha-MSH, Illustrated by Protease Gene Knockout and Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY VESICLES; PROHORMONE CONVERTASE-2; STIMULATED SECRETION; NUCLEOTIDE-SEQUENCE; CYSTEINE PROTEASES; PITUITARY-CELLS; PROOPIOMELANOCORTIN; BIOSYNTHESIS; ASPARTYL; BRAINS	The pituitary hormones adrenocorticotropic hormone (ACTH), beta-endorphin, and alpha-melanocyte stimulating hormone (alpha-MSH) are synthesized by proteolytic processing of their common proopiomelanocortin (POMC) precursor. Key findings from this study show that cathepsin L functions as a major proteolytic enzyme for the production of POMC-derived peptide hormones in secretory vesicles. Specifically, cathepsin L knockout mice showed major decreases in ACTH, beta-endorphin, and alpha-MSH that were reduced to 23, 18, and 7% of wild-type controls (100%) in pituitary. These decreased peptide levels were accompanied by increased levels of POMC consistent with proteolysis of POMC by cathepsin L. Immunofluorescence microscopy showed colocalization of cathepsin L with beta-endorphin and alpha-MSH in the intermediate pituitary and with ACTH in the anterior pituitary. In contrast, cathepsin L was only partially colocalized with the lysosomal marker Lamp-1 in pituitary, consistent with its extralysosomal function in secretory vesicles. Expression of cathepsin L in pituitary AtT-20 cells resulted in increased ACTH and beta-endorphin in the regulated secretory pathway. Furthermore, treatment of AtT-20 cells with CLIK-148, a specific inhibitor of cathepsin L, resulted in reduced production of ACTH and accumulation of POMC. These findings demonstrate a prominent role for cathepsin L in the production of ACTH, beta-endorphin, and alpha-MSH peptide hormones in the regulated secretory pathway.	[Funkelstein, Lydiane; Toneff, Thomas; Mosier, Charles; Hwang, Shin-Rong; Hook, Vivian] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Sch Med, Dept Med Neurosci, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Beuschlein, Felix; Lichtenauer, Urs D.; Reinheckel, Thomas; Peters, Christoph] Univ Freiburg, Inst Mol Med & Zellforsch, Freiburg, Germany; [Beuschlein, Felix] Univ Munich, Univ Hosp Innenstadt, Med Clin, Munich, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Freiburg; University of Munich	Hook, V (corresponding author), Univ Calif San Diego, Sch Pharm, 9500 Gilman Dr MC 0744, La Jolla, CA 92093 USA.	vhook@ucsd.edu	Lichtenauer, Urs/AFU-2746-2022; Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Beuschlein, Felix/0000-0001-7826-3984	National Institutes of Health [ROI MH 077305, ROI DA 04271, ROI NS 24553]; Deutsche Forschungsgemeinschaft; Landesstiftung Baden-Wuerttemberg; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024553, P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesstiftung Baden-Wuerttemberg; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants ROI MH 077305; ROI DA 04271, and ROI NS 24553 (to V.H.). This work was also supported by grants from the Deutsche Forschungsgemeinschaft (to T.R. and C.P.) and from the Landesstiftung Baden-Wuerttemberg (to F.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adan RAH, 2003, ANN NY ACAD SCI, V994, P267, DOI 10.1111/j.1749-6632.2003.tb03189.x; Allen RG, 2001, J NEUROSCI, V21, P5864, DOI 10.1523/JNEUROSCI.21-16-05864.2001; AZARYAN AV, 1994, FEBS LETT, V341, P197, DOI 10.1016/0014-5793(94)80456-7; AZARYAN AV, 1995, J BIOL CHEM, V270, P8201, DOI 10.1074/jbc.270.14.8201; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BOILEAU G, 1983, NUCLEIC ACIDS RES, V11, P8063, DOI 10.1093/nar/11.22.8063; Ciccotosto GD, 1999, J CELL BIOL, V144, P459, DOI 10.1083/jcb.144.3.459; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; DALAYEUN JF, 1993, BIOMED PHARMACOTHER, V47, P311, DOI 10.1016/0753-3322(93)90080-5; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FROHMAN LA, 1981, ENDOCRINOL METAB, P293; GAINER H, 1984, FEBS LETT, V175, P135, DOI 10.1016/0014-5793(84)80586-4; Hartwig A C, 1991, Anesth Prog, V38, P75; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; HOOK VYH, 1982, P NATL ACAD SCI-BIOL, V79, P6220, DOI 10.1073/pnas.79.20.6220; HOOK VYH, 1982, BIOCHEM BIOPH RES CO, V106, P1364, DOI 10.1016/0006-291X(82)91264-5; Hwang SR, 2007, J BIOL CHEM, V282, P9556, DOI 10.1074/jbc.M605510200; Hwang SR, 2007, J NEUROCHEM, V100, P1340, DOI 10.1111/j.1471-4159.2006.04325.x; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; Laurent V, 2004, ENDOCRINOLOGY, V145, P519, DOI 10.1210/en.2003-0829; Lechan RM, 2006, PEPTIDES, V27, P310, DOI 10.1016/j.peptides.2005.01.033; LOH YP, 1982, P NATL ACAD SCI-BIOL, V79, P108, DOI 10.1073/pnas.79.1.108; Miller R, 2003, J NEUROCHEM, V86, P556, DOI 10.1046/j.1471-4159.2003.01856.x; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; NORRIS DO, 1997, VERTEBRATE ENDOCRINO, P106; Pan H, 2005, BIOCHEMISTRY-US, V44, P4939, DOI 10.1021/bi047852m; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Sei C, 2003, PEPTIDES, V24, P717, DOI 10.1016/S0196-9781(03)00126-8; Sei C, 2002, PEPTIDES, V23, P1409, DOI 10.1016/S0196-9781(02)00079-7; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	35	55	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35652	35659		10.1074/jbc.M709010200	http://dx.doi.org/10.1074/jbc.M709010200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18849346	hybrid, Green Published			2022-12-27	WOS:000261687900039
J	Salter, MD; Nienhaus, K; Nienhaus, GU; Dewilde, S; Moens, L; Pesce, A; Nardini, M; Bolognesi, M; Olson, JS				Salter, Mallory D.; Nienhaus, Karin; Nienhaus, G. Ulrich; Dewilde, Sylvia; Moens, Luc; Pesce, Alessandra; Nardini, Marco; Bolognesi, Martino; Olson, John S.			The Apolar Channel in Cerebratulus lacteus Hemoglobin Is the Route for O-2 Entry and Exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND DOCKING SITES; X-RAY; STRUCTURAL DYNAMICS; TRUNCATED HEMOGLOBINS; NEMERTEAN WORM; HEME-PROTEINS; MYOGLOBIN; BINDING; MIGRATION; PATHWAYS	The major pathway for O-2 binding to mammalian myoglobins (Mb) and hemoglobins (Hb) involves transient upward movement of the distal histidine (His-64(E7)), allowing ligand capture in the distal pocket. The mini-globin from Cerebratulus lacteus (CerHb) appears to have an alternative pathway between the E and H helices that is made accessible by loss of the N-terminal A helix. To test this pathway, we examined the effects of changing the size of the E7 gate and closing the end of the apolar channel in CerHb by site-directed mutagenesis. Increasing the size of Gln-44(E7) from Ala to Trp causes variation of association (k'(O2)) and dissociation (k(O2)) rate coefficients, but the changes are not systematic. More significantly, the fractions (F-gem approximate to 0.05-0.19) and rates (k(gem) approximate to 50-100 mu s(-1)) of geminate CO recombination in the Gln-44(E7) mutants are all similar. In contrast, blocking the entrance to the apolar channel by increasing the size of Ala-55(E18) to Phe and Trp causes the following: 1) both k'(O2) and k(O2) to decrease roughly 4-fold; 2) F-gem for CO to increase from similar to 0.05 to 0.45; and 3) k(gem) to decrease from similar to 80 to similar to 9 mu s(-1), as ligands become trapped in the channel. Crystal structures and low temperature Fourier-transform infrared spectra of Phe-55 and Trp-55 CerHb confirm that the aromatic side chains block the channel entrance, with little effect on the distal pocket. These results provide unambiguous experimental proof that diatomic ligands can enter and exit a globin through an interior channel in preference to the more direct E7 pathway.	[Salter, Mallory D.; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Salter, Mallory D.; Olson, John S.] Rice Univ, WM Keck Ctr Computat Biol, Houston, TX 77005 USA; [Nienhaus, Karin; Nienhaus, G. Ulrich] Univ Ulm, Inst Biophys, D-89081 Ulm, Germany; [Nienhaus, G. Ulrich] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Dewilde, Sylvia; Moens, Luc] Univ Antwerp, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Pesce, Alessandra] Univ Genoa, Dept Phys, CNISM, I-16146 Genoa, Italy; [Pesce, Alessandra] Univ Genoa, Ctr Excellence Biomed Res, I-16146 Genoa, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, INFM, CNR, Dept Biomol Sci & Biotechnol, I-20131 Milan, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, CIMAINA, I-20131 Milan, Italy	Rice University; Rice University; Ulm University; University of Illinois System; University of Illinois Urbana-Champaign; University of Antwerp; University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Milan; University of Milan	Olson, JS (corresponding author), 6100 Main St,MS-140, Houston, TX 77005 USA.	olson@rice.edu	Nardini, Marco/B-7842-2017; Nienhaus, Gerd Ulrich/G-8698-2012; Bolognesi, Martino/B-7924-2017; Pesce, Alessandra/A-3660-2015	Nardini, Marco/0000-0002-3718-2165; Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Bolognesi, Martino/0000-0002-9253-5170; Olson, John/0000-0002-0760-5403	National Institutes of Health [GM 35649, HL 47020]; Robert A. Welch Foundation [C-612]; Houston Area Molecular Biophysics Training Grant [GM80820]; Deutsche Forschungsgemeinschaft [Ni 291/3]; Italian Ministry of University and Scientific Research [RBLA03B3KC_005]; University of Milano; Fund for Scientific Research Flanders Project [G.0331.04N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080820, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Houston Area Molecular Biophysics Training Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Milano; Fund for Scientific Research Flanders Project(FWO); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant National Institutes of Health Grants GM 35649 and HL 47020. This work was also supported by Robert A. Welch Foundation Grant C-612 (to J.S.O.), Predoctoral Training Fellowship from the Houston Area Molecular Biophysics Training Grant GM80820 (to M. D. S.), Deutsche Forschungsgemeinschaft Grant Ni 291/3 and the "Fonds der Chemischen Industrie," grants from the Italian Ministry of University and Scientific Research (FIRB Project "Biologia Strutturale" RBLA03B3KC_005) and from the University of Milano (to M. B.), and Fund for Scientific Research Flanders Project " Hypoxia and Nerve Globins" Grant G.0331.04N) (to L. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aranda R, 2006, ACTA CRYSTALLOGR D, V62, P776, DOI 10.1107/S0907444906017318; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERENDZEN J, 1990, P NATL ACAD SCI USA, V87, P1, DOI 10.1073/pnas.87.1.1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Bidon-Chanal A, 2006, PROTEINS, V64, P457, DOI 10.1002/prot.21004; BOLOGNESI M, 1982, J MOL BIOL, V158, P305, DOI 10.1016/0022-2836(82)90435-1; Bourgeois D, 2006, P NATL ACAD SCI USA, V103, P4924, DOI 10.1073/pnas.0508880103; Cao WX, 2004, BIOCHEMISTRY-US, V43, P7017, DOI 10.1021/bi0497291; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Crespo A, 2005, J AM CHEM SOC, V127, P4433, DOI 10.1021/ja0450004; Deng PC, 2007, GENE, V398, P208, DOI 10.1016/j.gene.2007.01.037; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 2004, P CCP4 STUDY WEEKEND, P114; Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298; Geuens E, 2004, IUBMB LIFE, V56, P653, DOI 10.1080/15216540500037471; GIBSON QH, 1993, J BIOL CHEM, V268, P16993; Goldberg DE, 1999, CHEM REV, V99, P3371, DOI 10.1021/cr970152l; Huang SC, 1996, J BIOL CHEM, V271, P958, DOI 10.1074/jbc.271.2.958; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; JOHNSON K, 1993, THESIS RICE U HOUSTO; JOHNSON KA, 1989, J MOL BIOL, V207, P459, DOI 10.1016/0022-2836(89)90269-6; KENDREW JC, 1963, SCIENCE, V139, P1259, DOI 10.1126/science.139.3561.1259; LAI HH, 1995, PROTEINS, V22, P322, DOI 10.1002/prot.340220404; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGM, 2003, MOSFLM USER GUIDE MO; Lim Manho, 2005, V305, P243; Milani M, 2005, J INORG BIOCHEM, V99, P97, DOI 10.1016/j.jinorgbio.2004.10.035; Milani M, 2003, IUBMB LIFE, V55, P623, DOI 10.1080/15216540310001628708; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; MOURANT JR, 1993, BIOPHYS J, V65, P1496, DOI 10.1016/S0006-3495(93)81218-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nienhaus K, 2005, BIOCHEMISTRY-US, V44, P5095, DOI 10.1021/bi047513t; Nienhaus K, 2005, J AM CHEM SOC, V127, P40, DOI 10.1021/ja0466917; Nienhaus K, 2003, J BIOL CHEM, V278, P42532, DOI 10.1074/jbc.M306888200; Nienhaus K, 2003, BIOCHEMISTRY-US, V42, P9633, DOI 10.1021/bi034787s; Nienhaus K, 2008, METHOD ENZYMOL, V437, P347, DOI 10.1016/S0076-6879(07)37018-3; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Olson J S, 1981, Methods Enzymol, V76, P631; Olson JS, 2008, SMALLEST BIOMOLECULES: DIATOMICS AND THEIR INTERACTIONS WITH HEME PROTEINS, P3, DOI 10.1016/B978-044452839-1.50002-4; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Olson JS, 2003, METH MOLEC MED, V82, P65; PERUTZ MF, 1964, NATURE, V203, P687, DOI 10.1038/203687a0; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pesce A, 2004, J BIOL CHEM, V279, P33662, DOI 10.1074/jbc.M403597200; Pesce A, 2002, STRUCTURE, V10, P725, DOI 10.1016/S0969-2126(02)00763-3; Pesce A, 2001, ACTA CRYSTALLOGR D, V57, P1897, DOI 10.1107/S0907444901015815; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Schmidt M, 2005, P NATL ACAD SCI USA, V102, P11704, DOI 10.1073/pnas.0504932102; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; SCHWEERS RL, 2003, THESIS RICE U; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SMITH RD, 1999, THESIS RICE U HOUSTO; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vandergon TL, 1998, J BIOL CHEM, V273, P16998, DOI 10.1074/jbc.273.27.16998; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123	63	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35689	35702		10.1074/jbc.M805727200	http://dx.doi.org/10.1074/jbc.M805727200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18840607	Green Published, hybrid			2022-12-27	WOS:000261687900043
J	Dickey, DM; Burnett, JC; Potter, LR				Dickey, Deborah M.; Burnett, John C., Jr.; Potter, Lincoln R.			Novel Bifunctional Natriuretic Peptides as Potential Therapeutics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGESTIVE-HEART-FAILURE; RECEPTOR-A; ATRIAL; NESIRITIDE; RISK	Synthetic atrial natriuretic peptide (carperitide) and B-type natriuretic peptide (BNP; nesiritide) are used to treat congestive heart failure. However, despite beneficial cardiac unloading properties, reductions in renal perfusion pressures limit their clinical effectiveness. Recently, CD-NP, a chimeric peptide composed of C-type natriuretic peptide (CNP) fused to the C-terminal tail of Dendroaspis natriuretic peptide (DNP), was shown to be more glomerular filtration rate-enhancing than BNP in dogs. However, the molecular basis for the increased responsiveness was not determined. Here, we show that the DNP tail has a striking effect on CNP, converting it from a non-agonist to a partial agonist of natriuretic peptide receptor (NPR)-A while maintaining the ability to activate NPR-B. This effect is specific for human receptors because CD-NP was only a slightly better activator of rat NPR-A due to the promiscuous nature of CNP in this species. Interesting, the DNP tail alone had no effect on any NPR even though it is effective in vivo. To further increase the potency of CD-NP for NPR-A, we converted two different triplet sequences within the CNP ring to their corresponding residues in BNP. Both variants demonstrated increased affinity and full agonist activity for NPR-A, whereas one was as potent as any NPR-A activator known. In contrast to a previous report, we found that DNP binds the natriuretic peptide clearance receptor (NPR-C). However, none of the chimeric peptides bound NPR-C with significantly higher affinity than endogenous ligands. We suggest that bifunctional chimeric peptides represent a new generation of natriuretic peptide therapeutics.	[Dickey, Deborah M.; Potter, Lincoln R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Potter, Lincoln R.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA; [Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Med, Div Cardiovasc Dis,Cardiorenal Res Lab, Rochester, MN 55905 USA; [Burnett, John C., Jr.] Mayo Clin, Coll Med, Dept Physiol, Div Cardiovasc Dis,Cardiorenal Res Lab, Rochester, MN 55905 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; Mayo Clinic	Potter, LR (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	potter@umn.edu			Medica; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066397] Funding Source: NIH RePORTER	Medica; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Minnesota-Mayo Partnership grant (to L.R.P. and J.C.B.) from Medica. CD-NP has been licensed by the Mayo Clinic to Nile Therapeutics, and J.C.B. is Chair of its Scientific Advisory Board. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Bryan PM, 2007, AM J PHYSIOL-RENAL, V292, pF1636, DOI 10.1152/ajprenal.00418.2006; Chen HH, 2002, J AM COLL CARDIOL, V40, P1186, DOI 10.1016/S0735-1097(02)02127-7; CUNNINGHAM BC, 1994, EMBO J, V13, P2508, DOI 10.1002/j.1460-2075.1994.tb06540.x; CURRIE MG, 1984, SCIENCE, V223, P67, DOI 10.1126/science.6419347; Dickey DM, 2007, ENDOCRINOLOGY, V148, P3518, DOI 10.1210/en.2007-0081; Johns DG, 2007, BIOCHEM BIOPH RES CO, V358, P145, DOI 10.1016/j.bbrc.2007.04.079; Langenickel TH, 2006, P NATL ACAD SCI USA, V103, P4735, DOI 10.1073/pnas.0510019103; Lisy O, 2001, HYPERTENSION, V37, P1089, DOI 10.1161/01.HYP.37.4.1089; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; MISONO KS, 1984, BIOCHEM BIOPH RES CO, V123, P444, DOI 10.1016/0006-291X(84)90250-X; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rose RA, 2008, J PHYSIOL-LONDON, V586, P353, DOI 10.1113/jphysiol.2007.144253; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; SCARBOROUGH RM, 1986, J BIOL CHEM, V261, P2960; SCHOENFELD JR, 1995, MOL PHARMACOL, V47, P172; Singh G, 2006, CIRC RES, V99, P183, DOI 10.1161/01.RES.0000232322.06633.d3; Socki T, 2005, J AM COLL CARDIOL, V45, P608, DOI 10.1016/j.jacc.2004.10.067; WEI CM, 1993, AM J PHYSIOL, V264, pH71, DOI 10.1152/ajpheart.1993.264.1.H71; WEI CM, 1993, J CLIN INVEST, V92, P2048, DOI 10.1172/JCI116800	22	67	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35003	35009		10.1074/jbc.M804538200	http://dx.doi.org/10.1074/jbc.M804538200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18940797	Green Published, hybrid			2022-12-27	WOS:000261469100057
J	Gorbikova, EA; Wikstrom, M; Verkhovsky, MI				Gorbikova, Elena A.; Wikstrom, Marten; Verkhovsky, Michael I.			The Protonation State of the Cross-linked Tyrosine during the Catalytic Cycle of Cytochrome c Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATR-FTIR SPECTROSCOPY; P-M INTERMEDIATE; PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; OXYGEN ACTIVATION; ESCHERICHIA-COLI; SUBUNIT-I; REDUCTION; TIME; RESOLUTION	Cytochrome c oxidase is the terminal complex of the respiratory chain in mitochondria and some aerobic bacteria and is responsible for most of the O-2 consumption in biology. The key reaction in the catalysis of O-2 reduction is O-O bond scission that requires four electrons and a proton. In our recent work (Gorbikova, E. A., Belevich, I., Wikstrom, M., and Verkhovsky, M. I. ( 2008) Proc. Natl. Acad. Sci. U. S. A. 105, 10733-10737), it was shown that the cross-linked Tyr-280 ( Paracoccus denitrificans numbering) provides the proton for O-O bond cleavage. The deprotonated Tyr-280 must be reprotonated later on in the catalytic cycle to serve as a proton donor for the next oxygen reduction event. To find the reaction step at which the crosslinked Tyr-280 becomes reprotonated, all further steps of the catalytic cycle after O-O bond cleavage were followed by infrared spectroscopy. We found that complete reprotonation of the tyrosine is linked to the formation of the one-electron reduced state coupled to reduction of the Cu-B site.	[Gorbikova, Elena A.; Wikstrom, Marten; Verkhovsky, Michael I.] Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, FI-00014 Helsinki, Finland	University of Helsinki	Verkhovsky, MI (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki Bioenerget Grp, POB 65,Viikinkaari 1, FI-00014 Helsinki, Finland.	michael.verkhovsky@helsinki.fi		Wikstrom, Marten/0000-0002-7527-4415; Gorbikova, Elena/0000-0002-6078-6012	Biocentrum Helsinki,; Sigrid Juselius Foundation; Academy of Finland; ISB Graduate School	Biocentrum Helsinki,; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); ISB Graduate School	This work was supported by grants from the Biocentrum Helsinki, the Sigrid Juselius Foundation, and the Academy of Finland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the ISB Graduate School.	Adelroth P, 1997, BIOCHEMISTRY-US, V36, P13824, DOI 10.1021/bi9629079; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Behr J, 1998, BIOCHEMISTRY-US, V37, P7400, DOI 10.1021/bi9731697; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; CHANCE B, 1975, P NATL ACAD SCI USA, V72, P1635, DOI 10.1073/pnas.72.4.1635; GARCIAHORSMAN JA, 1995, BIOCHEMISTRY-US, V34, P4428, DOI 10.1021/bi00013a035; Gerwert K, 1999, BIOL CHEM, V380, P931, DOI 10.1515/BC.1999.115; Gorbikova EA, 2006, BIOCHEMISTRY-US, V45, P5641, DOI 10.1021/bi060257v; Gorbikova EA, 2008, P NATL ACAD SCI USA, V105, P10733, DOI 10.1073/pnas.0802512105; Gorbikova EA, 2007, BIOCHEMISTRY-US, V46, P13141, DOI 10.1021/bi701614w; Gorbikova EA, 2007, BIOCHEMISTRY-US, V46, P4177, DOI 10.1021/bi602523a; HAN SW, 1990, NATURE, V348, P89, DOI 10.1038/348089a0; Hellwig P, 1996, FEBS LETT, V385, P53, DOI 10.1016/0014-5793(96)00342-0; Hellwig P, 1998, BIOCHEMISTRY-US, V37, P7390, DOI 10.1021/bi9725576; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P1685, DOI 10.1021/bi982282+; Iwaki M, 2004, BIOCHEMISTRY-US, V43, P14370, DOI 10.1021/bi048545j; Iwaki M, 2006, BIOCHEMISTRY-US, V45, P10873, DOI 10.1021/bi061114b; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jasaitis A, 1999, BIOCHEMISTRY-US, V38, P2697, DOI 10.1021/bi982275l; Kitagawa T, 2000, J INORG BIOCHEM, V82, P9, DOI 10.1016/S0162-0134(00)00155-0; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Lubben M, 1999, BIOCHEMISTRY-US, V38, P2048, DOI 10.1021/bi981859k; McCauley KM, 2000, J AM CHEM SOC, V122, P2403, DOI 10.1021/ja993774s; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; MOODY AJ, 1991, FEBS LETT, V293, P101, DOI 10.1016/0014-5793(91)81161-Z; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; MORGAN JE, 1995, BIOCHEMISTRY-US, V34, P15633, DOI 10.1021/bi00048a005; OGURA T, 1990, J BIOL CHEM, V265, P14721; OLIVEBERG M, 1989, BIOCHIM BIOPHYS ACTA, V977, P322, DOI 10.1016/S0005-2728(89)80087-8; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Pfitzner U, 2000, BIOCHEMISTRY-US, V39, P6756, DOI 10.1021/bi992235x; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; PROVENCHER SW, 1983, PROGR SCI COMPUTING, V2, P304; Ribacka C, 2005, BIOCHEMISTRY-US, V44, P16502, DOI 10.1021/bi0511336; Rich PR, 2002, BIOCHEMISTRY-US, V41, P967, DOI 10.1021/bi0109717; Riistama S, 1999, BIOCHEMISTRY-US, V38, P10670, DOI 10.1021/bi990885v; Siletsky S, 1999, BIOCHEMISTRY-US, V38, P4853, DOI 10.1021/bi982614a; Smirnova IA, 1999, BIOCHEMISTRY-US, V38, P6826, DOI 10.1021/bi982865j; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; VERKHOVSKY MI, 1994, BIOCHEMISTRY-US, V33, P3079, DOI 10.1021/bi00176a042; Verkhovsky MI, 1996, P NATL ACAD SCI USA, V93, P12235, DOI 10.1073/pnas.93.22.12235; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; WILSON DF, 1976, ARCH BIOCHEM BIOPHYS, V175, P160, DOI 10.1016/0003-9861(76)90495-1; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	46	48	48	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34907	34912		10.1074/jbc.M803511200	http://dx.doi.org/10.1074/jbc.M803511200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18931371	Green Published, hybrid			2022-12-27	WOS:000261469100047
J	Peng, LW; Shimizu, H; Shikanai, T				Peng, Lianwei; Shimizu, Hideyuki; Shikanai, Toshiharu			The Chloroplast NAD(P)H Dehydrogenase Complex Interacts with Photosystem I in Arabidopsis (Withdrawn Publication. See vol. 298, 2022)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							CYCLIC ELECTRON FLOW; NDH-1 COMPLEXES; THERMOSYNECHOCOCCUS-ELONGATUS; SUPRAMOLECULAR ORGANIZATION; STRUCTURAL-CHARACTERIZATION; SUBUNIT COMPOSITION; NADH DEHYDROGENASE; PROTEOMIC APPROACH; PROTEIN COMPLEXES; IDENTIFICATION	The chloroplast NAD( P) H dehydrogenase (NDH) complex is involved in photosystem I ( PSI) cyclic and chlororespiratory electron transport in higher plants. Although biochemical and genetic evidence for its subunit composition has accumulated, it is not enough to explain the complexes putative activity of NAD( P) H-dependent plastoquinone reduction. We analyzed the NDH complex by using blue native PAGE and found that it interacts with PSI to form a novel supercomplex. Mutants lacking NdhL and NdhM accumulated a pigment-protein complex with a slightly lower molecular mass than that of the NDH-PSI supercomplex; this may be an intermediate supercomplex including PSI. This intermediate is unstable in mutants lacking NdhB, NdhD, or NdhF, implying that it includes some NDH subunits. Analysis of thylakoid membrane complexes using sucrose density gradient centrifugation supported the presence of the NDH-PSI supercomplex in vivo. Although the NDH complex exists as a monomer in etioplasts, it interacts with PSI to form a supercomplex within 48 h during chloroplast development.	[Peng, Lianwei; Shikanai, Toshiharu] Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan; [Shimizu, Hideyuki] Kyushu Univ, Grad Sch Agr, Higashi Ku, Fukuoka 8128581, Japan	Kyoto University; Kyushu University	Shikanai, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan.	shikanai@pmg.bot.kyoto-u.ac.jp	Shikanai, Toshiharu/AAK-9112-2020		Japan Society for the Promotion of Science [19-07142, 17GS0316]; Ministry of Education, Culture, Sports, Science and Technology of Japan [16085206]; Ministry of Agriculture, Forestry and Fisheries of Japan [GPN0008]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	Supported by Japan Society for the Promotion of Science Grant 19-07142.; Supported by a grant-in-aid for Creative Scientific Research (17GS0316) from JSPS, Scientific Researchon Priority Areas ( 16085206) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Ministry of Agriculture, Forestry and Fisheries of Japan ( Genomics for Agricultural Innovation) Grant GPN0008.	Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; Battchikova N, 2005, J BIOL CHEM, V280, P2587, DOI 10.1074/jbc.M410914200; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Ben-Shem A, 2004, FEBS LETT, V564, P274, DOI 10.1016/S0014-5793(04)00360-6; BOEKEMA EJ, 1987, FEBS LETT, V217, P283, DOI 10.1016/0014-5793(87)80679-8; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; Darie CC, 2005, FEBS J, V272, P2705, DOI 10.1111/j.1742-4658.2005.04685.x; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Favory JJ, 2005, NUCLEIC ACIDS RES, V33, P5991, DOI 10.1093/nar/gki908; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; Guera A, 2000, PLANT CELL PHYSIOL, V41, P49, DOI 10.1093/pcp/41.1.49; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Heinemeyer J, 2004, PHYTOCHEMISTRY, V65, P1683, DOI 10.1016/j.phytochem.2004.04.022; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Ishihara S, 2007, PLANT PHYSIOL, V145, P668, DOI 10.1104/pp.107.105866; Ishikawa N, 2008, PLANT CELL PHYSIOL, V49, P1066, DOI 10.1093/pcp/pcn083; Kanervo E, 2008, PLANT CELL PHYSIOL, V49, P396, DOI 10.1093/pcp/pcn016; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Kouril R, 2005, PHOTOCH PHOTOBIO SCI, V4, P1091, DOI 10.1039/b505519a; Lennon AM, 2003, PLANTA, V218, P254, DOI 10.1007/s00425-003-1111-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma WM, 2006, PLANT CELL PHYSIOL, V47, P1432, DOI 10.1093/pcp/pcl008; MATSUBAYASHI T, 1987, MOL GEN GENET, V210, P385, DOI 10.1007/BF00327187; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Munshi MK, 2006, PLANT PHYSIOL, V141, P737, DOI 10.1104/pp.106.080267; Munshi MK, 2005, PLANT J, V44, P1036, DOI [10.1111/j.1365-313X.2005.02604, 10.1111/j.1365-313X.2005.02604.x]; Muraoka R, 2006, PLANT PHYSIOL, V142, P1683, DOI 10.1104/pp.106.088682; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ogawa T, 2007, PHOTOSYNTH RES, V93, P69, DOI 10.1007/s11120-006-9128-y; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Quiles MJ, 2002, J PLANT PHYSIOL, V159, P457, DOI 10.1078/0176-1617-00593; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; SHIKANAI T, 2007, FUNCT PLANT SCI BIOT, V1, P129; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Shimizu H, 2008, PLANT CELL PHYSIOL, V49, P835, DOI 10.1093/pcp/pcn058; TAKABAYASHI A, 2008, PLANT J IN PRESS; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zhang PP, 2005, BIOCHEM J, V390, P513, DOI 10.1042/BJ20050390; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	48	145	149	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34873	34879		10.1074/jbc.M803207200	http://dx.doi.org/10.1074/jbc.M803207200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18854313	Green Published, hybrid			2022-12-27	WOS:000261469100043
J	Shimojo, M				Shimojo, Masahito			Huntingtin Regulates RE1-silencing Transcription Factor/Neuron-restrictive Silencer Factor (REST/NRSF) Nuclear Trafficking Indirectly through a Complex with REST/NRSF-interacting LIM Domain Protein (RILP) and Dynactin p150(Glued)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; EMBRYONIC LETHALITY; TARGET GENES; DISEASE; LOCALIZATION; REPRESSOR; NEURONS; MICE; REST; HAP1	Huntingtin has been reported to regulate the nuclear translocation of the transcriptional repressor RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF). The REST/NRSF-interacting LIM domain protein ( RILP) has also been shown to regulate REST/NRSF nuclear translocation. Therefore, we were prompted to address the question of how two distinct proteins could have the same function. We initially used a yeast two-hybrid screen to look for an interaction between huntingtin and RILP. This screen identified dynactin p150(Glued) as an interacting protein. Coimmunoprecipitation of proteins in vitro expressed in a reticulocyte lysate system showed an interaction between REST/NRSF and RILP as well as between RILP and dynactin p150Glued. Coimmunoprecipitation analysis further showed a complex containing RILP, dynactin p150Glued, and huntingtin. Huntingtin did not interact directly with either REST/NRSF or RILP, but did interact with dynactin p150(Glued). The N-terminal fragment of wild-type huntingtin did not affect the interaction between dynactin p150Glued and RILP; however, mutant huntingtin weakened this interaction. We further show that HAP1 (huntingtin-associated protein-(1) under bar) prevents this complex from translocating REST/NRSF to the nucleus. Thus, this study suggests that REST/NRSF, dynactin p150Glued, huntingtin, HAP1, and RILP form a complex involved in the translocation of REST/NRSF into the nucleus and that HAP1 controls REST/NRSF cellular localization in neurons.	Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Shimojo, M (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Biomed Biol Sci Res Bldg,741 Limestone St, Lexington, KY 40536 USA.	mshim1@uky.edu	Shimojo, Masahito/T-8086-2019	Shimojo, Masahito/0000-0003-1859-4444	National Institutes of Health [P20RR020171]; National Center for Research Resources; National Institute of Mental Health [K01MH067123]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH067123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR020171 from the National Center for Research Resources and Grant K01MH067123 from the National Institute of Mental Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BATES G, 2002, HUNTINGTONS DIS; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Harper PS, 1991, HUNTINGTONS DIS; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Lunyak VV, 2005, CELL, V121, P499, DOI 10.1016/j.cell.2005.05.003; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Rong J, 2007, J NEUROSCI RES, V85, P3025, DOI 10.1002/jnr.21326; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Shimojo M, 2006, J NEUROCHEM, V96, P1130, DOI 10.1111/j.1471-4159.2005.03608.x; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Shimojo M, 2003, MOL CELL BIOL, V23, P9025, DOI 10.1128/MCB.23.24.9025-9031.2003; Thompson LM, 2003, NAT GENET, V35, P13, DOI 10.1038/ng0903-13; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	25	73	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34880	34886		10.1074/jbc.M804183200	http://dx.doi.org/10.1074/jbc.M804183200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18922795	hybrid, Green Published			2022-12-27	WOS:000261469100044
J	Jackson, NE; Wang, HW; Bryant, KJ; McNeil, HP; Husain, A; Liu, K; Tedla, N; Thomas, PS; King, GC; Hettiaratchi, A; Cairns, J; Hunt, JE				Jackson, Nicole E.; Wang, Hong-Wei; Bryant, Katherine J.; McNeil, H. Patrick; Husain, Ahsan; Liu, Ke; Tedla, Nicodemus; Thomas, Paul S.; King, Garry C.; Hettiaratchi, Anusha; Cairns, Jennifer; Hunt, John E.			Alternate mRNA Splicing in Multiple Human Tryptase Genes Is Predicted to Regulate Tetramer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; BETA-TRYPTASE; HUMAN LUNG; ALPHA; AIRWAY; INHIBITORS; RESPONSES; MOUSE; FORMS; PURIFICATION	Tryptases are serine proteases that are thought to be uniquely and proteolytically active as tetramers. Crystallographic studies reveal that the active tetramer is a flat ring structure composed of four monomers, with their active sites arranged around a narrow central pore. This model explains why many of the preferred substrates of tryptase are short peptides; however, it does not explain how tryptase cleaves large protein substrates such as fibronectin, although a number of studies have reported in vitro mechanisms for generating active monomers that could digest larger substrates. Here we suggest that alternate mRNA splicing of human tryptase genes generates active tryptase monomers (or dimers). We have identified a conserved pattern of alternate splicing in four tryptase alleles (alpha II, beta I, beta III, and delta I), representing three distinct tryptase gene loci. When compared with their full-length counterparts, the splice variants use an alternate acceptor site within exon 4. This results in the deletion of 27 nucleotides within the central coding sequence and 9 amino acids from the translated protein product. Although modeling suggests that the deletion can be easily accommodated by the enzymes structurally, it is predicted to alter the specificity by enlarging the S1' or S2' binding pocket and results in the complete loss of the "47 loop," reported to be critical for the formation of tetramers. Although active monomers can be generated in vitro using a range of artificial conditions, we suggest that alternate splicing is the in vivo mechanism used to generate active tryptase that can cleave large protein substrates.	[Hunt, John E.] Univ New S Wales, Ctr Infect & Inflammat Res, Dept Pathol, Sch Med Sci, Sydney, NSW 2052, Australia; [Bryant, Katherine J.; McNeil, H. Patrick] Univ New S Wales, S Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [King, Garry C.] Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2052, Australia; [Husain, Ahsan; Liu, Ke] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Alabama System; University of Alabama Birmingham	Hunt, JE (corresponding author), Univ New S Wales, Ctr Infect & Inflammat Res, Dept Pathol, Sch Med Sci, Sydney, NSW 2052, Australia.	j.hunt@unsw.edu.au	Husain, Ahsan/J-6861-2012; Bryant, Katherine/E-8574-2010	Husain, Ahsan/0000-0003-3426-3469; Bryant, Katherine/0000-0002-8686-623X; McNeil, Hugh Patrick/0000-0003-4336-2960	National Health and Medical Research Council of Australia; Australian Research Council Linkage Grant [LP0455637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079040] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Linkage Grant(Australian Research Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Health and Medical Research Council of Australia and Australian Research Council Linkage Grant LP0455637. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Buckley MG, 2001, CLIN EXP ALLERGY, V31, P1696, DOI 10.1046/j.1365-2222.2001.01213.x; Burgess LE, 1999, P NATL ACAD SCI USA, V96, P8348, DOI 10.1073/pnas.96.15.8348; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; CLARK JM, 1995, AM J RESP CRIT CARE, V152, P2076, DOI 10.1164/ajrccm.152.6.8520778; Cline MS, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P17; Gamba G, 2001, AM J PHYSIOL-RENAL, V281, pF781, DOI 10.1152/ajprenal.2001.281.5.F781; GotisGraham I, 1997, ARTHRITIS RHEUM, V40, P479, DOI 10.1002/art.1780400314; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Harvima RJ, 1999, ARCH DERMATOL RES, V291, P73, DOI 10.1007/s004030050386; He SH, 1997, J IMMUNOL, V159, P6216; He SH, 2001, EUR J PHARMACOL, V412, P223, DOI 10.1016/S0014-2999(01)00734-8; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; HOLGATE ST, 1986, J ALLERGY CLIN IMMUN, V77, P274, DOI 10.1016/S0091-6749(86)80104-X; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Krishna MT, 2001, J ALLERGY CLIN IMMUN, V107, P1039, DOI 10.1067/mai.2001.115631; Mirza H, 1997, BLOOD, V90, P3914, DOI 10.1182/blood.V90.10.3914; Nakao M, 2005, NUCLEIC ACIDS RES, V33, P2355, DOI 10.1093/nar/gki520; Niles AL, 1998, BIOTECHNOL APPL BIOC, V28, P125; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; PEARLMAN DA, 1995, AMBER VERSION 4 1; Peng Q, 2003, EUR J BIOCHEM, V270, P270, DOI 10.1046/j.1432-1033.2003.03385.x; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Rice KD, 1998, CURR PHARM DESIGN, V4, P381; Schwartz LB, 1995, J CLIN INVEST, V96, P2702, DOI 10.1172/JCI118337; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SEKIZAWA K, 1989, J CLIN INVEST, V83, P175, DOI 10.1172/JCI113855; Selwood T, 2002, BIOCHEMISTRY-US, V41, P3329, DOI 10.1021/bi015662v; Tremaine WJ, 2002, ALIMENT PHARM THERAP, V16, P407, DOI 10.1046/j.1365-2036.2002.01194.x; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Wang HW, 2002, J IMMUNOL, V169, P5145, DOI 10.4049/jimmunol.169.9.5145; Wong GW, 2001, J BIOL CHEM, V276, P49169, DOI 10.1074/jbc.M108677200; Wung JL, 1996, BIOTECHNIQUES, V21, P808	34	11	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34178	34187		10.1074/jbc.M807553200	http://dx.doi.org/10.1074/jbc.M807553200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18854315	hybrid, Green Published			2022-12-27	WOS:000261277700046
J	Mishra, VK; Palgunachari, MN; Krishna, R; Glushka, J; Segrest, JP; Anantharamaiah, GM				Mishra, Vinod K.; Palgunachari, Mayakonda N.; Krishna, Rama; Glushka, John; Segrest, Jere P.; Anantharamaiah, G. M.			Effect of Leucine to Phenylalanine Substitution on the Nonpolar Face of a Class A Amphipathic Helical Peptide on Its Interaction with Lipid HIGH RESOLUTION SOLUTION NMR STUDIES OF 4F-DIMYRISTOYLPHOSPHATIDYLCHOLINE DISCOIDAL COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR CD36; I-MIMETIC PEPTIDES; NUCLEAR-MAGNETIC-RESONANCE; E-NULL MICE; OXIDIZED PHOSPHOLIPIDS; TRANSGENIC MICE; APOA-I; MEMBRANE INTERACTIONS; SECONDARY STRUCTURE	Model class A amphipathic helical peptides mimic several properties of apolipoprotein A-I (apoA-I), the major protein component of high density lipoproteins. Previously, we reported the NMR structures of Ac-18A-NH2 (renamed as 2F because of two phenylalanines), the base-line model class A amphipathic helical peptide in the presence of lipid (Mishra, V. K., Anantharamaiah, G. M., Segrest, J. P., Palgunachari, M. N., Chaddha, M., Simon Sham, S. W., and Krishna, N. R. ( 2006) J Biol. Chem. 281, 6511-6519). Substitution of two Leu residues on the nonpolar face (Leu3 and Leu(14)) with Phe residues produced the peptide 4F (so named because of four phenylalanines), which has been extensively studied for its anti-inflammatory and antiatherogenic properties. Like 2F, 4F also forms discoidal nascent high density lipoprotein-like particles with 1,2-dimyristoylsn-glycero-3-phosphocholine (DMPC). Since subtle structural changes in the peptide-lipid complexes have been shown to be responsible for their antiatherogenic properties, we undertook high resolution NMR studies to deduce detailed structure of 4F in 4F center dot DMPC discs. Like 2F, 4F adopts a well defined amphipathic alpha-helical structure in association with the lipid at a 1:1 peptide/lipid weight ratio. Nuclear Overhauser effect (NOE) spectroscopy revealed a number of intermolecular close contacts between the aromatic residues in the hydrophobic face of the helix and the lipid acyl chain protons. Similar to 2F, the pattern of observed peptide-lipid NOEs is consistent with a parallel orientation of the amphipathic alpha helix, with respect to the plane of the lipid bilayer, on the edge of the disc (the belt model). However, in contrast to 2F in 2F alpha DMPC, 4F in the 4F alpha DMPC complex is located closer to the lipid headgroup as evidenced by a number of NOEs between 4F and DMPC headgroup protons. These NOEs are absent in the 2F center dot DMPC complex. In addition, the conformation of the DMPC sn-3 chain in 4F center dot DMPC complex is different than in the 2F center dot DMPC complex as evidenced by the NOE between lipid 2.CH and beta CH2 protons in 4F center dot DMPC, but not in 2F center dot DMPC, complex. Based on the results of this study, we infer that the antiatherogenic properties of 4F may result from its preferential interaction with lipid headgroups.	[Mishra, Vinod K.; Palgunachari, Mayakonda N.; Segrest, Jere P.; Anantharamaiah, G. M.] Univ Alabama Birmingham, Med Ctr, Dept Med, Atherosclerosis Res Unit, Birmingham, AL 35294 USA; [Krishna, Rama; Segrest, Jere P.; Anantharamaiah, G. M.] Univ Alabama Birmingham, Med Ctr, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Krishna, Rama; Segrest, Jere P.; Anantharamaiah, G. M.] Univ Alabama Birmingham, Med Ctr, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Glushka, John] Univ Georgia, Complex Carbohydrate Res Ctr, SE Collaboratory Biomol NMR, Athens, GA 30602 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Georgia; University of Georgia	Mishra, VK (corresponding author), Univ Alabama Birmingham, Med Ctr, Dept Med, Atherosclerosis Res Unit, D806,1808 7th Ave S, Birmingham, AL 35294 USA.	vmishra@uab.edu	Mishra, Vinod/S-1151-2019	Mishra, Vinod/0000-0002-4527-1512	National Institutes of Health [RO1HL089328, PO1 HL34343, CA-13148, GM66340]; NCRR, National Institutes of Health [1S10RR021064-01A1]; NIGMS; Georgia Research Alliance; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343, R01HL089328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Georgia Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL089328, PO1 HL34343 (NHLBI) and CA-13148 (NCI). The 600-MHz CryoProbe was funded by 1S10RR021064-01A1 (NCRR, National Institutes of Health). This research benefited from activities at the SE Collaboratory for High-Field Biomolecular NMR, a research resource at the University of Georgia, funded by NIGMS, National Institutes of Health (NIG MSEC Grant GM66340) and the Georgia Research Alliance. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anantharamaiah GM, 2007, J LIPID RES, V48, P1915, DOI 10.1194/jlr.R700010-JLR200; ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; BASUS VJ, 1989, METHOD ENZYMOL, V177, P132; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; CHUNG BH, 1985, J BIOL CHEM, V260, P256; Datta G, 2004, J BIOL CHEM, V279, P26509, DOI 10.1074/jbc.M314276200; Datta G, 2001, J LIPID RES, V42, P1096; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Duverger N, 1996, ARTERIOSCL THROM VAS, V16, P1424, DOI 10.1161/01.ATV.16.12.1424; Epand RM, 2004, J BIOL CHEM, V279, P51404, DOI 10.1074/jbc.M408581200; Epand RM, 2004, BIOCHEMISTRY-US, V43, P5073, DOI 10.1021/bi049786u; Gibbs AC, 1998, NAT STRUCT BIOL, V5, P284, DOI 10.1038/nsb0498-284; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Gupta H, 2005, CIRC RES, V97, P236, DOI 10.1161/01.RES.0000176530.66400.48; Gurtovenko AA, 2004, BIOPHYS J, V86, P3461, DOI 10.1529/biophysj.103.038760; Handattu SP, 2007, J BIOL CHEM, V282, P1980, DOI 10.1074/jbc.M606231200; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Jackson SP, 2007, NAT MED, V13, P1015, DOI 10.1038/nm0907-1015; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; Kruger AL, 2005, CIRCULATION, V111, P3126, DOI 10.1161/CIRCULATIONAHA.104.517102; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li XM, 2007, BIOCHEMISTRY-US, V46, P5009, DOI 10.1021/bi700163y; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; LUNDKATZ S, 1995, BIOCHEMISTRY-US, V34, P9219, DOI 10.1021/bi00028a035; Mishra VK, 2006, J BIOL CHEM, V281, P6511, DOI 10.1074/jbc.M511475200; Mishra VK, 2001, PEPTIDES, V22, P567, DOI 10.1016/S0196-9781(01)00365-5; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1426, DOI 10.1161/01.ATV.0000167412.98221.1a; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Ou JS, 2003, CIRCULATION, V107, P2337, DOI 10.1161/01.CIR.0000070589.61860.A9; Ou ZJ, 2003, CIRCULATION, V107, P1520, DOI 10.1161/01.CIR.0000061949.17174.B6; Peterson SJ, 2008, J LIPID RES, V49, P1658, DOI 10.1194/jlr.M800046-JLR200; Peterson SJ, 2007, J PHARMACOL EXP THER, V322, P514, DOI 10.1124/jpet.107.119479; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; SCHULTZ JR, 1992, J BIOL CHEM, V267, P21630; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SEGREST JP, 1992, J LIPID RES, V33, P141; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Van Lenten BJ, 2004, CIRCULATION, V110, P3252, DOI 10.1161/01.CIR.0000147232.75456.B3; Van Lenten BJ, 2002, CIRCULATION, V106, P1127, DOI 10.1161/01.CIR.0000030182.35880.3E; Van Lenten BJ, 2008, J LIPID RES, V49, P2302, DOI 10.1194/jlr.M800075-JLR200; VENKATACHALAPATHI YV, 1993, PROTEINS, V15, P349, DOI 10.1002/prot.340150403; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC	56	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34393	34402		10.1074/jbc.M806384200	http://dx.doi.org/10.1074/jbc.M806384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845546	Green Published, hybrid			2022-12-27	WOS:000261277700067
J	Jenkins, JL; Shen, HH; Green, MR; Kielkopf, CL				Jenkins, Jermaine L.; Shen, Haihong; Green, Michael R.; Kielkopf, Clara L.			Solution Conformation and Thermodynamic Characteristics of RNA Binding by the Splicing Factor U2AF(65)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SMALL-ANGLE SCATTERING; PROTEIN-PROTEIN INTERACTIONS; AUXILIARY FACTOR U2AF(65); RAY SOLUTION SCATTERING; POLYPYRIMIDINE-TRACT; U2 SNRNP; DOMAIN-STRUCTURE; STRUCTURAL BASIS; SEX-LETHAL	The U2 auxiliary factor large subunit (U2AF(65)) is an essential pre-mRNA splicing factor for the initial stages of spliceosome assembly. Tandem RNA recognition motifs (RRM)s of U2AF(65) recognize polypyrimidine tract signals adjacent to 3' splice sites. Despite the central importance of U2AF(65) for splice site recognition, the relative arrangement of the U2AF(65) RRMs and the energetic forces driving polypyrimidine tract recognition remain unknown. Here, the solution conformation of the U2AF(65) RNA binding domain determined using small angle x-ray scattering reveals a bilobal shape without apparent inter-domain contacts. The proximity of the N and C termini within the inter-RRM configuration is sufficient to explain the action of U2AF(65) on spliceosome components located both 5' and 3' to its binding site. Isothermal titration calorimetry further demonstrates that an unusually large enthalpy-entropy compensation underlies U2AF(65) recognition of an optimal polyuridine tract. Qualitative similarities were observed between the pairwise distance distribution functions of the U2AF(65) RNA binding domain and those either previously observed for N-terminal RRMs of Py tract-binding protein that lack interdomain contacts or calculated from the high resolution coordinates of a U2AF(65) deletion variant bound to RNA. To further test this model, the shapes and RNA interactions of the wild-type U2AF(65) RNA binding domain were compared with those of U2AF(65) variants containing either Py tract-binding protein linker sequences or a deletion within the inter-RRM linker. Results of these studies suggest inter-RRM conformational plasticity as a possible means for U2AF(65) to universally identify diverse pre-mRNA splice sites.	[Jenkins, Jermaine L.; Kielkopf, Clara L.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Shen, Haihong; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Shen, Haihong; Green, Michael R.] Univ Massachusetts, Sch Med, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA	University of Rochester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kielkopf, CL (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	clara_kielkopf@urmc.rochester.edu		Jenkins, Jermaine/0000-0003-2548-3275	National Institutes of Health [R01 GM070503, R01 GM035490]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035490, R01GM070503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM070503 ( to C. L. K.) and R01 GM035490 ( to M. R. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Banerjee H, 2003, RNA, V9, P88, DOI 10.1261/rna.2131603; Banerjee H, 2004, RNA, V10, P240, DOI 10.1261/rna.5153204; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Crichlow GV, 2008, EMBO J, V27, P277, DOI 10.1038/sj.emboj.7601936; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Guiner A, 1955, SMALL ANGLE SCATTERI, P167; Itoh H, 2004, RNA, V10, P1005, DOI 10.1261/rna.5221604; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kent OA, 2003, J BIOL CHEM, V278, P50572, DOI 10.1074/jbc.M307976200; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858; MULLEN MP, 1991, GENE DEV, V5, P642, DOI 10.1101/gad.5.4.642; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Ohnishi S, 2006, J AM CHEM SOC, V128, P16338, DOI 10.1021/ja066008b; Petoukhov MV, 2006, STRUCTURE, V14, P1021, DOI 10.1016/j.str.2006.04.005; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Sickmier EA, 2006, ACTA CRYSTALLOGR F, V62, P457, DOI 10.1107/S1744309106012504; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Singh R, 2000, RNA, V6, P901, DOI 10.1017/S1355838200000376; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Zagrovic B, 2005, J MOL BIOL, V353, P232, DOI 10.1016/j.jmb.2005.08.053; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0	46	26	26	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33641	33649		10.1074/jbc.M806297200	http://dx.doi.org/10.1074/jbc.M806297200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18842594	Green Published, hybrid			2022-12-27	WOS:000261183700070
J	Jeon, BN; Yoo, JY; Choi, WI; Lee, CE; Yoon, HG; Hur, MW				Jeon, Bu-Nam; Yoo, Jung-Yoon; Choi, Won-Il; Lee, Choong-Eun; Yoon, Ho-Geun; Hur, Man-Wook			Proto-oncogene FBI-1 (Pokemon/ZBTB7A) Represses Transcription of the Tumor Suppressor Rb Gene via Binding Competition with Sp1 and Recruitment of Co-repressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; DNA-BINDING; POZ DOMAIN; RETINOBLASTOMA GENE; PROMOTER; EXPRESSION; SEQUENCE; ELEMENTS; MIZF	FBI-1 (also called Pokemon/ZBTB7A) is a BTB/POZ-domain Kruppel-like zinc-finger transcription factor. Recently, FBI-1 was characterized as a proto-oncogenic protein, which represses tumor suppressor ARF gene transcription. The expression of FBI-1 is increased in many cancer tissues. We found that FBI-1 potently represses transcription of the Rb gene, a tumor suppressor gene important in cell cycle arrest. FBI-1 binds to four GC-rich promoter elements (FREs) located at bp -308 to -188 of the Rb promoter region. The Rb promoter also contains two Sp1 binding sites: GC-box 1 (bp -65 to -56) and GC-box 2 ( bp -18 to -9), the latter of which is also bound by FBI-1. We found that FRE3 ( bp -244 to -236) is also a Sp1 binding element. FBI-1 represses transcription of the Rb gene not only by binding to the FREs, but also by competing with Sp1 at the GC-box 2 and the FRE3. By binding to the FREs and/or the GC-box, FBI-1 represses transcription of the Rb gene through its POZ-domain, which recruits a co-repressor-histone deacetylase complex and deacetylates histones H3 and H4 at the Rb gene promoter. FBI-1 inhibits C2C12 myoblast cell differentiation by repressing Rb gene expression.	[Jeon, Bu-Nam; Yoo, Jung-Yoon; Choi, Won-Il; Yoon, Ho-Geun; Hur, Man-Wook] Yonsei Univ, Sch Med, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, Seoul 120752, South Korea; [Lee, Choong-Eun] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Yonsei University; Sungkyunkwan University (SKKU)	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac		Yoon, Ho-Geun Yoon/0000-0003-2718-3372; Yoo, Jung-Yoon/0000-0001-9366-3863; Hur, Man-Wook/0000-0002-3416-1334; CHOI, WONIL/0000-0002-4837-0436	National Research Laboratory [ROA-2003000-10318-0]; Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology [R13-2002054-05002-0]	National Research Laboratory(Korea Science and Engineering Foundation); Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology(Korea Science and Engineering Foundation)	This work was supported by National Research Laboratory Grant ROA-2003000-10318-0 (to M.W.H.) and Medical Research Center Grant R13-2002054-05002-0 from Korea Science and Engineering Foundation of the Korea Ministry of Science and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Delehouzee S, 2005, GENES CELLS, V10, P717, DOI 10.1111/j.1365-2443.2005.00873.x; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GILL RM, 1994, CELL GROWTH DIFFER, V5, P467; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Kwon HS, 1999, J BIOL CHEM, V274, P20, DOI 10.1074/jbc.274.1.20; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Magenta A, 2003, MOL CELL BIOL, V23, P2893, DOI 10.1128/MCB.23.8.2893-2906.2003; Morrison DJ, 1999, NUCLEIC ACIDS RES, V27, P1251, DOI 10.1093/nar/27.5.1251; NEVINS JR, 1992, SCIENCE, V258, P424; Pendergrast PS, 2002, MOL BIOL CELL, V13, P915, DOI 10.1091/mbc.01-08-0383; Pessler F, 2003, J BIOL CHEM, V278, P29327, DOI 10.1074/jbc.M302980200; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; Scambia G, 2006, ONCOGENE, V25, P5302, DOI 10.1038/sj.onc.1209620; Sekimata M, 2004, BIOCHEM BIOPH RES CO, V325, P653, DOI 10.1016/j.bbrc.2004.10.090; Sekimata M, 2004, NUCLEIC ACIDS RES, V32, P590, DOI 10.1093/nar/gkh249; Sowa Y, 1997, CANCER RES, V57, P3145; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1	29	78	87	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33199	33210		10.1074/jbc.M802935200	http://dx.doi.org/10.1074/jbc.M802935200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18801742	Green Published, hybrid			2022-12-27	WOS:000261183700023
J	Wang, Y; Dow, EC; Liang, YY; Ramakrishnan, R; Liu, HB; Sung, TL; Lin, X; Rice, AP				Wang, Yan; Dow, Eugene C.; Liang, Yao-Yun; Ramakrishnan, Rajesh; Liu, Hongbing; Sung, Tzu-Ling; Lin, Xia; Rice, Andrew P.			Phosphatase PPM1A Regulates Phosphorylation of Thr-186 in the Cdk9 T-loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; CYCLIN-DEPENDENT KINASES; 2C PROTEIN PHOSPHATASES; ELONGATION-FACTOR-B; P-TEFB; 7SK SNRNA; GENE-EXPRESSION; TAK/P-TEFB; TRANSCRIPTION; INDUCTION	Cdk9 is the catalytic subunit of a general RNA polymerase II elongation factor known as positive transcription elongation factor b (P-TEFb). The kinase function of P-TEFb requires phosphorylation of Thr-186 in the T-loop of Cdk9 to allow substrates to access the catalytic core of the enzyme. To identify human phosphatases that dephosphorylate the T-loop of Cdk9, we used a Thr-186-phosphospecific antiserum to screen a phosphatase expression library. Overexpression of PPM1A and the related PPM1B greatly reduced Cdk9 T-loop phosphorylation in vivo. PPM1A and Cdk9 appear to associate in vivo as the proteins could be co-immunoprecipitated. The short hairpin RNA depletion of PPM1A resulted in an increase in Cdk9 T-loop phosphorylation. In phosphatase reactions in vitro, purified PPM1A could dephosphorylate Thr-186 both with and without the association of 7SK RNA, a small nuclear RNA that is bound to similar to 50% of total cellular P-TEFb. PPM1B only efficiently dephosphorylated Cdk9 Thr-186 in vitro when 7SK RNA was depleted from P-TEFb. Taken together, our data indicate that PPM1A and to some extent PPM1B are important negative regulators of P-TEFb function.	[Wang, Yan; Dow, Eugene C.; Ramakrishnan, Rajesh; Liu, Hongbing; Sung, Tzu-Ling; Rice, Andrew P.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Liang, Yao-Yun; Lin, Xia] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Rice, AP (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	arice@bcm.tmc.edu		Rice, Andrew/0000-0002-1237-4769	National Institutes of Health [AI35381, DK073932]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI035381, R01AI035381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI35381 (to A. P. R.) and DK073932 (to X. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Ghose R, 2001, J VIROL, V75, P11336, DOI 10.1128/JVI.75.23.11336-11343.2001; Gold MO, 1998, J VIROL, V72, P4448, DOI 10.1128/JVI.72.5.4448-4453.1998; Haaland RE, 2003, AIDS, V17, P2429, DOI 10.1097/00002030-200311210-00004; He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003; Herrmann CH, 2001, J CELL SCI, V114, P1491; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liou LY, 2006, J LEUKOCYTE BIOL, V79, P388, DOI 10.1189/jlb.0805429; Liou LY, 2002, J VIROL, V76, P10579, DOI 10.1128/JVI.76.21.10579-10587.2002; Markert A, 2008, EMBO REP, V9, P569, DOI 10.1038/embor.2008.72; Marshall RM, 2005, J IMMUNOL, V175, P6402, DOI 10.4049/jimmunol.175.10.6402; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rice AP, 2003, CURR HIV RES, V1, P395, DOI 10.2174/1570162033485159; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; Sung TL, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-66; Wang Y, 2006, VIROLOGY, V352, P485, DOI 10.1016/j.virol.2006.05.013; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yu WD, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-32	31	44	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33578	33584		10.1074/jbc.M807495200	http://dx.doi.org/10.1074/jbc.M807495200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829461	hybrid, Green Published			2022-12-27	WOS:000261183700063
J	El Gazzar, M; Yoza, BK; Chen, X; Hu, J; Hawkins, GA; Mccall, CE				El Gazzar, Mohamed; Yoza, Barbara K.; Chen, Xiaoping; Hu, Jean; Hawkins, Gregory A.; Mccall, Charles E.			G9a and HP1 Couple Histone and DNA Methylation to TNF alpha Transcription Silencing during Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3 LYSINE-9 METHYLATION; NF-KAPPA-B; HETEROCHROMATIN PROTEIN-1; SUBSTRATE-SPECIFICITY; GENE-REGULATION; DE-NOVO; CHROMATIN; BINDING; METHYLTRANSFERASES; DNMT3A	TNF alpha gene expression is silenced in the endotoxin tolerant phenotype that develops in blood leukocytes after the initial activation phase of severe systemic inflammation or sepsis. The silencing phase can be mimicked in vitro by LPS stimulation. We reported that the TNF alpha transcription is disrupted in endotoxin tolerant THP-1 human promonocyte due to changes in transcription factor binding and enrichment with histone H3 dimethylated on lysine 9 (H3K9). Here we show that the TNF alpha promoter is hypermethylated during endotoxin tolerance and that H3K9 methylation and DNA methylation interact to silence TNF alpha expression. Chromatin immunoprecipitation and RNA interference analysis demonstrated that, in tolerant cells, TNF alpha promoter is bound by the H3K9 histone methyltransferase G9a which dimethylates H3K9 and creates a platform for HP1 binding, leading to the recruitment of the DNA methyltransferase Dnmt3a/b and an increase in promoter CpG methylation. Knockdown of HP1 resulted in a decreased Dnmt3a/b binding, sustained G9a binding, and a modest increase in TNF alpha transcription, but had no effect on H3K9 dimethylation. In contrast, G9a knockdown-disrupted promoter silencing and restored TNF alpha transcription in tolerant cells. This correlated with a near loss of H3K9 dimethylation, a significant decrease in HP1 and Dnmt3a/b binding and promoter CpG methylation. Our results demonstrate a central role for G9a in this process and suggest that histone methylation and DNA methylation cooperatively interact via HP1 to silence TNF alpha expression during endotoxin tolerance and may have implication for proinflammatory gene silencing associated with severe systemic inflammation.	[El Gazzar, Mohamed; Yoza, Barbara K.; Chen, Xiaoping; Hu, Jean; Mccall, Charles E.] Wake Forest Univ, Sch Med, Sect Mol Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Yoza, Barbara K.] Wake Forest Univ, Sch Med, Dept Gen Surg, Winston Salem, NC 27157 USA; [Hawkins, Gregory A.] Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	El Gazzar, M (corresponding author), Wake Forest Univ, Sch Med, Sect Mol Med, Dept Internal Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	melgazza@wfubmc.edu			National Institutes of Health [R01AI-09169, R01AI-065791]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009169, R01AI065791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI-09169 and R01AI-065791. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Brenner C, 2007, DEV CELL, V12, P843, DOI 10.1016/j.devcel.2007.05.011; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Craig JM, 2005, BIOESSAYS, V27, P17, DOI 10.1002/bies.20145; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; Dormann HL, 2006, CELL CYCLE, V5, P2842, DOI 10.4161/cc.5.24.3540; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GOLDFELD AE, 1990, P NATL ACAD SCI USA, V87, P9769, DOI 10.1073/pnas.87.24.9769; Goriely S, 2003, BLOOD, V101, P4894, DOI 10.1182/blood-2002-09-2851; GRANOWITZ EV, 1993, J IMMUNOL, V151, P1637; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Heo K, 2007, J BIOL CHEM, V282, P15476, DOI 10.1074/jbc.M610270200; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; MATHISON JC, 1990, J CLIN INVEST, V85, P1108, DOI 10.1172/JCI114542; MCCALL CE, 1993, J CLIN INVEST, V91, P853, DOI 10.1172/JCI116306; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; MUNOZ C, 1991, EUR J IMMUNOL, V21, P2177, DOI 10.1002/eji.1830210928; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Paz MF, 2003, HUM MOL GENET, V12, P2209, DOI 10.1093/hmg/ddg226; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; RIGGS AD, 1983, ADV CANCER RES, V40, P1, DOI 10.1016/S0065-230X(08)60678-8; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Valinluck V, 2007, CANCER RES, V67, P5583, DOI 10.1158/0008-5472.CAN-07-0846; Vincent JL, 2006, AM J RESP CRIT CARE, V173, P256, DOI 10.1164/rccm.200510-1604OE; VIRCA GD, 1989, J BIOL CHEM, V264, P21951; Wade PA, 2001, ONCOGENE, V20, P3166, DOI 10.1038/sj.onc.1204340; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yoza BK, 2000, SHOCK, V13, P236, DOI 10.1097/00024382-200003000-00011	70	131	134	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32198	32208		10.1074/jbc.M803446200	http://dx.doi.org/10.1074/jbc.M803446200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18809684	Green Published, hybrid			2022-12-27	WOS:000260893700006
J	Fitzgerald, ME; Drohat, AC				Fitzgerald, Megan E.; Drohat, Alexander C.			Coordinating the Initial Steps of Base Excision Repair APURINIC/APYRIMIDINIC ENDONUCLEASE 1 ACTIVELY STIMULATES THYMINE DNA GLYCOSYLASE BY DISRUPTING THE PRODUCT COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; AP-ENDONUCLEASE; CPG SITES; MISMATCH; BINDING; URACIL; MUTY; SPECIFICITY; TURNOVER	DNA glycosylases initiate base excision repair by removing damaged or mismatched bases, producing apurinic/apyrimidinic (AP) DNA. For many glycosylases, the AP-DNA remains tightly bound, impeding enzymatic turnover. A prominent example is thymine DNA glycosylase (TDG), which removes T from G.T mispairs and recognizes other lesions, with specificity for damage at CpG dinucleotides. TDG turnover is very slow; its activity appears to reach a plateau as the [product]/[enzyme] ratio approaches unity. The follow-on base excision repair enzyme, AP endonuclease 1 (APE1), stimulates the turnover of TDG and other glycosylases, involving a mechanism that remains largely unknown. We examined the catalytic activity of human TDG (hTDG), alone and with human APE1 (hAPE1), using pre-steady-state kinetics and a coupled-enzyme (hTDG-hAPE1) fluorescence assay. hTDG turnover is exceedingly slow for G.T (k(cat) = 0.00034 min(-1)) and G.U (k(cat) = 0.005 min(-1)) substrates, much slower than k(max) from single turnover experiments, confirming that AP-DNA release is rate-limiting. We find unexpectedly large differences in kcat for G.T, G.U, and G.FU substrates, indicating the excised base remains trapped in the product complex by AP-DNA. hAPE1 increases hTDG turnover by 42- and 26-fold for G.T and G.U substrates, the first quantitative measure of the effect of hAPE1. hAPE1 stimulates hTDG by disrupting the product complex rather than merely depleting (endonucleolytically) the AP-DNA. The enhancement is greater for hTDG catalytic core (residues 111-308 of 410), indicating the N- and C-terminal domains are dispensable for stimulatory interactions with hAPE1. Potential mechanisms for hAPE1 disruption of the of hTDG product complex are discussed.	[Fitzgerald, Megan E.; Drohat, Alexander C.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Drohat, AC (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, 108 N Greene St, Baltimore, MD 21201 USA.	adroh001@umaryland.edu		Drohat, Alex/0000-0002-7458-8770	National Institutes of Health [R01-GM72711]; University of Maryland Marlene and Stewart Greenebaum Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072711, T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Marlene and Stewart Greenebaum Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM72711 ( to A. C. D.). This work was also supported by the University of Maryland Marlene and Stewart Greenebaum Cancer Center.	Abu M, 2003, J BIOL CHEM, V278, P8739, DOI 10.1074/jbc.M211084200; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Bellacosa A, 1999, P NATL ACAD SCI USA, V96, P3969, DOI 10.1073/pnas.96.7.3969; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Drohat AC, 2000, J AM CHEM SOC, V122, P1840, DOI 10.1021/ja993254x; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; JOHNSON MD, 1992, PHYSICIAN SPORTSMED, V20, P61; Jost JP, 1999, NUCLEIC ACIDS RES, V27, P3245, DOI 10.1093/nar/27.16.3245; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Leatherbarrow R.J., 1998, GRAFIT 5; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Loeb LA, 1996, MUTAT RES-FUND MOL M, V350, P279, DOI 10.1016/0027-5107(95)00117-4; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; Maksimenko A, 2004, BIOCHEM BIOPH RES CO, V319, P240, DOI 10.1016/j.bbrc.2004.04.179; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; McCann JAB, 2003, J BIOL CHEM, V278, P29587, DOI 10.1074/jbc.M212474200; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Nguyen LH, 2000, J MOL BIOL, V298, P447, DOI 10.1006/jmbi.2000.3653; Noll DM, 1999, BIOCHEMISTRY-US, V38, P6374, DOI 10.1021/bi990335x; O'Neill RJ, 2003, J BIOL CHEM, V278, P20526, DOI 10.1074/jbc.M210860200; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Petronzelli F, 2000, J BIOL CHEM, V275, P32422, DOI 10.1074/jbc.M004535200; Pfeifer GP, 2000, MUTAT RES-FUND MOL M, V450, P155, DOI 10.1016/S0027-5107(00)00022-1; Pope MA, 2002, J BIOL CHEM, V277, P22605, DOI 10.1074/jbc.M203037200; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Privezentzev CV, 2001, MUTAT RES-FUND MOL M, V480, P277, DOI 10.1016/S0027-5107(01)00186-5; Scharer OD, 1997, P NATL ACAD SCI USA, V94, P4878, DOI 10.1073/pnas.94.10.4878; Scharer OD, 1998, J BIOL CHEM, V273, P8592, DOI 10.1074/jbc.273.15.8592; Sidorenko VS, 2007, DNA REPAIR, V6, P317, DOI 10.1016/j.dnarep.2006.10.022; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Sung JS, 2000, BIOCHEMISTRY-US, V39, P10224, DOI 10.1021/bi0007066; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Waters TR, 2000, MUTAT RES-REV MUTAT, V462, P137, DOI 10.1016/S1383-5742(00)00031-4; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Yang HJ, 2001, NUCLEIC ACIDS RES, V29, P743, DOI 10.1093/nar/29.3.743	57	77	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32680	32690		10.1074/jbc.M805504200	http://dx.doi.org/10.1074/jbc.M805504200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805789	Green Published, hybrid			2022-12-27	WOS:000260893700058
J	Garcia-Perez, C; Hajnoczky, G; Csordas, G				Garcia-Perez, Cecilia; Hajnoczky, Gyoergy; Csordas, Gyoergy			Physical Coupling Supports the Local Ca2+ Transfer between Sarcoplasmic Reticulum Subdomains and the Mitochondria in Heart Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM SIGNAL TRANSMISSION; SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTORS; RAT-HEART; CARDIAC MYOCYTES; RELEASE; DETERMINANTS; MICRODOMAINS; CONTRACTION	In many cell types, transfer of Ca2+ released via ryanodine receptors (RyR) to the mitochondrial matrix is locally supported by high [Ca2+] microdomains at close contacts between the sarcoplasmic reticulum (SR) and mitochondria. Here we studied whether the close contacts were secured via direct physical coupling in cardiac muscle using isolated rat heart mitochondria (RHMs). "Immuno-organelle chemistry" revealed RyR2 and calsequestrin-positive SR particles associated with mitochondria in both crude and Percoll-purified "heavy" mitochondrial fractions (cRHM and pRHM), to a smaller extent in the latter one. Mitochondria-associated vesicles were also visualized by electron microscopy in the RHMs. Western blot analysis detected greatly reduced presence of SR markers (calsequestrin, SERCA2a, and phospholamban) in pRHM, suggesting that the mitochondria-associated particles represented a small subfraction of the SR. Fluorescence calcium imaging in rhod2-loaded cRHM revealed mitochondrial matrix [Ca2+] ([Ca2+](m)) responses to caffeine-induced Ca2+ release that were prevented when thapsigargin was added to predeplete the SR or by mitochondrial Ca2+ uptake inhibitors. Importantly, caffeine failed to increase [Ca2+] in the large volume of the incubation medium, suggesting that local Ca2+ transfer between the SR particles and mitochondria mediated the [Ca2+](m) signal. Despite the substantially reduced SR presence, pRHM still displayed a caffeine-induced [Ca2+] m rise comparable with the one recorded in cRHM. Thus, a relatively small fraction of the total SR is physically coupled and transfers Ca2+ locally to the mitochondria in cardiac muscle. The transferred Ca2+ stimulates dehydrogenase activity and affects mitochondrial membrane permeabilization, indicating the broad significance of the physical coupling in mitochondrial function.	[Garcia-Perez, Cecilia; Hajnoczky, Gyoergy; Csordas, Gyoergy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Csordas, G (corresponding author), 1020 Locust St,Suites 260-261 JAH, Philadelphia, PA 19107 USA.	Gyorgy.Csordas@jefferson.edu	babakinejad, babak/G-2674-2012	Csordas, Gyorgy/0000-0003-3156-1460	American Heart Association [SDG 0435236N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051526] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an American Heart Association Grant SDG 0435236N.	Altschafl BA, 2007, BBA-BIOMEMBRANES, V1768, P1784, DOI 10.1016/j.bbamem.2007.04.011; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; BONCOMPAGNI S, 2008, BIOPHYS J, V94, pA306; Boncompagni S, 2007, BIOPHYS J, p313A; Brandes R, 1996, BIOPHYS J, V71, P1024, DOI 10.1016/S0006-3495(96)79303-7; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Csordas G, 2003, J BIOL CHEM, V278, P42273, DOI 10.1074/jbc.M305248200; Csordas G, 2001, TRENDS CARDIOVAS MED, V11, P269, DOI 10.1016/S1050-1738(01)00123-2; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; DENTON RM, 1980, BIOCHEM J, V190, P107, DOI 10.1042/bj1900107; DILISA F, 1993, CARDIOVASC RES, V27, P1840; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Feher JJ, 1998, J MOL CELL CARDIOL, V30, P1763, DOI 10.1006/jmcc.1998.0740; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; GANGULY PK, 1983, AM J PHYSIOL, V244, pE528, DOI 10.1152/ajpendo.1983.244.6.E528; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Isaeva EV, 2003, J PHYSIOL-LONDON, V547, P453, DOI 10.1113/jphysiol.2002.036129; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; KRONER H, 1986, ARCH BIOCHEM BIOPHYS, V251, P525, DOI 10.1016/0003-9861(86)90360-7; Maack C, 2007, BASIC RES CARDIOL, V102, P369, DOI 10.1007/s00395-007-0666-z; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; PRALONG WF, 1992, P NATL ACAD SCI USA, V89, P132, DOI 10.1073/pnas.89.1.132; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Saks VA, 2001, BIOCHEM J, V356, P643, DOI 10.1042/0264-6021:3560643; Shannon TR, 2005, CELL CALCIUM, V38, P497, DOI 10.1016/j.ceca.2005.07.002; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; SPAT A, 2008, CELL CALCIUM; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Xia RH, 2003, AM J PHYSIOL-CELL PH, V285, pC215, DOI 10.1152/ajpcell.00034.2002	44	110	112	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32771	32780		10.1074/jbc.M803385200	http://dx.doi.org/10.1074/jbc.M803385200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18790739	hybrid, Green Published			2022-12-27	WOS:000260893700066
J	Jung, H; Seong, HA; Ha, H				Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung			Direct Interaction between NM23-H1 and Macrophage Migration Inhibitory Factor (MIF) Is Critical for Alleviation of MIF-mediated Suppression of p53 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; RECEPTOR-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; CANCER-CELLS; PHOSPHOTRANSFERASE ACTIVITY; PHYSICAL INTERACTION; SIGNAL-TRANSDUCTION; GROWTH; PROLIFERATION; CYTOKINE	Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that is involved in host immune and inflammatory responses, as well as tumorigenesis. However, the regulatory mechanism of MIF function is unclear. Here we report that the NM23-H1 interacts with MIF in cells, as demonstrated by cotransfection and coimmunoprecipitation experiments. Analysis of cysteine (Cys) to serine (Ser) substitution mutants of NM23-H1 (C4S, C109S, and C145S) and MIF (C57S, C60S, and C81S) revealed that Cys(145) of NM23-H1 and Cys(60) of MIF are responsible for complex formation. NM23-H1-MIF complexes were dependent on reducing conditions, such as the presence of dithiothreitol or beta-mercaptoethanol, but not H2O2. NM23-H1 alleviated the MIF-mediated suppression of p53-induced apoptosis and cell cycle arrest by promoting the dissociation of MIF from MIF-p53 complexes. In addition, NM23-H1 significantly inhibited the MIF-induced proliferation of quiescent NIH 3T3 cells through a direct interaction with MIF, and decreased the MIF-induced activation of phosphatidylinositol 3-kinase/PDK1 and p44/p42 extracellular signal-regulated (ERK) mitogen-activated protein kinase. The results of the current study suggest that the NM23-H1 functions as a negative regulator of MIF.	[Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung] Chungbuk Natl Univ, Dept Biochem, Biotechnol Res Inst, Sch Life Sci, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Dept Biochem, Biotechnol Res Inst, Sch Life Sci, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr			Korea Science and Engineering Foundation (KOSEF) [R0A-2007-000-20006-0]; Korea government (Ministry of Science and Technology); National R&D Program for Cancer Control, Ministry of Health Welfare [0620090]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (Ministry of Science and Technology)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); National R&D Program for Cancer Control, Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation (KOSEF) Grant R0A-2007-000-20006-0 funded by the Korea government ( Ministry of Science and Technology) and in part by funds from the National R&D Program for Cancer Control, Ministry of Health & Welfare ( 0620090).	Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bucala R, 1996, FASEB J, V10, P1607, DOI 10.1096/fasebj.10.14.9002552; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; del Vecchio MT, 2000, PROSTATE, V45, P51, DOI 10.1002/1097-0045(20000915)45:1<51::AID-PROS6>3.0.CO;2-9; DELAROSA A, 1995, BIOESSAYS, V17, P53, DOI 10.1002/bies.950170111; ENGEL M, 1995, EUR J BIOCHEM, V234, P200, DOI 10.1111/j.1432-1033.1995.200_c.x; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Inoue H, 1996, BIOCHEM BIOPH RES CO, V218, P887, DOI 10.1006/bbrc.1996.0158; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kimura N, 2000, J BIOENERG BIOMEMBR, V32, P309, DOI 10.1023/A:1005549315846; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Li YX, 2004, EXP CELL RES, V300, P379, DOI 10.1016/j.yexcr.2004.07.019; Lombardi D, 2000, J CELL PHYSIOL, V182, P144, DOI 10.1002/(SICI)1097-4652(200002)182:2<144::AID-JCP2>3.3.CO;2-Y; Lu Q, 1996, J BIOL CHEM, V271, P32886, DOI 10.1074/jbc.271.51.32886; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Meyer-Siegler K, 2000, J INTERF CYTOK RES, V20, P769, DOI 10.1089/10799900050151030; Mitchell RA, 2000, SEMIN CANCER BIOL, V10, P359, DOI 10.1006/scbi.2000.0328; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Ogawa H, 2000, CYTOKINE, V12, P309, DOI 10.1006/cyto.1999.0562; Otero AD, 2000, J BIOENERG BIOMEMBR, V32, P269, DOI 10.1023/A:1005589029959; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Rochdi MD, 2004, J BIOL CHEM, V279, P18981, DOI 10.1074/jbc.M312621200; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Shen L, 2003, FEBS LETT, V540, P86, DOI 10.1016/S0014-5793(03)00229-1; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Wagner PD, 2000, BIOCHEM J, V346, P623, DOI 10.1042/0264-6021:3460623; Wagner PD, 2000, J BIOL CHEM, V275, P35570, DOI 10.1074/jbc.M006106200; WALLET V, 1990, J NATL CANCER I, V82, P1199, DOI 10.1093/jnci/82.14.1199	38	46	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32669	32679		10.1074/jbc.M806225200	http://dx.doi.org/10.1074/jbc.M806225200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18815136	hybrid			2022-12-27	WOS:000260893700057
J	Kothapalli, D; Flowers, J; Xu, T; Pure, E; Assoian, RK				Kothapalli, Devashish; Flowers, James; Xu, Tina; Pure, Ellen; Assoian, Richard K.			Differential Activation of ERK and Rac Mediates the Proliferative and Anti-proliferative Effects of Hyaluronan and CD44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CYCLIN D1 EXPRESSION; GENE-EXPRESSION; RECEPTOR ACTIVATION; KINASE ACTIVATION; TUMOR-SUPPRESSOR; TISSUE-INJURY; G1 PHASE; GROWTH; ADHESION	Hyaluronan, a widely distributed component of the extracellular matrix, exists in a high molecular weight (native) form and lower molecular weight form (HMW- and LMW-HA, respectively). These different forms of hyaluronan bind to CD44 but elicit distinct effects on cellular function. A striking example is the opposing effects of HMW- and LMW-HA on the proliferation of vascular smooth muscle cells; the binding of HMW-HA to CD44 inhibits cell cycle progression, whereas the binding of LMW-HA to CD44 stimulates cell cycle progression. We now report that cyclin D1 is the primary target of LMW-HA in human vascular smooth muscle cells, as it is for HMW- HA, and that the opposing cell cycle effects of these CD44 ligands result from differential regulation of signaling pathways to cyclin D1. HMW-HA binding to CD44 selectively inhibits the GTP loading of Rac and Rac-dependent signaling to the cyclin D1 gene, whereas LMW-HA binding to CD44 selectively stimulates ERK activation and ERK-dependent cyclin D1 gene expression. These data describe a novel mechanism of growth control in which a ligand-receptor system generates opposing effects on mitogenesis by differentially regulating signaling pathways to a common cell cycle target. They also emphasize how a seemingly subtle change in matrix composition can have a profound effect on cell proliferation.	[Kothapalli, Devashish; Flowers, James; Xu, Tina; Assoian, Richard K.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Pure, Ellen] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Pure, Ellen] Ludwig Inst Canc Res, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute; Ludwig Institute for Cancer Research	Assoian, RK (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	assoian@upenn.edu			National Institutes of Health [HL62250]; Commonwealth University Research Enhancement Program; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth University Research Enhancement Program; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL62250. This work was also supported by the Commonwealth University Research Enhancement Program, Pennsylvania Department of Health.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; Datto MB, 1997, MOL CELL BIOL, V17, P2030, DOI 10.1128/MCB.17.4.2030; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Hawkins CL, 1998, FREE RADICAL BIO MED, V24, P1396, DOI 10.1016/S0891-5849(98)00009-4; Heo SK, 2008, IMMUNOL LETT, V120, P57, DOI 10.1016/j.imlet.2008.07.002; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2; Klein EA, 2007, CELL CYCLE, V6, P1115, DOI 10.4161/cc.6.9.4147; Knudsen KE, 1999, J BIOL CHEM, V274, P27632, DOI 10.1074/jbc.274.39.27632; Kothapalli D, 2003, MOL PHARMACOL, V64, P249, DOI 10.1124/mol.64.2.249; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Otsui K, 2007, HEART VESSELS, V22, P416, DOI 10.1007/s00380-007-1001-1; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stewart SA, 2004, J BIOL CHEM, V279, P29109, DOI 10.1074/jbc.M404271200; Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu Q, 2000, GENE DEV, V14, P163; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034	48	66	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31823	31829		10.1074/jbc.M802934200	http://dx.doi.org/10.1074/jbc.M802934200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18806267	Green Published, hybrid			2022-12-27	WOS:000260760800065
J	Lehtinen, DA; Harvey, S; Mulcahy, MJ; Hollis, T; Perrino, FW				Lehtinen, Duane A.; Harvey, Scott; Mulcahy, Matthew J.; Hollis, Thomas; Perrino, Fred W.			The TREX1 Double-stranded DNA Degradation Activity Is Defective in Dominant Mutations Associated with Autoimmune Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; FAMILIAL CHILBLAIN LUPUS; MEDIATED CELL-DEATH; EXONUCLEASE TREX1; 3' TERMINI; ERYTHEMATOSUS; COMPLEX; BINDING; PROTEIN	Mutations in TREX1 have been linked to a spectrum of human autoimmune diseases including Aicardi-Goutieres syndrome (AGS), familial chilblain lupus (FCL), systemic lupus erythematosus, and retinal vasculopathy and cerebral leukodystrophy. A common feature in these conditions is the frequent detection of antibodies to double-stranded DNA (dsDNA). TREX1 participates in a cell death process implicating this major 3' -> 5' exonuclease in genomic DNA degradation to minimize potential immune activation by persistent self DNA. The TREX1 D200N and D18N dominant heterozygous mutations were identified in AGS and FCL, respectively. TREX1 enzymes containing the D200N and D18N mutations were compared using nicked dsDNA and single-stranded DNA (ssDNA) degradation assays. The TREX1(WT/D200N) and TREX1(WT/D18N) heterodimers are completely deficient at degrading dsDNA and degrade ssDNA at an expected similar to 2-fold lower rate than TREX1WT enzyme. Further, the D200N- and D18N-containing TREX1 homo-and heterodimers inhibit the dsDNA degradation activity of TREX1(WT) enzyme, providing a likely explanation for the dominant phenotype of these TREX1 mutant alleles in AGS and FCL. By comparison, the TREX1 R114H homozygous mutation causes AGS and is found as a heterozygous mutation in systemic lupus erythematosus. The TREX1(R114H/R114H) homodimer has dysfunctional dsDNA and ssDNA degradation activities and does not detectibly inhibit the TREX1(WT) enzyme, whereas the TREX1(WT/R114H) heterodimer has a functional dsDNA degradation activity, supporting the recessive genetics of TREX1 R114H in AGS. The dysfunctional dsDNA degradation activities of these disease-related TREX1 mutants could account for persistent dsDNA from dying cells leading to an aberrant immune response in these clinically related disorders.	[Lehtinen, Duane A.; Harvey, Scott; Mulcahy, Matthew J.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University School of Medicine	Perrino, FW (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu		Mulcahy, Matthew/0000-0001-5588-8762	National Institutes of Health [GM069962]; Alliance for Lupus Research [67692]; American Cancer Society [RSG-04-187-01-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F. W. P.). This work was also supported by Alliance for Lupus Research Grant 67692 (to F. W. P.) and American Cancer Society Grant RSG-04-187-01-GMC (to T. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Kolivras A, 2008, J CUTAN PATHOL, V35, P774, DOI 10.1111/j.1600-0560.2007.00900.x; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Perrino FW, 2008, J BIOL CHEM, V283, P21441, DOI 10.1074/jbc.M803629200; PERRINO FW, 1994, J BIOL CHEM, V269, P16357; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	24	91	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31649	31656		10.1074/jbc.M806155200	http://dx.doi.org/10.1074/jbc.M806155200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18805785	Green Published, hybrid			2022-12-27	WOS:000260760800046
J	Zuo, XS; Morris, JS; Shureiqi, I				Zuo, Xiangsheng; Morris, Jeffrey S.; Shureiqi, Imad			Chromatin Modification Requirements for 15-Lipoxygenase-1 Transcriptional Reactivation in Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLORECTAL-CARCINOMA; INDUCED APOPTOSIS; HISTONE ACETYLTRANSFERASE; ORGANELLE DEGRADATION; INDUCE APOPTOSIS; DOWN-REGULATION; UP-REGULATION; IN-VIVO; EXPRESSION; METHYLATION	15-Lipoxygenase-1 (15-LOX-1) contributes significantly to inflammation regulation and terminal cell differentiation. 15-LOX-1 is transcriptionally silenced in cancer cells, and its transcriptional reactivation (e. g. via histone deacetylase inhibitors (HDACIs)) is essential for restoring terminal cell differentiation to cancer cells. STAT-6 acetylation via the histone acetyltransferase KAT3B has been proposed to be necessary for 15-LOX-1 transcriptional activation. However, the exact mechanism underlying 15-LOX-1 transcriptional reactivation in cancer cells is still undefined, especially in regard to the contribution of 15-LOX-1 promoter histone modifications. We therefore examined the relative mechanistic contributions of 15-LOX-1 promoter histone modifications and STAT-6 to 15-LOX-1 transcriptional reactivation by HDACIs in colon cancer cells. We found that: 1) histone H3 and H4 acetylation in the 15-LOX-1 promoter through KAT3B was critical to 15-LOX-1 transcriptional activation; 2) 15-LOX-1 transcription was activated independently from STAT-6; and 3) dimethyl-histone H3 lysine 9 (H3K9me2) demethylation in the 15-LOX-1 promoter via the histone lysine demethylase KDM3A was an early and specific histone modification and was necessary for activation of transcription. These findings demonstrate that histone modification in the 15-LOX-1 promoter is important to 15-LOX-1 transcriptional silencing in colon cancer cells and that HDACIs can activate gene transcription via KDM3A demethylation of H3K9me2.	[Shureiqi, Imad] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Unit 1360, Houston, TX 77030 USA; [Morris, Jeffrey S.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA; [Shureiqi, Imad] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shureiqi, I (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Unit 1360, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ishureiqi@mdanderson.org	Shureiqi, imad/T-6214-2019	Shureiqi, Imad/0000-0003-2019-938X; Zuo, Xiangsheng/0000-0002-8593-1132	National Institutes of Health [CA106577, CA104278]; Caroline Wiess Law Endowment for Cancer Prevention; National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE [R01CA104278, R01CA106577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caroline Wiess Law Endowment for Cancer Prevention; National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106577 and CA104278. This work was also supported by the Caroline Wiess Law Endowment for Cancer Prevention and the National Colorectal Cancer Research Alliance. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; BAER AN, 1991, BIOCHEM BIOPH RES CO, V180, P98, DOI 10.1016/S0006-291X(05)81260-4; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Conrad DJ, 2000, AM J RESP CELL MOL, V22, P226, DOI 10.1165/ajrcmb.22.2.3786; Deguchi A, 2005, CANCER RES, V65, P8442, DOI 10.1158/0008-5472.CAN-05-1109; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Furumai R, 2002, CANCER RES, V62, P4916; Grullich C, 2001, FEBS LETT, V489, P51, DOI 10.1016/S0014-5793(01)02080-4; Hennig R, 2007, NEOPLASIA, V9, P917, DOI 10.1593/neo.07565; Heslin MJ, 2005, ANN SURG, V241, P941, DOI 10.1097/01.sla.0000164177.95620.c1; Heydeck D, 1998, BLOOD, V92, P2503, DOI 10.1182/blood.V92.7.2503.2503_2503_2510; Hill EM, 1998, AM J RESP CELL MOL, V18, P662, DOI 10.1165/ajrcmb.18.5.2985; Hsi LC, 2005, MOL CANCER THER, V4, P1740, DOI 10.1158/1535-7163.MCT-05-0218; Hsi LC, 2004, CANCER RES, V64, P8778, DOI 10.1158/0008-5472.CAN-04-1867; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P235, DOI 10.1016/j.plefa.2006.01.009; Kamitani H, 2001, CARCINOGENESIS, V22, P187, DOI 10.1093/carcin/22.1.187; Kamitani H, 2000, FEBS LETT, V467, P341, DOI 10.1016/S0014-5793(00)01155-8; Kim KS, 2005, PROSTAG LEUKOTR ESS, V73, P77, DOI 10.1016/j.plefa.2005.05.023; KROSCHWALD P, 1989, BIOCHEM BIOPH RES CO, V160, P954, DOI 10.1016/0006-291X(89)92528-X; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Liu C, 2004, EXP CELL RES, V297, P61, DOI 10.1016/j.yexcr.2004.02.014; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Munger KA, 1999, P NATL ACAD SCI USA, V96, P13375, DOI 10.1073/pnas.96.23.13375; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Nixon JB, 2004, PROSTAG LEUKOTR ESS, V70, P7, DOI 10.1016/j.plefa.2003.06.001; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shureiqi I, 2000, J NATL CANCER I, V92, P1136, DOI 10.1093/jnci/92.14.1136; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Shureiqi I, 2005, CANCER RES, V65, P11486, DOI 10.1158/0008-5472.CAN-05-2180; Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100; Shureiqi I, 2002, CANCER RES, V62, P1178; Shureiqi I, 2001, CANCER RES, V61, P4879; Shureiqi I, 2007, FASEB J, V21, P743, DOI 10.1096/fj.06-6830com; Spanbroek R, 2001, P NATL ACAD SCI USA, V98, P5152, DOI 10.1073/pnas.091076998; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; Wu J, 2003, CARCINOGENESIS, V24, P243, DOI 10.1093/carcin/24.2.243; Wu Y, 2008, MOL THER, V16, P886, DOI 10.1038/mt.2008.44; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160; Zuo XS, 2008, FASEB J, V22, P1981, DOI 10.1096/fj.07-098301	51	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31341	31347		10.1074/jbc.M803729200	http://dx.doi.org/10.1074/jbc.M803729200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18799463	Green Published, hybrid			2022-12-27	WOS:000260760800011
J	Shanmugam, N; Reddy, MA; Natarajan, R				Shanmugam, Narkunaraja; Reddy, Marpadga A.; Natarajan, Rama			Distinct Roles of Heterogeneous Nuclear Ribonuclear Protein K and microRNA-16 in Cyclooxygenase-2 RNA Stability Induced by S100b, a Ligand of the Receptor for Advanced Glycation End Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENTS; RIBONUCLEOPROTEIN-K; DIABETES COMPLICATIONS; 3'-UNTRANSLATED REGION; MOLECULAR-MECHANISMS; PROCESSING BODIES; BINDING PROTEINS; GENE-EXPRESSION; MONOCYTIC CELLS; OXIDANT STRESS	Advanced glycation end products play major roles in diabetic complications. They act via their receptor RAGE to induce inflammatory genes such as cyclooxygenase-2 (COX2). We examined the molecular mechanisms by which the RAGE ligand, S100b, induces COX-2 in monocytes. S100b significantly increased COX-2 mRNA accumulation in THP-1 monocytes at 2 h via mRNA stability. This was further confirmed by showing that S100b increased stability of luciferase-COX-2 3'-UTR mRNA. Chromatin immunoprecipitation and RNA immunoprecipitation revealed that S100b decreased occupancy of the DNA/RNA-binding protein, heterogeneous nuclear ribonuclear protein K (hnRNPK), at the COX-2 promoter but simultaneously increased its binding to the COX-2 3'-UTR. S100b treatment promoted the translocation of nuclear hnRNPK to cytoplasm, whereas a cytoplasmic translocation-deficient hnRNPK mutant inhibited S100b-induced COX-2 mRNA stability. Small interfering RNA-mediated specific knockdown of hnRNPK blocked S100b-induced COX-2 mRNA stability, whereas on the other hand, overexpression of hnRNPK increased S100b-induced COX-2 mRNA stability. S100b promoted the release of entrapped COX-2 mRNA from cytoplasmic processing bodies, sites of mRNA degradation. Furthermore, S100b significantly down-regulated the expression of a key microRNA, miR-16, which can destabilize COX-2 mRNA by binding to its 3'-UTR. MiR-16 inhibitor oligonucleotides increased, whereas, conversely, miR-16 mimic oligonucleotides decreased COX-2 mRNA stability in monocytes, further supporting the inhibitory effects of miR-16. Interestingly, hnRNPK knockdown increased miR-16 binding to COX-2 3'-UTR, indicating a cross-talk between them. These new results demonstrate that diabetic stimuli can efficiently stabilize inflammatory genes via opposing actions of key RNA-binding proteins and miRs.	[Natarajan, Rama] Beckman Res Inst City Hope, Dept Diabet, Div Diabet, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Natarajan, R (corresponding author), Beckman Res Inst City Hope, Dept Diabet, Div Diabet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	rnatarajan@coh.org		Reddy, Marpadga A/0000-0001-9259-7243	National Institutes of Health [R01 DK 065073]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 065073. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Bane TK, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf068; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chan JYH, 2008, INT J BIOCHEM CELL B, V40, P2078, DOI 10.1016/j.biocel.2008.02.005; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; Cosentino F, 2003, CIRCULATION, V107, P1017, DOI 10.1161/01.CIR.0000051367.92927.07; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Feliers D, 2007, AM J PHYSIOL-RENAL, V293, pF607, DOI 10.1152/ajprenal.00497.2006; Guha M, 2000, J BIOL CHEM, V275, P17728, DOI 10.1074/jbc.275.23.17728; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Lee SH, 2000, LIFE SCI, V68, P57, DOI 10.1016/S0024-3205(00)00920-6; McDaniel ML, 1996, P SOC EXP BIOL MED, V211, P24; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MOROHOSHI M, 1995, ANN NY ACAD SCI, V748, P562; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pontsler AV, 2002, J BIOL CHEM, V277, P13029, DOI 10.1074/jbc.M109546200; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Schonbeck U, 1999, AM J PATHOL, V155, P1281, DOI 10.1016/S0002-9440(10)65230-3; Shanmugam N, 2004, DIABETES, V53, P795, DOI 10.2337/diabetes.53.3.795; Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Shanmugam N, 2006, J BIOL CHEM, V281, P31212, DOI 10.1074/jbc.M602445200; Stains JP, 2005, BIOCHEM J, V385, P613, DOI 10.1042/BJ20040680; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Westwood ME, 1996, IMMUNOL LETT, V50, P17, DOI 10.1016/0165-2478(96)02496-0; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786	45	86	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36221	36233		10.1074/jbc.M806322200	http://dx.doi.org/10.1074/jbc.M806322200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18854308	hybrid, Green Published			2022-12-27	WOS:000261840500017
J	Baldwin, G; Novitskaya, V; Sadej, R; Pochec, E; Litynska, A; Hartmann, C; Williams, J; Ashman, L; Eble, JA; Berditchevski, F				Baldwin, Gouri; Novitskaya, Vera; Sadej, Rafal; Pochec, Ewa; Litynska, Anna; Hartmann, Christoph; Williams, Janelle; Ashman, Leonie; Eble, Johannes A.; Berditchevski, Fedor			Tetraspanin CD151 Regulates Glycosylation of alpha 3 beta 1 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; ALPHA(3)BETA(1) INTEGRIN; CELL-ADHESION; CORE FUCOSYLATION; LIGAND-BINDING; TM4SF PROTEIN; ASSOCIATION; SUPERFAMILY; COMPLEXES; HETERODIMERIZATION	The tetraspanin CD151 forms a stoichiometric complex with integrin alpha 3 beta 1 and regulates its endocytosis. We observed that down-regulation of CD151 in various epithelial cell lines changed glycosylation of alpha 3 beta 1. In contrast, glycosylation of other transmembrane proteins, including those associated with CD151 (e. g. alpha 6 beta 1, CD82, CD63, and emmprin/CD147) was not affected. The detailed analysis has shown that depletion of CD151 resulted in the reduction of Fuc alpha 1-2Gal and bisecting GlcNAc-beta(1 -> 4) linkage on N-glycans of the alpha 3 integrin subunit. The modulatory activity of CD151 toward alpha 3 beta 1 was specific, because stable knockdown of three other tetraspanins(i. e. CD9, CD63, and CD81) did not affect glycosylation of the integrin. Analysis of alpha 3 glycosylation in CD151-depleted breast cancer cells with reconstituted expression of various CD151 mutants has shown that a direct contact with integrin is required but not sufficient for the modulatory activity of the tetraspanin toward alpha 3 beta 1. We also found that glycosylation of CD151 is also critical; Asn1593Gln mutation in the large extracellular loop did not affect interactions of CD151 with other tetraspanins or alpha 3 beta 1 but negated its modulatory function. Changes in the glycosylation pattern of alpha 3 beta 1 observed in CD151-depleted cells correlated with a dramatic decrease in cell migration toward laminin-332. Migration toward fibronectin or static adhesion of cells to extracellular matrix ligands was not affected. Importantly, reconstituted expression of the wild-type CD151 but not glycosylation-deficient mutant restored the migratory potential of the cells. These results demonstrate that CD151 plays an important role in post-translation modification of alpha 3 beta 1 integrin and strongly suggest that changes in integrin glycosylation are critical for the promigratory activity of this tetraspanin.	[Baldwin, Gouri; Novitskaya, Vera; Sadej, Rafal; Berditchevski, Fedor] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Williams, Janelle; Ashman, Leonie] Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia; [Hartmann, Christoph; Eble, Johannes A.] Frankfurt Univ Hosp, Ctr Mol Med Dept, D-60590 Frankfurt, Germany; [Pochec, Ewa; Litynska, Anna] Jagiellonian Univ, Dept Glycoconjugate Biochem, PL-30060 Krakow, Poland	Cancer Research UK; University of Birmingham; University of Newcastle; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Jagiellonian University	Berditchevski, F (corresponding author), Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England.	f.berditchevski@bham.ac.uk	ASHMAN, LEONIE/G-7631-2013	ASHMAN, LEONIE/0000-0003-3559-3611; Sadej, Rafal/0000-0003-2583-7299	Cancer Research UK [C1322/A5705]; Deutsche Forschungsgemeinschaft [EXC147/1]	Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Cancer Research UK Grant C1322/A5705 ( to F. B.) and Deutsche Forschungsgemeinschaft Grant EXC147/1 (to J. A. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AKIYAMA SK, 1989, J BIOL CHEM, V264, P18011; ASHMAN LK, 1997, LEUKOCYTE TYPING 6 W; Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; BERDITCHEVSKI F, 1995, J BIOL CHEM, V270, P17784, DOI 10.1074/jbc.270.30.17784; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; CHAMMAS R, 1993, P NATL ACAD SCI USA, V90, P1795, DOI 10.1073/pnas.90.5.1795; Charrin S, 2003, BIOCHEM BIOPH RES CO, V304, P107, DOI 10.1016/S0006-291X(03)00545-X; DAHMS NM, 1986, J BIOL CHEM, V261, P3186; de Melker AA, 1999, BIOESSAYS, V21, P499, DOI 10.1002/(SICI)1521-1878(199906)21:6<499::AID-BIES6>3.0.CO;2-D; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Hakomori S, 2002, FEBS LETT, V531, P88, DOI 10.1016/S0014-5793(02)03479-8; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HEMLER ME, 1984, J IMMUNOL, V132, P3011; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Jee BK, 2007, BIOCHEM BIOPH RES CO, V359, P703, DOI 10.1016/j.bbrc.2007.05.159; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; KONIG R, 1988, J BIOL CHEM, V263, P9502; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Lau LM, 2004, BLOOD, V104, P2368, DOI 10.1182/blood-2003-12-4430; LE NF, 2006, MOL CELL PROTEOMICS, V5, P845; Lehmann M, 1996, J CELL BIOCHEM, V61, P266, DOI 10.1002/(SICI)1097-4644(19960501)61:2<266::AID-JCB10>3.0.CO;2-K; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Litynska A, 2000, ACTA BIOCHIM POL, V47, P427; Litynska A, 2002, ACTA BIOCHIM POL, V49, P491; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Mazzocca A, 2005, J BIOL CHEM, V280, P11329, DOI 10.1074/jbc.M410161200; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Ono M, 1999, CANCER RES, V59, P2335; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; OZ OK, 1989, INT J CANCER, V44, P343, DOI 10.1002/ijc.2910440226; Pochec E, 2006, EUR J CELL BIOL, V85, P47, DOI 10.1016/j.ejcb.2005.08.010; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Sasai K, 2003, J BIOL CHEM, V278, P25295, DOI 10.1074/jbc.M301913200; Sawada S, 2003, J BIOL CHEM, V278, P26323, DOI 10.1074/jbc.C300210200; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; SHEN LJ, 1995, J EXP MED, V181, P1773, DOI 10.1084/jem.181.5.1773; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Sincock PM, 1999, J CELL SCI, V112, P833; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Tachibana I, 1997, J BIOL CHEM, V272, P29181, DOI 10.1074/jbc.272.46.29181; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Vagin O, 2004, J BIOL CHEM, V279, P39026, DOI 10.1074/jbc.M405453200; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200; Xu JG, 2003, J BIOL CHEM, V278, P10770, DOI 10.1074/jbc.M207968200; Yamada M, 2008, FEBS J, V275, P3335, DOI 10.1111/j.1742-4658.2008.06481.x; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; ZHENG MZ, 1992, BIOCHEM BIOPH RES CO, V186, P1397, DOI 10.1016/S0006-291X(05)81561-X	76	50	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35445	35454		10.1074/jbc.M806394200	http://dx.doi.org/10.1074/jbc.M806394200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18852263	hybrid, Green Published			2022-12-27	WOS:000261687900016
J	Gleitsman, KR; Kedrowski, SMA; Lester, HA; Dougherty, DA				Gleitsman, Kristin Rule; Kedrowski, Sean M. A.; Lester, Henry A.; Dougherty, Dennis A.			An Intersubunit Hydrogen Bond in the Nicotinic Acetylcholine Receptor That Contributes to Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE DISULFIDE; UNNATURAL AMINO-ACIDS; IN-VIVO INCORPORATION; AGONIST BINDING; DELTA-SUBUNIT; ANGSTROM RESOLUTION; ION CHANNELS; ACH-BINDING; M2 DOMAIN; RESIDUES	The muscle nicotinic acetylcholine receptor is a large, allosteric, ligand-gated ion channel with the subunit composition alpha(2)beta gamma delta. Although much is now known about the structure of the binding site, relatively little is understood about how the binding event is communicated to the channel gate, causing the pore to open. Here we identify a key hydrogen bond near the binding site that is involved in the gating pathway. Using mutant cycle analysis with the novel unnatural residue alpha-hydroxyserine, we find that the backbone N-H of alpha Ser-191 in loop C makes a hydrogen bond to an anionic side chain of the complementary subunit upon agonist binding. However, the anionic partner is not the glutamate predicted by the crystal structures of the homologous acetylcholine-binding protein. Instead, the hydrogen-bonding partner is the extensively researched aspartate gamma Asp-174/delta Asp-180, which had originally been identified as a key binding residue for cationic agonists.	[Gleitsman, Kristin Rule; Kedrowski, Sean M. A.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health Grants [NS 34407, NS 11756]; National Science Foundation; National Research Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R01NS011756, R37NS034407] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Research Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 34407 and NS 11756. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Partially supported by a National Science Foundation graduate research fellowship.; Partially supported by a National Research Service Award training grant.	Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2007, BIOCHEMISTRY-US, V46, P630, DOI 10.1021/bi061638b; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603; CZAJKOWSKI C, 1995, J BIOL CHEM, V270, P3160, DOI 10.1074/jbc.270.7.3160; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; England PM, 1999, TETRAHEDRON LETT, V40, P6189, DOI 10.1016/S0040-4039(99)01300-3; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; LAGANIS ED, 1984, TETRAHEDRON LETT, V25, P5831, DOI 10.1016/S0040-4039(01)81697-X; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; Martin MD, 1997, BIOCHEMISTRY-US, V36, P10742, DOI 10.1021/bi970896t; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; MU T, 2006, THESIS CALIFORNIA I; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Rodriguez EA, 2006, P NATL ACAD SCI USA, V103, P8650, DOI 10.1073/pnas.0510817103; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Sine SM, 2002, J GEN PHYSIOL, V120, P483, DOI 10.1085/jgp.20028568; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VENKATACHALAN SP, 2008, P NATL ACAD SCI US; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	34	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35638	35643		10.1074/jbc.M807226200	http://dx.doi.org/10.1074/jbc.M807226200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952603	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000261687900037
J	Korkmaz, B; Kuhl, A; Bayat, B; Santoso, S; Jenne, DE				Korkmaz, Brice; Kuhl, Angelika; Bayat, Behnaz; Santoso, Sentot; Jenne, Dieter E.			A Hydrophobic Patch on Proteinase 3, the Target of Autoantibodies in Wegener Granulomatosis, Mediates Membrane Binding via NB1 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL ELASTASE; CATHEPSIN-G; POLYMORPHONUCLEAR NEUTROPHILS; PLASMA-MEMBRANE; ANTIGEN; SURFACE; CD177; AUTOANTIGEN; SITE; ANCA	Proteinase 3 (PR3), the target antigen of antineutrophil cytoplasm autoantibodies, which are found in patients with Wegener granulomatosis, is a neutrophil serine protease localized within cytoplasmic granules. Recently, the human neutrophil antigen NB1 was identified as a specific neutrophil cell surface receptor of PR3. We hypothesized that the unique hydrophobic cluster of PR3 that is not present on human neutrophil elastase and cathepsin G and presumably is also missing in other human PR3 homologs accounts for its binding to the NB1 receptor expressed on the cellular surface of NB1 cells. Instead of generating and testing various artificial human PR3 mutants, we cloned and expressed the very closely related gibbon (Hylobates pileatus) PR3 homolog, which did not bind to the human NB1 receptor. Moreover, a human-gibbon hybrid constructed from the N- and C-terminal half of the human and gibbon PR3, respectively, also did not interact with human NB1. The C-terminal half of gibbon PR3 differs only by 9 residues from human PR3, among which four closely spaced hydrophobic residues are substituted in a nonconservative manner (F166L, W218R, G219A, and L223H). The NB1-bound PR3 was active and was cleared from the surface by alpha-1-protease inhibitor. Conformational distortion of the hydrophobic 217-225 loop by alpha-1-protease inhibitor most likely triggers rapid solubilization.	[Korkmaz, Brice; Kuhl, Angelika; Jenne, Dieter E.] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Planegg Martinsried, Germany; [Bayat, Behnaz; Santoso, Sentot] Univ Giessen, Inst Clin Immunol & Transfus Med, D-35385 Giessen, Germany	Max Planck Society; Justus Liebig University Giessen	Jenne, DE (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Planegg Martinsried, Germany.	djenne@neuro.mpg.de	Jenne, Dieter Erich/AAP-1414-2020	KORKMAZ, BRICE/0000-0002-5159-8706	Deutsche Forschungsgemeinschaft [571]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 571) and the Bundesministerium fur Bildung und Forschung (Forschergruppe der Klinischen Infektiologie). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdel-Salam B, 2004, KIDNEY INT, V66, P1009, DOI 10.1111/j.1523-1755.2004.00849.x; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Campbell EJ, 2007, J BIOL CHEM, V282, P14645, DOI 10.1074/jbc.M608346200; David A, 2005, EXP CELL RES, V308, P156, DOI 10.1016/j.yexcr.2005.03.034; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Fridlich R, 2006, J CELL BIOCHEM, V99, P117, DOI 10.1002/jcb.20901; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; Goldmann WH, 1999, EUR J BIOCHEM, V261, P155, DOI 10.1046/j.1432-1327.1999.00259.x; Hajjar E, 2008, PROTEINS, V71, P1655, DOI 10.1002/prot.21853; Hopfner KP, 1998, P NATL ACAD SCI USA, V95, P9813, DOI 10.1073/pnas.95.17.9813; Jenne DE, 2006, CLIN NEPHROL, V66, P153; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kissel K, 2001, EUR J IMMUNOL, V31, P1301, DOI 10.1002/1521-4141(200105)31:5<1301::AID-IMMU1301>3.0.CO;2-J; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; Kurschus FC, 2005, BLOOD, V105, P2049, DOI 10.1182/blood-2004-06-2180; Rarok AA, 2003, J LEUKOCYTE BIOL, V74, P3, DOI 10.1189/jlb.1202611; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Specks U, 2007, J BIOCHEM, V141, P101, DOI 10.1093/jb/mvm008; Stronach D., 2004, SILK ROAD, V2, P9; Stroncek DF, 2007, CURR OPIN HEMATOL, V14, P688, DOI 10.1097/MOH.0b013e3282efed9e; van der Geld YM, 2001, J LEUKOCYTE BIOL, V69, P177; von Vietinghoff S, 2005, CLIN NEPHROL, V64, P453; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496	29	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35976	35982		10.1074/jbc.M806754200	http://dx.doi.org/10.1074/jbc.M806754200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18854317	hybrid			2022-12-27	WOS:000261687900072
J	Chou, AP; Maidment, N; Klintenberg, R; Casida, JE; Li, S; Fitzmaurice, AG; Fernagut, PO; Mortazavi, F; Chesselet, MF; Bronstein, JM				Chou, Arthur P.; Maidment, Nigel; Klintenberg, Rebecka; Casida, John E.; Li, Sharon; Fitzmaurice, Arthur G.; Fernagut, Pierre-Olivier; Mortazavi, Farzad; Chesselet, Marie-Francoise; Bronstein, Jeff M.			Ziram Causes Dopaminergic Cell Damage by Inhibiting E1 Ligase of the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; NEURONAL DEVELOPMENT; PESTICIDE EXPOSURE; MODEL; DITHIOCARBAMATE; SYSTEM; GLUTATHIONE; DYSFUNCTION; IMPAIRMENT	The etiology of Parkinson disease (PD) is unclear but may involve environmental toxins such as pesticides leading to dysfunction of the ubiquitin proteasome system (UPS). Here, we measured the relative toxicity of ziram (a UPS inhibitor) and analogs to dopaminergic neurons and examined the mechanism of cell death. UPS (26 S) activity was measured in cell lines after exposure to ziram and related compounds. Dimethyl- and diethyldithiocarbamates including ziram were potent UPS inhibitors. Primary ventral mesencephalic cultures were exposed to ziram, and cell toxicity was assessed by staining for tyrosine hydroxylase (TH) and NeuN antigen. Ziram caused a preferential damage to TH+ neurons and elevated alpha-synuclein levels but did not increase aggregate formation. Mechanistically, ziram altered UPS function through interfering with the targeting of substrates by inhibiting ubiquitin E1 ligase. Sodium dimethyldithiocarbamate administered to mice for 2 weeks resulted in persistent motor deficits and a mild reduction in striatal TH staining but no nigral cell loss. These results demonstrate that ziram causes selective dopaminergic cell damage in vitro by inhibiting an important degradative pathway implicated in the etiology of PD. Chronic exposure to widely used dithiocarbamate fungicides may contribute to the development of PD, and elucidation of its mechanism would identify a new potential therapeutic target.	[Chou, Arthur P.; Li, Sharon; Fitzmaurice, Arthur G.; Fernagut, Pierre-Olivier; Mortazavi, Farzad; Chesselet, Marie-Francoise; Bronstein, Jeff M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Maidment, Nigel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Fernagut, Pierre-Olivier; Mortazavi, Farzad; Chesselet, Marie-Francoise] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Bronstein, Jeff M.] Greater Angeles Vet Adm Med Ctr, Los Angeles, CA 90095 USA; [Klintenberg, Rebecka; Casida, John E.] Univ Calif Berkeley, Environm Chem & Toxicol Lab, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Berkeley	Bronstein, JM (corresponding author), Univ Calif Los Angeles, Sch Med, Reed Neurol Res Ctr, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	jbronste@ucla.edu	Mortazavi, Farzad/AAI-8136-2021; Mortazavi, Farzad/AFT-4660-2022	Mortazavi, Farzad/0000-0002-1911-5428; Mortazavi, Farzad/0000-0002-1911-5428; Fitzmaurice, Arthur/0000-0002-1509-3831; Fernagut, Pierre-Olivier/0000-0002-7737-5439	National Institutes of Health [5 U54 ESO12078]; Veterans Administration Grant SW PADRREC; National Institutes of Health Medical Scientist Training Program; Swedish Research Council; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Grant SW PADRREC; National Institutes of Health Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 U54 ESO12078. This work was also supported by Veterans Administration Grant SW PADRREC, the National Institutes of Health Medical Scientist Training Program (to A. P. C.), a postdoctoral fellowship from the Swedish Research Council (to R. K.), and funds from the Michael J. Fox Foundation (to F. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bordelon YM, 1999, NEUROSCIENCE, V93, P843, DOI 10.1016/S0306-4522(99)00239-0; Bove J, 2006, ANN NEUROL, V60, P260, DOI 10.1002/ana.20937; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; Burkitt MJ, 1998, ARCH BIOCHEM BIOPHYS, V353, P73, DOI 10.1006/abbi.1998.0618; Chow E, 2005, MOL CELL NEUROSCI, V29, P405, DOI 10.1016/j.mcn.2005.03.007; Cohen J., 1983, APPL MULTIPLE REGRES; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; Hwang DY, 2005, J NEUROSCI, V25, P2132, DOI 10.1523/JNEUROSCI.3718-04.2005; Jha N, 2002, J NEUROCHEM, V80, P555, DOI 10.1046/j.0022-3042.2001.00009.x; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kikuchi S, 2003, BRAIN RES, V964, P228, DOI 10.1016/S0006-8993(02)04030-1; Kordower JH, 2006, ANN NEUROL, V60, P264, DOI 10.1002/ana.20935; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Manning-Bog AB, 2006, ANN NEUROL, V60, P256, DOI 10.1002/ana.20938; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; McNaught KS, 2006, ANN NEUROL, V60, P243, DOI 10.1002/ana.20936; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; MONTINE TJ, 1995, NEURODEGENERATION, V4, P283, DOI 10.1016/1055-8330(95)90017-9; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Quilty MC, 2003, EXP NEUROL, V182, P195, DOI 10.1016/S0014-4886(03)00108-0; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Rideout HJ, 2004, J BIOL CHEM, V279, P46915, DOI 10.1074/jbc.M405146200; Rideout HJ, 2005, J NEUROCHEM, V93, P1304, DOI 10.1111/j.1471-4159.2005.03124.x; SCHMITT A, 1989, DEUT LEBENSM-RUNDSCH, V85, P111; Singleton AB, 2005, TRENDS NEUROSCI, V28, P416, DOI 10.1016/j.tins.2005.05.009; STAUB RE, 1995, CHEM RES TOXICOL, V8, P1063, DOI 10.1021/tx00050a010; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Wang XF, 2006, NEUROBIOL DIS, V23, P198, DOI 10.1016/j.nbd.2006.02.012; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zhou Y, 2004, NEUROSCIENCE, V128, P281, DOI 10.1016/j.neuroscience.2004.06.048	37	60	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34696	34703		10.1074/jbc.M802210200	http://dx.doi.org/10.1074/jbc.M802210200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18818210	Green Published, hybrid			2022-12-27	WOS:000261469100025
J	Macauley, MS; Bubb, AK; Martinez-Fleites, C; Davies, GJ; Vocadlo, DJ				Macauley, Matthew S.; Bubb, Abigail K.; Martinez-Fleites, Carlos; Davies, Gideon J.; Vocadlo, David J.			Elevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; SEQUENCE-BASED CLASSIFICATION; SUBSTRATE-ASSISTED CATALYSIS; STRUCTURAL INSIGHTS; NAG-THIAZOLINE; GLYCOSYLATION; MECHANISM; GLUCOSE; TRANSFERASE; PROTEINS	The O-GlcNAc post-translational modification is considered to act as a sensor of nutrient flux through the hexosamine biosynthetic pathway. A cornerstone of this hypothesis is that global elevation of protein O-GlcNAc levels, typically induced with the non-selective O-GlcNAcase inhibitor PUGNAc (O-(2-acetamido-2-deoxy-D-glycopyranosylidene) amino-N-phenylcarbamate), causes insulin resistance in adipocytes. Here we address the potential link between elevated O- GlcNAc and insulin resistance by using a potent and selective inhibitor of O- GlcNAcase (NButGT (1,2-dideoxy-2'-propyl-alpha-D-glucopyranoso-[2,1-D]-Delta 2'-thiazoline), 1200-fold selectivity). A comparison of the structures of a bacterial homologue of O-GlcNAcase in complex with PUGNAc or NButGT reveals that these inhibitors bind to the same region of the active site, underscoring the competitive nature of their inhibition of O- GlcNAcase and the molecular basis of selectivity. Treating 3T3-L1 adipocytes with NButGT induces rapid increases in global O- GlcNAc levels, but strikingly, NButGT treatment does not replicate the insulin desensitizing effects of the non-selective O- GlcNAcase inhibitor PUGNAc. Consistent with these observations, NButGT also does not recapitulate the impaired insulin-mediated phosphorylation of Akt that is induced by treatment with PUGNAc. Collectively, these results suggest that increases in global levels of O-GlcNAc-modified proteins of cultured adipocytes do not, on their own, cause insulin resistance.	[Macauley, Matthew S.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Bubb, Abigail K.; Martinez-Fleites, Carlos; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England	Simon Fraser University; University of York - UK	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Martinez Fleites, Carlos/F-8526-2010; Davies, Gideon J/A-9042-2011; Vocadlo, David J/E-5508-2014	Davies, Gideon J/0000-0002-7343-776X; Vocadlo, David J/0000-0001-6897-5558	Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council of Canada; Biotechnology and Biological Sciences Research Council; BBSRC [BB/F007124/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007124/1] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council of Canada (to D. J. V.) and the Biotechnology and Biological Sciences Research Council (to G. J. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hawkins M, 1997, J BIOL CHEM, V272, P4889, DOI 10.1074/jbc.272.8.4889; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Matthews JA, 2007, MOL CELL BIOCHEM, V298, P109, DOI 10.1007/s11010-006-9358-5; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOJIRI H, 1991, J BIOL CHEM, V266, P4531; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; Sale EM, 2008, CELL MOL LIFE SCI, V65, P113, DOI 10.1007/s00018-007-7274-9; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Stubbs KA, 2006, ORG BIOMOL CHEM, V4, P839, DOI 10.1039/b516273d; TRAXINGER RR, 1991, J BIOL CHEM, V266, P10148; VANECHTEN G, 1993, J BIOL CHEM, V268, P5341; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; WILLIAMS D, 1980, J BIOL CHEM, V255, P1253; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	51	98	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34687	34695		10.1074/jbc.M804525200	http://dx.doi.org/10.1074/jbc.M804525200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18842583	Green Published, hybrid			2022-12-27	WOS:000261469100024
J	Steiner, H; Winkler, E; Haass, C				Steiner, Harald; Winkler, Edith; Haass, Christian			Chemical Cross-linking Provides a Model of the gamma-Secretase Complex Subunit Architecture and Evidence for Close Proximity of the C-terminal Fragment of Presenilin with APH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; DISEASE-ASSOCIATED PRESENILIN-1; TRANSMEMBRANE DOMAIN; NICASTRIN; PEN-2; EXPRESSION; BINDING; PROTEIN; ORGANIZATION; ABSENCE	gamma-Secretase is an intramembrane cleaving aspartyl protease complex intimately implicated in Alzheimer disease pathogenesis. The protease is composed of the catalytic subunit presenilin (PS1 or PS2), the substrate receptor nicastrin (NCT), and two additional subunits, APH-1 (APH-1a, as long and short splice forms (APH-1aL, APH-1aS), or APH-1b) and PEN-2. Apart from the Alzheimer disease-associated beta-amyloid precursor protein, gamma-secretase has been shown to cleave a large number of other type I membrane proteins. Despite the progress in elucidating gamma-secretase function, basic questions concerning the precise organization of its subunits, their molecular interactions, and their exact stoichiometry in the complex are largely unresolved. Here we isolated endogenous human gamma-secretase from human embryonic kidney 293 cells and investigated the subunit architecture of the gamma-secretase complex formed by PS1, NCT, APH-1aL, and PEN-2 by chemical cross-linking. Using this approach, we provide evidence for the close neighborhood of the PS1 N- and C-terminal fragments (NTF and CTF, respectively), the PS1 NTF and PEN-2, the PS1 CTF and APH-1aL, and NCT and APH-1aL. We thus identify a previously unrecognized PS1 CTF/APH-1aL interaction, verify subunit interactions deduced previously from indirect approaches, and provide a model of the gamma-secretase complex subunit architecture. Finally, we further show that, like the PS1 CTF, the PS2 CTF also interacts with APH-1aL, and we provide evidence that these interactions also occur with the other APH-1 variants, suggesting similar subunit architectures of all gamma-secretase complexes.	[Steiner, Harald] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany	University of Munich; University of Munich	Steiner, H (corresponding author), Univ Munich, Dept Biochem, Adolf Butenandt Inst, Lab Neurodegenerat Dis Res, Schillerstr 44, D-80336 Munich, Germany.	harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB 596]; Alzheimer Research Award of the Hans and Ilse Breuer Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alzheimer Research Award of the Hans and Ilse Breuer Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 596 (to C. H. and H. S.) and the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Capell A, 2003, J BIOL CHEM, V278, P52519, DOI 10.1074/jbc.C300435200; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Edbauer D, 2004, J BIOL CHEM, V279, P37311, DOI 10.1074/jbc.M406228200; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hebert SS, 2004, NEUROBIOL DIS, V17, P260, DOI 10.1016/j.nbd.2004.08.002; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2006, BIOCHEMISTRY-US, V45, P7598, DOI 10.1021/bi060107k; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Morais VA, 2003, J BIOL CHEM, V278, P43284, DOI 10.1074/jbc.M305685200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Steiner Harald, 2004, Current Alzheimer Research, V1, P175, DOI 10.2174/1567205043332081; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200	52	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34677	34686		10.1074/jbc.M709067200	http://dx.doi.org/10.1074/jbc.M709067200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18801744	hybrid, Green Published			2022-12-27	WOS:000261469100023
J	Boudko, SP; Engel, J; Bachinger, HP				Boudko, Sergei P.; Engel, Juergen; Baechinger, Hans Peter			Trimerization and Triple Helix Stabilization of the Collagen XIX NC2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL; PROTEIN; MODEL; CHAIN; SUPERFAMILY; TRANSITIONS; SUBDOMAINS; MEMBRANE; TRIMERS; REQUIRE	The mechanisms of chain selection and assembly of fibril-associated collagens with interrupted triple helices (FACITs) must differ from that of fibrillar collagens, since they lack the characteristic C-propeptide. We analyzed two carboxyl-terminal noncollagenous domains, NC2 and NC1, of collagen XIX as potential trimerization units and found that NC2 forms a stable trimer and substantially stabilizes a collagen triple helix attached to either end. In contrast, the NC1 domain requires formation of an adjacent collagen triple helix to form interchain disulfide bridges. The NC2 domain of collagen XIX and probably of other FACITs is responsible for chain selection and trimerization.	[Boudko, Sergei P.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Boudko, Sergei P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Oregon Health & Science University; University of Basel	Bachinger, HP (corresponding author), 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Boudko, Sergei/0000-0003-3856-4859	Shriners Hospital for Children	Shriners Hospital for Children	This work was supported by a grant from Shriners Hospital for Children. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bachmann A, 2005, P NATL ACAD SCI USA, V102, P13897, DOI 10.1073/pnas.0505141102; Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918; Boudko SP, 2007, J MOL BIOL, V366, P1538, DOI 10.1016/j.jmb.2006.12.046; Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Deng YQ, 2006, STRUCTURE, V14, P889, DOI 10.1016/j.str.2006.03.007; Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8; Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; INOGUCHI K, 1995, J BIOCHEM-TOKYO, V117, P137, DOI 10.1093/oxfordjournals.jbchem.a124700; Jaalinoja J, 2008, BIOCHEM J, V409, P545, DOI 10.1042/BJ20070984; Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Liu J, 2006, BIOCHEMISTRY-US, V45, P15224, DOI 10.1021/bi061914m; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MAZZORANA M, 1993, J BIOL CHEM, V268, P3029; MAZZORANA M, 1995, MATRIX BIOL, V14, P583, DOI 10.1016/S0945-053X(05)80007-1; Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Myers JC, 2003, J BIOL CHEM, V278, P32047, DOI 10.1074/jbc.M304629200; MYERS JC, 1993, GENE, V123, P211, DOI 10.1016/0378-1119(93)90126-N; MYERS JC, 1994, J BIOL CHEM, V269, P18549; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Sumiyoshi H, 2004, J CELL BIOL, V166, P591, DOI 10.1083/jcb.200402054; YOSHIOKA H, 1992, GENOMICS, V13, P884, DOI 10.1016/0888-7543(92)90176-S	28	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34345	34351		10.1074/jbc.M806352200	http://dx.doi.org/10.1074/jbc.M806352200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18845531	Green Published, hybrid			2022-12-27	WOS:000261277700062
J	Abbott, KL; Matthews, RT; Pierce, M				Abbott, Karen L.; Matthews, Russell T.; Pierce, Michael			Receptor Tyrosine Phosphatase beta(RPTP beta) Activity and Signaling Are Attenuated by Glycosylation and Subsequent Cell Surface Galectin-1 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; MONOCLONAL-ANTIBODY HNK-1; MYELIN-ASSOCIATED GLYCOPROTEIN; EXPRESSION LEVELS; NERVOUS-SYSTEM; O-GLYCANS; N-GLYCANS; GNT-VB; ADHESION; BRAIN	O-Mannosyl-linked glycosylation is abundant within the central nervous system, yet very few glycoproteins with this glycan modification have been identified. Congenital diseases with significant neurological defects arise from inactivating mutations found within the glycosyltransferases that act early in the O-mannosyl glycosylation pathway. The N-acetylglucosaminyltransferase known as GnT-Vb or -IX is highly expressed in brain and branches O-mannosyl-linked glycans. Our results using SH-SY5Y neuroblastoma cells indicate that GnT-Vb activity promotes the addition of the O-mannosyl-linked HNK-1 modification found on the developmentally regulated and neuron-specific receptor protein-tyrosine phosphatase beta (RPTP beta). These changes in glycosylation accompany decreased cell-cell adhesion and increased rates of migration on laminin. In addition, we show that expression of GnT-Vb promotes its dimerization and inhibits RPTP beta intrinsic phosphatase activity, resulting in higher levels of phosphorylated beta-catenin, suggesting a mechanism by which GnT-Vb glycosylation couples to changes in cell adhesion. GnT-Vb-mediated glycosylation of RPTP beta promotes galectin-1 binding and RPTP beta levels of retention on the cell surface. N-Acetyllactosamine, but not sucrose, treatment of cells results in decreased RPTP retention, showing that galectin-1 binding contributes to the increased retention after GnT-Vb expression. These results place GnT-Vb as a regulator of RPTP beta signaling that influences cell-cell and cell-matrix interactions in the developing nervous system.	[Abbott, Karen L.; Pierce, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem, Athens, GA 30602 USA; [Matthews, Russell T.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Matthews, Russell T.] SUNY Upstate Med Sch, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	University System of Georgia; University of Georgia; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Abbott, KL (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem, 315 Riverbend Rd, Athens, GA 30602 USA.	kabbott@uga.edu			National Institutes of Health [RO1 CA64462]; Canary Fund/American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA064462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canary Fund/American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA64462 (NCI). This work was also supported by a Canary Fund/American Cancer Society Postdoctoral Fellowship (to K. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott KL, 2006, EXP CELL RES, V312, P2837, DOI 10.1016/j.yexcr.2006.05.022; ABO T, 1981, J IMMUNOL, V127, P1024; Allen HJ, 1998, GLYCOCONJUGATE J, V15, P691, DOI 10.1023/A:1006988515346; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Breen KC, 1998, MOL NEUROBIOL, V16, P163, DOI 10.1007/BF02740643; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; BURGER D, 1990, J NEUROCHEM, V54, P1569, DOI 10.1111/j.1471-4159.1990.tb01206.x; CAILLAUD JM, 1984, CANCER RES, V44, P4432; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; Dino MR, 2006, NEUROSCIENCE, V142, P1055, DOI 10.1016/j.neuroscience.2006.07.054; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; FINNE J, 1979, J BIOL CHEM, V254, P295; Fouillit M, 2000, GLYCOBIOLOGY, V10, P413, DOI 10.1093/glycob/10.4.413; GRUMET M, 1982, NATURE, V295, P693, DOI 10.1038/295693a0; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Hall H, 1997, EUR J BIOCHEM, V246, P233, DOI 10.1111/j.1432-1033.1997.t01-1-00233.x; Hall H, 1997, J NEUROCHEM, V68, P544; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; ILYAS AA, 1984, BIOCHEM BIOPH RES CO, V122, P1206, DOI 10.1016/0006-291X(84)91220-8; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Johnson G, 2001, INT J DEV NEUROSCI, V19, P439, DOI 10.1016/S0736-5748(01)00024-7; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; KIANG WL, 1981, J BIOL CHEM, V256, P529; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lander C, 1997, J NEUROSCI, V17, P1928; Lander C, 1998, J NEUROSCI, V18, P174; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; LIPINSKI M, 1983, J EXP MED, V158, P1775, DOI 10.1084/jem.158.5.1775; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; McGraw J, 2005, PAIN, V114, P7, DOI 10.1016/j.pain.2004.10.009; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ong E, 2002, J BIOL CHEM, V277, P18182, DOI 10.1074/jbc.M201312200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PEDRAZA L, 1995, J NEUROSCI RES, V40, P716, DOI 10.1002/jnr.490400603; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V362, P5, DOI 10.1016/j.bbrc.2007.06.050; RATHJEN FG, 1984, EMBO J, V3, P1; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; Sakaguchi M, 2007, CELL MOL LIFE SCI, V64, P1254, DOI 10.1007/s00018-007-6476-5; Schmidt JT, 1998, J NEUROBIOL, V37, P659, DOI 10.1002/(SICI)1097-4695(199812)37:4<659::AID-NEU13>3.0.CO;2-3; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHULLERPETROVIC S, 1983, NATURE, V306, P179, DOI 10.1038/306179a0; SCHWARTING GA, 1987, DEV BIOL, V120, P65, DOI 10.1016/0012-1606(87)90104-7; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Walzel H, 1999, IMMUNOL LETT, V67, P193, DOI 10.1016/S0165-2478(99)00012-7; WERNECKE H, 1985, J NEUROIMMUNOL, V9, P115, DOI 10.1016/S0165-5728(85)80012-6; Woodworth A, 2004, J BIOL CHEM, V279, P10413, DOI 10.1074/jbc.M312466200; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yuen CT, 1997, J BIOL CHEM, V272, P8924; Zhang WL, 2002, BIOCHEM J, V361, P153, DOI 10.1042/0264-6021:3610153	62	63	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33026	33035		10.1074/jbc.M803646200	http://dx.doi.org/10.1074/jbc.M803646200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18838383	Green Published, hybrid			2022-12-27	WOS:000261183700002
J	Coste, O; Brenneis, C; Linke, B; Pierre, S; Maeurer, C; Becker, W; Schmidt, H; Gao, W; Geisslinger, G; Scholich, K				Coste, Ovidiu; Brenneis, Christian; Linke, Bona; Pierre, Sandra; Maeurer, Christian; Becker, Wiebke; Schmidt, Helmut; Gao, Wei; Geisslinger, Gerd; Scholich, Klaus			Sphingosine 1-Phosphate Modulates Spinal Nociceptive Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPONTANEOUS TRANSMITTER RELEASE; DEPENDENT PROTEIN-KINASE; GLABROUS SKIN AFFERENTS; DORSAL-HORN; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; CAMP; HYPERALGESIA; EXPRESSION; CYCLASE	Sphingosine 1-Phosphate (S1P) modulates various cellular functions such as apoptosis, cell differentiation, and migration. Although S1P is an abundant signaling molecule in the central nervous system, very little is known about its influence on neuronal functions. We found that S1P concentrations were selectively decreased in the cerebrospinal fluid of adult rats in an acute and an inflammatory pain model. Pharmacological inhibition of sphingosine kinases (SPHK) decreased basal pain thresholds and SphK2 knock-out mice, but not SphK1 knock-out mice, had a significant decrease in withdrawal latency. Intrathecal application of S1P or sphinganine 1-phosphate (dihydro-S1P) reduced the pain-related (nociceptive) behavior in the formalin assay. S1P and dihydro-S1P inhibited cyclic AMP(cAMP) synthesis, a key second messenger of spinal nociceptive processing, in spinal cord neurons. By combining fluorescence resonance energy transfer (FRET)-based cAMP measurements with Multi Epitope Ligand Cartography (MELC), we showed that S1P decreased cAMP synthesis in excitatory dorsal horn neurons. Accordingly, intrathecal application of dihydro-S1P abolished the cAMP-dependent phosphorylation of NMDA receptors in the outer laminae of the spinal cord. Taken together, the data show that S1P modulates spinal nociceptive processing through inhibition of neuronal cAMP synthesis.	[Coste, Ovidiu; Brenneis, Christian; Linke, Bona; Pierre, Sandra; Maeurer, Christian; Becker, Wiebke; Schmidt, Helmut; Gao, Wei; Geisslinger, Gerd; Scholich, Klaus] Univ Frankfurt Klinikum, Inst Clin Pharmacol, ZAFES, Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Scholich, K (corresponding author), Univ Frankfurt Klinikum, Inst Clin Pharmacol, ZAFES, Pharmazentrum Frankfurt, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	scholich@em.uni-frankfurt.de			DFG [SCHO817-1, SCHO817-2]; LOEWE Lipid Signaling Forschungszentrum Frankfurt (LIFF); Aventis, Frankfurt, Germany	DFG(German Research Foundation (DFG)); LOEWE Lipid Signaling Forschungszentrum Frankfurt (LIFF); Aventis, Frankfurt, Germany(Sanofi-Aventis)	This work was supported in part by DFG (German Research Association) Grants SCHO817-1 and SCHO817-2, the LOEWE Lipid Signaling Forschungszentrum Frankfurt (LIFF), and in part by an unrestricted grant from Aventis, Frankfurt, Germany. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Bonnekoh B, 2006, EUR J DERMATOL, V16, P623, DOI 10.1684/ejd.2006.0005; Brailoiu E, 2003, BIOCHEM J, V373, P313, DOI 10.1042/BJ20030472; Brailoiu E, 2002, BRIT J PHARMACOL, V136, P1093, DOI 10.1038/sj.bjp.0704839; Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com; Choi SS, 2006, BRAIN RES, V1108, P28, DOI 10.1016/j.brainres.2006.06.048; Colombaioni L, 2004, BRAIN RES REV, V46, P328, DOI 10.1016/j.brainresrev.2004.07.014; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Ehnert C, 2004, J NEUROCHEM, V88, P948, DOI 10.1046/j.1471-4159.2003.02229.x; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hofacker A, 2005, J NEUROSCI, V25, P9005, DOI 10.1523/JNEUROSCI.2190-05.2005; Hornuss C, 2001, EUR J PHARMACOL, V429, P303, DOI 10.1016/S0014-2999(01)01329-2; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; Kim HW, 2006, BRIT J PHARMACOL, V148, P490, DOI 10.1038/sj.bjp.0706764; Kim KS, 2006, P NATL ACAD SCI USA, V103, P3908, DOI 10.1073/pnas.0508812103; Li S, 2006, MOL PHARMACOL, V70, P1742, DOI 10.1124/mol.106.025783; Lissandron V, 2005, J MOL BIOL, V354, P546, DOI 10.1016/j.jmb.2005.09.089; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Murata N, 2000, ANAL BIOCHEM, V282, P115, DOI 10.1006/abio.2000.4580; Nicholson R, 2005, NEUROSCI LETT, V380, P316, DOI 10.1016/j.neulet.2005.01.079; Persson S, 2006, J COMP NEUROL, V497, P683, DOI 10.1002/cne.20987; Pierre SC, 2004, EMBO J, V23, P3031, DOI 10.1038/sj.emboj.7600321; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Schmidt H, 2006, PROSTAG OTH LIPID M, V81, P162, DOI 10.1016/j.prostaglandins.2006.09.003; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; SHORTLAND P, 1993, J COMP NEUROL, V329, P491, DOI 10.1002/cne.903290406; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Suzuki M, 2006, NEUROSCI LETT, V399, P202, DOI 10.1016/j.neulet.2006.01.066; TAIWO YO, 1992, NEUROSCIENCE, V48, P479, DOI 10.1016/0306-4522(92)90507-X; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Tegeder I, 2004, P NATL ACAD SCI USA, V101, P3253, DOI 10.1073/pnas.0304076101; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Vasquez E, 2001, J NEUROSCI, V21, P9001, DOI 10.1523/JNEUROSCI.21-22-09001.2001; Watson AHD, 2003, J COMP NEUROL, V464, P497, DOI 10.1002/cne.10812; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Willis WD, 2001, ANN NY ACAD SCI, V933, P142; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhang YH, 2006, J NEUROPHYSIOL, V96, P1042, DOI 10.1152/jn.00120.2006; Zhao J, 2006, MOL CELL NEUROSCI, V31, P539, DOI 10.1016/j.mcn.2005.11.008; Zhao MG, 2006, J NEUROSCI, V26, P8923, DOI 10.1523/JNEUROSCI.2103-06.2006	48	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32442	32451		10.1074/jbc.M806410200	http://dx.doi.org/10.1074/jbc.M806410200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18805787	hybrid			2022-12-27	WOS:000260893700032
J	Higashi, K; Terui, Y; Suganami, A; Tamura, Y; Nishimura, K; Kashiwagi, K; Igarashi, K				Higashi, Kyohei; Terui, Yusuke; Suganami, Akiko; Tamura, Yutaka; Nishimura, Kazuhiro; Kashiwagi, Keiko; Igarashi, Kazuei			Selective Structural Change by Spermidine in the Bulged-out Region of Double-stranded RNA and Its Effect on RNA Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOPEPTIDE-BINDING PROTEIN; ESCHERICHIA-COLI; RAT-LIVER; POLYAMINE STIMULATION; THERMOPHILIC EUBACTERIA; BOVINE LYMPHOCYTES; CELL-PROLIFERATION; THERMAL-STABILITY; DNA INTERACTIONS; MESSENGER-RNA	Polyamines play important roles in cell growth mainly through their interaction with RNA. We have previously reported that polyamines stimulate the synthesis of oligopeptide-binding protein OppA in Escherichia coli and the formation of Ile-tRNA in rat liver (Igarashi, K., and Kashiwagi, K. (2000) Biochem. Biophys. Res. Commun. 271, 559-564). These effects involve an interaction of polyamines with the bulged-out region of double-stranded RNA in the initiation region of OppA mRNA and in the acceptor stem of rat liver tRNAIle. In this study, the effects of polyamines on E. coli OppA synthesis and rat liver Ile-tRNA formation were compared using OppA mRNA and tRNAIle with or without the bulged-out region of double-stranded RNA. The results indicate that the bulged-out region is involved in polyamine stimulation of OppA synthesis and Ile-tRNA formation. A selective structural change by spermidine in the bulged-out region of double-stranded RNA was confirmed by circular dichroism.	[Higashi, Kyohei; Nishimura, Kazuhiro; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chuo Ku, Chiba 2600856, Japan; [Terui, Yusuke; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Chiba 2880025, Japan; [Suganami, Akiko; Tamura, Yutaka] Chiba Univ, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan	Chiba University; Chiba University; Chiba University	Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	iga16077@p.chiba-u.ac.jp		Igarashi, Kazuei/0000-0003-3751-3187; Higashi, Kyohei/0000-0002-2622-4825; Nishimura, Kazuhiro/0000-0002-6209-5522	Ministry of Education, Science, Sports, and Culture of Japan; Futaba Electronics Memorial Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Futaba Electronics Memorial Foundation	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan and by a research grant from the Futaba Electronics Memorial Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; FEUERSTEIN BG, 1986, P NATL ACAD SCI USA, V83, P5948, DOI 10.1073/pnas.83.16.5948; HAMANA K, 1991, J BIOCHEM-TOKYO, V109, P444, DOI 10.1093/oxfordjournals.jbchem.a123401; HAMANA K, 1982, J BIOCHEM-TOKYO, V91, P1321, DOI 10.1093/oxfordjournals.jbchem.a133818; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Higashi K, 2008, BIOCHEM BIOPH RES CO, V370, P572, DOI 10.1016/j.bbrc.2008.03.137; Hosoya R, 2004, J GEN APPL MICROBIOL, V50, P271, DOI 10.2323/jgam.50.271; Hou MH, 2001, NUCLEIC ACIDS RES, V29, P5121, DOI 10.1093/nar/29.24.5121; Hyvonen MT, 2007, J BIOL CHEM, V282, P34700, DOI 10.1074/jbc.M704282200; IGARASHI K, 1975, BIOCHEM BIOPH RES CO, V64, P897, DOI 10.1016/0006-291X(75)90132-1; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Igarashi K, 1997, J BIOL CHEM, V272, P4058, DOI 10.1074/jbc.272.7.4058; IGARASHI K, 1982, ARCH BIOCHEM BIOPHYS, V219, P438, DOI 10.1016/0003-9861(82)90175-8; IGARASHI K, 1984, CANCER RES, V44, P5326; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; KUSAMAEGUCHI K, 1991, BIOCHEM BIOPH RES CO, V177, P745, DOI 10.1016/0006-291X(91)91851-3; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; NORRIS AT, 1964, P NATL ACAD SCI USA, V52, P330, DOI 10.1073/pnas.52.2.330; OGASAWARA T, 1989, J BIOCHEM-TOKYO, V105, P164, DOI 10.1093/oxfordjournals.jbchem.a122633; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Park MH, 1997, BIOL SIGNAL, V6, P115; PENG ZH, 1990, ARCH BIOCHEM BIOPHYS, V279, P138, DOI 10.1016/0003-9861(90)90473-C; PHILIPSON L, 1978, CELL, V13, P189, DOI 10.1016/0092-8674(78)90149-6; Sambrook J., 2001, MOL CLONING LAB MANU; SRIVENUGOPAL KS, 1987, NUCLEIC ACIDS RES, V15, P2563, DOI 10.1093/nar/15.6.2563; Tanabe T, 2004, J BIOCHEM, V135, P501, DOI 10.1093/jb/mvh066; Tereshko V, 2001, RNA, V7, P405, DOI 10.1017/S1355838201001935; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Yoshida M, 1999, J BIOL CHEM, V274, P22723, DOI 10.1074/jbc.274.32.22723; ZUBAY G, 1962, J MOL BIOL, V50, P689; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	36	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32989	32994		10.1074/jbc.M806027200	http://dx.doi.org/10.1074/jbc.M806027200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18824545	hybrid			2022-12-27	WOS:000260893700087
J	Soshilov, A; Denison, MS				Soshilov, Anatoly; Denison, Michael S.			Role of the Per/Arnt/Sim Domains in Ligand-dependent Transformation of the Aryl Hydrocarbon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR COMPLEX; SOLUBLE GUANYLYL CYCLASE; DNA-BINDING ACTIVITY; DIOXIN RECEPTOR; AH RECEPTOR; PAS DOMAINS; NUCLEAR TRANSLOCATOR; INDUCED ACTIVATION	The aryl hydrocarbon receptor (AhR) mediates the toxic and biological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. In a process termed transformation, ligand binding converts the AhR into its high affinity DNA binding form that represents a dimer of the AhR and Arnt, a closely related nuclear protein. During transformation, protein chaperone Hsp90 is thought to be replaced by Arnt in overlapping binding sites in the basic helix loop helix and PASB domains of the AhR. Here, analysis of AhR variants containing a modified PASB domain and AhR PASA-PASB fragments of various lengths revealed (i) an inhibitory effect on transformation concomitant with Hsp90 binding in the PASB domain, (ii) an ability of the PASA-PASB fragment of the AhR to reproduce key steps in the transformation process, and (iii) a ligand-dependent conformational change in the PASA domain consistent with increased PASA exposure during AhR transformation. Based on these results, we propose a new mechanism of AhR transformation through initiation of Arnt dimerization and Hsp90 displacement in AhR PASA/B domains. This study provides insights into mechanisms of AhR transformation, dimerization of PAS domain proteins, and Hsp90 dissociation in activation of its client proteins.	[Soshilov, Anatoly; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis	Denison, MS (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Meyer Hall,1 Shields Ave, Davis, CA 95616 USA.	msdenison@ucdavis.edu			National Institutes of Health NIEHS [R01ES007685, R01ES012498]; California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012498, R01ES007685] Funding Source: NIH RePORTER	National Institutes of Health NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health NIEHS Grants R01ES007685 and R01ES012498. This work was also supported by the California Agricultural Experiment Station. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTONSSON C, 1995, MOL CELL BIOL, V15, P756; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Bohonowych JE, 2007, TOXICOL SCI, V98, P99, DOI 10.1093/toxsci/kfm085; Chapman-Smith A, 2004, J BIOL CHEM, V279, P5353, DOI 10.1074/jbc.M310041200; COUMAILLEAU P, 1995, J BIOL CHEM, V270, P25291, DOI 10.1074/jbc.270.42.25291; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; DENISON MS, 2002, CURRENT PROTOCOLS TO; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Fukunaga BN, 1996, J BIOL CHEM, V271, P3743; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Heid SE, 2000, MOL PHARMACOL, V57, P82; Henry EC, 2003, MOL PHARMACOL, V63, P392, DOI 10.1124/mol.63.2.392; HENRY EC, 1993, BIOCHEM J, V294, P95, DOI 10.1042/bj2940095; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kronenberg S, 2000, NUCLEIC ACIDS RES, V28, P2286, DOI 10.1093/nar/28.12.2286; Lees MJ, 1999, MOL CELL BIOL, V19, P5811; LI H, 1994, J BIOL CHEM, V269, P28098; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; MCGUIRE J, 1994, MOL CELL BIOL, V14, P2438, DOI 10.1128/MCB.14.4.2438; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; McGuire J, 1995, J BIOL CHEM, V270, P31353, DOI 10.1074/jbc.270.52.31353; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Papapetropoulos A, 2005, MOL PHARMACOL, V68, P1133, DOI 10.1124/mol.105.012682; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; PERDEW GH, 1991, ARCH BIOCHEM BIOPHYS, V291, P284, DOI 10.1016/0003-9861(91)90136-7; Perdew GH, 1996, BIOCHEM MOL BIOL INT, V39, P589; Petrulis JR, 2003, J BIOL CHEM, V278, P2677, DOI 10.1074/jbc.M209331200; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; Pollenz RS, 2006, MOL PHARMACOL, V70, P1369, DOI 10.1124/mol.106.027672; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; PROBST MR, 1993, MOL PHARMACOL, V44, P511; Ramadoss P, 2005, BIOCHEMISTRY-US, V44, P11148, DOI 10.1021/bi050948b; Rushing SR, 2002, ARCH BIOCHEM BIOPHYS, V403, P189, DOI 10.1016/S0003-9861(02)00233-3; SANCHEZ ER, 1987, J BIOL CHEM, V262, P6986; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Sun WM, 1997, J BIOL CHEM, V272, P31845, DOI 10.1074/jbc.272.50.31845; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Zhou ZM, 2004, J BIOL CHEM, V279, P24935, DOI 10.1074/jbc.M402105200	48	61	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32995	33005		10.1074/jbc.M802414200	http://dx.doi.org/10.1074/jbc.M802414200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18806268	Green Published, hybrid			2022-12-27	WOS:000260893700088
J	von Marschall, Z; Fisher, LW				von Marschall, Zofia; Fisher, Larry W.			Dentin Matrix Protein-1 Isoforms Promote Differential Cell Attachment and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT-MEDIATED ATTACK; INTEGRIN-BINDING LIGAND; BONE SIALOPROTEIN; SIBLING PROTEINS; IN-VITRO; ALPHA-V-BETA-5 INTEGRINS; PHOSPHATE HOMEOSTASIS; SUBSTRATUM ADHESION; OSTEOPONTIN; EXPRESSION	Dentin matrix protein-1 (DMP1), bone sialoprotein (BSP), and osteopontin (OPN) are three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) co-expressed/secreted by skeletal and active ductal epithelial cells. Although etiological mechanisms remain unclear, DMP1 is the only one of these three genes currently known to have mutations resulting in human disease, and yet it remains the least studied. All three contain the highly conserved integrin-binding tripeptide, RGD, and experiments comparing the cell attachment and haptotactic migration-enhancing properties of DMP1 to BSP and OPN were performed using human skeletal (MG63 and primary dental pulp cells) and salivary gland (HSG) cells. Mutation of any SIBLING's RGD destroyed all attachment and migration activity. Using its alpha V beta 5 integrin, HSG cells attached to BSP but not to DMP1 or OPN. However, HSG cells could not migrate onto BSP in a modified Boyden chamber assay. Expression of alpha V beta 3 integrin enhanced HSG attachment to DMP1 and OPN and promoted haptotactic migration onto all three proteins. Interchanging the first four coding exons or the conserved amino acids adjacent to the RGD of DMP1 with corresponding sequences of BSP did not enhance the ability of DMP1 to bind alpha V beta 5. For alpha V beta 3 expressing cells, intact DMP1, its BMP1-cleaved C-terminal fragment, and exon six lacking all post-translational modifications worked equally well but the proteoglycan isoform of DMP1 had greatly reduced ability for cell attachment and migration. The sequence specificity of the proposed BMP1-cleavage site of DMP1 was verified by mutation analysis. Direct comparison of the three proteins showed that cells discriminate among these SIBLINGs and among DMP1 isoforms.	[von Marschall, Zofia; Fisher, Larry W.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Fisher, LW (corresponding author), Bldg 30,Room 228,9000 Rockville Pike, Bethesda, MD 20892 USA.	lfisher@dir.nidcr.nih.gov			National Institutes of Health Division of Intramural Research, NIDCR; Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000074] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Division of Intramural Research, NIDCR, and the Intramural Research Program.	AOTA S, 1994, J BIOL CHEM, V269, P24756; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; Bucciarelli E, 2007, BREAST CANCER RES TR, V105, P95, DOI 10.1007/s10549-006-9436-0; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6; Fedarko NS, 2000, J BIOL CHEM, V275, P16666, DOI 10.1074/jbc.M001123200; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FISHER LW, 1990, J BIOL CHEM, V265, P2347; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GEORGE A, 1993, J BIOL CHEM, V268, P12624; GREEN MR, 1973, ANAL BIOCHEM, V56, P43, DOI 10.1016/0003-2697(73)90167-X; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Helluin O, 2000, J BIOL CHEM, V275, P18337, DOI 10.1074/jbc.M001529200; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Huq NL, 2005, ARCH ORAL BIOL, V50, P599, DOI 10.1016/j.archoralbio.2004.12.009; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Kulkarni GV, 2000, ARCH ORAL BIOL, V45, P475, DOI 10.1016/S0003-9969(00)00010-8; LAMPUGNANI MG, 1991, LAB INVEST, V65, P96; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Ogbureke KUE, 2007, J HISTOCHEM CYTOCHEM, V55, P403, DOI 10.1369/jhc.6A7075.2007; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2006, J BIOL CHEM, V281, P8034, DOI 10.1074/jbc.M512964200; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Sung V, 1998, J CELL PHYSIOL, V176, P482, DOI 10.1002/(SICI)1097-4652(199809)176:3<482::AID-JCP5>3.0.CO;2-K; TAKADA Y, 2007, GENOME BIOL; Takagi H, 2002, J CELL SCI, V115, P3309; Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; YAMAGATA M, 1993, J CELL SCI, V106, P55; YAMAGATA M, 1994, J CELL SCI, V107, P2581; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005	41	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32730	32740		10.1074/jbc.M804283200	http://dx.doi.org/10.1074/jbc.M804283200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18819913	Green Published, hybrid			2022-12-27	WOS:000260893700062
J	Sorensen, HP; Vives, RR; Manetopoulos, C; Albrechtsen, R; Lydolph, MC; Jacobsen, J; Couchman, JR; Wewer, UM				Sorensen, Hans Peter; Vives, Romain R.; Manetopoulos, Christina; Albrechtsen, Reidar; Lydolph, Magnus C.; Jacobsen, Jonas; Couchman, John R.; Wewer, Ulla M.			Heparan Sulfate Regulates ADAM12 through a Molecular Switch Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; 12 MELTRIN ALPHA; SURFACE-PLASMON RESONANCE; CYSTEINE-RICH DOMAIN; INTRACELLULAR MATURATION; CHONDROCYTE PROLIFERATION; PROTEOLYTIC ACTIVITY; TUMOR PROGRESSION; CELL-SURFACE; GROWTH	The disintegrin and metalloproteases (ADAMs) are emerging as therapeutic targets in human disease, but specific drug design is hampered by potential redundancy. Unlike other metzincins, ADAM prodomains remain bound to the mature enzyme to regulate activity. Here ADAM12, a protease that promotes tumor progression and chondrocyte proliferation in osteoarthritic cartilage, is shown to possess a prodomain/catalytic domain cationic molecular switch, regulated by exogenous heparan sulfate and heparin but also endogenous cell surface proteoglycans and the polyanion, calcium pentosan polysulfate. Sheddase functions of ADAM12 are regulated by the switch, as are proteolytic functions in placental tissue and sera of pregnant women. Moreover, human heparanase, an enzyme also linked to tumorigenesis, can promote ADAM12 sheddase activity at the cell surface through cleavage of the inhibitory heparan sulfate. These data present a novel concept that might allow targeting of ADAM12 and suggest that other ADAMs may have specific regulatory activity embedded in their prodomain and catalytic domain structures.	[Sorensen, Hans Peter; Manetopoulos, Christina; Albrechtsen, Reidar; Lydolph, Magnus C.; Jacobsen, Jonas; Couchman, John R.; Wewer, Ulla M.] Univ Copenhagen, Dept Biomed, DK-2200 Copenhagen N, Denmark; [Sorensen, Hans Peter; Manetopoulos, Christina; Albrechtsen, Reidar; Lydolph, Magnus C.; Jacobsen, Jonas; Couchman, John R.; Wewer, Ulla M.] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Vives, Romain R.] Univ Grenoble 1, Inst Biol Struct, CNRS, Commissariat Energie Atom,UMR 5075, F-38027 Grenoble, France	University of Copenhagen; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Wewer, UM (corresponding author), Univ Copenhagen, Dept Biomed, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	ullaw@pai.ku.dk	Vives, Romain/I-9372-2012	Albrechtsen, Reidar/0000-0003-4180-1827	Danish Cancer Society [DP06052, DP05076]; Lundbeck Foundation; Novo Nordisk Foundation; Danish Medical Research Council; Carlsberg Foundation; Munksholm Foundation; Hartmann Foundation	Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Carlsberg Foundation(Carlsberg Foundation); Munksholm Foundation; Hartmann Foundation	This work was supported by Danish Cancer Society Grants DP06052 and DP05076, the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Medical Research Council, the Carlsberg Foundation, the Munksholm Foundation, and the Hartmann Foundation.	Beattie J, 2008, MOL CELL BIOCHEM, V307, P221, DOI 10.1007/s11010-007-9601-8; Booth BA, 1996, AM J PHYSIOL-ENDOC M, V271, pE465, DOI 10.1152/ajpendo.1996.271.3.E465; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; ESKO JD, 1987, J BIOL CHEM, V262, P12189; Fowlkes JL, 1996, J BIOL CHEM, V271, P14676, DOI 10.1074/jbc.271.25.14676; Fowlkes JL, 1997, ENDOCRINOLOGY, V138, P2280, DOI 10.1210/en.138.6.2280; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Garlisi CG, 2003, BIOCHEM BIOPH RES CO, V301, P35, DOI 10.1016/S0006-291X(02)02976-5; Ghosh P, 2002, BIOGERONTOLOGY, V3, P85, DOI 10.1023/A:1015219716583; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Gonzales PE, 2004, J BIOL CHEM, V279, P31638, DOI 10.1074/jbc.M401311200; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Irwin JC, 2000, ENDOCRINOLOGY, V141, P666, DOI 10.1210/en.141.2.666; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kristensen J, 2005, INT J BIOL MACROMOL, V37, P212, DOI 10.1016/j.ijbiomac.2005.10.011; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Kveiborg M, 2006, J BONE MINER RES, V21, P1288, DOI 10.1359/JBMR.060502; Laigaard J, 2003, PRENATAL DIAG, V23, P1086, DOI 10.1002/pd.762; Laigaard J, 2006, PRENATAL DIAG, V26, P689, DOI 10.1002/pd.1480; Leonard JD, 2005, BIOCHEM J, V387, P797, DOI 10.1042/BJ20041727; Li JP, 2008, ANTI-CANCER AGENT ME, V8, P64, DOI 10.2174/187152008783330824; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Martel-Pelletier J, 1998, INFLAMM RES, V47, P90, DOI 10.1007/s000110050288; Milla ME, 1999, J BIOL CHEM, V274, P30563, DOI 10.1074/jbc.274.43.30563; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oh M, 2004, BIOORG MED CHEM LETT, V14, P6071, DOI 10.1016/j.bmcl.2004.09.082; Okada A, 2008, ARTHRITIS RHEUM-US, V58, P778, DOI 10.1002/art.23262; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P5324, DOI 10.1021/bi060056r; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Scholefield Z, 2003, J CELL BIOL, V163, P97, DOI 10.1083/jcb.200303059; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Sorensen HP, 2008, PROTEIN EXPRES PURIF, V61, P175, DOI 10.1016/j.pep.2008.05.020; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Vives RR, 2004, J BIOL CHEM, V279, P54327, DOI 10.1074/jbc.M409760200; Vives RR, 2004, VIROLOGY, V321, P332, DOI 10.1016/j.virol.2004.01.015; Vives RR, 2001, BIOCHEM J, V354, P141, DOI 10.1042/0264-6021:3540141; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Warda M, 2008, GLYCOCONJUGATE J, V25, P441, DOI 10.1007/s10719-007-9090-8; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183	65	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31920	31932		10.1074/jbc.M804113200	http://dx.doi.org/10.1074/jbc.M804113200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18801731	hybrid			2022-12-27	WOS:000260760800074
J	Zhang, L; Bukulin, M; Kojro, E; Roth, A; Metz, VV; Fahrenholz, F; Nawroth, PP; Bierhaus, A; Postina, R				Zhang, Ling; Bukulin, Monika; Kojro, Elzbieta; Roth, Annette; Metz, Verena V.; Fahrenholz, Falk; Nawroth, Peter P.; Bierhaus, Angelika; Postina, Rolf			Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BLOOD-BRAIN-BARRIER; SOLUBLE RECEPTOR; SPLICE VARIANTS; ALPHA-SECRETASE; MATRIX METALLOPROTEINASES; MULTILIGAND RECEPTOR; RAGE RECEPTOR; EXPRESSION; CELLS	The receptor for advanced glycation end products ( RAGE) is a 55-kDa type I membrane glycoprotein of the immunoglobulin superfamily. Ligand-induced up-regulation of RAGE is involved in various pathophysiological processes, including late diabetic complications and Alzheimer disease. Application of recombinant soluble RAGE has been shown to block RAGE-mediated pathophysiological conditions. After expression of full-length RAGE in HEK cells we identified a 48-kDa soluble RAGE form (sRAGE) in the culture medium. This variant of RAGE is smaller than a 51-kDa soluble version derived from alternative splicing. The release of sRAGE can be induced by the phorbol ester PMA and the calcium ionophore calcimycin via calcium-dependent protein kinase C subtypes. Hydroxamic acid-based metalloproteinase inhibitors block the release of sRAGE, and by RNA interference experiments we identified ADAM10 and MMP9 to be involved in RAGE shedding. In protein biotinylation experiments we show that membrane-anchored full-length RAGE is the precursor of sRAGE and that sRAGE is efficiently released from the cell surface. We identified cleavage of RAGE to occur close to the cell membrane. Ectodomain shedding of RAGE simultaneously generates sRAGE and a membrane-anchored C-terminal RAGE fragment (RAGE-CTF). The amount of RAGE-CTF increases when RAGE-expressing cells are treated with a gamma-secretase inhibitor, suggesting that RAGE-CTF is normally further processed by gamma-secretase. Identification of these novel mechanisms involved in regulating the availability of cell surface-located RAGE and its soluble ectodomain may influence further research in RAGE-mediated processes in cell biology and pathophysiology.	[Zhang, Ling; Bukulin, Monika; Kojro, Elzbieta; Roth, Annette; Metz, Verena V.; Fahrenholz, Falk; Postina, Rolf] Johannes Gutenberg Univ Mainz, Inst Biochem, D-55099 Mainz, Germany; [Nawroth, Peter P.; Bierhaus, Angelika] Univ Heidelberg, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany	Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg	Postina, R (corresponding author), Johannes Gutenberg Univ Mainz, Inst Biochem, Becherweg 30, D-55099 Mainz, Germany.	postina@uni-mainz.de			Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany); Deutsche Forschungsgemeinschaft (DFG Priority Program SPP1085-Cellular Mechanisms of Alzheimer's Disease); DFG/SFB 405; Netzwerk Altersforschung	Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany); Deutsche Forschungsgemeinschaft (DFG Priority Program SPP1085-Cellular Mechanisms of Alzheimer's Disease)(German Research Foundation (DFG)); DFG/SFB 405(German Research Foundation (DFG)); Netzwerk Altersforschung	This work was supported in part by the Alzheimer Forschung Initiative e.V. (Dusseldorf, Germany) ( to R. P.) and the Deutsche Forschungsgemeinschaft (DFG Priority Program SPP1085-Cellular Mechanisms of Alzheimer's Disease) ( to R. P. and F. F.), DFG/SFB 405 (to P. P. N.), and the Netzwerk Altersforschung ( to A. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Belotti D, 2003, CANCER RES, V63, P5224; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Emanuele E, 2005, ARCH NEUROL-CHICAGO, V62, P1734, DOI 10.1001/archneur.62.11.1734; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Fiore E, 2002, ONCOGENE, V21, P5213, DOI 10.1038/sj.onc.1205684; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Geroldi D, 2005, J HYPERTENS, V23, P1725, DOI 10.1097/01.hjh.0000177535.45785.64; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Humpert PM, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-9; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Kojro E, 2006, FASEB J, V20, P512, DOI 10.1096/fj.05-4812fje; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ozaki N, 2005, BIOCHEM BIOPH RES CO, V329, P765, DOI 10.1016/j.bbrc.2005.02.031; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Racchi M, 1999, J NEUROCHEM, V72, P2464, DOI 10.1046/j.1471-4159.1999.0722464.x; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Renard C, 1997, MOL PHARMACOL, V52, P54, DOI 10.1124/mol.52.1.54; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; STRICKLIN GP, 1983, BIOCHEMISTRY-US, V22, P61, DOI 10.1021/bi00270a009; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Wendt T, 2006, ATHEROSCLEROSIS, V185, P70, DOI 10.1016/j.atherosclerosis.2005.06.013; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35	41	217	230	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35507	35516		10.1074/jbc.M806948200	http://dx.doi.org/10.1074/jbc.M806948200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18952609	hybrid			2022-12-27	WOS:000261687900022
J	Chen, GY; Sakuma, K; Kannagi, R				Chen, Guo-Yun; Sakuma, Keiichiro; Kannagi, Reiji			Significance of NF-kappa B/GATA Axis in Tumor Necrosis Factor-alpha-induced Expression of 6-Sulfated Cell Recognition Glycans in Human T-lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-SELECTIN LIGANDS; SIALYL-LEWIS-X; GATA TRANSCRIPTION FACTORS; HIGH ENDOTHELIAL VENULES; FUCOSYL-TRANSFERASE-VII; DENDRITIC CELLS; TNF-ALPHA; REGULATES EXPRESSION; ADHESION MOLECULE-1; HUMAN MONOCYTES	Sulfated glycans play critical roles in various cell recognition events among leukocytes. The 6-sulfated lactosamine glycans in particular have been widely noted for their importance because they are involved in cell recognition events mediated by cell-adhesion molecules such as selectins and sialic acid-recognizing molecules such as siglecs and also in the activation of CD44 in binding to extracellular matrix hyaluronate. A pro-inflammatory cytokine, tumor necrosis factor-alpha, induces expression of 6-sulfated glycans on human leukocytes. Here we report that the transcription of the GlcNAc6ST-1 gene, the gene encoding a sulfotransferase for 6-sulfated glycan synthesis, is induced in human T-lymphoid cells through tandem NF-kappa B and GATA motifs in its 5'-regulatory region. Results of our reporter assays, immunoprecipitation, and chromatin immunoprecipitation analyses indicated that GATA-3 and/or GATA-2, but not GATA-1, associates with NF-kappa B in a transcription factor complex on the 5'-regulatory region of the gene and acts synergistically with NF-kappa B in triggering GlcNAc6ST-1 transcription. Recently, a skin-homing subset of helper memory T cells exhibiting the Th2 marker CCR4 was shown to specifically express 6-sulfated glycans. The transactivation mechanism described here suggested that GlcNAc6ST-1 transcription is coordinated with the NF-kappa B/GATA-3 axis, which is known to figure heavily in Th2 cell differentiation. In line with this, in vitro differentiation of human T cells to Th2 cells was found to significantly induce GlcNAc6ST-1 transcription and 6-sulfated glycan expression.	[Kannagi, Reiji] Aichi Canc Ctr, Res Inst, Dept Mol Pathol, Chikusa Ku, Nagoya, Aichi 4648681, Japan	Aichi Cancer Center	Kannagi, R (corresponding author), Aichi Canc Ctr, Res Inst, Dept Mol Pathol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	kannagi-gi@umin.ac.jp	Chen, Guo-yun/C-2436-2011; Sakuma, Keiichiro/AAW-4733-2021; Kannagi, Reiji/Q-6459-2018	Kannagi, Reiji/0000-0003-4202-2921	Ministry of Education, Science, Sports and Culture, Japan [19590298, 17015051]; Ministry of Health and Welfare, Japan; Nagono Medical Foundation; Mitsubishi Pharma Research Foundation; National Institute of Biomedical Innovation	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Nagono Medical Foundation; Mitsubishi Pharma Research Foundation; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports and Culture, Japan (19590298 and on priority areas 17015051), grants-in-aid for the Third-Term Comprehensive Ten-year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan, a grant from the Nagono Medical Foundation, a grant from Mitsubishi Pharma Research Foundation, and a grant for the Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baumeister SHC, 2007, BLOOD, V110, P3078, DOI 10.1182/blood-2006-12-062984; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Boothby M, 2001, NAT IMMUNOL, V2, P471, DOI 10.1038/88652; Brown KL, 2001, J IMMUNOL, V167, P5367, DOI 10.4049/jimmunol.167.9.5367; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; Farrar JD, 2002, J CLIN INVEST, V109, P431, DOI 10.1172/JCI200215093; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; Hiraiwa N, 2003, BLOOD, V101, P3615, DOI 10.1182/blood-2002-07-2301; Kannagi R, 2002, CURR OPIN STRUC BIOL, V12, P599, DOI 10.1016/S0959-440X(02)00365-2; KANNAGI R, 2008, GLYCOCONJ J IN PRESS; Kimura N, 1999, P NATL ACAD SCI USA, V96, P4530, DOI 10.1073/pnas.96.8.4530; Kimura N, 2007, J BIOL CHEM, V282, P32200, DOI 10.1074/jbc.M702341200; La Ferla K, 2002, FASEB J, V16, P1811, DOI 10.1096/fj.02-0168fje; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; MANIATIS T, 1989, MOL CLONING LAB MANU, P187; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; Ohmori K, 2000, BIOCHEM BIOPH RES CO, V278, P90, DOI 10.1006/bbrc.2000.3768; Ohmori K, 2006, BLOOD, V107, P3197, DOI 10.1182/blood-2005-05-2185; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Schakel K, 2006, IMMUNITY, V24, P767, DOI 10.1016/j.immuni.2006.03.020; Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Tateno H, 2005, GLYCOBIOLOGY, V15, P1125, DOI 10.1093/glycob/cwi097; Tjew SL, 2005, GLYCOBIOLOGY, V15, p7C, DOI 10.1093/glycob/cwi050; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Uchimura K, 1998, J BIOCHEM-TOKYO, V124, P670, DOI 10.1093/oxfordjournals.jbchem.a022164; Uchimura K, 1998, J BIOL CHEM, V273, P22577, DOI 10.1074/jbc.273.35.22577; Uchimura K, 2006, TRENDS IMMUNOL, V27, P559, DOI 10.1016/j.it.2006.10.007; Umetani M, 2001, ARTERIOSCL THROM VAS, V21, P917, DOI 10.1161/01.ATV.21.6.917	39	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34563	34570		10.1074/jbc.M804271200	http://dx.doi.org/10.1074/jbc.M804271200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18849568	Green Published, hybrid			2022-12-27	WOS:000261469100010
J	Choi, E; Han, C; Park, I; Lee, B; Jin, S; Choi, H; Kim, DH; Park, ZY; Eddy, EM; Cho, C				Choi, Eunyoung; Han, Cecil; Park, Inju; Lee, Boyeon; Jin, Sora; Choi, Heejin; Kim, Do Han; Park, Zee Yong; Eddy, Edward M.; Cho, Chunghee			A Novel Germ Cell-specific Protein, SHIP1, Forms a Complex with Chromatin Remodeling Activity during Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-DEACETYLASES; MOUSE SPERMATOGENESIS; VALPROIC ACID; CO-REPRESSOR; SANT DOMAIN; N-COR; MEIOSIS; HSP70-2; GENES; IDENTIFICATION	To determine the mechanisms of spermatogenesis, it is essential to identify and characterize germ cell-specific genes. Here we describe a protein encoded by a novel germ cell-specific gene, Mm. 290718/ZFP541, identified from the mouse spermatocyte UniGene library. Theprotein contains specific motifs and domains potentially involved in DNA binding and chromatin reorganization. An antibody against Mm. 290718/ZFP541 revealed the existence of the protein in testicular spermatogenic cells (159 kDa) but not testicular and mature sperm. Immunostaining analysis of cells at various stages of spermatogenesis consistently showed that the protein is present in spermatocytes and round spermatids only. Transfection assays and immunofluorescence studies indicate that the protein is localized specifically in the nucleus. Proteomic analyses performed to explore the functional characteristics of Mm. 290718/ZFP541 showed that the protein forms a unique complex. Other major components of the complex included histone deacetylase 1 (HDAC1) and heat-shock protein A2. Disappearance of Mm. 290718/ZFP541 was highly correlated with hyperacetylation in spermatids during spermatogenesis, and specific domains of the protein were involved in the regulation of interactions and nuclear localization of HDAC1. Furthermore, we found that premature hyperacetylation, induced by an HDAC inhibitor, is associated with an alteration in the integrity of Mm. 290718/ZFP541 in spermatogenic cells. Our results collectively suggest that the Mm. 290718/ZFP541 complex is implicated in chromatin remodeling during spermatogenesis, and we provide further information on the previously unknown molecular mechanism. Consequently, we re-designate Mm. 290718/ZFP541 as "SHIP1" representing spermatogenic cell HDAC-interacting protein 1.	[Choi, Eunyoung; Han, Cecil; Park, Inju; Lee, Boyeon; Jin, Sora; Choi, Heejin; Kim, Do Han; Park, Zee Yong; Cho, Chunghee] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Choi, Eunyoung; Han, Cecil; Park, Inju; Lee, Boyeon; Jin, Sora; Choi, Heejin; Kim, Do Han; Park, Zee Yong; Cho, Chunghee] Gwangju Inst Sci & Technol, Res Ctr Biomol Nanotechnol, Kwangju 500712, South Korea; [Eddy, Edward M.] NIEHS, Gamete Biol Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cho, C (corresponding author), Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea.	choch@gist.ac.kr		Park, Inju/0000-0002-8850-5032	National Institutes of Health [ZO1 ES070077]; Korea Science and Engineering Foundation [RO1-2007-000-20116]; Korean Systems Biology Research Grant [M10503010001-06N0301-00110]; GIST Systems Biology Infrastructure Establishment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070076, ZIAES070076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Systems Biology Research Grant; GIST Systems Biology Infrastructure Establishment; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ZO1 ES070077 ( Project 1, Intramural Research Program, NIEHS). This work was also supported by the Korea Science and Engineering Foundation Grant RO1-2007-000-20116, Korean Systems Biology Research Grant M10503010001-06N0301-00110, and GIST Systems Biology Infrastructure Establishment grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Backliwal G, 2008, BIOTECHNOL BIOENG, V101, P182, DOI 10.1002/bit.21882; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Caron C, 2005, PROG MOLEC, V38, P65; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; Cho C, 2003, BIOL REPROD, V69, P211, DOI 10.1095/biolreprod.102.015115; Choi E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-256; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Hong S, 2005, J BIOL CHEM, V280, P7685, DOI 10.1074/jbc.M412444200; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Li W, 2007, ASIAN J ANDROL, V9, P345, DOI 10.1111/j.1745-7262.2007.00245.x; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; PHELPS BM, 1990, J CELL BIOL, V111, P1839, DOI 10.1083/jcb.111.5.1839; ROSARIO MO, 1992, DEV BIOL, V150, P1, DOI 10.1016/0012-1606(92)90002-X; Rousseaux S, 2008, REPROD BIOMED ONLINE, V16, P492, DOI 10.1016/S1472-6483(10)60456-7; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Solari F, 1999, DEVELOPMENT, V126, P2483; Wang L, 2008, EMBO REP, V9, P555, DOI 10.1038/embor.2008.67; Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371; Zhu DH, 1997, DEVELOPMENT, V124, P3007	36	35	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35283	35294		10.1074/jbc.M805590200	http://dx.doi.org/10.1074/jbc.M805590200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18849567	Green Published, hybrid			2022-12-27	WOS:000261469100084
J	Lu, YF; Tian, C; Danialou, G; Gilbert, R; Petrof, BJ; Karpati, G; Nalbantoglu, J				Lu, Yifan; Tian, Chai; Danialou, Gawiyou; Gilbert, Renald; Petrof, Basil J.; Karpati, George; Nalbantoglu, Josephine			Targeting Artificial Transcription Factors to the Utrophin A Promoter EFFECTS ON DYSTROPHIC PATHOLOGY AND MUSCLE FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MDX MOUSE MUSCLE; THERAPEUTIC UP-REGULATION; GENE-EXPRESSION; MUSCULAR-DYSTROPHY; PROTEIN; ACTIVATION; DUCHENNE; PHENOTYPE; GABP; HEREGULIN	Duchenne muscular dystrophy is caused by a genetic defect in the dystrophin gene. The absence of dystrophin results in muscle fiber necrosis and regeneration, leading to progressive muscle fiber loss. Utrophin is a close analogue of dystrophin. A substantial, ectopic expression of utrophin in the extrasynaptic sarcolemma of dystrophin-deficient muscle fibers can prevent deleterious effects of dystrophin deficiency. An alternative approach for the extrasynaptic up-regulation of utrophin involves the augmentation of utrophin transcription via the endogenous utrophin A promoter using custom-designed transcriptional activator proteins with zinc finger (ZFP) motifs. We tested a panel of custom-designed ZFP for their ability to activate the utrophin A promoter. Expression of one such ZFP efficiently increased, in a time-dependent manner, utrophin transcript and protein levels both in vitro and in vivo. In dystrophic mouse (mdx) muscles, administration of adenoviral vectors expressing this ZFP led to significant enhancement of muscle function with decreased necrosis, restoration of the dystrophin-associated proteins, and improved resistance to eccentric contractions. These studies provide evidence that specifically designed ZFPs can act as strong transcriptional activators of the utrophin A promoter. These may thus serve as attractive therapeutic agents for dystrophin deficiency states such as Duchenne muscular dystrophy.	[Lu, Yifan; Tian, Chai; Karpati, George; Nalbantoglu, Josephine] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Lu, Yifan; Tian, Chai; Karpati, George; Nalbantoglu, Josephine] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Danialou, Gawiyou; Petrof, Basil J.] McGill Univ, Div Resp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Danialou, Gawiyou; Petrof, Basil J.] McGill Univ, Meakins Christie Labs, Montreal, PQ H3A 1A1, Canada; [Gilbert, Renald] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	McGill University; McGill University; McGill University; McGill University; National Research Council Canada	Nalbantoglu, J (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	Josephine.nalbantoglu@mcgill.ca			United States Muscular Dystrophy Association; Canadian Institutes of Health Research [MOP-5366]	United States Muscular Dystrophy Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the United States Muscular Dystrophy Association and the Canadian Institutes of Health Research ( Grant MOP-5366). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angus LM, 2005, AM J PHYSIOL-CELL PH, V289, pC908, DOI 10.1152/ajpcell.00196.2005; Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Beerli RR, 2000, J BIOL CHEM, V275, P32617, DOI 10.1074/jbc.M005108200; Briguet A, 2003, NEUROMUSCULAR DISORD, V13, P143, DOI 10.1016/S0960-8966(02)00217-1; Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; CLERK A, 1993, HISTOCHEM J, V25, P554; Corbi N, 2000, GENE THER, V7, P1076, DOI 10.1038/sj.gt.3301204; DelloRusso C, 2002, P NATL ACAD SCI USA, V99, P12979, DOI 10.1073/pnas.202300099; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Deol JR, 2007, MOL THER, V15, P1767, DOI 10.1038/sj.mt.6300260; Disatnik MH, 1998, J NEUROL SCI, V161, P77, DOI 10.1016/S0022-510X(98)00258-5; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Dudley RWR, 2004, HUM GENE THER, V15, P145, DOI 10.1089/104303404772679959; Galvagni F, 2002, J BIOL CHEM, V277, P19106, DOI 10.1074/jbc.M109642200; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Gilbert R, 2003, HUM MOL GENET, V12, P1287, DOI 10.1093/hmg/ddg141; Gilbert R, 2002, MOL THER, V6, P501, DOI 10.1006/mthe.2002.0689; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Gyrd-Hansen M, 2002, J NEUROL SCI, V197, P27, DOI 10.1016/S0022-510X(02)00038-2; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Jasmin BJ, 2002, J PHYSIOL-PARIS, V96, P31, DOI 10.1016/S0928-4257(01)00078-X; Karpati G, 1997, NAT MED, V3, P22, DOI 10.1038/nm0197-22; KARPATI G, 1993, J NEUROPATH EXP NEUR, V52, P119, DOI 10.1097/00005072-199303000-00004; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liu Q, 2002, J BIOL CHEM, V277, P3850, DOI 10.1074/jbc.M110669200; Mattei E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000774; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Nguyen T M, 1991, J Cell Biol, V115, P1695, DOI 10.1083/jcb.115.6.1695; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Perkins KJ, 2001, NUCLEIC ACIDS RES, V29, P4843, DOI 10.1093/nar/29.23.4843; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795; Rybakova IN, 2002, MOL BIOL CELL, V13, P1512, DOI 10.1091/mbc.01-09-0446; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; SCHOFIELD J, 1993, DEV DYNAM, V198, P254, DOI 10.1002/aja.1001980403; Tan SY, 2003, P NATL ACAD SCI USA, V100, P11997, DOI 10.1073/pnas.2035056100; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Taylor J, 1997, NEUROPATH APPL NEURO, V23, P399; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Wakefield PM, 2000, GENE THER, V7, P201, DOI 10.1038/sj.gt.3301066; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200	54	19	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34720	34727		10.1074/jbc.M804518200	http://dx.doi.org/10.1074/jbc.M804518200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18945675	hybrid, Green Published			2022-12-27	WOS:000261469100028
J	Nunez, LR; Jesch, SA; Gaspar, ML; Almaguer, C; Villa-Garcia, M; Ruiz-Noriega, M; Patton-Vogt, J; Henry, SA				Nunez, Lilia R.; Jesch, Stephen A.; Gaspar, Maria L.; Almaguer, Claudia; Villa-Garcia, Manuel; Ruiz-Noriega, Monica; Patton-Vogt, Jana; Henry, Susan A.			Cell Wall Integrity MAPK Pathway Is Essential for Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; YEAST SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM STRESS; NEUROPATHY TARGET ESTERASE; GENOME-WIDE ANALYSIS; PHOSPHOLIPID BIOSYNTHESIS; SIGNALING PATHWAYS; GENE-EXPRESSION; CRYPTOCOCCUS-NEOFORMANS; TRANSMEMBRANE PROTEIN	The highly conserved yeast cell wall integrity mitogen-activated protein kinase pathway regulates cellular responses to cell wall and membrane stress. We report that this pathway is activated and essential for viability under growth conditions that alter both the abundance and pattern of synthesis and turnover of membrane phospholipids, particularly phosphatidylinositol and phosphatidylcholine. Mutants defective in this pathway exhibit a choline-sensitive inositol auxotrophy, yet fully derepress INO1 and other Opi1p-regulated genes when grown in the absence of inositol. Under these growth conditions, Mpk1p is transiently activated by phosphorylation and stimulates the transcription of known targets of Mpk1p signaling, including genes regulated by the Rlm1p transcription factor. mpk1 Delta cells also exhibit severe defects in lipid metabolism, including an abnormal accumulation of phosphatidylcholine, diacylglycerol, triacylglycerol, and free sterols, as well as aberrant turnover of phosphatidylcholine. Overexpression of the NTE1 phospholipase B gene suppresses the choline-sensitive inositol auxotrophy of mpk1 Delta cells, whereas overexpression of other phospholipase genes has no effect on this phenotype. These results indicate that an intact cell wall integrity pathway is required for maintaining proper lipid homeostasis in yeast, especially when cells are grown in the absence of inositol.	[Nunez, Lilia R.; Jesch, Stephen A.; Gaspar, Maria L.; Villa-Garcia, Manuel; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Almaguer, Claudia; Patton-Vogt, Jana] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Ruiz-Noriega, Monica] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Cornell University; Duquesne University; Carnegie Mellon University	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 260 Roberts Hall, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014		National Institutes of Health [GM019629, GM59817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019629, R01GM019629, R01GM059817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM019629 (to S. A. H.) and GM59817 (to J. P.-V.). This study is taken in part from the Ph.D. thesis of L. R. N., published under the name Lilia Nunez-Rodriguez (Cornell University, 2006). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alic N, 2003, J BIOL CHEM, V278, P41849, DOI 10.1074/jbc.M307760200; Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; ANTONSSON B, 1994, J BIOL CHEM, V269, P16821; ATKINSON KD, 1977, J BACTERIOL, V132, P806, DOI 10.1128/JB.132.3.806-817.1977; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Buehrer BM, 1997, MOL CELL BIOL, V17, P6517, DOI 10.1128/MCB.17.11.6517; Burnett WV, 1997, BIOTECHNIQUES, V22, P668, DOI 10.2144/97224st01; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang HJ, 2002, GENETICS, V162, P29; Chen R, 2007, MOL CELL BIOCHEM, V302, P179, DOI 10.1007/s11010-007-9439-0; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COOK SJ, 1989, BIOCHEM J, V263, P581, DOI 10.1042/bj2630581; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Dubois E, 2000, FEBS LETT, V486, P300, DOI 10.1016/S0014-5793(00)02318-8; ERREDE B, 1995, MOL REPROD DEV, V42, P477, DOI 10.1002/mrd.1080420416; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GREENBERG ML, 1982, GENETICS, V100, P19; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HANSON BA, 1982, J BACTERIOL, V151, P334, DOI 10.1128/JB.151.1.334-342.1982; HANSON BA, 1980, J BACTERIOL, V142, P79, DOI 10.1128/JB.142.1.79-89.1980; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; LEE KS, 1994, J BIOL CHEM, V269, P19725; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; LEVIN DE, 1994, CELL MOL BIOL RES, V40, P229; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P3987, DOI 10.1093/nar/19.14.3987; Mattison CP, 1999, MOL CELL BIOL, V19, P7651; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; MORI K, 1993, CELL, V74, P743; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; NISHIZUKA Y, 1984, SCIENCE, V225, P1365, DOI 10.1126/science.6147898; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NUNEZ L, 2006, THESIS CORNELL U ITH; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; RUIZNORIEGA M, 2000, THESIS CARNEGIE MELL; Schmitz HP, 2001, J MOL BIOL, V311, P1, DOI 10.1006/jmbi.2001.4848; Seidman C. E., 2003, CURRENT PROTOCOLS MO; Serrano R, 2006, J BIOL CHEM, V281, P39785, DOI 10.1074/jbc.M604497200; Staleva L, 2004, MOL BIOL CELL, V15, P5574, DOI 10.1091/mbc.E04-02-0142; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WATANABE M, 1994, J BIOL CHEM, V269, P16829; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; WHITE MJ, 1991, J BIOL CHEM, V266, P863; Xie ZH, 2001, MOL BIOL CELL, V12, P1117, DOI 10.1091/mbc.12.4.1117; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200	85	33	34	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34204	34217		10.1074/jbc.M806391200	http://dx.doi.org/10.1074/jbc.M806391200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18842580	Green Published, hybrid			2022-12-27	WOS:000261277700049
J	Malka, Y; Hornakova, T; Royer, Y; Knoops, L; Renauld, JC; Constantinescu, SN; Henis, YI				Malka, Yaniv; Hornakova, Tekla; Royer, Yohan; Knoops, Laurent; Renauld, Jean-Christophe; Constantinescu, Stefan N.; Henis, Yoav I.			Ligand-independent Homomeric and Heteromeric Complexes between Interleukin-2 or-9 Receptor Subunits and the gamma Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA RECEPTORS; TYROSINE KINASE JAK2; ERYTHROPOIETIN RECEPTOR; SIGNAL-TRANSDUCTION; CYTOKINE RECEPTOR; POLYCYTHEMIA-VERA; GROWTH-FACTOR; CYTOPLASMIC DOMAINS; CELL-GROWTH; T-CELLS	Signaling via interleukin-2 (IL-2) and interleukin-9 receptors (IL-2R and IL-9R) involves heteromeric interactions between specific interleukin receptor subunits, which bind Janus kinase 1 (JAK1) and the JAK3 binding common gamma chain (gamma(c)). The potential existence and roles of homomeric and heteromeric complexes before ligand binding and their modulation by ligand and JAK3 are unclear. Using computerized antibody-mediated immunofluorescence co-patching of epitope-tagged receptors at the surface of live cells, we demonstrate that IL-2R beta, IL-9R alpha, and gamma(c) each display a significant fraction of ligand-independent homomeric complexes (24-28% co-patching), whereas control co-patching levels with unrelated receptors are very low (7%). Heteromeric complex formation of IL2-R beta or IL-9R alpha with gamma(c) is also observed in the absence of ligand (15-30%). Ligand binding increases this hetero-oligomerization 2-fold but does not affect homo-oligomerization. Co-expression of IL-2R alpha does not affect the hetero-oligomerization of IL-2R beta and gamma(c). Recruitment of gamma(c) into heterocomplexes is partly at the expense of its homo-oligomerization, suggesting that a functional role of the latter may be to keep the receptors inactive in the absence of ligand. At the same time, the preformed complexes between gamma(c) and IL-2R beta or IL-9R alpha promote signaling by the JAK3 A572V mutant without ligand, supporting a pathophysiological role for the constitutive oligomerization in triggering ligand-independent activation of JAK3 (and perhaps other JAK mutants) mutants identified in several human cancers.	[Hornakova, Tekla; Royer, Yohan; Knoops, Laurent; Renauld, Jean-Christophe; Constantinescu, Stefan N.] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Hornakova, Tekla; Royer, Yohan; Knoops, Laurent; Renauld, Jean-Christophe; Constantinescu, Stefan N.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Malka, Yaniv; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Tel Aviv University	Constantinescu, SN (corresponding author), Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium.	stefan.constantinescu@bru.licr.org	Constantinescu, Stefan N/E-5277-2012; Renauld, Jean-Christophe/B-7268-2012	Henis, Yoav/0000-0002-1408-3877; Renauld, Jean-Christophe/0000-0003-1736-2131	Israeli Ministry of Health Chief Scientist's Office; Fonds National de la Recherche Scientifique (Belgium); Salus Sanguinis Foundation; Action de Recherche Concertee MEXP31C1(University Catholique de Louvain); Fondation Contre le Cancer (Brussels); PAI Program BCHM61B5 (Belgium); Atlantic Philantropies, New York	Israeli Ministry of Health Chief Scientist's Office; Fonds National de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Salus Sanguinis Foundation; Action de Recherche Concertee MEXP31C1(University Catholique de Louvain); Fondation Contre le Cancer (Brussels); PAI Program BCHM61B5 (Belgium); Atlantic Philantropies, New York	This research was supported in part by a grant from the Israeli Ministry of Health Chief Scientist's Office (to Y. I. H.). This work was also supported by the Fonds National de la Recherche Scientifique (Belgium), the Salus Sanguinis Foundation, the Action de Recherche Concertee MEXP31C1(University Catholique de Louvain), the Fondation Contre le Cancer (Brussels), PAI Program BCHM61B5 (Belgium), and the Atlantic Philantropies, New York (to S. N. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Constantinescu SN, 1999, EMBO J, V18, P3334, DOI 10.1093/emboj/18.12.3334; Constantinescu SN, 2003, J BIOL CHEM, V278, P43755, DOI 10.1074/jbc.M302974200; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demoulin JB, 1998, CYTOKINES CELL MOL T, V4, P243; DISANTO JP, 1994, EUR J IMMUNOL, V24, P3014, DOI 10.1002/eji.1830241214; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Gerland K, 2000, MOL CELL ENDOCRINOL, V168, P1, DOI 10.1016/S0303-7207(00)00314-2; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; Hofmann SR, 2004, MOL CELL BIOL, V24, P5039, DOI 10.1128/MCB.24.11.5039-5049.2004; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Keren T, 2001, J BIOL CHEM, V276, P28356, DOI 10.1074/jbc.M102235200; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; NELSON BH, 1994, NATURE, V369, P333, DOI 10.1038/369333a0; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; RENAULD J-C, 1990, Cytokine, V2, P9, DOI 10.1016/1043-4666(90)90037-T; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Sabath DF, 1999, BLOOD, V94, P365, DOI 10.1182/blood.V94.1.365.413a46_365_367; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Watowich SS, 1996, ANNU REV CELL DEV BI, V12, P91, DOI 10.1146/annurev.cellbio.12.1.91; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9	57	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33569	33577		10.1074/jbc.M803125200	http://dx.doi.org/10.1074/jbc.M803125200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18829468	hybrid, Green Published			2022-12-27	WOS:000261183700062
J	Han, MF; Yan, WM; Guo, W; Xi, D; Zhou, YY; Li, WN; Gao, S; Liu, MG; Levy, G; Luo, XP; Ning, Q				Han, Meifang; Yan, Weiming; Guo, Wei; Xi, Dong; Zhou, Yaoyong; Li, Weina; Gao, Sui; Liu, Mingfeng; Levy, Gary; Luo, Xiaoping; Ning, Qin			Hepatitis B Virus-induced hFGL2 Transcription Is Dependent on c-Ets-2 and MAPK Signal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-INDUCED FULMINANT-HEPATITIS; HEPATOCYTE GROWTH-FACTOR; FIBRINOGEN-LIKE PROTEIN; NECROSIS-FACTOR-ALPHA; X-PROTEIN; BREAST-CANCER; UP-REGULATION; MATRIX METALLOPROTEINASE-1; MEDIATED PHOSPHORYLATION; NUCLEOCAPSID PROTEIN	Fibrinogen-like protein 2 (FGL2)/fibroleukin plays a pivotal role in the pathogenesis of experimental and human fulminant and chronic viral hepatitis. To define the transcription factor(s) and upstream signal transduction pathways involved in the transcription of human FGL2 (hFGL2) in response to hepatitis B (HB) virus, hepatitis B core (HBc), hepatitis B virus S protein (HBs), or hepatitis B virus X protein (HBx) protein, expression plasmids were cotransfected with an hFGL2 promoter luciferase reporter construct into Chinese hamster ovary and HepG2 cells, respectively. HBc and HBx proteins, but not HBs protein, enhanced hFGL2 transcription in both cell lines. A strong regulatory region from -712 to -568 (relative to the transcriptional starting site) was shown to be responsible for hFGL2 gene transcription in response to both HBc and HBx proteins. c-Ets-2 was shown to be translocated to the nucleus in association with hFGL2 expression in response to both HBc and HBx proteins. Short hair pin RNA(shRNA) interference of c-Ets-2 expression inhibited hFGL2 gene transcription by 64.8 and 60.0% in response to HBc and HBx, respectively. c-Ets-2 protein was highly expressed in peripheral blood mononuclear cells from patients with severe chronic hepatitis B (CHB) in contrast to patients with mild CHB. Increased phosphorylation of ERK and JNK was detected in peripheral blood mononuclear cells from patients with severe CHB. ERK inhibitor PD098059 or ERK shRNA abolished the nuclear c-Ets-2 DNA binding activity and hFGL2 induction in response to HBc, whereas JNK inhibitor SP600125 or JNK shRNA abolished the nuclear c-Ets-2 DNA binding activity and hFGL2 induction in response to HBx. In conclusion, HBc and HBx proteins enhance transcription of hFGL2 through c-Ets-2 dependent on MAPK signal pathways.	[Luo, Xiaoping] Huazhong Univ Sci & Technol, Dept Pediat, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China; [Han, Meifang; Yan, Weiming; Guo, Wei; Xi, Dong; Zhou, Yaoyong; Li, Weina; Gao, Sui; Ning, Qin] Huazhong Univ Sci & Technol, Dept Infect Dis, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China; [Liu, Mingfeng; Levy, Gary] Univ Toronto, Univ Hlth Network, Toronto, ON M5G 2N2, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Luo, XP (corresponding author), Huazhong Univ Sci & Technol, Dept Pediat, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	xpluo@tjh.tjmu.edu.cn; qning@tjh.tjmu.edu.cn		Han, Meifang/0000-0002-1948-8128	National Science Fund of China [30571643, 30672380]; National Key Basic Research Program of China [2005CB522901, 2007CB512904]; 11th Five-Year Plan Key Project [2006BAI05A07, 2008ZX10202]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); 11th Five-Year Plan Key Project(National Key Technology R&D Program)	This work was supported by the National Science Fund of China Grants 30571643 and 30672380, National Key Basic Research Program of China Grants 2005CB522901 and 2007CB512904, and 11th Five-Year Plan Key Project Grants 2006BAI05A07 and 2008ZX10202.	Bonello MR, 2005, AM J PATHOL, V167, P1149, DOI 10.1016/S0002-9440(10)61203-5; Choi M, 2002, IUBMB LIFE, V53, P309, DOI 10.1080/15216540213466; Chung TW, 2003, CANCER RES, V63, P3453; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Ding JW, 1998, ADV EXP MED BIOL, V440, P609; FAKTOR O, 1990, J VIROL, V64, P1861, DOI 10.1128/JVI.64.4.1861-1863.1990; Fernandez M, 2003, J GEN VIROL, V84, P2073, DOI 10.1099/vir.0.18966-0; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Hyodo N, 2004, CLIN EXP IMMUNOL, V135, P462, DOI 10.1111/j.1365-2249.2003.02376.x; Jinnin M, 2005, NUCLEIC ACIDS RES, V33, P3540, DOI 10.1093/nar/gki648; Klein A, 2003, ONCOGENE, V22, P2910, DOI 10.1038/sj.onc.1206539; Kojima H, 2003, J HEPATOL, V39, P262, DOI 10.1016/S0168-8278(03)00215-0; Kwon JA, 2003, BIOL CHEM, V384, P203, DOI 10.1515/BC.2003.022; Lakatoo S, 2002, HEPATOLOGY, V36, p272A; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; LEVY GA, 1983, HEPATOLOGY, V3, P964; Levy GA, 2000, AM J PATHOL, V156, P1217, DOI 10.1016/S0002-9440(10)64992-9; LI C, 1992, J EXP MED, V176, P689, DOI 10.1084/jem.176.3.689; Lindemann RK, 2003, BIOCHEM J, V372, P787, DOI 10.1042/BJ20030046; Lindemann RK, 2003, INT J ONCOL, V22, P799; Liu MF, 2003, EUR J BIOCHEM, V270, P2274, DOI 10.1046/j.1432-1033.2003.03595.x; Liu MF, 2006, J IMMUNOL, V176, P7028, DOI 10.4049/jimmunol.176.11.7028; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; MACPHEE PJ, 1985, HEPATOLOGY, V5, P649, DOI 10.1002/hep.1840050422; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Manigold T, 2003, J MED VIROL, V71, P31, DOI 10.1002/jmv.10445; Marazzi S, 1998, J IMMUNOL, V161, P138; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; McGilvray ID, 1998, J BIOL CHEM, V273, P32222, DOI 10.1074/jbc.273.48.32222; Milich DR, 1998, J IMMUNOL, V160, P2013; MONDELLI M, 1986, J HEPATOL, V3, pS279, DOI 10.1016/S0168-8278(86)80132-5; Ning Q, 2005, J IMMUNOL, V174, P7403, DOI 10.4049/jimmunol.174.11.7403; Ning Q, 2003, J BIOL CHEM, V278, P15541, DOI 10.1074/jbc.M212806200; Ning Q, 1999, J BIOL CHEM, V274, P9930, DOI 10.1074/jbc.274.15.9930; Ozaki I, 2002, J HEPATOL, V36, P169, DOI 10.1016/S0168-8278(01)00245-8; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; PARR RL, 1995, J VIROL, V69, P5033, DOI 10.1128/JVI.69.8.5033-5038.1995; Petrovic N, 2003, J BIOL CHEM, V278, P49358, DOI 10.1074/jbc.M308071200; Rasul I, 1999, HEPATOLOGY, V30, p594A; RUEGG C, 1995, GENE, V160, P257, DOI 10.1016/0378-1119(95)00240-7; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; SETO E, 1990, NATURE, V344, P72, DOI 10.1038/344072a0; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; TYMMS MJ, 1994, MOL REPROD DEV, V39, P208, DOI 10.1002/mrd.1080390214; Wang HD, 1998, MOL CELL BIOL, V18, P7086, DOI 10.1128/MCB.18.12.7086; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yi YS, 2003, BBA-MOL BASIS DIS, V1638, P249, DOI 10.1016/S0925-4439(03)00090-5; Yoo YG, 2004, J BIOL CHEM, V279, P36242, DOI 10.1074/jbc.M401290200; Yuwaraj S, 2001, GENOMICS, V71, P330, DOI 10.1006/geno.2000.6444; Zhu CL, 2005, WORLD J GASTROENTERO, V11, P6936, DOI 10.3748/wjg.v11.i44.6936; Zhu CL, 2006, HUM GENE THER, V17, P589, DOI 10.1089/hum.2006.17.589; Zoulim F, 1996, J HEPATOL, V24, P155, DOI 10.1016/S0168-8278(96)80024-9	57	38	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32715	32729		10.1074/jbc.M806769200	http://dx.doi.org/10.1074/jbc.M806769200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18801734	hybrid			2022-12-27	WOS:000260893700061
J	Bode, G; Luken, A; Kerkhoff, C; Roth, J; Ludwig, S; Nacken, W				Bode, Guenther; Lueken, Aloys; Kerkhoff, Claus; Roth, Johannes; Ludwig, Stephan; Nacken, Wolfgang			Interaction between S100A8/A9 and Annexin A6 Is Involved in the Calcium-induced Cell Surface Exposition of S100A8/A9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE ACTIVATION; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; HUMAN NEUTROPHILS; BINDING PROTEINS; GENE-EXPRESSION; BREAST-CANCER; S100 PROTEINS; S100A8/S100A9; MRP14	The calcium binding S100A8/A9 complex (MRP8/14; calgranulin) is considered as an important proinflammatory mediator in acute and chronic inflammation and has recently gained attention as a molecular marker up-regulated in various human cancers. Here, we report that S100A8/A9 is expressed in breast cancer cell lines and is up-regulated by interleukin-1 beta and tumor necrosis factor-alpha in SKBR3 and MCF-7 cells. We identified the phospholipid-binding protein annexin A6 as a potential S100A8/A9 binding protein by affinity chromatography. This finding was verified by Southwestern overlay experiments and by coimmunoprecipitation with the S100A8/A9-specific monoclonal antibody 27E10. Immunocytochemical experiments demonstrated that S100A8/A9 and annexin A6 colocalize in SKBR3 breast cancer cells predominantly in membranous structures. Upon calcium influx both S100A8/A9 and annexin A6 are exposed on the cell surface of SKBR3 cells. Subcellular fractionation studies suggested that after A23187 stimulation membrane association of S100A8/A9 is not enhanced. However, both S100A8/A9 and annexin A6 are exposed on the cell surface of SKBR3 cells upon calcium influx. Experiments with artificial liposomes indicated that S100A8/A9 is able to associate with membranes independently of both annexin A6 and independently of calcium. Finally, cell surface expression of S100A8/A9 could not be observed in A23187-treated A431 and HaCaT cells. Both cell lines are known to be devoid of annexin A6. Repression of annexin A6 expression by small interfering RNA in SKBR3 cells abolishes the cell surface exposition of S100A8/A9 upon calcium influx, suggesting that annexin A6 contributes to the calcium-dependent cell surface exposition of the membrane associated-S100A8/A9 complex.	[Ludwig, Stephan; Nacken, Wolfgang] Univ Munster, Inst Mol Virol, ZMBE, D-48149 Munster, Germany; [Bode, Guenther; Lueken, Aloys; Kerkhoff, Claus; Roth, Johannes; Nacken, Wolfgang] Univ Munster, Inst Immunol, ZMBE, D-48149 Munster, Germany	University of Munster; University of Munster	Nacken, W (corresponding author), Univ Munster, Inst Mol Virol, ZMBE, Esmarch Str 56, D-48149 Munster, Germany.	nacken@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052	Interdisciplinary Center for Clinical Research (IZKF) [Na2/009/04]; Deutsche Forschungsgemeinschaft [KE 820/2-4, KE 820/6-1, SFB293 A16]	Interdisciplinary Center for Clinical Research (IZKF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded in part by the Interdisciplinary Center for Clinical Research (IZKF) Project Na2/009/04 (to W.N.) and by Deutsche Forschungsgemeinschaft Projects KE 820/2-4 and KE 820/6-1 (to C. K.) and SFB293 A16 (J. R.).	Anceriz N, 2007, BIOCHEM BIOPH RES CO, V354, P84, DOI 10.1016/j.bbrc.2006.12.203; Arai K, 2004, EUR J CANCER, V40, P1179, DOI 10.1016/j.ejca.2004.01.022; Berthier S, 2003, J BIOL CHEM, V278, P25499, DOI 10.1074/jbc.M209755200; Carlsson H, 2005, CANCER BIOL THER, V4, P998, DOI 10.4161/cbt.4.9.1969; Celis JE, 2006, FEBS LETT, V580, P2935, DOI 10.1016/j.febslet.2006.03.080; Chang N, 2007, AM J PHYSIOL-CELL PH, V292, pC1417, DOI 10.1152/ajpcell.00439.2006; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; Doussiere J, 2002, EUR J BIOCHEM, V269, P3246, DOI 10.1046/j.1432-1033.2002.03002.x; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Guignard F, 1996, EUR J BIOCHEM, V241, P265, DOI 10.1111/j.1432-1033.1996.0265t.x; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Kerkhoff C, 1999, J BIOL CHEM, V274, P32672, DOI 10.1074/jbc.274.46.32672; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Li C, 2004, BREAST CANCER RES TR, V87, P123, DOI 10.1023/B:BREA.0000041594.36418.f6; Lominadze G, 2005, J IMMUNOL, V174, P7257, DOI 10.4049/jimmunol.174.11.7257; Nacken W, 2004, FEBS LETT, V572, P289, DOI 10.1016/j.febslet.2004.07.024; Nacken W, 2007, FEBS LETT, V581, P5127, DOI 10.1016/j.febslet.2007.09.060; Newton RA, 1998, J IMMUNOL, V160, P1427; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Rammes A, 1997, J BIOL CHEM, V272, P9496; Robinson MJ, 2002, J BIOL CHEM, V277, P3658, DOI 10.1074/jbc.M102950200; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; SMYTHE E, 1994, J CELL BIOL, V124, P301, DOI 10.1083/jcb.124.3.301; Stroncek DF, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-36; Strzelecka-Kiliszek A, 2008, J CELL BIOCHEM, V104, P418, DOI 10.1002/jcb.21632; Thomas DDH, 2002, J BIOL CHEM, V277, P35496, DOI 10.1074/jbc.M110917200; Tiacci E, 2005, BLOOD, V105, P2812, DOI 10.1182/blood-2004-07-2630; vandenBos C, 1996, J IMMUNOL, V156, P1247; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Yui S, 2003, BIOL PHARM BULL, V26, P753	42	31	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31776	31784		10.1074/jbc.M803908200	http://dx.doi.org/10.1074/jbc.M803908200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786929	hybrid			2022-12-27	WOS:000260760800060
J	Fraczek, J; Kim, TW; Xiao, H; Yao, JH; Wen, Q; Li, YL; Casanova, JL; Pryjma, J; Li, XX				Fraczek, Jerzy; Kim, Tae Whan; Xiao, Hui; Yao, Jianhong; Wen, Qian; Li, Yali; Casanova, Jean-Laurent; Pryjma, Juliusz; Li, Xiaoxia			The Kinase Activity of IL-1 Receptor-associated Kinase 4 Is Required for Interleukin-1 Receptor/Toll-like Receptor-induced TAK1-dependent NF kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE-RECEPTOR; IRAK-4; INNATE; FAMILY; MEMBER; CELLS; TAK1	Two parallel interleukin-1 (IL-1)-mediated signaling pathways have been uncovered for IL-1R-TLR-mediated NF kappa B activation: TAK1-dependent and MEKK3-dependent pathways, respectively. The TAK1-dependent pathway leads to IKK alpha/beta phosphorylation and IKK beta activation, resulting in classic NF kappa B activation through I kappa B alpha phosphorylation and degradation. The TAK1-independent MEKK3-dependent pathway involves IKK gamma phosphorylation and IKK beta activation, resulting in NF kappa B activation through dissociation of phosphorylated I kappa B alpha from NF kappa B without I kappa B alpha degradation. IL-1 receptor-associated kinase 4 (IRAK4) belongs to the IRAK family of proteins and plays a critical role in IL-1R/TLR-mediated signaling. IRAK4 kinase-inactive mutant failed to mediate the IL-1R-TLR-induced TAK1-dependent NF kappa B activation pathway, but mediated IL-1-induced TAK1-independent NF kappa B activation and retained the ability to activate substantial gene expression, indicating a structural role of IRAK4 in mediating this alternative NF kappa B activation pathway. Deletion analysis of IRAK4 indicates the essential structural role of the IRAK4 death domain in receptor proximal signaling for mediating IL-1R-TLR-induced NF kappa B activation.	[Fraczek, Jerzy; Kim, Tae Whan; Xiao, Hui; Yao, Jianhong; Wen, Qian] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; [Fraczek, Jerzy; Pryjma, Juliusz] Jagiellonian Univ, Dept Immunol, Fac Biotechnol, PL-30387 Krakow, Poland; [Casanova, Jean-Laurent] Univ Paris 05, Unite Immunol & Hematol Pediat, Lab Genet Humaine Malad Infect, Unite Mixte Rech,INSERM,U550, F-75270 Paris 06, France; [Kim, Tae Whan] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Li, Yali] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Jagiellonian University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Case Western Reserve University; Case Western Reserve University	Li, XX (corresponding author), Cleveland Clin Fdn, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lix@ccf.org	Casanova, Jean-Laurent/I-3418-2017	Casanova, Jean-Laurent/0000-0002-7782-4169	National Institutes of Health [GM060020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060020 (to X.L.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kawagoe T, 2007, J EXP MED, V204, P1013, DOI 10.1084/jem.20061523; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Koziczak-Holbro M, 2008, EUR J IMMUNOL, V38, P788, DOI 10.1002/eji.200737886; Koziczak-Holbro M, 2007, J BIOL CHEM, V282, P13552, DOI 10.1074/jbc.M700548200; Lasker MV, 2005, J IMMUNOL, V175, P4175, DOI 10.4049/jimmunol.175.7.4175; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2008, EUR J IMMUNOL, V38, P614, DOI 10.1002/eji.200838161; Li XX, 1999, MOL CELL BIOL, V19, P4643; Lye E, 2004, J BIOL CHEM, V279, P40653, DOI 10.1074/jbc.M402666200; Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	29	44	51	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31697	31705		10.1074/jbc.M804779200	http://dx.doi.org/10.1074/jbc.M804779200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18794297	Green Published, hybrid			2022-12-27	WOS:000260760800052
J	Gonzalez, AM; Claiborne, J; Jones, JCR				Gonzalez, Annette M.; Claiborne, Jessica; Jones, Jonathan C. R.			Integrin Cross-talk in Endothelial Cells Is Regulated by Protein Kinase A and Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; TRANSDOMINANT INHIBITION; LIGAND-BINDING; IN-VITRO; PHOSPHORYLATION; MIGRATION; ALPHA(5)BETA(1); RECEPTOR; SUBUNIT; GROWTH	In endothelial cells (ECs) beta 1 integrin function-blocking antibodies inhibit alpha v beta 3 integrin-mediated adhesion to a recombinant alpha 4-laminin fragment (r alpha 4LN fragment). beta 1 integrin sequestration of talin is not the mechanism by which beta 1 integrin modulates alpha v beta 3 integrin ligand binding. Rather, treatment of the ECs with beta 1 integrin function-blocking antibodies enhances cAMP-dependent protein kinase (PKA) activity and increases beta 3 integrin serine phosphorylation. The PKA inhibitor H-89 abrogates the effect of beta 1 integrin function-blocking antibodies on beta 3 integrin serine phosphorylation and EC-r alpha 4LN fragment binding. beta 3 integrin contains a serine residue at position 752. To confirm the importance of this residue in alpha v beta 3 integrin-r alpha 4LN fragment binding, we mutated it to alanine (beta 3S752A) or aspartic acid (beta 3S752D). Chinese hamster ovary (CHO) cells expressing wild type or beta 3S752A integrin attach robustly to ligand. CHO cells expressing beta 3S752D integrin do not. Because the beta 3 cytoplasmic tail lacks a PKA consensus site, it is unlikely that PKA acts directly on beta 3 integrin. Instead, we have tested an hypothesis that PKA regulates beta 3 integrin serine phosphorylation indirectly through phosphorylation of inhibitor-1, which, when phosphorylated, inhibits protein phosphatase 1 (PP1). Treatment of ECs with beta 1 integrin function-blocking antibodies significantly increases phosphorylation of inhibitor-1. Furthermore, blocking PP1 activity pharmacologically inhibits alpha v beta 3-mediated cell adhesion to the r alpha 4LN fragment when both PKA and beta 1 integrin function are inhibited. Concomitantly, there is an increase in serine phosphorylation of the beta 3 integrin cytoplasmic tail. These results indicate a novel mechanism by which beta 1 integrin negatively modulates alpha v beta 3 integrin-ligand binding via activation of PKA and inhibition of PP1 activity.	[Gonzalez, Annette M.; Claiborne, Jessica; Jones, Jonathan C. R.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Gonzalez, AM (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	a-gonzalez2@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922	National Institutes of Health [RO1 HL67016, KO1 CA106386]; NATIONAL CANCER INSTITUTE [K01CA106386] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL67016 (to J. C. R. J.) and KO1 CA106386 (to A. M. G.).	Alt A, 2001, CANCER RES, V61, P4591; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Baker SE, 1997, CELL MOTIL CYTOSKEL, V37, P271, DOI 10.1002/(SICI)1097-0169(1997)37:3<271::AID-CM9>3.0.CO;2-9; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Bibbb JA, 2001, J BIOL CHEM, V276, P14490, DOI 10.1074/jbc.M007197200; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Borza CM, 2006, J BIOL CHEM, V281, P20932, DOI 10.1074/jbc.M601147200; Butler B, 2003, J BIOL CHEM, V278, P5264, DOI 10.1074/jbc.M206997200; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; CHEN YP, 1994, BLOOD, V84, P1857; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; DiazGonzalez F, 1996, MOL BIOL CELL, V7, P1939, DOI 10.1091/mbc.7.12.1939; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gonzalez AM, 2002, P NATL ACAD SCI USA, V99, P16075, DOI 10.1073/pnas.252649399; Harlow E., 1988, ANTIBODIES LAB MANUA; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hynes RO, 1999, BRAZ J MED BIOL RES, V32, P501, DOI 10.1590/S0100-879X1999000500002; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Imhof BA, 1997, EUR J IMMUNOL, V27, P3242, DOI 10.1002/eji.1830271223; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Kim S, 2002, J CLIN INVEST, V110, P933, DOI 10.1172/JCI200214268; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Ly DP, 2003, J BIOL CHEM, V278, P21878, DOI 10.1074/jbc.M212538200; MEHTA RJ, 1998, BIOCHEM J, P861; Nguyen BP, 2001, J BIOL CHEM, V276, P43860, DOI 10.1074/jbc.M103404200; Nikolopoulos SN, 2005, MOL CELL BIOL, V25, P6090, DOI 10.1128/MCB.25.14.6090-6102.2005; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; PACIFICI R, 1994, J IMMUNOL, V153, P2222; Porter JC, 1998, TRENDS CELL BIOL, V8, P390, DOI 10.1016/S0962-8924(98)01344-0; Riedel G, 1999, CELL MOL LIFE SCI, V55, P549, DOI 10.1007/s000180050313; Riederer MA, 2002, THROMB HAEMOSTASIS, V88, P858, DOI 10.1055/s-0037-1613314; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Schweitzer KM, 1997, LAB INVEST, V76, P25; SHIGENORI H, 2001, BLOOD, V97, P175; Simon KO, 1997, J BIOL CHEM, V272, P29380, DOI 10.1074/jbc.272.46.29380; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223	52	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31849	31860		10.1074/jbc.M801345200	http://dx.doi.org/10.1074/jbc.M801345200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18806263	Green Published, hybrid			2022-12-27	WOS:000260760800068
J	Zhao, JJ; Lin, JH; Yang, H; Kong, W; He, LL; Ma, X; Coppola, D; Cheng, JQ				Zhao, Jian-Jun; Lin, Jianhong; Yang, Hua; Kong, William; He, Lili; Ma, Xu; Coppola, Domenico; Cheng, Jin Q.			MicroRNA-221/222 Negatively Regulates Estrogen Receptor alpha and Is Associated with Tamoxifen Resistance in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ER-ALPHA; PROTEIN EXPRESSION; MICRORNAS; MIR-222; INHIBITION; GROWTH; DNMT1; BETA	A search for regulators of estrogen receptor alpha(ER alpha) expression has yielded a set of microRNAs (miRNAs) for which expression is specifically elevated in ER alpha-negative breast cancer. Here we show distinct expression of a panel of miRNAs between ER alpha-positive and ER alpha-negative breast cancer cell lines and primary tumors. Of the elevated miRNAs in ER alpha-negative cells, miR-221 and miR-222 directly interact with the 3'-untranslated region of ER alpha. Ectopic expression of miR-221 and miR-222 in MCF-7 and T47D cells resulted in a decrease in expression of ER alpha protein but not mRNA, whereas knockdown of miR-221 and miR-222 partially restored ER alpha in ER alpha protein-negative/mRNA-positive cells. Notably, miR-221- and/or miR-222-transfected MCF-7 and T47D cells became resistant to tamoxifen compared with vector-treated cells. Furthermore, knockdown of miR-221 and/or miR-222 sensitized MDA-MB-468 cells to tamoxifen-induced cell growth arrest and apoptosis. These findings indicate that miR-221 and miR-222 play a significant role in the regulation of ER alpha expression at the protein level and could be potential targets for restoring ER alpha expression and responding to antiestrogen therapy in a subset of breast cancers.	[Zhao, Jian-Jun; Lin, Jianhong; Yang, Hua; Kong, William; He, Lili; Coppola, Domenico; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Ma, Xu] Tsinghua Univ, Peking Union Med Coll, Natl Res Inst Family Planning, Beijing 100081, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; Tsinghua University	Cheng, JQ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org	He, Lili/A-6356-2012		National Institutes of Health [CA77935, CA107078]; United States Department of Defense [DAMD 17-02-1-0671]; Bankhead-Coley [07BB-01]; NATIONAL CANCER INSTITUTE [R01CA107078, R01CA077935, R29CA077935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); Bankhead-Coley; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77935 and CA107078. This work was also supported by United States Department of Defense Grant DAMD 17-02-1-0671 and Bankhead-Coley Grant 07BB-01.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Adams PD, 2003, CANCER BIOL THER, V2, P557, DOI 10.4161/cbt.2.5.588; Alkarain A., 2004, EJC Supplements, V2, P46, DOI 10.1016/S1359-6349(04)90138-3; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Cullen R, 2001, EUR J CANCER, V37, P1118, DOI 10.1016/S0959-8049(01)00088-0; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jarzabek K, 2005, EUR J CANCER, V41, P2924, DOI 10.1016/j.ejca.2005.09.010; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Silveri L, 2006, REPROD NUTR DEV, V46, P549, DOI 10.1051/rnd:2006026; Sun M, 2001, CANCER RES, V61, P5985; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang Jia-Wang, 2008, V414, P183; Yan L, 2003, CANCER BIOL THER, V2, P552, DOI 10.4161/cbt.2.5.469; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang XW, 2001, CANCER RES, V61, P7025; Zhao JJ, 2008, CHILD NERV SYST, V24, P485, DOI 10.1007/s00381-007-0520-5; Zhao JJ, 2006, CHILD NERV SYST, V22, P1419, DOI 10.1007/s00381-006-0173-9	30	414	442	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31079	31086		10.1074/jbc.M806041200	http://dx.doi.org/10.1074/jbc.M806041200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18790736	Green Published, hybrid			2022-12-27	WOS:000260544800062
